PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schmidt, RL; Straseski, JA; Raphael, KL; Adams, AH; Lehman, CM				Schmidt, Robert L.; Straseski, Joely A.; Raphael, Kalani L.; Adams, Austin H.; Lehman, Christopher M.			A Risk Assessment of the Jaffe vs Enzymatic Method for Creatinine Measurement in an Outpatient Population	PLOS ONE			English	Article							KIDNEY-DISEASE; RENAL-DISEASE; EQUATION; TIME	Background The Jaffe and enzymatic methods are the two most common methods for measuring serum creatinine. The Jaffe method is less expensive than the enzymatic method but is also more susceptible to interferences. Interferences can lead to misdiagnosis but interferences may vary by patient population. The overall risk associated with the Jaffe method depends on the probability of misclassification and the consequences of misclassification. This study assessed the risk associated with the Jaffe method in an outpatient population. We analyzed the discordance rate in the estimated glomerular filtration rate based on serum creatinine measurements obtained by the Jaffe and enzymatic method. Methods Method comparison and risk analysis. Five hundred twenty-nine eGFRs obtained by the Jaffe and enzymatic method were compared at four clinical decision limits. We determined the probability of discordance and the consequence of misclassification at each decision limit to evaluate the overall risk. Results We obtained 529 paired observations. Of these, 29 (5.5%) were discordant with respect to one of the decision limits (i.e. 15, 30, 45 or 60 ml/min/1.73m(2)). The magnitude of the differences (Jaffe result minus enzymatic result) were significant relative to analytical variation in 21 of the 29 (72%) of the discordant results. The magnitude of the differences were not significant relative to biological variation. The risk associated with misclassification was greatest at the 60 ml/min/1.73m(2) decision limit because the probability of misclassification and the potential for adverse outcomes were greatest at that decision limit. Conclusion The Jaffe method is subject to bias due to interfering substances ( loss of analytical specificity). The risk of misclassification is greatest at the 60 ml/min/1.73m(2) decision limit; however, the risk of misclassification due to bias is much less than the risk of misclassification due to biological variation. The Jaffe method may pose low risk in selected populations if eGFR results near the 60 ml/min/1.73m(2) decision limit are interpreted with caution.	[Schmidt, Robert L.; Straseski, Joely A.; Adams, Austin H.; Lehman, Christopher M.] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA; [Schmidt, Robert L.; Straseski, Joely A.; Adams, Austin H.; Lehman, Christopher M.] Univ Utah, Hlth Sci Ctr, ARUP Labs, Salt Lake City, UT USA; [Raphael, Kalani L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Div Nephrol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Schmidt, RL (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA.	Robert.Schmidt@hsc.utah.edu		Raphael, Kalani/0000-0002-1378-2609				Badrick T, 2013, INDIAN J CLIN BIOCHE, V28, P242, DOI 10.1007/s12291-012-0280-1; Cobbaert CM, 2009, CLIN CHEM, V55, P549, DOI 10.1373/clinchem.2008.116863; College of American Pathologists, 2014, CHEM THER MON PART S; Drion I, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-133; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fraser CG, 2001, BIOL VARIATION PRINC; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Greenberg N, 2012, CLIN CHEM, V58, P391, DOI 10.1373/clinchem.2011.172288; Horvath AR, 2014, CLIN CHIM ACTA, V427, P49, DOI 10.1016/j.cca.2013.09.018; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Killeen AA, 2013, ARCH PATHOL LAB MED, V137, P496, DOI 10.5858/arpa.2012-0134-CP; Klee GG, 2007, CLIN CHEM LAB MED, V45, P737, DOI 10.1515/CCLM.2007.168; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Myers GL, 2008, SCAND J CLIN LAB INV, V68, P57, DOI 10.1080/00365510802149887; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Panteghini M, 2008, SCAND J CLIN LAB INV, V68, P84, DOI 10.1080/00365510802149978; Peake Michael, 2006, Clin Biochem Rev, V27, P173; Qiu L, 2013, CLIN LAB, V59, P511, DOI 10.7754/Clin.Lab.2012.120524; Reinhard M, 2009, SCAND J CLIN LAB INV, V69, P931, DOI 10.3109/00365510903307947; Schmidt RL, 2015, CLIN CHIM ACTA, V440, P23, DOI 10.1016/j.cca.2014.10.043; Selvin E, 2013, AM J KIDNEY DIS, V61, P716, DOI 10.1053/j.ajkd.2012.11.048; Sim JJ, 2015, AM J MED; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Tholen DW, 2004, EP5A2 CLSI, V24, P25; Yoe C., 2011, PRIMER ON RISK ANALY, P1	27	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143205	10.1371/journal.pone.0143205	http://dx.doi.org/10.1371/journal.pone.0143205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599086	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600037
J	Goncalves, L; Santos, Z; Amado, M; Alves, D; Simoes, R; Delgado, AP; Correia, A; Cabral, J; Lapao, LV; Craveiro, I				Goncalves, Luzia; Santos, Zelia; Amado, Miguel; Alves, Daniela; Simoes, Rui; Delgado, Antonio Pedro; Correia, Artur; Cabral, Jorge; Lapao, Luis Velez; Craveiro, Isabel			Urban Planning and Health Inequities: Looking in a Small-Scale in a City of Cape Verde	PLOS ONE			English	Article							SOCIAL DETERMINANTS; PHYSICAL-ACTIVITY; CARDIOMETABOLIC RISK; BINOMIAL PROPORTION; BUILT ENVIRONMENT; SAMPLE-SIZE; OBESITY; ASSOCIATION; WEIGHT; POPULATIONS	Background The lack of high-quality data to support evidence-based policies continues to be a concern in African cities, which present marked social, economic and cultural disparities that may differently impact the health of the groups living in different urban contexts. This study explores three urban units-formal, transition and informal-of the capital of Cape Verde, in terms of overweight/obesity, cardiometabolic risk, physical activity and other aspects related to the urban environment. Methods Quantitative and qualitative research methods were used in this intra-urban study. A proportional stratified random sample (n = 1912 adults), based on geographical coordinates of private households, was selected to apply the UPHI-STAT questionnaire. In a second stage (n = 599), local nutritionists collected anthropometric measurements (e.g., height, waist circumference) and body composition by bioelectric impedance (e.g., body weight, body fat, muscle mass). In a third stage, pedometers were used to count study participants' steps on working and non-working days for one week (n = 118). After a preliminary statistical analysis, a qualitative study was developed to complement the quantitative approach. Generalized linear models, among others, were used in the multivariate analysis. Results Insecurity was the main concern among survey respondents in the three units, notwithstanding with significant differences (p < 0.001) among units. About three-quarters (76.6%) of the participants of the informal unit emphasised the need for more security. The formal unit presents an older age structure (61.3% above 40 years old) and the transition unit a younger age structure (only 30.5% above 40 years old). Some health-related variables were analysed in each unit, revealing an excess of chronic conditions reported by inhabitants of informal unit, compared with the formal unit despite the informal unit's younger age profile. The self-reported hypertension varied significantly among urban units (p < 0.001), with 19.3% in the formal unit, 11.4% in the transition unit and 22.5% in the informal unit. Women of the urban units present significant differences (5% level) for body mass index calculated from self-reported measures (p < 0.001), fat mass (p = 0.005), waist circumference (p = 0.046) and waist-to-height ratio (p = 0.017). For women, overall physical activity was 67.4% (95%CI [64.8,70.0]), with differences among urban units (p = 0.025). For men it was of 85.2% (95%CI [82.3,87.6]), without significant differences among urban units (p = 0.266). The percentage of women and men who reported physical activity in leisure time was discrepant, with 95%CI [22.6, 27.4] and [53.2, 60.2], respectively. The results of pedometers also indicated that men walk significantly more than women (p < 0.001), with a difference of approximately 2000 steps/day. Conclusions The data collection process itself also gave us some clues on the involvement of local communities, exploring the potential of social capital of these settings and the role of the woman in family and society in Cape Verde. The higher participation of women and residents of informal unit (the most disadvantaged groups) suggests these as the priority target groups for health promotion campaigns. The link between health planning, urban planning and security of the city needs to be reinforced to minimize health, social and gender inequalities.	[Goncalves, Luzia; Santos, Zelia; Alves, Daniela; Simoes, Rui; Delgado, Antonio Pedro; Correia, Artur; Cabral, Jorge; Lapao, Luis Velez; Craveiro, Isabel] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Saude Publ Int & Bioestat, P-1200 Lisbon, Portugal; [Goncalves, Luzia] Univ Lisbon, Ctr Estat & Aplicacoes, P-1699 Lisbon, Portugal; [Santos, Zelia] Hosp Egas Moniz, Ctr Hosp Lisboa Ocidental EPE, Serv Nutr & Dietet, Lisbon, Portugal; [Amado, Miguel] Univ Nova Lisboa, Fac Ciencias, GEOTPU, Costa Da Caparica, Portugal; [Delgado, Antonio Pedro] Minist Saude, Direccao Nacl Saude, Praia, Cabo Verde, Chile; [Correia, Artur] Minist Saude, Inst Nacl Saude Publ, Praia, Cabo Verde, Chile; [Lapao, Luis Velez; Craveiro, Isabel] IHMT UNL, Global Hlth & Trop Med, Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Egas Moniz Hospital; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Goncalves, L (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Saude Publ Int & Bioestat, P-1200 Lisbon, Portugal.	luziag@ihmt.unl.pt	Amado, Miguel/A-9721-2013; Gonçalves, Luzia/J-6649-2012; Lapão, Luis V/E-8465-2011; Craveiro, Isabel/J-4117-2012; Alves, Daniela Amaral/AAI-4117-2020	Amado, Miguel/0000-0002-9152-4226; Gonçalves, Luzia/0000-0002-9710-1945; Lapão, Luis V/0000-0003-0506-1294; Craveiro, Isabel/0000-0003-4348-1986; Alves, Daniela Amaral/0000-0001-6709-0504; Santos, Zelia/0000-0001-9806-5854	Fundacao para a Ciencia e Tecnologia (FCT)-Portugal [PTDC/ATP-EUR/5074/2012, PEst-OE/MAT/UI0006/2014]	Fundacao para a Ciencia e Tecnologia (FCT)-Portugal(Portuguese Foundation for Science and Technology)	This work has been supported by Fundacao para a Ciencia e Tecnologia (FCT)-Portugal-projects PTDC/ATP-EUR/5074/2012 and PEst-OE/MAT/UI0006/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-801; Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Akesson L, 2012, J ETHN MIGR STUD, V38, P237, DOI 10.1080/1369183X.2012.646420; Amado M, 2014, PTDCATPEUR50742012 I; Amado M, 2014, ENRGY PROCED, V50, P277, DOI 10.1016/j.egypro.2014.06.034; Azevedo V., 2009, 1 JORN LUS CARD SOC; Bowring AL, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-175; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Carpiano RM, 2008, SOC SCI MED, V67, P568, DOI 10.1016/j.socscimed.2008.04.017; Cook I, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-7; Corburn J., 2013, PLANNING HIST ENV SE; Corburn J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001285; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Dehghan M, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-26; Dorsey RR, 2009, OBESITY, V17, P790, DOI 10.1038/oby.2008.603; Doulougou B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-893; Drotbohm H, 2009, HIST FAM, V14, P132, DOI 10.1016/j.hisfam.2009.02.002; Durand CP, 2011, OBES REV, V12, pe173, DOI 10.1111/j.1467-789X.2010.00826.x; El Ati J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048153; Escritorio Regional Africano-OMS, 2009, ESTR COOP ORG MUND S; Fosgate GT, 2009, J VET DIAGN INVEST, V21, P3, DOI 10.1177/104063870902100102; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Goncalves L, 2012, J APPL STAT, V39, P2453, DOI 10.1080/02664763.2012.713919; INE CV, 2010, POP COND VID; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Kjellstrom T, 2008, ENVIRON URBAN, V20, P551, DOI 10.1177/0956247808096128; Lang Z, 2014, PREV VET MED, V113, P13, DOI 10.1016/j.prevetmed.2013.09.015; Leyden KM, 2003, AM J PUBLIC HEALTH, V93, P1546, DOI 10.2105/AJPH.93.9.1546; Madeira SLR, 2008, ANNOTATED BIBLIO RES; Malhotra R, 2008, S AFR J CLIN NUTR, V21, P315; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McGinn AP, 2008, J PHYS ACT HEALTH, V5, P117, DOI 10.1123/jpah.5.1.117; Mendes MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108136; Moges B, 2014, BMC CARDIOVASC DISOR, V14, pi2; Molata A, 2014, DIABETES CARE, V34, pi1032; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ngau P., 2013, TOWN COUNTRY NEW APP; Nicolaou M, 2012, EUR J PUBLIC HEALTH, V22, P859, DOI 10.1093/eurpub/ckr155; Northridge ME, 2011, J URBAN HEALTH, V88, P582, DOI 10.1007/s11524-011-9558-5; Ompad DC, 2007, J URBAN HEALTH, V84, pI42, DOI 10.1007/s11524-007-9168-4; Oyeyemi AL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-32; Pillay JD, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1381-6; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; R Core Team, 2021, R LANGUAGE ENV STAT; Reiczigel J, 2010, EPIDEMIOL INFECT, V138, P1674, DOI 10.1017/S0950268810000385; Rodrigues L, 2013, CONHECIMENTOS ATITUD; Roux AVD, 2007, REV EPIDEMIOL SANTE, V55, P13, DOI 10.1016/j.respe.2006.12.003; Sallis JF, 2012, CIRCULATION, V125, P729, DOI 10.1161/CIRCULATIONAHA.110.969022; Sergeant E.S.G, 2015, EPITOOLS EPIDEMIOLOG; Tomita A, 2013, J AFFECT DISORDERS, V144, P101, DOI 10.1016/j.jad.2012.05.066; UN Habitat, 2014, STAT AFR CIT 2014 RE; Unger A, 2007, PLOS MED, V4, P1561, DOI 10.1371/journal.pmed.0040295; Unit Nations, 2012, MILL DEV GOALS REP; United Nations-Office on Drugs and Crime, 2007, STUD CRIM CORR CAP V; Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3; Wan CS, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-249; Ware LJ, 2014, NUTR METAB CARDIOVAS, V24, P900, DOI 10.1016/j.numecd.2014.02.005; WHO, 2011, NCD COUNTR PROF; WHO, 2008, WAIST CIRCUMFERENCE; WHO, 2010, HIDD CIT UNM OV HLTH; WHO, 2014, NCD COUNTR PROF; World Health Organisation, 2004, WHO TECHN REP SER; World Health Organization, 2008, OUR CITIES OUR HLTH; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]; Zoettl PA, 2014, INT J CULTURAL STUD, V18, P1	68	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142955	10.1371/journal.pone.0142955	http://dx.doi.org/10.1371/journal.pone.0142955			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599004	gold, Green Published			2022-12-27	WOS:000365853900049
J	Shen, YT; Chen, H; Zhang, JS; Chen, YM; Wang, MY; Ma, JW; Hong, L; Liu, N; Fan, QH; Lu, XG; Tian, Y; Wang, AD; Dong, J; Lan, Q; Huang, Q				Shen, Yuntian; Chen, Hua; Zhang, Jinshi; Chen, Yanming; Wang, Mengyao; Ma, Jiawei; Hong, Lei; Liu, Ning; Fan, Qiuhong; Lu, Xueguan; Tian, Ye; Wang, Aidong; Dong, Jun; Lan, Qing; Huang, Qiang			Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/Progenitor Cells	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; STEM-CELLS; NUDE-MICE; GROWTH; RADIATION; BLOCKADE	Background Host malignant stromal cells induced by glioma stem/progenitor cells were revealed to be more radiation-resistant than the glioma stem/progenitor cells themselves after malignant transformation in nude mice. However, the mechanism underlying this phenomenon remains unclear. Methods Malignant stromal cells induced by glioma stem/progenitor cell 2 (GSC-induced host brain tumor cells, ihBTC2) were isolated and identified from the double color-coded orthotopic glioma nude mouse model. The survival fraction at 2 Gy (SF2) was used to evaluate the radiation resistance of ihBTC2, the human glioma stem/progenitor cell line SU3 and its radiation resistant sub-strain SU3-5R and the rat C6 glioma cell line. The mRNA of Notch 1 and Hes1 from ihBTC2 cells were detected using qPCR before and after 4 Gy radiation. The expression of the Notch 1, pAkt and Bcl-2 proteins were investigated by Western blot. To confirm the role of the Notch pathway in the radiation resistance of ihBTC2, Notch signaling blocker gamma secretase inhibitors (GSIs) were used. Results The ihBTC2 cells had malignant phenotypes, such as infinite proliferation, hyperpentaploid karyotype, tumorigenesis in nude mice and expression of protein markers of oligodendroglia cells. The SF2 of ihBTC2 cells was significantly higher than that of any other cell line (P<0.05, n = 3). The expression of Notch 1 and Hes1 mRNAs from ihBTC2 cells was significantly increased after radiation. Moreover, the Notch 1, pAkt and Bcl-2 proteins were significantly increased after radiation (P<0.05, n = 3). Inhibition of Notch signaling markedly enhanced the radiosensitivity of ihBTC2 cells. Conclusions In an orthotopic glioma model, the malignant transformation of host stromal cells was induced by glioma stem/progenitor cells. IhBTC2 cells are more radiation-resistant than the glioma stem/progenitor cells, which may be mediated by activation of the Notch signaling pathway.	[Zhang, Jinshi; Chen, Yanming; Ma, Jiawei; Dong, Jun; Lan, Qing; Huang, Qiang] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China; [Shen, Yuntian; Wang, Mengyao; Fan, Qiuhong; Lu, Xueguan; Tian, Ye] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China; [Shen, Yuntian; Wang, Mengyao; Fan, Qiuhong; Lu, Xueguan; Tian, Ye] Soochow Univ, Inst Radiotherapy & Oncol, Suzhou, Peoples R China; [Shen, Yuntian; Wang, Mengyao; Fan, Qiuhong; Lu, Xueguan; Tian, Ye] Suzhou Key Lab Radiat Oncol, Suzhou, Peoples R China; [Hong, Lei; Wang, Aidong] Soochow Univ, Affiliated Hosp 2, Lab Ctr, Suzhou, Peoples R China; [Chen, Hua] Nanjing Med Univ, Nanjing Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Chen, Hua; Liu, Ning] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Nanjing Medical University; Nanjing Medical University	Dong, J (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China.	djdongjun@163.com; szlq006@163.com	Dong, Jun/R-3857-2019	Dong, Jun/0000-0002-0026-6680	National Natural Science Foundation of China [81172400, 81302180, 81472739]; Suzhou Science and Technology Development Program [SYSD2013087]; Jiangsu Provincial Special Program of Clinical Medical Science [BL2014040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Science and Technology Development Program; Jiangsu Provincial Special Program of Clinical Medical Science	This study was supported by grants from the National Natural Science Foundation of China (grant nos. 81172400, 81302180, 81472739), the Suzhou Science and Technology Development Program (no. SYSD2013087) and the Jiangsu Provincial Special Program of Clinical Medical Science (BL2014040).	Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bourzac K, 2014, NATURE, V509, pS69, DOI 10.1038/509S69a; Chakraborty A, 2004, BONE MARROW TRANSPL, V34, P183, DOI 10.1038/sj.bmt.1704547; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chen H, 2011, BRAIN TUMORS CURRENT, P3; Chen PW, 2011, CLIN CANCER RES, V17, P7230, DOI 10.1158/1078-0432.CCR-11-1354; Dong J, 2012, CHINESE MED J-PEKING, V125, P4349, DOI 10.3760/cma.j.issn.0366-6999.2012.24.006; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; GOLDENBERG DM, 1981, SCIENCE, V212, P65, DOI 10.1126/science.7209521; Haase-Kohn C, 2014, BIOCHEM BIOPH RES CO, V446, P143, DOI 10.1016/j.bbrc.2014.02.126; Harris PS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-80; Mantoni TS, 2011, CANCER RES, V71, P3453, DOI 10.1158/0008-5472.CAN-10-1633; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Papadopoulou A, 2011, INT J ONCOL, V39, P989, DOI 10.3892/ijo.2011.1132; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saito N, 2014, STEM CELLS, V32, P301, DOI 10.1002/stem.1528; Tsai CS, 2007, INT J RADIAT ONCOL, V68, P499, DOI 10.1016/j.ijrobp.2007.01.041; Wan Y, 2012, CHIN J CANCER, V31, P207, DOI 10.5732/cjc.011.10336; Wang AD, 2015, MOL MED REP, V11, P2435, DOI 10.3892/mmr.2014.3032; Wang ED, 2011, AM J CLIN PATHOL, V135, P525, DOI 10.1309/AJCPPJUQ9DNR1GHP; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Wu J, 2012, TOHOKU J EXP MED, V226, P267, DOI 10.1620/tjem.226.267	24	26	30	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142594	10.1371/journal.pone.0142594	http://dx.doi.org/10.1371/journal.pone.0142594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599017	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900030
J	van Zuijdewijn, CLMD; Grooteman, MPC; Bots, ML; Blankestijn, PJ; Steppan, S; Buechel, J; Groenwold, RHH; Brandenburg, V; van den Dorpel, MA; ter Wee, PM; Nube, MJ; Vervloet, MG				van Zuijdewijn, Camiel L. M. de Roij; Grooteman, Muriel P. C.; Bots, Michiel L.; Blankestijn, Peter J.; Steppan, Sonja; Buechel, Janine; Groenwold, Rolf H. H.; Brandenburg, Vincent; van den Dorpel, Marinus A.; ter Wee, Piet M.; Nube, Menso J.; Vervloet, Marc G.			Serum Magnesium and Sudden Death in European Hemodialysis Patients	PLOS ONE			English	Article							CALCIUM ACETATE/MAGNESIUM CARBONATE; SMOOTH-MUSCLE-CELLS; ALL-CAUSE; ONLINE HEMODIAFILTRATION; CARDIOVASCULAR MORTALITY; SEVELAMER-HYDROCHLORIDE; VASCULAR CALCIFICATION; SIGNIFICANT PREDICTOR; ATHEROSCLEROSIS RISK; DISEASE	Despite suggestions that higher serum magnesium (Mg) levels are associated with improved outcome, the association with mortality in European hemodialysis (HD) patients has only scarcely been investigated. Furthermore, data on the association between serum Mg and sudden death in this patient group is limited. Therefore, we evaluated Mg in a post-hoc analysis using pooled data from the CONvective TRAnsport STudy (CONTRAST, NCT00205556), a randomized controlled trial (RCT) evaluating the survival risk in dialysis patients on hemodiafiltration (HDF) compared to HD with a mean follow-up of 3.1 years. Serum Mg was measured at baseline and 6, 12, 24 and 36 months thereafter. Cox proportional hazards models, adjusted for confounders using inverse probability weighting, were used to estimate hazard ratios (HRs) of baseline serum Mg on all-cause mortality, cardiovascular mortality, non-cardiovascular mortality and sudden death. A generalized linear mixed model was used to investigate Mg levels over time. Out of 714 randomized patients, a representative subset of 365 (51%) were analyzed in the present study. For every increase in baseline serum Mg of 0.1 mmol/L, the HR for all-cause mortality was 0.85 (95% CI 0.77-94), the HR for cardiovascular mortality 0.73 (95% CI 0.62-0.85) and for sudden death 0.76 (95% CI 0.62-0.93). These findings did not alter after extensive correction for potential confounders, including treatment modality. Importantly, no interaction was found between serum phosphate and serum Mg. Baseline serum Mg was not related to non-cardiovascular mortality. Mg decreased slightly but statistically significant over time (Delta -0.011 mmol/L/year, 95% CI -0.017 to -0.009, p = 0.03). In short, serum Mg has a strong, independent association with all-cause mortality, cardiovascular mortality and sudden death in European HD patients. Serum Mg levels decrease slightly over time.	[van Zuijdewijn, Camiel L. M. de Roij; Grooteman, Muriel P. C.; ter Wee, Piet M.; Nube, Menso J.; Vervloet, Marc G.] Vrije Univ Amsterdam Med Ctr, Dept Nephrol, Amsterdam, Netherlands; [van Zuijdewijn, Camiel L. M. de Roij; Grooteman, Muriel P. C.; ter Wee, Piet M.; Nube, Menso J.; Vervloet, Marc G.] Vrije Univ Amsterdam Med Ctr, VU Univ Med Ctr ICaR VU, Inst Cardiovasc Res, Amsterdam, Netherlands; [Bots, Michiel L.; Groenwold, Rolf H. H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Blankestijn, Peter J.] Univ Med Ctr Utrecht, Dept Nephrol, Utrecht, Netherlands; [Steppan, Sonja; Buechel, Janine] Fresenius Med Care, Bad Homburg, Germany; [Brandenburg, Vincent] Univ Hosp Aachen, Dept Cardiol & Vasc Med, Aachen, Germany; [van den Dorpel, Marinus A.] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; RWTH Aachen University; RWTH Aachen University Hospital; Maasstad Hospital	van Zuijdewijn, CLMD (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Nephrol, Amsterdam, Netherlands.	c.deroijvanzuijdewijn@vumc.nl	de Roij van Zuijdewijn, Camiel/AAE-7568-2020; Grooteman, Muriel/AAA-2602-2019	Grooteman, Muriel/0000-0001-5447-2546; Groenwold, Rolf/0000-0001-9238-6999; Vervloet, Marc/0000-0003-4607-9415; de Roij van Zuijdewijn, Camiel/0000-0002-6369-8341	Dutch Kidney Foundation (Nierstichting Nederland) [C02.2019]; Fresenius Medical Care (The Netherlands); Gambro Lundia AB (Sweden); Dr E.E. Twiss Fund; International Society of Nephrology/Baxter Extramural Grant Program; Dutch Organization for Health Research and Development (ZonMW) [17088.2802]; Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany; Fresenius Medical Care Deutschland GmbH; Roche Netherlands	Dutch Kidney Foundation (Nierstichting Nederland); Fresenius Medical Care (The Netherlands)(Netherlands Government); Gambro Lundia AB (Sweden); Dr E.E. Twiss Fund; International Society of Nephrology/Baxter Extramural Grant Program; Dutch Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany; Fresenius Medical Care Deutschland GmbH; Roche Netherlands	CONTRAST was financially supported by a grant from the Dutch Kidney Foundation (Nierstichting Nederland, grant C02.2019) and unrestricted grants from Fresenius Medical Care (The Netherlands) and Gambro Lundia AB (Sweden). Additional support was received from the Dr E.E. Twiss Fund, Roche Netherlands, the International Society of Nephrology/Baxter Extramural Grant Program, and the Dutch Organization for Health Research and Development (ZonMW, grant 17088.2802). The funders had no role in study design, data collection, analysis, or the decision to publish. The present project was additionally funded by a grant from Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany. Fresenius Medical Care Deutschland GmbH did not have any additional role in the study design, data collection, and analysis of the manuscript, but provided support in the form of salaries for authors (SS, JB) and intellectual content, and consented to publish the manuscript. The specific roles of the authors related to Fresenius Medical Care are articulated in the 'author contributions' section.	Adragao T, 2004, NEPHROL DIAL TRANSPL, V19, P1480, DOI 10.1093/ndt/gfh217; Covic A, 2013, NEPHROL DIAL TRANSPL, V28, P2383, DOI 10.1093/ndt/gft203; de Francisco ALM, 2010, NEPHROL DIAL TRANSPL, V25, P3707, DOI 10.1093/ndt/gfq292; Del Gobbo LC, 2013, AM J CLIN NUTR, V98, P160, DOI 10.3945/ajcn.112.053132; Fawcett WJ, 1999, BRIT J ANAESTH, V83, P302, DOI 10.1093/bja/83.2.302; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; Hruby A, 2014, JACC-CARDIOVASC IMAG, V7, P59, DOI 10.1016/j.jcmg.2013.10.006; Ishimura E, 2007, MAGNESIUM RES, V20, P237, DOI 10.1684/mrh.2007.0116; Kanbay M, 2012, AM J NEPHROL, V36, P228, DOI 10.1159/000341868; Kircelli F, 2012, NEPHROL DIAL TRANSPL, V27, P514, DOI 10.1093/ndt/gfr321; Lacson E, 2015, AM J KIDNEY DIS, V66, P1056, DOI 10.1053/j.ajkd.2015.06.014; Li L, 2015, AM J KIDNEY DIS, V66, P1047, DOI 10.1053/j.ajkd.2015.05.024; Liao FZ, 1998, AM HEART J, V136, P480, DOI 10.1016/S0002-8703(98)70224-8; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Lopes AA, 2010, J RENAL NUTR, V20, P224, DOI 10.1053/j.jrn.2009.10.002; Louvet L, 2013, NEPHROL DIAL TRANSPL, V28, P869, DOI 10.1093/ndt/gfs520; Maier Jeanette A. M., 2003, Molecular Aspects of Medicine, V24, P137; Matias PJ, 2014, BLOOD PURIFICAT, V38, P244, DOI 10.1159/000366124; MEEMA HE, 1987, KIDNEY INT, V32, P388, DOI 10.1038/ki.1987.222; de Oca AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089525; Mubagwa K, 2007, ARCH BIOCHEM BIOPHYS, V458, P73, DOI 10.1016/j.abb.2006.10.014; Naimi AI, 2014, EPIDEMIOLOGY, V25, P292, DOI 10.1097/EDE.0000000000000053; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Peacock JM, 2010, AM HEART J, V160, P464, DOI 10.1016/j.ahj.2010.06.012; Pearson PJ, 1998, ANN THORAC SURG, V65, P967, DOI 10.1016/S0003-4975(98)00020-4; Penne EL, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-8; Sakaguchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116273; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; Satayathum S, 2005, KIDNEY INT, V68, P330, DOI 10.1111/j.1523-1755.2005.00412.x; Shechter M, 2000, CIRCULATION, V102, P2353, DOI 10.1161/01.CIR.102.19.2353; Sigrist MK, 2007, CLIN J AM SOC NEPHRO, V2, P1241, DOI 10.2215/CJN.02190507; Yoshino M, 2006, J AM SOC NEPHROL, V17, P3510, DOI 10.1681/ASN.2006020156; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605	34	53	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143104	10.1371/journal.pone.0143104	http://dx.doi.org/10.1371/journal.pone.0143104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600017	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900065
J	Yan, C; Zhang, BB; Hua, H; Li, B; Zhang, B; Yu, Q; Li, XY; Liu, Y; Pan, W; Liu, XY; Tang, RX; Zheng, KY				Yan, Chao; Zhang, Bei-Bei; Hua, Hui; Li, Bo; Zhang, Bo; Yu, Qian; Li, Xiang-Yang; Liu, Ying; Pan, Wei; Liu, Xiang-Ye; Tang, Ren-Xian; Zheng, Kui-Yang			The Dynamics of Treg/Th17 and the Imbalance of Treg/Th17 in Clonorchis sinensis-Infected Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ROR-GAMMA-T; TGF-BETA; LIVER FIBROSIS; B-CELLS; GM-CSF; INDUCTION; EXPRESSION; CYTOKINE; PATHWAY	Clonorchiasis, caused by the liver fluke Clonorchis sinensis, is a chronic parasitic infection regulated by T cell subsets. An imbalance of CD4+CD25+Foxp3+ regulatory T (Treg) and interleukin (IL)-17-secreting T cells (Th17) may control inflammation and play an important role in the pathogenesis of immune evasion. In the present study, we assessed the dynamics of Treg/Th17 and determined whether the Treg/Th17 ratio is altered in C. sinensis infected mice. The results showed that the percentages of splenic Treg cells in CD4+ T cells were suppressed on day 14 post-infection (PI) but increased on day 56 PI, while Th17 cells were increased on day 56 PI compared with normal control (NC) mice. The Treg/Th17 ratio steadily increased from day 28 to day 56 PI. The hepatic levels of their specific transcription factors (Foxp3 for Treg and ROR gamma t for Th17) were increased in C. sinensis-infected mice from day 14 to 56 PI, and significantly higher than those in NC mice. Meanwhile, serum levels of IL-2 and IL-17 were profoundly increased in C. sinensis-infected mice throughout the experiment; while the concentrations of IL-6 and transforming growth factor beta(1) (TGF-beta(1)) peaked on day 14 PI, but then decreased on day 28 and 56 PI. Our results provide the first evidence of an increased Treg/Th17 ratio in C. sinensis-infected mice, suggesting that a Treg/Th17 imbalance may play a role in disease outcomes of clonorchiasis.	[Yan, Chao; Zhang, Bei-Bei; Hua, Hui; Li, Bo; Zhang, Bo; Yu, Qian; Li, Xiang-Yang; Liu, Ying; Pan, Wei; Liu, Xiang-Ye; Tang, Ren-Xian; Zheng, Kui-Yang] Xuzhou Med Coll, Dept Pathogen Biol & Immunol, Lab Infect & Immun, Xuzhou 221004, Jiangsu, Peoples R China	Xuzhou Medical University	Zheng, KY (corresponding author), Xuzhou Med Coll, Dept Pathogen Biol & Immunol, Lab Infect & Immun, Xuzhou 221004, Jiangsu, Peoples R China.	Tangrenxian-t@163.com; ZKY02@163.com	Yan, Chao/AAA-9403-2021		National Natural Science Foundation of China [81171590, 31302077, 81572019]; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences [SKLVEB2013KFKT005]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Starting Foundation for Talents of Xuzhou Medical College [53591317]; Science Foundation of Xuzhou Medical College [2014KJ08, 2014KJ10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Starting Foundation for Talents of Xuzhou Medical College; Science Foundation of Xuzhou Medical College	Project support was provided in part by the National Natural Science Foundation of China (Grant Nos. 81171590, 31302077 and 81572019), the Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant No. SKLVEB2013KFKT005), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Starting Foundation for Talents of Xuzhou Medical College (Grant No. 53591317), and the Science Foundation of Xuzhou Medical College (Grant Nos. 2014KJ08 and 2014KJ10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalid-Peralta L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/981468; Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; ATTWOOD HD, 1978, PATHOLOGY, V10, P153, DOI 10.3109/00313027809063494; Baumgart M, 2006, J IMMUNOL, V176, P5374, DOI 10.4049/jimmunol.176.9.5374; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Chen DH, 2013, IMMUNOLOGY, V139, P523, DOI 10.1111/imm.12105; Chen J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-152; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; D'Elia R, 2009, J IMMUNOL, V182, P2340, DOI 10.4049/jimmunol.0802767; Fang Yue-Yi, 2008, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V26, P99; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fu LinLin, 2008, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V3, P46; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kara EE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003905; Keswani T, 2014, EXP PARASITOL, V141, P82, DOI 10.1016/j.exppara.2014.03.003; Kim EM, 2012, PARASITOL INT, V61, P124, DOI 10.1016/j.parint.2011.07.001; Kim Jong In, 1992, Korean Journal of Parasitology, V30, P169, DOI 10.3347/kjp.1992.30.3.169; Kim TI, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001414; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039307; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martinez NE, 2014, J NEUROIMMUNOL, V276, P142, DOI 10.1016/j.jneuroim.2014.09.006; Mbow M, 2013, J INFECT DIS, V207, P186, DOI 10.1093/infdis/jis654; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Pang NN, 2014, INT IMMUNOPHARMACOL, V20, P248, DOI 10.1016/j.intimp.2014.02.038; Rouse BT, 2004, J IMMUNOL, V173, P2211, DOI 10.4049/jimmunol.173.4.2211; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shainheit MG, 2011, J IMMUNOL, V187, P5328, DOI 10.4049/jimmunol.1101445; Shen JQ, 2015, PARASITOL RES, V114, P1661, DOI 10.1007/s00436-015-4347-9; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Shin MH, 2003, INT ARCH ALLERGY IMM, V132, P48, DOI 10.1159/000073264; Smith KA, 2014, EUR J IMMUNOL, V44, P150, DOI 10.1002/eji.201343746; Sun XF, 2014, WORLD J GASTROENTERO, V20, P2062, DOI 10.3748/wjg.v20.i8.2062; Turaga PSD, 2000, INFECT IMMUN, V68, P1905, DOI 10.1128/IAI.68.4.1905-1911.2000; Tuxun T, 2012, PARASITE IMMUNOL, V34, P520, DOI 10.1111/j.1365-3024.2012.01383.x; Uddin MH, 2012, PARASITOL INT, V61, P118, DOI 10.1016/j.parint.2011.07.002; Wang XY, 2009, PARASITOL RES, V106, P15, DOI 10.1007/s00436-009-1622-7; Yan C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0675-y; Zhang HX, 2012, AM J REPROD IMMUNOL, V67, P112, DOI 10.1111/j.1600-0897.2011.01065.x; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	52	13	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143217	10.1371/journal.pone.0143217	http://dx.doi.org/10.1371/journal.pone.0143217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599407	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900078
J	Sakai, K; Komaki, H; Gonoi, T				Sakai, Kanae; Komaki, Hisayuki; Gonoi, Tohru			Identification and Functional Analysis of the Nocardithiocin Gene Cluster in Nocardia pseudobrasiliensis	PLOS ONE			English	Article							THIOPEPTIDE; ANTIBIOTICS; BIOSYNTHESIS; VARIANTS; STRAINS; TP-1161	Nocardithiocin is a thiopeptide compound isolated from the opportunistic pathogen Nocardia pseudobrasiliensis. It shows a strong activity against acid-fast bacteria and is also active against rifampicin-resistant Mycobacterium tuberculosis. Here, we report the identification of the nocardithiocin gene cluster in N. pseudobrasiliensis IFM 0761 based on conserved thiopeptide biosynthesis gene sequence and the whole genome sequence. The predicted gene cluster was confirmed by gene disruption and complementation. As expected, strains containing the disrupted gene did not produce nocardithiocin while gene complementation restored nocardithiocin production in these strains. The predicted cluster was further analyzed using RNA-seq which showed that the nocardithiocin gene cluster contains 12 genes within a 15.2-kb region. This finding will promote the improvement of nocardithiocin productivity and its derivatives production.	[Sakai, Kanae; Gonoi, Tohru] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Komaki, Hisayuki] Natl Inst Technol & Evaluat, Biol Resource Ctr, Chiba, Japan	Chiba University	Sakai, K (corresponding author), Chiba Univ, Med Mycol Res Ctr, Chiba, Japan.	wsakaiw@hotmail.com	gonoi, tohru/AAC-5181-2021; , gonoi/GRS-0648-2022	gonoi, tohru/0000-0003-3655-7911; , gonoi/0000-0003-3655-7911; Dalisay, Doralyn/0000-0003-2850-7797	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25305012]; Grants-in-Aid for Scientific Research [25305012] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), http://www.mext.go.jp/english/, #25305012, to TG. The funder had no role in this study.	Bhansali SG, 2015, ANTIMICROB AGENTS CH, V59, P1441, DOI 10.1128/AAC.04252-14; Bowers AA, 2010, J AM CHEM SOC, V132, P7519, DOI 10.1021/ja102339q; Chiba K, 2007, JPN J INFECT DIS, V60, P45; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; Engelhardt K, 2010, APPL ENVIRON MICROB, V76, P7093, DOI 10.1128/AEM.01442-10; Engelhardt K, 2010, APPL ENVIRON MICROB, V76, P4969, DOI 10.1128/AEM.00741-10; Haste NM, 2012, J ANTIBIOT, V65, P593, DOI 10.1038/ja.2012.77; Hwang KS, 2014, BIOTECHNOL ADV, V32, P255, DOI 10.1016/j.biotechadv.2013.10.008; Just-Baringo X, 2014, MAR DRUGS, V12, P317, DOI 10.3390/md12010317; Komaki H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-323; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Li WY, 2003, J ANTIBIOT, V56, P226, DOI 10.7164/antibiotics.56.226; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Mukai A, 2009, J ANTIBIOT, V62, P613, DOI 10.1038/ja.2009.90; Munoz J, 2007, J MED MICROBIOL, V56, P545, DOI 10.1099/jmm.0.46774-0; Minero MV, 2009, MEDICINE, V88, P250, DOI 10.1097/MD.0b013e3181afa1c8; Wang J, 2010, APPL ENVIRON MICROB, V76, P2335, DOI 10.1128/AEM.01790-09; Wilson JW, 2012, MAYO CLIN PROC, V87, P403, DOI 10.1016/j.mayocp.2011.11.016; Xu LB, 2013, BIOORG MED CHEM LETT, V23, P366, DOI 10.1016/j.bmcl.2012.10.065; Zhang FF, 2012, METHOD ENZYMOL, V516, P3, DOI 10.1016/B978-0-12-394291-3.00022-8	22	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143264	10.1371/journal.pone.0143264	http://dx.doi.org/10.1371/journal.pone.0143264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588225	gold, Green Published, Green Submitted			2022-12-27	WOS:000365251500047
J	Torgerson, DG; Giri, T; Druley, TE; Zheng, J; Huntsman, S; Seibold, MA; Young, AL; Schweiger, T; Yin-Declue, H; Sajol, GD; Schechtman, KB; Hernandez, RD; Randolph, AG; Bacharier, LB; Castro, M				Torgerson, Dara G.; Giri, Tusar; Druley, Todd E.; Zheng, Jie; Huntsman, Scott; Seibold, Max A.; Young, Andrew L.; Schweiger, Toni; Yin-Declue, Huiqing; Sajol, Geneline D.; Schechtman, Kenneth B.; Hernandez, Ryan D.; Randolph, Adrienne G.; Bacharier, Leonard B.; Castro, Mario			Pooled Sequencing of Candidate Genes Implicates Rare Variants in the Development of Asthma Following Severe RSV Bronchiolitis in Infancy	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; GENOME-WIDE ASSOCIATION; OF-FUNCTION MUTATIONS; EXHALED NITRIC-OXIDE; ATOPIC-DERMATITIS; POLYMORPHISM; FILAGGRIN; CHILDREN; NOS1; POPULATION	Severe infection with respiratory syncytial virus (RSV) during infancy is strongly associated with the development of asthma. To identify genetic variation that contributes to asthma following severe RSV bronchiolitis during infancy, we sequenced the coding exons of 131 asthma candidate genes in 182 European and African American children with severe RSV bronchiolitis in infancy using anonymous pools for variant discovery, and then directly genotyped a set of 190 nonsynonymous variants. Association testing was performed for physician-diagnosed asthma before the 7th birthday (asthma) using genotypes from 6,500 individuals from the Exome Sequencing Project (ESP) as controls to gain statistical power. In addition, among patients with severe RSV bronchiolitis during infancy, we examined genetic associations with asthma, active asthma, persistent wheeze, and bronchial hyperreactivity (methacholine PC20) at age 6 years. We identified four rare nonsynonymous variants that were significantly associated with asthma following severe RSV bronchiolitis, including single variants in ADRB2, FLG and NCAM1 in European Americans (p = 4.6x10(-4), 1.9x10(-13) and 5.0x10(-5), respectively), and NOS1 in African Americans (p = 2.3x10(-11)). One of the variants was a highly functional nonsynonymous variant in ADRB2 (rs1800888), which was also nominally associated with asthma (p = 0.027) and active asthma (p = 0.013) among European Americans with severe RSV bronchiolitis without including the ESP. Our results suggest that rare nonsynonymous variants contribute to the development of asthma following severe RSV bronchiolitis in infancy, notably in ADRB2. Additional studies are required to explore the role of rare variants in the etiology of asthma and asthma-related traits following severe RSV bronchiolitis.	[Torgerson, Dara G.; Huntsman, Scott] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Giri, Tusar; Schweiger, Toni; Yin-Declue, Huiqing; Sajol, Geneline D.; Castro, Mario] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Druley, Todd E.; Young, Andrew L.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO USA; [Zheng, Jie; Schechtman, Kenneth B.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Seibold, Max A.] Natl Jewish Hlth, Integrated Ctr Genes Environm & Hlth, Denver, CO USA; [Hernandez, Ryan D.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Inst Human Genet, San Francisco, CA 94143 USA; [Hernandez, Ryan D.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94143 USA; [Randolph, Adrienne G.] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA; [Bacharier, Leonard B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Bacharier, Leonard B.] St Louis Childrens Hosp, St Louis, MO 63178 USA	University of California System; University of California San Francisco; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Jewish Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Castro, M (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	castrom@DOM.wustl.edu		ZHENG, JIE/0000-0003-4958-2091; Young, Andrew/0000-0001-7698-3267; Giri, Tusar/0000-0003-1682-2300; Bacharier, Leonard/0000-0003-0432-2704; Druley, Todd/0000-0002-3245-7561; Randolph, Adrienne/0000-0002-3084-3071	National Institute of Health [RO1 HL092486, RO1 HL 61895, UL1 RR024992-01, R01-ES015794, R01-HL088133, T32-GM007546, R01-HL004464, R01-HL104608]; National Institute On Minority Health And Health Disparities [P60MD006902]; Alan A. and Edith L. Wolff Chair in Pulmonary and Critical Care Medicine; Flight Attendant Medical Research Institute; Sandler Foundation; American Asthma Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088133, R01HL092486, R01HL061895, R01HL104608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007546] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD006902] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute On Minority Health And Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Alan A. and Edith L. Wolff Chair in Pulmonary and Critical Care Medicine; Flight Attendant Medical Research Institute; Sandler Foundation; American Asthma Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding: This work was supported by grants from the National Institute of Health (www.nih.gov) (RO1 HL092486, RO1 HL 61895, UL1 RR024992-01, R01-ES015794, R01-HL088133, T32-GM007546, R01-HL004464, R01-HL104608), the National Institute On Minority Health And Health Disparities (P60MD006902), the Alan A. and Edith L. Wolff Chair in Pulmonary and Critical Care Medicine, the Flight Attendant Medical Research Institute (www.famri.org), the Sandler Foundation (www.sandlerfoundation.org), and the American Asthma Foundation (www.americanasthmafoundation.org).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ali M, 2003, PEDIAT ALLERG IMM-UK, V14, P261, DOI 10.1034/j.1399-3038.2003.00065.x; Ambrose HJ, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-37; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Baye Tesfaye M, 2011, BMC Proc, V5 Suppl 9, pS8, DOI 10.1186/1753-6561-5-S9-S8; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Bradley JP, 2005, PEDIATRICS, V115, pE7, DOI 10.1542/peds.2004-0059; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Brown SJ, 2009, BRIT J DERMATOL, V161, P884, DOI 10.1111/j.1365-2133.2009.09339.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dai Lu-ming, 2004, Sichuan Da Xue Xue Bao Yi Xue Ban, V35, P32; Dishy V, 2004, PHARMACOGENETICS, V14, P517, DOI 10.1097/01.fpc.0000114763.78957.ec; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Exome Variant Server, NHLBI GO EX SEQ PROJ; Gao Jin-ming, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P626; Gao PS, 2000, BIOCHEM BIOPH RES CO, V267, P761, DOI 10.1006/bbrc.1999.2030; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Grasemann H, 2000, BIOCHEM BIOPH RES CO, V272, P391, DOI 10.1006/bbrc.2000.2794; Haller G, 2009, J ALLERGY CLIN IMMUN, V124, P1204, DOI 10.1016/j.jaci.2009.09.013; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Holla LI, 2004, ALLERGY, V59, P548, DOI 10.1111/j.1398-9995.2004.00458.x; Immervoll T, 2001, HUM MUTAT, V18, P327, DOI 10.1002/humu.1194; Janzi M, 2012, GENES IMMUN, V13, P59, DOI 10.1038/gene.2011.55; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Martinez B, 2007, INT ARCH ALLERGY IMM, V144, P105, DOI 10.1159/000103221; Moore PE, 2009, PEDIATR PULM, V44, P649, DOI 10.1002/ppul.21033; Ober C, 2011, TRENDS GENET, V27, P107, DOI 10.1016/j.tig.2010.12.004; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randolph AG, 2014, CLIN EXP ALLERGY, V44, P231, DOI 10.1111/cea.12247; Ryan M, 2009, BIOINFORMATICS, V25, P1431, DOI 10.1093/bioinformatics/btp242; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Todd JL, 2011, AM J RESP CRIT CARE, V184, P873, DOI 10.1164/rccm.201106-0971PP; Torgerson DG, 2012, AM J HUM GENET, V90, P273, DOI 10.1016/j.ajhg.2012.01.008; Vallania FLM, 2010, GENOME RES, V20, P1711, DOI 10.1101/gr.109157.110; Ward ME, 2005, J CLIN INVEST, V115, P3128, DOI 10.1172/JCI20806; Wechsler ME, 2000, AM J RESP CRIT CARE, V162, P2043, DOI 10.1164/ajrccm.162.6.2003089; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Xu XP, 2002, AM J RESP CRIT CARE, V166, P775; Yang IV, 2012, AM J RESP CRIT CARE, V186, P1087, DOI 10.1164/rccm.201207-1178PP; Zhang J, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-4	50	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142649	10.1371/journal.pone.0142649	http://dx.doi.org/10.1371/journal.pone.0142649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587832	gold, Green Published			2022-12-27	WOS:000365251500012
J	Alison, M; Biran, V; Tanase, A; Bendavid, M; Blouet, M; Demene, C; Sebag, G; Tanter, M; Baud, O				Alison, Marianne; Biran, Valerie; Tanase, Anca; Bendavid, Matthieu; Blouet, Marie; Demene, Charlie; Sebag, Guy; Tanter, Mickael; Baud, Olivier			Quantitative Shear-Wave Elastography of the Liver in Preterm Neonates with Intra-Uterine Growth Restriction	PLOS ONE			English	Article							IMPULSE ARFI ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; HEPATITIS-B; BLOOD-FLOW; FIBROSIS; NUTRITION; CHOLESTASIS; STIFFNESS; OPERATION; DIAGNOSIS	The feasibility and reproducibility of liver stiffness measurements using Supersonic Shear-wave Imaging (SSI) in preterm neonate have not been reported. Our aim was to determine if liver stiffness differs between intra-uterine growth restriction (IUGR) and appropriate for gestational age (AGA) preterm infants with/without cholestasis. We measured liver stiffness (in kPa) in 45 AGA and 18 IUGR preterm infants, and assessed reproducibility in 26 preterms using Intraclass Correlation Coefficients (ICC) and Bland-Altman tests. Liver stiffness values were compared between AGA and IUGR with and without cholestasis and correlated with birth weight. Measurements showed high reproducibility (ICC = 0.94-0.98 for intra-operator, 0.86 for inter-operator) with good agreement (95% limits: -1.24 to 1.24 kPa). During the first postnatal week, liver stiffness was higher in IUGR (7.50 +/- 1.53 kPa) than in AGA infants (5.11 +/- 0.80 kPa, p<0.001). After day 8, liver stiffness remained unchanged in AGA but increased progressively in IUGR infants (15.57 +/- 6.49 kPa after day 21). Liver stiffness was higher in IUGR neonates with cholestasis (19.35 +/- 9.80 kPa) than without cholestasis (7.72 +/- 1.27 kPa, p<0.001). In conclusion, quantitative liver SSI in preterms is feasible and reproducible. IUGR preterms who will develop cholestasis present high liver stiffness even at birth, before biological cholestasis occurs.	[Alison, Marianne; Tanase, Anca; Blouet, Marie; Sebag, Guy] Robert Debre Children Univ Hosp, Dept Pediat Radiol, F-75019 Paris, France; [Alison, Marianne; Biran, Valerie; Tanase, Anca; Bendavid, Matthieu; Blouet, Marie; Sebag, Guy; Baud, Olivier] Denis Diderot Paris Univ, APHP, F-75019 Paris, France; [Alison, Marianne; Biran, Valerie; Tanase, Anca; Demene, Charlie; Sebag, Guy; Tanter, Mickael; Baud, Olivier] PremUP Fdn, F-75014 Paris, France; [Biran, Valerie; Bendavid, Matthieu; Baud, Olivier] Robert Debre Children Univ Hosp, Neonatal Intens Care Unit, F-75019 Paris, France; [Biran, Valerie; Bendavid, Matthieu; Baud, Olivier] Robert Debre Children Univ Hosp, INSERM, U1141, F-75019 Paris, France; [Demene, Charlie; Tanter, Mickael] ESPCI ParisTech, CNRS, UMR 7587, Inst Langevin,INSERM,U979, F-75005 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite	Baud, O (corresponding author), PremUP Fdn, F-75014 Paris, France.	olivier.baud@rdb.aphp.fr	Alison, Marianne/A-2253-2016; Biran, Valerie/GQY-8192-2022; Mickael, Tanter/H-4657-2012	Mickael, Tanter/0000-0001-7739-8051; Alison, Marianne/0000-0002-9245-9390	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC grant [339244-FUSIMAGINE]	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC grant(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 339244-FUSIMAGINE.	Arai H, 2010, TOHOKU J EXP MED, V221, P181, DOI 10.1620/tjem.221.181; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barr RG, 2015, RADIOLOGY, V276, P845, DOI 10.1148/radiol.2015150619; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Baserga Mariana C, 2004, J Perinatol, V24, P476, DOI 10.1038/sj.jp.7211137; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bercoff J, 2004, APPL PHYS LETT, V84, P2202, DOI 10.1063/1.1667613; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOEHM G, 1988, ACTA PAEDIATR SCAND, V77, P19, DOI 10.1111/j.1651-2227.1988.tb10591.x; Bohte AE, 2014, EUR RADIOL, V24, P638, DOI 10.1007/s00330-013-3046-0; Champion V, 2012, J PEDIATR GASTR NUTR, V55, P592, DOI 10.1097/MPG.0b013e3182616916; Christensen RD, 2007, J PERINATOL, V27, P284, DOI 10.1038/sj.jp.7211686; Creasy R.K., 1994, MATERNAL FETAL MED P, V3rd ed., P558; Dillman JR, 2015, PEDIATR RADIOL, V45, P1480, DOI 10.1007/s00247-015-3345-5; Ebbing C, 2008, REPROD SCI, V15, P166, DOI 10.1177/1933719107310307; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Fontanilla T, 2014, ULTRASOUND MED BIOL, V40, P470, DOI 10.1016/j.ultrasmedbio.2013.10.024; Gardosi J, 2011, PAEDIATR PERINAT EP, V25, P2, DOI 10.1111/j.1365-3016.2010.01166.x; Gateau J, 2011, IEEE T ULTRASON FERR, V58, P517, DOI 10.1109/TUFFC.2011.1836; Grgurevic I, 2015, EUR RADIOL, V25, P3214, DOI 10.1007/s00330-015-3728-x; Hanquinet S, 2015, PEDIATR RADIOL, V45, P1489, DOI 10.1007/s00247-015-3352-6; Hanquinet S, 2013, PEDIATR RADIOL, V43, P545, DOI 10.1007/s00247-012-2595-8; Jacobsson B, 2008, BJOG-INT J OBSTET GY, V115, P1250, DOI 10.1111/j.1471-0528.2008.01827.x; Jacquemin E, 1998, J PEDIATR-US, V133, P563, DOI 10.1016/S0022-3476(98)70070-8; Kahramaner Z, 2013, PEDIATR RADIOL, V43, P1464, DOI 10.1007/s00247-013-2729-7; Kelly DA, 2010, EARLY HUM DEV, V86, P683, DOI 10.1016/j.earlhumdev.2010.08.012; Kessler J, 2008, PEDIATR RES, V63, P315, DOI 10.1203/PDR.0b013e318163a1de; Kessler J, 2009, PEDIATR RES, V66, P113, DOI 10.1203/PDR.0b013e3181a29077; Leschied JR, 2015, PEDIATR RADIOL, V45, P366, DOI 10.1007/s00247-014-3149-z; Mamelle N., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P61; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Muller M, 2009, ULTRASOUND MED BIOL, V35, P219, DOI 10.1016/j.ultrasmedbio.2008.08.018; Robinson DT, 2008, J PEDIATR-US, V152, P59, DOI 10.1016/j.jpeds.2007.06.002; Roca B, 2012, J VIRAL HEPATITIS, V19, P711, DOI 10.1111/j.1365-2893.2012.01608.x; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Shin NY, 2014, J ULTRAS MED, V33, P853, DOI 10.7863/ultra.33.5.853; Sirli R, 2013, ULTRASOUND MED BIOL, V39, P1362, DOI 10.1016/j.ultrasmedbio.2013.03.021; Tanter M, 2014, IEEE T ULTRASON FERR, V61, P102, DOI [10.1109/TUFFC.2014.2882, 10.1109/TUFFC.2014.6689779]; Taylor B.N., 1994, GUIDELINES EVALUATIN, DOI DOI 10.6028/NIST.TN.1297; Van Gossum A, 2015, JPEN-PARENTER ENTER, V39, P719, DOI 10.1177/0148607114538057; Yoo BW, 2014, J THORAC CARDIOV SUR, V148, P1498, DOI 10.1016/j.jtcvs.2014.04.010; Zeng J, 2014, EUR RADIOL, V24, P2572, DOI 10.1007/s00330-014-3292-9	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143220	10.1371/journal.pone.0143220	http://dx.doi.org/10.1371/journal.pone.0143220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580807	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600100
J	Goda, H; Hatta, T; Kishigami, H; Suzuki, A; Ikeda, T				Goda, Hiroshi; Hatta, Tatsuo; Kishigami, Hirotoshi; Suzuki, Ayaka; Ikeda, Tamotsu			Does a Novel-Developed Product of Wheelchair Incorporating Pelvic Support Prevent Forward Head Posture during Prolonged Sitting?	PLOS ONE			English	Article							TRUNK MUSCLE-ACTIVITY; CHRONIC NECK PAIN; SHOULDER POSTURE; CERVICAL-SPINE; VDT WORK; DISABILITY; SEVERITY; PRESSURE; MOTION; ADULTS	Disabled elderly individuals with kyphosis or loss of muscle strength often display forward head posture (FHP). This study aimed to determine the utility of a wheelchair incorporating pelvic support in preventing FHP in disabled elderly individuals. In this study, 14 disabled elderly individuals (87.1 +/- 8.1 years) were selected. A wheelchair incorporating pelvic support (RX_ABS Lo) and a basic wheelchair (RX-1) were used. Each individual sat on both wheelchairs for 30 minutes. RX_ABS Lo has two belts to support the pelvic and thorax. Postures were recorded in the sagittal plane using a video camera. Cervical and trunk angles from horizontal were measured every 5 minutes. Simultaneously, contact areas and total pressures applied to the wheelchair seats and back supports were measured every 5 minutes. Comparisons of area under the curve values between the wheelchairs were performed using the paired t-test. Comparisons of time-dependent parameters for each wheelchair were performed using repeated one-way ANOVA. Cervical angles were greater when using RX_ABS Lo than RX-1. Although cervical angles were unchanged during 30 minutes when using RX_ABS Lo, the angles were significantly decreased after 30 minutes of using RX-1. Back support pressures and contact areas were greater for RX_ABS Lo than for RX-1. No significant difference in back support pressure distributions was observed during 30 minutes in the wheelchairs. The RX_ABS Lo may have utility in improving FHP by increasing cervical angles and improving stability with a back support to the upper thorax, lower thorax, and pelvis during prolonged sitting.	[Goda, Hiroshi; Suzuki, Ayaka] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Goda, Hiroshi] Japan Hlth Care Coll, Eniwa, Japan; [Goda, Hiroshi; Ikeda, Tamotsu] Nihon Welf Rehabil Sch, Eniwa, Japan; [Hatta, Tatsuo; Kishigami, Hirotoshi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Hatta, T (corresponding author), Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan.	thatta@hs.hokudai.ac.jp						Ben Mortenson W, 2012, J AM GERIATR SOC, V60, P1310, DOI 10.1111/j.1532-5415.2012.04038.x; Bonney RA, 2002, APPL ERGON, V33, P415, DOI 10.1016/S0003-6870(02)00036-4; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; Chiu TT, 2005, ARCH PHYS MED REHAB, V86, P534, DOI 10.1016/j.apmr.2004.02.030; Colombini D, 1986, ERGONOMICS WORKING P, P311; De Carvalho DE, 2012, APPL ERGON, V43, P876, DOI 10.1016/j.apergo.2011.12.007; Falla D, 2007, PHYS THER, V87, P408, DOI 10.2522/ptj.20060009; Fernandez-de-las-Penas C, 2006, CEPHALALGIA, V26, P314, DOI 10.1111/j.1468-2982.2005.01042.x; Giesbrecht EM, 2012, GERONTOLOGY, V58, P378, DOI 10.1159/000334819; Grandjean E., 1997, FITTING TASK HUMAN; HANTEN WP, 1991, ARCH PHYS MED REHAB, V72, P877, DOI 10.1016/0003-9993(91)90003-2; Harrison AL, 1996, J ORTHOP SPORT PHYS, V23, P353, DOI 10.2519/jospt.1996.23.6.353; Hiramatsu T, 2015, CLIN INTERV AGING, V10, P229, DOI 10.2147/CIA.S75211; Holmes MWR, 2013, ERGONOMICS, V56, P126, DOI 10.1080/00140139.2012.739206; Hung D, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-25; Kang JH, 2012, ANN REHABIL MED-ARM, V36, P98, DOI 10.5535/arm.2012.36.1.98; Khadilkar L, 2014, INT J SHOULDER SURG, V8, P1, DOI 10.4103/0973-6042.131847; Kishigami H, 2015, REHABIL ENG, V30, P28; Kishigami H, 2013, HOKKAIDO J OCCUP THE, V30, P116; Lau KT, 2010, MANUAL THER, V15, P457, DOI 10.1016/j.math.2010.03.009; Lee JH, 2011, J OCCUP HEALTH, V53, P350, DOI 10.1539/joh.11-0050-OA; Lee JH, 2011, IND HEALTH, V49, P403, DOI 10.2486/indhealth.MS1230; Li CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113644; Linder-Ganz E, 2007, Technol Health Care, V15, P195; MAJESKE C, 1984, PHYS THER, V64, P1531, DOI 10.1093/ptj/64.10.1531; Makhsous M, 2003, SPINE, V28, P1113, DOI 10.1097/00007632-200306010-00006; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mostamand J, 2013, J BODYW MOV THER, V17, P430, DOI 10.1016/j.jbmt.2012.11.002; Nishimura S, 2013, HOKKAIDO J OCCUP THE, V30, P8; O'Sullivan PB, 2002, SPINE, V27, P1238, DOI 10.1097/00007632-200206010-00019; Quek J, 2013, MANUAL THER, V18, P65, DOI 10.1016/j.math.2012.07.005; Roberts S. L, 2004, KINESIOLOGY MOVEMENT; Sakuma T, 2010, J ORAL REHABIL, V37, P583, DOI 10.1111/j.1365-2842.2010.02084.x; Sawada N, 2015, EUR GERIATR MED, V6, P286, DOI 10.1016/j.eurger.2014.11.001; Shahidi B, 2013, J ELECTROMYOGR KINES, V23, P1082, DOI 10.1016/j.jelekin.2013.05.009; Shaw G, 1991, Assist Technol, V3, P5; Silva AG, 2009, ARCH PHYS MED REHAB, V90, P669, DOI 10.1016/j.apmr.2008.10.018; SINAKI M, 1993, OSTEOPOROSIS INT, V3, P8, DOI 10.1007/BF01623170; Steele CM, 2011, FOLIA PHONIATR LOGO, V63, P36, DOI 10.1159/000319737; Triano JJ, 2013, CHIROPR MAN THER, V21, DOI [10.1186/2045-709X-21-36, 10.1186/2045-709X-21-21]; Tsukada N, 2006, J CROSS-CULT GERONTO, V21, P121, DOI 10.1007/s10823-006-9028-9; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Yip CHT, 2008, MANUAL THER, V13, P148, DOI 10.1016/j.math.2006.11.002; Yoo WG, 2008, IND HEALTH, V46, P289, DOI 10.2486/indhealth.46.289; Yoo WG, 2009, IND HEALTH, V47, P183, DOI 10.2486/indhealth.47.183; Zemp R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/916045	46	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142617	10.1371/journal.pone.0142617	http://dx.doi.org/10.1371/journal.pone.0142617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581089	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600050
J	Chen, MC; Chen, YL; Lee, CF; Hung, CH; Chou, TC				Chen, Meng-Chuan; Chen, Yen-Lin; Lee, Chi-Feng; Hung, Chih-Huang; Chou, Tz-Chong			Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1	PLOS ONE			English	Article							GROWTH-FACTOR-I; MYOSTATIN; CACHEXIA; HYPERTROPHY; INTERLEUKIN-6; INHIBITION; EXPRESSION; PATHWAYS; PROTEIN; CELLS	Skeletal muscle atrophy, the most prominent phenotypic feature of cancer cachexia, is often observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from Magnolia officinalis exhibits several pharmacological effects including anti-inflammatory and anticancer activities. In this study, we investigated whether magnolol supplementation protects against the development of cachexia symptoms in bladder cancer-bearing mice undergoing chemotherapy. Combined treatment of magnolol with chemotherapeutic drugs, such as gemcitabine and cisplatin (TGCM) or gemcitabine (TGM), markedly attenuates the body weight loss and skeletal muscle atrophy compared with conventional chemotherapy (TGC). The antiatrophic effect of magnolol may be associated with inhibition of myostatin and activin A formation, as well as FoxO3 transcriptional activity resulting from Akt activation, thereby suppressing ubiquitin ligases MuRF-1 and MAFbx/atrogin-1 expression, as well as proteasomal enzyme activity. Notably, magnolol-induced insulin-like growth factor 1 (IGF-1) production and related protein synthesis may also contribute to its protective effects. The decreased food intake, and intestinal injury and dysfunction observed in the mice of TGC group were significantly improved in the TGCM and TGM groups. Moreover, the increased inflammatory responses evidenced by elevation of proinflammatory cytokine formation and NF-kappa B activation occurred in the atrophying muscle of TGC group were markedly inhibited in mice of combined treatment with magnolol. In summary, these findings support that magnolol is a promising chemopreventive supplement for preventing chemotherapy-induced skeletal muscle atrophy associated with cancer cachexia by suppressing muscle protein degradation, and inflammatory responses, as well as increasing IGF-1-mediated protein synthesis.	[Chen, Meng-Chuan; Chou, Tz-Chong] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chen, Yen-Lin] Cardinal Tien Hosp, Dept Pathol, New Taipei, Taiwan; [Chen, Yen-Lin] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Lee, Chi-Feng] Natl Def Med Ctr, Inst Prevent Med, Div Biopharmaceut, Taipei, Taiwan; [Hung, Chih-Huang; Chou, Tz-Chong] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chou, Tz-Chong] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chou, Tz-Chong] China Med Univ, China Med Univ Hosp, Taichung, Taiwan	National Defense Medical Center; Fu Jen Catholic University; National Defense Medical Center; Tzu Chi University; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chou, TC (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	tcchou48@mail.tcu.edu.tw			Tzu-Chi General Hospital [TDRD103-40]	Tzu-Chi General Hospital	This study was supported by a grant from Tzu-Chi General Hospital (TDRD103-40). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P2036, DOI 10.1016/j.biocel.2005.03.014; Aversa Z, 2012, ANN SURG ONCOL, V19, P1350, DOI 10.1245/s10434-011-1720-5; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Braun TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106489; Chen MC, 2013, BIOCHEM PHARMACOL, V85, P1278, DOI 10.1016/j.bcp.2013.02.009; Cohen MH, 2001, J CLIN ONCOL, V19, P1229, DOI 10.1200/JCO.2001.19.4.1229; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; de Palma L, 2008, JOINT BONE SPINE, V75, P53, DOI 10.1016/j.jbspin.2007.04.019; Donohoe CL, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/601434; Ebner N, 2014, CURR OPIN SUPPORT PA, V8, P15, DOI 10.1097/SPC.0000000000000030; Eley HL, 2007, BIOCHEM J, V407, P113, DOI 10.1042/BJ20070651; Elkina Y, 2011, J CACHEXIA SARCOPENI, V2, P143, DOI 10.1007/s13539-011-0035-5; Fanzani A, 2011, TOXICOL APPL PHARM, V250, P312, DOI 10.1016/j.taap.2010.11.003; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Ge XM, 2013, MOL CELL ENDOCRINOL, V372, P23, DOI 10.1016/j.mce.2013.03.017; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; LAZARUS DD, 1993, LYMPHOKINE CYTOK RES, V12, P219; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; MacDonald V, 2009, CAN VET J, V50, P665; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Narsale AA, 2014, CURR OPIN SUPPORT PA, V8, P321, DOI 10.1097/SPC.0000000000000091; Onesti JK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/168407; Rhoads MG, 2010, EUR J CANCER, V46, P191, DOI 10.1016/j.ejca.2009.10.008; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Soares PMG, 2008, CANCER CHEMOTH PHARM, V63, P91, DOI 10.1007/s00280-008-0715-9; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Strucksberg KH, 2010, ANAL BIOCHEM, V399, P225, DOI 10.1016/j.ab.2009.12.026; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wing SS, 2011, CRIT REV CL LAB SCI, V48, P49, DOI 10.3109/10408363.2011.586171; Yamamoto H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/276186; Yu DS, 2007, J UROLOGY, V177, P738, DOI 10.1016/j.juro.2006.09.074; Zheng ZY, 2013, INT J MED SCI, V10, P653, DOI 10.7150/ijms.6050; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	39	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143594	10.1371/journal.pone.0143594	http://dx.doi.org/10.1371/journal.pone.0143594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600425	Green Submitted, gold, Green Published			2022-12-27	WOS:000365862600091
J	Kyeong, S; Jeong, C; Kang, H; Cho, HJ; Park, SJ; Yang, JK; Kim, S; Kim, HM; Jun, BH; Lee, YS				Kyeong, San; Jeong, Cheolhwan; Kang, Homan; Cho, Hong-Jun; Park, Sung-Jun; Yang, Jin-Kyoung; Kim, Sehoon; Kim, Hyung-Mo; Jun, Bong-Hyun; Lee, Yoon-Sik			Double-Layer Magnetic Nanoparticle-Embedded Silica Particles for Efficient Bio-Separation	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; HOLLOW SPHERES; DRUG-DELIVERY; CELL-SEPARATION; QUANTUM DOTS; NANOCLUSTERS	Superparamagnetic Fe3O4 nanoparticles (NPs) based nanomaterials have been exploited in various biotechnology fields including biomolecule separation. However, slow accumulation of Fe3O4 NPs by magnets may limit broad applications of Fe3O4 NP-based nanomaterials. In this study, we report fabrication of Fe3O4 NPs double-layered silica nanoparticles (DL MNPs) with a silica core and highly packed Fe3O4 NPs layers. The DL MNPs had a superparamagnetic property and efficient accumulation kinetics under an external magnetic field. Moreover, the magnetic field-exposed DL MNPs show quantitative accumulation, whereas Fe3O4 NPs single-layered silica nanoparticles (SL MNPs) and silica-coated Fe3O4 NPs produced a saturated plateau under full recovery of the NPs. DL MNPs are promising nanomaterials with great potential to separate and analyze biomolecules.	[Kyeong, San; Jeong, Cheolhwan; Park, Sung-Jun; Yang, Jin-Kyoung; Lee, Yoon-Sik] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Kang, Homan] Seoul Natl Univ, Nano Syst Inst, Seoul, South Korea; [Kang, Homan] Seoul Natl Univ, Interdisciplinary Program Nanosci & Technol, Seoul, South Korea; [Cho, Hong-Jun; Kim, Sehoon] Korea Inst Sci & Technol, Ctr Theragnosis, Seoul, South Korea; [Kim, Hyung-Mo; Jun, Bong-Hyun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Konkuk University	Jun, BH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	bjun@konkuk.ac.kr; yslee@snu.ac.kr	Kang, Homan/I-1528-2013; Lee, Yoon-Sik/W-3770-2018	Kang, Homan/0000-0002-0732-9779; Kim, Hyung-Mo/0000-0001-8507-089X	National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning [2014-A002-0065]	National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT & Future Planning(2014-A002-0065). Consulting service from Microbial Carbohydrate Resource Bank (MCRB) is gratefully acknowledged.	Amstad E, 2009, NANO LETT, V9, P4042, DOI 10.1021/nl902212q; Bai LL, 2014, J MATER CHEM B, V2, P4080, DOI 10.1039/c4tb00456f; Bourgeat-Lami E, 1998, J COLLOID INTERF SCI, V197, P293, DOI 10.1006/jcis.1997.5265; Bucak S, 2003, BIOTECHNOL PROGR, V19, P477, DOI 10.1021/bp0200853; Caruso F, 2001, CHEM MATER, V13, P109, DOI 10.1021/cm001164h; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; De M, 2008, ADV MATER, V20, P4225, DOI 10.1002/adma.200703183; Di Corato R, 2011, ACS NANO, V5, P1109, DOI 10.1021/nn102761t; Graf C, 2003, LANGMUIR, V19, P6693, DOI 10.1021/la0347859; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hui C, 2011, NANOSCALE, V3, P701, DOI 10.1039/c0nr00497a; Insin N, 2008, ACS NANO, V2, P197, DOI 10.1021/nn700344x; Jeong U, 2007, ADV MATER, V19, P33, DOI 10.1002/adma.200600674; Jia L, 2014, CHEM-EUR J, V20, P2065, DOI 10.1002/chem.201303659; Lalatonne Y, 2004, NAT MATER, V3, P121, DOI 10.1038/nmat1054; Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t; Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866; Mahmoudi M, 2011, ADV DRUG DELIVER REV, V63, P24, DOI 10.1016/j.addr.2010.05.006; Ovsyannikov SV, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/17/172201; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Rho WY, 2014, J IND ENG CHEM, V20, P2646, DOI 10.1016/j.jiec.2013.12.014; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; SONTI SV, 1995, J COLLOID INTERF SCI, V170, P575, DOI 10.1006/jcis.1995.1137; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Stoeva SI, 2005, J AM CHEM SOC, V127, P15362, DOI 10.1021/ja055056d; Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018; Tadic M, 2014, APPL SURF SCI, V322, P255, DOI 10.1016/j.apsusc.2014.09.181; Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202; Tartaj P, 2001, ADV MATER, V13, P1620, DOI 10.1002/1521-4095(200111)13:21<1620::AID-ADMA1620>3.0.CO;2-Z; Teja AS, 2009, PROG CRYST GROWTH CH, V55, P22, DOI 10.1016/j.pcrysgrow.2008.08.003; Vollmer C, 2011, COORDIN CHEM REV, V255, P2039, DOI 10.1016/j.ccr.2011.03.005; Xu CJ, 2004, J AM CHEM SOC, V126, P3392, DOI 10.1021/ja031776d; Xu HY, 2011, BIOMATERIALS, V32, P9758, DOI 10.1016/j.biomaterials.2011.08.076; Yi DK, 2005, J AM CHEM SOC, V127, P4990, DOI 10.1021/ja0428863	35	20	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143727	10.1371/journal.pone.0143727	http://dx.doi.org/10.1371/journal.pone.0143727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599084	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600110
J	Wang, Y; Ding, JT; Yang, HM; Yan, ZJ; Cao, W; Li, YB				Wang, Ying; Ding, Jia-tong; Yang, Hai-ming; Yan, Zheng-jie; Cao, Wei; Li, Yang-bai			Analysis of Pigeon (Columba) Ovary Transcriptomes to Identify Genes Involved in Blue Light Regulation	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; ACTIVATED PROTEIN-KINASE; RNA-SEQ DATA; CIRCADIAN CLOCK; FOLLICULAR DEVELOPMENT; MONOCHROMATIC LIGHT; MEIOTIC MATURATION; ESTROGEN-RECEPTOR; IMMUNE-RESPONSE; JAPANESE-QUAIL	Monochromatic light is widely applied to promote poultry reproductive performance, yet little is currently known regarding the mechanism by which light wavelengths affect pigeon reproduction. Recently, high-throughput sequencing technologies have been used to provide genomic information for solving this problem. In this study, we employed Illumina Hiseq 2000 to identify differentially expressed genes in ovary tissue from pigeons under blue and white light conditions and de novo transcriptome assembly to construct a comprehensive sequence database containing information on the mechanisms of follicle development. A total of 157,774 unigenes (mean length: 790 bp) were obtained by the Trinity program, and 35.83% of these unigenes were matched to genes in a non-redundant protein database. Gene description, gene ontology, and the clustering of orthologous group terms were performed to annotate the transcriptome assembly. Differentially expressed genes between blue and white light conditions included those related to oocyte maturation, hormone biosynthesis, and circadian rhythm. Furthermore, 17,574 SSRs and 533,887 potential SNPs were identified in this transcriptome assembly. This work is the first transcriptome analysis of the Columba ovary using Illumina technology, and the resulting transcriptome and differentially expressed gene data can facilitate further investigations into the molecular mechanism of the effect of blue light on follicle development and reproduction in pigeons and other bird species.	[Wang, Ying; Ding, Jia-tong; Yang, Hai-ming; Yan, Zheng-jie; Cao, Wei; Li, Yang-bai] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University	Ding, JT (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China.	jtding@yzu.edu.cn; hmyang@yzu.edu.cn			Priority Academic Program Development of Jiangsu Higher Education Institutions; Cultivate Funding of Six Kinds of High-level Personnel Selection in Jiangsu Province [2014 - NY - 036]	Priority Academic Program Development of Jiangsu Higher Education Institutions; Cultivate Funding of Six Kinds of High-level Personnel Selection in Jiangsu Province	This research was funded by grants from A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and The Cultivate Funding of Six Kinds of High-level Personnel Selection in Jiangsu Province (2014 - NY - 036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHOFF J, 1966, ECOLOGY, V47, P657, DOI 10.2307/1933949; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Campbell CL, 2015, POULTRY SCI; Choi TS, 1996, P NATL ACAD SCI USA, V93, P7032, DOI 10.1073/pnas.93.14.7032; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; FOSS DC, 1983, POULTRY SCI, V62, P1424; Gieffers C, 2001, MOL CELL, V7, P907, DOI 10.1016/S1097-2765(01)00234-9; Goerlich VC, 2010, J EXP ZOOL PART A, V313A, P328, DOI 10.1002/jez.600; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu HC, 2004, ENCY PIGEON BREEDING, P2; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Halevy O, 2006, AM J PHYSIOL-REG I, V290, pR1062, DOI 10.1152/ajpregu.00378.2005; HORSEMAN ND, 1995, ANNU REV NUTR, V15, P213; Hoshino Y, 2004, MOL REPROD DEV, V69, P77, DOI 10.1002/mrd.20150; Hussein TS, 2006, DEV BIOL, V296, P514, DOI 10.1016/j.ydbio.2006.06.026; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kunstner A, 2010, MOL ECOL, V19, P266, DOI 10.1111/j.1365-294X.2009.04487.x; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lewis PD, 2000, WORLD POULTRY SCI J, V56, P189, DOI 10.1079/WPS20000015; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Liu WJ, 2010, ANAT REC, V293, P1315, DOI 10.1002/ar.21174; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Maurer G, 2011, J AVIAN BIOL, V42, P494, DOI 10.1111/j.1600-048X.2011.05368.x; McGinnis J, 1967, PACIFIC POULTRYMAN, P24; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullis PE, 1997, J CLIN ENDOCR METAB, V82, P1739, DOI 10.1210/jc.82.6.1739; Nakao N, 2007, ENDOCRINOLOGY, V148, P3031, DOI 10.1210/en.2007-0044; NEBERT DW, 1987, DNA-J MOLEC CELL BIO, V6, P1, DOI 10.1089/dna.1987.6.1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; RIDDLE OSCAR, 1963, ANIMAL BEHAVIOUR, V11, P419, DOI 10.1016/0003-3472(63)90256-2; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Sadrzadeh A, 2011, AFR J BIOTECHNOL, V10, P9528; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; Schmitt A, 2002, J CELL SCI, V115, P2457; SILVER R, 1984, J EXP ZOOL, V232, P617, DOI 10.1002/jez.1402320330; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Thomas P, 2006, STEROIDS, V71, P310, DOI 10.1016/j.steroids.2005.09.015; Wang Y, 2015, POULTRY SCI; WASSERMAN WJ, 1982, DEV BIOL, V89, P152, DOI 10.1016/0012-1606(82)90303-7; WOODARD AE, 1969, POULTRY SCI, V48, P118, DOI 10.3382/ps.0480118; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Wunderer F, 2013, ENDOCRINOLOGY, V154, P2046, DOI 10.1210/en.2012-2274; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Xie D, 2008, POULTRY SCI, V87, P1535, DOI 10.3382/ps.2007-00317; Xu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055496; Yadav S, 2015, PHYSIOL BEHAV, V147, P163, DOI 10.1016/j.physbeh.2015.04.036; Yamamura K, 2014, MOL CELL ENDOCRINOL, V382, P131, DOI 10.1016/j.mce.2013.09.014; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshino O, 2006, P NATL ACAD SCI USA, V103, P10678, DOI 10.1073/pnas.0600507103; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zhang H, 2014, GENET MOL RES, V13, P1926, DOI 10.4238/2014.March.17.20; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhao WL, 1993, PRODUCTION SPECIAL E, P12	65	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143568	10.1371/journal.pone.0143568	http://dx.doi.org/10.1371/journal.pone.0143568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599806	Green Submitted, gold, Green Published			2022-12-27	WOS:000365862600087
J	Daubenspeck, JM; Jordan, DS; Simmons, W; Renfrow, MB; Dybvig, K				Daubenspeck, James M.; Jordan, David S.; Simmons, Warren; Renfrow, Matthew B.; Dybvig, Kevin			General N-and O-Linked Glycosylation of Lipoproteins in Mycoplasmas and Role of Exogenous Oligosaccharide	PLOS ONE			English	Article							PROTEIN GLYCOSYLATION; PULMONIS; SYSTEM; GENOME; ARTHRITIDIS; HOST	The lack of a cell wall, flagella, fimbria, and other extracellular appendages and the possession of only a single membrane render the mycoplasmas structurally simplistic and ideal model organisms for the study of glycoconjugates. Most species have genomes of about 800 kb and code for few proteins predicted to have a role in glycobiology. The murine pathogens Mycoplasma arthritidis and Mycoplasma pulmonis have only a single gene annotated as coding for a glycosyltransferase but synthesize glycolipid, polysaccharide and glycoproteins. Previously, it was shown that M. arthritidis glycosylated surface lipoproteins through O-linkage. In the current study, O-linked glycoproteins were similarly found in M. pulmonis and both species of mycoplasma were found to also possess N-linked glycans at residues of asparagine and glutamine. Protein glycosylation occurred at numerous sites on surface-exposed lipoproteins with no apparent amino acid sequence specificity. The lipoproteins of Mycoplasma pneumoniae also are glycosylated. Glycosylation was dependent on the glycosidic linkages from host oligosaccharides. As far as we are aware, N-linked glycoproteins have not been previously described in Gram-positive bacteria, the organisms to which the mycoplasmas are phylogenetically related. The findings indicate that the mycoplasma cell surface is heavily glycosylated with implications for the modulation of mycoplasma-host interactions.	[Daubenspeck, James M.; Simmons, Warren; Dybvig, Kevin] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA; [Jordan, David S.; Dybvig, Kevin] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Renfrow, Matthew B.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Dybvig, K (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA.	dybvig@uab.edu		Renfrow, Matthew B./0000-0002-4193-7305	National Institutes of Health [AI63909, AI93750]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093750, R01AI063909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI63909 and AI93750) to KD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonsen JH, 2012, J PROTEOME RES, V11, P5781, DOI 10.1021/pr300584x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brooks SA, 2009, MOL BIOTECHNOL, V43, P76, DOI 10.1007/s12033-009-9184-6; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Coyne MJ, 2013, MOL MICROBIOL, V88, P772, DOI 10.1111/mmi.12220; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Daubenspeck JM, 2009, MOL MICROBIOL, V72, P1235, DOI 10.1111/j.1365-2958.2009.06720.x; Dybvig K, 2008, INFECT IMMUN, V76, P4000, DOI 10.1128/IAI.00516-08; Dybvig K, 2010, FEMS MICROBIOL LETT, V311, P51, DOI 10.1111/j.1574-6968.2010.02078.x; Fletcher CM, 2011, J BIOL CHEM, V286, P3219, DOI 10.1074/jbc.M110.194506; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Gedcke D. A., 2001, AN58 ORTEC; Herrmann JL, 2000, FEBS LETT, V473, P358, DOI 10.1016/S0014-5793(00)01553-2; Iwashkiw JA, 2013, MOL MICROBIOL, V89, P14, DOI 10.1111/mmi.12265; Jordan DS, 2013, MOL MICROBIOL, V90, P1046, DOI 10.1111/mmi.12415; Jordan DS, 2013, MOL MICROBIOL, V89, P918, DOI 10.1111/mmi.12320; LINDSEY JR, 1971, AM J PATHOL, V64, P675; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lu QH, 2015, TRENDS MICROBIOL, V23, P630, DOI 10.1016/j.tim.2015.07.003; Luo WY, 2008, INFECT IMMUN, V76, P4989, DOI 10.1128/IAI.00667-08; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Plou FJ, 2002, CAN J CHEM, V80, P743, DOI 10.1139/V02-104; Russell D, 2009, CARBOHYD RES, V344, P1508, DOI 10.1016/j.carres.2009.06.033; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Simmons WL, 2013, MICROBIOL-SGM, V159, P737, DOI 10.1099/mic.0.064782-0; Staats CC, 2007, GENET MOL BIOL, V30, P225, DOI 10.1590/S1415-47572007000200009; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Valliere-Douglass JF, 2010, J BIOL CHEM, V285, P16012, DOI 10.1074/jbc.M109.096412; Wise Kim S., 1995, P227, DOI 10.1016/B978-012583805-4/50024-8; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	31	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143362	10.1371/journal.pone.0143362	http://dx.doi.org/10.1371/journal.pone.0143362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599081	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900099
J	He, YF; Wang, CQ; Yu, Y; Qian, J; Song, K; Sun, QM; Zhou, J				He, Yi-Feng; Wang, Chao-Qun; Yu, Yao; Qian, Jing; Song, Kang; Sun, Qi-Man; Zhou, Jian			Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection	PLOS ONE			English	Article							EXPRESSION; ANGIOGENESIS; CELLS	Background Tie2-expressing monocytes (TEMs) are found in various tumors, involved in forming tumor blood vessels and expressing several important proangiogenic factors. The goals of this study were to evaluate the value of TEMs in diagnosing and predicting the prognosis of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Methods Flow cytometry was performed to identify and count TEMs in peripheral blood monocytes from HCC patients (n = 84) receiving hepatectomy, HBV cirrhotic patients (n = 21), benign tumors patients (n = 15) and healthy volunteers (n = 23). Angiopoietin-2 (Ang-2) levels in the plasma were determined by enzyme linked immunosorbent assay. The distribution of TEMs in tumor tissue was observed by immunofluorescence staining. Then we determined the vascular area as a percentage of tumor area (vascular area/tumor area) by immunohistochemical staining. Finally the prognostic significance of TEMs and other clinicopathologic factors was evaluated. Results Percentage of TEMs in peripheral blood monocytes significantly increased in HCC patients compared with HBV cirrhotic patients and healthy donors (both P < 0.001). However there was no significance in benign liver tumor (P = 0.482). In addition, the percentage of circulating TEMs was positively correlated with plasma Ang-2 concentration (P < 0.001, r(2) = 0.294) and vascular area/tumor area (P < 0.001, r(2) = 0.126). Furthermore the percentage of intratumoral TEMs was significantly higher than that of paratumoral TEMs (P < 0.001). Increased circulating TEMs was associated with poor overall survival (P = 0.043) and a shorter time to recurrence (P = 0.041). Multivariate Cox analysis also revealed that the percentage of TEMs in peripheral blood was an independent factor for HCC patients' prognosis. Conclusions TEMs may promote angiogenesis in HCC regarding the angiopoietin/Tie2 signal pathway. Percentage of TEMs in peripheral blood monocytes may be applied as a biomarker for identifying HBV-related HCC and predicting the prognosis of these patients after resection.	[He, Yi-Feng; Wang, Chao-Qun; Yu, Yao; Song, Kang; Sun, Qi-Man; Zhou, Jian] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg, Shanghai 200032, Peoples R China; [He, Yi-Feng; Wang, Chao-Qun; Yu, Yao; Song, Kang; Sun, Qi-Man; Zhou, Jian] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Qian, Jing] Fudan Univ, Dept Immunol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhou, Jian] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhou, J (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg, Shanghai 200032, Peoples R China.	zhou.jian@zs-hospital.sh.cn		Zhou, Jian/0000-0002-7650-7540	National Natural Science Foundation of China [81101805]; Shanghai Health Bureau Scientific Research Found Projects [2009Y007]; Central Universities Research Found Projects for Improving Young Teachers' Ability of Fudan University [JJF152045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Health Bureau Scientific Research Found Projects; Central Universities Research Found Projects for Improving Young Teachers' Ability of Fudan University	This work was supported by grants from National Natural Science Foundation of China (No. 81101805; www.nsfc.gov.cn; YFH), Shanghai Health Bureau Scientific Research Found Projects (No. 2009Y007; www.wsjsw.gov.cn/wsj/; YFH) and Central Universities Research Found Projects for Improving Young Teachers' Ability of Fudan University (No. JJF152045; www.fudan.edu.cn; YFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chebib I, 2007, BIOMARK INSIGHTS, V2, P59; Coffelt SB, 2011, J IMMUNOL, V186, P4183, DOI 10.4049/jimmunol.1002802; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Escobar G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006353; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Forget MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098623; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Goede V, 2012, CANCER INVEST, V30, P225, DOI 10.3109/07357907.2011.636114; Huang HH, 2011, CLIN CANCER RES, V17, P1001, DOI 10.1158/1078-0432.CCR-10-2317; Lekas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043568; Matsubara T, 2012, HEPATOLOGY; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sugimachi K, 2003, J CLIN PATHOL, V56, P854, DOI 10.1136/jcp.56.11.854; Tanaka F, 2002, CANCER RES, V62, P7124; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562; Yu Y, 2001, AM J PATHOL, V159, P2271, DOI 10.1016/S0002-9440(10)63077-5	21	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143657	10.1371/journal.pone.0143657	http://dx.doi.org/10.1371/journal.pone.0143657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599011	Green Published, gold			2022-12-27	WOS:000365853900152
J	Maruyama, Y; Yokoyama, K; Yokoo, T; Shigematsu, T; Iseki, K; Tsubakihara, Y				Maruyama, Yukio; Yokoyama, Keitaro; Yokoo, Takashi; Shigematsu, Takashi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu			The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ERYTHROPOIETIN REQUIREMENTS; RECEIVING HEMODIALYSIS; ANEMIA MANAGEMENT; PRACTICE PATTERNS; RISK-FACTORS; DOUBLE-BLIND; IRON; HEMOGLOBIN; METAANALYSIS	Background/Aims Monitoring of serum ferritin levels is widely recommended in the management of anemia among patients on dialysis. However, associations between serum ferritin and mortality are unclear and there have been no investigations among patients undergoing peritoneal dialysis (PD). Methods Baseline data of 191,902 patients on dialysis (age, 65 +/- 13 years; male, 61.1%; median dialysis duration, 62 months) were extracted from a nationwide dialysis registry in Japan at the end of 2007. Outcomes, such as one-year mortality, were then evaluated using the registry at the end of 2008. Results Within one year, a total of 15,284 (8.0%) patients had died, including 6,210 (3.2%) cardiovascular and 2,707 (1.4%) infection-related causes. Higher baseline serum ferritin levels were associated with higher mortality rates among patients undergoing hemodialysis (HD). In contrast, there were no clear associations between serum ferritin levels and mortality among PD patients. Multivariate Cox regression analysis of HD patients showed that those in the highest serum ferritin decile group had higher rates of all-cause and cardiovascular mortality than those in the lowest decile group (hazard ratio [HR], 1.54; 95% confidence interval [CI], 1.31-1.81 and HR, 1.44; 95% CI, 1.13-1.84, respectively), whereas associations with infection-related mortality became non-significant (HR, 1.14; 95% CI, 0.79-1.65). Conclusions Using Japanese nationwide dialysis registry, higher serum ferritin values were associated with mortality not in PD patients but in HD patients.	[Maruyama, Yukio; Yokoyama, Keitaro; Yokoo, Takashi] Jikei Univ, Sch Med, Div Nephrol & Hypertens, Tokyo, Japan; [Shigematsu, Takashi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan	Jikei University	Maruyama, Y (corresponding author), Jikei Univ, Sch Med, Div Nephrol & Hypertens, Tokyo, Japan.	maruyama@td5.so-net.ne.jp						Akizawa T, 2014, THER APHER DIAL, V18, P24, DOI 10.1111/1744-9987.12202; [Anonymous], 2004, NEPHROL DIAL TRANSPL, V19, pii1; Bailie GR, 2013, NEPHROL DIAL TRANSPL, V28, P2570, DOI 10.1093/ndt/gft062; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Coronel F, 2003, J NEPHROL, V16, P697; Coyne DW, 2011, KIDNEY INT, V80, P240, DOI 10.1038/ki.2011.141; Cuevas X, 2012, BLOOD PURIFICAT, V33, P21, DOI 10.1159/000332395; Galic G, 2011, COLLEGIUM ANTROPOL, V35, P93; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hasuike Y, 2010, CLIN EXP NEPHROL, V14, P349, DOI 10.1007/s10157-010-0288-x; House AA, 1998, NEPHROL DIAL TRANSPL, V13, P1763, DOI 10.1093/ndt/13.7.1763; Ichii H, 2012, AM J NEPHROL, V36, P50, DOI 10.1159/000339285; Ishida JH, 2014, SEMIN DIALYSIS, V27, P26, DOI 10.1111/sdi.12168; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Kalantar-Zadeh K, 2006, CLIN J AM SOC NEPHRO, V1, pS9, DOI 10.2215/CJN.01390406; Kuragano T, 2014, KIDNEY INT, V86, P845, DOI 10.1038/ki.2014.114; Langston RD, 2003, KIDNEY INT, V64, P1398, DOI 10.1046/j.1523-1755.2003.00200.x; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Li SL, 2004, KIDNEY INT, V65, P1864, DOI 10.1111/j.1523-1755.2004.00584.x; Litton E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4822; Maruyama Y, 2012, CLIN NEPHROL, V78, P281, DOI 10.5414/CN107424; McFarlane PA, 2010, KIDNEY INT, V78, P215, DOI 10.1038/ki.2010.108; Molnar MZ, 2011, CLIN J AM SOC NEPHRO, V6, P1973, DOI 10.2215/CJN.01050211; Nakai S, 2009, THER APHER DIAL, V13, P457, DOI 10.1111/j.1744-9987.2009.00789.x; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Pollak VE, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-6; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Wetmore JB, 2015, AM J NEPHROL, V41, P354, DOI 10.1159/000431335	30	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143430	10.1371/journal.pone.0143430	http://dx.doi.org/10.1371/journal.pone.0143430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599216	Green Submitted, gold, Green Published			2022-12-27	WOS:000365853900119
J	Mishra, SR; Sharma, A; Bhandari, PM; Bhochhibhoya, S; Thapa, K				Mishra, Shiva Raj; Sharma, Abhishek; Bhandari, Parash Mani; Bhochhibhoya, Shristi; Thapa, Kiran			Depression and Health-Related Quality of Life among Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Nepal	PLOS ONE			English	Article							PREVALENCE; EQ-5D; CARE	Background Diabetes is accompanied by a marked reduction in patient's quality of life (QOL) and leads to higher disability-adjusted life years than most diseases. Depression further deteriorates QOL and is associated with poor treatment outcomes and lowered glycemic control in diabetes. We analysed the QOL and depression among the people living with diabetes in Nepal. Methods We conducted a cross-sectional survey among a random sample of 157 diabetic patients visiting diabetes clinic at a major teaching hospital in Kathmandu, Nepal. We administered the Nepali version of WHO-BREF for face to face interviews to obtain data on QOL scores. The Nepali version of Patient Health Questionnaire-9was also used to record responses on depression items. Results More than half of the respondents (54.1%) experienced depression with mean PHQ-9 score of 6.15 +/- 5.01 on a scale of 0-27. On a scale of 0 to 100, highest QOL mean score was reported in social relationship domain (57.32 +/- 11.83), followed by environment domain (54.71 +/- 7.74), psychological health (53.25 +/- 10.32) and physical health (50.74 +/- 11.83). After adjusting for other covariates, urban residence decreased the physical health score by 4.74 (beta = -4.74, 95% CI: -8.664,-0.821), social relationship domain score by 3.420 (beta = -3.420, 95% CI: -6.433,-0.406) and the overall QOL by 2.773 (beta = -2.773, 95% CI: -5.295,0.252). Having diagnosed with diabetes since more than 10 years increased physical health by 5.184 score points (beta = 5.184; 95% CI: 0.753, 9.615). Similarly, having severe depression decreased social relation domain score by 6.053 (beta = -6.053, 95% CI:-11.169,-. 936). Conclusion Having urban residence significantly decreased the physical health and social relation domain scores as well as the overall QOL scores. Similarly, having diagnosed since more than 10 years increased physical health domain score. Severe depression decreased social relationship domain score. Since depression affects QOL, we suggest early diagnosis and prompt treatment of depression in T2DM people as part of their routine primary care in Nepal.	[Mishra, Shiva Raj] Nepal Dev Soc, Bharatpur 10, Chitwan, Nepal; [Sharma, Abhishek] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Sharma, Abhishek] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA; [Bhandari, Parash Mani; Bhochhibhoya, Shristi; Thapa, Kiran] Tribhuvan Univ, Inst Med, Kathmandu, Nepal	Boston University; Boston University; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Mishra, SR (corresponding author), Nepal Dev Soc, Bharatpur 10, Chitwan, Nepal.	shivarajmishra@gmail.com	Mishra, Shiva Raj/C-4172-2014; Sharma, Abhishek/D-3730-2017	Mishra, Shiva Raj/0000-0002-2993-3504; 	Department of Medicine, Maharajgunj Medical Campus	Department of Medicine, Maharajgunj Medical Campus	We thank all the study participants for their time and information. We are grateful to the Department of Medicine, Maharajgunj Medical Campus and the staff members for their generous support during the study. We also thank Dipika Neupane, Sabita Thapa and Sarmila Dhakal for their support during data collection.	Baral N., 2000, SMJ, V41, P264; Bloom DE., 2012, GLOBAL EC BURDEN NON; Chaveepojnkamjorn Wisit, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P328; Chhetri M R, 2009, Nepal Med Coll J, V11, P34; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Eren I, 2008, DEPRESS ANXIETY, V25, P98, DOI 10.1002/da.20288; Giri S, 2013, HIV AIDS-RES PALLIAT, V5, P277, DOI 10.2147/HIV.S50726; Grandy S, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-99; Institute of Digital Research and Education UCLA, SPSS FAQ WHAT DOES C; Kiadaliri AA, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-54; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Porojan M, 2012, Rom J Intern Med, V50, P27; Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6; Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828; Sharma A, 2015, BMJ-BRIT MED J, V2015, ph2430; Shrestha S S, 2013, Kathmandu Univ Med J (KUMJ), V11, P226; Singh DL, 2003, DIABETIC MED, V20, P170, DOI 10.1046/j.1464-5491.2003.00829_4.x; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Thommasen Harvey V, 2005, Rural Remote Health, V5, P441; Wandell PE, 2005, SCAND J PRIM HEALTH, V23, P68, DOI 10.1080/02813430510015296; World Health Organization, PREV DIAB S E AS REG; World Health Organization, 1996, WHOQOL BRIEF INTR AD; Yekta Z, 2011, DIABETES METAB SYNDR, V4, P393, DOI 10.2147/DMSO.S27050	26	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141385	10.1371/journal.pone.0141385	http://dx.doi.org/10.1371/journal.pone.0141385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599008	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900011
J	Yun, D; Jeong, D; Cho, E; Jung, S				Yun, Deokgyu; Jeong, Daham; Cho, Eunae; Jung, Seunho			Colorimetric Detection of Some Highly Hydrophobic Flavonoids Using Polydiacetylene Liposomes Containing Pentacosa-10,12-diynoyl Succinoglycan Monomers	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI; SOLUBILITY ENHANCEMENT; MOLECULAR RECOGNITION; PLANT INTERACTIONS; BETA-CYCLODEXTRIN; COMPLEXATION; ACID; TRANSITION; SEPARATION; BACTERIA	Flavonoids are a group of plant secondary metabolites including polyphenolic molecules, and they are well known for antioxidant, anti-allergic, anti-inflammatory and anti-viral propertied. In general, flavonoids are detected with various non-colorimetric detection methods such as column liquid chromatography, thin-layer chromatography, and electrochemical analysis. For the first time, we developed a straightforward colorimetric detection system allowing recognition of some highly hydrophobic flavonoids such as alpha-naphthoflavone and beta-naphthoflavone, visually using 10,12-pentacosadiynoic acid (PCDA) derivatized with succinoglycan monomers isolated from Sinorhizobium meliloti. Besides changes in visible spectrum, we also demonstrate fluorescence changes using our detection system in the presence of those flavonoids. The succinoglycan monomers attached to PCDA molecules may function as an unstructured molecular capturer for some highly hydrophobic flavonoids by hydrophobic interactions, and transmit their molecular interactions as a color change throughout the PCDA liposome.	[Yun, Deokgyu; Jeong, Daham; Jung, Seunho] Konkuk Univ, Dept Biosci & Biotechnol, MCRB, Seoul, South Korea; [Yun, Deokgyu; Jeong, Daham; Cho, Eunae; Jung, Seunho] Konkuk Univ, Ctr Biotechnol Res UBITA CBRU, Seoul, South Korea; [Cho, Eunae] Konkuk Univ, Inst Ubiquitous Informat Technol & Applicat UBITA, Seoul, South Korea	Konkuk University; Konkuk University; Konkuk University	Jung, S (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, MCRB, Seoul, South Korea.	shjung@konkuk.ac.kr	Jung, Seunho/D-4555-2011	cho, eunae/0000-0002-5422-9463	Konkuk University; SDG	Konkuk University; SDG	This paper was supported by Konkuk University in 2014.; This paper was supported by Konkuk University in 2014. SDG.	Ahmad N, 2004, J INVEST DERMATOL, V123, P417, DOI 10.1111/j.0022-202X.2004.23307.x; Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637; Brady B., 2000, ORG SYNTH, V77, P220, DOI DOI 10.15227/ORGSYN.077.0220; Brencic A, 2005, MICROBIOL MOL BIOL R, V69, P155, DOI 10.1128/MMBR.69.1.155-194.2005; Charych D, 1996, CHEM BIOL, V3, P113, DOI 10.1016/S1074-5521(96)90287-2; CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021; Cheng Q, 1997, ADV MATER, V9, P481, DOI 10.1002/adma.19970090605; Cheng Q, 1998, LANGMUIR, V14, P1974, DOI 10.1021/la980185b; Cho E, 2014, J INCL PHENOM MACRO, V80, P427, DOI 10.1007/s10847-014-0431-5; Cho E, 2014, CARBOHYD RES, V389, P141, DOI 10.1016/j.carres.2013.12.015; Cho E, 2013, J INCL PHENOM MACRO, V76, P133, DOI 10.1007/s10847-012-0182-0; Choi JM, 2012, B KOREAN CHEM SOC, V33, P2091, DOI 10.5012/bkcs.2012.33.6.2091; Cote GL, 1995, KIRK OTHMER ENCY CHE; Datta A, 2015, CANCER LETT, V362, P25, DOI 10.1016/j.canlet.2015.03.009; de Rijke E, 2006, J CHROMATOGR A, V1112, P31, DOI 10.1016/j.chroma.2006.01.019; Ficarra R, 2002, J PHARMACEUT BIOMED, V29, P1005, DOI 10.1016/S0731-7085(02)00141-3; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Ji EK, 2003, B KOR CHEM SOC, V24, P667; Kim K, 2014, CARBOHYD POLYM, V106, P101, DOI 10.1016/j.carbpol.2014.02.017; Kolusheva S, 2001, J AM CHEM SOC, V123, P417, DOI 10.1021/ja0034139; Kumar S, 2013, SCI WORLD J, V2013; Kwon C, 2011, CARBOHYD RES, V346, P2308, DOI 10.1016/j.carres.2011.07.023; Kwon C, 2009, CARBOHYD RES, V344, P1347, DOI 10.1016/j.carres.2009.05.018; Kwon C, 2008, ELECTROPHORESIS, V29, P4284, DOI 10.1002/elps.200800127; Lee DC, 2002, MACROMOLECULES, V35, P4347, DOI 10.1021/ma011860i; Lee HY, 2011, SOFT MATTER, V7, P3273, DOI 10.1039/c0sm01243b; Lee J, 2008, J AM CHEM SOC, V130, P5010, DOI 10.1021/ja709996c; Lee J, 2009, ADV MATER, V21, P3674, DOI 10.1002/adma.200900639; Matsumoto K, 1998, INORG CHIM ACTA, V272, P162, DOI 10.1016/S0020-1693(97)06065-9; Mierziak J, 2014, MOLECULES, V19, P16240, DOI 10.3390/molecules191016240; Morris VJ, 1991, FOOD HYDROCOLLOID, V5, P185, DOI 10.1016/S0268-005X(09)80312-3; OLMSTED J, 1983, J PHYS CHEM-US, V87, P4790, DOI 10.1021/j150642a006; Pan JJ, 1997, LANGMUIR, V13, P1365, DOI 10.1021/la9602675; Rothwell JA, 2005, J AGR FOOD CHEM, V53, P4355, DOI 10.1021/jf0483669; Saenger WR, 1998, CHEM REV, V98, P1787, DOI 10.1021/cr9700181; Seo S, 2013, MACROMOL RAPID COMM, V34, P743, DOI 10.1002/marc.201200819; Sutherland IW, 1998, TRENDS BIOTECHNOL, V16, P41, DOI 10.1016/S0167-7799(97)01139-6; Thongmalai W, 2011, J MATER CHEM, V21, P16391, DOI 10.1039/c1jm12795k; Tommasini S, 2004, J PHARMACEUT BIOMED, V35, P379, DOI 10.1016/S0731-7085(03)00647-2; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Wang CG, 2005, ANAL BIOANAL CHEM, V382, P1708, DOI 10.1007/s00216-005-3345-7; Wang LX, 1999, J BACTERIOL, V181, P6788, DOI 10.1128/JB.181.21.6788-6796.1999	42	11	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143454	10.1371/journal.pone.0143454	http://dx.doi.org/10.1371/journal.pone.0143454			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600071	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900125
J	Ma, L; Han, X; Shen, ZS; Wang, WX; Di, ZR				Ma, Long; Han, Xiao; Shen, Zhesi; Wang, Wen-Xu; Di, Zengru			Efficient Reconstruction of Heterogeneous Networks from Time Series via Compressed Sensing	PLOS ONE			English	Article							EVOLUTIONARY GAMES	Recent years have witnessed a rapid development of network reconstruction approaches, especially for a series of methods based on compressed sensing. Although compressed-sensing based methods require much less data than conventional approaches, the compressed sensing for reconstructing heterogeneous networks has not been fully exploited because of hubs. Hub neighbors require much more data to be inferred than small-degree nodes, inducing a cask effect for the reconstruction of heterogeneous networks. Here, a conflict-based method is proposed to overcome the cast effect to considerably reduce data amounts for achieving accurate reconstruction. Moreover, an element elimination method is presented to use the partially available structural information to reduce data requirements. The integration of both methods can further improve the reconstruction performance than separately using each technique. These methods are validated by exploring two evolutionary games taking place in scale-free networks, where individual information is accessible and an attempt to decode the network structure from measurable data is made. The results demonstrate that for all of the cases, much data are saved compared to that in the absence of these two methods. Due to the prevalence of heterogeneous networks in nature and society and the high cost of data acquisition in large-scale networks, these approaches have wide applications in many fields and are valuable for understanding and controlling the collective dynamics of a variety of heterogeneous networked systems.	[Ma, Long; Han, Xiao; Shen, Zhesi; Wang, Wen-Xu; Di, Zengru] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Beijing Normal University	Wang, WX (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	wenxuwang@bnu.edu.cn; zdi@bnu.edu.cn	Shen, Zhesi/A-9307-2015	Shen, Zhesi/0000-0001-8414-7912; Han, Xiao/0000-0003-4219-7721	NNSFC [61573064, 61074116, 61374175]; Beijing Nova Programme, China; Fundamental Research Funds for the Central Universities	NNSFC(National Natural Science Foundation of China (NSFC)); Beijing Nova Programme, China(Beijing Municipal Science & Technology Commission); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	W.-X.W. was supported by NNSFC under Grant No. 61573064, NNSFC under Grant No. 61074116, Beijing Nova Programme, China and the Fundamental Research Funds for the Central Universities. Z.-R.D. was supported by NNSFC under Grant No. 61374175. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Barabasi AL, 2005, NAT PHYS, V1, P68, DOI 10.1038/nphys162; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baraniuk RG, 2007, IEEE SIGNAL PROC MAG, V24, P6, DOI 10.1109/MSP.2007.909718; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Caldarelli G, 2000, EUROPHYS LETT, V52, P386, DOI 10.1209/epl/i2000-00450-8; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; Cohen R., 2010, COMPLEX NETWORKS STR; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Gutig R, 2002, NEURAL COMPUT, V14, P121, DOI 10.1162/089976602753284473; Han X, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.028701; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Pipa G, 2003, NEUROCOMPUTING, V52-4, P31, DOI 10.1016/S0925-2312(02)00823-8; Ren J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058701; Romberg J, 2008, IEEE SIGNAL PROC MAG, V25, P14, DOI 10.1109/MSP.2007.914729; Shen Zhesi, 2014, Nat Commun, V5, P4323, DOI 10.1038/ncomms5323; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Timme M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.224101; Wang WX, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021021; Wang WX, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/48006; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106	30	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142837	10.1371/journal.pone.0142837	http://dx.doi.org/10.1371/journal.pone.0142837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588832	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500018
J	Verloop, WL; Hubens, LEG; Spiering, W; Doevendans, PA; Goldschmeding, R; Bleys, RLAW; Voskuil, M				Verloop, Willemien L.; Hubens, Lisette E. G.; Spiering, Wilko; Doevendans, Pieter A.; Goldschmeding, Roel; Bleys, Ronald L. A. W.; Voskuil, Michiel			The Effects of Renal Denervation on Renal Hemodynamics and Renal Vasculature in a Porcine Model	PLOS ONE			English	Article							SYMPATHETIC DENERVATION; ABLATION; PRESSURE	Rationale Recently, the efficacy of renal denervation (RDN) has been debated. It is discussed whether RDN is able to adequately target the renal nerves. Objective We aimed to investigate how effective RDN was by means of functional hemodynamic measurements and nerve damage on histology. Methods and Results We performed hemodynamic measurements in both renal arteries of healthy pigs using a Doppler flow and pressure wire. Subsequently unilateral denervation was performed, followed by repeated bilateral hemodynamic measurements. Pigs were terminated directly after RDN or were followed for 3 weeks or 3 months after the procedure. After termination, both treated and control arteries were prepared for histology to evaluate vascular damage and nerve damage. Directly after RDN, resting renal blood flow tended to increase by 29 +/- 67% (P = 0.01). In contrast, renal resistance reserve increased from 1.74 (1.28) to 1.88 (1.17) (P = 0.02) during follow-up. Vascular histopathology showed that most nerves around the treated arteries were located outside the lesion areas (8 +/- 7 out of 55 +/- 25 (14%) nerves per pig were observed within a lesion area). Subsequently, a correlation was noted between a more impaired adventitia and a reduction in renal resistance reserve (beta: -0.33; P = 0.05) at three weeks of follow-up. Conclusion Only a small minority of renal nerves was targeted after RDN. Furthermore, more severe adventitial damage was related to a reduction in renal resistance in the treated arteries at follow-up. These hemodynamic and histological observations may indicate that RDN did not sufficiently target the renal nerves. Potentially, this may explain the significant spread in the response after RDN.	[Verloop, Willemien L.; Hubens, Lisette E. G.; Doevendans, Pieter A.; Voskuil, Michiel] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Spiering, Wilko] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Bleys, Ronald L. A. W.] Univ Med Ctr Utrecht, Dept Anat, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Voskuil, M (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	m.voskuil@umcutrecht.nl						Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; DIBONA GF, 1989, AM J HYPERTENS, V2, pS119, DOI 10.1093/ajh/2.3.119S; Henegar JR, 2014, AM J HYPERTENS, V27, P1285, DOI 10.1093/ajh/hpu048; Kjeldsen SE, 2014, BLOOD PRESSURE, V23, P135, DOI 10.3109/08037051.2014.916896; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Mahfoud F, 2013, EUR HEART J; Mancia G, 1997, Ann Ital Med Int, V12, P217; Rippy MK, 2011, CLIN RES CARDIOL, V100, P1095, DOI 10.1007/s00392-011-0346-8; Sakakura K, 2014, J AM COLL CARDIOL, V64, P635, DOI 10.1016/j.jacc.2014.03.059; Schlaich MP, 2009, HYPERTENSION, V54, P1195, DOI 10.1161/HYPERTENSIONAHA.109.138610; Schlaich MP, 2009, NEW ENGL J MED, V361, P932, DOI 10.1056/NEJMc0904179; SMITHWICK RH, 1953, JAMA-J AM MED ASSOC, V152, P1501, DOI 10.1001/jama.1953.03690160001001; Steigerwald K, 2012, J HYPERTENS, V30, P2230, DOI 10.1097/HJH.0b013e32835821e5; Tellez A, 2013, TRANSL RES, V162, P381, DOI 10.1016/j.trsl.2013.07.002; Tsioufis C, 2013, INT J CARDIOL, V168, P987, DOI 10.1016/j.ijcard.2012.10.038; van de Hoef TP, 2012, CIRC-CARDIOVASC INTE, V5, P508, DOI 10.1161/CIRCINTERVENTIONS.111.965707; Vink EE, 2014, NEPHROL DIAL TRANSPL; Voskuil M, 2011, NETH HEART J, V19, P319, DOI 10.1007/s12471-011-0143-z; Voskuil M, 2014, ENDOVASCULAR INTERVE, P419; Waksman R, 2013, EUROINTERVENTION, V9, P738, DOI 10.4244/EIJV9I6A118; Wang Z, 2015, AM J HYPERTENS	21	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0141609	10.1371/journal.pone.0141609	http://dx.doi.org/10.1371/journal.pone.0141609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587981	Green Submitted, gold, Green Published			2022-12-27	WOS:000365251500005
J	Witzig, M; da Silva, AC; Green-Engert, R; Hoelzle, K; Zeller, E; Seifert, J; Hoelzle, LE; Rodehutscord, M				Witzig, Maren; da Silva, Amelia Camarinha; Green-Engert, Rebecca; Hoelzle, Katharina; Zeller, Ellen; Seifert, Jana; Hoelzle, Ludwig E.; Rodehutscord, Markus			Spatial Variation of the Gut Microbiota in Broiler Chickens as Affected by Dietary Available Phosphorus and Assessed by T-RFLP Analysis and 454 Pyrosequencing	PLOS ONE			English	Article							LENGTH-POLYMORPHISM ANALYSIS; LACTIC-ACID BACTERIA; RIBOSOMAL-RNA GENES; COMMUNITY STRUCTURE; GASTROINTESTINAL-TRACT; MINERAL PHOSPHORUS; INTESTINAL MICROBIOTA; PHYTATE HYDROLYSIS; PERFORMANCE; ILEAL	Molecular fingerprinting and sequencing based techniques have been widely used to characterize microbial communities. Terminal restriction fragment length polymorphism (T-RFLP) and 454-pyrosequencing were used to determine the microorganisms present in the different sections of the chicken gastrointestinal tract (GIT) (crop, jejunum, ileum and caeca). Broilers fed with diets differing in phosphorous (P) and calcium (Ca) as well as in phytase levels were used to study the microbiota of the upper and lower part of the GIT. A database with terminal restriction fragments (T-RF) of the most important organism present in the different gastrointestinal sections was constructed. The analysis revealed a distinct microbial assemblage on each section. Regardless of the diet, crop, jejunum and ileum were mainly colonized by Lactobacillaceae, and caeca were the most diverse site. The correlation between Lactobacillus crispatus and L. reuteri was positive in the crop, but negative in the jejunum. In crop samples, higher P and Ca levels led to a shift in the abundance of L. reuteri and L. crispatus to L. salivarius and L. taiwanensis whereas in the ileum supplementation of phytase favored L. salivarius and L. taiwanensis but resulted in decreased abundance of L. crispatus. Both methods were correlating significantly, being T-RFLP a reliable fingerprinting method to rapidly analyze large numbers of samples in a cost-effective and rapid manner. Results are easy to interpret with no need of deep bioinformatics knowledge and can be integrated with taxonomic information.	[Witzig, Maren; da Silva, Amelia Camarinha; Green-Engert, Rebecca; Hoelzle, Katharina; Zeller, Ellen; Seifert, Jana; Hoelzle, Ludwig E.; Rodehutscord, Markus] Univ Hohenheim, Inst Nutztierwissensch, Stuttgart, Germany	University Hohenheim	Witzig, M (corresponding author), Univ Hohenheim, Inst Nutztierwissensch, Stuttgart, Germany.	inst450@uni-hohenheim.de	Hoelzle, Ludwig/U-9030-2019	Camarinha Silva, Amelia/0000-0001-7814-6569; Rodehutscord, Markus/0000-0003-3156-7889; Seifert, Jana/0000-0002-7690-8539	Ministerium fur Wissenschaft, Forschung und Kultur des Landes Baden-Wurttemberg	Ministerium fur Wissenschaft, Forschung und Kultur des Landes Baden-Wurttemberg	This study was funded by the Ministerium fur Wissenschaft, Forschung und Kultur des Landes Baden-Wurttemberg. MR and LEH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Akyurek H, 2011, AFR J AGR RES, V6, P642; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Aydin A, 2010, J APPL POULTRY RES, V19, P422, DOI 10.3382/japr.2009-00123; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Bovee-Oudenhoven IM, 1999, J NUTR, V129, P607, DOI 10.1093/jn/129.3.607; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brugger SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052241; Castro-Carrera T, 2015, ANIMAL, V9, P582, DOI 10.1017/S1751731114002882; Castro-Carrera T, 2014, J DAIRY SCI, V97, P1661, DOI 10.3168/jds.2013-7243; Chambers JR, 2011, FOOD RES INT, V44, P3149, DOI 10.1016/j.foodres.2011.08.017; Chee SH, 2010, BRIT POULTRY SCI, V51, P368, DOI 10.1080/00071668.2010.503477; Choe HS, 2012, AM J INFECT CONTROL, V40, pE249, DOI 10.1016/j.ajic.2012.05.010; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collins RE, 2007, NUCLEIC ACIDS RES, V35, pW58, DOI 10.1093/nar/gkm384; Craven SE, 1998, J FOOD PROTECT, V61, P265, DOI 10.4315/0362-028X-61.3.265; Dersjant-Li Y, 2015, J SCI FOOD AGR, V95, P878, DOI 10.1002/jsfa.6998; Edelman S, 2003, VET MICROBIOL, V91, P41, DOI 10.1016/S0378-1135(02)00153-0; Egert M, 2003, APPL ENVIRON MICROB, V69, P2555, DOI 10.1128/AEM.69.5.2555-2562.2003; Egert M, 2005, J MICROBIOL METH, V61, P69, DOI 10.1016/j.mimet.2004.11.002; Geier MS, 2011, BRIT POULTRY SCI, V52, P564, DOI 10.1080/00071668.2011.607429; Geier MS, 2009, J APPL MICROBIOL, V106, P1540, DOI 10.1111/j.1365-2672.2008.04116.x; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Hanshew AS, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-43; Hilmi HTA, 2007, APPL ENVIRON MICROB, V73, P7867, DOI 10.1128/AEM.01128-07; Huber K, 2015, POULTRY SCI, V94, P1009, DOI 10.3382/ps/pev065; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Joo S, 2010, J MICROBIOL METH, V81, P61, DOI 10.1016/j.mimet.2010.01.025; Kiarie E, 2013, NUTR RES REV, V26, P71, DOI 10.1017/S0954422413000048; KOMISARCZUK S, 1987, REPROD NUTR DEV, V27, P907, DOI 10.1051/rnd:19870703; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Larsen N, 2007, INT J FOOD MICROBIOL, V114, P113, DOI 10.1016/j.ijfoodmicro.2006.10.033; Lee NK, 2013, ANN MICROBIOL, V63, P555, DOI 10.1007/s13213-012-0503-y; Maenz DD, 1998, POULTRY SCI, V77, P557, DOI 10.1093/ps/77.4.557; Mann E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086950; Metzler BU, 2008, J ANIM SCI, V86, P1544, DOI 10.2527/jas.2007-0267; Metzler-Zebeli BU, 2010, J ANIM SCI, V88, P147, DOI 10.2527/jas.2008-1560; Metzler-Zebeli BU, 2010, APPL ENVIRON MICROB, V76, P3692, DOI 10.1128/AEM.00257-10; Nordentoft S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-187; Palaciosa MC, 2008, LWT-FOOD SCI TECHNOL, V41, P82, DOI 10.1016/j.lwt.2007.02.005; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Ptak A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119770; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Shastak Y, 2014, POULTRY SCI, V93, P2548, DOI 10.3382/ps.2014-03961; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Taheri HR, 2009, POULTRY SCI, V88, P1586, DOI 10.3382/ps.2009-00041; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; Torok VA, 2011, APPL ENVIRON MICROB, V77, P3380, DOI 10.1128/AEM.02300-10; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; Vital M, 2015, ISME J, V9, P832, DOI 10.1038/ismej.2014.179; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Weremko D, 1997, ASIAN AUSTRAL J ANIM, V10, P551, DOI 10.5713/ajas.1997.551; Zeller E, 2015, POULTRY SCI, V94, P1018, DOI 10.3382/ps/pev087	60	38	39	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143442	10.1371/journal.pone.0143442	http://dx.doi.org/10.1371/journal.pone.0143442			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588075	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500062
J	Bell, A; Chiappe, LM				Bell, Alyssa; Chiappe, Luis M.			Identification of a New Hesperornithiform from the Cretaceous Niobrara Chalk and Implications for Ecologic Diversity among Early Diving Birds	PLOS ONE			English	Article							NORTH-AMERICA; BODY-SIZE; PENGUINS; CANADA; AVES	The Smoky Hill Member of the Niobrara Chalk in Kansas (USA) has yielded the remains of numerous members of the Hesperornithiformes, toothed diving birds from the late Early to Late Cretaceous. This study presents a new taxon of hesperornithiform from the Smoky Hill Member, Fumicollis hoffmani, the holotype of which is among the more complete hesperornithiform skeletons. Fumicollis has a unique combination of primitive (e.g. proximal and distal ends of femur not expanded, elongate pre-acetabular ilium, small and pyramidal patella) and derived (e.g. dorsal ridge on metatarsal IV, plantarly-projected curve in the distal shaft of phalanx III:1) hesperornithiform characters, suggesting it was more specialized than small hesperornithiforms like Baptornis advenus but not as highly derived as the larger Hesperornis regalis. The identification of Fumicollis highlights once again the significant diversity of hesperornithiforms that existed in the Late Cretaceous Western Interior Seaway. This diversity points to the existence of a complex ecosystem, perhaps with a high degree of niche partitioning, as indicated by the varying degrees of diving specializations among these birds.	[Bell, Alyssa; Chiappe, Luis M.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA		Bell, A (corresponding author), Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA.	abell@nhm.org		Chiappe, Luis/0000-0001-9661-0601	Dinosaur Institute	Dinosaur Institute	This study was made possible by Gretchen Augustyn, whose support of the Dinosaur Institute funded the postdoctoral fellowship of A. Bell.	Bardack D., 1968, Canadian Journal of Earth Sciences, V5, P145; BAUMEL JJ, 1993, HDB AVIAN ANATOMY NO, P00133; Bell A., 2013, THESIS; BRYANT LJ, 1983, PALEOBIOS, V40, P1; Buttendieck E, 1980, BENENNUNG SKELETTS B; Carpenter K., 2008, TOPICS GEOBIOLOGY, P421, DOI DOI 10.1017/S001675680530077X; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Chiappe LM, 2015, J SYST PAL; Chiappe LM, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3594[1:JBFTEC]2.0.CO;2; Cumbaa Stephen L., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P139; Dyke GJ, 2006, CRETACEOUS RES, V27, P947, DOI 10.1016/j.cretres.2006.05.001; Elzanowski A, 2000, J VERTEBR PALEONTOL, V20, P712, DOI 10.1671/0272-4634(2000)020[0712:AAQFTL]2.0.CO;2; Everhart Michael J., 2001, Transactions of the Kansas Academy of Science, V104, P59, DOI 10.1660/0022-8443(2001)104[0059:RTTBOT]2.0.CO;2; Everhart MJ, 2009, J VERTEBR PALEONTOL, V29, P952, DOI 10.1671/039.029.0301; Galton Peter M., 2002, P317; Hou L.I., 1999, GU JI ZHUI DONG WU X, V37, P231; Johansson LC, 2001, J EXP BIOL, V204, P1687; Kurochkin EN, 2005, AGE DINOSAURS RUSSIA, P533; Marsh O.C., 1872, AM J SCI ARTS, V3, P1; Marsh O.C., 1877, AM J SCI ARTS, V14, P79; Marsh O.C., 1880, ODONTORNITHES MONOGR, DOI [10.5962/bhl.title.61298, DOI 10.5962/BHL.TITLE.61298]; Martin L.D., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P35; MARTIN L D, 1984, Transactions of the Kansas Academy of Science, V87, P141, DOI 10.2307/3627850; Martin Larry D., 2012, Palaeoworld, V21, P59, DOI 10.1016/j.palwor.2012.02.005; Martin Larry D., 2002, P165; Miller AK, 2010, CONDOR, V112, P683, DOI 10.1525/cond.2010.090221; MONDEJAR SANCHEZ J. M., 2010, THESIS; Nessov L.A., 1983, Trudy Zoologicheskogo Instituta, V116, P108; Noren SR, 2000, COMP BIOCHEM PHYS A, V126, P181, DOI 10.1016/S1095-6433(00)00182-3; Panteleyev AV, 2004, PAL RES, V8, P1115; Rees J, 2005, PALAEONTOLOGY, V48, P1321, DOI 10.1111/j.1475-4983.2005.00507.x; Tokaryk TT, 1997, J VERTEBR PALEONTOL, V17, P172, DOI 10.1080/02724634.1997.10010961; Wilson LE, 2011, J SYST PALAEONTOL, V9, P9, DOI 10.1080/14772019.2010.502910; Wilson RP, 2010, FUNCT ECOL, V24, P646, DOI 10.1111/j.1365-2435.2009.01654.x; Zavalaga CB, 2007, MAR ECOL PROG SER, V336, P291, DOI 10.3354/meps336291; Zavalaga CB, 1997, CONDOR, V99, P1002, DOI 10.2307/1370156; Zinoviev AV, 2011, J SYST PALAEONTOL, V9, P65, DOI 10.1080/14772019.2010.512615	37	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141690	10.1371/journal.pone.0141690	http://dx.doi.org/10.1371/journal.pone.0141690			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580402	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600019
J	Heidary, N; Utesch, T; Zerball, M; Horch, M; Millo, D; Fritsch, J; Lenz, O; von Klitzing, R; Hildebrandt, P; Fischer, A; Mroginski, MA; Zebger, I				Heidary, Nina; Utesch, Tillmann; Zerball, Maximilian; Horch, Marius; Millo, Diego; Fritsch, Johannes; Lenz, Oliver; von Klitzing, Regine; Hildebrandt, Peter; Fischer, Anna; Mroginski, Maria Andrea; Zebger, Ingo			Orientation-Controlled Electrocatalytic Efficiency of an Adsorbed Oxygen-Tolerant Hydrogenase	PLOS ONE			English	Article							MEMBRANE-BOUND HYDROGENASE; RALSTONIA-EUTROPHA H16; NIFE HYDROGENASE; MOLECULAR-DYNAMICS; ABSORPTION-SPECTROSCOPY; ELECTRON-TRANSFER; ENZYME; IMMOBILIZATION; OXIDATION; SUBUNIT	Protein immobilization on electrodes is a key concept in exploiting enzymatic processes for bioelectronic devices. For optimum performance, an in-depth understanding of the enzyme-surface interactions is required. Here, we introduce an integral approach of experimental and theoretical methods that provides detailed insights into the adsorption of an oxygen-tolerant [NiFe] hydrogenase on a biocompatible gold electrode. Using atomic force microscopy, ellipsometry, surface-enhanced IR spectroscopy, and protein film voltammetry, we explore enzyme coverage, integrity, and activity, thereby probing both structure and catalytic H-2 conversion of the enzyme. Electrocatalytic efficiencies can be correlated with the mode of protein adsorption on the electrode as estimated theoretically by molecular dynamics simulations. Our results reveal that pre-activation at low potentials results in increased current densities, which can be rationalized in terms of a potential-induced re-orientation of the immobilized enzyme.	[Heidary, Nina; Utesch, Tillmann; Zerball, Maximilian; Horch, Marius; Lenz, Oliver; von Klitzing, Regine; Hildebrandt, Peter; Fischer, Anna; Mroginski, Maria Andrea; Zebger, Ingo] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Millo, Diego] Vrije Univ Amsterdam, Biomol Spectroscopy LaserLaB Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Fritsch, Johannes] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany; [Fischer, Anna] Univ Freiburg, Inst Anorgan & Analyt Chem, D-79104 Freiburg, Germany	Technical University of Berlin; Vrije Universiteit Amsterdam; Humboldt University of Berlin; University of Freiburg	Fischer, A (corresponding author), Tech Univ Berlin, Inst Chem, Str 17 Juni 135 & 124, D-10623 Berlin, Germany.	anna.fischer@ac.uni-freiburg.de; andrea.mroginski@tu-berlin.de; ingo.zebger@tu-berlin.de	Lenz, Oliver/C-1582-2019; von Klitzing, Regine/ABD-9728-2020; Horch, Marius/AAK-5439-2020; Fischer, Anna/ABG-8100-2021; Fischer, Anna T. L./L-8830-2015; Lenz, Oliver/N-5130-2019; Hildebrandt, Peter/J-5658-2014	Lenz, Oliver/0000-0003-4550-5128; von Klitzing, Regine/0000-0003-0555-5104; Horch, Marius/0000-0001-6656-1749; Fischer, Anna/0000-0003-4567-3009; Fischer, Anna T. L./0000-0003-4567-3009; Lenz, Oliver/0000-0003-4550-5128; Hildebrandt, Peter/0000-0003-1030-5900	Deutsche Forschungsgemeinschaft [EXC 314]; Technische Universitat Berlin; NWO [722.011.003]; Alexander von Humboldt-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Technische Universitat Berlin; NWO(Netherlands Organization for Scientific Research (NWO)); Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation)	This work was supported by EXC 314, "UniCat", Deutsche Forschungsgemeinschaft (http://www.dfg.de/); Technische Universitat Berlin (http://www.tu-berlin.de/) (to MZ); grant 722.011.003, NWO (http://www.nwo.nl); and Alexander von Humboldt-Stiftung (https://www.humboldt-foundation.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu Y, 2011, CHEM MATER, V23, P1798, DOI 10.1021/cm103087p; Ciaccafava A, 2012, ANGEW CHEM INT EDIT, V51, P953, DOI 10.1002/anie.201107053; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; Gutierrez-Sanchez C, 2011, LANGMUIR, V27, P6449, DOI 10.1021/la200141t; Gutierrez-Sanz O, 2013, J PHYS CHEM LETT, V4, P2794, DOI 10.1021/jz4013678; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Latour RA, 2008, BIOINTERPHASES, V3, pFC2, DOI 10.1116/1.2965132; Leopold MC, 2002, LANGMUIR, V18, P978, DOI 10.1021/la011683e; Lojou E, 2011, ELECTROCHIM ACTA, V56, P10385, DOI 10.1016/j.electacta.2011.03.002; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Millo D, 2011, ANGEW CHEM INT EDIT, V50, P2632, DOI 10.1002/anie.201006646; Millo D, 2009, J PHYS CHEM B, V113, P15344, DOI 10.1021/jp906575r; Miyake H, 2002, ELECTROCHEM COMMUN, V4, P973, DOI 10.1016/S1388-2481(02)00510-6; Oteri F, 2014, PHYS CHEM CHEM PHYS, V16, P11318, DOI 10.1039/c4cp00510d; Parkin A, 2012, CURR OPIN CHEM BIOL, V16, P26, DOI 10.1016/j.cbpa.2012.01.012; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plumere N, 2014, NAT CHEM, V6, P822, DOI [10.1038/nchem.2022, 10.1038/NCHEM.2022]; Rippers Y, 2012, CHEMPHYSCHEM, V13, P3852, DOI 10.1002/cphc.201200562; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Sezer M, 2011, J PHYS CHEM B, V115, P10368, DOI 10.1021/jp204665r; Utesch T, 2013, LANGMUIR, V29, P673, DOI 10.1021/la303635q; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Wisitruangsakul N, 2009, ANGEW CHEM INT EDIT, V48, P611, DOI 10.1002/anie.200802633	29	23	23	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143101	10.1371/journal.pone.0143101	http://dx.doi.org/10.1371/journal.pone.0143101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580976	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600083
J	Liang, QS; Anderson, WD; Jones, ST; Souza, CS; Hosoume, JM; Treptow, W; Covarrubias, M				Liang, Qiansheng; Anderson, Warren D.; Jones, Shelly T.; Souza, Caio S.; Hosoume, Juliana M.; Treptow, Werner; Covarrubias, Manuel			Positive Allosteric Modulation of Kv Channels by Sevoflurane: Insights into the Structural Basis of Inhaled Anesthetic Action	PLOS ONE			English	Article							GATED K+ CHANNELS; INTRACELLULAR T1-T1 INTERFACE; SHAKER POTASSIUM CHANNELS; MOLECULAR-DYNAMICS; VOLTAGE SENSOR; SODIUM-CHANNELS; ION CHANNELS; T1 DOMAIN; WILD-TYPE; ACTIVATION	Inhalational general anesthesia results from the poorly understood interactions of haloethers with multiple protein targets, which prominently includes ion channels in the nervous system. Previously, we reported that the commonly used inhaled anesthetic sevoflurane potentiates the activity of voltage-gated K+ (Kv) channels, specifically, several mammalian Kv1 channels and the Drosophila K-Shaw2 channel. Also, previous work suggested that the S4-S5 linker of K-Shaw2 plays a role in the inhibition of this Kv channel by n-alcohols and inhaled anesthetics. Here, we hypothesized that the S4-S5 linker is also a determinant of the potentiation of Kv1.2 and K-Shaw2 by sevoflurane. Following functional expression of these Kv channels in Xenopus oocytes, we found that converse mutations in Kv1.2 (G329T) and K-Shaw2 (T330G) dramatically enhance and inhibit the potentiation of the corresponding conductances by sevoflurane, respectively. Additionally, Kv1.2-G329T impairs voltage-dependent gating, which suggests that Kv1.2 modulation by sevoflurane is tied to gating in a state-dependent manner. Toward creating a minimal Kv1.2 structural model displaying the putative sevoflurane binding sites, we also found that the positive modulations of Kv1.2 and Kv1.2-G329T by sevoflurane and other general anesthetics are T1-independent. In contrast, the positive sevoflurane modulation of K-Shaw2 is T1-dependent. In silico docking and molecular dynamics-based free-energy calculations suggest that sevoflurane occupies distinct sites near the S4-S5 linker, the pore domain and around the external selectivity filter. We conclude that the positive allosteric modulation of the Kv channels by sevoflurane involves separable processes and multiple sites within regions intimately involved in channel gating.	[Liang, Qiansheng; Anderson, Warren D.; Jones, Shelly T.; Covarrubias, Manuel] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurosci, Philadelphia, PA 19107 USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Farber Inst Neurosci, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Souza, Caio S.; Hosoume, Juliana M.; Treptow, Werner] Univ Brasilia, Dept Biol Celular, Lab Biol Teor & Computac, Brasilia, DF, Brazil	Jefferson University; Jefferson University; Universidade de Brasilia	Covarrubias, M (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurosci, Philadelphia, PA 19107 USA.	Manuel.Covarrubias@jefferson.edu	Treptow, Werner/AAZ-5170-2020	Covarrubias, Manuel/0000-0002-0881-4143; Souza, Caio/0000-0003-2770-3315	National Institutes of Health [GM055876]; National Council of Technological and Scientific Development [470406/2011-9]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: National Institutes of Health, http://www.nih.gov/, GM055876, Dr. Roderic Eckenhoff (University of Pennsylvania); and the National Council of Technological and Scientific Development, http://www.cnpq.br/web/guest/geral, 470406/2011-9, Dr. Werner Treptow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2009, ANESTHESIOLOGY, V110, P766, DOI 10.1097/ALN.0b013e31819c461c; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; Barber AF, 2014, P NATL ACAD SCI USA, V111, P6726, DOI 10.1073/pnas.1405768111; Barber AF, 2012, J BIOL CHEM, V287, P40425, DOI 10.1074/jbc.M112.405787; Barber AF, 2011, BIOPHYS J, V101, P1613, DOI 10.1016/j.bpj.2011.08.026; Bhattacharji A, 2010, BRIT J PHARMACOL, V159, P1475, DOI 10.1111/j.1476-5381.2010.00642.x; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Chowdhury S, 2014, J GEN PHYSIOL, V144, P457, DOI 10.1085/jgp.201411185; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Delemotte L, 2011, P NATL ACAD SCI USA, V108, P6109, DOI 10.1073/pnas.1102724108; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Hemmings HC, 2009, BRIT J ANAESTH, V103, P61, DOI 10.1093/bja/aep144; Herold KE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00050; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Li JC, 2001, AM J PHYSIOL-CELL PH, V280, pC1130, DOI 10.1152/ajpcell.2001.280.5.C1130; Lioudyno MI, 2013, J NEUROSCI, V33, P16310, DOI 10.1523/JNEUROSCI.0344-13.2013; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lugli AK, 2009, EUR J ANAESTH, V26, P807, DOI 10.1097/EJA.0b013e32832d6b0f; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robbins CA, 2012, EPILEPSIA, V53, P134, DOI 10.1111/j.1528-1167.2012.03484.x; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Treptow W, 2006, BIOPHYS J, V90, pL64, DOI 10.1529/biophysj.106.080754; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang GY, 2007, J BIOL CHEM, V282, P13637, DOI 10.1074/jbc.M609182200; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	38	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143363	10.1371/journal.pone.0143363	http://dx.doi.org/10.1371/journal.pone.0143363			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599217	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600057
J	Su, SS; Hong, F; Liang, YL; Zhou, JQ; Liang, Y; Chen, KQ; Wang, XY; Wang, ZQ; Wang, ZQ; Chang, C; Han, WH; Gong, W; Qin, HT; Jiang, B; Xiong, HB; Peng, L				Su, Shasha; Hong, Feng; Liang, Yanling; Zhou, Jieqiong; Liang, Yan; Chen, Kequan; Wang, Xinying; Wang, Zhongqiu; Wang, Zhiqing; Chang, Cassie; Han, Weihua; Gong, Wei; Qin, Haitao; Jiang, Bo; Xiong, Huabao; Peng, Liang			Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; COLON-CANCER; SELF-RENEWAL; IN-VITRO; EPIGENETIC REGULATION; DNA METHYLATION; SMALL-INTESTINE; EXPRESSION; OVEREXPRESSION; IDENTIFICATION	Objective Leucine-rich-repeat-containing G-protein-coupled receptor 5 (lgr5) is a candidate marker for colorectal cancer stem cells (CSC). In the current study, we investigated the methylation status within thelgr5 promoter and evaluated its relationship with CSC differentiation, prognosis for colorectal cancer, and its clinicopathological features. Methods The methylation status within Lgr5 promoter was detected with a methylation-specific PCR in six colorectal cancer cell lines as well as 169 primary colorectal tumor tissues. Differentiation of CSC was examined with immunofluorescence and immunocytochemistry. Down-regulation of lgr5 was achieved with gene-specific siRNA. The associations between lgr5 methylation and the clinicopathological features as well as survival of patients were analyzed with statistical methods. Results The lgr5 promoter was methylated to different degrees for the six colorectal cell lines examined, with complete methylation observed in HCT116 cells in which the lgr5 expression was partially recovered following DAC treatment. The stem-cell sphere formation from HCT116 cells was accompanied by increasing methylation within the lgr5 promoter and decreasing expression of lgr5. Knocking down lgr5 by siRNA also led to stem-cell spheres formation. Among primary colorectal tumors, 40% (67/169) were positive for lgr5 methylation, while none of the normal colon tissues were positive for lgr5 methylation. Furthermore, lgr5 methylation significantly associated with higher tumor grade, and negative distant metastasis (p < 0.05), as well as better prognosis (p = 0.001) in patients with colorectal cancer. Conclusions Our data suggests that lgr5 methylation, through the regulation of lgr5 expression and colorectal CSC differentiation, may constitute a novel prognostic marker for colorectal cancer patients.	[Su, Shasha; Liang, Yanling; Zhou, Jieqiong; Liang, Yan; Chen, Kequan; Wang, Xinying; Wang, Zhongqiu; Wang, Zhiqing; Gong, Wei; Qin, Haitao; Jiang, Bo; Peng, Liang] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China; [Hong, Feng] Jining Med Univ, Inst Liver Dis, Affiliated Hosp, Jinan 273100, Shandong, Peoples R China; [Chang, Cassie; Xiong, Huabao] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, New York, NY 10029 USA; [Han, Weihua] XingTai Med Coll, Affiliated Hosp 2, Hebei 054002, Anhui, Peoples R China	Southern Medical University - China; Jining Medical University; Icahn School of Medicine at Mount Sinai	Peng, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China.	wsfirefly@126.com	Gong, Wei/AAH-3274-2019		National Natural Science foundation of China (NSFC) [81302156]; Guangzhou Pilot Project of Clinical and Translational Research Center [7415696196402]; Guangdong Provincial Bio-engineering Research Center for Gastroenterology Diseases	National Natural Science foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangzhou Pilot Project of Clinical and Translational Research Center; Guangdong Provincial Bio-engineering Research Center for Gastroenterology Diseases	This project was in part supported by National Natural Science foundation of China (NSFC. NO. 81302156), Guangzhou Pilot Project of Clinical and Translational Research Center (early gastrointestinal cancers, No.7415696196402), Guangdong Provincial Bio-engineering Research Center for Gastroenterology Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Chen KL, 2011, CLIN EXP METASTAS, V28, P751, DOI 10.1007/s10585-011-9407-7; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107013; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Fukuma M, 2013, EXP CELL RES, V319, P113, DOI 10.1016/j.yexcr.2012.10.011; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Ghods AJ, 2007, STEM CELLS, V25, P1645, DOI 10.1634/stemcells.2006-0624; Gopisetty G, 2013, ONCOGENE, V32, P3119, DOI 10.1038/onc.2012.331; Hammoud SS, 2013, CURR OPIN CELL BIOL, V25, P177, DOI 10.1016/j.ceb.2013.01.007; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hirsch D, 2014, CARCINOGENESIS, V35, P849, DOI 10.1093/carcin/bgt377; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Infanger DW, 2013, CANCER RES, V73, P7079, DOI 10.1158/0008-5472.CAN-13-1355; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu Z, 2014, NEOPLASMA, V61, P177, DOI 10.4149/neo_2014_016; Mancikova V, 2014, INT J CANCER, V135, P598, DOI 10.1002/ijc.28703; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Raggi C, 2014, HEPATOLOGY, V59, P2251, DOI 10.1002/hep.27026; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rubinfeld B, 1997, CANCER RES, V57, P4624; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Spizzo G, 2007, CANCER LETT, V246, P253, DOI 10.1016/j.canlet.2006.03.002; Su N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-43; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Ung M, 2014, EPIGENETICS OFFICIAL, V9; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Woodson K, 2006, EPIGENETICS-US, V1, P183, DOI 10.4161/epi.1.4.3530; Yamamoto M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3299; Yamamoto Y, 2003, HEPATOLOGY, V37, P528, DOI 10.1053/jhep.2003.50029; Yamanoi K, 2013, PATHOL INT, V63, P13, DOI 10.1111/pin.12013; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	52	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143513	10.1371/journal.pone.0143513	http://dx.doi.org/10.1371/journal.pone.0143513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599100	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600077
J	Zhao, Y; Li, GL; Sun, CY; Li, C; Wang, XC; Liu, HC; Zhang, PP; Zhao, XQ; Wang, XR; Jiang, Y; Yang, RF; Wan, KL; Zhou, L				Zhao, Yong; Li, Guilian; Sun, Chongyun; Li, Chao; Wang, Xiaochen; Liu, Haican; Zhang, Pingping; Zhao, Xiuqin; Wang, Xinrui; Jiang, Yi; Yang, Ruifu; Wan, Kanglin; Zhou, Lei			Locked Nucleic Acid Probe-Based Real-Time PCR Assay for the Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							MOLECULAR-DETECTION; DRUG-RESISTANCE; RPOB MUTATIONS; DIAGNOSTICS; IDENTIFICATION	Drug-resistant Mycobacterium tuberculosis can be rapidly diagnosed through nucleic acid amplification techniques by analyzing the variations in the associated gene sequences. In the present study, a locked nucleic acid (LNA) probe-based real-time PCR assay was developed to identify the mutations in the rpoB gene associated with rifampin (RFP) resistance in M. tuberculosis. Six LNA probes with the discrimination capability of one-base mismatch were designed to monitor the 23 most frequent rpoB mutations. The target mutations were identified using the probes in a "probe dropout" manner (quantification cycle = 0); thus, the proposed technique exhibited superiority in mutation detection. The LNA probe-based real-time PCR assay was developed in a two-tube format with three LNA probes and one internal amplification control probe in each tube. The assay showed excellent specificity to M. tuberculosis with or without RFP resistance by evaluating 12 strains of common non-tuberculosis mycobacteria. The limit of detection of M. tuberculosis was 10 genomic equivalents (GE)/reaction by further introducing a nested PCR method. In a blind validation of 154 clinical mycobacterium isolates, 142/142 (100%) were correctly detected through the assay. Of these isolates, 88/88 (100%) were determined as RFP susceptible and 52/54 (96.3%) were characterized as RFP resistant. Two unrecognized RFP-resistant strains were sequenced and were found to contain mutations outside the range of the 23 mutation targets. In conclusion, this study established a sensitive, accurate, and low-cost LNA probe-based assay suitable for a four-multiplexing real-time PCR instrument. The proposed method can be used to diagnose RFP-resistant tuberculosis in clinical laboratories.	[Zhao, Yong; Sun, Chongyun; Wang, Xiaochen; Zhang, Pingping; Wang, Xinrui; Yang, Ruifu; Zhou, Lei] Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Zhao, Yong; Sun, Chongyun; Wang, Xiaochen; Zhang, Pingping; Wang, Xinrui; Yang, Ruifu; Zhou, Lei] Beijing Key Lab POCT Bioemergency & Clin BZ0329, Beijing 100071, Peoples R China; [Li, Guilian; Li, Chao; Liu, Haican; Zhao, Xiuqin; Jiang, Yi; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China; [Sun, Chongyun] Chinese Peoples Liberat Army, Dept Clin Lab, Gen Hosp, Beijing, Peoples R China; [Wang, Xiaochen] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun 130118, Peoples R China; [Wang, Xinrui] Inst Plague Prevent & Control Hebei Prov, Zhangjiakou 075000, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese People's Liberation Army General Hospital; Jilin Agricultural University	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China.	wankanglin@icdc.cn; ammszhoulei@aliyun.com	Yang, Ruifu/A-2273-2011	Yang, Ruifu/0000-0003-3219-7269	National High Technology Research and Development Program of China [2013AA032205]; Major National Science and Technology Programs of China [2011ZX10004, 2012ZX1004801-002-004, 2012ZX1004801-004-015]; Beijing Nova Program of China [Z151100000315086]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major National Science and Technology Programs of China; Beijing Nova Program of China(Beijing Municipal Science & Technology Commission)	This study was supported by the National High Technology Research and Development Program of China (No. 2013AA032205), the Major National Science and Technology Programs of China (Grant Nos. 2011ZX10004, 2012ZX1004801-002-004, and 2012ZX1004801-004-015) and Beijing Nova Program of China (No. Z151100000315086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chakravorty S, 2012, J CLIN MICROBIOL, V50, P2194, DOI 10.1128/JCM.00143-12; Chen XY, 2014, J CLIN MICROBIOL, V52, P1540, DOI 10.1128/JCM.00065-14; de Freitas FAD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104100; El-Hajj HH, 2001, J CLIN MICROBIOL, V39, P4131, DOI 10.1128/JCM.39.11.4131-4137.2001; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hoek KGP, 2011, MOL DIAGN THER, V15, P189, DOI 10.2165/11593780-000000000-00000; Huang HR, 2002, TUBERCULOSIS, V82, P79, DOI 10.1054/tube.2002.0326; Johnson MP, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh046; Josefsen MH, 2009, MOL CELL PROBE, V23, P201, DOI 10.1016/j.mcp.2009.02.003; Lis P, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0225-4; Liu QY, 2013, J ANTIMICROB CHEMOTH, V68, P1097, DOI 10.1093/jac/dks509; Luo T, 2011, J CLIN MICROBIOL, V49, P3132, DOI 10.1128/JCM.02046-10; Mboowa G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-481; McNerney R, 2015, INT J INFECT DIS, V32, P81, DOI 10.1016/j.ijid.2015.01.012; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Noor KM, 2015, PATHOLOGY, V47, P250, DOI 10.1097/PAT.0000000000000232; Palomino JC, 2009, FEMS IMMUNOL MED MIC, V56, P103, DOI 10.1111/j.1574-695X.2009.00555.x; Roh SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126257; Salvi S, 2008, J AGR FOOD CHEM, V56, P4320, DOI 10.1021/jf800149j; Somerville W, 2005, J CLIN MICROBIOL, V43, P2996, DOI 10.1128/JCM.43.6.2996-2997.2005; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Wada T, 2004, J CLIN MICROBIOL, V42, P5277, DOI 10.1128/JCM.42.11.5277-5285.2004; Wang Q, 2012, EXP THER MED, V3, P503, DOI 10.3892/etm.2011.442; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Wilson ML, 2011, CLIN INFECT DIS, V52, P1350, DOI 10.1093/cid/cir146; Zaczek A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-10; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	29	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143444	10.1371/journal.pone.0143444	http://dx.doi.org/10.1371/journal.pone.0143444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599667	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600066
J	Cecchinato, F; Agha, NA; Martinez-Sanchez, AH; Luthringer, BJC; Feyerabend, F; Jimbo, R; Willumeit-Romer, R; Wennerberg, A				Cecchinato, Francesca; Agha, Nezha Ahmad; Martinez-Sanchez, Adela Helvia; Luthringer, Berengere Julie Christine; Feyerabend, Frank; Jimbo, Ryo; Willumeit-Roemer, Regine; Wennerberg, Ann			Influence of Magnesium Alloy Degradation on Undifferentiated Human Cells	PLOS ONE			English	Article							IN-VITRO CORROSION; RARE-EARTH; ANTIBODY-PRODUCTION; BONE; RESISTANCE; GROWTH; PH; BIOCOMPATIBILITY; METABOLISM; SCAFFOLDS	Background Magnesium alloys are of particular interest in medical science since they provide compatible mechanical properties with those of the cortical bone and, depending on the alloying elements, they have the capability to tailor the degradation rate in physiological conditions, providing alternative bioresorbable materials for bone applications. The present study investigates the in vitro short-term response of human undifferentiated cells on three magnesium alloys and high-purity magnesium (Mg). Materials and Methods The degradation parameters of magnesium-silver (Mg2Ag), magnesium-gadolinium (Mg10Gd) and magnesium-rare-earth (Mg4Y3RE) alloys were analysed after 1, 2, and 3 days of incubation in cell culture medium under cell culture condition. Changes in cell viability and cell adhesion were evaluated by culturing human umbilical cord perivascular cells on corroded Mg materials to examine how the degradation influences the cellular development. Results and Conclusions The pH and osmolality of the medium increased with increasing degradation rate and it was found to be most pronounced for Mg4Y3RE alloy. The biological observations showed that HUCPV exhibited a more homogeneous cell growth on Mg alloys compared to high-purity Mg, where they showed a clustered morphology. Moreover, cells exhibited a slightly higher density on Mg2Ag and Mg10Gd in comparison to Mg4Y3RE, due to the lower alkalinisation and osmolality of the incubation medium. However, cells grown on Mg10Gd and Mg4Y3RE generated more developed and healthy cellular structures that allowed them to better adhere to the surface. This can be attributable to a more stable and homogeneous degradation of the outer surface with respect to the incubation time.	[Cecchinato, Francesca; Jimbo, Ryo; Wennerberg, Ann] Fac Odontol, Dept Prosthodont, Malmo, Sweden; [Agha, Nezha Ahmad; Martinez-Sanchez, Adela Helvia; Luthringer, Berengere Julie Christine; Feyerabend, Frank; Willumeit-Roemer, Regine] Helmholtz Zentrum Geesthacht, D-21502 Geesthacht, Germany	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Cecchinato, F (corresponding author), Fac Odontol, Dept Prosthodont, Malmo, Sweden.	francesca.cecchinato@mah.se	Feyerabend, Frank/A-1124-2010; Willumeit, Regine/I-8029-2013; Luthringer, Bérengère/G-9039-2017	Feyerabend, Frank/0000-0001-9532-0207; Willumeit, Regine/0000-0002-6004-6946; Luthringer, Bérengère/0000-0002-8248-6715	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [n289163]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement non289163.	AHMAD Z, 1993, J MATER ENG PERFORM, V2, P739, DOI 10.1007/BF02650065; Ardelean H, 2001, MATER CORROS, V52, P889, DOI 10.1002/1521-4176(200112)52:12<889::AID-MACO889>3.0.CO;2-0; Banczek EP, 2009, J ALLOY COMPD, V479, P342, DOI 10.1016/j.jallcom.2008.12.075; Beaumont KG, 2012, CHEM BIOL, V19, P711, DOI 10.1016/j.chembiol.2012.04.016; BRUCE DW, 1963, TOXICOL APPL PHARM, V5, P750, DOI 10.1016/0041-008X(63)90067-X; Carey SP, 2011, STUD MECHANOBIOL TIS, V4, P29, DOI 10.1007/8415_2010_22; De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; deZengotita VM, 1998, CYTOTECHNOLOGY, V28, P213, DOI 10.1023/A:1008010605287; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Elias CN, 2008, JOM-US, V60, P46, DOI 10.1007/s11837-008-0031-1; ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B; Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024; Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0; HALEY TJ, 1961, BRIT J PHARM CHEMOTH, V17, P526, DOI 10.1111/j.1476-5381.1961.tb01139.x; Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006; Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010; Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037; Kajimura M, 1997, J PHYSIOL-LONDON, V503, P413, DOI 10.1111/j.1469-7793.1997.413bh.x; Kohn DH, 2002, J BIOMED MATER RES, V60, P292, DOI 10.1002/jbm.10050; Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008; Li N, 2013, J MATER SCI TECHNOL, V29, P489, DOI 10.1016/j.jmst.2013.02.005; Lin X, 2015, Open Biomed Eng J, V9, P56, DOI 10.2174/1874120701509010056; MACKENZIE C, 1961, J BIOPHYS BIOCHEM CY, V9, P141, DOI 10.1083/jcb.9.1.141; Ou CW, 2013, INT J ELECTROCHEM SC, V8, P9518; OZTURK SS, 1991, BIOTECHNOL BIOENG, V37, P989, DOI 10.1002/bit.260371015; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; Seuss F, 2011, J BIOMED MATER RES B, V99B, P276, DOI 10.1002/jbm.b.31896; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Nguyen TY, 2012, IEEE ENG MED BIO, P723, DOI 10.1109/EMBC.2012.6346033; Tie D, 2013, EUR CELLS MATER, V25, P284, DOI 10.22203/eCM.v025a20; Wang Y, 2009, MAT SCI ENG C-BIO S, V29, P1311, DOI 10.1016/j.msec.2008.09.051; Wei ZL, 2001, RARE METAL MAT ENG, V30, P147; Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331; Williams D, 1991, Med Device Technol, V2, P44; Willumeit R, 2011, ACTA BIOMATER, V7, P2704, DOI 10.1016/j.actbio.2011.03.004; Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293; Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028; Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001; Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015; Ye CH, 2012, APPL SURF SCI, V258, P3420, DOI 10.1016/j.apsusc.2011.11.087; Ye CH, 2013, T NONFERR METAL SOC, V23, P996, DOI 10.1016/S1003-6326(13)62558-3	46	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142117	10.1371/journal.pone.0142117	http://dx.doi.org/10.1371/journal.pone.0142117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600388	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900020
J	Er, F; Yuksel, D; Hellmich, M; Gassanov, N				Er, Fikret; Yueksel, Dilek; Hellmich, Martin; Gassanov, Natig			Comparison of Conventional versus Steerable-Catheter Guided Coronary Sinus Lead Positioning in Patients Undergoing Cardiac Resynchronization Device Implantation	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; THERAPY; DEFIBRILLATOR; PREVENTION	Objectives The aim of this study was to compare conventional versus steerable catheter guided coronary sinus (CS) cannulation in patients with advanced heart failure undergoing cardiac resynchronization therapy (CRT). Background Steerable catheter guided coronary sinus cannulation could reduce fluoroscopy time and contrast medium use during CRT implantation. Methods 176 consecutive patients with ischemic and non-ischemic heart failure undergoing CRT implantation from January 2008 to December 2012 at the University Hospital of Cologne were identified. During the study period two concurrent CS cannulation techniques were used: standard CS cannulation technique (standard-group, n = 113) and CS cannulation using a steerable electrophysiology (EP) catheter (EPCath-group, n = 63). Propensity-score matched pairs of conventional and EP-catheter guided CS cannulation made up the study population (n = 59 pairs). Primary endpoints were total fluoroscopy time and contrast medium amount used during procedure. Results The total fluoroscopy time was 30.9 min (interquartile range (IQR), 19.9-44.0 min) in the standard-group and 23.4 min (IQR, 14.2-34-2 min) in the EPCath-group (p = 0.011). More contrast medium was used in the standard-group (60.0 ml, IQR, 30.0-100 ml) compared to 25.0 ml (IQR, 20.0-50.0 ml) in the EPCath-group (P<0.001). Conclusions Use of steerable EP catheter was associated with significant reduction of fluoroscopy time and contrast medium use in patients undergoing CRT implantation.	[Er, Fikret; Yueksel, Dilek; Gassanov, Natig] Univ Hosp Munster, Klinikum Gutersloh, Dept Internal Med 1, Gutersloh, Germany; [Hellmich, Martin] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany	University of Cologne	Er, F (corresponding author), Univ Hosp Munster, Klinikum Gutersloh, Dept Internal Med 1, Gutersloh, Germany.	Fikret.Er@klinikum-guetersloh.de		Hellmich, Martin/0000-0001-5174-928X				Ando G, 2013, CATHETER CARDIO INTE, V82, P878, DOI 10.1002/ccd.25023; Bax JJ, 2005, J AM COLL CARDIOL, V46, P2168, DOI 10.1016/j.jacc.2005.09.020; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Capodanno D, 2016, J CARDIOVASC MED, V17, P524, DOI 10.2459/JCM.0000000000000215; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Er F, 2012, CIRCULATION, V126, P296, DOI 10.1161/CIRCULATIONAHA.112.096370; Gregoratos G, 2005, AM FAM PHYSICIAN, V71, P1563; Kennergren C, 1996, AM J CARDIOL, V78, P15, DOI 10.1016/S0002-9149(96)00497-3; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Niazi I, 2014, J INTERV CARD ELECTR, V41, P147, DOI 10.1007/s10840-014-9932-9; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Thibault B, 2015, PACE, V38, P63, DOI 10.1111/pace.12522; Wang LW, 2014, SCAND CARDIOVASC J, V48, P41, DOI 10.3109/14017431.2013.875623	14	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143292	10.1371/journal.pone.0143292	http://dx.doi.org/10.1371/journal.pone.0143292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599637	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900088
J	Figueroa, RI; Dapena, C; Bravo, I; Cuadrado, A				Figueroa, Rosa I.; Dapena, Carlos; Bravo, Isabel; Cuadrado, Angeles			The Hidden Sexuality of Alexandrium Minutum: An Example of Overlooked Sex in Dinoflagellates	PLOS ONE			English	Article							LIFE-CYCLES; GONYAULAX-TAMARENSIS; GENUS ALEXANDRIUM; CYST FORMATION; CELL-CYCLE; DINOPHYCEAE; DNA; REPRODUCTION; ORGANIZATION; SEGREGATION	Dinoflagellates are haploid eukaryotic microalgae in which rapid proliferation causes dense blooms, with harmful health and economic effects to humans. The proliferation mode is mainly asexual, as the sexual cycle is believed to be rare and restricted to stressful environmental conditions. However, sexuality is key to explaining the recurrence of many dinoflagellate blooms because in many species the fate of the planktonic zygotes (planozygotes) is the formation of resistant cysts in the seabed (encystment). Nevertheless, recent research has shown that individually isolated planozygotes in the lab can enter other routes besides encystment, a behavior of which the relevance has not been explored at the population level. In this study, using imaging flow cytometry, cell sorting, and Fluorescence In Situ Hybridization (FISH), we followed DNA content and nuclear changes in a population of the toxic dinoflagellate Alexandrium minutum that was induced to encystment. Our results first show that planozygotes behave like a population with an "encystment-independent" division cycle, which is light-controlled and follows the same Light: Dark (L:D) pattern as the cycle governing the haploid mitosis. Resting cyst formation was the fate of just a small fraction of the planozygotes formed and was restricted to a period of strongly limited nutrient conditions. The diploid-haploid turnover between L:D cycles was consistent with two-step meiosis. However, the diel and morphological division pattern of the planozygote division also suggests mitosis, which would imply that this species is not haplontic, as previously considered, but biphasic, because individuals could undergo mitotic divisions in both the sexual (diploid) and the asexual (haploid) phases. We also report incomplete genome duplication processes. Our work calls for a reconsideration of the dogma of rare sex in dinoflagellates.	[Figueroa, Rosa I.] Lund Univ, Aquat Ecol, S-22362 Lund, Sweden; [Figueroa, Rosa I.; Dapena, Carlos; Bravo, Isabel] IEO, Vigo 36390, Spain; [Cuadrado, Angeles] Univ Alcala UAH, Dept Biomed & Biotecnol, Alcala De Henares 28801, Spain	Lund University; Spanish Institute of Oceanography; Universidad de Alcala	Figueroa, RI (corresponding author), Lund Univ, Aquat Ecol, Biol Bldg, S-22362 Lund, Sweden.	rosa.figueroa@biol.lu.se	Bravo, Isabel/D-3147-2012; Cuadrado, Angeles/H-3470-2015; Figueroa, Rosa Isabel/M-7598-2015	Cuadrado, Angeles/0000-0003-0089-5249; Figueroa, Rosa Isabel/0000-0001-9944-7993; Bravo, Isabel/0000-0003-3764-745X	FORMAS (Sweden) [Formas 215-2010-824]; Spanish National Project CICAN [CGL2013-40671-R]; CCVIEO project	FORMAS (Sweden)(Swedish Research Council Formas); Spanish National Project CICAN; CCVIEO project	The present work was funded by a FORMAS (Sweden) project to RF (Formas 215-2010-824), the Spanish National Project CICAN (CGL2013-40671-R) to IB and RF and the CCVIEO project.; The present work was funded by a FORMAS (Sweden) project to RF (Formas 215-2010-824), the Spanish National Project CICAN (CGL2013-40671-R) to IB and RF and the CCVIEO project. We thank Isabel Ramilo for technical support.	ADAMICH M, 1976, PLANTA, V130, P1, DOI 10.1007/BF00390837; Alpermann TJ, 2010, J PHYCOL, V46, P18, DOI 10.1111/j.1529-8817.2009.00767.x; Alverca E, 2007, CYTOGENET GENOME RES, V116, P224, DOI 10.1159/000098191; Anderson D.M., 1998, PHYSL ECOLOGY HARMFU, V41, P29; ANDERSON DM, 1985, J PHYCOL, V21, P200; ANDERSON DM, 1985, J EXP MAR BIOL ECOL, V86, P1, DOI 10.1016/0022-0981(85)90039-5; ANDERSON DM, 1984, J PHYCOL, V20, P418, DOI 10.1111/j.0022-3646.1984.00418.x; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Bell G, 1982, MASTERPIECE NATURE E; BHAUD Y, 1988, J CELL SCI, V89, P197; BIECHELER B., 1952, B BIOL             S, V36, P1; Blackburn SI, 2001, PHYCOLOGIA, V40, P78, DOI 10.2216/i0031-8884-40-1-78.1; Bouligand Y, 2001, BIOCHIMIE, V83, P187, DOI 10.1016/S0300-9084(00)01211-6; Bravo Isabel, 2014, Microorganisms, V2, P11; Brosnahan ML, 2014, DEEP-SEA RES PT II, V103, P185, DOI 10.1016/j.dsr2.2013.05.034; Chow MH, 2010, EUKARYOT CELL, V9, P1577, DOI 10.1128/EC.00026-10; D'Souza TG, 2010, J HERED, V101, pS34, DOI 10.1093/jhered/esq005; Dapena C, 2015, PROTIST, V166, P146, DOI 10.1016/j.protis.2015.01.001; Davis L, 2001, P NATL ACAD SCI USA, V98, P8395, DOI 10.1073/pnas.121005598; Dia A, 2014, MOL ECOL, V23, P549, DOI 10.1111/mec.12617; Erdner DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022965; Figueroa RI, 2006, J PHYCOL, V42, P350, DOI 10.1111/j.1529-8817.2006.00191.x; Figueroa RI, 2006, J PHYCOL, V42, P67, DOI 10.1111/j.1529-8817.2006.00181.x; Figueroa RI, 2005, PHYCOLOGIA, V44, P658, DOI 10.2216/0031-8884(2005)44[658:EONFAD]2.0.CO;2; Figueroa RI, 2007, J PHYCOL, V43, P1039, DOI 10.1111/j.1529-8817.2007.00393.x; GAO XP, 1989, BRIT PHYCOL J, V24, P153; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Gerstein AC, 2009, J HERED, V100, P571, DOI 10.1093/jhered/esp057; Goodenough U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016154; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; HIMES M, 1975, P NATL ACAD SCI USA, V72, P4546, DOI 10.1073/pnas.72.11.4546; HURST LD, 1992, TRENDS ECOL EVOL, V7, P144, DOI 10.1016/0169-5347(92)90205-P; Figueroa RI, 2006, J PHYCOL, V42, P1028, DOI 10.1111/j.1529-8817.2006.00262.x; Figueroa RI, 2014, PROTIST, V165, P343, DOI 10.1016/j.protis.2014.04.001; Figueroa RI, 2010, DEEP-SEA RES PT II, V57, P190, DOI 10.1016/j.dsr2.2009.09.016; KONDRASHOV AS, 1994, NATURE, V370, P213, DOI 10.1038/370213a0; Kremp A, 2013, MICROPALEAEONTOLOGIC, P197; Larkins BA, 2001, J EXP BOT, V52, P183, DOI 10.1093/jexbot/52.355.183; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; LEVASSEUR M, 1993, J PHYCOL, V29, P587, DOI 10.1111/j.0022-3646.1993.00587.x; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; LOPER CL, 1980, T AM MICROSC SOC, V99, P343, DOI 10.2307/3226012; Mable BK, 1998, BIOESSAYS, V20, P453, DOI 10.1002/(SICI)1521-1878(199806)20:6<453::AID-BIES3>3.0.CO;2-N; Marangon I, 2012, NANO LETT, V12, P4830, DOI 10.1021/nl302273p; Nagai Satoshi, 2004, Plankton Biology and Ecology, V51, P103; Pfiester L.A., 1984, P181; Pfiester L.A., 1987, Botanical Monographs (Oxford), V21, P611; PFIESTER LA, 1976, J PHYCOL, V12, P234; PFIESTER LA, 1975, J PHYCOL, V11, P259, DOI 10.1111/j.1529-8817.1975.tb02776.x; PFIESTER LA, 1984, AM J BOT, V71, P1121, DOI 10.2307/2443388; Pfiester LA, 1989, INT REV CYTOL, V114, P249; Pouchet G., 1883, J ANATOMIE PHYSL, V19, P399; Raberg L, 2014, ECOL EVOL, V4, P4775, DOI 10.1002/ece3.1314; RAIKOV IB, 1995, EUR J PROTISTOL, V31, P1, DOI 10.1016/S0932-4739(11)80349-4; RILL RL, 1989, CHROMOSOMA, V98, P280, DOI 10.1007/BF00327314; Roy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034340; SILVA ES, 1995, PHYCOLOGIA, V34, P396, DOI 10.2216/i0031-8884-34-5-396.1; Stosch H.A. von., 1973, British phycol J, V8, P105; TaroncherOldenburg G, 1997, LIMNOL OCEANOGR, V42, P1178, DOI 10.4319/lo.1997.42.5_part_2.1178; Tillmann U, 2013, J PHYCOL, V49, P298, DOI 10.1111/jpy.12037; Uchida Takuji, 1996, Phycological Research, V44, P119, DOI 10.1111/j.1440-1835.1996.tb00040.x; von Stosch H. A., 1972, B SOC BOT FR S1, P201, DOI DOI 10.1080/00378941.1972.10839089; Wisecaver JH, 2011, ANNU REV MICROBIOL, V65, P369, DOI 10.1146/annurev-micro-090110-102841	64	29	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142667	10.1371/journal.pone.0142667	http://dx.doi.org/10.1371/journal.pone.0142667			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599692	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900035
J	Kannel, K; Alnek, K; Vahter, L; Gross-Paju, K; Uibo, R; Kisand, KV				Kannel, Karin; Alnek, Kristi; Vahter, Liina; Gross-Paju, Katrin; Uibo, Raivo; Kisand, Kalle V.			Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome	PLOS ONE			English	Article							LYMPHOCYTE STIMULATOR BLYS; NEUROMYELITIS-OPTICA; CEREBROSPINAL-FLUID; SERUM BAFF; EXPRESSION; APRIL; CXCL13; CSF; NEUTROPHILS; DISTINCT	Multiple sclerosis (MS) is mediated primarily by autoreactive T cells. However, evidence suggesting the involvement of humoral immunity in brain diseases has increased interest in the role of B cells and their products during MS pathogenesis. The major survival factor for B cells, BAFF has been shown to play a role in several autoimmune conditions. Elevated BAFF levels have been reported in MS animal model and during MS relapse in patients. Moreover, disease-modifying treatments (DMT) reportedly influence blood BAFF levels in MS patients, but the significance of these changes remains unclear. The present study addresses how blood BAFF levels are associated with the clinical course of relapsing-remitting MS and the effectiveness of DMT and short-term steroid treatment. During a prospective longitudinal follow-up of 2.3 years, BAFF was measured in the blood of 170 MS patients in the stable phase and within 186 relapses. BAFF levels were significantly higher in MS patients compared to healthy controls. However, stable MS patients without relapses exhibited significantly higher BAFF levels than relapsing patients. Treatment with interferon-beta and immunosuppressants raised BAFF blood levels. Interestingly, a similar effect was not seen in patients treated with glatiramer acetate. Short-term treatment with high doses of intravenous methylprednisolone did not significantly alter plasma BAFF levels in 65% of relapsing-remitting MS patients. BAFF were correlated weakly but significantly with monocyte and basophil counts, but not with other blood cell types (neutrophils, lymphocytes, or eosinophils) or inflammatory biomarkers. To our knowledge, this is the first report demonstrating that higher blood BAFF levels may reflect a more stable and effective MS treatment outcome. These results challenge hypotheses suggesting that elevated blood BAFF levels are associated with more severe disease presentation and could explain the recent failure of pharmaceutical trials targeting BAFF with soluble receptor for MS treatment.	[Kannel, Karin; Vahter, Liina; Gross-Paju, Katrin] West Tallinn Cent Hosp MS Ctr, Tallinn, Estonia; [Alnek, Kristi; Uibo, Raivo; Kisand, Kalle V.] Univ Tartu, Inst Biomed & Translat Med, Dept Immunol, EE-50090 Tartu, Estonia; [Gross-Paju, Katrin] Tallinn Univ Technol, Inst Clin Med, EE-19086 Tallinn, Estonia; [Vahter, Liina] Tallinn Univ, Inst Psychol, EE-10120 Tallinn, Estonia	University of Tartu; Tallinn University of Technology; Tallinn University	Kisand, KV (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Immunol, Ulikooli 18, EE-50090 Tartu, Estonia.	kalle.kisand@ut.ee	Kisand, Kalle/AAZ-2563-2020; Kisand, Kalle/S-5958-2016; Alnek, Kristi/E-3847-2019	Kisand, Kalle/0000-0002-7789-5565; Kisand, Kalle/0000-0002-7789-5565; Uibo, Raivo/0000-0002-2298-1300	Estonian Research Council [IUT20-43]; European Union Regional Development Fund	Estonian Research Council(Estonian Research Council); European Union Regional Development Fund(European Commission)	Funding provided by Estonian Research Council: grant no. IUT20-43 (RU) - http://www.etag.ee/teadusagentuur/ and European Union Regional Development Fund (RU) - http://ec.europa.eu/regional_policy/index.cfm/en/funding/erdf/.	Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; Frota ERC, 2009, NEUROSCI LETT, V460, P130, DOI 10.1016/j.neulet.2009.05.057; Deiss A, 2013, EXPERT REV NEUROTHER, V13, P313, DOI [10.1586/ERN.13.17, 10.1586/ern.13.17]; Franciotta D, 2011, J NEUROIMMUNOL, V230, P160, DOI 10.1016/j.jneuroim.2010.10.027; Fuhlhuber V, 2009, J NEUROIMMUNOL, V210, P87, DOI 10.1016/j.jneuroim.2009.03.006; Goodin DS, 2008, NEUROLOGY, V71, pS8, DOI 10.1212/WNL.0b013e31818f3d8b; Graber JJ, 2010, CLIN NEUROL NEUROSUR, V112, P583, DOI 10.1016/j.clineuro.2010.05.002; Gran B, 2001, Curr Neurol Neurosci Rep, V1, P263, DOI 10.1007/s11910-001-0029-3; Hamzaoui K, 2008, CLIN EXP RHEUMATOL, V26, pS64; Hedegaard CJ, 2011, MULT SCLER J, V17, P567, DOI 10.1177/1352458510393771; Hirst CL, 2012, MULT SCLER J, V18, P1152, DOI 10.1177/1352458511433919; Huntington ND, 2006, INT IMMUNOL, V18, P1473, DOI 10.1093/intimm/dxl080; Jin XZ, 2013, EXPERT OPIN BIOL TH, V13, P315, DOI 10.1517/14712598.2012.758248; Kappos L, 2014, LANCET NEUROL, V13, P353, DOI 10.1016/S1474-4422(14)70028-6; Kim JY, 2008, J NEUROIMMUNOL, V199, P151, DOI 10.1016/j.jneuroim.2008.05.010; Kowarik MC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-93; Kreuzaler M, 2012, J IMMUNOL, V188, P497, DOI 10.4049/jimmunol.1102321; Krumbholz M, 2008, BRAIN, V131, P1455, DOI 10.1093/brain/awn077; Krumbholz M, 2005, J AUTOIMMUN, V25, P298, DOI 10.1016/j.jaut.2005.08.004; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lehmann-Horn K, 2013, THER ADV NEUROL DISO, V6, P161, DOI 10.1177/1756285612474333; Liu X, 2013, AEROSP MANUF TECHNOL, V1, P1, DOI DOI 10.1109/TNNLS.2013.2287275; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Meinl E, 2011, J NEUROL SCI, V306, P180, DOI 10.1016/j.jns.2010.08.009; Nagai M, 2011, NEPHRON CLIN PRACT, V118, pC339, DOI 10.1159/000323393; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Nikolov NP, 2009, CURR OPIN RHEUMATOL, V21, P465, DOI 10.1097/BOR.0b013e32832eba21; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Quan C, 2013, MULT SCLER J, V19, P289, DOI 10.1177/1352458512454771; R Core Team, 2013, R LANG ENV STAT COMP; Ragheb S, 2011, MULT SCLER J, V17, P819, DOI 10.1177/1352458511398887; Scapini P, 2005, BLOOD, V105, P830, DOI 10.1182/blood-2004-02-0564; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Scapini P, 2008, IMMUNOL LETT, V116, P1, DOI 10.1016/j.imlet.2007.11.009; Sellebjerg F, 2011, EUR HDB NEUROLOGICAL, V1; Stohl William, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P351; Thangarajh M, 2004, J NEUROIMMUNOL, V152, P183, DOI 10.1016/j.jneuroim.2004.03.017; Thompson SAJ, 2010, J CLIN IMMUNOL, V30, P99, DOI 10.1007/s10875-009-9327-3; Tremlett H, 2008, J NEUROL NEUROSUR PS, V79, P1368, DOI 10.1136/jnnp.2008.145805; Tremlett H, 2009, NEUROLOGY, V73, P1616, DOI 10.1212/WNL.0b013e3181c1e44f; Vaknin-Dembinsky A, 2010, MULT SCLER, V16, P1453, DOI 10.1177/1352458510380416; Vannucchi G, 2012, J CLIN ENDOCR METAB, V97, pE755, DOI 10.1210/jc.2011-2614; Vincent FB, 2014, NAT REV RHEUMATOL, V10, P365, DOI 10.1038/nrrheum.2014.33; Wang HH, 2012, J CLIN IMMUNOL, V32, P1007, DOI 10.1007/s10875-012-9709-9; Xin G, 2013, NEPHROLOGY, V18, P209, DOI 10.1111/nep.12032	46	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143393	10.1371/journal.pone.0143393	http://dx.doi.org/10.1371/journal.pone.0143393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600308	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900105
J	Miltenburg, AS; Roggeveen, Y; Shields, L; van Elteren, M; van Roosmalen, J; Stekelenburg, J; Portela, A				Miltenburg, Andrea Solnes; Roggeveen, Yadira; Shields, Laura; van Elteren, Marianne; van Roosmalen, Jos; Stekelenburg, Jelle; Portela, Anayda			Impact of Birth Preparedness and Complication Readiness Interventions on Birth with a Skilled Attendant: A Systematic Review	PLOS ONE			English	Article							COMMUNITY-BASED APPROACH; MATERNAL HEALTH; SAFE MOTHERHOOD; NEONATAL-MORTALITY; COST-EFFECTIVENESS; ANTENATAL CARE; DISTRICT; DELIVERY; TRIAL; COUNTRIES	Background Increased preparedness for birth and complications is an essential part of antenatal care and has the potential to increase birth with a skilled attendant. We conducted a systematic review of studies to assess the effect of birth preparedness and complication readiness interventions on increasing birth with a skilled attendant. Methods PubMed, Embase, CINAHL and grey literature were searched for studies from 2000 to 2012 using a broad range of search terms. Studies were included with diverse designs and intervention strategies that contained an element of birth preparedness and complication readiness. Data extracted included population, setting, study design, outcomes, intervention description, type of intervention strategy and funding sources. Quality of the studies was assessed. The studies varied in BP/CR interventions, design, use of control groups, data collection methods, and outcome measures. We therefore deemed meta-analysis was not appropriate and conducted a narrative synthesis of the findings. Results Thirty-three references encompassing 20 different intervention programmes were included, of which one programmatic element was birth preparedness and complication readiness. Implementation strategies were diverse and included facility-, community-, or home-based services. Thirteen studies resulted in an increase in birth with a skilled attendant or facility birth. The majority of authors reported an increase in knowledge on birth preparedness and complication readiness. Conclusions Birth Preparedness and Complication Readiness interventions can increase knowledge of preparations for birth and complications; however this does not always correspond to an increase in the use of a skilled attendant at birth.	[Miltenburg, Andrea Solnes] Univ Oslo, Inst Hlth & Soc, Dept Community Med, Oslo, Norway; [Roggeveen, Yadira; van Roosmalen, Jos] Vrije Univ Amsterdam, Athena Inst Res Innovat & Commun Hlth & Life Sci, Fac Earth & Life Sci, Amsterdam, Netherlands; [Shields, Laura] Netherlands Inst Mental Hlth & Addict, Dept Int Mental Hlth, Utrecht, Netherlands; [van Elteren, Marianne] Univ Med Ctr VUmc, Inst Hlth & Care Res VU, Dept Med Humanities EMGO, Amsterdam, Netherlands; [Stekelenburg, Jelle] Leeuwarden Med Ctr, Dept Obstet & Gynaecol, Leeuwarden, Netherlands; [Portela, Anayda] WHO, Dept Maternal, Newborn, Child,Adolescent Hlth, CH-1211 Geneva, Switzerland	University of Oslo; Vrije Universiteit Amsterdam; Trimbos Institute; Medical Center Leeuwarden; World Health Organization	Miltenburg, AS (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Community Med, Oslo, Norway.	a.solnesmiltenburg@gmail.com	Stekelenburg, Jelle/B-3129-2017	Stekelenburg, Jelle/0000-0002-2732-6620; Portela, Anayda/0000-0001-6368-1585	WHO; Netherlands Society for Tropical Medicine and International Health	WHO(World Health Organization); Netherlands Society for Tropical Medicine and International Health	ASM received financial support from WHO to participate in the WHO Technical Consultation on health promotion interventions for maternal and newborn health, 15-17 July 2014, Geneva, where the initial results of this systematic review were presented and discussed. YR acknowledges financial support from the Netherlands Society for Tropical Medicine and International Health for writing her PhD thesis of which this study will be part. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; Ahluwalia IB, 2003, INT J GYNECOL OBSTET, V82, P231, DOI 10.1016/S0020-7292(03)00081-X; Ahluwalia IB, 2010, GLOB HEALTH PROMOT, V17, P39, DOI 10.1177/1757975909356627; [Anonymous], 2009, SYST REV CRD GUID UN; Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Barbey A, 2001, DINAJPUR SAFEMOTHER; Baya B, 2004, MEASURING EFFECTS BE; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Brazier E, 2009, SOC SCI MED, V69, P682, DOI 10.1016/j.socscimed.2009.06.023; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Church-Balin C., 2004, MNH PROGRAM EXPERIEN; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Di Mario S, 2005, WHAT IS EFFECTIVEN S; Edmonds JK, 2012, MIDWIFERY, V28, P554, DOI 10.1016/j.midw.2011.12.004; Effective Public Health Practice Project, 1998, EFFECTIVE PUBLIC HLT; Ekabua J., 2011, ISRN OBSTET GYNECOL, V2011, P1, DOI [10. 5402/ 2011/ 560641, DOI 10.5402/2011/560641]; Family Care international, 2007, TEST APPR INCR SKILL; Family Care International, 2003, CAR SEEK DUR PREGN D; Fonseca-Becker F, 2004, MEASURING EFFECTS BE; Glanz K., 2008, THEORY RES PRACTICE, V4th; Goodburn E, 2001, BRIT MED J, V322, P917, DOI 10.1136/bmj.322.7291.917; Graham W, 2008, TROP MED INT HEALTH, V13, P6, DOI 10.1111/j.1365-3156.2008.02082.x; Graham WJ, 2008, TROP MED INT HEALTH, V13, P1, DOI 10.1111/j.1365-3156.2008.02081.x; Graham WJ, 2002, LANCET, V359, P701, DOI 10.1016/S0140-6736(02)07817-0; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hiluf M, 2007, ETHIOP J HEALTH DEV, V22, P14; Hodgins S, 2010, J PERINATOL, V30, P388, DOI 10.1038/jp.2009.181; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hossain J, 2006, INT J GYNECOL OBSTET, V92, P320, DOI 10.1016/j.ijgo.2005.09.029; Hounton S, 2008, TROP MED INT HEALTH, V13, P44, DOI 10.1111/j.1365-3156.2008.02086.x; Hounton S, 2008, TROP MED INT HEALTH, V13, P14, DOI 10.1111/j.1365-3156.2008.02083.x; JHPIEGO, 2004, MON BIRTH PREP COMPL, P1; JHPIEGO, 2001, MAT NEON HLTH MNH PR; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; Kaharuza F., 2001, TIA MIMBA WEKA PESA; Kakaire O, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-12; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Kumar V, 2012, INT J GYNECOL OBSTET, V117, P48, DOI 10.1016/j.ijgo.2011.10.031; Magoma M, 2013, TROP MED INT HEALTH, V18, P435, DOI 10.1111/tmi.12069; Magoma M, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-64; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Midhet F, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-30; Miltenburg AS, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-11; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moore M., 2002, BEHAV CHANGE APPROAC; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; Mukhopadhyay Dipta Kanti, 2013, Indian J Public Health, V57, P147, DOI 10.4103/0019-557X.119827; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Mushi D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-14; Newlands D, 2008, TROP MED INT HEALTH, V13, P61, DOI 10.1111/j.1365-3156.2008.02088.x; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Popay J., 2006, GUIDANCE CONDUCT NAR; Portela A, 2003, BRIT MED BULL, V67, P59, DOI 10.1093/bmb/ldg013; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Requejo J, 2014, LANCET, P1; Sinha D., 2008, 5 POP COUNC; Skinner J, 2009, MIDWIFERY, V25, P738, DOI 10.1016/j.midw.2008.01.006; Solnes Miltenburg A, READY STEAD IN PRESS; Sood S, 2004, MEASURING EFFECTS BE; Sood S, 2004, MEASURING EFFECTS SI; Soubeiga D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-129; Stanton CK, 2004, EVALUATION REV, V28, P179, DOI 10.1177/0193841X03262577; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Turan JM, 2011, J MIDWIFERY WOM HEAL, V56, P8, DOI 10.1111/j.1542-2011.2010.00001.x; Urassa DP, 2012, TANZANIA J HLTH RES, V14, P1; Walsh D, 2006, MIDWIFERY, V22, P108, DOI 10.1016/j.midw.2005.05.004; WHO, 2015, WHO REC HLTH PROM IN; WHO, 2014, WHO TECHN CONS HLTH; WHO ICM FIGO, 2004, WHO ICM FIGO MAK PRE; World Health Organization, 2012, SOCIAL SCI METHODS R; World Health Organization, 2014, WHO REC COMM MOB FAC; World Health Organization (WHO), 2006, BIRTH EM PREP ANT CA	76	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143382	10.1371/journal.pone.0143382	http://dx.doi.org/10.1371/journal.pone.0143382			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599677	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900103
J	Scheiner, B; Mandorfer, M; Schwabl, P; Payer, BA; Bucsics, T; Bota, S; Aichelburg, MC; Grabmeier-Pfistershammer, K; Stattermayer, A; Ferenci, P; Trauner, M; Peck-Radosavljevic, M; Reiberger, T				Scheiner, Bernhard; Mandorfer, Mattias; Schwabl, Philipp; Payer, Berit Anna; Bucsics, Theresa; Bota, Simona; Aichelburg, Maximilian C.; Grabmeier-Pfistershammer, Katharina; Staettermayer, Albert; Ferenci, Peter; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas			The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection	PLOS ONE			English	Article							VIRUS/HEPATITIS-C-VIRUS; INTERFERON PLUS RIBAVIRIN; HIV-INFECTED PATIENTS; TRANSIENT ELASTOGRAPHY; PEGYLATED INTERFERON; VIRAL-HEPATITIS; HCV GENOTYPE; RISK-FACTORS; ANTIRETROVIRAL THERAPY; VIROLOGICAL RESPONSE	Background Faster fibrosis progression and hepatic steatosis are hallmarks of HIV/HCV coinfection. A single nucleotide polymorphism (SNP) of the PNPLA3-gene is associated with development of non-alcoholic steatohepatitis and a worse outcome in alcoholic liver disease. However, the role of PNPLA3 rs738409 SNP on liver fibrosis and steatosis, portal hypertension, and virological response in HIV/HCV coinfection remains unclear. Methods In this cross-sectional study PNPLA3 (rs738409) and IL28B (rs12979860) SNPs were determined in 177 HIV/HCV coinfected patients. Liver fibrosis and steatosis-staged by liver biopsy and transient elastography using the Controlled Attenuation Parameter (CAP)-and portal hypertension (hepatic venous pressure gradient, HVPG) were compared across PNPLA3 genotypes. Results 75 (42.4%) patients tested positive for a PNPLA3 minor/major risk allele (G/C: 66; G/G: 9) showed comparable fibrosis stages (median F2 vs. F2; p = 0.292) and similar amounts of hepatic steatosis (CAP: 203.5 +/- 41.9 vs. 215.5 +/- 59.7dB/m; p = 0.563) as compared to patients without a PNPLA3 risk allele. Advanced liver fibrosis was neither associated with PNPLA3 (p = 0.253) nor IL28B-genotype (p = 0.628), but with HCV-GT3 (p = 0.003), higher BMI (p = 0.008) and higher age (p = 0.007). Fibrosis progression rate (0.27 +/- 0.41 vs. 0.20 +/- 0.26 units/year; p = 0.984) and HVPG (3.9 +/- 2.6 vs. 4.4 +/- 3.0 mmHg; p = 0.472) were similar in patients with and without PNPLA3 risk alleles. SVR rates to PEGIFN/RBV therapy were similar across PNPLA3 genotypes. Conclusions The presence of a PNPLA3 risk allele had no independent impact on liver disease or virological response rates to PEGIFN/RBV therapy in our cohort of HIV/HCV coinfected patients.	[Scheiner, Bernhard; Mandorfer, Mattias; Schwabl, Philipp; Payer, Berit Anna; Bucsics, Theresa; Bota, Simona; Staettermayer, Albert; Ferenci, Peter; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria; [Scheiner, Bernhard; Mandorfer, Mattias; Schwabl, Philipp; Payer, Berit Anna; Aichelburg, Maximilian C.; Grabmeier-Pfistershammer, Katharina; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Vienna HIV & Liver Study Grp, Vienna, Austria; [Aichelburg, Maximilian C.; Grabmeier-Pfistershammer, Katharina] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Reiberger, T (corresponding author), Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria.	thomas.reiberger@meduniwien.ac.at	Mandorfer, Mattias/H-7603-2019; Reiberger, Thomas/H-7613-2019	Mandorfer, Mattias/0000-0003-2330-0017; Reiberger, Thomas/0000-0002-4590-3583; Grabmeier-Pfistershammer, Katharina/0000-0003-0665-5414; Schwabl, Philipp/0000-0002-7183-8076; Scheiner, Bernhard/0000-0002-4904-5133; Trauner, Michael/0000-0002-1275-6425; Mullner-Bucsics, Theresa/0000-0003-3901-4111; Stattermayer, Albert/0000-0003-0737-4091				Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Adinolfi LE, 2005, ALIMENT PHARM THER, V22, P52, DOI 10.1111/j.1365-2036.2005.02597.x; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Ampuero J, 2014, ANN HEPATOL, V13, P356, DOI 10.1016/S1665-2681(19)30842-7; Bani-Sadr F, 2006, AIDS, V20, P525, DOI 10.1097/01.aids.0000210606.63138.f5; Barreiro P, 2006, CLIN INFECT DIS, V42, P1032, DOI 10.1086/501021; Barreiro P, 2011, J INFECT DIS, V203, P1629, DOI 10.1093/infdis/jir113; Boursier J, 2015, HEPATOLOGY, V61, P18, DOI 10.1002/hep.27445; Castera L, 2014, HIV MED, V15, P30, DOI 10.1111/hiv.12082; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chang CC, 2013, IMMUNOL REV, V254, P114, DOI 10.1111/imr.12063; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Garcia-Tsao G, 2001, CURR OPIN GASTROEN, V17, P281, DOI 10.1097/00001574-200105000-00012; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Konerman MA, 2014, HEPATOLOGY, V59, P767, DOI 10.1002/hep.26741; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Labarga P, 2014, ANTIVIR THER, V19, P799, DOI 10.3851/IMP2816; Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926; Macias J, 2014, EXPERT OPIN PHARMACO, V15, P1837, DOI 10.1517/14656566.2014.934810; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Mandorfer M, 2014, J VIRAL HEPATITIS, V21, P33, DOI 10.1111/jvh.12118; Mandorfer M, 2014, LIVER INT; Mandorfer M, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12253; Mandorfer M, 2013, AIDS, V27, P227, DOI 10.1097/QAD.0b013e32835aa161; Morse CG, 2015, CLIN INFECT DIS; Neukam K, 2012, J HEPATOL, V56, P788, DOI 10.1016/j.jhep.2011.11.008; Payer BA, 2012, EUR J CLIN INVEST, V42, P599, DOI 10.1111/j.1365-2362.2011.02623.x; Peck-Radosavljevic M, 2013, WIEN KLIN WOCHENSCHR, V125, P200, DOI 10.1007/s00508-013-0337-z; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Price JC, 2014, AM J GASTROENTEROL, V109, P695, DOI 10.1038/ajg.2014.32; Reiberger T, 2008, EUR J CLIN INVEST, V38, P421, DOI 10.1111/j.1365-2362.2008.01958.x; Reiberger T, 2010, J VIRAL HEPATITIS, V17, P400, DOI 10.1111/j.1365-2893.2009.01197.x; Reiberger T, 2014, MINERVA GASTROENTERO; Reiberger T, 2012, ANTIVIR THER, V17, P1327, DOI 10.3851/IMP2349; Reiberger T, 2012, WIEN KLIN WOCHENSCHR, V124, P395, DOI 10.1007/s00508-012-0190-5; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, CURR OPIN LIPIDOL, V21, P247, DOI 10.1097/MOL.0b013e328338ca61; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Stattermayer AF, 2014, ALIMENT PHARM THER, V39, P1059, DOI 10.1111/apt.12717; Stattermayer AF, 2012, J HEPATOL, V57, P492, DOI 10.1016/j.jhep.2012.04.036; Sterling RK, 2008, HEPATOLOGY, V47, P1118, DOI 10.1002/hep.22134; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sulkowski MS, 2005, AIDS, V19, P585, DOI 10.1097/01.aids.0000163935.99401.25; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Theise ND, 2007, MODERN PATHOL, V20, pS3, DOI 10.1038/modpathol.3800693; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; Valenti L, 2012, ALIMENT PHARM THER, V35, P1434, DOI 10.1111/j.1365-2036.2012.05109.x; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Yasui K, 2014, J GASTROENTEROL; Zampino R, 2013, J VIRAL HEPATITIS, V20, P517, DOI 10.1111/jvh.12053	53	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143429	10.1371/journal.pone.0143429	http://dx.doi.org/10.1371/journal.pone.0143429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599080	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900118
J	Castede, S; Campoy, JA; Le Dantec, L; Quero-Garcia, J; Barreneche, T; Wenden, B; Dirlewanger, E				Castede, Sophie; Campoy, Jose Antonio; Le Dantec, Loick; Quero-Garcia, Jose; Barreneche, Teresa; Wenden, Benedicte; Dirlewanger, Elisabeth			Mapping of Candidate Genes Involved in Bud Dormancy and Flowering Time in Sweet Cherry (Prunus avium)	PLOS ONE			English	Article							MADS-BOX GENE; CONTROLS GROWTH CESSATION; PERSICA L. BATSCH; CHILLING REQUIREMENT; LOCUS-T; PHENOLOGICAL TRAITS; HEAT REQUIREMENTS; LOW-TEMPERATURE; BLOOM DATE; PEACH	The timing of flowering in perennial plants is crucial for their survival in temperate climates and is regulated by the duration of bud dormancy. Bud dormancy release and bud break depend on the perception of cumulative chilling during endodormancy and heat during the bud development. The objectives of this work were to identify candidate genes involved in dormancy and flowering processes in sweet cherry, their mapping in two mapping progenies 'Regina' x 'Garnet' and 'Regina' x 'Lapins', and to select those candidate genes which co-localized with quantitative trait loci (QTLs) associated with temperature requirements for bud dormancy release and flowering. Based on available data on flowering processes in various species, a list of 79 candidate genes was established. The peach and sweet cherry orthologs were identified and primers were designed to amplify sweet cherry candidate gene fragments. Based on the amplified sequences of the three parents of the mapping progenies, SNPs segregations in the progenies were identified. Thirty five candidate genes were genetically mapped in at least one of the two progenies and all were in silico mapped. Co-localization between candidate genes and QTLs associated with temperature requirements and flowering date were identified for the first time in sweet cherry. The allelic composition of the candidate genes located in the major QTL for heat requirements and flowering date located on linkage group 4 have a significant effect on these two traits indicating their potential use for breeding programs in sweet cherry to select new varieties adapted to putative future climatic conditions.	[Castede, Sophie; Campoy, Jose Antonio; Le Dantec, Loick; Quero-Garcia, Jose; Barreneche, Teresa; Wenden, Benedicte; Dirlewanger, Elisabeth] INRA, UMR Biol Fruit & Pathol 1332, F-33140 Villenave Dornon, France; [Castede, Sophie; Campoy, Jose Antonio; Le Dantec, Loick; Quero-Garcia, Jose; Barreneche, Teresa; Wenden, Benedicte; Dirlewanger, Elisabeth] Univ Bordeaux, UMR Biol Fruit & Pathol 1332, F-33140 Villenave Dornon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux	Dirlewanger, E (corresponding author), INRA, UMR Biol Fruit & Pathol 1332, F-33140 Villenave Dornon, France.	dirlewan@bordeaux.inra.fr	Wenden, Bénédicte/P-9519-2019; Campoy, José A/L-2699-2015	Wenden, Bénédicte/0000-0002-3064-5446; Campoy, José A/0000-0002-6018-5698; Dirlewanger, Elisabeth/0000-0003-3244-5197; BARRENECHE, Teresa/0000-0002-7852-1418	Aquitaine Region of France [2011-1201001]; INRA Meta Program 'Adaptation de l'agriculture et de la foret au changement climatique (ACCAF)	Aquitaine Region of France(Region Nouvelle-Aquitaine); INRA Meta Program 'Adaptation de l'agriculture et de la foret au changement climatique (ACCAF)	Sophie Castede's PhD grant was funded by the Aquitaine Region of France (2011-1201001: Etude et comprehension du determinisme genetique et moleculaire de la floraison chez le cerisier doux (Prunus avium) dans le but, a terme, de favoriser le choix de geniteurs et la creation de materiel vegetal adapte a lelevation de temperature prevue dans le cadre du rechauffement climatique et produisant des fruits de qualite) and by INRA Meta Program 'Adaptation de l'agriculture et de la foret au changement climatique (ACCAF; http://www.accaf.inra.fr/).	Alburquerque N, 2008, ENVIRON EXP BOT, V64, P162, DOI 10.1016/j.envexpbot.2008.01.003; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Bai SL, 2013, PLANT CELL PHYSIOL, V54, P1132, DOI 10.1093/pcp/pct067; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bielenberg DG, 2008, TREE GENET GENOMES, V4, P495, DOI 10.1007/s11295-007-0126-9; Bielenberg DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139406; Campoy JA, 2011, SCI HORTIC-AMSTERDAM, V130, P357, DOI 10.1016/j.scienta.2011.07.011; Campoy JA, 2012, EUR J AGRON, V37, P43, DOI 10.1016/j.eja.2011.10.004; Castede S, 2014, NEW PHYTOL, V202, P703, DOI 10.1111/nph.12658; Cooke JEK, 2012, PLANT CELL ENVIRON, V35, P1707, DOI 10.1111/j.1365-3040.2012.02552.x; Darbyshire R, 2013, INT J BIOMETEOROL, V57, P355, DOI 10.1007/s00484-012-0558-2; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Deal RB, 2007, PLANT CELL, V19, P74, DOI 10.1105/tpc.106.048447; Dirlewanger E, 2012, HEREDITY, V109, P280, DOI 10.1038/hdy.2012.38; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Fan S, 2010, NEW PHYTOL, V185, P917, DOI 10.1111/j.1469-8137.2009.03119.x; FISHMAN S, 1987, J THEOR BIOL, V124, P473, DOI 10.1016/S0022-5193(87)80221-7; Guedon Y, 2008, ECOL MODEL, V219, P189, DOI 10.1016/j.ecolmodel.2008.08.010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedley PE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-202; Heide OM, 2008, SCI HORTIC-AMSTERDAM, V115, P309, DOI 10.1016/j.scienta.2007.10.005; Heide OM, 2011, J EXP BOT, V62, P5397, DOI 10.1093/jxb/err213; Heide OM, 2005, TREE PHYSIOL, V25, P109, DOI 10.1093/treephys/25.1.109; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Horvath D, 2009, PLANT SCI, V177, P523, DOI 10.1016/j.plantsci.2009.09.002; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Jimenez S, 2012, ACTA HORTIC, V962, P161, DOI 10.17660/ActaHortic.2012.962.24; Jimenez S, 2010, PLANT MOL BIOL, V73, P157, DOI 10.1007/s11103-010-9608-5; Jimenez S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-25; Jimenez S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-81; Khan MRG, 2014, WIRES RNA, V5, P347, DOI 10.1002/wrna.1215; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Klagges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054743; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kryvych S, 2008, PLANT PHYSIOL BIOCH, V46, P160, DOI 10.1016/j.plaphy.2007.11.001; LANG GA, 1987, HORTSCIENCE, V22, P817; Lavee S., 1973, Acta Horticulturae, P225; Le Dantec L, 2012, 6 ROS GEN C; Leida C, 2012, NEW PHYTOL, V193, P67, DOI 10.1111/j.1469-8137.2011.03863.x; Li ZG, 2009, J EXP BOT, V60, P3521, DOI 10.1093/jxb/erp195; Luedeling E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020155; Luedeling E, 2009, ERWERBS-OBSTBAU, V51, P81, DOI 10.1007/s10341-009-0085-4; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Okie WR, 2011, HORTSCIENCE, V46, P245, DOI 10.21273/HORTSCI.46.2.245; Oliver SN, 2013, J EXP BOT, V64, P2413, DOI 10.1093/jxb/ert095; Olukolu BA, 2009, GENOME, V52, P819, DOI [10.1139/G09-050, 10.1139/g09-050]; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; RICHARDSON E A, 1974, Hortscience, V9, P331; Rinne PLH, 2011, PLANT CELL, V23, P130, DOI 10.1105/tpc.110.081307; Rinne PLH, 2001, PLANT J, V26, P249, DOI 10.1046/j.1365-313X.2001.01022.x; Ruckle ME, 2012, PLANT PHYSIOL, V159, P366, DOI 10.1104/pp.112.193599; Sanchez-Perez R, 2012, TREE GENET GENOMES, V8, P379, DOI 10.1007/s11295-011-0448-5; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Socquet-Juglard D, 2013, PLANT MOL BIOL REP, V31, P387, DOI 10.1007/s11105-012-0511-x; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trainin T, 2013, TREE GENET GENOMES, V9, P753, DOI 10.1007/s11295-012-0590-8; Van Ooijen J., 2006, SOFTWARE CALCULATION; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamane H, 2008, J AM SOC HORTIC SCI, V133, P708, DOI 10.21273/JASHS.133.5.708; Yamane H, 2011, J EXP BOT, V62, P3481, DOI 10.1093/jxb/err028; Zhang HL, 2010, J EXP BOT, V61, P2549, DOI 10.1093/jxb/erq092; Zhebentyayeva TN, 2014, TREE GENET GENOMES, V10, P35, DOI 10.1007/s11295-013-0660-6	69	51	51	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143250	10.1371/journal.pone.0143250	http://dx.doi.org/10.1371/journal.pone.0143250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587668	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500043
J	Huang, HC; Yang, HI; Chou, HC; Chen, CY; Hsieh, WS; Tsou, KI; Tsao, PN				Huang, Hsin-Chung; Yang, Hwai-I; Chou, Hung-Chieh; Chen, Chien-Yi; Hsieh, Wu-Shiun; Tsou, Kuo-Inn; Tsao, Po-Nien		Taiwan Premature Infant Dev	Preeclampsia and Retinopathy of Prematurity in Very-Low-Birth-Weight Infants: A Population-Based Study	PLOS ONE			English	Article							CIRCULATING ANGIOGENIC FACTORS; RISK-FACTORS; EPIDEMIOLOGIC ANALYSIS; PATHOPHYSIOLOGY	Preeclampsia and retinopathy of prematurity (ROP) are associated with impaired angiogenesis. Previous studies on the relationship between preeclampsia and ROP have produced conflicting results. The goal of this study was to evaluate the association between maternal preeclampsia and ROP using a large population-based cohort of very-low-birth-weight (VLBW) infants from 21 neonatal departments registered in the database of the Premature Baby Foundation of Taiwan. Multivariable logistic regression analysis was used to estimate the adjusted odds ratios (OR) and 95% confidence intervals (CI) for preeclampsia with reference to ROP and severe ROP. A total of 5,718 VLBW infants (844 cases with maternal preeclampsia) were included for analysis. The overall incidences of mild and severe ROP were 36.0% and 12.2%, respectively. Univariable analysis showed lower GA and lower birth weight, vaginal delivery, non-SGA, RDS, PDA, sepsis, transfusion, and absence of maternal preeclampsia to be associated with mild and severe ROP development. However, OR (95% CI) adjusted for the variables that were significant according to univariable analysis showed the risks of developing any-stage ROP and severe ROP for maternal preeclampsia to be 1.00 (0.84-1.20) and 0.89 (0.63-1.25), respectively. The results remained unchanged in stratified analyses according to SGA status. Our data showed that maternal preeclampsia was not associated with the subsequent development of any stage or severe ROP in VLBW infants.	[Huang, Hsin-Chung] Taipei City Hosp, Heping FuYou Branch, Dept Pediat, Taipei, Taiwan; [Yang, Hwai-I] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Yang, Hwai-I] Natl Yang Ming Univ, Grad Inst Clin Med, Taipei 112, Taiwan; [Chou, Hung-Chieh; Chen, Chien-Yi; Hsieh, Wu-Shiun; Tsao, Po-Nien] Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Tsou, Kuo-Inn] Fu Jen Catholic Univ, Catholic Tien Hosp, Dept Pediat, Taipei, Taiwan; [Tsou, Kuo-Inn] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan; [Tsao, Po-Nien] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan	Taipei City Hospital; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; Fu Jen Catholic University; National Taiwan University	Tsao, PN (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan.	tsaopn@ntu.edu.tw	Yang, Hwai-I/A-9470-2008; Chou, Hung-Chieh/AGZ-5161-2022; Chen, Chien-Yi/A-9680-2015	Yang, Hwai-I/0000-0002-3433-942X; Hsieh, Kai-Sheng/0000-0002-0294-9872; TSAO, PO-NIEN/0000-0002-6114-1769; CHOU, HUNG-CHIEH/0000-0002-8932-9472; Huang, Hsin-Chunag/0000-0002-1599-8542; Huang, Chao-Ching/0000-0003-2799-7181; HSIEH, WU-SHIUN/0000-0002-0609-3311; Tsou, Kuo-inn/0000-0002-5986-7624; Chen, Chien-Yi/0000-0002-6030-2655	National Taiwan University [104R7751]	National Taiwan University(National Taiwan University)	This work was supported by the National Taiwan University (grant no. 104R7751).	Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; Araz-Ersan B, 2013, BRIT J OPHTHALMOL, V97, P15, DOI 10.1136/bjophthalmol-2011-301411; Cavallaro G, 2014, ACTA OPHTHALMOL, V92, P2, DOI 10.1111/aos.12049; Cetinkaya M, 2010, J MATERN-FETAL NEO M, V23, P425, DOI [10.3109/14767050903184173, 10.1080/14767050903184173]; Dhaliwal CA, 2009, ARCH DIS CHILD-FETAL, V94, pF193, DOI 10.1136/adc.2008.143552; FLYNN JT, 1992, NEW ENGL J MED, V326, P1050, DOI 10.1056/NEJM199204163261603; Fortes JB, 2011, J PEDIATR-US, V158, P372, DOI 10.1016/j.jpeds.2010.08.051; Giannantonio C, 2008, J PEDIAT OPHTH STRAB, V45, P162, DOI 10.3928/01913913-20080501-12; Gilbert C, 2003, BMJ-BRIT MED J, V327, P760, DOI 10.1136/bmj.327.7418.760; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Gyamfi-Bannerman C, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.08.007; Hartnett ME, 2015, OPHTHALMOLOGY, V122, P200, DOI 10.1016/j.ophtha.2014.07.050; Holmstrom G, 1998, ACTA OPHTHALMOL SCAN, V76, P204, DOI 10.1034/j.1600-0420.1998.760216.x; Lad EM, 2009, AM J OPHTHALMOL, V148, P451, DOI 10.1016/j.ajo.2009.04.018; Lee JW, 2013, J MATERN-FETAL NEO M, V26, P811, DOI 10.3109/14767058.2013.764407; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2005, CLIN OBSTET GYNECOL, V48, P372, DOI 10.1097/01.grf.0000160313.82606.d7; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; Mehmet S, 2011, INT J OPHTHALMOL-CHI, V4, P634, DOI 10.3980/j.issn.2222-3959.2011.06.12; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Noori, 2011, CIRCULATION, V124, pE302, DOI 10.1161/CIR.0b013e318232376f; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Ozkan H, 2011, J PERINAT MED, V39, P523, DOI [10.1515/JPM.2011.071, 10.1515/jpm.2011.071]; Seiberth V, 2000, OPHTHALMOLOGICA, V214, P131, DOI 10.1159/000027482; Shah VA, 2005, ANN ACAD MED SINGAP, V34, P169; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wikstrand MH, 2011, ACTA PAEDIATR, V100, P1528, DOI 10.1111/j.1651-2227.2011.02394.x; Yang CY, 2011, PEDIATR NEONATOL, V52, P321, DOI 10.1016/j.pedneo.2011.08.004; Yen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075168; Yu XD, 2012, PEDIATRICS, V130, pE101, DOI 10.1542/peds.2011-3881; Zin A, 2013, CLIN PERINATOL, V40, P185, DOI 10.1016/j.clp.2013.02.001	37	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143248	10.1371/journal.pone.0143248	http://dx.doi.org/10.1371/journal.pone.0143248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588850	gold, Green Published, Green Submitted			2022-12-27	WOS:000365251500042
J	Kim, JS; Son, Y; Bae, MJ; Lee, SS; Park, SH; Lee, HJ; Lee, SI; Lee, CG; Kim, SD; Jo, WS; Kim, SH; Shin, IS				Kim, Joong Sun; Son, Yeonghoon; Bae, Min Ji; Lee, Seung Sook; Park, Sun Hoo; Lee, Hae June; Lee, Soong In; Lee, Chang Geun; Kim, Sung Dae; Jo, Wol Soon; Kim, Sung Ho; Shin, In Sik			Continuous Exposure to Low-Dose-Rate Gamma Irradiation Reduces Airway Inflammation in Ovalbumin-Induced Asthma	PLOS ONE			English	Article							REGULATORY T-CELLS; UP-REGULATION; RATE RADIATION; MATRIX-METALLOPROTEINASE-9; MICE	Although safe doses of radiation have been determined, concerns about the harmful effects of low-dose radiation persist. In particular, to date, few studies have investigated the correlation between low-dose radiation and disease development. Asthma is a common chronic inflammatory airway disease that is recognized as a major public health problem. In this study, we evaluated the effects of low-dose-rate chronic irradiation on allergic asthma in a murine model. Mice were sensitized and airway-challenged with ovalbumin (OVA) and were exposed to continuous low-dose-rate irradiation (0.554 or 1.818 mGy/h) for 24 days after initial sensitization. The effects of chronic radiation on proinflammatory cytokines and the activity of matrix metalloproteinase-9 (MMP-9) were investigated. Exposure to low-dose-rate chronic irradiation significantly decreased the number of inflammatory cells, methylcholine responsiveness (PenH value), and the levels of OVA-specific immunoglobulin E, interleukin (IL)-4, and IL-5. Furthermore, airway inflammation and the mucus production in lung tissue were attenuated and elevated MMP-9 expression and activity induced by OVA challenge were significantly suppressed. These results indicate that low-dose-rate chronic irradiation suppresses allergic asthma induced by OVA challenge and does not exert any adverse effects on asthma development. Our findings can potentially provide toxicological guidance for the safe use of radiation and relieve the general anxiety about exposure to low-dose radiation.	[Kim, Joong Sun; Bae, Min Ji; Lee, Chang Geun; Kim, Sung Dae; Jo, Wol Soon] DIRAMS, Res Ctr, Busan, South Korea; [Lee, Seung Sook; Park, Sun Hoo] Lab Radiat Exposure & Therapeut, Seoul, South Korea; [Son, Yeonghoon; Lee, Hae June] KIRAMS, Div Radiat Effect, Seoul, South Korea; [Lee, Soong In] Dongshin Univ, Coll Oriental Med, Jeonnam, South Korea; [Kim, Sung Ho; Shin, In Sik] Chonnam Natl Univ, Coll Vet Med, Gwangju, South Korea	Korea Institute of Radiological & Medical Sciences; Dongshin University; Chonnam National University	Kim, JS (corresponding author), DIRAMS, Res Ctr, Busan, South Korea.	jskim@dirams.re.kr; dvmshin@jnu.ac.kr			National R&D Program through the Korea Institute of Radiological and Medical Sciences [50586-2015]; Nuclear R&D Program of the Ministry of Science, ICT & Future Planning, Korea [50492-2015]; Global ATC program of Ministry of Trade, Industry Energy, Korea [51316-2014]	National R&D Program through the Korea Institute of Radiological and Medical Sciences; Nuclear R&D Program of the Ministry of Science, ICT & Future Planning, Korea; Global ATC program of Ministry of Trade, Industry Energy, Korea	This work was supported by National R&D Program through the Korea Institute of Radiological and Medical Sciences [50586-2015] and Nuclear R&D Program [50492-2015] of the Ministry of Science, ICT & Future Planning, Korea, and Global ATC program of Ministry of Trade, Industry & Energy, Korea [51316-2014].	Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Eldh T, 2012, STRAHLENTHER ONKOL, V188, P274, DOI 10.1007/s00066-011-0046-3; Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X; Fang SP, 2005, J RADIAT RES, V46, P151, DOI 10.1269/jrr.46.151; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Gong EJ, 2014, J RADIAT RES, V55, P54, DOI 10.1093/jrr/rrt090; HALL EJ, 1991, INT J RADIAT BIOL, V59, P595, DOI 10.1080/09553009114550531; Hong GU, 2014, RADIAT RES, V181, P425, DOI 10.1667/RR13547.1; Ina Y, 2005, INT J RADIAT BIOL, V81, P721, DOI 10.1080/09553000500519808; Jeon CM, 2014, INT IMMUNOPHARMACOL, V22, P414, DOI 10.1016/j.intimp.2014.07.013; Kim S-D., 2012, J RADIAT PROT RES, V37, P159; Ko FWS, 2005, CHEST, V127, P1919, DOI 10.1378/chest.127.6.1919; Lee MY, 2011, FOOD CHEM TOXICOL, V49, P829, DOI 10.1016/j.fct.2010.12.004; Mirzaie-Joniani H, 2002, CANCER, V94, P1210, DOI 10.1002/cncr.10287; Nakatsukasa H, 2010, RADIAT RES, V174, P313, DOI 10.1667/RR2121.1; Park BS, 2013, RADIAT RES, V179, P570, DOI 10.1667/RR3082.1; Park HR, 2013, INFLAMM RES, V62, P27, DOI 10.1007/s00011-012-0547-2; Piirila P, 2010, ALLERGY, V65, P61, DOI 10.1111/j.1398-9995.2009.02146.x; Ren HW, 2006, CELL IMMUNOL, V244, P50, DOI 10.1016/j.cellimm.2007.02.009; Rosanna D, 2012, CURR PHARM DESIGN, V18, P3889, DOI 10.2174/138161212802083716; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; SON YEONGHOON, 2013, [Journal of Radiation Protection and Research, 방사선방어학회지], V38, P179, DOI 10.14407/jrp.2013.38.4.179; Tanaka T, 2005, INT J RADIAT BIOL, V81, P731, DOI 10.1080/09553000500519790; Tsukimoto M, 2008, RADIAT RES, V170, P429, DOI 10.1667/RR1352.1; *UNSCEAR, 2000, HEALTH PHYS, V79, P314, DOI DOI 10.1097/00004032-200009000-00017; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Zhang YP, 2013, PHARMACOL RES, V71, P9, DOI 10.1016/j.phrs.2013.02.004; Zhang YH, 2014, ONCOL REP, V32, P1787, DOI 10.3892/or.2014.3419; Zhou Y, 2010, MOL MED REP, V3, P809, DOI 10.3892/mmr.2010.326	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143403	10.1371/journal.pone.0143403	http://dx.doi.org/10.1371/journal.pone.0143403			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588845	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500058
J	Paerhati, Y; Ishiguro, S; Ueda-Matsuo, R; Yang, P; Yamashita, T; Ito, K; Maekawa, H; Tani, H; Suzuki, K				Paerhati, Yisilahaiti; Ishiguro, Shinichi; Ueda-Matsuo, Risa; Yang, Ping; Yamashita, Tetsuro; Ito, Kikukatsu; Maekawa, Hideaki; Tani, Hiroko; Suzuki, Koichi			Expression of AmGR10 of the Gustatory Receptor Family in Honey Bee Is Correlated with Nursing Behavior	PLOS ONE			English	Article							APIS-MELLIFERA L; GENE-EXPRESSION; CHEMORECEPTOR SUPERFAMILY; MOLECULAR EVOLUTION; HEMOLYMPH SUGARS; SOCIAL-BEHAVIOR; DROSOPHILA; BRAIN; FOXP2	We investigated the association between the expression of a gene encoding gustatory receptor (G10) and division of labor in the honey bee, Apis mellifera. Among 10 GR genes encoding proteins 15% similar to 99% amino acid identity in the honey bee, we found that AmGR10 with 99% identity is involved in nursing or brood care. Expression of AmGR10 was restricted to organs of the hypopharyngeal gland, brain, and ovary in the nurse bee phase. Members of an extended nursing caste under natural conditions continued to express this gene. RNAi knockdown of AmGR10 accelerated the transition to foraging. Our findings demonstrate that this one gene has profound effects on the division of labor associated with the development and physiology of honeybee society.	[Paerhati, Yisilahaiti; Yang, Ping; Yamashita, Tetsuro; Ito, Kikukatsu] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan; [Ishiguro, Shinichi; Ueda-Matsuo, Risa; Suzuki, Koichi] Iwate Univ, Org Res Promot, Morioka, Iwate 020, Japan; [Maekawa, Hideaki] Biochem Sci Assoc, Shinagawa Ku, Tokyo, Japan; [Tani, Hiroko] Yamada Apiculture Ctr Inc, Inst Bee Prod & Hlth Sci, Okayama, Japan	Iwate University; Iwate University	Suzuki, K (corresponding author), Iwate Univ, Org Res Promot, Morioka, Iwate 020, Japan.	koichi@iwate-u.ac.jp			Yamada Honey Bee; JSPS KAKENHI [23228001]; Yamada Apicultural Center, Inc.	Yamada Honey Bee; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamada Apicultural Center, Inc.	Funding: This study was supported by a grant from Yamada Honey Bee (http://www.bee-lab.jp/) and in part by JSPS KAKENHI Grand no. 23228001 (http://www.jsps.go.jp/aboutus/index.html). Yamada Apicultural Center, Inc. provided support in the form of a salary for Dr. Hiroko Tani, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Amdam GV, 2010, ANIM BEHAV, V79, P973, DOI 10.1016/j.anbehav.2010.02.007; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Ament SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002596; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Denison Rachel, 2008, Invertebrate Neuroscience, V8, P1, DOI 10.1007/s10158-008-0066-6; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; FELL RD, 1990, COMP BIOCHEM PHYS A, V95, P539, DOI 10.1016/0300-9629(90)90735-B; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; Jung JW, 2015, J ASIA-PAC ENTOMOL, V18, P19, DOI 10.1016/j.aspen.2014.10.011; Leta MA, 1996, J INSECT PHYSIOL, V42, P239, DOI 10.1016/0022-1910(95)00106-9; Miyamoto T, 2013, CURR BIOL, V23, pR369, DOI 10.1016/j.cub.2013.04.002; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Ohashi K, 1997, EUR J BIOCHEM, V249, P797, DOI 10.1111/j.1432-1033.1997.t01-1-00797.x; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Tanaka H, 2005, J INSECT PHYSIOL, V51, P701, DOI 10.1016/j.jinsphys.2005.03.018; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807	31	8	9	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142917	10.1371/journal.pone.0142917	http://dx.doi.org/10.1371/journal.pone.0142917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588091	gold, Green Submitted, Green Published			2022-12-27	WOS:000365251500022
J	Kowalczyk, JE; Gruben, BS; Battaglia, E; Wiebenga, A; Majoor, E; de Vries, RP				Kowalczyk, Joanna E.; Gruben, Birgit S.; Battaglia, Evy; Wiebenga, Ad; Majoor, Eline; de Vries, Ronald P.			Genetic Interaction of Aspergillus nidulans galR, xlnR and araR in Regulating D-Galactose and L-Arabinose Release and Catabolism Gene Expression	PLOS ONE			English	Article							L-ARABINITOL 4-DEHYDROGENASE; D-XYLOSE REDUCTASE; BETA-GALACTOSIDASE; PATHWAY; NIGER; ENZYMES; DEHYDROGENASE; DEGRADATION; EVOLUTION; PENTOSE	In Aspergillus nidulans, the xylanolytic regulator XlnR and the arabinanolytic regulator AraR co-regulate pentose catabolism. In nature, the pentose sugars D-xylose and L-arabinose are both main building blocks of the polysaccharide arabinoxylan. In pectin and arabinogalactan, these two monosaccharides are found in combination with D-galactose. GalR, the regulator that responds to the presence of D-galactose, regulates the D-galactose catabolic pathway. In this study we investigated the possible interaction between XlnR, AraR and GalR in pentose and/or D-galactose catabolism in A. nidulans. Growth phenotypes and metabolic gene expression profiles were studied in single, double and triple disruptant A. nidulans strains of the genes encoding these paralogous transcription factors. Our results demonstrate that AraR and XlnR not only control pentose catabolic pathway genes, but also genes of the oxido-reductive D-galactose catabolic pathway. This suggests an interaction between three transcriptional regulators in D-galactose catabolism. Conversely, GalR is not involved in regulation of pentose catabolism, but controls only genes of the oxido-reductive D-galactose catabolic pathway.	[Kowalczyk, Joanna E.; Gruben, Birgit S.; Battaglia, Evy; Wiebenga, Ad; Majoor, Eline; de Vries, Ronald P.] Univ Utrecht, Fungal Physiol, CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Kowalczyk, Joanna E.; Gruben, Birgit S.; Battaglia, Evy; Wiebenga, Ad; Majoor, Eline; de Vries, Ronald P.] Univ Utrecht, Fungal Mol Physiol, Utrecht, Netherlands; [Gruben, Birgit S.; Battaglia, Evy] Univ Utrecht, Microbiol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Utrecht University; Utrecht University; Utrecht University	de Vries, RP (corresponding author), Univ Utrecht, Fungal Physiol, CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands.	r.devries@cbs.knaw.nl	de Vries, Ronald P./F-8125-2011	de Vries, Ronald P./0000-0002-4363-1123; Kowalczyk, Joanna/0000-0002-4417-0250	Dutch Technology Foundation STW; Applied Science division of NWO; Technology Program of the Ministry of Economic Affairs [016.130.609, UGC 07063, UGC 07938, UGC 14270]; Netherlands Organization for Scientific Research (NWO); Netherlands Genomics Initiative [93511035]; DOE-JGI CSP program [CSP2011-350]	Dutch Technology Foundation STW(Technologiestichting STW); Applied Science division of NWO(Netherlands Organization for Scientific Research (NWO)); Technology Program of the Ministry of Economic Affairs; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; DOE-JGI CSP program	JEK, EB and BSG were supported by grants of the Dutch Technology Foundation STW, Applied Science division of NWO and the Technology Program of the Ministry of Economic Affairs (http://www.stw.nl/) 016.130.609, UGC 07063, UGC 07938, & 14270 to RPdV. EM was supported by a grant from the Netherlands Organization for Scientific Research (NWO, www.nwo.nl) and the Netherlands Genomics Initiative 93511035 to R. P. de Vries. The authors acknowledge support of the DOE-JGI CSP program (http://jgi.doe.gov/collaborate-with-jgi/community-science-program/), project number CSP2011-350, for the genome sequences of the additional Aspergilli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JEK, EB and BSG were supported by grants of the Dutch Technology Foundation STW, Applied Science division of NWO and the Technology Program of the Ministry of Economic Affairs UGC 07063, 07938 & 14270 to RPdV. EM was supported by a grant from the Netherlands Organisation for Scientific Research (NWO) and the Netherlands Genomics Initiative 93511035 to RPdV. We acknowledge support of the DOE-JGI CSP program, project number CSP2011-350, for the genome sequences of the additional Aspergilli.	Battaglia E, 2011, STUD MYCOL, P31, DOI 10.3114/sim.2011.69.03; Battaglia E, 2014, RES MICROBIOL, V165; Christensen U, 2011, APPL ENVIRON MICROB, V77, P7084, DOI 10.1128/AEM.05290-11; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; de Groot MJL, 2007, FOOD TECHNOL BIOTECH, V45, P134; de Vries RP, 2004, APPL ENVIRON MICROB, V70, P3954, DOI 10.1128/AEM.70.7.3954-3959.2004; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; DEVRIES RP, 1994, FEMS MICROBIOL LETT, V123, P83, DOI 10.1016/0378-1097(94)90278-X; Fekete E, 2004, ARCH MICROBIOL, V181, P35, DOI 10.1007/s00203-003-0622-8; Fekete E, 2002, ARCH MICROBIOL, V179, P7, DOI 10.1007/s00203-002-0491-6; Fekete E, 2012, FEMS MICROBIOL LETT, V329, P198, DOI 10.1111/j.1574-6968.2012.02524.x; Flipphi M, 2009, FUNGAL GENET BIOL, V46, pS19, DOI 10.1016/j.fgb.2008.07.018; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gouet P, 2014, NUCLEIC ACIDS RES, V43; Gruben BS, 2012, FEBS LETT; Hasper AA, 2000, MOL MICROBIOL, V36, P193, DOI 10.1046/j.1365-2958.2000.01843.x; Koivistoinen OM, 2012, FEBS LETT, V586, P378, DOI 10.1016/j.febslet.2012.01.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohnen D, 1999, COMPREHENSIVE NATURA, V3, P497; Mojzita D, 2012, J BIOL CHEM, V287, P26010, DOI 10.1074/jbc.M112.372755; Mojzita D, 2012, FUNGAL GENET BIOL, V49, P152, DOI 10.1016/j.fgb.2011.11.005; Mojzita D, 2010, FEBS LETT, V584, P3540, DOI 10.1016/j.febslet.2010.06.037; Mojzita D, 2010, J BIOL CHEM, V285, P23622, DOI 10.1074/jbc.M110.113399; Pail M, 2004, EUR J BIOCHEM, V271, P1864, DOI 10.1111/j.1432-1033.2004.04088.x; Richard P, 2001, J BIOL CHEM, V276, P40631, DOI 10.1074/jbc.M104022200; ROBERTS CF, 1970, BIOCHIM BIOPHYS ACTA, V201, P267, DOI 10.1016/0304-4165(70)90301-6; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Seiboth B, 2007, MOL MICROBIOL, V66, P890, DOI 10.1111/j.1365-2958.2007.05953.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Todd RB, 2007, NAT PROTOC, V2, P811, DOI 10.1038/nprot.2007.112; van Peij NNME, 1998, MOL MICROBIOL, V27, P131, DOI 10.1046/j.1365-2958.1998.00666.x; vanKuyk PA, 2001, EUR J BIOCHEM, V268, P5414, DOI 10.1046/j.0014-2956.2001.02482.x; WITTEVEEN CFB, 1989, J GEN MICROBIOL, V135, P2163	34	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143200	10.1371/journal.pone.0143200	http://dx.doi.org/10.1371/journal.pone.0143200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580075	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600096
J	Miczajka, VL; Klein, AM; Pufal, G				Miczajka, Victoria L.; Klein, Alexandra-Maria; Pufal, Gesine			Elementary School Children Contribute to Environmental Research as Citizen Scientists	PLOS ONE			English	Article							ECOLOGICAL RESEARCH; DATA QUALITY; SCIENCE; BIODIVERSITY; PLANTS	Research benefits increasingly from valuable contributions by citizen scientists. Mostly, participating adults investigate specific species, ecosystems or phenology to address conservation issues, but ecosystem functions supporting ecosystem health are rarely addressed and other demographic groups rarely involved. As part of a project investigating seed predation and dispersal as ecosystem functions along an urban-rural gradient, we tested whether elementary school children can contribute to the project as citizen scientists. Specifically, we compared data estimating vegetation cover, measuring vegetation height and counting seeds from a seed removal experiment, that were collected by children and scientists in schoolyards. Children counted seeds similarly to scientists but under-or overestimated vegetation cover and measured different heights. We conclude that children can be involved as citizen scientists in research projects according to their skill level. However, more sophisticated tasks require specific training to become familiarized with scientific experiments and the development of needed skills and methods.	[Miczajka, Victoria L.; Klein, Alexandra-Maria; Pufal, Gesine] Univ Luneburg, Inst Ecol, D-21335 Luneburg, Germany	Leuphana University Luneburg	Pufal, G (corresponding author), Univ Freiburg, Chair Nat Conservat & Landscape Ecol, Inst Earth & Environm Sci, Tennenbacherstr 4, D-79106 Freiburg, Germany.	gesine.pufal@nature.uni-freiburg.de	Klein, Alexandra-Maria/J-5871-2016; Pufal, Gesine/K-7872-2016	Klein, Alexandra-Maria/0000-0003-2139-8575; Pufal, Gesine/0000-0002-2513-254X	Leuphana University of Luneburg; German Research Foundation (DFG); Albert Ludwigs University Freiburg; ProScience from the Leuphana University of Luneburg	Leuphana University of Luneburg; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg; ProScience from the Leuphana University of Luneburg	Victoria L. Miczajka was supported through a PhD scholarship from the Leuphana University of Luneburg and Gesine Pufal was financed by ProScience from the Leuphana University of Luneburg. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.; We thank all participating children, teachers, schools and the education authority in Hamburg and Lower Saxony. We are particularly grateful for the assistance given by Dr. Brunhild Landwehr for her very helpful didactical improvement of our environmental education concept and Felix Fornoff for many helpful discussions that improved the manuscript. Victoria L. Miczajka was supported through a PhD scholarship from the Leuphana University of Luneburg and Gesine Pufal was financed by ProScience from the Leuphana University of Luneburg. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. We also thank the editor and the anonymous reviewers for their helpful comments and suggestions, which greatly improved the manuscript.	[Anonymous], 2015, R PROJECT STAT COMPU; Balvanera P, 2014, BIOSCIENCE, V64, P49, DOI 10.1093/biosci/bit003; BENWARE CA, 1984, AM EDUC RES J, V21, P755, DOI 10.3102/00028312021004755; Bickford D, 2012, BIOL CONSERV, V151, P74, DOI 10.1016/j.biocon.2011.12.016; Bogner F. X., 1998, J ENVIRON EDUC, V29, P17, DOI DOI 10.1080/00958969809599124; Bonner RE, 2009, CAMB STUD AMER S, P1; Bouillion LM, 2001, J RES SCI TEACH, V38, P878, DOI 10.1002/tea.1037.abs; Braschler B, 2009, BIOSCIENCE, V59, P103, DOI 10.1525/bio.2009.59.2.2; Canfield DE, 2002, LAKE RESERV MANAGE, V18, P1; Carstens A, 2006, KERNCURRICULUM GRUND, P1; Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; Chandler M, 2012, FRONT ECOL ENVIRON, V10, P328, DOI 10.1890/110283; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Cooper CB, 2007, ECOL SOC, V12; Crall AW, 2011, CONSERV LETT, V4, P433, DOI 10.1111/j.1755-263X.2011.00196.x; Danielsen F, 2014, BIOSCIENCE, V64, P236, DOI 10.1093/biosci/biu001; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Donges C, 2006, KERNCURRICULUM GYMNA, P1; Droege S., 2007, CIT SCI TOOLK C, DOI [10.2190/PM.49.1.b, DOI 10.2190/PM.49.1.B]; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; Galloway AWE, 2006, WILDLIFE SOC B, V34, P1425, DOI 10.2193/0091-7648(2006)34[1425:TROCSA]2.0.CO;2; Galton M., 2009, CAMB J EDUC, V39, P119, DOI DOI 10.1080/03057640802701994; Genet KS, 2003, WILDLIFE SOC B, V31, P703; Havens K, 2012, FRONT ECOL ENVIRON, V10, P321, DOI 10.1890/110258; Henderson S, 2012, FRONT ECOL ENVIRON, V10, P283, DOI 10.1890/1540-9295-10.6.283; Hepper FN, 2003, BIODIVERS CONSERV, V12, P2503, DOI 10.1023/A:1025847029377; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Izard CE, 2000, IMAGIN COGN PERS, V19, P305, DOI [DOI 10.2190/GVVR-FTTL-VH9H-KKEL, 10.2190/GVVR-FTTL-VH9H-KKEL]; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Lemke A, 2009, J APPL ECOL, V46, P1122, DOI 10.1111/j.1365-2664.2009.01691.x; Lindemann-Matthies P, 2008, HUM ECOL, V36, P731, DOI 10.1007/s10745-008-9194-1; Low B, 2009, BIOL CONSERV, V142, P1548, DOI 10.1016/j.biocon.2009.02.003; Magnuson CS, 2000, J CAREER DEV, V27, P89, DOI 10.1177/089484530002700203; Michael J, 2006, ADV PHYSIOL EDUC, V30, P159, DOI 10.1152/advan.00053.2006; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Niven D, 2010, AM BIRDS, P1; Oberhauser K., 2008, AM ENTOMOL, V54, P103, DOI [10.1093/ae/54.2.103, DOI 10.1093/AE/54.2.103, DOI 10.1093/ae/54.2.103]; Prince M, 2004, J ENG EDUC, V93, P223, DOI 10.1002/j.2168-9830.2004.tb00809.x; Pufal G, 2013, J PLANT ECOL, V6, P468, DOI 10.1093/jpe/rtt011; Renz W, 2011, BILDUNGSPLAN GRUNDSC, P1; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Thomas M, 2011, GENET RESOUR CROP EV, V58, P321, DOI 10.1007/s10722-011-9662-0; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; Turke M, 2013, RENEW AGR FOOD SYST, P1; WYNN K, 1990, COGNITION, V36, P155, DOI 10.1016/0010-0277(90)90003-3	46	12	12	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143229	10.1371/journal.pone.0143229	http://dx.doi.org/10.1371/journal.pone.0143229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581087	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600102
J	Wever, KE; Hooijmans, CR; Riksen, NP; Sterenborg, TB; Sena, ES; Ritskes-Hoitinga, M; Warle, MC				Wever, Kimberley E.; Hooijmans, Carlijn R.; Riksen, Niels P.; Sterenborg, Thomas B.; Sena, Emily S.; Ritskes-Hoitinga, Merel; Warle, Michiel C.			Determinants of the Efficacy of Cardiac Ischemic Preconditioning: A Systematic Review and Meta-Analysis of Animal Studies	PLOS ONE			English	Review							REPERFUSION INJURY; SEARCH FILTER; BIAS; PUBLICATION; QUALITY; DISEASE; TRIALS	Background Ischemic preconditioning (IPC) of the heart is a protective strategy in which a brief ischemic stimulus immediately before a lethal ischemic episode potently limits infarct size. Although very promising in animal models of myocardial infarction, IPC has not yet been successfully translated to benefit for patients. Objective To appraise all preclinical evidence on IPC for myocardial infarction and identify factors hampering translation. Methods and results Using systematic review and meta-analysis, we identified 503 animal studies reporting infarct size data from 785 comparisons between IPC-treated and control animals. Overall, IPC reduced myocardial infarction by 24.6% [95% CI 23.5, 25.6]. Subgroup analysis showed that IPC efficacy was reduced in comorbid animals and non-rodents. Efficacy was highest in studies using 2-3 IPC cycles applied < 45 minutes before myocardial infarction. Local and remote IPC were equally effective. Reporting of study quality indicators was low: randomization, blinding and a sample size calculation were reported in 49%, 11% and 2% of publications, respectively. Conclusions Translation of IPC to the clinical setting may be hampered by the observed differences between the animals used in preclinical IPC studies and the patient population, regarding comorbidity, sex and age. Furthermore, the IPC protocols currently used in clinical trials could be optimized in terms of timing and the number of ischemic cycles applied. In order to inform future clinical trials successfully, future preclinical studies on IPC should aim to maximize both internal and external validity, since poor methodological quality may limit the value of the preclinical evidence.	[Wever, Kimberley E.; Hooijmans, Carlijn R.; Ritskes-Hoitinga, Merel] Radboud Univ Nijmegen Med Ctr, Systemat Review Ctr Lab Anim Experimentat SYRCLE, Nijmegen, Netherlands; [Riksen, Niels P.] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Riksen, Niels P.] Radboud Univ Nijmegen Med Ctr, Dept Pharmacol Toxicol, Nijmegen, Netherlands; [Sterenborg, Thomas B.; Warle, Michiel C.] Radboud Univ Nijmegen Med Ctr, Dept Surg, Nijmegen, Netherlands; [Sena, Emily S.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Edinburgh	Wever, KE (corresponding author), Radboud Univ Nijmegen Med Ctr, Systemat Review Ctr Lab Anim Experimentat SYRCLE, Nijmegen, Netherlands.	kim.wever@radboudumc.nl	Wever, Kimberley E./D-9705-2016; Ritskes-Hoitinga, Merel/GLT-8517-2022; Warle, M.C./L-4743-2015; Ritskes-Hoitinga, J./H-8083-2014; Riksen, Niels P/G-8260-2015; Hooijmans, C.R./L-4390-2015	Wever, Kimberley E./0000-0003-3635-3660; Ritskes-Hoitinga, Merel/0000-0001-5315-284X; Riksen, Niels P/0000-0001-9197-8124; Hooijmans, C.R./0000-0001-6435-5714; Sena, Emily S/0000-0002-3282-8502	Netherlands Organization for Health Research and Development (ZonMW) [104024065]; Laboratory Animal Science Association; Company of Biologists Ltd.; Clinical Fellowship of ZonMW; Netherlands Heart Foundation; National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) infrastructure award: ivSyRMAF, the CAMARADES-NC3Rs in vivo systematic review and meta-analysis facility; Company of Biologists	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Laboratory Animal Science Association; Company of Biologists Ltd.; Clinical Fellowship of ZonMW; Netherlands Heart Foundation(Netherlands Heart Foundation); National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) infrastructure award: ivSyRMAF, the CAMARADES-NC3Rs in vivo systematic review and meta-analysis facility; Company of Biologists	This work was supported by The Netherlands Organization for Health Research and Development (ZonMW, project #104024065). KEW performed part of this work with support of the Laboratory Animal Science Association and The Company of Biologists Ltd. NPR is supported by a Clinical Fellowship of ZonMW and the Netherlands Heart Foundation (dr. Dekker fellowship). ES' contribution was funded by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) infrastructure award: ivSyRMAF, the CAMARADES-NC3Rs in vivo systematic review and meta-analysis facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The Netherlands Organization for Health Research and Development (ZonMW, project #104024065). KEW performed part of this work with support of the Laboratory Animal Science Association and The Company of Biologists. NPR is supported by a Clinical Fellowship of ZonMW and the Netherlands Heart Foundation (dr. Dekker fellowship). ES' contribution was funded by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) infrastructure award: ivSyRMAF, the CAMARADES-NC3Rs in vivo systematic review and meta-analysis facility.	Alreja G, 2012, J INVASIVE CARDIOL, V24, P42; Brevoord D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042179; de Vries RBM, 2014, LAB ANIM-UK, V48, P88, DOI 10.1177/0023677213494374; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Healy DA, 2014, INT J SURG; Hirst JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098856; HOLM S, 1979, SCAND J STAT, V6, P65; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; Jansen Of, 2014, CIRC RES; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Ludman AJ, 2010, DIS MODEL MECH, V3, P35, DOI 10.1242/dmm.003855; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Pilcher JM, 2012, J ROY SOC MED, V105, P436, DOI 10.1258/jrsm.2012.120049; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Sena ES, 2010, J CEREBR BLOOD F MET, V30, P1905, DOI 10.1038/jcbfm.2010.116; [Shanthi Mendis PPaBN Organisation WH], 2011, POLICIES STRATEGIES, P164; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Takagi H, 2011, VASC ENDOVASC SURG, V45, P511, DOI 10.1177/1538574410379654; Tie HT, 2014, INT J CARDIOL; van den Munckhof I, 2013, AM J PHYSIOL-HEART C, V304, pH1727, DOI 10.1152/ajpheart.00054.2013; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	28	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142021	10.1371/journal.pone.0142021	http://dx.doi.org/10.1371/journal.pone.0142021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580958	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600031
J	Ye, YY; Zhang, YF; Chen, J; Liu, J; Li, XJ; Liu, YZ; Lang, Y; Lin, L; Yang, XJ; Jiang, XJ				Ye, Yuan-yuan; Zhang, Yuan-feng; Chen, Jia; Liu, Juan; Li, Xun-jun; Liu, Ya-zhen; Lang, Ying; Lin, Ling; Yang, Xin-Ju; Jiang, Xiao-Jiang			Internet-Based Cognitive Behavioral Therapy for Insomnia (ICBT-i) Improves Comorbid Anxiety and Depression-A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							SELF-HELP TREATMENT; PLACEBO-CONTROLLED TRIAL; HOSPITAL ANXIETY; SLEEP; SCALE; EFFICACY; INTERVENTION; INVENTORY; VALIDITY; SUPPORT	As the internet has become popularized in recent years, cognitive behavioral therapy for insomnia (CBT-i) has shifted from a face-to-face approach to delivery via the internet (internet-based CBT-i, ICBT-i). Several studies have investigated the effects of ICBT-i on comorbid anxiety and depression; however, the results remain inconclusive. Thus, a meta-analysis was conducted to determine the effects of ICBT-i on anxiety and depression. Electronic databases, including PubMed, EMBASE, PsycINFO and the Cochrane Library (throughout May 28, 2015), were systematically searched for randomized controlled trials (RCTs) of ICBT-i. Data were extracted from the qualified studies and pooled together. The standardized mean difference (SMD) and 95% confidence interval (95% CI) were calculated to assess the effects of ICBT-i on comorbid anxiety and depression. Nine records that included ten studies were ultimately qualified. The effect sizes (ESs) were -0.35 [-0.46, -0.25] for anxiety and -0.36 [-0.47, -0.26] for depression, which were stable using a between-group or within-group comparison and suggest positive effects of ICBT-i on both comorbid disorders. Although positive results were identified in this meta-analysis, additional high-quality studies with larger sample sizes are needed in the future.	[Ye, Yuan-yuan; Zhang, Yuan-feng; Liu, Juan; Li, Xun-jun; Liu, Ya-zhen; Lang, Ying; Lin, Ling; Yang, Xin-Ju; Jiang, Xiao-Jiang] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing, Peoples R China; [Chen, Jia] PLA 123 Hosp, Dept Neurol, Bengbu, Peoples R China	Army Medical University	Jiang, XJ (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing, Peoples R China.	15923589535@163.com			Science and Technology Achievement Transformation Fund of Third Military Medical University [2014XHZ10]	Science and Technology Achievement Transformation Fund of Third Military Medical University	This work was supported by Science and Technology Achievement Transformation Fund of Third Military Medical University (2014XHZ10).	Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; Ashworth DK, 2015, J COUNS PSYCHOL, V62, P115, DOI 10.1037/cou0000059; Bastien CH, 2004, J CONSULT CLIN PSYCH, V72, P653, DOI 10.1037/0022-006X.72.4.653; Becker PM, 2015, SLEEP MED CLIN, V10, P85, DOI 10.1016/j.jsmc.2014.11.003; Beekman A T, 1994, Tijdschr Gerontol Geriatr, V25, P95; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Belleville G, 2011, CLIN PSYCHOL REV, V31, P638, DOI 10.1016/j.cpr.2011.02.004; Blom K, 2015, BEHAV RES THER, V70, P47, DOI 10.1016/j.brat.2015.05.002; Blom K, 2015, SLEEP, V38, P267, DOI 10.5665/sleep.4412; Bonin EM, 2014, BEHAV RES THER, V55, P40, DOI 10.1016/j.brat.2014.01.005; Chen PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049113; Cheng SK, 2012, PSYCHOTHER PSYCHOSOM, V81, P206, DOI 10.1159/000335379; Cheung G, 2012, INT PSYCHOGERIATR, V24, P128, DOI 10.1017/S1041610211001426; DEBRUIN EJ, 2014, BEHAV SLEEP MED, V12, P235, DOI DOI 10.1080/15402002.2013.784703; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; Espie CA, 2014, SLEEP MED, V15, P913, DOI 10.1016/j.sleep.2014.03.001; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; Fernandez-Mendoza J, 2009, J ADOLESCENCE, V32, P1059, DOI 10.1016/j.adolescence.2009.03.005; Germain A, 2006, J CLIN SLEEP MED, V2, P403; Gros DF, 2007, PSYCHOL ASSESSMENT, V19, P369, DOI 10.1037/1040-3590.19.4.369; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Ho FYY, 2014, BEHAV RES THER, V63, P147, DOI 10.1016/j.brat.2014.10.002; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kaldo V, 2015, BEHAV RES THER, V71, P90, DOI 10.1016/j.brat.2015.06.001; Lancee J, 2013, BEHAV RES THER, V51, P797, DOI 10.1016/j.brat.2013.09.004; Lancee J, 2013, DEPRESS ANXIETY, V30, P149, DOI 10.1002/da.22004; Lancee J, 2012, BEHAV RES THER, V50, P22, DOI 10.1016/j.brat.2011.09.012; Lian YL, 2015, J PSYCHOSOM RES, V78, P45, DOI 10.1016/j.jpsychores.2014.09.009; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Okajima I, 2011, SLEEP BIOL RHYTHMS, V9, P24, DOI 10.1111/j.1479-8425.2010.00481.x; Ritterband LM, 2012, PSYCHO-ONCOLOGY, V21, P695, DOI 10.1002/pon.1969; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Strom L, 2004, J CONSULT CLIN PSYCH, V72, P113, DOI 10.1037/0022-006X.72.1.113; Suzuki E, 2008, J OCCUP HEALTH, V50, P387, DOI 10.1539/joh.L7154; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Takaesu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113753; Thiart H, 2015, SCAND J WORK ENV HEA, V41, P164, DOI 10.5271/sjweh.3478; Thiart H, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-169; Thorndike FP, 2013, J CLIN PSYCHOL, V69, P1078, DOI 10.1002/jclp.22032; Uhde TW, 2009, CURR PSYCHIAT REP, V11, P269, DOI 10.1007/s11920-009-0039-4; van Straten A, 2014, PSYCHOL MED, V44, P1521, DOI 10.1017/S0033291713002249; Vermeeren A, 2004, CNS DRUGS, V18, P297, DOI 10.2165/00023210-200418050-00003; Wise Jacqui, 2015, BMJ, V350, ph3076, DOI 10.1136/bmj.h3076; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	48	90	91	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142258	10.1371/journal.pone.0142258	http://dx.doi.org/10.1371/journal.pone.0142258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26581107	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600042
J	Duffy, JE; Ziegler, SL; Campbell, JE; Bippus, PM; Lefcheck, JS				Duffy, J. Emmett; Ziegler, Shelby L.; Campbell, Justin E.; Bippus, Paige M.; Lefcheck, Jonathan S.			Squidpops: A Simple Tool to Crowdsource a Global Map of Marine Predation Intensity	PLOS ONE			English	Article							GRAZING INTENSITY; TERRESTRIAL; ABUNDANCE; PATTERNS; FISH; LIMITATION; TEMPERATE; GRADIENTS; NITROGEN; EELGRASS	We present a simple, standardized assay, the squidpop, for measuring the relative feeding intensity of generalist predators in aquatic systems. The assay consists of a 1.3-cm diameter disk of dried squid mantle tethered to a rod, which is either inserted in the sediment in soft-bottom habitats or secured to existing structure. Each replicate squidpop is scored as present or absent after 1 and 24 hours, and the data for analysis are proportions of replicate units consumed at each time. Tests in several habitats of the temperate southeastern USA (Virginia and North Carolina) and tropical Central America (Belize) confirmed the assay's utility for measuring variation in predation intensity among habitats, among seasons, and along environmental gradients. In Belize, predation intensity varied strongly among habitats, with reef > seagrass = mangrove > unvegetated bare sand. Quantitative visual surveys confirmed that assayed feeding intensity increased with abundance and species richness of fishes across sites, with fish abundance and richness explaining up to 45% and 70% of the variation in bait loss respectively. In the southeastern USA, predation intensity varied seasonally, being highest during summer and declining in late autumn. Deployments in marsh habitats generally revealed a decline in mean predation intensity from fully marine to tidal freshwater sites. The simplicity, economy, and standardization of the squidpop assay should facilitate engagement of scientists and citizens alike, with the goal of constructing high-resolution maps of how top-down control varies through space and time in aquatic ecosystems, and addressing a broad array of long-standing hypotheses in macro-and community ecology.	[Duffy, J. Emmett] Smithsonian Inst, Tennenbaum Marine Observ Network, Washington, DC 20560 USA; [Duffy, J. Emmett; Ziegler, Shelby L.; Lefcheck, Jonathan S.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA USA; [Campbell, Justin E.] Smithsonian Marine Stn, Ft Pierce, FL USA; [Bippus, Paige M.] Coll Charleston, Charleston, SC 29401 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; William & Mary; Virginia Institute of Marine Science; Smithsonian Institution; Smithsonian National Museum of Natural History; College of Charleston	Duffy, JE (corresponding author), Smithsonian Inst, Tennenbaum Marine Observ Network, Washington, DC 20560 USA.	duffye@si.edu	Lefcheck, Jonathan/H-8768-2019; Duffy, J. Emmett/ABF-9200-2020	Lefcheck, Jonathan/0000-0002-8787-1786; Duffy, J. Emmett/0000-0001-8595-6391; Ziegler, Shelby/0000-0001-7218-0811	National Science Foundation [OCE-1336206]; Smithsonian Institution's Caribbean Coral Reef Ecosystem Program; Tennenbaum Marine Observatories Network; National Science Foundation's Research Experiences for Undergraduates program [OCE-062882]	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution's Caribbean Coral Reef Ecosystem Program; Tennenbaum Marine Observatories Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); National Science Foundation's Research Experiences for Undergraduates program	This work was supported by the National Science Foundation (award OCE-1336206 to JED), and the Smithsonian Institution's Caribbean Coral Reef Ecosystem Program and Tennenbaum Marine Observatories Network. PB was also supported by the National Science Foundation's Research Experiences for Undergraduates program (award OCE-062882 to Drs. Linda Schaffner and Rochelle Seitz, VIMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson RB, 1987, PALEOBIOLOGY; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Douglass JG, 2010, LIMNOL OCEANOGR, V55, P1499, DOI 10.4319/lo.2010.55.4.1499; DUFFY JE, 1994, ECOLOGY, V75, P1304, DOI 10.2307/1937456; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V137, P195, DOI 10.1016/0022-0981(90)90185-F; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; HAY ME, 1984, ECOLOGY, V65, P446, DOI 10.2307/1941407; HAY ME, 1981, AM NAT, V118, P520, DOI 10.1086/283845; HAY ME, 1981, AQUAT BOT, V11, P97, DOI 10.1016/0304-3770(81)90051-6; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Madin EMP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00014; Manyak-Davis A, 2013, AM NAT, V182, P347, DOI 10.1086/671170; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Meyer ST, 2015, TRENDS ECOL EVOL, V30, P390, DOI 10.1016/j.tree.2015.04.006; Moles AT, 2013, IDEAS ECOL EVOL, V6, P1, DOI 10.4033/iee.2013.6.1.c; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; OGDEN JC, 1973, SCIENCE, V182, P715, DOI 10.1126/science.182.4113.715; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Peterson BJ, 2001, MAR ECOL PROG SER, V224, P77, DOI 10.3354/meps224077; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Rotjan RD, 2006, J EXP MAR BIOL ECOL, V335, P292, DOI 10.1016/j.jembe.2006.03.015; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; WILSON KA, 1987, FISH B-NOAA, V85, P53; Wood SA, 2010, ECOL LETT, V13, P1160, DOI 10.1111/j.1461-0248.2010.01508.x	39	34	34	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142994	10.1371/journal.pone.0142994	http://dx.doi.org/10.1371/journal.pone.0142994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599815	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600024
J	Park, SH; Gong, JH; Choi, YJ; Kang, MK; Kim, YH; Kang, YH				Park, Sin-Hye; Gong, Ju-Hyun; Choi, Yean-Jung; Kang, Min-Kyung; Kim, Yun-Ho; Kang, Young-Hee			Kaempferol Inhibits Endoplasmic Reticulum Stress-Associated Mucus Hypersecretion in Airway Epithelial Cells And Ovalbumin-Sensitized Mice	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MUC5AC GENE-EXPRESSION; HUMAN HEALTH; ER STRESS; ASTHMA; INFLAMMATION; LUNG; DISEASE; COPD; MECHANISM	Mucus hypersecretion is an important pathological feature of chronic airway diseases, such as asthma and pulmonary diseases. MUC5AC is a major component of the mucus matrix forming family of mucins in the airways. The initiation of endoplasmic reticulum (ER)-mediated stress responses contributes to the pathogenesis of airway diseases. The present study investigated that ER stress was responsible for airway mucus production and this effect was blocked by the flavonoid kaempferol. Oral administration of >= 10 mg/kg kaempferol suppressed mucus secretion and goblet cell hyperplasia observed in the bronchial airway and lung of BALB/c mice sensitized with ovalbumin (OVA). TGF-beta and tunicamycin promoted MUC5AC induction after 72 h in human bronchial airway epithelial BEAS-2B cells, which was dampened by 20 mu M kaempferol. Kaempferol inhibited tunicamycin-induced ER stress of airway epithelial cells through disturbing the activation of the ER trans-membrane sensor ATF6 and IRE1 alpha. Additionally, this compound demoted the induction of ER chaperones such as GRP78 and HSP70 and the splicing of XBP-1 mRNA by tunicamycin. The in vivo study further revealed that kaempferol attenuated the induction of XBP-1 and IRE1 alpha in epithelial tissues of OVA-challenged mice. TGF-beta and tunicamycin induced TRAF2 with JNK activation and such induction was deterred by kaempferol. The inhibition of JNK activation encumbered the XBP-1 mRNA splicing and MUC5AC induction by tunicamycin and TGF-beta. These results demonstrate that kaempferol alleviated asthmatic mucus hypersecretion through blocking bronchial epithelial ER stress via the inhibition of IRE1 alpha-TRAF2-JNK activation. Therefore, kaempferol may be a potential therapeutic agent targeting mucus hypersecretion-associated pulmonary diseases.	[Park, Sin-Hye; Gong, Ju-Hyun; Choi, Yean-Jung; Kang, Min-Kyung; Kim, Yun-Ho; Kang, Young-Hee] Hallym Univ, Dept Food & Nutr, Chunchon, South Korea	Hallym University	Kang, YH (corresponding author), Hallym Univ, Dept Food & Nutr, Chunchon, South Korea.	yhkang@hallym.ac.kr			Hallym University [HRF-2013-00]; National Research Foundation of Korea [2015R1A2A2A01006666]	Hallym University; National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by Hallym University Research Fund, 2013 (HRF-2013-00), and the National Research Foundation of Korea (2015R1A2A2A01006666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2000, J BIOMATER APPL, V14, P243, DOI 10.1106/9D4B-L6PP-7CTF-BY8G; Bosse Y, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-66; Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen AY, 2013, FOOD CHEM, V138, P2099, DOI 10.1016/j.foodchem.2012.11.139; Danahay H, 2015, CELL REP, V10, P239, DOI 10.1016/j.celrep.2014.12.017; Goh FY, 2012, EUR J PHARMACOL, V679, P109, DOI 10.1016/j.ejphar.2012.01.002; Gong JH, 2014, LAB INVEST, V94, P297, DOI 10.1038/labinvest.2013.137; Gong JH, 2012, J NUTR, V142, P47, DOI 10.3945/jn.111.150748; Gosens R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-73; Gras D, 2013, PHARMACOL THERAPEUT, V140, P290, DOI 10.1016/j.pharmthera.2013.07.008; Groneberg DA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-18; Hannum SM, 2004, CRIT REV FOOD SCI, V44, P1, DOI 10.1080/10408690490263756; Hasnain SZ, 2013, GASTROENTEROLOGY, V144, P357, DOI 10.1053/j.gastro.2012.10.043; Hauber Hans-Peter, 2008, Inflammation & Allergy Drug Targets, V7, P30, DOI 10.2174/187152808784165153; Hoffman SM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-141; Izuhara K, 2009, CURR MED CHEM, V16, P2867, DOI 10.2174/092986709788803196; Kim HJ, 2008, J NUTR BIOCHEM, V19, P536, DOI 10.1016/j.jnutbio.2007.06.010; Kim JH, 2009, AM J RHINOL ALLERGY, V23, P385, DOI 10.2500/ajra.2009.23.3337; Kim SR, 2015, ALLERGY ASTHMA IMMUN, V7, P106, DOI 10.4168/aair.2015.7.2.106; Kim Suil, 2004, Treat Respir Med, V3, P147, DOI 10.2165/00151829-200403030-00003; Kim V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116108; Kim WD, 1997, EUR RESPIR J, V10, P1914, DOI 10.1183/09031936.97.10081914; Kitaguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038038; Lai H, 2010, J AEROSOL MED PULM D, V23, P219, DOI 10.1089/jamp.2009.0802; Lea S, 2014, EUR RESPIR J, V43, P409, DOI 10.1183/09031936.00187812; Makhija L, 2014, AM J RESP CELL MOL, V50, P923, DOI 10.1165/rcmb.2013-0320OC; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Martino MB, 2013, MUCOSAL IMMUNOL, V6, P639, DOI 10.1038/mi.2012.105; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; Munakata Mitsuru, 2006, Allergol Int, V55, P235, DOI 10.2332/allergolint.55.235; Ribeiro CMP, 2012, CURR MOL MED, V12, P872; Schroeder BW, 2012, AM J RESP CELL MOL, V47, P178, DOI 10.1165/rcmb.2011-0421OC; Shale DJ, 2004, EUR RESPIR J, V23, P797, DOI 10.1183/09031936.0.00018404; Shinkai M, 2008, PHARMACOL THERAPEUT, V117, P393, DOI 10.1016/j.pharmthera.2007.11.001; Soltys BJ, 1996, J CELL SCI, V109, P1909; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683; Wang GQ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-21; Yamauchi Kohei, 2007, Allergol Int, V56, P321, DOI 10.2332/allergolint.R-07-151; Yang T, 2012, INT IMMUNOPHARMACOL, V13, P73, DOI 10.1016/j.intimp.2012.03.006; Yang YC, 2012, ALLERGY, V67, P1193, DOI 10.1111/j.1398-9995.2012.02880.x	42	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143526	10.1371/journal.pone.0143526	http://dx.doi.org/10.1371/journal.pone.0143526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599511	Green Published, gold			2022-12-27	WOS:000365862600079
J	Benziger, CP; Bernabe-Ortiz, A; Gilman, RH; Checkley, W; Smeeth, L; Malaga, G; Miranda, JJ				Benziger, Catherine P.; Bernabe-Ortiz, Antonio; Gilman, Robert H.; Checkley, William; Smeeth, Liam; Malaga, German; Miranda, J. Jaime		CRONICAS Cohort Study Grp	Metabolic Abnormalities Are Common among South American Hispanics Subjects with Normal Weight or Excess Body Weight: The CRONICAS Cohort Study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; MASS INDEX; CARDIOVASCULAR-DISEASE; HEALTHY OBESITY; COLLABORATIVE ANALYSIS; POOLED ANALYSIS; RISK-FACTORS; OVERWEIGHT; PREVALENCE; POPULATION	Objective We aimed to characterize metabolic status by body mass index (BMI) status. Methods The CRONICAS longitudinal study was performed in an age-and-sex stratified random sample of participants aged 35 years or older in four Peruvian settings: Lima (Peru's capital, costal urban, highly urbanized), urban and rural Puno (both high-altitude), and Tumbes (costal semirural). Data from the baseline study, conducted in 2010, was used. Individuals were classified by BMI as normal weight (18.5-24.9 kg/m(2)), overweight (25.0-29.9 kg/m(2)), and obese (>= 30 kg/m(2)), and as metabolically healthy (0-1 metabolic abnormality) or metabolically unhealthy (>= 2 abnormalities). Abnormalities included individual components of the metabolic syndrome, high-sensitivity C-reactive protein, and insulin resistance. Results A total of 3088 (age 55.6 +/- 12.6 years, 51.3% females) had all measurements. Of these, 890 (28.8%), 1361 (44.1%) and 837 (27.1%) were normal weight, overweight and obese, respectively. Overall, 19.0% of normal weight in contrast to 54.9% of overweight and 77.7% of obese individuals had >= 3 risk factors (p<0.001). Among normal weight individuals, 43.1% were metabolically unhealthy, and age >= 65 years, female, and highest socioeconomic groups were more likely to have this pattern. In contrast, only 16.4% of overweight and 3.9% of obese individuals were metabolically healthy and, compared to Lima, the rural and urban sites in Puno were more likely to have a metabolically healthier profile. Conclusions Most Peruvians with overweight and obesity have additional risk factors for cardiovascular disease, as well as a majority of those with a healthy weight. Prevention programs aimed at individuals with a normal BMI, and those who are overweight and obese, are urgently needed, such as screening for elevated fasting cholesterol and glucose.	[Benziger, Catherine P.; Bernabe-Ortiz, Antonio; Malaga, German; Miranda, J. Jaime] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Benziger, Catherine P.] Univ Washington, Div Cardiol, Seattle, WA 98195 USA; [Gilman, Robert H.; Checkley, William] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Global Dis Epidemiol & Control, Baltimore, MD USA; [Gilman, Robert H.] Asociac Benef PRISMA, Lima, Peru; [Checkley, William] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, Baltimore, MD USA; [Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Malaga, German; Miranda, J. Jaime] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia	Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	jaime.miranda@upch.pe	Benziger, Catherine/AAN-3344-2021; Smeeth, Liam/X-5862-2018	Benziger, Catherine/0000-0002-8992-6197; Miranda, J. Jaime/0000-0002-4738-5468; Smeeth, Liam/0000-0002-9168-6022; Huicho, Luis/0000-0002-5272-5885; Montori, Victor/0000-0003-0595-2898; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Leon-Velarde Servetto, Fabiola/0000-0001-8398-2406; Wise, Robert/0000-0002-8353-2349; Checkley, William/0000-0003-1106-8812; Malaga, German/0000-0002-7828-300X; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; National Institutes of Health; Fogarty International Center through the International Clinical Research Fellows Program at Vanderbilt University [R24 TW007988]; Wellcome Trust; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K24ES021098] Funding Source: NIH RePORTER	United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center through the International Clinical Research Fellows Program at Vanderbilt University; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project and authors ABO, RHG, WC, and JJM have been funded with Federal funds from the United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN268200900033C. CPB was supported by the National Institutes of Health and Fogarty International Center through the International Clinical Research Fellows Program at Vanderbilt University (R24 TW007988). LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay LR, 2013, NUTR REV, V71, P168, DOI 10.1111/j.1753-4887.2012.00533.x; Bernabe-Ortiz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035127; Bobbioni-Harsch E, 2012, OBESITY, V20, P2063, DOI 10.1038/oby.2012.69; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conus F, 2004, J CLIN ENDOCR METAB, V89, P5013, DOI 10.1210/jc.2004-0265; Daeppen JB, 2000, ALCOHOL CLIN EXP RES, V24, P659, DOI 10.1097/00000374-200005000-00010; Dalleck LC, 2014, DIABET METAB SYND OB, V7, P369, DOI 10.2147/DMSO.S67441; Durward CM, 2012, J OBES, V2012, DOI 10.1155/2012/460321; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS259, DOI 10.1123/jpah.7.s2.s259; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Jacoby E, 2003, PREV MED, V37, P396, DOI 10.1016/S0091-7435(03)00159-2; Miranda JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054056; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; de Mola CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092550; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Medina-Lezama J, 2010, DIABETES CARE, V33, P1385, DOI 10.2337/dc09-2353; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Miranda J Jaime, 2012, BMJ Open, V2, pe000610, DOI 10.1136/bmjopen-2011-000610; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x; Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754; Pataky Z, 2011, INT J OBESITY, V35, P1208, DOI 10.1038/ijo.2010.264; Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102; Poterico JA, 2012, OBESITY, V20, P2283, DOI 10.1038/oby.2011.288; Shea JL, 2011, OBESITY, V19, P624, DOI 10.1038/oby.2010.174; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Soriguer F, 2013, J CLIN ENDOCR METAB, V98, P2318, DOI 10.1210/jc.2012-4253; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; Webber L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039589; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0	42	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0138968	10.1371/journal.pone.0138968	http://dx.doi.org/10.1371/journal.pone.0138968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599322	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000365853900002
J	Mkenda, P; Mwanauta, R; Stevenson, PC; Ndakidemi, P; Mtei, K; Belmain, SR				Mkenda, Prisila; Mwanauta, Regina; Stevenson, Philip C.; Ndakidemi, Patrick; Mtei, Kelvin; Belmain, Steven R.			Extracts from Field Margin Weeds Provide Economically Viable and Environmentally Benign Pest Control Compared to Synthetic Pesticides	PLOS ONE			English	Article							TITHONIA-DIVERSIFOLIA; TEPHROSIA-VOGELII; LIPPIA-JAVANICA; ECOLOGICAL INTENSIFICATION; BOTANICAL INSECTICIDES; SESQUITERPENE LACTONES; ANTIFEEDANT; YIELD; EFFICACY; PLANTS	Plants with pesticidal properties have been investigated for decades as alternatives to synthetics, but most progress has been shown in the laboratory. Consequently, research on pesticidal plants is failing to address gaps in our knowledge that constrain their uptake. Some of these gaps are their evaluation of their efficacy under field conditions, their economic viability and impact on beneficial organisms. Extracts made from four abundant weed species found in northern Tanzania, Tithonia diversifolia, Tephrosia vogelii, Vernonia amygdalina and Lippia javanica offered effective control of key pest species on common bean plants (Phaseolus vulgaris) that was comparable to the pyrethroid synthetic, Karate. The plant pesticide treatments had significantly lower effects on natural enemies (lady beetles and spiders). Plant pesticide treatments were more cost effective to use than the synthetic pesticide where the marginal rate of return for the synthetic was no different from the untreated control, around 4USD/ha, compared to a rate of return of around 5.50USD/ha for plant pesticide treatments. Chemical analysis confirmed the presence of known insecticidal compounds in water extracts of T. vogelii (the rotenoid deguelin) and T. diversifolia (the sesquiterpene lactone tagitinin A). Sesquiterpene lactones and the saponin vernonioside C were also identified in organic extracts of V. amygdalina but only the saponin was recorded in water extracts which are similar to those used in the field trial. Pesticidal plants were better able to facilitate ecosystem services whilst effectively managing pests. The labour costs of collecting and processing abundant plants near farm land were less than the cost of purchasing synthetic pesticides.	[Mkenda, Prisila; Mwanauta, Regina; Ndakidemi, Patrick; Mtei, Kelvin] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania; [Stevenson, Philip C.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Stevenson, Philip C.; Belmain, Steven R.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	Nelson Mandela African Institution of Science & Technology; Royal Botanic Gardens, Kew; University of Greenwich	Belmain, SR (corresponding author), Univ Greenwich, Nat Resources Inst, Chatham, Kent, England.	s.r.belmain@gre.ac.uk	stevenson, philip c/E-8741-2013; Belmain, Steven R/F-7758-2012; Stevenson, Philip C/E-8822-2013; MKENDA, PRISILA ANDREA/ABE-1774-2020	stevenson, philip c/0000-0002-0736-3619; Belmain, Steven R/0000-0002-5590-7545; Stevenson, Philip C/0000-0002-0736-3619; 	McKnight Foundation grant [13-335]; European Union 9th European Development Fund grant from the African Caribbean and Pacific Science and Technology Programme [FED/2013/329-272]	McKnight Foundation grant; European Union 9th European Development Fund grant from the African Caribbean and Pacific Science and Technology Programme	This research was funded by a McKnight Foundation grant (Grant No: 13-335) https://www.mcknight.org/grant-programs/international/collaborative-crop-research and a European Union 9th European Development Fund grant from the African Caribbean and Pacific Science and Technology Programme (FED/2013/329-272), http://www.acp-st.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate T, 1996, ANNU REV ENTOMOL, V41, P45, DOI 10.1146/annurev.en.41.010196.000401; Adedire CO, 2004, ANN APPL BIOL, V144, P185, DOI 10.1111/j.1744-7348.2004.tb00332.x; Adeniyi SA, 2010, INT J PHYS SCI, V5, P753; Akhtar Y., 2008, Phytochemistry Reviews, V7, P77, DOI 10.1007/s11101-006-9048-7; Ambrsio SR, 2008, PHYTOCHEMISTRY, V69, P2052, DOI 10.1016/j.phytochem.2008.03.019; Amoabeng BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078651; Asawalam EF, 2008, AFR J BIOTECHNOL, V7, P2957; Bagnarello G, 2009, REV BIOL TROP, V57, P1201; Belmain S., 2001, Pesticide Outlook, V12, P233, DOI 10.1039/b110542f; Belmain SR, 2012, J AGR FOOD CHEM, V60, P10055, DOI 10.1021/jf3032217; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Brown PR, 2005, CROP PROT, V24, P101, DOI 10.1016/j.cropro.2004.06.012; Cassida JE, 2012, PYRETHRUM NATURAL IN; Chagas-Paula DA, 2012, CHEM BIODIVERS, V9, P210, DOI 10.1002/cbdv.201100019; Chukwujekwu JC, 2009, S AFR J BOT, V75, P176, DOI 10.1016/j.sajb.2008.10.001; De la Fuente M, 2012, FOOD TECHNOL BIOTECH, V50, P315; Gadzirayi CT, 2009, AFR J BIOTECHNOL, V8, P4134; GANJIAN I, 1983, PHYTOCHEMISTRY, V22, P2525, DOI 10.1016/0031-9422(83)80154-X; Grobbelaar E, 2008, AFR ENTOMOL, V16, P7, DOI 10.4001/1021-3589-16.1.7; Grzywacz D, 2014, FOOD SECUR, V6, P71, DOI 10.1007/s12571-013-0313-5; Gu JQ, 2002, J NAT PROD, V65, P532, DOI 10.1021/np010545m; HILL D.S., 2008, PESTS CROPS WARMER C; Hillocks RJ, 2006, EUPHYTICA, V150, P215, DOI 10.1007/s10681-006-9112-9; Ibarra-Perez FJ, 1999, CROP SCI, V39, P428, DOI 10.2135/cropsci1999.0011183X0039000200022x; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470; Isman MB, 2014, TRENDS PLANT SCI, V19, P140, DOI 10.1016/j.tplants.2013.11.005; JISAKA M, 1992, TETRAHEDRON, V48, P625, DOI 10.1016/S0040-4020(01)88123-0; Juarez ZN, 2014, NAT PROD COMMUN, V9, P895; Kasina JM, 2009, J ECON ENTOMOL, V102, P467, DOI 10.1603/029.102.0201; Kawuki RS, 2005, CROP PROT, V24, P473, DOI 10.1016/j.cropro.2004.09.017; Madzimure J, 2011, TROP ANIM HEALTH PRO, V43, P481, DOI 10.1007/s11250-010-9720-1; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; Miranda MAFM, 2015, J NAT PROD, V78, P1083, DOI 10.1021/acs.jnatprod.5b00040; Mkenda PA, 2015, INT J TROP INSECT SC, V35, P172, DOI 10.1017/S174275841500017X; Mujovo SF, 2008, NAT PROD RES, V22, P1047, DOI 10.1080/14786410802250037; Ndakidemi PA, 2006, AUST J EXP AGR, V46, P571, DOI 10.1071/EA03157; Nyirenda SP, 2011, AFRICAN J AGR RES, V6; Oyewole IO, 2008, J MED PLANTS RES, V2, P171; Pereira PS, 1997, PHYTOCHEMISTRY, V45, P1445, DOI 10.1016/S0031-9422(97)00142-8; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; Rabe T, 2002, J ETHNOPHARMACOL, V80, P91, DOI 10.1016/S0378-8741(02)00010-7; Rubia EG, 1996, CROP PROT, V15, P335, DOI 10.1016/0261-2194(95)00102-6; Singh P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104377; Stark J.D., 2004, NEEM TODAY NEW MILLE, DOI [10.1007/1-4020-2596-3_6, DOI 10.1007/1-4020-2596-3_6]; Stevenson PC, 2012, PHYTOCHEMISTRY, V78, P135, DOI 10.1016/j.phytochem.2012.02.025; Stevenson PC, 2009, J AGR FOOD CHEM, V57, P8860, DOI 10.1021/jf901599j; Tittonell P, 2013, FIELD CROP RES, V143, P76, DOI 10.1016/j.fcr.2012.10.007; Viljoen AM, 2005, J ETHNOPHARMACOL, V96, P271, DOI 10.1016/j.jep.2004.09.017	49	51	53	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143530	10.1371/journal.pone.0143530	http://dx.doi.org/10.1371/journal.pone.0143530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599609	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000365853900137
J	Alshboul, Z; Lorke, A				Alshboul, Zeyad; Lorke, Andreas			Carbon Dioxide Emissions from Reservoirs in the Lower Jordan Watershed	PLOS ONE			English	Article							METHANE EMISSIONS; SURFACE WATERS; SUPERSATURATION; TERRESTRIAL; VARIABILITY; IRRIGATION; ALKALINITY; MECHANISMS; HYDRATION; QUALITY	We have analyzed monthly hydrological, meteorological and water quality data from three irrigation and drinking water reservoirs in the lower Jordan River basin and estimated the atmospheric emission rates of CO2. The data were collected between 2006 and 2013 and show that the reservoirs, which differ in size and age, were net sources of CO2. The estimated surface fluxes were comparable in magnitude to those reported for hydroelectric reservoirs in the tropical and sub-tropical zones. Highest emission rates were observed for a newly established reservoir, which was initially filled during the sampling period. In the two older reservoirs, CO2 partial pressures and fluxes were significantly decreasing during the observation period, which could be related to simultaneously occurring temporal trends in water residence time and chemical composition of the water. The results indicate a strong influence of water and reservoir management (e.g. water consumption) on CO2 emission rates, which is affected by the increasing anthropogenic pressure on the limited water resources in the study area. The low wind speed and relatively high pH favored chemical enhancement of the CO2 gas exchange at the reservoir surfaces, which caused on average a four-fold enhancement of the fluxes. A sensitivity analysis indicates that the uncertainty of the estimated fluxes is, besides pH, mainly affected by the poorly resolved wind speed and resulting uncertainty of the chemical enhancement factor.	[Alshboul, Zeyad; Lorke, Andreas] Univ Koblenz Landau, Inst Environm Sci, D-76829 Landau, Germany	University of Koblenz & Landau	Alshboul, Z (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Fortstr 7, D-76829 Landau, Germany.	zeyad@uni-landau.de	Lorke, Andreas/B-9195-2008	Lorke, Andreas/0000-0001-5533-1817; Alshboul, Zeyad/0000-0002-9445-3347	Sustainable Water Management Program (NAWAM) of German Academic Exchange Service (DAAD) [A/12/91768]	Sustainable Water Management Program (NAWAM) of German Academic Exchange Service (DAAD)	This work was funded by Sustainable Water Management Program (NAWAM) of German Academic Exchange Service (DAAD), (Grant number: A/12/91768).	Abril G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002457; Abril G, 2014, BIOGEOSCI DISC, V11, P11701, DOI [10.5194/bgd-11-11701-2014, DOI 10.5194/BGD-11-11701-2014]; Al-Ghazawi ZD, 2008, CLEAN TECHNOL ENVIR, V10, P341, DOI 10.1007/s10098-008-0145-8; Al-Sheriadeh MS, 1999, ENVIRON GEOL, V37, P234, DOI 10.1007/s002540050381; Al-Taani AA, 2013, ARAB J GEOSCI, V6, P1131, DOI 10.1007/s12517-011-0428-y; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Bade DL, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002684; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; Crawford JT, 2014, GLOBAL BIOGEOCHEM CY; Crusius J, 2003, LIMNOL OCEANOGR, V48, P1010, DOI 10.4319/lo.2003.48.3.1010; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Evans JP, 2009, CLIMATIC CHANGE, V92, P417, DOI 10.1007/s10584-008-9438-5; Farber E, 2004, GEOCHIM COSMOCHIM AC, V68, P1989, DOI 10.1016/j.gca.2003.09.021; Gunkel A, 2012, WATER RESOUR MANAG, V26, P963, DOI 10.1007/s11269-011-9903-1; HOOVER TE, 1969, J GEOPHYS RES, V74, P456, DOI 10.1029/JB074i002p00456; Humborg C, 2010, GLOBAL CHANGE BIOL, V16, P1966, DOI 10.1111/j.1365-2486.2009.02092.x; Jiang ZP, 2014, GLOBAL BIOGEOCHEM CY, V28, P729, DOI 10.1002/2013GB004678; JOHNSON KS, 1982, LIMNOL OCEANOGR, V27, P849, DOI 10.4319/lo.1982.27.5.0849; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Lopez P, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001614; Maeck A, 2014, BIOGEOSCIENCES, V11, P2925, DOI 10.5194/bg-11-2925-2014; Maeck A, 2013, ENVIRON SCI TECHNOL, V47, P8130, DOI 10.1021/es4003907; Millero FJ, 1998, MAR CHEM, V60, P111, DOI 10.1016/S0304-4203(97)00084-4; Morales-Pineda M, 2014, J GEOPHYS RES-BIOGEO, V119, P509, DOI 10.1002/2013JG002317; Parkhurst D L, 2013, DESCRIPTION INPUT EX, V6, DOI 10.3133/tm6A43; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/ngeo1830, 10.1038/NGEO1830]; Saadoun I., 2008, JORDAN J BIOL SCI, V1, P67; Saadoun I, 2008, TURK J BIOL, V32, P291; Saadoun I, 2010, OCEANOL HYDROBIOL ST, V39, P189, DOI 10.2478/v10009-010-0057-x; Shatanawi M, 1996, WATER RES, V30, P2915, DOI 10.1016/S0043-1354(96)00176-5; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; Teodoru CR, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004187; Teodoru CR, 2011, ECOSYSTEMS, V14, P28, DOI 10.1007/s10021-010-9393-7; Tortajada C, 2012, IMPACTS LARGE DAMS G; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; von Schiller D, 2014, INLAND WATERS, V4, P377, DOI 10.5268/IW-4.4.746; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Wanninkhof R, 1996, LIMNOL OCEANOGR, V41, P689, DOI 10.4319/lo.1996.41.4.0689; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140	45	4	4	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143381	10.1371/journal.pone.0143381	http://dx.doi.org/10.1371/journal.pone.0143381			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588241	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500055
J	Petrovic, I; Milivojevic, M; Popovic, J; Schwirtlich, M; Rankovic, B; Stevanovic, M				Petrovic, Isidora; Milivojevic, Milena; Popovic, Jelena; Schwirtlich, Marija; Rankovic, Branislava; Stevanovic, Milena			SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; IN-VITRO; PANCREATIC-CANCER; REDUNDANT ROLES; HUMAN EPIDERMIS; TGF-BETA; EXPRESSION; PATHWAY; GROWTH; INHIBITION	Although there is much evidence showing functional relationship between Hedgehog pathway, in particular Sonic hedgehog, and SOX transcription factors during embryonic development, scarce data are available regarding their crosstalk in cancer cells. SOX18 protein plays an important role in promoting tumor angiogenesis and therefore emerged as a promising potential target in antiangiogenic tumor therapy. Recently it became evident that expression of SOX18 gene in tumors is not restricted to endothelium of accompanying blood and lymphatic vessels, but in tumor cells as well. In this paper we have identified human SOX18 gene as a novel target gene of Hedgehog signaling in cervical carcinoma cell lines. We have presented data showing that expression of SOX18 gene is regulated by GLI1 and GLI2 transcription factors, final effectors of Hedgehog signaling, and that modulation of Hedgehog signaling activity in considerably influence SOX18 expression. We consider important that Hedgehog pathway inhibitors reduced SOX18 expression, thus showing, for the first time, possibility for manipulationwith SOX18 gene expression. In addition, we analyzed the role of SOX18 in malignant potential of cervical carcinoma cell line, and showed that its overexpression has no influence on cells proliferation and viability, but substantially promotes migration and invasion of cells in vitro. Pro-migratory effect of SOX18 suggests its role in promoting malignant spreading, possibly in response to Hedgehog activation.	[Petrovic, Isidora; Milivojevic, Milena; Popovic, Jelena; Schwirtlich, Marija; Rankovic, Branislava; Stevanovic, Milena] Univ Belgrade, Lab Human Mol Genet, Inst Mol Genet & Genet Engn, Belgrade 11000, Serbia	University of Belgrade	Petrovic, I (corresponding author), Univ Belgrade, Lab Human Mol Genet, Inst Mol Genet & Genet Engn, POB 23, Belgrade 11000, Serbia.	isidorapetrovic@imgge.bg.ac.rs	Popovic, Jelena/S-6304-2017	Popovic, Jelena/0000-0001-8565-1555; milivojevic, milena/0000-0002-1938-8020; Schwirtlich, Marija/0000-0002-2183-0164; Petrovic, Isidora/0000-0002-9816-2184	Ministry of Education, Science and Technological Development, Republic of Serbia [173051]	Ministry of Education, Science and Technological Development, Republic of Serbia	This work was funded by the Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No 173051, www.mpn.gov.rs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki VI, 2010, JNCI-J NATL CANCER I, V102, P1148, DOI 10.1093/jnci/djq257; Alexandrova AY, 2008, BIOCHEMISTRY-MOSCOW+, V73, P733, DOI 10.1134/S0006297908070018; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Castillo SD, 2012, EXPERT OPIN THER TAR, V16, P903, DOI 10.1517/14728222.2012.709239; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chaudary N, 2012, CANCER-AM CANCER SOC, V118, P3105, DOI 10.1002/cncr.26635; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Darby IA, 2001, LAB INVEST, V81, P937, DOI 10.1038/labinvest.3780304; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Eichberger T, 2004, J INVEST DERMATOL, V122, P1180, DOI 10.1111/j.0022-202X.2004.22505.x; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Grujicic NK, 2005, GENE, V344, P287, DOI 10.1016/j.gene.2004.11.006; Gu DS, 2013, MOL CANCER THER, V12, P1038, DOI 10.1158/1535-7163.MCT-12-1030; Hargrave M, 2000, DEV BIOL, V219, P142, DOI 10.1006/dbio.1999.9581; Hoeth M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030982; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Khoshyomn S, 1999, J NEURO-ONCOL, V45, P111, DOI 10.1023/A:1006375316331; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kwon YJ, 2011, CLIN EXP METASTAS, V28, P437, DOI 10.1007/s10585-011-9382-z; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lin SH, 2013, JNCI-J NATL CANCER I, V105, P686, DOI 10.1093/jnci/djt055; Lu BJ, 2008, AM J CLIN PATHOL, V130, P897, DOI 10.1309/AJCPW1W8GJBQGCNI; Luo M, 2008, MED HYPOTHESES, V70, P880, DOI 10.1016/j.mehy.2007.07.024; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; MERZAK A, 1994, BRIT J CANCER, V70, P199, DOI 10.1038/bjc.1994.280; Milivojevic M, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1287, DOI 10.1134/S0006297913110096; Mordhorst LB, 2014, GYNECOL ONCOL, V135, P305, DOI 10.1016/j.ygyno.2014.08.026; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Perrot CY, 2013, PHARMACOL THERAPEUT, V137, P183, DOI 10.1016/j.pharmthera.2012.10.002; Petrovic I, 2010, EXP MOL MED, V42, P132, DOI 10.3858/emm.2010.42.2.015; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Popovic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091852; Popovic J, 2010, BBA-GENE REGUL MECH, V1799, P411, DOI 10.1016/j.bbagrm.2010.01.002; Pula B, 2014, ANTICANCER RES, V34, P4029; Pula B, 2013, CELL ONCOL, V36, P469, DOI 10.1007/s13402-013-0151-7; Ramaswamy B, 2012, CANCER RES, V72, P5048, DOI 10.1158/0008-5472.CAN-12-1248; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Roy S, 2002, J CELL SCI, V115, P4393, DOI 10.1242/jcs.00158; Samarzija I, 2012, BIOCHEM BIOPH RES CO, V425, P64, DOI 10.1016/j.bbrc.2012.07.051; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Scotting PJ, 1996, NEUROPATH APPL NEURO, V22, P469, DOI 10.1111/j.1365-2990.1996.tb01118.x; Shevde LA, 2014, INT J CANCER, V135, P1, DOI 10.1002/ijc.28424; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Thu Kelsie L, 2014, Oncoscience, V1, P326; Vervoort SJ, 2013, ONCOGENE, V32, P3397, DOI 10.1038/onc.2012.506; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wickstrom M, 2013, INT J CANCER, V132, P1516, DOI 10.1002/ijc.27820; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Xuan YH, 2006, MODERN PATHOL, V19, P1139, DOI 10.1038/modpathol.3800600; Young N, 2006, J NATL CANCER I, V98, P1060, DOI 10.1093/jnci/djj299; Zhu YZ, 2012, INT J MOL SCI, V13, P15767, DOI 10.3390/ijms131215767	70	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143591	10.1371/journal.pone.0143591	http://dx.doi.org/10.1371/journal.pone.0143591			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588701	Green Published, gold, Green Submitted			2022-12-27	WOS:000365251500065
J	Sunol, R; Wagner, C; Arah, OA; Kristensen, S; Pfaff, H; Klazinga, N; Thompson, CA; Wang, A; DerSarkissian, M; Bartels, P; Michel, P; Groene, O				Sunol, Rosa; Wagner, Cordula; Arah, Onyebuchi A.; Kristensen, Solvejg; Pfaff, Holger; Klazinga, Niek; Thompson, Caroline A.; Wang, Aolin; DerSarkissian, Maral; Bartels, Paul; Michel, Philippe; Groene, Oliver		DUQuE Project Consortium	Implementation of Departmental Quality Strategies Is Positively Associated with Clinical Practice: Results of a Multicenter Study in 73 Hospitals in 7 European Countries	PLOS ONE			English	Article							HEALTH-CARE; IMPROVEMENT IMPLEMENTATION; SENSITIVITY-ANALYSIS; REGIONAL-VARIATIONS; MANAGEMENT-SYSTEMS; BIAS FORMULAS; OF-CARE; SAFETY; PERFORMANCE; OUTCOMES	Background Given the amount of time and resources invested in implementing quality programs in hospitals, few studies have investigated their clinical impact and what strategies could be recommended to enhance its effectiveness. Objective To assess variations in clinical practice and explore associations with hospital-and department-level quality management systems. Design Multicenter, multilevel cross-sectional study. Setting and Participants Seventy-three acute care hospitals with 276 departments managing acute myocardial infarction, deliveries, hip fracture, and stroke in seven countries. Intervention None. Measures Predictor variables included 3 hospital- and 4 department-level quality measures. Six measures were collected through direct observation by an external surveyor and one was assessed through a questionnaire completed by hospital quality managers. Dependent variables included 24 clinical practice indicators based on case note reviews covering the 4 conditions (acute myocardial infarction, deliveries, hip fracture and stroke). A directed acyclic graph was used to encode relationships between predictors, outcomes, and covariates and to guide the choice of covariates to control for confounding. Results and Limitations Data were provided on 9021 clinical records by 276 departments in 73 hospitals. There were substantial variations in compliance with the 24 clinical practice indicators. Weak associations were observed between hospital quality systems and 4 of the 24 indicators, but on analyzing department-level quality systems, strong associations were observed for 8 of the 11 indicators for acute myocardial infarction and stroke. Clinical indicators supported by higher levels of evidence were more frequently associated with quality systems and activities. Conclusions There are significant gaps between recommended standards of care and clinical practice in a large sample of hospitals. Implementation of department-level quality strategies was significantly associated with good clinical practice. Further research should aim to develop clinically relevant quality standards for hospital departments, which appear to be more effective than generic hospital-wide quality systems.	[Sunol, Rosa] Univ Autonoma Barcelona, Avedis Donabedian Res Inst FAD, E-08193 Barcelona, Spain; [Sunol, Rosa] Red Invest Serv Salud Enfermedades Cron REDISSEC, Barcelona, Spain; [Wagner, Cordula] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Wagner, Cordula] Vrije Univ Amsterdam, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands; [Arah, Onyebuchi A.; Wang, Aolin; DerSarkissian, Maral] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Kristensen, Solvejg; Bartels, Paul] Danish Clin Registries, Aarhus, Denmark; [Kristensen, Solvejg; Bartels, Paul] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Pfaff, Holger] Univ Cologne, Inst Med Sociol Hlth Serv Res & Rehabil Sci, D-50931 Cologne, Germany; [Pfaff, Holger] Univ Cologne, Ctr Hlth Serv Res Cologne, D-50931 Cologne, Germany; [Klazinga, Niek] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Thompson, Caroline A.] PAMFRI, Palo Alto, CA USA; [Michel, Philippe] Univ Lyon 1, Hosp Civils Lyon, F-69365 Lyon, France; [Groene, Oliver] Univ London London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1E 7HT, England	Autonomous University of Barcelona; Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; University of California System; University of California Los Angeles; Aalborg University; University of Cologne; University of Cologne; University of Amsterdam; Academic Medical Center Amsterdam; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of London; London School of Hygiene & Tropical Medicine	Sunol, R (corresponding author), Univ Autonoma Barcelona, Avedis Donabedian Res Inst FAD, E-08193 Barcelona, Spain.	rsunol@fadq.org	Kringos, Dionne/ABE-2290-2020; Car, Mate/F-2184-2017; Pfaff, Holger/D-2630-2009; Sunol, Rosa/AAS-7276-2021; michel, philippe/J-9443-2017; Pfaff, Holger/AAT-6014-2020; Escoval, Ana/B-7979-2014	Kringos, Dionne/0000-0003-2711-4713; Car, Mate/0000-0002-7005-0500; Pfaff, Holger/0000-0001-9154-6575; Sunol, Rosa/0000-0003-1902-833X; michel, philippe/0000-0001-8455-8332; Pfaff, Holger/0000-0001-9154-6575; Escoval, Ana/0000-0002-0269-4742; Thompson, Caroline/0000-0001-9990-9756; Eiras, Margarida/0000-0001-5759-7336; Mannion, Russell/0000-0002-0680-8049; Arah, Onyebuchi/0000-0002-9067-1697; Lombarts, Kiki/0000-0001-6167-0620; Wang, Aolin/0000-0002-3490-648X	European Commission [241822]	European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding: This work was supported by the European Commission's Seventh Framework Program FP7/2007-2013 [ec.europa.eu/index_en.htm] under the grant agreement number 241822. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding to pay the Open Access publication charges for this article was provided under grant agreement no. 241822. There was not additional extra funding received for this study.	Alexander JA, 2011, MED CARE, V49, pS6, DOI 10.1097/MLR.0b013e3181e1709c; [Anonymous], 2014, R LANG ENV STAT COMP; Arah OA, 2008, ANN EPIDEMIOL, V18, P637, DOI 10.1016/j.annepidem.2008.04.003; Arah OA, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-5; Barach P, 2006, QUAL SAF HEALTH CARE, V15, pI10, DOI 10.1136/qshc.2005.015859; Berwick DM, 2003, MED CARE, V41, pI30; Cohen AB, 2008, MED CARE RES REV, V65, P571, DOI 10.1177/1077558708318285; Donabedian A, 2005, MILBANK Q, V83, P691, DOI 10.1111/j.1468-0009.2005.00397.x; Duckers M, 2009, INT J QUAL HEALTH C, V21, P330, DOI 10.1093/intqhc/mzp031; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Goodman SG, 2009, AM HEART J, V158, P193, DOI 10.1016/j.ahj.2009.06.003; Goto A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4533; Greenfield D, 2008, INT J QUAL HEALTH C, V20, P172, DOI 10.1093/intqhc/mzn005; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Groene O, 2013, INT J QUAL HEALTH C, V25, P525, DOI 10.1093/intqhc/mzt058; Groene O, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-281; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Hakkinen U, 2013, HLTH POLICY, V112; Hearld LR, 2008, MED CARE RES REV, V65, P259, DOI 10.1177/1077558707309613; Kunkel S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-104; Macinati MS, 2008, HEALTH POLICY, V85, P228, DOI 10.1016/j.healthpol.2007.07.013; Makai P, 2009, HEALTH POLICY, V90, P175, DOI 10.1016/j.healthpol.2008.09.009; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mohr JJ, 2002, QUAL SAF HEALTH CARE, V11, P45, DOI 10.1136/qhc.11.1.45; Nelson EC, 1996, JOINT COMM J QUAL IM, V22, P243, DOI 10.1016/S1070-3241(16)30228-0; Orton JD, 2013, SYSTEMS COUPLED LOOS, V15, P203; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Runciman WB, 2012, MED J AUSTRALIA, V197, P100, DOI 10.5694/mja12.10510; Secanell M, 2014, INT J QUAL HEALTH C, V26, P5, DOI 10.1093/intqhc/mzu025; Shortell SM, 1998, MILBANK Q, V76, P593, DOI 10.1111/1468-0009.00107; Sunol R, 2009, QUAL SAF HEALTH CARE, V18, pI62, DOI 10.1136/qshc.2008.029439; Sunol R, 2014, INT J QUAL HEALTH C, V26, P47, DOI 10.1093/intqhc/mzu016; Thompson CA, 2014, ANN EPIDEMIOL, V24, P747, DOI 10.1016/j.annepidem.2014.07.014; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P42, DOI 10.1097/EDE.0b013e3181f74493; Wagner C, 2014, INT J QUAL HEALTH C, V26, P27, DOI 10.1093/intqhc/mzu026; Wagner C, 2014, INT J QUAL HEALTH C, V26, P16, DOI 10.1093/intqhc/mzu021; Wagner C, 1999, INT J QUAL HEALTH C, V11, P119, DOI 10.1093/intqhc/11.2.119; Wagner C, 2014, INT J QUAL HEALTH C, V26, P66, DOI 10.1093/intqhc/mzu020; Wagner C, 2014, INT J QUAL HEALTH C, V26, P36, DOI 10.1093/intqhc/mzu019; Weiner BJ, 2006, HEALTH SERV RES, V41, P307, DOI 10.1111/j.1475-6773.2005.00483.x; Weiner BJ, 2006, MED CARE RES REV, V63, P29, DOI 10.1177/1077558705283122; Wieck K.E., 1995, SENSE MAKING ORG	45	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0141157	10.1371/journal.pone.0141157	http://dx.doi.org/10.1371/journal.pone.0141157			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW8LQ	26588842	gold, Green Published, Green Accepted			2022-12-27	WOS:000365251500002
J	Allen, JE; Crowder, R; El-Deiry, WS				Allen, Joshua E.; Crowder, Roslyn; El-Deiry, Wafik S.			First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent	PLOS ONE			English	Article							INDUCED APOPTOSIS; TRAIL; GENE; CHEMOTHERAPY; TOXICITY; CONVERGE	We previously identified ONC201 (TIC10) as a first-in-class orally active small molecule with robust antitumor activity that is currently in clinical trials in advanced cancers. Here, we further investigate the safety characteristics of ONC201 in preclinical models that reveal an excellent safety profile at doses that exceed efficacious doses by 10-fold. In vitro studies indicated a strikingly different dose-response relationship when comparing tumor and normal cells where maximal effects are much stronger in tumor cells than in normal cells. In further support of a wide therapeutic index, investigation of tumor and normal cell responses under identical conditions demonstrated large apoptotic effects in tumor cells and modest anti-proliferative effects in normal cells that were non-apoptotic and reversible. Probing the underlying mechanism of apoptosis indicated that ONC201 does not induce DR5 in normal cells under conditions that induce DR5 in tumor cells; DR5 is a pro-apoptotic TRAIL receptor previously linked to the anti-tumor mechanism of ONC201. GLP toxicology studies in Sprague-Dawley rats and beagle dogs at therapeutic and exaggerated doses revealed no dose-limiting toxicities. Observations in both species at the highest doses were mild and reversible at doses above 10-fold the expected therapeutic dose. The no observed adverse event level (NOAEL) was >= 42 mg/kg in dogs and >= 125 mg/kg in rats, which both correspond to a human dose of approximately 1.25 g assuming standard allometric scaling. These results provided the rationale for the 125 mg starting dose in dose escalation clinical trials that began in 2015 in patients with advanced cancer.	[Allen, Joshua E.] Oncoceutics Inc, Philadelphia, PA 19103 USA; [Crowder, Roslyn] Stetson Univ, Dept Biol, Deland, FL 32723 USA; [El-Deiry, Wafik S.] Fox Chase Canc Ctr, Lab Translat Oncol & Expt Canc Therapeut, Dept Oncol & Mol Therapeut Program, Philadelphia, PA 19111 USA	Stetson University; Fox Chase Cancer Center	El-Deiry, WS (corresponding author), Fox Chase Canc Ctr, Lab Translat Oncol & Expt Canc Therapeut, Dept Oncol & Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	wafik.eldeiry@gmail.com	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266	Oncoceutics; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA173453] Funding Source: NIH RePORTER	Oncoceutics; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	W. S. El-Deiry is an American Cancer Society Research Professor. This work was supported by Oncoceutics and a Pennsylvania Department of Health grant awarded to Oncoceutics.	Allen JE, 2015, CANCER RES, V75, P1668, DOI 10.1158/0008-5472.CAN-14-2356; Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Allen JE, 2012, CANCER BIOL THER, V13, P1143, DOI 10.4161/cbt.21354; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Ishizawa J, 2014, ONC201 INDUCES P53 I; Kuribayashi K, 2008, CANCER BIOL THER, V7, P2034, DOI 10.4161/cbt.7.12.7460; Liu S, 2014, CANCER TREAT REV, V40, P883, DOI 10.1016/j.ctrv.2014.05.003; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Mohile Supriya Gupta, 2012, Am Soc Clin Oncol Educ Book, P321, DOI 10.14694/EdBook_AM.2012.32.321; PLENDERLEITH IH, 1990, CAN FAM PHYSICIAN, V36, P1827; Prabhu VV, 2015, CANCER RES, V75, P1423, DOI 10.1158/0008-5472.CAN-13-3451; Talekar MK, 2015, CELL CYCLE, V14, P2422, DOI 10.1080/15384101.2015.1054086; Wagner J, 2014, ONCOTARGET, V5, P12728, DOI 10.18632/oncotarget.2890; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200	17	32	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143082	10.1371/journal.pone.0143082	http://dx.doi.org/10.1371/journal.pone.0143082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580220	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600079
J	Aung, NM; Kaung, M; Kyi, TT; Kyaw, MP; Min, M; Htet, ZW; Anstey, NM; Kyi, MM; Hanson, J				Aung, Ne Myo; Kaung, Myat; Kyi, Tint Tint; Kyaw, Myat Phone; Min, Myo; Htet, Zaw Win; Anstey, Nicholas M.; Kyi, Mar Mar; Hanson, Josh			The Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with Malaria	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; RESUSCITATION; MORTALITY; DYSFUNCTION; MANAGEMENT; SEVERITY; CHLORIDE; THERAPY; BALANCE; BOLUS	Background A conservative approach to fluid resuscitation improves survival in children with severe malaria; however, this strategy has not been formally evaluated in adults with the disease. Methods Adults hospitalised with malaria at two tertiary referral hospitals in Myanmar received intravenous fluid replacement with isotonic saline, administered at a maintenance rate using a simple weight-based algorithm. Clinical and biochemical indices were followed sequentially. Results Of 61 adults enrolled, 34 (56%) had Plasmodium falciparum mono-infection, 17 (28%) Plasmodium vivax mono-infection and 10 (16%) mixed infection; 27 (44%) patients were at high risk of death (P. falciparum infection and RCAM score >= 2). In the first six hours of hospitalisation patients received a mean 1.7 ml/kg/hour (range: 1.3-2.2) of intravenous fluid and were able to drink a mean of 0.8 ml/kg/hour (range: 0-3). Intravenous fluid administration and oral intake were similar for the remainder of the first 48 hours of hospitalisation. All 61 patients survived to discharge. No patient developed Adult Respiratory Distress Syndrome, a requirement for renal replacement therapy or hypotension (mean arterial pressure < 60mmHg). Plasma lactate was elevated (> 2 mmol/L) on enrolment in 26 (43%) patients but had declined by 6 hours in 25 (96%) and was declining at 24 hours in the other patient. Plasma creatinine was elevated (> 120 mu mol/L) on enrolment in 17 (28%) patients, but was normal or falling in 16 (94%) at 48 hours and declining in the other patient by 72 hours. There was no clinically meaningful increase in plasma lactate or creatinine in any patient with a normal value on enrolment. Patients receiving fluid replacement with the conservative fluid replacement algorithm were more likely to survive than historical controls in the same hospitals who had received fluid replacement guided by clinical judgement in the year prior to the study (p = 0.03), despite having more severe disease (p < 0.001). Conclusions A conservative fluid resuscitation strategy appears safe in adults hospitalised with malaria.	[Aung, Ne Myo; Kyi, Tint Tint; Htet, Zaw Win; Kyi, Mar Mar] Insein Gen Hosp, Yangon, Myanmar; [Kaung, Myat] Hpa An Hosp, Hpa An, Kayin State, Myanmar; [Kyaw, Myat Phone] Dept Med Res Lower Myanmar, Yangon, Myanmar; [Min, Myo] Myanmar Med Assoc, Yangon, Myanmar; [Anstey, Nicholas M.; Hanson, Josh] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia	Charles Darwin University; Menzies School of Health Research	Hanson, J (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	drjoshhanson@gmail.com	Hanson, Josh/ABD-9328-2020; , Myat-Phone-Kyaw/P-1750-2019	Htet, Zaw Win/0000-0001-6913-5198; Hanson, Josh/0000-0002-1423-3839	National Health and Medical Research Council of Australia [1037304, 1042072, 1054195]; National Health and Medical Research Council of Australia [1037304, 1042072, 1054195]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health and Medical Research Council of Australia (Program Grant 1037304 and Fellowships to NA [1042072] and JH [1054195]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, Trans R Soc Trop Med Hyg, V84 Suppl 2, P1; [Anonymous], 2011, GUID DIAGN MAN MAL M; Anstey NM, 2012, ADV PARASIT, V80, P151, DOI 10.1016/B978-0-12-397900-1.00003-7; Anstey NM, 2007, PLOS MED, V4, P1291, DOI 10.1371/journal.pmed.0040267; Bagshaw SM, 2007, CURR OPIN CRIT CARE, V13, P541, DOI 10.1097/MCC.0b013e3282e2a978; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bellomo R, 2012, CRIT CARE MED, V40, P1753, DOI 10.1097/CCM.0b013e318246b9c6; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; DAVIS TME, 1990, J CLIN INVEST, V86, P793, DOI 10.1172/JCI114776; DAVIS TME, 1992, CLIN INFECT DIS, V15, P256, DOI 10.1093/clinids/15.2.256; Day NPJ, 1996, LANCET, V348, P219, DOI 10.1016/S0140-6736(96)09096-4; Day NPJ, 2000, CRIT CARE MED, V28, P1833, DOI 10.1097/00003246-200006000-00025; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Faiz MA, 2005, LANCET, V366, P717; Gachot B, 1998, Rev Prat, V48, P273; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; HALL A, 1985, LANCET, V1, P1453; Hanson J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0365-9; Hanson J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0642-6; Hanson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087020; Hanson J, 2012, J INFECT DIS, V206, P571, DOI 10.1093/infdis/jis400; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Hanson JP, 2013, CRIT CARE MED, V41, P972, DOI 10.1097/CCM.0b013e31827466d2; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Hilton AK, 2012, CRIT CARE, V16, DOI 10.1186/cc11154; Kaung M, 2015, MALARIA J, V14; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Krajewski ML, 2015, BRIT J SURG, V102, P24, DOI 10.1002/bjs.9651; Krishnan A, 2003, CRIT CARE MED, V31, P2278, DOI 10.1097/01.CCM.0000079603.82822.69; Maitland K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-68; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Newton PN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-229; Nguansangiam S, 2007, TROP MED INT HEALTH, V12, P1037, DOI 10.1111/j.1365-3156.2007.01881.x; OH TH, 1980, ANESTHESIOLOGY, V53, P351, DOI 10.1097/00000542-198010000-00020; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Raghunathan K, 2014, CRIT CARE MED, V42, P1585, DOI 10.1097/CCM.0000000000000305; SPITZ S, 1946, Mil Surg, V99, P555; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; WARRELL DA, 1985, BRIT MED J, V291, P1573, DOI 10.1136/bmj.291.6508.1573; WHO, WHO GUID TREATM MAL; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; World Health Organization, 2009, INT MAN AD AD ILLN 2; Yeo TW, 2013, J INFECT DIS, V207, P528, DOI 10.1093/infdis/jis692; Yunos NM, 2010, CRIT CARE, V14, DOI 10.1186/cc9052	45	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143062	10.1371/journal.pone.0143062	http://dx.doi.org/10.1371/journal.pone.0143062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581060	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600075
J	Stavrinou, P; Mavrogiorgou, MC; Polyzoidis, K; Kreft-Kerekes, V; Timmer, M; Marselos, M; Pappas, P				Stavrinou, Pantelis; Mavrogiorgou, Maria-Christina; Polyzoidis, Konstantinos; Kreft-Kerekes, Vincenzo; Timmer, Marco; Marselos, Marios; Pappas, Periklis			Expression Profile of Genes Related to Drug Metabolism in Human Brain Tumors	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; RODENT GLIOMA MODEL; PHASE-II TRIAL; CYTOCHROME-P450 EXPRESSION; ALDEHYDE DEHYDROGENASES; PLUS O-6-BENZYLGUANINE; LUNG-CANCER; ENZYMES; TEMOZOLOMIDE; RISK	Background Endogenous and exogenous compounds as well as carcinogens are metabolized and detoxified by phase I and II enzymes, the activity of which could be crucial to the inactivation and hence susceptibility to carcinogenic factors. The expression of these enzymes in human brain tumor tissue has not been investigated sufficiently. We studied the association between tumor pathology and the expression profile of seven phase I and II drug metabolizing genes (CYP1A1, CYP1B1, ALDH3A1, AOX1, GSTP1, GSTT1 and GSTM3) and some of their proteins. Methods Using qRT-PCR and western blotting analysis the gene and protein expression in a cohort of 77 tumors were investigated. The major tumor subtypes were meningioma, astrocytoma and brain metastases, -the later all adenocarcinomas from a lung primary. Results Meningeal tumors showed higher expression levels for AOX1, CYP1B1, GSTM3 and GSTP1. For AOX1, GSTM and GSTP1 this could be verified on a protein level as well. A negative correlation between the WHO degree of malignancy and the strength of expression was identified on both transcriptional and translational level for AOX1, GSTM3 and GSTP1, although the results could have been biased by the prevalence of meningiomas and glioblastomas in the inevitably bipolar distribution of the WHO grades. A correlation between the gene expression and the protein product was observed for AOX1, GSTP1 and GSTM3 in astrocytomas. Conclusions The various CNS tumors show different patterns of drug metabolizing gene expression. Our results suggest that the most important factor governing the expression of these enzymes is the histological subtype and to a far lesser extent the degree of malignancy itself.	[Stavrinou, Pantelis; Kreft-Kerekes, Vincenzo; Timmer, Marco] Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany; [Polyzoidis, Konstantinos] AHEPA Univ Hosp, Dept Neurosurg, Thessaloniki, Greece; [Mavrogiorgou, Maria-Christina; Marselos, Marios; Pappas, Periklis] Univ Ioannina, Pharmacol Lab, GR-45110 Ioannina, Greece	University of Cologne; Aristotle University of Thessaloniki; Ahepa University Hospital; University of Ioannina	Stavrinou, P (corresponding author), Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany.	pantelis.stavrinou@uk-koeln.de	Stavrinou, Pantelis/R-9115-2019	Stavrinou, Pantelis/0000-0001-8653-1395	KESY grant (Central Health Committee - Ministry of Health) [61/2048]	KESY grant (Central Health Committee - Ministry of Health)	This work was supported by the KESY grant 61/2048 (Central Health Committee - Ministry of Health; M.M.).	Achary MP, 2000, CYTOGENET CELL GENET, V91, P39, DOI 10.1159/000056815; Backos DS, 2012, BIOCHEM PHARMACOL, V83, P1005, DOI 10.1016/j.bcp.2011.11.016; Barnett JA, 2007, CLIN CANCER RES, V13, P3559, DOI 10.1158/1078-0432.CCR-06-2430; Brem S, 2007, CANCER CHEMOTH PHARM, V60, P643, DOI 10.1007/s00280-006-0407-2; Chen LC, 2011, ONCOL REP, V26, P1617, DOI 10.3892/or.2011.1458; De Roos AJ, 2006, NEURO-ONCOLOGY, V8, P145, DOI 10.1215/15228517-2005-003; De Roos AJ, 2003, CANCER EPIDEM BIOMAR, V12, P14; Dolan ME, 1997, CLIN CANCER RES, V3, P837; Fichtner I, 2004, BREAST CANCER RES TR, V87, P97, DOI 10.1023/B:BREA.0000041586.64371.88; Goth-Goldstein R, 2000, CARCINOGENESIS, V21, P2119, DOI 10.1093/carcin/21.11.2119; Gribben JG, 2005, CLIN CANCER RES, V11, P4430, DOI 10.1158/1078-0432.CCR-04-2111; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Huang HG, 2005, NEUROL RES, V27, P371, DOI 10.1179/016164105X39833; Iyer L, 1998, EUR J CANCER, V34, P1493, DOI 10.1016/S0959-8049(98)00230-5; Jounaidi Y, 2002, CURR DRUG METAB, V3, P609, DOI 10.2174/1389200023337027; Kim B, 2007, CANCER RES, V67, P7431, DOI 10.1158/0008-5472.CAN-07-0003; Kitamura S, 2006, DRUG METAB PHARMACOK, V21, P83, DOI 10.2133/dmpk.21.83; Lai R, 2005, CANCER EPIDEM BIOMAR, V14, P1784, DOI 10.1158/1055-9965.EPI-05-0105; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; McFadyen Morag C E, 2005, Future Oncol, V1, P259, DOI 10.1517/14796694.1.2.259; Milne E, 2013, INT J CANCER, V133, P253, DOI 10.1002/ijc.28004; Mukherjee A, 2006, INT J ONCOL, V29, P1287; MURRAY GI, 1994, GUT, V35, P599, DOI 10.1136/gut.35.5.599; Murray GI, 1997, CANCER RES, V57, P3026; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nishimura M, 2006, DRUG METAB PHARMACOK, V21, P357, DOI 10.2133/dmpk.21.357; Oyama T, 2007, FRONT BIOSCI, V12, P4497, DOI 10.2741/2404; Oyama T, 2007, FRONT BIOSCI-LANDMRK, V12, P2299, DOI 10.2741/2232; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Peters S, 2013, INT J CANCER, V132, P2975, DOI 10.1002/ijc.27972; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Quinn JA, 2009, J CLIN ONCOL, V27, P1262, DOI 10.1200/JCO.2008.18.8417; Quinn JA, 2009, CLIN CANCER RES, V15, P1064, DOI 10.1158/1078-0432.CCR-08-2130; Recinos VR, 2010, NEUROSURGERY, V66, P530, DOI 10.1227/01.NEU.0000365263.14725.39; Salnikova LE, 2010, ACTA NATURAE, V2, P58, DOI 10.32607/20758251-2010-2-4-58-65; Schafer A, 2012, NEURO-ONCOLOGY, V14, P1452, DOI 10.1093/neuonc/nos270; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Sreerama L, 1997, CLIN CANCER RES, V3, P1901; STRANGE RC, 1992, BIOCHIM BIOPHYS ACTA, V1139, P222, DOI 10.1016/0925-4439(92)90138-D; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Uchida Y, 2013, UROL ONCOL-SEMIN ORI, V31, P115, DOI 10.1016/j.urolonc.2010.09.017; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Vergote I, INT J GYNECOL CANC, V20, P772; Wahid M, 2013, ASIAN PAC J CANCER P, V14, P7187, DOI 10.7314/APJCP.2013.14.12.7187; Wrensch M, 2004, CANCER EPIDEM BIOMAR, V13, P461	47	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143285	10.1371/journal.pone.0143285	http://dx.doi.org/10.1371/journal.pone.0143285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580399	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600107
J	Tripathi, KP; Evangelista, D; Zuccaro, A; Guarracino, MR				Tripathi, Kumar Parijat; Evangelista, Daniela; Zuccaro, Antonio; Guarracino, Mario Rosario			Transcriptator: An Automated Computational Pipeline to Annotate Assembled Reads and Identify Non Coding RNA	PLOS ONE			English	Article							NONCODING RNAS; PROTEIN FAMILIES	RNA-seq is a new tool to measure RNA transcript counts, using high-throughput sequencing at an extraordinary accuracy. It provides quantitative means to explore the transcriptome of an organism of interest. However, interpreting this extremely large data into biological knowledge is a problem, and biologist-friendly tools are lacking. In our lab, we developed Transcriptator, a web application based on a computational Python pipeline with a user-friendly Java interface. This pipeline uses the web services available for BLAST (Basis Local Search Alignment Tool), QuickGO and DAVID (Database for Annotation, Visualization and Integrated Discovery) tools. It offers a report on statistical analysis of functional and Gene Ontology (GO) annotation's enrichment. It helps users to identify enriched biological themes, particularly GO terms, pathways, domains, gene/proteins features and protein-protein interactions related informations. It clusters the transcripts based on functional annotations and generates a tabular report for functional and gene ontology annotations for each submitted transcript to the web server. The implementation of QuickGo web-services in our pipeline enable the users to carry out GO-Slim analysis, whereas the integration of PORTRAIT (Prediction of transcriptomic non coding RNA (ncRNA) by ab initio methods) helps to identify the non coding RNAs and their regulatory role in transcriptome. In summary, Transcriptator is a useful software for both NGS and array data. It helps the users to characterize the de-novo assembled reads, obtained from NGS experiments for non-referenced organisms, while it also performs the functional enrichment analysis of differentially expressed transcripts/genes for both RNA-seq and micro-array experiments. It generates easy to read tables and interactive charts for better understanding of the data. The pipeline is modular in nature, and provides an opportunity to add new plugins in the future. Web application is freely available at: http://www-labgtp.na.icar.cnr.it/Transcriptator	[Tripathi, Kumar Parijat; Evangelista, Daniela; Zuccaro, Antonio; Guarracino, Mario Rosario] Natl Res Council Italy CNR, High Performance Comp & Networking Inst ICAR, Lab Genom Transcript & Prote LAB GTP, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Calcolo e Reti ad Alte Prestazioni (ICAR-CNR)	Tripathi, KP (corresponding author), Natl Res Council Italy CNR, High Performance Comp & Networking Inst ICAR, Lab Genom Transcript & Prote LAB GTP, Via Pietro Castellino 111, Naples, Italy.	kumpar@na.icar.cnr.it	Guarracino, Mario Rosario/L-3815-2013	Guarracino, Mario Rosario/0000-0003-2870-8134; EVANGELISTA, DANIELA/0000-0001-6602-2382	INTEROMICS flagship project [PON02-00612-3461281, PON02-00619-3470457]; National Research University Higher School of Economics RSF grant [365 14-41-00039]	INTEROMICS flagship project; National Research University Higher School of Economics RSF grant	Mario R Guarracino received funding from INTEROMICS flagship project PON02-00612-3461281 and PON02-00619-3470457 and National Research University Higher School of Economics RSF grant 365 14-41-00039.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arrial RT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-239; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Cokelaer T, 2013, BIOINFORMATICS, V29, P3241, DOI 10.1093/bioinformatics/btt547; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Karntanut W, 2002, CHEMOSPHERE, V47, P1059, DOI 10.1016/S0045-6535(02)00050-4; Karntanut Wanchamai, 2007, Songklanakarin Journal of Science and Technology, V29, P869; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Liu JF, 2006, PLOS GENET, V2, P529, DOI 10.1371/journal.pgen.0020029; Martin VJ, 1997, BIOL BULL, V192, P345, DOI 10.2307/1542745; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nagaraj SH, 2007, NUCLEIC ACIDS RES, V35, pW143, DOI 10.1093/nar/gkm378; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Rosa A, 2013, INT J MOL SCI, V14, P14346, DOI 10.3390/ijms140714346; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Shimizu Kana, 2006, Journal of Bioinformatics and Computational Biology, V4, P649, DOI 10.1142/S0219720006002260; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Toffano-Nioche C, 2013, METHODS, V63, P60, DOI 10.1016/j.ymeth.2013.06.003; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Villegas VE, 2015, INT J MOL SCI, V16, P3251, DOI 10.3390/ijms16023251; Wang X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S16; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wenger Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-204; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wu SC, 2010, CELL RES, V20, P1109, DOI 10.1038/cr.2010.114	44	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140268	10.1371/journal.pone.0140268	http://dx.doi.org/10.1371/journal.pone.0140268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581084	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600005
J	Gao, CY; Xie, R; Yu, CY; Ma, RS; Dong, WJ; Meng, H; Zhang, Y; Si, Y; Zhang, Z; Novakovic, V; Zhang, Y; Kou, JJ; Bi, YY; Li, BX; Xie, RJ; Gilbert, GE; Zhou, J; Shi, JL				Gao, Chunyan; Xie, Rui; Yu, Chengyuan; Ma, Ruishuang; Dong, Weijun; Meng, Huan; Zhang, Yan; Si, Yu; Zhang, Zhuo; Novakovic, Valerie; Zhang, Yong; Kou, Junjie; Bi, Yayan; Li, Baoxin; Xie, Rujuan; Gilbert, Gary E.; Zhou, Jin; Shi, Jialan			Thrombotic Role of Blood and Endothelial Cells in Uremia through Phosphatidylserine Exposure and Microparticle Release	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; CIRCULATING MICROPARTICLES; RISK; APOPTOSIS; MEMBRANES; PROLIFERATION; EPIDEMIOLOGY; HEMODIALYSIS; COAGULATION	The mechanisms contributing to an increased risk of thrombosis in uremia are complex and require clarification. There is scant morphological evidence of membrane-dependent binding of factor Xa (FXa) and factor Va (FVa) on endothelial cells (EC) in vitro. Our objectives were to confirm that exposed phosphatidylserine (PS) on microparticle (MP), EC, and peripheral blood cell (PBC) has a prothrombotic role in uremic patients and to provide visible and morphological evidence of PS-dependent prothrombinase assembly in vitro. We found that uremic patients had more circulating MP (derived from PBC and EC) than controls. Additionally, patients had more exposed PS on their MPs and PBCs, especially in the hemodialysis group. In vitro, EC exposed more PS in uremic toxins or serum. Moreover, reconstitution experiments showed that at the early stages, PS exposure was partially reversible. Using confocal microscopy, we observed that PS-rich membranes of EC and MP provided binding sites for FVa and FXa. Further, exposure of PS in uremia resulted in increased generation of FXa, thrombin, and fibrin and significantly shortened coagulation time. Lactadherin, a protein that blocks PS, reduced 80% of procoagulant activity on PBC, EC, and MP. Our results suggest that PBC and EC in uremic milieu are easily injured or activated, which exposes PS and causes a release of MP, providing abundant procoagulant membrane surfaces and thus facilitating thrombus formation. Blocking PS binding sites could become a new therapeutic target for preventing thrombosis.	[Gao, Chunyan; Shi, Jialan] Harbin Med Univ, Hosp 1, Dept Hematol, Harbin, Peoples R China; [Gao, Chunyan; Ma, Ruishuang; Zhang, Yan; Si, Yu; Zhang, Zhuo; Zhou, Jin] Harbin Med Univ Daqing, Dept Med Lab Sci & Technol, Daqing, Peoples R China; [Xie, Rui; Xie, Rujuan] Harbin Med Univ, Hosp 3, Dept Gastrointestinal Oncol, Harbin, Peoples R China; [Yu, Chengyuan] Harbin Med Univ, Hosp 1, Dept Nephrol, Harbin, Peoples R China; [Dong, Weijun] Harbin Med Univ, Hosp 5, Dept Gen Surg, Harbin, Peoples R China; [Meng, Huan; Kou, Junjie; Bi, Yayan] Harbin Med Univ, Hosp 2, Dept Cardiol, Harbin, Peoples R China; [Zhang, Yong; Li, Baoxin] Harbin Med Univ, Dept Pharmacol, Harbin, Peoples R China; [Novakovic, Valerie; Gilbert, Gary E.; Shi, Jialan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Med Dept,VA Boston Healthcare Syst, Boston, MA 02115 USA	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Xie, RJ (corresponding author), Harbin Med Univ, Hosp 3, Dept Gastrointestinal Oncol, Harbin, Peoples R China.	hydwkyuliang@yahoo.com.cn; jinzhouh85@163.com; jialan_shi@hms.harvard.edu		Shi, Jialan/0000-0001-5642-5436	National Natural Science Foundation of China [81470301, 81400097, 81270588]; National Natural Science Foundation of Heilongjiang Province [H2015109]; Heilongjiang Postdoctoral Science Foundation [LBH-Z13153]; China Postdoctoral Science Foundation [2014M550202]; Seed Fund of Harbin Medical University-Daqing [DQ2013-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Heilongjiang Postdoctoral Science Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Seed Fund of Harbin Medical University-Daqing	The study design, data collection, and analysis were supported by grants from the National Natural Science Foundation of China (81470301, 81400097, 81270588). The decision to publish and preparation of the manuscript were surpported by the National Natural Science Foundation of Heilongjiang Province (H2015109), Project Funded by Heilongjiang Postdoctoral Science Foundation (LBH-Z13153), Project Funded by China Postdoctoral Science Foundation (2014M550202), and Seed Fund of Harbin Medical University-Daqing (DQ2013-05).	Al-Dorzi HM, 2013, THROMB RES, V132, P671, DOI 10.1016/j.thromres.2013.09.036; Amabile N, 2012, NEPHROL DIAL TRANSPL, V27, P1873, DOI 10.1093/ndt/gfr573; Atkinson BT, 2010, BLOOD, V116, P4675, DOI 10.1182/blood-2010-05-283986; Bonomini M, 2004, J THROMB HAEMOST, V2, P1275, DOI 10.1111/j.1538-7836.2004.00837.x; Bonomini M, 1999, J AM SOC NEPHROL, V10, P1982; Capodanno D, 2012, CIRCULATION, V125, P2649, DOI 10.1161/CIRCULATIONAHA.111.084996; Carracedo J, 1995, J AM SOC NEPHROL, V6, P1586; Carracedo J, 2013, EXP GERONTOL, V48, P766, DOI 10.1016/j.exger.2013.04.004; Cendoroglo M, 1999, J AM SOC NEPHROL, V10, P93; Chitalia VC, 2013, CIRCULATION, V127, P365, DOI 10.1161/CIRCULATIONAHA.112.118174; Daniel L, 2006, KIDNEY INT, V69, P1416, DOI 10.1038/sj.ki.5000306; Daniel L, 2008, NEPHROL DIAL TRANSPL, V23, P2129, DOI 10.1093/ndt/gfn029; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Faure V, 2006, J THROMB HAEMOST, V4, P566, DOI 10.1111/j.1538-7836.2005.01780.x; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gao CY, 2013, THROMB HAEMOSTASIS, V109, P1079, DOI 10.1160/TH12-12-0894; Hiramoto JS, 2012, AM J KIDNEY DIS, V60, P225, DOI 10.1053/j.ajkd.2012.02.335; Hou J, 2011, VOX SANG, V100, P187, DOI 10.1111/j.1423-0410.2010.01375.x; Hvarregaard J, 1996, EUR J BIOCHEM, V240, P628, DOI 10.1111/j.1432-1033.1996.0628h.x; Lutz J, 2014, NEPHROL DIAL TRANSPL, V29, P29, DOI 10.1093/ndt/gft209; Ocak G, 2014, CIRCULATION, V129, P683, DOI 10.1161/CIRCULATIONAHA.113.002385; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Pavord S, 2011, BLOOD REV, V25, P271, DOI 10.1016/j.blre.2011.07.001; Ple H, 2012, THROMB HAEMOSTASIS, V108, P605, DOI 10.1160/TH12-03-0153; Serradell M, 2003, NEPHROL DIAL TRANSPL, V18, P1079, DOI 10.1093/ndt/gfg161; Shantsila E, 2014, THROMB HAEMOSTASIS, V111, P1009, DOI 10.1160/TH13-11-0937; Shashar M, 2014, SEMIN DIAL; Shi J, 2008, J THROMB HAEMOST, V6, P1167, DOI 10.1111/j.1538-7836.2008.03010.x; Shi J, 2006, CYTOM PART A, V69A, P1193, DOI 10.1002/cyto.a.20345; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Whitman IR, 2012, J AM SOC NEPHROL, V23, P1929, DOI 10.1681/ASN.2012010037; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	36	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142835	10.1371/journal.pone.0142835	http://dx.doi.org/10.1371/journal.pone.0142835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26580207	Green Published, Green Submitted, gold			2022-12-27	WOS:000365070700081
J	Panikkar, B; Brugge, D; Gute, DM; Hyatt, RR				Panikkar, Bindu; Brugge, Doug; Gute, David M.; Hyatt, Raymond R.			"They See Us As Machines:" The Experience of Recent Immigrant Women in the Low Wage Informal Labor Sector	PLOS ONE			English	Article							OCCUPATIONAL-HEALTH; PRECARIOUS EMPLOYMENT; WORK; GENDER; MIGRATION; ASTHMA; JOB; SOMERVILLE; NETWORKS; OUTCOMES	This study explores the organization of work and occupational health risk as elicited from recently immigrated women (n = 8) who have been in the US for less than three years and employed in informal work sectors such as cleaning and factory work in the greater Boston area in Massachusetts. Additional interviews (n = 8) with Community Key Informants with knowledge of this sector and representatives of temporary employment agencies in the area provides further context to the interviews conducted with recent immigrant women. These results were also compared with our immigrant occupational health survey, a large project that spawned this study. Responses from the study participants suggest health outcomes consistent with being a day-laborer scholarship, new immigrant women are especially at higher risk within these low wage informal work sectors. A difference in health experiences based on ethnicity and occupation was also observed. Low skilled temporary jobs are fashioned around meeting the job performance expectations of the employer; the worker's needs are hardly addressed, resulting in low work standards, little worker protection and poor health outcomes. The rising prevalence of non-standard employment or informal labor sector requires that policies or labor market legislation be revised to meet the needs presented by these marginalized workers.	[Panikkar, Bindu] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA; [Brugge, Doug; Hyatt, Raymond R.] Tufts Univ, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Gute, David M.] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA	University of Vermont; Massachusetts Department of Public Health; Tufts University; Tufts University	Panikkar, B (corresponding author), Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA.	bindu.panikkar@uvm.edu		Brugge, Doug/0000-0002-6812-2720; Gute, David/0000-0001-6743-213X	National Institute for Occupational and Safety and Health [R25 OH008776-04]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R25OH008776] Funding Source: NIH RePORTER	National Institute for Occupational and Safety and Health; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This research was supported by Grant R25 OH008776-04: from the National Institute for Occupational and Safety and Health.	Ahonen EQ, 2009, J EPIDEMIOL COMMUN H, V63, P936, DOI 10.1136/jech.2008.077016; Ahonen EQ, 2007, SCAND J WORK ENV HEA, V33, P96, DOI 10.5271/sjweh.1112; Ahonen EQ, 2010, AM J IND MED, V53, P405, DOI 10.1002/ajim.20710; Akhavan Sharareh, 2007, Work, V28, P135; Albarran CR, 2011, J ASSOC NURSE AIDS C, V22, P173, DOI 10.1016/j.jana.2010.08.001; Arif AA, 2008, OCCUP MED-OXFORD, V58, P458, DOI 10.1093/occmed/kqn082; Artazcoz L, 2007, J EPIDEMIOL COMMUN H, V61, P39, DOI 10.1136/jech.2007.059774; Batalova J, IMMIGRANT WOMEN US; Borak J, 2005, IWPRS 8 INT WOM POL; Buchanan S, 2010, AM J IND MED, V53, P116, DOI 10.1002/ajim.20724; Centers for Disease Control and Prevention (CDC), METH 2 CYAN; Collins H, 1999, BLACK FEMINIST THOUG; Cranford CJ, 2003, RELAT IND-IND RELAT, V58, P454, DOI 10.7202/007495ar; Ellerman A, 2009, STATES MIGRANTS DEPO; Environmental Protection Agency (EPA), RUL UND REL DISCL AL; Eun-Ok I, 2002, HEALTH CARE WOMEN IN, V21, P105; Ferrie JE, 2002, J EPIDEMIOL COMMUN H, V56, P450, DOI 10.1136/jech.56.6.450; Flaskerud JH, CONCEPTUALIZING VULN; Glenn E.N., 1999, REVISIONING GENDER, P3; Gulati L, 1997, ECON POLIT WEEKLY, V32, P3029; Gute DM, 2009, AM J PUBLIC HEALTH, V99, P495; Hagan JM, 1998, AM SOCIOL REV, V63, P55, DOI 10.2307/2657477; Hondagneu-Sotelo P, 2003, GENDER AND U.S. IMMIGRATION: CONTEMPORARY TRENDS, P3; Kanaiaupuni SM, 2000, SOC FORCES, V78, P1311, DOI 10.2307/3006176; Kempton J, 2002, MIGRANTS UK THEIR CH; Krause N, 2005, AM J IND MED, V48, P326, DOI 10.1002/ajim.20221; Krieger N, 2006, INT J HEALTH SERV, V36, P51, DOI 10.2190/3EMB-YKRH-EDJ2-0H19; Lewis R, 2001, CLIN ENV HLTH TOX EX; Light I, 1999, INT MIGR REV, V33, P5, DOI 10.2307/2547320; Livingston G, 2006, POPUL RES POLICY REV, V25, P43, DOI 10.1007/s11113-006-0002-6; Malmusi D, 2010, SOC SCI MED, V71, P1610, DOI 10.1016/j.socscimed.2010.07.043; Marfleet P, 2011, J VOCAT BEHAV, V78, P381, DOI 10.1016/j.jvb.2011.03.022; Marmot M, 2001, RES FINDINGS; Mattingly DJ, 2001, ANN ASSOC AM GEOGR, V91, P370, DOI 10.1111/0004-5608.00249; Medina-Ramon M, 2006, EUR RESPIR J, V27, P1196, DOI 10.1183/09031936.06.00085405; Medina-Ramon M, 2005, OCCUP ENVIRON MED, V62, P598, DOI 10.1136/oem.2004.017640; Messing K, 1997, WOMEN HEALTH, V25, P39, DOI 10.1300/J013v25n04_03; Messing K, 2006, ENVIRON RES, V101, P149, DOI 10.1016/j.envres.2005.03.015; New Jersey Department of Health and Senior Services (NJDH), METH 2 CYAN; Occupational Safety and Health Administration (OSHA), 1985, METH 2 CYAN ETH 2 CY; Panikkar B, 2013, AM J IND MED    0710; Panikkar B, 2013, J IMMIGR MINOR HEALT, V15, P882, DOI 10.1007/s10903-012-9702-7; Panikkar B, 2012, INT J ENV RES PUB HE, V9, P4452, DOI 10.3390/ijerph9124452; Parrado EA, 2005, AM SOCIOL REV, V70, P606, DOI 10.1177/000312240507000404; Pessar PR, 2003, INT MIGR REV, V37, P812; Portes A., 1985, LATIN JOURNEY CUBAN; Quinlan M, 2001, INT J HEALTH SERV, V31, P335, DOI 10.2190/607H-TTV0-QCN6-YLT4; Sassen Saskia, 1998, GLOBALIZATION ITS DI; Smith PM, 2009, AM J IND MED, V52, P341, DOI 10.1002/ajim.20683; Tompa Emile, 2007, Work, V28, P209; Valenzuela A, 2003, ANNU REV SOCIOL, V29, P307, DOI 10.1146/annurev.soc.29.010202.100044; Vosko LF, 2003, SOCIAL DIFFERENTIATI; Zhou Y, 2000, WOMEN STUD INT FORUM, V23, P445, DOI 10.1016/S0277-5395(00)00106-0; Zock JP, 2007, AM J RESP CRIT CARE, V176, P735, DOI 10.1164/rccm.200612-1793OC; Zock JP, 2009, J ALLERGY CLIN IMMUN, V124, P731, DOI 10.1016/j.jaci.2009.06.007; Zock JP, 2001, SCAND J WORK ENV HEA, V27, P76, DOI 10.5271/sjweh.590; Zong J, 2013, FREQUENTLY REQUESTED	57	10	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142686	10.1371/journal.pone.0142686	http://dx.doi.org/10.1371/journal.pone.0142686			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7DU	26600083	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600015
J	Polo, G; Labruna, MB; Ferreira, F				Polo, Gina; Labruna, Marcelo Bahia; Ferreira, Fernando			Satellite Hyperspectral Imagery to Support Tick-Borne Infectious Diseases Surveillance	PLOS ONE			English	Article							CAPYBARAS HYDROCHOERUS-HYDROCHAERIS; LYME-DISEASE; RICKETTSIA-RICKETTSII; PRINCIPAL COMPONENTS; AMBLYOMMA-CAJENNENSE; BORRELIA-BURGDORFERI; SPOTTED-FEVER; PUBLIC-HEALTH; LANDSAT TM; AREA	This study proposed the use of satellite hyperspectral imagery to support tick-borne infectious diseases surveillance based on monitoring the variation in amplifier hosts food sources. To verify this strategy, we used the data of the human rickettsiosis occurrences in southeastern Brazil, region in which the emergence of this disease is associated with the rising capybara population. Spatio-temporal analysis based on Monte Carlo simulations was used to identify risk areas of human rickettsiosis and hyperspectral moderate-resolution imagery was used to identify the increment and expansion of sugarcane crops, main food source of capybaras. In general, a pixel abundance associated with increment of sugarcane crops was detected in risk areas of human rickettsiosis. Thus, the hypothesis that there is a spatio-temporal relationship between the occurrence of human rickettsiosis and the sugarcane crops increment was verified. Therefore, due to the difficulty of monitoring locally the distribution of infectious agents, vectors and animal host's, satellite hyperspectral imagery can be used as a complementary tool for the surveillance of tick-borne infectious diseases and potentially of other vector-borne diseases.	[Polo, Gina; Ferreira, Fernando] Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Lab Epidemiol & Biostat, Sao Paulo, Brazil; [Labruna, Marcelo Bahia] Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Parasit Dis Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Polo, G (corresponding author), Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Lab Epidemiol & Biostat, Sao Paulo, Brazil.	gina@vps.fmvz.usp.br	Ferreira, Fernando/C-9038-2013; Labruna, Marcelo B/B-6241-2013	Ferreira, Fernando/0000-0002-9160-7355; Labruna, Marcelo B/0000-0002-9675-3132; Polo, Gina/0000-0001-5569-7392	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/12213-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant number: 2014/12213-1 (GP), (http://bvs.fapesp.br/en/pesquisador/673996/gina-paola-polo-infante/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt Geir, 2006, Int J Health Geogr, V5, P15, DOI 10.1186/1476-072X-5-15; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Allman E, 2004, MATHEMATICAL MODELS, P371; Beck LR, 1997, AM J TROP MED HYG, V56, P99, DOI 10.4269/ajtmh.1997.56.99; Biradar CM, 2011, INT J REMOTE SENS, V32, P367, DOI 10.1080/01431160903464179; BURGDORFER W., 1988, BIOL RICKETTSIAL DIS, V1, P33; Cousens S, 2001, LANCET, V357, P1002, DOI 10.1016/S0140-6736(00)04236-7; CVE-SES. Centro de Vigilancia Epidemiologica, 2013, DISTRIBUICAO DOS CAS; Ferraz KMPMD, 2007, J BIOGEOGR, V34, P223, DOI 10.1111/j.1365-2699.2006.01568.x; Del Fiol FD, 2010, REV PANAM SALUD PUBL, V27, P461, DOI 10.1590/S1020-49892010000600008; Estrada-Pena A, 2002, ENVIRON HEALTH PERSP, V110, P635, DOI 10.1289/ehp.02110635; Fang HL, 1998, INT J REMOTE SENS, V19, P521, DOI 10.1080/014311698216134; Felix GA, 2014, BRAZ J BIOL, V74, P779, DOI 10.1590/1519-6984.02113; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Garni R, 2014, INFECT GENET EVOL, V28, P725, DOI 10.1016/j.meegid.2014.09.036; Gaudart Jean, 2005, BMC Med Res Methodol, V5, P22, DOI 10.1186/1471-2288-5-22; GLASS GE, 1994, AM J TROP MED HYG, V51, P538, DOI 10.4269/ajtmh.1994.51.538; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; IBGE, 2010, BRAZILIAN INSTITUTE; INPE. Instituto de Pesquisas Espaciais, 2013, CANASAT MONITORAMENT; Jain M, 2013, REMOTE SENS ENVIRON, V134, P210, DOI 10.1016/j.rse.2013.02.029; James MC, 2013, PARASITOLOGY, V140, P237, DOI 10.1017/S003118201200145X; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Keshava N, 2002, IEEE SIGNAL PROC MAG, V19, P44, DOI 10.1109/79.974727; Krawczak FS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-7; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Labruna MB, 2009, ANN NY ACAD SCI, V1166, P156, DOI 10.1111/j.1749-6632.2009.04516.x; Labruna MB., 2013, CAPYBARA BIOL USE CO, P371; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; LEE JB, 1990, IEEE T GEOSCI REMOTE, V28, P295, DOI 10.1109/36.54356; Liu H, 2012, REMOTE SENS ENVIRON, V117, P57, DOI 10.1016/j.rse.2011.06.023; Martinez-Casasnovas JA, 2005, EUR J AGRON, V23, P159, DOI 10.1016/j.eja.2004.11.004; Moreira JR, 2013, CAPYBARA BIOL USE CO, P3, DOI [10.1007/978-1-4614-4000-0_1, DOI 10.1007/978-1-4614-4000-0_1]; Mostashari F, 2003, EMERG INFECT DIS, V9, P641; NASA. National Aeronautics and Space Administration, 2014, MODERATE RESOLUTION; Niebylski ML, 1999, APPL ENVIRON MICROB, V65, P773; Ojasti J., 1973, ESTUDIO BIOLOGICO DE; Patil GP, 2003, STAT SCI, V18, P457, DOI 10.1214/ss/1081443229; Pinter A, 2011, VEPA SUPLEMENTO, V8, P19; Polo G, 2013, PREVENTIVE VETERINAR; Polo G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119190; QUARMBY NA, 1992, INT J REMOTE SENS, V13, P415, DOI 10.1080/01431169208904046; Rodarmel C., 2002, SURV LAND INF SCI, V62, P115; Sao-Paulo, 2013, DISTRIBUICAO DOS CAS; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; SINGH A, 1985, INT J REMOTE SENS, V6, P883, DOI 10.1080/01431168508948511; Small C, 2012, REMOTE SENS ENVIRON, V124, P793, DOI 10.1016/j.rse.2012.05.031; Soares JF, 2012, MED VET ENTOMOL, V26, P139, DOI 10.1111/j.1365-2915.2011.00982.x; Souza CE, 2009, VET PARASITOL, V161, P116, DOI 10.1016/j.vetpar.2008.12.010; Tatem AJ, 2004, REMOTE SENS ENVIRON, V93, P42, DOI 10.1016/j.rse.2004.06.014; Thenkabail PS, 2012, HYPERSPECTRAL REMOTE SENSING OF VEGETATION, P1; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; Rudorff BFT, 2010, REMOTE SENS-BASEL, V2, P1057, DOI 10.3390/rs2041057; Vicente LE, 2012, PESQUI AGROPECU BRAS, V47, P1337, DOI 10.1590/S0100-204X2012000900019; Winters AM, 2008, AM J TROP MED HYG, V79, P581, DOI 10.4269/ajtmh.2008.79.581; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Wood CL, 2013, TRENDS ECOL EVOL, V28, P239, DOI 10.1016/j.tree.2012.10.011; Xiao XM, 2005, REMOTE SENS ENVIRON, V95, P480, DOI 10.1016/j.rse.2004.12.009	58	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143736	10.1371/journal.pone.0143736	http://dx.doi.org/10.1371/journal.pone.0143736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599337	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600112
J	Smith, AN; Creighton, JC; Belk, MC				Smith, Ashlee N.; Creighton, J. Curtis; Belk, Mark C.			Differences in Patterns of Reproductive Allocation between the Sexes in Nicrophorus orbicollis	PLOS ONE			English	Article							BIPARENTAL BURYING BEETLE; PARENTAL CARE; BROOD SIZE; CALLOSOBRUCHUS-MACULATUS; COSTS; BENEFITS; LONGEVITY; BEHAVIOR; LIFE; VESPILLOIDES	Organisms are selected to maximize lifetime reproductive success by balancing the costs of current reproduction with costs to future survival and fecundity. Males and females typically face different reproductive costs, which makes comparisons of their reproductive strategies difficult. Burying beetles provide a unique system that allows us to compare the costs of reproduction between the sexes because males and females are capable of raising offspring together or alone and carcass preparation and offspring care represent the majority of reproductive costs for both sexes. Because both sexes perform the same functions of carcass preparation and offspring care, we predict that they would experience similar costs and have similar life history patterns. In this study we assess the cost of reproduction in male Nicrophorus orbicollis and compare to patterns observed in females. We compare the reproductive strategies of single males and females that provided pre- and post-hatching parental care. There is a cost to reproduction for both males and females, but the sexes respond to these costs differently. Females match brood size with carcass size, and thus maximize the lifetime number of offspring on a given size carcass. Males cull proportionately more offspring on all carcass sizes, and thus have a lower lifetime number of offspring compared to females. Females exhibit an adaptive reproductive strategy based on resource availability, but male reproductive strategies are not adaptive in relation to resource availability.	[Smith, Ashlee N.; Creighton, J. Curtis] Purdue Univ Calumet, Dept Biol Sci, Hammond, IN USA; [Smith, Ashlee N.; Belk, Mark C.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Purdue University System; Purdue University; Brigham Young University	Smith, AN (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	ashlee.n.smith@gmail.com		Smith, Ashlee/0000-0001-8941-8574	Purdue University Calumet; Biology Department	Purdue University Calumet; Biology Department	This research was funded in part by a graduate research grant from Purdue University Calumet and funds from the Biology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT J, 1987, BEHAV ECOL SOCIOBIOL, V21, P179, DOI 10.1007/BF00303208; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Benowitz KM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1124; Billman EJ, 2014, BEHAV ECOL, V25, P813, DOI 10.1093/beheco/aru051; Castrejon F, 2012, SW ENTOMOLOGIST, V3, P103; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Creighton JC, 2009, AM NAT, V174, P673, DOI 10.1086/605963; Creighton JC, 2005, BEHAV ECOL, V16, P1031, DOI 10.1093/beheco/ari084; EGGERT AK, 1992, BEHAV ECOL, V3, P243, DOI 10.1093/beheco/3.3.243; Eggert AK, 1997, SOCIAL BEHAV INSECTS, P216; Eggert AK, 2011, ANIM BEHAV, V82, P1227, DOI 10.1016/j.anbehav.2011.09.001; FETHERSTON IA, 1990, ETHOLOGY, V85, P177, DOI 10.1111/j.1439-0310.1990.tb00398.x; Field J, 2007, P ROY SOC B-BIOL SCI, V274, P445, DOI 10.1098/rspb.2006.3745; Gilbert JDJ, 2010, ECOL ENTOMOL, V35, P639, DOI 10.1111/j.1365-2311.2010.01221.x; Gilg MR, 2003, AM MIDL NAT, V149, P306, DOI 10.1674/0003-0031(2003)149[0306:RDLSIT]2.0.CO;2; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Houston AI, 2013, ANIM BEHAV, V86, P667, DOI 10.1016/j.anbehav.2013.08.001; Hunt J, 2002, J EVOLUTION BIOL, V15, P57, DOI 10.1046/j.1420-9101.2002.00374.x; Kolliker M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1489, DOI 10.1007/s00265-007-0381-7; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Kotiaho JS, 2003, J INSECT PHYSIOL, V49, P817, DOI 10.1016/S0022-1910(03)00117-3; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Muller JK, 2007, BEHAV ECOL, V18, P196, DOI 10.1093/beheco/arl073; MULLER JK, 1990, J INSECT BEHAV, V3, P265, DOI 10.1007/BF01417917; MULLER JK, 1990, BEHAV ECOL SOCIOBIOL, V27, P11, DOI 10.1007/BF00183307; Ohgushi T, 1996, OECOLOGIA, V106, P345, DOI 10.1007/BF00334562; Paukku S, 2005, J INSECT PHYSIOL, V51, P1220, DOI 10.1016/j.jinsphys.2005.06.012; Prowse N, 1997, J INSECT PHYSIOL, V43, P501, DOI 10.1016/S0022-1910(97)00014-0; Rauter CM, 2004, ANIM BEHAV, V68, P695, DOI 10.1016/j.anbehav.2003.09.018; Rauter CM, 1999, P ROY SOC B-BIOL SCI, V266, P1691, DOI 10.1098/rspb.1999.0833; Roff Derek A., 1992; Rosenheim JA, 1999, EVOL ECOL, V13, P141, DOI 10.1023/A:1006612519265; Sakaluk SK, 2008, J INSECT BEHAV, V21, P153, DOI 10.1007/s10905-007-9115-y; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; SCOTT MP, 1990, ANIM BEHAV, V39, P274, DOI 10.1016/S0003-3472(05)80871-1; SCOTT MP, 1990, BEHAV ECOL SOCIOBIOL, V26, P31, DOI 10.1007/BF00174022; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRUMBO ST, 1991, BEHAVIOUR, V117, P82, DOI 10.1163/156853991X00139; Trumbo ST, 1995, ETHOL ECOL EVOL, V7, P313, DOI 10.1080/08927014.1995.9522939; Trumbo ST, 2006, ANIM BEHAV, V72, P1159, DOI 10.1016/j.anbehav.2006.05.004; Walling CA, 2008, P NATL ACAD SCI USA, V105, P18430, DOI 10.1073/pnas.0803146105; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Zink AG, 2003, BEHAV ECOL, V14, P687, DOI 10.1093/beheco/arg044	44	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143762	10.1371/journal.pone.0143762	http://dx.doi.org/10.1371/journal.pone.0143762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600016	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600118
J	Becerra-Artiles, A; Dominguez-Amorocho, O; Stern, LJ; Calvo-Calle, JM				Becerra-Artiles, Aniuska; Dominguez-Amorocho, Omar; Stern, Lawrence J.; Calvo-Calle, J. Mauricio			A Simple Proteomics-Based Approach to Identification of Immunodominant Antigens from a Complex Pathogen: Application to the CD4 T Cell Response against Human Herpesvirus 6B	PLOS ONE			English	Article							SDS-POLYACRYLAMIDE-GELS; MULV-INDUCED TUMORS; HOUSE-DUST MITE; HLA-DR; NITROCELLULOSE IMMUNOBLOTS; DERMATOPHAGOIDES-FARINAE; TRANSPLANT RECIPIENTS; HUMAN CYTOMEGALOVIRUS; MULTIPLE-SCLEROSIS; VIRAL-INFECTIONS	Most of humanity is chronically infected with human herpesvirus 6 (HHV-6), with viral replication controlled at least in part by a poorly characterized CD4 T cell response. Identification of viral epitopes recognized by CD4 T cells is complicated by the large size of the herpesvirus genome and a low frequency of circulating T cells responding to the virus. Here, we present an alternative to classical epitope mapping approaches used to identify major targets of the T cell response to a complex pathogen like HHV-6B. In the approach presented here, extracellular virus preparations or virus-infected cells are fractionated by SDS-PAGE, and eluted fractions are used as source of antigens to study cytokine responses in direct ex vivo T cell activation studies. Fractions inducing significant cytokine responses are analyzed by mass spectrometry to identify viral proteins, and a subset of peptides from these proteins corresponding to predicted HLA-DR binders is tested for IFN-gamma production in seropositive donors with diverse HLA haplotypes. Ten HHV-6B viral proteins were identified as immunodominant antigens. The epitope-specific response to HHV-6B virus was complex and variable between individuals. We identified 107 peptides, each recognized by at least one donor, with each donor having a distinctive footprint. Fourteen peptides showed responses in the majority of donors. Responses to these epitopes were validated using in vitro expanded cells and naturally expressed viral proteins. Predicted peptide binding affinities for the eight HLA-DRB1 alleles investigated here correlated only modestly with the observed CD4 T cell responses. Overall, the response to the virus was dominated by peptides from the major capsid protein U57 and major antigenic protein U11, but responses to other proteins including glycoprotein H (U48) and tegument proteins U54 and U14 also were observed. These results provide a means to follow and potentially modulate the CD4 T-cell immune response to HHV-6B.	[Becerra-Artiles, Aniuska; Dominguez-Amorocho, Omar; Stern, Lawrence J.; Calvo-Calle, J. Mauricio] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Stern, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	lawrence.stern@umassmed.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases [U19-AI057319, U19-AI109858, HHSN27220140046C]; NIH [U19-AI057319, U19-AI109858, HHSN27220140046C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319, U19AI109858] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx) grants U19-AI057319 (to JMCC), U19-AI109858 (to LJS), and HHSN27220140046C (to LJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by NIH grants U19-AI057319, U19-AI109858, and HHSN27220140046C. We acknowledge advice and assistance provided by James Evans and Karin Green at the University of Massachusetts Medical School Proteomics and Mass Spectrometry Facility, and we thank blood donors for their cooperation. The authors declare no commercial or financial conflict of interest.	Agut H, 2015, CLIN MICROBIOL REV, V28, P313, DOI 10.1128/CMR.00122-14; AHITUV A, 1982, CANCER IMMUNOL IMMUN, V14, P16; ANDERSEN P, 1993, J IMMUNOL METHODS, V161, P29, DOI 10.1016/0022-1759(93)90195-D; Aoki J, 2015, BIOL BLOOD MARROW TR, V21, P2017, DOI 10.1016/j.bbmt.2015.07.022; Becerra A, 2014, CURR OPIN VIROL, V9, P154, DOI 10.1016/j.coviro.2014.10.001; Beckhove P, 2010, J CLIN INVEST, V120, P2230, DOI 10.1172/JCI37646; Bhaskar S, 2000, J IMMUNOASSAY, V21, P355, DOI 10.1080/01971520009349542; Cacoub P, 2011, AM J MED, V124, P588, DOI 10.1016/j.amjmed.2011.01.017; Calvo-Calle JM, 2007, PLOS PATHOG, V3, P1511, DOI 10.1371/journal.ppat.0030144; Calvo-Calle JM, 2014, HUMAN HERPESVIRUSES, P235; Chiozzini C, 2014, AIDS, V28, P2189, DOI 10.1097/QAD.0000000000000389; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Dulery R, 2012, BIOL BLOOD MARROW TR, V18, P1080, DOI 10.1016/j.bbmt.2011.12.579; Emery VC, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P875; Fernandez-Ponce C, 2014, PLOS ONE, DOI [10.1371/journal.pone.008519, DOI 10.1371/J0URNAL.P0NE.008519]; Fuhrmann S, 2008, J INFECT DIS, V197, P1455, DOI 10.1086/587692; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Gamvrellis A, 2004, IMMUNOL CELL BIOL, V82, P506, DOI 10.1111/j.0818-9641.2004.01271.x; Gerdemann U, 2013, BLOOD, V121, P207, DOI 10.1182/blood-2012-05-430413; Glosson NL, 2007, VIROLOGY, V365, P125, DOI 10.1016/j.virol.2007.03.048; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; GULLE H, 1990, J IMMUNOL METHODS, V133, P253, DOI 10.1016/0022-1759(90)90366-4; Haberthur K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002367; Halawi M, 2015, IMMUN INFLAMM DIS, V3, P118, DOI 10.1002/iid3.55; Hata A, 2002, NEW ENGL J MED, V347, P26, DOI 10.1056/NEJMoa013441; Iampietro M, 2014, EUR J IMMUNOL, V44, P3573, DOI 10.1002/eji.201444931; Jing LC, 2013, J VIROL, V87, P2617, DOI 10.1128/JVI.03047-12; Jing LC, 2009, J IMMUNOL METHODS, V347, P36, DOI 10.1016/j.jim.2009.05.011; Johnson DC, 2002, CURR TOP MICROBIOL, V269, P101; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; KIRKLAND TN, 1991, INFECT IMMUN, V59, P3952, DOI 10.1128/IAI.59.11.3952-3961.1991; KLEIN BY, 1980, J IMMUNOL METHODS, V38, P325, DOI 10.1016/0022-1759(80)90281-1; Kurien BT, 2003, J IMMUNOL METHODS, V274, P1, DOI 10.1016/S0022-1759(02)00523-9; Laing KJ, 2015, J INFECT DIS, V212, P1022, DOI 10.1093/infdis/jiv164; LAMB JR, 1988, J IMMUNOL METHODS, V110, P1, DOI 10.1016/0022-1759(88)90076-2; Leen AM, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1318; Martin LK, 2012, EUR J IMMUNOL, V42, P2901, DOI 10.1002/eji.201242439; Mohan JF, 2013, MOL IMMUNOL, V55, P166, DOI 10.1016/j.molimm.2012.10.024; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; Mori Y, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P833; Nastke MD, 2012, J VIROL, V86, P4776, DOI 10.1128/JVI.06573-11; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Ogata M, 2015, BONE MARROW TRANSPL, V50, P1030, DOI 10.1038/bmt.2015.76; OHEHIR R, 1989, INT ARCH ALLER A IMM, V88, P170, DOI 10.1159/000234775; OHEHIR RE, 1987, IMMUNOLOGY, V62, P635; OSULLIVAN D, 1991, J IMMUNOL, V147, P2663; Papadopoulou A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008825; PHAM BN, 1989, CLIN EXP IMMUNOL, V77, P168; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Romanets-Korbut O, 2016, CELL MOL IMMUNOL, V13, P828, DOI 10.1038/cmi.2015.55; Sant AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00340; Sebelin-Wulf K, 2007, TRANSPL IMMUNOL, V17, P203, DOI 10.1016/j.trim.2006.10.006; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; SHARON R, 1984, CANCER IMMUNOL IMMUN, V18, P203; Southwood S, 1998, J IMMUNOL, V160, P3363; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tejada-Simon MV, 2003, ANN NEUROL, V53, P189, DOI 10.1002/ana.10425; Tel J, 2010, J IMMUNOL, V184, P4276, DOI 10.4049/jimmunol.0903286; Tosato Giovanna, 2007, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0722s76; Tu WW, 2004, J IMMUNOL, V172, P3260, DOI 10.4049/jimmunol.172.5.3260; Verhoeven DHJ, 2015, PEDIATR INFECT DIS J, V34, P1118, DOI 10.1097/INF.0000000000000824; Verweij MC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004743; Virtanen JO, 2012, CNS NEUROL DISORD-DR, V11, P528; Walton S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00105; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; YAKUSHIJIN Y, 1992, J VIROL, V66, P2773, DOI 10.1128/JVI.66.5.2773-2779.1992; Yao K, 2010, J MED VIROL, V82, P1669, DOI 10.1002/jmv.21861; Yin Liusong, 2014, Curr Protoc Immunol, V106, DOI 10.1002/0471142735.im0510s106; Yin LS, 2012, J IMMUNOL, V189, P3983, DOI 10.4049/jimmunol.1200626; Yoshikawa T, 2002, J INFECT DIS, V185, P847, DOI 10.1086/339411; Yoshikawa T, 2011, J CLIN VIROL, V50, P65, DOI 10.1016/j.jcv.2010.09.017; Yoshikawa Tetsushi, 2010, Brain and Nerve (Tokyo), V62, P869; YOUNG DB, 1986, IMMUNOLOGY, V59, P167; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	77	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142871	10.1371/journal.pone.0142871	http://dx.doi.org/10.1371/journal.pone.0142871			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599878	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900044
J	Behrens, M; Huwel, S; Galla, HJ; Humpf, HU				Behrens, Matthias; Huewel, Sabine; Galla, Hans-Joachim; Humpf, Hans-Ulrich			Blood-Brain Barrier Effects of the Fusarium Mycotoxins Deoxynivalenol, 3 Acetyldeoxynivalenol, and Moniliformin and Their Transfer to the Brain	PLOS ONE			English	Article							IN-VITRO; ENDOTHELIAL-CELLS; JUNCTION PROTEINS; PRIMARY CULTURES; ORAL TOXICITY; TRANSPORT; MODEL; PERMEABILITY; METABOLISM; EXPOSURE	Background Secondary metabolites produced by Fusarium fungi frequently contaminate food and feed and have adverse effects on human and animal health. Fusarium mycotoxins exhibit a wide structural and biosynthetic diversity leading to different toxicokinetics and toxicodynamics. Several studies investigated the toxicity of mycotoxins, focusing on very specific targets, like the brain. However, it still remains unclear how fast mycotoxins reach the brain and if they impair the integrity of the blood-brain barrier. This study investigated and compared the effects of the Fusarium mycotoxins deoxynivalenol, 3-acetyldeoxynivalenol and moniliformin on the blood-brain barrier. Furthermore, the transfer properties to the brain were analyzed, which are required for risk assessment, including potential neurotoxic effects. Methods Primary porcine brain capillary endothelial cells were cultivated to study the effects of the examined mycotoxins on the blood-brain barrier in vitro. The barrier integrity was monitored by cellular impedance spectroscopy and C-14 radiolabeled sucrose permeability measurements. The distribution of the applied toxins between blood and brain compartments of the cell monolayer was analyzed by high performance liquid chromatography-mass spectrometry to calculate transfer rates and permeability coefficients. Results Deoxynivalenol reduced the barrier integrity and caused cytotoxic effects at 10 mu M concentrations. Slight alterations of the barrier integrity were also detected for 3-acetyldeoxynivalenol. The latter was transferred very quickly across the barrier and additionally cleaved to deoxynivalenol. The transfer of deoxynivalenol and moniliformin was slower, but clearly exceeded the permeability of the negative control. None of the compounds was enriched in one of the compartments, indicating that no efflux transport protein is involved in their transport.	[Behrens, Matthias; Humpf, Hans-Ulrich] Univ Munster, Inst Food Chem, Corrensstr 45, D-48149 Munster, Germany; [Huewel, Sabine; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster; University of Munster	Humpf, HU (corresponding author), Univ Munster, Inst Food Chem, Corrensstr 45, D-48149 Munster, Germany.	humpf@wwu.de	Humpf, Hans-Ulrich/AAV-4845-2020	Humpf, Hans-Ulrich/0000-0003-3296-3058; Behrens, Matthias/0000-0001-5425-8144				Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alassane-Kpembi I, 2015, ARCH TOXICOL, V89, P1337, DOI 10.1007/s00204-014-1309-4; Alassane-Kpembi I, 2013, TOXICOL APPL PHARM, V272, P191, DOI 10.1016/j.taap.2013.05.023; ALTPETER F, 1994, APPL MICROBIOL BIOT, V41, P384, DOI [10.1007/s002530050161, 10.1007/BF00212246]; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Beuckmann CT, 1997, CYTOTECHNOLOGY, V24, P11, DOI 10.1023/A:1007936323956; Beyer Marita, 2009, Mycotoxin Res, V25, P41, DOI 10.1007/s12550-009-0006-2; Bonnet MS, 2012, TOXINS, V4, P1120, DOI 10.3390/toxins4111120; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Eriksen GS, 2003, ARCH ANIM NUTR, V57, P335, DOI 10.1080/00039420310001607699; Ficheux AS, 2013, TOXICON, V71, P1, DOI 10.1016/j.toxicon.2013.04.024; Franke H, 1999, BRAIN RES, V818, P65, DOI 10.1016/S0006-8993(98)01282-7; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Gerding J, 2015, MYCOTOXIN RES, V31, P127, DOI 10.1007/s12550-015-0223-9; Gerding J, 2014, MOL NUTR FOOD RES, V58, P2358, DOI 10.1002/mnfr.201400406; Goyarts T, 2006, TOXICOL LETT, V163, P171, DOI 10.1016/j.toxlet.2005.10.007; Hoheisel D, 1998, BIOCHEM BIOPH RES CO, V244, P312, DOI 10.1006/bbrc.1997.8051; Jestoi M, 2008, CRIT REV FOOD SCI, V48, P21, DOI 10.1080/10408390601062021; Jonsson M, 2015, TOXICOL LETT, V233, P38, DOI 10.1016/j.toxlet.2014.11.006; Jonsson M, 2013, FOOD CHEM TOXICOL, V53, P27, DOI 10.1016/j.fct.2012.11.023; Kim JA, 2006, J CEREBR BLOOD F MET, V26, P209, DOI 10.1038/sj.jcbfm.9600181; Knasmuller S, 1997, MUTAT RES-GEN TOX EN, V391, P39, DOI 10.1016/S0165-1218(97)00030-X; Lohmann C, 2002, J DRUG TARGET, V10, P263, DOI 10.1080/10611860290031903; Lohrey L, 2011, SYNLETT, P2242, DOI 10.1055/s-0030-1261189; Maresca M, 2013, TOXINS, V5, P784, DOI 10.3390/toxins5040784; Mulac D, 2012, MOL NUTR FOOD RES, V56, P475, DOI 10.1002/mnfr.201100431; Naik P, 2012, J PHARM SCI-US, V101, P1337, DOI 10.1002/jps.23022; Ohtsuki S, 2013, MOL PHARMACEUT, V10, P289, DOI 10.1021/mp3004308; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pinton P, 2012, TOXICOL SCI, V130, P180, DOI 10.1093/toxsci/kfs239; Pinton P, 2010, J NUTR, V140, P1956, DOI 10.3945/jn.110.123919; PRELUSKY DB, 1990, J ENVIRON SCI HEAL B, V25, P395, DOI 10.1080/03601239009372697; PRELUSKY DB, 1988, FUND APPL TOXICOL, V10, P276, DOI 10.1016/0272-0590(88)90312-0; RABIE CJ, 1982, APPL ENVIRON MICROB, V43, P517, DOI 10.1128/AEM.43.3.517-521.1982; Razafimanjato H, 2011, GLIA, V59, P1672, DOI 10.1002/glia.21214; Sarkanj B, 2013, FOOD CHEM TOXICOL, V62, P231, DOI 10.1016/j.fct.2013.08.043; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.045; Schrot S, 2005, BIOPHYS J, V89, P3904, DOI 10.1529/biophysj.104.058750; Scientific Committee on Food, 1999, OPIN FUS TOX 1; Sergent T, 2006, TOXICOL LETT, V164, P167, DOI 10.1016/j.toxlet.2005.12.006; Thanabalasundaram G, 2011, METHODS MOL BIOL, V686, P379, DOI 10.1007/978-1-60761-938-3_19; THIEL PG, 1978, BIOCHEM PHARMACOL, V27, P483, DOI 10.1016/0006-2952(78)90381-7; Videmann B, 2007, FOOD CHEM TOXICOL, V45, P1938, DOI 10.1016/j.fct.2007.04.011; von Bargen KW, 2012, J AGR FOOD CHEM, V60, P3586, DOI 10.1021/jf300323d; Warth B, 2012, TOXICOL LETT, V211, P85, DOI 10.1016/j.toxlet.2012.02.023; Weidner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060484; Weidner M, 2013, CHEM RES TOXICOL, V26, P347, DOI 10.1021/tx3004664; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; WHO, 2011, WHO TECH REP SER, V959, P1	51	36	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143640	10.1371/journal.pone.0143640	http://dx.doi.org/10.1371/journal.pone.0143640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600019	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900150
J	Borys, C; Lutz, J; Strauss, B; Altmann, U				Borys, Constanze; Lutz, Johannes; Strauss, Bernhard; Altmann, Uwe			Effectiveness of a Multimodal Therapy for Patients with Chronic Low Back Pain Regarding Pre-Admission Healthcare Utilization	PLOS ONE			English	Article							MULTIDISCIPLINARY REHABILITATION; EUROPEAN GUIDELINES; GERMAN; MANAGEMENT; IMPACT; LIFE	Objective The aim of the study was to examine the effectiveness of an intensive inpatient three-week multimodal therapy. We focused especially on the impact on the multimodal therapy outcome of the pre-admission number of treatment types patients had received and of medical specialist groups patients had consulted. Methods 155 patients with chronic low back pain and indication for multimodal therapy were evaluated with respect to pain intensity, depression, anxiety, well-being, and pre-admission health care utilization. In our controlled clinical trial we compared N = 66 patients on the waiting list with N = 89 patients who received immediate treatment. The waiting list patients likewise attended multimodal therapy after the waiting period. Longitudinal post-treatment data for both were collected at three- and twelve-month follow-ups. The impact of pre-admission health care utilization on multimodal therapy outcome (post) was analysed by structural equation model. Results Compared to the control group, multimodal therapy patients' pain intensity and psychological variables were significantly reduced. Longitudinal effects with respect to pre-measures were significant at three-month follow-up for pain intensity (ES = -0.48), well-being (ES = 0.78), anxiety (ES = -0.33), and depression (ES = -0.30). Effect sizes at twelve-month follow- up were small for anxiety (ES = -0.22), and moderate for general well-being (ES = 0.61). Structural equation model revealed that a higher number of pre-admission treatment types was associated with poorer post-treatment outcomes in pain intensity, well-being, and depression. Conclusion Multimodal therapy proved to be effective with regard to improvements in pain intensity, depression, anxiety, and well-being. The association between treatment effect and number of pre-admission pain treatment types suggests that patients would benefit more from attending multimodal therapy in an earlier stage of health care.	[Borys, Constanze; Strauss, Bernhard; Altmann, Uwe] Univ Jena, Inst Psychosocial Med & Psychotherapy, Univ Hosp Jena, Jena, Germany; [Lutz, Johannes] Cent Hosp Bad Berka, Interdisciplinary Pain Ctr, Bad Berka, Germany	Friedrich Schiller University of Jena; Zentralklinik Bad Berka	Borys, C (corresponding author), Univ Jena, Inst Psychosocial Med & Psychotherapy, Univ Hosp Jena, Jena, Germany.	Constanze.Borys@med.uni-jena.de		Altmann, Uwe/0000-0002-3429-2895	Berufsgenossenschaft Nahrungsmittel und Gastgewerbe	Berufsgenossenschaft Nahrungsmittel und Gastgewerbe	CB received a general grant for doctoral thesis from Berufsgenossenschaft Nahrungsmittel und Gastgewerbe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Altenstetter C, 2003, AM J PUBLIC HEALTH, V93, P38, DOI 10.2105/AJPH.93.1.38; Angst F, 2006, J PAIN, V7, P807, DOI 10.1016/j.jpain.2006.03.009; Bertelsmann-Stiftung, 2007, GES RUECK INN KONZ V; Borys C, 2013, SCHMERZ, V27, P588, DOI 10.1007/s00482-013-1370-6; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Chenot JF, 2008, EUR J PAIN, V12, P275, DOI 10.1016/j.ejpain.2007.06.004; Chrubasik S, 1998, EUR J ANAESTH, V15, P397, DOI 10.1097/00003643-199807000-00004; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gross DP, 2005, SPINE, V30, P235, DOI 10.1097/01.brs.0000150485.51681.80; Guzman J, 2001, BMJ-BRIT MED J, V322, P1511, DOI 10.1136/bmj.322.7301.1511; HAUTZINGER M, 1995, PSYCHIAT PRAX, V39, P302; Herda C., 1998, MARBURGER FRAGEBOGEN; Hildebrandt J, 1997, SPINE, V22, P990, DOI 10.1097/00007632-199705010-00011; Hinz A, 2002, DIAGNOSTICA, V48, P112, DOI 10.1026//0012-1924.48.2.112; Kamper SJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000963.pub3; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Kuchler A, 2012, SCHMERZ, V26, P670, DOI 10.1007/s00482-012-1223-8; Michaelson P, 2004, CLIN J PAIN, V20, P447, DOI 10.1097/00002508-200411000-00010; Muthen L, 1998, STAT ANAL LATENT VAR; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; Nationale Versorgungsleitlinie Kreuzschmerz, 2010, BUND; Robert-Koch-Institute, 2013, GESUNDHEITSBERICHTER; Rothman MG, 2013, CLIN J PAIN, V29, P195, DOI 10.1097/AJP.0b013e318250e544; Turk DC, 2008, PAIN, V137, P276, DOI 10.1016/j.pain.2007.09.002; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143139	10.1371/journal.pone.0143139	http://dx.doi.org/10.1371/journal.pone.0143139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599232	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900069
J	Chen, HL; Yang, B; Liu, DY; Liu, WB; Liu, YL; Zhang, XH; Hu, LF				Chen, Huiling; Yang, Bo; Liu, Dayou; Liu, Wenbin; Liu, Yanlong; Zhang, Xiuhua; Hu, Lufeng			Using Blood Indexes to Predict Overweight Statuses: An Extreme Learning Machine-Based Approach	PLOS ONE			English	Article							BODY-MASS INDEX; FEEDFORWARD NETWORKS; LOGISTIC-REGRESSION; GLUCOSE-TOLERANCE; OBESITY; CLASSIFICATION; DISEASE; NUMBER; RISK	The number of the overweight people continues to rise across the world. Studies have shown that being overweight can increase health risks, such as high blood pressure, diabetes mellitus, coronary heart disease, and certain forms of cancer. Therefore, identifying the overweight status in people is critical to prevent and decrease health risks. This study explores a new technique that uses blood and biochemical measurements to recognize the overweight condition. A new machine learning technique, an extreme learning machine, was developed to accurately detect the overweight status from a pool of 225 overweight and 251 healthy subjects. The group included 179 males and 297 females. The detection method was rigorously evaluated against the real-life dataset for accuracy, sensitivity, specificity, and AUC (area under the receiver operating characteristic (ROC) curve) criterion. Additionally, the feature selection was investigated to identify correlating factors for the overweight status. The results demonstrate that there are significant differences in blood and biochemical indexes between healthy and overweight people (p-value < 0.01). According to the feature selection, the most important correlated indexes are creatinine, hemoglobin, hematokrit, uric Acid, red blood cells, high density lipoprotein, alanine transaminase, triglyceride, and. gamma-glutamyl transpeptidase. These are consistent with the results of Spearman test analysis. The proposed method holds promise as a new, accurate method for identifying the overweight status in subjects.	[Chen, Huiling; Liu, Wenbin] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Peoples R China; [Yang, Bo; Liu, Dayou] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Chen, Huiling; Yang, Bo; Liu, Dayou] Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China; [Liu, Yanlong] Wenzhou Med Univ, Coll Pharmaceut Sci, Wenzhou, Peoples R China; [Zhang, Xiuhua; Hu, Lufeng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pharmaceut, Wenzhou, Peoples R China	Wenzhou University; Jilin University; Jilin University; Wenzhou Medical University; Wenzhou Medical University	Zhang, XH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Pharmaceut, Wenzhou, Peoples R China.	wzxiuhuazhang@163.com; hulufeng79@sina.com	chen, huiling/J-2477-2013; liu, wen/HGE-3071-2022; Chen, Huiling/N-8510-2019; liu, yan/HGV-1365-2022	Chen, Huiling/0000-0002-7714-9693; 	National Natural Science Foundation of China (NSFC) [61303113, 61133011, 61373053, 61272018, 61402337, 61572226, 61572367, 81300311]; key construction academic subject (medical innovation) of Zhejiang Province [11-CX26]; Zhejiang Provincial Natural Science Foundation of China [R1110261, LQ13G010007, LQ13F020011, LY14F020035]; young talents project of the First Affiliated Hospital of Wenzhou Medical University [qnyc 043]; open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University [93K172013K01]; Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences; Jilin Province Natural Science Foundation [20150101052JC]; Science and Technology Plan Project of Wenzhou, China [G20140048]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); key construction academic subject (medical innovation) of Zhejiang Province; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); young talents project of the First Affiliated Hospital of Wenzhou Medical University; open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University; Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences; Jilin Province Natural Science Foundation; Science and Technology Plan Project of Wenzhou, China	This research is supported by the National Natural Science Foundation of China (NSFC) (61303113, 61133011, 61373053, 61272018 and 61402337). This work is also supported by the key construction academic subject (medical innovation) of Zhejiang Province (11-CX26), Zhejiang Provincial Natural Science Foundation of China (R1110261, LQ13G010007, LQ13F020011, LY14F020035), and the young talents project of the First Affiliated Hospital of Wenzhou Medical University (qnyc 043), the open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University under Grant No. 93K172013K01, the Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by the National Natural Science Foundation of China (NSFC) (61303113, 61133011, 61572226, 61572367, 61373053, 61272018, 81300311 and 61402337). This work is also supported by the key construction academic subject (medical innovation) of Zhejiang Province (11-CX26), Zhejiang Provincial Natural Science Foundation of China (R1110261, LQ13G010007, LQ13F020011, LY14F020035), and the young talents project of the First Affiliated Hospital of Wenzhou Medical University (qnyc 043), Jilin Province Natural Science Foundation under grants 20150101052JC, the Science and Technology Plan Project of Wenzhou, China (G20140048), the open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University under Grant No. 93K172013K01, the Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences.	Almoosawi S, 2012, FOOD FUNCT, V3, P1035, DOI 10.1039/c2fo30060e; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Duda R.O., 2000, PATTERN CLASSIFICATI; Ergun U, 2009, J MED SYST, V33, P67, DOI 10.1007/s10916-008-9165-5; Evans EM, 2006, INT J OBESITY, V30, P837, DOI 10.1038/sj.ijo.0803208; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferenci T, 2010, IEEE ENG MED BIO, P3883, DOI 10.1109/IEMBS.2010.5627672; Hardalac Firat, 2004, J Med Syst, V28, P129, DOI 10.1023/B:JOMS.0000023296.42481.a1; Heydari ST, 2012, J MED SYST, V36, P2449, DOI 10.1007/s10916-011-9711-4; Hsu CW, 2003, TECHNICAL REPORT, P1; Hu LF, 2015, COMPUT BIOL MED, V59, P116, DOI 10.1016/j.compbiomed.2015.02.003; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2003, IEEE T NEURAL NETWOR, V14, P274, DOI 10.1109/TNN.2003.809401; Huang GB, 1998, IEEE T NEURAL NETWOR, V9, P224, DOI 10.1109/72.655045; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Hyska J, 2014, J COMMUN HEALTH, V39, P828, DOI 10.1007/s10900-014-9888-9; Kong APS, 2008, ACTA PAEDIATR, V97, P1738, DOI 10.1111/j.1651-2227.2008.01056.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lee BJ, 2013, ARTIF INTELL MED, V58, P51, DOI 10.1016/j.artmed.2013.02.001; Lee MF, 2013, GENET TEST MOL BIOMA, V17, P40, DOI 10.1089/gtmb.2012.0231; Liu T, 2015, INT J SYST SCI, V46, P919, DOI 10.1080/00207721.2013.801096; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mohammed AA, 2011, PATTERN RECOGN, V44, P2588, DOI 10.1016/j.patcog.2011.03.013; Moreno R, 2014, NEUROCOMPUTING, V128, P207, DOI 10.1016/j.neucom.2013.03.057; Pal M, 2009, INT J REMOTE SENS, V30, P3835, DOI 10.1080/01431160902788636; Rolandsson O, 2001, J INTERN MED, V249, P279, DOI 10.1046/j.1365-2796.2001.00813.x; Sabah Khandker Md Nurus, 2014, BMC Res Notes, V7, P246, DOI 10.1186/1756-0500-7-246; Salzberg SL, 1997, DATA MIN KNOWL DISC, V1, P317, DOI 10.1023/A:1009752403260; Seo DC, 2014, INT J BEHAV MED, V21, P682, DOI 10.1007/s12529-013-9322-1; Suresh S, 2009, APPL SOFT COMPUT, V9, P541, DOI 10.1016/j.asoc.2008.07.005; Valavanis IK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-453; Van Pelt RE, 2001, INT J OBESITY, V25, P1183, DOI 10.1038/sj.ijo.0801640; Vikoren LA, 2013, BRIT J NUTR, V109, P648, DOI 10.1017/S0007114512001717; Yan WL, 2015, ETHNIC HEALTH, V20, P365, DOI 10.1080/13557858.2014.921894; Zhang RX, 2007, IEEE ACM T COMPUT BI, V4, P485, DOI 10.1109/TCBB.2007.1012; Zheng RD, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/362147	39	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143003	10.1371/journal.pone.0143003	http://dx.doi.org/10.1371/journal.pone.0143003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600199	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900056
J	Chu, C; Belavy, DL; Armbrecht, G; Bansmann, M; Felsenberg, D; Zheng, GY				Chu, Chengwen; Belavy, Daniel L.; Armbrecht, Gabriele; Bansmann, Martin; Felsenberg, Dieter; Zheng, Guoyan			Fully Automatic Localization and Segmentation of 3D Vertebral Bodies from CT/MR Images via a Learning-Based Method	PLOS ONE			English	Article							CT	In this paper, we address the problems of fully automatic localization and segmentation of 3D vertebral bodies from CT/MR images. We propose a learning-based, unified random forest regression and classification framework to tackle these two problems. More specifically, in the first stage, the localization of 3D vertebral bodies is solved with random forest regression where we aggregate the votes from a set of randomly sampled image patches to get a probability map of the center of a target vertebral body in a given image. The resultant probability map is then further regularized by Hidden Markov Model (HMM) to eliminate potential ambiguity caused by the neighboring vertebral bodies. The output from the first stage allows us to define a region of interest (ROI) for the segmentation step, where we use random forest classification to estimate the likelihood of a voxel in the ROI being foreground or background. The estimated likelihood is combined with the prior probability, which is learned from a set of training data, to get the posterior probability of the voxel. The segmentation of the target vertebral body is then done by a binary thresholding of the estimated probability. We evaluated the present approach on two openly available datasets: 1) 3D T2-weighted spine MR images from 23 patients and 2) 3D spine CT images from 10 patients. Taking manual segmentation as the ground truth (each MR image contains at least 7 vertebral bodies from T11 to L5 and each CT image contains 5 vertebral bodies from L1 to L5), we evaluated the present approach with leave-one-out experiments. Specifically, for the T2-weighted MR images, we achieved for localization a mean error of 1.6 mm, and for segmentation a mean Dice metric of 88.7% and a mean surface distance of 1.5 mm, respectively. For the CT images we achieved for localization a mean error of 1.9 mm, and for segmentation a mean Dice metric of 91.0% and a mean surface distance of 0.9 mm, respectively.	[Chu, Chengwen; Zheng, Guoyan] Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland; [Belavy, Daniel L.] Free Univ Berlin, Ctr Muscle & Bone Res, Charite Univ Med Berlin, D-12200 Berlin, Germany; [Belavy, Daniel L.] Humboldt Univ, D-12200 Berlin, Germany; [Belavy, Daniel L.; Armbrecht, Gabriele; Felsenberg, Dieter] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia; [Bansmann, Martin] Krankenhaus Porz Rhein gGmbH, Inst Diagnost & Intervent Radiol, D-51149 Cologne, Germany	University of Bern; Humboldt University of Berlin; Deakin University	Zheng, GY (corresponding author), Stauffacherstr 78, CH-3014 Bern, Switzerland.	guoyan.zheng@istb.unibe.ch	Belavy, Daniel/P-4947-2016; Zheng, Guoyan/C-8079-2014; , Guoyan/M-3617-2018	Belavy, Daniel/0000-0002-9307-832X; , Guoyan/0000-0003-4173-0379; Armbrecht, Gabriele/0000-0002-6578-338X	Swiss National Science Foundation [205321_157207/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation (http://www.snf.ch/en/Pages/default.aspx) with the grant no. 205321_157207/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the Swiss National Science Foundation with Project No. 205321_157207/1.	Ali AM, 2014, COMPUT MED IMAG GRAP, V38, P586, DOI 10.1016/j.compmedimag.2014.04.009; Aslan M. S., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3951, DOI 10.1109/ICPR.2010.961; Ben Ayed I, 2012, LECT NOTES COMPUT SC, V7510, P520, DOI 10.1007/978-3-642-33415-3_64; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carballido-Gamio J, 2004, IEEE T MED IMAGING, V23, P36, DOI 10.1109/TMI.2003.819929; Chen C, 2014, LECT NOTES COMPUT SC, V8679, P50, DOI 10.1007/978-3-319-10581-9_7; Chu CW, 2015, ANN BIOMED ENG, V43, P1247, DOI 10.1007/s10439-014-1176-4; Criminisi A, 2011, LECT NOTES COMPUT SC, V6533, P106, DOI 10.1007/978-3-642-18421-5_11; Cuingnet R, 2012, LECT NOTES COMPUT SC, V7512, P66, DOI 10.1007/978-3-642-33454-2_9; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Egger J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031064; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Glocker B, 2012, LECT NOTES COMPUT SC, V7512, P590, DOI 10.1007/978-3-642-33454-2_73; Huang SH, 2009, IEEE T MED IMAGING, V28, P1595, DOI 10.1109/TMI.2009.2023362; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Ibragimov B, 2014, IEEE T MED IMAGING, V33, P861, DOI 10.1109/TMI.2013.2296976; Jaeger F, 2011, NORMALIZATION MAGNET; Jager F, 2009, IEEE T MED IMAGING, V28, P137, DOI 10.1109/TMI.2008.2004429; Klinder T, 2008, LECT NOTES COMPUT SC, V5241, P227, DOI 10.1007/978-3-540-85988-8_28; Klinder T, 2009, MED IMAGE ANAL, V13, P471, DOI 10.1016/j.media.2009.02.004; Kolmogorov V, 2004, IEEE T PATTERN ANAL, V26, P147, DOI 10.1109/TPAMI.2004.1262177; Li CM, 2014, MAGN RESON IMAGING, V32, P913, DOI 10.1016/j.mri.2014.03.010; Li K, 2006, IEEE T PATTERN ANAL, V28, P119, DOI 10.1109/TPAMI.2006.19; Lindner C, 2013, IEEE T MED IMAGING, V32, P1462, DOI 10.1109/TMI.2013.2258030; Lootus M, 2013, LNCVB, V17, P219; Ma J, 2013, COMPUT VIS IMAGE UND, V117, P1072, DOI 10.1016/j.cviu.2012.11.016; Miao J, 2013, EUR SPINE J, V22, P425, DOI 10.1007/s00586-012-2428-3; Oktay A, 2011, LNCS, V6893, P159; Schmidt S, 2007, LECT NOTES COMPUT SC, V4584, P122; Schwarzenberg R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093389; Song Q, 2013, IEEE T MED IMAGING, V32, P376, DOI 10.1109/TMI.2012.2227120; Stern D, 2011, PHYS MED BIOL, V56, P7505, DOI 10.1088/0031-9155/56/23/011; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Yang C., 2005, ADV NEURAL INFORM PR, V17, P1561; Yao JH, 2006, I S BIOMED IMAGING, P390; Zhan YQ, 2012, LECT NOTES COMPUT SC, V7510, P141, DOI 10.1007/978-3-642-33415-3_18; Zukic D, 2012, VISION MODELING VISU, P135, DOI DOI 10.2312/PE/VMV/VMV12/135-142; Zukic D, 2014, COMPUT GRAPH FORUM, V33, P190, DOI 10.1111/cgf.12343	40	43	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143327	10.1371/journal.pone.0143327	http://dx.doi.org/10.1371/journal.pone.0143327			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599505	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900094
J	Daudigeos-Dubus, E; Le Dret, L; Lanvers-Kaminsky, C; Bawa, O; Opolon, P; Vievard, A; Villa, I; Pages, M; Bosq, J; Vassal, G; Zopf, D; Geoerger, B				Daudigeos-Dubus, Estelle; Le Dret, Ludivine; Lanvers-Kaminsky, Claudia; Bawa, Olivia; Opolon, Paule; Vievard, Albane; Villa, Irene; Pages, Melanie; Bosq, Jacques; Vassal, Gilles; Zopf, Dieter; Geoerger, Birgit			Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SIMIAN SARCOMA-VIRUS; HIGH-GRADE GLIOMAS; COLORECTAL-CANCER; PHASE-II; HUMAN NEUROBLASTOMA; METASTATIC-DISEASE; ANGIOGENIC FACTORS; INHIBITS GROWTH; SOLID TUMORS	The multikinase inhibitor regorafenib (BAY 73-4506) exerts both anti-angiogenic and anti-tumorigenic activity in adult solid malignancies mainly advanced colorectal cancer and gastrointestinal stromal tumors. We intended to explore preclinically the potential of regorafenib against solid pediatric malignancies alone and in combination with anticancer agents to guide the pediatric development plan. In vitro effects on cell proliferation were screened against 33 solid tumor cell lines of the Innovative Therapies for Children with Cancer (ITCC) panel covering five pediatric solid malignancies. Regorafenib inhibited cell proliferation with a mean half maximal growth inhibition of 12.5 mu mol/L (range 0.7 mu mol/L to 28 mu mol/L). In vivo, regorafenib was evaluated alone at 10 or 30 mg/kg/d or in combination with radiation, irinotecan or the mitogen-activated protein kinase kinase (MEK) inhibitor refametinib against various tumor types, including patient-derived brain tumor models with an amplified platelet-derived growth factor receptor A (PDGFRA) gene. Regorafenib alone significantly inhibited tumor growth in all xenografts derived from nervous system and connective tissue tumors. Enhanced effects were observed when regorafenib was combined with irradiation and irinotecan against PDGFRA amplified IGRG93 glioma and IGRM57 medulloblastoma respectively, resulting in 100% tumor regressions. Antitumor activity was associated with decreased tumor vascularization, inhibition of PDGFR signaling, and induction of apoptotic cell death. Our work demonstrates that regorafenib exhibits significant antitumor activity in a wide spectrum of preclinical pediatric models through inhibition of angiogenesis and induction of apoptosis. Furthermore, radio- and chemosensitizing effects were observed with DNA damaging agents in PDGFR amplified tumors.	[Daudigeos-Dubus, Estelle; Le Dret, Ludivine; Vassal, Gilles; Geoerger, Birgit] Univ Paris 11, UMR 8203, Vectorol & Anticanc Therapeut, Villejuif, France; [Daudigeos-Dubus, Estelle; Le Dret, Ludivine; Vassal, Gilles; Geoerger, Birgit] CNRS, UMR 8203, Vectorol & Anticanc Therapeut, F-91405 Orsay, France; [Daudigeos-Dubus, Estelle; Le Dret, Ludivine; Vassal, Gilles; Geoerger, Birgit] Gustave Roussy, UMR 8203, Vectorol & Anticanc Therapeut, Villejuif, France; [Lanvers-Kaminsky, Claudia] Univ Childrens Hosp, Dept Pediat Hematol & Oncol, Munster, Germany; [Bawa, Olivia; Opolon, Paule] Gustave Roussy, PFEP Plateforme Evaluat Preclin, Villejuif, France; [Vievard, Albane] Tribvn, Chatillon, France; [Villa, Irene; Bosq, Jacques] Gustave Roussy, Pathol Lab, Villejuif, France; [Pages, Melanie] St Annes Hosp, Dept Neuropathol, Paris, France; [Pages, Melanie] Paris Descartes Univ, Paris, France; [Zopf, Dieter] Bayer Pharma Aktiengesell, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Bayer AG; Bayer Healthcare Pharmaceuticals	Geoerger, B (corresponding author), Univ Paris 11, UMR 8203, Vectorol & Anticanc Therapeut, Villejuif, France.	birgit.geoerger@gustaveroussy.fr	Pages, Melanie/S-1875-2019; Lanvers-Kaminsky, Claudia/AAY-2071-2021		Bayer Pharma Aktiengesellschaft; Enfants et Sante; Societe Francaise des Cancers de l'Enfant; Tribvn	Bayer Pharma Aktiengesellschaft; Enfants et Sante; Societe Francaise des Cancers de l'Enfant; Tribvn	This preclinical evaluation was supported by: Bayer Pharma Aktiengesellschaft, (BG), 'Enfants et Sante' and the 'Societe Francaise des Cancers de l'Enfant'. Bayer Pharma Aktiengesellschaft provided support in the form of salaries for authors [DZ] and had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Tribvn provided support in the form of salaries for authors [AV] and had a collaborative role in data analysis and preparation of the manuscript without financial support. The specific roles of these authors are articulated in the 'author contributions' section.	Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; [Anonymous], 2013, ONCOL WILLISTON PARK, V27, P164; [Anonymous], 2012, ONCOL WILLISTON PARK, V26, P896; Aprile G, 2013, BIODRUGS, V27, P213, DOI 10.1007/s40259-013-0014-9; Bruix J, 2013, EUR J CANCER, V49, P3412, DOI 10.1016/j.ejca.2013.05.028; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carr BI, 2013, J CELL PHYSIOL, V228, P1344, DOI 10.1002/jcp.24291; Cassinelli G, 2013, BIOCHEM PHARMACOL, V85, P1424, DOI 10.1016/j.bcp.2013.02.023; Chan ASY, 1998, AM J SURG PATHOL, V22, P816, DOI 10.1097/00000478-199807000-00004; Crose LES, 2012, CLIN CANCER RES, V18, P3780, DOI 10.1158/1078-0432.CCR-10-3063; D'Alessandro R, 2013, CANCER CHEMOTH PHARM, V72, P869, DOI 10.1007/s00280-013-2269-8; Daudigeos-Dubus E, 2014, IN VIVO, V28, P425; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Fakhari M, 2002, J PEDIATR SURG, V37, P582, DOI 10.1053/jpsu.2002.31614; Geoerger B, 2002, CANCER RES, V62, P764; George S, 2012, J CLIN ONCOL, V30, P2401, DOI 10.1200/JCO.2011.39.9394; Grill J, 2013, NEURO-ONCOLOGY, V15, P1236, DOI 10.1093/neuonc/not097; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Gururangan S, 2010, J CLIN ONCOL, V28, P3069, DOI 10.1200/JCO.2009.26.8789; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hinson ARP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00183; Jeong YK, 2013, TUMORI, V99, P176, DOI 10.1700/1283.14189; Keles GE, 1995, ONCOL RES, V7, P493; Komuro H, 2001, J CANCER RES CLIN, V127, P739; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Miyagami Mitsusuke, 2005, Medical Molecular Morphology, V38, P36, DOI 10.1007/s00795-004-0273-0; Mross K, 2012, CLIN CANCER RES, V18, P2658, DOI 10.1158/1078-0432.CCR-11-1900; Narayana A, 2010, NEURO-ONCOLOGY, V12, P985, DOI 10.1093/neuonc/noq033; Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; PETER M, 1995, BRIT J CANCER, V72, P96, DOI 10.1038/bjc.1995.283; Peter M, 2001, LAB INVEST, V81, P905, DOI 10.1038/labinvest.3780299; Phillips JJ, 2013, BRAIN PATHOL, V23, P565, DOI 10.1111/bpa.12043; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Rechsteiner M, 2015, ANN ONCOL, V26, P246, DOI 10.1093/annonc/mdu471; Rossler J, 2011, INT J CANCER, V128, P2748, DOI 10.1002/ijc.25611; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Sajithlal GB, 2013, MOL PHARMACOL, V84, P562, DOI 10.1124/mol.113.088005; Sanceau J, 2002, ONCOGENE, V21, P7700, DOI 10.1038/sj.onc.1205881; Schiavetti A, 2012, PEDIATR BLOOD CANCER, V59, P627, DOI 10.1002/pbc.24072; Schmieder R, 2014, INT J CANCER, V135, P1487, DOI 10.1002/ijc.28669; Schultheis B, 2013, ANN ONCOL, V24, P1560, DOI 10.1093/annonc/mdt056; Serra M, 2001, MODERN PATHOL, V14, P710, DOI 10.1038/modpathol.3880377; Sherman JH, 2014, J CLIN NEUROSCI, V21, P131, DOI 10.1016/j.jocn.2013.04.010; Sie M, 2014, CRIT REV ONCOL HEMAT, V89, P418, DOI 10.1016/j.critrevonc.2013.09.005; Skorski T, 2002, NAT REV CANCER, V2, P351, DOI 10.1038/nrc799; Spaniol K, 2011, ANTI-CANCER DRUG, V22, P531, DOI 10.1097/CAD.0b013e3283454526; Taylor M, 2009, CLIN CANCER RES, V15, P4561, DOI 10.1158/1078-0432.CCR-08-2363; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; Vassal G, 1996, INT J CANCER, V69, P146, DOI 10.1002/(SICI)1097-0215(19960422)69:2<146::AID-IJC14>3.0.CO;2-7; Virag J, 2014, PATHOL ONCOL RES, V20, P417, DOI 10.1007/s12253-013-9711-4; Waha A, 2003, J NEUROPATH EXP NEUR, V62, P1192, DOI 10.1093/jnen/62.11.1192; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Wohrle S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077652; Zopf D, 2010, AACR 101 ANN M ONL P; Zwerner JP, 2002, ONCOGENE, V21, P3847, DOI 10.1038/sj.onc.1205486	60	32	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142612	10.1371/journal.pone.0142612	http://dx.doi.org/10.1371/journal.pone.0142612			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599335	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900031
J	Lim, S; Nash, D; Hollod, L; Harris, TG; Lennon, MC; Thorpe, LE				Lim, Sungwoo; Nash, Denis; Hollod, Laura; Harris, Tiffany G.; Lennon, Mary Clare; Thorpe, Lorna E.			Influence of Jail Incarceration and Homelessness Patterns on Engagement in HIV Care and HIV Viral Suppression among New York City Adults Living with HIV/AIDS	PLOS ONE			English	Article							OUTCOMES	Objectives Both homelessness and incarceration are associated with housing instability, which in turn can disrupt continuity of HIV medical care. Yet, their impacts have not been systematically assessed among people living with HIV/AIDS (PLWHA). Methods We studied a retrospective cohort of 1,698 New York City PLWHA with both jail incarceration and homelessness during 2001-05 to evaluate whether frequent transitions between jail incarceration and homelessness were associated with a lower likelihood of continuity of HIV care during a subsequent one-year follow-up period. Using matched jail, single-adult homeless shelter, and HIV registry data, we performed sequence analysis to identify trajectories of these events and assessed their influence on engagement in HIV care and HIV viral suppression via marginal structural modeling. Results Sequence analysis identified four trajectories; 72% of the cohort had sporadic experiences of both brief incarceration and homelessness, whereas others experienced more consistent incarceration or homelessness during early or late months. Trajectories were not associated with differential engagement in HIV care during follow-up. However, compared with PLWHA experiencing early bouts of homelessness and later minimal incarceration/homelessness events, we observed a lower prevalence of viral suppression among PLWHA with two other trajectories: those with sporadic, brief occurrences of incarceration/homelessness (0.67, 95% CI = 0.50,0.90) and those with extensive incarceration experiences (0.62, 95% CI = 0.43,0.88). Conclusions Housing instability due to frequent jail incarceration and homelessness or extensive incarceration may exert negative influences on viral suppression. Policies and services that support housing stability should be strengthened among incarcerated and sheltered PLWHA to reduce risk of adverse health conditions.	[Lim, Sungwoo; Harris, Tiffany G.] New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, Queens, NY 10013 USA; [Nash, Denis; Lennon, Mary Clare; Thorpe, Lorna E.] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Hollod, Laura] Johnson & Johnson, Monitoring & Evaluat, Corp Contribut, New Brunswick, NJ USA; [Harris, Tiffany G.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Lennon, Mary Clare] CUNY, Grad Ctr, PhD Program Sociol, New York, NY USA	New York City Department of Health & Mental Hygiene; City University of New York (CUNY) System; Johnson & Johnson; Johnson & Johnson USA; Columbia University; City University of New York (CUNY) System	Lim, S (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, Queens, NY 10013 USA.	slim1@health.nyc.gov	Nash, Denis/AFI-7485-2022	Lim, Sungwoo/0000-0002-4890-0396; Harris, Tiffany/0000-0003-2212-0874; Nash, Denis/0000-0002-3280-5386	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER; NIMH NIH HHS [P30 MH043520] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aidala AA, 2007, AIDS BEHAV, V11, pS101, DOI 10.1007/s10461-007-9276-x; Aidala AA, 2007, AIDS BEHAV, V11, pS1, DOI 10.1007/s10461-007-9302-z; Althoff AL, 2013, AIDS BEHAV, V17, P156, DOI 10.1007/s10461-012-0372-1; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Johnson MO, 2003, AIDS PATIENT CARE ST, V17, P645, DOI 10.1089/108729103771928708; Jordan AO, 2013, AIDS BEHAV, V17, P212, DOI 10.1007/s10461-012-0352-5; Leaver CA, 2007, AIDS BEHAV, V11, pS85, DOI 10.1007/s10461-007-9246-3; Lim S, 2015, AM J EPIDEMIOL, V181, P261, DOI 10.1093/aje/kwu313; Lim S, 2012, AM J EPIDEMIOL, V175, P519, DOI 10.1093/aje/kwr327; Meyer JP, 2014, LANCET HIV, V1, pE77, DOI 10.1016/S2352-3018(14)70022-0; Meyer JP, 2014, JAMA INTERN MED, V174, P721, DOI 10.1001/jamainternmed.2014.601; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rich JD, 2011, NEW ENGL J MED, V364, P2081, DOI 10.1056/NEJMp1102385; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; RUBIN DB, 1980, J AM STAT ASSOC, V75, P591, DOI 10.2307/2287653; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2007, HIV CLIN TRIALS, V8, P205, DOI 10.1310/hct0804-205; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P42, DOI 10.1097/EDE.0b013e3181f74493; Wiewel EW, 2015, JAIDS-J ACQ IMM DEF, V68, P217, DOI 10.1097/QAI.0000000000000424	25	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141912	10.1371/journal.pone.0141912	http://dx.doi.org/10.1371/journal.pone.0141912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599877	Green Published, gold			2022-12-27	WOS:000365853900017
J	Plantier, L; Marchand-Adam, S; Boyer, L; Taille, C; Delclaux, C				Plantier, Laurent; Marchand-Adam, Sylvain; Boyer, Laurent; Taille, Camille; Delclaux, Christophe			Methacholine-Induced Variations in Airway Volume and the Slope of the Alveolar Capnogram Are Distinctly Associated with Airflow Limitation and Airway Closure	PLOS ONE			English	Article							SMOOTH-MUSCLE; VENTILATION HETEROGENEITY; FORCED OSCILLATION; NITROGEN WASHOUT; ASTHMA; HYPERRESPONSIVENESS; RESPONSIVENESS; DYSFUNCTION; BRONCHOCONSTRICTION; DETERMINANT	Mechanisms driving alteration of lung function in response to inhalation of a methacholine aerosol are incompletely understood. To explore to what extent large and small airways contribute to airflow limitation and airway closure in this context, volumetric capnography was performed before (n = 93) and after (n = 78) methacholine provocation in subjects with an intermediate clinical probability of asthma. Anatomical dead space (VDaw), reflecting large airway volume, and the slope of the alveolar capnogram (slope3), an index of ventilation heterogeneity linked to small airway dysfunction, were determined. At baseline, VDaw was positively correlated with lung volumes, FEV1 and peak expiratory flow, while slope3 was not correlated with any lung function index. Variations in VDaw and slope3 following methacholine stimulation were correlated to a small degree (R-2 = -0.20). Multivariate regression analysis identified independent associations between variation in FEV1 and variations in both VDaw (Standardized Coefficient-SC = 0.66) and Slope3 (SC = 0.35). By contrast, variation in FVC was strongly associated with variations in VDaw (SC = 0.8) but not Slope3. Thus, alterations in the geometry and/or function of large and small airways were weakly correlated and contributed distinctly to airflow limitation. While both large and small airways contributed to airflow limitation as assessed by FEV1, airway closure as assessed by FVC reduction mostly involved the large airways.	[Plantier, Laurent; Taille, Camille] Labex Inflamex, INSERM UMR 1152, Paris, France; [Plantier, Laurent; Taille, Camille] Univ Paris Diderot, PRES Sorbonne Paris Cite, Paris, France; [Plantier, Laurent] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Serv Physiol Explorat Fonct, DHU FIRE, F-75877 Paris 18, France; [Marchand-Adam, Sylvain] Hop Bretonneau, Serv Pneumol, Tours, France; [Marchand-Adam, Sylvain] Univ Tours, Tours, France; [Boyer, Laurent] INSERM U955, Creteil, France; [Boyer, Laurent] Univ Paris Est, Creteil, France; [Boyer, Laurent] Hop Henri Mondor, Assistance Publ Hop Paris, Serv Physiol Explorat Fonct, F-94010 Creteil, France; [Taille, Camille] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Serv Pneumol, F-75877 Paris 18, France; [Delclaux, Christophe] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Physiol Explorat Fonct, Paris, France; [Delclaux, Christophe] Univ Paris 05, Paris, France; [Delclaux, Christophe] INSERM CIC Plurithemat 9201, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Tours; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Plantier, L (corresponding author), Univ Tours, Hop Bretonneau, Serv Pneumol, CEPR INSERM UMR1100, Tours, France.	laurent.plantier@inserm.fr	Plantier, Laurent/GVT-8757-2022	marchand-adam, sylvain/0000-0002-9522-3738; Boyer, Laurent/0000-0002-2608-6696; Plantier, Laurent/0000-0002-3426-2936				Alfieri V, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0086-1; Babik B, 2012, CRIT CARE, V16, DOI 10.1186/cc11659; BARNES PJ, 1983, AM REV RESPIR DIS, V127, P758; Beretta E, 2014, RESP PHYSIOL NEUROBI, V192, P23, DOI 10.1016/j.resp.2013.12.002; Bohadana AB, 1999, EUR RESPIR J, V13, P295, DOI 10.1034/j.1399-3003.1999.13b13.x; Bokov P, 2014, RESP PHYSIOL NEUROBI, V203, P15, DOI 10.1016/j.resp.2014.08.017; Bokov P, 2010, RESP PHYSIOL NEUROBI, V173, P1, DOI 10.1016/j.resp.2010.05.011; Bouaziz N, 1996, PEDIATR PULM, V22, P7, DOI 10.1002/(SICI)1099-0496(199607)22:1<7::AID-PPUL2>3.0.CO;2-P; Boudewijn IM, 2013, ALLERGY, V68, P1419, DOI 10.1111/all.12242; Brusasco V, 2005, EUR RESPIR J, V26, P1, DOI 10.1183/09031936.05.00034205; Chapman DG, 2008, EUR RESPIR J, V32, P1563, DOI 10.1183/09031936.00114007; Chinn S, 1997, EUR RESPIR J, V10, P2495, DOI 10.1183/09031936.97.10112495; CHITANO P, 1993, J APPL PHYSIOL, V75, P2013, DOI 10.1152/jappl.1993.75.5.2013; Clini E, 1996, Monaldi Arch Chest Dis, V51, P194; Cohen J, 2008, RESP MED, V102, P1264, DOI 10.1016/j.rmed.2008.04.007; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Donovan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074101; Downie SR, 2007, THORAX, V62, P684, DOI 10.1136/thx.2006.069682; Drummond GB, 2006, BRIT J ANAESTH, V96, P4, DOI 10.1093/bja/aei289; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Farrow CE, 2012, J APPL PHYSIOL, V113, P958, DOI 10.1152/japplphysiol.01618.2011; FLETCHER R, 1981, BRIT J ANAESTH, V53, P77, DOI 10.1093/bja/53.1.77; Hardaker KM, 2013, RESP PHYSIOL NEUROBI, V189, P106, DOI 10.1016/j.resp.2013.07.009; Harris RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053216; JACKSON AC, 1981, J APPL PHYSIOL, V50, P1286, DOI 10.1152/jappl.1981.50.6.1286; James A, 2000, EUR RESPIR J, V15, P782, DOI 10.1034/j.1399-3003.2000.15d25.x; Kim WW, 2012, AM J ROENTGENOL, V199, P975, DOI 10.2214/AJR.11.7624; King GG, 2005, RESP PHYSIOL NEUROBI, V148, P165, DOI 10.1016/j.resp.2005.05.001; King GG, 2004, EUR RESPIR J, V24, P211, DOI 10.1183/09031936.04.00047503; Koopman M, 2011, PEDIATR PULM, V46, P266, DOI 10.1002/ppul.21362; Kotaru C, 2005, J APPL PHYSIOL, V98, P1028, DOI 10.1152/japplphysiol.01186.2003; Koulouris NG, 2004, RESP PHYSIOL NEUROBI, V140, P293, DOI 10.1016/j.resp.2004.01.005; Laprise C, 1997, AM J RESP CRIT CARE, V156, P403, DOI 10.1164/ajrccm.156.2.9606053; Litonjua AA, 1999, AM J RESP CRIT CARE, V159, P1574, DOI 10.1164/ajrccm.159.5.9803063; McLeod D, 2012, J APPL PHYSIOL, V113, P1233, DOI 10.1152/japplphysiol.00133.2012; Okazawa M, 1996, AM J RESP CRIT CARE, V154, P1557, DOI 10.1164/ajrccm.154.5.8912780; Olsson K, 1999, CLIN PHYSIOL, V19, P426; OSMANLIEV D, 1982, AM REV RESPIR DIS, V126, P179; Pellegrino R, 2001, J APPL PHYSIOL, V91, P2190, DOI 10.1152/jappl.2001.91.5.2190; PETERSSON G, 1990, INT J MICROCIRC, V9, P205; PETTY TL, 1980, AM REV RESPIR DIS, V121, P449, DOI 10.1164/arrd.1980.121.3.449; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Romero Pablo V, 2007, Int J Chron Obstruct Pulmon Dis, V2, P381; Samee S, 2003, J ALLERGY CLIN IMMUN, V111, P1205, DOI 10.1067/mai.2003.1544; SEKIZAWA K, 1986, AM REV RESPIR DIS, V133, P593; Siddiqui S, 2010, J APPL PHYSIOL, V109, P1170, DOI 10.1152/japplphysiol.01168.2009; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; STERK PJ, 1993, EUR RESPIR J, V6, P53, DOI 10.1183/09041950.053s1693; Stromberg NOT, 2000, PEDIATR PULM, V29, P94, DOI 10.1002/(SICI)1099-0496(200002)29:2<94::AID-PPUL3>3.0.CO;2-B; Tgavalekos NT, 2005, J APPL PHYSIOL, V99, P2388, DOI 10.1152/japplphysiol.00391.2005; Thompson BR, 2013, J ALLERGY CLIN IMMUN, V131, P1322, DOI 10.1016/j.jaci.2013.01.054; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Veronez L, 2010, LUNG, V188, P263, DOI 10.1007/s00408-009-9213-z; Wongviriyawong C, 2012, J APPL PHYSIOL, V112, P237, DOI 10.1152/japplphysiol.01400.2010	54	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143550	10.1371/journal.pone.0143550	http://dx.doi.org/10.1371/journal.pone.0143550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599006	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900143
J	Porth, I; Klapste, J; McKown, AD; La Mantia, J; Guy, RD; Ingvarsson, PK; Hamelin, R; Mansfield, SD; Ehlting, J; Douglas, CJ; El-Kassaby, YA				Porth, Ilga; Klapste, Jaroslav; McKown, Athena D.; La Mantia, Jonathan; Guy, Robert D.; Ingvarsson, Par K.; Hamelin, Richard; Mansfield, Shawn D.; Ehlting, Juergen; Douglas, Carl J.; El-Kassaby, Yousry A.			Evolutionary Quantitative Genomics of Populus trichocarpa	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SPRUCE PICEA-SITCHENSIS; LOCAL ADAPTATION; TRAIT VARIATION; GENE FLOW; ARABIDOPSIS-THALIANA; POPULATION-STRUCTURE; NATURAL-POPULATIONS; BLACK COTTONWOOD; CLIMATE-CHANGE	Forest trees generally show high levels of local adaptation and efforts focusing on understanding adaptation to climate will be crucial for species survival and management. Here, we address fundamental questions regarding the molecular basis of adaptation in undomesticated forest tree populations to past climatic environments by employing an integrative quantitative genetics and landscape genomics approach. Using this comprehensive approach, we studied the molecular basis of climate adaptation in 433 Populus trichocarpa (black cottonwood) genotypes originating across western North America. Variation in 74 field-assessed traits (growth, ecophysiology, phenology, leaf stomata, wood, and disease resistance) was investigated for signatures of selection (comparing Q(ST)-F-ST) using clustering of individuals by climate of origin (temperature and precipitation). 29,354 SNPs were investigated employing three different outlier detection methods and marker-inferred relatedness was estimated to obtain the narrow-sense estimate of population differentiation in wild populations. In addition, we compared our results with previously assessed selection of candidate SNPs using the 25 topographical units (drainages) across the P. trichocarpa sampling range as population groupings. Narrow-sense QST for 53% of distinct field traits was significantly divergent from expectations of neutrality (indicating adaptive trait variation); 2,855 SNPs showed signals of diversifying selection and of these, 118 SNPs (within 81 genes) were associated with adaptive traits (based on significant QST). Many SNPs were putatively pleiotropic for functionally uncorrelated adaptive traits, such as autumn phenology, height, and disease resistance. Evolutionary quantitative genomics in P. trichocarpa provides an enhanced understanding regarding the molecular basis of climate-driven selection in forest trees and we highlight that important loci underlying adaptive trait variation also show relationship to climate of origin. We consider our approach the most comprehensive, as it uncovers the molecular mechanisms of adaptation using multiple methods and tests. We also provide a detailed outline of the required analyses for studying adaptation to the environment in a population genomics context to better understand the species' potential adaptive capacity to future climatic scenarios.	[Porth, Ilga; Klapste, Jaroslav; McKown, Athena D.; La Mantia, Jonathan; Guy, Robert D.; Hamelin, Richard; El-Kassaby, Yousry A.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada; [Porth, Ilga] Univ Laval, Fac Foresterie Geog & Geomat, Dept Sci Bois & Foret, Quebec City, PQ G1V 0A6, Canada; [Klapste, Jaroslav] Czech Univ Life Sci, Dept Genet & Physiol Forest Trees, Prague 16521, Czech Republic; [La Mantia, Jonathan] USDA, Corn Soybean & Wheat Qual Res Unit, Wooster, OH 44691 USA; [Ingvarsson, Par K.] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden; [Mansfield, Shawn D.] Univ British Columbia, Dept Wood Sci, Vancouver, BC V6T 1Z4, Canada; [Ehlting, Juergen] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada; [Ehlting, Juergen] Univ Victoria, Ctr Forest Biol, Victoria, BC V8W 3N5, Canada; [Douglas, Carl J.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; Laval University; Czech University of Life Sciences Prague; United States Department of Agriculture (USDA); Umea University; University of British Columbia; University of Victoria; University of Victoria; University of British Columbia	El-Kassaby, YA (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada.	y.el-kassaby@ubc.ca	Guy, Robert/GPX-8421-2022; Ingvarsson, Pär/G-2748-2010; El-Kassaby, Yousry A/K-9856-2016; Porth, Ilga M/N-4862-2015; Klapste, Jaroslav/B-6668-2016; Hamelin, Richard/F-7006-2010	El-Kassaby, Yousry A/0000-0002-4887-8977; Porth, Ilga M/0000-0002-9344-6348; Klapste, Jaroslav/0000-0001-5504-3735; McKown, Athena/0000-0002-7402-9952; Mansfield, Shawn/0000-0002-0175-554X; Hamelin, Richard/0000-0003-4006-532X; Ehlting, Jurgen/0000-0003-2302-696X; Ingvarsson, Par/0000-0001-9225-7521	Genome British Columbia Applied Genomics Innovation Program [103BIO]; Genome Canada Large-Scale Applied Research Project [168BIO]	Genome British Columbia Applied Genomics Innovation Program; Genome Canada Large-Scale Applied Research Project(Genome Canada)	This work was supported by Genome British Columbia Applied Genomics Innovation Program (Project 103BIO) and Genome Canada Large-Scale Applied Research Project (Project 168BIO), funds to RDG, RCH, JE, SDM, CJD, and YE-K.	Aitken S. N., 2013, ANNU REV ECOL EVOL S, V44, P367, DOI DOI 10.1146/annurev-ecolsys-110512-135747; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Anderson JT, 2011, TRENDS GENET, V27, P258, DOI 10.1016/j.tig.2011.04.001; [Anonymous], 2010, NAT GENET, V42, P551, DOI 10.1038/ng0710-551; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072126; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bivand R, 2014, SPDEP SPATIAL DEPEND; Black BL, 2002, TREE PHYSIOL, V22, P717, DOI 10.1093/treephys/22.10.717; Camanes G, 2012, PLANT PHYSIOL, V158, P1054, DOI 10.1104/pp.111.184424; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; CHANDRASHEKAR M, 1981, PHYTOPATHOLOGY, V71, P421, DOI 10.1094/Phyto-71-421; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Cronk QCB, 2005, NEW PHYTOL, V166, P39, DOI 10.1111/j.1469-8137.2005.01369.x; Di Giuseppe E, 2013, THEOR APPL CLIMATOL, V114, P39, DOI 10.1007/s00704-012-0801-0; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Eckenwalder J.E, 1996, SYSTEMATICS EVOLUTIO; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Endler J.A., 1977, Monographs in Population Biology, pi; Epperson B. K., 2003, GEOGRAPHICAL GENETIC; Evans LM, 2014, NAT GENET, V46, P1089, DOI 10.1038/ng.3075; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Fabbrini F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-47; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Fracheboud Y, 2009, PLANT PHYSIOL, V149, P1982, DOI 10.1104/pp.108.133249; Frentiu FD, 2008, P R SOC B, V275, P639, DOI 10.1098/rspb.2007.1032; Geraldes A, 2013, MOL ECOL RESOUR, V13, P306, DOI 10.1111/1755-0998.12056; Geraldes A, 2014, EVOLUTION, V68, P3260, DOI 10.1111/evo.12497; Geraldes A, 2011, MOL ECOL RESOUR, V11, P81, DOI 10.1111/j.1755-0998.2010.02960.x; Gilmour A. R., 2002, ASREML USER GUIDE RE; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hanninen H, 2011, TRENDS PLANT SCI, V16, P412, DOI 10.1016/j.tplants.2011.05.001; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hemani G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003295; Henderson C. R, 1984, APPL LINEAR MODELS A; Holliday JA, 2008, NEW PHYTOL, V178, P103, DOI 10.1111/j.1469-8137.2007.02346.x; Holliday JA, 2012, P ROY SOC B-BIOL SCI, V279, P1675, DOI 10.1098/rspb.2011.1805; HOWE GT, 1995, PHYSIOL PLANTARUM, V93, P695, DOI 10.1111/j.1399-3054.1995.tb05119.x; Jannink JL, 2007, GENETICS, V176, P553, DOI 10.1534/genetics.106.062992; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Kalcsits LA, 2009, TREES-STRUCT FUNCT, V23, P971, DOI 10.1007/s00468-009-0339-7; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Kremer A, 2012, HEREDITY, V108, P375, DOI 10.1038/hdy.2011.81; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; La Mantia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078423; Larisch C, 2012, PLANT PHYSIOL, V160, P1515, DOI 10.1104/pp.112.202291; Le Corre V, 2012, MOL ECOL, V21, P1548, DOI 10.1111/j.1365-294X.2012.05479.x; Lefevre F, 2013, ANN FOREST SCI, P1; LEWONTIN RC, 1973, GENETICS, V74, P175; Lexer C, 2012, NEW PHYTOL, V196, P652, DOI 10.1111/j.1469-8137.2012.04362.x; Lind MI, 2011, EVOLUTION, V65, P684, DOI 10.1111/j.1558-5646.2010.01122.x; Lippert C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01815; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luquez V, 2008, TREE GENET GENOMES, V4, P279, DOI 10.1007/s11295-007-0108-y; Lynch M., 1998, GENETICS ANAL QUANTI; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; McKown AD, 2014, MOL ECOL, V23, P5771, DOI 10.1111/mec.12969; McKown AD, 2014, NEW PHYTOL, V203, P535, DOI 10.1111/nph.12815; McKown AD, 2014, NEW PHYTOL, V201, P1263, DOI 10.1111/nph.12601; McKown AD, 2013, OECOLOGIA, V172, P653, DOI 10.1007/s00442-012-2531-5; Mimura M, 2007, HEREDITY, V99, P224, DOI 10.1038/sj.hdy.6800987; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Petterle A, 2013, CURR OPIN PLANT BIOL, V16, P301, DOI 10.1016/j.pbi.2013.02.006; Porth I., 2014, Diversity, V6, P283, DOI 10.3390/d6020283; Porth I, 2015, BIOTECHNOL J, V10, P510, DOI 10.1002/biot.201400194; Porth I, 2013, NEW PHYTOL, V200, P710, DOI 10.1111/nph.12422; Porth I, 2013, NEW PHYTOL, V197, P777, DOI 10.1111/nph.12014; Prunier J, 2011, MOL ECOL, V20, P1702, DOI 10.1111/j.1365-294X.2011.05045.x; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Ritland K, 1996, EVOLUTION, V50, P1074, DOI 10.1111/j.1558-5646.1996.tb02348.x; Rohde A, 2011, TREE PHYSIOL, V31, P472, DOI 10.1093/treephys/tpr038; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Saether SA, 2007, J EVOLUTION BIOL, V20, P1563, DOI 10.1111/j.1420-9101.2007.01328.x; Sannigrahi P, 2010, BIOFUEL BIOPROD BIOR, V4, P209, DOI 10.1002/bbb.206; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; SCHNEE FB, 1984, EVOLUTION, V38, P42, DOI 10.1111/j.1558-5646.1984.tb00258.x; Schnute Jon T., 2004, Canadian Technical Report of Fisheries and Aquatic Sciences, V2549, P1; Slavov GT, 2010, HEREDITY, V105, P348, DOI 10.1038/hdy.2010.73; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Slavov GT, 2010, PLANT GENET GENOMICS, V8, P15, DOI 10.1007/978-1-4419-1541-2_2; Soolanayakanahally RY, 2013, PLANT CELL ENVIRON, V36, P116, DOI 10.1111/j.1365-3040.2012.02560.x; Sork VL, 2013, TREE GENET GENOMES, P1; Stanton BJ, 2010, PLANT GENET GENOMICS, V8, P309, DOI 10.1007/978-1-4419-1541-2_14; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Tsumura Y, 2012, HEREDITY, V109, P349, DOI 10.1038/hdy.2012.50; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Wang YY, 2011, PLANT CELL, V23, P1945, DOI 10.1105/tpc.111.083618; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Xie CY, 2009, CAN J FOREST RES, V39, P519, DOI 10.1139/X08-190; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285; Yeaman S, 2013, P NATL ACAD SCI USA, V110, pE1743, DOI 10.1073/pnas.1219381110	99	17	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142864	10.1371/journal.pone.0142864	http://dx.doi.org/10.1371/journal.pone.0142864			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599762	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900043
J	Wen, JH; Ye, F; Li, SJ; Huang, XJ; Yang, L; Xiao, XS; Xie, XM				Wen, Jiahuai; Ye, Feng; Li, Shuaijie; Huang, Xiaojia; Yang, Lu; Xiao, Xiangsheng; Xie, Xiaoming			The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I-III Breast Cancer Patients Undergoing Surgical Treatment	PLOS ONE			English	Article							AXILLARY NODES; CHOLESTEROL; EXPRESSION; SURVIVAL; LUNG; INFLAMMATION; FIBRINOGEN; INHIBITORS; OBESITY; WOMEN	Background Previous studies have indicated the prognostic value of various laboratory parameters in cancer patients. This study was to establish a prognostic index (PI) model for breast cancer patients based on the potential prognostic factors. Methods A retrospective study of 1661 breast cancer patients who underwent surgical treatment between January 2002 and December 2008 at Sun Yat-sen University Cancer Center was conducted. Multivariate analysis (Cox regression model) was performed to determine the independent prognostic factors and a prognostic index (PI) model was devised based on these factors. Survival analyses were used to estimate the prognostic value of PI, and the discriminatory ability of PI was compared with Nottingham Prognostic Index (NPI) by evaluating the area under the receiver operating characteristics curves (AUC). Results The mean survival time of all participants was 123.6 months. The preoperative globulin >30.0g/L, triglyceride >1.10mmol/L and fibrinogen >2.83g/L were identified as risk factors for shorter cancer-specific survival. The novel prognostic index model was established and enrolled patients were classified as low- (1168 patients, 70.3%), moderate- (410 patients, 24.7%) and high-risk groups (83 patients, 5.0%), respectively. Compared with the low-risk group, higher risks of poor clinical outcome were indicated in the moderate-risk group [Hazard ratio (HR): 1.513, 95% confidence interval (CI): 1.169-1.959, p = 0.002] and high-risk group (HR: 2.481, 95% CI: 1.653-3.724, p< 0.001). Conclusions The prognostic index based on three laboratory parameters was a novel and practicable prognostic tool. It may serve as complement to help predict postoperative survival in breast cancer patients.	[Wen, Jiahuai; Ye, Feng; Li, Shuaijie; Huang, Xiaojia; Yang, Lu; Xiao, Xiangsheng; Xie, Xiaoming] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Xie, XM (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	xiexm@sysucc.org.cn	xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81472575, 81272514, 81372133]; Key Programme of the National Natural Science Foundation of China [31030061]; Science and Technology Planning Project of Guangdong and Guangzhou [2013B060300009, 2014J4100169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Programme of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong and Guangzhou	This work was supported by funds from the National Natural Science Foundation of China (81472575, 81272514, 81372133), the Key Programme of the National Natural Science Foundation of China (31030061), and the Science and Technology Planning Project of Guangdong and Guangzhou (2013B060300009, 2014J4100169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1982, SCAND J IMMUNOL, V15, P109, DOI 10.1111/j.1365-3083.1982.tb00628.x; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Alli PM, 2005, ONCOGENE, V24, P39, DOI 10.1038/sj.onc.1208174; Amaral BB, 2007, SEMIN ROENTGENOL, V42, P253, DOI 10.1053/j.ro.2007.07.002; Azab B, 2013, INT J COLORECTAL DIS, V28, P1629, DOI 10.1007/s00384-013-1748-z; Bala Dinavahi V, 2001, Asian Pac J Cancer Prev, V2, P123; Berra E, 2000, BIOCHEM PHARMACOL, V60, P1171, DOI 10.1016/S0006-2952(00)00423-8; Berthold D, 2010, ANN ONCOL, V21, DOI 10.1093/annonc/mdp556; Bureau F, 2002, BLOOD, V99, P3683, DOI 10.1182/blood.V99.10.3683; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carlson RW, 2012, J NATL COMPR CANC NE, V10, P821, DOI 10.6004/jnccn.2012.0086; COHEN MH, 1981, CANCER TREAT REP, V65, P187; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Leo A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt337; DVORAK HF, 1992, ANN NY ACAD SCI, V667, P101, DOI 10.1111/j.1749-6632.1992.tb51603.x; Fedele P, 2015, CRIT REV ONCOL HEMAT; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gong Y, 2014, EUR REV MED PHARMACO, V18, P2808; Guo QQ, 2009, PANCREAS, V38, pE75, DOI 10.1097/MPA.0b013e3181987d86; HIGASHIYAMA M, 1992, BRIT J CANCER, V65, P300, DOI 10.1038/bjc.1992.60; Jung HA, 2015, TUMOR BIOL, V36, P1073, DOI 10.1007/s13277-014-2730-2; Kang M, 2015, PLOS ONE, V10; Kapil U, 2013, J BREAST CANCER, V16, P129, DOI 10.4048/jbc.2013.16.1.129; Kataoka H, 1999, AM J PATHOL, V154, P457, DOI 10.1016/S0002-9440(10)65292-3; Kollias J, 1999, EUR J CANCER, V35, P908, DOI 10.1016/S0959-8049(99)00056-8; Lee AHS, 2008, PATHOL ONCOL RES, V14, P113, DOI 10.1007/s12253-008-9067-3; Liu XA, 2015, CARCINOGENESIS, V36, P243, DOI 10.1093/carcin/bgu247; Nieswandt B, 1999, CANCER RES, V59, P1295; Orucevic A, 2015, BREAST J, V21, P147, DOI 10.1111/tbj.12367; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; PIERCE JH, 1991, ONCOGENE, V6, P1189; Polterauer S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.008; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Ray G, 2001, CLIN BIOCHEM, V34, P71, DOI 10.1016/S0009-9120(00)00200-9; Schoppmann SF, 2006, BREAST CANCER RES TR, V99, P135, DOI 10.1007/s10549-006-9190-3; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sok M, 2009, WIEN KLIN WOCHENSCHR, V121, P314, DOI 10.1007/s00508-009-1169-8; TARTTER PI, 1981, CANCER, V47, P2222, DOI 10.1002/1097-0142(19810501)47:9<2222::AID-CNCR2820470919>3.0.CO;2-5; Ulmer H, 2009, BRIT J CANCER, V101, P1202, DOI 10.1038/sj.bjc.6605264; Vinh-Hung V, 2003, INT J ONCOL, V22, P697; Yamashita H, 2009, WORLD J SURG, V33, P1298, DOI 10.1007/s00268-009-9992-7	46	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143537	10.1371/journal.pone.0143537	http://dx.doi.org/10.1371/journal.pone.0143537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600129	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900140
J	Yasuda, K; Takahashi, M; Mori, N				Yasuda, Kunihiko; Takahashi, Mayumi; Mori, Nozomu			Mdm20 Modulates Actin Remodeling through the mTORC2 Pathway via Its Effect on Rictor Expression	PLOS ONE			English	Article							N-TERMINAL ACETYLTRANSFERASES; TRANSCRIPTION FACTOR FKHR; COFILIN PHOSPHORYLATION; KINASE 1; PROTEIN; YEAST; COMPLEX; GROWTH; IDENTIFICATION; ACETYLATION	NatB is an N-terminal acetyltransferase consisting of a catalytic Nat5 subunit and an auxiliary Mdm20 subunit. In yeast, NatB acetylates N-terminal methionines of proteins during de novo protein synthesis and also regulates actin remodeling through N-terminal acetylation of tropomyosin (Trpm), which stabilizes the actin cytoskeleton by interacting with actin. However, in mammalian cells, the biological functions of the Mdm20 and Nat5 subunits are not well understood. In the present study, we show for the first time that Mdm20-knockdown (KD), but not Nat5-KD, in HEK293 and HeLa cells suppresses not only cell growth, but also cellular motility. Although stress fibers were formed in Mdm20-KD cells, and not in control or Nat5-KD cells, the localization of Trpm did not coincide with the formation of stress fibers in Mdm20-KD cells. Notably, knockdown of Mdm20 reduced the expression of Rictor, an mTORC2 complex component, through post-translational regulation. Additionally, PKC alpha(S657) phosphorylation, which regulates the organization of the actin cytoskeleton, was also reduced in Mdm20-KD cells. Our data also suggest that FoxO1 phosphorylation is regulated by the Mdm20-mTORC2-Akt pathway in response to serum starvation and insulin stimulation. Taken together, the present findings suggest that Mdm20 acts as a novel regulator of Rictor, thereby controlling mTORC2 activity, and leading to the activation of PKC alpha(S657) and FoxO1.	[Yasuda, Kunihiko; Takahashi, Mayumi; Mori, Nozomu] Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, Nagasaki 852, Japan	Nagasaki University	Yasuda, K (corresponding author), Tokai Gakuin Univ, Fac Hlth & Welf, Dept Registered Dietitians, Gifu, Japan.	kyasuda@tokaigakuin-u.ac.jp; morinosm@nagasaki-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, KY, https://kaken.nii.ac.jp/d/p/26430072.en.html. The work was also supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, NM, https://kaken.nii.ac.jp/d/p/22300121.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; HERMANN GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kim JH, 2011, GENE DEV, V25, P730, DOI 10.1101/gad.2028611; Lee JW, 2011, J BIOL CHEM, V286, P6423, DOI 10.1074/jbc.M110.180661; LIU HP, 1992, J CELL BIOL, V118, P285, DOI 10.1083/jcb.118.2.285; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ohyama K, 2012, GENE EXPR PATTERNS, V12, P36, DOI 10.1016/j.gep.2011.11.001; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Taylor R.C., 2011, COLD SPRING HARB PER, V3; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Van Damme P, 2012, P NATL ACAD SCI USA, V109, P12449, DOI 10.1073/pnas.1210303109; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yasuda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082523; Yu Jae-Ran, 1998, Korean Journal of Parasitology, V36, P227, DOI 10.3347/kjp.1998.36.4.227; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142943	10.1371/journal.pone.0142943	http://dx.doi.org/10.1371/journal.pone.0142943			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600389	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900047
J	Kumar, P; Segers-Nolten, IMJ; Schilderink, N; Subramaniam, V; Huber, M				Kumar, Pravin; Segers-Nolten, Ine M. J.; Schilderink, Nathalie; Subramaniam, Vinod; Huber, Martina			Parkinson's Protein alpha-Synuclein Binds Efficiently and with a Novel Conformation to Two Natural Membrane Mimics	PLOS ONE			English	Article							COMPREHENSIVE SOFTWARE PACKAGE; LEWY-BODY FORMATION; NEUROTRANSMITTER RELEASE; LIPID VESICLES; BROKEN HELIX; IN-VITRO; DISEASE; EPR; AFFINITY; DYNAMICS	Binding of human alpha-Synuclein, a protein associated with Parkinson's disease, to natural membranes is thought to be crucial in relation to its pathological and physiological function. Here the binding of alpha S to small unilamellar vesicles mimicking the inner mitochondrial and the neuronal plasma membrane is studied in situ by continuous wave and pulsed electron paramagnetic resonance. Local binding information of alpha S spin labeled by MTSL at positions 56 and 69 respectively shows that also helix 2 (residues 50-100) binds firmly to both membranes. By double electron-electron resonance (DEER) on the mutant spin labeled at positions 27 and 56 (alpha S 27/56) a new conformation on the membrane is found with a distance of 3.6 nm/3.7 nm between residues 27 and 56. In view of the low negative charge density of these membranes, the strong interaction is surprising, emphasizing that function and pathology of alpha S could involve synaptic vesicles and mitochondria.	[Kumar, Pravin; Huber, Martina] Leiden Univ, Dept Phys, Huygens Kammerlingh Onnes Lab, Leiden, Netherlands; [Segers-Nolten, Ine M. J.; Schilderink, Nathalie; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, Nanobiophys, NL-7500 AE Enschede, Netherlands; [Subramaniam, Vinod] FOM Inst AMOLF, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Twente; AMOLF	Huber, M (corresponding author), Leiden Univ, Dept Phys, Huygens Kammerlingh Onnes Lab, Leiden, Netherlands.	huber@physics.leidenuniv.nl	Subramaniam, Vinod/B-4197-2010	Subramaniam, Vinod/0000-0001-6712-7266; Kumar, Pravin/0000-0002-7966-578X	Netherlands Organisation for Scientific Research (NWO) [700.58.014]; Foundation for Fundamental Research on Matter (FOM) part of NWO [10SMPA04]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Foundation for Fundamental Research on Matter (FOM) part of NWO	Funding: This work was supported by the Netherlands Organisation for Scientific Research (NWO), grant 700.58.014 to M.H. (http://www.nwo.nl/), and the Foundation for Fundamental Research on Matter (FOM), which is part of NWO, grant number 10SMPA04 in the context of the program entitled "A Single Molecule View on Protein Aggregation" to M. H. and V.S. (http://www.fom.nl/live/home.pag). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Devi L, 2010, BBA-MOL BASIS DIS, V1802, P11, DOI 10.1016/j.bbadis.2009.07.007; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2002, CHEMPHYSCHEM, V3, P927, DOI 10.1002/1439-7641(20021115)3:11<927::AID-CPHC927>3.0.CO;2-Q; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Liu SM, 2004, EMBO J, V23, P4506, DOI 10.1038/sj.emboj.7600451; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Milov AD, 1997, APPL MAGN RESON, V12, P495, DOI 10.1007/BF03164129; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Parkinson J, 1817, ESSAY SHAKING PALSY; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Robotta M, 2014, CHEMBIOCHEM, V15, P2499, DOI 10.1002/cbic.201402281; Robotta M, 2012, BIOCHEMISTRY-US, V51, P3960, DOI 10.1021/bi300357a; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Shvadchak VV, 2014, BIOCHEMISTRY-US, V53, P279, DOI 10.1021/bi401427t; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanovic AND, 2014, FEBS J, V281, P2838, DOI 10.1111/febs.12824; Steigmiller S, 2005, BBA-BIOENERGETICS, V1708, P143, DOI 10.1016/j.bbabio.2005.03.013; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Veldhuis G, 2009, CHEMBIOCHEM, V10, P436, DOI 10.1002/cbic.200800644; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yong-Kee CJ, 2012, NEUROTOX RES, V21, P185, DOI 10.1007/s12640-011-9259-6; Zigoneanu IG, 2012, BBA-BIOMEMBRANES, V1818, P512, DOI 10.1016/j.bbamem.2011.11.024	48	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142795	10.1371/journal.pone.0142795	http://dx.doi.org/10.1371/journal.pone.0142795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588454	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500016
J	Marik, PE; Cavallazzi, R				Marik, Paul E.; Cavallazzi, Rodrigo			Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DEEP-VEIN THROMBOSIS; RECURRENT VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; 1ST EPISODE; RISK; THERAPY; DURATION; PREDICT; COHORT; BIAS	Background Patients who have had an unprovoked deep venous thrombosis (DVT) or pulmonary embolus (PE) are at a high risk for recurrent venous thromboembolism (VTE). Extended "lifelong" anticoagulation has been recommended in these patients. However, the risk benefit ratio of this approach is controversial and the role of the direct oral anticoagulants (DOACs) and aspirin is unclear. Furthermore, in some patients with a "weak provoking factor" there is clinical equipoise regarding continuation or cessation of anticoagulant therapy after treatment of the acute VTE event. Objective A systematic review and meta-analysis to determine the risks (major bleeding) and benefits (recurrent VTE and mortality) of extended anticoagulation with vitamin k antagonists (VKA), DOACs and aspirin in patients with an unprovoked VTE and in those patients with clinical equipoise regarding continuation or cessation of anticoagulant therapy. In addition, we sought to determine the risk of recurrent VTE events once extended anti-thrombotic therapy was discontinued. Data Sources MEDLINE, Cochrane Register of Controlled Trials, citation review of relevant primary and review articles. Study Selection Randomized placebo-controlled trials (RCTs) that compared the risk of recurrent VTE in patients with an unprovoked DVT or PE who had been treated for at least 3 months with VKA or a DOAC and were then randomized to receive an oral anti-thrombotic agent or placebo for at least 6 additional months. We included studies that included patients in whom clinical equipoise existed regarding the continuation or cessation of anticoagulant therapy. Data Extraction Independent extraction of articles by both authors using predefined data fields, including study quality indicators. Data were abstracted on study size, study setting, initial event (DVT or PE), percentage of patients where the initial VTE event was unprovoked, the number of recurrent VTE events, major bleeds and mortality during the period of extended anticoagulation in the active treatment and placebo arms. In addition, we recorded the event rate once extended treatment was stopped. Meta-analytic techniques were used to summarize the data. Studies were grouped according to the type of anti-thrombotic agent. Data Synthesis Seven studies which enrolled 6778 patients met our inclusion criteria; two studies evaluated the extended use of Coumadin, three studies evaluated a DOAC and two studies evaluated the use of aspirin. The duration of followup varied from 6 to 37 months. In the Coumadin and aspirin studies 100% of the randomized patients had an unprovoked VTE, while in the DOAC studies between 73.5% and 93.2% of the VTE events were unprovoked. In the control group recurrent VTE occurred in 9.7% of patients compared to 2.8% in the active treatment group (OR 0.21; 95% CI 0.11-0.42, p<0.0001). VKA, DOACs and aspirin significantly reduced the risk of recurrent VTE, with VKA and DOACs being significantly more effective than aspirin. Major bleeding events occurred in 12 patients in the control group (0.4%) and 25 of 3815 (0.6%) patients in the active treatment group (OR 1.64; 95% CI 0.69-3.90, NS). There were 39 (1.3%) deaths in control patients and 33 (0.9%) deaths in the anti-thrombotic group during the treatment period (OR 0.73; 95% CI 0.40-1.33, NS). Patients whose initial VTE event was a PE were more likely to have a recurrent PE than a DVT. The annualized event rate after discontinuation of extended antithrombotic therapy was 4.4% in the control group and 6.5% in the active treatment arm. Conclusions VKA, DOACs and aspirin significantly reduced the risk of recurrent VTE, with DOACs and VKA being more effective than aspirin. The decision regarding life-long anticoagulation following an unprovoked DVT or PE should depend on the patients' risk for recurrent PE as well as the patients' values and preferences.	[Marik, Paul E.] Eastern Virginia Med Sch, Div Pulm & Crit Care Med, Norfolk, VA 23501 USA; [Cavallazzi, Rodrigo] Univ Louisville, Div Pulm Crit Care & Sleep Med, Louisville, KY 40292 USA	Eastern Virginia Medical School; University of Louisville	Marik, PE (corresponding author), Eastern Virginia Med Sch, Div Pulm & Crit Care Med, Norfolk, VA 23501 USA.	marikpe@evms.edu	Marik, Paul E/U-9733-2019					Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Baglin T, 2010, J THROMB HAEMOST, V8, P2436, DOI 10.1111/j.1538-7836.2010.04022.x; Baglin T, 2010, BRIT J HAEMATOL, V149, P209, DOI 10.1111/j.1365-2141.2009.08022.x; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; BERLIN JA, 1989, STAT MED, V8, P141, DOI 10.1002/sim.4780080202; Biljana M, 1999, STUD HEALTH TECHNOL, V68, P323; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Brignardello-Petersen R, 2014, POL ARCH MED WEWN, V124, P659, DOI 10.20452/pamw.2546; Carrier M, 2011, J THROMB HAEMOST, V9, P1119, DOI 10.1111/j.1538-7836.2011.04254.x; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Couturaud F, 2015, JAMA-J AM MED ASSOC, V314, P31, DOI 10.1001/jama.2015.7046; Douketis J, 2011, BMJ-BRIT MED J, V342, pd813, DOI DOI 10.1136/BMJ.D813; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M., 2001, SYSTEMATIC REV HLTH; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2014, BLOOD, V123, P1794, DOI 10.1182/blood-2013-12-512681; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Middeldorp S, 2015, JAMA-J AM MED ASSOC, V314, P72, DOI 10.1001/jama.2015.2693; Middeldorp S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001367.pub3; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Prandoni P, 2009, ANN INTERN MED, V150, P577, DOI 10.7326/0003-4819-150-9-200905050-00003; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Tosetto A, 2012, J THROMB HAEMOST, V10, P1019, DOI 10.1111/j.1538-7836.2012.04735.x	37	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143252	10.1371/journal.pone.0143252	http://dx.doi.org/10.1371/journal.pone.0143252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587983	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500045
J	Mellerup, E; Andreassen, OA; Bennike, B; Dam, H; Djurovic, S; Hansen, T; Jorgensen, MB; Kessing, LV; Koefoed, P; Melle, I; Mors, O; Werge, T; Moeller, GL				Mellerup, Erling; Andreassen, Ole A.; Bennike, Bente; Dam, Henrik; Djurovic, Srdjan; Hansen, Thomas; Jorgensen, Martin Balslev; Kessing, Lars Vedel; Koefoed, Pernille; Melle, Ingrid; Mors, Ole; Werge, Thomas; Moeller, Gert Lykke			Combinations of Genetic Data Present in Bipolar Patients, but Absent in Control Persons	PLOS ONE			English	Article							SNP INTERACTIONS; BREAST-CANCER; ASSOCIATION; POLYMORPHISMS; EXPRESSION; DISEASE; SEARCH; NRF2	The main objective of the study was to find combinations of genetic variants significantly associated with bipolar disorder. In a previous study of bipolar disorder, combinations of three single nucleotide polymorphism (SNP) genotypes taken from 803 SNPs were analyzed, and four clusters of combinations were found to be significantly associated with bipolar disorder. In the present study, combinations of four SNP genotypes taken from the same 803 SNPs were analyzed, and one cluster of combinations was found to be significantly associated with bipolar disorder. Combinations from the new cluster and from the four previous clusters were identified in the genomes of 209 of the 607 patients in the study whereas none of the 1355 control participants had any of these combinations in their genome.	[Mellerup, Erling; Bennike, Bente; Koefoed, Pernille] Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Neuropsychiat, Blegdamsvej 9 O-6102, DK-2100 Copenhagen, Denmark; [Dam, Henrik; Jorgensen, Martin Balslev; Kessing, Lars Vedel; Koefoed, Pernille] Rigshosp, Copenhagen Univ Hosp, Dept O, Psychiat Ctr Copenhagen, DK-2100 Copenhagen, Denmark; [Andreassen, Ole A.; Melle, Ingrid] Oslo Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Andreassen, Ole A.; Djurovic, Srdjan; Melle, Ingrid] Univ Oslo, Inst Psychiat, N-0407 Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, N-0407 Oslo, Norway; [Hansen, Thomas; Werge, Thomas] Copenhagen Univ Hosp, Dept Biol Psychiat, Mental Hlth Ctr Sct Hans, iPSYCH, DK-4000 Roskilde, Denmark; [Mors, Ole] Aarhus Univ Hosp, Ctr Psyciatr Res, iPSYCH, DK-8240 Risskov, Denmark; [Moeller, Gert Lykke] Tech Univ Denmark, Genokey ApS, ScionDTU, DK-2970 Horsholm, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oslo; University of Oslo; University of Oslo; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Technical University of Denmark	Mellerup, E (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Neuropsychiat, Blegdamsvej 9 O-6102, DK-2100 Copenhagen, Denmark.	mellerup@sund.ku.dk	Jorgensen, Martin Balslev MBJ/K-5758-2012; Hansen, Thomas/GWZ-2858-2022; Andreassen, Ole A./AAY-7531-2020; Hansen, Thomas Folkmann/O-5965-2014; Melle, Ingrid S/B-4858-2011	Jorgensen, Martin Balslev MBJ/0000-0002-1321-8901; Hansen, Thomas Folkmann/0000-0001-6703-7762; Melle, Ingrid S/0000-0002-9783-548X; Mors, Ole/0000-0002-5660-0393; Kessing, Lars/0000-0001-9377-9436; Djurovic, Srdjan/0000-0002-8140-8061	Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		Brunner G, 2013, J CANCER RES CLIN, V139, P249, DOI 10.1007/s00432-012-1322-z; Capasso M, 2014, CANCER GENET-NY, V207, P94, DOI 10.1016/j.cancergen.2014.02.004; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Goudey B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S10; Hartikainen JM, 2012, CANCER RES, V72, P5537, DOI 10.1158/0008-5472.CAN-12-1474; Hu XH, 2010, CELL RES, V20, P854, DOI 10.1038/cr.2010.68; Jiang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046771; Kam-Thong T, 2011, EUR J HUM GENET, V19, P465, DOI 10.1038/ejhg.2010.196; Koefoed P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023812; Mellerup E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044623; Milne RL, 2014, HUM MOL GENET, V23, P1934, DOI 10.1093/hmg/ddt581; Pers TH, 2011, GENET EPIDEMIOL, V35, P318, DOI 10.1002/gepi.20580; Prabhu S, 2012, GENOME RES, V22, P2230, DOI 10.1101/gr.137885.112; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; Wu QQ, 2011, AM J PHYSIOL-RENAL, V300, pF1180, DOI 10.1152/ajprenal.00353.2010; Xie Q, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S4; Yee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069321	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143432	10.1371/journal.pone.0143432	http://dx.doi.org/10.1371/journal.pone.0143432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587987	Green Published, gold, Green Submitted			2022-12-27	WOS:000365251500061
J	Pei, LJ; Zhou, YD; Tan, G; Mao, F; Yang, DS; Guan, JH; Lin, Y; Wang, XJ; Zhang, YN; Zhang, XH; Shen, SJ; Xu, ZH; Sun, Q; Huang, YG				Pei, Lijian; Zhou, Yidong; Tan, Gang; Mao, Feng; Yang, Dongsheng; Guan, Jinghong; Lin, Yan; Wang, Xuejing; Zhang, Yanna; Zhang, Xiaohui; Shen, Songjie; Xu, Zhonghuang; Sun, Qiang; Huang, Yuguang		Outcomes Res Consortium	Ultrasound-Assisted Thoracic Paravertebral Block Reduces Intraoperative Opioid Requirement and Improves Analgesia after Breast Cancer Surgery: A Randomized, Controlled, Single-Center Trial	PLOS ONE			English	Article							KILLER-CELL ACTIVITY; POSTOPERATIVE-NAUSEA; HUMAN CADAVERS; RECURRENCE; PAIN; MANAGEMENT; HALOTHANE; PLACEMENT; CATHETERS; PROPOFOL	Objectives The contribution of ultrasound-assisted thoracic paravertebral block to postoperative analgesia remains unclear. We compared the effect of a combination of ultrasound assisted-thoracic paravertebral block and propofol general anesthesia with opioid and sevoflurane general anesthesia on volatile anesthetic, propofol and opioid consumption, and postoperative pain in patients having breast cancer surgery. Methods Patients undergoing breast cancer surgery were randomly assigned to ultrasound-assisted paravertebral block with propofol general anesthesia (PPA group, n = 121) or fentanyl with sevoflurane general anesthesia (GA group, n = 126). Volatile anesthetic, propofol and opioid consumption, and postoperative pain intensity were compared between the groups using noninferiority and superiority tests. Results Patients in the PPA group required less sevoflurane than those in the GA group (median [interquartile range] of 0 [0, 0] vs. 0.4 [0.3, 0.6] minimum alveolar concentration [MAC]hours), less intraoperative fentanyl requirements (100 [50, 100] vs. 250 [200, 300]mu g,), less intense postoperative pain (median visual analog scale score 2 [1, 3.5] vs. 3 [2, 4.5]), but more propofol (median 529 [424, 672] vs. 100 [100, 130] mg). Noninferiority was detected for all four outcomes; one-tailed superiority tests for each outcome were highly significant at P<0.001 in the expected directions. Conclusions The combination of propofol anesthesia with ultrasound-assisted paravertebral block reduces intraoperative volatile anesthetic and opioid requirements, and results in less post operative pain in patients undergoing breast cancer surgery.	[Pei, Lijian; Tan, Gang; Xu, Zhonghuang; Huang, Yuguang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Anesthesiol, Beijing 100730, Peoples R China; [Zhou, Yidong; Mao, Feng; Guan, Jinghong; Lin, Yan; Wang, Xuejing; Zhang, Yanna; Zhang, Xiaohui; Shen, Songjie; Sun, Qiang] Chinese Acad Med Sci, Dept Breast Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Yang, Dongsheng] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Yang, Dongsheng] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Huang, YG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Anesthesiol, Beijing 100730, Peoples R China.	hyug1999@163.com	Mao, Feng/B-8280-2019	lijian, Pei/0000-0001-7174-9105				BEILIN B, 1989, Brain Behavior and Immunity, V3, P129, DOI 10.1016/0889-1591(89)90013-5; Belzarena Sérgio D., 2008, Rev. Bras. Anestesiol., V58, P561, DOI 10.1590/S0034-70942008000600001; Cowie B, 2010, ANESTH ANALG, V110, P1735, DOI 10.1213/ANE.0b013e3181dd58b0; ERSKINE R, 1992, CAN J ANAESTH, V39, P905, DOI 10.1007/BF03008337; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Fodale V, 2014, SCI WORLD J, DOI 10.1155/2014/328513; Kairaluoma PM, 2004, ANESTH ANALG, V99, P1837, DOI 10.1213/01.ANE.0000136775.15566.87; Kranke P, 2014, EUR J ANAESTH, V31, P651, DOI 10.1097/EJA.0000000000000080; LEWIS J W, 1983, Natural Immunity and Cell Growth Regulation, V3, P43; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Loop T, 2004, ANESTHESIOLOGY, V101, P710, DOI 10.1097/00000542-200409000-00020; Luyet C, 2011, BRIT J ANAESTH, V106, P246, DOI 10.1093/bja/aeq309; Luyet C, 2009, BRIT J ANAESTH, V102, P534, DOI 10.1093/bja/aep015; Mammoto T, 2002, CANCER LETT, V184, P165, DOI 10.1016/S0304-3835(02)00210-0; MARKOVIC SN, 1993, ANESTHESIOLOGY, V78, P700, DOI 10.1097/00000542-199304000-00013; Mascha EJ, 2012, ANESTH ANALG, V114, P1304, DOI 10.1213/ANE.0b013e3182504435; Melamed R, 2003, ANESTH ANALG, V97, P1331, DOI 10.1213/01.ANE.0000082995.44040.07; Moller JF, 2007, ANESTH ANALG, V105, P1848, DOI 10.1213/01.ane.0000286135.21333.fd; Oguz S, 2007, J ANESTH, V21, P449, DOI 10.1007/s00540-007-0531-0; Okutani Hiroai, 2012, Osaka City Med J, V58, P83; Page GG, 2001, PAIN, V90, P191, DOI 10.1016/S0304-3959(00)00403-6; Pei LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114667; Raft J, 2013, BRIT J ANAESTH, V111, P1031, DOI 10.1093/bja/aet398; Riain SCO, 2010, ANESTH ANALG, V110, P248, DOI 10.1213/ANE.0b013e3181c35906; Rittner HL, 2008, BRIT J ANAESTH, V101, P40, DOI 10.1093/bja/aen078; Rittner HL, 2002, ANAESTHESIST, V51, P351, DOI 10.1007/s00101-002-0306-9; Rohmel J, 2006, BIOMETRICAL J, V48, P916, DOI 10.1002/bimj.200510289; Schnabel A, 2010, BRIT J ANAESTH, V105, P842, DOI 10.1093/bja/aeq265; Sessler DI, 2008, CONTEMP CLIN TRIALS, V29, P517, DOI 10.1016/j.cct.2008.01.002; Sessler DI, 2008, EUR J CANCER PREV, V17, P269, DOI 10.1097/CEJ.0b013e3282f0c005; Skolnik A, 2014, CURR OPIN ANESTHESIO, V27, P605, DOI 10.1097/ACO.0000000000000128; Stamatiou G, 2004, ANAESTHESIA, V59, P723, DOI 10.1111/j.1365-2044.2004.03848.x; Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85; Vila H, 2007, CURR OPIN ANESTHESIO, V20, P316, DOI 10.1097/ACO.0b013e328166780e; Wu J, 2015, CAN J ANESTH, V62, P241, DOI 10.1007/s12630-014-0285-8; Zhou D, 2012, WORLD J GASTROENTERO, V18, P3089, DOI 10.3748/wjg.v18.i24.3089	36	21	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142249	10.1371/journal.pone.0142249	http://dx.doi.org/10.1371/journal.pone.0142249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588217	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500007
J	Wang, ZS; Guo, WD; Wu, LQ; Yi, X; Geng, C; Li, YJ; Yao, RY				Wang, Zu-Sen; Guo, Wei-Dong; Wu, Li-Qun; Yi, Xin; Geng, Chao; Li, Yu-Jun; Yao, Ru-Yong			Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration	PLOS ONE			English	Article							POOR-PROGNOSIS; BREAST-CANCER; EXPRESSION; MARKERS; SURVIVAL; CELLS; PROGRESSION; METASTASIS	Cytokeratin 19 (CK-19) is a prognostic indicator of recurrence and metastasis of hepatocellular carcinoma (HCC) following radical resection. To investigate the role of CK-19 in assessment of early recurrence and prognosis in patients with hepatitis B virus (HBV)-related HCC following radical resection. In total, 235 patients with HBV-related HCC (age, 15-82 years; mean age, 54 +/- 10 years) undergoing radical resection were screened for inclusion from January 2005 to December 2010. Malignant tissues and adjacent non-malignant tissues were sampled during surgery, and CK-19 and Ki-67 expression was determined by tissue microarray and immunohistochemistry. CK-19 mRNA levels in 30 randomly selected frozen HCC specimens were examined by reverse transcription polymerase chain reaction from January 2011 to June 2011. Correlations of CK-19 and Ki-67 expression with tumor recurrence, metastasis, disease-free survival (DFS), and overall survival (OS) were analyzed. Elevated CK-19 expression was correlated with early recurrence (P=0.001), shorter DFS (P=0.001), and reduced OS (P = 0.010). CK-19 expression was correlated with the Ki-67 index (P = 0.037), histological differentiation (P = 0.016), focal number (P = 0.044), and blood vessel tumor embolism (P = 0.002). Patients with metastasis within 1 year exhibited stronger CK-19 expression than did patients withoutmetastasis (P < 0.05). Furthermore, early recurrence was associated with elevated CK-19 mRNA levels (chi(2) = 5.761, P = 0.016). When confirmed by a low alpha-fetoprotein concentration (< 400 mu g/L), CK-19 expression in surgical biopsy specimens taken from patients with HCC during radical resection is an additional valuable indicator of early recurrence, distant metastasis, and poor prognosis in HBV-positive patients.	[Wang, Zu-Sen; Guo, Wei-Dong; Wu, Li-Qun; Yi, Xin; Geng, Chao] Qingdao Univ, Dept Hepatobiliary Surg, Coll Med, Affiliated Hosp, Qingdao 266003, Shandong, Peoples R China; [Li, Yu-Jun] Qingdao Univ, Dept Pathol, Coll Med, Affiliated Hosp, Qingdao 266003, Shandong, Peoples R China; [Yao, Ru-Yong] Qingdao Univ, Dept Cent Lab, Coll Med, Affiliated Hosp, Qingdao 266003, Shandong, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Wu, LQ (corresponding author), Qingdao Univ, Dept Hepatobiliary Surg, Coll Med, Affiliated Hosp, Qingdao 266003, Shandong, Peoples R China.	wulq5810@126.com						Alix-Panabieres C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2326; Ananthakrishnan Ashwin, 2006, Semin Intervent Radiol, V23, P47, DOI 10.1055/s-2006-939841; Ding SJ, 2004, MOL CELL PROTEOMICS, V3, P73, DOI 10.1074/mcp.M300094-MCP200; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Hsu YC, 2006, J CLIN ONCOL, V24, P3780, DOI 10.1200/JCO.2005.03.7499; Kao WY, 2012, CLIN RADIOL, V67, P429, DOI 10.1016/j.crad.2011.10.009; King KL, 1998, J GASTROEN HEPATOL, V13, P273, DOI 10.1111/j.1440-1746.1998.01555.x; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Lang HK, 2007, J AM COLL SURGEONS, V205, P27, DOI 10.1016/j.jamcollsurg.2007.03.002; MAEDA T, 1995, HUM PATHOL, V26, P956, DOI 10.1016/0046-8177(95)90084-5; Oh BK, 2008, LAB INVEST, V88, P144, DOI 10.1038/labinvest.3700710; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Shim JH, 2013, ANN SURG, V257, P708, DOI 10.1097/SLA.0b013e318273be70; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Uenishi T, 2003, CANCER SCI, V94, P851, DOI 10.1111/j.1349-7006.2003.tb01366.x; Wang YB, 2011, EUR REV MED PHARMACO, V15, P592; Wu F, 2002, INT J ONCOL, V20, P31; Wu PC, 1999, J HEPATOL, V31, P965; Xiang ZL, 2011, MOL BIOL REP, V38, P3531, DOI 10.1007/s11033-010-0463-x; Yang XR, 2008, CLIN CANCER RES, V14, P3850, DOI 10.1158/1078-0432.CCR-07-4338; Zhang Guo-Qing, 2008, Ai Zheng, V27, P1297	22	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142727	10.1371/journal.pone.0142727	http://dx.doi.org/10.1371/journal.pone.0142727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588210	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500015
J	Zhang, H; Hu, HM; Wu, C; Yu, H; Dong, HJ				Zhang, Hao; Hu, Huimei; Wu, Christina; Yu, Hai; Dong, Hengjin			Impact of China's Public Hospital Reform on Healthcare Expenditures and Utilization: A Case Study in ZJ Province	PLOS ONE			English	Article							SUPPLIER-INDUCED DEMAND; CLINICAL-PRACTICE; ANTIBIOTIC ABUSE; SYSTEM; POLICY; GUIDELINES; PHYSICIANS; MARKET; AUDIT	Background High drug costs due to supplier-induced demand (SID) obstruct healthcare accessibility in China. Drug prescriptions can generate markup-related profits, and the low prices of other medical services can lead to labor-force underestimations; therefore, physicians are keen to prescribe drugs rather than services. Thus, in China, a public hospital reform has been instituted to cancel markups and increase service prices. Methods A retrospective pre/post-reform study was conducted in ZJ province to assess the impact of the reform on healthcare expenditures and utilization, ultimately to inform policy development and decision-making. The main indicators are healthcare expenditures and utilization. Results Post-reform, drug expenditures per visit decreased by 8.2% and 15.36% in outpatient and inpatient care, respectively; service expenditures per visit increased by 23.03% and 27.69% in outpatient and inpatient care, respectively. Drug utilization per visit increased by 5.58% in outpatient care and underwent no significant change in inpatient care. Both were lower than the theoretical drug-utilization level, which may move along the demand curve because of patient-initiated demand (PID); this indicates that SID-promoted drug utilization may decrease. Finally, service utilization per visit increased by 6% in outpatient care and by 13.10% in inpatient care; both were higher than the theoretical level moving along the demand curve, and this indicates that SID-promoted service utilization may increase. Conclusion The reform reduces drug-prescription profits by eliminating drug markups; additionally, it compensates for service costs by increasing service prices. Post-reform, the SID of drug prescriptions decreased, which may reduce drug-resource waste. The SID of services increased, with potentially positive and negative effects: accessibility to services may be promoted when physicians provide more services, but the risk of resource waste may also increase. This warrants further research. It is recommended that comprehensive measures that control SID and promote physician enthusiasm be carried out concurrently.	[Zhang, Hao; Wu, Christina; Dong, Hengjin] Zhejiang Univ, Sch Med, Ctr Hlth Policy Studies, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Huimei] Hangzhou Med Coll, Sch Publ Hlth, Dept Hlth Informat Management, Hangzhou, Zhejiang, Peoples R China; [Yu, Hai] Zhejiang Univ, Sch Med, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Medical College; Zhejiang University	Dong, HJ (corresponding author), Zhejiang Univ, Sch Med, Ctr Hlth Policy Studies, Hangzhou 310003, Zhejiang, Peoples R China.	donghj@zju.edu.cn			National Science Foundation in ZJ Province, China [LY13G030003]; Medicine and Health Science Foundation of Family Planning Commission in ZJ Province, China [2014KYA055]	National Science Foundation in ZJ Province, China; Medicine and Health Science Foundation of Family Planning Commission in ZJ Province, China	Funding: The manuscript is funded by National Science Foundation in ZJ Province, China. The grant numbers: LY13G030003. The website: http://www.zjnsf.gov.cn. The authors who received the funding: HD. The manuscript is also funded by Medicine and Health Science Foundation of Family Planning Commission in ZJ Province, China. The grant numbers: 2014KYA055. The website: http://www.zjuwst.cov.cn. The authors who received the funding: HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard M, 2002, INCENTIVE CONTRACTS; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Burgers JS, 2003, INT J QUAL HEALTH C, V15, P31, DOI 10.1093/intqhc/15.1.31; Chen YW, 2013, CHINESE PHARM AFFAIR, V3, P255; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Chinas State Food and Drug Administration, 2014, ANN REP NAT ADV DRUG; Chow GC., 2006, EC ANAL HLTH CARE CH; Currie J, 2014, J DEV ECON, V110, P39, DOI 10.1016/j.jdeveco.2014.05.006; Currie J, 2011, J HEALTH ECON, V30, P933, DOI 10.1016/j.jhealeco.2011.05.009; Delattre E, 2003, HEALTH ECON, V12, P741, DOI 10.1002/hec.823; Ding XY, 2014, CHINA HLTH HUMAN RES, V5, P74; Dong HJ, 1999, SOC SCI MED, V48, P777, DOI 10.1016/S0277-9536(98)00414-6; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Fan YL, 2011, CHINA J PHARM EC, V5, P18; Folland S, 2007, EC HLTH HLTH CARE; Fujisawa R, 2008, REMUNERATION GEN PRA; Grytten J, 2001, J HEALTH ECON, V20, P379, DOI 10.1016/S0167-6296(00)00087-4; Health Zhejiang on line, 2015, GOV SUBS RES BAS HLT; Horwitz JR, 2005, HEALTH AFFAIR, V24, P790, DOI 10.1377/hlthaff.24.3.790; Hu H., 2008, POPULATION DEV, V3, P12; Hu HM, 2013, CHINESE J HOSP ADM, V29, P329; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Hu SP, 2003, J INFECTION, V46, P161, DOI 10.1053/jinf.2002.1078; Hua XY, 2014, MED PHILOS, V35, P36; Huang CR, 2004, CHINESE HLTH EC, V23, P57; Jiang MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070836; Kingma M, 1992, HUMAN RESOURCES DEV, V2, P1; Lakdawalla D, 2009, J PUBLIC ECON, V93, P541, DOI 10.1016/j.jpubeco.2008.11.003; Li L, 2008, CHINESE HLTH EC, V27, P5; Li XW, 2014, CHINESE HLTH SERVICE, V5, P335; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Liao RM, 2013, WORLD CLIN DRUGS, V34, P347; Liu XZ, 2000, HEALTH POLICY PLANN, V15, P157, DOI 10.1093/heapol/15.2.157; Mao Z., 2006, CHIN HLTH EC, V25, P65; Medscape, 2014, PHYS COMP REP 2013; Meng Q, 2015, HLTH POLICY PLANNING, V20, P185; Ministry of Health, 2013, CHIN HLTH STAT DIG 2; Ministry of Health, 2013, CHIN HLTH STAT YB 20; National Statistical Bureau, 2013, CHIN STAT YB 2012; Newhouse J, 2012, HDB HLTH EC; OECD Library, 2010, HLTH GLANC EUR 2010; Ramesh M, 2009, SOC SCI MED, V68, P2256, DOI 10.1016/j.socscimed.2009.03.038; Ran LM, 2013, J HUAZHONG U SCI-MED, V33, P309, DOI 10.1007/s11596-013-1116-9; Rizzo JA, 1996, MED CARE RES REV, V53, P243, DOI 10.1177/107755879605300301; Shigeoka H, 2014, J HEALTH ECON, V35, P162, DOI 10.1016/j.jhealeco.2014.03.003; Song Yan, 2014, J Pharm Policy Pract, V7, P12, DOI 10.1186/2052-3211-7-12; The Government of Zhejiang Province, 2014, ZHEJ PROV HLTH STAT; The Government of Zhejiang Province, 2014, GEN SIT ZHEJ PROV; The Government of Zhejiang Province, 2009, GUID TRIAL REF PUBL; The Ministry of health and other five Ministries, 2010, GUID PIL REF PUBL HO; The peoples Government of Zhejiang Province, 2013, STAT B; The peoples Government of Zhejiang Province, 2014, STAT B; Wang HJ, 2012, CHINA J MODERN MED, V12, P99; WHO, 2008, THE WORLD HEALTH REP; WHO, 2003, ESS MED HLTH PROD IN; WOLINSKY A, 1993, RAND J ECON, V24, P380, DOI 10.2307/2555964; World Health Organization, 2000, THE WORLD HEALTH REP; Yang JQ, 2010, HEALTH CARE ANAL, V18, P294, DOI 10.1007/s10728-009-0127-y; Ye CY, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-519; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhang J, 2009, CHINESE J HOSP ADM, V25, P521; Zhang J, 2009, CHINESE J HOSP ADM, V25, P521; Zhang WS, 2008, EUR J CLIN PHARMACOL, V64, P821, DOI 10.1007/s00228-008-0489-3; Zhang XC, 2011, HEALTH POLICY, V100, P181, DOI 10.1016/j.healthpol.2010.10.003; Zhang YH, 2005, INT MED HLTH GUIDANC, V13, P18; Zhao T, 2014, ECON REV, V1, P12; Zheng ZY, 2003, CHINESE HLTH RESOURC, V6, P225	69	29	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143130	10.1371/journal.pone.0143130	http://dx.doi.org/10.1371/journal.pone.0143130			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW8LQ	26588244	Green Submitted, gold, Green Published			2022-12-27	WOS:000365251500031
J	Brasier, AR; Zhao, YX; Spratt, HM; Wiktorowicz, JE; Ju, HU; Wheat, LJ; Baden, L; Stafford, S; Wu, Z; Issa, N; Caliendo, AM; Denning, DW; Soman, K; Clancy, CJ; Nguyen, MH; Sugrue, MW; Alexander, BD; Wingard, JR				Brasier, Allan R.; Zhao, Yingxin; Spratt, Heidi M.; Wiktorowicz, John E.; Ju, Hyunsu; Wheat, L.; Baden, Lindsey; Stafford, Susan; Wu, Zheng; Issa, Nicolas; Caliendo, Angela M.; Denning, David W.; Soman, Kizhake; Clancy, Cornelius J.; Nguyen, M. Hong; Sugrue, Michele W.; Alexander, Barbara D.; Wingard, John R.			Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens	PLOS ONE			English	Article							FUMIGATUS CONIDIA; BIOMARKER PANEL; DIAGNOSIS; INFECTIONS; DISEASE; BINDING; GALACTOMANNAN; INFLAMMATION; SPECTRUM	Invasive pulmonary aspergillosis (IPA) is an opportunistic fungal infection in patients undergoing chemotherapy for hematological malignancy, hematopoietic stem cell transplant, or other forms of immunosuppression. In this group, Aspergillus infections account for the majority of deaths due to mold pathogens. Although early detection is associated with improved outcomes, current diagnostic regimens lack sensitivity and specificity. Patients undergoing chemotherapy, stem cell transplantation and lung transplantation were enrolled in a multi-site prospective observational trial. Proven and probable IPA cases and matched controls were subjected to discovery proteomics analyses using a biofluid analysis platform, fractionating plasma into reproducible protein and peptide pools. From 556 spots identified by 2D gel electrophoresis, 66 differentially expressed post-translationally modified plasma proteins were identified in the leukemic subgroup only. This protein group was rich in complement components, acute-phase reactants and coagulation factors. Low molecular weight peptides corresponding to abundant plasma proteins were identified. A candidate marker panel of host response (9 plasma proteins, 4 peptides), fungal polysaccharides (galactomannan), and cell wall components (beta-D glucan) were selected by statistical filtering for patients with leukemia as a primary underlying diagnosis. Quantitative measurements were developed to qualify the differential expression of the candidate host response proteins using selective reaction monitoring mass spectrometry assays, and then applied to a separate cohort of 57 patients with leukemia. In this verification cohort, a machine learning ensemble-based algorithm, generalized pathseeker (GPS) produced a greater case classification accuracy than galactomannan (GM) or host proteins alone. In conclusion, Integration of host response proteins with GM improves the diagnostic detection of probable IPA in patients undergoing treatment for hematologic malignancy. Upon further validation, early detection of probable IPA in leukemia treatment will provide opportunities for earlier interventions and interventional clinical trials.	[Brasier, Allan R.; Zhao, Yingxin] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Brasier, Allan R.; Zhao, Yingxin; Spratt, Heidi M.; Wiktorowicz, John E.; Ju, Hyunsu] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Brasier, Allan R.; Zhao, Yingxin; Spratt, Heidi M.; Wiktorowicz, John E.; Soman, Kizhake] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Spratt, Heidi M.; Ju, Hyunsu] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Wiktorowicz, John E.; Soman, Kizhake] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Wheat, L.] MiraVista Labs, Indianapolis, IN USA; [Baden, Lindsey; Issa, Nicolas] Harvard Univ, Boston, MA 02115 USA; [Stafford, Susan; Wu, Zheng] Univ Texas Med Branch, Biomol Resource Facil, Galveston, TX 77555 USA; [Caliendo, Angela M.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Denning, David W.] Univ Manchester, Manchester, Lancs, England; [Clancy, Cornelius J.] Univ Pittsburgh, Pittsburgh, PA USA; [Nguyen, M. Hong; Sugrue, Michele W.; Wingard, John R.] Univ Florida, Gainesville, FL USA; [Alexander, Barbara D.] Duke Univ, Med Ctr, Durham, NC USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Harvard University; University of Texas System; University of Texas Medical Branch Galveston; Brown University; University of Manchester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida; Duke University	Brasier, AR (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	arbrasie@utmb.edu	Denning, David/AAC-6931-2019	Denning, David/0000-0001-5626-2251; Brasier, Allan/0000-0002-5012-4090; Alexander, Barbara/0000-0001-5868-0529; Wingard, John/0000-0001-7478-5398	NIAID Clinical Proteomics Center [HHSN272200800048C, UL1TR000071 UTMB CTSA]; NIEHS [P30 ES006676]; Aspergillus Technology Consortium NIAID [HHSN266200700023C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	NIAID Clinical Proteomics Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Aspergillus Technology Consortium NIAID; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the following grants: the NIAID Clinical Proteomics Center, HHSN272200800048C (ARB), UL1TR000071 UTMB CTSA (ARB), NIEHS P30 ES006676 (ARB), and the Aspergillus Technology Consortium NIAID Contract # HHSN266200700023C (JW). The funding agencies had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Balloy V, 2005, INFECT IMMUN, V73, P494, DOI 10.1128/IAI.73.1.494-503.2005; Barnes PD, 2006, INFECT DIS CLIN N AM, V20, P545, DOI 10.1016/j.idc.2006.06.001; BOUCHARA JP, 1995, TRENDS MICROBIOL, V3, P327, DOI 10.1016/S0966-842X(00)88965-9; Brasier AR, 2012, CTS-CLIN TRANSL SCI, V5, P8, DOI 10.1111/j.1752-8062.2011.00377.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Clancy CJ, 2007, J CLIN MICROBIOL, V45, P1759, DOI 10.1128/JCM.00077-07; COULOT P, 1994, INFECT IMMUN, V62, P2169, DOI 10.1128/IAI.62.6.2169-2177.1994; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Erjavec Z, 2009, CLIN MICROBIOL INFEC, V15, P625, DOI 10.1111/j.1469-0691.2009.02929.x; Greene RE, 2007, CLIN INFECT DIS, V44, P373, DOI 10.1086/509917; Gundry RL, 2007, PROTEOM CLIN APPL, V1, P73, DOI 10.1002/prca.200600276; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Jamaluddin M, 2010, J VIROL, V84, P9533, DOI 10.1128/JVI.01005-10; Ju Hyunsu, 2013, BMC Res Notes, V6, P365, DOI 10.1186/1756-0500-6-365; Kami M, 2005, BONE MARROW TRANSPL, V36, P85, DOI 10.1038/sj.bmt.1704997; KOZEL TR, 1989, INFECT IMMUN, V57, P3412, DOI 10.1128/IAI.57.11.3412-3417.1989; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Marty FM, 2009, MED MYCOL, V47, pS233, DOI 10.1080/13693780802308454; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; Pickering JW, 2005, J CLIN MICROBIOL, V43, P5957, DOI 10.1128/JCM.43.12.5957-5962.2005; Pretzer E, 2008, ANAL BIOCHEM, V374, P250, DOI 10.1016/j.ab.2007.12.014; Rodland EK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-144; Speth Cornelia, 2012, Interdiscip Perspect Infect Dis, V2012, P463794, DOI 10.1155/2012/463794; Spratt H., 2013, METHODS IN PRESS; STURTEVANT JE, 1992, INFECT IMMUN, V60, P1913, DOI 10.1128/IAI.60.5.1913-1918.1992; Tyagarajan K, 2003, ELECTROPHORESIS, V24, P2348, DOI 10.1002/elps.200305478; Vogl G, 2008, MOL IMMUNOL, V45, P1485, DOI 10.1016/j.molimm.2007.08.011; VONEIFF M, 1995, RESPIRATION, V62, P341, DOI 10.1159/000196477; Wheat L. J., 2005, Clinical Microbiology Newsletter, V27, P51, DOI 10.1016/j.clinmicnews.2005.04.001	37	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143165	10.1371/journal.pone.0143165	http://dx.doi.org/10.1371/journal.pone.0143165			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581097	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600094
J	Cervantes-Yoshida, K; Leidy, RA; Carlson, SM				Cervantes-Yoshida, Kristina; Leidy, Robert A.; Carlson, Stephanie M.			Contemporary Land Change Alters Fish Communities in a San Francisco Bay Watershed, California, USA	PLOS ONE			English	Article							MACROINVERTEBRATE ASSEMBLAGES; STREAM BIODIVERSITY; URBANIZATION; LANDSCAPE; HABITAT; CATCHMENT; COVER; SCALE; CLASSIFICATION; PERSISTENCE	Urbanization is one of the leading threats to freshwater biodiversity, and urban regions continue to expand globally. Here we examined the relationship between recent urbanization and shifts in stream fish communities. We sampled fishes at 32 sites in the Alameda Creek Watershed, near San Francisco, California, in 1993-1994 and again in 2009, and we quantified univariate and multivariate changes in fish communities between the sampling periods. Sampling sites were classified into those downstream of a rapidly urbanizing area ("urbanized sites"), and those found in less impacted areas ("low-impacted sites"). We calculated the change from non-urban to urban land cover between 1993 and 2009 at two scales for each site (the total watershed and a 3km buffer zone immediately upstream of each site). Neither the mean relative abundance of native fish nor nonnative species richness changed significantly between the survey periods. However, we observed significant changes in fish community composition (as measured by Bray-Curtis dissimilarity) and a decrease in native species richness between the sampling periods at urbanized sites, but not at low-impacted sites. Moreover, the relative abundance of one native cyprinid (Lavinia symmetricus) decreased at the urbanized sites but not at low-impacted sites. Increased urbanization was associated with changes in the fish community, and this relationship was strongest at the smaller (3km buffer) scale. Our results suggest that ongoing land change alters fish communities and that contemporary resurveys are an important tool for examining how freshwater taxa are responding to recent environmental change.	[Cervantes-Yoshida, Kristina; Carlson, Stephanie M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Leidy, Robert A.] US EPA, San Francisco, CA USA	University of California System; University of California Berkeley; United States Environmental Protection Agency	Cervantes-Yoshida, K (corresponding author), San Francisco Bay Reg Water Qual Control Board, Oakland, CA 94612 USA.	kcervantesyoshida@gmail.com		Carlson, Stephanie/0000-0003-3055-6483	National Science Foundation Graduate Research Fellowship Program [DGE1106400]; Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	Support was provided by the National Science Foundation Graduate Research Fellowship Program, grant number: DGE1106400 to KCY [https://www.nsfgrfp.org]. Publication made possible in part by support from the Berkeley Research Impact Initiative (BRII) sponsored by the UC Berkeley Library. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; Brim-Box J, 2014, MAR FRESHWATER RES, V65, P562, DOI 10.1071/MF13131; Burkhead NM, 2012, BIOSCIENCE, V62, P798, DOI 10.1525/bio.2012.62.9.5; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; de Jesus-Crespo R, 2011, J N AM BENTHOL SOC, V30, P739, DOI 10.1899/10-081.1; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Esselman PC, 2010, ECOL FRESHW FISH, V19, P439, DOI 10.1111/j.1600-0633.2010.00430.x; Fitzpatrick FA, 2001, J AM WATER RESOUR AS, V37, P1489, DOI 10.1111/j.1752-1688.2001.tb03655.x; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Gibbs JP, 2005, ECOL APPL, V15, P1148, DOI 10.1890/03-5408; Gutierrez M, 2014, SAN FRANCISCO G 0501; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Heard MJ, 2012, DIVERS DISTRIB, V18, P1232, DOI 10.1111/j.1472-4642.2012.00918.x; Helms BS, 2009, J N AM BENTHOL SOC, V28, P991, DOI 10.1899/08-162.1; Henshaw PC, 2000, J AM WATER RESOUR AS, V36, P1219, DOI 10.1111/j.1752-1688.2000.tb05722.x; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Johnston CE, 2009, ECOL FRESHW FISH, V18, P33, DOI 10.1111/j.1600-0633.2008.00319.x; Kearns FR, 2005, LANDSCAPE ECOL, V20, P113, DOI 10.1007/s10980-004-2261-0; King RS, 2011, ECOL APPL, V21, P1659, DOI 10.1890/10-1357.1; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Labay B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025145; Lammert M, 1999, ENVIRON MANAGE, V23, P257, DOI 10.1007/s002679900184; Leidy R.A, 2007, SAN FRANCISCO ESTUAR, P530; Leidy RA, 2005, CALIF FISH GAME, V91, P219; Leidy RA, 2011, AQUAT CONSERV, V21, P472, DOI 10.1002/aqc.1208; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Maloney KO, 2011, FRESHWATER BIOL, V56, P611, DOI 10.1111/j.1365-2427.2010.02522.x; Marchetti MP, 2006, BIOL CONSERV, V127, P310, DOI 10.1016/j.biocon.2005.04.025; Matthews WJ, 2013, OECOLOGIA, V173, P955, DOI 10.1007/s00442-013-2646-3; McDonald Robert I., 2013, P31; Meals DW, 2010, J ENVIRON QUAL, V39, P85, DOI 10.2134/jeq2009.0108; Morgan RP, 2005, J N AM BENTHOL SOC, V24, P643, DOI 10.1899/0887-3593(2005)024\\[0643:UEOSFA\\]2.0.CO;2; Moyle P.B., 2002, INLAND FISHES CALIFO; Moyle P.B., 2015, FISH SPECIES SPECIAL; Moyle PB, 2011, BIOL CONSERV, V144, P2414, DOI 10.1016/j.biocon.2011.06.002; Patton TM, 1998, CONSERV BIOL, V12, P1120, DOI 10.1046/j.1523-1739.1998.97087.x; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Peter S, 2011, ECOL FRESHW FISH, V20, P251, DOI 10.1111/j.1600-0633.2011.00490.x; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Poole KE, 2004, J N AM BENTHOL SOC, V23, P114, DOI 10.1899/0887-3593(2004)023<0114:RODMBT>2.0.CO;2; Riley SPD, 2005, CONSERV BIOL, V19, P1894, DOI 10.1111/j.1523-1739.2005.00295.x; Roy AH, 2005, J N AM BENTHOL SOC, V24, P656, DOI 10.1899/0887-3593(2005)024\\[0656:IHAAAM\\]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Stanfield LW, 2013, RIVER RES APPL, V29, P891, DOI 10.1002/rra.2585; Stanford B, 2013, SFEI PUBLICATION, V679; Strayer DL, 2003, ECOSYSTEMS, V6, P407, DOI 10.1007/s10021-002-0170-0; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Wang LZ, 2001, ENVIRON MANAGE, V28, P255, DOI 10.1007/s0026702409; Weijters MJ, 2009, AQUAT CONSERV, V19, P104, DOI 10.1002/aqc.989; Wenger SJ, 2008, CAN J FISH AQUAT SCI, V65, P1250, DOI 10.1139/F08-046	57	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141707	10.1371/journal.pone.0141707	http://dx.doi.org/10.1371/journal.pone.0141707			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580560	gold, Green Submitted, Green Published			2022-12-27	WOS:000365154600020
J	Kang, H; Chung, YS; Kim, SW; Choi, GJ; Kim, BG; Park, SW; Seok, JW; Hong, J				Kang, Hyun; Chung, Yoon Sang; Kim, Sang Wook; Choi, Geun Joo; Kim, Beom Gyu; Park, Suk Won; Seok, Ju Won; Hong, Joonhwa			Effect of Temperature-Sensitive Poloxamer Solution/Gel Material on Pericardial Adhesion Prevention: Supine Rabbit Model Study Mimicking Cardiac Surgery	PLOS ONE			English	Article							HYALURONIC-ACID; MITOMYCIN-C; REDUCTION; MEMBRANE; BARRIER; COMBINATION; EFFICACY; CLOSURE; FILM; GEL	Objective We investigated the mobility of a temperature-sensitive poloxamer/Alginate/CaCl2 mixture (PACM) in relation to gravity and cardiac motion and the efficacy of PACM on the prevention of pericardial adhesion in a supine rabbit model. Methods A total of 50 rabbits were randomly divided into two groups according to materials applied after epicardial abrasion: PACM and dye mixture (group PD; n = 25) and saline as the control group (group CO; n = 25). In group PD, rabbits were maintained in a supine position with appropriate sedation, and location of mixture of PACM and dye was assessed by CT scan at the immediate postoperative period and 12 hours after surgery. The grade of adhesions was evaluated macroscopically and microscopically two weeks after surgery. Results In group PD, enhancement was localized in the anterior pericardial space, where PACM and dye mixture was applied, on immediate post-surgical CT scans. However, the volume of the enhancement was significantly decreased at the anterior pericardial space 12 hours later (P < .001). Two weeks after surgery, group PD had significantly lower macroscopic adhesion score (P = .002) and fibrosis score (P = .018) than did group CO. Inflammation score and expression of anti-macrophage antibody in group PD were lower than those in group CO, although the differences were not significant. Conclusions In a supine rabbit model study, the anti-adhesion effect was maintained at the area of PACM application, although PACM shifted with gravity and heart motion. For more potent pericardial adhesion prevention, further research and development on the maintenance of anti-adhesion material position are required.	[Kang, Hyun; Choi, Geun Joo] Chung Ang Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul 156756, South Korea; [Chung, Yoon Sang; Kim, Sang Wook; Hong, Joonhwa] Chung Ang Univ, Coll Med, Heart Res Inst, Seoul 156756, South Korea; [Kim, Sang Wook] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Kang, Hyun; Chung, Yoon Sang; Hong, Joonhwa] Chung Ang Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul 156756, South Korea; [Kim, Beom Gyu] Chung Ang Univ, Coll Med, Dept Surg, Seoul 156756, South Korea; [Park, Suk Won] Chung Ang Univ, Coll Med, Dept Radiat Oncol, Seoul 156756, South Korea; [Seok, Ju Won] Chung Ang Univ, Coll Med, Dept Nucl Med, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Hong, J (corresponding author), Chung Ang Univ, Coll Med, Heart Res Inst, Seoul 156756, South Korea.	jhong@cau.ac.kr	Kang, Hyun/AAE-7872-2020; Choi, Geun Joo/AAF-5102-2021	Kang, Hyun/0000-0003-2844-5880; Hong, Joonhwa/0000-0003-2212-2861	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology [NRF-2015R1A2A2A01005153]	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (NRF-2015R1A2A2A01005153) (http://www.nrf.re.kr/nrftot_cms/index.jsp?pmi-sso-return2=none). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (NRF-2015R1A2A2A01005153).	Alizzi AM, 2012, HEART LUNG CIRC, V21, P22, DOI 10.1016/j.hlc.2011.10.002; Colak N, 2013, CARDIOVASC PATHOL, V22, P368, DOI 10.1016/j.carpath.2013.02.001; Colak N, 2013, CAN J CARDIOL, V29, P712, DOI 10.1016/j.cjca.2012.05.005; Connors RC, 2007, J SURG RES, V140, P237, DOI 10.1016/j.jss.2007.03.014; DUNCAN DA, 1988, J SURG RES, V45, P44, DOI 10.1016/0022-4804(88)90019-4; Edwards GA, 1997, J BIOMED MATER RES, V34, P291; GALLO JI, 1978, ANN THORAC SURG, V26, P149, DOI 10.1016/S0003-4975(10)63658-2; Hong JH, 2011, J SURG RES, V166, P206, DOI 10.1016/j.jss.2010.09.034; Kaushal S, 2011, J THORAC CARDIOV SUR, V141, P789, DOI 10.1016/j.jtcvs.2010.11.043; Lassaletta AD, 2012, J THORAC CARDIOV SUR, V143, P953, DOI 10.1016/j.jtcvs.2011.12.016; LEACH RE, 1990, AM J OBSTET GYNECOL, V162, P1317, DOI 10.1016/0002-9378(90)90044-8; MEUS PJ, 1983, J THORAC CARDIOV SUR, V85, P54; MITCHELL JD, 1994, J THORAC CARDIOV SUR, V107, P1481, DOI 10.1016/S0022-5223(12)70149-6; Naito Y, 2008, J THORAC CARDIOV SUR, V135, P850, DOI 10.1016/j.jtcvs.2007.10.062; Oh SH, 2005, J BIOMED MATER RES A, V72A, P306, DOI 10.1002/jbm.a.30239; Orhan A, 2014, HEART LUNG CIRC, V23, P357, DOI 10.1016/j.hlc.2013.10.080; Park JS, 2011, J SURG RES, V168, P49, DOI 10.1016/j.jss.2009.09.025; Park SO, 2013, AESTHET PLAST SURG, V37, P543, DOI 10.1007/s00266-013-0087-3; REVUELTA JM, 1985, J THORAC CARDIOV SUR, V89, P451; Saeidi Mahmood, 2009, Interact Cardiovasc Thorac Surg, V9, P26, DOI 10.1510/icvts.2009.204669; SEIFER DB, 1990, J GYNECOL SURG, V6, P3, DOI 10.1089/gyn.1990.6.3; Shen J, 2014, ARTIF ORGANS, V38, P224, DOI 10.1111/aor.12140; Sohn EJ, 2013, OPHTHAL PLAST RECONS, V29, P458, DOI 10.1097/IOP.0b013e3182a22bae; Vlahos A, 2001, AM SURGEON, V67, P15	24	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143359	10.1371/journal.pone.0143359	http://dx.doi.org/10.1371/journal.pone.0143359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580394	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600116
J	Shen, KN; Sun, J; Cao, XX; Zhou, DB; Li, J				Shen, Kaini; Sun, Jian; Cao, Xinxin; Zhou, Daobin; Li, Jian			Comparison of Different Buffers for Protein Extraction from Formalin-Fixed and Paraffin-Embedded Tissue Specimens	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; ANTIGEN RETRIEVAL; MASS-SPECTROMETRY; EXPRESSION; SAMPLES; GENE	We determined the best extraction buffer for proteomic investigation using formalin-fixation and paraffin-embedded (FFPE) specimens. A Zwittergent 3-16 based buffer, sodium dodecyl sulfate (SDS)-containing buffer with/without polyethylene glycol 20000 (PEG20000), urea-containing buffer, and FFPE-FASP protein preparation kit were compared for protein extraction from different types of rat FFPE tissues, including the heart, brain, liver, lung, and kidney. All of the samples were divided into two groups of laser microdissected (LMD) and non-LMD specimens. For both kinds of specimens, Zwittergent was the most efficient buffer for identifying peptides and proteins, was broadly applicable to different tissues without impairing the enzymatic digestion, and was well compatible with mass spectrometry analysis. As a high molecular weight carrier substance, PEG20000 improved the identification of peptides and proteins; however, such an advantage is limited to tissues containing submicrograms to micrograms of protein. Considering its low lytic strength, urea-containing buffer would not be the first alternative for protein recovery. In conclusion, Zwittergent 3-16 is an effective buffer for extracting proteins from FFPE specimens for downstream proteomics analysis.	[Shen, Kaini; Cao, Xinxin; Zhou, Daobin; Li, Jian] Chinese Acad Med Sci, Dept Hematol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Shen, Kaini; Sun, Jian; Cao, Xinxin; Zhou, Daobin; Li, Jian] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Jian] Chinese Acad Med Sci, Dept Pathol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Li, J (corresponding author), Chinese Acad Med Sci, Dept Hematol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	lijian@pumch.cn		Sun, Jian/0000-0003-4997-2604; Li, Jian/0000-0002-4549-0694	National Nature Science Foundation of China [81370672]; Beijing Municipal Science & Technology Commission [Z131107002213050]; Peking Union Medical College New Star	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Peking Union Medical College New Star	This work was funded by the National Nature Science Foundation of China (81370672, for Jian Li), Beijing Municipal Science & Technology Commission (Z131107002213050, for Jian Li), and Peking Union Medical College New Star (2011, for Jian Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; Azimzadeh O, 2010, J PROTEOME RES, V9, P4710, DOI 10.1021/pr1004168; Craven RA, 2013, PROTEOM CLIN APPL, V7, P273, DOI 10.1002/prca.201200065; Crockett DK, 2005, LAB INVEST, V85, P1405, DOI 10.1038/labinvest.3700343; Fowler CB, 2007, LAB INVEST, V87, P836, DOI 10.1038/labinvest.3700596; Grantzdorffer I, 2010, EXP MOL PATHOL, V88, P190, DOI 10.1016/j.yexmp.2009.09.009; Guo T, 2007, J HISTOCHEM CYTOCHEM, V55, P763, DOI 10.1369/jhc.7A7177.2007; Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200; Klockenbusch C, 2012, ANAL BIOANAL CHEM, V404, P1057, DOI 10.1007/s00216-012-6065-9; Maes E, 2013, AMINO ACIDS, V45, P205, DOI 10.1007/s00726-013-1494-0; Magdeldin S, 2012, PROTEOMICS, V12, P1045, DOI 10.1002/pmic.201100550; Nirmalan NJ, 2011, J PROTEOME RES, V10, P896, DOI 10.1021/pr100812d; Palmer-Toy DE, 2005, J PROTEOME RES, V4, P2404, DOI 10.1021/pr050208p; Rodriguez FJ, 2008, LAB INVEST, V88, P1024, DOI 10.1038/labinvest.2008.72; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scicchitano MS, 2009, J HISTOCHEM CYTOCHEM, V57, P849, DOI 10.1369/jhc.2009.953497; SEKINE M, 1990, J BIOCHEM-TOKYO, V108, P103, DOI 10.1093/oxfordjournals.jbchem.a123147; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Sun W, 2006, MOL CELL PROTEOMICS, V5, P769, DOI 10.1074/mcp.T500022-MCP200; Tanca A, 2012, PROTEOM CLIN APPL, V6, P7, DOI 10.1002/prca.201100044; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wisniewski JR, 2013, PROTEOM CLIN APPL, V7, P225, DOI 10.1002/prca.201200046; Wisniewski JR, 2011, J PROTEOME RES, V10, P3040, DOI 10.1021/pr200019m; Yamashita S, 2007, PROG HISTOCHEM CYTO, V41, P141, DOI 10.1016/j.proghi.2006.09.001	24	19	19	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142650	10.1371/journal.pone.0142650	http://dx.doi.org/10.1371/journal.pone.0142650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580073	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600053
J	Liu, Y; Zhou, MY; Gao, ZX; Ren, W; Yang, FL; He, H; Zhao, JR				Liu, Ya; Zhou, Miaoyi; Gao, Zhaoxu; Ren, Wen; Yang, Fengling; He, Hang; Zhao, Jiuran			RNA-Seq Analysis Reveals MAPKKK Family Members Related to Drought Tolerance in Maize	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MEDIATES OSMOTIC-STRESS; SIGNAL-TRANSDUCTION; GENE FAMILY; ZEA-MAYS; DIFFERENTIAL GENE; CANDIDATE GENES; SALICYLIC-ACID; ARABIDOPSIS; EXPRESSION	The mitogen-activated protein kinase (MAPK) cascade is an evolutionarily conserved signal transduction pathway that is involved in plant development and stress responses. As the first component of this phosphorelay cascade, mitogen-activated protein kinase kinase kinases (MAPKKKs) act as adaptors linking upstream signaling steps to the core MAPK cascade to promote the appropriate cellular responses; however, the functions of MAPKKKs in maize are unclear. Here, we identified 71 MAPKKK genes, of which 14 were novel, based on a computational analysis of the maize (Zea mays L.) genome. Using an RNA-seq analysis in the leaf, stem and root of maize under well-watered and drought-stress conditions, we identified 5,866 differentially expressed genes (DEGs), including 8 MAPKKK genes responsive to drought stress. Many of the DEGs were enriched in processes such as drought stress, abiotic stimulus, oxidation-reduction, and metabolic processes. The other way round, DEGs involved in processes such as oxidation, photosynthesis, and starch, proline, ethylene, and salicylic acid metabolism were clearly co-expressed with the MAPKKK genes. Furthermore, a quantitative real-time PCR (qRT-PCR) analysis was performed to assess the relative expression levels of MAPKKKs. Correlation analysis revealed that there was a significant correlation between expression levels of two MAPKKKs and relative biomass responsive to drought in 8 inbred lines. Our results indicate that MAPKKKs may have important regulatory functions in drought tolerance in maize.	[Liu, Ya; Zhou, Miaoyi; Ren, Wen; Yang, Fengling; Zhao, Jiuran] Beijing Acad Agr & Forestry Sci, Maize Res Ctr, Beijing 100097, Peoples R China; [Gao, Zhaoxu; He, Hang] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, Beijing 100871, Peoples R China; [Gao, Zhaoxu; He, Hang] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Adv Agr Sci, Beijing 100871, Peoples R China	Beijing Academy of Agriculture & Forestry; Peking University; Peking University	He, H (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, Beijing 100871, Peoples R China.	hehang@pku.edu.cn; maizezhao@126.com	He, Hang/ABF-4074-2020; Ren, Wen/HCI-0284-2022	Ren, Wen/0000-0003-1698-6161; He, Hang/0000-0003-3165-283X	National Transgenic Major Program of China [2014ZX0800303B]; Program of Beijing New Scientific Star [Z111105054511066]	National Transgenic Major Program of China; Program of Beijing New Scientific Star	This work was supported by the National Transgenic Major Program of China (2014ZX0800303B) and the Program of Beijing New Scientific Star (Z111105054511066).	Agrawal GK, 2003, BIOCHEM BIOPH RES CO, V300, P775, DOI 10.1016/S0006-291X(02)02868-1; Agrawal GK, 2002, BIOCHEM BIOPH RES CO, V294, P1009, DOI 10.1016/S0006-291X(02)00571-5; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; BANNO H, 1993, MOL CELL BIOL, V13, P4745, DOI 10.1128/MCB.13.8.4745; BARKOSKY RR, 1993, J CHEM ECOL, V19, P237, DOI 10.1007/BF00993692; Berberich T, 1999, MOL GEN GENET, V262, P534, DOI 10.1007/s004380051115; Bosch M, 2011, J EXP BOT, V62, P3545, DOI 10.1093/jxb/err045; Cai GH, 2014, J PLANT PHYSIOL, V171, P1003, DOI 10.1016/j.jplph.2014.02.012; Champion A, 2004, TRENDS PLANT SCI, V9, P123, DOI 10.1016/j.tplants.2004.01.005; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Ding Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-141; Dolezal AL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00384; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; He Q, 2014, J PLANT GROWTH REGUL; Huang HJ, 2002, PHYSIOL PLANTARUM, V114, P572, DOI 10.1034/j.1399-3054.2002.1140410.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Jeong MJ, 2006, PLANT CELL TISS ORG, V85, P151, DOI 10.1007/s11240-005-9064-0; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jonak C, 1996, P NATL ACAD SCI USA, V93, P11274, DOI 10.1073/pnas.93.20.11274; Jouannic S, 1999, GENE, V229, P171, DOI 10.1016/S0378-1119(99)00012-8; Jouannic S, 1999, GENE, V233, P1, DOI 10.1016/S0378-1119(99)00152-3; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kim SH, 2011, BIOCHEM BIOPH RES CO, V412, P150, DOI 10.1016/j.bbrc.2011.07.064; Kong XP, 2013, BIOCHEM BIOPH RES CO, V441, P964, DOI 10.1016/j.bbrc.2013.11.008; Kong XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057714; Kong XP, 2011, PLANT CELL REP, V30, P2097, DOI 10.1007/s00299-011-1116-9; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Krugman T, 2011, FUNCT INTEGR GENOMIC, V11, P565, DOI 10.1007/s10142-011-0231-6; Kumar K, 2008, PLANT PHYSIOL BIOCH, V46, P891, DOI 10.1016/j.plaphy.2008.05.014; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Ligterink W, 2001, INT REV CYTOL, V201, P209, DOI 10.1016/S0074-7696(01)01004-X; Lin F, 2009, J EXP BOT, V60, P3221, DOI 10.1093/jxb/erp157; Liu YK, 2013, PLANT MOL BIOL REP, V31, P1446, DOI 10.1007/s11105-013-0623-y; Liu YK, 2012, MOL BIOL REP, V39, P2957, DOI 10.1007/s11033-011-1057-y; Long L, 2014, PLANT CELL TISS ORG, V116, P153, DOI 10.1007/s11240-013-0392-1; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Matsuoka D, 2002, PLANT J, V29, P637, DOI 10.1046/j.0960-7412.2001.01246.x; Mizoguchi T, 2000, RES PRO CEL, V27, P29; Mizoguchi T, 1996, P NATL ACAD SCI USA, V93, P765, DOI 10.1073/pnas.93.2.765; Morris PC, 2001, NEW PHYTOL, V151, P67, DOI 10.1046/j.1469-8137.2001.00167.x; Muoma JVO, 2014, AMERICAN JOURNAL OF, V5; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Ronde J. A. de, 2000, African Crop Science Journal, V8, P85; Roosens NH, 2002, MOL BREEDING, V9, P73, DOI 10.1023/A:1026791932238; Salvo SAGD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111407; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Shou HX, 2004, J EXP BOT, V55, P1013, DOI 10.1093/jxb/erh129; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Virk N, 2013, ACTA PHYSIOL PLANT, V35, P1211, DOI 10.1007/s11738-012-1160-2; Wang JX, 2010, J INTEGR PLANT BIOL, V52, P442, DOI 10.1111/j.1744-7909.2010.00906.x; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wrzaczek M, 2001, BIOL CELL, V93, P81, DOI 10.1016/S0248-4900(01)01121-2; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Wu T, 2011, MOL BIOL REP, V38, P3967, DOI 10.1007/s11033-010-0514-3; Xiao BZ, 2009, MOL PLANT, V2, P73, DOI 10.1093/mp/ssn068; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Xu J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-83; Yue X, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/546930; Zhang HW, 2010, TRANSGENIC RES, V19, P809, DOI 10.1007/s11248-009-9357-x; Zhang MY, 2012, J PLANT PHYSIOL, V169, P1501, DOI 10.1016/j.jplph.2012.06.008; Zhang ZJ, 2010, PLANTA, V232, P765, DOI 10.1007/s00425-010-1208-8	74	24	26	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143128	10.1371/journal.pone.0143128	http://dx.doi.org/10.1371/journal.pone.0143128			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599013	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600031
J	Magalhaes, FH; Elias, LA; da Silva, CR; de Lima, FF; de Toledo, DR; Kohn, AF				Magalhaes, Fernando Henrique; Elias, Leonardo Abdala; da Silva, Cristiano Rocha; de Lima, Felipe Fava; de Toledo, Diana Rezende; Kohn, Andre Fabio			D1 and D2 Inhibitions of the Soleus H-Reflex Are Differentially Modulated during Plantarflexion Force and Position Tasks	PLOS ONE			English	Article							ELBOW FLEXOR MUSCLES; VISUO-MOTOR SKILL; PRESYNAPTIC INHIBITION; IA AFFERENTS; HOMOSYNAPTIC DEPRESSION; FATIGUING CONTRACTIONS; CONFIDENCE-INTERVALS; SPINAL MOTONEURONS; ELECTRICAL NOISE; HAND MUSCLE	Presynaptic inhibition (PSI) has been shown to modulate several neuronal pathways of functional relevance by selectively gating the connections between sensory inputs and spinal motoneurons, thereby regulating the contribution of the stretch reflex circuitry to the ongoing motor activity. In this study, we investigated whether a differential regulation of Ia afferent inflow by PSI may be associated with the performance of two types of plantarflexion sensoriomotor tasks. The subjects (in a seated position) controlled either: 1) the force level exerted by the foot against a rigid restraint (force task, FT); or 2) the angular position of the ankle when sustaining inertial loads (position task, PT) that required the same level of muscle activation observed in FT. Subjects were instructed to maintain their force/position at target levels set at similar to 10% of maximum isometric voluntary contraction for FT and 90 degrees for PT, while visual feedback of the corresponding force/position signals were provided. Unconditioned H-reflexes (i.e. control reflexes) and H-reflexes conditioned by electrical pulses applied to the common peroneal nerve with conditioning-to-test intervals of 21 ms and 100 ms (corresponding to D1 and D2 inhibitions, respectively) were evoked in a random fashion. A significant main effect for the type of the motor task (FT vs PT) (p = 0.005, eta(2)(p) = 0.603) indicated that PTs were undertaken with lower levels of Ia PSI converging onto the soleus motoneuron pool. Additionally, a significant interaction between the type of inhibition (D1 vs D2) and the type of motor task (FT vs PT) (p = 0.038, eta(2)(p) = 0.395) indicated that D1 inhibition was associated with a significant reduction in PSI levels from TF to TP (p = 0.001, eta(2)(p) = 0.731), whereas no significant difference between the tasks was observed for D2 inhibition (p = 0.078, eta(2)(p) = 0.305). These results suggest that D1 and D2 inhibitions of the soleus H-reflex are differentially modulated during the performance of plantarflexion FT and PT. The reduced level of ongoing PSI during PT suggests that, in comparison to FT, there is a larger reliance on inputs from muscle spindles primary afferents when the neuromuscular system is required to maintain position-controlled plantarflexion contractions.	[Magalhaes, Fernando Henrique] Univ Sao Paulo, EACH USP, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil; [Magalhaes, Fernando Henrique; Elias, Leonardo Abdala; da Silva, Cristiano Rocha; de Lima, Felipe Fava; de Toledo, Diana Rezende; Kohn, Andre Fabio] Univ Sao Paulo, EPUSP, Biomed Engn Lab, Sao Paulo, SP, Brazil; [Magalhaes, Fernando Henrique; da Silva, Cristiano Rocha; Kohn, Andre Fabio] Univ Sao Paulo, Neurosci Program, Sao Paulo, SP, Brazil; [Elias, Leonardo Abdala] Univ Estadual Campinas, Sch Elect & Comp Engn, Dept Biomed Engn, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Magalhaes, FH (corresponding author), Univ Sao Paulo, EACH USP, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil.	fhmagalhaes@usp.br	Silva, Cristiano Rocha/P-1183-2016; Kohn, Andre F/N-4982-2016; Magalhães, Fernando Henrique/A-1894-2013; Elias, Leonardo Abdala/C-4169-2008	Silva, Cristiano Rocha/0000-0001-8545-3321; Kohn, Andre F/0000-0002-9770-3348; Magalhães, Fernando Henrique/0000-0003-0783-6102; Elias, Leonardo Abdala/0000-0003-4488-3063; Fava de Lima, Felipe/0000-0002-7102-8532	FAPESP [2011/17193-0, 2011/13222-6, 2013/10433-1, 2012/09321-1, 2013/14667-7]; CNPq [303313/2011-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a grant from FAPESP (http://www.fapesp.br/) to AFK (#2011/17193-0) and a fellowship to AFK by CNPq (http://www.cnpq.br/) (#303313/2011-0). FHM, LAE, CRS and DRT were recipients of fellowships from FAPESP (http://www.fapesp.br/), grants #2011/13222-6, #2013/10433-1, #2012/09321-1, #2013/14667-7, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimonetti JM, 2000, J PHYSIOL-LONDON, V522, P125, DOI 10.1111/j.1469-7793.2000.t01-1-00125.xm; Aymard C, 2000, BRAIN, V123, P1688, DOI 10.1093/brain/123.8.1688; Aymard C, 2001, EXP BRAIN RES, V137, P127, DOI 10.1007/s002210000662; Baudry S, 2011, J NEUROPHYSIOL, V106, P265, DOI 10.1152/jn.00954.2010; Baudry S, 2010, J NEUROPHYSIOL, V103, P623, DOI 10.1152/jn.00839.2009; Baudry S, 2009, EXP BRAIN RES, V199, P83, DOI 10.1007/s00221-009-1951-x; Baudry S, 2009, CLIN NEUROPHYSIOL, V120, P210, DOI 10.1016/j.clinph.2008.10.013; BROUWER B, 1990, ELECTROEN CLIN NEURO, V76, P509, DOI 10.1016/0013-4694(90)90002-2; CAPADAY C, 1995, CAN J PHYSIOL PHARM, V73, P436, DOI 10.1139/y95-056; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; de Noordhout AM, 1999, BRAIN, V122, P1327, DOI 10.1093/brain/122.7.1327; Elias LA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003944; Elias LA, 2012, J COMPUT NEUROSCI, V33, P515, DOI 10.1007/s10827-012-0398-4; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Faist M, 1996, EXP BRAIN RES, V109, P441; FAIST M, 1994, BRAIN, V117, P1449, DOI 10.1093/brain/117.6.1449; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P729, DOI 10.1113/jphysiol.1987.sp016680; Hunter SK, 2003, J APPL PHYSIOL, V94, P2439, DOI 10.1152/japplphysiol.01038.2002; Hunter SK, 2002, J NEUROPHYSIOL, V88, P3087, DOI 10.1152/jn.00232.2002; Iles JF, 1996, J PHYSIOL-LONDON, V491, P197, DOI 10.1113/jphysiol.1996.sp021207; Kagamihara Y, 2005, J CLIN NEUROPHYSIOL, V22, P136, DOI 10.1097/01.WNP.0000158948.00901.4E; KERNELL D, 1990, BRAIN RES, V507, P176, DOI 10.1016/0006-8993(90)90542-J; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; Kohn AF, 1997, EXP BRAIN RES, V116, P375, DOI 10.1007/PL00005765; Kossev A, 1998, ELECTROMYOGR MOTOR C, V109, P245, DOI 10.1016/S0924-980X(98)00012-5; Lamy JC, 2009, BRAIN, V132, P734, DOI 10.1093/brain/awn310; Lauber B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032433; Leonard CT, 1999, BRAIN RES, V817, P1, DOI 10.1016/S0006-8993(98)01096-8; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Magalhaes FH, 2014, EUR J APPL PHYSIOL, V114, P1129, DOI 10.1007/s00421-014-2846-5; Magalhaes FH, 2012, EXP BRAIN RES, V217, P175, DOI 10.1007/s00221-011-2983-6; Maluf KS, 2007, CLIN NEUROPHYSIOL, V118, P2063, DOI 10.1016/j.clinph.2007.06.009; Maluf KS, 2005, EXP BRAIN RES, V167, P165, DOI 10.1007/s00221-005-0017-y; Masani K, 2008, J NEUROPHYSIOL, V100, P1465, DOI 10.1152/jn.00801.2007; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; Mello EM, 2013, HUM MOVEMENT SCI, V32, P1310, DOI 10.1016/j.humov.2013.05.004; Meunier S, 1998, EXP BRAIN RES, V119, P415, DOI 10.1007/s002210050357; Mezzarane RA, 2013, ELECTRODIAGNOSIS NEW, P57; Mezzarane RA, 2007, EXP BRAIN RES, V180, P377, DOI 10.1007/s00221-007-0865-8; Mezzarane RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121496; Mezzarane RA, 2012, J NEUROPHYSIOL, V108, P1176, DOI 10.1152/jn.00831.2011; Misiaszek JE, 2003, MUSCLE NERVE, V28, P144, DOI 10.1002/mus.10372; MIZUNO Y, 1971, J NEUROPHYSIOL, V34, P1010, DOI 10.1152/jn.1971.34.6.1010; Morita H, 1998, J NEUROPHYSIOL, V80, P610, DOI 10.1152/jn.1998.80.2.610; Motta-Oishi AAP, 2013, MED HYPOTHESES, V81, P784, DOI 10.1016/j.mehy.2013.08.013; Nakajima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076313; Perez MA, 2005, J PHYSIOL-LONDON, V568, P343, DOI 10.1113/jphysiol.2005.089904; Perez MA, 2006, J PHYSIOL-LONDON, V573, P843, DOI 10.1113/jphysiol.2006.105361; Pierrot-Deseilligny E, 2012, CIRCUITRY HUMAN SPIN, Vxxiii; PierrotDeseilligny E, 1997, J NEUROSCI METH, V74, P189, DOI 10.1016/S0165-0270(97)02249-8; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; Poortvliet PC, 2015, EXP BRAIN RES; Roche N, 2012, CLIN NEUROPHYSIOL, V123, P1391, DOI 10.1016/j.clinph.2011.11.006; Rossi-Durand C, 2002, SOMATOSENS MOT RES, V19, P286, DOI 10.1080/0899022021000037755; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Rudomin P, 1998, PRESYNAPTIC INHIBITI, Vxiv; Rudroff T, 2005, MUSCLE NERVE, V31, P78, DOI 10.1002/mus.20241; Sogaard K, 1996, ELECTROMYOGR MOTOR C, V101, P453, DOI 10.1016/S0921-884X(96)95629-5; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; TAX AAM, 1989, EXP BRAIN RES, V76, P55, DOI 10.1007/BF00253623; TAX AAM, 1990, EXP BRAIN RES, V81, P567, DOI 10.1007/BF02423505; THOMAS CK, 1987, J NEUROPHYSIOL, V57, P311, DOI 10.1152/jn.1987.57.1.311; Watanabe RN, 2015, J NEUROSCI, V35, P13687, DOI 10.1523/JNEUROSCI.1950-15.2015; Watanabe RN, 2013, I IEEE EMBS C NEUR E, P794, DOI 10.1109/NER.2013.6696054; Watanabe RN, 2013, J NEUROPHYSIOL, V110, P2592, DOI 10.1152/jn.00073.2013; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	67	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143862	10.1371/journal.pone.0143862	http://dx.doi.org/10.1371/journal.pone.0143862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599909	Green Submitted, gold, Green Published			2022-12-27	WOS:000365862600125
J	Margolick, JB; Apuzzo, L; Singer, J; Wong, H; Lee, T; Gallant, JE; El-Helou, P; Loutfy, MR; Rachlis, A; Fraser, C; Kasper, K; Tremblay, C; Tossonian, H; Conway, B				Margolick, Joseph B.; Apuzzo, Linda; Singer, Joel; Wong, Hubert; Lee, Terry; Gallant, Joel E.; El-Helou, Phillippe; Loutfy, Mona R.; Rachlis, Anita; Fraser, Christopher; Kasper, Kenneth; Tremblay, Cecile; Tossonian, Harout; Conway, Brian			A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RESPONSES	Background It has been proposed that initiation of antiretroviral treatment (ART) very soon after establishment of HIV infection may be beneficial by improving host control of HIV replication and delaying disease progression. Methods People with documented HIV infection of less than 12 months' duration in Baltimore MD and seven Canadian sites were randomized to either a) observation and deferred ART, or b) immediate treatment with ART for 12 months. All subjects not receiving ART were followed quarterly and permanent ART was initiated according to contemporaneous treatment guidelines. The endpoint of the trial was total ART-free time from study entry until initiation of permanent ART. Results One hundred thirteen people were randomized, 56 to the observation arm and 57 to the immediate treatment arm. Twenty-three had acute (<2 months) infection and 90 early (2-12 months) infection. Of those randomized to the immediate treatment arm, 37 completed 12 months of ART according to protocol, 9 declined to stop ART after 12 months, and 11 were nonadherent to the protocol or lost to follow-up. Comparing those in the observation arm to either those who completed 12 months of ART or all 56 who were randomized to immediate ART, there was no significant difference between the arms in treatment-free interval after study entry, which was about 18 months in both arms. Conclusions This study did not find a benefit from administration of a brief, time-limited (12-month) course of ART in acute or early HIV infection.	[Margolick, Joseph B.; Apuzzo, Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Singer, Joel; Wong, Hubert; Lee, Terry] CIHR Canadian HIV Trials Network, Vancouver, BC, Canada; [Gallant, Joel E.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [El-Helou, Phillippe] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Loutfy, Mona R.] Maple Leaf Med Clin, Toronto, ON, Canada; [Rachlis, Anita] Sunnybrook Hlth Sci, Toronto, ON, Canada; [Fraser, Christopher] Cool Aid Community Hlth Ctr, Victoria, BC, Canada; [Kasper, Kenneth] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Tremblay, Cecile] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Tossonian, Harout; Conway, Brian] Vancouver Infect Dis Ctr, Vancouver, BC, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Universite de Montreal	Margolick, JB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	Jmargol1@jhu.edu		Wong, Hubert/0000-0001-8840-4509	National Institutes of Health [AI056990, UL1RR025005]; CIHR Canadian HIV Trials Network; Janssen Therapeutics; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Janssen Therapeutics; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI056990 and UL1RR025005 (JBM) and by the CIHR Canadian HIV Trials Network; Clinical Trials registration #: NCT00106171. Gilead Sciences, GlaxoSmithKline, Bristol-MyersSquibb, and Abbott Laboratories provided antiretroviral medications for this study and additional financial support was provided by Janssen Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH, V68, P1169, DOI 10.1093/jac/dks533; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; KINLOCHDELOES S, 1995, NEW ENGL J MED, V333, P408, DOI 10.1056/NEJM199508173330702; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Kshatriya R, 2008, J CLIN MICROBIOL, V46, P3482, DOI 10.1128/JCM.00665-08; Lichterfeld M, 2013, ANN INTERN MED, V159, P425, DOI 10.7326/0003-4819-159-6-201309170-00010; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; O'Brien M, 2012, CURR HIV-AIDS REP, V9, P101, DOI 10.1007/s11904-012-0113-0; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Phair JP, 1997, J INFECT DIS, V175, P959, DOI 10.1086/514000; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Streeck H, 2006, J INFECT DIS, V194, P734, DOI 10.1086/503811; Tossonian H, 2012, J INFECT DIS, V205, P10, DOI 10.1093/infdis/jir702	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143259	10.1371/journal.pone.0143259	http://dx.doi.org/10.1371/journal.pone.0143259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600459	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600042
J	Hepping, AM; Ploegmakers, JJW; Geertzen, JHB; Bulstra, SK; Stevens, M				Hepping, Ann M.; Ploegmakers, Joris J. W.; Geertzen, Jan H. B.; Bulstra, Sjoerd K.; Stevens, Martin			The Influence of Hand Preference on Grip Strength in Children and Adolescents; A Cross-Sectional Study of 2284 Children and Adolescents	PLOS ONE			English	Article							PINCH STRENGTH; LEFT-HANDEDNESS; 19-YEAR-OLDS; RELIABILITY; PERFORMANCE; SELECTION; VALIDITY; DOMINANT; VALUES; NORMS	Introduction In adults the preferred hand is often considered to be around 10% stronger than the non-preferred hand. Whether the same is true for children and adolescents remains unclear. The objective of this study is therefore to determine whether there is a difference in grip strength between the preferred and non-preferred hand in developing children, to establish whether this difference is similar for children of a different gender or hand preference, and whether there is a difference in grip strength of the preferred hand of left-preferent (LP) and right-preferent (RP) children. Design Cross-sectional study. Participants Participants were recruited from schools in the northern provinces of the Netherlands. The study included healthy children and adolescents in the age range of 4-17 years. Outcome Measures Each child was allowed a total of four attempts using the JAMAR hand dynamometer, two attempts with each hand. All individual attempts were scored. Hand preference was determined by asking which hand was used to write, or in the case of 4- and 5-year-olds, which hand was used to draw a shape. Results The study population comprised 2284 children and adolescents. RP boys and girls scored significantly higher with their preferred hand, the difference amounting to 9.5 and 10.1% respectively. LP girls scored significantly higher with their preferred hand, but this difference was only 3.0%. For LP boys no significant difference was found in favor of either hand. LP children score higher with the non-preferred hand and tie scores on both hands more often than RP children. Conclusion The 10% rule of hand preference is applicable to RP children ranging in age between 4 and 17 years, but not to LP children. In contrast to LP boys, LP girls are generally significantly stronger with their preferred hand.	[Hepping, Ann M.; Geertzen, Jan H. B.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Ploegmakers, Joris J. W.; Bulstra, Sjoerd K.; Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands	University of Groningen; University of Groningen	Hepping, AM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.	a.m.hepping@umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894				AGER CL, 1984, AM J OCCUP THER, V38, P107, DOI 10.5014/ajot.38.2.107; American Medical Association, 1993, GUIDES EVALUATION PE; American Society of Hand Therapists, 1992, CLIN ASSESSMENT RECO; ANNETT M, 1967, Q J EXP PSYCHOL, V19, P327, DOI 10.1080/14640746708400109; Armstrong CA, 1999, J HAND SURG-BRIT EUR, V24B, P421, DOI 10.1054/jhsb.1999.0236; BALOGUN JA, 1991, ARCH PHYS MED REHAB, V72, P280; Bear-Lehman Jane, 2002, J Hand Ther, V15, P340; BECHTOL CO, 1954, J BONE JOINT SURG AM, V36-A, P820, DOI 10.2106/00004623-195436040-00013; BEUKELAAR LJ, 1986, NEUROPSYCHOLOGIA, V24, P301, DOI 10.1016/0028-3932(86)90066-7; Bohannon RW, 2003, PERCEPT MOTOR SKILL, V96, P728, DOI 10.2466/PMS.96.3.728-730; Burmeister LF, 1974, SIZE STRENGTH DEV HA; Butterfield SA, 2009, PERCEPT MOTOR SKILL, V109, P362, DOI 10.2466/PMS.109.2.362-370; CARLIER M, 1993, NEUROPSYCHOLOGIA, V31, P233, DOI 10.1016/0028-3932(93)90087-G; Clerke A, 2001, AM J OCCUP THER, V55, P206, DOI 10.5014/ajot.55.2.206; CROSBY CA, 1994, J HAND SURG-AM, V19A, P665, DOI 10.1016/0363-5023(94)90280-1; Dassonville P, 1997, P NATL ACAD SCI USA, V94, P14015, DOI 10.1073/pnas.94.25.14015; De Smet L, 2001, J PEDIATR ORTHOP B, V10, P352, DOI 10.1097/00009957-200110000-00017; Fess EE., 1992, CLIN ASSESSMENT RECO, P41; Incel Nurgul Arinci, 2002, SMJ Singapore Medical Journal, V43, P234; Innes E, 1999, AUST OCCUP THER J, V46, P120, DOI DOI 10.1046/J.1440-1630.1999.00182.X; MATHIOWETZ V, 1986, AM J OCCUP THER, V40, P705, DOI 10.5014/ajot.40.10.705; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Molenaar HM, 2008, J BONE JOINT SURG AM, V90A, P1053, DOI 10.2106/JBJS.G.00469; Molenaar HM, 2010, CLIN ORTHOP RELAT R, V468, P217, DOI 10.1007/s11999-009-0881-z; NEWMAN DG, 1984, ARCH DIS CHILD, V59, P453, DOI 10.1136/adc.59.5.453; PETERSEN P, 1989, AM J OCCUP THER, V43, P444, DOI 10.5014/ajot.43.7.444; Ploegmakers JJW, 2013, J PHYSIOTHER, V59, P255, DOI 10.1016/S1836-9553(13)70202-9; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; ROSZKOWSKI M J, 1981, Journal of Clinical Neuropsychology, V3, P199, DOI 10.1080/01688638108403126; ROSZKOWSKI MJ, 1982, INT J CLIN NEUROPSYC, V4, P35; Scharoun SM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00082; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; van den Beld WA, 2006, DISABIL REHABIL, V28, P1303, DOI 10.1080/09638280600631047; Vingerhoets G, 2012, HUM BRAIN MAPP, V33, P763, DOI 10.1002/hbm.21247; Yahagi S, 1999, NEUROSCI LETT, V276, P185, DOI 10.1016/S0304-3940(99)00823-X	36	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143476	10.1371/journal.pone.0143476	http://dx.doi.org/10.1371/journal.pone.0143476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599429	Green Submitted, gold, Green Published			2022-12-27	WOS:000365853900131
J	Kumagai, K; Tabu, K; Sasaki, F; Takami, Y; Morinaga, Y; Mawatari, S; Hashimoto, S; Tanoue, S; Kanmura, S; Tamai, T; Moriuchi, A; Uto, H; Tsubouchi, H; Ido, A				Kumagai, Kotaro; Tabu, Kazuaki; Sasaki, Fumisato; Takami, Yoichiro; Morinaga, Yuko; Mawatari, Seiichi; Hashimoto, Shinichi; Tanoue, Shiroh; Kanmura, Shuji; Tamai, Tsutomu; Moriuchi, Akihiro; Uto, Hirofumi; Tsubouchi, Hirohito; Ido, Akio			Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; DC-HIL; ENDOTHELIAL-CELLS; TISSUE-REPAIR; OSTEOACTIVIN; REGENERATION; EXPRESSION; ACTIVATION; RATS; DEPLETION	Background and aims Glycoprotein nonmetastatic melanoma B (Gpnmb), a transmembrane glycoprotein that is expressed in macrophages, negatively regulates inflammation. We have reported that Gpnmb is strongly expressed in the livers of rats fed a choline-deficient, L-amino acid-defined (CDAA) diet. However, the role of macrophage-expressed Gpnmb in liver injury is still unknown. This study aimed to clarify the characteristics of infiltrating macrophages that express Gpnmb, and the involvement of Gpnmb in the repair process in response to liver injury. Methods C57BL/6J, DBA/2J [DBA] and DBA/2J-Gpnmb(+) [DBA-g+] mice were treated with a single intraperitoneal injection of carbon tetrachloride (CCl4) at a dose of 1.0 mL/kg body weight. Mice were sacrificed at predetermined time points, followed by measurement of serum alanine aminotransferase (ALT) levels and histological examination. Expression of Gpnmb, pro-/anti-inflammatory cytokines, and profibrotic/antifibrotic factors were examined by quantitative RT-PCR and/or Western blotting. Immunohistochemistry, fluorescent immunostaining and flow cytometry were used to determine the expression of Gpnmb, CD68, CD11b and alpha-SMA, phagocytic activity, and the presence of apoptotic bodies. We used quantitative RT-PCR and ELISA to examine TGF-beta and MMP-13 expression and the concentrations and supernatants of isolated infiltrating hepatic macrophages transfected with siGpnmb. Results In C57BL/6J mice, serum ALT levels increased at two days after CCl4 injection and decreased at four days. Gpnmb expression in the liver was stimulated four days after CCl4 injection. Histological examination and flow cytometry showed that Gpnmb-positive cells were almost positive for CD68-positive macrophages, contained engulfed apoptotic bodies and exhibited enhanced phagocytic activity. Isolated infiltrating hepatic macrophages transfected with siGpnmb showed high MMP-13 secretion. There was no significant difference in the magnitude of CCl4-induced liver injury between DBA-g+ and DBA mice. However, hepatic MMP-13 expression, as well as alpha-SMA expression and collagen production, increased significantly in DBA-g+ compared with DBA mice. Conclusions Gpnmb-positive macrophages infiltrate the liver during the recovery phase of CCl4-induced acute liver injury and contribute to the balance between fibrosis and fibrolysis in the repair process following acute liver injury.	[Kumagai, Kotaro; Tabu, Kazuaki; Sasaki, Fumisato; Morinaga, Yuko; Mawatari, Seiichi; Hashimoto, Shinichi; Tanoue, Shiroh; Kanmura, Shuji; Tamai, Tsutomu; Moriuchi, Akihiro; Uto, Hirofumi; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima 890, Japan; [Takami, Yoichiro] Shujitsu Univ, Sch Pharm, Pharmaceut Care & Hlth Sci, Okayama, Japan; [Uto, Hirofumi] Miyazaki Med Ctr Hosp, Ctr Digest & Liver Dis, Miyazaki, Japan; [Tsubouchi, Hirohito] Kagoshima City Hosp, Kagoshima, Japan	Kagoshima University; Kagoshima City Hospital	Kumagai, K (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima 890, Japan.	kumakou@m2.kufm.kagoshima-u.ac.jp	Sasaki, Fumisato/AAQ-6470-2020	Sasaki, Fumisato/0000-0003-4824-4154	Ministry of Education, Culture, Sports, Science and Technology of Japan [22590742, 26461013]; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research (#22590742, AI, https://kaken.nii.ac.jp/d/p/22590742.ja.html and #26461013, AI, https://kaken.nii.ac.jp/d/p/26461013.ja.html) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and for the Intractable Hepato-Biliary Diseases Study Group of Japan from the Ministry of Health, Labour and Welfare of Japan.	Abe H, 2007, BIOCHEM BIOPH RES CO, V356, P610, DOI 10.1016/j.bbrc.2007.03.035; Ahn JH, 2002, BLOOD, V100, P1742, DOI 10.1182/blood.V100.5.1742.h81702001742_1742_1754; Alber A, 2012, INT J EXP PATHOL, V93, P243, DOI 10.1111/j.1365-2613.2012.00833.x; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085; Bourbonnais E, 2012, GASTROENTEROLOGY, V142, P130, DOI 10.1053/j.gastro.2011.09.033; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Haralanova-Ilieva B, 2005, J HEPATOL, V42, P565, DOI 10.1016/j.jhep.2004.12.021; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Hu SL, 2009, EUR J PHARMACOL, V616, P287, DOI 10.1016/j.ejphar.2009.06.044; Imamura M, 2005, GASTROENTEROLOGY, V128, P138, DOI 10.1053/j.gastro.2004.10.005; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mo JS, 2003, J EXP MED, V197, P1335, DOI 10.1084/jem.20022041; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1152/ajpcell.00565.2004; Onaga M, 2003, J HEPATOL, V39, P779, DOI 10.1016/S0168-8278(03)00361-1; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Possamai LA, 2014, J HEPATOL, V61, P439, DOI 10.1016/j.jhep.2014.03.031; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042596; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369	44	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143413	10.1371/journal.pone.0143413	http://dx.doi.org/10.1371/journal.pone.0143413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599547	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900113
J	Ryckmans, J; Millet, K; Warlop, L				Ryckmans, Jan; Millet, Kobe; Warlop, Luk			The Influence of Facial Characteristics on the Relation between Male 2D:4D and Dominance	PLOS ONE			English	Article							DIGIT RATIO 2D4D; AGGRESSIVE-BEHAVIOR; FINGER LENGTH; ACADEMIC-PERFORMANCE; TESTOSTERONE LEVELS; SEX-HORMONES; ANGRY FACES; HUMAN BRAIN; 2D-4D; PREDICTS	Although relations between 2D:4D and dominance rank in both baboons and rhesus macaques have been observed, evidence in humans is mixed. Whereas behavioral patterns in humans have been discovered that are consistent with these animal findings, the evidence for a relation between dominance and 2D:4D is weak or inconsistent. The present study provides experimental evidence thatmale 2D:4D is related to dominance after (fictitious) male-male interaction when the other man has a dominant, but not a submissive or neutral face. This finding provides evidence that the relationship between 2D:4D and dominance emerges in particular, predictable situations and that merely dominant facial characteristics of another person are enough to activate supposed relationships between 2D:4D and dominance.	[Ryckmans, Jan; Warlop, Luk] Katholieke Univ Leuven, Fac Econ & Business, Res Ctr Mkt & Consumer Sci, Leuven, Belgium; [Millet, Kobe] Vrije Univ Amsterdam, Dept Mkt, Amsterdam, Netherlands; [Warlop, Luk] BI Norwegian Business Sch, Dept Mkt, Oslo, Norway	KU Leuven; Vrije Universiteit Amsterdam; BI Norwegian Business School	Millet, K (corresponding author), Vrije Univ Amsterdam, Dept Mkt, Amsterdam, Netherlands.	kobe.millet@vu.nl		Millet, Kobe/0000-0003-4365-6109; warlop, luk/0000-0002-7162-6372				[Anonymous], 2007, FACEGEN MOD 3 2 DEM; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Auger J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1532; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Bosch-Domenech A, 2014, PSYCHONEUROENDOCRINO, V43, P1, DOI 10.1016/j.psyneuen.2014.01.023; Brosnan M, 2011, PERS INDIV DIFFER, V51, P371, DOI 10.1016/j.paid.2010.07.009; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Cogsdill EJ, 2014, PSYCHOL SCI, V25, P1132, DOI 10.1177/0956797614523297; Collias NE, 2002, BEHAVIOUR, V139, P801, DOI 10.1163/156853902320262826; Crewther B, 2015, EARLY HUM DEV, V91, P451, DOI 10.1016/j.earlhumdev.2015.04.011; DeBruine L. M, 2004, AUTOMETRIC SOFTWARE; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Garbarino E, 2011, J RISK UNCERTAINTY, V42, P1, DOI 10.1007/s11166-010-9109-6; Getov S, 2015, SOC COGN AFFECT NEUR, V10, P690, DOI 10.1093/scan/nsu103; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Hampson E, 2008, ARCH SEX BEHAV, V37, P133, DOI 10.1007/s10508-007-9263-3; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Hopp RN, 2012, PERS INDIV DIFFER, V52, P643, DOI 10.1016/j.paid.2011.12.013; Howlett C, 2015, BEHAV ECOL SOCIOBIOL, V69, P61, DOI 10.1007/s00265-014-1817-5; Josephs RA, 2011, COGNITIVE SCI, V14, P16; Josephs RA, 2006, J PERS SOC PSYCHOL, V90, P999, DOI 10.1037/0022-3514.90.6.999; Kilduff L, 2013, J SPORT SCI, V31, P677, DOI 10.1080/02640414.2012.747690; Kilduff LP, 2013, EVOL PSYCHOL-US, V11, P953, DOI 10.1177/147470491301100502; Longman D, 2011, AM J PHYS ANTHROPOL, V144, P337, DOI 10.1002/ajpa.21407; Maner JK, 2014, SOC PSYCHOL PERS SCI, V5, P119, DOI 10.1177/1948550613488948; Manning J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00009; Manning JT, 2008, AM J HUM BIOL, V20, P451, DOI 10.1002/ajhb.20767; Manning JT, 2007, ARCH SEX BEHAV, V36, P223, DOI 10.1007/s10508-007-9171-6; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; McIntyre MH, 2009, J HUM EVOL, V56, P361, DOI 10.1016/j.jhevol.2008.12.004; Mehta PH, 2006, HORM BEHAV, V50, P684, DOI 10.1016/j.yhbeh.2006.07.001; Millet K, 2008, AM J HUM BIOL, V20, P110, DOI 10.1002/ajhb.20689; Millet K, 2011, PERS INDIV DIFFER, V51, P397, DOI 10.1016/j.paid.2010.04.005; Millet K, 2009, BRIT J PSYCHOL, V100, P151, DOI 10.1348/000712608X324359; Moskowitz DS, 2015, PERS INDIV DIFFER, V75, P97, DOI 10.1016/j.paid.2014.11.008; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; Nelson E, 2010, BEHAV ECOL SOCIOBIOL, V64, P1001, DOI 10.1007/s00265-010-0915-2; Nelson E, 2010, AM J PHYS ANTHROPOL, V141, P395, DOI 10.1002/ajpa.21157; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Putman P, 2004, EMOTION, V4, P305, DOI 10.1037/1528-3542.4.3.305; Putz DA, 2004, EVOL HUM BEHAV, V25, P182, DOI 10.1016/j.evolhumbehav.2004.03.005; Ronay R, 2011, J EXP SOC PSYCHOL, V47, P702, DOI 10.1016/j.jesp.2010.11.009; Roney JR, 2004, HORM BEHAV, V45, P285, DOI 10.1016/j.yhbeh.2003.12.008; Ruiz-de-la-Torre JL, 1999, PHYSIOL BEHAV, V68, P109, DOI 10.1016/S0031-9384(99)00165-1; Schaefer Katrin, 2009, Biology Theory, V4, P98, DOI 10.1162/biot.2009.4.1.98; Stanton SJ, 2009, J RES PERS, V43, P942, DOI 10.1016/j.jrp.2009.04.001; Stewart LH, 2012, J EXP PSYCHOL GEN, V141, P715, DOI 10.1037/a0027950; Stillman TF, 2010, EVOL HUM BEHAV, V31, P298, DOI 10.1016/j.evolhumbehav.2009.12.001; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Talarovicova A, 2009, HORM BEHAV, V55, P235, DOI 10.1016/j.yhbeh.2008.10.010; Terburg D, 2012, PSYCHOL SCI, V23, P459, DOI 10.1177/0956797611433336; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2013, DATABASE DOMINANCEFA; Todorov A, 2013, EMOTION, V13, P724, DOI 10.1037/a0032335; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; van der Meij L, 2012, AGGRESSIVE BEHAV, V38, P208, DOI 10.1002/ab.21422; Vermeersch H, 2008, HORM BEHAV, V54, P340, DOI 10.1016/j.yhbeh.2008.02.017; Voracek M, 2006, PERCEPT MOTOR SKILL, V103, P427, DOI 10.2466/PMS.103.2.427-446; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219; Zebrowitz L. A., 1997, READING FACES WINDOW; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	68	13	14	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143307	10.1371/journal.pone.0143307	http://dx.doi.org/10.1371/journal.pone.0143307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26600255	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000365853900090
J	van Noort, JM; Bsibsi, M; Nacken, PJ; Verbeek, R; Venneker, EHG				van Noort, Johannes M.; Bsibsi, Malika; Nacken, Peter J.; Verbeek, Richard; Venneker, Edna H. G.			Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial	PLOS ONE			English	Article							HEAT-SHOCK; T-CELLS; CANDIDATE AUTOANTIGEN; AUTOIMMUNE; ACTIVATION; EXPRESSION; PROTEIN; OLIGODENDROCYTES; OSTEOPONTIN; MECHANISMS	As a molecular chaperone and activator of Toll-like receptor 2-mediated protective responses by microglia and macrophages, the small heat shock protein alpha B-crystallin (HspB5) exerts therapeutic effects in different animal models for neuroinflammation, including the model for multiple sclerosis (MS). Yet, HspB5 can also stimulate human antigenspecific memory T cells to release IFN-gamma, a cytokine with well-documented detrimental effects during MS. In this study, we explored in a Phase IIa randomized clinical trial the therapeutic application of HspB5 in relapsing-remitting MS (RR-MS), using intravenous doses sufficient to support its protective effects, but too low to trigger pathogenic memory T-cell responses. These sub-immunogenic doses were selected based on in vitro analysis of the dose-response profile of human T cells and macrophages to HspB5, and on the immunological effects of HspB5 in healthy humans as established in a preparatory Phase I study. In a 48-week randomized, placebo-controlled, double-blind Phase IIa trial, three bimonthly intravenous injections of 7.5, 12.5 or 17.5 mg HspB5 were found to be safe and well tolerated in RR-MS patients. While predefined clinical endpoints did not differ significantly between the relatively small groups of MS patients treated with either HspB5 or placebo, repeated administration especially of the lower doses of HspB5 led to a progressive decline in MS lesion activity as monitored by magnetic resonance imaging (MRI), which was not seen in the placebo group. Exploratory linear regression analysis revealed this decline to be significant in the combined group receiving either of the two lower doses, and to result in a 76% reduction in both number and total volumes of active MRI lesions at 9 months into the study. These data provide the first indication for clinical benefit resulting from intervention in RRMS with HspB5.	[van Noort, Johannes M.; Bsibsi, Malika; Nacken, Peter J.; Verbeek, Richard; Venneker, Edna H. G.] Delta Crystallon, Leiden, Netherlands		van Noort, JM (corresponding author), Delta Crystallon, Leiden, Netherlands.	hans@deltacrystallon.com		van Noort, Johannes/0000-0002-9060-5921	Delta Crystallon BV; Delta Crystallon	Delta Crystallon BV; Delta Crystallon	The funder Delta Crystallon BV provided support in the form of salaries for authors [JMvN, MB, PJN, RV and EHGV] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This commercial affiliation does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.; We are grateful to all volunteers as well as all MS patients, their physicians and caregivers for participation in our studies. We thank dr. F. Hoppener and L. Boneva for coordinating the clinical studies, and drs. F. Barkhof, J. Cohen, G. Giovannoni, R. Ransohoff and L. Steinman for helpful discussions. The authors are paid employees or consultant of Delta Crystallon, the sponsor of the studies. We dedicate this article to the memory of Jan Schram	Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Bajramovic JJ, 1997, J NEUROIMMUNOL, V78, P143, DOI 10.1016/S0165-5728(97)00092-1; Bajramovic JJ, 2000, J IMMUNOL, V164, P4359, DOI 10.4049/jimmunol.164.8.4359; Bsibsi M, 2014, ACTA NEUROPATHOL, V128, P215, DOI 10.1007/s00401-014-1317-8; Bsibsi M, 2013, J NEUROPATH EXP NEUR, V72, P970, DOI 10.1097/NEN.0b013e3182a776bf; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; Daniel C, 2011, ADV IMMUNOL, V112, P177, DOI 10.1016/B978-0-12-387827-4.00005-X; David A, 2014, P NATL ACAD SCI USA, V111, P7735, DOI 10.1073/pnas.1406218111; Goldbaum O, 2001, J NEUROCHEM, V78, P1233, DOI 10.1046/j.1471-4159.2001.00507.x; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hilliard BA, 2000, EXP MOL PATHOL, V68, P29, DOI 10.1006/exmp.1999.2290; Kagitani-Shimono K, 2006, NEUROPATH APPL NEURO, V32, P64, DOI 10.1111/j.1365-2990.2005.00690.x; Klopstein A, 2012, J NEUROSCI, V32, P14478, DOI 10.1523/JNEUROSCI.0923-12.2012; Kurnellas MP, 2012, J BIOL CHEM, V287, P36423, DOI 10.1074/jbc.M112.371229; Masilamoni JG, 2006, BBA-MOL BASIS DIS, V1762, P284, DOI 10.1016/j.bbadis.2005.11.007; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42; PANITCH HS, 1987, LANCET, V1, P893; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Racke MK, 1996, ANN NEUROL, V39, P46, DOI 10.1002/ana.410390108; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Sinclair C, 2005, NEUROPATH APPL NEURO, V31, P292, DOI 10.1111/j.1365-2990.2004.00638.x; Tajouri L, 2003, MOL BRAIN RES, V119, P170, DOI 10.1016/j.molbrainres.2003.09.008; van Noort JM, 2006, MULT SCLER J, V12, P287, DOI 10.1191/135248506ms1271oa; van Noort JM, 2013, BIOMATERIALS, V34, P831, DOI 10.1016/j.biomaterials.2012.10.028; van Noort JM, 2012, CNS NEUROL DISORD-DR, V11, P556; van Noort JM, 2010, J NEUROPATH EXP NEUR, V69, P694, DOI 10.1097/NEN.0b013e3181e4939c; van Sechel AC, 1999, J IMMUNOL, V162, P129; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Wang YH, 2012, J MOL NEUROSCI, V46, P138, DOI 10.1007/s12031-011-9537-z; Wang YH, 2011, OPHTHALMIC RES, V45, P164, DOI 10.1159/000319944; Wu N, 2014, LIFE SCI, V94, P17, DOI 10.1016/j.lfs.2013.10.034; Ying X, 2008, J MOL NEUROSCI, V35, P253, DOI 10.1007/s12031-007-9010-1	36	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143366	10.1371/journal.pone.0143366	http://dx.doi.org/10.1371/journal.pone.0143366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599332	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900100
J	Verty, ANA; Stefanidis, A; McAinch, AJ; Hryciw, DH; Oldfield, B				Verty, A. N. A.; Stefanidis, A.; McAinch, A. J.; Hryciw, D. H.; Oldfield, Brian			Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; CANNABINOID RECEPTOR; INSULIN SENSITIVITY; INDUCED EMESIS; WEIGHT-LOSS; BRAIN-STEM; HIGH-FAT; ANTAGONIST; ACTIVATION; EXPRESSION	The cannabinoid receptor 2 (CB2) is well known for its immune modulatory role. However, recent localisation of CB2 receptors in metabolically active tissue suggests that the CB2 receptor plays a significant role in energy homeostasis. This study was designed to investigate the impact of chronic CB2 receptor stimulation on food intake, body weight and mood. Lean male C57BL/6 mice were injected i.p. with the selective CB2 receptor agonist, JWH-015 (0.0, 1.0, 5.0 and 10.0 mg kg(-1)) to establish dose response parameters. Mice made obese following exposure to a diet consisting of 19.4 MJ/kg (4641 Kcal/kg) of energy (19.0% protein, 21.0% total fat, 4.7% crude fiber, and 4.7% AD fiber were given either vehicle or 10 mg/kg JWH-015. Impact on mood, food intake, body weight, plasma metabolites, expression of key metabolic proteins in the brown adipose tissue (BAT) and white adipose tissue (WAT), and markers of inflammation were measured. High dose (10 mg/kg) JWH-015 reduced food intake after 1, 2, 4, and 24 h in lean mice. When given to diet induced obese (DIO) mice, a 10 mg/kg dose of JWH-015 significantly reduced body weight compared to vehicle. This dose led to a shift in markers of lipid metabolism and inflammation in WAT consistent with lipolysis and improved immune response. Furthermore, JWH-015 (10 mg/kg) produced a transient reduction in food intake and significant reduction in fat mass and adipocyte cell size. Importantly, JWH-015 produced an anxiolytic response in the elevated plus maze while having no effect on immobility time in the forced swim test. It should be noted that though the 10 mg/kg dose produced positive effects on the obese state, the possibility that these effects are mediated via non-CB2 receptor mechanisms cannot be ruled out. These results demonstrate a role for CB2 receptors in modulating energy homeostasis and obesity associated metabolic pathologies in the absence of any adverse impact on mood.	[Verty, A. N. A.; Stefanidis, A.; Oldfield, Brian] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; [Verty, A. N. A.; McAinch, A. J.; Hryciw, D. H.] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis Prevent & Management, St Albans, Vic 3021, Australia; [Hryciw, D. H.] Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia	Monash University; Victoria University; University of Melbourne	Oldfield, B (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.	brian.oldfield@monash.edu	Hryciw, Deanne/P-2642-2019	Hryciw, Deanne/0000-0003-1697-8890; Oldfield, Brian/0000-0002-8609-6589; McAinch, Andrew/0000-0002-8762-4865	National Health and Medical Research Council (NHMRC) Principle Research Fellowship; NHMRC Peter Doherty Postdoctoral Research Fellowship; Australian Government's Collaborative Research Networks (CRN) program; National Health and Medical Research Council (NHMRC) Peter Doherty Postdoctoral Research Fellowship	National Health and Medical Research Council (NHMRC) Principle Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Postdoctoral Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Government's Collaborative Research Networks (CRN) program(Australian Government); National Health and Medical Research Council (NHMRC) Peter Doherty Postdoctoral Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Funding: BJO was the recipient of a National Health and Medical Research Council (NHMRC) Principle Research Fellowship. ANAV was the recipient of a NHMRC Peter Doherty Postdoctoral Research Fellowship during the conduct of these studies. ANAV is currently a Research Fellow at the Centre for Chronic Disease Prevention and Management, College of Health and Biomedicine, Victoria University. AJM was supported through the Australian Government's Collaborative Research Networks (CRN) program.; ANAV was the recipient of the National Health and Medical Research Council (NHMRC) Peter Doherty Postdoctoral Research Fellowship during the conduct of these studies. ANAV is currently a Research Fellow at the Centre for Chronic Disease Prevention and Management, College of Health and Biomedicine, Victoria University. AJM is supported through the Australian Government's Collaborative Research Networks (CRN) program.	Agirregoitia E, 2010, FERTIL STERIL, V93, P1378, DOI 10.1016/j.fertnstert.2009.01.153; Agudo J, 2010, DIABETOLOGIA, V53, P2629, DOI 10.1007/s00125-010-1894-6; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bermudez-Silva FJ, 2007, EUR J PHARMACOL, V565, P207, DOI 10.1016/j.ejphar.2007.02.066; Borner C, 2009, J BIOL CHEM, V284, P35450, DOI 10.1074/jbc.M109.006338; Buckley NE, 2008, BRIT J PHARMACOL, V153, P309, DOI 10.1038/sj.bjp.0707527; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cavuoto P, 2007, BIOCHEM BIOPH RES CO, V364, P105, DOI 10.1016/j.bbrc.2007.09.099; Chin CN, 1999, J PHARMACOL EXP THER, V291, P837; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Darmani NA, 2001, PHARMACOL BIOCHEM BE, V69, P239, DOI 10.1016/S0091-3057(01)00531-7; Darmani NA, 2001, EUR J PHARMACOL, V430, P49, DOI 10.1016/S0014-2999(01)01355-3; De Vry J, 2004, EUR J PHARMACOL, V483, P55, DOI 10.1016/j.ejphar.2003.10.012; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Doyon C, 2006, DIABETES, V55, P3403, DOI 10.2337/db06-0504; Garcia-Gutierrez MS, 2011, J PSYCHOPHARMACOL, V25, P111, DOI 10.1177/0269881110379507; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Griffin G, 1997, EUR J PHARMACOL, V339, P53, DOI 10.1016/S0014-2999(97)01336-8; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Ishiguro H, 2007, PHARMACOGENOMICS J, V7, P380, DOI 10.1038/sj.tpj.6500431; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Li C, 2011, DIABETES OBES METAB, V13, P903, DOI 10.1111/j.1463-1326.2011.01422.x; Mallat A, 2006, J Endocrinol Invest, V29, P58; Manganiello VC, 1996, CURR TOP CELL REGUL, V34, P63, DOI 10.1016/S0070-2137(96)80003-3; McKallip RJ, 2002, BLOOD, V100, P627, DOI 10.1182/blood-2002-01-0098; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; McLaughlin PJ, 2005, PSYCHOPHARMACOLOGY, V180, P286, DOI 10.1007/s00213-005-2171-0; MEIER MK, 1984, INT J OBESITY, V8, P215; Molina-Holgado F, 2003, J NEUROSCI, V23, P6470; Murataeva N, 2012, PHARMACOL RES, V66, P437, DOI 10.1016/j.phrs.2012.08.002; Onaivi ES, 2008, ANN NY ACAD SCI, V1139, P426, DOI 10.1196/annals.1432.035; Onaivi ES, 2008, ANN NY ACAD SCI, V1139, P434, DOI 10.1196/annals.1432.036; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Parker LA, 2011, BRIT J PHARMACOL, V163, P1411, DOI 10.1111/j.1476-5381.2010.01176.x; Perwitz N, 2010, DIABETES OBES METAB, V12, P158, DOI 10.1111/j.1463-1326.2009.01133.x; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Roche R, 2006, HISTOCHEM CELL BIOL, V126, P177, DOI 10.1007/s00418-005-0127-4; Romero-Sandoval A, 2008, ANESTHESIOLOGY, V108, P722, DOI 10.1097/ALN.0b013e318167af74; Romero-Zerbo SY, 2012, J NEUROENDOCRINOL, V24, P1106, DOI 10.1111/j.1365-2826.2012.02325.x; Ryan AS, 2004, DIABETES CARE, V27, P1699, DOI 10.2337/diacare.27.7.1699; Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Simoneau II, 2001, ANESTHESIOLOGY, V94, P882, DOI 10.1097/00000542-200105000-00029; Sindelka G, 2002, PHYSIOL RES, V51, P85; Spoto B, 2006, BIOCHIMIE, V88, P1889, DOI 10.1016/j.biochi.2006.07.019; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Straczkowski M, 2005, DIABETES CARE, V28, P2036, DOI 10.2337/diacare.28.8.2036; Thornton C, 2008, J BIOL CHEM, V283, P17116, DOI 10.1074/jbc.M708987200; Trebicka J, 2011, LIVER INT, V31, P862, DOI 10.1111/j.1478-3231.2011.02496.x; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Van Sickle MD, 2003, AM J PHYSIOL-GASTR L, V285, pG566, DOI 10.1152/ajpgi.00113.2003; Van Sickle MD, 2001, GASTROENTEROLOGY, V121, P767, DOI 10.1053/gast.2001.28466; Verty ANA, 2009, OBESITY, V17, P254, DOI 10.1038/oby.2008.509; Verty ANA, 2005, NEUROPHARMACOLOGY, V49, P1101, DOI 10.1016/j.neuropharm.2005.03.025; Verty ANA, 2004, NEUROSCI LETT, V354, P217, DOI 10.1016/j.neulet.2003.10.035; Wang Mengmeng, 2011, Drug Metab Lett, V5, P55, DOI 10.2174/187231211794455280; Werner NA, 2003, BRAIN RES, V967, P290, DOI 10.1016/S0006-8993(02)04274-9; Williams CM, 2002, PHYSIOL BEHAV, V76, P241, DOI 10.1016/S0031-9384(02)00725-4; Williams CM, 2002, PHARMACOL BIOCHEM BE, V71, P333, DOI 10.1016/S0091-3057(01)00694-3; Zhang Q, 2006, ANAL BIOANAL CHEM, V386, P1345, DOI 10.1007/s00216-006-0717-6; Zhang X, 2009, CLIN EXP PHARMACOL P, V36, P631, DOI 10.1111/j.1440-1681.2008.05129.x	76	60	60	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0140592	10.1371/journal.pone.0140592	http://dx.doi.org/10.1371/journal.pone.0140592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588700	Green Published, Green Accepted, gold			2022-12-27	WOS:000365251500001
J	Zaske, R; Muhl, C; Schweinberger, SR				Zaeske, Romi; Muehl, Constanze; Schweinberger, Stefan R.			Benefits for Voice Learning Caused by Concurrent Faces Develop over Time	PLOS ONE			English	Article							EARWITNESS TESTIMONY; RECOGNITION; VARIETY; SPEAKER; MEMORY	Recognition of personally familiar voices benefits from the concurrent presentation of the corresponding speakers' faces. This effect of audiovisual integration is most pronounced for voices combined with dynamic articulating faces. However, it is unclear if learning unfamiliar voices also benefits from audiovisual face-voice integration or, alternatively, is hampered by attentional capture of faces, i.e., "face-overshadowing". In six study-test cycles we compared the recognition of newly-learned voices following unimodal voice learning vs. bimodal face-voice learning with either static (Exp. 1) or dynamic articulating faces (Exp. 2). Voice recognition accuracies significantly increased for bimodal learning across study-test cycles while remaining stable for unimodal learning, as reflected in numerical costs of bimodal relative to unimodal voice learning in the first two study-test cycles and benefits in the last two cycles. This was independent of whether faces were static images (Exp. 1) or dynamic videos (Exp. 2). In both experiments, slower reaction times to voices previously studied with faces compared to voices only may result from visual search for faces during memory retrieval. A general decrease of reaction times across study-test cycles suggests facilitated recognition with more speaker repetitions. Overall, our data suggest two simultaneous and opposing mechanisms during bimodal face-voice learning: while attentional capture of faces may initially impede voice learning, audiovisual integration may facilitate it thereafter.	[Zaeske, Romi; Schweinberger, Stefan R.] Univ Jena, Inst Psychol, Dept Gen Psychol & Cognit Neurosci, Jena, Germany; [Muehl, Constanze] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	Friedrich Schiller University of Jena; Bangor University	Zaske, R (corresponding author), Univ Jena, Inst Psychol, Dept Gen Psychol & Cognit Neurosci, Jena, Germany.	romi.zaeske@uni-jena.de	Schweinberger, Stefan/A-1860-2009	Schweinberger, Stefan/0000-0001-5762-0188	Deutsche Forschungsgemeinschaft [ZA 745/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was funded by ZA 745/1-1, granted to RZ and SS (Deutsche Forschungsgemeinschaft; http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2003, PSYCHOL SCI, V14, P427, DOI 10.1111/1467-9280.01458; Armstrong HA, 1996, J GEN PSYCHOL, V123, P259, DOI 10.1080/00221309.1996.9921278; Boersma Paul, 2002, GLOT INT, V5, P341; BRICKER PD, 1966, J ACOUST SOC AM, V40, P1441, DOI 10.1121/1.1910246; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Cook S, 1997, APPL COGNITIVE PSYCH, V11, P95; Cook S, 1997, APPL COGNITIVE PSYCH, V11, P527, DOI 10.1002/(SICI)1099-0720(199712)11:6<527::AID-ACP483>3.0.CO;2-B; Hanley JR, 2009, MEMORY, V17, P830, DOI 10.1080/09658210903264175; Hanley JR, 2000, Q J EXP PSYCHOL-A, V53, P1105, DOI 10.1080/02724980050156317; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Kamachi M, 2003, CURR BIOL, V13, P1709, DOI 10.1016/j.cub.2003.09.005; LEGGE GE, 1984, J EXP PSYCHOL LEARN, V10, P298; MACMILLAN NA, 1985, PSYCHOL BULL, V98, P185, DOI 10.1037/0033-2909.98.1.185; MCALLISTER HA, 1993, BASIC APPL SOC PSYCH, V14, P161, DOI 10.1207/s15324834basp1402_3; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Neuner F, 2000, BRAIN COGNITION, V44, P342, DOI 10.1006/brcg.1999.1196; POLLACK I, 1954, J ACOUST SOC AM, V26, P403, DOI 10.1121/1.1907349; ROEBUCK R, 1993, APPL COGNITIVE PSYCH, V7, P475, DOI 10.1002/acp.2350070603; Schweinberger SR, 2007, Q J EXP PSYCHOL, V60, P1446, DOI 10.1080/17470210601063589; Schweinberger SR, 2011, CORTEX, V47, P1026, DOI 10.1016/j.cortex.2010.11.011; Sheffert SM, 2004, PERCEPT PSYCHOPHYS, V66, P352, DOI 10.3758/BF03194884; Stevenage SV, 2011, APPL COGNITIVE PSYCH, V25, P112, DOI 10.1002/acp.1649; von Kriegstein K, 2005, J COGNITIVE NEUROSCI, V17, P367, DOI 10.1162/0898929053279577; Wiese H, 2014, NEUROPSYCHOLOGIA, V56, P26, DOI 10.1016/j.neuropsychologia.2013.12.023; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004; Zaske R, 2014, J NEUROSCI, V34, P10821, DOI 10.1523/JNEUROSCI.0581-14.2014	26	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143151	10.1371/journal.pone.0143151	http://dx.doi.org/10.1371/journal.pone.0143151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW8LQ	26588847	gold, Green Published			2022-12-27	WOS:000365251500034
J	Bled, F; Summers, S; Martell, D; Petroelje, TR; Beyer, DE; Belant, JL				Bled, Florent; Summers, Savanna; Martell, Deborah; Petroelje, Tyler R.; Beyer, Dean E., Jr.; Belant, Jerrold L.			Effects of Prey Presence and Scale on Bobcat Resource Selection during Winter	PLOS ONE			English	Article							HARES LEPUS-AMERICANUS; DEN-SITE SELECTION; HOME-RANGE SIZE; HABITAT SELECTION; SNOWSHOE HARES; LYNX-RUFUS; GRIZZLY BEARS; SPACE USE; ROADS; LANDSCAPE	Factors relevant to resource selection in carnivores may vary across spatial and temporal scales, both in magnitude and rank. Understanding relationships among carnivore occupancy, prey presence, and habitat characteristics, as well as their interactions across multiple scales, is necessary to improve our understanding of resource selection and predict population changes. We used a multi-scale dynamic hierarchical co-occurrence model with camera data to study bobcat and snowshoe hare occupancy in the Upper Peninsula of Michigan during winter 2012-2013. Bobcat presence was influenced at the local scale by snowshoe hare presence, and by road density at the local and larger scale when hare were absent. Hare distribution was related primarily to vegetation cover types, and detectability varied in space and time. Bobcat occupancy dynamics were influenced by different factors depending on the spatial scale considered and the resource availability context. Moreover, considering observed co-occurrence, we suggest that bobcat presence had a greater effect on hare occupancy than hare presence on bobcat occupancy. Our results highlight the importance of studying carnivore distributions in the context of predator-prey relationships and its interactions with environmental covariates at multiple spatial scales. Our approach can be applied to other carnivore species to provide insights beneficial for management and conservation.	[Bled, Florent; Summers, Savanna; Martell, Deborah; Petroelje, Tyler R.; Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA; [Beyer, Dean E., Jr.] Michigan Dept Nat Resources, Wildlife Div, Marquette, MI USA	Mississippi State University	Bled, F (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA.	florent.bled@gmail.com	Belant, Jerrold/HDM-7749-2022	Petroelje, Tyler/0000-0003-4957-6732	Federal Aid in Wildlife Restoration; Michigan Department of Natural Resources; Safari Club International Foundation; Michigan Involvement Committee of Safari Club International Foundation; Undergraduate Research Scholars Program of Mississippi State University	Federal Aid in Wildlife Restoration; Michigan Department of Natural Resources; Safari Club International Foundation; Michigan Involvement Committee of Safari Club International Foundation; Undergraduate Research Scholars Program of Mississippi State University	This study was supported by the Federal Aid in Wildlife Restoration; Michigan Department of Natural Resources; Safari Club International Foundation; Michigan Involvement Committee of Safari Club International Foundation; and Undergraduate Research Scholars Program of Mississippi State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, US CENSUS TOPOLOGICA; BAILEY TN, 1974, J WILDLIFE MANAGE, V38, P435, DOI 10.2307/3800874; Bailey TN, 1979, P BOBC RES C NAT WIL, V6, P62; BERGIN TM, 1992, CONDOR, V94, P903, DOI 10.2307/1369287; Bled F, 2013, ECOL EVOL, V3, P4896, DOI 10.1002/ece3.858; BOUTIN S, 1984, OECOLOGIA, V62, P393, DOI 10.1007/BF00384273; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Boyle KA, 1987, BIOL REPORT, V82; BRADLEY LC, 1988, J RANGE MANAGE, V41, P322, DOI 10.2307/3899388; Cain AT, 2003, BIOL CONSERV, V114, P189, DOI 10.1016/S0006-3207(03)00023-5; Carpenter B., 2009, BAYESIAN COUNTERPART; Chamberlain M, 2003, AM MIDL NAT, V149, P395, DOI 10.1674/0003-0031(2003)149[0395:SUMAHS]2.0.CO;2; Congdon P, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0470092394; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Elfstrom M, 2008, WILDLIFE BIOL, V14, P176, DOI 10.2981/0909-6396(2008)14[176:SODHBS]2.0.CO;2; Erb PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042574; Evink GL., 1996, P TRANSPORTATION REL; Fahrig L, 2009, ECOL SOC, V14; Feierabend D, 2014, J MAMMAL, V95, P525, DOI 10.1644/13-MAMM-A-199; FULLER TK, 1985, J MAMMAL, V66, P568, DOI 10.2307/1380938; Gelman A., 2009, WHAT IS BAYESIAN COU; Gelman A., 2021, BAYESIAN DATA ANAL; Godbois IA, 2003, PROCEEDINGS OF THE FIFTY-SEVENTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P228; Hodges KE, 2005, CAN J ZOOL, V83, P280, DOI 10.1139/Z05-015; Jin S., 2011, REMOTE SENS ENVIRON, V132, P159, DOI DOI 10.1016/J.RSE.2013.01.012; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Kamler JF, 2000, CAN FIELD NAT, V114, P388; KEITH LB, 1993, CAN J ZOOL, V71, P1385, DOI 10.1139/z93-191; KEITH LB, 1984, WILDLIFE MONOGR, P1; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; KNICK ST, 1990, WILDLIFE MONOGR, P1; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Krebs C.J., 2001, ECOSYSTEM DYNAMICS B; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Lewis CW, 2011, J MAMMAL, V92, P561, DOI 10.1644/10-MAMM-A-095.1; Libal NS, 2012, URSUS, V23, P226, DOI 10.2192/URSUS-D-12-00002.1; LITVAITIS JA, 1986, J WILDLIFE MANAGE, V50, P110, DOI 10.2307/3801498; LITVAITIS JA, 1985, J WILDLIFE MANAGE, V49, P866, DOI 10.2307/3801359; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mao JS, 2005, J WILDLIFE MANAGE, V69, P1691, DOI 10.2193/0022-541X(2005)69[1691:HSBEBA]2.0.CO;2; McCann NP, 2011, CAN J ZOOL, V89, P509, DOI [10.1139/Z11-016, 10.1139/z11-016]; MCCORD CM, 1974, J MAMMAL, V55, P428, DOI 10.2307/1379010; McLoughlin PD, 2002, OECOLOGIA, V132, P102, DOI 10.1007/s00442-002-0941-5; MURRAY DL, 1994, CAN J ZOOL, V72, P1444, DOI 10.1139/z94-191; O'Donoghue M, 1997, THESIS; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; ORR C D, 1982, Wildlife Society Bulletin, V10, P147; PIETZ PJ, 1983, J WILDLIFE MANAGE, V47, P686, DOI 10.2307/3808604; R Core Team, 2014, LANG ENV STAT COMP; ROLLEY RE, 1985, J WILDLIFE MANAGE, V49, P913, DOI 10.2307/3801369; Royle J. A., 2008, HIERARCHICAL MODELIN; Saunders SC, 2002, BIOL CONSERV, V103, P209, DOI 10.1016/S0006-3207(01)00130-6; Shannon G, 2014, PEERJ, V2, DOI 10.7717/peerj.532; SIEVERT PR, 1985, J WILDLIFE MANAGE, V49, P854, DOI 10.2307/3801358; Squires JR, 2008, J WILDLIFE MANAGE, V72, P1497, DOI 10.2193/2007-396; Stricker HK, 2012, WILDLIFE SOC B, V36, P257, DOI 10.1002/wsb.137; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Ten Hwang Y, 2007, CAN J ZOOL, V85, P33, DOI 10.1139/Z06-192; Thorn M, 2009, S AFR J WILDL RES, V39, P1, DOI 10.3957/056.039.0101; Thornton DH, 2013, ECOGRAPHY, V36, P610, DOI 10.1111/j.1600-0587.2012.07737.x; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Tucker SA, 2008, J WILDLIFE MANAGE, V72, P1114, DOI 10.2193/2007-291; Waddle JH, 2010, ECOL APPL, V20, P1467, DOI 10.1890/09-0850.1; Waller BW, 2013, MAMM STUDY, V38, P211, DOI 10.3106/041.038.0309; Whittington J, 2004, ECOL SOC, V9; Wilton CM, 2016, J MAMMAL IN PRESS; WOLFF JO, 1980, ECOL MONOGR, V50, P111, DOI 10.2307/2937249	69	3	3	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143347	10.1371/journal.pone.0143347	http://dx.doi.org/10.1371/journal.pone.0143347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581103	Green Published, gold			2022-12-27	WOS:000365154600112
J	McCain, J; Gentile, B; Campbell, WK				McCain, Jessica; Gentile, Brittany; Campbell, W. Keith			A Psychological Exploration of Engagement in Geek Culture	PLOS ONE			English	Article							NARCISSISTIC PERSONALITY-INVENTORY; SELF-ESTEEM; INTERPERSONAL MONITOR; NEED; INTELLIGENCE; SATISFACTION; VALIDATION; SCHIZOTYPY; VALIDITY; SCALE	Geek culture is a subculture of enthusiasts that is traditionally associated with obscure media (Japanese animation, science fiction, video games, etc.). However, geek culture is becoming increasingly mainstream; for example, in the past year alone, Dragon*Con, a major Geek convention in Atlanta, Georgia, attracted an attendance of over 57,000 members. The present article uses an individual differences approach to examine three theoretical accounts of geek culture. Seven studies (N = 2354) develop the Geek Culture Engagement Scale (GCES) to quantify geek engagement and assess its relationships to theoretically relevant personality and individual differences variables. These studies present evidence that individuals may engage in geek culture in order to maintain narcissistic self-views (the great fantasy migration hypothesis), to fulfill belongingness needs (the belongingness hypothesis), and to satisfy needs for creative expression (the need for engagement hypothesis). Geek engagement is found to be associated with elevated grandiose narcissism, extraversion, openness to experience, depression, and subjective wellbeing across multiple samples. These data lay the groundwork for further exploration of geek culture as well as provide a foundation for examining other forms of subculture participation.	[McCain, Jessica; Campbell, W. Keith] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Gentile, Brittany] ICON Plc, Outcomes Res, San Francisco, CA USA	University System of Georgia; University of Georgia; ICON plc	McCain, J (corresponding author), Univ Georgia, Dept Psychol, Athens, GA 30602 USA.	mccainjl@uga.edu		Gentile, Brittany/0000-0002-6302-5593	Icon Plc	Icon Plc	The authors received no specific funding for this work. Icon Plc provided support in the form of salaries for Brittany Gentile, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Ackerman RA, 2011, ASSESSMENT, V18, P67, DOI 10.1177/1073191110382845; Alfonso V.C., 2013, ESSENTIALS CROSS BAT; [Anonymous], 2013, BOX OFF MOJ COM BOOK; Ashton MC, 2000, J RES PERS, V34, P198, DOI 10.1006/jrpe.1999.2276; Baard PP, 2004, J APPL SOC PSYCHOL, V34, P2045, DOI 10.1111/j.1559-1816.2004.tb02690.x; Bachman J, 1983, MONITORING FUTURE CO; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; Campbell WK, 2004, J PERS ASSESS, V83, P29, DOI 10.1207/s15327752jpa8301_04; CLARIDGE G, 1984, PERS INDIV DIFFER, V5, P633, DOI 10.1016/0191-8869(84)90111-9; Deci E.L., 1980, ADV EXPT SOCIAL PSYC, P39, DOI [DOI 10.1016/S0065-2601(08)60130-6, 10.1016/S0065-2601(08)60130-6]; DECI EL, 1985, J RES PERS, V19, P109, DOI 10.1016/0092-6566(85)90023-6; Denison R, 2011, CREAT IND J, V3, P221, DOI [10.13896/cij.3.3.221_1, DOI 10.1386/CIJ.3.3.221_]; Denison R, 2011, INT J CULTURAL STUD, V14, P449, DOI 10.1177/1367877910394565; DeYoung CG, 2012, J RES PERS, V46, P63, DOI 10.1016/j.jrp.2011.12.003; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; EMMONS RA, 1984, J PERS ASSESS, V48, P291, DOI 10.1207/s15327752jpa4803_11; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Fleischhauer M, 2010, PERS SOC PSYCHOL B, V36, P82, DOI 10.1177/0146167209351886; Gentile B, 2013, PSYCHOL ASSESSMENT, V25, P1120, DOI 10.1037/a0033192; Harris JA, 2004, PERS INDIV DIFFER, V36, P913, DOI 10.1016/S0191-8869(03)00161-2; Hendin HM, 1997, J RES PERS, V31, P588, DOI 10.1006/jrpe.1997.2204; Heywood HB, 1931, P R SOC LOND A-CONTA, V134, P486, DOI 10.1098/rspa.1931.0209; Hill RW, 1998, CURR PSYCHOL, V17, P163, DOI 10.1007/s12144-998-1003-x; Hodgins HS, 1996, PERS SOC PSYCHOL B, V22, P227, DOI 10.1177/0146167296223001; Ibraham I, 2013, P POP CULTURE ASS AM; Iwasaki Y, 2000, LEISURE SCI, V22, P163, DOI 10.1080/01490409950121843; Jancovich M, 2002, CULT STUD, V16, P306, DOI 10.1080/09502380110107607; Jennings MK, 2003, PUBLIC OPIN QUART, V67, P311, DOI 10.1086/376947; KERNIS MH, 1994, J RES PERS, V28, P4, DOI 10.1006/jrpe.1994.1002; Klinger E, 2009, J RES PERS, V43, P506, DOI 10.1016/j.jrp.2008.12.017; KOLIN EA, 1964, J CONSULT PSYCHOL, V28, P477; Konzack L, 2006, P IN FUN N GAM C, P71; La Guardia JG, 2000, J PERS SOC PSYCHOL, V79, P367, DOI 10.1037//0022-3514.79.3.367; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Leary MR, 2003, PSYCHOL INQ, V14, P270; Lord F. M., 1968, STAT THEORIES MENTAL; LYNN SJ, 1986, J PERS SOC PSYCHOL, V51, P404, DOI 10.1037/0022-3514.51.2.404; Martindale C., 1999, HDB CREATIVITY, P137, DOI [DOI 10.1017/CBO9780511807916.009, 10.1017/CBO9780511807916.009]; McArthur JA, 2009, J COMMUN INQ, V33, P58, DOI 10.1177/0196859908325676; McCarty C, 2007, SOC NETWORKS, V29, P300, DOI 10.1016/j.socnet.2006.12.005; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Merckelbach H, 2001, PERS INDIV DIFFER, V31, P987, DOI 10.1016/S0191-8869(00)00201-4; Miller GF, 2007, SCHIZOPHR RES, V93, P317, DOI 10.1016/j.schres.2007.02.007; Morf CC, 2001, PSYCHOL INQ, V12, P177, DOI 10.1207/S15327965PLI1204_1; Mullins-Sweatt SN, 2006, ASSESSMENT, V13, P119, DOI 10.1177/1073191106286748; Naumann LP, 2009, PERS SOC PSYCHOL B, V35, P1661, DOI 10.1177/0146167209346309; Nerdsl Woo B., 2012, THESIS; O'Connor BP, 2001, J PERS SOC PSYCHOL, V81, P1119, DOI 10.1037/0022-3514.81.6.1119; Paulhus DL, 1998, J PERS SOC PSYCHOL, V74, P1197, DOI 10.1037/0022-3514.74.5.1197; Putnam R. D., 2001, BOWLING ALONE COLLAP; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Rosenberg M., SOC ADOLESCENT SELF; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rosenthal SA, 2006, LEADERSHIP QUART, V17, P617, DOI 10.1016/j.leaqua.2006.10.005; Runco MA, 2011, RUNCO CREATIVITY ASS; SAUCIER G, 1994, J PERS ASSESS, V63, P506, DOI 10.1207/s15327752jpa6303_8; Schuldberg D, 2000, CREATIVITY RES J, V13, P5; Sedikides C, 2004, J PERS SOC PSYCHOL, V87, P400, DOI 10.1037/0022-3514.87.3.400; Shipley WC, 1940, J PSYCHOL, V9, P371, DOI 10.1080/00223980.1940.9917704; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; TOCCI JASON, 2009, THESIS; Trepte S, 2006, PSYCHOLOGY OF ENTERTAINMENT, P255; Twenge J. M., 2012, J PERS SOC PSYCHOL, V102, P1045, DOI DOI 10.1037/A0027408; Twenge JM, 2008, J PERS, V76, P875, DOI 10.1111/j.1467-6494.2008.00507.x; Twenge JM, 2012, SELF IDENTITY, V11, P409, DOI 10.1080/15298868.2011.576820; TWENGE JEAN M., 2009, NARCISSISM EPIDEMIC; Vazire S, 2008, J RES PERS, V42, P1439, DOI 10.1016/j.jrp.2008.06.007; Wallace HM, 2009, SELF IDENTITY, V8, P78, DOI 10.1080/15298860802194346; Wechsler D., 2012, WAIS 4 KASIKIRJA; Whiteman N., 2009, CONVERGENCE-US, V15, P391, DOI DOI 10.1177/1354856509342341; Woo B, 2012, EUR J CULT STUD, V15, P659, DOI 10.1177/1367549412445758; Zuckerman M, DEV SENSATION SEEKIN	80	18	18	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142200	10.1371/journal.pone.0142200	http://dx.doi.org/10.1371/journal.pone.0142200			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26580564	gold, Green Published			2022-12-27	WOS:000365154600038
J	Suffoletto, B; Kristan, J; Chung, T; Jeong, K; Fabio, A; Monti, P; Clark, DB				Suffoletto, Brian; Kristan, Jeffrey; Chung, Tammy; Jeong, Kwonho; Fabio, Anthony; Monti, Peter; Clark, Duncan B.			An Interactive Text Message Intervention to Reduce Binge Drinking in Young Adults: A Randomized Controlled Trial with 9-Month Outcomes	PLOS ONE			English	Article							ALCOHOL-USE; MOTIVATIONAL INTERVENTIONS; COLLEGE-STUDENTS; BEHAVIOR-CHANGE; EMERGENCY CARE; AUDIT-C; VALIDATION; DEPENDENCE	Background Binge drinking is associated with numerous negative consequences. The prevalence and intensity of binge drinking is highest among young adults. This randomized trial tested the efficacy of a 12-week interactive text message intervention to reduce binge drinking up to 6 months after intervention completion among young adults. Methods and Findings Young adult participants (18-25 y; n = 765) drinking above the low-risk limits (AUDIT-C score >3/4 women/men), but not seeking alcohol treatment, were enrolled from 4 Emergency Departments (EDs) in Pittsburgh, PA. Participants were randomized to one of three conditions in a 2:1:1 allocation ratio: SMS Assessments + Feedback (SA+F), SMS Assessments (SA), or control. For 12 weeks, SA+F participants received texts each Thursday querying weekend drinking plans and prompting drinking limit goal commitment and each Sunday querying weekend drinking quantity. SA+F participants received tailored feedback based on their text responses. To contrast the effects of SA+F with self-monitoring, SA participants received texts on Sundays querying drinking quantity, but did not receive alcohol-specific feedback. The control arm received standard care. Follow-up outcome data collected through web-based surveys were provided by 78% of participants at 3-months, 63% at 6-months and 55% at 9-months. Multiple imputation-derived, intent-to-treat models were used for primary analysis. At 9-months, participants in the SA+F group reported greater reductions in the number of binge drinking days than participants in the control group (incident rate ratio [IRR] 0.69; 95% CI .59 to .79), lower binge drinking prevalence (odds ratio [OR] 0.52; 95% CI 0.26 to 0.98]), less drinks per drinking day (beta - .62; 95% CI -1.10 to -0.15) and lower alcohol-related injury prevalence (OR 0.42; 95% CI 0.21 to 0.88). Participants in the SA group did not reduce drinking or alcohol-related injury relative to controls. Findings were similar using complete case analyses. Conclusions An interactive text-message intervention was more effective than self-monitoring or controls in reducing alcohol consumption and alcohol-related injury prevalence up to 6 months after intervention completion. These findings, if replicated, suggest a scalable approach to help achieve sustained reductions in binge drinking and accompanying injuries among young adults.	[Suffoletto, Brian; Kristan, Jeffrey] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15213 USA; [Chung, Tammy; Clark, Duncan B.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Jeong, Kwonho; Fabio, Anthony] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Monti, Peter] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University	Suffoletto, B (corresponding author), Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15213 USA.	suffbp@upmc.edu	Chung, Tammy/B-9712-2017; Suffoletto, Brian/M-4800-2019	Chung, Tammy/0000-0002-1527-2792; Suffoletto, Brian/0000-0002-9628-5260; Fabio, Anthony/0000-0002-6808-4939	Emergency Medicine Foundation Grant;  [K23 AA023284];  [K05 AA019681];  [P01 AA019072];  [R01AA016482];  [P50DA05605]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA023284, R01AA016482, K05AA019681, P01AA019072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005605] Funding Source: NIH RePORTER	Emergency Medicine Foundation Grant; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was supported by an Emergency Medicine Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Suffoletto is supported by K23 AA023284. Dr. Monti is supported by K05 AA019681 and P01 AA019072. D. Clark is supported by R01AA016482 and P50DA05605.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Bernstein E, 2010, ALCOHOL ALCOHOLISM, V45, P514, DOI 10.1093/alcalc/agq058; Bertholet N, 2014, ALCOHOL CLIN EXP RES, V38, P853, DOI 10.1111/acer.12274; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Carey KB, 2012, CLIN PSYCHOL REV, V32, P690, DOI 10.1016/j.cpr.2012.08.001; Carey KB, 2009, ADDICTION, V104, P1807, DOI 10.1111/j.1360-0443.2009.02691.x; Clark DB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000214; Cohn AM, 2011, ALCOHOL CLIN EXP RES, V35, P2209, DOI 10.1111/j.1530-0277.2011.01571.x; Cunningham RM, 2010, ANN EMERG MED, V55, P556, DOI 10.1016/j.annemergmed.2010.03.004; D'Onofrio G, 2012, ANN EMERG MED, V60, P181, DOI 10.1016/j.annemergmed.2012.02.006; Del Boca FK, 2004, J CONSULT CLIN PSYCH, V72, P155, DOI 10.1037/0022-006X.72.2.155; Donovan DM, 2015, J SUBST ABUSE TREAT, V50, P67, DOI 10.1016/j.jsat.2014.10.013; Fortuna RJ, 2010, J GEN INTERN MED, V25, P663, DOI 10.1007/s11606-010-1313-1; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Hingson RW, 2009, J STUD ALCOHOL DRUGS, P12, DOI 10.15288/jsads.2009.s16.12; Humeniuk R, 2008, ADDICTION, V103, P1039, DOI 10.1111/j.1360-0443.2007.02114.x; Kanny D, 2015, MMWR-MORBID MORTAL W, V63, P1238; Kohut A., 2011, GLOBAL DIGITAL COMMU; Kristan J, 2015, TRANSL BEHAV MED, V5, P45, DOI 10.1007/s13142-014-0298-4; Mason M, 2015, PREV SCI, V16, P181, DOI 10.1007/s11121-014-0498-7; McCambridge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023748; McPherson S, 2013, HUM PSYCHOPHARM CLIN, V28, P506, DOI 10.1002/hup.2339; Mello MJ, 2005, ANN EMERG MED, V45, P620, DOI 10.1016/j.annemergmed.2005.01.026; Michie S, 2012, ADDICTION, V107, P1431, DOI 10.1111/j.1360-0443.2012.03845.x; Monti PM, 2007, ADDICTION, V102, P1234, DOI 10.1111/j.1360-0443.2007.01878.x; Morgenstern J, 2014, ALCOHOL RES-CURR REV, V36, P101; Potts R, 1997, J PEDIATR PSYCHOL, V22, P533, DOI 10.1093/jpepsy/22.4.533; Rubinsky AD, 2013, ALCOHOL CLIN EXP RES, V37, P1380, DOI 10.1111/acer.12092; Searles JS, 2000, PSYCHOL ADDICT BEHAV, V14, P277, DOI 10.1037/0893-164X.14.3.277; Smith A, 2011, AM TEST MESSAGING; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H; Suffoletto B, 2014, ANN EMERG MED, V64, P664, DOI 10.1016/j.annemergmed.2014.06.010; Suffoletto B, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-93; Suffoletto B, 2012, ALCOHOL CLIN EXP RES, V36, P552, DOI 10.1111/j.1530-0277.2011.01646.x; Taggart IH, 2013, J EMERG MED, V45, P962, DOI 10.1016/j.jemermed.2013.05.065	38	77	77	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142877	10.1371/journal.pone.0142877	http://dx.doi.org/10.1371/journal.pone.0142877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26580802	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000365154600064
J	Beileke, S; Claassen, H; Wagner, W; Matthies, C; Ruf, C; Hartmann, A; Garreis, F; Paulsen, F; Schicht, M; Brauer, L				Beileke, Stephanie; Claassen, Horst; Wagner, Walter; Matthies, Cord; Ruf, Christian; Hartmann, Arndt; Garreis, Fabian; Paulsen, Friedrich; Schicht, Martin; Braeuer, Lars			Expression and Localization of Lung Surfactant Proteins in Human Testis	PLOS ONE			English	Article							PULMONARY SURFACTANT; CHRONIC RHINOSINUSITIS; MUCOSA	Background Surfactant proteins (SPs) have been described in various tissues and fluids including tissues of the nasolacrimal apparatus, airways and digestive tract. Human testis have a glandular function as a part of the reproductive and the endocrine system, but no data are available on SPs in human testis and prostate under healthy and pathologic conditions. Objective The aim of the study was the detection and characterization of the surfactant proteins A, B, C and D (SP-A, SP-B, SP-C, SP-D) in human testis. Additionally tissue samples affected by testicular cancer were investigated. Results Surfactant proteins A, B, C and D were detected using RT-PCR in healthy testis. By means of Western blot analysis, these SPs were detected at the protein level in normal testis, seminoma and seminal fluid, but not in spermatozoa. Expression of SPs was weaker in seminoma compared to normal testicular tissue. SPs were localized in combination with vimentin immunohistochemically in cells of Sertoli and Leydig. Conclusion Surfactant proteins seem to be inherent part of the human testis. By means of physicochemical properties the proteins appear to play a role during immunological and rheological process of the testicular tissue. The presence of SP-B and SP-C in cells of Sertoli correlates with their function of fluid secretion and may support transportation of spermatozoa. In seminoma the expression of all SP's was generally weaker compared to normal germ cells. This could lead to a reduction of immunomodulatory and rheology processes in the germ cell tumor.	[Beileke, Stephanie; Garreis, Fabian; Paulsen, Friedrich; Schicht, Martin; Braeuer, Lars] Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany; [Claassen, Horst] Univ Halle Wittenberg, Inst Anat & Cell Biol, D-06108 Halle, Saale, Germany; [Wagner, Walter; Matthies, Cord; Ruf, Christian] Fed Armed Forces Hosp Hamburg, Dept Urol, Hamburg, Germany; [Hartmann, Arndt] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany	University of Erlangen Nuremberg; Martin Luther University Halle Wittenberg; University of Erlangen Nuremberg	Brauer, L (corresponding author), Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany.	lars.braeuer@anatomie2.med.uni-erlangen.de		Schicht, Martin/0000-0001-5155-5477; Paulsen, Friedrich/0000-0002-0527-0953	German Research Foundation (DFG) [1329/12-1 BR, BR 3681/2-1]; Wilhelm Roux Program, Halle, Germany [FKZ 17/20]	German Research Foundation (DFG)(German Research Foundation (DFG)); Wilhelm Roux Program, Halle, Germany	This study was supported by the German Research Foundation (DFG, Program Grants 1329/12-1 BR and BR 3681/2-1) and the Wilhelm Roux Program, Halle, Germany (Program Grants FKZ 17/20).	Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bourbon JR, 2001, COMP BIOCHEM PHYS A, V129, P151, DOI 10.1016/S1095-6433(01)00312-9; Brauer L, 2007, CURR EYE RES, V32, P931, DOI 10.1080/02713680701694369; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Brauer L, 2009, HISTOCHEM CELL BIOL, V132, P331, DOI 10.1007/s00418-009-0609-x; Brauer L, 2012, BIOMED TECH, V2011, P0113; Castano JP, 1997, AM J PHYSIOL-ENDOC M, V272, pE390, DOI 10.1152/ajpendo.1997.272.3.E390; CURSTEDT T, 1988, EUR J BIOCHEM, V172, P521, DOI 10.1111/j.1432-1033.1988.tb13918.x; Davidoff MS, 1996, BIOMED REV, V6, P11; Ferguson JS, 1999, J IMMUNOL, V163, P312; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Glowina A, 2011, ATEMWEGS LUNGENKRA S, V31, P1; Hartshorn Kevan L, 2010, Front Biosci (Schol Ed), V2, P527; Holstein A F, 1996, Int J Urol, V3, P165; Holstein Adolf-Friedrich, 2003, Reprod Biol Endocrinol, V1, P107, DOI 10.1186/1477-7827-1-107; Holstein AF, 1981, DERMATOL PRAXIS, P503; Holstein AF, 2003, MANNLICHE GESCHLECHT, P799; Holstein AF, 1977, UROLOGE            B, VB 17, P1; Kankavi O, 2014, RENAL FAILURE, V36, P258, DOI 10.3109/0886022X.2013.846831; Kim JK, 2007, AM J PHYSIOL-LUNG C, V292, pL879, DOI 10.1152/ajplung.00156.2006; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Krege S, 2008, EUR UROL, V53, P478, DOI 10.1016/j.eururo.2007.12.024; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Liu J, 2015, SHOCK, V43, P31, DOI 10.1097/SHK.0000000000000270; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; NOTTER RH, 1987, CHEM PHYS LIPIDS, V44, P1, DOI 10.1016/0009-3084(87)90002-8; Oberley RE, 2005, PROSTATE, V65, P241, DOI 10.1002/pros.20292; Ooi EH, 2007, LARYNGOSCOPE, V117, P51, DOI 10.1097/01.mlg.0000243196.75418.6f; Paananen R, 2001, AM J PHYSIOL-LUNG C, V280, pL214, DOI 10.1152/ajplung.2001.280.2.L214; Paulsen F, 2004, CELL TISSUE RES, V316, P167, DOI 10.1007/s00441-004-0877-7; Ruf CG, 2013, J UROLOGY, V190, P1046, DOI 10.1016/j.juro.2013.04.022; Salari R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002644; Schicht M, 2013, AM J RHINOL ALLERGY, V27, P24, DOI 10.2500/ajra.2013.27.3838; Schlosser RJ, 2006, ANN OTO RHINOL LARYN, V115, P40; Schob S, 2013, PLOS ONE, V8, DOI [10.1371/annotation/920eb90c-4f7f-4468-ae9c-1198b7b952fc, DOI 10.1371/ANNOTATION/920EB90C-4F7F-4468-AE9C-1198B7B952FC]; van de Wetering JK, 2004, EUR J BIOCHEM, V271, P1229, DOI 10.1111/j.1432-1033.2004.04040.x; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Von Neergaard K., 1929, Z GES EXP MED, V66, P373; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; WHITSETT JA, 1986, PEDIATR RES, V20, P744, DOI 10.1203/00006450-198608000-00009; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; YU SH, 1990, BIOCHIM BIOPHYS ACTA, V1046, P233, DOI 10.1016/0005-2760(90)90236-Q	45	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143058	10.1371/journal.pone.0143058	http://dx.doi.org/10.1371/journal.pone.0143058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599233	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600027
J	Kim, S; Oh, Y; Schweighofer, N				Kim, Sungshin; Oh, Youngmin; Schweighofer, Nicolas			Between-Trial Forgetting Due to Interference and Time in Motor Adaptation	PLOS ONE			English	Article							OPPOSING VISUOMOTOR ROTATIONS; CONTEXTUAL INTERFERENCE; SKILL ACQUISITION; DUAL ADAPTATION; MEMORY; MODELS; PERFORMANCE; INTERVALS; STATE	Learning a motor task with temporally spaced presentations or with other tasks intermixed between presentations reduces performance during training, but can enhance retention post training. These two effects are known as the spacing and contextual interference effect, respectively. Here, we aimed at testing a unifying hypothesis of the spacing and contextual interference effects in visuomotor adaptation, according to which forgetting between trials due to either spaced presentations or interference by another task will promote between-trial forgetting, which will depress performance during acquisition, but will promote retention. We first performed an experiment with three visuomotor adaptation conditions: a short inter-trial-interval (ITI) condition (SHORT-ITI); a long ITI condition (LONG-ITI); and an alternating condition with two alternated opposite tasks (ALT), with the same single-task ITI as in LONG-ITI. In the SHORT-ITI condition, there was fastest increase in performance during training and largest immediate forgetting in the retention tests. In contrast, in the ALT condition, there was slowest increase in performance during training and little immediate forgetting in the retention tests. Compared to these two conditions, in the LONG-ITI, we found intermediate increase in performance during training and intermediate immediate forgetting. To account for these results, we fitted to the data six possible adaptation models with one or two time scales, and with interference in the fast, or in the slow, or in both time scales. Model comparison confirmed that two time scales and some degree of interferences in either time scale are needed to account for our experimental results. In summary, our results suggest that retention following adaptation is modulated by the degree of between-trial forgetting, which is due to time-based decay in single adaptation task and interferences in multiple adaptation tasks.	[Kim, Sungshin; Oh, Youngmin] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Schweighofer, Nicolas] Univ So Calif, Biokinesiol & Phys Therapy, Los Angeles, CA 90089 USA; [Schweighofer, Nicolas] Univ Montpellier I, Euromov, Lab M2H, Montpellier, France	University of Southern California; University of Southern California; Universite de Montpellier	Kim, S (corresponding author), Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA.	sung.kim3@northwestern.edu	Schweighofer, Nicolas/A-3675-2008; Kim, Sungshin/AAE-5645-2019	Schweighofer, Nicolas/0000-0003-3362-6088; Kim, Sungshin/0000-0001-9500-4677	NSF BCS (National Science Foundation Behavioral and Cognitive Sciences) [1031899]	NSF BCS (National Science Foundation Behavioral and Cognitive Sciences)	This work was funded by grant NSF BCS (National Science Foundation Behavioral and Cognitive Sciences) 1031899.	Anguera JA, 2010, J COGNITIVE NEUROSCI, V22, P1917, DOI 10.1162/jocn.2009.21351; Bock O, 2005, EXP BRAIN RES, V163, P258, DOI 10.1007/s00221-005-2231-z; Callan DE, 2010, HUM BRAIN MAPP, V31, P645, DOI 10.1002/hbm.20894; Choi YG, 2008, J MOTOR BEHAV, V40, P273, DOI 10.3200/JMBR.40.4.273-280; CUDDY LJ, 1982, J VERB LEARN VERB BE, V21, P451, DOI 10.1016/S0022-5371(82)90727-7; Della-Maggiore V, 2005, J NEUROPHYSIOL, V93, P2254, DOI 10.1152/jn.00984.2004; DiCiccio TJ, 1996, STAT SCI, V11, P189; Ebbinghaus H., 1913, MEMORY CONTRIBUTION; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; Francis JT, 2005, EXP BRAIN RES, V167, P128, DOI 10.1007/s00221-005-0062-6; Hirashima M, 2012, CURR BIOL, V22, P432, DOI 10.1016/j.cub.2012.01.042; Huang VS, 2007, J NEUROPHYSIOL, V97, P3976, DOI 10.1152/jn.01281.2006; Imamizu H, 2007, EXP BRAIN RES, V181, P395, DOI 10.1007/s00221-007-0940-1; Ingram JN, 2013, CURR BIOL, V23, P1107, DOI 10.1016/j.cub.2013.04.079; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Keisler A, 2010, J NEUROSCI, V30, P14817, DOI 10.1523/JNEUROSCI.4160-10.2010; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; LEE TD, 1983, J EXP PSYCHOL LEARN, V9, P730, DOI 10.1037/0278-7393.9.4.730; MAGILL RA, 1990, HUM MOVEMENT SCI, V9, P241, DOI 10.1016/0167-9457(90)90005-X; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Pauwels L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100906; Pekny SE, 2011, J NEUROSCI, V31, P13829, DOI 10.1523/JNEUROSCI.1704-11.2011; Pyle WH, 1919, J EDUC PSYCHOL, V10, P107, DOI 10.1037/h0064909; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Roediger HL, 1985, CONTEMP PSYCHOL, V30, P519; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Schweighofer N, 2011, J NEUROPHYSIOL, V106, P2632, DOI 10.1152/jn.00399.2011; SHEA JB, 1979, J EXP PSYCHOL-HUM L, V5, P179, DOI 10.1037/0278-7393.5.2.179; Shelhamer M, 2005, ANN NY ACAD SCI, V1039, P166, DOI 10.1196/annals.1325.016; Sing Gary N B, 2009, ADV COMPUTATIONAL MO; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Tanaka H, 2012, NEURAL COMPUT, V24, P939, DOI 10.1162/NECO_a_00262; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Woolley DG, 2007, EXP BRAIN RES, V179, P155, DOI 10.1007/s00221-006-0778-y; Woolley DG, 2011, EXP BRAIN RES, V212, P213, DOI 10.1007/s00221-011-2720-1; Wrisberg C, 2004, MOTOR LEARNING PERFO; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008	40	24	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142963	10.1371/journal.pone.0142963	http://dx.doi.org/10.1371/journal.pone.0142963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7DU	26599075	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600022
J	Orri, M; Revah-Levy, A; Farges, O				Orri, Massimiliano; Revah-Levy, Anne; Farges, Olivier			Surgeons' Emotional Experience of Their Everyday Practice - A Qualitative Study	PLOS ONE			English	Article							AMERICAN SURGEONS; CAREER SATISFACTION; OPERATING-ROOM; US-SURGEONS; BURNOUT; PATIENT; COMMUNICATION; TEAMWORK; EVENTS; STRESS	Background Physicians' emotions affect both patient care and personal well-being. Surgeons appear at particularly high risk, as evidenced by the high rate of burnout and the alarming consequences in both their personal lives and professional behavior. The aim of this qualitative study is to explore the emotional experiences of surgeons and their impact on their surgical practice. Methods and Findings 27 purposively selected liver and pancreatic surgeons from10 teaching hospitals (23men, 4 women) participated. Inclusion took place until data saturation was reached. Data were collected through individual interviews and thematically analyzed independently by 3 researchers (a psychologist, a psychiatrist, and a surgeon). 7 themes emerged from the analysis, categorized in 3 main or superordinate themes, which described surgeons' emotional experience before, during, and after surgery. Burdensome emotions are present throughout all 3 periods (and invade life outside the hospital)-surgeons' own emotions, their perception of patients' emotions, and their entwinement. The interviewees described the range of emotional situations they face (with patients, families, colleagues), the influence of the institutional framework (time pressure and fatigue, cultural pressure to satisfy the ideal image of a surgeon), as well as the emotions they feel (including especially anxiety, fear, distress, guilt, and accountability). Conclusions Emotions are ubiquitous in surgeons' experience, and their exposure to stress is chronic rather than acute. Considering emotions only in terms of their relations to operative errors (as previous studies have done) is limiting. Although complications are quite rare events, the concern for possible complications is an oppressive experience, regardless of whether or not they actually occur.	[Orri, Massimiliano] INSERM, U1178, F-75679 Paris, France; [Orri, Massimiliano] Univ Paris 05, Univ Paris Sud, Paris, France; [Orri, Massimiliano; Farges, Olivier] Hop Beaujon, Assistance Publ Hop Paris, Dept Hepatobiliopancreat Surg & Liver Transplanta, F-92118 Clichy, France; [Revah-Levy, Anne] Hop Argenteuil, Ctr Soins Psychotherapeut Transit Adolescents, F-75107 Argenteuil, France; [Revah-Levy, Anne; Farges, Olivier] Paris Diderot Univ, Sorbonne Paris Cite, INSERM, ECSTRA Team,UMR 1153, Paris, France; [Revah-Levy, Anne; Farges, Olivier] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Orri, M (corresponding author), INSERM, U1178, 97 Blvd Port Royal, F-75679 Paris, France.	massimiliano.orri@gmail.com	Orri, Massimiliano/S-9220-2019	Orri, Massimiliano/0000-0003-1389-2610; revah-levy, anne/0000-0003-1805-6275	Programme Hospitalier de Recherche Clinique grant (PHRC) from the French Ministry of Health [AOM 11060]; Association de Chirurgie Hepato-Biliaire et de Transplantation Hepatique (ACHBT)	Programme Hospitalier de Recherche Clinique grant (PHRC) from the French Ministry of Health; Association de Chirurgie Hepato-Biliaire et de Transplantation Hepatique (ACHBT)	This study was funded by a Programme Hospitalier de Recherche Clinique grant (PHRC National 2011, AOM 11060) from the French Ministry of Health awarded to OF and by the Association de Chirurgie Hepato-Biliaire et de Transplantation Hepatique (ACHBT). OF granted the funding. The funders had no role in study design, data. collection and analysis, decision to publish, or preparation of the manuscript.	Ader R, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, pXV, DOI 10.1016/B978-012088576-3/50001-0; Balch CM, 2009, ARCH SURG-CHICAGO, V144, P371, DOI 10.1001/archsurg.2008.575; Bar-Sela G, 2012, J CANCER EDUC, V27, P786, DOI 10.1007/s13187-012-0407-3; Benson S, 2007, ANZ J SURG, V77, pA79, DOI [10.1111/j.1445-2197.2007.04129_12.x, DOI 10.1111/J.1445-2197.2007.04129_12.X]; Campbell DA, 2001, SURGERY, V130, P696, DOI 10.1067/msy.2001.116676; CLARKE PJ, 1981, AM J ORTHOPSYCHIAT, V51, P71, DOI 10.1111/j.1939-0025.1981.tb01349.x; Cochran A, 2015, AM J SURG, V209, P65, DOI 10.1016/j.amjsurg.2014.09.017; Colli A, 2014, AM J PSYCHIAT, V171, P102, DOI 10.1176/appi.ajp.2013.13020224; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Halpern J, 2003, J GEN INTERN MED, V18, P670, DOI 10.1046/j.1525-1497.2003.21017.x; Jin CJ, 2012, ANN SURG, V256, P989, DOI 10.1097/SLA.0b013e3182583135; Karliczek A, 2009, INT J COLORECTAL DIS, V24, P569, DOI 10.1007/s00384-009-0658-6; Leasure EL, 2013, ACAD MED, V88, P585, DOI 10.1097/ACM.0b013e31828b0289; Leung A, 2012, ACAD MED, V87, P1368, DOI 10.1097/ACM.0b013e3182677587; Lown BA, 2010, ACAD MED, V85, P1073, DOI 10.1097/ACM.0b013e3181dbf741; Luu S, 2012, MED EDUC, V46, P1179, DOI 10.1111/medu.12058; Mache S, 2010, LANGENBECK ARCH SURG, V395, P81, DOI 10.1007/s00423-009-0541-5; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Moulton CA, 2010, ACAD MED, V85, P1571, DOI 10.1097/ACM.0b013e3181f073dd; Novick RJ, 2015, J SURG EDUC, V72, P302, DOI 10.1016/j.jsurg.2014.09.009; Orri M, 2014, ANN SURG, V260, P721, DOI 10.1097/SLA.0000000000000962; Patton M. Q., 2001, QUALITATIVE RES EVAL; Pecanac KE, 2014, ANN SURG, V259, P458, DOI 10.1097/SLA.0000000000000314; Pinto A, 2013, BRIT J SURG, V100, P1748, DOI 10.1002/bjs.9308; Rikkers LF, 2001, SURGERY, V130, P702; Shanafelt TD, 2014, J CLIN ONCOL, V32, P678, DOI 10.1200/JCO.2013.51.8480; Shanafelt TD, 2014, ANN SURG, V259, P82, DOI 10.1097/SLA.0b013e3182a58fa4; Shanafelt TD, 2012, ANN SURG, V255, P625, DOI 10.1097/SLA.0b013e31824b2fa0; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Skevington SM, 2012, PSYCHOL HEALTH MED, V17, P1, DOI 10.1080/13548506.2011.592841; Soltner C, 2011, BRIT J ANAESTH, V106, P680, DOI 10.1093/bja/aer034; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Upton D, 2012, SURGERY, V151, P493, DOI 10.1016/j.surg.2011.09.035; Warschkow R, 2010, SURGERY, V148, P901, DOI 10.1016/j.surg.2010.03.001; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726	40	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143763	10.1371/journal.pone.0143763	http://dx.doi.org/10.1371/journal.pone.0143763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7DU	26600126	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600119
J	Tang, YJ; Dong, W; Wan, KY; Zhang, LG; Li, C; Zhang, LL; Liu, N				Tang, Yanjun; Dong, Wei; Wan, Keyu; Zhang, Ligang; Li, Chun; Zhang, Lili; Liu, Ning			Exopolysaccharide Produced by Lactobacillus Plantarum Induces Maturation of Dendritic Cells in BALB/c Mice	PLOS ONE			English	Article							FERMENTED MILK; NITRIC-OXIDE; PEYERS PATCH; BACTERIA; IMMUNITY; SIGNALS; RANTES; ENCEPHALOMYELITIS; DIFFERENTIATION; PROLIFERATION	Lactobacillus plantarum (L. plantarum) exopolysaccharide (EPS) is an important bioactive component in fermented functional foods. However, there is a lack of data concerning the effects of L. plantarum EPS on maturation of mouse dendritic cells (DCs). In this study, we purified L. plantarum EPS and examined its effects on cytokines production by dendritic cells in serum and intestinal fluid of BALB/c mice, then investigated its effects on phenotypic and functional maturation of mouse bone marrow-derived dendritic cells (BMDCs). Cytokines (nitric oxide, IL-12p70, IL-10 and RANTES) in serum and intestinal fluid were analyzed by enzyme linked immunosorbent assay (ELISA) after the mice received EPS for 2, 5 and 7 days, respectively. DCs derived from bone marrow of BALB/c mouse were treated with EPS, then the phenotypic maturation of BMDCs was analyzed using flow cytometer and the functional maturation of BMDCs was analyzed by ELISA, and, lastly, mixed lymphocyte proliferation was performed. We found the molecular weight of purified EPS was approximately 2.4x10(6) Da and it was composed of ribose, rhamnose, arabinose, xylose, mannose, glucose and galactose in a molar ratio of 2:1:1:10:4:205:215. We observed that L. plantarum EPS enriched production of nitric oxide, IL-12p70 and RANTES, and decreased the secretion of IL-10 in the serum or intestinal fluid as well as in the supernatant of DCs treated with the EPS. The EPS also up-regulated the expression of MHC II and CD86 on DCs surface and promoted T cells to proliferate in vitro. Our data provide direct evidence to suggest that L. plantarum EPS can effectively induce maturation of DCs in mice.	[Tang, Yanjun; Dong, Wei; Wan, Keyu; Zhang, Ligang; Li, Chun; Zhang, Lili; Liu, Ning] Northeast Agr Univ, Coll Food Sci, Minist Educ, Key Lab Dairy Sci, Harbin, Peoples R China; [Liu, Ning] Natl Dairy Engn & Res Ctr, Harbin, Peoples R China; [Tang, Yanjun; Zhang, Ligang; Li, Chun; Zhang, Lili; Liu, Ning] Synerget Innovat Ctr Food Safety & Nutr, Harbin, Peoples R China; [Tang, Yanjun] Heilongjiang Bayi Agr Univ, Coll Food Sci, Daqing, Peoples R China	Northeast Agricultural University - China; Heilongjiang Bayi Agricultural University	Li, C (corresponding author), Northeast Agr Univ, Coll Food Sci, Minist Educ, Key Lab Dairy Sci, Harbin, Peoples R China.	spxylch@126.com; ningliuneau@outlook.com		Zhang, Lili/0000-0002-1053-292X	Ministry of Education of the People's Republic of China [IRT-0959-202]; Science & Technology Bureau of Harbin [2011RFXXN042]; Education Department of Heilongjiang Province [YJSCX2012-043HLJ]	Ministry of Education of the People's Republic of China(Ministry of Education, China); Science & Technology Bureau of Harbin; Education Department of Heilongjiang Province	NL received the funding "Program for Changjiang Scholars and Innovative Research Team in University (IRT-0959-202)" supported by Ministry of Education of the People's Republic of China (http://www.moe.gov.cn/) for the study design, data collection and analysis, decision to publish. NL received the funding "Project of Special Funds for Harbin Technological Innovation Talent (2011RFXXN042)" supported by Science & Technology Bureau of Harbin (http://www.hrbinfo.gov.cn/) for data collection and analysis. YJT received the funding "Postgraduate Innovative Research Projects of Heilongjiang Province Office of Education (YJSCX2012-043HLJ)" supported by the Education Department of Heilongjiang Province (http://www.hlje.net/) for preparation of the manuscript.	Adams S, 2005, J CLIN IMMUNOL, V25, P87, DOI 10.1007/s10875-005-2814-2; Adikari SB, 2005, CYTOKINE MODULATED D; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; de LeBlanc AD, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-27; de St Groth BF, 1998, IMMUNOL TODAY, V19, P448, DOI 10.1016/S0167-5699(98)01328-0; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Gaizka GI, 2010, BIORESOURCE TECHNOL, V101, P9254, DOI 10.1016/j.biortech.2010.07.050; Georgieva R, 2009, INT DAIRY J, V19, P696, DOI 10.1016/j.idairyj.2009.06.006; HERSHKOVIZ R, 1995, J AUTOIMMUN, V8, P741, DOI 10.1006/jaut.1995.0055; Huang SY, 2013, FERTIL STERIL, V100, P234, DOI 10.1016/j.fertnstert.2013.02.052; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ismail B, 2010, ARCH MICROBIOL, V192, P1049, DOI 10.1007/s00203-010-0636-y; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Khanna A, 2000, J IMMUNOL, V164, P1346, DOI 10.4049/jimmunol.164.3.1346; Kim Y, 2009, BIOCHEM BIOPH RES CO, V379, P324, DOI 10.1016/j.bbrc.2008.12.053; Lee M, 2000, J KOREAN MED SCI, V15, P217, DOI 10.3346/jkms.2000.15.2.217; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Liu CH, 2010, BIORESOURCE TECHNOL, V101, P5528, DOI 10.1016/j.biortech.2010.01.151; Lu LN, 1997, J IMMUNOL, V158, P5676; Maddur MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5092; Galdeano CM, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-64; Mathara JM, 2008, CURR MICROBIOL, V56, P315, DOI 10.1007/s00284-007-9084-6; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Nichols CM, 2005, MICROB ECOL, V49, P578, DOI 10.1007/s00248-004-0093-8; Nicoletti C, 2010, GUT MICROBES, V1, P131, DOI 10.4161/gmic.1.3.11711; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Pan DD, 2010, CARBOHYD POLYM, V80, P908, DOI 10.1016/j.carbpol.2010.01.005; Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1; Reid SD, 2000, CURR OPIN IMMUNOL, V12, P114, DOI 10.1016/S0952-7915(99)00059-X; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Serafini B, 2000, AM J PATHOL, V157, P1991, DOI 10.1016/S0002-9440(10)64838-9; Sheu SC, 2013, PROCESS BIOCHEM, V48, P1402, DOI 10.1016/j.procbio.2013.06.012; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Vila-Coro AJ, 1999, J IMMUNOL, V163, P3037; Welman AD, 2003, TRENDS BIOTECHNOL, V21, P269, DOI 10.1016/S0167-7799(03)00107-0; WU L, 1995, EUR J IMMUNOL, V25, P418, DOI 10.1002/eji.1830250217; Zhu J, 2007, CELL BIOL INT, V31, P615, DOI 10.1016/j.cellbi.2006.12.002	45	24	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143743	10.1371/journal.pone.0143743	http://dx.doi.org/10.1371/journal.pone.0143743			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599612	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600115
J	Vonghia, L; Magrone, T; Verrijken, A; Michielsen, P; Van Gaal, L; Jirillo, E; Francque, S				Vonghia, Luisa; Magrone, Thea; Verrijken, An; Michielsen, Peter; Van Gaal, Luc; Jirillo, Emilio; Francque, Sven			Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features	PLOS ONE			English	Article							AMINOPYRINE BREATH TEST; REGULATORY T-CELLS; PORTAL-HYPERTENSION; INSULIN-RESISTANCE; INDEPENDENT PREDICTORS; RAT MODEL; STEATOHEPATITIS; FIBROSIS; OBESITY; NAFLD	Background Haemodynamic impairment, inflammatory mediators and glucose metabolism disturbances have been implicated in the pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Aim To investigate the cytokine profile in NAFLD patients in peripheral (P) and hepatic venous (HV) blood and to compare with histology, haemodynamic and metabolic parameters. Methods 40 obese patients with an indication for a transjugular liver biopsy were enrolled. Besides an extended liver and metabolic work-up, interleukin (IL) 1B, IL4, IL6, IL10, IL23, tumour necrosis factor (TNF) a and interferon (INF). were measured in plasma obtained from P and HV blood by means of multiplex immunoassay. The T helper (Th) 1/Th2, the macrophage M1/M2 and the IL10/IL17a ratios were calculated. Results A decrease of the P-IL10/IL17-ratio and an increase of the P-M1/M2-ratio (p<0.05) were observed in NASH versus no-NASH patients. A P-M1/M2-ratio increase was detected also in patients with portal hypertension in comparison with patients without it (p<0.05). Moreover diabetic patients showed an increase of the P-Th1/Th2-ratio in comparison with non-diabetic ones (p<0.05). The P-M1/M2 ratio positively correlated with steatosis grade (r = 0.39, p = 0.02) and insulin (r = 0.47, p = 0.003). The HV-M1/M2 ratio positively correlated with fasting insulin and Hepatic Venous Pressure Gradient (r = 0.47, p = 0.003). IL6 correlated with the visceral fat amount (r = 0.36, p = 0.02). The P- and HV-IL10/IL17 ratios negatively correlated with fasting insulin (respectively r = -0.4, p = 0.005 and r = 0.4, p = 0.01). Conclusions A proinflammatory cytokine state is associated with more disturbed metabolic, histological, and haemodynamic features in NAFLD obese patients. An increase of the M1/M2 ratio and a decrease of the IL10/IL17 ratio play a key role in this process.	[Vonghia, Luisa; Magrone, Thea; Michielsen, Peter; Jirillo, Emilio; Francque, Sven] Univ Bari, Dept Basic Med Sci Neurosci & Sensory Organs, Bari, Italy; [Vonghia, Luisa] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium; [Verrijken, An; Van Gaal, Luc] Univ Antwerp Hosp, Dept Endocrinol Diabet & Metab Dis, Antwerp, Belgium; [Verrijken, An; Michielsen, Peter; Van Gaal, Luc; Francque, Sven] Univ Antwerp, Lab Expt Med & Paediat, Div Gastroenterol, B-2020 Antwerp, Belgium	Universita degli Studi di Bari Aldo Moro; University of Antwerp; University of Antwerp; University of Antwerp	Vonghia, L (corresponding author), Univ Bari, Dept Basic Med Sci Neurosci & Sensory Organs, Bari, Italy.	luisa.vonghia@uza.be	Magrone, Thea/AAG-3444-2019; Vonghia, Luisa/ABC-4169-2020; Michielsen, Peter/D-7088-2017	Magrone, Thea/0000-0002-0503-9110; Vonghia, Luisa/0000-0002-3999-9259; Michielsen, Peter/0000-0001-7232-8927				Abbas AE, 2013, J AM SOC ECHOCARDIOG, V26, P1170, DOI 10.1016/j.echo.2013.06.003; Aller MA, 2013, WORLD J GASTROENTERO, V19, P7992, DOI 10.3748/wjg.v19.i44.7992; ANDUS T, 1991, HEPATOLOGY, V13, P364, DOI 10.1016/0270-9139(91)92454-G; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Asrani Sumeet K, 2013, Curr Gastroenterol Rep, V15, P308, DOI 10.1007/s11894-012-0308-y; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Bosch J, 2006, SEMIN LIVER DIS, V26, P348, DOI 10.1055/s-2006-951603; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chang YH, 2012, INT J OBESITY, V36, P993, DOI 10.1038/ijo.2011.168; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Francque S, 2011, INT J OBESITY, V35, P270, DOI 10.1038/ijo.2010.134; Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019; Francque S, 2012, LAB INVEST, V92, P1428, DOI 10.1038/labinvest.2012.103; Francque S, 2010, EUR J GASTROEN HEPAT, V22, P1449, DOI 10.1097/MEG.0b013e32833f14a1; Francque S, 2010, LIVER INT, V30, P365, DOI 10.1111/j.1478-3231.2009.02136.x; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Groszmann Roberto, 2006, Clin Liver Dis, V10, P499, DOI 10.1016/j.cld.2006.08.005; Guo Y, 2013, HEPATO-GASTROENTEROL, V60, P581, DOI 10.5754/hge11381; Hebel K, 2011, J IMMUNOL, V187, P5627, DOI 10.4049/jimmunol.1003998; Kalambokis G, 2007, J HEPATOL, V47, P284, DOI 10.1016/j.jhep.2007.05.001; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; LEBREC D, 1982, GASTROENTEROLOGY, V83, P338; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lim S, 2015, INT J CARDIOL, V201, P408, DOI 10.1016/j.ijcard.2015.08.107; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Madhumitha H, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-1; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; MERKEL C, 1992, GUT, V33, P836, DOI 10.1136/gut.33.6.836; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Pasarin M, 2011, J HEPATOL, V55, P1095, DOI 10.1016/j.jhep.2011.01.053; PERRI F, 1994, DIGEST DIS SCI, V39, P2445, DOI 10.1007/BF02087664; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Tang Y, 2011, CLIN EXP IMMUNOL, V166, P281, DOI 10.1111/j.1365-2249.2011.04471.x; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tsochatzis EA, 2009, SCAND J GASTROENTERO, V44, P6, DOI 10.1080/00365520802273058; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Vonghia L, 2013, INT J MOL SCI, V14, P19867, DOI 10.3390/ijms141019867; Waidmann O, 2013, J HEPATOL, V58, P956, DOI 10.1016/j.jhep.2013.01.005; Wiest R, 2011, CYTOKINE, V53, P178, DOI 10.1016/j.cyto.2010.06.013; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	53	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143380	10.1371/journal.pone.0143380	http://dx.doi.org/10.1371/journal.pone.0143380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599575	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600058
J	Zhang, T; Chen, J; Jia, XF				Zhang, Ting; Chen, Juan; Jia, Xiaofeng			Identification of the Key Fields and Their Key Technical Points of Oncology by Patent Analysis	PLOS ONE			English	Article							CANCER; BIOTRANSFORMATION; DEOXYGENATION; STATISTICS; PEPTIDES; DELIVERY; VACCINES	Background This paper aims to identify the key fields and their key technical points of oncology by patent analysis. Methodology/Principal Findings Patents of oncology applied from 2006 to 2012 were searched in the Thomson Innovation database. The key fields and their key technical points were determined by analyzing the Derwent Classification (DC) and the International Patent Classification (IPC), respectively. Patent applications in the top ten DC occupied 80% of all the patent applications of oncology, which were the ten fields of oncology to be analyzed. The number of patent applications in these ten fields of oncology was standardized based on patent applications of oncology from 2006 to 2012. For each field, standardization was conducted separately for each of the seven years (2006-2012) and the mean of the seven standardized values was calculated to reflect the relative amount of patent applications in that field; meanwhile, regression analysis using time (year) and the standardized values of patent applications in seven years (2006-2012) was conducted so as to evaluate the trend of patent applications in each field. Two-dimensional quadrant analysis, together with the professional knowledge of oncology, was taken into consideration in determining the key fields of oncology. The fields located in the quadrant with high relative amount or increasing trend of patent applications are identified as key ones. By using the same method, the key technical points in each key field were identified. Altogether 116,820 patents of oncology applied from 2006 to 2012 were retrieved, and four key fields with twenty-nine key technical points were identified, including "natural products and polymers" with nine key technical points, "fermentation industry" with twelve ones, "electrical medical equipment" with four ones, and "diagnosis, surgery" with four ones. Conclusions/Significance The results of this study could provide guidance on the development direction of oncology, and also help researchers broaden innovative ideas and discover new technological opportunities.	[Zhang, Ting] Chinese Acad Med Sci, Inst Med Informat & Lib, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Information - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, T (corresponding author), Chinese Acad Med Sci, Inst Med Informat & Lib, Beijing 100730, Peoples R China.	brendatingting@126.com			Peking Union Medical College Youth Fund; Fundamental Research Funds for the Central Universities [3332013151]; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences; Peking Union Medical College [GTZK201508]	Peking Union Medical College Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences; Peking Union Medical College	This study is supported by Peking Union Medical College Youth Fund and the Fundamental Research Funds for the Central Universities (3332013151) and State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College (GTZK201508).	Beccari S, 2013, PEPTIDES, V44, P127, DOI 10.1016/j.peptides.2013.03.027; Bhattia HN, 2014, PHYTOMEDICINE, V21, P1597, DOI 10.1016/j.phymed.2014.05.011; Boichenko AP, 2014, J PROTEOME RES, V13, P4995, DOI 10.1021/pr500601w; Cao H, 2015, BIOTECHNOL ADV, V33, P214, DOI 10.1016/j.biotechadv.2014.10.012; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Di Rosa M, 2013, CRIT REV ONCOL HEMAT, V88, P594, DOI 10.1016/j.critrevonc.2013.07.016; Ding MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109348; Diorio C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047815; Donker M, 2014, LANCET ONCOL, V15, P1303, DOI 10.1016/S1470-2045(14)70460-7; Esmat SM, 2014, DERMATOL SURG, V40, P1349, DOI 10.1097/DSS.0000000000000172; Fenoglio D, 2015, HUM VACC IMMUNOTHER, V11, P838, DOI 10.1080/21645515.2015.1012032; Fura A, 2004, J MED CHEM, V47, P4339, DOI 10.1021/jm040066v; Gerken JM, 2012, SCIENTOMETRICS, V91, P645, DOI 10.1007/s11192-012-0635-7; Gutta P, 2007, ORG LETT, V9, P1069, DOI 10.1021/ol070007m; Hassan LEA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090806; Horiguchi T, 2008, J LABELLED COMPD RAD, V51, P325, DOI 10.1002/jlcr.1529; Horvat G, 2015, EUR J PHARM SCI, V67, P1, DOI 10.1016/j.ejps.2014.10.013; Kim YS, 2010, J AGR FOOD CHEM, V58, P3177, DOI 10.1021/jf904163k; Kundra R, 2001, SCIENTOMETRICS, V52, P519, DOI 10.1023/A:1014264403859; Lee YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107027; Li H, 2008, TETRAHEDRON, V64, P6561, DOI 10.1016/j.tet.2008.04.008; Mazonakis M, 2015, PHYS MED BIOL, V60, P2375, DOI 10.1088/0031-9155/60/6/2375; Miller KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035953; Negishi O, 2009, J AGR FOOD CHEM, V57, P9956, DOI 10.1021/jf901204m; Norikura T, 2011, J AGR FOOD CHEM, V59, P6974, DOI 10.1021/jf200461j; Nugue G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072021; Okuyama R, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27010; Pehlivan SB, 2015, J PHARM SCI-US, V104, P1709, DOI 10.1002/jps.24385; Petersen KS, 2007, J MED CHEM, V50, P5824, DOI 10.1021/jm070882d; Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101; Schloegl C, 2010, SCIENTOMETRICS, V82, P567, DOI 10.1007/s11192-010-0172-1; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Signori E, 2015, CANCER IMMUNOL IMMUN, V64, P1349, DOI 10.1007/s00262-015-1676-6; Sitek B, 2009, J PROTEOME RES, V8, P1647, DOI 10.1021/pr800890j; Ugolini D, 1997, SCIENTOMETRICS, V38, P265, DOI 10.1007/BF02457413; Wang OC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021130; Wang ZL, 2015, CANCER IMMUNOL IMMUN, V64, P1057, DOI 10.1007/s00262-015-1713-5; Woo JK, 2014, ORG LETT, V16, P2826, DOI 10.1021/ol500868s; Yan G, 2014, EUR J PHARM SCI, V52, P215, DOI 10.1016/j.ejps.2013.11.015; Yoon J, 2013, SCIENTOMETRICS, V94, P313, DOI 10.1007/s11192-012-0830-6; Yu Q, 2011, SCIENTOMETRICS, V89, P553, DOI 10.1007/s11192-011-0465-z; Zhang SS, 2014, J AGR FOOD CHEM, V62, P1581, DOI 10.1021/jf4053012; Zhang YH, 2012, ACS MED CHEM LETT, V3, P402, DOI 10.1021/ml300038t; Zheng L, 2014, ACM T KNOWL DISCOV D, V9, DOI 10.1145/2611380; Zhou X, 2014, SCIENTOMETRICS, V100, P705, DOI 10.1007/s11192-014-1317-4; Zhou XJ, 2015, EUR J PHARM SCI, V66, P90, DOI 10.1016/j.ejps.2014.10.004	46	6	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143573	10.1371/journal.pone.0143573	http://dx.doi.org/10.1371/journal.pone.0143573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7DU	26599967	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600088
J	Bales, MB; Schier, LA; Blonde, GD; Spector, AC				Bales, Michelle B.; Schier, Lindsey A.; Blonde, Ginger D.; Spector, Alan C.			Extensive Gustatory Cortex Lesions Significantly Impair Taste Sensitivity to KCl and Quinine but Not to Sucrose in Rats	PLOS ONE			English	Article							INSULAR CORTEX; CORTICAL-NEURONS; AVERSION; RESPONSES; AVOIDANCE; AMYGDALA; HYPOTHALAMUS; PROJECTIONS; NEOCORTEX; REPRESENTATION	Recently, we reported that large bilateral gustatory cortex (GC) lesions significantly impair taste sensitivity to salts in rats. Here we extended the tastants examined to include sucrose and quinine in rats with ibotenic acid-induced lesions in GC (GCX) and in sham-operated controls (SHAM). Presurgically, immediately after drinking NaCl, rats received a LiCl or saline injection (i.p.), but postsurgical tests indicated a weak conditioned taste aversion (CTA) even in controls. The rats were then trained and tested in gustometers to discriminate a tastant from water in a two-response operant taste detection task. Psychometric functions were derived for sucrose, KCl, and quinine. Our mapping system was used to determine placement, size, and symmetry of the lesions (similar to 91% GC damage on average). For KCl, there was a significant rightward shift (Delta EC50 = 0.57 log(10) units; p < 0.001) in the GCX psychometric function relative to SHAM, replicating our prior work. There was also a significant lesion-induced impairment (Delta EC50 = 0.41 log(10) units; p = 0.006) in quinine sensitivity. Surprisingly, taste sensitivity to sucrose was unaffected by the extensive lesions and was comparable between GCX and SHAM rats. The fact that such large bilateral GC lesions did not shift sucrose psychometric functions relative to SHAM, but did significantly compromise quinine and KCl sensitivity suggests that the neural circuits responsible for the detection of specific taste stimuli are partially dissociable. Lesion-induced impairments were observed in expression of a postsurgical CTA to a maltodextrin solution as assessed in a taste-oriented brief-access test, but were not reflected in a longer term 46-h two-bottle test. Thus, deficits observed in rats after extensive damage to the GC are also dependent on the test used to assess taste function. In conclusion, the degree to which the GC is necessary for the maintenance of normal taste detectability apparently depends on the chemical andor perceptual features of the stimulus.	[Spector, Alan C.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Spector, AC (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	spector@psy.fsu.edu	Spector, Alan/W-2925-2019		National Institute on Deafness and Other Communication Disorders [R01-DC-DC009821, T32 DC000044]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC000044] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by a research grant from the National Institute on Deafness and Other Communication Disorders (R01-DC-DC009821 (ACS)) and an FSU Chemical Senses Training (CTP) Grant Award (T32 DC000044 (MBB)) from the National Institute on Deafness and Other Communication Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; BENJAMIN RM, 1959, J COMP NEUROL, V111, P231, DOI 10.1002/cne.901110203; BENJAMIN RM, 1955, J COMP PHYSIOL PSYCH, V48, P119, DOI 10.1037/h0041257; BENJAMIN RM, 1955, J NEUROPHYSIOL, V18, P56, DOI 10.1152/jn.1955.18.1.56; Bermudez-Rattoni F, 2004, NAT REV NEUROSCI, V5, P209, DOI 10.1038/nrn1344; BERMUDEZRATTONI F, 1991, BRAIN RES, V549, P165, DOI 10.1016/0006-8993(91)90616-4; Blonde GD, 2006, BEHAV NEUROSCI, V120, P580, DOI 10.1037/0735-7044.120.3.580; Blonde GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117515; BRAUN JJ, 1981, EXP NEUROL, V72, P711, DOI 10.1016/0014-4886(81)90020-0; BRAUN JJ, 1972, PHYSIOL BEHAV, V9, P637; BRAUN JJ, 1982, PHYSIOL PSYCHOL, V10, P13; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Cubero I, 1999, BRAIN RES, V839, P323, DOI 10.1016/S0006-8993(99)01745-X; DUNN LT, 1988, BEHAV NEUROSCI, V102, P3, DOI 10.1037/0735-7044.102.1.3; Fontanini A, 2006, J NEUROPHYSIOL, V96, P3183, DOI 10.1152/jn.00804.2006; Fresquet N, 2004, BEHAV BRAIN RES, V153, P357, DOI 10.1016/j.bbr.2003.12.011; Gardner MPH, 2014, J NEUROSCI, V34, P13000, DOI 10.1523/JNEUROSCI.1820-14.2014; Geddes RI, 2008, BEHAV NEUROSCI, V122, P1038, DOI 10.1037/a0012748; Hanamori T, 1998, J NEUROPHYSIOL, V79, P2535, DOI 10.1152/jn.1998.79.5.2535; Hashimoto K, 2014, CHEM SENSES, V39, P57, DOI 10.1093/chemse/bjt054; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kida I, 2011, NEUROIMAGE, V56, P1520, DOI 10.1016/j.neuroimage.2011.03.007; KIEFER SW, 1984, BEHAV NEUROSCI, V98, P590; KIEFER SW, 1992, BEHAV NEUROSCI, V106, P140, DOI 10.1037/0735-7044.106.1.140; King CT, 2015, BRAIN RES, V1599, P9, DOI 10.1016/j.brainres.2014.12.035; KOSAR E, 1986, BRAIN RES, V379, P342, DOI 10.1016/0006-8993(86)90788-2; KOSAR E, 1986, BRAIN RES, V379, P329, DOI 10.1016/0006-8993(86)90787-0; Kusumoto-Yoshida I, 2015, P NATL ACAD SCI USA, V112, P1190, DOI 10.1073/pnas.1416573112; Lin JY, 2009, BRAIN RES, V1292, P52, DOI 10.1016/j.brainres.2009.07.033; Lin JY, 2009, BEHAV NEUROSCI, V123, P810, DOI 10.1037/a0016460; LORDEN JF, 1976, J COMP PHYSIOL PSYCH, V90, P665, DOI 10.1037/h0077237; Lundy RF, 2004, J NEUROPHYSIOL, V91, P1143, DOI 10.1152/jn.00840.2003; MacDonald CJ, 2012, J PHYSIOL-LONDON, V590, P3169, DOI 10.1113/jphysiol.2012.233486; Maier JX, 2013, J NEUROPHYSIOL, V109, P2108, DOI 10.1152/jn.00917.2012; Naor C, 1996, BEHAV BRAIN RES, V79, P61, DOI 10.1016/0166-4328(95)00262-6; Nerad L, 1996, NEUROBIOL LEARN MEM, V66, P44, DOI 10.1006/nlme.1996.0042; NISSENBAUM JW, 1987, NEUROSCI BIOBEHAV R, V11, P187, DOI 10.1016/S0149-7634(87)80025-8; NORGREN R, 1975, BRAIN RES, V92, P123, DOI 10.1016/0006-8993(75)90531-4; OGAWA H, 1990, NEUROSCI RES, V9, P196, DOI 10.1016/0168-0102(90)90004-X; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PFAFFMANN C, 1977, ANN NY ACAD SCI, V290, P18, DOI 10.1111/j.1749-6632.1977.tb39713.x; Reynolds SM, 2005, J NEUROSCI, V25, P11757, DOI 10.1523/JNEUROSCI.3432-05.2005; Roman C, 2007, EUR J NEUROSCI, V26, P2627, DOI 10.1111/j.1460-9568.2007.05872.x; Roman C, 2006, BEHAV NEUROSCI, V120, P1257, DOI 10.1037/0735-7044.120.6.1257; Rosenblum K, 1997, J NEUROSCI, V17, P5129; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sakai N, 1999, NEUROSCI RES, V35, P53, DOI 10.1016/S0168-0102(99)00067-X; Schier LA, 2016, J COMP NEUROL, V524, P54, DOI 10.1002/cne.23822; Schier LA, 2014, P NATL ACAD SCI USA, V111, P1162, DOI 10.1073/pnas.1315624111; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Spector A. C., 2003, Handbook of olfaction and gustation, P861; SPECTOR AC, 1988, BEHAV NEUROSCI, V102, P942, DOI 10.1037/0735-7044.102.6.942; Spector AC, 2000, NEUROSCI BIOBEHAV R, V24, P391, DOI 10.1016/S0149-7634(00)00013-0; Spector AC, 2015, CHEM SENSES, V40, P187, DOI 10.1093/chemse/bju072; Stapleton JR, 2006, J NEUROSCI, V26, P4126, DOI 10.1523/JNEUROSCI.0092-06.2006; Stehberg J, 2011, NEUROBIOL LEARN MEM, V95, P14, DOI 10.1016/j.nlm.2010.10.002; VANDERKOOY D, 1984, J COMP NEUROL, V224, P1, DOI 10.1002/cne.902240102; YAMAMOTO T, 1980, J NEUROPHYSIOL, V44, P440, DOI 10.1152/jn.1980.44.3.440; YAMAMOTO T, 1984, J NEUROPHYSIOL, V51, P616, DOI 10.1152/jn.1984.51.4.616; YAMAMOTO T, 1989, J NEUROPHYSIOL, V61, P1244, DOI 10.1152/jn.1989.61.6.1244	62	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143419	10.1371/journal.pone.0143419	http://dx.doi.org/10.1371/journal.pone.0143419			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599914	gold, Green Published			2022-12-27	WOS:000365853900114
J	Garcia, AE; Kasim, N; Tamboli, RA; Gonzalez, RS; Antoun, J; Eckert, EA; Marks-Shulman, PA; Dunn, J; Wattacheril, J; Wallen, T; Abumrad, NN; Flynn, CR				Garcia, Anna E.; Kasim, Nader; Tamboli, Robyn A.; Gonzalez, Raul S.; Antoun, Joseph; Eckert, Emily A.; Marks-Shulman, Pamela A.; Dunn, Julia; Wattacheril, Julia; Wallen, Taylor; Abumrad, Naji N.; Flynn, Charles Robb			Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; INSULIN-RESISTANCE ATHEROSCLEROSIS; ALANINE AMINOTRANSFERASE ACTIVITY; METABOLIC SYNDROME; DIABETES-MELLITUS; HEPATIC STEATOSIS; PARTICLE-SIZE; BARIATRIC SURGERY; ADIPOSE-TISSUE; STEATOHEPATITIS	Triglyceride content in the liver is regulated by the uptake, production and elimination of lipoproteins, and derangements in these processes contribute to nonalcoholic fatty liver disease (NAFLD). Previous studies show a direct relationship between intrahepatic fat and production of apolipoprotein B100 (apoB100) containing particles, VLDL and LDL, but little consensus exists regarding changes in lipoprotein production in the development of simple steatosis (SS) versus nonalcoholic steatohepatitis (NASH). Further, ethnic variations in lipoproteins among SS and NASH are unknown as is how such variations might contribute to the differential prevalence of disease among Caucasians versus African Americans. In this study, we assessed plasma lipoprotein profiles by nuclear magnetic resonance (NMR) spectroscopy in 70 non-diabetic class III obese females recruited from the surgical weight loss clinic. Of these, 51 females were stratified by biopsy-staged NAFLD severity (histologically normal, SS, or NASH). NASH females displayed increased circulating triglycerides and increased VLDL particle number and size relative to those with histologically normal livers, while total and large LDL concentration decreased in SS versus NASH and correlated with increased insulin resistance (via HOMA2-IR). When Caucasian women were examined alone (n = 41), VLDL and triglycerides increased between normal and SS, while total LDL and apoB100 decreased between SS and NASH along with increased insulin resistance. Compared to Caucasians with SS, African American women with SS displayed reduced triglycerides, VLDL, and small LDL and a more favorable small to large HDL ratio despite having increased BMI and HOMA2-IR. These findings suggest that ApoB100 and lipoprotein subclass particle number and size can delineate steatosis from NASH in obese Caucasian females, but should be interpreted with caution in other ethnicities as African Americans with SS display relatively improved lipoprotein profiles. This may reflect variation in the relationship between dyslipidemia and NAFLD progression across gender and ethnicity.	[Garcia, Anna E.; Tamboli, Robyn A.; Antoun, Joseph; Eckert, Emily A.; Marks-Shulman, Pamela A.; Abumrad, Naji N.; Flynn, Charles Robb] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [Kasim, Nader] Le Bonheur Childrens Fdn Res Ctr, Memphis, TN 38103 USA; [Gonzalez, Raul S.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Dunn, Julia] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Wattacheril, Julia] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Wallen, Taylor] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Columbia University; Central Michigan University	Flynn, CR (corresponding author), Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA.	robb.flynn@vanderbilt.edu	Kasim, Nader/AAL-4648-2020; Gonzalez, Raul/AHD-0586-2022; Flynn, Charles/M-3895-2015	Kasim, Nader/0000-0002-6112-1047; Garcia Whitlock, Anna/0000-0003-2980-9885; Dunn, Julia/0000-0001-9561-0183; Flynn, Charles/0000-0002-3749-0598	National Institutes of Health (NIH) grant: Vanderbilt Clinical and Translational Science Award [UL1 RR024975]; National Institutes of Health (NIH) grant: Vanderbilt Diabetes Research and Training Center [NIH/NIDDK DK070860, DK091748, P30 DK020593]; National Institutes of Health (NIH) grant: Vanderbilt Digestive Disease Research Center [P30 DK058404]; National Institutes of Health (NIH) grant: Medical Student Research Training Program [T32 DK007061]; National Institutes of Health (NIH) grant: NIH/NIDDK [2T32 DK007673]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091748, T35DK007383, P30DK058404, T32DK007061, P30DK020593, R01DK070860, T32DK007673] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant: Vanderbilt Clinical and Translational Science Award; National Institutes of Health (NIH) grant: Vanderbilt Diabetes Research and Training Center; National Institutes of Health (NIH) grant: Vanderbilt Digestive Disease Research Center; National Institutes of Health (NIH) grant: Medical Student Research Training Program; National Institutes of Health (NIH) grant: NIH/NIDDK; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding support was from the following National Institutes of Health (NIH) grants: UL1 RR024975 (Vanderbilt Clinical and Translational Science Award to CRF, JW and NNA), NIH/NIDDK DK070860 and DK091748 to NNA, P30 DK020593 (Vanderbilt Diabetes Research and Training Center), P30 DK058404 (Vanderbilt Digestive Disease Research Center), NIH/NIDDK 2T32 DK007673 to JJW, T32 DK007061 (Medical Student Research Training Program) to AEG. Patients studied were enrolled under protocols registered at ClinicalTrials.gov (NCT00983463; NCT00802204; NCT00790309; NCT00884494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chan DC, 2010, ARTERIOSCL THROM VAS, V30, P1043, DOI 10.1161/ATVBAHA.109.202275; Charlton N, 2002, HEPATOLOGY, V35, P898, DOI 10.1053/jhep.2002.32527; Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519; DeFilippis AP, 2013, ATHEROSCLEROSIS, V227, P429, DOI 10.1016/j.atherosclerosis.2013.01.022; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; El-Badry AM, 2009, ANN SURG, V250, P691, DOI 10.1097/SLA.0b013e3181bcd6dd; Ellington AA, 2008, ADV CLIN CHEM, V46, P295, DOI 10.1016/S0065-2423(08)00408-3; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; Frazier-Wood AC, 2013, HUM GENET, V132, P405, DOI 10.1007/s00439-012-1256-1; Fujita K, 2009, HEPATOLOGY, V50, P772, DOI 10.1002/hep.23094; Garvey WT, 2003, DIABETES, V52, P453, DOI 10.2337/diabetes.52.2.453; Geloneze B, 2009, ARQ BRAS ENDOCRINOL, V53, P281, DOI 10.1590/S0004-27302009000200020; Ghamar-Chehreh Mohammad Ebrahim, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P702, DOI 10.1016/S2221-1691(12)60213-5; Ginsberg HN, 2006, OBESITY, V14, p41S, DOI 10.1038/oby.2006.281; Goff DC, 2005, METABOLISM, V54, P264, DOI 10.1016/j.metabol.2004.09.002; Kallwitz ER, 2009, AM J GASTROENTEROL, V104, P64, DOI 10.1038/ajg.2008.12; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lorenzo C, 2013, DIABETOLOGIA, V56, P746, DOI 10.1007/s00125-012-2826-4; Lynch CS, 2007, J GEN INTERN MED, V22, P908, DOI 10.1007/s11606-007-0218-0; Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060; Magkos F, 2010, OBESITY, V18, P1510, DOI 10.1038/oby.2010.90; Mannisto VT, 2014, J LIPID RES, V55, P2676, DOI 10.1194/jlr.P054387; Maximos M, 2015, HEPATOLOGY, V61, P153, DOI 10.1002/hep.27395; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Mora S, 2010, DIABETES, V59, P1153, DOI 10.2337/db09-1114; Morling JR, 2014, J HEPATOL, V60, P384, DOI 10.1016/j.jhep.2013.10.017; Musso G, 2012, HEPATOLOGY, V56, P933, DOI 10.1002/hep.25739; Obika M, 2012, EXP DIABETES RES, DOI 10.1155/2012/145754; Oh SY, 2006, METABOLISM, V55, P1604, DOI 10.1016/j.metabol.2006.07.021; Osei K, 2010, CURR DIABETES REP, V10, P199, DOI 10.1007/s11892-010-0116-4; Otvos JD, 2011, J CLIN LIPIDOL, V5, P105, DOI 10.1016/j.jacl.2011.02.001; Otvos James D, 2002, Clin Lab, V48, P171; Pan JJ, 2014, WORLD J HEPATOL, V6, P274, DOI 10.4254/wjh.v6.i5.274; RANDLE PJ, 1963, LANCET, V1, P785; Ruhl Constance E, 2004, Clin Liver Dis, V8, P501, DOI 10.1016/j.cld.2004.04.008; Shalaurova I, 2014, METAB SYNDR RELAT D, V12, P422, DOI 10.1089/met.2014.0050; Shelness GS, 2005, CURR OPIN LIPIDOL, V16, P325, DOI 10.1097/01.mol.0000169353.12772.eb; Siddiqui MS, 2015, CLIN GASTROENTEROL H, V13, P1000, DOI 10.1016/j.cgh.2014.10.008; Sumner AE, 2008, GENDER MED, V5, P361, DOI 10.1016/j.genm.2008.11.003; Tacer KF, 2011, J LIPIDS, V2011, DOI 10.1155/2011/783976; Targher G, 2013, SEMIN THROMB HEMOST, V39, P214, DOI 10.1055/s-0033-1334866; Toledo FGS, 2006, DIABETES CARE, V29, P1845, DOI 10.2337/dc06-0455; Verges B, 2010, ATHEROSCLEROSIS, V211, P353, DOI 10.1016/j.atherosclerosis.2010.01.028; Wee CC, 2014, J GEN INTERN MED, V29, P68, DOI 10.1007/s11606-013-2603-1; Yu SSK, 2012, METAB SYNDR RELAT D, V10, P77, DOI 10.1089/met.2011.0108	53	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142676	10.1371/journal.pone.0142676	http://dx.doi.org/10.1371/journal.pone.0142676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599819	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900036
J	Zhang, XL; Zhai, LM; Rong, CZ; Qin, X; Li, S				Zhang, Xiaolian; Zhai, Limin; Rong, Chengzhi; Qin, Xue; Li, Shan			Association of Ghrelin Gene Polymorphisms and Serum Ghrelin Levels with the Risk of Hepatitis B Virus-Related Liver Diseases in a Chinese Population	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ENDOTHELIAL-CELLS; CANCER RISK; TNF-ALPHA; RATS; HBV; PROGRESSION; INFECTION; INJURY; ACTIVATION	Background The functions of ghrelin (GHRL) include anti-inflammatory effects, reduction of the fibrogenic response, protection of liver tissue, and regulation of cell proliferation. Genetic variations in the GHRL gene may play an important role in the development of chronic hepatitis B (CHB), liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Therefore, we investigated whether GHRL gene polymorphisms and its serum levels are associated with hepatitis B virus (HBV)-related diseases risk in a Chinese population. Methods 176 patients with CHB, 106 patients with HBV-related LC, 151 patients with HBV-related HCC, and 167 healthy controls were recruited in the study. Genotyping of GHRL rs26311, rs27647, rs696217, and rs34911341 polymorphisms were determined with the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing. The serum GHRL concentrations were determined using enzyme-linked immunosorbent assay (ELISA). Results Binary logistic regression analyses adjusting for gender and age revealed that a significant increased risk of LC was found in the GHRL rs26311 GC genotype and combined GC+CC genotypes when compared with the GG genotype (GC vs. GG: OR = 1.671, 95% CI = 1.013-2.757, P = 0.044; GC+CC vs. GG: OR = 1.674, 95% CI = 1.040-2.696, P = 0.034). In subgroup analysis by gender, binary logistic regression analyses adjusting for age showed that the GHRL rs26311 C allele and combined GC+CC genotypes were associated with a significantly increased risk to LC in males (C vs. G OR = 1.416, 95% CI = 1.017-1.972, P = 0.040; GC+CC vs. GG: OR = 1.729, 95% CI = 1.019-2.933, P = 0.042). In addition, we found significant decreased serum GHRL levels in LC patients compared with the healthy controls. However, there was no significant association of the GHRL rs26311 polymorphism with serum GHRL levels in LC patients. Conclusions These observations suggest that the GHRL rs26311 polymorphism is associated with an increased risk to HBV-related LC, especially in men. We also found an inverse association of serum GHRL levels with LC.	[Zhang, Xiaolian; Zhai, Limin; Rong, Chengzhi; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Qin, X (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; lis8858@126.com						Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Ataseven H, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/78380; Camacho S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07919; Campa D, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-112; Carey William D, 2009, Cleve Clin J Med, V76 Suppl 3, pS2, DOI 10.3949/ccjm.76.s3.01; Chang L, 2003, ACTA PHARMACOL SIN, V24, P45; Chopin LK, 2012, ENDOCR REV, V33, P849, DOI 10.1210/er.2011-1007; Delporte C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/518909; Deng B, 2015, INT J CLIN EXP MED, V8, P579; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dossus L, 2008, CARCINOGENESIS, V29, P1360, DOI 10.1093/carcin/bgn083; Granado M, 2005, AM J PHYSIOL-ENDOC M, V288, pE486, DOI 10.1152/ajpendo.00196.2004; Harkisoen S, 2012, ANN HEPATOL, V11, P164, DOI 10.1016/S1665-2681(19)31020-8; Iseri SO, 2008, REGUL PEPTIDES, V146, P73, DOI 10.1016/j.regpep.2007.08.014; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; Li Y, 2013, ENDOCRINE, V43, P376, DOI 10.1007/s12020-012-9761-5; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Liang XF, 2013, VACCINE, V31, pJ21, DOI 10.1016/j.vaccine.2013.08.012; Liao N, 2013, GENE, V517, P179, DOI 10.1016/j.gene.2012.12.094; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110061; Majchrzak K, 2012, POL J VET SCI, V15, P189, DOI 10.2478/v10181-011-0133-5; Moreno M, 2010, HEPATOLOGY, V51, P974, DOI 10.1002/hep.23421; Motawi TK, 2013, GENE, V527, P516, DOI 10.1016/j.gene.2013.06.053; Qin Y, 2014, LIVER INT, V34, P567, DOI 10.1111/liv.12286; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sato T, 2012, J BIOCHEM, V151, P119, DOI 10.1093/jb/mvr134; Tacke F, 2003, J HEPATOL, V38, P447, DOI 10.1016/S0168-8278(02)00438-5; Takezawa J, 2009, OBES RES CLIN PRACT, V3, P179, DOI 10.1016/j.orcp.2009.04.003; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Ukkola O, 2002, OBES RES, V10, P782, DOI 10.1038/oby.2002.106; Ukkola O, 2001, J CLIN ENDOCR METAB, V86, P3996, DOI 10.1210/jc.86.8.3996; Wajnrajch MP., 2000, J ENDOCR GENET, V1, P231, DOI [10.1515/ijdhd.2000.1.4.231, DOI 10.1515/IJD-HD.2000.1.4.231, DOI 10.1515/IJDHD.2000.1.4.231]; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Xu LL, 2008, BIOMED ENVIRON SCI, V21, P188, DOI 10.1016/S0895-3988(08)60027-6; Yamawaki H, 2015, J NEUROGASTROENTEROL, V21, P93, DOI 10.5056/jnm14086; Yang YF, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-11; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Zeng Z, 2014, WORLD J GASTROENTERO, V20, P7696, DOI 10.3748/wjg.v20.i24.7696; Zhou P, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000730	40	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143069	10.1371/journal.pone.0143069	http://dx.doi.org/10.1371/journal.pone.0143069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599409	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900061
J	Craig, JM; Laszlo, AH; Derrington, IM; Ross, BC; Brinkerhoff, H; Nova, IC; Doering, K; Tickman, BI; Svet, MT; Gundlach, JH				Craig, Jonathan M.; Laszlo, Andrew H.; Derrington, Ian M.; Ross, Brian C.; Brinkerhoff, Henry; Nova, Ian C.; Doering, Kenji; Tickman, Benjamin I.; Svet, Mark T.; Gundlach, Jens H.			Direct Detection of Unnatural DNA Nucleotides dNaM and d5SICS using the MspA Nanopore	PLOS ONE			English	Article							SINGLE; DISCRIMINATION; MOLECULES	Malyshev et al. showed that the four-letter genetic code within a living organism could be expanded to include the unnatural DNA bases dNaM and d5SICS. However, verification and detection of these unnatural bases in DNA requires new sequencing techniques. Here we provide proof of concept detection of dNaM and d5SICS in DNA oligomers via nanopore sequencing using the nanopore MspA. We find that both phi29 DNA polymerase and Hel308 helicase are capable of controlling the motion of DNA containing dNaM and d5SICS through the pore and that single reads are sufficient to detect the presence and location of dNaM and d5SICS within single molecules.	[Craig, Jonathan M.; Laszlo, Andrew H.; Derrington, Ian M.; Ross, Brian C.; Brinkerhoff, Henry; Nova, Ian C.; Doering, Kenji; Tickman, Benjamin I.; Svet, Mark T.; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gundlach, JH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	jens@phys.washington.edu		Laszlo, Andrew/0000-0002-7853-0533; Gundlach, Jens Horst/0000-0002-0773-8038; Craig, Jonathan M/0000-0003-4791-5112	National Human Genome Research Institute [R01HG005115]; Amgen Foundation; Amgen scholars program at University of Washington; National Institute of Health, NHGRI [R01HG005115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005115] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Amgen Foundation(Amgen); Amgen scholars program at University of Washington; National Institute of Health, NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Human Genome Research Institute grant R01HG005115 https://www.genome.gov/ to JMC AHL IMD BCR HB ICN KD BIT JHG, and Amgen Foundation; Amgen scholars program at University of Washington www.amgen.com to MTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institute of Health, NHGRI grant R01HG005115. M. T.S. was supported through the Amgen Scholars program at the University of Washington. We thank Illumina for providing Hel308.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Derrington IM, 2015, NAT BIOTECHNOL, V33, P1073, DOI 10.1038/nbt.3357; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Laszlo AH, 2013, P NATL ACAD SCI USA, V110, P18904, DOI 10.1073/pnas.1310240110; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723; Schreiber J, 2013, P NATL ACAD SCI USA, V110, P18910, DOI 10.1073/pnas.1310615110; Wescoe ZL, 2014, J AM CHEM SOC, V136, P16582, DOI 10.1021/ja508527b; Yang ZY, 2011, J AM CHEM SOC, V133, P15105, DOI 10.1021/ja204910n	13	23	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143253	10.1371/journal.pone.0143253	http://dx.doi.org/10.1371/journal.pone.0143253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588074	gold, Green Published, Green Submitted			2022-12-27	WOS:000365251500046
J	Nishimura, O; Hosoda, K; Kawaguchi, E; Yazawa, S; Hayashi, T; Inoue, T; Umesono, Y; Agata, K				Nishimura, Osamu; Hosoda, Kazutaka; Kawaguchi, Eri; Yazawa, Shigenobu; Hayashi, Tetsutaro; Inoue, Takeshi; Umesono, Yoshihiko; Agata, Kiyokazu			Unusually Large Number of Mutations in Asexually Reproducing Clonal Planarian Dugesia japonica	PLOS ONE			English	Article							RNA-SEQ DATA; STEM-CELLS; SCHMIDTEA-MEDITERRANEA; SEXUAL REPRODUCTION; HEAD-REGENERATION; READ ALIGNMENT; TIGRINA GIRARD; FAR-EAST; GENE; GENOME	We established a laboratory clonal strain of freshwater planarian (Dugesia japonica) that was derived from a single individual and that continued to undergo autotomous asexual reproduction for more than 20 years, and we performed large-scale genome sequencing and transcriptome analysis on it. Despite the fact that a completely clonal strain of the planarian was used, an unusually large number of mutations were detected. To enable quantitative genetic analysis of such a unique organism, we developed a new model called the Reference Gene Model, and used it to conduct large-scale transcriptome analysis. The results revealed large numbers of mutations not only outside but also inside gene-coding regions. Non-synonymous SNPs were detected in 74% of the genes for which valid ORFs were predicted. Interestingly, the high-mutation genes, such as metabolism- and defense-related genes, were correlated with genes that were previously identified as diverse genes among different planarian species. Although a large number of amino acid substitutions were apparently accumulated during asexual reproduction over this long period of time, the planarian maintained normal body-shape, behaviors, and physiological functions. The results of the present study reveal a unique aspect of asexual reproduction.	[Nishimura, Osamu; Kawaguchi, Eri; Yazawa, Shigenobu; Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Global COE Program Evolut & Biodivers, Sakyo Ku, Kyoto, Japan; [Nishimura, Osamu; Hosoda, Kazutaka; Yazawa, Shigenobu; Inoue, Takeshi; Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan; [Yazawa, Shigenobu] Nagoya Univ, Cellular & Struct Physiol Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hayashi, Tetsutaro] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan; [Hayashi, Tetsutaro] RIKEN, Adv Ctr Comp & Commun, Wako, Saitama, Japan; [Umesono, Yoshihiko] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan	Kyoto University; Kyoto University; Nagoya University; RIKEN; RIKEN; University of Hyogo	Agata, K (corresponding author), Kyoto Univ, Grad Sch Sci, Global COE Program Evolut & Biodivers, Sakyo Ku, Kyoto, Japan.	agata@mdb.biophys.kyoto-u.ac.jp	Yazawa, Shigenobu/E-6395-2014; Nishimura, Osamu/AAC-1236-2020; Hayashi, Tetsutaro/Q-5085-2018; Inoue, Takeshi/S-5623-2019	Yazawa, Shigenobu/0000-0003-4539-3875; Nishimura, Osamu/0000-0003-1969-2580; Hayashi, Tetsutaro/0000-0003-1679-5525; Inoue, Takeshi/0000-0003-3289-4478; Agata, Kiyokazu/0000-0002-5195-2576	Ministry of Education, Culture, Sports, Science and Technology of Japan [A06, 17GS0318]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Frontier Research Program, a Grant-in-Aid for Global COE Program to KA (A06) (http://www.jsps.go.jp/j-globalcoe/05_kyoten.html), and a Grant-in-Aid for Creative Scientific Research to KA (17GS0318) (https://www.jsps.go.jp/j-grantsinaid/18_sousei/c_hyouka_kekka20.html) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-731; Agata K, 1999, SEMIN CELL DEV BIOL, V10, P377, DOI 10.1006/scdb.1999.0324; Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; BESSHO Y, 1992, J MOL EVOL, V34, P324, DOI 10.1007/BF00160239; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Curtis W., 1902, PROC BOST SOC NAT HI, V30, P515; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldsmith E, 1939, ANAT REC           S, V75, P158; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Handberg-Thorsager M, 2007, DEV GENES EVOL, V217, P403, DOI 10.1007/s00427-007-0146-3; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hayashi T, 2010, DEV GROWTH DIFFER, V52, P131, DOI 10.1111/j.1440-169X.2009.01157.x; HYMAN LIBBIE H., 1939, TRANS AMER MICROSC SOC, V58, P264, DOI 10.2307/3222879; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Inoue T, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-014-0010-z; Inoue T, 2014, J NEUROSCI, V34, P15701, DOI 10.1523/JNEUROSCI.5379-13.2014; Kajitani R., 2014, GENOME RES; KAWAKATSU M, 1995, HYDROBIOLOGIA, V305, P55, DOI 10.1007/BF00036363; Kenk R, 1937, BIOL BULL-US, V73, P280, DOI 10.2307/1537589; Kobayashi C, 2007, DEV BIOL, V306, P714, DOI 10.1016/j.ydbio.2007.04.010; Kobayashi K, 1999, ZOOL SCI, V16, P291, DOI 10.2108/zsj.16.291; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krueger F., TRIM GALORE; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma CX, 2010, J GENET GENOMICS, V37, P713, DOI 10.1016/S1673-8527(09)60089-8; Ma CX, 2010, J GENET GENOMICS, V37, P621, DOI 10.1016/S1673-8527(09)60081-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MIX MC, 1969, NATL CANCER I MONOGR, P693; Morgan T. H., 1898, Archiv fuer Entwicklungsmechanik, Vvii, P364; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nishimura O, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-289; Ogawa K, 2002, DEV BIOL, V250, P59, DOI 10.1006/dbio.2002.0790; OKI I, 1981, HYDROBIOLOGIA, V84, P53, DOI 10.1007/BF00026163; ORII H, 1993, BIOCHEM BIOPH RES CO, V192, P1395, DOI 10.1006/bbrc.1993.1571; Oviedo NJ, 2008, DIS MODEL MECH, V1, P131, DOI 10.1242/dmm.000117; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Pineda D, 2002, MECH DEVELOP, V119, pS167, DOI 10.1016/S0925-4773(03)00111-4; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Raska O, 2011, FOLIA BIOL-PRAGUE, V57, P223; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sakai M, 2012, ZOOL SCI, V29, P672, DOI 10.2108/zsj.29.672; Salo E, 2002, J EXP ZOOL, V292, P528, DOI 10.1002/jez.90001; Sandmann T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r76; Sato K, 2006, DEV GROWTH DIFFER, V48, P615, DOI 10.1111/j.1440-169x.2006.00897.x; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Smed_Genome, SCHM MED GEN SEQ PRO; Tasaka K, 2013, INT J DEV BIOL, V57, P69, DOI 10.1387/ijdb.120114mm; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tyler S, 2013, TURBELLARIAN TAXONOM; VOWINCKEL C, 1970, BIOL BULL-US, V138, P77, DOI 10.2307/1540293; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang YY, 2007, P NATL ACAD SCI USA, V104, P5901, DOI 10.1073/pnas.0609708104; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Welch DBM, 2004, P NATL ACAD SCI USA, V101, P1622, DOI 10.1073/pnas.2136686100; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Yang X, 2013, BRIEF BIOINFORM, V14, P56, DOI 10.1093/bib/bbs015; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106	72	32	34	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143525	10.1371/journal.pone.0143525	http://dx.doi.org/10.1371/journal.pone.0143525			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588467	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500064
J	Oliveira, TL; Grassmann, AA; Schuch, RA; Neto, ACPS; Mendonca, M; Hartwig, DD; Alexander McBride, AJ; Dellagostin, OA				Oliveira, Thais Larre; Grassmann, Andre Alex; Schuch, Rodrigo Andrade; Pinto Seixas Neto, Amilton Clair; Mendonca, Marcelo; Hartwig, Daiane Drawanz; Alexander McBride, Alan John; Dellagostin, Odir Antonio			Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; PATHOGENIC LEPTOSPIRA; GENE-EXPRESSION; HAMSTER MODEL; GENOME; IDENTIFICATION; LIPL32; LIGA; CHALLENGE; INFECTION	The identification of potential vaccine candidates against leptospirosis remains a challenge. However, one such candidate is OmpL37, a potentially surface-exposed antigen that has the highest elastin-binding ability described to date, suggesting that it plays an important role in host colonization. In order to evaluate OmpL37's ability to induce a protective immune response, prime-boost, DNA and subunit vaccine strategies were tested in the hamster model of lethal leptospirosis. The humoral immune response was evaluated using an indirect ELISA test, and the cytokine profile in whole blood was determined by quantitative real-time PCR. Unlike the DNA vaccine, the administration of recombinant OmpL37 induced a strong IgG antibody response. When individually administrated, both formulations stimulated a TNF-alpha mediated inflammatory response. However, none of the OmpL37 formulations or vaccination strategies induced protective immunity. Further studies are required towards the identification of new vaccine targets against leptospirosis.	[Oliveira, Thais Larre; Grassmann, Andre Alex; Schuch, Rodrigo Andrade; Pinto Seixas Neto, Amilton Clair; Mendonca, Marcelo; Hartwig, Daiane Drawanz; Alexander McBride, Alan John; Dellagostin, Odir Antonio] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Programa Posgrad Biotecnol, Pelotas, RS, Brazil; [Hartwig, Daiane Drawanz] Univ Fed Pelotas, Inst Biol, Dept Microbiol & Parasitol, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas	Dellagostin, OA (corresponding author), Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Programa Posgrad Biotecnol, Pelotas, RS, Brazil.	odirad@terra.com.br	Oliveira, Thaís/P-5974-2019; McBride, Alan/D-4106-2012; Dellagostin, Odir/C-2331-2009; Mendonça, Marcelo MM/I-6435-2013	McBride, Alan/0000-0001-9682-540X; Dellagostin, Odir/0000-0003-2803-4088; Mendonça, Marcelo MM/0000-0001-7415-457X; Grassmann, Andre/0000-0002-3910-2165; Hartwig, Daiane/0000-0003-3604-0832	CAPES; CNPq [407180/2013-3]; FAPERGS; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian funding agencies CAPES, CNPq (grant # 407180/2013-3), and FAPERGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Michele dos Santos for the technical assistance provided during this study. This work was supported by Brazilian funding agencies CAPES, CNPq and FAPERGS.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Bulach DM, 2000, J MOL MICROB BIOTECH, V2, P375; Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004; Cao XJ, 2010, CELL RES, V20, P197, DOI 10.1038/cr.2009.127; CAVAILLON JM, 1992, CIRC SHOCK, V38, P145; Chirathaworn C, 2014, BRAZ J INFECT DIS, V18, P77, DOI 10.1016/j.bjid.2013.08.002; Chou LF, 2012, GENE, V511, P364, DOI 10.1016/j.gene.2012.09.074; del Rio B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011199; Dellagostin OA, 2011, HUM VACCINES, V7, P1215, DOI 10.4161/hv.7.11.17944; Etz H, 2002, P NATL ACAD SCI USA, V99, P6573, DOI 10.1073/pnas.092569199; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Feng CY, 2009, BRAZ J MED BIOL RES, V42, P796, DOI 10.1590/S0100-879X2009005000013; Fernandes CPH, 2007, HYBRIDOMA, V26, P35, DOI 10.1089/hyb.2006.033; Fraga TR, 2011, SCAND J IMMUNOL, V73, P408, DOI 10.1111/j.1365-3083.2010.02505.x; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Grassmann AA, 2012, CLIN VACCINE IMMUNOL, V19, P740, DOI 10.1128/CVI.05720-11; Haake David A, 2006, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12e02s02; Hartwig DD, 2013, CLIN VACCINE IMMUNOL, V20, P747, DOI 10.1128/CVI.00034-13; He HJ, 2008, CELL MOL IMMUNOL, V5, P385, DOI 10.1038/cmi.2008.48; Health Surveillance Secretary, 2013, LEPT CAS NOT REC; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Koizumi N, 2005, J Postgrad Med, V51, P210; Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007; Lourdault K, 2014, INFECT IMMUN, V82, P893, DOI 10.1128/IAI.01533-13; Lucas DSD, 2011, VACCINE, V29, P3413, DOI 10.1016/j.vaccine.2011.02.084; Matsui M, 2012, APPL ENVIRON MICROB, V78, P6372, DOI 10.1128/AEM.00911-12; Matsunaga J, 2010, MOL MICROBIOL; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06; Murray GL, 2013, VACCINE, V31, P495, DOI 10.1016/j.vaccine.2012.11.028; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Picardeau M, 2014, DIAGN MICR INFEC DIS, V78, P1, DOI 10.1016/j.diagmicrobio.2013.09.012; Pinne M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000815; Pinne M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006071; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ricaldi JN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001853; Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053; Sorensen HP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-27; Vernel-Pauillac F, 2006, INFECT IMMUN, V74, P4172, DOI 10.1128/IAI.00447-06; Vernel-Pauillac F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000582; Zuerner RL, 2011, CLIN VACCINE IMMUNOL, V18, P684, DOI 10.1128/CVI.00288-10	47	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142821	10.1371/journal.pone.0142821	http://dx.doi.org/10.1371/journal.pone.0142821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588685	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500017
J	Portale, AA; Zhang, MYH; David, V; Martin, A; Jiao, Y; Gu, WK; Perwad, F				Portale, Anthony A.; Zhang, Martin Y. H.; David, Valentin; Martin, Aline; Jiao, Yan; Gu, Weikuan; Perwad, Farzana			Characterization of FGF23-Dependent Egr-1 Cistrome in the Mouse Renal Proximal Tubule	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-23; CHRONIC KIDNEY-DISEASE; VITAMIN-D METABOLISM; X-LINKED HYPOPHOSPHATEMIA; PHOSPHATE-TRANSPORT; PARATHYROID-HORMONE; MINERAL METABOLISM; HYP MICE; SIGNALING PATHWAY; SERUM PHOSPHORUS	Fibroblast growth factor 23 (FGF23) is a potent regulator of phosphate (Pi) and vitamin D homeostasis. The transcription factor, early growth response 1 (egr-1), is a biomarker for FGF23-induced activation of the ERK1/2 signaling pathway. We have shown that ERK1/2 signaling blockade suppresses renal egr-1 gene expression and prevents FGF23-induced hypophosphatemia and 1,25-dihydroxyvitamin D (1,25(OH)(2)D) suppression in mice. To test whether egr-1 itself mediates these renal actions of FGF23, we administered FGF23 to egr-1(-/-) and wild-type (WT) mice. In WT mice, FGF23 induced hypophosphatemia and suppressed expression of the renal Na/Pi cotransporters, Npt2a and Npt2c. In FGF23-treated egr-1(-/-) mice, hypophosphatemic response was greatly blunted and Na/Pi cotransporter expression was not suppressed. In contrast, FGF23 induced equivalent suppression of serum 1,25(OH) 2D concentrations by suppressing renal cyp27b1 and stimulating cyp24a1 mRNA expression in both groups of mice. Thus, downstream of receptor binding and ERK1/2 signaling, we can distinguish the effector pathway that mediates FGF23-dependent inhibition of Pi transport from the pathway that mediates inhibition of 1,25(OH) 2D synthesis in the kidney. Furthermore, we demonstrate that the hypophosphatemic effect of FGF23 is significantly blunted in Hyp/egr-1(-/-) mice; specifically, serum Pi concentrations and renal Npt2a and Npt2c mRNA expression are significantly higher in Hyp/egr-1(-/-) mice than in Hyp mice. We then characterized the egr-1 cistrome in the kidney using ChIP-sequencing and demonstrate recruitment of egr-1 to regulatory DNA elements in proximity to several genes involved in Pi transport. Thus, our data demonstrate that the effect of FGF23 on Pi homeostasis is mediated, at least in part, by activation of egr-1.	[Portale, Anthony A.; Zhang, Martin Y. H.; Perwad, Farzana] Univ Calif San Francisco, Dept Pediat, Div Nephrol, San Francisco, CA 94110 USA; [David, Valentin; Martin, Aline] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Nephrol Hypertens, Chicago, IL 60611 USA; [Jiao, Yan; Gu, Weikuan] Univ Tennessee, Ctr Hlth Sci, Dept Orthopaed Surg, Memphis, TN 38163 USA	University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine; University of Tennessee System; University of Tennessee Health Science Center	Perwad, F (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Nephrol, San Francisco, CA 94110 USA.	perwadf@peds.ucsf.edu			University of California San Francisco Clinical and Translational Science Institute-Strategic Opportunity Support grant; UCSF Pediatric Nephrology Innovative Research Fund	University of California San Francisco Clinical and Translational Science Institute-Strategic Opportunity Support grant; UCSF Pediatric Nephrology Innovative Research Fund	Funding: This work was supported by University of California San Francisco Clinical and Translational Science Institute-Strategic Opportunity Support grant (to FP), and the UCSF Pediatric Nephrology Innovative Research Fund (to AAP).	Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barthel TK, 2007, J STEROID BIOCHEM, V103, P381, DOI 10.1016/j.jsbmb.2006.12.054; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Biber J, 2013, ANNU REV PHYSIOL, V75, P535, DOI 10.1146/annurev-physiol-030212-183748; Blaine J, 2009, AM J PHYSIOL-CELL PH, V297, pC1339, DOI 10.1152/ajpcell.00260.2009; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; Cunningham R, 2010, UROL RES, V38, P257, DOI 10.1007/s00240-010-0294-1; Dai B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044161; Farrow EG, 2009, J AM SOC NEPHROL, V20, P955, DOI 10.1681/ASN.2008070783; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FRIEDLAENDER MM, 1989, PFLUG ARCH EUR J PHY, V415, P372, DOI 10.1007/BF00370890; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Koldamova R, 2014, NEUROBIOL DIS, V63, P107, DOI 10.1016/j.nbd.2013.11.005; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lanzano L, 2011, AM J PHYSIOL-CELL PH, V301, pC850, DOI 10.1152/ajpcell.00412.2010; Lederer ED, 2008, FASEB J, V22; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; LU MQ, 1994, AM J PHYSIOL-RENAL, V267, pF624, DOI 10.1152/ajprenal.1994.267.4.F624; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marks J, 2010, AM J PHYSIOL-RENAL, V299, pF285, DOI 10.1152/ajprenal.00508.2009; Marsell R, 2008, NEPHROL DIAL TRANSPL, V23, P827, DOI 10.1093/ndt/gfm672; Meyer MH, 2004, PHYSIOL GENOMICS, V18, P4, DOI 10.1152/physiolgenomics.00210.2003; Miyamoto K, 2005, THER APHER DIAL, V9, P331, DOI 10.1111/j.1744-9987.2005.00292.x; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; O'Geen H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-689; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Pietrosemoli N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003144; PITTS TO, 1988, J CLIN ENDOCR METAB, V67, P876, DOI 10.1210/jcem-67-5-876; Portale AA, 2014, CLIN J AM SOC NEPHRO, V9, P344, DOI 10.2215/CJN.05840513; Ranch D, 2011, J BONE MINER RES, V26, P1883, DOI 10.1002/jbmr.401; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2011, J BIOL CHEM, V286, P37216, DOI 10.1074/jbc.M111.288357; Weinman EJ, 2011, AM J PHYSIOL-RENAL, V300, pF231, DOI 10.1152/ajprenal.00532.2010; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; Zhang MYH, 2012, ENDOCRINOLOGY, V153, P1806, DOI 10.1210/en.2011-1831; Zhang MYH, 2002, ENDOCRINOLOGY, V143, P587, DOI 10.1210/en.143.2.587; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142924	10.1371/journal.pone.0142924	http://dx.doi.org/10.1371/journal.pone.0142924			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588476	gold, Green Published			2022-12-27	WOS:000365251500024
J	Welz, C; Emmert, S; Canis, M; Becker, S; Baumeister, P; Shimizu, T; Morfill, GE; Harreus, U; Zimmermann, JL				Welz, Christian; Emmert, Steffen; Canis, Martin; Becker, Sven; Baumeister, Philipp; Shimizu, Tetsuji; Morfill, Gregor E.; Harreus, Uli; Zimmermann, Julia L.			Cold Atmospheric Plasma: A Promising Complementary Therapy for Squamous Head and Neck Cancer	PLOS ONE			English	Article							NONTHERMAL PLASMA; CELL	Head and neck squamous cell cancer (HNSCC) is the 7th most common cancer worldwide. Despite the development of new therapeutic agents such as monoclonal antibodies, prognosis did not change for the last decades. Cold atmospheric plasma (CAP) presents the most promising new technology in cancer treatment. In this study the efficacy of a surface micro discharging (SMD) plasma device against two head and neck cancer cell lines was proved. Effects on the cell viability, DNA fragmentation and apoptosis induction were evaluated with the MTT assay, alkaline microgel electrophoresis (comet assay) and Annexin-V/PI staining. MTT assay revealed that the CAP treatment markedly decreases the cell viability for all tested treatment times (30, 60, 90, 120 and 180 s). IC 50 was reached within maximal 120 seconds of CAP treatment. Comet assay analysis showed a dose dependent high DNA fragmentation being one of the key players in anti-cancer activity of CAP. Annexin-V/PI staining revealed induction of apoptosis in CAP treated HNSCC cell lines but no significant dose dependency was seen. Thus, we confirmed that SMD Plasma technology is definitely a promising new approach on cancer treatment.	[Welz, Christian; Canis, Martin] Univ Gottingen, Dept Otorhinolaryngol Head & Neck Surg, D-37073 Gottingen, Germany; [Emmert, Steffen] Univ Gottingen, Dept Dermatol Venereol & Allergol, D-37073 Gottingen, Germany; [Becker, Sven] Johannes Gutenberg Univ Mainz, Dept Otolaryngol Head & Neck Surg, D-55122 Mainz, Germany; [Baumeister, Philipp] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany; [Shimizu, Tetsuji; Morfill, Gregor E.; Zimmermann, Julia L.] Terraplasma GmbH, Garching, Germany; [Harreus, Uli] Evangel Hosp Dusseldorf, Dept Otolaryngol Head & Neck Surg, Dusseldorf, Germany	University of Gottingen; University of Gottingen; Johannes Gutenberg University of Mainz; University of Munich	Welz, C (corresponding author), Univ Gottingen, Dept Otorhinolaryngol Head & Neck Surg, D-37073 Gottingen, Germany.	Christian.welz@med.uni-goettingen.de	Becker, Sven/AAV-5316-2021; Becker, Sven/AEN-1860-2022; Strebhardt, Klaus/E-8765-2011; Shimizu, Tetsuji/L-1478-2018	Shimizu, Tetsuji/0000-0001-9432-1152	Friedrich-Baur-Stiftung Munich [40/13]	Friedrich-Baur-Stiftung Munich	Funding: The work was supported by the Friedrich-Baur-Stiftung Munich (GrandNumber 40/13) [http://www.baur-stiftung.de/front_content.php?idcat=76]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, CANC FACTS FIG 2014; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; David B. G., 2012, J PHYS D, V45; Denaro N, 2014, ONCOLOGY-BASEL, V86, P212, DOI 10.1159/000357712; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Guerrero-Preston R, 2014, INT J MOL MED; Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45; Heinlin J, 2013, WOUND REPAIR REGEN, V21, P800, DOI 10.1111/wrr.12078; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Isbary G, 2012, BRIT J DERMATOL, V167, P404, DOI 10.1111/j.1365-2133.2012.10923.x; Isbary G, 2013, EXPERT REV MED DEVIC, V10, P367, DOI [10.1586/erd.13.4, 10.1586/ERD.13.4]; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Koritzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064498; Lupu Andreea-Roxana, 2010, Roum Arch Microbiol Immunol, V69, P67; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Morfill G, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113041; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Seaman JC, 2013, CLIN CHEST MED, V34, P417, DOI 10.1016/j.ccm.2013.04.006; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tokar JL, 2013, GASTROINTEST ENDOSC, V78, P197, DOI 10.1016/j.gie.2013.04.164; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Welz C, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/4/045401; Yan X, 2010, IEEE T PLASMA SCI, V38, P2451, DOI 10.1109/TPS.2010.2056393; YOKOI T, 1989, Tumor Research, V24, P57; Zhang XH, 2008, APPL PHYS LETT, V93, P1; Zimmermann JL, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/073037	31	42	43	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0141827	10.1371/journal.pone.0141827	http://dx.doi.org/10.1371/journal.pone.0141827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588072	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500006
J	Baarine, M; Khan, M; Singh, A; Singh, I				Baarine, Mauhamad; Khan, Mushfiquddin; Singh, Avtar; Singh, Inderjit			Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; C6 GLIAL-CELLS; AXONAL DEGENERATION; MOUSE MODEL; SKIN FIBROBLASTS; OXIDATIVE STRESS; GENE-EXPRESSION; LIGNOCERIC ACID; BETA-OXIDATION; STEM-CELLS	X-ALD is an inherited neurodegenerative disorder where mutations in the ABCD1 gene result in clinically diverse phenotypes: the fatal disorder of cerebral childhood ALD (cALD) or a milder disorder of adrenomyeloneuropathy (AMN). The various models used to study the pathobiology of X-ALD disease lack the appropriate presentation for different phenotypes of cALD vs AMN. This study demonstrates that induced pluripotent stem cells (IPSC) derived brain cells astrocytes (Ast), neurons and oligodendrocytes (OLs) express morphological and functional activities of the respective brain cell types. The excessive accumulation of saturated VLCFA, a "hallmark" of X-ALD, was observed in both AMN OLs and cALD OLs with higher levels observed in cALD OLs than AMN OLs. The levels of ELOVL1 (ELOVL Fatty Acid Elongase 1) mRNA parallel the VLCFA load in AMN and cALD OLs. Furthermore, cALD Ast expressed higher levels of proinflammatory cytokines than AMN Ast and control Ast with or without stimulation with lipopolysaccharide. These results document that IPSC-derived Ast and OLs from cALD and AMN fibroblasts mimic the respective biochemical disease phenotypes and thus provide an ideal platform to investigate the mechanism of VLCFA load in cALD OLs and VLCFA-induced inflammatory disease mechanisms of cALD Ast and thus for testing of new therapeutics for AMN and cALD disease of X-ALD.	[Baarine, Mauhamad; Khan, Mushfiquddin; Singh, Avtar; Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Childrens Res Inst, Charleston, SC 29425 USA	Medical University of South Carolina	Singh, I (corresponding author), Med Univ S Carolina, Dept Pediat, Childrens Res Inst, 171 Ashley Ave, Charleston, SC 29425 USA.	singhi@musc.edu	Singh, Ashok/HGF-2506-2022		NIH, Bethesda, MD [NS-22576, NS72511, NS-64195, NS-37766]; NIH Grants from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR-018823, C06 RR-015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037766, R01NS022576, R37NS022576, R01NS064195, R01NS072511] Funding Source: NIH RePORTER	NIH, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Grants from the Extramural Research Facilities Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by grants (NS-22576, NS72511, NS-64195, and NS-37766) from the NIH, Bethesda, MD. This work was also supported by NIH Grants C06 RR-018823 and C06 RR-015455 from the Extramural Research Facilities Program of the National Center for Research Resources.; The authors would like to thank Dr. Choi Sueng for calcium efflux analysis assistance. We greatly appreciate the help of Ms. Joyce Bryan for technical assistance. These studies were supported by grants (NS-22576, NS72511, NS-64195, and NS-37766) from the NIH, Bethesda, MD. This work was also supported by NIH Grants C06 RR-018823 and C06 RR-015455 from the Extramural Research Facilities Program of the National Center for Research Resources.	Aubourg P, 2007, ANN ENDOCRINOL-PARIS, V68, P403, DOI 10.1016/j.ando.2007.04.002; Baarine M, 2012, NEUROSCIENCE, V213, P1, DOI 10.1016/j.neuroscience.2012.03.058; Baarine M., 2014, J NEUROCHEM; Baarine M, 2009, J NEUROCHEM, V111, P119, DOI 10.1111/j.1471-4159.2009.06311.x; Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; Berger J, 2010, BRAIN PATHOL, V20, P845, DOI 10.1111/j.1750-3639.2010.00393.x; Di Benedetto R, 2008, NEUROCHEM INT, V52, P1106, DOI 10.1016/j.neuint.2007.11.007; Di Biase A, 2004, NEUROCHEM INT, V44, P215, DOI 10.1016/S0197-0186(03)00162-1; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dubois-Dalcq M, 1999, TRENDS NEUROSCI, V22, P4, DOI 10.1016/S0166-2236(98)01319-8; Engelen M, 2012, J INHERIT METAB DIS, V35, P1137, DOI 10.1007/s10545-012-9471-4; Ferrer I, 2005, HUM MOL GENET, V14, P3565, DOI 10.1093/hmg/ddi384; FEUTZ AC, 1995, J NEUROCYTOL, V24, P865, DOI 10.1007/BF01179985; ForssPetter S, 1997, J NEUROSCI RES, V50, P829, DOI 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W; Fourcade S, 2008, HUM MOL GENET, V17, P1762, DOI 10.1093/hmg/ddn085; Fourcade S, 2014, BIOCHIMIE, V98, P143, DOI 10.1016/j.biochi.2013.09.012; Galea E, 2012, BBA-MOL BASIS DIS, V1822, P1475, DOI 10.1016/j.bbadis.2012.02.005; Galino J, 2011, ANTIOXID REDOX SIGN, V15, P2095, DOI 10.1089/ars.2010.3877; GANSER AL, 1988, DEV NEUROSCI-BASEL, V10, P99, DOI 10.1159/000111961; Gondcaille C, 2005, J CELL BIOL, V169, P93, DOI 10.1083/jcb.200501036; Grimm S, 2004, NAT REV GENET, V5, P179, DOI 10.1038/nrg1291; Hein S, 2008, HUM MOL GENET, V17, P1750, DOI 10.1093/hmg/ddn066; Hopfl G, 2004, METH MOL B, V254, P79; Jang J, 2011, ANN NEUROL, V70, P402, DOI 10.1002/ana.22486; Khan M, 1998, J NEUROCHEM, V71, P78; Khan M, 2010, J LIPID RES, V51, P1685, DOI 10.1194/jlr.M002329; Kobayashi T, 1997, BIOCHEM BIOPH RES CO, V232, P631, DOI 10.1006/bbrc.1997.6340; LAZO O, 1990, J LIPID RES, V31, P583; Lopez-Erauskin J, 2013, HUM MOL GENET, V22, P3296, DOI 10.1093/hmg/ddt186; Lopez-Erauskin J, 2012, BRAIN, V135, P3584, DOI 10.1093/brain/aws292; Lopez-Erauskin J, 2011, ANN NEUROL, V70, P84, DOI 10.1002/ana.22363; Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110; Lu JF, 1997, P NATL ACAD SCI USA, V94, P9366, DOI 10.1073/pnas.94.17.9366; Moser H, 2001, METABOLIC MOL BASIS; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Niedringhaus M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08353; Ofman R, 2010, EMBO MOL MED, V2, P90, DOI 10.1002/emmm.201000061; POULOS A, 1986, CLIN GENET, V29, P397; POWERS JM, 1974, AM J PATHOL, V76, P481; Pujol A, 2002, HUM MOL GENET, V11, P499, DOI 10.1093/hmg/11.5.499; Ross CA, 2014, HUM MOL GENET; SINGH I, 1984, PEDIATR RES, V18, P286, DOI 10.1203/00006450-198403000-00016; SINGH I, 1984, P NATL ACAD SCI-BIOL, V81, P4203, DOI 10.1073/pnas.81.13.4203; Singh I, 1998, FEBS LETT, V426, P342, DOI 10.1016/S0014-5793(98)00370-6; SINGH I, 1992, J BIOL CHEM, V267, P13306; Singh I, 2010, BRAIN PATHOL, V20, P838, DOI 10.1111/j.1750-3639.2010.00392.x; Singh J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070712; Smith BT, 2000, EXP CELL RES, V254, P309, DOI 10.1006/excr.1999.4757; Uto Takuhiro, 2008, Dev Neurosci, V30, P410, DOI 10.1159/000191212; WANDERS RJA, 1987, CLIN CHIM ACTA, V166, P255, DOI 10.1016/0009-8981(87)90428-1; WANDERS RJA, 1988, BIOCHEM BIOPH RES CO, V153, P618, DOI 10.1016/S0006-291X(88)81140-9; Wang XM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt130; Weber FD, 2014, HUM MOL GENET, V23, P2542, DOI 10.1093/hmg/ddt645; Xu H, 2013, FASEB J, V27, P4157, DOI 10.1096/fj.12-226555; Yamada T, 2004, J NEUROL SCI, V218, P91, DOI 10.1016/j.jns.2003.11.006; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	56	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143238	10.1371/journal.pone.0143238	http://dx.doi.org/10.1371/journal.pone.0143238			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581106	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600103
J	Schilling, J; Loziuk, PL; Muddiman, DC; Daniels, HV; Reading, BJ				Schilling, Justin; Loziuk, Philip L.; Muddiman, David C.; Daniels, Harry V.; Reading, Benjamin J.			Mechanisms of Egg Yolk Formation and Implications on Early Life History of White Perch (Morone americana)	PLOS ONE			English	Article							VERTEBRATE VITELLOGENIN GENE; MULLET MUGIL-CEPHALUS; PATTERN-RECOGNITION RECEPTOR; TANDEM MASS-SPECTROMETRY; MULTIPLE VITELLOGENINS; OOCYTE MATURATION; 2 FORMS; LIPOPROTEIN RECEPTORS; FUNDULUS-HETEROCLITUS; PELAGOPHIL TELEOST	The three white perch (Morone americana) vitellogenins (VtgAa, VtgAb, VtgC) were quantified accurately and precisely in the liver, plasma, and ovary during pre-, early-, mid-, and post-vitellogenic oocyte growth using protein cleavage-isotope dilution mass spectrometry (PC-IDMS). Western blotting generally mirrored the PC-IDMS results. By PC-IDMS, VtgC was quantifiable in pre-vitellogenic ovary tissues and VtgAb was quantifiable in pre-vitellogenic liver tissues however, neither protein was detected by western blotting in these respective tissues at this time point. Immunohistochemistry indicated that VtgC was present within pre-vitellogenic oocytes and localized to lipid droplets within vitellogenic oocytes. Affinity purification coupled to tandem mass spectrometry using highly purified VtgC as a bait protein revealed a single specific interacting protein (Y-box binding protein 2a-like [Ybx2a-like]) that eluted with suramin buffer and confirmed that VtgC does not bind the ovary vitellogenin receptors (LR8 and Lrp13). Western blotting for LR8 and Lrp13 showed that both receptors were expressed during vitellogenesis with LR8 and Lrp13 expression highest in early-and mid-vitellogenesis, respectively. The VtgAa within the ovary peaked during post-vitellogenesis, while VtgAb peaked during early-vitellogenesis in both white perch and the closely related striped bass (M. saxatilis). The VtgC was steadily accumulated by oocytes beginning during pre-vitellogenesis and continued until post-vitellogenesis and its composition varies widely between striped bass and white perch. In striped bass, the VtgC accounted for 26% of the vitellogenin-derived egg yolk, however in the white perch it comprised only 4%. Striped bass larvae have an extended developmental window and these larvae have yolk stores that may enable them to survive in the absence of food for twice as long as white perch after hatch. Thus, the VtgC may play an integral role in providing nutrients to late stage fish larvae prior to the onset of exogenous feeding and its composition in the egg yolk may relate to different early life histories among this diverse group of animals.	[Schilling, Justin; Daniels, Harry V.; Reading, Benjamin J.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Loziuk, Philip L.; Muddiman, David C.] N Carolina State Univ, Dept Chem, WM Keck FTMS Lab Human Hlth Res, Raleigh, NC 27695 USA; [Muddiman, David C.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Reading, BJ (corresponding author), N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA.	bjreadin@ncsu.edu		Muddiman, David/0000-0003-2216-499X; Reading, Benjamin/0000-0002-0778-4069	North Carolina Hatch Project [NC 06819]; North Carolina Agricultural Foundation	North Carolina Hatch Project; North Carolina Agricultural Foundation	This research was funded by North Carolina Hatch Project NC 06819 and the North Carolina Agricultural Foundation.	Aebersold R, 2013, MOL CELL PROTEOMICS, V12, P2381, DOI 10.1074/mcp.E113.031658; Amano H, 2008, MOL REPROD DEV, V75, P1307, DOI 10.1002/mrd.20864; Amano H, 2007, MAR BIOL, V152, P1215, DOI 10.1007/s00227-007-0768-z; Amano H, 2007, J EXP ZOOL PART A, V307A, P324, DOI 10.1002/jez.388; BABIN PJ, 1989, J LIPID RES, V30, P467; Bergey LL, 2003, N AM J FISH MANAGE, V23, P558, DOI 10.1577/1548-8675(2003)023<0558:VOACSB>2.0.CO;2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN SA, 1986, BIOCHEM BIOPH RES CO, V139, P333, DOI 10.1016/S0006-291X(86)80118-8; Cohen AM, 2006, J MASS SPECTROM, V41, P646, DOI 10.1002/jms.1023; Cohen AM, 2009, RAPID COMMUN MASS SP, V23, P1049, DOI 10.1002/rcm.3966; ELDRIDGE MB, 1981, T AM FISH SOC, V110, P111, DOI 10.1577/1548-8659(1981)110<111:EOFAFF>2.0.CO;2; Finn RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000169; Finn RN, 2007, BIOL REPROD, V76, P936, DOI 10.1095/biolreprod.106.055772; Finn RN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-2; Garcia J, 2010, FISH SHELLFISH IMMUN, V29, P293, DOI 10.1016/j.fsi.2010.04.010; Hiramatsu N, 2013, FISH PHYSIOL BIOCHEM, V39, P29, DOI 10.1007/s10695-012-9612-6; Hiramatsu N, 2002, FISH PHYSIOL BIOCHEM, V26, P355, DOI 10.1023/B:FISH.0000009266.58556.9a; JACKSON LF, 1995, T AM FISH SOC, V124, P563, DOI 10.1577/1548-8659(1995)124&lt;0563:ROWPTA&gt;2.3.CO;2; Kingon GLA, 2013, METHODS, V61, P323, DOI 10.1016/j.ymeth.2013.04.004; Kolarevic J, 2008, MOL REPROD DEV, V75, P1011, DOI 10.1002/mrd.20845; LAFLEUR GJ, 1995, J MOL EVOL, V41, P505, DOI 10.1007/BF00160323; LaFleur GJ, 2005, BIOL REPROD, V73, P815, DOI 10.1095/biolreprod.105.041335; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MANSUETI ROMEO J., 1964, CHESAPEAKE SCI, V5, P3, DOI 10.2307/1350789; Matsubara T, 1999, DEV BIOL, V213, P18, DOI 10.1006/dbio.1999.9365; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; North EW, 2003, MAR ECOL PROG SER, V260, P219, DOI 10.3354/meps260219; Ohkubo N, 2003, GEN COMP ENDOCR, V131, P353, DOI 10.1016/S0016-6480(03)00035-2; Plumel MI, 2013, J PROTEOME RES, V12, P4122, DOI 10.1021/pr400444m; Reading BJ, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P635; Reading BJ, 2014, J LIPID RES, V55, P2287, DOI 10.1194/jlr.M050286; Reading BJ, 2011, BIOL REPROD, V84, P392, DOI 10.1095/biolreprod.110.087981; Reading BJ, 2009, MAR BIOTECHNOL, V11, P169, DOI 10.1007/s10126-008-9133-6; Reith M, 2001, J EXP ZOOL, V291, P58, DOI 10.1002/jez.5; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sawaguchi S, 2006, MOL REPROD DEV, V73, P719, DOI 10.1002/mrd.20446; Sawaguchi S, 2005, BIOL REPROD, V72, P1045, DOI 10.1095/biolreprod.104.037895; Sawaguchi S, 2005, ZOOL SCI, V22, P701, DOI 10.2108/zsj.22.701; Sawaguchi S, 2008, CYBIUM, V32, P262; Schilling J, 2015, PROTEOMICS, V15, P2678, DOI 10.1002/pmic.201400606; Schilling J, 2014, J PROTEOME RES, V13, P1515, DOI 10.1021/pr401067g; TAFURI SR, 1990, P NATL ACAD SCI USA, V87, P9028, DOI 10.1073/pnas.87.22.9028; Wang H, 2000, GENE, V256, P303, DOI 10.1016/S0378-1119(00)00376-0; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Williams VN, 2014, FISH PHYSIOL BIOCHEM, V40, P395, DOI 10.1007/s10695-013-9852-0; Williams VN, 2014, J EXP ZOOL PART A, V321, P301, DOI 10.1002/jez.1859; Zhang FG, 2004, ENVIRON TOXICOL CHEM, V23, P1408, DOI 10.1897/03-425; Zhang J, 2011, MAR BIOTECHNOL, V13, P441, DOI 10.1007/s10126-010-9315-x; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	51	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143225	10.1371/journal.pone.0143225	http://dx.doi.org/10.1371/journal.pone.0143225			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580971	Green Published, gold			2022-12-27	WOS:000365154600101
J	Shuert, C; Horning, M; Mellish, JA				Shuert, Courtney; Horning, Markus; Mellish, Jo-Ann			The Effect of Novel Research Activities on Long-term Survival of Temporarily Captive Steller Sea Lions (Eumetopias jubatus)	PLOS ONE			English	Article							CAPTURE-RECAPTURE DATA; AIC MODEL SELECTION; MARKED ANIMALS; FLIPPER BANDS; ALASKA; POPULATIONS; TRANSMITTERS; DISPERSAL; PINNIPEDS; INFERENCE	Two novel research approaches were developed to facilitate controlled access to, and long-term monitoring of, juvenile Steller sea lions for periods longer than typically afforded by traditional fieldwork. The Transient Juvenile Steller sea lion Project at the Alaska SeaLife Center facilitated nutritional, physiological, and behavioral studies on the platform of temporary captivity. Temporarily captive sea lions (TJs, n = 35) were studied, and were intraperitoneally implanted with Life History Transmitters (LHX tags) to determine causes of mortality post-release. Our goal was to evaluate the potential for long-term impacts of temporary captivity and telemetry implants on the survival of study individuals. A simple open-population Cormack-Jolly-Seber mark-recapture model was built in program MARK, incorporating resightings of uniquely branded study individuals gathered by several contributing institutions. A priori models were developed to weigh the evidence of effects of experimental treatment on survival with covariates of sex, age, capture age, cohort, and age class. We compared survival of experimental treatment to a control group of n = 27 free-ranging animals (FRs) that were sampled during capture events and immediately released. Sex has previously been show to differentially affect juvenile survival in Steller sea lions. Therefore, sex was included in all models to account for unbalanced sex ratios within the experimental group. Considerable support was identified for the effects of sex, accounting for over 71% of total weight for all a priori models with delta AICc < 5, and over 91% of model weight after removal of pretending variables. Overall, most support was found for the most parsimonious model based on sex and excluding experimental treatment. Models including experimental treatment were not supported after post-hoc considerations of model selection criteria. However, given the limited sample size, alternate models including effects of experimental treatments remain possible and effects may yet become apparent in larger sample sizes.	[Shuert, Courtney; Mellish, Jo-Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA; [Shuert, Courtney; Horning, Markus; Mellish, Jo-Ann] Alaska SeaLife Ctr, Seward, AK 99664 USA; [Horning, Markus] Oregon State Univ, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Mellish, Jo-Ann] North Pacific Res Board, Anchorage, AK 99501 USA	University of Alaska System; University of Alaska Fairbanks; Oregon State University	Shuert, C (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA.	crshuert@alaska.edu	Horning, Markus/I-3019-2015	Horning, Markus/0000-0001-6178-4935; Shuert, Courtney/0000-0002-3202-4897	Alaska SeaLife Center; National Marine Fisheries Service; North Pacific Research Board [R1011, R1310]; Pollock Conservation Cooperative Research Center; School of Fisheries and Ocean Sciences at the University of Alaska Fairbanks; Graduate Student Research Award	Alaska SeaLife Center; National Marine Fisheries Service; North Pacific Research Board; Pollock Conservation Cooperative Research Center; School of Fisheries and Ocean Sciences at the University of Alaska Fairbanks; Graduate Student Research Award	This work was supported by funding over the last decade by the Alaska SeaLife Center (to JM www.alaskasealife.org), the National Marine Fisheries Service, the North Pacific Research Board (R1011 and R1310 to JM and MH), the Pollock Conservation Cooperative Research Center (to JM and MH, https://www.sfos.uaf.edu/pcc/) and the School of Fisheries and Ocean Sciences at the University of Alaska Fairbanks. This work was also supported by 2014 Graduate Student Research Award (to CS, www.nprb.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Alaska Department of Fish and Game, the National Marine Mammal Laboratory, as well as the Alaska SeaLife Center for their generous exchange of brand resighting data and research framework advice. We would also like to thank the many husbandry technicians and researchers that have participated in the Transient Juvenile Steller sea lion project over the last decade. This work was supported by funding over the last decade by the Alaska SeaLife Center (no grant numbers-to JM www.alaskasealife.org), the National Marine Fisheries Service, the North Pacific Research Board (R1011 and R1310 to JM and MH), the Pollock Conservation Cooperative Research Center (no grant numbers-to JM and MH https://www.sfos.uaf.edu/pcc/.), and the School of Fisheries and Ocean Sciences at the University of Alaska Fairbanks. This work was also supported by 2014 Graduate Student Research Award to CS www.nprb.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Anderson DR, 1998, J APPL STAT, V25, P263, DOI 10.1080/02664769823250; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Bonner SJ, 2010, BIOMETRICS, V66, P1256, DOI 10.1111/j.1541-0420.2010.01390.x; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Calkins DG, 2013, J EXP MAR BIOL ECOL, V441, P55, DOI 10.1016/j.jembe.2013.01.011; CASTELLINI MA, 1993, MAR MAMMAL SCI, V9, P48, DOI 10.1111/j.1748-7692.1993.tb00425.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Fritz LW, 2014, ENDANGER SPECIES RES, V26, P13, DOI 10.3354/esr00634; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Goldstein Tracey, 2007, Aquatic Mammals, V33, P337, DOI 10.1578/AM.33.3.2007.337; Hall AJ, 2002, FUNCT ECOL, V16, P462, DOI 10.1046/j.1365-2435.2002.00649.x; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Horning M, 2005, IEEE J OCEANIC ENG, V30, P807, DOI 10.1109/JOE.2005.862135; Horning Markus, 2010, Endangered Species Research, V10, P135, DOI 10.3354/esr00220; Horning M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-51; Jemison LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070167; King JC, 2007, MAR MAMMAL SCI, V23, P262, DOI 10.1111/j.1748-7692.2007.00108.x; Laake J., 2013, 201301 AFSC NOAA NAT, P1; Le Maho Y, 2011, CR BIOL, V334, P378, DOI 10.1016/j.crvi.2011.04.004; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Maniscalco JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096328; McAllister DC, 2001, COLD WATER DIVING SC, P98, DOI DOI 10.4027/CWDS.2001; Mellish Jo-Ann E., 2006, Aquatic Mammals, V32, P58, DOI 10.1578/AM.32.1.2006.58; Merrick RL, 1996, HOT BRANDING TECHNIQ, P1; Pendleton GW, 2006, CAN J ZOOL, V84, P1163, DOI 10.1139/Z06-103; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Thomton JD, 2007, J WILDLIFE DIS, V43, P258, DOI 10.7589/0090-3558-43.2.258; Thomton Jamie D., 2008, Endangered Species Research, V4, P195, DOI 10.3354/esr00062; TRITES AW, 1990, FUNCT ECOL, V4, P753, DOI 10.2307/2389442; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	35	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141948	10.1371/journal.pone.0141948	http://dx.doi.org/10.1371/journal.pone.0141948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580549	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600029
J	Alves, Z; Melo, A; Figueiredo, AR; Coimbra, MA; Gomes, AC; Rocha, SM				Alves, Zelia; Melo, Andre; Figueiredo, Ana Raquel; Coimbra, Manuel A.; Gomes, Ana C.; Rocha, Silvia M.			Exploring the Saccharomyces cerevisiae Volatile Metabolome: Indigenous versus Commercial Strains	PLOS ONE			English	Article							MINIMUM REPORTING STANDARDS; MONOTERPENE ALCOHOLS; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; SENSORY PROFILES; YEAST; AROMA; BIOTRANSFORMATION; METABOANALYST; FERMENTATION	Winemaking is a highly industrialized process and a number of commercial Saccharomyces cerevisiae strains are used around the world, neglecting the diversity of native yeast strains that are responsible for the production of wines peculiar flavours. The aim of this study was to in-depth establish the S. cerevisiae volatile metabolome and to assess inter-strains variability. To fulfill this objective, two indigenous strains (BT2652 and BT2453 isolated from spontaneous fermentation of grapes collected in Bairrada Appellation, Portugal) and two commercial strains (CSc1 and CSc2) S. cerevisiae were analysed using a methodology based on advanced multidimensional gas chromatography (HS-SPME/GCxGC-ToFMS) tandem with multivariate analysis. A total of 257 volatile metabolites were identified, distributed over the chemical families of acetals, acids, alcohols, aldehydes, ketones, terpenic compounds, esters, ethers, furan-type compounds, hydrocarbons, pyrans, pyrazines and S-compounds. Some of these families are related with metabolic pathways of amino acid, carbohydrate and fatty acid metabolism as well as mono and sesquiterpenic biosynthesis. Principal Component Analysis (PCA) was used with a dataset comprising all variables (257 volatile components), and a distinction was observed between commercial and indigenous strains, which suggests inter-strains variability. In a second step, a subset containing esters and terpenic compounds (C-10 and C-15), metabolites of particular relevance to wine aroma, was also analysed using PCA. The terpenic and ester profiles express the strains variability and their potential contribution to the wine aromas, specially the BT2453, which produced the higher terpenic content. This research contributes to understand the metabolic diversity of indigenous wine microflora versus commercial strains and achieved knowledge that may be further exploited to produce wines with peculiar aroma properties.	[Alves, Zelia; Figueiredo, Ana Raquel; Coimbra, Manuel A.; Rocha, Silvia M.] Univ Aveiro, Dept Chem, P-3810193 Aveiro, Portugal; [Alves, Zelia; Figueiredo, Ana Raquel; Coimbra, Manuel A.; Rocha, Silvia M.] Univ Aveiro, QOPNA, P-3810193 Aveiro, Portugal; [Melo, Andre; Figueiredo, Ana Raquel; Gomes, Ana C.] Parque Tecnol Cantanhede, Biocant Biotechnol Innovat Ctr, Genom Unit, P-3060197 Cantanhede, Portugal; [Melo, Andre] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Melo, Andre] Univ Aveiro, CESAM, P-3810193 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Rocha, SM (corresponding author), Univ Aveiro, Dept Chem, P-3810193 Aveiro, Portugal.	smrocha@ua.pt	Coimbra, Manuel A./L-2527-2014; Gomes, Ana Catarina/A-2628-2015	Coimbra, Manuel A./0000-0001-8898-6342; Rocha, Silvia/0000-0002-0396-3019; Gomes, Ana Catarina/0000-0002-4989-6026	European Regional Development Fund (FEDER) through the Competitive Factors Thematic Operational Program (COMPETE); FCT, Portugal [62/94 QOPNA, FCT UID/QUI/00062/2013]; project HoliWine: Holistic approaches to oenology [FCOMP-01-0124-FEDER-027411]	European Regional Development Fund (FEDER) through the Competitive Factors Thematic Operational Program (COMPETE); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); project HoliWine: Holistic approaches to oenology	Funding is acknowledged from the European Regional Development Fund (FEDER) through the Competitive Factors Thematic Operational Program (COMPETE) and from the FCT, Portugal, for supporting the Organic Chemistry Research Unit (62/94 QOPNA, under projects FCT UID/QUI/00062/2013), and project HoliWine: Holistic approaches to oenology (FCOMP-01-0124-FEDER-027411).	Barbosa C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122709; Bell S, 2005, IMPLICATIONS NITROGE, P242; Bisson LF, 2010, ANNU REV FOOD SCI T, V1, P139, DOI 10.1146/annurev.food.080708.100734; Rojas IB, 2012, WORLD J MICROB BIOT, V28, P3311, DOI 10.1007/s11274-012-1142-y; Callejon RM, 2010, ANAL CHIM ACTA, V660, P68, DOI 10.1016/j.aca.2009.09.040; Carrau FM, 2005, FEMS MICROBIOL LETT, V243, P107, DOI 10.1016/j.femsle.2004.11.050; CHEONG MW, 2011, J ESSENT OIL RES, V23, P34; Coelho E, 2006, ANAL CHIM ACTA, V563, P204, DOI 10.1016/j.aca.2005.11.018; Cordente AG, 2012, APPL MICROBIOL BIOT, V96, P601, DOI 10.1007/s00253-012-4370-z; Etschmann MMW, 2008, APPL MICROBIOL BIOT, V80, P579, DOI 10.1007/s00253-008-1573-4; Fiehn O, 2007, METABOLOMICS, V3, P175, DOI 10.1007/s11306-007-0070-6; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Franco-Duarte R, 2011, ELECTROPHORESIS, V32, P1447, DOI 10.1002/elps.201000640; Gomes Pereira AS, 2012, THESIS; Goodacre R, 2007, METABOLOMICS, V3, P231, DOI 10.1007/s11306-007-0081-3; Horak T, 2009, J AGR FOOD CHEM, V57, P11081, DOI 10.1021/jf9028305; Hu LS, 2011, J MED PLANTS RES, V5, P3298; King A, 2000, YEAST, V16, P499, DOI 10.1002/(SICI)1097-0061(200004)16:6<499::AID-YEA548>3.3.CO;2-5; Lambrechts M. G., 2000, South African Journal of Enology and Viticulture, V21, P97; Liang HY, 2013, FOOD RES INT, V51, P855, DOI 10.1016/j.foodres.2013.01.056; Lourenco AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055439; Martini A, 2003, INT MICROBIOL, V6, P207, DOI 10.1007/s10123-003-0135-y; Moreno-Garcia J, 2014, INT J FOOD MICROBIOL, V172, P21, DOI 10.1016/j.ijfoodmicro.2013.11.030; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Procopio S, 2011, EUR FOOD RES TECHNOL, V233, P721, DOI 10.1007/s00217-011-1567-9; Rocha SM, 2007, J CHROMATOGR A, V1161, P292, DOI 10.1016/j.chroma.2007.05.093; Romano P, 1998, FOOD TECHNOL BIOTECH, V36, P69; Romano P, 1997, FOOD TECHNOL BIOTECH, V35, P255; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Saberi S, 2012, FOOD RES INT, V48, P725, DOI 10.1016/j.foodres.2012.06.012; Schuller D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032507; Styger G, 2011, J IND MICROBIOL BIOT, V38, P1145, DOI 10.1007/s10295-011-1018-4; Sumby KM, 2010, FOOD CHEM, V121, P1, DOI 10.1016/j.foodchem.2009.12.004; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Swiegers JH, 2006, CURR GENET, V50, P161, DOI 10.1007/s00294-006-0084-z; Swiegers JH, 2005, AUST J GRAPE WINE R, V11, P139, DOI 10.1111/j.1755-0238.2005.tb00285.x; Takoi K, 2010, J AGR FOOD CHEM, V58, P5050, DOI 10.1021/jf1000524; Tang J, 2011, CURR GENOMICS, V12, P391, DOI 10.2174/138920211797248619; Tufariello M, 2014, LWT-FOOD SCI TECHNOL, V58, P35, DOI 10.1016/j.lwt.2014.03.016; Ugliano M, 2006, J AGR FOOD CHEM, V54, P6322, DOI 10.1021/jf0607718; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356	43	44	44	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143641	10.1371/journal.pone.0143641	http://dx.doi.org/10.1371/journal.pone.0143641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600152	gold, Green Published			2022-12-27	WOS:000365862600098
J	Fraser, DI; Liu, KT; Reid, BJ; Hawkins, E; Sevier, A; Pyle, M; Robinson, JW; Ouellette, PHR; Ballantyne, JS				Fraser, David I.; Liu, Kyle T.; Reid, Bryan J.; Hawkins, Emily; Sevier, Andrew; Pyle, Michelle; Robinson, Jacob W.; Ouellette, Pierre H. R.; Ballantyne, James S.			Widespread Natural Occurrence of Hydroxyurea in Animals	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; NITRIC-OXIDE; RIBONUCLEOTIDE REDUCTASE; UREA TRANSPORTER; MAMMALIAN-CELLS; DNA SYNTHESIS; INHIBITION; ACID; INTERMEDIATE; METABOLISM	Here we report the widespread natural occurrence of a known antibiotic and antineoplastic compound, hydroxyurea in animals from many taxonomic groups. Hydroxyurea occurs in all the organisms we have examined including invertebrates (molluscs and crustaceans), fishes from several major groups, amphibians and mammals. The species with highest concentrations was an elasmobranch (sharks, skates and rays), the little skate Leucoraja erinacea with levels up to 250 mu M, high enough to have antiviral, antimicrobial and antineoplastic effects based on in vitro studies. Embryos of L. erinacea showed increasing levels of hydroxyurea with development, indicating the capacity for hydroxyurea synthesis. Certain tissues of other organisms (e.g. skin of the frog (64 mu M), intestine of lobster (138 mu M) gills of the surf clam (100 mu M)) had levels high enough to have antiviral effects based on in vitro studies. Hydroxyurea is widely used clinically in the treatment of certain human cancers, sickle cell anemia, psoriasis, myeloproliferative diseases, and has been investigated as a potential treatment of HIV infection and its presence at high levels in tissues of elasmobranchs and other organisms suggests a novel mechanism for fighting disease that may explain the disease resistance of some groups. In light of the known production of nitric oxide from exogenously applied hydroxyurea, endogenous hydoxyurea may play a hitherto unknown role in nitric oxide dynamics.	[Fraser, David I.; Liu, Kyle T.; Reid, Bryan J.; Hawkins, Emily; Sevier, Andrew; Pyle, Michelle; Ouellette, Pierre H. R.; Ballantyne, James S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Robinson, Jacob W.] Durham Coll, Oshawa, ON, Canada	University of Guelph	Ballantyne, JS (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	jballant@uoguelph.ca	Ouellette, Pierre/GSO-0159-2022		Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by Natural Science and Engineering Research Council of Canada www.nserc-crsng.gc.ca.	Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Ballantyne JS, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1807; BERGLUND O, 1979, J BIOL CHEM, V254, P253; BOUCHER JL, 1994, BIOCHEM BIOPH RES CO, V203, P1614, DOI 10.1006/bbrc.1994.2371; Burkitt MJ, 2006, BLOOD, V107, P2219, DOI 10.1182/blood-2005-08-3429; Crow G.L., 2004, ELASMOBRANCH HUSBAND, V1st ed., P467; Dresler WFC, 1869, LIEBIGS ANN CHEM, V150, P1317; ELFORD HL, 1968, BIOCHEM BIOPH RES CO, V33, P129, DOI 10.1016/0006-291X(68)90266-0; FABRICIUS E, 1971, REV EUR ETUD CL BIOL, V16, P679; Fontecave M, 1998, FEBS LETT, V421, P277, DOI 10.1016/S0014-5793(97)01572-X; Frick NT, 2008, COMP BIOCHEM PHYS A, V151, P85, DOI 10.1016/j.cbpa.2008.06.003; GALE GR, 1964, CANCER RES, V24, P1012; Gaylor DW, 2000, TOXICOLOGY, V149, P17, DOI 10.1016/S0300-483X(00)00228-6; Topal JLG, 2006, J PHARMACOL EXP THER, V318, P1368, DOI 10.1124/jpet.106.103747; GRIMES D J, 1990, NOAA Technical Report NMFS, P63; Harshbarger J. C., 1977, Annals NY Acad Sci, V298, P280, DOI 10.1111/j.1749-6632.1977.tb19272.x; Harshbarger JC, 1981, PHYLETIC APPROACHES, P357; Hoff GR, 2009, J FISH BIOL, V74, P483, DOI 10.1111/j.1095-8649.2008.02138.x; Kettani T, 2009, J CHROMATOGR B, V877, P446, DOI 10.1016/j.jchromb.2008.12.048; King SB, 2004, FREE RADICAL BIO MED, V37, P737, DOI 10.1016/j.freeradbiomed.2004.02.073; King SB, 2003, CURR MED CHEM, V10, P437, DOI 10.2174/0929867033368213; LARSEN IK, 1982, EUR J BIOCHEM, V125, P75; LORI F, 1994, SCIENCE, V266, P801, DOI 10.1126/science.7973634; Mariotti F, 2013, AM J CLIN NUTR, V97, P972, DOI 10.3945/ajcn.112.048025; Martinez-Rojano H, 2008, ANTIMICROB AGENTS CH, V52, P3642, DOI 10.1128/AAC.00124-08; MOHLER WC, 1964, CANCER CHEMOTH REP, P1; Morgan RL, 2003, J EXP BIOL, V206, P3285, DOI 10.1242/jeb.00554; Mori M, 2007, J NUTR, V137, p1616S, DOI 10.1093/jn/137.6.1616S; Mylniczenko ND, 2007, J AQUAT ANIM HEALTH, V19, P159, DOI 10.1577/H06-039.1; Nozaki A, 2010, ARCH VIROL, V155, P601, DOI 10.1007/s00705-010-0624-1; Parker JN, 2004, HYDROXYUREA MED DICT; PFEIFFER SE, 1967, CANCER RES, V27, P124; RAHMATULLAH M, 1980, CLIN CHIM ACTA, V107, P3, DOI 10.1016/0009-8981(80)90407-6; Roa D, 1997, J CLIN LAB ANAL, V11, P208, DOI 10.1002/(SICI)1098-2825(1997)11:4<208::AID-JCLA6>3.0.CO;2-4; Robinson JW, 2011, AMINO ACIDS, V40, P689, DOI 10.1007/s00726-010-0703-3; ROSENKRANZ HS, 1966, VIROLOGY, V28, P510, DOI 10.1016/0042-6822(66)90235-2; ROSENKRANZ HS, 1973, J BACTERIOL, V115, P682, DOI 10.1128/JB.115.2.682-690.1973; Schlapfer E, 2003, AIDS, V17, P1613, DOI [10.1097/00002030-200307250-00005, 10.1097/01.aids.0000072664.21517.ad]; Scott DK, 2010, METHODS MOL BIOL, V603, P279, DOI 10.1007/978-1-60761-459-3_26; SINCLAIR WK, 1965, SCIENCE, V150, P1729, DOI 10.1126/science.150.3704.1729; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; SVENSSON ML, 1981, ARCH MICROBIOL, V129, P210, DOI 10.1007/BF00425252; VEALE D, 1988, CANCER CHEMOTH PHARM, V21, P53; Villani P, 1996, J CLIN PHARMACOL, V36, P117, DOI 10.1002/j.1552-4604.1996.tb04176.x; Walker AL, 2011, EXP HEMATOL, V39, P446, DOI 10.1016/j.exphem.2011.01.004; World Health Organization, 2013, WHO MOD LIST ESS MED; YARBRO JW, 1965, P NATL ACAD SCI USA, V53, P1033, DOI 10.1073/pnas.53.5.1033; YOUNG CW, 1964, SCIENCE, V146, P1172, DOI 10.1126/science.146.3648.1172; Zhao D, 2007, BBA-BIOMEMBRANES, V1768, P1815, DOI 10.1016/j.bbamem.2007.04.010	49	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142890	10.1371/journal.pone.0142890	http://dx.doi.org/10.1371/journal.pone.0142890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600157	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600021
J	Kang, CG; Liu, Y; Guo, DS; Qin, K				Kang, Chaogui; Liu, Yu; Guo, Diansheng; Qin, Kun			A Generalized Radiation Model for Human Mobility: Spatial Scale, Searching Direction and Trip Constraint	PLOS ONE			English	Article							EXPONENTIAL LAW; POWER-LAW; PATTERNS; DISTANCE	We generalized the recently introduced "radiation model", as an analog to the generalization of the classic "gravity model", to consolidate its nature of universality for modeling diverse mobility systems. By imposing the appropriate scaling exponent., normalization factor. and system constraints including searching direction and trip OD constraint, the generalized radiation model accurately captures real human movements in various scenarios and spatial scales, including two different countries and four different cities. Our analytical results also indicated that the generalized radiation model outperformed alternative mobility models in various empirical analyses.	[Kang, Chaogui; Qin, Kun] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan 430072, Hubei, Peoples R China; [Liu, Yu] Peking Univ, Inst Remote Sensing & Geog Informat Syst, Beijing 100871, Peoples R China; [Guo, Diansheng] Univ S Carolina, Dept Geog, Columbia, SC 29208 USA; [Qin, Kun] Wuhan Univ, Collaborat Innovat Ctr Geospatial Technol, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Peking University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Wuhan University	Kang, CG (corresponding author), Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan 430072, Hubei, Peoples R China.	cgkang@whu.edu.cn	Guo, Diansheng/AAM-5882-2020; Liu, Yu/D-4022-2012; Kang, Chaogui/H-7806-2014	Liu, Yu/0000-0002-0016-2902; Guo, Diansheng/0000-0003-3483-4153; Kang, Chaogui/0000-0002-0122-9419	National Natural Science of China [41271368, 41428102]; National Natural Science Foundation of China [41471326]; Fundamental Research Funds of the Central Universities [2042015kf0183]	National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of the Central Universities(Fundamental Research Funds for the Central Universities)	YL is founded by the National Natural Science of China (No. 41271368 and No. 41428102). KQ is founded by the National Natural Science Foundation of China (No. 41471326) and the Fundamental Research Funds of the Central Universities (No. 2042015kf0183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Chen YG, 2015, CHAOS SOLITON FRACT, V77, P174, DOI 10.1016/j.chaos.2015.05.022; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Haynes K.E., 1984, GRAVITY SPATIAL INTE, V2; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Karamshuk D, 2013, P 19 ACM SIGKDD INT, P793; Lenormand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045985; Liang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02983; Liu Y, 2012, J GEOGR SYST, V14, P463, DOI 10.1007/s10109-012-0166-z; Masucci AP, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022812; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Palchykov V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06174; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ren Y, 2014, NATURE COMMUNICATION, V5, P3547; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Sorensen Th, 1948, K DANSKE VIDENSK SEL, V5, P1, DOI DOI 10.3109/00016924809131205; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01001; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WILSON AG, 1971, ENVIRON PLANN, V3, P1, DOI 10.1068/a030001; Wilson AG, 1970, ENTROPY IN URBAN AND; Yan XY, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0834; Yang YX, 2014, SCI REP-UK, V4, DOI 10.1038/srep05662; Zheng V.W., 2010, P 19 INT C WORLD WID, DOI DOI 10.1145/1772690.1772795; Zheng Y, 2011, UBICOMP'11: PROCEEDINGS OF THE 2011 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P89, DOI 10.1145/2030112.2030126; Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063	28	42	43	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143500	10.1371/journal.pone.0143500	http://dx.doi.org/10.1371/journal.pone.0143500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600153	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600073
J	Laguardia-Nascimento, M; Branco, KMGR; Gasparini, MR; Giannattasio-Ferraz, S; Leite, LR; Araujo, FMG; Salim, ACD; Nicoli, JR; de Oliveira, GC; Barbosa-Stancioli, EF				Laguardia-Nascimento, Mateus; Grillo Ribeiro Branco, Kelly Moreira; Gasparini, Marcela Ribeiro; Giannattasio-Ferraz, Silvia; Leite, Laura Rabelo; Gomes Araujo, Flavio Marcos; de Matos Salim, Anna Christina; Nicoli, Jacques Robert; de Oliveira, Guilherme Correa; Barbosa-Stancioli, Edel Figueiredo			Vaginal Microbiome Characterization of Nellore Cattle Using Metagenomic Analysis	PLOS ONE			English	Article							HUMAN GUT; DIVERSITY; BACTERIAL; IDENTIFICATION; GROWTH; TRACT; PREVALENCE; UROVAGINA; INFECTION; ARCHAEA	Understanding of microbial communities inhabiting cattle vaginal tract may lead to a better comprehension of bovine physiology and reproductive health being of great economic interest. Up to date, studies involving cattle microbiota are focused on the gastrointestinal tract, and little is known about the vaginal microbiota. This study aimed to investigate the vaginal microbiome in Nellore cattle, heifers and cows, pregnant and non-pregnant, using a culture independent approach. The main bacterial phyla found were Firmicutes (similar to 40-50%), Bacteroidetes (similar to 15-25%) and Proteobacteria (similar to 5-25%), in addition to similar to 10-20% of non-classified bacteria. 45-55% of the samples were represented by only ten OTUs: Aeribacillus, Bacteroides, Clostridium, Ruminococcus, Rikenella, Alistipes, Bacillus, Eubacterium, Prevotella and non-classified bacteria. Interestingly, microbiota from all 20 animals could be grouped according to the respiratory metabolism of the main OTUs found, creating three groups of vaginal microbiota in cattle. Archaeal samples were dominated by the Methano-brevibacter genus (Euryarchaeota, similar to 55-70%). Ascomycota was the main fungal phylum (similar to 80-95%) and Mycosphaerella the most abundant genus (similar to 70-85%). Hormonal influence was not clear, but a tendency for the reduction of bacterial and increase of archaeal populations in pregnant animals was observed. Eukaryotes did not vary significantly between pregnant and non-pregnant animals, but tended to be more abundant on cows than on heifers. The present work describes a great microbial variability in the vaginal community among the evaluated animals and groups (heifers and cows, pregnant and non-pregnant), which is significantly different from the findings previously reported using culture dependent methods, pointing out the need for further studies on this issue. The microbiome found also indicates that the vaginal colonization appears to be influenced by the gastrointestinal community.	[Laguardia-Nascimento, Mateus; Grillo Ribeiro Branco, Kelly Moreira; Gasparini, Marcela Ribeiro; Giannattasio-Ferraz, Silvia; Nicoli, Jacques Robert; Barbosa-Stancioli, Edel Figueiredo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Leite, Laura Rabelo; Gomes Araujo, Flavio Marcos; de Matos Salim, Anna Christina; de Oliveira, Guilherme Correa] Fiocruz MS, Rene Rachou Res Ctr, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Barbosa-Stancioli, EF (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.	edelfb@icb.ufmg.br	Nicoli, Jacques R/K-4807-2015; Barbosa-Stancioli, Edel F/J-7230-2012; Oliveira, Guilherme/E-2624-2014	Nicoli, Jacques R/0000-0003-2390-2608; Barbosa-Stancioli, Edel F/0000-0001-6584-4333; Oliveira, Guilherme/0000-0003-0054-3438	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473879/2013-1, 309312/2012-4]; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [RED-00014-14]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant 473879/2013-1) EFBS (http://www.cnpq.br/); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant 309312/2012-4) GCO (http://www.cnpq.br/); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG Grant RED-00014-14) GCO (http://www.fapemig.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amin J. D., 1996, Bulletin of Animal Health and Production in Africa, V44, P15; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Branco KMGR, 2010, BRAZ J MED BIOL RES, V43, P338, DOI [10.1590/S0100-879X2010007500013, 10.1590/S0100-879X2010000400003]; BRYANT MP, 1970, AM J CLIN NUTR, V23, P1440; Carberry CA, 2014, APPL ENVIRON MICROB, V80, P586, DOI 10.1128/AEM.03131-13; Dhillon B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1132; DOHMEN MJW, 1995, THERIOGENOLOGY, V43, P1379, DOI 10.1016/0093-691X(95)00123-P; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; El-Said A. H. M., 2008, Mycobiology, V36, P1, DOI 10.4489/MYCO.2008.36.1.001; Faveri M, 2011, J PERIODONTAL RES, V46, P338, DOI 10.1111/j.1600-0765.2011.01347.x; Gaci N, 2014, WORLD J GASTROENTERO, V20, P16062, DOI 10.3748/wjg.v20.i43.16062; Gautam G, 2009, THERIOGENOLOGY, V71, P1451, DOI 10.1016/j.theriogenology.2008.12.027; HERTHELIUS M, 1989, INFECT IMMUN, V57, P2447, DOI 10.1128/IAI.57.8.2447-2451.1989; Hristov AN, 2012, J ANIM SCI, V90, P4449, DOI 10.2527/jas.2011-4624; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Khelaifia S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00073-14; Kim M, 2014, J ANIM SCI, V92, P683, DOI 10.2527/jas.2013-6841; Kwiatkowski NP, 2012, J MOL DIAGN, V14, P393, DOI 10.1016/j.jmoldx.2012.02.004; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Larsen A, 2013, FEMS MICROBIOL ECOL, V85, P483, DOI 10.1111/1574-6941.12136; LeBlanc SJ, 2011, THERIOGENOLOGY, V76, P1610, DOI 10.1016/j.theriogenology.2011.07.017; Lee J, 2013, ADVANCES IN MODELING AND DESIGN OF ADHESIVELY BONDED SYSTEMS, P1; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; McCann JC, 2014, BIOINFORM BIOL INSIG, V8, P109, DOI 10.4137/BBI.S15389; McDonald MC, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00102; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minana-Galbis D, 2010, INT J SYST EVOL MICR, V60, P1600, DOI 10.1099/ijs.0.003699-0; Moreno C, 2011, NAT PROD COMMUN, V6, P835; NELSEN TC, 1985, J ANIM SCI, V61, P470, DOI 10.2527/jas1985.612470x; Oikonomou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085904; Oliveira LJ, 2012, REPROD DOMEST ANIM, V47, P384, DOI 10.1111/j.1439-0531.2012.02102.x; Otero C, 1999, ANAEROBE, V5, P305, DOI 10.1006/anae.1999.0245; Otero C, 2000, LETT APPL MICROBIOL, V31, P251, DOI 10.1046/j.1365-2672.2000.00809.x; Patel V, 2014, APPL MICROBIOL BIOT, V98, P9749, DOI 10.1007/s00253-014-6153-1; Pereira CB, 2015, J ANTIBIOT, V68, P436, DOI 10.1038/ja.2015.11; Petri RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104167; REID G, 1985, INFECT IMMUN, V49, P320, DOI 10.1128/IAI.49.2.320-324.1985; Reti KL, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-8; Sevim E, 2011, J BACTERIOL, V193, P575, DOI 10.1128/JB.01193-10; SIJPESTEIJN AK, 1951, J GEN MICROBIOL, V5, P869, DOI 10.1099/00221287-5-5-869; Singh J, 2008, VET J, V175, P301, DOI 10.1016/j.tvjl.2007.02.003; Singh Jagtar, 2009, Biotechnology Journal, V4, P480, DOI 10.1002/biot.200800201; Snelling TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106491; STJEAN G, 1988, VET SURG, V17, P258, DOI 10.1111/j.1532-950X.1988.tb01011.x; Swartz Jeffrey D, 2014, Front Vet Sci, V1, P19, DOI 10.3389/fvets.2014.00019; Switt AIM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-26; USDA, 2014, LIV POULTR WORLD MAR; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Wagner RD, 2011, ANTIMICROB AGENTS CH, V55, P4990, DOI 10.1128/AAC.00008-11; Williams EJ, 2005, THERIOGENOLOGY, V63, P102, DOI 10.1016/j.theriogenology.2004.03.017; Ziemer CJ, 2014, APPL ENVIRON MICROB, V80, P574, DOI 10.1128/AEM.03016-13	56	60	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143294	10.1371/journal.pone.0143294	http://dx.doi.org/10.1371/journal.pone.0143294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599789	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600045
J	Mei, ZH; Shen, W; Wang, Y; Yang, JZ; Zhou, T; Zhou, H				Mei, Zaihuan; Shen, Wei; Wang, Yan; Yang, Jingzhi; Zhou, Ting; Zhou, Hua			Unidirectional Fabric Drape Testing Method	PLOS ONE			English	Article								In most cases, fabrics such as curtains, skirts, suit pants and so on are draped under their own gravity parallel to fabric plane while the gravity is perpendicular to fabric plane in traditional drape testing method. As a result, it does not conform to actual situation and the test data is not convincing enough. To overcome this problem, this paper presents a novel method which simulates the real mechanical conditions and ensures the gravity is parallel to the fabric plane. This method applied a low-cost Kinect Sensor device to capture the 3-dimensional (3D) drape profile, thus we obtained the drape degree parameters and aesthetic parameters by 3D reconstruction and image processing and analysis techniques. The experiment was conducted on our self-devised drape-testing instrument by choosing different kinds of weave structure fabrics as our testing samples and the results were compared with those of traditional method and subjective evaluation. Through regression and correlation analysis we found that this novel testing method was significantly correlated with the traditional and subjective evaluation method. We achieved a new, non-contact 3D measurement method for drape testing, namely unidirectional fabric drape testing method. This method is more suitable for evaluating drape behavior because it is more in line with actual mechanical conditions of draped fabrics and has a well consistency with the requirements of visual and aesthetic style of fabrics.	[Mei, Zaihuan; Shen, Wei; Wang, Yan; Yang, Jingzhi; Zhou, Ting; Zhou, Hua] Zhejiang Sci Tech Univ, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Zhou, H (corresponding author), Zhejiang Sci Tech Univ, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou, Zhejiang, Peoples R China.	hzzh@zstu.edu.cn						Agrawal S.A., 2011, MAN MADE TEXTILES IN, V39, P363; Agrawal S.A., 2013, INT J ENG RES APPL, V3, P261; Behera BK, 2006, J TEXT I, V97, P147, DOI 10.1533/joti.2005.0150; Chauncey C.C., 1960, TEXT RES J, V30, P66, DOI DOI 10.1177/004051756003000109; CHU CC, 1950, TEXT RES J, V20, P539, DOI 10.1177/004051755002000802; Collier BJ, 1991, CLOTH TEXT RES J, V10, P46, DOI DOI 10.1177/0887302X9101000107; Cusick G.E., 1965, J TEXT I, V56, P596, DOI DOI 10.1080/19447026508662319; Gersak J., 2004, International Journal of Clothing Science and Technology, V16, P238, DOI 10.1108/09556220410520513; Gersak J, 2003, TEKSTIL, V52, P368; Izadi S, 2011, P ACM S US INT SOFTW, V11, P16; Jeong YJ, 1998, J TEXT I, V89, P59, DOI 10.1080/00405009808658597; Kenkare N., 2005, J TEXT APPAREL TECHN, V4, P1; Lim H, 2011, FIBER POLYM, V12, P1077, DOI 10.1007/s12221-011-1077-1; Lojen DZ, 2007, FIBRES TEXT EAST EUR, V15, P39; Mizutani C, 2005, TEXT RES J, V75, P81, DOI 10.1177/004051750507500115; Newcombe RA, 2011, INT SYM MIX AUGMENT, P127, DOI 10.1109/ISMAR.2011.6092378; Peirce F.T., 1930, J TEXT I, V21, P377, DOI DOI 10.1080/19447023008661529; Sanad R., 2012, J FIBRE BIOENGINEERI, V5, P341, DOI [DOI 10.3993/jfbi12201201, 10.3993/jfbi12201201]; [沈毅 SHEN Yi], 2008, [纺织学报, Journal of Textile Research], V29, P118; Thilagavathi G, 2003, INDIAN J FIBRE TEXT, V28, P41; Thilagavathi G., 2003, INDIAN TEXTILE J, V113, P27; Tsai KH, 2009, FIBRES TEXT EAST EUR, V17, P54; Vangheluwe L., 1993, INT J CLOTH SCI TECH, V5, P5, DOI DOI 10.1108/eb003022	23	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143648	10.1371/journal.pone.0143648	http://dx.doi.org/10.1371/journal.pone.0143648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600387	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600099
J	Sun, JS; Yang, M; Sreevatsan, S; Davies, PR				Sun, Jisun; Yang, My; Sreevatsan, Srinand; Davies, Peter R.			Prevalence and Characterization of Staphylococcus aureus in Growing Pigs in the USA	PLOS ONE			English	Article							LIVESTOCK-ASSOCIATED MRSA; METHICILLIN-RESISTANT; UNITED-STATES; MOLECULAR CHARACTERIZATION; NASAL COLONIZATION; RISK-FACTOR; SLAUGHTER; CARRIAGE; STRAINS; FARMERS	A decade of research of methicillin-resistant S. aureus (MRSA) in pigs shows that the prevalence and predominant genotypes (i.e., ST398, ST9, ST5) of MRSA vary widely geographically, yet knowledge of the epidemiology of S. aureus generally in swine remains rudimentary. To characterize S. aureus, including MRSA, in the US swine industry, we sampled 38 swine herds in 11 states in major swine producing regions. The herds sampled included pigs sourced from 9 different breeding stock companies, and the sample was likely biased towards larger herds that use regular veterinary services. Twenty nasal swabs were collected from 36 groups of growing pigs by 36 swine veterinarians, 2 more herds were sampled opportunistically, and a historically MRSA-positive herd was included as a positive control. S. aureus was detected on 37 of the 38 herds, and in 77% of pigs sampled. Other than the positive control herd, no MRSA were detected in the study sample, yielding a 95% upper confidence limit of 9.3% for MRSA herd prevalence. All but two (ST1-t127; ST2007-t8314) of 1200 isolates belonged to three MLST lineages (ST9, ST398, and ST5) that have been prominent in studies of MRSA in pigs globally. A total of 35 spa types were detected, with the most prevalent being t337 (ST9), t034 (ST398), and t002 (ST5). A purposively diverse subset of 128 isolates was uniformly negative on PCR testing for major enterotoxin genes. The findings support previous studies suggesting a relatively low herd prevalence of MRSA in the US swine industry, but confirm that methicillin susceptible variants of the most common MRSA genotypes found in swine globally are endemic in the US. The absence of enterotoxin genes suggests that the source of toxigenic S. aureus capable of causing foodborne enterotoxicosis from pork products is most likely post-harvest contamination.	[Sun, Jisun; Yang, My; Sreevatsan, Srinand; Davies, Peter R.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Davies, PR (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	davie001@umn.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403	National Pork Board [13-056]	National Pork Board	Funded by National Pork Board Grant #13-056 (http://www.pork.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso Y, 2012, VET MICROBIOL, V157, P246, DOI 10.1016/j.vetmic.2011.12.023; Alt K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-69; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Bennett SD, 2013, CLIN INFECT DIS, V57, P425, DOI 10.1093/cid/cit244; Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378; Boost MV, 2012, VET REC, V171, P156, DOI 10.1136/vr.100779; Broens EM, 2011, PREV VET MED, V102, P41, DOI 10.1016/j.prevetmed.2011.06.005; Chroboczek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068462; Chuang YY, 2015, INT J ANTIMICROB AG, V45, P334, DOI 10.1016/j.ijantimicag.2014.12.007; Crombe F, 2012, MICROB DRUG RESIST, V18, P125, DOI 10.1089/mdr.2011.0138; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Davies PR, 2011, EMERG INFECT DIS, V17, P1152, DOI [10.3201/eid/1706.101394, 10.3201/eid1706.101394]; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Dressler AE, 2012, VET REC, V170, P495, DOI 10.1136/vr.100570; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Espinosa-Gongora C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101988; Fall C, 2012, FOODBORNE PATHOG DIS, V9, P962, DOI 10.1089/fpd.2012.1197; Frana TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053738; Gordoncillo MJ, 2012, ZOONOSES PUBLIC HLTH, V59, P212, DOI 10.1111/j.1863-2378.2011.01437.x; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Guinane CM, 2011, VIRULENCE, V2, P241, DOI 10.4161/viru.2.3.16193; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hau SJ, PLOS ONE ACCEPTED; He WQ, 2013, FOODBORNE PATHOG DIS, V10, P782, DOI 10.1089/fpd.2012.1452; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Lekkerkerk WSN, 2015, J CLIN MICROBIOL, V53, P1836, DOI 10.1128/JCM.02702-14; Linhares LL, 2015, J VET DIAGN INVEST, V27, P55, DOI 10.1177/1040638714559598; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Miko BA, 2013, J CLIN MICROBIOL, V51, P874, DOI 10.1128/JCM.00923-12; Molla B, 2012, J CLIN MICROBIOL, V50, P3687, DOI 10.1128/JCM.01971-12; Moodley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049344; Nadimpalli M, 2015, OCCUP ENVIRON MED, V72, P90, DOI 10.1136/oemed-2014-102095; Normanno G, 2015, FOOD MICROBIOL, V51, P51, DOI 10.1016/j.fm.2015.04.007; OEDING P, 1972, ACTA PATHOLOG MICROB, VB 80, P525; Osadebe LU, 2013, ZOONOSES PUBLIC HLTH, V60, P234, DOI 10.1111/j.1863-2378.2012.01527.x; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; Smith TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063704; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Sun J, 2015, PROCEEDINGS 11TH INT, P157; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; Verkade E, 2013, CLIN INFECT DIS, V57, pE11, DOI 10.1093/cid/cit228; Viana D, 2015, NAT GENET, V47, P361, DOI 10.1038/ng.3219; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wales A, 2013, ISRN Vet Sci, V2013, P943126, DOI 10.1155/2013/943126; Wardyn SE, 2015, CLIN INFECT DIS, V61, P59, DOI 10.1093/cid/civ234; Weese JS, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-41; Yan XM, 2014, INT J MED MICROBIOL, V304, P379, DOI 10.1016/j.ijmm.2013.12.003	53	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143670	10.1371/journal.pone.0143670	http://dx.doi.org/10.1371/journal.pone.0143670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599635	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600103
J	Wu, SM; Duncan, F; Anderson, NH; Kuppuswamy, A; Macloed, MR; Mead, GE				Wu, Simiao; Duncan, Fiona; Anderson, Niall H.; Kuppuswamy, Annapoorna; Macloed, Malcolm R.; Mead, Gillian E.			Exploratory Cohort Study of Associations between Serum C - Reactive Protein and Fatigue after Stroke	PLOS ONE			English	Article							ISCHEMIC-STROKE; INFLAMMATORY RESPONSE; POSTSTROKE FATIGUE; INFECTION	Background and Aim Post-stroke fatigue is a common and distressing problem but little is known about its biological mechanisms. This cohort study was to investigate associations between C-reactive protein (CRP) and fatigue after stroke. Methods Patients were assessed at one, six and 12 months after their stroke onset, with the Fatigue Assessment Scale, a case definition of post-stroke fatigue, Hospital Anxiety and Depression Scale, and daily step counts. Blood samples were collected at each assessment and the CRP level was determined by a standard CRP immunoassay. Cross-sectional associations between CRP and fatigue at each time point were determined by Pearson correlation coefficient and independent-samples t-test. Whether CRP levels at one month predict fatigue scores at six and 12 months was explored by multiple linear regression, with anxiety, depression, and daily step counts as covariates. Results Sixty-five patients (mean age 67 years, 65% men) were included: 61 at one month, 49 at six months, and 41 at 12 months. CRP levels and fatigue scores were not associated at one month (p = 0.88) or 12 months (p = 0.56), but weakly associated at six months (r = 0.27, p = 0.04); however, this association was no longer significant (p = 0.14) after controlling for the effects of covariates. The CRP level was not associated with the fulfilment of case definition of post-stroke fatigue at any time points (all p > 0.05). The CRP level at one month was not a significant predictor for fatigue levels at either six months (p = 0.93) or 12 months (p = 0.78). Conclusions There is insufficient evidence for the association between CRP and PSF in stroke patients. Future studies with larger sample sizes and controlling for potential confounders are needed to investigate whether this association exists.	[Wu, Simiao; Macloed, Malcolm R.; Mead, Gillian E.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Wu, Simiao] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Peoples R China; [Duncan, Fiona] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Anderson, Niall H.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Kuppuswamy, Annapoorna] UCL, Sobell Dept Motor Neurosci, London, England	University of Edinburgh; Sichuan University; Glasgow Caledonian University; University of Edinburgh; University of London; University College London	Mead, GE (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	gillian.e.mead@ed.ac.uk		Kuppuswamy, Annapoorna/0000-0002-4288-0814; WU, SIMIAO/0000-0002-4557-7386	Chief Scientist Office of Scottish Government [CZH/4/536]; University of Edinburgh; China Scholarships Council [2011624011]	Chief Scientist Office of Scottish Government; University of Edinburgh; China Scholarships Council	This study was supported by The Chief Scientist Office of Scottish Government (CZH/4/536, http://www.cso.scot.nhs.uk/) and The University of Edinburgh and China Scholarships Council joint scholarship (2011624011, http://www.ed.ac.uk/student-funding/postgraduate/international/region/asia/china-council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour VL, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/863031; Beamer NB, 1998, NEUROLOGY, V50, P1722, DOI 10.1212/WNL.50.6.1722; Becker K, 2015, J STROKE CEREBROVASC, V24, P618, DOI 10.1016/j.jstrokecerebrovasdis.2014.10.008; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Di Napoli M, 2005, STROKE, V36, P1316, DOI 10.1161/01.STR.0000165929.78756.ed; Di Napoli M, 2001, STROKE, V32, P917, DOI 10.1161/01.STR.32.4.917; Duncan F, 2015, STROKE, V46, P1052, DOI 10.1161/STROKEAHA.114.008079; Duncan F, 2014, J PSYCHOSOM RES, V77, P368, DOI 10.1016/j.jpsychores.2014.06.013; Emsley HCA, 2003, J NEUROIMMUNOL, V139, P93, DOI 10.1016/S0165-5728(03)00134-6; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Harel O, 2009, J APPL STAT, V36, P1109, DOI 10.1080/02664760802553000; Klimas NG, 2012, BRAIN BEHAV IMMUN, V26, P1202, DOI 10.1016/j.bbi.2012.06.006; Lynch J, 2007, J PSYCHOSOM RES, V63, P539, DOI 10.1016/j.jpsychores.2007.08.004; McKechnie F, 2010, J ROY COLL PHYS EDIN, V40, P9, DOI 10.4997/JRCPE.2010.103; Michielsen HJ, 2004, EUR J PSYCHOL ASSESS, V20, P39, DOI 10.1027/1015-5759.20.1.39; Morris G, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0259-2; Ormstad H, 2011, J NEUROL, V258, P670, DOI 10.1007/s00415-011-5962-8; Reiner AP, 2008, ARTERIOSCL THROM VAS, V28, P1407, DOI 10.1161/ATVBAHA.108.167437; Wu SM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007030.pub3; Wu SM, 2015, STROKE, V46, P893, DOI 10.1161/STROKEAHA.114.006647; Wu SM, 2014, STROKE, V45, P1778, DOI 10.1161/STROKEAHA.113.004584; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	22	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143784	10.1371/journal.pone.0143784	http://dx.doi.org/10.1371/journal.pone.0143784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599129	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600122
J	Jeong, YK; Kim, MS; Lee, JY; Kim, EH; Ha, H				Jeong, Youn Kyoung; Kim, Mi-Sook; Lee, Ji Young; Kim, Eun Ho; Ha, Hunjoo			Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins	PLOS ONE			English	Article							IN-VITRO; RAD51 OVEREXPRESSION; IONIZING-RADIATION; NECK-CANCER; P53; RESISTANCE; HEAD; PROLIFERATION; TARGET; AMPK	The present study addressed whether the combination of metformin and ionizing radiation (IR) would show enhanced antitumor effects in radioresistant p53-deficient colorectal cancer cells, focusing on repair pathways for IR-induced DNA damage. Metformin caused a higher reduction in clonogenic survival as well as greater radiosensitization and inhibition of tumor growth of p53(-/-) than of p53(+/+) colorectal cancer cells and xenografts. Metformin combined with IR induced accumulation of tumor cells in the G2/M phase and delayed the repair of IR-induced DNA damage. In addition, this combination significantly decreased levels of p53-related homologous recombination (HR) repair compared with IR alone, especially in p53(-/-) colorectal cancer cells and tumors. In conclusion, metformin enhanced radiosensitivity by inducing G2/M arrest and reducing the expression of DNA repair proteins even in radioresistant HCT116 p53(-/)-colorectal cancer cells and tumors. Our study provides a scientific rationale for the clinical use of metformin as a radiosensitizer in patients with p53-deficient colorectal tumors, which are often resistant to radiotherapy.	[Jeong, Youn Kyoung; Ha, Hunjoo] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Jeong, Youn Kyoung; Lee, Ji Young] Korea Inst Radiol & Med Sci, Res Ctr Radiotherapy, Seoul, South Korea; [Kim, Mi-Sook] Korea Inst Radiol & Med Sci, Dept Radiat Oncol, Seoul, South Korea; [Kim, Eun Ho] Korea Inst Radiol & Med Sci, Div Heavy Ion Clin Res, Seoul, South Korea	Ewha Womans University; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences	Kim, MS (corresponding author), Korea Inst Radiol & Med Sci, Dept Radiat Oncol, Seoul, South Korea.	mskim@kirams.re.kr; hha@ewha.ac.kr		Ha, Hunjoo/0000-0002-5601-1265	Ministry of Science, ICT and Future Planning, Republic of Korea [50541-2014]; National Research Foundation - Korean Ministry of Education, Science, and Technology [2012R1A2A1A0300692]	Ministry of Science, ICT and Future Planning, Republic of Korea; National Research Foundation - Korean Ministry of Education, Science, and Technology	The work was supported by the following: 1. MSK: grant (50541-2014) from the Ministry of Science, ICT and Future Planning, Republic of Korea (http://www.msip.go.kr); and 2. HH: National Research Foundation grants (2012R1A2A1A0300692) funded by Korean Ministry of Education, Science, and Technology. (http://www.nrf.re.kr).	Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; Collis SJ, 2001, NUCLEIC ACIDS RES, V29, P1534, DOI 10.1093/nar/29.7.1534; Couture C, 2002, CANCER-AM CANCER SOC, V94, P713, DOI 10.1002/cncr.10232; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fong V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028714; Gray R, 2001, LANCET, V358, P1291; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Hiro J, 2008, INT J ONCOL, V32, P1305; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Kawashima A, 2012, ADV UROL, V2012, DOI 10.1155/2012/812398; Kim EH, 2014, J RADIAT RES, V55, P432, DOI 10.1093/jrr/rrt131; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Koukourakis MI, 2001, INT J RADIAT ONCOL, V50, P27, DOI 10.1016/S0360-3016(00)01561-3; Lazaro-Trueba I, 2006, CELL CYCLE, V5, P1062, DOI 10.4161/cc.5.10.2764; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; Liu JF, 2012, ONCOL REP, V28, P1406, DOI 10.3892/or.2012.1932; Luo QQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-517; Muaddi H, 2013, RADIOTHER ONCOL, V108, P446, DOI 10.1016/j.radonc.2013.06.014; Nunez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; Zhang T, 2013, INT J MOL SCI, V14, P24603, DOI 10.3390/ijms141224603	31	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143596	10.1371/journal.pone.0143596	http://dx.doi.org/10.1371/journal.pone.0143596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599019	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900147
J	Kryukova, OV; Tikhomirova, VE; Golukhova, EZ; Evdokimov, VV; Kalantarov, GF; Trakht, IN; Schwartz, DE; Dull, RO; Gusakov, AV; Uporov, IV; Kost, OA; Danilov, SM				Kryukova, Olga V.; Tikhomirova, Victoria E.; Golukhova, Elena Z.; Evdokimov, Valery V.; Kalantarov, Gavreel F.; Trakht, Ilya N.; Schwartz, David E.; Dull, Randal O.; Gusakov, Alexander V.; Uporov, Igor V.; Kost, Olga A.; Danilov, Sergei M.			Tissue Specificity of Human Angiotensin I-Converting Enzyme	PLOS ONE			English	Article							MALE GENITAL-TRACT; MONOCLONAL-ANTIBODIES; N-DOMAIN; POSTTRANSLATIONAL MODIFICATIONS; GLYCOSYLATION SITES; PLASMA-MEMBRANE; SEMINAL PLASMA; HUMAN-PROSTATE; HUMAN TESTIS; HUMAN BLOOD	Background Angiotensin-converting enzyme (ACE), which metabolizes many peptides and plays a key role in blood pressure regulation and vascular remodeling, as well as in reproductive functions, is expressed as a type-1 membrane glycoprotein on the surface of endothelial and epithelial cells. ACE also presents as a soluble form in biological fluids, among which seminal fluid being the richest in ACE content -50-fold more than that in blood. Methods/Principal Findings We performed conformational fingerprinting of lung and seminal fluid ACEs using a set of monoclonal antibodies (mAbs) to 17 epitopes of human ACE and determined the effects of potential ACE-binding partners on mAbs binding to these two different ACEs. Patterns of mAbs binding to ACEs from lung and from seminal fluid dramatically differed, which reflects difference in the local conformations of these ACEs, likely due to different patterns of ACE glycosylation in the lung endothelial cells and epithelial cells of epididymis/prostate (source of seminal fluid ACE), confirmed by mass-spectrometry of ACEs tryptic digests. Conclusions Dramatic differences in the local conformations of seminal fluid and lung ACEs, as well as the effects of ACE-binding partners on mAbs binding to these ACEs, suggest different regulation of ACE functions and shedding from epithelial cells in epididymis and prostate and endothelial cells of lung capillaries. The differences in local conformation of ACE could be the base for the generation of mAbs distingushing tissue-specific ACEs.	[Kryukova, Olga V.; Tikhomirova, Victoria E.; Gusakov, Alexander V.; Uporov, Igor V.; Kost, Olga A.] Moscow MV Lomonosov State Univ, Fac Chem, Moscow 117234, Russia; [Golukhova, Elena Z.] Bakulev Ctr Cardiovasc Surg, Moscow, Russia; [Evdokimov, Valery V.] Inst Urol, Moscow, Russia; [Kalantarov, Gavreel F.; Trakht, Ilya N.] Columbia Univ, Dept Med, New York, NY USA; [Schwartz, David E.; Dull, Randal O.; Danilov, Sergei M.] Univ Illinois, Dept Anesthesiol, Chicago, IL USA	Lomonosov Moscow State University; Russian Academy of Medical Sciences; Bakulev Scientific Center for Cardiovascular Surgery; Columbia University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kost, OA (corresponding author), Moscow MV Lomonosov State Univ, Fac Chem, Moscow 117234, Russia.	olga.a.kost@gmail.com; danilov@uic.edu	Gusakov, Alexander V/B-7783-2013; Golukhova, Elena/Q-1768-2015; Tikhomirova, Victoria/E-4966-2019	Gusakov, Alexander V/0000-0002-5234-4863; Golukhova, Elena/0000-0002-6252-0322; Tikhomirova, Victoria/0000-0003-4368-3430; Uporov, Igor/0000-0003-3190-2851; Bulaeva, Naida/0000-0002-5091-0518	Ministry of Science and Education of Russian Federation [14.Z50.31.0026]; Department of Anesthesiology, University of Illinois at Chicago	Ministry of Science and Education of Russian Federation(Ministry of Education and Science, Russian Federation); Department of Anesthesiology, University of Illinois at Chicago	This work was supported in parts by 1) Ministry of Science and Education of Russian Federation, grant 14.Z50.31.0026; 2) Department of Anesthesiology, University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Ministry of Science and Education of Russian Federation, grant 14.Z50.31.0026, and by the Department of Anesthesiology, University of Illinois at Chicago.	Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Balyasnikova IV, 2005, HYBRIDOMA, V24, P14, DOI 10.1089/hyb.2005.24.14; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Beyazit F, 2015, ARCH GYNECOL OBSTET, V292, P415, DOI 10.1007/s00404-015-3661-x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brogren H, 2008, THROMB RES, V122, P271, DOI 10.1016/j.thromres.2008.04.008; CHING SF, 1983, ARTERIOSCLEROSIS, V3, P581, DOI 10.1161/01.ATV.3.6.581; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov SM, 2008, J CARDIOVASC PHARM, V52, P90, DOI 10.1097/FJC.0b013e31817fd3bc; Danilov SM, 2007, BIOCHEMISTRY-US, V46, P9019, DOI 10.1021/bi700489v; Danilov SM, 2010, J PROTEOME RES, V9, P5782, DOI 10.1021/pr100564r; Danilov SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010438; Danilov SM, 2005, CLIN CHEM, V51, P1040, DOI 10.1373/clinchem.2004.045633; Ehlers MR, 1989, BIOCHEMISTRY-US, V8, P5311; EHLERS MRW, 1992, BIOCHEM BIOPH RES CO, V183, P199, DOI 10.1016/0006-291X(92)91628-4; Elzanaty S, 2007, ANDROLOGIA, V39, P60, DOI 10.1111/j.1439-0272.2007.00764.x; ERDOS EG, 1985, LAB INVEST, V52, P437; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087844; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087843; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; HOHLBRUGGER G, 1984, FERTIL STERIL, V41, P324; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; Jokubaitis VJ, 2008, BLOOD, V111, P4055, DOI 10.1182/blood-2007-05-091710; Kohlstedt K, 2002, CIRC RES, V91, P749, DOI 10.1161/01.RES.0000038114.17939.C8; Kost OA, 2000, J MOL RECOGNIT, V13, P360, DOI 10.1002/1099-1352(200011/12)13:6<360::AID-JMR508>3.3.CO;2-B; KRASSNIGG F, 1989, INT J ANDROL, V12, P22, DOI 10.1111/j.1365-2605.1989.tb01282.x; LANZILLO JJ, 1983, ARCH BIOCHEM BIOPHYS, V227, P434, DOI 10.1016/0003-9861(83)90473-3; Liddy KA, 2013, GENOME MED, V5, DOI 10.1186/gm424; LIEBERMAN J, 1983, LAB INVEST, V48, P711; Lui T, 2005, J PROTEOME RES, V4, P2070; Metzger R, 2011, MICROVASC RES, V81, P206, DOI 10.1016/j.mvr.2010.12.003; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; Nassis L, 2001, J PATHOL, V195, P571, DOI 10.1002/path.999; Nikolaeva MA, 2006, AM J REPROD IMMUNOL, V55, P54, DOI 10.1111/j.1600-0897.2005.00326.x; Osawa S, 2006, CLIN CHIM ACTA, V366, P146, DOI 10.1016/j.cca.2005.09.031; Parkin ET, 2004, PROTEIN PEPTIDE LETT, V11, P423, DOI 10.2174/0929866043406544; Pauls K, 2003, ANDROLOGIA, V35, P32, DOI 10.1046/j.1439-0272.2003.00535.x; RIPKA JE, 1993, BIOCHEM BIOPH RES CO, V196, P503, DOI 10.1006/bbrc.1993.2278; Salvesen G., 2012, HDB PROTEOLYTIC ENZY, V3rd, P480; Skirgello OE, 2006, BIOCHEMISTRY-US, V45, P4831, DOI 10.1021/bi052591h; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; VIVET F, 1987, HISTOCHEMISTRY, V86, P499, DOI 10.1007/BF00500623; WEI L, 1991, J BIOL CHEM, V266, P5540; West MB, 2010, J BIOL CHEM, V285, P29511, DOI 10.1074/jbc.M110.145938; Woodman ZL, 2000, BIOCHEM J, V347, P711, DOI 10.1042/0264-6021:3470711; YOKOYAMA M, 1980, CLIN CHIM ACTA, V100, P253, DOI 10.1016/0009-8981(80)90274-0; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	50	14	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143455	10.1371/journal.pone.0143455	http://dx.doi.org/10.1371/journal.pone.0143455			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600189	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900126
J	Romanolo, KF; Gorski, L; Wang, S; Lauzon, CR				Romanolo, K. F.; Gorski, L.; Wang, S.; Lauzon, C. R.			Rapid Identification and Classification of Listeria spp. and Serotype Assignment of Listeria monocytogenes Using Fourier Transform-Infrared Spectroscopy and Artificial Neural Network Analysis	PLOS ONE			English	Article							FT-IR SPECTROSCOPY; UNITED-STATES; DISCRIMINATION; PATHOGENS; CULTURES; ASSAY	The use of Fourier Transform-Infrared Spectroscopy (FT-IR) in conjunction with Artificial Neural Network software NeuroDeveloper (TM) was examined for the rapid identification and classification of Listeria species and serotyping of Listeria monocytogenes. A spectral library was created for 245 strains of Listeria spp. to give a biochemical fingerprint from which identification of unknown samples were made. This technology was able to accurately distinguish the Listeria species with 99.03% accuracy. Eleven serotypes of Listeria monocytogenes including 1/2a, 1/2b, and 4b were identified with 96.58% accuracy. In addition, motile and non-motile forms of Listeria were used to create a more robust model for identification. FT-IR coupled with NeuroDeveloper (TM) appear to be a more accurate and economic choice for rapid identification of pathogenic Listeria spp. than current methods.	[Romanolo, K. F.; Lauzon, C. R.] Calif State Univ East Bay, Dept Biol Sci, Hayward, CA 94542 USA; [Romanolo, K. F.; Gorski, L.] ARS, USDA, Western Reg Res Ctr, Albany, CA USA; [Wang, S.] Bruker Opt Inc, Fremont, CA USA	California State University System; California State University East Bay; United States Department of Agriculture (USDA); Bruker Corporation	Lauzon, CR (corresponding author), Calif State Univ East Bay, Dept Biol Sci, Hayward, CA 94542 USA.	Carol.Lauzon@csueastbay.edu		Gorski, Lisa/0000-0003-2387-1012	CSUPERB (CSU Program for Education and Research in Biotechnology) Joint Venture Program [FY 13/14]; Agricultural Research Service CRIS project [2030-42000-046-00D]; Bruker Optics, Inc	CSUPERB (CSU Program for Education and Research in Biotechnology) Joint Venture Program; Agricultural Research Service CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Bruker Optics, Inc	This work was funded by a grant from CSUPERB (CSU Program for Education and Research in Biotechnology) Joint Venture Program FY 13/14 (https://www.calstate.edu/csuperb/) and funds from Agricultural Research Service CRIS project 2030-42000-046-00D. Bruker Optics, Inc provided support in the form of salary for SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Al-Holy MA, 2006, FOOD MICROBIOL, V23, P162, DOI 10.1016/j.fm.2005.01.017; Al-Qadiri HM, 2008, J FOOD SCI, V73, pM54, DOI 10.1111/j.1750-3841.2007.00640.x; Burgula Y, 2007, REV MIDINFRARED FORU; CDC, 2013, FOOD BIT BACK PROT T; Chee J.-Y., 2010, CURRENT RES TECHNOLO; Davis R, 2011, INT J FOOD MICROBIOL, V150, P140, DOI 10.1016/j.ijfoodmicro.2011.07.024; Doumith M, 2005, J FOOD PROTECT, V68, P2648, DOI 10.4315/0362-028X-68.12.2648; Janbu AO, 2008, FEMS MICROBIOL LETT, V278, P164, DOI 10.1111/j.1574-6968.2007.00995.x; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Lefier D, 1997, FEMS MICROBIOL LETT, V147, P45, DOI 10.1016/S0378-1097(96)00500-9; Lin MS, 2004, J AGR FOOD CHEM, V52, P5769, DOI 10.1021/jf049354q; Maquelin K, 2003, J CLIN MICROBIOL, V41, P324, DOI 10.1128/JCM.41.1.324-329.2003; Palumbo JD, 2003, J CLIN MICROBIOL, V41, P564, DOI 10.1128/JCM.41.2.564-571.2003; Rebuffo CA, 2006, APPL ENVIRON MICROB, V72, P994, DOI 10.1128/AEM.72.2.994-1000.2006; Rebuffo-Scheer CA, 2007, APPL ENVIRON MICROB, V73, P1036, DOI 10.1128/AEM.02004-06; Rohilla A., 2010, HDB BACTERIOLOGY, P302; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; TAPPERO JW, 1995, JAMA-J AM MED ASSOC, V273, P1118, DOI 10.1001/jama.273.14.1118; Vaz M, 2013, J MICROBIOL METH, V93, P102, DOI 10.1016/j.mimet.2013.02.008; Wang S., 2014, COMMUNICATIONS	20	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143425	10.1371/journal.pone.0143425	http://dx.doi.org/10.1371/journal.pone.0143425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600423	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900117
J	Bencsik, M; Le Conte, Y; Reyes, M; Pioz, M; Whittaker, D; Crauser, D; Delso, NS; Newton, MI				Bencsik, Martin; Le Conte, Yves; Reyes, Maritza; Pioz, Maryline; Whittaker, David; Crauser, Didier; Delso, Noa Simon; Newton, Michael I.			Honeybee Colony Vibrational Measurements to Highlight the Brood Cycle	PLOS ONE			English	Article							APIS-MELLIFERA; BEES; GROWTH; GAIN	Insect pollination is of great importance to crop production worldwide and honey bees are amongst its chief facilitators. Because of the decline of managed colonies, the use of sensor technology is growing in popularity and it is of interest to develop new methods which can more accurately and less invasively assess honey bee colony status. Our approach is to use accelerometers to measure vibrations in order to provide information on colony activity and development. The accelerometers provide amplitude and frequency information which is recorded every three minutes and analysed for night time only. Vibrational data were validated by comparison to visual inspection data, particularly the brood development. We show a strong correlation between vibrational amplitude data and the brood cycle in the vicinity of the sensor. We have further explored the minimum data that is required, when frequency information is also included, to accurately predict the current point in the brood cycle. Such a technique should enable beekeepers to reduce the frequency with which visual inspections are required, reducing the stress this places on the colony and saving the beekeeper time.	[Bencsik, Martin; Whittaker, David; Newton, Michael I.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England; [Le Conte, Yves; Reyes, Maritza; Pioz, Maryline; Crauser, Didier] INRA, UR Abeilles & Environm 406, F-84914 Avignon, France; [Delso, Noa Simon] CARI, B-1348 Louvain, Belgium	Nottingham Trent University; INRAE	Bencsik, M (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England.	Martin.Bencsik@ntu.ac.uk	Pioz, Maryline/AAI-3325-2020; Le Conte, Yves/M-4442-2018; Newton, Michael I/B-8866-2008; Le Conte, Yves M/B-3246-2016; Le Conte, Yves/AAP-2379-2021	Le Conte, Yves/0000-0002-8466-5370; Newton, Michael I/0000-0003-4231-1002; Le Conte, Yves M/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370; Pioz, Maryline/0000-0003-0331-4403	Research Executive Agency [315146]; European Union's Research Executive Agency [315146]	Research Executive Agency; European Union's Research Executive Agency	The authors received funding from the Research Executive Agency through the Grant 'Swarmonitor', ref nb 315146.; We gratefully acknowledge the European Union's Research Executive Agency for funding under project reference No 315146. We acknowledge Claudia Dussaubat at INRA, David Parker and Catherine Procter at NTU for their contribution and to the Swarmonitor consortium members for helpful discussions.	[Anonymous], 2013, HOL APPR RISK ASS MU, DOI [10.2805/53269, DOI 10.2805/53269]; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Bencsik M, 2011, COMPUT ELECTRON AGR, V76, P44, DOI 10.1016/j.compag.2011.01.004; Delaplane K. S., 2010, CROP POLLINATION BEE; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; Engel Michael S., 1999, Journal of Hymenoptera Research, V8, P165; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Grzeda U, 2014, MED WETER, V70, P729; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; Health Canada, 2013, EV CAN BEE MORT 2013; Human H., 2013, J APICULT RES, V52; Imdorf A., 2001, COURSE DETERMINATION; Jarvis RM, 2004, ANAL CHEM, V76, P40, DOI 10.1021/ac034689c; Kaplan K, 2008, AGR RES, V56, P8; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Leonhardt SD, 2013, BASIC APPL ECOL, V14, P461, DOI 10.1016/j.baae.2013.06.003; LOUVEAUX J., 1966, ANN ABEILLE [PARIS], V9, P323, DOI 10.1051/apido:19660402; Maisonnasse A, 2015, 3 JOURN RECH AP PAR; Marletto Franco, 1992, Apicoltore Moderno, V83, P209; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Meikle WG, 2015, APIDOLOGIE, V46, P10, DOI 10.1007/s13592-014-0298-x; Mussen EC, 2004, ENVIRON ENTOMOL, V33, P1151, DOI 10.1603/0046-225X-33.5.1151; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Tasei JN, 2001, APIDOLOGIE, V32, P527, DOI 10.1051/apido:2001102; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Zacepins A, 2015, BIOSYST ENG, V130, P60, DOI 10.1016/j.biosystemseng.2014.12.001; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	31	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141926	10.1371/journal.pone.0141926	http://dx.doi.org/10.1371/journal.pone.0141926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580393	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600028
J	Gagliani, N; Jofra, T; Posgai, AL; Atkinson, MA; Battaglia, M				Gagliani, Nicola; Jofra, Tatiana; Posgai, Amanda L.; Atkinson, Mark A.; Battaglia, Manuela			Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice	PLOS ONE			English	Article							TRANSPLANT TOLERANCE; PANCREATIC-ISLETS; TYPE-1	The destruction of beta cells in type 1 diabetes (T1D) results in loss of insulin production and glucose homeostasis. Treatment of non-obese diabetic (NOD) mice with immunedepleting/modulating agents (e.g., anti-CD3, murine anti-thymocyte-globulin (mATG)) can lead to diabetes reversal. However, for preclinical studies with these and other agents seeking to reverse disease at onset, the necessity for exogenous insulin administration is debated. Spontaneously diabetic NOD mice were treated with a short-course of mATG and insulin provided as drug therapy or by way of allogeneic islet implants. Herein we demonstrate that exogenous insulin administration is required to achieve disease reversal with mATG in NOD mice. Unexpectedly, we also observed that provision of insulin by way of allogeneic islet implantation in combination with mATG leads to a pronounced reversal of diabetes as well as restoration of tolerance to self-islets. Expansion/induction of regulatory cells was observed in NOD mice stably cured with mATG and allogeneic islets. These data suggest that transient provision of allogeneic insulin-producing islets might provide a temporary window for immune depletion to be more effective and instilling stable tolerance to endogenous beta cells. These findings support the use of a never before explored approach for preserving beta cell function in patients with recent onset T1D.	[Gagliani, Nicola; Jofra, Tatiana; Battaglia, Manuela] IRCCS San Raffaele Sci Inst, DRI, Milan, Italy; [Gagliani, Nicola] Univ Vita Salute San Raffaele, Milan, Italy; [Posgai, Amanda L.; Atkinson, Mark A.] Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32610 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; State University System of Florida; University of Florida	Battaglia, M (corresponding author), IRCCS San Raffaele Sci Inst, DRI, Milan, Italy.	battaglia.manuela@hsr.it	Jofra, Tatiana/AAN-4727-2020	Jofra, Tatiana/0000-0003-2825-155X; Battaglia, Manuela/0000-0003-4535-3152; Posgai, Amanda/0000-0002-9491-0958; Gagliani, Nicola/0000-0001-8514-1395	Juvenile Diabetes Research Foundation Grant [7-2006-328]	Juvenile Diabetes Research Foundation Grant(Juvenile Diabetes Research Foundation)	This work has been supported by the Juvenile Diabetes Research Foundation Grant 7-2006-328 (http://jdrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav E, 2008, DIABETES, V57, P2883, DOI 10.2337/db07-1817; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Atkinson MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002757; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Fousteri G, 2015, DIABETOLOGIA, V58, P1319, DOI 10.1007/s00125-015-3540-9; Gagliani N, 2013, AM J TRANSPLANT, V13, P1963, DOI 10.1111/ajt.12333; Haller MJ, 2015, J CLIN INVEST, V125, P448, DOI 10.1172/JCI78492; MAKI T, 1992, P NATL ACAD SCI USA, V89, P3434, DOI 10.1073/pnas.89.8.3434; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Parker MJ, 2009, DIABETES, V58, P2277, DOI 10.2337/db09-0557; Pettus J, 2013, CLIN IMMUNOL, V149, P317, DOI 10.1016/j.clim.2013.04.006; Roep BO, 2014, NAT REV ENDOCRINOL, V10, P229, DOI 10.1038/nrendo.2014.2; Zhao CF, 2008, IMMUNOLOGY, V125, P48, DOI 10.1111/j.1365-2567.2008.02819.x	13	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142318	10.1371/journal.pone.0142318	http://dx.doi.org/10.1371/journal.pone.0142318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580221	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600045
J	Bedran, TBL; Morin, MP; Spolidorio, DP; Grenier, D				Lombardo Bedran, Telma Blanca; Morin, Marie-Pierre; Spolidorio, Denise Palomari; Grenier, Daniel			Black Tea Extract and Its Theaflavin Derivatives Inhibit the Growth of Periodontopathogens and Modulate Interleukin-8 and beta-Defensin Secretion in Oral Epithelial Cells	PLOS ONE			English	Article							GREEN TEA; PORPHYROMONAS-GINGIVALIS; PERIODONTAL-DISEASE; HEALTH; POLYPHENOLS; COMBINATION; CONSUMPTION; EXPRESSION; CHEMOKINES; THERAPY	Over the years, several studies have brought evidence suggesting that tea polyphenols, mostly from green tea, may have oral health benefits. Since few data are available concerning the beneficial properties of black tea and its theaflavin derivatives against periodontal disease, the objective of this study was to investigate their antibacterial activity as well as their ability to modulate interleukin-8 and human beta-defensin (hBD) secretion in oral epithelial cells. Among the periodontopathogenic bacteria tested, Porphyromonas gingivalis was found to be highly susceptible to the black tea extract and theaflavins. Moreover, our data indicated that the black tea extract, theaflavin and theaflavin-3,3'-digallate can potentiate the antibacterial effect of metronidazole and tetracycline against P. gingivalis. Using lipopolysaccharide-stimulated oral epithelial cells, the black tea extract (100 mu g/ml), as well as theaflavin and theaflavin-3,3'-digallate (50 mu g/ml) reduced interleukin-8 (IL-8) secretion by 85%, 79%, and 86%, respectively, thus suggesting an anti-inflammatory property. The ability of the black tea extract and its theaflavin derivatives to induce the secretion of the antimicrobial peptides hBD-1, hBD-2 and hBD-4 by oral epithelial cells was then evaluated. Our results showed that the black tea extract as well as theaflavin-3,3'-digallate were able to increase the secretion of the three hBDs. In conclusion, the ability of a black tea extract and theaflavins to exert antibacterial activity against major periodontopathogens, to attenuate the secretion of IL-8, and to induce hBD secretion in oral epithelial cells suggest that these components may have a beneficial effect against periodontal disease.	[Lombardo Bedran, Telma Blanca] UNINOVE Univ, Sao Paulo Dent Sch, Sao Paulo, Brazil; [Morin, Marie-Pierre; Grenier, Daniel] Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada; [Spolidorio, Denise Palomari] State Univ Sao Paulo, Araraquara Dent Sch, Dept Oral Diag & Surg, Sao Paulo, Brazil	Universidade Nove de Julho; Laval University; Universidade Estadual Paulista	Grenier, D (corresponding author), Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Spolidorio, Denise Madalena Palomari/P-3530-2016	Spolidorio, Denise Madalena Palomari/0000-0003-2376-1024	Laboratoire de Controle Microbiologique	Laboratoire de Controle Microbiologique	This work was supported by Laboratoire de Controle Microbiologique 2015 (DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; Aneja R, 2004, CRIT CARE MED, V32, P2097, DOI 10.1097/01.CCM.0000142661.73633.15; Asahi Y, 2014, J APPL MICROBIOL, V116, P1164, DOI 10.1111/jam.12458; Berezow AB, 2011, PERIODONTOL 2000, V55, P36, DOI 10.1111/j.1600-0757.2010.00350.x; Betts JW, 2012, J MICROB BIOTEC FOOD, V2, P1068; Butt MS, 2014, CRIT REV FOOD SCI, V54, P1002, DOI 10.1080/10408398.2011.623198; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Canas PG, 2015, J AM DENT ASSOC, V146, P150, DOI 10.1016/j.adaj.2014.12.015; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Chung WO, 2007, CURR PHARM DESIGN, V13, P3073, DOI 10.2174/138161207782110435; Dale BA, 2002, PERIODONTOL 2000, V30, P70, DOI 10.1034/j.1600-0757.2002.03007.x; Ebersole JL, 2013, PERIODONTOL 2000, V62, P163, DOI 10.1111/prd.12005; Gamonal J, 2001, J PERIODONTAL RES, V36, P194, DOI 10.1034/j.1600-0765.2001.360309.x; Gardner EJ, 2007, EUR J CLIN NUTR, V61, P3, DOI 10.1038/sj.ejcn.1602489; Gursoy Ulvi Kahraman, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.15127; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Hayat K, 2015, CRIT REV FOOD SCI, V55, P939, DOI 10.1080/10408398.2012.678949; Hirasawa M, 2002, J PERIODONTAL RES, V37, P433, DOI 10.1034/j.1600-0765.2002.01640.x; Hosokawa Y, 2010, MOL NUTR FOOD RES, V54, pS151, DOI 10.1002/mnfr.200900549; Jain A, 2013, TOXICOL LETT, V220, P82, DOI 10.1016/j.toxlet.2013.04.010; Jin LJ, 2002, J CLIN PERIODONTOL, V29, P604, DOI 10.1034/j.1600-051X.2002.290704.x; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Komatsuzawa H, 2007, CURR PHARM DESIGN, V13, P3084, DOI 10.2174/138161207782110426; Kong LX, 2015, ARCH ORAL BIOL, V60, P12, DOI 10.1016/j.archoralbio.2014.08.019; Koyama Y, 2010, PREV MED, V50, P173, DOI 10.1016/j.ypmed.2010.01.010; Kushiyama M, 2009, J PERIODONTOL, V80, P372, DOI 10.1902/jop.2009.080510 ; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Loesche WJ, 2001, CLIN MICROBIOL REV, V14, P727, DOI 10.1128/CMR.14.4.727-752.2001; Lombardo Bedran TB, J PERIODONT RES, V201, P615; Milward MR, 2007, CLIN EXP IMMUNOL, V148, P307, DOI 10.1111/j.1365-2249.2007.03342.x; Morin MP, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0557-z; Narotzki B, 2012, ARCH ORAL BIOL, V57, P429, DOI 10.1016/j.archoralbio.2011.11.017; Otomo-Corgel Joan, 2012, J Evid Based Dent Pract, V12, P20, DOI 10.1016/S1532-3382(12)70006-4; Otte JM, 2008, J CELL BIOCHEM, V104, P2286, DOI 10.1002/jcb.21787; Palaska I, 2013, EUR J PHARMACOL, V720, P77, DOI 10.1016/j.ejphar.2013.10.047; PANYANGARM Y, 1988, CU DENT J, V11, P43; Pinto MD, 2013, FOOD RES INT, V53, P558, DOI 10.1016/j.foodres.2013.01.038; Ramos R, 2011, PEPTIDES, V32, P1469, DOI 10.1016/j.peptides.2011.06.005; Sharma V, 2009, CRIT REV FOOD SCI, V49, P379, DOI 10.1080/10408390802068066; Silva TA, 2007, J DENT RES, V86, P306, DOI 10.1177/154405910708600403; Sirk TW, 2011, J AGR FOOD CHEM, V59, P3780, DOI 10.1021/jf2006547; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Varoni EM, 2012, CURR MED CHEM, V19, P1706; Vuong QV, 2014, CRIT REV FOOD SCI, V54, P523, DOI 10.1080/10408398.2011.594184; Xu X, 2011, ANTIMICROB AGENTS CH, V55, P1229, DOI 10.1128/AAC.01016-10; Zhang J, 1998, CARIES RES, V32, P233, DOI 10.1159/000016458	47	34	36	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143158	10.1371/journal.pone.0143158	http://dx.doi.org/10.1371/journal.pone.0143158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581041	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600093
J	Ahmad, A; Mbofung, GY; Acharya, J; Schmidt, CL; Robertson, AE				Ahmad, Azeem; Mbofung, Gladys Y.; Acharya, Jyotsna; Schmidt, Clarice L.; Robertson, Alison E.			Characterization and Comparison of Clavibacter michiganensis subsp nebraskensis Strains Recovered from Epiphytic and Symptomatic Infections of Maize in Iowa	PLOS ONE			English	Article							GOSSS BACTERIAL WILT; GENETIC DIVERSITY; ANION CHANNEL; LEAF-BLIGHT; 1ST REPORT; CORN	Clavibacter michiganensis subsp. nebraskensis (Cmn), the causal organism of Goss's wilt and leaf blight of maize, can be detected in the phyllosphere of its host prior to disease development. We compared the morphology and pathogenicity of 37 putative isolates of Cmn recovered from asymptomatic and symptomatic maize leaves. Thirty-three of the isolates produced mucoid orange colonies, irrespective of the source of isolation and all but four of these isolates were pathogenic on maize. The remaining 4 isolates recovered from asymptomatic leaves had large fluidal yellow colonies, and were non-pathogenic on maize. Isolates varied in their aggressiveness on a susceptible hybrid of maize but no significant differences in aggressiveness were detected between epiphytic isolates and those recovered from diseased maize tissues. The genomics of Cmn is poorly understood; therefore as a first step to determining what genes may play a role in virulence, we compared 33 putative virulence gene sequences from 6 pathogenic and a non-pathogenic isolate recovered from the phyllosphere. Sequence polymorphisms were detected in 5 genes, cellulase A, two endoglucanases, xylanase B and a pectate lyase but there was no relationship with pathogenicity. Further research is needed to determine what genes play a role in virulence of Cmn. Our data show however, that the virulence factors in Cmn likely differ from those reported for the closely related subspecies michiganensis and sepedonicus.	[Ahmad, Azeem; Mbofung, Gladys Y.; Acharya, Jyotsna; Schmidt, Clarice L.; Robertson, Alison E.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA	Iowa State University	Robertson, AE (corresponding author), Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA.	alisonr@iastate.edu		Robertson, Alison/0000-0003-4281-6350				Agarkova IV, 2011, CAN J MICROBIOL, V57, P366, DOI [10.1139/W11-016, 10.1139/w11-016]; Bentley SD, 2008, J BACTERIOL, V190, P2150, DOI 10.1128/JB.01598-07; BIDDLE JA, 1990, PLANT DIS, V74, P908, DOI 10.1094/PD-74-0908; Bradley C., 2010, BULLETIN; Brody JR, 2011, BIOINFORMATICS, V36, P214; Cho MS, 2012, J MICROBIOL, V50, P496, DOI 10.1007/s12275-012-1611-x; Claflin L.E., 1999, COMPENDIUM CORN DIS, V3rd edition, P4; Eichenlaub R, 2006, PLANT-ASSOCIATED BACTERIA, P385; Eichenlaub R, 2011, ANNU REV PHYTOPATHOL, V49, P445, DOI 10.1146/annurev-phyto-072910-095258; GROSS DC, 1979, J GEN MICROBIOL, V115, P479, DOI 10.1099/00221287-115-2-479; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hollier CA, 2014, PHYTOPATHOLOGY S2, V104, P5; Howard RJ, 2015, PLANT DIS, V99, P1034, DOI 10.1094/PDIS-11-14-1117-PDN; Jackson T. A., 2007, Plant Health Progress, P0919; Jackson TA, 2007, GOSSS BACTERIAL WILT; Korus KA, 2011, PLANT DIS, V95, P73, DOI 10.1094/PDIS-07-10-0541; Korus KA, 2011, THESIS; Louws FJ, 1998, PHYTOPATHOLOGY, V88, P862, DOI 10.1094/PHYTO.1998.88.8.862; Madden L.V., 2007, STUDY PLANT DIS EPID; Malvick D, 2010, PLANT DIS, V94, P1064, DOI 10.1094/PDIS-94-8-1064A; Marlay S., 2011, EXTERNAL PUBLICATION; MELETZUS D, 1991, J BACTERIOL, V173, P184, DOI 10.1128/jb.173.1.184-190.1991; Michalke A, 2001, EUR BIOPHYS J BIOPHY, V30, P421, DOI 10.1007/s002490100154; Michalke A, 2001, LANGMUIR, V17, P2251, DOI 10.1021/la0013493; Robertson A, 2008, INTEGRATED CROP MANA; Ruhl G, 2009, PLANT DIS, V93, P841, DOI 10.1094/PDIS-93-8-0841B; SCHURHOLZ T, 1991, J MEMBRANE BIOL, V123, P1, DOI 10.1007/BF01993957; SCHURHOLZ T, 1993, BIOPHYS J, V64, P58, DOI 10.1016/S0006-3495(93)81340-7; Schuster ML, 1975, UNL RES B; Shepherd L, 1999, THESIS; Stewart S, 2011, BIOTECHNOL LETT, V33, P2217, DOI 10.1007/s10529-011-0682-9; VIDAVER AK, 1974, INT J SYST BACTERIOL, V24, P482, DOI 10.1099/00207713-24-4-482; Waleron M, 2011, EUR J PLANT PATHOL, V131, P341, DOI 10.1007/s10658-011-9812-4; WYSONG DS, 1973, PLANT DIS REP, V/057, P291; Zaluga J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-392	35	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143553	10.1371/journal.pone.0143553	http://dx.doi.org/10.1371/journal.pone.0143553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599211	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600083
J	Waterworth, P; Pescud, M; Braham, R; Dimmock, J; Rosenberg, M				Waterworth, Pippa; Pescud, Melanie; Braham, Rebecca; Dimmock, James; Rosenberg, Michael			Factors Influencing the Health Behaviour of Indigenous Australians: Perspectives from Support People	PLOS ONE			English	Article							HIGH-RISK BEHAVIOR; NONDOMINANT MINORITIES; DETERMINANTS; SMOKING; DISEASE; COMMUNITIES; BURDEN; RACISM	Disparities between the health of Indigenous and non-Indigenous populations continue to be prevalent within Australia. Research suggests that Indigenous people participate in health risk behaviour more often than their non-Indigenous counterparts, and that such behaviour has a substantial impact on health outcomes. Although this would indicate that reducing health risk behaviour may have positive effects on health outcomes, the factors that influence Indigenous health behaviour are still poorly understood. This study aimed to interview people who support Indigenous groups to gain an understanding of their views on the factors influencing health behaviour within Indigenous groups in Western Australia. Twenty nine people participated in the study. The emergent themes were mapped against the social ecological model. The results indicated that: (1) culture, social networks, history, racism, socioeconomic disadvantage, and the psychological distress associated with some of these factors interact to affect health behaviour in a complex manner; (2) the desire to retain cultural identity and distinctiveness may have both positive and negative influence on health risk behaviour; (3) strong social connections to family and kin that is intensified by cultural obligations, appears to affirm and disrupt positive health behaviour; (4) the separation between Indigenous and non-Indigenous social connection/networks that appeared to be fostered by marginalisation and racism may influence the effect of social networks on health behaviour; and (5) communication between Indigenous and non-Indigenous people may be interrupted by distrust between the groups, which reduces the influence of some non-Indigenous sources on the health behaviour of Indigenous people.	[Waterworth, Pippa; Braham, Rebecca; Dimmock, James; Rosenberg, Michael] Univ Western Australia, Sch Sport Sci Exercise & Hlth M408, Crawley, Australia; [Pescud, Melanie] Australian Natl Univ, Regulatory Inst Network, Canberra, ACT, Australia	University of Western Australia; Australian National University	Waterworth, P (corresponding author), Univ Western Australia, Sch Sport Sci Exercise & Hlth M408, Crawley, Australia.	philippa.waterworth@research.uwa.edu.au		Dimmock, James/0000-0002-4475-8169; Pescud, Melanie/0000-0002-9073-3093	Australian Research Council [LP100100150]	Australian Research Council(Australian Research Council)	Australian Research Council LP100100150 http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A, 2013, PLOS ONE, V8; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Atkinson J., 2002, TRAUMA TRAILS RECREA; Australian Bureau of Statistics, 2011, COMM PROF; Australian Bureau of Statistics, 2013, 4727 0 55 001 AUSTR; Australian Bureau of Statistics, 2012, HLTH WELF AUSTR AB T; Australian Institute of Health and Welfare, 2012, AUSTR HLTH SER; BAGOZZI RP, 1992, SOC PSYCHOL QUART, V55, P178, DOI 10.2307/2786945; Barnes B, 2010, DEV RES INFORM NATL; Barnes B, 2010, DEV RES INFORM LOCAL; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Broome R, 1994, ABORIGINAL AUSTR; Brough M., 2004, HEALTH PROMOT J AUST, V15, P215, DOI [10.1071/HE04215, DOI 10.1071/HE04215]; Brough M, 2006, J SOCIOL, V42, P396, DOI 10.1177/1440783306069996; Brough MK, 2007, BANDAIDS EXPLORING U; Carson B., 2007, SOCIAL DETERMINANTS; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Council of Australian Governments, 2008, NAT PARTN AGR CLOS G; Creswell J. W., 2007, QUALITATIVE INQUIRY; Cunningham J, 2010, POPUL HEALTH METR, V8, P1; Cunningham J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-95; Dixon J, 2009, SOC SCI MED, V68, P2206, DOI 10.1016/j.socscimed.2009.03.025; Dudgeon P, 2010, WORKING TOGETHER ABO; Factor R, 2013, AM J PUBLIC HEALTH, V103, P2245, DOI 10.2105/AJPH.2013.301212; Factor R, 2011, SOC SCI MED, V73, P1292, DOI 10.1016/j.socscimed.2011.07.027; Fordham S., 1986, URBAN REV, V18, P176, DOI [https://doi.org/10.1007/BF01112192, DOI 10.1007/BF01112192]; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gould D, 1999, HUMAN KINETICS J, V13; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Grimley S, 1996, AUSTR J INDIGENOUS E, V24, P6; Hardin J, 2015, CRIT PUBLIC HEALTH, V25, P125, DOI 10.1080/09581596.2014.909581; Henderson G., 2007, BANDAIDS EXPLORING U, P136; Hunter E, 1993, ABORIGINAL HLTH HIST; Johnston V, 2008, SOC SCI MED, V67, P1708, DOI 10.1016/j.socscimed.2008.09.016; Kelaher M, 2014, MED J AUSTRALIA, V201, P1; Larson A, 2007, AUST NZ J PUBL HEAL, V31, P322, DOI 10.1111/j.1753-6405.2007.00079.x; Liamputtong P., 2007, RES VULNERABLE; Lynch J., 2000, AUST EPIDEMIOL, V7, P7; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mathers CD, 2000, MED J AUSTRALIA, V172, P592, DOI 10.5694/j.1326-5377.2000.tb124125.x; Maykut P., 1994, BEGINNING QUALITATIV; McLaren S, 2009, J HOMOSEXUAL, V56, P1, DOI 10.1080/00918360802551365; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; Mitchell J., 2007, SOCIAL DETERMINANTS; Moore SN, 2011, CRIT PUBLIC HEALTH, V21, P441, DOI 10.1080/09581596.2011.620604; Muecke S, 2010, ABORIGINAL AUSTR 1 N; Myers DG, 2007, SOCIAL PSYCHOL PSYCH; Nelson A, 2010, HEALTH EDUC RES, V25, P498, DOI 10.1093/her/cyq025; Paradies Y, 2009, ETHNIC RACIAL STUD, V32, P548, DOI 10.1080/01419870802065234; Pascoe B, 2012, LITTEL RED YELLOW BL; Passey ME, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-55; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Perugini M, 2001, BRIT J SOC PSYCHOL, V40, P79, DOI 10.1348/014466601164704; Petrie D, 2008, SOC SCI MED, V67, P1717, DOI 10.1016/j.socscimed.2008.09.017; Pholi K, 2009, AUST REV PUBLIC AFF, V9, P1; Priest N, 2012, HEALTH SOCIOL REV, V21, P180, DOI 10.5172/hesr.2012.21.2.180; Reilly RE, 2008, ETHNIC HEALTH, V13, P351, DOI 10.1080/13557850801903046; Reynolds H., 1982, OTHER SIDE FRONTIER; Richmond CAM, 2008, SOC SCI MED, V67, P1423, DOI 10.1016/j.socscimed.2008.06.028; Schutt R. K., 2012, INVESTIGATING SOCIAL; Scott J., 1990, DOMINANTION ARTS RES; Shinn C, 2012, COCHRANE LIB; Silverman D., 2013, DOING QUALITATIVE RE; SMITH C., 2004, COUNTRY KIN CULTURE; Strauss A., 1990, BASICS QUALITATIVE R; Streeton Rosemarie, 2004, Nurse Res, V12, P35; Subramanian SV, 2002, ANNU REV PUBL HEALTH, V23, P287, DOI 10.1146/annurev.publhealth.23.100901.140540; Thurston WE, 2005, CRIT PUBLIC HEALTH, V15, P229, DOI [10.1080/09581590500372121, DOI 10.1080/09581590500372121]; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240; Wilkinson RG, 2003, SOCIAL DETERMINANTS; Wood L, 2008, SOC SCI MED, V66, P2378, DOI 10.1016/j.socscimed.2008.01.024	73	34	34	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142323	10.1371/journal.pone.0142323	http://dx.doi.org/10.1371/journal.pone.0142323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7DU	26599437	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000365862600010
J	Bulganin, L; Wittmann, BC				Bulganin, Lisa; Wittmann, Bianca C.			Reward and Novelty Enhance Imagination of Future Events in a Motivational-Episodic Network	PLOS ONE			English	Article							PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; DOPAMINE NEURONS; NEURAL BASIS; HIPPOCAMPUS; MEMORY; OPTIMISM; FMRI; CONNECTIVITY; ANTICIPATION	Thinking about personal future events is a fundamental cognitive process that helps us make choices in daily life. We investigated how the imagination of episodic future events is influenced by implicit motivational factors known to guide decision making. In a two-day functional magnetic resonance imaging (fMRI) study, we controlled learned reward association and stimulus novelty by pre-familiarizing participants with two sets of words in a reward learning task. Words were repeatedly presented and consistently followed by monetary reward or no monetary outcome. One day later, participants imagined personal future events based on previously rewarded, unrewarded and novel words. Reward association enhanced the perceived vividness of the imagined scenes. Reward and novelty-based construction of future events were associated with higher activation of the motivational system (striatum and substantia nigra/ventral tegmental area) and hippocampus, and functional connectivity between these areas increased during imagination of events based on reward-associated and novel words. These data indicate that implicit past motivational experience contributes to our expectation of what the future holds in store.	[Bulganin, Lisa; Wittmann, Bianca C.] Univ Giessen, Dept Psychol, D-35390 Giessen, Germany	Justus Liebig University Giessen	Wittmann, BC (corresponding author), Univ Giessen, Dept Psychol, D-35390 Giessen, Germany.	bianca.wittmann@psychol.uni-giessen.de	Wittmann, Bianca/C-1931-2008	Wittmann, Bianca/0000-0002-2583-3311				Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2011, HIPPOCAMPUS, V21, P1045, DOI 10.1002/hipo.20870; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Baayen R. H, 1995, CELEX LEXICAL DATABA; Benoit RG, 2014, P NATL ACAD SCI USA, V111, P16550, DOI 10.1073/pnas.1419274111; Benoit RG, 2011, J NEUROSCI, V31, P6771, DOI 10.1523/JNEUROSCI.6559-10.2011; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Blackwell SE, 2013, PSYCHIAT RES, V206, P56, DOI 10.1016/j.psychres.2012.09.047; Bolding MS, 2013, BIOL PSYCHIAT, V73, P289, DOI 10.1016/j.biopsych.2012.07.035; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Bunzeck N, 2012, HUM BRAIN MAPP, V33, P1309, DOI 10.1002/hbm.21288; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; D'Argembeau A, 2008, NEUROIMAGE, V40, P398, DOI 10.1016/j.neuroimage.2007.11.025; Daffner KR, 1998, NEUROREPORT, V9, P787, DOI 10.1097/00001756-199803300-00004; De Brigard F, 2012, CONSCIOUS COGN, V21, P1085, DOI 10.1016/j.concog.2012.06.007; Duzel E, 2010, NEUROSCI BIOBEHAV R, V34, P660, DOI 10.1016/j.neubiorev.2009.08.006; Duzel E, 2009, TRENDS NEUROSCI, V32, P321, DOI 10.1016/j.tins.2009.02.005; Floresco SB, 2007, J PSYCHIATR NEUROSCI, V32, P400; Foley NC, 2014, J NEUROSCI, V34, P7947, DOI 10.1523/JNEUROSCI.4171-13.2014; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gaesser B, 2014, P NATL ACAD SCI USA, V111, P4415, DOI 10.1073/pnas.1402461111; Gaesser B, 2013, HIPPOCAMPUS, V23, P1150, DOI 10.1002/hipo.22152; Garrison J, 2013, NEUROSCI BIOBEHAV R, V37, P1297, DOI 10.1016/j.neubiorev.2013.03.023; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Glimcher PW., 2014, NEUROECONOMICS, VSecond Second, P373, DOI [10.1016/B978-0-12-416008-8.00020-6, DOI 10.1016/B978-0-12-416008-8.00020-6]; Goschke T, 2014, NEUROPSYCHOLOGIA, V62, P403, DOI 10.1016/j.neuropsychologia.2014.07.015; Gottlieb J, 2014, J NEUROSCI, V34, P15497, DOI 10.1523/JNEUROSCI.3270-14.2014; Guitart-Masip M, 2010, J NEUROSCI, V30, P1721, DOI 10.1523/JNEUROSCI.5331-09.2010; Haber SN, 2014, NEURON, V83, P1019, DOI 10.1016/j.neuron.2014.08.031; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Hutton C., 2004, P ISMRM 12 KYOT JAP, P1084; Ihalainen JA, 1999, NEUROSCI LETT, V277, P71, DOI 10.1016/S0304-3940(99)00840-X; Kahn I, 2013, HIPPOCAMPUS, V23, P187, DOI 10.1002/hipo.22077; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Krebs RM, 2009, NEUROPSYCHOLOGIA, V47, P2272, DOI 10.1016/j.neuropsychologia.2009.01.015; Lahl O, 2009, BEHAV RES METHODS, V41, P13, DOI 10.3758/BRM.41.1.13; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; Legault M, 2001, EUR J NEUROSCI, V13, P819, DOI 10.1046/j.0953-816x.2000.01448.x; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Martin VC, 2011, P NATL ACAD SCI USA, V108, P13858, DOI 10.1073/pnas.1105816108; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Mendelsohn A, 2014, NEURON, V81, P207, DOI 10.1016/j.neuron.2013.10.019; Murty VP, 2013, LEARN MEMORY, V20, P229, DOI 10.1101/lm.029728.112; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Saigusa T, 1999, NEUROSCIENCE, V88, P1153, DOI 10.1016/S0306-4522(98)00275-9; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schomaker J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050599; Schott BH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015984; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Sharot T, 2012, CURR BIOL, V22, P1477, DOI 10.1016/j.cub.2012.05.053; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Szpunar KK, 2013, J EXP PSYCHOL GEN, V142, P323, DOI 10.1037/a0028877; Szpunar KK, 2009, CEREB CORTEX, V19, P1539, DOI 10.1093/cercor/bhn191; Tobler PN, 2003, J NEUROSCI, V23, P10402; Weiler JA, 2010, HIPPOCAMPUS, V20, P685, DOI 10.1002/hipo.20695; Williams JMG, 1999, Q J EXP PSYCHOL-A, V52, P555, DOI 10.1080/027249899390963; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wittmann BC, 2008, NEURON, V58, P967, DOI 10.1016/j.neuron.2008.04.027; Wittmann BC, 2007, NEUROIMAGE, V38, P194, DOI 10.1016/j.neuroimage.2007.06.038; Wittmann BC, 2011, LEARN MEMORY, V18, P296, DOI 10.1101/lm.1996811	71	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143477	10.1371/journal.pone.0143477	http://dx.doi.org/10.1371/journal.pone.0143477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599537	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900132
J	Dauletbaev, N; Das, M; Cammisano, M; Chen, H; Singh, S; Kooi, C; Leigh, R; Beaudoin, T; Rousseau, S; Lands, LC				Dauletbaev, Nurlan; Das, Mithun; Cammisano, Maria; Chen, He; Singh, Sareen; Kooi, Cora; Leigh, Richard; Beaudoin, Trevor; Rousseau, Simon; Lands, Larry C.			Rhinovirus Load Is High despite Preserved Interferon-beta Response in Cystic Fibrosis Bronchial Epithelial Cells	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; PSEUDOMONAS-AERUGINOSA; RESPIRATORY VIRUSES; CYTOKINE PRODUCTION; VIRAL REPLICATION; AIRWAY EPITHELIUM; DOWN-REGULATION; HELA-CELLS; IFN-BETA; INFECTION	Lung disease in cystic fibrosis (CF) is often exacerbated following acute upper respiratory tract infections caused by the human rhinovirus (HRV). Pathophysiology of these exacerbations is presently unclear and may involve deficient innate antiviral or exaggerated inflammatory responses in CF airway epithelial cells. Furthermore, responses of CF cells to HRV may be adversely affected by pre-exposure to virulence factors of Pseudomonas (P.) aeruginosa, the microorganism that frequently colonizes CF airways. Here we examined production of antiviral cytokine interferon-beta and inflammatory chemokine interleukin-8, expression of the interferon-responsive antiviral gene 2'-5'-oligoadenylate synthetase 1 (OAS1), and intracellular virus RNA load in primary CF (delF508 CFTR) and healthy airway epithelial cells following inoculation with HRV16. Parallel cells were exposed to virulence factors of P. aeruginosa prior to and during HRV16 inoculation. CF cells exhibited production of interferon-beta and interleukin-8, and expression of OAS1 at levels comparable to those in healthy cells, yet significantly higher HRV16 RNA load during early hours post-inoculation with HRV16. In line with this, HRV16 RNA load was higher in the CFBE41o-dF cell line overexpessing delF508 CFTR, compared with the isogenic control CFBE41o-WT (wildtype CFTR). Pre-exposure to virulence factors of P. aeruginosa did not affect OAS1 expression or HRV16 RNA load, but potentiated interleukin-8 production. In conclusion, CF cells demonstrate elevated HRV RNA load despite preserved interferon-beta and OAS1 responses. High HRV load in CF airway epithelial cells appears to be due to deficiencies manifesting early during HRV infection, and may not be related to interferon-beta.	[Dauletbaev, Nurlan; Das, Mithun; Cammisano, Maria; Chen, He; Singh, Sareen; Lands, Larry C.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Kooi, Cora; Leigh, Richard] Univ Calgary, Dept Med & Physiol & Pharmacol, Calgary, AB, Canada; [Beaudoin, Trevor; Rousseau, Simon] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Lands, Larry C.] Montreal Childrens Hosp, Div Resp, Montreal, PQ H3H 1P3, Canada	McGill University; University of Calgary; McGill University; McGill University	Dauletbaev, N (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	nurlan.dauletbaev@mail.mcgill.ca		Das, Mithun/0000-0002-6752-9633; Rousseau, Simon/0000-0002-8773-575X	Cystic Fibrosis Canada; Krieble Foundation	Cystic Fibrosis Canada; Krieble Foundation	The funders of the authors' study were Cystic Fibrosis Canada and Krieble Foundation (recipient for both: Larry Lands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amineva SP, 2011, J GEN VIROL, V92, P2549, DOI 10.1099/vir.0.031302-0; ARRUDA E, 1995, J INFECT DIS, V171, P1329, DOI 10.1093/infdis/171.5.1329; Bai JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118286; BARDIN PG, 1994, AM J RESP CELL MOL, V10, P207, DOI 10.1165/ajrcmb.10.2.8110476; Becker TM, 2013, ANN ALLERG ASTHMA IM, V111, P397, DOI 10.1016/j.anai.2013.07.029; Berube J, 2010, J BIOL CHEM, V285, P22299, DOI 10.1074/jbc.M109.098566; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Burns JL, 2012, INFLUENZA OTHER RESP, V6, P218, DOI 10.1111/j.1750-2659.2011.00292.x; Chattoraj SS, 2011, INFECT IMMUN, V79, P4131, DOI 10.1128/IAI.05120-11; Dauletbaev N, 2015, BRIT J PHARMACOL, V172, P4757, DOI 10.1111/bph.13249; Dauletbaev N, 2015, J IMMUNOL, V195, P2829, DOI 10.4049/jimmunol.1400840; Dauletbaev N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.205724; Dauletbaev N, 2010, RESPIRATION, V79, P234, DOI 10.1159/000255342; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Djukanovic R, 2014, AM J RESP CRIT CARE, V190, P145, DOI 10.1164/rccm.201312-2235OC; Esposito S, 2014, JPN J INFECT DIS, V67, P399, DOI 10.7883/yoken.67.399; Flight WG, 2014, THORAX, V69, P247, DOI 10.1136/thoraxjnl-2013-204000; Goffard A, 2014, J CLIN VIROL, V60, P147, DOI 10.1016/j.jcv.2014.02.005; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; HAFF RF, 1966, J BACTERIOL, V91, P2339, DOI 10.1128/JB.91.6.2339-2342.1966; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Kelly C, 2013, AM J PHYSIOL-LUNG C, V304, pL371, DOI 10.1152/ajplung.00372.2011; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Kieninger E, 2013, CHEST, V143, P782, DOI 10.1378/chest.12-0954; LONBERGHOLM K, 1972, J VIROL, V9, P29, DOI 10.1128/JVI.9.1.29-40.1972; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Mosser AG, 2002, J INFECT DIS, V185, P734, DOI 10.1086/339339; Nakagome K, 2014, J ALLERGY CLIN IMMUN, V134, P332, DOI 10.1016/j.jaci.2014.01.029; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; PONOMARIEVA TI, 1972, ARCH GES VIRUSFORSCH, V39, P92, DOI 10.1007/BF01241532; Roussel L, 2011, J CYST FIBROS, V10, P107, DOI 10.1016/j.jcf.2010.11.005; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Schogler A, 2015, EUR RESPIR J, V45, P428, DOI 10.1183/09031936.00102014; Shabram P, 2000, MOL THER, V2, P420, DOI 10.1006/mthe.2000.0212; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; STOTT EJ, 1970, J GEN VIROL, V6, P15, DOI 10.1099/0022-1317-6-1-15; Sutanto EN, 2011, AM J RESP CELL MOL, V44, P761, DOI 10.1165/rcmb.2010-0368OC; TOMASSINI JE, 1989, P NATL ACAD SCI USA, V86, P4907, DOI 10.1073/pnas.86.13.4907; WINTHER B, 1986, JAMA-J AM MED ASSOC, V256, P1763, DOI 10.1001/jama.256.13.1763; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wu Q, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-26; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x	44	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143129	10.1371/journal.pone.0143129	http://dx.doi.org/10.1371/journal.pone.0143129			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599098	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900068
J	Ferreira, HS; Lucio, GMA; Assuncao, ML; Silva, BCV; Oliveira, JS; Florencio, TMMT; Geraldes, AAR; Horta, BL				Ferreira, Haroldo S.; Lucio, Glicia Maris A.; Assuncao, Monica L.; Silva, Barbara Coelho V.; Oliveira, Juliana S.; Florencio, Telma Maria M. T.; Geraldes, Amandio Aristides R.; Horta, Bernardo L.			High Blood Pressure among Students in Public and Private Schools in Maceio, Brazil	PLOS ONE			English	Article							RISK-FACTORS; CHILDREN; OBESITY; PREVALENCE; HYPERTENSION; ADOLESCENTS; STATE; SCHOOLCHILDREN; OVERWEIGHT; TRENDS	The prevalence of hypertension in childhood is increasing, and investigation of its distribution is important for planning timely interventions. This study assessed the prevalence of high blood pressure (HBP) and associated factors in students between 9 and 11 years of age enrolled in public and private schools in Maceio, Brazil. A cross-sectional study was performed in a probabilistic sample of students (10.3 +/- 0.5 years). The students were selected from a systematic sampling of 80 schools (40 public and 40 private). To maintain similar proportions of students existing in public and private schools in Maceio, 21 and 14 students were randomly selected from each public and private school, respectively. The prevalence ratio (PR) was estimated using Poisson regression. A total of 1,338 students were evaluated (800 from public schools and 538 from private schools). No differences were observed between school types in terms of student age and gender (p > 0.05). The prevalence of obesity (19.9% vs. 9.0%; PR = 2.2; 95% CI = 1.67-2.92) and hypertension (21.2% vs. 11.4%; PR = 1.86; 95% CI = 1.45-2.40) were higher in private schools. The association between high blood pressure and type of school (public or private) remained statistically significant even after adjustment for obesity (PR = 1.53; 95% CI = 1.19-1.97). In conclusion: (a) students from private schools have higher socioeconomic status, BMI, and HBP prevalence compared to those of public school; (b) among the evaluated students, the prevalence of obesity only partially explained the higher prevalence of high blood pressure among students from private schools. Other factors related to lifestyle of children from private schools may explain the higher prevalence of HBP. This results show the need to implement measures to promote healthy lifestyles in the school environment, since children with HBP are more likely to become hypertensive adults. Therefore, early detection and intervention in children with HBP is an important action for the prevention of hypertension in adulthood.	[Ferreira, Haroldo S.; Assuncao, Monica L.; Florencio, Telma Maria M. T.] Univ Fed Alagoas, Fac Nutr, Maceio, Alagoas, Brazil; [Lucio, Glicia Maris A.; Silva, Barbara Coelho V.] Univ Fed Alagoas, Fac Nutr, Postgrad Program Nutr, Maceio, Alagoas, Brazil; [Oliveira, Juliana S.] Univ Fed Pernambuco, Acad Ctr Vitoria, Vitoria De Santo Antao, PE, Brazil; [Geraldes, Amandio Aristides R.] Univ Fed Alagoas, Educ Ctr, Maceio, Alagoas, Brazil; [Horta, Bernardo L.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil	Universidade Federal de Alagoas; Universidade Federal de Alagoas; Universidade Federal de Pernambuco; Universidade Federal de Alagoas; Universidade Federal de Pelotas	Ferreira, HS (corresponding author), Univ Fed Alagoas, Fac Nutr, Maceio, Alagoas, Brazil.	haroldo.ufal@gmail.com	Ferrreira, Haroldo S/H-9513-2015; Florencio, Telma/AAE-3394-2019; Geraldes, Amandio AR/I-7977-2014; Horta, Bernardo/A-7604-2008; Ferrreira, Haroldo/ABG-4233-2020	Ferrreira, Haroldo S/0000-0002-1789-3138; Horta, Bernardo/0000-0001-9843-412X; Ferrreira, Haroldo/0000-0002-1789-3138; Geraldes, Amandio/0000-0002-4222-2264	FAPEAL (Foundation for Research Support of the State of Alagoas); CNPq (National Research Council) under the PRONEM programme - Support Emerging Research Groups [20110818-006-0018-0017]	FAPEAL (Foundation for Research Support of the State of Alagoas); CNPq (National Research Council) under the PRONEM programme - Support Emerging Research Groups	This work was supported by FAPEAL (Foundation for Research Support of the State of Alagoas) and CNPq (National Research Council) under the PRONEM programme - Support Emerging Research Groups (grant number 20110818-006-0018-0017).	Bammann K, 2013, PEDIATR OBES, V8, P1, DOI 10.1111/j.2047-6310.2012.00075.x; de Souza MGB, 2010, ARQ BRAS CARDIOL, V94, P714, DOI 10.1590/S0066-782X2010005000039; Beunza JJ, 2007, AM J HYPERTENS, V20, P1156, DOI 10.1016/j.amjhyper.2007.06.007; Borges LMP, 2007, REV SAUDE PUBL, V41, P530, DOI 10.1590/S0034-89102006005000040; Brasil Instituto Nacional de Estudos e Pesquisas Educacionais, 2013, CENS ED 2012; Chiolero A, 2007, J HUM HYPERTENS, V21, P120, DOI 10.1038/sj.jhh.1002125; Costanzi CB, 2009, J PEDIAT-BRAZIL, V85, P335, DOI [10.2223/JPED.1913, 10.1590/S0021-75572009000400011]; de Oliveira TC, 2010, REV SAUDE PUBL, V44, P996, DOI 10.1590/S0034-89102010000600003; de Queiroz VM, 2010, ARQ BRAS CARDIOL, V95, P629, DOI 10.1590/S0066-782X2010001500011; Rezende Dilermando Fazito de, 2003, Arq. Bras. Cardiol., V81, P381, DOI 10.1590/S0066-782X2003001200005; Christofaro DGD, 2009, ARQ BRAS CARDIOL, V92, P9, DOI 10.1590/S0066-782X2009000100003; Dong B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009050; Farajian P, 2008, BRIT J NUTR, V99, P918, DOI 10.1017/S000711450783741X; Fernandes RA, 2008, REV ASSOC MED BRAS, V54, P334, DOI 10.1590/S0104-42302008000400019; Fernandes RA, 2011, CIENC SAUDE COLETIVA, V16, P4051, DOI 10.1590/S1413-81232011001100010; Ferreira HD, 2013, CAD SAUDE PUBLICA, V29, P793, DOI [10.1590/S0102-311X2013000800016, 10.1590/S0102-311X2013000400016]; Frisancho AR, 1990, ANTHROPOMETRIC STAND; Furusawa EA, 2011, AM J HYPERTENS, V24, P893, DOI 10.1038/ajh.2011.72; Hendriksen MAH, 2014, AM J CLIN NUTR, V99, P446, DOI 10.3945/ajcn.113.062018; Huang RC, 2015, AM J HYPERTENS, V28, P1056, DOI 10.1093/ajh/hpu266; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Nogueira PCK, 2007, REV ASSOC MED BRAS, V53, P426, DOI 10.1590/S0104-42302007000500019; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Magalhães Marina Gabriella Pereira de Andrada, 2013, Rev. bras. epidemiol., V16, P849, DOI 10.1590/S1415-790X2013000400005; Miyazaki Y, 2015, SOC SCI MED, V128, P57, DOI 10.1016/j.socscimed.2014.12.032; Mocanu V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/537451; Monego Estelamaris T., 2006, Arq. Bras. Cardiol., V87, P37, DOI 10.1590/S0066-782X2006001400006; Moura Adriana A, 2004, J. Pediatr. (Rio J.), V80, P35, DOI 10.1590/S0021-75572004000100008; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Oliveira Ana Mayra A. de, 2004, Arq Bras Endocrinol Metab, V48, P849, DOI 10.1590/S0004-27302004000600011; Pinto SL, 2011, CAD SAUDE PUBLICA, V27, P1065, DOI 10.1590/S0102-311X2011000600004; Mazaro IAR, 2011, REV ASSOC MED BRAS, V57, P674, DOI 10.1590/S0104-42302011000600015; Gomes BDR, 2009, CAD SAUDE PUBLICA, V25, P375, DOI 10.1590/S0102-311X2009000200016; Rosaneli CF, 2014, ARQ BRAS CARDIOL, V103, P238, DOI 10.5935/abc.20140104; Seidell JC, 2015, NEDERLANDS TIJDSCHRI, V158, pA8503; Silva Giselia Alves Pontes da, 2005, Rev. Bras. Saude Mater. Infant., V5, P53, DOI 10.1590/S1519-38292005000100007; Takahashi H, 2015, BLOOD PRESS MONIT, V20, P286, DOI 10.1097/MBP.0000000000000127; Thibault H, 2013, PUBLIC HEALTH NUTR, V16, P193, DOI 10.1017/S136898001200359X; VI Diretrizes Brasileiras de Hipertensao, 2010, ARQUIVOS BRASILEIROS, V95, pI; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; WHO, 2009, ANTHROPLUS PERS COMP; World Health Organization (WHO), 2007, GROWTH REF 5 19 YEAR; Zhang YX, 2015, INT J CARDIOL, V179, P536, DOI 10.1016/j.ijcard.2014.10.163	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142982	10.1371/journal.pone.0142982	http://dx.doi.org/10.1371/journal.pone.0142982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599324	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900050
J	Homann, J; Suo, J; Schmidt, M; de Bruin, N; Scholich, K; Geisslinger, G; Ferreiros, N				Homann, Julia; Suo, Jing; Schmidt, Mike; de Bruin, Natasja; Scholich, Klaus; Geisslinger, Gerd; Ferreiros, Nerea			In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse	PLOS ONE			English	Article							ASPIRIN-TRIGGERED LIPOXINS; FORMYL PEPTIDE RECEPTORS; DOCOSAHEXAENOIC ACID; STABLE ANALOGS; 15-EPI-LIPOXIN A(4); SKIN INFLAMMATION; LEUKOTRIENE B-4; INDUCED COLITIS; RESOLUTION; ACTIVATION	The activation and infiltration of polymorphonuclear neutrophils (PMN) are critical key steps in inflammation. PMN-mediated inflammation is limited by anti-inflammatory and pro-resolving mechanisms, including specialized pro-resolving lipid mediators (SPM). We examined the effects of 15-epi-LXA(4) on inflammation and the biosynthesis of pro-inflammatory mediators, such as prostaglandins, leukotriene B-4 and various hydroxyeicosatetraenoic acids and SPM, in an oxazolone (OXA)-induced hypersensitivity model for dermal inflammation. 15-epi-LXA(4) (100 mu M, 5 mu L subcutaneously injected) significantly (P < 0.05) reduced inflammation in skin, 24 hours after the OXA challenge, as compared to skin treated with vehicle. No significant influence on the biosynthesis of prostaglandins or leukotriene B-4 was observed, whereas the level of 15S-hydroxy-eicosatetraenoic acid was significantly (P < 0.05) lower in the skin areas treated with 15-epi-LXA(4). In spite of the use of a fully validated analytical procedure, no SPM were detected in the biological samples. To investigate the reason for the lack of analytical signal, we tried to mimic the production of SPM (lipoxins, resolvins, maresin and protectin) by injecting them subcutaneously into the skin of mice and studying the in vivo availability and distribution of the compounds. All analytes showed very little lateral distribution in skin tissue and their levels were markedly decreased (> 95%) 2 hours after injection. However, docosahexaenoic acid derivatives were biologically more stable than SPM derived from arachidonic acid or eicosapentaenoic acid.	[Homann, Julia; Suo, Jing; Scholich, Klaus; Geisslinger, Gerd; Ferreiros, Nerea] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, D-60054 Frankfurt, Germany; [Schmidt, Mike; de Bruin, Natasja; Geisslinger, Gerd] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp TMP, Frankfurt, Germany	Goethe University Frankfurt; Fraunhofer Gesellschaft	Ferreiros, N (corresponding author), Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, D-60054 Frankfurt, Germany.	ferreirosbouzas@em.uni-frankfurt.de	de Bruin, Natasja/D-8063-2014	de Bruin, Natasja/0000-0002-2456-2783	Deutsche Forschungsgemeinschaft (DFG) [SFB 1039/Z01]; Land Hessen, (LOEWE-Zentrum Translationale Medizin und Pharmakologie)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Land Hessen, (LOEWE-Zentrum Translationale Medizin und Pharmakologie)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), SFB 1039/Z01 and Land Hessen, (LOEWE-Zentrum Translationale Medizin und Pharmakologie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Canetti C, 2001, BRIT J PHARMACOL, V134, P1619, DOI 10.1038/sj.bjp.0704403; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; Christophe T, 2002, SCAND J IMMUNOL, V56, P470, DOI 10.1046/j.1365-3083.2002.01149.x; EKERDT R, 1992, ARCH DERMATOL RES, V284, pS18, DOI 10.1007/BF00638235; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Fiorucci S, 2004, P NATL ACAD SCI USA, V101, P15736, DOI 10.1073/pnas.0404722101; Forsman H, 2011, SCAND J IMMUNOL, V74, P227, DOI 10.1111/j.1365-3083.2011.02570.x; Forsman H, 2009, SCAND J IMMUNOL, V70, P396, DOI 10.1111/j.1365-3083.2009.02311.x; Freire MO, 2013, PERIODONTOL 2000, V63, P149, DOI 10.1111/prd.12034; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gronert K, 2001, AM J PATHOL, V158, P3, DOI 10.1016/S0002-9440(10)63937-5; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Hanson J, 2013, BIOCHEM PHARMACOL, V85, P1795, DOI 10.1016/j.bcp.2013.04.019; Homann J, 2014, J CHROMATOGR A, V1360, P150, DOI 10.1016/j.chroma.2014.07.068; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kishida T, 2012, J TOXICOL SCI, V37, P1143, DOI 10.2131/jts.37.1143; Knorr RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115357; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Maddox JF, 1997, J BIOL CHEM, V272, P6972, DOI 10.1074/jbc.272.11.6972; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; MARKS F, 1981, CANCER RES, V41, P696; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; McMahon B, 2002, FASEB J, V16, P1817, DOI 10.1096/fj.02-0416fje; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; MUFSON RA, 1979, CANCER RES, V39, P4791; Nicolaou A, 2013, PROSTAG LEUKOTR ESS, V88, P131, DOI 10.1016/j.plefa.2012.03.009; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; PALMBLAD J, 1981, BLOOD, V58, P658; Petasis NA, 2005, PROSTAG LEUKOTR ESS, V73, P301, DOI 10.1016/j.plefa.2005.05.020; Schottelius AJ, 2002, J IMMUNOL, V169, P7063, DOI 10.4049/jimmunol.169.12.7063; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; SIMCHOWITZ L, 1994, AM J PHYSIOL-CELL PH, V267, pC1525, DOI 10.1152/ajpcell.1994.267.6.C1525; Sisignano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081228; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Takano T, 1997, J EXP MED, V185, P1693, DOI 10.1084/jem.185.9.1693; Takano T, 1998, J CLIN INVEST, V101, P819, DOI 10.1172/JCI1578; Tkalcevic VI, 2012, INFLAMMATION, V35, P192, DOI 10.1007/s10753-011-9305-9; Tungen JE, 2014, J NAT PROD, V77, P2241, DOI 10.1021/np500498j; US Department of Health and Human Services, 2001, GUID IND BIOAN METH; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; Vaughn MW, 2002, J IMMUNOL, V169, P3363, DOI 10.4049/jimmunol.169.6.3363; Wang X, 2014, ALZHEIMERS DEMENTIA; Weiss GA, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-89; Yacoubian S, 2007, NAT CLIN PRACT RHEUM, V3, P570, DOI 10.1038/ncprheum0616; Zhang GJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/930124	60	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143141	10.1371/journal.pone.0143141	http://dx.doi.org/10.1371/journal.pone.0143141			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599340	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900070
J	Powell, JSV; Babbitt, KJ				Powell, Jessica S. Veysey; Babbitt, Kimberly J.			Despite Buffers, Experimental Forest Clearcuts Impact Amphibian Body Size and Biomass	PLOS ONE			English	Article							SALAMANDERS AMBYSTOMA-MACULATUM; POOL-BREEDING AMPHIBIANS; SPOTTED SALAMANDERS; WOOD FROG; LARVAL DENSITY; TERRESTRIAL SALAMANDERS; TIMBER MANAGEMENT; RANA-SYLVATICA; LARGE-SCALE; POSTBREEDING EMIGRATION	Forest buffers are a primary tool used to protect wetland-dependent wildlife. Though implemented widely, buffer efficacy is untested for most amphibian species. Consequently, it remains unclear whether buffers are sufficient for maintaining amphibian populations and if so, how wide buffers should be. We present evidence from a six-year, landscape-scale experiment testing the impacts of clearcutting, buffer width, and hydroperiod on body size and condition and biomass of breeding adults for two amphibian species at 11 vernal pools in the northeastern United States. We randomly assigned treatments (i.e., reference, 100m buffer, 30m buffer) across pools, clearcut to create buffers, and captured all spotted salamanders and wood frogs. Clearcuts strongly and negatively impacted size, condition, and biomass, but wider buffers mitigated effect magnitude and duration. Among recaptured individuals, for example, 30m-treatment salamanders were predicted to be about 9.5 mm shorter than, while 100m-treatment salamanders did not differ in length from, reference-treatment salamanders. Similarly, among recaptured frogs, mean length in the 30m treatment was predicted to decrease by about 1 mm/year, while in the 100m and reference treatments, length was time-invariant. Some, but not all, metrics recovered with time. For example, female new-captured and recaptured salamanders were predicted, respectively and on average, to weigh 4.5 and 7 g less in the 30m versus reference treatment right after the cut. While recaptured-female mass was predicted to recover by 9.5 years post-cut, new-captured-female mass did not recover. Hydroperiod was an important mediator: in the 100m treatment, cutting predominately affected pools that were stressed hydrologically. Overall, salamanders and female frogs were impacted more than male frogs. Our results highlight the importance of individualized metrics like body size, which can reveal sublethal effects and illuminate mechanisms by which habitat disturbance impacts wildlife populations. Individualized metrics thus provide critical insights that complement species occurrence and abundance-based population assessments.	[Powell, Jessica S. Veysey; Babbitt, Kimberly J.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Powell, JSV (corresponding author), Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA.	jss4@unh.edu		Veysey Powell, Jessica/0000-0002-6706-9075	National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service [2003-35101-12922, 2007-35101-18281]; Northeastern States Research Cooperative; Robert and Patricia Switzer Foundation; University of New Hampshire Graduate School; University of New Hampshire Cooperative Extension; New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture McIntire-Stennis Project [0226124, 2614]	National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Northeastern States Research Cooperative; Robert and Patricia Switzer Foundation; University of New Hampshire Graduate School; University of New Hampshire Cooperative Extension; New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture McIntire-Stennis Project	The project was supported by grants to KJB from: the National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service (http://www.csrees.usda.gov/funding/rfas/nri_rfa.html), grant numbers: 2003-35101-12922 and 2007-35101-18281; and the Northeastern States Research Cooperative (http://nsrcforest.org/). The project was also supported by fellowships to JSVP from: the Robert and Patricia Switzer Foundation (http://www.switzernetwork.org/), the University of New Hampshire Graduate School (http://www.gradschool.unh.edu/), and the University of New Hampshire Cooperative Extension (http://extension.unh.edu/). Partial funding was provided by a grant to KJB from the New Hampshire Agricultural Experiment Station (http://www.colsa.unh.edu/aes). This is Scientific Contribution number: 2614. This work was supported by the USDA National Institute of Food and Agriculture McIntire-Stennis Project, accession number: 0226124. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BT, 2010, CLIMATIC CHANGE, V99, P403, DOI 10.1007/s10584-009-9674-3; [Anonymous], 1999, FOREST REGENERATION; Apodaca JJ, 2015, FORESTS, V6, P827, DOI 10.3390/f6030827; Ardia DR, 2005, FUNCT ECOL, V19, P414, DOI 10.1111/j.1365-2435.2005.00997.x; Aubry KB, 2000, J WILDLIFE MANAGE, V64, P1041, DOI 10.2307/3803215; Babbitt KJ, 2003, CAN J ZOOL, V81, P1539, DOI 10.1139/Z03-131; Baber MJ, 2004, OIKOS, V107, P16; Baldwin RF, 2006, CAN J ZOOL, V84, P1604, DOI 10.1139/Z06-146; Baldwin RF, 2006, J HERPETOL, V40, P442, DOI 10.1670/0022-1511(2006)40[442:CPFASW]2.0.CO;2; Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; Bauer DM, 2013, ECOL ECON, V95, P159, DOI 10.1016/j.ecolecon.2013.08.013; Bauer DM, 2010, ECOL APPL, V20, P798, DOI 10.1890/08-2209.1; Beck CW, 2000, FUNCT ECOL, V14, P32, DOI 10.1046/j.1365-2435.2000.00386.x; Beese W. J., 2005, General Technical Report - Pacific Northwest Research Station, USDA Forest Service, P55; Begon M., 1996, ECOLOGY; Bellis E. D., 1962, American Midland Naturalist, V68, P139, DOI 10.2307/2422640; BENNETT AF, 1989, AM J PHYSIOL, V256, pR1200, DOI 10.1152/ajpregu.1989.256.6.R1200; Benton TG, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P41; BERVEN KA, 1981, EVOLUTION, V35, P707, DOI 10.1111/j.1558-5646.1981.tb04931.x; BERVEN KA, 1988, COPEIA, P605, DOI 10.2307/1445378; BERVEN KA, 1990, EVOLUTION, V44, P2047, DOI 10.1111/j.1558-5646.1990.tb04310.x; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; BERVEN KA, 1983, AM ZOOL, V23, P85; Berven KA, 2009, COPEIA, P328, DOI 10.1643/CH-08-052; Blomquist SM, 2007, J HERPETOL, V41, P430, DOI 10.1670/0022-1511(2007)41[430:EARHLE]2.0.CO;2; Bonte D, 2009, J EVOLUTION BIOL, V22, P1242, DOI 10.1111/j.1420-9101.2009.01737.x; Brepson L, 2013, BEHAV ECOL, V24, P488, DOI 10.1093/beheco/ars189; Brodeur JC, 2011, ECOTOX ENVIRON SAFE, V74, P1370, DOI 10.1016/j.ecoenv.2011.04.024; Brodman R, 1996, COPEIA, P372, DOI 10.2307/1446853; Burghelea C, 2013, AMPHIBIA-REPTILIA, V34, P505, DOI 10.1163/15685381-00002908; Chandler CH, 2008, MOL ECOL, V17, P1564, DOI 10.1111/j.1365-294X.2007.03614.x; Chazal AC, 1998, ECOL APPL, V8, P1133, DOI 10.1890/1051-0761(1998)008[1133:ROMSTC]2.0.CO;2; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; Church DR, 2007, ECOLOGY, V88, P891, DOI 10.1890/06-0896; Cole EC, 1997, J WILDLIFE MANAGE, V61, P656, DOI 10.2307/3802173; Cooperman MD, 2004, CAN J ZOOL, V82, P1795, DOI 10.1139/Z04-150; CORN PS, 1989, FOREST ECOL MANAG, V29, P39, DOI 10.1016/0378-1127(89)90055-8; Coster SS, 2015, HERPETOL CONSERV BIO, V10, P64; Coster SS, 2015, MOL ECOL, V24, P742, DOI 10.1111/mec.13062; Crawford JA, 2007, CONSERV BIOL, V21, P152, DOI 10.1111/j.1523-1739.2006.00556.x; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; De Meester L, 2005, AQUAT CONSERV, V15, P715, DOI 10.1002/aqc.748; DeGraaf R.M., 2001, UPNE; Deichmann JL, 2008, J HERPETOL, V42, P238, DOI 10.1670/07-0731.1; Delgado-Acevedo J, 2008, CONSERV BIOL, V22, P773, DOI 10.1111/j.1523-1739.2008.00930.x; Demaynadier PG, 1998, CONSERV BIOL, V12, P340, DOI 10.1046/j.1523-1739.1998.96412.x; deMaynadier PG, 2008, SCI CONSERVATION VER, P392; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; DUCEY PK, 1988, COPEIA, P1008, DOI 10.2307/1445725; Dupuis L, 1999, FOREST ECOL MANAG, V124, P35, DOI 10.1016/S0378-1127(99)00051-1; DuShane GP, 1944, ECOLOGY, V25, P414, DOI 10.2307/1932016; Egan RS, 2004, WETLANDS, V24, P1, DOI 10.1672/0277-5212(2004)024[0001:WPAOBW]2.0.CO;2; Eggert C, 2003, CAN J ZOOL, V81, P46, DOI 10.1139/Z02-224; EMERSON SB, 1978, EVOLUTION, V32, P551, DOI 10.1111/j.1558-5646.1978.tb04598.x; ENGE KM, 1986, FOREST ECOL MANAG, V14, P177, DOI 10.1016/0378-1127(86)90116-7; Faccio SD, 2003, J HERPETOL, V37, P479, DOI 10.1670/155-02A; FAO, 2012, STAT WORLDS FOR 2012; Ferner John W., 2010, P123; Ficetola GF, 2009, CONSERV BIOL, V23, P114, DOI 10.1111/j.1523-1739.2008.01081.x; Freidenfelds NA, 2011, FOREST ECOL MANAG, V261, P2115, DOI 10.1016/j.foreco.2011.03.005; FRETWELL S D, 1972, P217; Friedland A. J., 2004, Journal of Sustainable Forestry, V18, P1, DOI 10.1300/J091v18n01_01; Garner TWJ, 2011, GLOBAL CHANGE BIOL, V17, P667, DOI 10.1111/j.1365-2486.2010.02272.x; GFGS, 2009, GOOD FOR GRAN STAT A; Gibbons JW, 2006, CONSERV BIOL, V20, P1457, DOI 10.1111/j.1523-1739.2006.00443.x; GILL DE, 1985, ECOLOGY, V66, P344, DOI 10.2307/1940384; GOATER CP, 1993, OIKOS, V66, P129, DOI 10.2307/3545205; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Guerry AD, 2002, CONSERV BIOL, V16, P745, DOI 10.1046/j.1523-1739.2002.00557.x; Hannon SJ, 2002, CAN J FOREST RES, V32, P1784, DOI 10.1139/X02-092; Harper CA, 1999, FOREST ECOL MANAG, V114, P245, DOI 10.1016/S0378-1127(98)00355-7; Harper EB, 2008, CONSERV BIOL, V22, P1205, DOI 10.1111/j.1523-1739.2008.01015.x; Harpole DN, 1999, FOREST ECOL MANAG, V114, P349, DOI 10.1016/S0378-1127(98)00365-X; Hart DD, 2010, FRESHWATER BIOL, V55, P258, DOI 10.1111/j.1365-2427.2009.02370.x; Hawkes VC, 2012, FOREST ECOL MANAG, V274, P67, DOI 10.1016/j.foreco.2012.02.015; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; HEATWOLE HAROLD, 1961, AMER MIDLAND NAT, V66, P301, DOI 10.2307/2423030; Holbrook CT, 2004, COPEIA, P932, DOI 10.1643/CE-04-037R1; Homan RN, 2003, ANIM CONSERV, V6, P11, DOI 10.1017/S13679430030032; Homyack JA, 2011, J WILDLIFE MANAGE, V75, P1267, DOI 10.1002/jwmg.175; Homyack JA, 2010, WILDLIFE RES, V37, P332, DOI 10.1071/WR08093; HOWARD RD, 1985, EVOLUTION, V39, P260, DOI 10.1111/j.1558-5646.1985.tb05665.x; Humfeld SC, 2013, BEHAV ECOL, V24, P859, DOI 10.1093/beheco/art024; Irland L.C, 1999, NE CHANGING FOREST; Janin A, 2011, BIOL CONSERV, V144, P1008, DOI 10.1016/j.biocon.2010.12.009; JOHNALDER HB, 1990, COPEIA, P856, DOI 10.2307/1446453; Johnston B, 2002, CAN J ZOOL, V80, P2170, DOI 10.1139/Z02-213; Johst K, 1997, OIKOS, V78, P612, DOI 10.2307/3545624; KAPLAN RH, 1979, AM NAT, V113, P671, DOI 10.1086/283425; Karraker NE, 2006, BIOL CONSERV, V131, P132, DOI 10.1016/j.biocon.2006.02.013; Klenner W, 2009, FOREST ECOL MANAG, V258, pS1, DOI 10.1016/j.foreco.2009.10.037; Knox CB, 1999, MAINE AMPHIBIANS REP, P111; Komoroski MJ, 1998, PHYSIOL ZOOL, V71, P633, DOI 10.1086/515989; Lee P, 2004, J ENVIRON MANAGE, V70, P165, DOI 10.1016/j.jenvman.2003.11.009; Lemckert FL, 2011, FOREST ECOL MANAG, V262, P1199, DOI 10.1016/j.foreco.2011.06.014; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; MacCracken JG, 2012, J HERPETOL, V46, P346, DOI 10.1670/10-292; Madison DM, 1998, COPEIA, P402; Madison DM, 1997, J HERPETOL, V31, P542, DOI 10.2307/1565607; MARSHALL WH, 1955, ECOLOGY, V36, P381, DOI 10.2307/1929572; Mazerolle MJ, 2001, J HERPETOL, V35, P13, DOI 10.2307/1566017; McMurry ST, 2009, J HERPETOL, V43, P421, DOI 10.1670/07-126R2.1; MEDIFW, 2005, MAIN COMPR WILDL CON; Morris KM, 2007, J WILDLIFE MANAGE, V71, P1034, DOI 10.2193/2005-469; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Neckel-Oliveira S, 2006, BIOL CONSERV, V128, P308, DOI 10.1016/j.biocon.2005.09.037; NEWMAN RA, 1994, COPEIA, P372; Olson DH, 2007, FOREST SCI, V53, P331; Patrick DA, 2008, ECOLOGY, V89, P2563, DOI 10.1890/07-0906.1; Patrick DA, 2006, FOREST ECOL MANAG, V234, P323, DOI 10.1016/j.foreco.2006.07.015; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Perkins DW, 2006, J WILDLIFE MANAGE, V70, P657, DOI 10.2193/0022-541X(2006)70[657:EORTMO]2.0.CO;2; Peterson CE, 2002, PNWGTR564 US DEP AGR; Peterson CE, 2009, FOREST ECOL MANAG, V258, P409, DOI 10.1016/j.foreco.2008.12.029; Petranka JW, 2004, ECOL APPL, V14, P1065, DOI 10.1890/02-5394; Petranka JW, 1998, HERPETOLOGICA, V54, P1; Petranka JW, 1999, OECOLOGIA, V120, P621, DOI 10.1007/s004420050898; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pollett KL, 2010, FOREST ECOL MANAG, V260, P1083, DOI 10.1016/j.foreco.2010.06.035; Ponsero A, 1998, ARCH HYDROBIOL, V142, P343; Popescu VD, 2011, ECOL APPL, V21, P1283, DOI 10.1890/10-0658.1; POUGH FH, 1980, AM NAT, V115, P92, DOI 10.1086/283547; Powell JSV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133642; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; READING CJ, 1995, OECOLOGIA, V102, P453, DOI 10.1007/BF00341357; Regester KJ, 2006, OECOLOGIA, V147, P303, DOI 10.1007/s00442-005-0266-2; Regester KJ, 2006, COPEIA, P640, DOI 10.1643/0045-8511(2006)6[640:DROSAM]2.0.CO;2; Regosin JV, 2004, COPEIA, P152, DOI 10.1643/CE-02-119R2; Regosin JV, 2003, CAN J ZOOL, V81, P596, DOI 10.1139/Z03-046; Reniers J, 2015, OECOLOGIA, V178, P931, DOI 10.1007/s00442-015-3258-x; Renken RB, 2004, CONSERV BIOL, V18, P174, DOI 10.1111/j.1523-1739.2004.00312.x; Rittenhouse TAG, 2009, ECOLOGY, V90, P1620, DOI 10.1890/08-0326.1; Rittenhouse TAG, 2008, COPEIA, P807, DOI 10.1643/CH-07-176; Rodenhouse NL, 2009, CAN J FOREST RES, V39, P249, DOI 10.1139/X08-160; Rothermel BB, 2006, CAN J ZOOL, V84, P797, DOI 10.1139/Z06-056; Rothermel BB, 2005, J HERPETOL, V39, P619, DOI 10.1670/251-04A.1; ROWE CL, 1995, OECOLOGIA, V102, P397, DOI 10.1007/BF00341351; Russell KR, 2002, J WILDLIFE MANAGE, V66, P603, DOI 10.2307/3803127; Schauble CS, 2004, BIOL J LINN SOC, V82, P39, DOI 10.1111/j.1095-8312.2004.00315.x; Schriever TA, 2014, AQUAT SCI, V76, P131, DOI 10.1007/s00027-013-0320-9; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Scott D.E., 1995, AMBYSTOMA OPACUM HER, V51, P462; Scott DE, 2007, OECOLOGIA, V153, P521, DOI 10.1007/s00442-007-0755-6; SCOTT DE, 1990, ECOLOGY, V71, P296, DOI 10.2307/1940269; SCOTT DE, 1994, ECOLOGY, V75, P1383, DOI 10.2307/1937462; SEMLITSCH RD, 1987, ECOLOGY, V68, P994, DOI 10.2307/1938370; SEMLITSCH RD, 1985, OECOLOGIA, V65, P305, DOI 10.1007/BF00378903; SEMLITSCH RD, 1987, COPEIA, P61, DOI 10.2307/1446038; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Seymour RS, 2006, ALLG FORST JAGDZTG, V177, P104; SHOOP CR, 1965, SCIENCE, V149, P558, DOI 10.1126/science.149.3683.558; SHOOP CR, 1974, ECOLOGY, V55, P440, DOI 10.2307/1935233; Sieg AE, 2010, THESIS; Skelly DK, 1999, ECOLOGY, V80, P2326, DOI 10.1890/0012-9658(1999)080[2326:LTDDOA]2.0.CO;2; Smith MA, 2005, ECOGRAPHY, V28, P110; Smyers SD, 2002, HERPETOLOGICA, V58, P422, DOI 10.1655/0018-0831(2002)058[0422:IAICOB]2.0.CO;2; Snodgrass JW, 2000, ECOL APPL, V10, P1219, DOI 10.1890/1051-0761(2000)010[1219:DOEOLA]2.0.CO;2; SPOTILA JR, 1972, ECOL MONOGR, V42, P95, DOI 10.2307/1942232; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Taylor BE, 2006, CONSERV BIOL, V20, P792, DOI 10.1111/j.1523-1739.2005.00321.x; Taylor BE, 1997, HERPETOLOGICA, V53, P132; Tilghman JM, 2012, BIOL CONSERV, V152, P1, DOI 10.1016/j.biocon.2012.03.030; Todd BD, 2006, BIOL CONSERV, V133, P178, DOI 10.1016/j.biocon.2006.06.003; Turtle SL, 2000, J HERPETOL, V34, P60, DOI 10.2307/1565239; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Vesely DG, 2002, FOREST SCI, V48, P291; Veysey JS, 2011, LANDSCAPE ECOL, V26, P661, DOI 10.1007/s10980-011-9590-6; Veysey JS, 2009, BIOL CONSERV, V142, P2227, DOI 10.1016/j.biocon.2009.04.024; WALLS SC, 1990, ECOLOGY, V71, P307, DOI 10.2307/1940270; Watson RT, 2004, BEHAV PROCESS, V65, P201, DOI 10.1016/j.beproc.2003.09.007; Welsh HH, 2008, BIOL CONSERV, V141, P1149, DOI 10.1016/j.biocon.2008.02.014; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; WHITFORD WG, 1973, AM ZOOL, V13, P505; WHITFORD WG, 1967, PHYSIOL ZOOL, V40, P127, DOI 10.1086/physzool.40.2.30152447; Willson John D., 2010, P229; Windmiller B. S., 1996, THESIS; WOODWARD BD, 1982, COPEIA, P157, DOI 10.2307/1444279; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x	179	4	4	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143505	10.1371/journal.pone.0143505	http://dx.doi.org/10.1371/journal.pone.0143505			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600386	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900134
J	Slocum, C; Gerrard, P; Black-Schaffer, R; Goldstein, R; Singhal, A; DiVita, MA; Ryan, CM; Mix, J; Purohit, M; Niewczyk, P; Kazis, L; Zafonte, R; Schneider, JC				Slocum, Chloe; Gerrard, Paul; Black-Schaffer, Randie; Goldstein, Richard; Singhal, Aneesh; DiVita, Margaret A.; Ryan, Colleen M.; Mix, Jacqueline; Purohit, Maulik; Niewczyk, Paulette; Kazis, Lewis; Zafonte, Ross; Schneider, Jeffrey C.			Functional Status Predicts Acute Care Readmissions from Inpatient Rehabilitation in the Stroke Population	PLOS ONE			English	Article							HOSPITAL READMISSIONS; PERFORMANCE; COMPLICATIONS; VALIDATION; DISCHARGE; HEALTH	Objective Acute care readmission risk is an increasingly recognized problem that has garnered significant attention, yet the reasons for acute care readmission in the inpatient rehabilitation population are complex and likely multifactorial. Information on both medical comorbidities and functional status is routinely collected for stroke patients participating in inpatient rehabilitation. We sought to determine whether functional status is a more robust predictor of acute care readmissions in the inpatient rehabilitation stroke population compared with medical comorbidities using a large, administrative data set. Methods A retrospective analysis of data from the Uniform Data System for Medical Rehabilitation from the years 2002 to 2011 was performed examining stroke patients admitted to inpatient rehabilitation facilities. A Basic Model for predicting acute care readmission risk based on age and functional status was compared with models incorporating functional status and medical comorbidities (Basic-Plus) or models including age and medical comorbidities alone (Age-Comorbidity). C-statistics were compared to evaluate model performance. Findings There were a total of 803,124 patients: 88,187 (11%) patients were transferred back to an acute hospital: 22,247 (2.8%) within 3 days, 43,481 (5.4%) within 7 days, and 85,431 (10.6%) within 30 days. The C-statistics for the Basic Model were 0.701, 0.672, and 0.682 at days 3, 7, and 30 respectively. As compared to the Basic Model, the best-performing Basic-Plus model was the Basic+Elixhauser model with C-statistics differences of +0.011, +0.011, and +0.012, and the best-performing Age-Comorbidity model was the Age+Elixhauser model with C-statistic differences of -0.124, -0.098, and -0.098 at days 3, 7, and 30 respectively. Conclusions Readmission models for the inpatient rehabilitation stroke population based on functional status and age showed better predictive ability than models based on medical comorbidities.	[Slocum, Chloe; Gerrard, Paul; Black-Schaffer, Randie; Goldstein, Richard; Zafonte, Ross; Schneider, Jeffrey C.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02138 USA; [Slocum, Chloe; Gerrard, Paul; Black-Schaffer, Randie; Zafonte, Ross; Schneider, Jeffrey C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Singhal, Aneesh] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [DiVita, Margaret A.; Mix, Jacqueline; Niewczyk, Paulette] Uniform Data Syst Med Rehabil, Amherst, NY USA; [Niewczyk, Paulette] Daemen Coll, Hlth Care Studies Dept, Amherst, NY USA; [Ryan, Colleen M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Sumner Redstone Burn Ctr,Surg Serv, Boston, MA USA; [Ryan, Colleen M.] Shriners Hosp Children Boston, Boston, MA USA; [Purohit, Maulik] Ft Belvoir Community Hosp, Natl Intrepid Ctr Excellence, Intrepid Spirit 1, Neurorehabil & Traumat Brain Injury, Ft Belvoir, VA USA; [Kazis, Lewis] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA	Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University	Schneider, JC (corresponding author), Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02138 USA.	jcschneider@partners.org	Schneider, Jeffrey/AAO-2126-2020; Black-Schaffer, Randie/AAY-4671-2021	Ryan, Colleen/0000-0002-6455-936X; DiVita, Margaret/0000-0002-4878-2959				Bhattacharya P, 2011, J NEUROL SCI, V307, P50, DOI 10.1016/j.jns.2011.05.022; BREZINSKI D, 1991, AM HEART J, V121, P1374, DOI 10.1016/0002-8703(91)90141-4; Brosseau Lucie, 1996, Physiotherapy Theory and Practice, V12, P161, DOI 10.3109/09593989609036432; Burke RE, 2013, JAMA INTERN MED, V173, P695, DOI 10.1001/jamainternmed.2013.171; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari Matteo, 2008, BMC Geriatr, V8, P34, DOI 10.1186/1471-2318-8-34; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chung DM, 2012, AM J PHYS MED REHAB, V91, P387, DOI 10.1097/PHM.0b013e3182aac27; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faulk CE, 2013, PM&R, V5, P757, DOI 10.1016/j.pmrj.2013.06.002; Gerrard P, 2015, AM J MANAG CARE, V21, pE282; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; Hamilton BB, 1999, ARCH PHYS MED REHAB, V80, P385, DOI 10.1016/S0003-9993(99)90274-5; Hodgson CL, 2013, CRIT CARE, V17, DOI 10.1186/cc11820; Hoyer EH, 2014, J HOSP MED, V9, P277, DOI 10.1002/jhm.2152; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Lin MF, 2013, INFORM SYST RES, V24, P906, DOI 10.1287/isre.2013.0480; Lo A, 2012, INT J STROKE, V7, P118, DOI 10.1111/j.1747-4949.2011.00694.x; Marks E, 2013, JAMA INTERN MED, V173, P629, DOI 10.1001/jamainternmed.2013.4065; Ohman EM, 2000, JAMA-J AM MED ASSOC, V284, P876, DOI 10.1001/jama.284.7.876; Ottenbacher KJ, 2012, J GERONTOL A-BIOL, V67, P875, DOI 10.1093/gerona/glr247; Pepe MS, 2013, STAT MED, V32, P1467, DOI 10.1002/sim.5727; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneider JC, 2013, PM&R, V5, P114, DOI 10.1016/j.pmrj.2012.07.014; Schneider JC, 2012, J TRAUMA ACUTE CARE, V73, P1596, DOI 10.1097/TA.0b013e318270d73d; Stillman G, 2009, PM&R, V1, P234, DOI 10.1016/j.pmrj.2008.10.014; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P712, DOI 10.1016/S0003-9993(03)04850-5; UB Foundation Activities Inc., 2004, UN DAT SYST MED REH; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	35	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142180	10.1371/journal.pone.0142180	http://dx.doi.org/10.1371/journal.pone.0142180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599009	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900021
J	Voinson, M; Billiard, S; Alvergne, A				Voinson, Marina; Billiard, Sylvain; Alvergne, Alexandra			Beyond Rational Decision-Making: Modelling the Influence of Cognitive Biases on the Dynamics of Vaccination Coverage	PLOS ONE			English	Article							IMITATION DYNAMICS; SELF-INTEREST; BEHAVIOR; RISK; IMMUNIZATION; STRATEGIES; PERCEPTION; CONTAGION	Background Theoretical studies predict that it is not possible to eradicate a disease under voluntary vaccination because of the emergence of non-vaccinating "free-riders" when vaccination coverage increases. A central tenet of this approach is that human behaviour follows an economic model of rational choice. Yet, empirical studies reveal that vaccination decisions do not necessarily maximize individual self-interest. Here we investigate the dynamics of vaccination coverage using an approach that dispenses with payoff maximization and assumes that risk perception results from the interaction between epidemiology and cognitive biases. Methods We consider a behaviour-incidence model in which individuals perceive actual epidemiological risks as a function of their opinion of vaccination. As a result of confirmation bias, sceptical individuals (negative opinion) overestimate infection cost while pro-vaccines individuals (positive opinion) overestimate vaccination cost. We considered a feedback between individuals and their environment as individuals could change their opinion, and thus the way they perceive risks, as a function of both the epidemiology and the most common opinion in the population. Results For all parameter values investigated, the infection is never eradicated under voluntary vaccination. For moderately contagious diseases, oscillations in vaccination coverage emerge because individuals process epidemiological information differently depending on their opinion. Conformism does not generate oscillations but slows down the cultural response to epidemiological change. Conclusion Failure to eradicate vaccine preventable disease emerges from the model because of cognitive biases that maintain heterogeneity in how people perceive risks. Thus, assumptions of economic rationality and payoff maximization are not mandatory for predicting commonly observed dynamics of vaccination coverage. This model shows that alternative notions of rationality, such as that of ecological rationality whereby individuals use simple cognitive heuristics, offer promising new avenues for modelling vaccination behaviour.	[Voinson, Marina; Billiard, Sylvain] Univ Lille Sci & Technol, UMR Evo Eco Paleo 8198, Villeneuve Dascq, France; [Alvergne, Alexandra] Univ Oxford, Sch Anthropol & Museum Ethnog, Oxford, England	Universite de Lille - ISITE; Universite de Lille; University of Oxford	Alvergne, A (corresponding author), Univ Oxford, Sch Anthropol & Museum Ethnog, Oxford, England.	alexandra.alvergne@anthro.ox.ac.uk	billiard, sylvain/A-2108-2009	billiard, sylvain/0000-0003-2135-3246; Marina, Voinson/0000-0001-6085-9974; Alvergne, Alexandra/0000-0002-3151-9919	School of Anthropology and Museum Ethnography at Oxford, UK; "Chair Modelisation Mathematique et Biodiversite" of Veolia Environnement-Ecole Polytechnique-Museum National d'Histoire Naturelle-Fondation X, France	School of Anthropology and Museum Ethnography at Oxford, UK; "Chair Modelisation Mathematique et Biodiversite" of Veolia Environnement-Ecole Polytechnique-Museum National d'Histoire Naturelle-Fondation X, France	The authors have been supported by the School of Anthropology and Museum Ethnography at Oxford, UK, as well as by the "Chair Modelisation Mathematique et Biodiversite" of Veolia Environnement-Ecole Polytechnique-Museum National d'Histoire Naturelle-Fondation X, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ASCH DA, 1994, MED DECIS MAKING, V14, P118, DOI 10.1177/0272989X9401400204; Bauch C. T., 2013, MODELING INTERPLAY H, P1; Bauch CT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002452; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Bhattacharyya S, 2010, J THEOR BIOL, V267, P276, DOI 10.1016/j.jtbi.2010.09.005; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; BRUNER JS, 1949, J PERS, V18, P206, DOI 10.1111/j.1467-6494.1949.tb01241.x; Campbell E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01905; Caprara A, 1998, TROP MED INT HEALTH, V3, P996, DOI 10.1046/j.1365-3156.1998.00341.x; Chen FH, 2006, J MATH BIOL, V53, P253, DOI 10.1007/s00285-006-0006-1; Coelho FC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000425; d'Onofrio A., 2013, MODELING INTERPLAY H, P267; Durbach N., 2007, BODILY MATTERS ANTIV; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Gigerenzer G., 2001, BOUNDED RATIONALITY; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Liu XN, 2008, J THEOR BIOL, V253, P1, DOI 10.1016/j.jtbi.2007.10.014; Manfredi P., 2013, MODELING INTERPLAY H; Mbah MLN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002469; Meszaros JR, 1996, J CLIN EPIDEMIOL, V49, P697, DOI 10.1016/0895-4356(96)00007-8; Miller JC, 2007, PHYSICA A, V386, P780, DOI 10.1016/j.physa.2007.08.054; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Oraby T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10724; Oraby T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3172; Perisic A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-77; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; Scherer CW, 2003, RISK ANAL, V23, P261, DOI 10.1111/1539-6924.00306; Schimit PHT, 2011, ECOL MODEL, V222, P1651, DOI 10.1016/j.ecolmodel.2011.02.019; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Sturm LA, 2005, J DEV BEHAV PEDIATR, V26, P441, DOI 10.1097/00004703-200512000-00009; Todd PM, 2012, ECOLOGICAL RATIONALI, DOI [10.1093/acprof:oso/9780195315448.001.0001, DOI 10.1093/ACPROF:0S0/9780195315448.001.0001]; Vardavas R, 2013, MODELING INTERPLAY H, P203, DOI DOI 10.1007/978-1-4614-5474-8_13; Walters CE, 2013, THEOR POPUL BIOL, V90, P56, DOI 10.1016/j.tpb.2013.09.010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wells CR, 2012, EPIDEMICS-NETH, V4, P139, DOI 10.1016/j.epidem.2012.06.002; Wheelock A, 2013, EXPERT REV VACCINES, V12, P893, DOI 10.1586/14760584.2013.814841; Wolfram Research, 2012, MATHEMATICA; Xia S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0013; Xia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060373; Young ME, 2013, HEALTH RISK SOC, V15, P103, DOI 10.1080/13698575.2012.748884	50	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142990	10.1371/journal.pone.0142990	http://dx.doi.org/10.1371/journal.pone.0142990			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599688	Green Published, gold			2022-12-27	WOS:000365853900054
J	Alizadeh, M; Zamani, M; Baharun, S; Manaf, AA; Sakurai, K; Anada, H; Keshavarz, H; Chaudhry, SA; Khan, MK				Alizadeh, Mojtaba; Zamani, Mazdak; Baharun, Sabariah; Manaf, Azizah Abdul; Sakurai, Kouichi; Anada, Hiroki; Keshavarz, Hassan; Chaudhry, Shehzad Ashraf; Khan, Muhammad Khurram			Cryptanalysis and Improvement of "A Secure Password Authentication Mechanism for Seamless Handover in Proxy Mobile IPv6 Networks"	PLOS ONE			English	Article							REMOTE USER AUTHENTICATION; SMART-CARD; KEY ESTABLISHMENT; SCHEME; PROTOCOL; EFFICIENT; IDENTITY; ARCHITECTURE; BELLARE	Proxy Mobile IPv6 is a network-based localized mobility management protocol that supports mobility without mobile nodes' participation in mobility signaling. The details of user authentication procedure are not specified in this standard, hence, many authentication schemes have been proposed for this standard. In 2013, Chuang et al., proposed an authentication method for PMIPv6, called SPAM. However, Chuang et al.'s Scheme protects the network against some security attacks, but it is still vulnerable to impersonation and password guessing attacks. In addition, we discuss other security drawbacks such as lack of revocation procedure in case of loss or stolen device, and anonymity issues of the Chuang et al.'s scheme. We further propose an enhanced authentication method to mitigate the security issues of SPAM method and evaluate our scheme using BAN logic.	[Alizadeh, Mojtaba; Sakurai, Kouichi] Kyushu Univ, Fac Informat Sci & Elect Engn, Fukuoka 812, Japan; [Zamani, Mazdak] Kean Univ, Dept Comp Sci, Union, NJ USA; [Alizadeh, Mojtaba; Baharun, Sabariah; Keshavarz, Hassan] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Kuala Lumpur, Malaysia; [Manaf, Azizah Abdul] Univ Teknol Malaysia, Adv Informat Sch, Kuala Lumpur, Malaysia; [Anada, Hiroki] Inst Syst Informat Technol & Nanotechnol ISIT, Fukuoka, Japan; [Chaudhry, Shehzad Ashraf] Int Islamic Univ, Dept Comp Sci & Software Engn, Islamabad, Pakistan; [Khan, Muhammad Khurram] King Saud Univ, Ctr Excellence Informat Assurance, Riyadh, Saudi Arabia	Kyushu University; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; International Islamic University, Pakistan; King Saud University	Alizadeh, M (corresponding author), Kyushu Univ, Fac Informat Sci & Elect Engn, Fukuoka 812, Japan.	malizadeh@ieee.org	Chaudhry, Shehzad Ashraf/Y-3430-2019; KHAN, MUHAMMAD KHURRAM/E-4836-2014; Manaf, Azizah Abdul/Q-4838-2019; Zamani, Mazdak/A-1687-2013; Alizadeh, Mojtaba/I-1297-2013	Chaudhry, Shehzad Ashraf/0000-0002-9321-6956; KHAN, MUHAMMAD KHURRAM/0000-0001-6636-0533; Zamani, Mazdak/0000-0002-6421-0053; Alizadeh, Mojtaba/0000-0002-5601-8387	Japan Student Services Organization (JASSO); Sakurai Lab, Graduate School and Faculty of Information Science and Electrical Engineering, Kyushu University, Fukuoka Japan; Deanship of Scientific Research at King Saud University [PRG-1436-16]; Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia; Kyushu University, Fukuoka Japan; Kyushu University, Fukuoka, Japan	Japan Student Services Organization (JASSO)(Japan Student Services Organization); Sakurai Lab, Graduate School and Faculty of Information Science and Electrical Engineering, Kyushu University, Fukuoka Japan; Deanship of Scientific Research at King Saud University(King Saud University); Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia; Kyushu University, Fukuoka Japan; Kyushu University, Fukuoka, Japan	This work was supported by Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, Japan Student Services Organization (JASSO), and Sakurai Lab, Graduate School and Faculty of Information Science and Electrical Engineering, Kyushu University, Fukuoka Japan. Muhammad Khurram Khan extends his sincere appreciations to the Deanship of Scientific Research at King Saud University for its funding for the Prolific Research Group (PRG-1436-16). Authors acknowledge support from Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, Japan Student Services Organization (JASSO), and Kyushu University, Fukuoka Japan.r Authors acknowledge the support from Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, Japan Student Services Organization (JASSO), and Kyushu University, Fukuoka, Japan. The authors extend their sincere appreciations to the Deanship of Scientific Research at King Saud University for its funding this Prolific Research Group (PRG-1436-16).	Alizadeh M, 2015, JURNAL TEKNOLOGI, V72, P27, DOI [http://dx.doi.org/10.11113/jt.v72.3935, DOI 10.11113/JT.V72.3935]; Alizadeh M, 2015, J TEKNOL, V72; Armando A, 2005, LECT NOTES COMPUT SC, V3576, P281; Blanchet B., 2012, PROVERIF CRYPTOGRAPH; BURROWS M, 1990, ACM T COMPUT SYST, V8, P18, DOI [10.1145/77648.77649, 10.1145/74851.74852]; Ch SA, 2015, MULTIMED TOOLS APPL, V74, P1711, DOI 10.1007/s11042-014-2283-9; Chaudhry SA, 2015, SECUR COMMUN NETW, V8, P3782, DOI 10.1002/sec.1299; Chaudhry SA, 2016, ELECTRON COMMER RES, V16, P113, DOI 10.1007/s10660-015-9192-5; Chaudhry SA, 2017, PEER PEER NETW APPL, V10, P1, DOI 10.1007/s12083-015-0400-9; Chaudhry SA, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0244-0; Chaudhry SA, 2015, IET COMMUN, V9, P1034, DOI 10.1049/iet-com.2014.1082; Chen HM, 2012, J MED SYST, V36, P3907, DOI 10.1007/s10916-012-9862-y; Chien HY, 2001, J SYST SOFTWARE, V55, P287, DOI 10.1016/S0164-1212(00)00077-7; Chiussi FM, 2002, MOBILITY MANAGEMENT, DOI [http://dx.doi.org/10.1109/MCOM.2002.1031839, DOI 10.1109/MC0M.2002.1031839]; Choo KKR, 2007, INFORMATICA-LITHUAN, V18, P547; Choo KKR, 2007, COMPUT J, V50, P591, DOI 10.1093/comjnl/bxm019; Choo KKR, 2006, COMPUT COMMUN, V29, P2788, DOI 10.1016/j.comcom.2005.10.030; Choo KKR, 2014, INFORM SCIENCES, V281, P182, DOI 10.1016/j.ins.2014.05.041; Choo KKR, 2009, SPRINGER SCI BUSINES, V41, DOI [http://dx.doi.org/10.1007/978-0-387-87969-7, DOI 10.1007/978-0-387-87969-7]; Chuang MC, 2013, IEEE SYST J, V7, P102, DOI 10.1109/JSYST.2012.2209276; Das ML, 2004, IEEE T CONSUM ELECTR, V50, P629, DOI 10.1109/TCE.2004.1309441; Fan CI, 2005, COMPUT SECUR, V24, P619, DOI 10.1016/j.cose.2005.03.006; Farash MS, 2017, INT J COMMUN SYST, V30, DOI 10.1002/dac.3019; Gundavelli S., 2008, 5213 RFC IETF; Guo P, 2014, J INTERNET TECHNOL, V15, P929, DOI 10.6138/JIT.2014.15.6.05; Haller N. M., 1994, Proceedings Internet Society Symposium on Network and Distributed System Security 1994, P151; He D, 2015, AUTHENTICATION PROTO, DOI [http://dx.doi.org/10.1109/MCOM.2015.7010518, DOI 10.1109/MC0M.2015.7010518]; He DB, 2015, INFORM SCIENCES, V321, P263, DOI 10.1016/j.ins.2015.02.010; He DB, 2015, IEEE SYST J, V9, P816, DOI 10.1109/JSYST.2014.2301517; He DB, 2014, WIRELESS PERS COMMUN, V74, P229, DOI 10.1007/s11277-013-1282-x; Hsieh WB, 2014, WIREL COMMUN MOB COM, V14, P995, DOI 10.1002/wcm.2252; Hwang MS, 2000, IEEE T CONSUM ELECTR, V46, P28, DOI 10.1109/30.826377; Jiang Q., 2012, ADV INTELLIGENT SOFT, P345, DOI [http://dx.doi.org/10.1007/978-3-642-25185-6-45, DOI 10.1007/978-3-642-25185-6-45]; Johnson D, 2004, 3775 RFC; Juang WS, 2004, IEEE T CONSUM ELECTR, V50, P251, DOI 10.1109/TCE.2004.1277870; Khan Muhammad Khurram, 2013, Advances in Brain Inspired Cognitive Systems. 6th International Conference, BICS 2013. Proceedings: LNCS 7888, P271, DOI 10.1007/978-3-642-38786-9_31; Khan MK, 2014, SECUR COMMUN NETW, V7, P399, DOI 10.1002/sec.791; Kim S, 2006, LECT NOTES COMPUT SC, V4317, P63; Koblitz N., 2000, QUARTER CENTURY PUBL, P103, DOI [http://dx.doi.org/10.1007/978-1-4757-6856-5-5, DOI 10.1007/978-1-4757-6856-5-5]; Kocher P., 1999, Advances in Cryptology - CRYPTO'99. 19th Annual International Cryptology Conference. Proceedings, P388; Kocher P., 1998, INTRO DIFFERENTIAL P; Koodli ER, 2009, RFC5568 IETF; Ku WC, 2005, IEICE T COMMUN, VE88B, P2165, DOI 10.1093/ietcom/e88-b.5.2165; Kumari S, 2017, PEER PEER NETW APPL, V10, P92, DOI 10.1007/s12083-015-0409-0; Kumari S, 2014, SECUR COMMUN NETW, V7, P1921, DOI 10.1002/sec.906; LAMPORT L, 1981, COMMUN ACM, V24, P770, DOI 10.1145/358790.358797; Lee NY, 2005, COMPUT STAND INTER, V27, P177, DOI 10.1016/j.csi.2004.06.001; Lee SW, 2005, COMPUT STAND INTER, V27, P181, DOI 10.1016/j.csi.2004.02.002; Li CT, 2008, COMPUT COMMUN, V31, P2803, DOI 10.1016/j.comcom.2007.12.005; Li X, 2014, SECUR COMMUN NETW, V7, P1488, DOI 10.1002/sec.767; Li X, 2013, J NETW COMPUT APPL, V36, P1365, DOI 10.1016/j.jnca.2013.02.034; Li X, 2013, MATH COMPUT MODEL, V58, P85, DOI 10.1016/j.mcm.2012.06.033; Li X, 2012, J NETW COMPUT APPL, V35, P763, DOI 10.1016/j.jnca.2011.11.009; Li X, 2011, J NETW COMPUT APPL, V34, P73, DOI 10.1016/j.jnca.2010.09.003; Ma CG, 2014, INT J COMMUN SYST, V27, P2215, DOI 10.1002/dac.2468; Mathuria A. M., 1995, Australian Computer Science Communications, V17, P370; Messerges TS, 2002, IEEE T COMPUT, V51, P541, DOI 10.1109/TC.2002.1004593; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Nam J, 2013, KSII T INTERNET INF, V7, P3244, DOI 10.3837/tiis.2013.12.016; Rhee HS, 2009, COMPUT STAND INTER, V31, P6, DOI 10.1016/j.csi.2007.11.017; Shen J, 2015, J INTERNET TECHNOL, V16, P171; Soliman H., 2008, 5380 RFC IETF; Soto I, 2010, INT PROTOC J, V13, P2; Wang SB, 2009, SCI CHINA SER F, V52, P1358, DOI 10.1007/s11432-009-0135-4; Wang YY, 2009, COMPUT COMMUN, V32, P583, DOI 10.1016/j.comcom.2008.11.008; Wen FT, 2012, COMPUT ELECTR ENG, V38, P381, DOI 10.1016/j.compeleceng.2011.11.010; Xu J, 2009, COMPUT STAND INTER, V31, P723, DOI 10.1016/j.csi.2008.09.006; Yoon EJ, 2007, IEICE T COMMUN, VE90B, P331, DOI 10.1093/ietcom/e90-b.2.331; You I, 2012, THESIS	69	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142716	10.1371/journal.pone.0142716	http://dx.doi.org/10.1371/journal.pone.0142716			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580963	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600058
J	Shin, SH; Jung, DH; Kim, JH; Chung, HS; Park, JC; Shin, SK; Lee, SK; Lee, YC				Shin, Seung Hwan; Jung, Da Hyun; Kim, Jie-Hyun; Chung, Hyun Soo; Park, Jun Chul; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan			Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia	PLOS ONE			English	Article							CANCER; SEROPREVALENCE; INFECTION; DIAGNOSIS; KOREA	Purpose There is insufficient data about the role of eradication of H. pylori after endoscopic resection (ER) for gastric dysplasia. The aim was to investigate the benefit of H. pylori eradication after ER in patients with gastric dysplasia to prevent metachronous gastric neoplasms. Materials and Methods We retrospectively reviewed 1872 patients who underwent ER of gastric dysplasia. We excluded patients with a follow-up period of <2 years or who had not undergone tests for active H. pylori infection. A total of 282 patients were enrolled. The patients were categorized into those without active H. pylori infection (H. pylori-negative group, n = 124), those who successfully underwent H. pylori eradication (eradicated group, n = 122), and those who failed or did not undergo H. pylori eradication (persistent group, n = 36). Results Metachronous recurrence was diagnosed in 36 patients, including 19 in the H. pylori-negative group, 10 in the eradicated group, and 7 in the persistent group. The cumulative incidence of metachronous recurrence was significantly lower in the H. pylori-eradicated group in comparison with either of the H. pylori-persistent (non-eradicated or failed) groups (p = 0.039). Similarly, the incidence of metachronous recurrence was significantly lower in the H. pylori-eradicated group compared with the H. pylori-negative group (p = 0.041). Conclusion Successful H. pylori eradication may reduce the development of metachronous gastric neoplasms after ER in patients with gastric dysplasia.	[Shin, Seung Hwan; Jung, Da Hyun; Chung, Hyun Soo; Park, Jun Chul; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Jie-Hyun] Yonsei Univ, Coll Med, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jung, DH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	leah1004@yuhs.ac	Park, Jun Chul/H-7218-2019; Kim, Jie-Hyun/Q-9061-2019	Park, Jun Chul/0000-0001-8018-0010; Kim, Jie-Hyun/0000-0002-9198-3326; Lee, Yong Chan/0000-0001-8800-6906; Chung, Hyunsoo/0000-0001-5159-357X; Shin, Sung Kwan/0000-0001-5466-1400; Lee, Sang Kil/0000-0002-0721-0364; Jung, Da Hyun/0000-0001-6668-3113				[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Bae SE, 2014, AM J GASTROENTEROL, V109, P60, DOI 10.1038/ajg.2013.404; Choi CW, 2014, DIGEST DIS SCI, V59, P421, DOI 10.1007/s10620-013-2874-8; Choi J, 2014, CLIN GASTROENTEROL H, V12, P793, DOI 10.1016/j.cgh.2013.09.057; CORREA P, 1988, CANCER RES, V48, P3554; de Vries AC, 2007, HELICOBACTER, V12, P1, DOI 10.1111/j.1523-5378.2007.00541.x; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Genta RM, 2010, AM J SURG PATHOL, V34, pE25, DOI 10.1097/PAS.0b013e3181e51067; Gutierrez-Gonzalez L, 2011, GASTROENTEROLOGY, V140, P1251, DOI 10.1053/j.gastro.2010.12.051; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kang KJ, 2010, J KOREAN MED ASSOC, V53, P283, DOI 10.5124/jkma.2010.53.4.283; Kato M, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1928-5; Kim SG, 2014, J GASTROEN HEPATOL, V29, P1371, DOI 10.1111/jgh.12607; Kim YJ, 2010, ENDOSCOPY, V42, P620, DOI 10.1055/s-0030-1255524; Kim YI, 2014, HELICOBACTER, V19, P194, DOI 10.1111/hel.12116; Maehata Y, 2012, GASTROINTEST ENDOSC, V75, P39, DOI 10.1016/j.gie.2011.08.030; Nasu J, 2005, ENDOSCOPY, V37, P990, DOI 10.1055/s-2005-870198; Schlansky B, 2011, AM J GASTROENTEROL, V106, P1978, DOI 10.1038/ajg.2011.213; Stolte M, 2003, VIRCHOWS ARCH, V442, P99, DOI 10.1007/s00428-002-0680-3; Sugano K, 2013, J GASTROEN HEPATOL, V28, P906, DOI 10.1111/jgh.12209; Woodward M, 2000, J CLIN EPIDEMIOL, V53, P175, DOI 10.1016/S0895-4356(99)00171-7; Yim JY, 2007, HELICOBACTER, V12, P333, DOI 10.1111/j.1523-5378.2007.00504.x	24	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143257	10.1371/journal.pone.0143257	http://dx.doi.org/10.1371/journal.pone.0143257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580072	gold, Green Submitted, Green Published			2022-12-27	WOS:000365154600105
J	Suri, AK; Fleysher, R; Lipton, ML				Suri, Asif K.; Fleysher, Roman; Lipton, Michael L.			Subject Based Registration for Individualized Analysis of Diffusion Tensor MRI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ALGORITHMS; FSL; DTI	Registration of subject and control brains to a common anatomical space or template is the basis for quantitatively delineating regions of abnormality in an individual brain. Normally, a brain atlas is chosen as the template. Limitations in the registration process result in persistent differences between individual subject brains and template, which can be a source of error in an analysis. We propose a new approach to the registration process where the subject of interest is the registration template. Through this change, we eliminate errors due to differences between a brain template and a subject's brain. We applied this method to the analysis of FA values derived from DTI data of 20 individual mTBI patients as compared to 48 healthy controls. Subject-centered analysis resulted in identification of significantly fewer regions of abnormally low FA compared to two separate atlas-centered analyses, with subject-centered abnormalities essentially representing the common subset of abnormal low FA regions detected by the two atlas-centered methods. Whereas each atlas-centered approach demonstrated abnormalities in nearly every subject (19/20 and 20/20), the subject-centered approach demonstrated abnormalities in fewer than half the subjects (9/20). This reduction of diffusion abnormalities observed using the subject-centered approach is due to elimination of misregistration errors that occur when registering the subject of interest to a template. Evaluation of atlas-centered analyses demonstrated that 9.8% to 13.3% of subject GM and CSF was misregistered onto the WM of the brain atlas, resulting in the observation of additional low FA clusters compared to the subject-centered approach. Without careful evaluation, these misregistrations could be misinterpreted as pathology. An additional benefit of the subject-centered approach is that diffusion abnormalities can now be visualized directly in the subject's anatomical space, rather than interpolating results from the brain atlas space, and can thereby enhance correlation with other components of an imaging protocol.	[Suri, Asif K.; Fleysher, Roman; Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, New York, NY 10010 USA; [Suri, Asif K.] Bronx Psychiat Ctr, Dept Psychiat, New York, NY USA; [Suri, Asif K.; Lipton, Michael L.] Montefiore Med Ctr, Dept Radiol, New York, NY USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA	Yeshiva University; Montefiore Medical Center; Yeshiva University; Yeshiva University	Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Radiol, New York, NY 10010 USA.	Michael.Lipton@einstein.yu.edu			National Institutes of Health; National Institutes of Neurological Disorders and Stroke [R01 NS082432]; Dana Foundation David Mahoney Neuroimaging Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dana Foundation David Mahoney Neuroimaging Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health, National Institutes of Neurological Disorders and Stroke (grant R01 NS082432) and the Dana Foundation David Mahoney Neuroimaging Program.	Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; ARDEKANI BA, 1995, J COMPUT ASSIST TOMO, V19, P615, DOI 10.1097/00004728-199507000-00022; Aubert-Broche B, 2006, NEUROIMAGE, V32, P138, DOI 10.1016/j.neuroimage.2006.03.052; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mori S, 2009, CURR OPIN NEUROL, V22, P362, DOI 10.1097/WCO.0b013e32832d954b; Naidich TP, 2001, AM J NEURORADIOL, V22, P885; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Sabuncu MR, 2009, LECT NOTES COMPUT SC, V5761, P565, DOI 10.1007/978-3-642-04268-3_70; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yeo BTT, 2008, MED IMAGE ANAL, V12, P603, DOI 10.1016/j.media.2008.06.005	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142288	10.1371/journal.pone.0142288	http://dx.doi.org/10.1371/journal.pone.0142288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580077	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600044
J	Westgate, MJ; Scheele, BC; Ikin, K; Hoefer, AM; Beaty, RM; Evans, M; Osborne, W; Hunter, D; Rayner, L; Driscoll, DA				Westgate, Martin J.; Scheele, Ben C.; Ikin, Karen; Hoefer, Anke Maria; Beaty, R. Matthew; Evans, Murray; Osborne, Will; Hunter, David; Rayner, Laura; Driscoll, Don A.			Citizen Science Program Shows Urban Areas Have Lower Occurrence of Frog Species, but Not Accelerated Declines	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ECOLOGICAL RESEARCH; CONSERVATION; EXTINCTION; LANDSCAPE; BIODIVERSITY; HABITAT; TOOL; CHRONOSEQUENCES; URBANIZATION	Understanding the influence of landscape change on animal populations is critical to inform biodiversity conservation efforts. A particularly important goal is to understand how urban density affects the persistence of animal populations through time, and how these impacts can be mediated by habitat provision; but data on this question are limited for some taxa. Here, we use data from a citizen science monitoring program to investigate the effect of urbanization on patterns of frog species richness and occurrence over 13 years. Sites surrounded by a high proportion of bare ground (a proxy for urbanization) had consistently lower frog occurrence, but we found no evidence that declines were restricted to urban areas. Instead, several frog species showed declines in rural wetlands with low-quality habitat. Our analysis shows that urban wetlands had low but stable species richness; but also that population trajectories are strongly influenced by vegetation provision in both the riparian zone and the wider landscape. Future increases in the extent of urban environments in our study area are likely to negatively impact populations of several frog species. However, existing urban areas are unlikely to lose further frog species in the medium term. We recommend that landscape planning and management focus on the conservation and restoration of rural wetlands to arrest current declines, and the revegetation of urban wetlands to facilitate the re-expansion of urban-sensitive species.	[Westgate, Martin J.; Scheele, Ben C.; Ikin, Karen; Rayner, Laura] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 2601, Australia; [Ikin, Karen; Driscoll, Don A.] Australian Natl Univ, ARC Ctr Excellence Environm Decis, Canberra, ACT 2601, Australia; [Hoefer, Anke Maria] ACT & Reg Frogwatch, Ginninderra Catchment Grp, Canberra, ACT 2615, Australia; [Beaty, R. Matthew] CSIRO Land & Water, Canberra, ACT 2601, Australia; [Evans, Murray] ACT Govt, Environm & Planning Directorate, Canberra, ACT 2601, Australia; [Osborne, Will] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Hunter, David] NSW Off Environm & Heritage, Queanbeyan, NSW 2620, Australia; [Driscoll, Don A.] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Burwood, Vic 3125, Australia	Australian National University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Canberra; Office of Environment & Heritage - New South Wales; Deakin University	Westgate, MJ (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, GPO Box 4, Canberra, ACT 2601, Australia.	martin.westgate@anu.edu.au	Ikin, Karen/G-2845-2012; Westgate, Martin/I-1839-2019	Westgate, Martin/0000-0003-0854-2034; Driscoll, Don/0000-0002-1560-5235; Scheele, Benjamin/0000-0001-7284-629X	Ginninderra Catchment Group; ACT Government's Environment and Planning Directorate; Australian Government's 'Caring for Country' scheme; Australian Research Council Centre of Excellence for Environmental Decisions	Ginninderra Catchment Group; ACT Government's Environment and Planning Directorate; Australian Government's 'Caring for Country' scheme(Australian Government); Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council)	ACT Frogwatch and region is supported by the Ginninderra Catchment Group, and has received funding from the ACT Government's Environment and Planning Directorate and the Australian Government's 'Caring for Country' scheme. The Australian Research Council Centre of Excellence for Environmental Decisions funded publication of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Aronson MFJ, 2014, P ROY SOC B, P281; Baker PJ, 2005, MAMMAL REV, V35, P302, DOI 10.1111/j.1365-2907.2005.00071.x; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Bennett, 2011, REPTILES FROGS AUSTR; BIVAND R., 2014, SPDEP SPATIAL DEPEND; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brand AB, 2010, CONSERV BIOL, V24, P295, DOI 10.1111/j.1523-1739.2009.01301.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cooper CB, 2007, ECOL SOC, V12; Darcovich Kerry, 2008, Australian Zoologist, V34, P236; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Feyisa GL, 2014, LANDSCAPE URBAN PLAN, V123, P87, DOI 10.1016/j.landurbplan.2013.12.008; Ficetola GF, 2004, BIOL CONSERV, V119, P219, DOI 10.1016/j.biocon.2003.11.004; Gagne SA, 2010, ENVIRON CONSERV, V37, P128, DOI 10.1017/S0376892910000421; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; Hamer AJ, 2008, BIOL CONSERV, V141, P2432, DOI 10.1016/j.biocon.2008.07.020; Hamer AJ, 2011, ECOL APPL, V21, P378, DOI 10.1890/10-0390.1; Hamer AJ, 2010, AUSTRAL ECOL, V35, P568, DOI 10.1111/j.1442-9993.2009.02068.x; Hazell D, 2001, BIOL CONSERV, V102, P155, DOI 10.1016/S0006-3207(01)00096-9; Heard GW, 2015, ECOL LETT, V18, P853, DOI 10.1111/ele.12463; Hitchings SP, 1997, HEREDITY, V79, P117, DOI 10.1038/hdy.1997.134; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hunter DA, 2010, DIS AQUAT ORGAN, V92, P209, DOI 10.3354/dao02118; Ikin K, 2013, LANDSCAPE ECOL, V28, P45, DOI 10.1007/s10980-012-9811-7; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; Jansen A, 2003, BIOL CONSERV, V109, P207, DOI 10.1016/S0006-3207(02)00148-9; Jenkins M, 2003, CONSERV BIOL, V17, P20, DOI 10.1046/j.1523-1739.2003.01719.x; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Kazemi F, 2011, LANDSCAPE URBAN PLAN, V101, P139, DOI 10.1016/j.landurbplan.2011.02.006; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Osborne W, 1990, BOGONG, V11, P4; Osborne W. S., 1996, Australian Zoologist, V30, P190; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parris KM, 2006, J ANIM ECOL, V75, P757, DOI 10.1111/j.1365-2656.2006.01096.x; Pautasso M, 2007, ECOL LETT, V10, P16, DOI 10.1111/j.1461-0248.2006.00993.x; Pillsbury FC, 2008, ECOL APPL, V18, P1107, DOI 10.1890/07-1899.1; Piper PJ, 2001, INT J OSTEOARCHAEOL, V11, P336, DOI 10.1002/oa.571; Radeloff VC, 2010, P NATL ACAD SCI USA, V107, P940, DOI 10.1073/pnas.0911131107; Rayner L, 2015, DIVERS DISTRIB, V21, P428, DOI 10.1111/ddi.12293; Rayner L, 2014, ECOGRAPHY, V37, P43, DOI 10.1111/j.1600-0587.2013.00388.x; Scheele B, 2014, BIOL CONSERV, V170, P86, DOI 10.1016/j.biocon.2013.12.034; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schwartz MW, 2002, BIOSCIENCE, V52, P601, DOI 10.1641/0006-3568(2002)052[0601:CSDUP]2.0.CO;2; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Shulse CD, 2012, ECOL APPL, V22, P1675, DOI 10.1890/11-0212.1; Skelly DK, 2001, ISRAEL J ZOOL, V47, P313, DOI 10.1092/BVT1-LUYF-2XG6-B007; Smallbone LT, 2011, LANDSCAPE URBAN PLAN, V101, P43, DOI 10.1016/j.landurbplan.2011.01.002; Soga M, 2013, ANIM CONSERV, V16, P1, DOI 10.1111/j.1469-1795.2012.00572.x; Stagoll K, 2012, CONSERV LETT, V5, P115, DOI 10.1111/j.1755-263X.2011.00216.x; Szabo JK, 2012, IBIS, V154, P468, DOI 10.1111/j.1474-919X.2012.01229.x; Szabo JK, 2010, ECOL APPL, V20, P2157, DOI 10.1890/09-0877.1; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Tulloch AIT, 2013, DIVERS DISTRIB, V19, P465, DOI 10.1111/j.1472-4642.2012.00947.x; United Nations, 2014, REV WORLD URB PROSP; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; van Dijk AIJM, 2013, WATER RESOUR RES, V49, P1040, DOI 10.1002/wrcr.20123; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wilson HB, 2011, CONSERV BIOL, V25, P747, DOI 10.1111/j.1523-1739.2011.01671.x	67	17	18	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140973	10.1371/journal.pone.0140973	http://dx.doi.org/10.1371/journal.pone.0140973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580412	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600010
J	Herington, JL; Swale, DR; Brown, N; Shelton, EL; Choi, H; Williams, CH; Hong, CC; Paria, BC; Denton, JS; Reese, J				Herington, Jennifer L.; Swale, Daniel R.; Brown, Naoko; Shelton, Elaine L.; Choi, Hyehun; Williams, Charles H.; Hong, Charles C.; Paria, Bibhash C.; Denton, Jerod S.; Reese, Jeff			High-Throughput Screening of Myometrial Calcium-Mobilization to Identify Modulators of Uterine Contractility	PLOS ONE			English	Article							SMOOTH-MUSCLE; OXYTOCIN ANTAGONISTS; PRETERM DELIVERY; IN-VITRO; MECHANISMS; INHIBITION; TOCOLYTICS; RECEPTORS; PREGNANCY; PATHWAYS	The uterine myometrium (UT-myo) is a therapeutic target for preterm labor, labor induction, and postpartum hemorrhage. Stimulation of intracellular Ca2+-release in UT-myo cells by oxytocin is a final pathway controlling myometrial contractions. The goal of this study was to develop a dual-addition assay for high-throughput screening of small molecular compounds, which could regulate Ca2+-mobilization in UT-myo cells, and hence, myometrial contractions. Primary murine UT-myo cells in 384-well plates were loaded with a Ca2+-sensitive fluorescent probe, and then screened for inducers of Ca2+-mobilization and inhibitors of oxytocin-induced Ca2+-mobilization. The assay exhibited robust screening statistics (Z' = 0.73), DMSO-tolerance, and was validated for high-throughput screening against 2,727 small molecules from the Spectrum, NIH Clinical I and II collections of well-annotated compounds. The screen revealed a hit-rate of 1.80% for agonist and 1.39% for antagonist compounds. Concentration-dependent responses of hit-compounds demonstrated an EC50 less than 10 mu M for 21 hit-antagonist compounds, compared to only 7 hit-agonist compounds. Subsequent studies focused on hit-antagonist compounds. Based on the percent inhibition and functional annotation analyses, we selected 4 confirmed hit-antagonist compounds (benzbromarone, dipyridamole, fenoterol hydrobromide and nisoldipine) for further analysis. Using an ex vivo isometric contractility assay, each compound significantly inhibited uterine contractility, at different potencies (IC50). Overall, these results demonstrate for the first time that high-throughput small-molecules screening of myometrial Ca2+-mobilization is an ideal primary approach for discovering modulators of uterine contractility.	[Herington, Jennifer L.; Brown, Naoko; Shelton, Elaine L.; Paria, Bibhash C.; Reese, Jeff] Vanderbilt Univ, Sch Med, Dept Pediat, Div Neonatol, Nashville, TN 37212 USA; [Swale, Daniel R.] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Choi, Hyehun] Vanderbilt Univ, Sch Med, Dept Pediat, Div Crit Care Med, Nashville, TN 37212 USA; [Williams, Charles H.; Reese, Jeff] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Hong, Charles C.; Denton, Jerod S.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA	Vanderbilt University; Louisiana State University System; Louisiana State University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Herington, JL (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Div Neonatol, Nashville, TN 37212 USA.	jennifer.l.herington@vanderbilt.edu	; Williams, Charles/H-2351-2015	Reese, Jeff/0000-0001-8751-6146; Williams, Charles/0000-0002-0331-5652; Shelton, Elaine/0000-0003-0929-2882	Vanderbilt Office of Clinical and Translational Scientist Development; CTSA from the National Center for Advancing Translational Sciences [UL1TR000445, KL2TR000446]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD044741, HD081121]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044741, R01HD081121] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000446, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115305] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000771] Funding Source: NIH RePORTER	Vanderbilt Office of Clinical and Translational Scientist Development; CTSA from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by research funds (J. L. H.) from the Vanderbilt Office of Clinical and Translational Scientist Development and CTSA award numbers UL1TR000445 and KL2TR000446 from the National Center for Advancing Translational Sciences. This work was also supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [Grants HD044741 (B. C. P.), HD081121 to (J. R.)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Baumbach J, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.011; Buhimschi CS, 2000, AM J OBSTET GYNECOL, V183, P68, DOI 10.1067/mob.2000.105348; Burghardt RC, 1999, BIOL REPROD, V60, P777, DOI 10.1095/biolreprod60.4.777; Cirillo R, 2003, J PHARMACOL EXP THER, V306, P253, DOI 10.1124/jpet.103.049395; Crankshaw DJ, 2013, REPROD SCI, V20, P882, DOI 10.1177/1933719112468949; de Heus R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b744; Devost D, 2007, AM J PHYSIOL-ENDOC M, V292, pE1, DOI 10.1152/ajpendo.00529.2005; Eglen R, 2011, ASSAY DRUG DEV TECHN, V9, P108, DOI 10.1089/adt.2010.0305; Fejgin MD, 1998, J SOC GYNECOL INVEST, V5, P251, DOI 10.1016/S1071-5576(98)00021-5; Fitzgibbon J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-2; Giles W, 2007, BEST PRACT RES CL OB, V21, P857, DOI 10.1016/j.bpobgyn.2007.03.011; Groom KM, 2000, BRIT J OBSTET GYNAEC, V107, P1182, DOI 10.1111/j.1471-0528.2000.tb11132.x; Haas DM, 2014, INT J WOMENS HEALTH, V6, P343, DOI 10.2147/IJWH.S44048; Kamel RM, 2010, ARCH GYNECOL OBSTET, V281, P975, DOI 10.1007/s00404-010-1365-9; Kasten F H, 1975, Adv Exp Med Biol, V53, P389; Kitazawa T, 1998, BRIT J PHARMACOL, V123, P173, DOI 10.1038/sj.bjp.0701583; LI FF, 1992, ACTA PHARM SINIC, V13, P59; LIPSHITZ J, 1977, BRIT J OBSTET GYNAEC, V84, P737, DOI 10.1111/j.1471-0528.1977.tb12482.x; McCloskey C, 2014, EMBO MOL MED, V6, P1161, DOI 10.15252/emmm.201403944; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Mitchell BF, 2013, FACTS VIEWS VIS OBGY, V5, P72; Munglue P, 2013, REPROD SCI, V20, P437, DOI 10.1177/1933719112459223; Nonnenmacher A, 2009, Z Geburtshilfe Neonatol, V213, P201, DOI 10.1055/s-0029-1225640; Norman JE, 1997, J REPROD FERTIL, V110, P249; Norwitz ER, 1999, NEW ENGL J MED, V341, P660, DOI 10.1056/NEJM199908263410906; Oger S, 2004, BIOL REPROD, V70, P458, DOI 10.1095/biolreprod.103.023051; Olson DM, 2008, EXPERT OPIN EMERG DR, V13, P695, DOI 10.1517/14728210802568764 ; PAK SC, 1994, BIOL REPROD, V51, P1140, DOI 10.1095/biolreprod51.6.1140; Petraglia F, 2010, ENDOCR REV, V31, P783, DOI 10.1210/er.2009-0019; Pierce SL, 2010, PHYSIOL GENOMICS, V42, P310, DOI 10.1152/physiolgenomics.00058.2010; Prudencio AB, 2013, DIANAS, V2; Robinson H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046278; Savitsky AG, 2013, J MATERN-FETAL NEO M, V26, P566, DOI 10.3109/14767058.2012.738261; Sawdy R, 1998, BRIT J PHARMACOL, V125, P1212, DOI 10.1038/sj.bjp.0702211; Shynlova O, 2009, EUR J OBSTET GYN R B, V144, pS2, DOI 10.1016/j.ejogrb.2009.02.044; Stymiest JL, 2005, J ORG CHEM, V70, P7799, DOI 10.1021/jo050539l; Tong WC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00399; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Tribe RM, 2000, BIOL REPROD, V63, P748, DOI 10.1095/biolreprod63.3.748; Voltolini C, 2013, REPROD SCI, V20, P1274, DOI 10.1177/1933719113477496; Vrachnis N, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/350546; WHO, 2012, WORLD HLTH ORG WHO G; Yasuda K, 2007, REPRODUCTION, V133, P797, DOI 10.1530/REP-06-0041; Young RC, 2001, J SOC GYNECOL INVEST, V8, P210, DOI 10.1016/S1071-5576(01)00109-5; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	46	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143243	10.1371/journal.pone.0143243	http://dx.doi.org/10.1371/journal.pone.0143243			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600013	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600041
J	Miller, RR; Hird, TJ; Tang, P; Zlosnik, JEA				Miller, Ruth R.; Hird, Trevor J.; Tang, Patrick; Zlosnik, James E. A.			Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA-COMPLEX; LUNG TRANSPLANTATION; PSEUDOMONAS-CEPACIA; EXOPOLYSACCHARIDE BIOSYNTHESIS; PHOSPHOTYROSINE PHOSPHATASE; EPIDEMIOLOGY; INFECTION; BACTERIA; TRANSMISSION; MULTIVORANS	Burkholderia cepacia complex bacteria are amongst the most feared of pathogens in cystic fibrosis (CF). The BCC comprises at least 20 distinct species that can cause chronic and unpredictable lung infections in CF. Historically the species B. cenocepacia has been the most prevalent in CF infections and has been associated in some centers with high rates of mortality. Modeling chronic infection by B. cenocepacia in the laboratory is challenging and no models exist which effectively recapitulate CF disease caused by BCC bacteria. Therefore our understanding of factors that contribute towards the morbidity and mortality caused by this organism is limited. In this study we used whole-genome sequencing to examine the evolution of 3 clonal clinical isolates of B. cenocepacia from a patient with cystic fibrosis. The first isolate was from the beginning of infection, and the second two almost 10 years later during the final year of the patients' life. These isolates also demonstrated phenotypic heterogeneity, with the first isolate displaying the mucoid phenotype (conferred by the overproduction of exopolysaccharide), while one of the later two was nonmucoid. In addition we also sequenced a nonmucoid derivative of the initial mucoid isolate, acquired in the laboratory by antibiotic pressure. Examination of sequence data revealed that the two late stage isolates shared 20 variant nucleotides in common compared to the early isolate. However, despite their isolation within 10 months of one another, there was also considerable variation between the late stage isolates, including 42 single nucleotide variants and three deletions. Additionally, no sequence differences were identified between the initial mucoid isolate and its laboratory acquired nonmucoid derivative, however transcript analysis indicated at least partial down regulation of genes involved in exopolysaccharide production. Our study examines the progression of B. cenocepacia throughout chronic infection, including establishment of sub-populations likely evolved from the original isolate, suggestive of parallel evolution. Additionally, the lack of sequence differences between two of the isolates with differing mucoid phenotypes suggests that other factors, such as gene regulation, come into play in establishing the mucoid phenotype.	[Miller, Ruth R.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Miller, Ruth R.; Tang, Patrick] Univ British Columbia, British Columbia Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada; [Hird, Trevor J.; Zlosnik, James E. A.] Univ British Columbia, Fac Med, Dept Pediat, Ctr Understanding & Preventing Infect Children, Vancouver, BC, Canada; [Tang, Patrick] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Zlosnik, JEA (corresponding author), Univ British Columbia, Fac Med, Dept Pediat, Ctr Understanding & Preventing Infect Children, Vancouver, BC, Canada.	jzlosnik@cfri.ubc.ca		Zlosnik, James/0000-0002-9708-9034; Tang, Patrick/0000-0003-1583-5484	Cystic Fibrosis Canada [20R32976]; BC CDC Foundation for Population and Public Health [20R67183]	Cystic Fibrosis Canada; BC CDC Foundation for Population and Public Health	This work was supported by Cystic Fibrosis Canada (www.cysticfibrosis.ca, Grant#: 20R32976), and by BC CDC Foundation for Population and Public Health (http://www.bccdc.ca/util/about/BCCDCFoundation/default.htm, Grant #20R67183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoli K, 2014, APPL ENVIRON MICROB, V80, P1340, DOI 10.1128/AEM.03330-13; Alexander BD, 2008, AM J TRANSPLANT, V8, P1025, DOI 10.1111/j.1600-6143.2008.02186.x; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Bartholdson SJ, 2008, MICROBIOL-SGM, V154, P2513, DOI 10.1099/mic.0.2008/019216-0; Bosi E, 2015, BIOINFORMATICS, V31, P2443, DOI 10.1093/bioinformatics/btv171; Boussaud V, 2008, THORAX, V63, P732, DOI 10.1136/thx.2007.089458; Chiarini Luigi, 2004, J Cyst Fibros, V3, P165, DOI 10.1016/j.jcf.2004.04.004; Conway BAD, 2004, J INFECT DIS, V190, P957, DOI 10.1086/423141; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Coutinho CP, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00012; Cuzzi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094372; Darling AE, 2010, PLOS ONE, P5; De Smet B, 2015, INT J SYST EVOL MICR, V65, P2265, DOI 10.1099/ijs.0.000251; De Soyza A, 2010, J HEART LUNG TRANSPL, V29, P1395, DOI 10.1016/j.healun.2010.06.007; Dolfi S, 2015, CARBOHYD RES, V411, P42, DOI 10.1016/j.carres.2015.04.012; Drevinek P, 2005, J MED MICROBIOL, V54, P655, DOI 10.1099/jmm.0.46025-0; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Ferreira AS, 2007, APPL ENVIRON MICROB, V73, P524, DOI 10.1128/AEM.01450-06; Ferreira AS, 2015, INFECT IMMUN, V83, P812, DOI 10.1128/IAI.02713-14; Ferreira AS, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00016; Ferreira AS, 2010, APPL ENVIRON MICROB, V76, P441, DOI 10.1128/AEM.01828-09; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; GOVAN JRW, 1993, LANCET, V342, P15, DOI 10.1016/0140-6736(93)91881-L; Herasimenka Y, 2007, J CYST FIBROS, V6, P145, DOI 10.1016/j.jcf.2006.06.004; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Kalferstova L, 2015, J CLIN MICROBIOL, V53, P1515, DOI 10.1128/JCM.03605-14; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; LIPUMA JJ, 1990, LANCET, V336, P1094, DOI 10.1016/0140-6736(90)92571-X; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Marvig RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003741; Murray S, 2008, AM J RESP CRIT CARE, V178, P363, DOI 10.1164/rccm.200712-1834OC; Nzula S, 2002, J ANTIMICROB CHEMOTH, V50, P265, DOI 10.1093/jac/dkf137; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Peeters C, 2013, SYST APPL MICROBIOL, V36, P483, DOI 10.1016/j.syapm.2013.06.003; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Price EP, 2015, J CLIN MICROBIOL, V53, P282, DOI 10.1128/JCM.02560-14; Price EP, 2013, MBIO, V4, DOI 10.1128/mBio.00388-13; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Traverse CC, 2013, P NATL ACAD SCI USA, V110, pE250, DOI 10.1073/pnas.1207025110; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zlosnik JEA, 2008, J CLIN MICROBIOL, V46, P1470, DOI 10.1128/JCM.02273-07; Zlosnik JEA, 2015, ANN AM THORAC SOC, V12, P70, DOI 10.1513/AnnalsATS.201408-395OC; Zlosnik JEA, 2011, AM J RESP CRIT CARE, V183, P67, DOI 10.1164/rccm.201002-0203OC; Zlosnik JEA, 2010, J INFECT DIS, V202, P770, DOI 10.1086/655663	54	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143472	10.1371/journal.pone.0143472	http://dx.doi.org/10.1371/journal.pone.0143472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599356	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600069
J	Norambuena, F; Morais, S; Emery, JA; Turchini, GM				Norambuena, Fernando; Morais, Sofia; Emery, James A.; Turchini, Giovanni M.			Arachidonic Acid and Eicosapentaenoic Acid Metabolism in Juvenile Atlantic Salmon as Affected by Water Temperature	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; POLYUNSATURATED FATTY-ACIDS; SOLE SOLEA-SENEGALENSIS; BETA-OXIDATION CAPACITY; DIETARY FISH-OIL; RAINBOW-TROUT; SALAR L.; GENE-EXPRESSION; LIPID-METABOLISM; TELEOST FISH	Salmons raised in aquaculture farms around the world are increasingly subjected to suboptimal environmental conditions, such as high water temperatures during summer seasons. Aerobic scope increases and lipid metabolism changes are known plasticity responses of fish for a better acclimation to high water temperature. The present study aimed at investigating the effect of high water temperature on the regulation of fatty acid metabolism in juvenile Atlantic salmon fed different dietary ARA/EPA ratios (arachidonic acid, 20: 4n-6/eicosapentaenoic acid, 20: 5n-3), with particular focus on apparent in vivo enzyme activities and gene expression of lipid metabolism pathways. Three experimental diets were formulated to be identical, except for the ratio EPA/ARA, and fed to triplicate groups of Atlantic salmon (Salmo salar) kept either at 10 degrees C or 20 degrees C. Results showed that fatty acid metabolic utilisation, and likely also their dietary requirements for optimal performance, can be affected by changes in their relative levels and by environmental temperature in Atlantic salmon. Thus, the increase in temperature, independently from dietary treatment, had a significant effect on the beta-oxidation of a fatty acid including EPA, as observed by the apparent in vivo enzyme activity and mRNA expression of ppar alpha-transcription factor in lipid metabolism, including beta-oxidation genes-and cpt1-key enzyme responsible for the movement of LC-PUFA from the cytosol into the mitochondria for beta-oxidation-, were both increased at the higher water temperature. An interesting interaction was observed in the transcription and in vivo enzyme activity of Delta 5fad-time-limiting enzyme in the biosynthesis pathway of EPA and ARA. Such, at lower temperature, the highest mRNA expression and enzyme activity was recorded in fish with limited supply of dietary EPA, whereas at higher temperature these were recorded in fish with limited ARA supply. In consideration that fish at higher water temperature recorded a significantly increased feed intake, these results clearly suggested that at high, sub-optimal water temperature, fish metabolism attempted to increment its overall ARA status - the most bioactive LC-PUFA participating in the inflammatory response-by modulating the metabolic fate of dietary ARA (expressed as % of net intake), reducing its beta-oxidation and favouring synthesis and deposition. This correlates also with results from other recent studies showing that both immune- and stress-responses in fish are up regulated in fish held at high temperatures. This is a novel and fundamental information that warrants industry and scientific attention, in consideration of the imminent increase in water temperatures, continuous expansion of aquaculture operations, resources utilisation in aquafeed and much needed seasonal/adaptive nutritional strategies.	[Norambuena, Fernando; Emery, James A.; Turchini, Giovanni M.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic 3280, Australia; [Morais, Sofia] IRTA, San Carlos de la Rapita 43540, Spain	Deakin University; IRTA	Norambuena, F (corresponding author), BioMar Chile SA, Bernardino 1981,Piso 3,Parque Ind San Andres, Puerto Montt, Chile.	f.norambuena@deakin.edu.au	Morais, Sofia/D-8921-2011	Turchini, Giovanni/0000-0003-0694-4283	Australian Research Council [DP1093570]; European Commission [274184]	Australian Research Council(Australian Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported under the Australian Research Council's Discovery Projects funding scheme (Project DP1093570). The views expressed herein are those of the authors and are not necessarily those of the Australian Research Council. SM was supported by the European Commission Marie Curie Actions (FP7-PEOPLE-2010-RG, Project No. 274184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MJ, 2000, BRIT J NUTR, V84, P619; Martins DA, 2012, BRIT J NUTR, V108, P864, DOI 10.1017/S0007114511006143; AOAC, 2005, AN FEED OFF METH AN, P52; Arts MT, 2012, LIPIDS, V47, P1181, DOI 10.1007/s11745-012-3719-5; Beasley D, 1999, AM J PHYSIOL-HEART C, V276, pH1369, DOI 10.1152/ajpheart.1999.276.4.H1369; BELL JG, 2011, FISH OIL REPLACEMENT, P21; BELL MV, 1986, COMP BIOCHEM PHYS B, V83, P711, DOI 10.1016/0305-0491(86)90135-5; Bendiksen EA, 2003, FISH PHYSIOL BIOCHEM, V29, P133, DOI 10.1023/B:FISH.0000035937.68098.83; Benitez-Santana T, 2007, AQUACULTURE, V264, P408, DOI 10.1016/j.aquaculture.2006.10.024; Berge RK, 1999, BIOCHEM J, V343, P191, DOI 10.1042/0264-6021:3430191; Bordoni A, 2006, GENES NUTR, V1, P95, DOI 10.1007/BF02829951; Buzzi M, 1996, BBA-LIPID LIPID MET, V1299, P235, DOI 10.1016/0005-2760(95)00211-1; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Coccia E, 2014, LIPIDS, V49, P1033, DOI 10.1007/s11745-014-3939-y; Cochrane K, 2009, CLIMATE CHANGE IMPLI; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Egginton S, 1996, J FISH BIOL, V49, P753, DOI 10.1111/j.1095-8649.1996.tb00074.x; FARKAS T, 1976, LIPIDS, V11, P401, DOI 10.1007/BF02532847; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fountoulaki E, 2003, AQUACULTURE, V225, P309, DOI 10.1016/S0044-8486(03)00298-9; Froyland L, 2000, AQUACULT NUTR, V6, P85; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; HAGAR AF, 1985, J COMP PHYSIOL B, V156, P35, DOI 10.1007/BF00692924; HAZEL JR, 1984, AM J PHYSIOL, V246, pR460, DOI 10.1152/ajpregu.1984.246.4.R460; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZEL JR, 1979, AM J PHYSIOL, V236, pR91, DOI 10.1152/ajpregu.1979.236.1.R91; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Higgs D, 2000, ENCY AQUACULTURE, P476; Holen E, 2015, FISH SHELLFISH IMMUN, P1; Huguet CT, 2015, AQUACULTURE, V436, P160, DOI 10.1016/j.aquaculture.2014.11.011; Jobling M, 2003, AQUAC RES, V34, P1423, DOI 10.1111/j.1365-2109.2003.00970.x; Jorgensen Sven Martin, 2014, BMC Physiology, V14, P2, DOI 10.1186/1472-6793-14-2; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kieffer JD, 1998, J EXP BIOL, V201, P3123; Klaiman JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024464; Kowalska A, 2014, AQUACULT INT, V22, P185, DOI 10.1007/s10499-013-9684-z; Le WP, 2000, BBA-MOL CELL BIOL L, V1485, P121, DOI 10.1016/S1388-1981(00)00034-2; Leaver MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-299; Ma JJ, 2013, J WORLD AQUACULT SOC, V44, P311, DOI 10.1111/jwas.12032; Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850; McKenzie DJ, 1998, FISH PHYSIOL BIOCHEM, V19, P111, DOI 10.1023/A:1007779619087; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Moya-Falcon C, 2006, COMP BIOCHEM PHYS B, V145, P68, DOI 10.1016/j.cbpb.2006.06.004; NEAS NP, 1985, J EXP ZOOL, V233, P51, DOI 10.1002/jez.1402330108; Neuman C, 2016, AQUAC RES, V47, P660, DOI 10.1111/are.12522; Ng WK, 2010, AQUACULTURE, V309, P165, DOI 10.1016/j.aquaculture.2010.08.035; Norambuena F, 2016, AQUACULTURE, V450, P48, DOI 10.1016/j.aquaculture.2015.06.044; Norambuena F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081705; Norambuena F, 2013, GEN COMP ENDOCR, V191, P92, DOI 10.1016/j.ygcen.2013.06.006; Norambuena F, 2013, AQUACULTURE, V372, P80, DOI 10.1016/j.aquaculture.2012.10.035; Norambuena F, 2012, GEN COMP ENDOCR, V177, P256, DOI 10.1016/j.ygcen.2012.04.009; Nordgarden U, 2003, AQUACULT NUTR, V9, P295, DOI 10.1046/j.1365-2095.2003.00260.x; Olsen RE, 1998, AQUAC RES, V29, P695, DOI 10.1046/j.1365-2109.1998.29100695.x; Orr S, 2013, BIOCHEMICAL PHYSIOLO; Rett BS, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-36; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Sargent JR, 1995, J APPL ICHTHYOL, V11, P183, DOI 10.1111/j.1439-0426.1995.tb00018.x; SCHUNKE M, 1983, BIOCHIM BIOPHYS ACTA, V734, P70, DOI 10.1016/0005-2736(83)90076-7; Sessler AM, 1998, J NUTR, V128, P923, DOI 10.1093/jn/128.6.923; SINCLAIR AJ, 1983, LIPIDS, V18, P877, DOI 10.1007/BF02534565; Stenslokken KO, 2002, J COMP PHYSIOL B, V172, P363, DOI 10.1007/s00360-002-0258-z; Stipanuk MH, 2013, BIOCHEMICAL PHYSIOLO; Stubhaug I, 2007, AQUACULT NUTR, V13, P145, DOI 10.1111/j.1365-2095.2007.00462.x; TEBBEY PW, 1992, BIOCHIM BIOPHYS ACTA, V1171, P27, DOI 10.1016/0167-4781(92)90136-N; Tian JJ, 2014, AQUACULTURE, V430, P57, DOI 10.1016/j.aquaculture.2014.03.020; Tocher DR, 2015, AQUACULTURE, V449, P94, DOI 10.1016/j.aquaculture.2015.01.010; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2004, COMP BIOCHEM PHYS B, V137, P49, DOI 10.1016/j.cbpc.2003.10.002; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Turchini GM, 2007, LIPIDS, V42, P1065, DOI 10.1007/s11745-007-3105-x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Van Anholt RD, 2004, J EXP BIOL, V207, P3419, DOI 10.1242/jeb.01166; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veilleux HD, 2015, NAT CLIM CHANGE, V5, P1074, DOI [10.1038/nclimate2724, 10.1038/NCLIMATE2724]; Wall R., 2010, FATTY ACIDS FROM FIS, P280; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200; Wijendran V, 2013, PROSTAG LEUKOTR ESS, V89, P345, DOI 10.1016/j.plefa.2013.08.004; WILLUMSEN N, 1993, LIPIDS, V28, P683, DOI 10.1007/BF02535987; WODTKE E, 1978, BIOCHIM BIOPHYS ACTA, V529, P280, DOI 10.1016/0005-2760(78)90071-1	82	37	37	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143622	10.1371/journal.pone.0143622	http://dx.doi.org/10.1371/journal.pone.0143622			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599513	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600094
J	Duong, J; Booth, SC; McCartney, NK; Rabin, HR; Parkins, MD; Storey, DG				Duong, Jessica; Booth, Sean C.; McCartney, Nathan K.; Rabin, Harvey R.; Parkins, Michael D.; Storey, Douglas G.			Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis	PLOS ONE			English	Article							TRANSMISSIBLE STRAINS; CLINICAL-OUTCOMES; CHRONIC INFECTION; CLONAL STRAINS; RISK-FACTORS; SPREAD; IDENTIFICATION; EXACERBATION; POPULATION; VIRULENCE	Epidemic strains of Pseudomonas aeruginosa have been found worldwide among the cystic fibrosis (CF) patient population. Using pulse-field gel electrophoresis, the Prairie Epidemic Strain (PES) has recently been found in one-third of patients attending the Calgary Adult CF Clinic in Canada. Using multi-locus sequence typing, PES isolates from unrelated patients were found to consistently have ST192. Though most patients acquired PES prior to enrolling in the clinic, some patients were observed to experience strain replacement upon transitioning to the clinic whereby local non-epidemic P. aeruginosa isolates were displaced by PES. Here we genotypically and phenotypically compared PES to other P. aeruginosa epidemic strains (OES) found around the world as well as local non-epidemic CF P. aeruginosa isolates in order to characterize PES. Since some epidemic strains are associated with worse clinical outcomes, we assessed the pathogenic potential of PES to determine if these isolates are virulent, shared properties with OES, and if its phenotypic properties may offer a competitive advantage in displacing local non-epidemic isolates during strain replacement. As such, we conducted a comparative analysis using fourteen phenotypic traits, including virulence factor production, biofilm formation, planktonic growth, mucoidy, and antibiotic susceptibility to characterize PES, OES, and local non-epidemic isolates. We observed that PES and OES could be differentiated from local non-epidemic isolates based on biofilm growth with PES isolates being more mucoid. Pairwise comparisons indicated that PES produced significantly higher levels of proteases and formed better biofilms than OES but were more susceptible to antibiotic treatment. Amongst five patients experiencing strain replacement, we found that super-infecting PES produced lower levels of proteases and elastases but were more resistant to antibiotics compared to the displaced non-epidemic isolates. This comparative analysis is the first to be completed on a large scale between groups of epidemic and non-epidemic CF P. aeruginosa isolates.	[Duong, Jessica; Booth, Sean C.; McCartney, Nathan K.; Storey, Douglas G.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Parkins, Michael D.; Storey, Douglas G.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Rabin, Harvey R.; Parkins, Michael D.] Univ Calgary, Dept Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Storey, DG (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	storey@ucalgary.ca	Booth, Sean Cameron/H-6480-2019; Storey, Doug/AAH-3066-2022; Storey, Doug/AFM-0647-2022	Booth, Sean Cameron/0000-0003-2552-5324; Storey, Douglas/0000-0001-8927-0493	Natural Science and Engineering Research Council [RGPIN 203595-2013]; Cystic Fibrosis Canada	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada	This study was funded by a Natural Science and Engineering Research Council Discovery Grant (RGPIN 203595-2013) to DGS and a Cystic Fibrosis Canada grant to MDP.	Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beaudoin T, 2010, CAN J MICROBIOL, V56, P548, DOI [10.1139/W10-043, 10.1139/w10-043]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BODEY GP, 1983, REV INFECT DIS, V5, P279; Bradbury R, 2008, RESPIROLOGY, V13, P886, DOI 10.1111/j.1440-1843.2008.01383.x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chambers D, 2005, EUR RESPIR J, V26, P651, DOI 10.1183/09031936.05.00126704; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Denning GM, 1998, AM J PHYSIOL-LUNG C, V274, pL893, DOI 10.1152/ajplung.1998.274.6.L893; Dettman JR, 2013, P NATL ACAD SCI USA, V110, P21065, DOI 10.1073/pnas.1307862110; European Bioplastics, 2015, BIOPL FURTH EFF WAST, P1; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; Foweraker JE, 2005, J ANTIMICROB CHEMOTH, V55, P921, DOI 10.1093/jac/dki146; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Kidd TJ, 2013, EUR RESPIR J, V41, P1091, DOI 10.1183/09031936.00060512; Kidd TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044199; Kidd TJ, 2011, J CLIN MICROBIOL, V49, P263, DOI 10.1128/JCM.01421-10; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Konings AF, 2013, INFECT IMMUN, V81, P2697, DOI 10.1128/IAI.00418-13; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Lam JC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0856-5; Lelong E, 2011, CLIN MICROBIOL INFEC, V17, P1415, DOI 10.1111/j.1469-0691.2010.03431.x; LONON MK, 1988, J CLIN MICROBIOL, V26, P979, DOI 10.1128/JCM.26.5.979-984.1988; Luna RA, 2013, J CLIN MICROBIOL, V51, P1237, DOI 10.1128/JCM.02157-12; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Manos J, 2013, EUR J CLIN MICROBIOL, V32, P1583, DOI 10.1007/s10096-013-1916-7; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; McCallum SJ, 2001, LANCET, V358, P558, DOI 10.1016/S0140-6736(01)05715-4; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; O'Carroll MR, 2004, EUR RESPIR J, V24, P101, DOI 10.1183/09031936.04.00122903; Parkins MD, 2014, J CLIN MICROBIOL, V52, P1127, DOI 10.1128/JCM.03218-13; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; PEDERSEN SS, 1992, THORAX, V47, P6, DOI 10.1136/thx.47.1.6; PEDERSEN SS, 1986, J ANTIMICROB CHEMOTH, V17, P505, DOI 10.1093/jac/17.4.505; Poonja A, 2015, 29 ANN N AM CYST FIB; ROMLING U, 1994, J INFECT DIS, V170, P1616, DOI 10.1093/infdis/170.6.1616; RUST L, 1994, METHOD ENZYMOL, V235, P554; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; SOKOL PA, 1979, J CLIN MICROBIOL, V9, P538; Somayaji R, 2015, 38 ANN EUR CYST FIBR; Stapper AP, 2004, J MED MICROBIOL, V53, P679, DOI 10.1099/jmm.0.45539-0; Storey DG, 1998, INFECT IMMUN, V66, P2521, DOI 10.1128/IAI.66.6.2521-2528.1998; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; Waine DJ, 2009, J CLIN MICROBIOL, V47, P3444, DOI 10.1128/JCM.00459-09; Waters V, 2012, EUR RESPIR J, V40, P61, DOI 10.1183/09031936.00159111; WOODS DE, 1991, J INFECT DIS, V163, P143, DOI 10.1093/infdis/163.1.143; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	60	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143466	10.1371/journal.pone.0143466	http://dx.doi.org/10.1371/journal.pone.0143466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599104	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900129
J	Giese, APJ; Guarnaschelli, JG; Ward, JA; Choo, DI; Riazuddin, S; Ahmed, ZM				Giese, Arnaud P. J.; Guarnaschelli, Jess G.; Ward, Jonette A.; Choo, Daniel I.; Riazuddin, Salma; Ahmed, Zubair M.			Radioprotective Effect of Aminothiol PrC-210 on Irradiated Inner Ear of Guinea Pig	PLOS ONE			English	Article							RADIATION-THERAPY; AMIFOSTINE; PROTECTS	Radiotherapy of individuals suffering with head & neck or brain tumors subserve the risk of sensorineural hearing loss. Here, we evaluated the protective effect of Aminothiol PrC-210 (3-(methyl-amino)-2-((methylamino) methyl) propane-1-thiol) on the irradiated inner ear of guinea pigs. An intra-peritoneal or intra-tympanic dose of PrC-210 was administered prior to receiving a dose of gamma radiation (3000 cGy) to each ear. Auditory Brainstem Responses (ABRs) were recorded one week and two weeks after the radiation and compared with the sham animal group. ABR thresholds of guinea pigs that received an intraperitoneal dose of PrC-210 were significantly better compared to the non-treated, control animals at one week post-radiation. Morphologic analysis of the inner ear revealed significant inflammation and degeneration of the spiral ganglion in the irradiated animals not treated with PrC-210. In contrast, when treated with PrC-210 the radiation effect and injury to the spiral ganglion was significantly alleviated. PrC-210 had no apparent cytotoxic effect in vivo and did not affect the morphology or count of cochlear hair cells. These findings suggest that aminothiol PrC-210 attenuated radiation-induced cochlea damage for at least one week and protected hearing.	[Giese, Arnaud P. J.; Riazuddin, Salma; Ahmed, Zubair M.] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Guarnaschelli, Jess G.] Univ Cincinnati, Dept Radiat Oncol, Cincinnati, OH 45221 USA; [Guarnaschelli, Jess G.] TriHlth Canc Inst, Dept Radiat Oncol, Cincinnati, OH USA; [Ward, Jonette A.; Choo, Daniel I.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Otolaryngol Head & Neck Surg, Cincinnati, OH 45229 USA	University System of Maryland; University of Maryland Baltimore; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Guarnaschelli, JG (corresponding author), Univ Cincinnati, Dept Radiat Oncol, Cincinnati, OH 45221 USA.	Jessica_Guarnaschelli@trihealth.com; zahmed@smail.umaryland.edu	Giese, Arnaud P.J./P-1683-2019	Giese, Arnaud/0000-0001-7228-9542	Department of Radiation, University of Cincinnati	Department of Radiation, University of Cincinnati	Supported by funds from Department of Radiation, University of Cincinnati. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. F. Smith, J. Breneman, W. Barrett, M. Lamba, and W. Kassing for their support and helpful discussion. We also thank M. Davis and J. Bailey for their technical assistance. Supported by the funds from Department of Radiation, University of Cincinnati.	Altas E, 2006, ANN CLIN LAB SCI, V36, P312; Altas E, 2006, BIOL PHARM BULL, V29, P1460, DOI 10.1248/bpb.29.1460; Fleury B, 2010, CANCER RADIOTHER, V14, P284, DOI 10.1016/j.canrad.2010.02.011; GAMBLE JE, 1968, ARCH OTOLARYNGOL, V88, P156; Huang E, 2002, INT J RADIAT ONCOL, V52, P599, DOI 10.1016/S0360-3016(01)02641-4; Ingham NJ, 1998, ACTA OTO-LARYNGOL, V118, P673; Johnke RM, 2014, FUTURE ONCOL, V10, P2345, DOI 10.2217/fon.14.175; Lessa Ricardo Miranda, 2009, Braz. j. otorhinolaryngol., V75, P694; Low WK, 2008, ACTA OTO-LARYNGOL, V128, P440, DOI 10.1080/00016480701762490; Mujica-Mota MA, 2014, HEARING RES, V312, P60, DOI 10.1016/j.heares.2014.03.003; Oshima CTF, 2015, ANTICANCER RES, V35, P2817; Page EE, 2015, J PLAST RECONSTR AES, V68, P98, DOI 10.1016/j.bjps.2014.08.054; Peebles DD, 2012, RADIAT RES, V178, P57, DOI 10.1667/RR2806.1; Pyun JH, 2011, NEUROSCIENCE, V199, P410, DOI 10.1016/j.neuroscience.2011.09.012; Soref CM, 2012, INT J RADIAT ONCOL, V82, pE701, DOI 10.1016/j.ijrobp.2011.11.038; Stieber VW, 2007, NEUROL CLIN, V25, P1005, DOI 10.1016/j.ncl.2007.07.005; WINTHER FO, 1969, ACTA OTO-LARYNGOL, V68, P98, DOI 10.3109/00016486909121548; Yildirim BA, 2015, RETINA-J RET VIT DIS, V35, P1458, DOI 10.1097/IAE.0000000000000493; Young YH, 1999, J LARYNGOL OTOL, V113, P815, DOI 10.1017/S0022215100145281	19	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143606	10.1371/journal.pone.0143606	http://dx.doi.org/10.1371/journal.pone.0143606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599238	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900148
J	Zhang, C; Liu, FF; Chang, H; Li, HG; Zhou, X; Lu, J; Qin, CK; Sun, YJ; Sun, HD; Lin, JB				Zhang, Chi; Liu, Fangfeng; Chang, Hong; Li, Hongguang; Zhou, Xu; Lu, Jun; Qin, Chengkun; Sun, Yongjie; Sun, Huidong; Lin, Jianbo			Less Aggressive Surgical Procedure for Treatment of Solid Pseudopapillary Tumor: Limited Experience from a Single Institute	PLOS ONE			English	Article							CLINICAL-FEATURES; PANCREAS; NEOPLASM; DIAGNOSIS; PROGNOSIS; DISTINCT; HEAD	Objectives To evaluate the clinical characteristics and radiological features of solid pseudopapillary tumor (SPT) and assess surgical therapy strategy. Methods A retrospective review was performed in 62 patients pathologically confirmed of SPT treated between 2003 and 2014. The clinical features, radiological examinations and surgical strategies were analyzed. Results 56 females and 6 males were included in this study, mean age was 26 years old (range: 8-66 years old) with mean size of the tumor was 7.2 cm (range: 3-15 cm), and most tumor were commonly located in the head of pancreas (n = 29). Among all the cases, 3 patients had liver metastasis and underwent resection of SPT and liver metastasis. Furthermore, we performed 29 cases of local tumor excision; other patients underwent pancreaticoduo-denectomy, middle pancreatectomy, middle pancreatectomy with splenectomy, distal pancreatectomy with spleen preservation, distal pancreatectomy with splenectomy and duodenum-preserving pancreatic head resection. No patient suffered from lymph node metastases. After median follow-up of 46 months (range: 2-135 months), no mortality or local recurrence or distant metastasis was found. Conclusions Solid pseudopapillary tumor is a latent malignant tumor with excellent prognosis. If feasible, less aggressive resection without regular lymphadenectomy is recommended for treatment of patients with SPT.	[Zhang, Chi; Liu, Fangfeng; Chang, Hong; Li, Hongguang; Zhou, Xu; Lu, Jun; Qin, Chengkun; Sun, Yongjie; Sun, Huidong; Lin, Jianbo] Shandong Univ, Dept Gen Surg, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Chang, H (corresponding author), Shandong Univ, Dept Gen Surg, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China.	changhong@sdu.edu.cn						Adams AL, 2008, ADV ANAT PATHOL, V15, P39, DOI 10.1097/PAP.0b013e31815e5237; Akiyama H, 2002, J GASTROINTEST CANC, V32, P47, DOI 10.1385/IJGC:32:1:47; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; BEGER HG, 1985, SURGERY, V97, P467; Butte JM, 2011, J GASTROINTEST SURG, V15, P350, DOI 10.1007/s11605-010-1337-1; Cai YQ, 2014, WORLD J GASTROENTERO, V20, P6939, DOI 10.3748/wjg.v20.i22.6939; Cai YQ, 2014, J GASTROINTEST SURG, V18, P935, DOI 10.1007/s11605-014-2476-6; Chang Hong, 2010, Int J Med Sci, V7, P309; Chetty R, 2008, HUM PATHOL, V39, P1407, DOI 10.1016/j.humpath.2008.05.015; Dan D, 2014, CASE REP MED, V2014, DOI 10.1155/2014/356379; de Castro SMM, 2007, WORLD J SURG, V31, P1129, DOI 10.1007/s00268-006-0214-2; El Nakeeb A, 2013, INT J SURG, V11, P447, DOI 10.1016/j.ijsu.2013.04.009; Geers C, 2006, AM J SURG PATHOL, V30, P1243, DOI 10.1097/01.pas.0000213311.28682.b2; Kawamoto S, 2011, CLIN IMAG, V35, P21, DOI 10.1016/j.clinimag.2009.11.007; Kim MJ, 2014, BRIT J SURG, V101, P1266, DOI 10.1002/bjs.9577; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; Li ZJ, 2011, SURG TODAY, V41, P91, DOI 10.1007/s00595-009-4225-0; Machado MCC, 2008, SURGERY, V143, P29, DOI 10.1016/j.surg.2007.07.030; Morikawa T, 2013, SURG TODAY, V43, P26, DOI 10.1007/s00595-012-0345-z; Papavramidis T, 2005, J AM COLL SURGEONS, V200, P965, DOI 10.1016/j.jamcollsurg.2005.02.011; Pettinato G, 2002, DIAGN CYTOPATHOL, V27, P325, DOI 10.1002/dc.10189; Raffel A, 2004, SURG ONCOL, V13, P1, DOI 10.1016/j.suronc.2003.09.003; Rebhandl W, 2001, J SURG ONCOL, V76, P289, DOI 10.1002/jso.1048; Romics L, 2010, LANGENBECK ARCH SURG, V395, P747, DOI 10.1007/s00423-010-0599-0; Sperti C, 2008, WORLD J GASTROENTERO, V14, P960, DOI 10.3748/wjg.14.960; Tanaka Y, 2001, CANCER RES, V61, P8401; Wang WB, 2014, EJSO-EUR J SURG ONC, V40, P1572, DOI 10.1016/j.ejso.2014.05.012; Yagci A, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-308; Yang F, 2008, J GASTROEN HEPATOL, V23, P1847, DOI 10.1111/j.1440-1746.2008.05526.x; Ye JH, 2012, J SURG ONCOL, V106, P728, DOI 10.1002/jso.23195; Yin QH, 2012, EUR J RADIOL, V81, P3010, DOI 10.1016/j.ejrad.2012.03.013; Yu PF, 2010, WORLD J GASTROENTERO, V16, P1209, DOI 10.3748/wjg.v16.i10.1209; Zhang Hao, 2006, Hepatobiliary Pancreat Dis Int, V5, P454	33	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143452	10.1371/journal.pone.0143452	http://dx.doi.org/10.1371/journal.pone.0143452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599966	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900124
J	Tedesco, P; Visone, M; Parrilli, E; Tutino, ML; Perrin, E; Maida, I; Fani, R; Ballestriero, F; Santos, R; Pinilla, C; Di Schiavi, E; Tegos, G; de Pascale, D				Tedesco, Pietro; Visone, Marco; Parrilli, Ermenegilda; Tutino, Maria Luisa; Perrin, Elena; Maida, Isabel; Fani, Renato; Ballestriero, Francesco; Santos, Radleigh; Pinilla, Clemencia; Di Schiavi, Elia; Tegos, George; de Pascale, Donatella			Investigating the Role of the Host Multidrug Resistance Associated Protein Transporter Family in Burkholderia cepacia Complex Pathogenicity Using a Caenorhabditis elegans Infection Model	PLOS ONE			English	Article							CYSTIC-FIBROSIS; VIRULENCE FACTORS; IVERMECTIN RESISTANCE; CENOCEPACIA STRAINS; PSEUDOMALLEI KILLS; FULL VIRULENCE; SP NOV.; EFFLUX; IDENTIFICATION; DIVERSITY	This study investigated the relationship between host efflux system of the non-vertebrate nematode Caenorhabditis elegans and Burkholderia cepacia complex (Bcc) strain virulence. This is the first comprehensive effort to profile host-transporters within the context of Bcc infection. With this aim, two different toxicity tests were performed: a slow killing assay that monitors mortality of the host by intestinal colonization and a fast killing assay that assesses production of toxins. A Virulence Ranking scheme was defined, that expressed the toxicity of the Bcc panel members, based on the percentage of surviving worms. According to this ranking the 18 Bcc strains were divided in 4 distinct groups. Only the Cystic Fibrosis isolated strains possessed profound nematode killing ability to accumulate in worms' intestines. For the transporter analysis a complete set of isogenic nematode single Multidrug Resistance associated Protein (MRP) efflux mutants and a number of efflux inhibitors were interrogated in the host toxicity assays. The Bcc pathogenicity profile of the 7 isogenic C. elegans MRP knock-out strains functionality was classified in two distinct groups. Disabling host transporters enhanced nematode mortality more than 50% in 5 out of 7 mutants when compared to wild type. In particular mrp-2 was the most susceptible phenotype with increased mortality for 13 out 18 Bcc strains, whereas mrp-3 and mrp-4 knockouts had lower mortality rates, suggesting a different role in toxin-substrate recognition. The use of MRP efflux inhibitors in the assays resulted in substantially increased (>40% on average) mortality of wild-type worms.	[Tedesco, Pietro; Visone, Marco; de Pascale, Donatella] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Tedesco, Pietro; Parrilli, Ermenegilda; Tutino, Maria Luisa] Univ Naples Federico II, Dept Chem Sci, I-80126 Naples, Italy; [Tedesco, Pietro; Parrilli, Ermenegilda; Tutino, Maria Luisa] Univ Naples Federico II, Sch Biotechnol Sci, I-80126 Naples, Italy; [Perrin, Elena; Maida, Isabel; Fani, Renato] Univ Florence, Dept Biol, Lab Microbial & Mol Evolut, I-50019 Florence, Italy; [Ballestriero, Francesco] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Ballestriero, Francesco] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia; [Santos, Radleigh; Pinilla, Clemencia; Tegos, George] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Santos, Radleigh; Pinilla, Clemencia; Tegos, George] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Di Schiavi, Elia] CNR, Inst Biosci & BioResources, I-80131 Naples, Italy; [Di Schiavi, Elia] CNR, Inst Genet & Biophys, I-80131 Naples, Italy; [Tegos, George] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Tegos, George] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Naples Federico II; University of Naples Federico II; University of Florence; University of New South Wales Sydney; University of New South Wales Sydney; Torrey Pines Institute for Molecular Studies, Florida; Torrey Pines Institute for Molecular Studies, California; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Tegos, G (corresponding author), Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA.	gtegos@tpims.org; d.depascale@ibp.cnr.it	parrilli, ermenegilda/K-4616-2016; Di Schiavi, Elia/B-8046-2015; Tedesco, Pietro/AAB-5740-2021; Perrin, Elena/AAX-2762-2020	parrilli, ermenegilda/0000-0002-9002-5409; Di Schiavi, Elia/0000-0002-8179-6666; Tutino, Maria Luisa/0000-0002-4978-6839; Tedesco, Pietro/0000-0003-0165-5386; Perrin, Elena/0000-0001-5148-3178	EU-KBBE project PharmaSea [312184]; "Fondazione Adriano Buzzati-Traverso" fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	EU-KBBE project PharmaSea; "Fondazione Adriano Buzzati-Traverso" fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was supported by the EU-KBBE 2012-2016 project PharmaSea, grant No 312184. Elena Perrin is financially supported by a "Fondazione Adriano Buzzati-Traverso" fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe E, 2011, VIRULENCE, V2, P158, DOI 10.4161/viru.2.2.15337; Ardelli BF, 2013, VET PARASITOL, V191, P264, DOI 10.1016/j.vetpar.2012.09.021; Bazzini S, 2011, APPL MICROBIOL BIOT, V92, P887, DOI 10.1007/s00253-011-3616-5; Bhatt S, 2011, J BACTERIOL, V193, P4516, DOI 10.1128/JB.05197-11; BRENNER S, 1974, GENETICS, V77, P71; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Cardona ST, 2005, FEMS MICROBIOL LETT, V250, P97, DOI 10.1016/j.femsle.2005.06.050; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Cooper VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007961; Currie E, 2007, GENETICS, V177, P1569, DOI 10.1534/genetics.107.080689; De Smet B, 2015, INT J SYST EVOL MICR, V65, P2265, DOI 10.1099/ijs.0.000251; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Eilers M, 2008, EXP BIOL MED, V233, P1149, DOI 10.3181/0802-RM-59; Fallon JP, 2011, MICROBIOL-SGM, V157, P1481, DOI 10.1099/mic.0.043786-0; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Harland DN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-83; Horger KS, 2015, BBA-BIOMEMBRANES, V1848, P643, DOI 10.1016/j.bbamem.2014.10.023; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; James CE, 2009, INT J PARASITOL, V39, P213, DOI 10.1016/j.ijpara.2008.06.009; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; Kurz CL, 2007, BIOCHEM BIOPH RES CO, V363, P438, DOI 10.1016/j.bbrc.2007.08.190; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lee SH, 2013, P NATL ACAD SCI US; Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016707; Leitao J.H., 2011, INT J MICROBIOL, V2011; Lionakis MS, 2011, VIRULENCE, V2, P521, DOI 10.4161/viru.2.6.18520; Lu SE, 2009, BIOCHEMISTRY-US, V48, P8312, DOI 10.1021/bi900814c; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Markey KM, 2006, J MED MICROBIOL, V55, P967, DOI 10.1099/jmm.0.46618-0; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Mylonakis Eleftherios, 2003, Expert Rev Anti Infect Ther, V1, P167, DOI 10.1586/14787210.1.1.167; Nash EF, 2010, PEDIAT PULMONOL; O'Grady EP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037611; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Olsen RJ, 2011, VIRULENCE, V2, P111, DOI 10.4161/viru.2.2.14338; Ooi SK, 2012, VIRULENCE, V3, P485, DOI 10.4161/viru.21808; Peeters C, 2013, SYST APPL MICROBIOL, V36, P483, DOI 10.1016/j.syapm.2013.06.003; Pirone L, 2008, ENVIRON MICROBIOL, V10, P2773, DOI 10.1111/j.1462-2920.2008.01697.x; Ramsay KA, 2013, J CLIN MICROBIOL, V51, P3975, DOI 10.1128/JCM.01360-13; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rose H, 2009, J ANTIMICROB CHEMOTH, V63, P502, DOI 10.1093/jac/dkn540; Schwager S, 2013, INFECT IMMUN, V81, P143, DOI 10.1128/IAI.00768-12; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Sousa SA, 2010, MICROBIOL-SGM, V156, P896, DOI 10.1099/mic.0.035139-0; Springman AC, 2009, APPL ENVIRON MICROB, V75, P5250, DOI 10.1128/AEM.00877-09; Stiernagle T, 2006, MAINTENANCE C ELEGAN; Strouse JJ, 2013, ANAL BIOCHEM, V437, P77, DOI 10.1016/j.ab.2013.02.018; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tegos GP, 2012, VIRULENCE, V3, P234, DOI 10.4161/viru.19844; Thomson ELS, 2012, VIRULENCE, V3, P286, DOI 10.4161/viru.19355; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Wei SP, 2014, J BIOL CHEM, V289, P19942, DOI 10.1074/jbc.M114.562116; Wopperer J, 2006, APPL ENVIRON MICROB, V72, P1579, DOI 10.1128/AEM.72.2.1579-1587.2006; Yan RF, 2012, VET PARASITOL, V190, P519, DOI 10.1016/j.vetpar.2012.06.038	58	3	4	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142883	10.1371/journal.pone.0142883	http://dx.doi.org/10.1371/journal.pone.0142883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587842	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500020
J	Adams, RV; Burg, TM				Adams, Rachael V.; Burg, Theresa M.			Gene Flow of a Forest-Dependent Bird across a Fragmented Landscape	PLOS ONE			English	Article							PLANT HYBRID ZONES; MALURUS-CORONATUS-CORONATUS; GAP-CROSSING DECISIONS; RIPARIAN COTTONWOODS; POPULATION-GENETICS; SOUTHERN ALBERTA; RIVER; PATTERNS; HABITAT; SOFTWARE	Habitat loss and fragmentation can affect the persistence of populations by reducing connectivity and restricting the ability of individuals to disperse across landscapes. Dispersal corridors promote population connectivity and therefore play important roles in maintaining gene flow in natural populations inhabiting fragmented landscapes. In the prairies, forests are restricted to riparian areas along river systems which act as important dispersal corridors for forest dependent species across large expanses of unsuitable grassland habitat. However, natural and anthropogenic barriers within riparian systems have fragmented these forested habitats. In this study, we used microsatellite markers to assess the fine-scale genetic structure of a forest-dependent species, the black-capped chickadee (Poecile atricapillus), along 10 different river systems in Southern Alberta. Using a landscape genetic approach, landscape features (e.g., land cover) were found to have a significant effect on patterns of genetic differentiation. Populations are genetically structured as a result of natural breaks in continuous habitat at small spatial scales, but the artificial barriers we tested do not appear to restrict gene flow. Dispersal between rivers is impeded by grasslands, evident from isolation of nearby populations (similar to 50 km apart), but also within river systems by large treeless canyons (> 100 km). Significant population genetic differentiation within some rivers corresponded with zones of different cottonwood (riparian poplar) tree species and their hybrids. This study illustrates the importance of considering the impacts of habitat fragmentation at small spatial scales as well as other ecological processes to gain a better understanding of how organisms respond to their environmental connectivity. Here, even in a common and widespread songbird with high dispersal potential, small breaks in continuous habitats strongly influenced the spatial patterns of genetic variation.	[Adams, Rachael V.; Burg, Theresa M.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Adams, RV (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	rachael.adams@uleth.ca		Wilbourn, Rachael V./0000-0003-3015-6332	ACA Grants in Biodiversity [43559-4115-8001]; Alberta Conservation Association (ACA Grants in Biodiversity Program)	ACA Grants in Biodiversity; Alberta Conservation Association (ACA Grants in Biodiversity Program)	RVA-ACA Grants in Biodiversity (Grant number: 43559-4115-8001) funded this work (http://www.acabiodiversity.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for the project was provided by the Alberta Conservation Association (ACA Grants in Biodiversity Program). We thank E. Carpenter, A. Curtis, K. Dohms, J. Hindley, L. Lait, P. Narvez and P. Pulgarin for help with sample collection and to C. Goater and H. Jiskoot for their constructive comments. We are also grateful to C. Langhorn, C. Bonifacio and L. Philipsen for their assistance with GIS as well as S. Rood and K. Floate for sharing their expertise and knowledge. Finally we thank the two anonymous reviewers and editor, Sam Banks, for their constructive comments on the manuscript.	Adams RV, 2015, HEREDITY, V114, P143, DOI 10.1038/hdy.2014.64; Alp M, 2012, FRESHWATER BIOL, V57, P969, DOI 10.1111/j.1365-2427.2012.02758.x; Amlin NM, 2003, TREES-STRUCT FUNCT, V17, P351, DOI 10.1007/s00468-003-0245-3; Amos JN, 2014, ECOLOGY, V95, P1556, DOI 10.1890/13-1328.1; Auguie B, 2017, GRIDEXTRA MISCELLANE; Barton K, 2015, MUMLN MULT INFERENCE; Bates D., 2015, LME4 LINEAR MIXED EF; Benjamini Y, 2001, ANN STAT, V29, P1165; Brayshaw TC, 1965, CAN DEP FOR PUBL, V1109; Christian DP, 1997, J WILDLIFE MANAGE, V61, P171, DOI 10.2307/3802426; Clarke RT, 2002, J AGRIC BIOL ENVIR S, V7, P361, DOI 10.1198/108571102320; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Cushman Samuel A., 2013, Diversity-Basel, V5, P51; Dallimer M, 2012, DIVERS DISTRIB, V18, P742, DOI 10.1111/j.1472-4642.2012.00891.x; Dawson GM, 1885, GEOLOGICAL MAP REGIO; Desrochers A, 1997, CONSERV BIOL, V11, P1204, DOI 10.1046/j.1523-1739.1997.96187.x; Desrochers Andre, 2007, P243; Doherty PF, 2002, ECOLOGY, V83, P844, DOI 10.1890/0012-9658(2002)083[0844:SOPRBI]2.0.CO;2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans LM, 2012, CONSERV GENET, V13, P1601, DOI 10.1007/s10592-012-0409-z; Evans LM, 2008, EVOLUTION, V62, P3027, DOI 10.1111/j.1558-5646.2008.00497.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Falush D, 2003, GENETICS, V164, P1567; FINCH DM, 1989, ECOLOGY, V70, P866, DOI 10.2307/1941355; Floate KD, 1997, J ANIM ECOL, V66, P179, DOI 10.2307/6020; Floate KD, 2004, CAN J BOT, V82, P253, DOI [10.1139/B03-135, 10.1139/b03-135]; Floate KD, 2016, NEW PHYTOL, V209, P832, DOI 10.1111/nph.13622; GILL FB, 1993, EVOLUTION, V47, P195, DOI 10.1111/j.1558-5646.1993.tb01210.x; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Gom LA, 1999, CAN J BOT, V77, P1095, DOI 10.1139/cjb-77-8-1095; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gray LJ, 1989, 11 N AM PRAIR C U NE, P292; HAAS CA, 1995, CONSERV BIOL, V9, P845, DOI 10.1046/j.1523-1739.1995.09040845.x; Hannon SJ, 2002, CAN J FOREST RES, V32, P1784, DOI 10.1139/X02-092; Heggenes J, 2006, ECOL FRESHW FISH, V15, P366, DOI 10.1111/j.1600-0633.2006.00146.x; Hindley JA, 2013, THESIS; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Hudman SP, 2013, FRESHWATER BIOL, V58, P441, DOI 10.1111/fwb.12079; Jansen A, 2001, BIOL CONSERV, V100, P173, DOI 10.1016/S0006-3207(00)00235-4; Jansson R, 2000, ECOLOGY, V81, P899, DOI 10.1890/0012-9658(2000)081[0899:FORFIR]2.0.CO;2; Jedlicka JA, 2014, WILSON J ORNITHOL, V126, P60, DOI 10.1676/13-058.1; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; JOHNSON AR, 1992, LANDSCAPE ECOL, V7, P63, DOI 10.1007/BF02573958; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalischuk AR, 1997, CAN J BOT, V75, P1349, DOI 10.1139/b97-847; Koen EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011785; Kondo T, 2009, AM J BOT, V96, P1532, DOI 10.3732/ajb.0800273; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MARTINSEN GD, 1994, WILSON BULL, V106, P474; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Mosner E, 2012, BIOL CONSERV, V153, P211, DOI 10.1016/j.biocon.2012.05.005; Naiman RJ, 2005, ECOSYSTEM FUNCTION IN HETEROGENEOUS LANDSCAPES, P279, DOI 10.1007/0-387-24091-8_14; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neraas LP, 2001, MOL ECOL, V10, P1153, DOI 10.1046/j.1365-294X.2001.01269.x; Olson DH, 2007, FOREST ECOL MANAG, V246, P81, DOI 10.1016/j.foreco.2007.03.053; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phillipsen IC, 2013, ECOGRAPHY, V36, P731, DOI 10.1111/j.1600-0587.2012.00002.x; Pollux BJA, 2007, MOL ECOL, V16, P313, DOI 10.1111/j.1365-294X.2006.03146.x; Pravosudov VV, 2012, MOL ECOL, V21, P4486, DOI 10.1111/j.1365-294X.2012.05721.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robertson OJ, 2009, AUSTRAL ECOL, V34, P435, DOI 10.1111/j.1442-9993.2009.01945.x; ROOD SB, 1989, CAN J BOT, V67, P1744, DOI 10.1139/b89-221; Rood SB, 2003, BIOSCIENCE, V53, P647, DOI 10.1641/0006-3568(2003)053[0647:FFFFAS]2.0.CO;2; ROOD SB, 1995, CAN J BOT, V73, P1250, DOI 10.1139/b95-136; ROOD SB, 1990, ENVIRON MANAGE, V14, P451, DOI 10.1007/BF02394134; ROOD SB, 1986, CAN J BOT, V64, P1382, DOI 10.1139/b86-189; Rood Stewart B., 1995, Rivers, V5, P195; Rottenborn SC, 1999, BIOL CONSERV, V88, P289, DOI 10.1016/S0006-3207(98)00128-1; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sieving KE, 1996, AUK, V113, P944, DOI 10.2307/4088877; Skroblin A, 2014, AUST J ZOOL, V62, P251, DOI 10.1071/ZO13087; Skroblin A, 2012, AUSTRAL ECOL, V37, P874, DOI 10.1111/j.1442-9993.2011.02331.x; Smith SM, 1993, BIRDS N AM, P39; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Van Looy K, 2009, BIOL CONSERV, V142, P870, DOI 10.1016/j.biocon.2008.12.006; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Vignieri SN, 2005, MOL ECOL, V14, P1925, DOI 10.1111/j.1365-294X.2005.02568.x; Werth S, 2014, FRESHWATER BIOL, V59, P2502, DOI 10.1111/fwb.12449; WHITHAM TG, 1989, SCIENCE, V244, P1490, DOI 10.1126/science.244.4911.1490; Whitham TG, 1999, ECOLOGY, V80, P416; Whitham TG, 1996, USDA ROCKY, V283, P103; Whitham Thomas G., 1996, P247; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wright S, 1943, GENETICS, V28, P114; WWF, 2006, FREE FLOW RIV EC LUX; Yang RC, 2004, EVOLUTION, V58, P1839; Young PS, 2011, REV FISH BIOL FISHER, V21, P713, DOI 10.1007/s11160-011-9211-0	102	14	14	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140938	10.1371/journal.pone.0140938	http://dx.doi.org/10.1371/journal.pone.0140938			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580222	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600009
J	Combs, D; Goodwin, JL; Quan, SF; Morgan, WJ; Parthasarathy, S				Combs, Daniel; Goodwin, James L.; Quan, Stuart F.; Morgan, Wayne J.; Parthasarathy, Sairam			Modified STOP-Bang Tool for Stratifying Obstructive Sleep Apnea Risk in Adolescent Children	PLOS ONE			English	Article							QUALITY-OF-LIFE; PUBERTAL SELF-ASSESSMENT; NECK CIRCUMFERENCE; PROXY PROBLEM; QUESTIONNAIRE; POLYSOMNOGRAPHY; RELIABILITY; MATURATION; DIAGNOSIS; PATTERN	Purpose Obstructive sleep apnea (OSA) is prevalent in children and diagnostic polysomnography is costly and not readily available in all areas. We developed a pediatric modification of a commonly used adult clinical prediction tool for stratifying the risk of OSA and the need for polysomnography. Methods A total of 312 children (age 9-17 years) from phase 2 of the Tucson Children's Assessment of Sleep Apnea cohort study, with complete anthropomorphic data, parent questionnaires, and home polysomnograms were included. An adolescent modification of STOP-Bang (teen STOP-Bang) was developed and included snoring, tired, observed apnea, blood pressure >= 95th percentile, BMI > 95th percentile, academic problems, neck circumference > 95th percentile for age, and male gender. An apnea-hypopnea index >= 1.5 events/hour was considered diagnostic of OSA. Results Receiver Operator Characteristic (ROC) curves for parent-reported STOP-Bang scores were generated for teenage and pre-teen children. A STOP-Bang score of < 3 in teenagers was associated with a negative predictive value of 0.96. ROC curves were also generated based upon child-reported sexual maturity rating (SMR; n = 291). The ability of teen STOP-Bang to discriminate the presence or absence of OSA as measured by the AUC for children with SMR >= 4 (0.83; 95% CI 0.71-0.95) was better than children with SMR < 4 (0.63; 95% CI 0.46-0.81; p = 0.048). Conclusions In community dwelling adolescents, teen STOP-Bang may be useful in stratifying the risk of OSA.	[Combs, Daniel; Morgan, Wayne J.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Combs, Daniel; Goodwin, James L.; Quan, Stuart F.; Morgan, Wayne J.; Parthasarathy, Sairam] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Combs, Daniel; Parthasarathy, Sairam] Univ Arizona, Dept Med, Tucson, AZ USA; [Quan, Stuart F.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Quan, Stuart F.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Parthasarathy, Sairam] Univ Arizona, Ctr Sleep Disorders, Tucson, AZ USA; [Parthasarathy, Sairam] Univ Arizona, Div Pulm Allergy Crit Care & Sleep Med, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Arizona; University of Arizona	Combs, D (corresponding author), Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA.	dcombs@peds.arizona.edu		Combs, Daniel/0000-0003-3821-3629	National Institutes of Health Grant [HL062373, HL095748, HL095799]; Patient Centered Outcomes Research Institute contract [IHS-1306-2505]; Arizona Respiratory Center, University of Arizona, Tucson, AZ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062373, R01HL095748, R01HL095799] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patient Centered Outcomes Research Institute contract(Patient-Centered Outcomes Research Institute - PCORI); Arizona Respiratory Center, University of Arizona, Tucson, AZ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grants (HL062373 to S.Q. and HL095748 and HL095799 to S.P.); Patient Centered Outcomes Research Institute contract (IHS-1306-2505 to S.P.); and salary support for D.C. from Arizona Respiratory Center, University of Arizona, Tucson, AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca CB, 2010, VALUE HEALTH, V13, P778, DOI 10.1111/j.1524-4733.2010.00732.x; Boynton Grace, 2013, J Sleep Disord Treat Care, V2, DOI 10.4172/2325-9639.1000121; Budhiraja R, 2009, SLEEP MED CLIN, V4, P9, DOI 10.1016/j.jsmc.2008.11.002; Chan NPT, 2008, J PAEDIATR CHILD H, V44, P353, DOI 10.1111/j.1440-1754.2008.01311.x; Chervin RD, 2000, SLEEP MED, V1, P21, DOI 10.1016/S1389-9457(99)00009-X; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Constantin E, 2010, PEDIATRICS, V125, pE162, DOI 10.1542/peds.2009-0731; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; Dayyat E, 2007, SLEEP MED CLIN, V2, P433, DOI 10.1016/j.jsmc.2007.05.004; Erichsen D, 2012, CLIN PEDIATR, V51, P1125, DOI 10.1177/0009922812464548; Friedman BC, 2003, SLEEP, V26, P999, DOI 10.1093/sleep/26.8.999; Fuentes-Pradera MA, 2004, EUR RESPIR J, V23, P250, DOI 10.1183/09031936.03.00022003; Goodwin JL, 2005, J CLIN SLEEP MED, V1, P247; Goodwin JL, 2001, SLEEP, V24, P937, DOI 10.1093/sleep/24.8.937; Kadmon G, 2014, INT J PEDIATR OTORHI, V78, P2116, DOI 10.1016/j.ijporl.2014.09.018; Kadmon G, 2013, INT J PEDIATR OTORHI, V77, P1461, DOI 10.1016/j.ijporl.2013.06.009; Kaemingk KL, 2003, J INT NEUROPSYCH SOC, V9, P1016, DOI 10.1017/S1355617703970056; Katz S, 2015, PEDIATR PULM, V50, P196, DOI 10.1002/ppul.23003; Katz SL, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-159; Lohman T.G., 1991, ANTHROPOMETRIC STAND, Vvi; Marcus CL, 2012, PEDIATRICS, V130, P576, DOI 10.1542/peds.2012-1671; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Montgomery-Downs HE, 2005, EUR RESPIR J, V25, P336, DOI 10.1183/09031936.05.00082904; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Perfect MM, 2013, SLEEP, V36, P517, DOI 10.5665/sleep.2536; Prevention CfDCa, CLIN GROWTH CHARTS; Raslich MA, 2007, BIOCHEM MEDICA, V17, P151; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rollof L, 2012, J PEDIATR ENDOCR MET, V25, P125, DOI 10.1515/JPEM.2011.440; Sattoe JNT, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-10; Spilsbury JC, 2014, SLEEP; Tapia IE, 2013, PAEDIATR RESPIR REV, V14, P199, DOI 10.1016/j.prrv.2012.05.006; Taylor SJC, 2001, PAEDIATR PERINAT EP, V15, P88; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Vetter TR, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-85; Willis BH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000746; Witmans MB, 2003, AM J RESP CRIT CARE, V168, P1540, DOI 10.1164/ajrccm.168.12.954; Wu Y, 2001, J ADOLESCENT HEALTH, V28, P197, DOI 10.1016/S1054-139X(00)00163-4; Xu ZF, 2008, CHEST, V133, P684, DOI 10.1378/chest.07-1611	41	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142242	10.1371/journal.pone.0142242	http://dx.doi.org/10.1371/journal.pone.0142242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581088	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600041
J	Ke, CF; Hou, Y; Zhang, HY; Yang, K; Wang, JT; Guo, B; Zhang, F; Li, HL; Zhou, XH; Li, Y; Li, K				Ke, Chaofu; Hou, Yan; Zhang, Haiyu; Yang, Kai; Wang, Jingtao; Guo, Bing; Zhang, Fan; Li, Hailong; Zhou, Xiaohua; Li, Ying; Li, Kang			Plasma Metabolic Profiles in Women are Menopause Dependent	PLOS ONE			English	Article							OVARIAN-CANCER; SPECTROMETRY DATA; MASS; IDENTIFICATION; BIOMARKERS; DENSITY; CELL	Menopause is an endocrinological transition that greatly affects health and disease susceptibility in middle-aged and elderly women. To gain new insights into the metabolic process of menopause, plasma metabolic profiles in 115 pre-and post-menopausal women were systematically analyzed by ultra-performance liquid chromatography/mass spectrometry in conjunction with univariate and multivariate statistical analysis. Metabolic signatures revealed considerable differences between pre-and post-menopausal women, and clear separations were observed between the groups in partial least-squares discriminant analysis score plots. In total, 28 metabolites were identified as potential metabolite markers for menopause, including up-regulated acylcarnitines, fatty acids, lysophosphatidylcholines, lysophosphatidylethanolamines, and down-regulated pregnanediol-3-glucuronide, dehydroepiandrosterone sulfate, p-hydroxyphenylacetic acid and dihydrolipoic acid. These differences highlight that significant alterations occur in fatty acid beta-oxidation, phospholipid metabolism, hormone metabolism and amino acid metabolism in post-menopausal women. In conclusion, our plasma metabolomics study provides novel understanding of the metabolic profiles related to menopause, and will be useful for investigating menopause-related diseases and assessing metabolomic confounding factors.	[Ke, Chaofu; Hou, Yan; Zhang, Haiyu; Yang, Kai; Wang, Jingtao; Guo, Bing; Zhang, Fan; Li, Hailong; Li, Kang] Harbin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Harbin 150086, Peoples R China; [Zhou, Xiaohua] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Li, Ying] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin 150086, Peoples R China	Harbin Medical University; University of Washington; University of Washington Seattle; Harbin Medical University	Li, Y (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin 150086, Peoples R China.	liying_helen@163.com; likang@ems.hrbmu.edu.cn		Zhou, Xiaohua/0000-0001-7935-1222	National Natural Science Foundation of China [NSFC 81473072, 81172767]; Specialized Research Fund for the Doctoral Program of Higher Education of China [SRFDP 20122307110004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Financial support by grants from the National Natural Science Foundation of China (NSFC 81473072, 81172767, http://www.nsfc.gov.cn/) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP 20122307110004, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) are gratefully acknowledged. Kang Li is the recipient of all three funders.; Financial support by grants from the National Natural Science Foundation of China (NSFC 81473072, 81172767) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP 20122307110004) are gratefully acknowledged.	Auro K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5708; Bulati Matteo, 2008, Immun Ageing, V5, P9, DOI 10.1186/1742-4933-5-9; Fong MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019963; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Ke CF, 2015, INT J CANCER, V136, P516, DOI 10.1002/ijc.29010; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Magnusson M, 2013, EUR HEART J, V34, P1982, DOI 10.1093/eurheartj/ehs424; Ng DJY, 2011, METABOLOMICS, V7, P155, DOI 10.1007/s11306-010-0250-7; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Oliveira PJ, 2012, J LIPIDS, V2012, DOI 10.1155/2012/365798; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Rizzoli R, 2001, J MOL ENDOCRINOL, V26, P79, DOI 10.1677/jme.0.0260079; Sammaritano LR, 2012, AUTOIMMUN REV, V11, pA430, DOI 10.1016/j.autrev.2011.11.006; Shufelt C, 2010, J CLIN ENDOCR METAB, V95, P4985, DOI 10.1210/jc.2010-0143; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; STOKES J, 1987, CIRCULATION, V75, P65; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Sun M, 2013, MOL BIOSYST, V9, P3059, DOI 10.1039/c3mb70216b; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Twiss JJ, 2007, J AM ACAD NURSE PRAC, V19, P602, DOI 10.1111/j.1745-7599.2007.00260.x; Wang CS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05383; Warburton Darren E R, 2007, Vasc Health Risk Manag, V3, P673; Watanabe T, 2002, J CARDIOVASC PHARM, V39, P449, DOI 10.1097/00005344-200203000-00017; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yamatani H, 2014, MENOPAUSE, V21, P170, DOI 10.1097/GME.0b013e318296431a; Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x; Zhang HY, 2015, MOL BIOSYST, V11, P516, DOI 10.1039/c4mb00407h; Zhang T, 2013, J PROTEOME RES, V12, P505, DOI 10.1021/pr3009572; Zheng H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/537157; Zhou MS, 2010, CANCER EPIDEM BIOMAR, V19, P2262, DOI 10.1158/1055-9965.EPI-10-0126	33	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141743	10.1371/journal.pone.0141743	http://dx.doi.org/10.1371/journal.pone.0141743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580805	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600021
J	Pialasse, JP; Descarreaux, M; Mercier, P; Blouin, J; Simoneau, M				Pialasse, Jean-Philippe; Descarreaux, Martin; Mercier, Pierre; Blouin, Jean; Simoneau, Martin			The Vestibular-Evoked Postural Response of Adolescents with Idiopathic Scoliosis Is Altered	PLOS ONE			English	Article							LORDOSIS BEHAVIOR; BALANCE REACTIONS; STIMULATION; ORGANIZATION; SENSITIVITY; INTEGRATION; MECHANISMS; INCREASES; VELOCITY; ETIOLOGY	Adolescent idiopathic scoliosis is a multifactorial disorder including neurological factors. A dysfunction of the sensorimotor networks processing vestibular information could be related to spine deformation. This study investigates whether feed-forward vestibulomotor control or sensory reweighting mechanisms are impaired in adolescent scoliosis patients. Vestibular evoked postural responses were obtained using galvanic vestibular stimulation while participants stood with their eyes closed and head facing forward. Lateral forces under each foot and lateral displacement of the upper body of adolescents with mild (n = 20) or severe (n = 16) spine deformation were compared to those of healthy control adolescents (n = 16). Adolescent idiopathic scoliosis patients demonstrated greater lateral displacement and net lateral forces than controls both during and immediately after vestibular stimulation. Altered sensory reweighting of vestibular and proprioceptive information changed balance control of AIS patients during and after vestibular stimulation. Therefore, scoliosis onset could be related to abnormal sensory reweighting, leading to altered sensorimotor processes.	[Pialasse, Jean-Philippe; Simoneau, Martin] Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ, Canada; [Pialasse, Jean-Philippe; Simoneau, Martin] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Descarreaux, Martin] Univ Quebec Trois Rivieres, Dept Sci Act Phys, Trois Rivieres, PQ GA9 5H7, Canada; [Mercier, Pierre] Clin Orthopedie Infantile Quebec, Quebec City, PQ, Canada; [Blouin, Jean] Aix Marseille Univ, Lab Neurosci Cognit, FR 3C 3512, CNRS, Marseille, France	Laval University; Laval University; University of Quebec; University of Quebec Trois Rivieres; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Simoneau, M (corresponding author), Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ, Canada.	martin.simoneau@kin.ulaval.ca	Simoneau, Martin/AAE-3727-2020	Simoneau, Martin/0000-0003-3207-1973; Descarreaux, Martin/0000-0002-3545-5860; Blouin, Jean/0000-0002-8118-8994	Fondation Yves Cotrel-Institut de France; Fondation Chiropratique du Quebec; Ordre des chiropraticiens du Quebec; Fonds de Recherche du Quebec en Sante; European Chiropractic Union	Fondation Yves Cotrel-Institut de France; Fondation Chiropratique du Quebec; Ordre des chiropraticiens du Quebec; Fonds de Recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); European Chiropractic Union	Funding for this study was provided by a research grant from the Fondation Yves Cotrel-Institut de France (MS and JB). The first author (JPP) received scholarships (JPP) from the Fondation Chiropratique du Quebec and the Ordre des chiropraticiens du Quebec in partnership with the Fonds de Recherche du Quebec en Sante and from the European Chiropractic Union.	ADLER N, 1986, J ORTHOPAED RES, V4, P102, DOI 10.1002/jor.1100040113; Ali AS, 2003, J PHYSIOL-LONDON, V546, P615, DOI 10.1113/jphysiol.2002.030031; Ardic FN, 2000, ACTA OTO-LARYNGOL, V120, P39; BARRIOS C, 1992, INT ORTHOP, V16, P146, DOI 10.1007/BF00180206; BARRIOS C, 1987, SPINE, V12, P433, DOI 10.1097/00007632-198706000-00003; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; BYL NN, 1993, J ORTHOP RES, V11, P215, DOI 10.1002/jor.1100110209; Byl NN, 1997, J ORTHOP SPORT PHYS, V26, P60, DOI 10.2519/jospt.1997.26.2.60; Day BL, 2002, BRAIN, V125, P2081, DOI 10.1093/brain/awf212; Domenech J, 2011, EUR SPINE J, V20, P1069, DOI 10.1007/s00586-011-1776-8; Gauchard GC, 2001, SPINE, V26, P1052, DOI 10.1097/00007632-200105010-00014; GENTINE A, 1990, ACTA OTO-LARYNGOL, V110, P328, DOI 10.3109/00016489009122556; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; Haumont T, 2011, SPINE, V36, pE847, DOI 10.1097/BRS.0b013e3181ff5837; HERMAN R, 1985, SPINE, V10, P1, DOI 10.1097/00007632-198501000-00001; Horak FB, 2001, J NEUROPHYSIOL, V86, P575, DOI 10.1152/jn.2001.86.2.575; Lambert FM, 2013, J NEUROSCI, V33, P6845, DOI 10.1523/JNEUROSCI.4842-12.2013; Lambert FM, 2009, J NEUROSCI, V29, P12477, DOI 10.1523/JNEUROSCI.2583-09.2009; Lion A, 2013, SPINE, V38, P238, DOI 10.1097/BRS.0b013e31826a3b05; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; Manzoni D, 2002, ARCH ITAL BIOL, V140, P67; Marsden JF, 2005, J NEUROL NEUROSUR PS, V76, P670, DOI 10.1136/jnnp.2004.046565; Marsden JF, 2003, J PHYSIOL-LONDON, V548, P949, DOI 10.1113/jphysiol.2002.029991; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; SAHLSTRAND T, 1978, ACTA ORTHOP SCAND, V49, P354, DOI 10.3109/17453677809050088; SAHLSTRAND T, 1980, SCAND J REHABIL MED, V12, P25; SAHLSTRAND T, 1979, ACTA ORTHOP SCAND, V50, P275, DOI 10.3109/17453677908989768; SAHLSTRAND T, 1980, SPINE, V5, P512, DOI 10.1097/00007632-198011000-00005; SCHWARTZGIBLIN S, 1984, EXP NEUROL, V85, P297, DOI 10.1016/0014-4886(84)90142-0; SCHWARTZGIBLIN S, 1984, BRAIN RES, V299, P247, DOI 10.1016/0006-8993(84)90706-6; SIEGEL JM, 1983, J NEUROPHYSIOL, V50, P696, DOI 10.1152/jn.1983.50.3.696; Simoneau M, 2006, EXP BRAIN RES, V170, P576, DOI 10.1007/s00221-005-0246-0; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; Simoneau M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-102; WANG Wen, 2011, J METEOROL ENV, V27, P1, DOI DOI 10.1097/BP0.0B013E3181F73C12; Wardman DL, 2003, J PHYSIOL-LONDON, V547, P293, DOI 10.1113/jphysiol.2002.030767; WEINSTEIN SL, 1994, J PEDIATR ORTHOPED, V14, P561, DOI 10.1097/01241398-199409000-00001; Wiener-Vacher SR, 1998, J PEDIATR-US, V132, P1028, DOI 10.1016/S0022-3476(98)70403-2; YAMADA K, 1984, CLIN ORTHOP RELAT R, P50; [No title captured]	42	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143124	10.1371/journal.pone.0143124	http://dx.doi.org/10.1371/journal.pone.0143124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580068	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600087
J	te Molder, L; Sonnenberg, A				te Molder, Lisa; Sonnenberg, Arnoud			PKD2 and RSK1 Regulate Integrin beta 4 Phosphorylation at Threonine 1736	PLOS ONE			English	Article							PROTEIN-KINASE; EPIDERMOLYSIS-BULLOSA; CYTOPLASMIC DOMAIN; IN-VITRO; ALPHA-6-BETA-4; ACTIVATION; PLECTIN; SUBUNIT; SKIN; HEMIDESMOSOMES	The integrin alpha 6 beta 4, a major component of hemidesmosomes (HDs), stabilizes keratinocyte cell adhesion to the epidermal basement membrane through binding to the cytoskeletal linker protein plectin and association with keratin filaments. Disruption of the alpha 6 beta 4-plectin interaction through phosphorylation of the beta 4 subunit results in a reduction in adhesive strength of keratinocytes to laminin-332 and the dissolution of HDs. Previously, we have demonstrated that phosphorylation of T1736 in the C-terminal end of the beta 4 cytoplasmic domain disrupts the interaction of beta 4 with the plakin domain of plectin. Furthermore, we showed that beta 4-T1736 can be phosphorylated by PKD1 in vitro, and although both PMA and EGF induced T1736 phosphorylation, only PMA was able to activate PKD1. Here, we show that depletion of [Ca2+](i) augments PMA- and EGF-induced phosphorylation of beta 4-T1736 and that this is caused by inhibition of the calcium-sensitive protein phosphatase calcineurin and augmentation of ERK1/2 activation. We also show that in keratinocytes the PMA-stimulated phosphorylation of beta 4-T1736 primarily is mediated by PKD2 activation downstream of PKC delta. On the other hand, both the EGF-stimulated phosphorylation of T1736 and the EGF-induced dissolution of HDs are dependent on a functional MAPK signaling pathway, and treatment with the RSK inhibitor BI-D1870 prevented EGF-stimulated phosphorylation of beta 4-T1736. Moreover, phosphorylation of beta 4-T1736 is enhanced by overexpression of wild-type RSK1, while it is reduced by the expression of kinase-inactive RSK1 or by siRNA-mediated depletion of RSK1. In summary, our data indicate that different stimuli can lead to the phosphorylation of beta 4-T1736 by either PKD2 or RSK1.	[te Molder, Lisa; Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Sonnenberg, A (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.sonnenberg@nki.nl			Dutch Cancer Society [2009-4485]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by a grant (2009-4485) from the Dutch Cancer Society. The funder had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Alt A, 2004, BIOCHEM BIOPH RES CO, V314, P17, DOI 10.1016/j.bbrc.2003.12.053; Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bouameur JE, 2013, J CELL SCI, V126, P4195, DOI 10.1242/jcs.127779; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; Frijns E, 2012, MOL BIOL CELL, V23, P1475, DOI 10.1091/mbc.E11-11-0957; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Ji QS, 2000, ONCOGENE, V19, P1853, DOI 10.1038/sj.onc.1203517; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kashyap T, 2012, J BIOL CHEM, V287, P32440, DOI 10.1074/jbc.M112.385245; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; Koster J, 2001, J INVEST DERMATOL, V117, P1405, DOI 10.1046/j.0022-202x.2001.01567.x; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Niessen CM, 1997, MOL BIOL CELL, V8, P555, DOI 10.1091/mbc.8.4.555; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; Ohkura K, 1998, BIOL PHARM BULL, V21, P1; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; Seltmann K, 2013, J INVEST DERMATOL, V133, P181, DOI 10.1038/jid.2012.256; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; Uitto J, 2001, ARCH DERMATOL, V137, P1458; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	41	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143357	10.1371/journal.pone.0143357	http://dx.doi.org/10.1371/journal.pone.0143357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580203	Green Submitted, gold, Green Published			2022-12-27	WOS:000365154600115
J	Bhatt, SP; Misra, A; Nigam, P; Guleria, R; Pasha, MAQ				Bhatt, Surya Prakash; Misra, Anoop; Nigam, Priyanka; Guleria, Randeep; Pasha, M. A. Qadar			Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; METABOLIC SYNDROME; SOUTH ASIANS; VISCERAL FAT; STEATOSIS; ADOLESCENTS; CHILDREN; POPULATION; PREVALENCE	Objective In this study, we have attempted comparison of detailed body composition phenotype of Asian Indians with non-alcoholic fatty liver disease (NAFLD) vs. those without, in a case controlled manner. We also aim to analyse prediction equations for NAFLD for non-diabetic Asian Indians, and compare performance of these with published prediction equations researched from other populations. Methods In this case-control study, 162 cases and 173 age-and sex-matched controls were recruited. Clinical, anthropometric, metabolic, and body composition profiles, and liver ultrasound were done. Fasting insulin levels, value of homeostasis model assessment of insulin resistance (HOMA-IR), and serum high sensitive C-reactive protein (hs-CRP) levels were evaluated. Multivariate logistic and linear regression analyses were used to arrive at prediction equations for fatty liver [Indian fatty liver index (IFLI)]. Results As compared to those without fatty liver, those with fatty liver exhibited the following; Excess dorsocervical fat ('Buffalo hump'), skin tags, xanthelasma, 'double chin', arcus; excess total, abdominal and subcutaneous adiposity, and high blood pressure, blood glucose, measures of insulin resistance (fasting insulin and HOMA-IR values), lipids and hs-CRP levels. Two prediction equations were developed; Clinical [Indian Fatty Liver Index-Clinical; IFLIC]: 1(double chin) + 15.5 (systolic blood pressure) + 13.8 (buffalo hump); and IFLI-Clinical and Biochemical (CB): serum triglycerides+ 12 (insulin)+ 1(systolic blood pressure) + 18 (buffalo hump). On ROC Curve analysis, IFLI performed better than all published prediction equations, except one. Conclusion Non-diabetic Asian Indians with NAFLD researched by us were overweight/obese, had excess abdominal and subcutaneous fat, multiple other phenotypic markers, had higher insulin resistance, glycemia, dyslipidemia and subclinical inflammation than those without. Prediction score developed by us for NAFLD; IFLI-C and IFLI-CB, should be useful for clinicians and researchers.	[Bhatt, Surya Prakash; Misra, Anoop; Nigam, Priyanka] Diabet Fdn India, New Delhi, India; [Bhatt, Surya Prakash; Misra, Anoop; Nigam, Priyanka] Natl Diabet Obes & Cholesterol Fdn N DOC, New Delhi, India; [Bhatt, Surya Prakash; Guleria, Randeep] All India Inst Med Sci, Dept Pulm Med & Sleep Disorders, New Delhi, India; [Misra, Anoop] Fortis C DOC Ctr Excellence Diabet Metab Dis & En, New Delhi, India; [Bhatt, Surya Prakash; Pasha, M. A. Qadar] CSIR, Inst Genom & Integrat Biol, Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Misra, A (corresponding author), Diabet Fdn India, New Delhi, India.	anoopmisra@gmail.com	Bhatt, Surya/K-5263-2019; Bhatt, Surya Prakash/X-5941-2018	Bhatt, Surya/0000-0001-9489-9747; Bhatt, Surya Prakash/0000-0001-9489-9747	Indian Council of Medical Research Government of India [5/9/70/2008-RHM]	Indian Council of Medical Research Government of India(Indian Council of Medical Research (ICMR))	This study was fully supported by a grant from the Indian Council of Medical Research (No. 5/9/70/2008-RHM) Government of India. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj S, 2009, INDIAN J MED RES, V129, P285; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bedogni G, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-98; Bhatt SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040977; CHANDALIA M, 2012, J CLIN ENDOCR METAB, V97, P4663, DOI [DOI 10.1210/jc.2012-2018, DOI 10.1210/JC.2012-2018]; Chowdhury B, 1996, METABOLISM, V45, P634, DOI 10.1016/S0026-0495(96)90036-0; Damaso AR, 2008, DIGEST LIVER DIS, V40, P132, DOI 10.1016/j.dld.2007.09.009; Dudeja V, 2001, BRIT J NUTR, V86, P105, DOI 10.1079/BJN2001382; Fallo F, 2009, NUTR METAB CARDIOVAS, V19, P646, DOI 10.1016/j.numecd.2008.12.007; Garg A, 2004, INT TXB DIABETES MEL; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Joseph L, 2011, DIABETES TECHNOL THE, V13, P899, DOI 10.1089/dia.2011.0014; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI DOI 10.1093/AJE/KWS448; Lin YC, 2010, PEDIATR NEONATOL, V51, P149, DOI 10.1016/S1875-9572(10)60028-9; Liu SH, 2013, J GASTROENTEROL, V48, P1151, DOI 10.1007/s00535-012-0715-8; Madhavan Malini, 2005, Lipids Health Dis, V4, P20, DOI 10.1186/1476-511X-4-20; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Misra A, 2014, DIABETIC MED, V31, P1153, DOI 10.1111/dme.12540; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, PLOS ONE IN PRESS; Misra A., 2008, DIABETES RES CLIN PR, V79, P1; Misra A, 2013, NUTRIENTS, V5, P2708, DOI 10.3390/nu5072708; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Mohan V, 2009, DIABETES RES CLIN PR, V84, P84, DOI 10.1016/j.diabres.2008.11.039; Nishi T, 2015, J DIABETES INVEST, V6, P309, DOI 10.1111/jdi.12290; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; PETERS J, 1992, ANN HUM BIOL, V19, P17, DOI 10.1080/03014469200001882; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; Santos RR, 2006, REV BRAS NUTR CLIN, V21, P229; TAM K-M, 1986, Taiwan yixuehui zazhi, V85, P45	35	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142260	10.1371/journal.pone.0142260	http://dx.doi.org/10.1371/journal.pone.0142260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599361	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600009
J	Kaye, KS; Patel, DA; Stephens, JM; Khachatryan, A; Patel, A; Johnson, K				Kaye, Keith S.; Patel, Dipen A.; Stephens, Jennifer M.; Khachatryan, Alexandra; Patel, Ayush; Johnson, Kenneth			Rising United States Hospital Admissions for Acute Bacterial Skin and Skin Structure Infections: Recent Trends and Economic Impact	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; RESISTANT STAPHYLOCOCCUS-AUREUS; PRACTICE GUIDELINES; DISEASES SOCIETY; EMERGENCE; AMERICA; VISITS	Background The number of ambulatory patients seeking treatment for skin and skin structure infections (SSSI) are increasing. The objective of this study is to determine recent trends in hospital admissions and healthcare resource utilization and identify covariates associated with hospital costs and mortality for hospitalized adult patients with a primary SSSI diagnosis in the United States. Methods We performed a retrospective cross-sectional analysis (years 2005-2011) of data from the US Healthcare Cost and Utilization Project National Inpatient Sample. Recent trends, patient characteristics, and healthcare resource utilization for patients hospitalized with a primary SSSI diagnosis were evaluated. Descriptive and bivariate analyses were conducted to assess patient and hospital characteristics. Results A total of 1.8% of hospital admissions for the years 2005 through 2011 were for adult patients with a SSSI primary diagnosis. SSSI-related hospital admissions significantly changed during the study period (P<.001 for trend) ranging from 1.6% (in 2005) to 2.0% (in 2011). Mean hospital length of stay (LOS) decreased from 5.4 days in the year 2005 to 5.0 days in the year 2011 (overall change, P<.001) with no change in hospital costs. Patients with postoperative wound infections had the longest hospital stays (adjusted mean, 5.81 days; 95% confidence interval (CI), 5.80-5.83) and highest total costs (adjusted mean, $9388; 95% CI, $9366-$9410). Year of hospital admission was strongly associated with mortality; infection type, all patient refined diagnosis related group severity of illness level, and LOS were strongly associated with hospital costs. Conclusions Hospital admissions for adult patients in the United States with a SSSI primary diagnosis continue to increase. Decreasing hospital inpatient LOS and mortality rate may be due to improved early treatment. Future research should focus on identifying alternative treatment processes for patients with SSSI that could shift management from inpatient to outpatient treatment settings.	[Kaye, Keith S.] Wayne State Univ, Detroit, MI USA; [Kaye, Keith S.] Detroit Med Ctr, Detroit, MI USA; [Patel, Dipen A.; Stephens, Jennifer M.; Khachatryan, Alexandra; Patel, Ayush] Pharmerit Int, Bethesda, MD 20814 USA; [Johnson, Kenneth] Durata Therapeut, Chicago, IL USA	Wayne State University; Detroit Medical Center	Stephens, JM (corresponding author), Pharmerit Int, Bethesda, MD 20814 USA.	jstephens@pharmerit.com	Kaye, Keith/AAF-1048-2019		Durata Therapeutics	Durata Therapeutics	This study was funded by Durata Therapeutics, and the funders had role in study conceptualization, design and manuscript writing. Pharmerit authors were involved with study design, data analysis and preparation of the manuscript.	Edelsberg J, 2008, INFECT CONT HOSP EP, V29, P160, DOI 10.1086/526444; Edelsberg J, 2009, EMERG INFECT DIS, V15, P1516, DOI 10.3201/eid1509.081228; [Food and Drug Administration Center for Drug Evaluation Research Guidance for industry US Department of Health and Human Services], 2013, GUID IND AC BACT SKI; HCUP Nationwide Inpatient Sample (NIS), 2012, HCUP NATIONWIDE INPA; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Merritt C, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-26; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Qualls ML, 2012, CLIN INFECT DIS, V55, P103, DOI 10.1093/cid/cis342; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Suaya JA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-296	11	62	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143276	10.1371/journal.pone.0143276	http://dx.doi.org/10.1371/journal.pone.0143276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599005	Green Submitted, gold, Green Published			2022-12-27	WOS:000365862600043
J	MacNamara, A; Collins, D				MacNamara, Aine; Collins, Dave			Second Chances: Investigating Athletes' Experiences of Talent Transfer	PLOS ONE			English	Article							PSYCHOLOGICAL CHARACTERISTICS; PERFORMANCE; SKILLS; SPORT; IDENTIFICATION; EXPERTISE; PATHWAY	Talent transfer initiatives seek to transfer talented, mature individuals from one sport to another. Unfortunately talent transfer initiatives seem to lack an evidence-based direction and a rigorous exploration of the mechanisms underpinning the approach. The purpose of this exploratory study was to identify the factors which successfully transferring athletes cite as facilitative of talent transfer. In contrast to the anthropometric and performance variables that underpin current talent transfer initiatives, participants identified a range of psycho-behavioral and environmental factors as key to successful transfer. We argue that further research into the mechanisms of talent transfer is needed in order to provide a strong evidence base for the methodologies employed in these initiatives.	[MacNamara, Aine; Collins, Dave] Univ Cent Lancashire, Inst Coaching & Performance, Preston PR1 2HE, Lancs, England	University of Central Lancashire	MacNamara, A (corresponding author), Univ Cent Lancashire, Inst Coaching & Performance, Preston PR1 2HE, Lancs, England.	Amacnamara1@uclan.ac.uk						Abbott A, 2004, J SPORT SCI, V22, P395, DOI 10.1080/02640410410001675324; Abbott Angela, 2005, Nonlinear Dynamics Psychol Life Sci, V9, P61; Baker J, 2004, HIGH ABIL STUD, V15, P211, DOI 10.1080/1359813042000314781; Bransford JD, 1999, REV RES EDUC, V24, P61, DOI 10.3102/0091732X024001061; CAMPIONE JC, 1990, DIAGNOSTIC MONITORING OF SKILL AND KNOWLEDGE ACQUISITION, P141; Collins R, 2014, J SPORT SCI, V32, P1621, DOI 10.1080/02640414.2014.908324; Cote J., 1993, SPORT PSYCHOL, V6, P55; De Corte E, 2003, CURR DIR PSYCHOL SCI, V12, P142, DOI 10.1111/1467-8721.01250; Dickens WT, 2001, PSYCHOL REV, V108, P346, DOI 10.1037/0033-295X.108.2.346; Drasch K, 2013, QUAL QUANT, V47, P817, DOI 10.1007/s11135-011-9568-0; Duckworth AL, 2001, J PERS SOC PSYCHOL, V92, P1087; Ericsson K.A., 1991, GEN THEORY EXPERTISE; Ericsson KA, 1993, EXPERT PERFORMANCE S, P371; Feldman DH., 1995, HDB PARENTING, V1995, P285; Gagne F., 2000, INT HDB GIFTEDNESS T, P670; Gagne F., 1999, PSYCHOL MUSIC, V27, P38, DOI [10.1177/0305735699271004, DOI 10.1177/0305735699271004]; Halson S, 2006, INTJ SPORT PHYSIOL, V1, P65, DOI 10.1123/ijspp.1.1.65; Haskell RE., 2001, TRANSFER LEARNING CO; Hatano Giyoo, 1999, INT J EDUC RES, V31, P645, DOI DOI 10.1016/S0883-0355(99)00029-4; Helsen WF, 2000, J SPORT SCI, V18, P727; MacMahon C., 2008, DEV SPORT EXPERTISE, P60; MacNamara A, 2011, J SPORT SCI, V29, P1353, DOI 10.1080/02640414.2011.568510; MacNamara A, 2010, SPORT PSYCHOL, V24, P52, DOI 10.1123/tsp.24.1.52; MacNamara A, 2010, SPORT PSYCHOL, V24, P74, DOI 10.1123/tsp.24.1.74; Martindale RJJ, 2010, J SPORT SCI, V28, P1209, DOI 10.1080/02640414.2010.495993; Mayer RC, 1999, HDB ED PSYCHOL, P47; Ollis S, 2006, J SPORT SCI, V24, P309, DOI 10.1080/17461390500188710; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Phillips E, 2010, SPORTS MED, V40, P271, DOI 10.2165/11319430-000000000-00000; Pinder RA, 2013, J SPORT SCI, V31, P803, DOI 10.1080/02640414.2012.718090; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Simonton DK, 2001, CURR DIR PSYCHOL SCI, V10, P39, DOI 10.1111/1467-8721.00110; Slavin RE, 2008, EUR EDUC RES J, V7, P124, DOI 10.2304/eerj.2008.7.1.124; Sparkes AC, 1998, SPORT PSYCHOL, V12, P363, DOI 10.1123/tsp.12.4.363; Strauss A., 1998, BASICS QUALITATIVE R; UK Sport, 2008, LOND 2012 IT COULD B; UK Sport, SPORT GIANTS CEL 5 A; UK Sport, TAL ID CONF DEV FIND; Vaeyens R, 2009, J SPORT SCI, V27, P1367, DOI 10.1080/02640410903110974; Van Yperen NW, 2009, SPORT PSYCHOL, V23, P317, DOI 10.1123/tsp.23.3.317	40	11	12	11	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143592	10.1371/journal.pone.0143592	http://dx.doi.org/10.1371/journal.pone.0143592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7DU	26600303	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600090
J	Masso, A; Sanchez, A; Gimenez-Llort, L; Lizcano, JM; Canete, M; Garcia, B; Torres-Lista, V; Puig, M; Bosch, A; Chillon, M				Masso, Anna; Sanchez, Angela; Gimenez-Llort, Lydia; Lizcano, Jose Miguel; Canete, Manuel; Garcia, Belen; Torres-Lista, Virginia; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel			Secreted and Transmembrane alpha Klotho Isoforms Have Different Spatio-Temporal Profiles in the Brain during Aging and Alzheimer's Disease Progression	PLOS ONE			English	Article							TRANSCRIPTS ENCODING MEMBRANE; ANTIAGING PROTEIN KLOTHO; ENHANCES COGNITION; RHESUS-MONKEY; GENE; MOUSE; MICE; EXPRESSION; CLEAVAGE; IDENTIFICATION	The Klotho protein is a beta-glucuronidase, and its overexpression is associated with life extension. Its mechanism of action is not fully understood, although it has been recently reported that alpha Klotho improves synaptic and cognitive functions, and it may also influence a variety of structures and functions during CNS maturation and aging. The alpha Klotho gene has two transcripts, one encoding a transmembrane isoform (m-KL), and the other a putative secreted isoform (s-KL). Unfortunately, little is known about the secreted alpha Klotho isoform, since available antibodies cannot discriminate s-KL from the KL1 domain cleaved from the transmembrane isoform. This study shows, for the first time, that the klotho transcript produced by alternative splicing generates a stable protein (70 kDa), and that in contrast to the transmembrane Klotho isoform, it is ten times more abundant in the brain than in the kidney suggesting that the two isoforms may have different functions. We also studied whether klotho expression in the CNS was influenced by aging, Alzheimer's disease (AD), or a healthy lifestyle, such as voluntary moderate continuous exercise. We observed a strong correlation between high expression levels of the two klotho transcripts and the healthy status of the animals. Expression of Klotho in brain areas decayed more rapidly in the 3xTg-AD model of AD than in healthy animals, whilst moderate continuous exercise in adulthood prevents the decline in expression of both klotho transcripts.	[Masso, Anna; Sanchez, Angela; Lizcano, Jose Miguel; Canete, Manuel; Garcia, Belen; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Masso, Anna; Sanchez, Angela; Canete, Manuel; Garcia, Belen; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy CBATEG, Bellaterra, Spain; [Gimenez-Llort, Lydia; Lizcano, Jose Miguel; Torres-Lista, Virginia] Univ Autonoma Barcelona, Inst Neurociencies, Bellaterra, Spain; [Gimenez-Llort, Lydia; Torres-Lista, Virginia] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Bellaterra, Spain; [Chillon, Miguel] ICREA, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; ICREA	Chillon, M (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain.	miguel.chillon@uab.es	Bosch, Assumpcio/C-7593-2015; Llort, Lydia Gimenez/AAS-7415-2020; lizcano, jose m/AAK-3577-2020; Giménez-Llort, Lydia/I-3347-2015; Lizcano, Jose M/E-6080-2010; Giménez-Llort, Lydia/AAI-5182-2021; Torres-Lista, Virginia/AAM-6753-2020; Masso, Anna/AAA-7656-2019	Bosch, Assumpcio/0000-0002-7205-2796; lizcano, jose m/0000-0002-3154-5383; Lizcano, Jose M/0000-0002-3154-5383; Giménez-Llort, Lydia/0000-0002-4091-489X; Torres-Lista, Virginia/0000-0002-0603-5111; 	Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR14-1354, SGR09-1300]; Universitat Autonoma de Barcelona; FPU-Ministerio de Educacion, Cultura y Deporte national fellowship; ICREA Funding Source: Custom	Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Universitat Autonoma de Barcelona; FPU-Ministerio de Educacion, Cultura y Deporte national fellowship; ICREA(ICREA)	This work was supported by the Agencia de Gestio d'Ajuts Universitaris i de Recerca SGR14-1354 and SGR09-1300. M.P. and A.S. have been recipients of the TSR program from the Universitat Autonoma de Barcelona, and of an FPU-Ministerio de Educacion, Cultura y Deporte national fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-155; Bartke A, 2006, TRENDS ENDOCRIN MET, V17, P33, DOI 10.1016/j.tem.2006.01.002; Bektas A, 2004, MAMM GENOME, V15, P759, DOI 10.1007/s00335-004-2375-3; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen CD, 2014, BIOCHEMISTRY-US, V53, P5579, DOI 10.1021/bi500409n; Chen CD, 2013, J NEUROSCI, V33, P1927, DOI 10.1523/JNEUROSCI.2080-12.2013; Clinton SM, 2013, BRAIN RES, V1527, P1, DOI 10.1016/j.brainres.2013.06.044; Di Bona D, 2014, REJUV RES, V17, P212, DOI 10.1089/rej.2013.1523; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Forster RE, 2011, BIOCHEM BIOPH RES CO, V414, P557, DOI 10.1016/j.bbrc.2011.09.117; Garcia-Mesa Y, 2016, J GERONTOL A-BIOL, V71, P40, DOI 10.1093/gerona/glv005; Garcia-Mesa Y, 2011, J ALZHEIMERS DIS, V24, P421, DOI 10.3233/JAD-2011-101635; German DC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.018; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; King GD, 2012, AGE, V34, P1405, DOI 10.1007/s11357-011-9315-4; Kosakai A, 2011, BRAIN RES, V1382, P109, DOI 10.1016/j.brainres.2011.01.056; Kuang X, 2014, NEUROBIOL AGING, V35, P169, DOI 10.1016/j.neurobiolaging.2013.07.019; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Matsubara T, 2014, AM J PHYSIOL-HEART C, V306, pH348, DOI 10.1152/ajpheart.00429.2013; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Nagai Taku, 2003, FASEB Journal, V17, P50; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Papaconstantinou J, 2009, MOL CELL ENDOCRINOL, V299, P89, DOI 10.1016/j.mce.2008.11.025; Park SJ, 2014, ENDOCRINOL METAB, V29, P336, DOI 10.3803/EnM.2014.29.3.336; Phelps M, 2013, BIOGERONTOLOGY, V14, P729, DOI 10.1007/s10522-013-9447-2; Semba RD, 2014, NEUROSCI LETT, V558, P37, DOI 10.1016/j.neulet.2013.10.058; Shiozaki M, 2008, NEUROSCIENCE, V152, P924, DOI 10.1016/j.neuroscience.2008.01.032; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Uchida A, 2001, J NEUROSCI RES, V64, P364, DOI 10.1002/jnr.1087; Wang YH, 2009, AGEING RES REV, V8, P43, DOI 10.1016/j.arr.2008.10.002	36	41	43	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143623	10.1371/journal.pone.0143623	http://dx.doi.org/10.1371/journal.pone.0143623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599613	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600095
J	Chung, T; Youn, H; Yeom, CJ; Kang, KW; Chung, JK				Chung, Taemoon; Youn, Hyewon; Yeom, Chan Joo; Kang, Keon Wook; Chung, June-Key			Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; N-LINKED GLYCOSYLATION; THYROID NA+/I-SYMPORTER; REPORTER GENE; CYCLIC-AMP; EXPRESSION; BREAST; TUNICAMYCIN; CELLS; GLYCOPROTEIN	Purpose Human sodium/iodide symporter (hNIS) protein is a membrane glycoprotein that transports iodide ions into thyroid cells. The function of this membrane protein is closely regulated by post-translational glycosylation. In this study, we measured glycosylation-mediated changes in subcellular location of hNIS and its function of iodine uptake. Methods HeLa cells were stably transfected with hNIS/tdTomato fusion gene in order to monitor the expression of hNIS. Cellular localization of hNIS was visualized by confocal microscopy of the red fluorescence of tdTomato. The expression of hNIS was evaluated by RT-PCR and immunoblot analysis. Functional activity of hNIS was estimated by radioiodine uptake. Cyclic AMP (cAMP) and tunicamycin were used to stimulate and inhibit glycosylation, respectively. In vivo images were obtained using a Maestro fluorescence imaging system. Results cAMP-mediated Glycosylation of NIS resulted in increased expression of hNIS, stimulating membrane translocation, and enhanced radioiodine uptake. In contrast, inhibition of glycosylation by treatment with tunicamycin dramatically reduced membrane translocation of intracellular hNIS, resulting in reduced radioiodine uptake. In addition, our hNIS/tdTomato fusion reporter successfully visualized cAMP-induced hNIS expression in xenografted tumors from mouse model. Conclusions These findings clearly reveal that the membrane localization of hNIS and its function of iodine uptake are glycosylation-dependent, as our results highlight enhancement of NIS expression and glycosylation with subsequent membrane localization after cAMP treatment. Therefore, enhancing functional NIS by the increasing level of glycosylation may be suggested as a promising therapeutic strategy for cancer patients who show refractory response to conventional radioiodine treatment.	[Chung, Taemoon; Youn, Hyewon; Yeom, Chan Joo; Kang, Keon Wook; Chung, June-Key] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Chung, Taemoon; Kang, Keon Wook; Chung, June-Key] Seoul Natl Univ, Coll Med, Biomed Sci, Seoul, South Korea; [Chung, Taemoon; Youn, Hyewon; Kang, Keon Wook; Chung, June-Key] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Youn, Hyewon; Chung, June-Key] Seoul Natl Univ, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea; [Youn, Hyewon] Seoul Natl Univ Hosp, Canc Imaging Ctr, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Youn, H (corresponding author), Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea.	hwyoun@snu.ac.kr; jkchung@snu.ac.kr	Kang, Keon Wook/J-1385-2012	Kang, Keon Wook/0000-0003-2622-9017; Youn, Hyewon/0000-0003-1006-2689	National Research Foundation (NRF) - Ministry of Science and ICT & Future Planning (MSIP) [2011-0030001, 2012M2A2A7014020]; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C0311020014, HI13C0826, HI14C1072]; KRIBB Research Initiative Program; SNUH Research funds [03-2011-0420111150, 03-2012-0320120360]	National Research Foundation (NRF) - Ministry of Science and ICT & Future Planning (MSIP); Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; KRIBB Research Initiative Program; SNUH Research funds	This work was supported by grants from the National Research Foundation (NRF) funded by the Ministry of Science and ICT & Future Planning (MSIP) (2011-0030001, 2012M2A2A7014020), and the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C0311020014, HI13C0826, HI14C1072), the KRIBB Research Initiative Program, and SNUH Research funds (03-2011-0420111150, 03-2012-0320120360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2000, GENE THER, V7, P694, DOI 10.1038/sj.gt.3301145; Bengel FM, 2005, EUR J NUCL MED MOL I, V32, pS404, DOI 10.1007/s00259-005-1898-5; Beyer S, 2011, ENDOCRINOLOGY, V152, P782, DOI 10.1210/en.2010-0782; Boelaert K, 2003, LANCET, V361, P796, DOI 10.1016/S0140-6736(03)12720-1; Cho JY, 2000, GENE THER, V7, P740, DOI 10.1038/sj.gt.3301170; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Dricu A, 1997, CANCER RES, V57, P543; Dwyer RM, 2011, STEM CELLS, V29, P1149, DOI 10.1002/stem.665; Gao XF, 2014, ASIAN J ANDROL, V16, P120, DOI 10.4103/1008-682X.122354; Guo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102011; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Johnson AS, 2004, MICROBIOL-SGM, V150, P2815, DOI 10.1099/mic.0.27223-0; Kang JH, 2005, J NUCL MED, V46, P479; Kang JH, 2008, J NUCL MED, V49, p164S, DOI 10.2967/jnumed.107.045955; Knostman KAB, 2004, J CLIN ENDOCR METAB, V89, P5196, DOI 10.1210/jc.2004-0907; Knostman KAB, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-137; Kogai T, 2006, ENDOCR-RELAT CANCER, V13, P797, DOI 10.1677/erc.1.01143; KONRAD M, 1994, J BIOL CHEM, V269, P8659; Konrad M, 1996, BIOCHEM J, V316, P575, DOI 10.1042/bj3160575; LARSSON O, 1993, J CELL SCI, V106, P299; LEAVITT R, 1977, J VIROL, V21, P375, DOI 10.1128/JVI.21.1.375-385.1977; Levy O, 1997, P NATL ACAD SCI USA, V94, P5568, DOI 10.1073/pnas.94.11.5568; Levy O, 1998, J BIOL CHEM, V273, P22657, DOI 10.1074/jbc.273.35.22657; Luster M, 2008, EUR J NUCL MED MOL I, V35, P1941, DOI 10.1007/s00259-008-0883-1; Min JJ, 2001, EUR J NUCL MED, V28, P639, DOI 10.1007/s002590100509; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; Riedel C, 2001, J BIOL CHEM, V276, P21458, DOI 10.1074/jbc.M100561200; Seo JH, 2010, J NUCL MED, V51, P1637, DOI 10.2967/jnumed.110.077891; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shin JH, 2004, EUR J NUCL MED MOL I, V31, P425, DOI 10.1007/s00259-003-1394-8; Spitzweg Christine, 2002, Hormones (Athens), V1, P22; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Yeom CJ, 2015, MOL IMAGING, V14, DOI 10.2310/7290.2014.00056; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	39	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142984	10.1371/journal.pone.0142984	http://dx.doi.org/10.1371/journal.pone.0142984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599396	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900051
J	Ito, F; Ku, AW; Bucsek, MJ; Muhitch, JB; Vardam-Kaur, T; Kim, M; Fisher, DT; Camoriano, M; Khoury, T; Skitzki, JJ; Gollnick, SO; Evans, SS				Ito, Fumito; Ku, Amy W.; Bucsek, Mark J.; Muhitch, Jason B.; Vardam-Kaur, Trupti; Kim, Minhyung; Fisher, Daniel T.; Camoriano, Marta; Khoury, Thaer; Skitzki, Joseph J.; Gollnick, Sandra O.; Evans, Sharon S.			Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer	PLOS ONE			English	Article							RADIO-FREQUENCY ABLATION; RENAL-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; SPONTANEOUS REGRESSION; BREAST-CARCINOMA; THERMAL ABLATION; DENDRITIC CELLS; TUMOR-GROWTH; IMPACT; MOUSE	Purpose While surgical resection is a cornerstone of cancer treatment, local and distant recurrences continue to adversely affect outcome in a significant proportion of patients. Evidence that an alternative debulking strategy involving radiofrequency ablation (RFA) induces antitumor immunity prompted the current investigation of the efficacy of performing RFA prior to surgical resection (pre-resectional RFA) in a preclinical mouse model. Experimental Design Therapeutic efficacy and systemic immune responses were assessed following pre-resectional RFA treatment of murine CT26 colon adenocarcinoma. Results Treatment with pre-resectional RFA significantly delayed tumor growth and improved overall survival compared to sham surgery, RFA, or resection alone. Mice in the pre-resectional RFA group that achieved a complete response demonstrated durable antitumor immunity upon tumor re-challenge. Failure to achieve a therapeutic benefit in immunodeficient mice confirmed that tumor control by pre-resectional RFA depends on an intact adaptive immune response rather than changes in physical parameters that make ablated tumors more amenable to a complete surgical excision. RFA causes a marked increase in intratumoral CD8(+) T lymphocyte infiltration, thus substantially enhancing the ratio of CD8(+) effector T cells: FoxP3(+) regulatory T cells. Importantly, pre-resectional RFA significantly increases the number of antigen-specific CD8(+) T cells within the tumor microenvironment and tumor-draining lymph node but had no impact on infiltration by myeloid-derived suppressor cells, M1 macrophages or M2 macrophages at tumor sites or in peripheral lymphoid organs (i.e., spleen). Finally, pre-resectional RFA of primary tumors delayed growth of distant tumors through a mechanism that depends on systemic CD8(+) T cell-mediated antitumor immunity. Conclusion Improved survival and antitumor systemic immunity elicited by pre-resectional RFA support the translational potential of this neoadjuvant treatment for cancer patients with high-risk of local and systemic recurrence.	[Ito, Fumito; Ku, Amy W.; Bucsek, Mark J.; Muhitch, Jason B.; Vardam-Kaur, Trupti; Kim, Minhyung; Fisher, Daniel T.; Camoriano, Marta; Evans, Sharon S.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Ito, Fumito; Kim, Minhyung; Skitzki, Joseph J.] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA; [Ito, Fumito] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Muhitch, Jason B.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Vardam-Kaur, Trupti] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Edwin L Steele Lab,Dept Radiat Oncol, Boston, MA USA; [Khoury, Thaer] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Gollnick, Sandra O.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Michigan System; University of Michigan; Roswell Park Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Evans, SS (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	sharon.evans@roswellpark.org		Ito, Fumito/0000-0002-6866-671X; Muhitch, Jason/0000-0002-7703-1425	National Institutes of Health [CA79765, AI082039, CA098156, CA109480, P30CA016056]; Jennifer Linscott Tietgen Family Foundation; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA098156, P01CA055791, R01CA079765, R01CA109480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI082039, R01AI082039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jennifer Linscott Tietgen Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (CA79765 and AI082039 to S.S. Evans; CA098156 and CA109480 to S.O. Gollnick; and P30CA016056 to Roswell Park Cancer Institute); and the Jennifer Linscott Tietgen Family Foundation (J.J. Skitzki and S.S. Evans). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ali MY, 2005, J HEPATOL, V43, P817, DOI 10.1016/j.jhep.2005.04.016; Arihara F, 2013, CANCER IMMUNOL IMMUN, V62, P1421, DOI 10.1007/s00262-013-1447-1; Behm B, 2016, GUT, V65, P134, DOI 10.1136/gutjnl-2014-308286; BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Brackett CM, 2013, J IMMUNOL, V191, P4348, DOI 10.4049/jimmunol.1103621; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Burak WE, 2003, CANCER, V98, P1369, DOI 10.1002/cncr.11642; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; de Bethlenfalva-Hora CE, 2014, CLIN SCI, V126, P243, DOI 10.1042/CS20130089; de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; den Brok MHMGM, 2006, BRIT J CANCER, V95, P896, DOI 10.1038/sj.bjc.6603341; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; den Brok MHMGM, 2004, CANCER RES, V64, P4024, DOI 10.1158/0008-5472.CAN-03-3949; Dromi SA, 2009, RADIOLOGY, V251, P58, DOI 10.1148/radiol.2511072175; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Evrard S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114404; Fisher DT, 2011, J CLIN INVEST, V121, P3846, DOI 10.1172/JCI44952; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gameiro SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070417; Harrison L, 2004, ONCOLOGIST, V9, P31, DOI 10.1634/theoncologist.9-90005-31; Hyder O, 2013, SURGERY, V153, P811, DOI 10.1016/j.surg.2012.12.005; Iida N, 2010, CANCER RES, V70, P6556, DOI 10.1158/0008-5472.CAN-10-0096; Ito F, 2009, ANN SURG, V250, P210, DOI 10.1097/SLA.0b013e3181afe0ab; Izzo F, 2001, CANCER, V92, P2036, DOI 10.1002/1097-0142(20011015)92:8<2036::AID-CNCR1542>3.0.CO;2-W; Jeffrey SS, 1999, ARCH SURG-CHICAGO, V134, P1064, DOI 10.1001/archsurg.134.10.1064; Johnson EE, 2009, CLIN CANCER RES, V15, P4875, DOI 10.1158/1078-0432.CCR-09-0110; Katz SC, 2013, ANN SURG ONCOL, V20, P946, DOI 10.1245/s10434-012-2668-9; Kim H, 2008, KOREAN J RADIOL, V9, P470, DOI 10.3348/kjr.2008.9.5.470; Kroeze SGC, 2012, J UROLOGY, V188, P607, DOI 10.1016/j.juro.2012.03.116; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Liu Q, 2009, MOL THER, V17, P2049, DOI 10.1038/mt.2009.221; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Michel S, 2008, BRIT J CANCER, V99, P1867, DOI 10.1038/sj.bjc.6604756; MOLE RH, 1953, BRIT J RADIOL, V26, P234, DOI 10.1259/0007-1285-26-305-234; Picardo A, 1998, SURGERY, V124, P57, DOI 10.1067/msy.1998.88371; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Rai R, 2005, J SURG RES, V129, P147, DOI 10.1016/j.jss.2005.03.020; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sanchez-Ortiz RF, 2003, J UROLOGY, V170, P178, DOI 10.1097/01.ju.0000070823.38336.7b; Schneider T, 2015, CLIN EXP IMMUNOL, V180, P467, DOI 10.1111/cei.12596; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; SOANES WA, 1970, J UROLOGY, V104, P154, DOI 10.1016/S0022-5347(17)61690-2; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vicari AP, 2000, J IMMUNOL, V165, P1992, DOI 10.4049/jimmunol.165.4.1992; Whiteside TL, 2012, SEMIN CANCER BIOL, V22, P327, DOI 10.1016/j.semcancer.2012.03.004; Wissniowski TT, 2003, CANCER RES, V63, P6496; Wong SL, 2010, J CLIN ONCOL, V28, P493, DOI 10.1200/JCO.2009.23.4450; Yang WL, 2004, ANN SURG ONCOL, V11, P399, DOI 10.1245/ASO.2004.08.013; Zerbini A, 2006, CANCER RES, V66, P1139, DOI 10.1158/0008-5472.CAN-05-2244; Zerbini A, 2008, J IMMUNOTHER, V31, P271, DOI 10.1097/CJI.0b013e318160ff1c; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	63	27	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143370	10.1371/journal.pone.0143370	http://dx.doi.org/10.1371/journal.pone.0143370			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599402	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900101
J	Mufenda, J; Gebhardt, S; van Rooyen, R; Theron, G				Mufenda, Josef; Gebhardt, Stefan; van Rooyen, Rita; Theron, Gerhard			Introducing a Mobile-Connected Umbilical Doppler Device (UmbiFlow (TM)) into a Primary Care Maternity Setting: Does This Reduce Unnecessary Referrals to Specialised Care? Results of a Pilot Study in Kraaifontein, South Africa	PLOS ONE			English	Article							RISK PREGNANCIES; CENTILE CHART; GROWTH; ARTERY; MANAGEMENT; WEIGHT; VELOCIMETRY; DIAGNOSIS; LIGHT	Objectives UmbiFlow (TM) is a mobile-connected Doppler device that utilises a continuous waveform to measure resistance in the umbilical artery. The main aim of this pilot study was to determine whether the use of UmbiFlow (TM) for umbilical artery Doppler in patients with a suspected decreased symphysis fundal (SF) growth could safely lead to a decreased number of patients requiring referral to a more specialised level of care. A secondary aim of the study was to evaluate the effectiveness of UmbiFlow (TM) Doppler as a screening tool for concealed placental insufficiency in late bookers by using a single screening cut-off value that will be abnormal for any gestation > 28 weeks. Methods The cohort comprised two groups of patients: The first group included all follow-up patients with suspected intra-uterine growth restriction (a decreased symphysis-fundus measurement based on serial assessment) who underwent on-site UmbiFlow (TM) Doppler testing performed by the midwife directly after the clinical examination. The second group included late bookers, where gestation was uncertain; but estimated > 28 weeks based on clinical grounds. This group was comprised of unselected patients who report to antenatal care late for the first time and received an UmbiFlow (TM) Doppler test for concealed placental insufficiency. Results UmbiFlow (TM) Doppler could reduce the number of false referrals to hospital by 55%. A single UmbiFlow (TM) Doppler test in late bookers appeared to identify a group of women at moderate risk of lower birth weight babies.	[Mufenda, Josef; Gebhardt, Stefan; Theron, Gerhard] Univ Stellenbosch, Dept Obstet & Gynaecol, Cape Town, South Africa; [Mufenda, Josef; Gebhardt, Stefan; Theron, Gerhard] Tygerberg Hosp, Cape Town, South Africa; [van Rooyen, Rita] MHealth Inc, San Diego, CA 92130 USA	Stellenbosch University; Tygerberg Hospital	Gebhardt, S (corresponding author), Univ Stellenbosch, Dept Obstet & Gynaecol, Cape Town, South Africa.	gsgeb@sun.ac.za		Gebhardt, Gabriel/0000-0001-8999-8193	Medical Research Council of South Africa; Council for Scientific and Industrial Research of South Africa; CSIR's	Medical Research Council of South Africa(South African Medical Research Council); Council for Scientific and Industrial Research of South Africa; CSIR's	The equipment used in this study as well as the salary for the research nurse was sponsored and funded entirely by the Medical Research Council of South Africa as well as the Council for Scientific and Industrial Research of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Council for Scientific & Industrial Research (CSIR), in collaboration with the Medical Research Council (MRC), developed the UmbiFlow (TM) system for use at primary health care clinics, aimed at ante-natal care. In order to test the system's impact in a primary health care setting, CSIR contracted Rita van Rooyen, of mHealth Inc., to help facilitate the running of a clinical study. This required consultation with the other authors of the study. CSIR's financial contribution was to the salary of Rita van Rooyen as well as to provide the UmbiFlow (TM) systems to the study. The CSIR did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of Rita van Rooyen as an author is articulated in the "author contributions" section.	Alfirevic Z, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001450.pub3; Ananth CV, 2014, SEMIN PERINATOL, V38, P131, DOI 10.1053/j.semperi.2014.03.001; [Anonymous], 2012, OBST GYN ULTR POL PR; Bolz N, 2013, J PERINAT MED, V41, P165, DOI 10.1515/jpm-2012-0042; BRINK AL, 1987, S AFR MED J, V72, P250; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Filmar G, 2013, ARCH GYNECOL OBSTET, V288, P279, DOI 10.1007/s00404-013-2764-5; Goffinet F, 1997, BRIT J OBSTET GYNAEC, V104, P425, DOI 10.1111/j.1471-0528.1997.tb11493.x; Higgins M, 2014, AM J OBSTET GYNECOL, V210, pS209, DOI 10.1016/j.ajog.2013.10.446; Lausman A, 2012, J OBSTET GYNAECOL CA, V34, P17, DOI 10.1016/S1701-2163(16)35129-5; MacDonald TM, 2015, AUST NZ J OBSTET GYN, V55, P3, DOI 10.1111/ajo.12264; Mason D, 2014, TYGERBERG HOSP PERIN; McClure EM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-73; Odendaal HJ, 2008, SAJOG-S AFR J OBSTET, V14, P33; Parra-Saavedra M, 2013, PLACENTA, V34, P1136, DOI 10.1016/j.placenta.2013.09.018; PATTINSON RC, 1989, S AFR MED J, V76, P623; Savchev S, 2014, FETAL DIAGN THER, V36, P129, DOI 10.1159/000360419; Theron GB, 2008, SAMJ S AFR MED J, V98, P270; Theron GB, 1995, S AFR MED J, V85, P1289; Theron GB, 2005, SAMJ S AFR MED J, V95, P62; Theron GB, 2002, INT J GYNECOL OBSTET, V79, P263, DOI 10.1016/S0020-7292(02)00300-4; THERON GB, 1992, INT J GYNECOL OBSTET, V39, P93, DOI 10.1016/0020-7292(92)90903-V; Thompson ML, 1997, EUR J OBSTET GYN R B, V72, P3, DOI 10.1016/S0301-2115(96)02643-7; Vedmedovska N, 2011, ARCH GYNECOL OBSTET, V284, P1087, DOI 10.1007/s00404-010-1781-x; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142743	10.1371/journal.pone.0142743	http://dx.doi.org/10.1371/journal.pone.0142743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600311	gold, Green Published			2022-12-27	WOS:000365853900038
J	Zhu, J; Wang, BB; Miao, QH; Tan, YG; Li, CF; Chen, ZY; Guo, HM; Liu, GQ				Zhu, Jie; Wang, Binbin; Miao, Qiuhong; Tan, Yonggui; Li, Chuanfeng; Chen, Zongyan; Guo, Huimin; Liu, Guangqing			Viral Genome-Linked Protein (VPg) Is Essential for Translation Initiation of Rabbit Hemorrhagic Disease Virus (RHDV)	PLOS ONE			English	Article							SUBGENOMIC RNAS; CALICIVIRUS; VISUALIZATION; EIF4E; CELLS; 4E	Rabbit hemorrhagic disease virus (RHDV), the causative agent of rabbit hemorrhagic disease, is an important member of the caliciviridae family. Currently, no suitable tissue culture system is available for proliferating RHDV, limiting the study of the pathogenesis of RHDV. In addition, the mechanisms underlying RHDV translation and replication are largely unknown compared with other caliciviridae viruses. The RHDV replicon recently constructed in our laboratory provides an appropriate model to study the pathogenesis of RHDV without in vitro RHDV propagation and culture. Using this RHDV replicon, we demonstrated that the viral genome-linked protein (VPg) is essential for RHDV translation in RK-13 cells for the first time. In addition, we showed that VPg interacts with eukaryotic initiation factor 4E (eIF4E) in vivo and in vitro and that eIF4E silencing inhibits RHDV translation, suggesting the interaction between VPg and eIF4E is involved in RHDV translation. Our results support the hypothesis that VPg serves as a novel cap substitute during the initiation of RHDV translation.	[Zhu, Jie; Wang, Binbin; Miao, Qiuhong; Tan, Yonggui; Li, Chuanfeng; Chen, Zongyan; Guo, Huimin; Liu, Guangqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Liu, GQ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China.	liugq@shvri.ac.cn	chen, zongyan/ABG-9170-2021; Zhu, Jie/X-6219-2019; Miao, Qiuhong/AAJ-1747-2020	Zhu, Jie/0000-0001-7941-4166; Miao, Qiuhong/0000-0003-3670-6227	Chinese Natural Sciences Foundation [31270194]; Innovation Project of Science and Technology Commission Foundation of Shanghai [13391901602]; National Advanced Technology Research and Development Program of China (863 Program) [2011AA10A200]	Chinese Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Innovation Project of Science and Technology Commission Foundation of Shanghai; National Advanced Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Chinese Natural Sciences Foundation (31270194), http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; the Innovation Project of Science and Technology Commission Foundation of Shanghai (No. 13391901602), http://www.cn-hightech.org/zjzz.asp; the National Advanced Technology Research and Development Program of China (863 Program) (No. 2011AA10A200), http://finance.most.gov.cn/. All funders had important roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchemin C, 2007, J VIROL, V81, P775, DOI 10.1128/JVI.01277-06; Cancellotti F.M., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P409; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; FINKEL T, 1993, J BIOL CHEM, V268, P5; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Goodfellow IG, 2008, INT J BIOCHEM CELL B, V40, P2675, DOI 10.1016/j.biocel.2007.10.023; Gregg D A, 1991, Rev Sci Tech, V10, P435; Grzela R, 2006, BIOCHIMIE, V88, P887, DOI 10.1016/j.biochi.2006.02.012; Kerppola Tom K, 2013, Cold Spring Harb Protoc, V2013, P727, DOI 10.1101/pdb.prot076497; Kerppola Tom K, 2013, Cold Spring Harb Protoc, V2013, P714, DOI 10.1101/pdb.top076489; Kodama Y, 2012, METHOD CELL BIOL, V113, P107, DOI 10.1016/B978-0-12-407239-8.00006-9; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Lee C. S., 1987, Korean Journal of Veterinary Research, V27, P277; Liu GQ, 2006, CHINESE SCI BULL, V51, P1698, DOI 10.1007/s11434-006-2044-x; Liu S. J., 1984, Animal Husbandry and Veterinary Medicine (Xumu yu Shouyi), V16, P253; Luo Y, 1997, BIOTECHNIQUES, V22, P350, DOI 10.2144/97222pf02; MEYERS G, 1991, VIROLOGY, V184, P664, DOI 10.1016/0042-6822(91)90436-F; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Miller WA, 2000, VIROLOGY, V273, P1, DOI 10.1006/viro.2000.0421; Miyoshi H, 2006, BIOCHIMIE, V88, P329, DOI 10.1016/j.biochi.2005.09.002; Morisse J.-P., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P269; MOUSSA A, 1992, VET MICROBIOL, V33, P375, DOI 10.1016/0378-1135(92)90065-2; Nowotny N, 1997, ARCH VIROL, V142, P657, DOI 10.1007/s007050050109; PARRA F, 1990, J VIROL, V64, P4013, DOI 10.1128/JVI.64.8.4013-4015.1990; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Wang BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060316; Wang BinBin, 2013, Journal of Northwest A & F University - Natural Science Edition, V41, P45; [杨宗伟 YANG Zongwei], 2011, [甘肃农业大学学报, Journal of Gansu Agricultural University], V46, P8	30	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143467	10.1371/journal.pone.0143467	http://dx.doi.org/10.1371/journal.pone.0143467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599265	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900130
J	Maeda, D; Akiyama, Y; Morikawa, T; Kunita, A; Ota, Y; Katoh, H; Niimi, A; Nomiya, A; Ishikawa, S; Goto, A; Igawa, Y; Fukayama, M; Homma, Y				Maeda, Daichi; Akiyama, Yoshiyuki; Morikawa, Teppei; Kunita, Akiko; Ota, Yasunori; Katoh, Hiroto; Niimi, Aya; Nomiya, Akira; Ishikawa, Shumpei; Goto, Akiteru; Igawa, Yasuhiko; Fukayama, Masashi; Homma, Yukio			Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation	PLOS ONE			English	Article							BLADDER PAIN SYNDROME; SYNDROME/INTERSTITIAL CYSTITIS; RHEUMATOID-ARTHRITIS; TISSUE; CLASSIFICATION; REPERTOIRE; EXPRESSION; SYMPTOMS; PREDICT	Interstitial cystitis (IC) is a chronic bladder disease with urinary frequency, bladder discomfort or bladder pain of unknown etiology. Based on cystoscopic findings, patients with IC are classified as either Hunner-type/classic IC (HIC), presenting with a specific Hunner lesion, or non-Hunner-type IC (NHIC), presenting with no Hunner lesion, but post-hydrodistension mucosal bleeding. Inflammatory cell infiltration, composed predominantly of lymphocytes, plasma cells and epithelial denudation, has in the past been documented as a major pathological IC finding. However, the significance of the pathological evaluation of IC, especially with regard to the difference between HIC and NHIC, has been downplayed in recent years. In this study, we performed immunohistochemical quantification of infiltrating T-lymphocytes, B-lymphocytes and plasma cells, and measured the amount of residual epithelium in urinary bladder biopsy specimens taken from patients with HIC and NHIC, and those with no IC, using image analysis software. In addition, in situ hybridization of the light chains was performed to examine clonal B-cell expansion. Lymphoplasmacytic infiltration was significantly more severe in HIC specimens than in NHIC specimens (P <0.0001). Substantial lymphoplasmacytic inflammation (>= 200 cells/mm(2)) was observed in 93% of HIC specimens, whereas only 8% of NHIC specimens were inflamed. Plasmacytic infiltration was more prominent in HIC specimens compared with NHIC and non-IC cystitis specimens (P <0.005). Furthermore, expansion of light-chain-restricted B-cells was observed in 31% of cases of HIC. The amount of residual epithelium was decreased in HIC specimens compared with NHIC specimens and non-IC cystitis specimens (P <0.0001). These results suggest that NHIC and HIC are distinct pathological entities, with the latter characterized by pancystitis, frequent clonal B-cell expansion and epithelial denudation. An abnormality in the B-cell population may be involved in the pathogenesis of HIC.	[Maeda, Daichi; Morikawa, Teppei; Kunita, Akiko; Fukayama, Masashi] Univ Tokyo, Dept Pathol, Grad Sch Med, Tokyo, Japan; [Maeda, Daichi; Goto, Akiteru] Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita 010, Japan; [Akiyama, Yoshiyuki; Niimi, Aya; Nomiya, Akira; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Akiyama, Yoshiyuki; Igawa, Yasuhiko] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo, Japan; [Ota, Yasunori] Univ Tokyo, Inst Med Sci, Dept Pathol, Tokyo, Japan; [Katoh, Hiroto; Ishikawa, Shumpei] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo, Japan	University of Tokyo; Akita University; University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU)	Maeda, D (corresponding author), Univ Tokyo, Dept Pathol, Grad Sch Med, Tokyo, Japan.	maeda-tky@umin.ac.jp	Igawa, Yasuhiko/AAY-9505-2021; Katoh, Hiroto/ADO-8117-2022; Goto, Akiteru/P-5775-2014	Goto, Akiteru/0000-0001-8776-9004	Ministry of Education, Science, Sports and Culture; Mitsui Life Social Welfare Foundation	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsui Life Social Welfare Foundation	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) (YH), 'Basic Science and Platform Technology Program for Innovative Biological Medicine' (SI) from the Ministry of Education, Science, Sports and Culture, and Mitsui Life Social Welfare Foundation (DM).	Bahler DW, 1998, BLOOD, V91, P1864, DOI 10.1182/blood.V91.6.1864.1864_1864_1872; CHRISTMAS TJ, 1994, BRIT J UROL, V73, P508, DOI 10.1111/j.1464-410X.1994.tb07635.x; Denson MA, 2000, J UROLOGY, V164, P1908, DOI 10.1016/S0022-5347(05)66915-7; Doorenspleet ME, 2014, ANN RHEUM DIS, V73, P756, DOI 10.1136/annrheumdis-2012-202861; FALL M, 1987, J UROLOGY, V137, P35, DOI 10.1016/S0022-5347(17)43863-8; Fall M, 2001, Urology, V57, P129, DOI 10.1016/S0090-4295(01)01101-3; Fall M, 2014, INT J UROL, V21, P79, DOI 10.1111/iju.12325; Ferraccioli G, 2007, AUTOIMMUN REV, V7, P109, DOI 10.1016/j.autrev.2007.02.013; Gamper M, 2013, INT UROGYNECOL J, V24, P2049, DOI 10.1007/s00192-013-2112-0; Gamper M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-199; GILLENWATER JY, 1988, J UROLOGY, V140, P203, DOI 10.1016/S0022-5347(17)41529-1; HANNO P, 1990, J UROLOGY, V143, P278, DOI 10.1016/S0022-5347(17)39933-0; Hanno P, 2009, NEUROUROL URODYNAM, V28, P274, DOI 10.1002/nau.20687; HARRINGTON DS, 1990, J UROLOGY, V144, P868, DOI 10.1016/S0022-5347(17)39611-8; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Hunner GL, 1915, BOSTON MED SURG J, V172, P660, DOI 10.1056/NEJM191505061721802; Keller JJ, 2013, NEUROUROL URODYNAM, V32, P980, DOI 10.1002/nau.22348; Leiby BE, 2007, J UROLOGY, V177, P142, DOI 10.1016/j.juro.2006.08.096; Logadottir Y, 2014, INT J UROL, V21, P75, DOI 10.1111/iju.12370; Logadottir Y, 2013, SCAND J UROL, V47, P52, DOI 10.3109/00365599.2012.699100; LYNES WL, 1990, AM J SURG PATHOL, V14, P969, DOI 10.1097/00000478-199010000-00011; MACDERMOTT JP, 1991, BRIT J UROL, V67, P44, DOI 10.1111/j.1464-410X.1991.tb15068.x; MESSING E M, 1978, Urology, V12, P381, DOI 10.1016/0090-4295(78)90286-8; Nitze M, 1907, LEHRBUCH KYSTOSKOPIE; Owens GP, 2003, J IMMUNOL, V171, P2725, DOI 10.4049/jimmunol.171.5.2725; Pacella Mauro, 2010, Arch Ital Urol Androl, V82, P122; Peeker R, 1998, SCAND J UROL NEPHROL, V32, P395; Peeker R, 2002, J UROLOGY, V167, P2470, DOI 10.1016/S0022-5347(05)65006-9; Pereira MI, 2014, WORLD J GASTROENTERO, V20, P684, DOI 10.3748/wjg.v20.i3.684; Rossberger J, 2010, SCAND J UROL NEPHROL, V44, P433, DOI 10.3109/00365599.2010.515613; SAMOSZUK MK, 1985, DIAGN CLIN IMMUNOL, V3, P133; Tomaszewski JE, 2001, UROLOGY, V57, P67, DOI 10.1016/S0090-4295(01)01166-9; Ueda T, 2003, INT J UROL, V10, pS1, DOI 10.1046/j.1442-2042.10.s1.1.x; van de Merwe JP, 2008, EUR UROL, V53, P60, DOI 10.1016/j.eururo.2007.09.019; van de Merwe JP, 2007, NAT CLIN PRACT UROL, V4, P484, DOI 10.1038/ncpuro0874; Wenniger LJMD, 2013, HEPATOLOGY, V57, P2390, DOI 10.1002/hep.26232	36	99	100	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143316	10.1371/journal.pone.0143316	http://dx.doi.org/10.1371/journal.pone.0143316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587589	Green Published, gold, Green Submitted			2022-12-27	WOS:000365251500051
J	Pavulraj, S; Bera, BC; Joshi, A; Anand, T; Virmani, M; Vaid, RK; Shanmugasundaram, K; Gulati, BR; Rajukumar, K; Singh, R; Misri, J; Singh, RK; Tripathi, BN; Virmani, N				Pavulraj, Selvaraj; Bera, Bidhan Chandra; Joshi, Alok; Anand, Taruna; Virmani, Meenakshi; Vaid, Rajesh Kumar; Shanmugasundaram, Karuppusamy; Gulati, Baldev Raj; Rajukumar, K.; Singh, Rajendra; Misri, Jyoti; Singh, Raj Kumar; Tripathi, Bhupendra Nath; Virmani, Nitin			Pathology of Equine Influenza virus (H3N8) in Murine Model	PLOS ONE			English	Article							A H5N1 VIRUS; MOUSE MODEL; ENHANCED VIRULENCE; ANIMAL-MODELS; MICE; INFECTION; PATHOGENESIS; VACCINE; REPLICATION; DISEASE	Equine influenza viruses (EIV)-H3N8 continue to circulate in equine population throughout the world. They evolve by the process of antigenic drift that leads to substantial change in the antigenicity of the virus, thereby necessitating substitution of virus strain in the vaccines. This requires frequent testing of the new vaccines in the in vivo system; however, lack of an appropriate laboratory animal challenge model for testing protective efficacy of equine influenza vaccine candidates hinders the screening of new vaccines and other therapeutic approaches. In the present investigation, BALB/c mouse were explored for suitability for conducting pathogenecity studies for EIV. The BALB/c mice were inoculated intranasally @ 2x10(6.24) EID50 with EIV (H3N8) belonging to Clade 2 of Florida sublineage and monitored for setting up of infection and associated parameters. All mice inoculated with EIV exhibited clinical signs viz. loss in body weights, lethargy, dyspnea, etc, between 3 and 5 days which commensurate with lesions observed in the respiratory tract including rhinitis, tracheitis, bronchitis, bronchiolitis, alveolitis and diffuse interstitial pneumonia. Transmission electron microscopy, immunohistochemistry, virus quantification through titration and qRT-PCR demonstrated active viral infection in the upper and lower respiratory tract. Serology revealed rise in serum lactate dehydrogenase levels along with sero-conversion. The pattern of disease progression, pathological lesions and virus recovery from nasal washings and lungs in the present investigations in mice were comparable to natural and experimental EIV infection in equines. The findings establish BALB/c mice as small animal model for studying EIV (H3N8) infection and will have immense potential for dissecting viral pathogenesis, vaccine efficacy studies, preliminary screening of vaccine candidates and antiviral therapeutics against EIV.	[Pavulraj, Selvaraj; Bera, Bidhan Chandra; Anand, Taruna; Vaid, Rajesh Kumar; Shanmugasundaram, Karuppusamy; Gulati, Baldev Raj; Tripathi, Bhupendra Nath; Virmani, Nitin] Natl Res Ctr Equines, Hisar, Haryana, India; [Joshi, Alok] Vet Hosp Naini, Almora, Uttarakhand, India; [Virmani, Meenakshi] Lala Lajpat Rai Univ Vet & Anim Sci, Dept Vet Physiol & Biochem, Hisar, Haryana, India; [Rajukumar, K.] Natl Inst High Secur Anim Dis, Bhopal, MP, India; [Singh, Rajendra] Indian Vet Res Inst, Div Pathol, Bareilly, UP, India; [Misri, Jyoti] Krishi Bhavan, Div Anim Sci, New Delhi, India; [Singh, Raj Kumar] Indian Vet Res Inst, Bareilly, UP, India	Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Lala Lajpat Rai University of Veterinary & Animal Sciences; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of High Security Animal Diseases; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Virmani, N (corresponding author), Natl Res Ctr Equines, Hisar, Haryana, India.	nvirmani@gmail.com	Gulati, Baldev/AAF-7492-2020; Selvaraj, Pavulraj/AAV-8266-2021; Pavulraj, Selvaraj/AAA-3927-2021; Vaid, Rajesh K./E-3519-2013	Gulati, Baldev/0000-0002-4338-7941; Vaid, Rajesh K./0000-0002-7554-5238; , Shanmugasundaram Karuppusamy/0000-0001-5965-2087; Singh, Rajendra/0000-0002-8586-3221; Singh, Rajkumar/0000-0003-4649-2015	Indian Council of Agricultural Research; Indian Veterinary Research Institute	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR)); Indian Veterinary Research Institute(Indian Council of Agricultural Research (ICAR))	Funding: The present study was funded by Indian Council of Agricultural Research from institutional grant. Indian Veterinary Research Institute provided junior research fellowship to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewes CH, 1934, LANCET, V2, P859; Baz M, 2015, J VIROL, V89, P1652, DOI 10.1128/JVI.02449-14; Baz M, 2013, J VIROL, V87, P6901, DOI 10.1128/JVI.03520-12; Begg AP, 2011, AUST VET J, V89, P19, DOI 10.1111/j.1751-0813.2011.00731.x; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Belser JA, 2011, J VIROL, V85, P1563, DOI 10.1128/JVI.02231-10; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Boon ACM, 2010, J VIROL, V84, P7662, DOI 10.1128/JVI.02444-09; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Castleman WL, 2010, VET PATHOL, V47, P507, DOI 10.1177/0300985810363718; Crouch CF, 2004, VACCINE, V23, P418, DOI 10.1016/j.vaccine.2004.01.074; Cullinane A, 2013, VET MICROBIOL, V167, P205, DOI 10.1016/j.vetmic.2013.03.029; Driskell EA, 2010, VIROLOGY, V399, P280, DOI 10.1016/j.virol.2010.01.005; Dybing JK, 2000, J VIROL, V74, P1443, DOI 10.1128/JVI.74.3.1443-1450.2000; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Gerber H., 1970, Proceedings 2nd int. Conf. Equine Infect. Dis., Paris, 1969., P63; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Guarner J, 2006, CLIN INFECT DIS, V43, P132, DOI 10.1086/505122; Heldens JGM, 2010, VACCINE, V28, P6989, DOI 10.1016/j.vaccine.2010.08.043; Hirst GK, 1941, SCIENCE, V94, P22, DOI 10.1126/science.94.2427.22; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Kendra W, 2012, THESIS; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kuiken T, 2003, VET PATHOL, V40, P304, DOI 10.1354/vp.40-3-304; Landolt GA, 2006, EQUINE INFECT DIS; Lau YF, 2010, J VIROL, V84, P8639, DOI 10.1128/JVI.00596-10; Lee YN, 2011, VIROLOGY, V417, P57, DOI 10.1016/j.virol.2011.05.005; Liu GL, 2013, VACCINE, V31, P5398, DOI 10.1016/j.vaccine.2013.09.009; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Lu ZC, 2009, J CLIN MICROBIOL, V47, P3907, DOI 10.1128/JCM.00598-09; LUNA LG, 1968, MANUAL HISTOLOGY STA; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; MANICASSAMY B, 2010, PLOS PATHOG, V6, DOI DOI 10.1371/J0URNAL.PPAT.1000745; Mernoli MJ, 2009, VIROLOGY, V393, P338, DOI 10.1016/j.virol.2009.08.021; Mette V, 2011, INFLUENZA RES TREAT; MILLER WC, 1965, VET REC, V77, P455; Mukhopadhyay S, 2010, AM J CLIN PATHOL, V133, P380, DOI 10.1309/AJCPXY17SULQKSWK; MUMFORD JA, 1990, EQUINE VET J, V22, P93, DOI 10.1111/j.2042-3306.1990.tb04217.x; MUMFORD JA, 1994, EPIDEMIOL INFECT, V112, P421, DOI 10.1017/S0950268800057848; MUMFORD JA, 1994, VACCINE, V12, P857, DOI 10.1016/0264-410X(94)90297-6; MUMFORD JA, 1998, TXB INFLUENZA, P146; Muranaka Masanori, 2012, Journal of Equine Science, V23, P17, DOI 10.1294/jes.23.17; Muto NA, 2012, JPN J INFECT DIS, V65, P383, DOI 10.7883/yoken.65.383; Ning ZY, 2009, VET RES COMMUN, V33, P895, DOI 10.1007/s11259-009-9307-3; Nishimura H, 2000, J GEN VIROL, V81, P2503, DOI 10.1099/0022-1317-81-10-2503; Paillot R, 2013, VET MICROBIOL, V162, P396, DOI 10.1016/j.vetmic.2012.10.019; Patterson-Kane JC, 2008, EQUINE VET J, V40, P199, DOI 10.2746/042516408X292214; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Pica N, 2011, J VIROL, V85, P12825, DOI 10.1128/JVI.05930-11; Quan FS, 2008, VACCINE, V26, P3352, DOI 10.1016/j.vaccine.2008.03.055; REED L. J., 1938, AMER JOUR HYG, V27, P493; Scocco P, 2008, HISTOL HISTOPATHOL, V23, P973, DOI 10.14670/HH-23.973; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tang XH, 2009, J GEN VIROL, V90, P386, DOI 10.1099/vir.0.007054-0; Tate MD, 2011, MICROBES INFECT, V13, P202, DOI 10.1016/j.micinf.2010.10.004; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Teluguakula N., 2011, AM J PATHOL, V179, P199, DOI [10.1016/i.aipath.2011.03.013, DOI 10.1016/J.AJPATH.2011.03.013]; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Uraki R, 2013, J VIROL, V87, P2226, DOI 10.1128/JVI.01565-12; Virmani N, 2008, VET REC, V163, P607, DOI 10.1136/vr.163.20.607-a; Virmani N, 2010, VET MICROBIOL, V143, P224, DOI 10.1016/j.vetmic.2009.12.007; WEBSTER RG, 1993, EQUINE VET J, V25, P537, DOI 10.1111/j.2042-3306.1993.tb03009.x; Wu J, 2010, VACCINE, V28, P2775, DOI 10.1016/j.vaccine.2010.01.037; Xu JP, 2011, INFECT GENET EVOL, V11, P2125, DOI 10.1016/j.meegid.2011.07.002; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zachary TP, 2012, INFLUENZA OTHER RESP, V7, P472; Zhu ZQ, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.50	75	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143094	10.1371/journal.pone.0143094	http://dx.doi.org/10.1371/journal.pone.0143094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587990	Green Published, gold, Green Submitted			2022-12-27	WOS:000365251500029
J	Abokyi, LN; Asante, KP; Mahama, E; Gyaase, S; Sulemana, A; Kwarteng, A; Ayaam, J; Dosoo, D; Adu-Gyasi, D; Etego, SA; Ogutu, B; Akweongo, P; Owusu-Agyei, S				Abokyi, Livesy Naafoe; Asante, Kwaku Poku; Mahama, Emmanuel; Gyaase, Stephaney; Sulemana, Abubakari; Kwarteng, Anthony; Ayaam, Jennifer; Dosoo, David; Adu-Gyasi, Dennis; Etego, Seeba Amenga; Ogutu, Bernhards; Akweongo, Patricia; Owusu-Agyei, Seth			Use of Antimalarial in the Management of Fever during a Community Survey in the Kintampo Districts of Ghana	PLOS ONE			English	Article							ARTEMISININ-COMBINATION THERAPY; AFFORDABLE MEDICINES FACILITY; MALARIA TREATMENT; TREATMENT BEHAVIOR; AFRICAN COUNTRIES; TANZANIA; DECLINE; BURDEN; IMPLEMENTATION; EPIDEMIOLOGY	Background Epidemiology of malaria and related fevers in most parts of Africa is changing due to scale up of interventions such as appropriate use of ACTs in the effort towards sustained control and eventual elimination of malaria. The use of ACTs in the management of malaria-associated fever was evaluated in the Kintampo districts of Ghana. Methods Household survey was conducted between October 2009 and February, 2011. A random selection of 370 households was generated from 25,000 households existing within the Health and Demographic Surveillance Systems in Kintampo, Ghana at the time. All household members present at the time of survey in the eligible households were interviewed based on a two weeks reported fever recall and the use of antimalarial for the management of fever. A finger-prick blood sample was also obtained from each member of the household present and later examined for malaria parasites using microscopy. Descriptive analysis was performed, with univariate and multivariate analysis used to identify predictors of fever and malaria parasitemia. Results A total of 1436 individuals were interviewed from 370 households. Overall, fever prevalence was 23.8% (341/1436) and was 38.8% (77/198) in children < 5 years, 21.3% (264/1238) in older children plus adults. Participants who sought treatment for fever were 84% (285/341) with 47.7%(136/285) using any anti-malarial. Artemisinin-based Combination Therapy use was in 69.1% (94/136) of cases while 30.9% used mono-therapies. Malaria parasitaemia rate was 28.2% (397/1407). Conclusion The study reports high community fever prevalence, frequent use of antimalarials for fever treatment and relatively high use of mono-therapies especially in children < 5 years in an area with high malaria parasite prevalence in Ghana.	[Abokyi, Livesy Naafoe; Asante, Kwaku Poku; Mahama, Emmanuel; Gyaase, Stephaney; Sulemana, Abubakari; Kwarteng, Anthony; Ayaam, Jennifer; Dosoo, David; Adu-Gyasi, Dennis; Etego, Seeba Amenga; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo Reg, Ghana; [Ogutu, Bernhards] INDEPTH Network, Accra, Ghana; [Akweongo, Patricia] Coll Hlth Sci, Sch Publ Hlth, Legon, Accra, Ghana	Kintampo Health Research Centre; INDEPTH Network	Abokyi, LN (corresponding author), Kintampo Hlth Res Ctr, POB 200, Kintampo, Brong Ahafo Reg, Ghana.	livesy.abokyi@kintampo-hrc.org		AKWEONGO, PATRICIA/0000-0001-6728-3365; Adu-Gyasi, Dennis/0000-0002-9449-2565; Owusu-Agyei, Seth/0000-0002-0807-1781	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was part of a bigger project (Indepth Effectiveness and safety studies of antimalarials in AFrica-INESS) funded by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study team is most grateful to the community members of Kintampo North Municipality and Kintampo South District particularly the study participants. We also thank the field, computing, laboratory and administrative staff of the Kintampo Health Research Centre for their support. We acknowledge the pivotal role of INDEPTH Network especially the INESS secretariat in securing funds and coordinating the study. The study was supported by grant from the Bill and Melinda Gates Foundation to the INDEPTH-Network. Kintampo Health Research Centre is a member of the INDEPTH Network.	Abdelgader TM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-11; Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190; [Anonymous], 1998, COCHRANE DB SYST REV; [Anonymous], GHAN MULT IND CLUST; Ansah EK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1019; Asante KP, 2009, J TROPICAL MED; Asante KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-211; Asante KP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-409; Baiden F, 2014, Ghana Med J, V48, P112; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-300; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Dodoo ANO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-2; Elmardi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-128; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; GHS, 2009, GHAN NAT ANT POL; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-132; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-317; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Malm KL, 2013, J PUBLIC HEALTH POL, V34, P302, DOI 10.1057/jphp.2013.12; Mazigo Humphrey D, 2011, BMC Res Notes, V4, P359, DOI 10.1186/1756-0500-4-359; Meyrowitsch DW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-188; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Novignon Jacob, 2012, BMC Res Notes, V5, P380, DOI 10.1186/1756-0500-5-380; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Osei-Kwakye K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058107; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Owusu-Agyei S, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19033; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Owusu-Agyei S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002530; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Sabot O, 2011, HEALTH POLICY PLANN, V26, P441, DOI 10.1093/heapol/czr067; Swysen C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-223; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO Guidelines Approved by the Guidelines Review Committee, 2010, GLOB TUB CONTR WHO R, P2010; World Health Organization, 2008, WORLD MALARIA REPORT; Yusuf OB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-235	47	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142106	10.1371/journal.pone.0142106	http://dx.doi.org/10.1371/journal.pone.0142106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580076	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600035
J	Potestio, ML; Boyd, JM; Bagshaw, SM; Heyland, D; Oxland, P; Doig, CJ; Zygun, D; Stelfox, HT				Potestio, Melissa L.; Boyd, Jamie M.; Bagshaw, Sean M.; Heyland, Daren; Oxland, Peter; Doig, Christopher J.; Zygun, Dave; Stelfox, Henry T.			Engaging the Public to Identify Opportunities to Improve Critical Care: A Qualitative Analysis of an Open Community Forum	PLOS ONE			English	Article							OF-LIFE CARE; INTENSIVE-CARE; HOSPITALIZED-PATIENTS; FAMILY SATISFACTION; MORAL DISTRESS; FOCUS GROUPS; HEALTH-CARE; UNIT; ICU; DISCUSSIONS	Objective To engage the public to understand how to improve the care of critically ill patients. Design A qualitative content analysis of an open community forum (Cafe Scientifique). Setting Public venue in Calgary, Alberta, Canada. Participants Members of the general public including patients, families of patients, health care providers, and members of the community at large. Methods A panel of researchers, decision-makers, and a family member led a Cafe Scientifique, an informal dialogue between the populace and experts, over three-hours to engage the public to understand how to improve the care of critically ill patients. Conventional qualitative content analysis was used to analyze the data. The inductive analysis occurred in three phases: coding, categorizing, and developing themes. Results Thirty-eight members of the public (former ICU patients, family members of patients, providers, community members) attended. Participants focused the discussion and provided concrete suggestions for improvement around communication (family as surrogate voice, timing of conversations, decision tools) and provider well-being and engagement, as opposed to medical interventions in critical care. Conclusions Cafe participants believe patient and family centered care is important to ensure high-quality care in the ICU. A Cafe Scientifique is a valuable forum to engage the public to contribute to priority setting areas for research in critical care, as well as a platform to share lived experience. Research stakeholders including health care organizations, governments, and funding organizations should provide more opportunities for the public to engage in meaningful conversations about how to best improve healthcare.	[Potestio, Melissa L.] Alberta Hlth Serv, Res Prior & Implementat, Calgary, AB, Canada; [Potestio, Melissa L.; Boyd, Jamie M.; Stelfox, Henry T.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Boyd, Jamie M.] Univ Calgary, Res & Innovat Ctr W21C, Calgary, AB, Canada; [Bagshaw, Sean M.; Zygun, Dave] Univ Alberta, Div Crit Care Med, Fac Med & Dent, Alberta Hlth Serv, Edmonton, AB, Canada; [Heyland, Daren] Queens Univ, Kingston Gen Hosp, Dept Crit Care Med, Clin Evaluat Res Unit, Kingston, ON, Canada; [Oxland, Peter] Alberta Hlth Serv, Crit Care, Calgary, AB, Canada; [Oxland, Peter] Univ Calgary, Calgary, AB, Canada; [Doig, Christopher J.] Univ Calgary, Dept Crit Care Med, Alberta Hlth Serv, Calgary, AB, Canada	Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Alberta; Queens University - Canada; Alberta Health Services (AHS); University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary	Stelfox, HT (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.	tstelfox@ucalgary.ca	Doig, Christopher/AAC-7949-2020	Doig, Christopher/0000-0002-8576-9139; Stelfox, Henry/0000-0003-1231-1490	Canadian Institutes of Health Research [SCI-131811]; O'Brien Institute for Public Health at the University of Calgary; Alberta Innovates [201300477, 201201137] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); O'Brien Institute for Public Health at the University of Calgary; Alberta Innovates	This work was supported by an operating grant from Canadian Institutes of Health Research (SCI-131811). The funder had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.; We thank the O'Brien Institute for Public Health at the University of Calgary for their financial support of the Cafe Scientifique. We thank Dr. Day, Ms. Roe and Ms. Rabatach for assisting with coordination of the Cafe Scientifique.	Arnetz BB, 2001, SOC SCI MED, V52, P203, DOI 10.1016/S0277-9536(00)00220-3; Auriemma CL, 2014, JAMA INTERN MED, V174, P1085, DOI 10.1001/jamainternmed.2014.1183; Bagshaw SM, 2014, CAN MED ASSOC J, V186, pE95, DOI 10.1503/cmaj.130639; Beumer CM, 2008, DIMENS CRIT CARE NUR, V27, P263, DOI 10.1097/01.DCC.0000338871.77658.03; Brondani MA, 2010, ARCH SEX BEHAV, V39, P1453, DOI 10.1007/s10508-009-9578-3; Brown S, 2010, STRATEGY PATIENT ORI; Bryman A., 2008, SOCIAL RES METHODS; Corley MC, 2002, NURS ETHICS, V9, P636, DOI 10.1191/0969733002ne557oa; Cullen DJ, 1997, CRIT CARE MED, V25, P1289, DOI 10.1097/00003246-199708000-00014; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; Gagliardi AR, 2014, J TRAUMA ACUTE CARE, V77, P749, DOI 10.1097/TA.0000000000000432; Glaser B.G, 1978, THEORETICAL SENSITIV; Guevara-Lopez U, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0003-2; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Hartog CS, 2014, J CRIT CARE, V29, P128, DOI 10.1016/j.jcrc.2013.08.024; Heyland DK, 2010, CAN MED ASSOC J, V182, pE747, DOI 10.1503/cmaj.100131; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Institute of Medicine Committee on the Quality of Health Care in America, 1990, MED STRAT QUAL ASS; Johnson AR, 2013, J PALLIAT CARE, V29, P99, DOI 10.1177/082585971302900206; Karanikola MNK, 2012, DIMENS CRIT CARE NUR, V31, P37, DOI 10.1097/DCC.0b013e31823a55b8; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kompanje EJO, 2013, CURR OPIN CRIT CARE, V19, P630, DOI 10.1097/MCC.0000000000000026; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lind R, 2011, INTENS CARE MED, V37, P1143, DOI 10.1007/s00134-011-2253-x; MacQueen K.M., 1998, CAM J, V10, P31, DOI [10.1177/1525822X980100020301, DOI 10.1177/1525822X980100020301, 10.1177/1525822x980100020301]; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Morse J. M., 1995, QUALITATIVE RES METH; Moyen E, 2008, CRIT CARE, V12, DOI 10.1186/cc6813; Nelson JE, 2010, CRIT CARE MED, V38, P808, DOI 10.1097/CCM.0b013e3181c5887c; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Price Bob, 2010, Paediatr Nurs, V22, P26; Reimer-Kirkham S, 2015, HEALTH COMMUN, V30, P496, DOI 10.1080/10410236.2013.868398; Robinson R, 2010, DIMENS CRIT CARE NUR, V29, P197, DOI 10.1097/DCC.0b013e3181e6c344; Schenker Y, 2012, J GEN INTERN MED, V27, P1657, DOI 10.1007/s11606-012-2129-y; St Ledger U, 2013, J ADV NURS, V69, P1869, DOI 10.1111/jan.12053; Sundararajan K, 2012, ANAESTH INTENS CARE, V40, P159, DOI 10.1177/0310057X1204000120; Thelen Mary, 2005, Crit Care Nurse, V25, P28; Wall RJ, 2007, CHEST, V132, P1425, DOI 10.1378/chest.07-0419; Wiegand DL, 2015, AACN ADV CRIT CARE, V26, P142, DOI 10.1097/NCI.0000000000000085; Wiegand DL, 2013, J GERONTOL NURS, V39, P60, DOI 10.3928/00989134-20130530-04; Wong P, 2015, INTENS CRIT CARE NUR, V31, P51, DOI 10.1016/j.iccn.2014.06.005; You JJ, 2014, CMAJ, V186, P679, DOI DOI 10.1503/CMAJ.140673; You JJ, 2015, JAMA INTERN MED, V175, P549, DOI 10.1001/jamainternmed.2014.7732; You JJ, 2014, CAN MED ASSOC J, V186, P425, DOI 10.1503/cmaj.121274	46	20	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143088	10.1371/journal.pone.0143088	http://dx.doi.org/10.1371/journal.pone.0143088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26580406	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600080
J	Raihana, S; Dunsmuir, D; Huda, T; Zhou, GH; Rahman, QSU; Garde, A; Moinuddin, M; Karlen, W; Dumont, GA; Kissoon, N; El Arifeen, S; Larson, C; Ansermino, JM				Raihana, Shahreen; Dunsmuir, Dustin; Huda, Tanvir; Zhou, Guohai; Rahman, Qazi Sadeq-ur; Garde, Ainara; Moinuddin, Md; Karlen, Walter; Dumont, Guy A.; Kissoon, Niranjan; El Arifeen, Shams; Larson, Charles; Ansermino, J. Mark			Development and Internal Validation of a Predictive Model Including Pulse Oximetry for Hospitalization of Under-Five Children in Bangladesh	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; OXYGEN-SATURATION; CASE-MANAGEMENT; VITAL SIGNS; INFECTIONS; HYPOXEMIA; MORTALITY; ADMISSION; EMERGENCY; COUNTRIES	Background The reduction in the deaths of millions of children who die from infectious diseases requires early initiation of treatment and improved access to care available in health facilities. A major challenge is the lack of objective evidence to guide front line health workers in the community to recognize critical illness in children earlier in their course. Methods We undertook a prospective observational study of children less than 5 years of age presenting at the outpatient or emergency department of a rural tertiary care hospital between October 2012 and April 2013. Study physicians collected clinical signs and symptoms from the facility records, and with a mobile application performed recordings of oxygen saturation, heart rate and respiratory rate. Facility physicians decided the need for hospital admission without knowledge of the oxygen saturation. Multiple logistic predictive models were tested. Findings Twenty-five percent of the 3374 assessed children, with a median (interquartile range) age of 1.02 (0.42-2.24), were admitted to hospital. We were unable to contact 20% of subjects after their visit. A logistic regression model using continuous oxygen saturation, respiratory rate, temperature and age combined with dichotomous signs of chest indrawing, lethargy, irritability and symptoms of cough, diarrhea and fast or difficult breathing predicted admission to hospital with an area under the receiver operating characteristic curve of 0.89 (95% confidence interval -CI: 0.87 to 0.90). At a risk threshold of 25% for admission, the sensitivity was 77% (95% CI: 74% to 80%), specificity was 87% (95% CI: 86% to 88%), positive predictive value was 70% (95% CI: 67% to 73%) and negative predictive value was 91% (95% CI: 90% to 92%). Conclusion A model using oxygen saturation, respiratory rate and temperature in combination with readily obtained clinical signs and symptoms predicted the need for hospitalization of critically ill children. External validation of this model in a community setting will be required before adoption into clinical practice.	[Raihana, Shahreen; Huda, Tanvir; Rahman, Qazi Sadeq-ur; Moinuddin, Md; El Arifeen, Shams] Int Ctr Diarrhoeal Dis Res, Ctr Child & Adolescent Hlth, Dhaka 1000, Bangladesh; [Dunsmuir, Dustin; Dumont, Guy A.; Kissoon, Niranjan; Larson, Charles; Ansermino, J. Mark] British Columbia Childrens Hosp, Ctr Int Child Hlth, Vancouver, BC V6H 3V4, Canada; [Dunsmuir, Dustin; Ansermino, J. Mark] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Zhou, Guohai] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Garde, Ainara; Karlen, Walter; Dumont, Guy A.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada; [Kissoon, Niranjan; Larson, Charles] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada	International Centre for Diarrhoeal Disease Research (ICDDR); BC Childrens Hospital; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Ansermino, JM (corresponding author), British Columbia Childrens Hosp, Ctr Int Child Hlth, Vancouver, BC V6H 3V4, Canada.	anserminos@yahoo.ca	Karlen, Walter/AAN-9397-2020; Karlen, Walter/C-6290-2008; Moinuddin, Mohammed/AAP-4454-2021; Kissoon, Niranjan/AAC-6140-2021; Garde, Ainara/J-9442-2017	Karlen, Walter/0000-0001-8643-3074; Karlen, Walter/0000-0001-8643-3074; Moinuddin, Mohammed/0000-0001-9364-390X; Garde, Ainara/0000-0002-9503-6908; Kissoon, Niranjan/0000-0001-8847-9973; Zhou, Guohai/0000-0002-8826-403X; Dumont, Guy/0000-0003-2048-4391; Ansermino, J Mark/0000-0001-8427-2035; Dunsmuir, Dustin/0000-0001-9717-3685; Arifeen, Shams/0000-0002-5372-5932	Canadian Department of Foreign Affairs, Trade and Development's MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH) [S065353-001]	Canadian Department of Foreign Affairs, Trade and Development's MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH)	This study was a component of the project titled Interrupting Pathways to Maternal, Newborn and Early Childhood Sepsis (IPSI) (Project # S065353-001) that was funded by the Canadian Department of Foreign Affairs, Trade and Development's MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH), received by CL, http://www.international.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, UNICEF PROGR REPORT; Ansermino JM, 2013, ANESTH ANALG, V117, P883, DOI 10.1213/ANE.0b013e3182a1f22f; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; BENATAR SR, 1973, BRIT J ANAESTH, V45, P711, DOI 10.1093/bja/45.7.711; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Duke T, 2009, ANN TROP PAEDIATR, V29, P165, DOI 10.1179/027249309X12467994190011; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Dunsmuir D, 2012, ANESTHESIA ANALGESIA, V115, pS21; Ginsburg AS, 2012, J TROP PEDIATRICS, V58, P389, DOI 10.1093/tropej/fmr103; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Kallander K, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2130; Kalter HD, 1997, B WORLD HEALTH ORGAN, V75, P65; Karlen W, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone0099266, DOI 10.1371/J0URNAL.P0NE.0099266]; Keahey L, 2002, ANN EMERG MED, V40, P300, DOI 10.1067/mem.2002.126813; Laman M, 2005, ANN TROP PAEDIATR, V25, P23, DOI 10.1179/146532805X23317; Launay E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107286; Little R.J.A., 2002, STAT ANAL MISSING DA; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Marsh DR, 2012, AM J TROP MED HYG, V87, P2, DOI 10.4269/ajtmh.2012.12-0504; Modi P, 2013, J EMERG MED, V45, P752, DOI 10.1016/j.jemermed.2013.04.041; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nijman RG, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4224; ONYANGO FE, 1993, BRIT MED J, V306, P612, DOI 10.1136/bmj.306.6878.612; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Petersen CL, 2013, ACM SIGPLAN NOTICES, V48, P357, DOI [10.1145/2500365.2500615, 10.1145/2544174.2500615]; Petersen CL, 2013, SENSORS-BASEL, V13, P16882, DOI 10.3390/s131216882; R Development Core Team, 2012, R LANG ENV STAT COMP; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599, DOI 10.1152/jappl.1979.46.3.599; Spruijt B, 2013, J CLIN EPIDEMIOL, V66, P453, DOI 10.1016/j.jclinepi.2012.09.014; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Walsh P, 2004, EUR J EMERG MED, V11, P265, DOI 10.1097/00063110-200410000-00005; West J. B., 2011, RESP PHYSL ESSENTIAL, V9th; World Health Organization, 2014, REV WHO CLASS TREATM	40	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143213	10.1371/journal.pone.0143213	http://dx.doi.org/10.1371/journal.pone.0143213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580403	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600098
J	Rode, KD; Wilson, RR; Regehr, EV; St Martin, M; Douglas, DC; Olson, J				Rode, Karyn D.; Wilson, Ryan R.; Regehr, Eric V.; St Martin, Michelle; Douglas, David C.; Olson, Jay			Increased Land Use by Chukchi Sea Polar Bears in Relation to Changing Sea Ice Conditions	PLOS ONE			English	Article							URSUS-MARITIMUS; TERRESTRIAL FOODS; BEHAVIOR; PREDATOR; ECOLOGY; GEESE; SIZE	Recent observations suggest that polar bears (Ursus maritimus) are increasingly using land habitats in some parts of their range, where they have minimal access to their preferred prey, likely in response to loss of their sea ice habitat associated with climatic warming. We used location data from female polar bears fit with satellite radio collars to compare land use patterns in the Chukchi Sea between two periods (1986-1995 and 2008-2013) when substantial summer sea-ice loss occurred. In both time periods, polar bears predominantly occupied sea-ice, although land was used during the summer sea-ice retreat and during the winter for maternal denning. However, the proportion of bears on land for > 7 days between August and October increased between the two periods from 20.0% to 38.9%, and the average duration on land increased by 30 days. The majority of bears that used land in the summer and for denning came to Wrangel and Herald Islands (Russia), highlighting the importance of these northernmost land habitats to Chukchi Sea polar bears. Where bears summered and denned, and how long they spent there, was related to the timing and duration of sea ice retreat. Our results are consistent with other studies supporting increased land use as a common response of polar bears to sea-ice loss. Implications of increased land use for Chukchi Sea polar bears are unclear, because a recent study observed no change in body condition or reproductive indices between the two periods considered here. This result suggests that the ecology of this region may provide a degree of resilience to sea ice loss. However, projections of continued sea ice loss suggest that polar bears in the Chukchi Sea and other parts of the Arctic may increasingly use land habitats in the future, which has the potential to increase nutritional stress and human-polar bear interactions.	[Rode, Karyn D.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Wilson, Ryan R.; Regehr, Eric V.; St Martin, Michelle] US Fish & Wildlife Serv, Marine Mammals Management, Anchorage, AK 99503 USA; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, Juneau, AK 99801 USA; [Olson, Jay] Brigham Young Univ, Plant & Wildlife Sci, Provo, UT 84602 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; Brigham Young University	Rode, KD (corresponding author), US Geol Survey, Alaska Sci Ctr, 4210 Univ Dr, Anchorage, AK 99508 USA.	krode@usgs.gov	Douglas, David C./AAU-1087-2021	Douglas, David C./0000-0003-0186-1104; Rode, Karyn/0000-0002-3328-8202	USFWS Marine Mammals Management; USGS Changing Arctic Ecosystem Initiative; Detroit Zoological Association; State of Alaska Coastal Impact Assessment Program	USFWS Marine Mammals Management; USGS Changing Arctic Ecosystem Initiative; Detroit Zoological Association; State of Alaska Coastal Impact Assessment Program	Funding for this study was provided by the USFWS Marine Mammals Management, USGS Changing Arctic Ecosystem Initiative, the Detroit Zoological Association and the State of Alaska Coastal Impact Assessment Program. Only the USFWS and USGS contributed to study design, data collection and analysis, decision to publish and preparation of the manuscript. In-kind support was received from Teck Alaska, Inc.	Aars J, 2009, MAR MAMMAL SCI, V25, P35, DOI 10.1111/j.1748-7692.2008.00228.x; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Atkinson SN, 1996, PHYSIOL ZOOL, V69, P304, DOI 10.1086/physzool.69.2.30164186; Bengtson JL, 2005, POLAR BIOL, V28, P833, DOI 10.1007/s00300-005-0009-1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Derocher AE, 2011, MAR ECOL PROG SER, V441, P273, DOI 10.3354/meps09406; Derocher A.E., 2012, POLAR BEARS COMPLETE; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Derocher AE, 2013, CONSERV LETT, V6, P368, DOI 10.1111/conl.12009; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Durner GM, 2006, 701815N240 USGS AL S; Ferguson SH, 2000, J MAMMAL, V81, P1118, DOI 10.1644/1545-1542(2000)081<1118:RBDOPB>2.0.CO;2; Fischbach AS, 2007, POLAR BIOL, V30, P1395, DOI 10.1007/s00300-007-0300-4; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Freitas C, 2012, MAR ECOL PROG SER, V447, P289, DOI 10.3354/meps09516; Hobson KA, 2009, CAN J ZOOL, V87, P50, DOI 10.1139/Z08-137; Hooten MB, 2014, STAT METHODOL, V17, P82, DOI 10.1016/j.stamet.2012.12.001; Iverson SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3128; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Johnson DS, 2013, CRAWL FIT CONTINUOUS; Kelly B, 2010, NATURE, V468, P891, DOI 10.1038/468891a; Kochnev AA, 2002, P MAR MAMM HOL M SEP; Kochnev AA, 2003, TRADITIONAL KNOWLEDG, P1; Lunn NJ, 2014, DEMOGRAPHY POPULATIO; Mahoney A. R., 2012, MAPPING CHARACTERIZA; Manly B.F.J., 2002, RESOURCE SELECTION A; Miller S, 2015, J MAMM IN PRESS; Obbard M., 2010, POL BEARS P 15 WORK; Olson J, 2015, THESIS; Ovsyanikov NG, 2005, ZOOL ZH, V84, P94; Ovsyanikov NG, 2010, P MAR MAMM HOL M OCT; Ovsyanikov NG, 2008, P MAR MAMM HOL OD UK, P407; Pagano AM, 2012, CAN J ZOOL, V90, P663, DOI 10.1139/Z2012-033; Prop J, 2015, FRONTIERS E IN PRESS; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAMSAY MA, 1991, OECOLOGIA, V86, P598, DOI 10.1007/BF00318328; RAMSAY MA, 1991, CAN J ZOOL, V69, P298, DOI 10.1139/z91-048; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Rockwell RF, 2011, OIKOS, V120, P696, DOI 10.1111/j.1600-0706.2010.18837.x; Rode KD, 2015, FRONT ECOL ENVIRON, V13, P138, DOI 10.1890/140202; Rode KD, 2014, GLOBAL CHANGE BIOL, V20, P76, DOI 10.1111/gcb.12339; Rode KD, 2010, J MAMMAL, V91, P1517, DOI 10.1644/09-MAMM-A-399.1; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Schliebe S, 2008, POLAR BIOL, V31, P999, DOI 10.1007/s00300-008-0439-7; Smith PA, 2010, POLAR BIOL, V33, P1149, DOI 10.1007/s00300-010-0791-2; Stempniewicz L, 2006, ARCTIC, V59, P247; Stirling I, 1999, ARCTIC, V52, P294; STIRLING I, 1989, J WILDLIFE DIS, V25, P159, DOI 10.7589/0090-3558-25.2.159; Stroeve JC, 2014, GEOPHYS RES LETT, V41, P1216, DOI 10.1002/2013GL058951; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Therneau T., 2013, PACKAGE SURVIVAL ANA, P37; VanDerWal J., 2014, R PACKAGE VERSION, V1, P1, DOI DOI 10.1016/J.TWS.2014.06.001; Voorhees H, 2014, ARCTIC IN PRESS, P67; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Whiteman JP, 2015, SCIENCE, V349, P295, DOI 10.1126/science.aaa8623; Zar JH, 1999, BIOSTATISTICAL ANAL	61	59	60	2	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142213	10.1371/journal.pone.0142213	http://dx.doi.org/10.1371/journal.pone.0142213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580809	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600039
J	Tyminski, JP; de la Parra-Venegas, R; Cano, JG; Hueter, RE				Tyminski, John P.; de la Parra-Venegas, Rafael; Gonzzlez Cano, Jaime; Hueter, Robert E.			Vertical Movements and Patterns in Diving Behavior of Whale Sharks as Revealed by Pop-Up Satellite Tags in the Eastern Gulf of Mexico	PLOS ONE			English	Article							RHINCODON-TYPUS SMITH; NINGALOO REEF; CARCHARODON-CARCHARIAS; HABITAT PREFERENCES; WESTERN-AUSTRALIA; GEOMAGNETIC-FIELD; PACIFIC-OCEAN; INDIAN-OCEAN; DIEL; MIGRATION	The whale shark (Rhincodon typus) is a wide-ranging, filter-feeding species typically observed at or near the surface. This shark's sub-surface habits and behaviors have only begun to be revealed in recent years through the use of archival and satellite tagging technology. We attached pop-up satellite archival transmitting tags to 35 whale sharks in the southeastern Gulf of Mexico off the Yucatan Peninsula from 2003-2012 and three tags to whale sharks in the northeastern Gulf off Florida in 2010, to examine these sharks' long-term movement patterns and gain insight into the underlying factors influencing their vertical habitat selection. Archived data were received from 31 tags deployed on sharks of both sexes with total lengths of 5.5-9 m. Nine of these tags were physically recovered facilitating a detailed long-term view into the sharks' vertical movements. Whale sharks feeding inshore on fish eggs off the northeast Yucatan Peninsula demonstrated reverse diel vertical migration, with extended periods of surface swimming beginning at sunrise followed by an abrupt change in the mid-afternoon to regular vertical oscillations, a pattern that continued overnight. When in oceanic waters, sharks spent about 95% of their time within epipelagic depths (<200 m) but regularly undertook very deep ("extreme") dives (>500 m) that largely occurred during daytime or twilight hours (max. depth recorded 1,928 m), had V-shaped depth-time profiles, and comprised more rapid descents (0.68 m sec(-1)) than ascents (0.50 m sec(-1)). Nearly half of these extreme dives had descent profiles with brief but conspicuous changes in vertical direction at a mean depth of 475 m. We hypothesize these stutter steps represent foraging events within the deep scattering layer, however, the extreme dives may have additional functions. Overall, our results demonstrate complex and dynamic patterns of habitat utilization for R. typus that appear to be in response to changing biotic and abiotic conditions influencing the distribution and abundance of their prey.	[Tyminski, John P.; Hueter, Robert E.] Mote Marine Lab, Ctr Shark Res, Sarasota, FL 34236 USA; [de la Parra-Venegas, Rafael] Chooj Ajauil AC, Cancun, Quintana Roo, Mexico; [Gonzzlez Cano, Jaime] Comis Nacl Areas Nat Protegidas, Proyecto Domino, Cancun, Quintana Roo, Mexico	Mote Marine Laboratory & Aquarium	Tyminski, JP (corresponding author), Mote Marine Lab, Ctr Shark Res, Sarasota, FL 34236 USA.	johnski@mote.org			Georgia Aquarium; Christopher Reynolds Foundation; National Geographic Society; Mote Marine Laboratory; Mexico Small Grants Program - UNDP/Global Environment Facility	Georgia Aquarium; Christopher Reynolds Foundation; National Geographic Society(National Geographic Society); Mote Marine Laboratory; Mexico Small Grants Program - UNDP/Global Environment Facility	This research was supported by funding from Georgia Aquarium (www.georgiaaquarium.org), Christopher Reynolds Foundation (www.creynolds.org), National Geographic Society (www.ngs.org), Mote Marine Laboratory (www.mote.org) and an anonymous private foundation. The Natural Protected Areas National Commission of Mexico (SEMARNAT/CONANP) provided personnel, biological station facilities, boats, fuel and conventional tags during the early stages of the work (2003-2009). Those stages also were supported in part by a Mexico Small Grants Program funded by the UNDP/Global Environment Facility, as provided by the Mexican NGO SER de Quintana Roo A.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhilesh KV, 2013, ENVIRON BIOL FISH, V96, P713, DOI 10.1007/s10641-012-0063-9; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Berumen ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103536; Braun CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088170; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Brunnschweiler JM, 2012, AM FISH S S, V76, P457; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Cartamil D, 2010, MAR FRESHWATER RES, V61, P596, DOI 10.1071/MF09153; Chapman DD, 2007, MAR ECOL PROG SER, V344, P271, DOI 10.3354/meps06941; Chatfield C., 2004, ANAL TIME SERIES INT; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Collette BB, 1983, FAO FISH SYNOPOSIS, V125, P137; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Comfort CM, 2015, DEEP-SEA RES PT II, V115, P116, DOI 10.1016/j.dsr2.2014.04.005; Compango LJV, 2001, FAO SPECIES CATALOGU, P269; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Di Santo V, 2011, J FISH BIOL, V78, P195, DOI 10.1111/j.1095-8649.2010.02853.x; Dove ADM, 2015, BIOL BULL-US, V228, P65, DOI 10.1086/BBLv228n1p65; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Gleiss AC, 2013, MAR BIOL, V160, P2981, DOI 10.1007/s00227-013-2288-3; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Graves JE, 2009, FISH B-NOAA, V107, P373; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Hays GC, 2015, J ANIM ECOL, V84, P587, DOI 10.1111/1365-2656.12355; Hoffmayer Eric R., 2007, Gulf and Caribbean Research, V19, P69; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Kaartvedt S, 2009, MAR ECOL PROG SER, V395, P109, DOI 10.3354/meps08174; Kaltenberg A. M., 2007, Gulf of Mexico Science, V25, P97; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; Krylov VV., 2014, BIOL B REV, V4, P222, DOI [10.1134/S2079086414030049, DOI 10.1134/S2079086414030049]; Li W, 2012, J FISH BIOL, V80, P1608, DOI 10.1111/j.1095-8649.2012.03250.x; MACDONALD KC, 1980, J GEOPHYS RES, V85, P3670, DOI 10.1029/JB085iB07p03670; Meyer CG, 2005, J R SOC INTERFACE, V2, P129, DOI 10.1098/rsif.2004.0021; Moretzsohn F, 2015, GULFBASE RESOURCE DA; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Nakamura I, 2015, J ANIM ECOL, V84, P590, DOI 10.1111/1365-2656.12346; Nelson DR, 1997, ENVIRON BIOL FISH, V49, P389, DOI 10.1023/A:1007369619576; Norman B, IUCN RED LIST THREAT; Pade NG, 2009, J EXP MAR BIOL ECOL, V370, P64, DOI 10.1016/j.jembe.2008.12.002; R Core Team, 2018, R LANG ENV STAT COMP; Riley MJ, 2009, ENVIRON BIOL FISH, V86, P371, DOI 10.1007/s10641-009-9541-0; Rohner CA, 2015, J PLANKTON RES, V37, P352, DOI 10.1093/plankt/fbv010; Rohner CA, 2013, MAR ECOL PROG SER, V493, P219, DOI 10.3354/meps10500; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Sims DW, 2010, CRC MAR BIOL SER, P351; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; Sims DW, 2009, FISH LOCOMOTION ETHO, P407; Stewart BS, 2005, ENVIRON BIOL FISH, V74, P184, DOI 10.1007/s10641-005-2229-1; Thorrold SR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5274; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Tyminski JP, 2012, MOTE MARINE LAB TECH, V1633, P1; Wang YM, 2012, INTEGR ZOOL, V7, P94, DOI [10.1111/j.1749-4877.2012.00279.x, 10.1111/j.1749-4877.2011.00278.x]; Weng KC, 2009, J FISH BIOL, V74, P1434, DOI 10.1111/j.1095-8649.2009.02209.x; Weng KC, 2004, FISH B-NOAA, V102, P221; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; Willis J, 2009, BEHAV ECOL SOCIOBIOL, V64, P57, DOI 10.1007/s00265-009-0818-2; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8	65	38	38	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142156	10.1371/journal.pone.0142156	http://dx.doi.org/10.1371/journal.pone.0142156			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580405	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600037
J	Zhang, XY; Hou, JL; Wang, GX; Jiang, HB; Wang, YF; Sun, ZH; Jiang, XF; Yu, QH; Liu, HJ				Zhang, Xiaoyan; Hou, Jilun; Wang, Guixing; Jiang, Hongbo; Wang, Yufen; Sun, Zhaohui; Jiang, Xiufeng; Yu, Qinghai; Liu, Haijin			Gonadal Transcriptome Analysis in Sterile Double Haploid Japanese Flounder	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; RAINBOW-TROUT; FOLLICULAR ATRESIA; 11-BETA-HYDROXYLASE GENE; OVARIAN DEVELOPMENT; MOLECULAR-CLONING; GROWTH-HORMONE; EXPRESSION; PROLACTIN; FISH	Sterility is a serious problem that can affect all bionts. In teleosts, double haploids (DHs) induced by mitogynogenesis are often sterile. This sterility severely restricts the further application of DHs for production of clones, genetic analysis, and breeding. However, sterile DH individuals are good source materials for investigation of the molecular mechanisms of gonad development, especially for studies into the role of genes that are indispensable for fish reproduction. Here, we used the Illumina sequencing platform to analyze the transcriptome of sterile female DH Japanese flounder in order to identify major genes that cause sterility and to provide a molecular basis for an intensive study of gonadal development in teleosts. Through sequencing, assembly, and annotation, we obtained 52,474 contigs and found that 60.7% of these shared homologies with existing sequences. A total of 1225 differentially expressed unigenes were found, including 492 upregulated and 733 downregulated genes. Gene Ontology and KEGG analyses showed that genes showing significant upregulation, such as CYP11A1, CYP11B2, CYP17, CYP21, HSD3 beta, bcl2l1, and PRLR, principally correlated with sterol metabolic process, steroid biosynthetic process, and the Jak-stat signaling pathway. The significantly downregulated genes were primarily associated with immune response, antigen processing and presentation, cytokine-cytokine receptor interaction, and protein digestion and absorption. Using a co-expression network analysis, we conducted a comprehensive comparison of gene expression in the gonads of fertile and sterile female DH Japanese flounder. Identification of genes showing significantly different expression will provide further insights into DH reproductive dysfunction and oocyte maturation processes in teleosts.	[Zhang, Xiaoyan; Hou, Jilun; Wang, Guixing; Wang, Yufen; Sun, Zhaohui; Jiang, Xiufeng; Yu, Qinghai] Chinese Acad Fishery Sci, Beidaihe Cent Expt Stn, Qinhuangdao, Peoples R China; [Jiang, Hongbo] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang 110161, Peoples R China; [Liu, Haijin] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China	Chinese Academy of Fishery Sciences; Beidaihe Central Experiment Station, CAFS; Shenyang Agricultural University; Chinese Academy of Fishery Sciences	Hou, JL (corresponding author), Chinese Acad Fishery Sci, Beidaihe Cent Expt Stn, Qinhuangdao, Peoples R China.	jilunhou@126.com; liuhaijin2005@126.com	wang, guixing/GQP-1217-2022		National High Technology Research and Development Program in China [2012BAD26B01]; Special Scientific Research Funds for Central Non-profit Institutes Chinese Academy of Fishery Sciences [2014A03XK02]	National High Technology Research and Development Program in China(National High Technology Research and Development Program of China); Special Scientific Research Funds for Central Non-profit Institutes Chinese Academy of Fishery Sciences	The work was funded by National High Technology Research and Development Program in China (2012BAD26B01) and Special Scientific Research Funds for Central Non-profit Institutes Chinese Academy of Fishery Sciences (2014A03XK02).	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Arukwe A, 2001, MAR POLLUT BULL, V42, P643, DOI 10.1016/S0025-326X(01)00062-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BABIN PJ, 1987, J BIOL CHEM, V262, P4290; Bannister LA, 2007, PLOS BIOL, V5, P1016, DOI 10.1371/journal.pbio.0050105; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; BESSEAU L, 1994, CELL TISSUE RES, V276, P123, DOI 10.1007/BF00354791; Bobe J, 2009, COMP BIOCHEM PHYS A, V153, P63, DOI 10.1016/j.cbpa.2008.10.021; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bongers ABJ, 1999, VIABLE ANDROGENETIC; Bureik M, 2002, BIOL CHEM, V383, P1537, DOI 10.1515/BC.2002.174; Carnevali O, 2006, GEN COMP ENDOCR, V146, P195, DOI 10.1016/j.ygcen.2005.12.007; Cavaco JEB, 2003, QUANTIFICATION PROLA, P588; Cerda J, 2008, REV FISH SCI, V16, P56, DOI 10.1080/10641260802324685; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; de Vlaming VL, 1972, ENV CONTROL TELEOST, P131; Ding YX, 2013, GENE, V527, P82, DOI 10.1016/j.gene.2013.05.037; Ding YX, 2012, GEN COMP ENDOCR, V179, P107, DOI 10.1016/j.ygcen.2012.08.003; Draghici S, 2007, SYSTEMS BIOL APPROAC, P1537; EDERY M, 1984, GEN COMP ENDOCR, V56, P19, DOI 10.1016/0016-6480(84)90056-X; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063259; Guraya SS, 1994, GONADAL DEV PRODUCTI, P15; Hayashi M, 2012, MOL REPROD DEV, V79, P870, DOI 10.1002/mrd.22127; Hsu HJ, 2009, MOL CELL ENDOCRINOL, V312, P31, DOI 10.1016/j.mce.2009.07.030; Huang S, 2010, FERTIL STERIL, V94, P205, DOI 10.1016/j.fertnstert.2009.03.005; Huang W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-711; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Izquierdo MS, 2001, AQUACULTURE, V197, P25, DOI 10.1016/S0044-8486(01)00581-6; Jiang JQ, 1998, MOL CELL ENDOCRINOL, V146, P207, DOI 10.1016/S0303-7207(98)00147-6; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; KAGAWA H, 1983, BIOL REPROD, V29, P301, DOI 10.1095/biolreprod29.2.301; Kazeto Y, 2000, GEN COMP ENDOCR, V118, P123, DOI 10.1006/gcen.1999.7449; Keller L, 2002, INBREEDING EFFECTS W, P230; KJORSVIK E, 1990, ADV MAR BIOL, V26, P71, DOI 10.1016/S0065-2881(08)60199-6; Komen H, 2007, AQUACULTURE, V269, P150, DOI 10.1016/j.aquaculture.2007.05.009; Kuribayashi K, 2008, CANCER BIOL THER, V7, P2034, DOI 10.4161/cbt.7.12.7460; Kusakabe M, 2002, MOL REPROD DEV, V62, P456, DOI 10.1002/mrd.10145; LANG I, 1981, CELL TISSUE RES, V220, P201; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lisurek M, 2004, MOL CELL ENDOCRINOL, V215, P149, DOI 10.1016/j.mce.2003.11.008; Liu SJ, 2000, J STEROID BIOCHEM, V75, P291, DOI 10.1016/S0960-0760(00)00186-2; Ma DL, 2014, BIOCHIMIE, V103, P101, DOI 10.1016/j.biochi.2014.04.010; Miranda ACL, 1999, TISSUE CELL, V31, P480, DOI 10.1054/tice.1999.0045; MullerBelecke A, 1995, AQUACULTURE, V137, P57, DOI 10.1016/0044-8486(95)01114-5; NAGAHAMA Y, 1985, DEV BIOL, V109, P428, DOI 10.1016/0012-1606(85)90469-5; Nematollahi MA, 2014, AQUACULTURE, V418, P165, DOI [10.1016/j.aquaculture.2013.10.011, 10.1016/j.aquaculture.2013.10.0]; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reisch N, 2015, BEST PRACT RES CL EN, V29, P33, DOI 10.1016/j.beem.2014.11.002; Saidapur S K, 1978, Int Rev Cytol, V54, P225, DOI 10.1016/S0074-7696(08)60169-2; Sandra O, 2000, J MOL ENDOCRINOL, V24, P215, DOI 10.1677/jme.0.0240215; Santos HB, 2005, J FISH BIOL, V67, P1446, DOI 10.1111/j.1095-8649.2005.00854.x; SJ TC, 1996, REV FISH BIOL FISHER, V6, P287; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Tacon P, 2000, GEN COMP ENDOCR, V117, P54, DOI 10.1006/gcen.1999.7388; Takesono A, 2012, P NATL ACAD SCI USA, V109, P3371, DOI 10.1073/pnas.1200642109; Tingaud-Sequeira A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-434; von Schalburg KR, 2005, BIOL REPROD, V72, P687, DOI 10.1095/biolreprod.104.034967; WALLACE RA, 1990, J ELECTRON MICR TECH, V16, P175, DOI 10.1002/jemt.1060160302; Wood AW, 2003, MOL REPROD DEV, V65, P219, DOI 10.1002/mrd.10272; Yamamoto E, 1999, AQUACULTURE, V173, P235, DOI 10.1016/S0044-8486(98)00448-7; Zhang Xiao-yan, 2014, Marine Fisheries, V36, P503; Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230; Zhou LY, 2007, BIOCHEM BIOPH RES CO, V362, P619, DOI 10.1016/j.bbrc.2007.08.044	69	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143204	10.1371/journal.pone.0143204	http://dx.doi.org/10.1371/journal.pone.0143204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580217	Green Submitted, gold, Green Published			2022-12-27	WOS:000365154600097
J	Amelkina, O; Zschockelt, L; Painer, J; Serra, R; Villaespesa, F; Braun, BC; Jewgenow, K				Amelkina, Olga; Zschockelt, Lina; Painer, Johanna; Serra, Rodrigo; Villaespesa, Francisco; Braun, Beate C.; Jewgenow, Katarina			Apoptosis-Related Factors in the Luteal Phase of the Domestic Cat and Their Involvement in the Persistence of Corpora Lutea in Lynx	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RAT CORPUS-LUTEUM; CYCLE-DEPENDENT CHANGES; FAS/FAS LIGAND SYSTEM; IBERIAN LYNX; FAS LIGAND; ESTROUS-CYCLE; ENZYME-ACTIVITY; CELL APOPTOSIS; AND-9 PROTEINS	The corpus luteum (CL) is a transient gland formed in the ovary after ovulation and is the major source of progesterone. In the Iberian and Eurasian lynx, CL physiologically persist after parturition and retain their capacity to produce progesterone, thus suppressing the ovarian activity. This unique reproductive characteristic has a big impact on the success of assisted reproduction techniques in the endangered Iberian lynx. The mechanisms behind CL persistence are not yet understood and require extensive studies on potential luteotropic and luteolytic factors in felids. Because the apoptosis system has been shown to be involved in structural regression of CL in many species, we aimed to investigate the capacity of perCL to undergo apoptosis. In addition, we performed initial studies on the apoptosis system in the luteal phase of the domestic cat. No previous research on this system has been made in this species. Our factors of interest included agents of the intrinsic apoptosis pathway, i.e., pro-survival B-cell CLL/lymphoma 2 (BCL2) and pro-apoptotic BCL2-associated X protein (BAX), the executioner caspase-3 (CASP3), as well as of the extrinsic pathway, i.e., pro-apoptotic receptor FAS, and tumor necrosis factor (TNF) and its receptors (pro-apoptotic TNFRSF1A and pro-survival TNFRSF1B). We analyzed the relative mRNA levels of these factors, as well as protein localization of CASP3 and TNF during stages of pregnancy and the non-pregnant luteal phase in CL of domestic cats. The same factors were investigated in freshly ovulated CL (frCL) and perCL of Iberian and Eurasian lynx, which were histologically analyzed. All factors were present in the CL tissue of both domestic cat and lynx throughout all analyzed stages. The presence of pro-apoptotic factors BAX, CASP3, FAS and TNFRSF1A in perCL of the Eurasian and Iberian lynx might indicate the potential sensitivity of perCL to apoptotic signals. The expression of pro-survival factors BCL2 and TNFRSF1B was significantly higher in perCL compared to frCL of studied Iberian lynx, suggesting the potential involvement of these factors in the structural integrity of perCL. In both Iberian lynx and pregnant and non-pregnant domestic cats, the expression of TNFRSF1A was significantly higher in forming CL compared to other stages, suggesting the conserved involvement of this factor in the tissue reorganization during formation of the feline CL. The mRNA levels of CASP3 and TNFRSF1B were highest during regression stages of domestic cat CL. The current study provides initial results on the possible involvement of the apoptosis system in the structure and function of the feline CL and in its physiological persistence.	[Amelkina, Olga; Zschockelt, Lina; Painer, Johanna; Braun, Beate C.; Jewgenow, Katarina] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol, Berlin, Germany; [Serra, Rodrigo] Ctr Nacl Reprod Lince Iberico, Iberian Iynx Capt Breeding Program, Silves, Portugal; [Villaespesa, Francisco] Ctr Cria Lince Iberico El Acebuche, Iberian Iynx Capt Breeding Program, Huelva, Spain	Leibniz Institut fur Zoo und Wildtierforschung	Amelkina, O (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol, Berlin, Germany.	olga.amelkina@gmail.com	Schölkopf, Bernhard/A-7570-2013; Rätsch, Gunnar/B-8182-2009; Braun, Beate C/J-8641-2016; Rätsch, Gunnar/O-5914-2017; Scholz, Matthias/B-3508-2018	Schölkopf, Bernhard/0000-0002-8177-0925; Rätsch, Gunnar/0000-0001-5486-8532; Scholz, Matthias/0000-0003-1414-5924; Painer - Gigler, Johanna/0000-0003-3929-511X; Jewgenow, Katarina/0000-0002-6173-840X	German Research Foundation (DFG) [Je 163/11-1]; German Academic Exchange Service (DAAD) [A/10/86242]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The work was supported by the German Research Foundation (DFG; Je 163/11-1; URL http://www.dfg.de/en/) and German Academic Exchange Service (DAAD; A/10/86242; https://www.daad.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo M, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-50; Amelkina O, 2015, THERIOGENOLOGY, V83, P711, DOI 10.1016/j.theriogenology.2014.11.008; Baird DD, 2003, BIOL REPROD, V68, P448, DOI 10.1095/biolreprod.102.008425; Braun BC, 2012, J STEROID BIOCHEM, V132, P295, DOI 10.1016/j.jsbmb.2012.07.005; Braun BC, 2012, REPRODUCTION, V143, P399, DOI 10.1530/REP-11-0316; Carambula SF, 2002, ENDOCRINOLOGY, V143, P1495, DOI 10.1210/en.143.4.1495; Carnaby K, 2012, REPRODUCTION, V144, P477, DOI 10.1530/REP-12-0166; Casas-Marce M, 2013, MOL ECOL, V22, P5503, DOI 10.1111/mec.12498; Castracane VD, 1998, HUM REPROD UPDATE, V4, P383, DOI 10.1093/humupd/4.4.383; CROWE DM, 1975, J MAMMAL, V56, P177, DOI 10.2307/1379615; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Davis JS, 2002, FRONT BIOSCI-LANDMRK, V7, pD1949, DOI 10.2741/davis1; DUKE KL, 1949, ANAT RECORD, V103, P111, DOI 10.1002/ar.1091030108; Duncan A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-90; Duncan WC, 2000, REV REPROD, V5, P12, DOI 10.1530/revreprod/5.1.12; Fanson KV, 2010, GEN COMP ENDOCR, V169, P217, DOI 10.1016/j.ygcen.2010.09.003; Ferreira-Dias G, 2007, REPROD DOMEST ANIM, V42, P380, DOI 10.1111/j.1439-0531.2006.00795.x; Galvao AM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/420186; Galvao AM, 2010, BIOL REPROD, V83, P901, DOI 10.1095/biolreprod.110.084699; Gillies LA, 2014, J CELL BIOCHEM, V115, P632, DOI 10.1002/jcb.24709; Goritz F, 2009, REPROD DOMEST ANIM, V44, P87, DOI 10.1111/j.1439-0531.2009.01380.x; Goyeneche AA, 2003, BIOL REPROD, V68, P2322, DOI 10.1095/biolreprod.102.013540; Goyeneche AA, 2003, BIOL REPROD, V68, P151, DOI 10.1095/biolreprod.102.007898; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hojo T, 2010, J REPROD DEVELOP, V56, P515, DOI 10.1262/jrd.10-056T; IUCN, IUCN RED LIST THREAT; Jewgenow K, 2014, REPROD BIOL, V14, P83, DOI 10.1016/j.repbio.2014.03.002; Jewgenow K, 2009, J ANDROL, V30, P460, DOI 10.2164/jandrol.108.006726; JUENGEL JL, 1993, ENDOCRINOLOGY, V132, P249, DOI 10.1210/en.132.1.249; Knospe C, 2002, ANAT HISTOL EMBRYOL, V31, P37, DOI 10.1046/j.1439-0264.2002.00360.x; Komatsu K, 2003, MOL REPROD DEV, V65, P345, DOI 10.1002/mrd.10312; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Korzekwa A, 2008, REPROD BIOL, V8, P245, DOI 10.1016/S1642-431X(12)60015-1; Kowalewski MP, 2014, REPROD BIOL, V14, P89, DOI 10.1016/j.repbio.2013.11.004; Kuranaga E, 1999, BIOCHEM BIOPH RES CO, V260, P167, DOI 10.1006/bbrc.1999.0858; Kuranaga E, 2000, FEBS LETT, V472, P137, DOI 10.1016/S0014-5793(00)01426-5; KVAM T, 1991, Z SAUGETIERKD, V56, P146; Liszewska E, 2005, PROSTAG OTH LIPID M, V78, P67, DOI 10.1016/j.prostaglandins.2005.03.003; Magata F, 2012, J REPROD DEVELOP, V58, P445, DOI 10.1262/jrd.2011-049; McCormack JT, 1998, BIOL REPROD, V58, P255, DOI 10.1095/biolreprod58.1.255; McCracken JA, 1999, PHYSIOL REV, V79, P263, DOI 10.1152/physrev.1999.79.2.263; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Okuda Kiyoshi, 2003, Reprod Biol Endocrinol, V1, P95, DOI 10.1186/1477-7827-1-95; Painer J, 2014, THERIOGENOLOGY, V82, P557, DOI 10.1016/j.theriogenology.2014.05.004; Painer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090469; Palomares F, 2005, BIOL CONSERV, V122, P53, DOI 10.1016/j.biocon.2004.06.020; Palomares F, 2012, CONSERV BIOL, V26, P689, DOI 10.1111/j.1523-1739.2012.01870.x; Pate JL, 2012, REPROD DOMEST ANIM, V47, P297, DOI 10.1111/j.1439-0531.2012.02089.x; Peluffo MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1215, DOI 10.1152/ajpendo.00261.2007; Peluffo MC, 2006, REPRODUCTION, V132, P465, DOI 10.1530/rep.1.00910; Peluffo MC, 2009, MOL REPROD DEV, V76, P367, DOI 10.1002/mrd.20970; Peluffo MC, 2005, J CLIN ENDOCR METAB, V90, P2327, DOI 10.1210/jc.2004-2214; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Poole KG, 2003, CAN FIELD NAT, V117, P360, DOI 10.22621/cfn.v117i3.738; RODGER FE, 1995, HUM REPROD, V10, P1566, DOI 10.1093/HUMREP/10.6.1566; Schnorr B., 2006, EMBRYOLOGIE HAUSTIER; Siemieniuch MJ, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-89; SimuEn, 2012, 10 YEARS CONSERVING; Skarzynski DJ, 2013, REPROD DOMEST ANIM, V48, P25, DOI 10.1111/rda.12203; Slot KA, 2006, J ENDOCRINOL, V188, P179, DOI 10.1677/joe.1.06165; Stewart RA, 2010, GEN COMP ENDOCR, V166, P409, DOI 10.1016/j.ygcen.2009.12.016; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Sugino N, 2000, J CLIN ENDOCR METAB, V85, P4379, DOI 10.1210/jc.85.11.4379; Sugino N, 2007, J REPROD DEVELOP, V53, P977, DOI 10.1262/jrd.19047; Suzuki C, 2014, VET RES COMMUN, V38, P1, DOI 10.1007/s11259-013-9575-9; Taniguchi H, 2002, BIOL REPROD, V66, P754, DOI 10.1095/biolreprod66.3.754; Telleria CM, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-53; Terranova PF, 1997, DOMEST ANIM ENDOCRIN, V14, P1, DOI 10.1016/S0739-7240(96)00094-X; TSUTSUI T, 1993, J REPROD FERTIL, P29; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERHAGE HG, 1976, BIOL REPROD, V14, P579, DOI 10.1095/biolreprod14.5.579; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; WILDT DE, 1981, BIOL REPROD, V25, P15, DOI 10.1095/biolreprod25.1.15; Woshner VM, 2001, PROCEEDINGS OF THE FIFTY-FIFTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P427; Zambelli D, 2006, THERIOGENOLOGY, V66, P135, DOI 10.1016/j.theriogenology.2006.04.004; Zorrilla LM, 2013, REPROD DOMEST ANIM, V48, P755, DOI 10.1111/rda.12156; Zschockelt L, 2015, J STEROID BIOCHEM, V154, P75, DOI 10.1016/j.jsbmb.2015.07.001; Zschockelt L, 2014, J STEROID BIOCHEM, V144, P373, DOI 10.1016/j.jsbmb.2014.08.010	82	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143414	10.1371/journal.pone.0143414	http://dx.doi.org/10.1371/journal.pone.0143414			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599641	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600062
J	Chen, SC; Telinius, N; Lin, HT; Huang, MC; Lin, CC; Chou, CH; Hjortdal, J				Chen, Shih-Cheng; Telinius, Niklas; Lin, Han-Tse; Huang, Min-Chang; Lin, Chien-Chen; Chou, Cheng-Hung; Hjortdal, Jesper			Use of Fish Scale-Derived BioCornea to Seal Full-Thickness Corneal Perforations in Pig Models	PLOS ONE			English	Article							TISSUE QUALITY PARAMETERS; AMNIOTIC MEMBRANE; DONOR CORNEAS; FIBRIN GLUE; MANAGEMENT; MATRIX; MULTILAYER; VALIDATION	The aim of this study was to test the use of BioCornea, a fish scale-derived collagen matrix for sealing full-thickness corneal perforations in mini-pigs. Two series of experiments were carried out in 8 Lan-Yu and 3 Gottingen mini-pigs, respectively. A 2mm central full thickness corneal perforation was made with surgical scissors and 2mm trephines. The perforations were sealed immediately by suturing BioCornea to the wounded cornea. The conditions of each patched cornea were followed-up daily for 3 or 4 days. Status of operated eyes was assessed with slit lamp examination or optical coherence tomography (OCT). Animals were sacrificed after the study period and the corneas operated were fixated for histological examination. Both OCT imaging and handheld slit lamp observations indicated that a stable ocular integrity of the perforated corneas was maintained, showing no leakage of aqueous humor, normal depth of anterior chamber and only mild swelling of the wounded cornea. Hematoxylin and eosin staining of the patched cornea showed no epithelial ingrowths to the perforated wounds and no severe leucocyte infiltration of the stroma. The fish scale-derived BioCornea is capable to seal full-thickness corneal perforation and stabilize the integrity of ocular anterior chamber in pre-clinic mini-pig models. BioCornea seems to be a safe and effective alternative for emergency treatment of corneal perforations.	[Chen, Shih-Cheng] Aeon Astron Europe BV, Leiden, Netherlands; [Telinius, Niklas; Hjortdal, Jesper] Aarhus Univ Hosp, Dept Ophthalmol, DK-8000 Aarhus, Denmark; [Lin, Han-Tse; Huang, Min-Chang; Lin, Chien-Chen; Chou, Cheng-Hung] Body Organ Biomed Corp, Taipei, Taiwan	Aarhus University	Hjortdal, J (corresponding author), Aarhus Univ Hosp, Dept Ophthalmol, DK-8000 Aarhus, Denmark.	jesper.hjortdal@dadlnet.dk		Chen, Shih-Cheng/0000-0002-4764-0510	Aeon Astron Europe; Aeon Astron Europe B.V.; Body Organ Biomedical Corp.	Aeon Astron Europe; Aeon Astron Europe B.V.; Body Organ Biomedical Corp.	Aeon Astron Europe sponsored all experiments. The expenditures associated with the experiments were covered by Aeon Astron Europe B.V. and Body Organ Biomedical Corp. Aeon Astron Europe B.V. and Body Organ Biomedical Corp. provided support in the form of salaries for authors SCC, HTL, MCH, CCL and CHC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aslam SA, 2007, INJURY, V38, P594, DOI 10.1016/j.injury.2006.04.122; Chirila T V, 1999, Gesnerus, V56, P96; Du LQ, 2011, ARTIF ORGANS, V35, P691, DOI 10.1111/j.1525-1594.2010.01174.x; Grau AE, 2012, CORNEA, V31, P98, DOI 10.1097/ICO.0b013e31821f28a2; Griffith M, 2014, CURR OPIN OPHTHALMOL, V25, P240, DOI 10.1097/ICU.0000000000000049; Hamill M Bowes, 2002, Ophthalmol Clin North Am, V15, P185, DOI 10.1016/S0896-1549(02)00018-4; Hart A, 1997, INJURY, V28, P527, DOI 10.1016/S0020-1383(97)83472-9; Ikoma T, 2003, J STRUCT BIOL, V142, P327, DOI 10.1016/S1047-8477(03)00053-4; Jhanji V, 2011, SURV OPHTHALMOL, V56, P522, DOI 10.1016/j.survophthal.2011.06.003; Kara S, 2014, CASE REP OPHTHALMOL, V2014, DOI 10.1155/2014/351534; Kim EC, 2010, CAN J OPHTHALMOL, V45, P9; Lee W, 2014, INT J OPHTHALMOL-CHI, V7, P587, DOI 10.3980/j.issn.2222-3959.2014.04.01; Lekskul M, 2000, CORNEA, V19, P313, DOI 10.1097/00003226-200005000-00011; Lin CC, 2010, EUR CELLS MATER, V19, P50, DOI 10.22203/eCM.v019a06; Lynch AP, 2013, EXP EYE RES, V108, P42, DOI 10.1016/j.exer.2012.12.012; Michael JG, 2002, ANN EMERG MED, V40, P69, DOI 10.1067/mem.2002.124757; Nubile M, 2007, J CATARACT REFR SURG, V33, P1636, DOI 10.1016/j.jcrs.2007.04.040; Omobolanle Adio Adedayo, 2012, BMC Res Notes, V5, P683, DOI 10.1186/1756-0500-5-683; PORTNOY SL, 1989, SURV OPHTHALMOL, V34, P47, DOI 10.1016/0039-6257(89)90129-X; Rana M, 2013, CONTACT LENS ANTERIO, V36, P156, DOI 10.1016/j.clae.2013.03.006; Rijneveld WJ, 2011, ACTA OPHTHALMOL, V89, P734, DOI 10.1111/j.1755-3768.2009.01805.x; Rijneveld WJ, 2010, CORNEA, V29, P128, DOI 10.1097/ICO.0b013e3181ac07bc; Savino G, 2010, ACTA OPHTHALMOL, V88, pe15, DOI 10.1111/j.1755-3768.2009.01522.x; Sharma A, 2003, OPHTHALMOLOGY, V110, P291, DOI 10.1016/S0161-6420(02)01558-0; Sii F, 2005, CLIN EXP OPHTHALMOL, V33, P532, DOI 10.1111/j.1442-9071.2005.01076.x; Solomon A, 2002, OPHTHALMOLOGY, V109, P694, DOI 10.1016/S0161-6420(01)01032-6; Taravella MJ, 2001, CORNEA, V20, P220, DOI 10.1097/00003226-200103000-00024; van Essen TH, 2013, INVEST OPHTH VIS SCI, V54, P3224, DOI 10.1167/iovs.13-11799; Vora Gargi K, 2013, Int Ophthalmol Clin, V53, P1, DOI 10.1097/IIO.0b013e3182a12c08; Yuan F, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/914542; Zhou Y, 2011, CORNEA, V30, P73, DOI 10.1097/ICO.0b013e3181dc8184	31	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143511	10.1371/journal.pone.0143511	http://dx.doi.org/10.1371/journal.pone.0143511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599018	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600076
J	Fan, QQ; Song, AP; Xin, JJ; Chen, SM; Jiang, JF; Wang, YJ; Li, XR; Chen, FD				Fan, Qingqing; Song, Aiping; Xin, Jingjing; Chen, Sumei; Jiang, Jiafu; Wang, Yinjie; Li, Xiran; Chen, Fadi			CmWRKY15 Facilitates Alternaria tenuissima Infection of Chrysanthemum	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; STRESS TOLERANCE; FACTOR GENES; ARABIDOPSIS; RESISTANCE; EXPRESSION; DEFENSE; ABA; BIOSYNTHESIS; PATHOGENS	Abscisic acid (ABA) has an important role in the responses of plants to pathogens due to its ability to induce stomatal closure and interact with salicylic acid (SA) and jasmonic acid (JA). WRKY transcription factors serve as antagonistic or synergistic regulators in the response of plants to a variety of pathogens. Here, we demonstrated that CmWRKY15, a group IIa WRKY family member, was not transcriptionally activated in yeast cells. Subcellular localization experiments in which onion epidermal cells were transiently transfected with CmWRKY15 indicated that CmWRKY15 localized to the nucleus in vivo. The expression of CmWRKY15 could be markedly induced by the presence of Alternaria tenuissima inoculum in chrysanthemum. Furthermore, the disease severity index (DSI) data of CmWRKY15-overexpressing plants indicated that CmWRKY15 overexpression enhanced the susceptibility of chrysanthemum to A. tenuissima infection compared to controls. To illustrate the mechanisms by which CmWRKY15 regulates the response to A. tenuissima inoculation, the expression levels of ABA-responsive and ABA signaling genes, such as ABF4, ABI4, ABI5, MYB2, RAB18, DREB1A, DREB2A, PYL2, PP2C, RCAR1, SnRK2.2, SnRK2.3, NCED3A, NCED3B, GTG1, AKT1, AKT2, KAT1, KAT2, and KC1were compared between transgenic plants and controls. In summary, our data suggest that CmWRKY15 might facilitate A. tenuissima infection by antagonistically regulating the expression of ABA-responsive genes and genes involved in ABA signaling, either directly or indirectly.	[Fan, Qingqing; Song, Aiping; Xin, Jingjing; Chen, Sumei; Jiang, Jiafu; Wang, Yinjie; Li, Xiran; Chen, Fadi] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Fan, Qingqing; Chen, Fadi] Jiangsu Prov Engn Lab Modern Facil Agr Technol &, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chen, FD (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chenfd@njau.edu.cn			National Natural Science Foundation of China [31471913, 31301809]; National Science Fund for Distinguished Young Scholars [31425022]; Fundamental Research Funds for the Central Universities [KYTZ201401]; Special Fund for Agroscientific Research in the Public Interest [201403039]; Six Talent Peaks Project in Jiangsu Province [2013-NY-022]; China Postdoctoral Science Foundation [2014M561673, 2015T80564]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Agroscientific Research in the Public Interest; Six Talent Peaks Project in Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was funded by the National Natural Science Foundation of China (31471913, 31301809), the National Science Fund for Distinguished Young Scholars (31425022), the Fundamental Research Funds for the Central Universities (KYTZ201401), Special Fund for Agroscientific Research in the Public Interest (201403039), the Six Talent Peaks Project in Jiangsu Province (2013-NY-022), and the China Postdoctoral Science Foundation (2014M561673, 2015T80564).	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Campbell R, 2010, PLANT PHYSIOL, V154, P656, DOI 10.1104/pp.110.158733; Cormack RS, 2002, BBA-GENE STRUCT EXPR, V1576, P92, DOI 10.1016/S0167-4781(02)00298-1; De Coninck B, 2015, TRENDS PLANT SCI, V20, P91, DOI 10.1016/j.tplants.2014.09.007; De Vleesschauwer D, 2010, PLANT PHYSIOL, V152, P2036, DOI 10.1104/pp.109.152702; Deng YM, 2012, SCI HORTIC-AMSTERDAM, V134, P185, DOI 10.1016/j.scienta.2011.11.012; Espasandin FD, 2014, PLANT PHYSIOL BIOCH, V76, P29, DOI 10.1016/j.plaphy.2013.12.018; Fan LM, 2008, P NATL ACAD SCI USA, V105, P8476, DOI 10.1073/pnas.0800980105; Fan XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126148; Gao HS, 2012, PLANTA, V235, P979, DOI 10.1007/s00425-011-1558-x; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Li PL, 2015, PLANT CELL REP, V34, P1365, DOI 10.1007/s00299-015-1793-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammarella ND, 2015, PHYTOCHEMISTRY, V112, P110, DOI 10.1016/j.phytochem.2014.07.010; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Schluttenhofer C, 2014, BMC GENOMICS, V15; Schon M, 2013, MOL PLANT MICROBE IN, V26, P758, DOI 10.1094/MPMI-11-12-0265-R; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Song AP, 2014, INT J MOL SCI, V15, P14442, DOI 10.3390/ijms150814442; Song AP, 2014, PLANT PHYSIOL BIOCH, V80, P114, DOI 10.1016/j.plaphy.2014.03.030; Song AP, 2014, INT J MOL SCI, V15, P5063, DOI 10.3390/ijms15035063; Song AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057229; Song WW, 2011, PLANT PHYSIOL BIOCH, V49, P693, DOI 10.1016/j.plaphy.2011.03.018; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Ulferts S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0409-x; Wang QS, 2011, GENETICA, V139, P973, DOI 10.1007/s10709-011-9599-4; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097265; Xu G, 2011, RUSS J PLANT PHYSL+, V58, P491, DOI 10.1134/S1021443711030216; Yang B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-68; Yang X, 2015, INT J MOL SCI, V16, P7608, DOI 10.3390/ijms16047608; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhu ZG, 2012, PLANT CELL REP, V31, P2109, DOI 10.1007/s00299-012-1321-1	42	10	15	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143349	10.1371/journal.pone.0143349	http://dx.doi.org/10.1371/journal.pone.0143349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600125	Green Submitted, gold, Green Published			2022-12-27	WOS:000365862600053
J	Mena-Ulecia, K; Tiznado, W; Caballero, J				Mena-Ulecia, Karel; Tiznado, William; Caballero, Julio			Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA	PLOS ONE			English	Article							QUANTITATIVE STRUCTURE; CRYSTALLOGRAPHIC ANALYSIS; STRUCTURAL REQUIREMENTS; DRUG-RESISTANCE; FREE-ENERGY; FACTOR-XA; BINDING; POTENT; OXYGUANIDINES; SPECIFICITY	Non-peptidic thrombin inhibitors (TIs; 177 compounds) with diverse groups at motifs P-1 (such as oxyguanidine, amidinohydrazone, amidine, amidinopiperidine), P-2 (such as cyano-fluorophenylacetamide, 2-(2-chloro-6-fluorophenyl)acetamide), and P-3 (such as phenylethyl, arylsulfonate groups) were studied using molecular modeling to analyze their interactions with S-1, S-2, and S-3 subsites of the thrombin binding site. Firstly, a protocol combining docking and three dimensional quantitative structure-activity relationship was performed. We described the orientations and preferred active conformations of the studied inhibitors, and derived a predictive CoMSIA model including steric, donor hydrogen bond, and acceptor hydrogen bond fields. Secondly, the dynamic behaviors of some selected TIs (compounds 26, 133, 147, 149, 162, and 177 in this manuscript) that contain different molecular features and different activities were analyzed by creating the solvated models and using molecular dynamics (MD) simulations. We used the conformational structures derived from MD to accomplish binding free energetic calculations using MM-GBSA. With this analysis, we theorized about the effect of van der Waals contacts, electrostatic interactions and solvation in the potency of TIs. In general, the contents reported in this article help to understand the physical and chemical characteristics of thrombin-inhibitor complexes.	[Mena-Ulecia, Karel; Tiznado, William] Univ Andres Bello, Fac Ciencias Exactas, Dept Quim, Santiago, Chile; [Mena-Ulecia, Karel; Caballero, Julio] Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, Talca, Chile	Universidad Andres Bello; Universidad de Talca	Caballero, J (corresponding author), Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, 2 Norte 685,Casilla 721, Talca, Chile.	jcaballero@utalca.cl	Caballero, Julio/G-3654-2014; Tiznado, william/G-7479-2014	Caballero, Julio/0000-0003-0182-1444; Tiznado, william/0000-0002-6061-8879	Fondecyt, Chile [1130141]	Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the grant no. 1130141 (J.C.) from Fondecyt, Chile. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Adasme-Carreno F, 2014, PHYS CHEM CHEM PHYS, V16, P14047, DOI 10.1039/c4cp01378f; [Anonymous], 1699, SYBYL VERS 7 3; [Anonymous], 2007, MAESTR VERS 9 0; [Anonymous], 2011, LIGPR VERS 2 5; Bhunia SS, 2011, J CHEM INF MODEL, V51, P1966, DOI 10.1021/ci200185q; Bohm M, 1999, J MED CHEM, V42, P458, DOI 10.1021/jm981062r; BUSH BL, 1993, J COMPUT AID MOL DES, V7, P587, DOI 10.1007/BF00124364; Caballero J, 2008, BIOORGAN MED CHEM, V16, P6103, DOI 10.1016/j.bmc.2008.04.048; Caballero J, 2011, CHEM BIOL DRUG DES, V78, P631, DOI 10.1111/j.1747-0285.2011.01186.x; Caballero J, 2011, J COMPUT AID MOL DES, V25, P349, DOI 10.1007/s10822-011-9425-1; Caballero J, 2009, MOL DIVERS, V13, P493, DOI 10.1007/s11030-009-9140-1; Coppens M, 2012, CIRC RES, V111, P920, DOI 10.1161/CIRCRESAHA.112.264903; de Candia M, 2013, J MED CHEM, V56, P8696, DOI 10.1021/jm401169a; Deswal S, 2006, EUR J MED CHEM, V41, P1339, DOI 10.1016/j.ejmech.2006.07.001; Doweyko AM, 2004, J COMPUT AID MOL DES, V18, P587, DOI 10.1007/s10822-004-4068-0; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fuentes E, 2014, THROMB HAEMOSTASIS, V111, P491, DOI 10.1160/TH13-05-0386; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hou TJ, 2007, J MED CHEM, V50, P1177, DOI 10.1021/jm0609162; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kontogiorgis CA, 2003, CURR MED CHEM, V10, P525, DOI 10.2174/0929867033457935; Kreutter KD, 2008, BIOORG MED CHEM LETT, V18, P2865, DOI 10.1016/j.bmcl.2008.03.087; Lee L, 2007, BIOORG MED CHEM LETT, V17, P6266, DOI 10.1016/j.bmcl.2007.09.013; Li ML, 2015, EUR J MED CHEM, V96, P122, DOI 10.1016/j.ejmech.2015.04.012; Lu TB, 2000, BIOORG MED CHEM LETT, V10, P83, DOI 10.1016/S0960-894X(99)00616-2; Lu TB, 2004, BIOORG MED CHEM LETT, V14, P3727, DOI 10.1016/j.bmcl.2004.05.002; Lu TB, 1998, BIOORG MED CHEM LETT, V8, P1595, DOI 10.1016/S0960-894X(98)00290-X; Lu TB, 2000, BIOORG MED CHEM LETT, V10, P79, DOI 10.1016/S0960-894X(99)00617-4; Lu TB, 2010, J MED CHEM, V53, P1843, DOI 10.1021/jm901802n; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Melnikova I, 2009, NAT REV DRUG DISCOV, V8, P353, DOI 10.1038/nrd2851; Mena-Ulecia K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109639; Muley L, 2010, J MED CHEM, V53, P2126, DOI 10.1021/jm9016416; Munoz C, 2012, J MOL GRAPH MODEL, V32, P39, DOI 10.1016/j.jmgm.2011.10.005; Nilsson M, 2009, J MED CHEM, V52, P2708, DOI 10.1021/jm8011849; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Ramirez-Galicia G, 2012, J ENZYM INHIB MED CH, V27, P174, DOI 10.3109/14756366.2011.582467; Silva VD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024735; Soll RM, 2000, BIOORG MED CHEM LETT, V10, P1, DOI 10.1016/S0960-894X(99)00632-0; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Tanaka KA, 2009, ANESTH ANALG, V108, P1433, DOI 10.1213/ane.0b013e31819bcc9c; Tomczuk B, 2003, BIOORG MED CHEM LETT, V13, P1495, DOI 10.1016/S0960-894X(03)00125-2; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Verma RP, 2005, BIOORGAN MED CHEM, V13, P4597, DOI 10.1016/j.bmc.2005.05.002; Wang W, 2001, P NATL ACAD SCI USA, V98, P14937, DOI 10.1073/pnas.251265598	48	64	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142774	10.1371/journal.pone.0142774	http://dx.doi.org/10.1371/journal.pone.0142774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599107	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600018
J	Nibouche, S; Mississipi, S; Fartek, B; Delatte, H; Reynaud, B; Costet, L				Nibouche, Samuel; Mississipi, Stelly; Fartek, Benjamin; Delatte, Helene; Reynaud, Bernard; Costet, Laurent			Host Plant Specialization in the Sugarcane Aphid Melanaphis sacchari	PLOS ONE			English	Article							YELLOW-LEAF-VIRUS; ECOLOGICAL SPECIALIZATION; SCHIZAPHIS-GRAMINUM; HEMIPTERA; RESISTANCE; POPULATIONS; DIVERGENCE; EXPERIENCE; CLONALITY; HOMOPTERA	Most aphids are highly specialized on one or two related plant species and generalist species often include sympatric populations adapted to different host plants. Our aim was to test the hypothesis of the existence of host specialized lineages of the aphid Melanaphis sacchari in Reunion Island. To this end, we investigated the genetic diversity of the aphid and its association with host plants by analyzing the effect of wild sorghum Sorghum bicolor subsp. verticilliflorum or sugarcane as host plants on the genetic structuring of populations and by performing laboratory host transfer experiments to detect trade-offs in host use. Genotyping of 31 samples with 10 microsatellite loci enabled identification of 13 multilocus genotypes (MLG). Three of these, Ms11, Ms16 and Ms15, were the most frequent ones. The genetic structure of the populations was linked to the host plants. Ms11 and Ms16 were significantly more frequently observed on sugarcane, while Ms15 was almost exclusively collected in colonies on wild sorghum. Laboratory transfer experiments demonstrated the existence of fitness trade-offs. An Ms11 isofemale lineage performed better on sugarcane than on sorghum, whereas an Ms15 lineage developed very poorly on sugarcane, and two Ms16 lineages showed no significant difference in performances between both hosts. Both field and laboratory results support the existence of host plant specialization in M. sacchari in Reunion Island, despite low genetic differentiation. This study illustrates the ability of asexual aphid lineages to rapidly undergo adaptive changes including shifting from one host plant to another.	[Nibouche, Samuel; Mississipi, Stelly; Fartek, Benjamin; Delatte, Helene; Reynaud, Bernard; Costet, Laurent] Cirad, UMR PVBMT, F-97410 Saint Pierre, Reunion, France; [Fartek, Benjamin] Univ la Reunion, UMR PVBMT, F-97410 Saint Pierre, Reunion, France	CIRAD; University of La Reunion	Nibouche, S (corresponding author), Cirad, UMR PVBMT, F-97410 Saint Pierre, Reunion, France.	samuel.nibouche@cirad.fr	Costet, Laurent/C-2281-2011; Nibouche, Samuel/C-1964-2008; Costet, Laurent/AAQ-1579-2020	Nibouche, Samuel/0000-0003-2675-1382; Costet, Laurent/0000-0003-3199-2885	European Union; Conseil Regional de la Reunion; Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD); European Union; Conseil Regional de la Reunion; Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD)	European Union(European Commission); Conseil Regional de la Reunion; Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD); European Union(European Commission); Conseil Regional de la Reunion; Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD)	This work was funded by the European Union: European regional development fund (ERDF), by the Conseil Regional de la Reunion and by the Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Ahmad Y, 2007, PLANT DIS, V91, P253, DOI 10.1094/PDIS-91-3-0253; Andris M, 2010, MOL ECOL RESOUR, V10, P1106, DOI 10.1111/j.1755-0998.2010.02916.x; [Anonymous], 2012, GEN VERS 5 6 6; Anstead JA, 2002, B ENTOMOL RES, V92, P17, DOI 10.1079/BER2001141; Armstrong JS, 2015, J ECON ENTOMOL, V108, P576, DOI 10.1093/jee/tou065; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Blackman RL, 1990, WORLD PERSPECTIVES B, P197; Brewer M, 2013, 25 TEX PLANT PROT C; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; DEBARRO PJ, 1995, MOL ECOL, V4, P375, DOI 10.1111/j.1365-294X.1995.tb00230.x; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Fartek B, 2012, ENTOMOL EXP APPL, V144, P270, DOI 10.1111/j.1570-7458.2012.01286.x; Fartek B, 2014, PLANT BREEDING, V133, P771, DOI 10.1111/pbr.12204; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Lopes-da-Silva M., 2014, Current Agricultural Science and Technology, V20, P21; Loxdale HD, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P535, DOI 10.1007/978-90-481-2770-2_25; Margaritopoulos JT, 2006, B ENTOMOL RES, V96, P153, DOI 10.1079/BER2005410; Margaritopoulos JT, 2003, B ENTOMOL RES, V93, P131, DOI 10.1079/BER2002222; Mead F. W., 1978, COOP PLANT PEST REP, V3, P475; MONTLLOR CB, 1983, ENTOMOL EXP APPL, V34, P99, DOI 10.1007/BF00300907; Nibouche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106067; Peccoud J, 2010, CR BIOL, V333, P474, DOI 10.1016/j.crvi.2010.03.004; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Ramirez CC, 2000, J INSECT BEHAV, V13, P699, DOI 10.1023/A:1007844027368; Remaudiere G., 1997, CATALOGUE WORLDS APH; Rott P., 2008, Sugar Cane International, V26, P18; SAS Institute, 2008, SAS ONLINEDOC 9 2; Singh BU, 2004, CROP PROT, V23, P739, DOI 10.1016/j.cropro.2004.01.004; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stroup W. W., 2013, GEN LINEAR MIXED MOD; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; VIA S, 1990, ANNU REV ENTOMOL, V35, P421, DOI 10.1146/annurev.en.35.010190.002225; VIA S, 1991, ECOLOGY, V72, P1420, DOI 10.2307/1941114; WEBER G, 1985, Z ANGEW ENTOMOL, V100, P100; White WH, 2001, FLA ENTOMOL, V84, P435, DOI 10.2307/3496505; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	43	17	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143704	10.1371/journal.pone.0143704	http://dx.doi.org/10.1371/journal.pone.0143704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600253	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600106
J	Reisinger, N; Schaumberger, S; Nagl, V; Hessenberger, S; Schatzmayr, G				Reisinger, Nicole; Schaumberger, Simone; Nagl, Veronika; Hessenberger, Sabine; Schatzmayr, Gerd			Concentration Dependent Influence of Lipopolysaccharides on Separation of Hoof Explants and Supernatant Lactic Acid Concentration in an Ex Vivo/In Vitro Laminitis Model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EQUINE LAMINITIS; ENDOTOXIN CONCENTRATION; PLASMA-CONCENTRATIONS; GLUCOSE-TRANSPORT; ENDOTHELIAL-CELLS; INSULIN DYNAMICS; HORSES; ACTIVATION; INTERLEUKIN-6	Laminitis is one of the most common diseases in horses. It is not only painful for the animal, but also has a significant financial impact on the equine industry. This multifactorial disease affects the connective tissue of the hoof. However, the pathogenesis of laminitis is still not fully understood. Endotoxins, also known as lipopolysaccharides (LPS), and bacterial exotoxins seem to play an important role during the development of laminitis. The aim of our study was to investigate the effect of increasing LPS concentrations (0, 2.5, 5, 10, and 100 mu g/mL) on cell viability of isolated epidermal and dermal hoof cells as well as on the tissue integrity of hoof explants. Furthermore, glucose, acetic acid, lactic acid, and propionic acid concentrations in explant supernatants were measured to evaluate the energy metabolism in the hoof tissue. LPS did not exhibit cytotoxic effects on epidermal or dermal cells. Force required to separate LPS treated hoof explants decreased in a concentration dependent manner. Specifically, explants incubated with 10 and 100 mu g/mL needed significantly less force to separate compared to control explants. Lactic acid concentrations were significantly decreased in explants incubated with 5, 10, or 100 mu g/mL LPS, while glucose, acetic acid and propionic acid concentrations were unaffected by LPS treatment. Our study indicates that LPS has no cytotoxic effect on epidermal and dermal cells isolated from hoof tissue, but impairs integrity of hoof explants. In addition, LPS led to an alteration of the lactic acid production in the lamellar tissue. Since our data highlight that LPS can affect the integrity of the equine hoof tissue in vitro, endotoxins should be further explored for their contribution to facilitate the development of laminitis.	[Reisinger, Nicole; Schaumberger, Simone; Nagl, Veronika; Hessenberger, Sabine; Schatzmayr, Gerd] BIOMIN Res Ctr, Tulln, Austria		Reisinger, N (corresponding author), BIOMIN Res Ctr, Tulln, Austria.	nicole.reisinger@biomin.net		Nagl, Veronika/0000-0002-8534-4149; Reisinger, Nicole/0000-0002-9207-452X	Austrian Research Promotion Agency [839107]; Biomin Research Center	Austrian Research Promotion Agency; Biomin Research Center	This work was supported by Austrian Research Promotion Agency (https://www.ffg.at/) (839107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biomin Research Center provided support in the form of salaries for authors NR, SS, VN, SH, and GS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen D., 1998, ACUTE LAMINITIS; Asplin KE, 2011, EQUINE VET J, V43, P196, DOI 10.1111/j.2042-3306.2010.00127.x; Bailey SR, 2009, VET IMMUNOL IMMUNOP, V129, P167, DOI 10.1016/j.vetimm.2008.11.009; Barton MH, 1999, J VET INTERN MED, V13, P457, DOI 10.1892/0891-6640(1999)013&lt;0457:TNFAIA&gt;2.3.CO;2; Brooks AC, 2009, VET IMMUNOL IMMUNOP, V129, P174, DOI 10.1016/j.vetimm.2008.11.008; de Laat MA, 2015, EQUINE VET J, V47, P494, DOI 10.1111/evj.12320; de Laat MA, 2012, VET IMMUNOL IMMUNOP, V145, P395, DOI 10.1016/j.vetimm.2011.12.016; DUNCAN SG, 1985, AM J VET RES, V46, P1287; Fessler J F, 1989, Equine Vet J Suppl, P24, DOI 10.1111/j.2042-3306.1989.tb05650.x; French KR, 2004, EQUINE VET J, V36, P261, DOI 10.2746/0425164044877170; GARNER HE, 1977, J ANIM SCI, V45, P1037; HUNT RJ, 1990, AM J VET RES, V51, P1703; Katz LM, 2012, EQUINE VET J, V44, P752, DOI 10.1111/j.2042-3306.2012.00664.x; Kim ID, 2009, TOXICOL IN VITRO, V23, P1014, DOI 10.1016/j.tiv.2009.06.019; Kyaw-Tanner M, 2004, EQUINE VET J, V36, P221, DOI 10.2746/0425164044877242; Kyaw-Tanner MT, 2008, EQUINE VET J, V40, P482, DOI 10.2746/042516408X270353; Lankveld DPK, 2005, VET RES, V36, P257, DOI 10.1051/vetres:2004061; Loftus JP, 2007, AM J VET RES, V68, P1205, DOI 10.2460/ajvr.68.11.1205; Mani V, 2013, J ANIM SCI, V91, P2141, DOI 10.2527/jas.2012-6053; Medina-Torres CE, 2016, EQUINE VET J, V48, P246, DOI 10.1111/evj.12417; Medina-Torres CE, 2016, EQUINE VET J, V48, P114, DOI 10.1111/evj.12377; Medina-Torres CE, 2014, VET J, V201, P275, DOI 10.1016/j.tvjl.2014.05.030; Medina-Torres Carlos E, 2011, Vet J, V190, pe54, DOI 10.1016/j.tvjl.2011.02.026; Menzies-Gow NJ, 2004, EQUINE VET J, V36, P273, DOI 10.2746/0425164044877260; Mungall BA, 2002, J COMP PATHOL, V126, P9, DOI 10.1053/jcpa.2001.0515; Mungall BA, 2001, VET MICROBIOL, V79, P209, DOI 10.1016/S0378-1135(00)00359-X; Pass M A, 1998, Equine Vet J Suppl, P133; Patan-Zugaj B, 2012, AM J VET RES, V73, P1462, DOI 10.2460/ajvr.73.9.1462; Peek SF, 2004, VET CLIN PATH, V33, P29, DOI 10.1111/j.1939-165X.2004.tb00346.x; Pollitt CC, 1996, EQUINE VET J, V28, P38, DOI 10.1111/j.2042-3306.1996.tb01588.x; Reisinger N, 2014, TOXINS, V6, P2962, DOI 10.3390/toxins6102962; Sharma R, 2016, J TISSUE ENG REGEN M, V10, P627, DOI 10.1002/term.1788; SPROUSE RF, 1987, EQUINE VET J, V19, P25, DOI 10.1111/j.2042-3306.1987.tb02571.x; Tadros EM, 2012, VET IMMUNOL IMMUNOP, V150, P90, DOI 10.1016/j.vetimm.2012.09.002; Toth F, 2009, EQUINE VET J, V41, P852, DOI 10.2746/042516409X479027; Toth F, 2008, AM J VET RES, V69, P82, DOI 10.2460/ajvr.69.1.82; US Department of Agriculture, 2000, LAMENESS LAMINITIS U; Vidovic A, 1999, PFERDEHEILKUNDE, V15, P325, DOI 10.21836/PEM19990405; Visser MB, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-16; Wattle O., 2004, Clinical Techniques in Equine Practice, V3, P22, DOI 10.1053/j.ctep.2004.07.002; Wunn D, 1999, AM J VET RES, V60, P128; Yang H, 2002, PHYTOTHER RES, V16, P43, DOI 10.1002/ptr.912; Yue G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-608	43	7	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143754	10.1371/journal.pone.0143754	http://dx.doi.org/10.1371/journal.pone.0143754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599864	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600117
J	Ye, WM; Zeng, YS; Kerns, J				Ye, Weimin; Zeng, Yongsan; Kerns, James			Molecular Characterisation and Diagnosis of Root-Knot Nematodes (Meloidogyne spp.) from Turfgrasses in North Carolina, USA	PLOS ONE			English	Article							MARYLANDI INFECTING BERMUDAGRASS; 1ST REPORT; PHYLOGENETIC-RELATIONSHIPS; INTERGENIC REGION; IDENTIFICATION; JAVANICA; PCR; DIVERSITY; INCOGNITA; BRAZIL	Root-knot nematodes (Meloidogyne spp.) are the most common and destructive plant-parasitic nematode group worldwide and adversely influence both crop quality and yield. In this study, a total of 51 root-knot nematode populations from turfgrasses were tested, of which 44 were from North Carolina, 6 from South Carolina and 1 from Virginia. Molecular characterisation was performed on these samples by DNA sequencing on the ribosomal DNA 18S, ITS and 28S D2/D3. Species-specific primers were developed to identify turfgrass root-knot nematode through simplex or duplex PCR. Four species were identified, including M. marylandi Jepson & Golden in Jepson, 1987, M. graminis (Sledge & Golden, 1964) Whitehead, 1968, M. incognita (Kofoid & White, 1919) Chitwood, 1949 and M. naasi Franklin, 1965 through a combined analysis of DNA sequencing and PCR by species-specific primers. M. marylandi has been reported from North Carolina and South Carolina for the first time. Molecular diagnosis using PCR by species-specific primers provides a rapid and cheap species identification approach for turfgrass root-knot nematodes.	[Ye, Weimin] North Carolina Dept Agr & Consumer Serv, Nematode Assay Sect, Div Agron, Raleigh, NC 27607 USA; [Zeng, Yongsan; Kerns, James] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Zeng, Yongsan] Zhongkai Univ Agr & Engn, Dept Plant Protect, Guangzhou, Guangdong, Peoples R China	University of North Carolina; North Carolina State University; Zhongkai University of Agriculture & Engineering	Ye, WM (corresponding author), North Carolina Dept Agr & Consumer Serv, Nematode Assay Sect, Div Agron, Raleigh, NC 27607 USA.	weimin.ye@ncagr.gov	Kerns, James/AAC-3208-2020	Kerns, James/0000-0002-1980-0126	Carolinas Golf Course Superintendents Association Rounds 4 Research	Carolinas Golf Course Superintendents Association Rounds 4 Research	This work was supported by the Carolinas Golf Course Superintendents Association Rounds 4 Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MAM, 2007, PLANT PATHOL, V56, P190, DOI 10.1111/j.1365-3059.2006.01455.x; Adam MAM, 2005, NEMATOLOGY, V7, P599, DOI 10.1163/156854105774384840; Adams BJ, 2010, ROOT-KNOT NEMATODES, P119; [Anonymous], 1992, THESIS; Araki Masaaki, 1992, Japanese Journal of Nematology, V22, P49; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Berry SD, 2008, MOL CELL PROBE, V22, P168, DOI 10.1016/j.mcp.2008.01.003; Blok VC, 1997, J NEMATOL, V29, P16; Blok VC, 2010, ROOT-KNOT NEMATODES, P98; BYRD DW, 1976, J NEMATOL, V8, P206; Carneiro RMDG, 2014, NEMATOLOGY, V16, P289, DOI 10.1163/15685411-00002765; Cherry T, 1997, J NEMATOL, V29, P23; Crow W. T., 2005, Outlooks on Pest Management, V16, P10, DOI 10.1564/16feb04; De Ley IT, 2002, J NEMATOL, V34, P319; Eisenback J. D., 1985, An advanced treatise on Meloidogyne. Volume 1: Biology and control., P95; Emmons R., 1995, TURFGRASS SCI MANAGE; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FRANKLIN MARY T., 1965, NEMATOLOGICA, V11, P79; GOLDEN AM, 1989, J NEMATOL, V21, P453; Holterman MHM, 2012, J PHYTOPATHOL, V160, P59, DOI 10.1111/j.1439-0434.2011.01859.x; Hu MX, 2011, PHYTOPATHOLOGY, V101, P1270, DOI 10.1094/PHYTO-04-11-0095; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphreys-Pereira DA, 2014, NEMATOLOGY, V16, P643, DOI 10.1163/15685411-00002794; Hunt DJ, 2010, ROOT-KNOT NEMATODES, P55; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Jepson S.B., 1987, P263; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lyman GT, 2007, APPL TURFGRASS SCI, DOI 1094/ATS-2007-1107-01-RS; McClure MA, 2012, PLANT DIS, V96, P635, DOI 10.1094/PDIS-09-11-0808; Mullin PG, 2005, NEMATOLOGY, V7, P59, DOI 10.1163/1568541054192199; MULVEY RH, 1975, CAN J ZOOL, V53, P1528, DOI 10.1139/z75-188; Nischwitz C, 2013, PLANT DIS, V97, P1424, DOI 10.1094/PDIS-03-13-0263-RE; Oka Y, 2003, NEMATOLOGY, V5, P727, DOI 10.1163/156854103322746904; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Powers TO, 2005, J NEMATOL, V37, P226; Randig O, 2002, GENOME, V45, P862, DOI [10.1139/g02-054, 10.1139/G02-054]; Salazar L, 2013, PLANT DIS, V97, P1005, DOI 10.1094/PDIS-11-12-1079-PDN; Sekora NS, 2012, PLANT DIS, V96, P1583, DOI 10.1094/PDIS-06-12-0544-PDN; SLEDGE EB, 1964, P HELM SOC WASH, V31, P83; Starr JL, 2007, NEMATROPICA, V37, P43; Tigano MS, 2005, NEMATOLOGY, V7, P851, DOI 10.1163/156854105776186325; Vandenbossche B, 2011, NEMATOLOGY, V13, P245, DOI 10.1163/138855410X517084; Vrain T.C., 1992, J NEMATOL, V29, P250; Walker N, 2014, PLANT DIS, V98, P1286, DOI 10.1094/PDIS-04-14-0399-PDN; Ye W, 2012, CAROLINAS GREEN  MAR, P26; Zeng Y, 2015, PLANT DIS IN PRESS; Zeng YS, 2012, ZOOTAXA, P1; Zijlstra C, 2000, NEMATOLOGY, V2, P847, DOI 10.1163/156854100750112798	49	43	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143556	10.1371/journal.pone.0143556	http://dx.doi.org/10.1371/journal.pone.0143556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599462	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600084
J	Ahn, SJ; Park, KH; Ryoo, NK; Hong, JH; Jung, C; Yoon, CH; Han, MK; Woo, SJ				Ahn, Seong Joon; Park, Kyu Hyung; Ryoo, Na-Kyung; Hong, Jeong-Ho; Jung, Cheolkyu; Yoon, Chang-Hwan; Han, Moon-Ku; Woo, Se Joon			No-Reflow Phenomenon in Central Retinal Artery Occlusion: Incidence, Risk Factors, and Clinical Implications	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LOCAL INTRAARTERIAL FIBRINOLYSIS; CONSERVATIVE TREATMENT; THROMBOLYSIS; REPERFUSION; APPEARANCE; PREDICTOR; PROGNOSIS; TIME	Purpose To investigate the incidence and risk factors of the no-reflow phenomenon in central retinal artery occlusion (CRAO) patients and to determine its effects on visual and anatomic outcomes. Methods In 102 eyes with CRAO in which arterial recanalization was obtained within 1 week from baseline, fluorescein angiography images obtained at baseline and 1 week were retrospectively reviewed. The no-reflow phenomenon in the retina was defined as macular capillary nonperfusion following arterial recanalization on fluorescein angiographs. We investigated the incidence and risk factors for the no-reflow phenomenon and compared the anatomical and visual outcomes between eyes with and without the phenomenon. Results Among the 102 CRAO eyes with arterial recanalization, 39 exhibited the no-reflow phenomenon, resulting in an incidence of 38.2%. The incidence among the eyes with treatment-induced and spontaneous recanalization was 43.4% and 15.8%, respectively, and it increased with the CRAO stage. CRAO stage and increased central macular thickness were risk factors for the phenomenon, with an odds ratio of 4.47 [95% confidence interval (CI), 1.19-16.8; P = 0.027] and 1.69 (95% CI, 1.12-2.55; P = 0.012) per 100-mu m increase, respectively. The visual outcome was significantly poorer and retinal atrophy and photoreceptor disruption was greater in eyes with the no-reflow phenomenon than in those without. Conclusions The no-reflow phenomenon may occur after arterial recanalization in approximately one-third of CRAO patients and can affect anatomical and visual outcomes. This phenomenon may provide an additional explanation regarding the permanent retinal damage and vision loss in eyes with CRAO.	[Ahn, Seong Joon; Park, Kyu Hyung; Ryoo, Na-Kyung; Woo, Se Joon] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Hong, Jeong-Ho] Keimyung Univ, Dongsan Med Ctr, Dept Neurol, Taegu, South Korea; [Hong, Jeong-Ho; Han, Moon-Ku] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Songnam, South Korea; [Jung, Cheolkyu] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Songnam, South Korea; [Yoon, Chang-Hwan] Seoul Natl Univ, Bundang Hosp, Dept Cardiol, Songnam, South Korea	Seoul National University (SNU); Keimyung University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.	sejoon1@hanmail.net	Hong, Jeong-Ho/T-8099-2018; Hong, Jeong-Ho/AAE-1002-2022	Hong, Jeong-Ho/0000-0002-8235-9855; Hong, Jeong-Ho/0000-0002-8235-9855; HAN, MOON-KU/0000-0003-0166-387X; Yoon, Chang-Hwan/0000-0001-6305-4442	Seoul National University Bundang Hospital Research Fund [14-2014-022]	Seoul National University Bundang Hospital Research Fund	This work was supported by a grant from the Seoul National University Bundang Hospital Research Fund (Grant No. 14-2014-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2015, AM J OPHTHALMOL, V159, P667, DOI 10.1016/j.ajo.2015.01.001; Ahn SJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/209735; Ahn SJ, 2013, INVEST OPHTH VIS SCI, V54, P2115, DOI 10.1167/iovs.12-11542; AMES A, 1968, AM J PATHOL, V52, P437; Biousse V, 2007, J NEURO-OPHTHALMOL, V27, P215, DOI 10.1097/WNO.0b013e31814b1f66; Bolognese L, 2004, CIRCULATION, V109, P1121, DOI 10.1161/01.CIR.0000118496.44135.A7; Brosh D, 2007, AM J CARDIOL, V99, P442, DOI 10.1016/j.amjcard.2006.08.054; DAVID NJ, 1961, ARCH NEUROL-CHICAGO, V5, P165, DOI 10.1001/archneur.1961.00450140047004; Fiess A, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-28; Galiuto L, 2008, J AM COLL CARDIOL, V51, P552, DOI 10.1016/j.jacc.2007.09.051; Hayreh SS, 2011, PROG RETIN EYE RES, V30, P359, DOI 10.1016/j.preteyeres.2011.05.001; Hayreh SS, 2005, AM J OPHTHALMOL, V140, P376, DOI 10.1016/j.ajo.2005.03.038; Hayreh SS, 2004, EXP EYE RES, V78, P723, DOI 10.1016/S0014-4835(03)00214-8; Henriques JPS, 2003, CIRCULATION, V107, P2115, DOI 10.1161/01.CIR.0000065221.06430.ED; ITO H, 1992, CIRCULATION, V85, P1699, DOI 10.1161/01.CIR.85.5.1699; Ito H, 1998, AM J CARDIOL, V81, p8G, DOI 10.1016/S0002-9149(98)00046-0; Ito H, 2001, J Cardiol, V37 Suppl 1, P39; Ito H, 1996, CIRCULATION, V93, P223, DOI 10.1161/01.CIR.93.2.223; Ito H, 2006, NAT CLIN PRACT CARD, V3, P499, DOI 10.1038/ncpcardio0632; ITO U, 1980, STROKE, V11, P517, DOI 10.1161/01.STR.11.5.517; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; OJI EO, 1978, T OPHTHAL SOC UK, V98, P156; Schmidt DP, 2002, AM J NEURORADIOL, V23, P1301; Schumacher M, 2010, OPHTHALMOLOGY, V117, P1367, DOI 10.1016/j.ophtha.2010.03.061; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142852	10.1371/journal.pone.0142852	http://dx.doi.org/10.1371/journal.pone.0142852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599539	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900042
J	Dantoft, TM; Skovbjerg, S; Andersson, L; Claeson, AS; Lind, N; Nordin, S; Brix, S				Dantoft, Thomas Meinertz; Skovbjerg, Sine; Andersson, Linus; Claeson, Anna-Sara; Lind, Nina; Nordin, Steven; Brix, Susanne			Inflammatory Mediator Profiling of n-butanol Exposed Upper Airways in Individuals with Multiple Chemical Sensitivity	PLOS ONE			English	Article							EPITHELIAL LINING FLUID; POPULATION-BASED SURVEY; NEUROGENIC INFLAMMATION; CYTOKINE PROFILE; NASAL LAVAGE; PREVALENCE; SYMPTOMS; RELEASE; ALLERGY	Background Multiple Chemical Sensitivity (MCS) is a chronic condition characterized by reports of recurrent symptoms in response to low level exposure to various chemical substances. Recent findings suggests that dysregulation of the immune system may play a role in MCS pathophysiology. Objectives The aim of this study was to examine baseline and low dose n-butanol-induced upper airway inflammatory response profiles in MCS subjects versus healthy controls. Method Eighteen participants with MCS and 18 age- and sex-matched healthy controls were enrolled in the study. Epithelial lining fluid was collected from the nasal cavity at three time points: baseline, within 15 minutes after being exposed to 3.7 ppm n-butanol in an exposure chamber and four hours after exposure termination. A total of 19 cytokines and chemokines were quantified. Furthermore, at baseline and during the exposure session, participants rated the perceived intensity, valence and levels of symptoms and autonomic recordings were obtained. Results The physiological and psychophysical measurements during the n-butanol exposure session verified a specific response in MCS individuals only. However, MCS subjects and healthy controls displayed similar upper airway inflammatory mediator profiles (P>0.05) at baseline. Likewise, direct comparison of mediator levels in the MCS group and controls after n-butanol exposure revealed no significant group differences. Conclusion We demonstrate no abnormal upper airway inflammatory mediator levels in MCS subjects before or after a symptom-eliciting exposure to low dose n-butanol, implying that upper airways of MCS subjects are functionally intact at the level of cytokine and chemokine production and secretory capacity. This suggests that previous findings of increased cytokine plasma levels in MCS are unlikely to be caused by systemic priming via excessive upper airway inflammatory processes.	[Dantoft, Thomas Meinertz] Copenhagen Univ Hosp, Danish Res Ctr Chem Sensit, Gentofte, Denmark; [Dantoft, Thomas Meinertz; Brix, Susanne] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Skovbjerg, Sine] Capital Reg, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Andersson, Linus; Claeson, Anna-Sara; Lind, Nina; Nordin, Steven] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Andersson, Linus] Univ Gavle, Dept Occupat & Publ Hlth Sci, Umea, Sweden	University of Copenhagen; Technical University of Denmark; Umea University; University of Gavle	Dantoft, TM (corresponding author), Copenhagen Univ Hosp, Danish Res Ctr Chem Sensit, Gentofte, Denmark.	thomas.meinertz.dantoft@regionh.dk	Dantoft, Thomas M/N-2702-2017; Pedersen, Susanne Brix/B-3484-2009; Andersson, Linus/ADC-9439-2022	Dantoft, Thomas M/0000-0001-7437-7052; Pedersen, Susanne Brix/0000-0001-8951-6705; Andersson, Linus/0000-0003-4088-0025; Lind Ranneberg, Nina/0000-0003-4045-8748; Claeson, Anna-Sara/0000-0001-5026-4934	Swedish Research Council for Health, Working Life and Welfare [2011-0396]; Swedish Research Council Formas; Danish Ministry of the Environment (Danish Research Centre for Chemical Sensitivities)	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Danish Ministry of the Environment (Danish Research Centre for Chemical Sensitivities)	This work was supported by the Swedish Research Council for Health, Working Life and Welfare (2011-0396) (http://www.forte.se/en/, SN); the Swedish Research Council Formas (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html, AC); the Danish Ministry of the Environment (http://eng.mim.dk/, sponsored the Danish Research Centre for Chemical Sensitivities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2015, INT ARCH OCCUP ENV H; Andersson L, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00816; BARSKY AJ, 1988, PSYCHOSOM MED, V50, P510, DOI 10.1097/00006842-198809000-00007; Bartha L, 1999, ARCH ENVIRON HEALTH, V54, P147; BASCOM R, 1992, TOXICOL IND HEALTH, V8, P221; Bascom R, 1997, ENVIRON HEALTH PERSP, V105, P531, DOI 10.2307/3433365; Bazzichi L, 2007, CLIN EXP RHEUMATOL, V25, P225; Berg ND, 2008, INT ARCH OCC ENV HEA, V81, P881, DOI 10.1007/s00420-007-0282-0; BISGAARD H, 1987, CLIN SCI, V73, P217, DOI 10.1042/cs0730217; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; Cain WS, 1989, ENT-EAR NOSE THROAT, V68, P322; Caress SM, 2004, AM J PUBLIC HEALTH, V94, P746, DOI 10.2105/AJPH.94.5.746; Caress SM, 2003, ENVIRON HEALTH PERSP, V111, P1490, DOI 10.1289/ehp.5940; Chawes BLK, 2010, J ALLERGY CLIN IMMUN, V125, P1387, DOI 10.1016/j.jaci.2010.01.039; Cohen N, 1997, ENVIRON HEALTH PERSP, V105, P527, DOI 10.2307/3433364; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1988, SOCIAL PSYCHOL HLTH; Dantoft TM, 2014, PSYCHONEUROENDOCRINO, V40, P140, DOI 10.1016/j.psyneuen.2013.11.012; Das-Munshi Jayati, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P274, DOI 10.1097/MOO.0b013e328259c360; De Luca C., 2010, TOXICOL APPL PHARM; Folsgaard NV, 2013, AM J RESP CRIT CARE, V187, P589, DOI 10.1164/rccm.201207-1297OC; Folsgaard NV, 2012, AM J RESP CRIT CARE, V185, P275, DOI 10.1164/rccm.201108-1471OC; Genuis SJ, 2013, CLIN THER, V35, P572, DOI 10.1016/j.clinthera.2013.04.003; Gibson PR, 2003, ENVIRON HEALTH PERSP, V111, P1498, DOI 10.1289/ehp.5936; Graveling RA, 1999, OCCUP ENVIRON MED, V56, P73, DOI 10.1136/oem.56.2.73; Hausteiner C, 2005, INT J HYG ENVIR HEAL, V208, P271, DOI 10.1016/j.ijheh.2005.03.006; Hentschel J, 2014, J IMMUNOL METHODS, V404, P41, DOI 10.1016/j.jim.2013.12.003; Howarth Peter H, 2005, J Allergy Clin Immunol, V115, pS414, DOI 10.1016/j.jaci.2004.12.1134; Johansson A, 2005, INT ARCH OCC ENV HEA, V78, P559, DOI 10.1007/s00420-005-0616-8; Johansson MW, 2012, AM J RESP CRIT CARE, V185, P237, DOI 10.1164/rccm.201111-2010ED; Kimata H, 2004, INT J HYG ENVIR HEAL, V207, P159, DOI 10.1078/1438-4639-00262; Kreutzer R, 1999, AM J EPIDEMIOL, V150, P1; Lacour M, 2005, INT J HYG ENVIR HEAL, V208, P141, DOI 10.1016/j.ijheh.2005.01.017; LEVIN AS, 1992, TOXICOL IND HEALTH, V8, P95; Levin AS, 1987, OCCUPATIONAL MED STA, V2, P669; MEGGS WJ, 1995, ENVIRON HEALTH PERSP, V103, P54, DOI 10.2307/3432256; MEGGS WJ, 1992, TOXICOL IND HEALTH, V8, P203; Meggs WJ, 1999, TOXICOL IND HEALTH, V15, P331, DOI 10.1177/074823379901500307; MEGGS WJ, 1993, ENVIRON HEALTH PERSP, V101, P234, DOI 10.2307/3431548; Nagata Y., 2003, ODOR MEAS REV, P118; Nordin S, 2003, ACTA OTO-LARYNGOL, V123, P536, DOI 10.1080/00016480310001411; Park Jungwee, 2007, Health Rep, V18, P43; PIPKORN U, 1987, NEW ENGL J MED, V316, P1506, DOI 10.1056/NEJM198706113162403; RUTH JH, 1986, AM IND HYG ASSOC J, V47, pA142, DOI 10.1080/15298668691389595; Skovbjerg S, 2009, SCAND J PUBLIC HEALT, V37, P621, DOI 10.1177/1403494809105430; Sorg BA, 1999, TOXICOL IND HEALTH, V15, P346, DOI 10.1191/074823399678846916; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; van Thriel C, 2002, INT J HYG ENVIR HEAL, V204, P367	48	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143534	10.1371/journal.pone.0143534	http://dx.doi.org/10.1371/journal.pone.0143534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599866	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900139
J	Poirot, E; Vittinghoff, E; Ishengoma, D; Alifrangis, M; Carneiro, I; Hashim, R; Baraka, V; Mosha, J; Gesase, S; Chandramohan, D; Gosling, R				Poirot, Eugenie; Vittinghoff, Eric; Ishengoma, Deus; Alifrangis, Michael; Carneiro, Ilona; Hashim, Ramadhan; Baraka, Vito; Mosha, Jacklin; Gesase, Samwel; Chandramohan, Daniel; Gosling, Roland			Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PHASE-III TRIAL; AFRICAN CHILDREN; G6PD DEFICIENCY; DOUBLE-BLIND; DEHYDROGENASE-DEFICIENCY; ELIMINATION; ADOLESCENTS; ARTESUNATE; STRATEGIES	Background Chlorproguanil-dapsone (CD) has been linked to hemolysis in symptomatic glucose-6-phosphate dehydrogenase deficient (G6PDd) children. Few studies have explored the effects of G6PD status on hemolysis in children treated with Intermittent Preventive Treatment in infants (IPTi) antimalarial regimens. We sought to examine the joint effects of G6PD status and IPTi antimalarial treatment on incidence of hemolysis in asymptomatic children treated with CD, sulfadoxine-pyrimethamine (SP), and mefloquine (MQ). Methods A secondary analysis of data from a double-blind, placebo-controlled trial of IPTi was conducted. Hemoglobin (Hb) measurements were made at IPTi doses, regular follow-up and emergency visits. G6PD genotype was determined at 9 months looking for SNPs for the A-genotype at coding position 202. Multivariable linear and logistic regression models were used to examine hemolysis among children with valid G6PD genotyping results. Hemolysis was defined as the absolute change in Hb or as any post-dose Hb <8 g/dL. These outcomes were assessed using either a single follow-up Hb on day 7 after an IPTi dose or Hb obtained 1 to 14 or 28 days after each IPTi dose. Findings Relative to placebo, CD reduced Hb by approximately 0.5 g/dL at day 7 and within 14 days of an IPTi dose, and by 0.2 g/dL within 28 days. Adjusted declines in the CD group were larger than in the MQ and SP groups. At day 7, homo-/hemizygous genotype was associated with higher odds of Hb < 8 g/dL (adjusted odds ratio = 6.7, 95% CI 1.7 to 27.0) and greater absolute reductions in Hb (-0.6 g/dL, 95% CI -1.1 to 0.003). There was no evidence to suggest increased reductions in Hb among homo-/hemizygous children treated with CD compared to placebo, SP or MQ. Conclusions While treatment with CD demonstrated greater reductions in Hb at 7 and 14 days after an IPTi dose compared to both SP and MQ, there was no evidence that G6PD deficiency exacerbated the adverse effects of CD, despite evidence for higher hemolysis risk among G6PDd infants.	[Poirot, Eugenie; Vittinghoff, Eric; Gosling, Roland] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Poirot, Eugenie; Gosling, Roland] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Ishengoma, Deus; Baraka, Vito; Gesase, Samwel] Natl Inst Med Res, Tanga Med Res Ctr, Tanga, Tanzania; [Alifrangis, Michael] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Alifrangis, Michael] Rigshosp, Natl Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Carneiro, Ilona; Chandramohan, Daniel] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Hashim, Ramadhan; Mosha, Jacklin] Natl Inst Med Res, Mwanza Intervent Trial Unit, Mwanza, Tanzania; [Baraka, Vito] Univ Antwerp, Dept Epidemiol, Int Hlth Unit, B-2020 Antwerp, Belgium	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institute of Medical Research; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; University of Antwerp	Poirot, E (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	Eugenie.poirot@ucsf.edu	Ishengoma, Deus/J-9484-2019	Ishengoma, Deus/0000-0003-2040-3416; Baraka, Vito/0000-0001-9694-9293; Alifrangis, Michael/0000-0002-3835-3333; Mosha, Jacklin/0000-0001-7940-8903	IPTi Consortium - Bill & Melinda Gates Foundation; Gates Malaria Partnership - Bill & Melinda Gates Foundation; Eugene Cota-Robles Fellowship Award through the Graduate Division at the University of California San Francisco; Earle C. Anthony Sciences Fellowship Award through the Graduate Division at the University of California San Francisco	IPTi Consortium - Bill & Melinda Gates Foundation; Gates Malaria Partnership - Bill & Melinda Gates Foundation; Eugene Cota-Robles Fellowship Award through the Graduate Division at the University of California San Francisco; Earle C. Anthony Sciences Fellowship Award through the Graduate Division at the University of California San Francisco	The original parent trial was funded by the IPTi Consortium and by the Gates Malaria Partnership, both of which are supported by the Bill & Melinda Gates Foundation. EP was supported by the Eugene Cota-Robles (2014) and the Earle C. Anthony Sciences (2015) Fellowship Awards offered through the Graduate Division at the University of California San Francisco.	Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Brabin BJ, 2004, DRUG SAFETY, V27, P633, DOI 10.2165/00002018-200427090-00002; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; DERN RJ, 1954, J LAB CLIN MED, V43, P303; DERN RJ, 1954, J LAB CLIN MED, V44, P171; Enevold A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-61; Gesase S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004569; Giao PT, 2001, CLIN PHARMACOKINET, V40, P343, DOI 10.2165/00003088-200140050-00003; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Hughes WT, 1998, CLIN INFECT DIS, V27, P191, DOI 10.1086/514626; Johnson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007246; Jollow DJ, 2001, ADV EXP MED BIOL, V500, P595; Lang T, 2003, LANCET INFECT DIS, V3, P162, DOI 10.1016/S1473-3099(03)00547-4; Luzzatto L, 2014, BRIT J HAEMATOL, V164, P469, DOI 10.1111/bjh.12665; MCCAFFREY RP, 1971, ANN INTERN MED, V74, P722, DOI 10.7326/0003-4819-74-5-722; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Olliaro P, 2011, AM J TROP MED HYG, V85, P619, DOI 10.4269/ajtmh.2011.11-0154; Pamba A, 2012, BLOOD, V120, P4123, DOI 10.1182/blood-2012-03-416032; Polski JM, 1998, J CLIN PATHOL-MOL PA, V51, P215, DOI 10.1136/mp.51.4.215; Premji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006682; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Siddiqui T, 1998, MIL MED, V163, P434, DOI 10.1093/milmed/163.6.434; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; Tiono AB, 2009, AM J TROP MED HYG, V81, P969, DOI 10.4269/ajtmh.2009.09-0351; TUGWELL P, 1973, LANCET, V1, P968; USANGA EA, 1985, NATURE, V313, P793, DOI 10.1038/313793a0; Vittinghoff E, 2012, REGRESSION METHODS B; Wolf Ronni, 2002, Dermatol Online J, V8, P2; Wozel G, 2014, ARCH DERMATOL RES, V306, P103, DOI 10.1007/s00403-013-1409-7	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142414	10.1371/journal.pone.0142414	http://dx.doi.org/10.1371/journal.pone.0142414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599634	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000365853900024
J	Go, YM; Liang, YL; Uppal, K; Soltow, QA; Promislow, DEL; Wachtman, LM; Jones, DP				Go, Young-Mi; Liang, Yongliang; Uppal, Karan; Soltow, Quinlyn A.; Promislow, Daniel E. L.; Wachtman, Lynn M.; Jones, Dean P.			Metabolic Characterization of the Common Marmoset (Callithrix jacchus)	PLOS ONE			English	Article							NEW-WORLD PRIMATES; METHIONINE ADENOSYLTRANSFERASE; S-ADENOSYLMETHIONINE; HEART-MITOCHONDRIA; L-TRYPTOPHAN; PLASMA; MICE; DIET; CONVERSION; CARNITINE	High-resolution metabolomics has created opportunity to integrate nutrition and metabolism into genetic studies to improve understanding of the diverse radiation of primate species. At present, however, there is very little information to help guide experimental design for study of wild populations. In a previous non-targeted metabolomics study of common marmosets (Callithrix jacchus), Rhesus macaques, humans, and four non-primate mammalian species, we found that essential amino acids (AA) and other central metabolites had interspecies variation similar to intraspecies variation while non-essential AA, environmental chemicals and catabolic waste products had greater interspecies variation. The present study was designed to test whether 55 plasma metabolites, including both nutritionally essential and non-essential metabolites and catabolic products, differ in concentration in common marmosets and humans. Significant differences were present for more than half of the metabolites analyzed and included AA, vitamins and central lipid metabolites, as well as for catabolic products of AA, nucleotides, energy metabolism and heme. Three environmental chemicals were present at low nanomolar concentrations but did not differ between species. Sex and age differences in marmosets were present for AA and nucleotide metabolism and warrant additional study. Overall, the results suggest that quantitative, targeted metabolomics can provide a useful complement to non-targeted metabolomics for studies of diet and environment interactions in primate evolution.	[Go, Young-Mi; Liang, Yongliang; Uppal, Karan; Soltow, Quinlyn A.; Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Clin Biomarkers Lab, Atlanta, GA 30322 USA; [Promislow, Daniel E. L.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Promislow, Daniel E. L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Wachtman, Lynn M.] Harvard Univ, New England Primate Res Ctr, Southborough, MA 01772 USA	Emory University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University	Jones, DP (corresponding author), Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Clin Biomarkers Lab, Atlanta, GA 30322 USA.	dpjones@emory.edu		Promislow, Daniel/0000-0001-7088-4495; Uppal, Karan/0000-0001-5985-1668	NIH [AG038746, ES023485, ES 025632, HL113451, ES019776, OD018006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES019776, R01ES023485, R21ES025632, T32ES012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038746, P30AG013280] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH grants, AG038746 (DJ, DP, LW), ES023485 (DJ, YG), ES 025632 (DJ, YG), HL113451 (DJ), ES019776 (DJ), and OD018006 (DJ).	Banton SA, 2015, J AM ASS LA IN PRESS; Barton RA, 2006, AM J PRIMATOL, V68, P545, DOI 10.1002/ajp.20251; Baxter VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082747; Berstad A, 2014, SCAND J GASTROENTERO, V49, P1493, DOI 10.3109/00365521.2014.936034; Bouchardet da Fonseca G.A., 1984, Primates, V25, P441, DOI 10.1007/BF02381667; Bravo R, 2013, AGE, V35, P1277, DOI 10.1007/s11357-012-9419-5; Capuron L, 2014, CURR PHARM DESIGN, V20, P6048, DOI 10.2174/1381612820666140317110217; CHALMERS DT, 1983, LAB ANIM, V17, P270, DOI 10.1258/002367783781062217; Coimbra-Fiho AF, 1978, TREE GOUGING EXUDATE, P105; Committee NRCU, 2011, GUIDE CARE USE LAB A; Cribbs SK, 2014, AIDS RES HUM RETROV, V30, P579, DOI [10.1089/aid.2013.0198, 10.1089/AID.2013.0198]; Frediani JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108854; GARBER PA, 1992, AM J PHYS ANTHROPOL, V88, P411, DOI 10.1002/ajpa.1330880402; Go YM, 2015, TOXICOL SCI, V148, P531, DOI 10.1093/toxsci/kfv198; Go YM, 2015, TOXICOL SCI, V147, P524, DOI 10.1093/toxsci/kfv149; Go YM, 2015, AMINO ACIDS, V47, P589, DOI 10.1007/s00726-014-1893-x; Go YM, 2015, AM J PHYSIOL-REG I, V308, pR62, DOI 10.1152/ajpregu.00278.2014; GUTTLER F, 1984, EUR J PEDIATR, V142, P126, DOI 10.1007/BF00445592; He C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004860; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; Ingenbleek Y, 2013, NUTR REV, V71, P413, DOI 10.1111/nure.12050; Johnson JM, 2010, ANALYST, V135, P2864, DOI 10.1039/c0an00333f; Jones DP, 2012, ANNU REV NUTR, V32, P183, DOI 10.1146/annurev-nutr-072610-145159; Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054; KLOSTERMAN LL, 1986, ENDOCRINOLOGY, V118, P424, DOI 10.1210/endo-118-1-424; Liu WJ, 2013, ASIAN PAC J CANCER P, V14, P6433, DOI 10.7314/APJCP.2013.14.11.6433; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Lu SC, 2005, ALCOHOL, V35, P227, DOI 10.1016/j.alcohol.2005.03.011; Ludlage E, 2003, COMPARATIVE MED, V53, P369; McWhorter TJ, 2007, AM J PRIMATOL, V69, P1399, DOI 10.1002/ajp.20443; Muller N, 2014, AM J PRIMATOL, V76, P230, DOI 10.1002/ajp.22225; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; PARADIES G, 1994, ANN NY ACAD SCI, V717, P233, DOI 10.1111/j.1749-6632.1994.tb12093.x; Park YH, 2012, TOXICOLOGY, V295, P47, DOI 10.1016/j.tox.2012.02.007; PETERS JH, 1971, COMP BIOCHEM PHYSIOL, V39, P639, DOI 10.1016/0305-0491(71)90208-2; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Ross Corinna N, 2012, J Aging Res, V2012, P567143, DOI 10.1155/2012/567143; Salinas JL, 2014, MEM I OSWALDO CRUZ, V109, P589, DOI 10.1590/0074-0276140043; Sethumadhavan S, 2006, BIOGERONTOLOGY, V7, P101, DOI 10.1007/s10522-006-6497-8; Shibata K, 2003, ADV EXP MED BIOL, V527, P435; Soltow QA, 2013, METABOLOMICS, V9, pS132, DOI 10.1007/s11306-011-0332-1; Tardif S, 1998, LAB ANIM SCI, V48, P264; Tardif SD, 2011, ILAR J, V52, P54, DOI 10.1093/ilar.52.1.54; Tardif SD, 2009, OBESITY, V17, P1499, DOI 10.1038/oby.2009.77; Tardito S, 2012, AMINO ACIDS, V42, P2507, DOI 10.1007/s00726-011-0981-4; Terakata M, 2013, J NUTR, V143, P1046, DOI 10.3945/jn.113.176875; Uppal K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-15; Villasenor A, 2014, BRIT J PHARMACOL, V171, P2230, DOI 10.1111/bph.12494; Wachtman LM, 2011, COMPARATIVE MED, V61, P278; Wachtman LM, 2011, OBESITY, V19, P1145, DOI 10.1038/oby.2010.303; Yamada H, 2012, FREE RADICAL BIO MED, V52, P1716, DOI 10.1016/j.freeradbiomed.2012.02.033; Yu TW, 2009, BIOINFORMATICS, V25, P1930, DOI 10.1093/bioinformatics/btp291; Zagajewski J, 2012, J PHYSIOL PHARMACOL, V63, P613; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100; Zhao JY, 2015, DIABETES CARE, V38, P220, DOI 10.2337/dc14-2033; Zhou XM, 2014, NAT GENET, V46, P1303, DOI 10.1038/ng.3137; Ziegler TE, 2013, J AM ASSOC LAB ANIM, V52, P756	59	21	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142916	10.1371/journal.pone.0142916	http://dx.doi.org/10.1371/journal.pone.0142916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581102	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600067
J	Nouatin, O; Gbedande, K; Ibitokou, S; Vianou, B; Houngbegnon, P; Ezinmegnon, S; Borgella, S; Akplogan, C; Cottrell, G; Varani, S; Massougbodji, A; Moutairou, K; Troye-Blomberg, M; Deloron, P; Luty, AJF; Fievet, N				Nouatin, Odilon; Gbedande, Komi; Ibitokou, Samad; Vianou, Bertin; Houngbegnon, Parfait; Ezinmegnon, Sem; Borgella, Sophie; Akplogan, Carine; Cottrell, Gilles; Varani, Stefania; Massougbodji, Achille; Moutairou, Kabirou; Troye-Blomberg, Marita; Deloron, Philippe; Luty, Adrian J. F.; Fievet, Nadine			Infants' Peripheral Blood Lymphocyte Composition Reflects Both Maternal and Post-Natal Infection with Plasmodium falciparum	PLOS ONE			English	Article							REGULATORY T-CELLS; ALPHA-INDUCED APOPTOSIS; HUMAN NK-CELLS; CORD BLOOD; PLACENTAL MALARIA; IMMUNE-RESPONSES; IN-UTERO; CYTOKINE RESPONSES; TGF-BETA; CD4(+)	Maternal parasitoses modulate fetal immune development, manifesting as altered cellular immunological activity in cord blood that may be linked to enhanced susceptibility to infections in early life. Plasmodium falciparum typifies such infections, with distinct placental infection-related changes in cord blood exemplified by expanded populations of parasite antigen-specific regulatory T cells. Here we addressed whether such early-onset cellular immunological alterations persist through infancy. Specifically, in order to assess the potential impacts of P. falciparum infections either during pregnancy or during infancy, we quantified lymphocyte subsets in cord blood and in infants' peripheral blood during the first year of life. The principal age-related changes observed, independent of infection status, concerned decreases in the frequencies of CD4(+), NKdim and NKT cells, whilst CD8(+), Treg and Teff cells' frequencies increased from birth to 12 months of age. P. falciparum infections present at delivery, but not those earlier in gestation, were associated with increased frequencies of Treg and CD8(+) T cells but fewer CD4(+) and NKT cells during infancy, thus accentuating the observed age-related patterns. Overall, P. falciparum infections arising during infancy were associated with a reversal of the trends associated with maternal infection i.e. with more CD4(+) cells, with fewer Treg and CD8(+) cells. We conclude that maternal P. falciparum infection at delivery has significant and, in some cases, year-long effects on the composition of infants' peripheral blood lymphocyte populations. Those effects are superimposed on separate and independent age-as well as infant infection-related alterations that, respectively, either match or run counter to them.	[Nouatin, Odilon; Gbedande, Komi; Ibitokou, Samad; Vianou, Bertin; Houngbegnon, Parfait; Ezinmegnon, Sem; Borgella, Sophie; Akplogan, Carine; Cottrell, Gilles; Massougbodji, Achille; Fievet, Nadine] Univ Abomey Calavi, Fac Sci Sante, CERPAGE, Cotonou, Benin; [Nouatin, Odilon; Gbedande, Komi; Ibitokou, Samad; Vianou, Bertin; Houngbegnon, Parfait; Ezinmegnon, Sem; Akplogan, Carine; Moutairou, Kabirou] Univ Abomey Calavi, Fac Sci & Tech, Dept Biochim & Biol Cellulaire, Cotonou, Benin; [Borgella, Sophie; Cottrell, Gilles; Deloron, Philippe; Fievet, Nadine] Inst Rech Dev, MERIT UMR Mere & Enfant Face Infect Trop D216, Paris, France; [Cottrell, Gilles; Deloron, Philippe; Fievet, Nadine] Univ Paris 05, Fac Pharm, PRES Sorbonne Paris Cite, Paris, France; [Varani, Stefania] Univ Bologna, Microbiol Unit, Dept Diagnost Expt & Specialty Med, Bologna, Italy; [Troye-Blomberg, Marita] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Luty, Adrian J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	University of Abomey Calavi; University of Abomey Calavi; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Bologna; Stockholm University; Radboud University Nijmegen	Fievet, N (corresponding author), Univ Abomey Calavi, Fac Sci Sante, CERPAGE, Cotonou, Benin.	fievet.nadine@ird.fr	Varani, Stefania/AAZ-1856-2021; Troye-Blomberg, Marita/B-9210-2016; Luty, Adrian/CAH-2547-2022; Deloron, Philippe/G-6305-2010	Troye-Blomberg, Marita/0000-0002-2804-0325; Deloron, Philippe/0000-0003-4705-2484; Luty, Adrian John Frederick/0000-0001-8830-3425; Cottrell, Gilles/0000-0002-7964-8963; VARANI, STEFANIA/0000-0003-0862-4937; GBEDANDE, Komi/0000-0002-3229-5566; Fievet, Nadine/0000-0003-2272-9794	European 7th Framework Programme [200889]; Ministere des Affaires Etrangeres of France (project REFS) [2006-22]; Institut de Recherche pour le Developpement; AIRD-DPF; French Ambassy	European 7th Framework Programme(European Commission); Ministere des Affaires Etrangeres of France (project REFS); Institut de Recherche pour le Developpement; AIRD-DPF; French Ambassy	This paper describes work undertaken in the context of the STOPPAM project, 'Strategies To Prevent Pregnancy Associated Malaria' (www.stoppam.org), a Small & Medium Scale Collaborative Project supported by the European 7th Framework Programme under contract number 200889. This work was also supported by the Ministere des Affaires Etrangeres of France (project REFS No. 2006-22), the Institut de Recherche pour le Developpement, which contributed to the study financially and with research material. Financial support was also provided by the AIRD-DPF to SI and KG (PhD research scholarship) and the French Ambassy to KG (PhD research scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2008, J INFECT DIS, V198, P928, DOI 10.1086/591057; Aggarwal S, 2000, GENES IMMUN, V1, P271, DOI 10.1038/sj.gene.6363674; Ateba-Ngoa U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114630; Azuma T, 2003, CANCER RES, V63, P4516; Huynh BT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-72; Bisseye C, 2011, CLIN EXP IMMUNOL, V166, P366, DOI 10.1111/j.1365-2249.2011.04467.x; Bisseye C, 2009, CLIN EXP IMMUNOL, V158, P287, DOI 10.1111/j.1365-2249.2009.04014.x; Borgella S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080624; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brickley EB, 2015, J INFECT DIS, V211, P436, DOI 10.1093/infdis/jiu454; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; Brustoski K, 2006, J INFECT DIS, V193, P146, DOI 10.1086/498578; Brustoski K, 2005, J IMMUNOL, V174, P1738, DOI 10.4049/jimmunol.174.3.1738; Chelimo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024852; Clemente A, 2011, CELL MICROBIOL, V13, P1328, DOI 10.1111/j.1462-5822.2011.01622.x; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Cuna WR, 2009, J PARASITOL, V95, P891, DOI 10.1645/GE-1927.1; D'Andrea A, 2000, EUR J IMMUNOL, V30, P1544, DOI 10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO;2-I; Dalle JH, 2005, PEDIATR RES, V57, P649, DOI 10.1203/01.PDR.0000156501.55431.20; Dauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fievet N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-251; Finney OC, 2010, EUR J IMMUNOL, V40, P47, DOI 10.1002/eji.200939708; Flanagan KL, 2010, EUR J IMMUNOL, V40, P1062, DOI 10.1002/eji.200939638; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Fuchizawa T, 2007, CLIN IMMUNOL, V125, P237, DOI 10.1016/j.clim.2007.08.004; Fujimaki W, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/305859; Gbedande K, 2013, INFECT IMMUN, V81, P2686, DOI 10.1128/IAI.00237-13; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Grindebacke H, 2009, J IMMUNOL, V183, P4360, DOI 10.4049/jimmunol.0901091; Gupta S, 2005, INT J BIOCHEM CELL B, V37, P1034, DOI 10.1016/j.biocel.2004.08.013; Harner S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015714; Hartgers FC, 2009, J INFECT DIS, V199, P1528, DOI 10.1086/598687; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Horowitz A, 2010, J IMMUNOL, V184, P6043, DOI 10.4049/jimmunol.1000106; Horowitz A, 2010, METHODS MOL BIOL, V612, P429, DOI 10.1007/978-1-60761-362-6_29; Hrdy J, 2012, CLIN EXP IMMUNOL, V170, P10, DOI 10.1111/j.1365-2249.2012.04630.x; Kabyemela E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077214; Kalanda BF, 2005, EARLY HUM DEV, V81, P841, DOI 10.1016/j.earlhumdev.2005.06.006; Kurtis JD, 2011, INFECT IMMUN, V79, P1254, DOI 10.1128/IAI.01072-10; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Mackroth MS, 2011, J IMMUNOL, V186, P2780, DOI 10.4049/jimmunol.1001188; Malhotra I, 2006, J INFECT DIS, V193, P1005, DOI 10.1086/500472; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Menzies SK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002718; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2012, ADV IMMUNOL, V115, P73, DOI 10.1016/B978-0-12-394299-9.00003-5; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; Ngoa UA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-388; Othoro C, 2008, INFECT IMMUN, V76, P1678, DOI 10.1128/IAI.01420-07; Pied S, 2000, J IMMUNOL, V164, P1463, DOI 10.4049/jimmunol.164.3.1463; Rachas A, 2012, CLIN INFECT DIS, V55, P672, DOI 10.1093/cid/cis490; Ralainirina N, 2007, J LEUKOCYTE BIOL, V81, P144, DOI 10.1189/jlb.0606409; REICHERT T, 1991, CLIN IMMUNOL IMMUNOP, V60, P190, DOI 10.1016/0090-1229(91)90063-G; Romagnani C, 2005, EUR J IMMUNOL, V35, P2452, DOI 10.1002/eji.200526069; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Shahabuddin S, 1998, CLIN DIAGN LAB IMMUN, V5, P632, DOI 10.1128/CDLI.5.5.632-635.1998; Smith NL, 2014, J IMMUNOL, V193, P177, DOI 10.4049/jimmunol.1400553; Soulard V, 2011, INFECT IMMUN, V79, P2801, DOI 10.1128/IAI.00203-11; Sundstrom Y, 2007, SCAND J IMMUNOL, V66, P335, DOI 10.1111/j.1365-3083.2007.01980.x; Tang Jie, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P365; Thornton CA, 2010, CURR ALLERGY ASTHM R, V10, P444, DOI 10.1007/s11882-010-0148-5; van der Vliet HJJ, 2000, BLOOD, V95, P2440, DOI 10.1182/blood.V95.7.2440.007k35_2440_2442; Vekemans J, 2000, INFECT IMMUN, V68, P5430, DOI 10.1128/IAI.68.9.5430-5434.2000; Walther B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-6; Walther B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-16; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Watanabe H, 2003, PARASITOL INT, V52, P61, DOI 10.1016/S1383-5769(02)00085-5	79	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0139606	10.1371/journal.pone.0139606	http://dx.doi.org/10.1371/journal.pone.0139606			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580401	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600001
J	Palumbo, GA; Scisciani, C; Pediconi, N; Lupacchini, L; Alfalate, D; Guerrieri, F; Calvo, L; Salerno, D; Di Cocco, S; Levrero, M; Belloni, L				Palumbo, Gianna Aurora; Scisciani, Cecilia; Pediconi, Natalia; Lupacchini, Leonardo; Alfalate, Dulce; Guerrieri, Francesca; Calvo, Ludovica; Salerno, Debora; Di Cocco, Silvia; Levrero, Massimo; Belloni, Laura			IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENE-EXPRESSION; LIVER; INTERLEUKIN-6; STAT3; IL-6; REPLICATION; ACTIVATION; PROTEIN; DNA	The HBV covalently closed circular DNA (cccDNA) is organized as a mini-chromosome in the nuclei of infected hepatocytes by histone and non-histone proteins. Transcription from the cccDNA of the RNA replicative intermediate termed pre-genome (pgRNA), is the critical step for genome amplification and ultimately determines the rate of HBV replication. Multiple evidences suggest that cccDNA epigenetic modifications, such as histone modifications and DNA methylation, participate in regulating the transcriptional activity of the HBV cccDNA. Inflammatory cytokines (TNF alpha, LT beta) and the pleiotropic cytokine interleukin-6 (IL6) inhibit hepatitis B virus (HBV) replication and transcription. Here we show, in HepG2 cells transfected with linear HBV monomers and HBV-infected NTCP-HepG2 cells, that IL6 treatment leads to a reduction of cccDNA-bound histone acetylation paralleled by a rapid decrease in 3.5kb/pgRNA and subgenomic HBV RNAs transcription without affecting cccDNA chromatinization or cccDNA levels. IL6 repressive effect on HBV replication is mediated by a loss of HNF1 alpha and HNF4 alpha binding to the cccDNA and a redistribution of STAT3 binding from the cccDNA to IL6 cellular target genes.	[Palumbo, Gianna Aurora; Scisciani, Cecilia; Lupacchini, Leonardo; Calvo, Ludovica; Salerno, Debora; Di Cocco, Silvia; Levrero, Massimo; Belloni, Laura] Univ Roma La Sapienza, Dept Internal Med DMISM, I-00185 Rome, Italy; [Pediconi, Natalia] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy; [Alfalate, Dulce; Levrero, Massimo] CRCL, INSERM, U1052, Lyon, France; [Guerrieri, Francesca; Salerno, Debora; Levrero, Massimo; Belloni, Laura] IIT Sapienza, Ctr Life NanoSci CLNS, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Istituto Italiano di Tecnologia - IIT	Levrero, M (corresponding author), Univ Roma La Sapienza, Dept Internal Med DMISM, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	massimo.levrero@uniroma1.it; laura.belloni@iit.it	Salerno, Debora/AAM-9940-2021; guerrieri, francesca/G-3908-2013; Lupacchini, Leonardo/C-2626-2017; Belloni, Laura/S-1432-2019; Guerrieri, Francesca/K-5504-2016; Levrero, Massimo/G-5680-2016	Guerrieri, Francesca/0000-0003-2751-6050; LUPACCHINI, LEONARDO/0000-0002-9172-7461; Guerrieri, Francesca/0000-0002-2021-4394; SALERNO, DEBORA/0000-0003-0504-1904; Levrero, Massimo/0000-0002-4978-0875	Ministero dell'Istruzione, dell'Universita e della Ricerca FIRB [RBAP10XKNC]; Ministero della Salute [43-2317822]; Fondazione Cariplo [2011-0644]; Agence Nationale de la Recherche [ANR 14 ACHN 0028 PAN]; University of Lyon-St Etienne [14IA09-ANR PALSE]; Gilead Sciences Research Scholars Program in Liver Diseases [000324-14-AR]; MIUR-FIRB; Regione Lazio; CARIPLO; IIT; Fundacao Calouste Gulbenkian; Fundacao para a Ciencia e a Tecnologia, Portugal	Ministero dell'Istruzione, dell'Universita e della Ricerca FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministero della Salute(Ministry of Health, Italy); Fondazione Cariplo(Fondazione Cariplo); Agence Nationale de la Recherche(French National Research Agency (ANR)); University of Lyon-St Etienne; Gilead Sciences Research Scholars Program in Liver Diseases; MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Regione Lazio(Regione Lazio); CARIPLO(Fondazione Cariplo); IIT(Istituto Italiano di Tecnologia - IIT); Fundacao Calouste Gulbenkian(European Commission); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Support was provided by the following grants: a) Ministero dell'Istruzione, dell'Universita e della Ricerca FIRB RBAP10XKNC to ML [www.istruzione.it/web/ricerca/home]; b) Ministero della Salute, Ric Fin Conv 43-2317822 to ML [www.salute.gov.it/porta/.../p2_5.jsp?...Ricerca%20sanitaria...finalizzata]; c) Fondazione Cariplo, 2011-0644 to ML [www.fondazionecariplo.it/it/strategia/settori-di-intervento/ricerca/]; d) Agence Nationale de la Recherche, ANR 14 ACHN 0028 PAN to ML [www.agence-nationale-recherche.fr/]; e) University of Lyon-St Etienne, 14IA09-ANR PALSE to ML [palse.universite-lyon.fr/]; f) Gilead Sciences Research Scholars Program in Liver Diseases, 000324-14-AR to LB [researchscholars.gilead.com/]. The following fellowships and support were also provided: GAP, CS, LC are supported by research contracts from MIUR-FIRB, Regione Lazio and CARIPLO, respectively. FG, DS and LB are recipients of research contracts supported by IIT. DA is supported by a fellowship from Fundacao Calouste Gulbenkian and Fundacao para a Ciencia e a Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Benhenda S, 2013, J VIROL, V87, P4360, DOI 10.1128/JVI.02574-12; Bock CT, 2001, J MOL BIOL, V307, P183, DOI 10.1006/jmbi.2000.4481; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1545, DOI 10.1016/j.ijrobp.2008.12.072; Curtil C, 2014, FASEB J, V28, P1454, DOI 10.1096/fj.13-236372; Ducroux A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004343; Galun E, 2000, VIROLOGY, V270, P299, DOI 10.1006/viro.2000.0210; GILLES PN, 1992, J VIROL, V66, P3955, DOI 10.1128/JVI.66.6.3955-3960.1992; GUNTHER S, 1995, J VIROL, V69, P5437; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Hatziapostolou M, 2013, CELL, V28, P152; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hong MH, 2012, TRANSFORMING GROWTH, V7; KAKUMU S, 1991, AM J GASTROENTEROL, V86, P1804; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Kuo TM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-41; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li J, 2002, J VIROL, V76, P5875, DOI 10.1128/JVI.76.12.5875-5881.2002; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Oh MK, 2011, J BIOL CHEM, V286, P8857, DOI 10.1074/jbc.M110.150557; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; Pollicino T, 2011, J VIROL, V85, P432, DOI 10.1128/JVI.01609-10; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Scisciani C, 2012, J HEPATOL, V56, pS18, DOI 10.1016/S0168-8278(12)60055-5; Song LH, 2003, J CLIN VIROL, V28, P93, DOI 10.1016/S1386-6532(02)00271-8; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Tropberger P, 2015, P NATL ACAD SCI US; Waris G, 2002, J VIROL, V76, P2721, DOI 10.1128/JVI.76.6.2721-2729.2002; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P287; Zhang DX, 1996, J BIOL CHEM, V271, P9503, DOI 10.1074/jbc.271.16.9503; Zheng DL, 2009, J HEPATOL, V50, P377, DOI 10.1016/j.jhep.2008.10.019; Zheng YY, 2004, J VIROL, V78, P6908, DOI 10.1128/JVI.78.13.6908-6914.2004	37	51	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142599	10.1371/journal.pone.0142599	http://dx.doi.org/10.1371/journal.pone.0142599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580974	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600049
J	Delgado, E; Cuevas, MT; Dominguez, F; Vega, Y; Cabello, M; Fernandez-Garcia, A; Perez-Losada, M; Castro, MA; Montero, V; Sanchez, M; Marino, A; Alvarez, H; Ordonez, P; Ocampo, A; Miralles, C; Perez-Castro, S; Lopez-Alvarez, MJ; Rodriguez, R; Trigo, M; Diz-Aren, J; Hinojosa, C; Bachiller, P; Hernaez-Crespo, S; Cisterna, R; Garduno, E; Perez-Alvarez, L; Thomson, MM				Delgado, Elena; Teresa Cuevas, Maria; Dominguez, Francisco; Vega, Yolanda; Cabello, Marina; Fernandez-Garcia, Aurora; Perez-Losada, Marcos; Angeles Castro, Maria; Montero, Vanessa; Sanchez, Monica; Marino, Ana; Alvarez, Hortensia; Ordonez, Patricia; Ocampo, Antonio; Miralles, Celia; Perez-Castro, Sonia; Jose Lopez-Alvarez, Maria; Rodriguez, Raul; Trigo, Matilde; Diz-Aren, Julio; Hinojosa, Carmen; Bachiller, Pablo; Hernaez-Crespo, Silvia; Cisterna, Ramon; Garduno, Eugenio; Perez-Alvarez, Lucia; Thomson, Michael M.			Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; TRANSMISSION CLUSTER; POPULATION-DYNAMICS; GENETIC DIVERSITY; INFECTION; TYPE-1; IDENTIFICATION	We recently reported the rapid expansion of an HIV-1 subtype F cluster among men who have sex with men (MSM) in the region of Galicia, Northwest Spain. Here we update this outbreak, analyze near full-length genomes, determine phylogenetic relationships, and estimate its origin. For this study, we used sequences of HIV-1 protease-reverse transcriptase and env V3 region, and for 17 samples, near full-length genome sequences were obtained. Phylogenetic analyses were performed via maximum likelihood. Locations and times of most recent common ancestors were estimated using Bayesian inference. Among samples analyzed by us, 100 HIV-1 F1 subsubtype infections of monophyletic origin were diagnosed in Spain, including 88 in Galicia and 12 in four other regions. Most viruses (n = 90) grouped in a subcluster (Galician subcluster), while 7 from Valladolid (Central Spain) grouped in another subcluster. At least 94 individuals were sexually-infected males and at least 71 were MSM. Seventeen near full-length genomes were uniformly of F1 subsubtype. Through similarity searches and phylogenetic analyses, we identified 18 viruses from four other Western European countries [Switzerland (n = 8), Belgium (n = 5), France (n = 3), and United Kingdom (n = 2)] and one from Brazil, from samples collected in 2005-2011, which branched within the subtype F cluster, outside of both Spanish subclusters, most of them corresponding to recently infected individuals. The most probable geographic origin and age of the Galician subcluster was Ferrol, Northwest Galicia, around 2007, while the Western European cluster probably emerged in Switzerland around 2002. In conclusion, a recently expanded HIV-1 subtype F cluster, the largest non-subtype B cluster reported in Western Europe, continues to spread among MSM in Spain; this cluster is part of a larger cluster with a wide geographic circulation in diverse Western European countries.	[Delgado, Elena; Teresa Cuevas, Maria; Dominguez, Francisco; Vega, Yolanda; Cabello, Marina; Fernandez-Garcia, Aurora; Montero, Vanessa; Sanchez, Monica; Perez-Alvarez, Lucia; Thomson, Michael M.] Inst Salud Carlos III, Ctr Nacl Microbiol, HIV Biol & Variabil Unit, Madrid, Spain; [Perez-Losada, Marcos] Ctr Invest Biodiversidade & Recursos Genet CIBIO, Vairao, Portugal; [Angeles Castro, Maria] Complejo Hosp Univ A Coruna, Dept Internal Med, La Coruna, Spain; [Marino, Ana; Alvarez, Hortensia] Complejo Hosp Univ Arquitecto Marcide, Dept Internal Med, Infect Dis Unit, Ferrol, A Coruna, Spain; [Ordonez, Patricia] Complejo Hosp Univ Arquitecto Marcide, Dept Microbiol, Ferrol, A Coruna, Spain; [Ocampo, Antonio; Miralles, Celia] Complejo Hosp Univ Vigo, Dept Internal Med, Vigo, Pontevedra, Spain; [Perez-Castro, Sonia] Complejo Hosp Univ Vigo, Dept Microbiol, Vigo, Pontevedra, Spain; [Jose Lopez-Alvarez, Maria] Hosp Univ Lucus Augusti, Infect Disesases Unit, Lugo, Spain; [Rodriguez, Raul] Complejo Hosp Univ Ourense, Dept Internal Med, Orense, Spain; [Trigo, Matilde] Complejo Hosp Prov Pontevedra, Dept Microbiol, Pontevedra, Spain; [Diz-Aren, Julio] Complejo Hosp Prov Pontevedra, Dept Internal Med, Pontevedra, Spain; [Hinojosa, Carmen] Hosp Clin Univ Valladolid, Dept Internal Med, Valladolid, Spain; [Bachiller, Pablo] Hosp Univ Rio Hortega, Dept Internal Med, Valladolid, Spain; [Hernaez-Crespo, Silvia; Cisterna, Ramon] Hosp Univ Basurto, Dept Clin Microbiol & Infect Control, Bilbao, Vizcaya, Spain; [Garduno, Eugenio] Hosp Infanta Cristina, Dept Microbiol, Badajoz, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidade do Porto; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Complejo Hospitalario Universitario de Ferrol; Complejo Hospitalario Universitario de Ferrol; Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Vigo; Hospital Universitario Lucus Augusti-Lugo; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Complexo Hospitalario Universitario de Pontevedra; Complexo Hospitalario Universitario de Pontevedra; Hospital del Rio Hortega; Basurto Hospital	Thomson, MM (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, HIV Biol & Variabil Unit, Madrid, Spain.	mthomson@isciii.es	Perez-Losada, Marcos/I-4407-2013; Dominguez, Francisco/AAA-7260-2020; Thomson, Michael M/P-8949-2017; gonzalez-nico, maria teresa cuevas/E-2001-2014; Delgado, Elena/E-2785-2019	Perez-Losada, Marcos/0000-0002-2585-4657; Dominguez, Francisco/0000-0002-7620-8081; Thomson, Michael M/0000-0002-0622-7527; gonzalez-nico, maria teresa cuevas/0000-0002-4195-1975; Dominguez, Francisco/0000-0002-8573-5668; Matilde, Trigo Dapota/0000-0001-7006-2854; Delgado, Elena/0000-0002-0754-8533; PEREZ CASTRO, SONIA/0000-0003-1734-1904; OCAMPO HERMIDA, ANTONIO/0000-0002-3176-9758	Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain [EC11-272]; European Network of Excellence EUROPRISE (Rational Design of HIV Vaccines and Microbicides) [LSHP-CT-2006-037611]; European Research Infrastructures for Poverty Related Diseases (EURIPRED) [312661]; Instituto de Salud Carlos III, Subdireccion General de Evaluacion, and Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I [RD12/0017/0026]; Conselleria de Sanidade, Government of Galicia, Spain [MVI 1291/08]; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain [MVI-1255-08]; District of Columbia Developmental Center for AIDS Research [P30AI087714]; George Washington University; CIBER in Epidemiology and Public Health, Instituto de Salud Carlos III, Madrid, Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714] Funding Source: NIH RePORTER	Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain; European Network of Excellence EUROPRISE (Rational Design of HIV Vaccines and Microbicides); European Research Infrastructures for Poverty Related Diseases (EURIPRED); Instituto de Salud Carlos III, Subdireccion General de Evaluacion, and Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I; Conselleria de Sanidade, Government of Galicia, Spain; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain; District of Columbia Developmental Center for AIDS Research; George Washington University; CIBER in Epidemiology and Public Health, Instituto de Salud Carlos III, Madrid, Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received support from the Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain, grant EC11-272; European Network of Excellence EUROPRISE (Rational Design of HIV Vaccines and Microbicides), grant LSHP-CT-2006-037611; European Research Infrastructures for Poverty Related Diseases (EURIPRED). Seventh Framework Programme: FP7-Capacities-infrastructures-2012-1, grant agreement 312661; Instituto de Salud Carlos III, Subdireccion General de Evaluacion, and Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I, through project RD12/0017/0026; Conselleria de Sanidade, Government of Galicia, Spain (MVI 1291/08); and the Osakidetza-Servicio Vasco de Salud, Basque Country, Spain (MVI-1255-08). Marcos Perez-Losada was supported by a DC D-CFAR Research Award from the District of Columbia Developmental Center for AIDS Research (P30AI087714) and by an University Facilitating Fund award from George Washington University. Aurora Fernandez-Garcia is supported by CIBER in Epidemiology and Public Health, Instituto de Salud Carlos III, Madrid, Spain.	Ambrosioni J, 2012, AIDS, V26, P2079, DOI 10.1097/QAD.0b013e32835805b6; Antoniadou ZA, 2014, AIDS RES HUM RETROV, V30, P225, DOI [10.1089/AID.2013.0166, 10.1089/aid.2013.0166]; Audelin AM, 2013, JAIDS-J ACQ IMM DEF, V62, P102, DOI 10.1097/QAI.0b013e318276becc; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Castro E, 2010, AIDS RES HUM RETROV, V26, P1233, DOI 10.1089/aid.2010.0083; Chalmet K, 2012, J INFECT DIS, V205, P174, DOI 10.1093/infdis/jir714; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Ciccozzi M, 2007, AIDS, V21, P1213, DOI 10.1097/QAD.0b013e32813aee1a; Cuevas M, 2009, EURO SURVEIL, V14; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Delgado E, 2002, J ACQ IMMUN DEF SYND, V29, P536, DOI 10.1097/00126334-200204150-00016; Delgado E, 2012, J ANTIMICROB CHEMOTH, V67, P25, DOI 10.1093/jac/dkr438; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Han XX, 2013, JAIDS-J ACQ IMM DEF, V64, P16, DOI 10.1097/QAI.0b013e3182932210; Hraber P, 2014, J VIROL, V88, P12623, DOI 10.1128/JVI.01705-14; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kuiken C, 2000, AM J EPIDEMIOL, V152, P814, DOI 10.1093/aje/152.9.814; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Monno L, 2012, J CLIN VIROL, V55, P370, DOI 10.1016/j.jcv.2012.08.014; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Paraskevis D, 2015, INFECT GENET EVOL, V30, P96, DOI 10.1016/j.meegid.2014.12.012; Perez L, 2006, AIDS RES HUM RETROV, V22, P724, DOI 10.1089/aid.2006.22.724; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shcherbakova NS, 2014, AIDS RES HUM RETROV, V30, P912, DOI [10.1089/aid.2014.0075, 10.1089/AID.2014.0075]; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Skar H, 2011, J VIROL, V85, P510, DOI 10.1128/JVI.01413-10; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; Thomson MM, 2012, JAIDS-J ACQ IMM DEF, V59, pE49, DOI 10.1097/QAI.0b013e3182400fc4; Thomson MM, 2011, VIROLOGY, V415, P30, DOI 10.1016/j.virol.2011.03.021; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Cardoso LPV, 2009, J CLIN VIROL, V46, P134, DOI 10.1016/j.jcv.2009.07.009; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Ye JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054238; Yebra G, 2014, ARCH VIROL, V159, P1079, DOI 10.1007/s00705-013-1933-y; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	50	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143325	10.1371/journal.pone.0143325	http://dx.doi.org/10.1371/journal.pone.0143325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599410	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600051
J	van Werkhoven, CH; Huijts, SM; Postma, DF; Oosterheert, JJ; Bonten, MJM				van Werkhoven, Cornelis H.; Huijts, Susanne M.; Postma, Douwe F.; Oosterheert, Jan Jelrik; Bonten, Marc J. M.			Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia	PLOS ONE			English	Article							BLOOD CULTURES; MANAGEMENT; GUIDELINES; ACCURACY	Introduction The diagnostic yield of blood cultures is limited in patients with community-acquired pneumonia (CAP). Yet, positive blood culture results provide important information for antibiotic treatment and for monitoring epidemiologic trends. We investigated the potential of clinical predictors to improve the cost-benefit ratio of obtaining blood cultures. Methods Data from two prospective cohort studies of adults with suspected CAP, admitted to non-ICU wards, were combined. Two models were created, one using readily available parameters and one additionally including laboratory parameters. Results 3,786 patients were included (2,626 (69%) with X-ray confirmed CAP). Blood cultures were obtained from 2,977 (79%) patients (and from 2,107 (80%) with X-ray confirmed CAP). 266 (8.9%) of the patients with a blood culture had bacteraemia. Clinical predictors of bacteraemia were absence of pre-admission antibiotic treatment, pleuritic pain, gastro-intestinal symptoms, tachycardia, tachypnea, hypotension and absence of hypoxia. After including laboratory results in the model, younger age, C-reactive protein, leukocytosis or leukopenia, low thrombocyte count, low sodium level, elevated urea and elevated arterial pH were added, while gastro-intestinal symptoms and hypotension were no longer significant. The area under the receiver operating characteristics curve was 0.66 (95% confidence interval 0.63-0.70) for the first model and 0.76 (95% confidence interval 0.73-0.79) for the second model. Conclusion In conclusion, in patients hospitalized with CAP, bacteraemia was moderately predictable using clinical parameters only. We recommend against the use of a risk prediction model for the decision to obtain blood cultures.	[van Werkhoven, Cornelis H.; Huijts, Susanne M.; Postma, Douwe F.; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Huijts, Susanne M.] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Postma, Douwe F.; Oosterheert, Jan Jelrik] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Postma, Douwe F.] Diakonessenhuis Utrecht, Dept Internal Med, Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Diakonessenhuis; Utrecht University; Utrecht University Medical Center	van Werkhoven, CH (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	c.h.vanwerkhoven@umcutrecht.nl	Postma, Douwe F./AAB-9922-2022; van Werkhoven, Henri/F-7915-2013	Postma, Douwe F./0000-0002-0675-8459; van Werkhoven, Henri/0000-0002-0626-4635; Oosterheert, Jan Jelrik/0000-0001-6146-3808	Netherlands Organization for Health Research and Development (ZONmw) [171202002]; Wyeth by Pfizer Inc [6115A1-3012]	Netherlands Organization for Health Research and Development (ZONmw)(Netherlands Organization for Health Research and Development); Wyeth by Pfizer Inc	CAP-START was supported by a financial grant from The Netherlands Organization for Health Research and Development (ZONmw, Health care efficiency research, project id: 171202002). CAP-pilot was supported by a financial grant from Wyeth, which was acquired by Pfizer Inc in October 2009. (study number 6115A1-3012). No funding has been received for the current manuscript.	Campbell SG, 2003, CHEST, V123, P1142, DOI 10.1378/chest.123.4.1142; Capelastegui A, 2010, J INFECTION, V61, P364, DOI 10.1016/j.jinf.2010.07.015; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; Colice GL, 2004, CHEST, V125, P2140, DOI 10.1378/chest.125.6.2140; Corbo J, 2004, EMERG MED J, V21, P446, DOI 10.1136/emj.2003.005306; Falguera M, 2009, CLIN INFECT DIS, V49, P409, DOI 10.1086/600291; Huijts SM, 2013, EUR RESPIR J, V42, P1283, DOI 10.1183/09031936.00137412; LeBude B, 2014, JAMA INTERN MED, V174, P1546, DOI 10.1001/jamainternmed.2014.3687; Lee CC, 2012, DIAGN MICR INFEC DIS, V73, P168, DOI 10.1016/j.diagmicrobio.2012.02.009; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARRIE TJ, 1989, REV INFECT DIS, V11, P586; Metersky ML, 2004, AM J RESP CRIT CARE, V169, P342, DOI 10.1164/rccm.200309-1248OC; Muller B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-10; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Paolucci M, 2010, INT J ANTIMICROB AG, V36, pS6, DOI 10.1016/j.ijantimicag.2010.11.010; Previsdomini M, 2012, CROAT MED J, V53, P30, DOI 10.3325/cmj.2012.53.30; R Core Team, 2021, R LANGUAGE ENV STAT; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Skerrett SJ, 1999, CLIN CHEST MED, V20, P531, DOI 10.1016/S0272-5231(05)70234-3; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Werkhoven CH, 2014, NETH J MED, V72, P170; Wiersinga WJ, 2012, NETH J MED, V70, P90	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143817	10.1371/journal.pone.0143817	http://dx.doi.org/10.1371/journal.pone.0143817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599636	gold, Green Published			2022-12-27	WOS:000365862600124
J	Galdino, TVD; Picanco, MC; Ferreira, DO; Silva, GAR; de Souza, TC; Silva, GA				da Silva Galdino, Tarcisio Visintin; Picanco, Marcelo Coutinho; Ferreira, Dalton Oliveira; Resende Silva, Geverson Aelton; de Souza, Thadeu Carlos; Silva, Gerson Adriano			Is the Performance of a Specialist Herbivore Affected by Female Choices and the Adaptability of the Offspring?	PLOS ONE			English	Article							AMERICAN TOMATO PINWORM; TUTA-ABSOLUTA MEYRICK; OVIPOSITION PREFERENCE; HELICOVERPA-ARMIGERA; EVOLUTIONARY ECOLOGY; PHYTOPHAGOUS INSECTS; NATURAL ENEMIES; PLANT DEFENSE; HOST-PLANT; SOIL TYPE	The performance of herbivorous insects is related to the locations of defenses and nutrients found in the different plant organs on which they feed. In this context, the females of herbivorous insect species select certain parts of the plant where their offspring can develop well. In addition, their offspring can adapt to plant defenses. A system where these ecological relationships can be studied occurs in the specialist herbivore, Tuta absoluta, on tomato plants. In our experiments we evaluated: (i) the performance of the herbivore T. absoluta in relation to the tomato plant parts on which their offspring had fed, (ii) the spatial distribution of the insect stages on the plant canopy and (iii) the larval resistance to starvation and their walking speed at different instar stages. We found that the T. absoluta females preferred to lay their eggs in the tomato plant parts where their offspring had greater chances of success. We verified that the T. absoluta females laid their eggs on both sides of the leaves to better exploit resources. We also observed that the older larvae (3rd and 4th instars) moved to the most nutritious parts of the plant, thus increasing their performance. The T. absoluta females and offspring (larvae) were capable of identifying plant sites where their chances of better performance were higher. Additionally, their offspring (larvae) spread across the plant to better exploit the available plant nutrients. These behavioral strategies of T. absoluta facilitate improvement in their performance after acquiring better resources, which help reduce their mortality by preventing the stimulation of plant defense compounds and the action of natural enemies.	[da Silva Galdino, Tarcisio Visintin] Univ Fed Vicosa, Dept Plant Sci, Vicosa, MG, Brazil; [Picanco, Marcelo Coutinho; Ferreira, Dalton Oliveira; Resende Silva, Geverson Aelton; de Souza, Thadeu Carlos; Silva, Gerson Adriano] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Galdino, TVD (corresponding author), Univ Fed Vicosa, Dept Plant Sci, Vicosa, MG, Brazil.	tarcsilva@gmail.com	Galdino, Tarcisio V S/J-2437-2015; De Oliveira Ferreira, Dalton/GVC-5262-2022; Picanço, Marcelo Coutinho/P-6172-2019; Silva, Gerson Adriano/AAK-4887-2020; Picanço, Marcelo/AAQ-2477-2020	Galdino, Tarcisio V S/0000-0001-7317-0789; De Oliveira Ferreira, Dalton/0000-0002-8777-5719; Silva, Gerson Adriano/0000-0002-1445-9758; Picanço, Marcelo/0000-0002-1294-6210	Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES Foundation (Brazilian Ministry of Education)); National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq); Research Support Foundation of Minas Gerais State Foundation for Research Aid (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG)	Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES Foundation (Brazilian Ministry of Education)); National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Support Foundation of Minas Gerais State Foundation for Research Aid (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG)	Fellowships and financial resources were granted to the authors by the Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES Foundation (Brazilian Ministry of Education)), the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq), and the Research Support Foundation of Minas Gerais State Foundation for Research Aid (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; ALVARADORODRIGUEZ B, 1982, J ECON ENTOMOL, V75, P895, DOI 10.1093/jee/75.5.895; Antonio AD, 2011, PESQUI AGROPECU BRAS, V46, P74, DOI 10.1590/S0100-204X2011000100010; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bjorkman C, 1997, OIKOS, V79, P45, DOI 10.2307/3546088; COELHO MDF, 1987, PESQUI AGROPECU BRAS, V22, P129; Cornelissen T, 2006, ECOL ENTOMOL, V31, P32, DOI 10.1111/j.0307-6946.2006.00752.x; Cunningham JP, 2012, J EVOLUTION BIOL, V25, P244, DOI 10.1111/j.1420-9101.2011.02435.x; Galdino TVD, 2011, CIENC AGROTEC, V35, P869, DOI 10.1590/S1413-70542011000500002; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Ellis JD, 2004, ENVIRON ENTOMOL, V33, P794, DOI 10.1603/0046-225X-33.4.794; Faraji F, 2002, ECOL ENTOMOL, V27, P660, DOI 10.1046/j.1365-2311.2002.00456.x; Friedman M, 2004, J CHROMATOGR A, V1054, P143, DOI 10.1016/j.chroma.2004.04.049; Gary C, 1998, J EXP BOT, V49, P49, DOI 10.1093/jexbot/49.318.49; Gontijo PC, 2013, ANN APPL BIOL, V162, P50, DOI 10.1111/aab.12000; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Hou BH, 2006, APPL ENTOMOL ZOOL, V41, P515, DOI 10.1303/aez.2006.515; Hoy CW, 1998, ANNU REV ENTOMOL, V43, P571, DOI 10.1146/annurev.ento.43.1.571; Hulthen AD, 2006, AUST J ENTOMOL, V45, P16, DOI 10.1111/j.1440-6055.2006.00518.x; Irvin NA, 2004, FLA ENTOMOL, V87, P504, DOI 10.1653/0015-4040(2004)087[0504:OPOHCF]2.0.CO;2; Johnson MTJ, 2011, FUNCT ECOL, V25, P305, DOI 10.1111/j.1365-2435.2011.01838.x; Johnson SN, 2006, ECOL ENTOMOL, V31, P395, DOI 10.1111/j.1365-2311.2006.00776.x; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Kloth KJ, 2012, TRENDS PLANT SCI, V17, P311, DOI 10.1016/j.tplants.2012.01.002; Knolhoff LM, 2014, ANNU REV ENTOMOL, V59, P263, DOI 10.1146/annurev-ento-011613-161945; Kozukue N, 2004, J AGR FOOD CHEM, V52, P2079, DOI 10.1021/jf0306845; Leite G. L. D., 1998, Manejo Integrado de Plagas, V49, P26; Leite GLD, 2001, SCI HORTIC-AMSTERDAM, V89, P103, DOI 10.1016/S0304-4238(00)00224-7; Li YX, 2015, INSECT SCI, V22, P273, DOI 10.1111/1744-7917.12104; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu TX, 2002, J ECON ENTOMOL, V95, P360, DOI 10.1603/0022-0493-95.2.360; Maluf WR, 2010, EUPHYTICA, V176, P113, DOI 10.1007/s10681-010-0234-8; Miranda Moacyr Mascarenhas Motta, 2005, Cienc. Rural, V35, P204, DOI 10.1590/S0103-84782005000100033; Miranda MMM, 1998, BIOCONTROL SCI TECHN, V8, P597, DOI 10.1080/09583159830117; Pereira EJG, 2007, BIOCONTROL SCI TECHN, V17, P441, DOI 10.1080/09583150701309337; Picanco MC, 2007, AGR FOREST ENTOMOL, V9, P327, DOI 10.1111/j.1461-9563.2007.00346.x; Rajapakse CNK, 2006, PHYSIOL ENTOMOL, V31, P270, DOI 10.1111/j.1365-3032.2006.00517.x; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; Robert CAM, 2012, ECOL LETT, V15, P55, DOI 10.1111/j.1461-0248.2011.01708.x; Scriber JM, 2002, ENTOMOL EXP APPL, V104, P217, DOI 10.1023/A:1021292604205; SCRIBER JM, 1979, ECOLOGY, V60, P829, DOI 10.2307/1936618; Silva DJH., 2007, TOMATE TECNOLOGIA PR, P7; Silva GA, 2011, PEST MANAG SCI, V67, P913, DOI 10.1002/ps.2131; Slansky F. Jr, 1985, P87; Southwood TRE, 2000, ECOLOGICAL METHODS M; Stadler E, 2009, PHYTOCHEM REV, V8, P207, DOI 10.1007/s11101-008-9108-2; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Wang D, 2009, PEST MANAG SCI, V65, P223, DOI 10.1002/ps.1672; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220; [No title captured]	52	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143389	10.1371/journal.pone.0143389	http://dx.doi.org/10.1371/journal.pone.0143389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600074	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900104
J	Koh, MJ; Kim, W; Kang, JI; Namkoong, K; Kim, SJ				Koh, Min Jung; Kim, Wonji; Kang, Jee In; Namkoong, Kee; Kim, Se Joo			Lack of Association between Oxytocin Receptor (OXTR) Gene Polymorphisms and Alexithymia: Evidence from Patients with Obsessive-Compulsive Disorder	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; BEHAVIOR; VASOPRESSIN; POPULATION; EMOTION; EMPATHY; SCALE; VULNERABILITY; ADOLESCENTS; DEPRESSION	Oxytocin receptor gene single nucleotide polymorphisms have been associated with structural and functional alterations in brain regions, which involve social-emotional processing. Therefore, oxytocin receptor gene polymorphisms may contribute to individual differences in alexithymia, which is considered to be a dysfunction of emotional processing. The aim of this study was to evaluate the association between oxytocin receptor gene single nucleotide polymorphisms or haplotypes and alexithymia in patients with obsessive-compulsive disorder. We recruited 355 patients with obsessive-compulsive disorder (234 men, 121 women). Alexithymia was measured by using the Toronto Alexithymia Scale. We performed single-marker and haplotype association analyses with eight single nucleotide polymorphisms (rs237885, rs237887, rs2268490, rs4686301, rs2254298, rs13316193, rs53576, and rs2268498) in the oxytocin receptor gene. There were no significant associations between any of the eight single nucleotide polymorphism of the oxytocin receptor gene and alexithymia. In addition, a six-locus haplotype block (rs237885-rs237887-rs2268490-rs4686301-rs2254298-rs13316193) was not significantly associated with alexithymia. These findings suggest that genetic variations in the oxytocin receptor gene may not explain a significant part of alexithymia in patients with obsessive-compulsive disorder.	[Koh, Min Jung] Bundang Jesaeng Hosp, Dept Psychiat, Seongnam Gyeonggi, South Korea; [Koh, Min Jung] Yonsei Univ, Grad Sch, Dept Psychiat, Seoul 120749, South Korea; [Kim, Wonji] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Kang, Jee In; Namkoong, Kee; Kim, Se Joo] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kang, Jee In; Namkoong, Kee; Kim, Se Joo] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea	Yonsei University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea.	kimsejoo@yuhs.ac		NAMKOONG, KEE/0000-0003-1400-8057; kang, jee in/0000-0002-2818-7183; KIM, SE JOO/0000-0002-5438-8210	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0022363]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by a grant (to S. J. Kim) from the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0022363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bakermans-Kranenburg MJ, 2014, PSYCHIAT GENET, V24, P45, DOI 10.1097/YPG.0b013e3283643684; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Berthoz S, 2005, EUR PSYCHIAT, V20, P291, DOI 10.1016/j.eurpsy.2004.06.013; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; Brune M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-38; Cochran DM, 2013, HARVARD REV PSYCHIAT, V21, P219, DOI 10.1097/HRP.0b013e3182a75b7d; Constantinou E, 2014, BIOL PSYCHOL, V103, P212, DOI 10.1016/j.biopsycho.2014.09.011; De Berardis D, 2005, EUR ARCH PSY CLIN N, V255, P350, DOI 10.1007/s00406-005-0573-y; Domes G, 2007, BIOL PSYCHIAT, V62, P1187, DOI 10.1016/j.biopsych.2007.03.025; FeldmanHall O, 2013, CORTEX, V49, P899, DOI 10.1016/j.cortex.2012.10.015; First M.B., 2014, STRUCTURED CLIN INTE; Goodman W, 1991, VERHALTENSTHERAPIE, V1, P226; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Haviland MG, 2004, J PERS ASSESS, V82, P306, DOI 10.1207/s15327752jpa8203_06; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Jorgensen MM, 2007, PSYCHOTHER PSYCHOSOM, V76, P369, DOI 10.1159/000107565; Kang JI, 2012, J AFFECT DISORDERS, V141, P286, DOI 10.1016/j.jad.2012.04.001; Kano M, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-1; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Kogan A, 2011, P NATL ACAD SCI USA, V108, P19189, DOI 10.1073/pnas.1112658108; Krueger F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00004; Kumsta R, 2013, CURR OPIN NEUROBIOL, V23, P11, DOI 10.1016/j.conb.2012.09.004; Lane A, 2013, INT J PSYCHOL, V48, P676, DOI 10.1080/00207594.2012.677540; Laursen HR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00423; Lee JK, 2003, J HUM GENET, V48, P213, DOI 10.1007/s10038-003-0011-9; LEE YH, 1996, J KOREAN NEUROPSYCHI, V35, P888; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; Liu XX, 2010, J HUM GENET, V55, P137, DOI 10.1038/jhg.2009.140; LoParo D, 2015, MOL PSYCHIATR, V20, P640, DOI 10.1038/mp.2014.77; Luminet O, 2011, BIOL PSYCHOL, V87, P401, DOI 10.1016/j.biopsycho.2011.05.005; McQuaid RJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00128; Melchers M, 2013, BEHAV NEUROSCI, V127, P780, DOI 10.1037/a0033748; Montag C, 2011, BIOL PSYCHIAT, V69, P601, DOI 10.1016/j.biopsych.2010.10.026; Montag C, 2013, WORLD J BIOL PSYCHIA, V14, P500, DOI 10.3109/15622975.2012.677547; Montag C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051882; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Nyffeler Johanna, 2014, J Mol Psychiatry, V2, P1, DOI 10.1186/2049-9256-2-1; Park J, 2010, PROG NEURO-PSYCHOPH, V34, P697, DOI 10.1016/j.pnpbp.2010.03.029; Picardi A, 2011, J PSYCHOSOM RES, V71, P256, DOI 10.1016/j.jpsychores.2011.02.016; Poulin MJ, 2012, PSYCHOL SCI, V23, P446, DOI 10.1177/0956797611428471; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Roh D, 2011, J NERV MENT DIS, V199, P690, DOI 10.1097/NMD.0b013e318229d209; Rushton JP, 2004, P ROY SOC B-BIOL SCI, V271, P2583, DOI 10.1098/rspb.2004.2941; RUSHTON JP, 1984, ACTA GENET MED GEMEL, V33, P265, DOI 10.1017/S0001566000007315; Samur D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00861; Sayar K, 2001, ISRAEL J PSYCHIAT, V38, P81; Seo SS, 2009, PSYCHIAT INVEST, V6, P173, DOI 10.4306/pi.2009.6.3.173; Tansey KE, 2010, NEUROSCI LETT, V474, P163, DOI 10.1016/j.neulet.2010.03.035; Taylor GJ, 2000, CAN J PSYCHIAT, V45, P134, DOI 10.1177/070674370004500203; Taylor GJ, 1997, DISORDERS AFFECT REG, Vxxii; Tost H, 2011, BIOL PSYCHIAT, V70, pE37, DOI 10.1016/j.biopsych.2011.06.034; Uzefovsky F, 2015, HORM BEHAV, V67, P60, DOI 10.1016/j.yhbeh.2014.11.007; van der Velde J, 2013, NEUROSCI BIOBEHAV R, V37, P1774, DOI 10.1016/j.neubiorev.2013.07.008; Wermter AK, 2010, AM J MED GENET B, V153B, P629, DOI 10.1002/ajmg.b.31032; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013	61	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143168	10.1371/journal.pone.0143168	http://dx.doi.org/10.1371/journal.pone.0143168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599592	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900071
J	Lu, L; Guo, J; Li, SF; Li, A; Zhang, LY; Liu, ZH; Luo, XG				Lu, Lin; Guo, Jiang; Li, Sufen; Li, Ang; Zhang, Liyang; Liu, Zhenhua; Luo, Xugang			Influence of Phytase Transgenic Corn on the Intestinal Microflora and the Fate of Transgenic DNA and Protein in Digesta and Tissues of Broilers	PLOS ONE			English	Article							ENDOGENOUS PLANT DNA; LAYING HENS; GASTROINTESTINAL-TRACT; POLYACRYLAMIDE-GELS; FEED; GENE; SUPPLEMENTATION; AVAILABILITY; DEGRADATION; PERFORMANCE	An experiment was conducted to investigate the effect of phytase transgenic corn (PTC) on intestinal microflora, and the fate of transgenic DNA and protein in the digesta and tissues of broilers. A total of 160 1-day-old Arbor Acres commercial male broilers were randomly assigned to 20 cages (8 chicks per cage) with 10 cages (replicates) for each treatment. Birds were fed with a diet containing either PTC (54.0% during 1-21 days and 61.0% during 22-42 days) or non-transgenic isogenic control corn (CC) for a duration of 42 days. There were no significant differences (P>0.05) between birds fed with the PTC diets and those fed with the CC diets in the quantities of aerobic bacteria, anaerobic bacteria, colibacillus and lactobacilli, or microbial diversities in the contents of ileum and cecum. Transgenic phyA2 DNA was not detected, but phyA2 protein was detected in the digesta of duodenum and jejunum of broilers fed with the PTC diets. Both transgenic phyA2 DNA and protein fragments were not found in the digesta of the ileum and rectum, heart, liver, kidney, and breast or thigh muscles of broilers fed with the PTC diets. It was concluded that PTC had no adverse effect on the quantity and diversity of gut microorganisms; Transgenic phyA2 DNA or protein was rapidly degraded in the intestinal tract and was not transferred to the tissues of broilers.	[Lu, Lin; Guo, Jiang; Zhang, Liyang; Luo, Xugang] Chinese Acad Agr Sci, Inst Anim Sci, Mineral Nutr Res Div, Beijing 100193, Peoples R China; [Guo, Jiang; Li, Ang] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Peoples R China; [Li, Sufen] Hebei Normal Univ Sci & Technol, Dept Anim Sci, Qinhuangdao, Peoples R China; [Liu, Zhenhua] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Nutr, Amherst, MA 01003 USA	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Fujian Agriculture & Forestry University; Hebei Normal University of Science & Technology; University of Massachusetts System; University of Massachusetts Amherst	Luo, XG (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Mineral Nutr Res Div, Beijing 100193, Peoples R China.	wlysz@263.net			Genetically Modified Organisms Breeding Major Projects (Beijing, P. R. China) [2009ZX08011-005B]; Agricultural Science and Technology Innovation Program (Beijing, P. R. China) [ASTIP-IAS08]; China Agriculture Research System (Beijing, P. R. China) [CARS-42]	Genetically Modified Organisms Breeding Major Projects (Beijing, P. R. China); Agricultural Science and Technology Innovation Program (Beijing, P. R. China); China Agriculture Research System (Beijing, P. R. China)	This work was supported by the Genetically Modified Organisms Breeding Major Projects (project No. 2009ZX08011-005B; Beijing, P. R. China), the Agricultural Science and Technology Innovation Program (ASTIP-IAS08; Beijing, P. R. China), and China Agriculture Research System (project No. CARS-42; Beijing, P. R. China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson PH, 1999, SCIENCE, V283, P2015, DOI 10.1126/science.283.5410.2015; Ash J, 2003, J APPL POULTRY RES, V12, P242, DOI 10.1093/japr/12.2.242; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bassam BJ, 2007, NAT PROTOC, V2, P2649, DOI 10.1038/nprot.2007.330; Bertoni G, 2005, VET RES COMMUN, V29, P13, DOI 10.1007/s11259-005-0004-6; Chambers PA, 2002, J ANTIMICROB CHEMOTH, V49, P161, DOI 10.1093/jac/49.1.161; Chen RM, 2008, TRANSGENIC RES, V17, P633, DOI 10.1007/s11248-007-9138-3; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; Chrastinova L, 2002, P SOC NUTR PHYSL, V11, P195; Denbow DM, 1998, POULTRY SCI, V77, P878, DOI 10.1093/ps/77.6.878; Du H, 2006, AGR SCI; Engelen AJ, 2001, J AOAC INT, V84, P629; Gao CQ, 2013, POULTRY SCI, V92, P2923, DOI 10.3382/ps.2013-03226; Gao CQ, 2012, POULTRY SCI, V91, P1142, DOI 10.3382/ps.2011-01915; Gaskins HR, 1997, GASTROINTESTINAL MIC, V2; Guertler P, 2010, LIVEST SCI, V131, P250, DOI 10.1016/j.livsci.2010.04.010; Jennings JC, 2003, J ANIM SCI, V81, P1447; Jennings JC, 2003, POULTRY SCI, V82, P371, DOI 10.1093/ps/82.3.371; Leske KL, 1999, POULTRY SCI, V78, P1151, DOI 10.1093/ps/78.8.1151; Li SF, 2013, J ANIM SCI, V91, P298, DOI 10.2527/jas.2012-5211; Liu J., 2012, AM J MOL BIOL, V2, P217; Lu L, 2013, ANIM PROD SCI, V53, P142, DOI 10.1071/AN12123; Lu L, 2010, BIOL TRACE ELEM RES, V138, P181, DOI 10.1007/s12011-010-8623-3; Ma QG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061138; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; National Research Council, 1994, NUTR REQ POULTR; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Netherwood T, 2004, NAT BIOTECHNOL, V22, P204, DOI 10.1038/nbt934; Nyannor EKD, 2009, POULTRY SCI, V88, P1413, DOI 10.3382/ps.2009-00003; Onyango EM, 2005, POULTRY SCI, V84, P248, DOI 10.1093/ps/84.2.248; PEELER HT, 1972, J ANIM SCI, V35, P695; REDDY NR, 1982, ADV FOOD RES, V28, P1; Reid CA, 1999, ANIM SCI, V68, P503, DOI 10.1017/S1357729800050529; Sanden M, 2004, AQUACULTURE, V237, P391, DOI 10.1016/j.aquaculture.2004.04.004; SAVORY CJ, 1992, BRIT J NUTR, V67, P91, DOI 10.1079/BJN19920011; Schubbert R, 1997, P NATL ACAD SCI USA, V94, P961, DOI 10.1073/pnas.94.3.961; Scott M. L., 1982, NUTR CHICKEN, V3rd; Tony MA, 2003, ARCH ANIM NUTR, V57, P235, DOI 10.1080/00039420310001594397; Walsh MC, 2013, BRIT J NUTR, V109, P873, DOI 10.1017/S0007114512002607; Xu ZR, 2003, POULTRY SCI, V82, P1030, DOI 10.1093/ps/82.6.1030; Zhang ZB, 2000, J ANIM SCI, V78, P2868; [赵康宁 Zhao Kangning], 2012, [南京农业大学学报, Journal of Nanjing Agricultural University], V35, P118	43	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143408	10.1371/journal.pone.0143408	http://dx.doi.org/10.1371/journal.pone.0143408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599444	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900112
J	Preussel, K; Milde-Busch, A; Schmich, P; Wetzstein, M; Stark, K; Werber, D				Preussel, Karina; Milde-Busch, Astrid; Schmich, Patrick; Wetzstein, Matthias; Stark, Klaus; Werber, Dirk			Risk Factors for Sporadic Non-Pregnancy Associated Listeriosis in Germany-Immunocompromised Patients and Frequently Consumed Ready-To-Eat Products	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; MONOCYTOGENES INFECTION; SOCIOECONOMIC-STATUS; PASTEURIZED MILK; UNITED-STATES; FOOD; CHEESE; OUTBREAK; SUSCEPTIBILITY; CONTAMINATION	Non-pregnancy associated (N-PA) listeriosis, caused by Listeria monocytogenes, is a rare but severe disease, and is predominantly food-borne. Most cases appear sporadic and their infection vehicle remains unknown. Incidence has increased since 2008 in Germany. We aimed to identify underlying conditions and foods associated with sporadic N-PA listeriosis in Germany. We performed a nationwide case-control study from March 2012-December 2013. Cases were sporadic N-PA listeriosis patients notified to public health. Control subjects were age (40-65 years, 66-75 years, >= 76 years) frequency-matched persons from a nationwide random telephone sample. A structured questionnaire collected information on underlying diseases, therapies and > 60 food items. We conducted multivariable logistic regression analysis, adjusting for host factors identified by causal diagram theory, and calculated population attributable fractions. We enrolled 109 cases and 1982 controls. Cases' median age was 69 years, 55% were male, 44% received immunosuppressive therapy within 3 months prior to illness onset; a further 28% had at least one immunocompromising disease. In multivariable analysis, immunosuppressive therapy (OR 8.8, 95%CI 4.9-15.6), immunocompromising disease (OR 2.7; 95% CI 1.4-5.2), gastric acid suppression (OR 3.0; 95%CI 1.4-6.3), the consumption of cold cooked sausages (OR 2.6; 95% CI 1.6-4.4), the preferred consumption of packaged cheese (OR 2.1; 95%CI 1.3-3.5) and pre-sliced cheese (OR 2.2; 95%CI 1.3-3.7) were significantly associated with N-PA listeriosis. These foods accounted for 59% of all cases. Typical high risk foods, e.g. cold seafood, certain types of cheeses, tended to be negatively associated with disease. In conclusion, immunosuppressive therapy and frequently consumed ready-to-eat foods are the main risk factors for sporadic N-PA listeriosis in Germany. To reduce their risk, immunocompromised persons should consume the identified foods well before the `use-by' date. The microbiological criteria for Listeria monocytogenes in ready-to-eat foods may insufficiently protect persons who are markedly immunocompromised.	[Preussel, Karina; Milde-Busch, Astrid; Stark, Klaus; Werber, Dirk] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Schmich, Patrick; Wetzstein, Matthias] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Preussel, K (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	preusselk@rki.de	Werber, Dirk/L-2264-2019	Werber, Dirk/0000-0002-8076-788X				Ahrens D, 2012, INT J CLIN PRACT, V66, P767, DOI 10.1111/j.1742-1241.2012.02973.x; [Anonymous], 2013, MILCH MARKETING, P16; Bavarian Consumer Organisation, 2013, MARK CHECK UP SELF L; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; BOHNSACK JF, 1986, ANNU REV MED, V37, P49, DOI 10.1146/annurev.me.37.020186.000405; Cartwright EJ, 2013, EMERG INFECT DIS, V19, P1, DOI [10.3201/eid1901.120393, 10.3201/eid1908.121511]; Dalton CB, 2011, EPIDEMIOL INFECT, V139, P437, DOI 10.1017/S0950268810000944; DEMARIE S, 1993, EUR J CLIN MICROBIOL, V12, P36; FDA/FSIS (U.S. Food and Drug Administration/Food Safety and Inspection Service), 2003, QUANT ASS REL RISK P; Friesema IH, 2015, EURO SURVEILL, V20; Fuchs J, 2012, BUNDESGESUNDHEITSBLA, V55, P576, DOI 10.1007/s00103-012-1464-9; Gan YH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003794; Gillespie IA, 2010, FOODBORNE PATHOG DIS, V7, P1373, DOI 10.1089/fpd.2010.0568; GLASS KA, 1989, APPL ENVIRON MICROB, V55, P1565, DOI 10.1128/AEM.55.6.1565-1569.1989; Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013; Gould LH, 2014, FOODBORNE PATHOG DIS, V11, P545, DOI 10.1089/fpd.2013.1650; Goulet V, 1996, SCAND J INFECT DIS, V28, P367, DOI 10.3109/00365549609037921; Goulet V, 2012, CLIN INFECT DIS, V54, P652, DOI 10.1093/cid/cir902; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hader S., 1998, TELEFONSTICHPROBEN D, P69, DOI [DOI 10.1007/978-3-322-83334-1_6, 10.1007/978-3-322-83334-1_6]; Hartung M, 2012, ZOONOTIC PATHOGENS G; HO JL, 1986, ARCH INTERN MED, V146, P520, DOI 10.1001/archinte.146.3.520; Hoffmann F, 2015, Z GASTROENTEROL, V53, P95, DOI 10.1055/s-0034-1384973; Hulshof KFAM, 2003, EUR J CLIN NUTR, V57, P128, DOI 10.1038/sj.ejcn.1601503; JENSEN A, 1994, SCAND J INFECT DIS, V26, P171, DOI 10.3109/00365549409011781; Johansson T, 1999, INT J FOOD MICROBIOL, V47, P111, DOI 10.1016/S0168-1605(99)00019-7; Jungjohann SM, 2005, BRIT J NUTR, V93, P361, DOI 10.1079/BJN20041333; Koch J, 2010, FOODBORNE PATHOG DIS, V7, P1581, DOI 10.1089/fpd.2010.0631; Koscielska-Kasprzak K, 2014, ARCH IMMUNOL THER EX, V62, P47, DOI 10.1007/s00005-013-0254-x; Kousta M, 2010, FOOD CONTROL, V21, P805, DOI 10.1016/j.foodcont.2009.11.015; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P814, DOI 10.1007/s00103-013-1695-4; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P131, DOI 10.1007/s00103-012-1583-3; Little CL, 2008, FOOD MICROBIOL, V25, P304, DOI 10.1016/j.fm.2007.10.007; Max Rubner Institute, 2008, NAT FOOD CONS SURV 2; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miettinen MK, 1999, J CLIN MICROBIOL, V37, P2358, DOI 10.1128/JCM.37.7.2358-2360.1999; Mook P, 2013, EPIDEMIOL INFECT, V141, P36, DOI 10.1017/S095026881200026X; Mook P, 2011, EMERG INFECT DIS, V17, P38, DOI 10.3201/eid1701.101174; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Nocon M, 2006, ALIMENT PHARM THER, V23, P1601, DOI 10.1111/j.1365-2036.2006.02924.x; Norton DM, 2001, APPL ENVIRON MICROB, V67, P646, DOI 10.1128/AEM.67.2.646-653.2001; Pal A, 2009, J FOOD PROTECT, V72, P1878, DOI 10.4315/0362-028X-72.9.1878; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pouillot R, 2012, CLIN INFECT DIS, V54, pS405, DOI 10.1093/cid/cis269; Roche SM, 2003, INFECT IMMUN, V71, P3429, DOI 10.1128/IAI.71.6.3429-3436.2003; SCHLECH WF, 1993, INT J FOOD MICROBIOL, V18, P15, DOI 10.1016/0168-1605(93)90003-Y; Sheen S, 2008, FOODBORNE PATHOG DIS, V5, P135, DOI 10.1089/fpd.2007.0049; Sheth K, 2001, Curr Opin Crit Care, V7, P99, DOI 10.1097/00075198-200104000-00008; Silk BJ, 2013, MMWR-MORBID MORTAL W, V62, P448, DOI 10.1016/j.annemergmed.2013.08.006; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Van Boxel OS, 2009, ALIMENT PHARM THER, V29, P571, DOI 10.1111/j.1365-2036.2008.03900.x; Varma JK, 2007, CLIN INFECT DIS, V44, P521, DOI 10.1086/509920; Voigt LF, 2003, AM J EPIDEMIOL, V157, P66, DOI 10.1093/aje/kwf185; WALKER SJ, 1990, J APPL BACTERIOL, V68, P157, DOI 10.1111/j.1365-2672.1990.tb02561.x; Wallace FM, 2003, J FOOD PROTECT, V66, P584, DOI 10.4315/0362-028X-66.4.584; WENGER JD, 1990, J FOOD PROTECT, V53, P1015, DOI 10.4315/0362-028X-53.12.1015; Werber D, 2013, EPIDEMIOL INFECT, V141, P961, DOI 10.1017/S0950268812001550; Whitley E, 2000, J APPL MICROBIOL, V88, P52, DOI 10.1046/j.1365-2672.2000.00859.x; Yde M, 2012, EURO SURVEILL, V17; Yeretssian G, 2009, P NATL ACAD SCI USA, V106, P9016, DOI 10.1073/pnas.0813362106	61	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142986	10.1371/journal.pone.0142986	http://dx.doi.org/10.1371/journal.pone.0142986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599484	Green Published, gold			2022-12-27	WOS:000365853900052
J	Alves, CH; Ober-Blobaum, JL; Brouwers-Haspels, I; Asmawidjaja, PS; Mus, AMC; Razawy, W; Molendijk, M; Clausen, BE; Lubberts, E				Alves, C. Henrique; Ober-Blobaum, Julia L.; Brouwers-Haspels, Inge; Asmawidjaja, Patrick S.; Mus, Adriana M. C.; Razawy, Wida; Molendijk, Marlieke; Clausen, Bjorn E.; Lubberts, Erik			Dendritic Cell-Specific Deletion of beta-Catenin Results in Fewer Regulatory T-Cells without Exacerbating Autoimmune Collagen-Induced Arthritis	PLOS ONE			English	Article							BONE EROSION; RESPONSES; ACTIVATION; EXPRESSION; INDUCTION; IMMUNE; JOINT; WNT; OSTEOCLASTOGENESIS; INFLAMMATION	Dendritic cells (DCs) are professional antigen presenting cells that have the dual ability to stimulate immunity and maintain tolerance. However, the signalling pathways mediating tolerogenic DC function in vivo remain largely unknown. The beta-catenin pathway has been suggested to promote a regulatory DC phenotype. The aim of this study was to unravel the role of beta-catenin signalling to control DC function in the autoimmune collagen-induced arthritis model (CIA). Deletion of beta-catenin specifically in DCs was achieved by crossing conditional knockout mice with a CD11c-Cre transgenic mouse line. Bone marrow-derived DCs (BMDCs) were generated and used to study the maturation profile of these cells in response to a TLR2 or TLR4 ligand stimulation. CIA was induced by intra-dermal immunization with 100 mu g chicken type II collagen in complete Freund's adjuvant on days 0 and 21. CIA incidence and severity was monitored macroscopically and by histology. The T cell profile as well as their cytokine production were analysed by flow cytometry. Lack of beta-catenin specifically in DCs did not affect the spontaneous, TLR2- or TLR4-induced maturation and activation of BMDCs or their cytokine production. Moreover, no effect on the incidence and severity of CIA was observed in mice lacking beta-catenin in CD11c(+) cells. A decreased frequency of splenic CD3(+) CD8(+) T cells and of regulatory T cells (Tregs) (CD4(+)CD25(high)FoxP3(+)), but no changes in the frequency of splenic Th17 (CCR6(+)CXCR3(-)CCR4(+)), Th2 (CCR6(-)CXCR3(-)CCR4(+)) and Th1 (CCR6(-)CXCR3(+)CCR4(-)) cells were observed in these mice under CIA condition. Furthermore, the expression of IL-17A, IL-17F, IL-22, IL-4 or IFN gamma was also not affected. Our data indicate that ablation of beta-catenin expression in DCs did not alter the course and severity of CIA. We conclude that although deletion of beta-catenin resulted in a lower frequency of Tregs, this decrease was not sufficient to aggravate the onset and severity of CIA.	[Alves, C. Henrique; Brouwers-Haspels, Inge; Asmawidjaja, Patrick S.; Mus, Adriana M. C.; Razawy, Wida; Molendijk, Marlieke; Lubberts, Erik] Erasmus MC, Univ Med Ctr, Dept Rheumatol, Rotterdam, Netherlands; [Alves, C. Henrique; Brouwers-Haspels, Inge; Asmawidjaja, Patrick S.; Mus, Adriana M. C.; Razawy, Wida; Molendijk, Marlieke; Clausen, Bjorn E.; Lubberts, Erik] Erasmus MC, Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands; [Ober-Blobaum, Julia L.; Clausen, Bjorn E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Johannes Gutenberg University of Mainz	Clausen, BE (corresponding author), Erasmus MC, Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands.	bclausen@uni-mainz.de; e.lubberts@erasmusmc.nl	CLAUSEN, Björn Erik/A-8229-2010; Lubberts, Erik/AAI-4657-2020; Alves, Henrique/AAH-3017-2019	CLAUSEN, Björn Erik/0000-0002-2484-7842; Alves, Henrique/0000-0001-9776-5701	Dutch Arthritis Association (Reumafonds) [11-1-306]	Dutch Arthritis Association (Reumafonds)	Funding: This work was supported by a grant from the Dutch Arthritis Association (Reumafonds, no. 11-1-306) to BEC and EL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini A, 2011, CELL IMMUNOL, V270, P114, DOI 10.1016/j.cellimm.2011.04.007; Brault V, 2001, DEVELOPMENT, V128, P1253; Campbell IK, 2000, EUR J IMMUNOL, V30, P1568, DOI 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Corneth OBJ, 2014, ARTHRITIS RHEUMATOL, V66, P340, DOI 10.1002/art.38229; Cosmi L, 2014, CYTOM PART A, V85A, P36, DOI 10.1002/cyto.a.22348; Fu CM, 2010, IMMUNOL RES, V46, P72, DOI 10.1007/s12026-009-8126-5; Hong Y, 2015, CANCER RES, V75, P656, DOI 10.1158/0008-5472.CAN-14-2377; Isaacs JD, 2010, NAT REV IMMUNOL, V10, P605, DOI 10.1038/nri2804; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kelchtermans H, 2005, ARTHRITIS RES THER, V7, pR402, DOI 10.1186/ar1500; Kong N, 2012, ANN RHEUM DIS, V71, P1567, DOI 10.1136/annrheumdis-2011-201052; Leung BP, 2002, J IMMUNOL, V169, P7071, DOI 10.4049/jimmunol.169.12.7071; Liang XJ, 2014, J LEUKOCYTE BIOL, V95, P179, DOI 10.1189/jlb.0613330; Lim DS, 2009, EUR J IMMUNOL, V39, P1334, DOI 10.1002/eji.200838987; Liu Y, 2014, CLIN REV ALLERG IMMU, V47, P136, DOI 10.1007/s12016-013-8402-y; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Manoharan I, 2014, J IMMUNOL, V193, P4203, DOI 10.4049/jimmunol.1400614; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mellman I, 2010, SCIENCE, V329, P767, DOI 10.1126/science.1194185; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Nakamura Y, 2005, AM J PATHOL, V167, P97, DOI 10.1016/S0002-9440(10)62957-4; O'Garra A, 1998, CURR BIOL, V8, pR646, DOI 10.1016/S0960-9822(07)00413-7; Pan M, 2004, J CLIN IMMUNOL, V24, P481, DOI 10.1023/B:JOCI.0000040919.16739.44; Ren YN, 2014, INT IMMUNOPHARMACOL, V21, P247, DOI 10.1016/j.intimp.2014.05.004; Salazar L, 2008, ANN RHEUM DIS, V67, P1235, DOI 10.1136/ard.2007.072199; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Suryawanshi A, 2015, J IMMUNOL, V194, P3295, DOI 10.4049/jimmunol.1402691; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tanaka I, 2005, BIOCHEM BIOPH RES CO, V334, P973, DOI 10.1016/j.bbrc.2005.06.196; van Hamburg JP, 2009, ARTHRITIS RHEUM-US, V60, P750, DOI 10.1002/art.24329; VANDERLUGT B, 2011, PLOS ONE, V0006; Yago T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2297	38	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142972	10.1371/journal.pone.0142972	http://dx.doi.org/10.1371/journal.pone.0142972			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587585	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500027
J	Fritsch, M; Schmidt, N; Groticke, I; Frisk, AL; Keator, CS; Koch, M; Slayden, OD				Fritsch, Martin; Schmidt, Nicole; Groeticke, Ina; Frisk, Anna-Lena; Keator, Christopher S.; Koch, Markus; Slayden, Ov D.			Application of a Patient Derived Xenograft Model for Predicative Study of Uterine Fibroid Disease	PLOS ONE			English	Article							MENSTRUAL-CYCLE; REPRODUCTIVE-TRACT; LEIOMYOMAS; PROGESTERONE; EXPRESSION; GROWTH; ESTROGEN; GENE; RECEPTORS; PROLIFERATION	Human uterine fibroids, benign tumors derived from the smooth muscle layers of the uterus, impose a major health burden to up to 50% of premenopausal women in their daily life. To improve our understanding of this disease, we developed and characterized a patient-derived xenograft model by subcutaneous transplantation of pieces of human uterine fibroid tissue into three different strains of severe combined immunodeficient mice. Engrafted uterine fibroid tissue preserved the classical morphology with interwoven bundles of smooth muscle cells and an abundant deposition of collagenous matrix, similar to uterine fibroids in situ. The grafts expressed both estrogen receptor 1 and progesterone receptor. Additionally, both receptors were up-regulated by estrogen treatment. Growth of the fibroid grafts was dependent on 17 beta-estradiol and progesterone supplementation at levels similar to women with the disease and was studied for up to 60 days at maximum. Co-treatment with the antiprogestin mifepristone reduced graft growth (four independent donors, p<0.0001 two-sided t-test), as did treatment with the mTOR inhibitor rapamycin (three independent donors, p<0.0001 two-sided t-test). This in vivo animal model preserves the main histological and functional characteristics of human uterine fibroids, is amenable to intervention by pharmacological treatment, and can thus serve as an adequate model for the development of novel therapies.	[Fritsch, Martin; Schmidt, Nicole; Groeticke, Ina; Frisk, Anna-Lena; Koch, Markus] Bayer Pharma AG, Global Drug Discovery, Berlin, Germany; [Keator, Christopher S.; Slayden, Ov D.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	Bayer AG; Bayer Healthcare Pharmaceuticals; Oregon Health & Science University; Oregon National Primate Research Center	Fritsch, M (corresponding author), Bayer Pharma AG, Global Drug Discovery, Berlin, Germany.	martin.fritsch@bayer.com			Bayer Pharma AG; Oregon Science and Health University Primate Center [P51OD011092]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Bayer Pharma AG; Oregon Science and Health University Primate Center; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was supported by Bayer Pharma AG. The funder provided support in the form of salaries for the authors (MF, NS, IG, ALF and MK) at the time this work was conducted. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ODS and CSK were supported by a core grant of the Oregon Science and Health University Primate Center (Grant number P51OD011092). The specific role of each author is articulated in the "authors contributions" section.	Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Baird DD, 2011, FERTIL STERIL, V95, P242, DOI 10.1016/j.fertnstert.2010.05.011; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Borkowska J, 2011, INT J DERMATOL, V50, P13, DOI 10.1111/j.1365-4632.2010.04727.x; Brosens I, 1998, FERTIL STERIL, V69, P232, DOI 10.1016/S0015-0282(97)00472-X; Cai SL, 2003, AM J PATHOL, V162, P457, DOI 10.1016/S0002-9440(10)63840-0; Cai YR, 2007, INT J ONCOL, V31, P1379; Cardozo ER, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2011.12.002, 10.1016/j.ajog.2012.08.020]; Chu PG, 2001, MODERN PATHOL, V14, P465, DOI 10.1038/modpathol.3880335; Crabtree JS, 2009, CANCER RES, V69, P6171, DOI 10.1158/0008-5472.CAN-08-4471; CRAMER SF, 1985, OBSTET GYNECOL, V66, P36; Downes E, 2010, EUR J OBSTET GYN R B, V152, P96, DOI 10.1016/j.ejogrb.2010.05.012; EVERITT JI, 1995, AM J PATHOL, V146, P1556; Gibbs LK, 2007, J AM ASSOC LAB ANIM, V46, P61; Gupta S, 2008, BEST PRACT RES CL OB, V22, P615, DOI 10.1016/j.bpobgyn.2008.01.008; Hassan MH, 2011, HUM REPROD, V26, P3008, DOI 10.1093/humrep/der280; Hassan MH, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.02.010; Hennig Y, 1999, MOL HUM REPROD, V5, P1150, DOI 10.1093/molehr/5.12.1150; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Jacobson GF, 2006, OBSTET GYNECOL, V107, P1278, DOI 10.1097/01.AOG.0000210640.86628.ff; Jacobson GF, 2007, AM J OBSTET GYNECOL, V196, P601, DOI 10.1016/j.ajog.2007.03.009; KAWAGUCHI K, 1991, VIRCHOWS ARCH A, V419, P309, DOI 10.1007/BF01606522; KAWAGUCHI K, 1989, AM J OBSTET GYNECOL, V160, P637, DOI 10.1016/S0002-9378(89)80046-8; Klemke M, 2010, CANCER GENET CYTOGEN, V196, P119, DOI 10.1016/j.cancergencyto.2009.09.021; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Lee BS, 1998, J CLIN ENDOCR METAB, V83, P219, DOI 10.1210/jc.83.1.219; Leppert PC, 2004, FERTIL STERIL, V82, P1182, DOI 10.1016/j.fertnstert.2004.04.030; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; MATSUSHITA K, 1984, UROL INT, V39, P303, DOI 10.1159/000280998; Mavrelos D, 2010, ULTRASOUND OBST GYN, V35, P238, DOI 10.1002/uog.7482; Mayer A, 2008, CANCER RES, V68, P4719, DOI 10.1158/0008-5472.CAN-07-6339; MURPHY AA, 1994, CURR OPIN OBSTET GYN, V6, P269; Peddada SD, 2008, P NATL ACAD SCI USA, V105, P19887, DOI 10.1073/pnas.0808188105; Rammeh-Rommani S, 2005, J Gynecol Obstet Biol Reprod (Paris), V34, P568; RYAN KD, 1980, ENDOCRINOLOGY, V106, P959, DOI 10.1210/endo-106-3-959; Severino MF, 1996, MOL HUM REPROD, V2, P823, DOI 10.1093/molehr/2.11.823; Shimomura Y, 1998, J CLIN ENDOCR METAB, V83, P2192, DOI 10.1210/jc.83.6.2192; Slayden OD, 2004, ARCH HISTOL CYTOL, V67, P393, DOI 10.1679/aohc.67.393; Stewart L, 2008, ARCH DERMATOL, V144, P1584, DOI 10.1001/archdermatol.2008.517; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Tsuiji K, 2010, TOHOKU J EXP MED, V222, P55, DOI 10.1620/tjem.222.55; Wagenfeld A, 2013, HUM REPROD, V28, P2253, DOI 10.1093/humrep/det247; WALMER DK, 1992, ENDOCRINOLOGY, V131, P1458, DOI 10.1210/en.131.3.1458; Watanabe K, 2006, HISTOPATHOLOGY, V48, P563, DOI 10.1111/j.1365-2559.2006.02368.x; Wu XX, 2000, ACTA OBSTET GYN SCAN, V79, P397, DOI 10.1034/j.1600-0412.2000.079005397.x; Zaitseva M, 2006, MOL HUM REPROD, V12, P187, DOI 10.1093/molehr/gal018; Zhai YL, 1999, INT J GYNECOL PATHOL, V18, P20, DOI 10.1097/00004347-199901000-00004	47	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142429	10.1371/journal.pone.0142429	http://dx.doi.org/10.1371/journal.pone.0142429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588841	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500010
J	Presutti, D; Santini, S; Cardinali, B; Papoff, G; Lalli, C; Samperna, S; Fustaino, V; Giannini, G; Ruberti, G				Presutti, Dario; Santini, Simonetta; Cardinali, Beatrice; Papoff, Giuliana; Lalli, Cristiana; Samperna, Simone; Fustaino, Valentina; Giannini, Giuseppe; Ruberti, Giovina			MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE-KINASE INHIBITORS; SMALL-MOLECULE INHIBITOR; LUNG-CANCER PATIENTS; ACQUIRED-RESISTANCE; GEFITINIB TREATMENT; SOMATIC MUTATIONS; DRUG-RESISTANCE; KRAS MUTATION; AXL KINASE	Epidermal growth factor receptor (EGFR), member of the human epidermal growth factor receptor (HER) family, plays a critical role in regulating multiple cellular processes including proliferation, differentiation, cell migration and cell survival. Deregulation of the EGFR signaling has been found to be associated with the development of a variety of human malignancies including lung, breast, and ovarian cancers, making inhibition of EGFR the most promising molecular targeted therapy developed in the past decade against cancer. Human non small cell lung cancers (NSCLC) with activating mutations in the EGFR gene frequently experience significant tumor regression when treated with EGFR tyrosine kinase inhibitors (TKIs), although acquired resistance invariably develops. Resistance to TKI treatments has been associated to secondary mutations in the EGFR gene or to activation of additional bypass signaling pathways including the ones mediated by receptor tyrosine kinases, Fas receptor and NF-kappa B. In more than 30-40% of cases, however, the mechanisms underpinning drug-resistance are still unknown. The establishment of cellular and mouse models can facilitate the unveiling of mechanisms leading to drug-resistance and the development or validation of novel therapeutic strategies aimed at overcoming resistance and enhancing outcomes in NSCLC patients. Here we describe the establishment and characterization of EGFR TKI-resistant NSCLC cell lines and a pilot study on the effects of a combined MET and EGFR inhibitors treatment. The characterization of the erlotinib-resistant cell lines confirmed the association of EGFR TKI resistance with loss of EGFR gene amplification and/or AXL overexpression and/or MET gene amplification and MET receptor activation. These cellular models can be instrumental to further investigate the signaling pathways associated to EGFR TKI-resistance. Finally the drugs combination pilot study shows that MET gene amplification and MET receptor activation are not sufficient to predict a positive response of NSCLC cells to a cocktail of MET and EGFR inhibitors and highlights the importance of identifying more reliable biomarkers to predict the efficacy of treatments in NSCLC patients resistant to EGFR TKI.	[Presutti, Dario; Santini, Simonetta; Cardinali, Beatrice; Papoff, Giuliana; Lalli, Cristiana; Samperna, Simone; Fustaino, Valentina; Ruberti, Giovina] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Giannini, Giuseppe] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Sapienza University Rome	Ruberti, G (corresponding author), CNR, Inst Cell Biol & Neurobiol, Campus Adriano Buzzati Traverso, Rome, Italy.	giovina.ruberti@cnr.it	PAPOFF, GIULIANA/AAX-9520-2020; Cardinali, Beatrice/M-8862-2015; Giannini, Giuseppe/B-5672-2013	PAPOFF, GIULIANA/0000-0003-2251-8794; Cardinali, Beatrice/0000-0002-3333-3384; Giannini, Giuseppe/0000-0003-0299-4056; FUSTAINO, VALENTINA/0000-0002-5708-8715; RUBERTI, Giovina/0000-0003-2367-9709; Presutti, Dario/0000-0002-0207-6338	Project FaReBio di Qualita; Italian Ministry of Economy and Finance; CNR Project "Personalised Medicine"	Project FaReBio di Qualita; Italian Ministry of Economy and Finance; CNR Project "Personalised Medicine"	GR was partially funded by Project FaReBio di Qualita, a grant from the Italian Ministry of Economy and Finance to the CNR and the CNR Project "Personalised Medicine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Bae SY, 2015, ONCOTARGET, V6, P10146, DOI 10.18632/oncotarget.3380; Barker AJ, 2001, BIOORG MED CHEM LETT, V11, P1911, DOI 10.1016/S0960-894X(01)00344-4; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Cappuzzo F, 2009, ANN ONCOL, V20, P298, DOI 10.1093/annonc/mdn635; Carlomagno F, 2002, CANCER RES, V62, P7284; Cerchia L, 2012, MOL THER, V20, P2291, DOI 10.1038/mt.2012.163; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chou TY, 2005, CLIN CANCER RES, V11, P3750, DOI 10.1158/1078-0432.CCR-04-1981; Choughule A, 2014, BRIT J CANCER, V111, P2203, DOI 10.1038/bjc.2014.401; Christensen JG, 2003, CANCER RES, V63, P7345; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Cui JJ, 2012, J MED CHEM, V55, P8091, DOI 10.1021/jm300967g; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Giles FJ, 2009, LEUKEMIA, V23, P1698, DOI 10.1038/leu.2009.111; Giles KM, 2013, MOL CANCER THER, V12, P2541, DOI 10.1158/1535-7163.MCT-13-0170; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gozdzik-Spychalska J, 2014, CURR TREAT OPTION ON, V15, P670, DOI 10.1007/s11864-014-0313-5; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hirsch FR, 2002, BRIT J CANCER, V86, P1449, DOI 10.1038/sj.bjc.6600286; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Irmer D, 2007, ONCOGENE, V26, P5693, DOI 10.1038/sj.onc.1210383; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kobayashi S, 2008, NEW ENGL J MED, V352, P786; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li S, 2014, BRIT J CANCER, V110, P2812, DOI 10.1038/bjc.2014.210; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Morabito A, 2009, ONCOLOGIST, V14, P378, DOI 10.1634/theoncologist.2008-0261; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moyer JD, 1997, CANCER RES, V57, P4838; Mueller Kelly L, 2010, J Mol Signal, V5, P8, DOI 10.1186/1750-2187-5-8; Neel DS, 2013, CLIN CANCER RES, V19, P3, DOI 10.1158/1078-0432.CCR-12-3232; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Rho JK, 2014, CANCER RES, V74, P253, DOI 10.1158/0008-5472.CAN-13-1103; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Ryan AJ, 2005, BRIT J CANCER, V92, pS6, DOI 10.1038/sj.bjc.6602603; Sattler M, 2003, CANCER RES, V63, P5462; Shibasaki S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-554; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Tang H, 2014, ASSAY DRUG DEV TECHN, V12, P80, DOI 10.1089/adt.2013.540; Tanizaki J, 2011, BRIT J CANCER, V105, P807, DOI 10.1038/bjc.2011.322; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Xu ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063598; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zou HY, 2012, MOL CANCER THER, V11, P1036, DOI 10.1158/1535-7163.MCT-11-0839	80	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143333	10.1371/journal.pone.0143333	http://dx.doi.org/10.1371/journal.pone.0143333			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580964	gold, Green Submitted, Green Published			2022-12-27	WOS:000365154600110
J	Camats, N; Fernandez-Cancio, M; Audi, L; Mullis, PE; Moreno, F; Casado, IG; Lopez-Siguero, JP; Corripio, R; de la Vega, JAB; Blanco, JA; Fluck, CE				Camats, Nuria; Fernandez-Cancio, Monica; Audi, Laura; Mullis, Primus E.; Moreno, Francisca; Gonzalez Casado, Isabel; Pedro Lopez-Siguero, Juan; Corripio, Raquel; Bermudez de la Vega, Jose Antonio; Antonio Blanco, Jose; Flueck, Christa E.			Human MAMLD1 Gene Variations Seem Not Sufficient to Explain a 46,XY DSD Phenotype	PLOS ONE			English	Article							SEX DEVELOPMENT; MYOTUBULAR MYOPATHY; MALE HYPOGENITALISM; MUTATIONS; HYPOSPADIAS; DISORDER; XQ28; CXORF6; MTM1; POLYMORPHISMS	MAMLD1 is thought to cause disordered sex development in 46, XY patients. But its role is controversial because some MAMLD1 variants are also detected in normal individuals, several MAMLD1 mutations have wild-type activity in functional tests, and the male Mamld1-knockout mouse has normal genitalia and reproduction. Our aim was to search for MAMLD1 variations in 108 46, XY patients with disordered sex development, and to test them functionally. We detected MAMDL1 variations and compared SNP frequencies in controls and patients. We tested MAMLD1 transcriptional activity on promoters involved in sex development and assessed the effect of MAMLD1 on androgen production. MAMLD1 expression in normal steroid-producing tissues and mutant MAMLD1 protein expression were also assessed. Nine MAMLD1 mutations (7 novel) were characterized. In vitro, most MAMLD1 variants acted similarly to wild type. Only the L210X mutation showed loss of function in all tests. We detected no effect of wild-type or MAMLD1 variants on CYP17A1 enzyme activity in our cell experiments, and Western blots revealed no significant differences for MAMLD1 protein expression. MAMLD1 was expressed in human adult testes and adrenals. In conclusion, our data support the notion that MAMLD1 sequence variations may not suffice to explain the phenotype in carriers and that MAMLD1 may also have a role in adult life.	[Camats, Nuria; Mullis, Primus E.; Flueck, Christa E.] Univ Childrens Hosp Bern, Dept Clin Res, Pediat Endocrinol & Diabetol, Bern, Switzerland; [Fernandez-Cancio, Monica; Audi, Laura] Univ Autonoma Barcelona, Pediat Endocrinol Res Unit, Vall dHebron Inst Recerca,Hosp Univ Vall dHebron, CIBERER Ctr Biomed Res Rare Dis,Inst Salud Carlos, E-08193 Barcelona, Spain; [Moreno, Francisca] Hosp Infantil La Fe, Pediat Endocrinol, Valencia, Spain; [Gonzalez Casado, Isabel] Hosp Univ La Paz, Pediat Endocrinol, Madrid, Spain; [Pedro Lopez-Siguero, Juan] Hosp Materno Infantil, Pediat Endocrinol, Malaga, Spain; [Corripio, Raquel] Hosp Sabadell, Pediat Endocrinol, Sabadell, Spain; [Bermudez de la Vega, Jose Antonio] Hosp Univ Virgen Macarena, Pediat Endocrinol, Seville, Spain; [Antonio Blanco, Jose] Hosp Badalona Germans Trias & Pujol, Pediat Urol, Badalona, Spain	University of Bern; University Hospital of Bern; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Universitario Virgen Macarena; Hospital Germans Trias i Pujol	Fluck, CE (corresponding author), Univ Childrens Hosp Bern, Dept Clin Res, Pediat Endocrinol & Diabetol, Bern, Switzerland.	christa.flueck@dkf.unibe.ch	Camats, Nuria/K-8326-2017	Camats, Nuria/0000-0002-4863-8201; Fernandez Cancio, Monica/0000-0003-1872-3488; Flueck, Christa/0000-0002-4568-5504; Corripio, Raquel/0000-0003-3344-8269	Swiss National Science Foundation [320030-146127]; Instituto de Salud Carlos III, Madrid, Spain [CIBERER U-712]; University and Research Management and Evaluation Agency, Barcelona, Spain [2009SGR31]; private Foundation Bangerter-Rhyner, Basel, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); University and Research Management and Evaluation Agency, Barcelona, Spain; private Foundation Bangerter-Rhyner, Basel, Switzerland	This work was supported by grants of the Swiss National Science Foundation (320030-146127) to CEF, the Instituto de Salud Carlos III, Madrid, Spain CIBERER U-712 to MFC, the University and Research Management and Evaluation Agency, Barcelona, Spain (2009SGR31) to LA, and the private Foundation Bangerter-Rhyner, Basel, Switzerland to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Audi L, 2010, J CLIN ENDOCR METAB, V95, P1876, DOI 10.1210/jc.2009-2146; Bartsch O, 1999, CYTOGENET CELL GENET, V85, P310, DOI 10.1159/000015284; Baxter RM, 2013, ANNU REV GENOM HUM G, V14, P371, DOI 10.1146/annurev-genom-091212-153417; Brandao MP, 2011, ADV EXP MED BIOL, V707, P129, DOI 10.1007/978-1-4419-8002-1_28; Camats N, 2012, J CLIN ENDOCR METAB, V97, pE1294, DOI 10.1210/jc.2011-3169; Chen YG, 2010, EUR J MED GENET, V53, P122, DOI 10.1016/j.ejmg.2010.03.005; De Lorenzi L, 2010, SEX DEV, V4, P352, DOI 10.1159/000319527; Fernandez-Cancio M, 2011, INT J ANDROL, V34, pE526, DOI 10.1111/j.1365-2605.2010.01136.x; Fluck CE, 2004, MOL ENDOCRINOL, V18, P1144, DOI 10.1210/me.2003-0342; Fukami M, 2008, J BIOL CHEM, V283, P5525, DOI 10.1074/jbc.M703289200; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Gaspari L, 2011, EUR J ENDOCRINOL, V165, P579, DOI 10.1530/EJE-11-0580; Hu LJ, 1996, HUM MOL GENET, V5, P139, DOI 10.1093/hmg/5.1.139; Huang NW, 2000, J BIOL CHEM, V275, P2852, DOI 10.1074/jbc.275.4.2852; Igarashi M, 2015, SEX DEV, V9, P130, DOI 10.1159/000380842; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kalfa N, 2011, J PEDIATR UROL, V7, P585, DOI 10.1016/j.jpurol.2011.09.005; Kalfa N, 2008, EUR J ENDOCRINOL, V159, P453, DOI 10.1530/EJE-08-0085; Kalfa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032505; Kon Masafumi, 2015, Mol Cell Pediatr, V2, P7, DOI 10.1186/s40348-015-0018-2; Laporte J, 1997, GENOMICS, V41, P458, DOI 10.1006/geno.1997.4662; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Metwalley Kotb Abbass, 2012, J Med Case Rep, V6, P428, DOI 10.1186/1752-1947-6-428; Miyado M, 2012, ENDOCRINOLOGY, V153, P6033, DOI 10.1210/en.2012-1324; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019123; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Nowacka-Woszuk J, 2014, ANIM REPROD SCI, V151, P42, DOI 10.1016/j.anireprosci.2014.10.001; O'Shaughnessy PJ, 2007, J CLIN ENDOCR METAB, V92, P4792, DOI 10.1210/jc.2007-1690; Ogata T, 2012, SEMIN REPROD MED, V30, P410, DOI 10.1055/s-0032-1324725; Oliveira J, 2013, EUR J HUM GENET, V21, P540, DOI 10.1038/ejhg.2012.201; Ruiz-Arana IL, 2015, NOVEL HEMIZYGOUS MUT, DOI [10.1159/000371603, DOI 10.1159/000371603]; SWITONSKI M, 2012, HYPOSPADIAS MALE 78, V6, P128, DOI DOI 10.1159/000330921; Tsai TC, 2005, NEUROMUSCULAR DISORD, V15, P245, DOI 10.1016/j.nmd.2004.12.005; Zhang GJ, 2010, HUM MUTAT, V31, P1286, DOI 10.1002/humu.21389	35	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142831	10.1371/journal.pone.0142831	http://dx.doi.org/10.1371/journal.pone.0142831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26580071	gold, Green Published, Green Submitted			2022-12-27	WOS:000365070700079
J	Torkzaban, B; Kayvanjoo, AH; Ardalan, A; Mousavi, S; Mariotti, R; Baldoni, L; Ebrahimie, E; Ebrahimi, M; Hosseini-Mazinani, M				Torkzaban, Bahareh; Kayvanjoo, Amir Hossein; Ardalan, Arman; Mousavi, Soraya; Mariotti, Roberto; Baldoni, Luciana; Ebrahimie, Esmaeil; Ebrahimi, Mansour; Hosseini-Mazinani, Mehdi			Machine Learning Based Classification of Microsatellite Variation: An Effective Approach for Phylogeographic Characterization of Olive Populations	PLOS ONE			English	Article							OLEA-EUROPAEA L.; CULTIVATED OLIVES; GENETIC DIVERSITY; IDENTIFICATION; MARKERS; WILD	Finding efficient analytical techniques is overwhelmingly turning into a bottleneck for the effectiveness of large biological data. Machine learning offers a novel and powerful tool to advance classification and modeling solutions in molecular biology. However, these methods have been less frequently used with empirical population genetics data. In this study, we developed a new combined approach of data analysis using microsatellite marker data from our previous studies of olive populations using machine learning algorithms. Herein, 267 olive accessions of various origins including 21 reference cultivars, 132 local ecotypes, and 37 wild olive specimens from the Iranian plateau, together with 77 of the most represented Mediterranean varieties were investigated using a finely selected panel of 11 microsatellite markers. We organized data in two '4-targeted' and '16-targeted' experiments. A strategy of assaying different machine based analyses (i.e. data cleaning, feature selection, and machine learning classification) was devised to identify the most informative loci and the most diagnostic alleles to represent the population and the geography of each olive accession. These analyses revealed microsatellite markers with the highest differentiating capacity and proved efficiency for our method of clustering olive accessions to reflect upon their regions of origin. A distinguished highlight of this study was the discovery of the best combination of markers for better differentiating of populations via machine learning models, which can be exploited to distinguish among other biological populations.	[Torkzaban, Bahareh; Ardalan, Arman; Mousavi, Soraya; Hosseini-Mazinani, Mehdi] Natl Inst Genet Engn & Biotechnol, Tehran, Iran; [Kayvanjoo, Amir Hossein; Ebrahimi, Mansour] Univ Qom, Sch Basic Sci, Dept Biol, Qom, Iran; [Ardalan, Arman] Royal Inst Technol, Dept Gene Technol, Sci Life Lab, KTH, Solna, Sweden; [Mariotti, Roberto; Baldoni, Luciana] CNR, Inst Biosci & Bioresources, Perugia, Italy; [Ebrahimie, Esmaeil] Shiraz Univ, Coll Agr, Inst Biotechnol, Shiraz, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Biol Sci, Dept Genet & Evolut, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Univ S Australia, Sch Informat Technol & Math Sci, Div Informat Technol Engn & Environm, Adelaide, SA 5001, Australia; [Ebrahimie, Esmaeil] Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, Adelaide, SA 5001, Australia	Royal Institute of Technology; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Shiraz University; University of Adelaide; University of South Australia; Flinders University South Australia	Ebrahimi, M (corresponding author), Univ Qom, Sch Basic Sci, Dept Biol, Qom, Iran.	mansour@future.org; hosseini@nigeb.ac.ir	Mousavi, Soraya/P-4604-2018; Ebrahimie, Esmaeil/AAN-2611-2020; Baldoni, Luciana/A-4411-2016; mariotti, roberto/AAG-7294-2021; Ebrahimi, Mansour/AAO-9096-2021	Mousavi, Soraya/0000-0002-4433-2512; Ebrahimie, Esmaeil/0000-0002-4431-2861; Baldoni, Luciana/0000-0002-3221-333X; mariotti, roberto/0000-0002-9111-5123; Ebrahimi, Mansour/0000-0001-7011-2567; Kayvanjoo, Amir Hossein/0000-0003-1315-8336; BALDONI, LUCIANA/0000-0002-6636-0055	National Institute of Genetic Engineering & Biotechnology (NIGEB), Iran [437]	National Institute of Genetic Engineering & Biotechnology (NIGEB), Iran	This study was supported by the National Institute of Genetic Engineering & Biotechnology (NIGEB), Iran, in the form of funds for project number 437.	Akthar F, 2012, RAPIDMINER 5 OPERATO; Alba V, 2009, SCI HORTIC-AMSTERDAM, V123, P11, DOI 10.1016/j.scienta.2009.07.007; Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Baldoni L, 2009, MOL BREEDING, V24, P213, DOI 10.1007/s11032-009-9285-8; Beiki AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044164; Belaj A, 2003, THEOR APPL GENET, V107, P736, DOI 10.1007/s00122-003-1301-5; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Besnard G, 2007, J BIOGEOGR, V34, P736, DOI 10.1111/j.1365-2699.2006.01653.x; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Caruana Rich, 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865.[38]X; Dastkar E., 2013, Crop Breeding Journal, V3, P99; Diez CM, 2012, CROP SCI, V52, P211, DOI 10.2135/cropsci2011.02.0110; Ebrahimi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096984; Gomes S, 2012, GENETIC DIVERSITY IN PLANTS, P15; Grossman D, 2004, LEARNING BAYESIAN NE, P46; Guinand B, 2002, J HERED, V93, P260, DOI 10.1093/jhered/93.4.260; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hosseini-Mazinani M, 2013, IRANIAN OLIVE CATALO; Hosseini-Mazinani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093146; Hosseini-Mazinani S, 2002, ACTA HORTIC, V634, P145; Kaniewski D, 2012, BIOL REV, V87, P885, DOI 10.1111/j.1469-185X.2012.00229.x; Kingsford C, 2008, NAT BIOTECHNOL, V26, P1011, DOI 10.1038/nbt0908-1011; Kohavi Ronny, 2002, HDB DATA MINING KNOW, P267; Kotsiantis SB, 2007, FRONT ARTIF INTEL AP, V160, P3; Langley, 1994, SELECTION RELEVANT F, P171; Lewis D. D., 1998, Machine Learning: ECML-98. 10th European Conference on Machine Learning. Proceedings, P4, DOI 10.1007/BFb0026666; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Mousavi S, 2014, GENET RESOUR CROP EV, V61, P775, DOI 10.1007/s10722-013-0071-4; Nasa C, 2012, INT J COMPUTER APPL, V52; Nasiri J, 2015, J THEORETICAL BIOL; Noormohammadi Z, 2012, GENET MOL RES, V11, P707, DOI 10.4238/2012.March.19.4; Noormohammadi Z, 2007, HORTSCIENCE, V42, P1545, DOI 10.21273/HORTSCI.42.7.1545; Noormohammadi Zahra, 2009, Acta Biologica Szegediensis, V53, P27; Omrani-Sabbaghi A, 2007, SCI HORTIC-AMSTERDAM, V112, P439, DOI 10.1016/j.scienta.2006.12.051; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Poljuha D, 2008, SCI HORTIC-AMSTERDAM, V115, P223, DOI 10.1016/j.scienta.2007.08.018; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sarri V, 2006, GENOME, V49, P1606, DOI 10.1139/G06-126; Schlecht J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000093; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Weiss S. M., 1990, COMPUTER SYSTEMS LEA; Zhang H., 2004, P 17 INT FLOR ART IN; Zhao YH, 2008, ADV SPACE RES, V41, P1955, DOI 10.1016/j.asr.2007.07.020	47	9	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143465	10.1371/journal.pone.0143465	http://dx.doi.org/10.1371/journal.pone.0143465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599001	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000365862600068
J	Guillon, A; Chevaleyre, C; Barc, C; Berri, M; Adriaensen, H; Lecompte, F; Villemagne, T; Pezant, J; Delaunay, R; Moenne-Loccoz, J; Berthon, P; Bahr, A; Wolf, E; Klymiuk, N; Attucci, S; Ramphal, R; Sarradin, P; Buzoni-Gatel, D; Si-Tahar, M; Caballero, I				Guillon, Antoine; Chevaleyre, Claire; Barc, Celine; Berri, Mustapha; Adriaensen, Hans; Lecompte, Francois; Villemagne, Thierry; Pezant, Jeremy; Delaunay, Remi; Moenne-Loccoz, Joseph; Berthon, Patricia; Baehr, Andrea; Wolf, Eckhard; Klymiuk, Nikolai; Attucci, Sylvie; Ramphal, Reuben; Sarradin, Pierre; Buzoni-Gatel, Dominique; Si-Tahar, Mustapha; Caballero, Ignacio			Computed Tomography (CT) Scanning Facilitates Early Identification of Neonatal Cystic Fibrosis Piglets	PLOS ONE			English	Article							MECONIUM ILEUS; INTESTINAL-OBSTRUCTION; LUNG-DISEASE; MODEL; PATHOPHYSIOLOGY; EXPRESSION; NUMBERS; TISSUE	Background Cystic Fibrosis (CF) is the most prevalent autosomal recessive disease in the Caucasian population. A cystic fibrosis transmembrane conductance regulator knockout (CFTR-/-) pig that displays most of the features of the human CF disease has been recently developed. However, CFTR-/- pigs presents a 100% prevalence of meconium ileus that leads to death in the first hours after birth, requiring a rapid diagnosis and surgical intervention to relieve intestinal obstruction. Identification of CFTR-/- piglets is usually performed by PCR genotyping, a procedure that lasts between 4 to 6 h. Here, we aimed to develop a procedure for rapid identification of CFTR-/- piglets that will allow placing them under intensive care soon after birth and immediately proceeding with the surgical correction. Methods and Principal Findings Male and female CFTR+/- pigs were crossed and the progeny was examined by computed tomography (CT) scan to detect the presence of meconium ileus and facilitate a rapid postnatal surgical intervention. Genotype was confirmed by PCR. CT scan presented a 94.4% sensitivity to diagnose CFTR-/- piglets. Diagnosis by CT scan reduced the birth-to-surgery time from a minimum of 10 h down to a minimum of 2.5 h and increased the survival of CFTR-/- piglets to a maximum of 13 days post-surgery as opposed to just 66 h after later surgery. Conclusion CT scan imaging of meconium ileus is an accurate method for rapid identification of CFTR-/- piglets. Early CT detection of meconium ileus may help to extend the lifespan of CFTR-/- piglets and, thus, improve experimental research on CF, still an incurable disease.	[Guillon, Antoine; Attucci, Sylvie; Ramphal, Reuben; Si-Tahar, Mustapha] INSERM, UMR 1100, EA6305, Ctr Etud Pathol Resp, Tours, France; [Guillon, Antoine] CHU Tours, Serv Reanimat Polyvalente, Tours, France; [Chevaleyre, Claire; Berri, Mustapha; Berthon, Patricia; Buzoni-Gatel, Dominique; Caballero, Ignacio] INRA, UMR1282, ISP, F-37380 Nouzilly, France; [Barc, Celine; Pezant, Jeremy; Delaunay, Remi; Sarradin, Pierre] INRA, UMR1277, PFIE, F-37380 Nouzilly, France; [Adriaensen, Hans; Lecompte, Francois] INRA, CIRE, F-37380 Nouzilly, France; [Villemagne, Thierry] CHU Clocheville, Tours, France; [Moenne-Loccoz, Joseph] CHU Tours, Serv Anesthesie Reanimat, Tours, France; [Baehr, Andrea; Wolf, Eckhard; Klymiuk, Nikolai] Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany; [Baehr, Andrea; Wolf, Eckhard; Klymiuk, Nikolai] Ludwig Maximilians Univ Munchen, Ctr Innovat Med Models, Munich, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; INRAE; INRAE; INRAE; CHU Tours; CHU Tours; University of Munich; University of Munich	Caballero, I (corresponding author), INRA, UMR1282, ISP, F-37380 Nouzilly, France.	icaballerop@tours.inra.fr	Si-Tahar, Mustapha/W-8034-2019; Klymiuk, Nikolai/AAB-8345-2022; SI-TAHAR, Mustapha/L-4149-2014; Adriaensen, Hans/N-6699-2018; Wolf, Eckhard/AAT-7500-2021	Si-Tahar, Mustapha/0000-0002-5792-7742; Klymiuk, Nikolai/0000-0003-3532-1659; SI-TAHAR, Mustapha/0000-0002-5792-7742; Wolf, Eckhard/0000-0002-0430-9510; guillon, antoine/0000-0002-4884-8620; Barc, Celine/0000-0002-5912-4652; Caballero, Ignacio/0000-0002-0628-4134	Foundation Vaincre la Mucoviscidose [RF20130500925]; Region Centre, France [32000604]	Foundation Vaincre la Mucoviscidose; Region Centre, France(Region Centre-Val de Loire)	This research was supported by the Foundation Vaincre la Mucoviscidose (http://www.vaincrelamuco.org/), grant RF20130500925, and Region Centre, France (http://www.regioncentre-valdeloire.fr/), grant 32000604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrons GA, 1996, RADIOGRAPHICS, V16, P871, DOI 10.1148/radiographics.16.4.8835977; Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Bodas M, 2010, DISCOV MED, V9, P346; Brea D, 2012, BIOCHEM J, V447, P363, DOI 10.1042/BJ20120818; Burjonrappa SC, 2010, J PERINATOL, V30, P27, DOI 10.1038/jp.2009.102; Carlyle BE, 2012, J PEDIATR SURG, V47, P772, DOI 10.1016/j.jpedsurg.2012.02.019; Casaccia G, 2003, PEDIATR SURG INT, V19, P75, DOI 10.1007/s00383-002-0781-8; Constantine S, 2004, Australas Radiol, V48, P450, DOI 10.1111/j.1440-1673.2004.01345.x; CORDES D O, 1971, New Zealand Veterinary Journal, V19, P108, DOI 10.1080/00480169.1971.33943; Drumm ML, 2012, ANNU REV PATHOL-MECH, V7, P267, DOI 10.1146/annurev-pathol-011811-120900; GORDON JI, 1985, J BIOL CHEM, V260, P1995; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Klymiuk N, 2012, J MOL MED, V90, P597, DOI 10.1007/s00109-011-0839-y; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Nassenstein K, 2005, GUT, V54, P1662, DOI 10.1136/gut.2005.075994; Neal MR, 1997, J ULTRAS MED, V16, P263; Okamoto K, 2005, JPEN-PARENTER ENTER, V29, P56, DOI 10.1177/014860710502900156; Okamoto K, 2013, ANN SURG, V258, P1059, DOI 10.1097/SLA.0b013e31827a0e05; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Scotet V, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.08.033; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Stoltz DA, 2013, J CLIN INVEST, V123, P2685, DOI 10.1172/JCI68867; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; van der Doef Hubert P J, 2011, Curr Gastroenterol Rep, V13, P265, DOI 10.1007/s11894-011-0185-9; Veyrac C, 2012, PEDIATR RADIOL, V42, P107, DOI 10.1007/s00247-011-2173-5; Ware LB, 2008, AM J PHYSIOL-LUNG C, V294, pL149, DOI 10.1152/ajplung.00472.2007; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222; ZHOU L, 1994, SCIENCE, V266, P1705, DOI 10.1126/science.7527588	32	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143459	10.1371/journal.pone.0143459	http://dx.doi.org/10.1371/journal.pone.0143459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600426	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900128
J	Syam, AF; Miftahussurur, M; Makmun, D; Nusi, IA; Zain, LH; Zulkhairi; Akil, F; Uswan, WB; Simanjuntak, D; Uchida, T; Adi, P; Utari, AP; Rezkitha, YAA; Subsomwong, P; Nasronudin; Suzuki, R; Yamaoka, Y				Syam, Ari Fahrial; Miftahussurur, Muhammad; Makmun, Dadang; Nusi, Iswan Abbas; Zain, Lukman Hakim; Zulkhairi; Akil, Fardah; Uswan, Willi Brodus; Simanjuntak, David; Uchida, Tomohisa; Adi, Pangestu; Utari, Amanda Pitarini; Rezkitha, Yudith Annisa Ayu; Subsomwong, Phawinee; Nasronudin; Suzuki, Rumiko; Yamaoka, Yoshio			Risk Factors and Prevalence of Helicobacter pylori in Five Largest Islands of Indonesia: A Preliminary Study	PLOS ONE			English	Article							INFECTION; IDENTIFICATION; GASTROSCOPY; MANAGEMENT; GENOTYPES; DISEASES; REGION	The prevalence of Helicobacter pylori infection in Indonesia is still controversial and mainly investigated in the largest ethnic group, Javanese. We examined the prevalence of H. pylori infection using four different tests including culture, histology confirmed by immunohistochemistry and rapid urease test. We also analyzed risk factors associated with H. pylori infection in five largest islands in Indonesia. From January 2014-February 2015 we consecutively recruited a total of 267 patients with dyspeptic symptoms in Java, Papua, Sulawesi, Borneo and Sumatera Island. Overall, the prevalence of H. pylori infection was 22.1%(59/267). Papuan, Batak and Buginese ethnics had higher risk for H. pylori infection than Javanese, Dayak and Chinese ethnics (OR = 30.57, 6.31, 4.95; OR = 28.39, 5.81, 4.61 and OR = 23.23, 4.76, 3.77, respectively, P < 0.05). The sensitivity and specificity for RUT and culture were 90.2%, 92.9% and 80.5%, 98.2%, respectively. The patients aged 50-59 years group had significantly higher H. pylori infection than 30-39 years group (OR 2.98, P = 0.05). Protestant had significantly higher H. pylori infection rate than that among Catholic (OR 4.42, P = 0.008). It was also significantly lower among peoples who used tap water as source of drinking water than from Wells/river (OR 9.67, P = 0.03). However only ethnics as become independent risk factors for H. pylori infection. Although we confirmed low prevalence of H. pylori in Javanese; predominant ethnic in Indonesia, several ethnic groups had higher risk of H. pylori infection. The age, religion and water source may implicate as a risk factor for H. pylori infection in Indonesia.	[Syam, Ari Fahrial; Makmun, Dadang] Univ Indonesia, Div Gastroenterol, Dept Internal Med, Fac Med, Jakarta, Indonesia; [Miftahussurur, Muhammad; Subsomwong, Phawinee; Suzuki, Rumiko; Yamaoka, Yoshio] Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan; [Miftahussurur, Muhammad; Nusi, Iswan Abbas] Airlangga Univ, Fac Med, Gastroenterohepatol Div, Dept Internal Med, Surabaya, Indonesia; [Miftahussurur, Muhammad; Adi, Pangestu; Rezkitha, Yudith Annisa Ayu; Nasronudin] Airlangga Univ, Inst Trop Dis, Surabaya, Indonesia; [Zain, Lukman Hakim; Zulkhairi] Univ Sumatera Utara, Fac Med, Dept Internal Med, Div Gastroenterohepatol, Medan, Indonesia; [Akil, Fardah] Hasanuddin Univ, Fac Med, Dept Internal Med, Ctr Gastroenterohepatol, Makassar, Indonesia; [Uswan, Willi Brodus] Santo Antonius Hosp, Dept Internal Med, Pontianak, Indonesia; [Simanjuntak, David] Yowari Hosp, Dept Internal Med, Jayapura, Indonesia; [Uchida, Tomohisa] Oita Univ, Dept Mol Pathol, Fac Med, Yufu, Japan; [Yamaoka, Yoshio] Baylor Coll Med, Dept Gastroenterol & Hepatol, Houston, TX 77030 USA; [Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX USA	University of Indonesia; Oita University; Airlangga University; Airlangga University; University of North Sumatra; Universitas Hasanuddin; Oita University; Baylor College of Medicine; Baylor College of Medicine	Yamaoka, Y (corresponding author), Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan.	yyamaoka@oita-u.ac.jp	Syam, Ari Fahrial/ABI-4994-2020; Miftahussurur, Muhammad/AAB-6151-2021	Miftahussurur, Muhammad/0000-0003-1415-6033; Syam, Ari Fahrial/0000-0003-0041-3553; Akil, Fardah/0000-0002-4222-6011; effendi, wiwin is/0000-0003-3716-2452; Subsomwong, Phawinee/0000-0002-9961-9350; Rezkitha, Yudith Annisa Ayu/0000-0001-7600-9114; nasronudin, nasronudin/0000-0001-7882-9992; Yamaoka, Yoshio/0000-0002-1222-5819	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24406015, 24659200, 25293104, 26640114, 15H02657, 221S0002, 26440198]; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK062813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This report is based on work supported in part by grants from the National Institutes of Health (DK62813) (YY), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (24406015, 24659200, 25293104, 26640114, 15H02657 and 221S0002) (YY), (26440198) (RS). This work was also supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits and the Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST).	Abdullah M, 2009, WORLD J GASTROENTERO, V15, P4928, DOI 10.3748/wjg.15.4928; Al-Hawajri AA, 2004, DIGEST DIS SCI, V49, P1091, DOI 10.1023/B:DDAS.0000037793.28069.44; Arinton I Gede, 2011, Acta Med Indones, V43, P88; Aulia Diana, 2009, Acta Med Indones, V41, P107; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; CHOW TKF, 1995, J GASTROEN HEPATOL, V10, P562, DOI 10.1111/j.1440-1746.1995.tb01347.x; Destura Raul V, 2004, Ann Clin Microbiol Antimicrob, V3, P25, DOI 10.1186/1476-0711-3-25; Dube C., 2009, Reviews on Environmental Health, V24, P1; Elitsur Y, 2009, J CLIN GASTROENTEROL, V43, P147, DOI 10.1097/MCG.0b013e318157e4e7; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Lee YY, 2013, HELICOBACTER, V18, P338, DOI 10.1111/hel.12058; Lee YY, 2012, HELICOBACTER, V17, P54, DOI 10.1111/j.1523-5378.2011.00917.x; Maran S, 2013, WORLD J GASTROENTERO, V19, P3615, DOI 10.3748/wjg.v19.i23.3615; Mhaskar RS, 2013, J GLOB INFECT DIS, V5, P60, DOI 10.4103/0974-777X.112288; Miftahussurur M, 2015, EPIDEMIOL INFECT, V143, P986, DOI 10.1017/S095026881400154X; Miftahussurur M, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0042-0; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Nguyen LT, 2010, EUR J CLIN MICROBIOL, V29, P651, DOI 10.1007/s10096-010-0909-z; Nguyen TL, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-114; Parsonnet J, 1999, JAMA-J AM MED ASSOC, V282, P2240, DOI 10.1001/jama.282.23.2240; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Perger R, 2013, ZOOKEYS, P77, DOI 10.3897/zookeys.293.5133; Rahim AA, 2010, AM J TROP MED HYG, V83, P1119, DOI 10.4269/ajtmh.2010.10-0226; RICHENS J, 1989, PAPUA NEW GUINEA MED, V32, P23; Sahara S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-223; Saragih J Boas, 2007, Acta Med Indones, V39, P79; Shiota S, 2014, J MED MICROBIOL, V63, P1189, DOI 10.1099/jmm.0.075275-0; Shiota S, 2010, EXPERT REV GASTROENT, V4, P149, DOI [10.1586/egh.10.7, 10.1586/EGH.10.7]; Sugimoto M, 2011, J GASTROEN HEPATOL, V26, P1677, DOI 10.1111/j.1440-1746.2011.06817.x; Sugimoto M, 2009, J GASTROEN HEPATOL, V24, P1725, DOI 10.1111/j.1440-1746.2009.06047.x; Syam AF, 2006, WORLD J GASTROENTERO, V12, P6216, DOI 10.3748/wjg.v12.i38.6216; Syam AF, 2005, WORLD J GASTROENTERO, V11, P386, DOI 10.3748/wjg.v11.i3.386; Tokudome S, 2005, CANCER SCI, V96, P873, DOI 10.1111/j.1349-7006.2005.00122.x; Tokudome S, 2005, CANCER LETT, V219, P57, DOI 10.1016/j.canlet.2004.09.043; Tumonggor MK, 2013, J HUM GENET, V58, P165, DOI 10.1038/jhg.2012.154; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Utsumi T, 2009, J CLIN MICROBIOL, V47, P1842, DOI 10.1128/JCM.02328-08; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Zhao Y, 2012, ASIAN PAC J CANCER P, V13, P1247, DOI 10.7314/APJCP.2012.13.4.1247	40	50	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0140186	10.1371/journal.pone.0140186	http://dx.doi.org/10.1371/journal.pone.0140186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599790	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000365853900007
J	Beatty, CD; Andres, JA; Sherratt, TN				Beatty, Christopher D.; Andres, Jose A.; Sherratt, Thomas N.			Conspicuous Coloration in Males of the Damselfly Nehalennia irene (Zygoptera: Coenagrionidae): Do Males Signal Their Unprofitability to Other Males?	PLOS ONE			English	Article							SEXUAL SELECTION; MATE RECOGNITION; CUES; EVOLUTION; POLYMORPHISM; COMPETITION; EXPRESSION; BEHAVIOR; ODONATA; TRAIT	In damselflies, sexual colour dimorphism is commonly explained as a consequence of selection on traits that increase male attractiveness to females. However, while many species in the damselfly family Coenagrionidae (Insecta: Odonata) are sexually dimorphic, the males do not engage in displays, and male competition for mates resembles a "scramble". An alternative explanation for the sexual differences in coloration within these species is that sexual dimorphism has evolved as a sex-related warning signal, with males signalling their uprofitability as mates to other males, thereby avoiding harassment from conspecifics. We evaluated an underlying assumption of the theory that male-male harassment rate is influenced by colour by comparing harassment of males of the species Nehalennia irene that had been painted to make them appear: (i) similar to an unaltered male (blue), (ii) different from a male (orange) and (iii) more similar to a female (black). When caged together we found that blue-painted males experienced significantly lower harassment than black-painted males. When unpainted males were caged with each type of painted male we found that blue-painted males and the unpainted males housed in the same cages experienced lower rates of harassment than males housed in cages where some males were painted black, suggesting that a single, reliable signal of unprofitability may benefit the individuals that carry it. While our results do not in themselves demonstrate that sexual colour dimorphism originally evolved as an intra-specific warning signal, they do show that harassment is influenced by coloration, and that such selection could conceivably maintain male coloration as a warning signal.	[Beatty, Christopher D.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Beatty, Christopher D.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Andres, Jose A.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Sherratt, Thomas N.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Santa Clara University; Cornell University; University of Saskatchewan; Carleton University	Beatty, CD (corresponding author), Santa Clara Univ, Dept Biol, 500 El Camino Real, Santa Clara, CA 95053 USA.	cbeatty@scu.edu	Beatty, Christopher/ABE-6438-2020	Beatty, Christopher/0000-0003-2641-0000	Natural Sciences Engineering and Research Council of Canada (NSERC) [315748]; Canadian Fund for Innovation (CFI) [335414]	Natural Sciences Engineering and Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Fund for Innovation (CFI)(Canada Foundation for Innovation)	This project was supported by funding awarded to Thomas N. Sherratt from the Natural Sciences Engineering and Research Council of Canada (NSERC grant #315748) and the Canadian Fund for Innovation (CFI grant #335414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Andres JA, 2002, ANIM BEHAV, V63, P677, DOI 10.1006/anbe.2001.1948; BATTIN TJ, 1993, B ZOOL, V60, P353, DOI 10.1080/11250009309355839; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Brownell VR, 2000, DAMSELFLIES DRAGONFL; Bybee SM, 2012, ORG DIVERS EVOL, V12, P241, DOI 10.1007/s13127-012-0090-6; CONRAD KF, 1992, BIOL J LINN SOC, V45, P255, DOI 10.1111/j.1095-8312.1992.tb00643.x; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbett PS, 1999, DRAGONFLIES BEHAV EC; Cordero A, 1998, ANIM BEHAV, V55, P185, DOI 10.1006/anbe.1997.0603; Cordero Rivera Adolfo, 2001, Animal Behaviour Forum, V61, pF1; Cordoba-Aguilar A, 2009, BEHAV ECOL SOCIOBIOL, V63, P751, DOI 10.1007/s00265-009-0709-6; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FINCKE OM, 1994, ANIM BEHAV, V47, P1249, DOI 10.1006/anbe.1994.1174; Fisher RA, 1930, GENETICAL THEORY NAT; GIBBONS DW, 1992, J ANIM ECOL, V61, P283, DOI 10.2307/5321; Gorb SN, 1998, J INSECT BEHAV, V11, P73, DOI 10.1023/A:1020818617066; Grether GF, 1996, EVOLUTION, V50, P1949, DOI 10.1111/j.1558-5646.1996.tb03582.x; Hooper RE, 1999, PHYSIOL ENTOMOL, V24, P364, DOI 10.1046/j.1365-3032.1999.00152.x; Iserbyt A, 2011, ECOL ENTOMOL, V36, P544, DOI 10.1111/j.1365-2311.2011.01300.x; Lam E., 2004, DAMSELFLIES NE GUIDE; LAVOIE-DORNIK J, 1988, Odonatologica, V17, P337; Miller MN, 1999, J INSECT BEHAV, V12, P801, DOI 10.1023/A:1020957110842; Papaj DR, 2005, P ROY SOC B-BIOL SCI, V272, P2519, DOI 10.1098/rspb.2005.3186; Poulton EB, 1890, COLOURS ANIMALS THEI; R Core Team, 2021, R LANGUAGE ENV STAT; ROBERTSON HM, 1985, ANIM BEHAV, V33, P805, DOI 10.1016/S0003-3472(85)80013-0; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Schultz TD, 2008, ANIM BEHAV, V76, P1357, DOI 10.1016/j.anbehav.2008.04.024; Sherratt TN, 2002, P ROY SOC B-BIOL SCI, V269, P741, DOI 10.1098/rspb.2001.1944; Sherratt TN, 2003, AM NAT, V162, P377, DOI 10.1086/378047; Sherratt TN, 2001, ANIM BEHAV, V62, P653, DOI 10.1006/anbe.2001.1789; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Ubukata H., 1987, ANIMAL SOC THEORIES; Van Gossum H, 2007, ECOSCIENCE, V14, P1, DOI 10.2980/1195-6860(2007)14[1:RIBNDS]2.0.CO;2; Van Gossum H, 2007, BIOL J LINN SOC, V90, P501, DOI 10.1111/j.1095-8312.2007.00740.x; Van Gossum H, 2011, EVOL ECOL, V25, P139, DOI 10.1007/s10682-010-9388-z; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Xu MZ, 2014, ANIM BEHAV, V92, P9, DOI 10.1016/j.anbehav.2014.03.016; YANG EC, 1991, J COMP PHYSIOL A, V169, P663	40	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142684	10.1371/journal.pone.0142684	http://dx.doi.org/10.1371/journal.pone.0142684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587979	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500013
J	Calderon, LE; Liu, S; Arnold, N; Breakall, B; Rollins, J; Ndinguri, M				Calderon, Lindsay E.; Liu, Shu; Arnold, Nova; Breakall, Bethany; Rollins, Joseph; Ndinguri, Margaret			Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration	PLOS ONE			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); ACETYLCHOLINE-RECEPTOR; MESENCHYMAL TRANSITION; CIGARETTE-SMOKING; MOUSE MODEL; METASTASIS; ACTIVATION; INHIBITION; INVASION; RISK	Objectives Calcium independent group VIA phospholipase A(2) (iPLA(2)beta) and Matrix Metalloproteinase-9 (MMP-9) are upregulated in many disease states; their involvement with cancer cell migration has been a recent subject for study. Further, the molecular mechanisms mediating nicotine-induced breast cancer cell progression have not been fully investigated. This study aims to investigate whether iPLA(2)beta mediates nicotine-induced breast cancer cell proliferation and migration through both in-vitro and in-vivo techniques. Subsequently, the ability of Bromoenol Lactone (BEL) to attenuate the severity of nicotine-induced breast cancer was examined. Method and Results We found that BEL significantly attenuated both basal and nicotine-induced 4T1 breast cancer cell proliferation, via an MTT proliferation assay. Breast cancer cell migration was examined by both a scratch and transwell assay, in which, BEL was found to significantly decrease both basal and nicotine-induced migration. Additionally, nicotine-induced MMP-9 expression was found to be mediated in an iPLA(2)beta dependent manner. These results suggest that iPLA(2)beta plays a critical role in mediating both basal and nicotine-induced breast cancer cell proliferation and migration in-vitro. In an in-vivo mouse breast cancer model, BEL treatment was found to significantly reduce both basal (p<0.05) and nicotine-induced tumor growth (p<0.01). Immunohistochemical analysis showed BEL decreased nicotine-induced MMP-9, HIF-1alpha, and CD31 tumor tissue expression. Subsequently, BEL was observed to reduce nicotine-induced lung metastasis. Conclusion The present study indicates that nicotine-induced migration is mediated by MMP-9 production in an iPLA(2)beta dependent manner. Our data suggests that BEL is a possible chemotherapeutic agent as it was found to reduce both nicotine-induced breast cancer tumor growth and lung metastasis.	[Calderon, Lindsay E.; Arnold, Nova; Breakall, Bethany; Rollins, Joseph] Eastern Kentucky Univ, Dept Biol, Richmond, KY 40475 USA; [Liu, Shu] Hebei Univ, Hlth Sci Ctr, Dept Physiol, Tianjin 071000, Hebei, Peoples R China; [Ndinguri, Margaret] Eastern Kentucky Univ, Dept Chem, Richmond, KY 40475 USA	Hebei University	Calderon, LE (corresponding author), Eastern Kentucky Univ, Dept Biol, Richmond, KY 40475 USA.	Lindsay.Calderon@eku.edu		Calderon, Lindsay/0000-0003-0919-0077	National Science Foundation [1355438]; Public Health Service Grant [GM102776]; Hebei Providence Nature Science Foundation [H2015201137]; Office Of The Director [1355438] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM102776] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Hebei Providence Nature Science Foundation; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Science Foundation, 1355438, Public Health Service Grant GM102776, and Hebei Providence Nature Science Foundation, H2015201137.	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Ali T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071748; Andersson G, 1997, J ORAL PATHOL MED, V26, P117, DOI 10.1111/j.1600-0714.1997.tb00033.x; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bavarva JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067252; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Calderon LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031850; Chen CS, 2011, BREAST CANCER RES TR, V125, P73, DOI 10.1007/s10549-010-0821-3; Choi JY, 2011, J BREAST CANCER, V14, P88, DOI 10.4048/jbc.2011.14.2.88; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Davis JA, 2005, J NEUROSCI, V25, P8708, DOI 10.1523/JNEUROSCI.2853-05.2005; Desantis C., 2013, CA CANC J CLIN; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Di Cello F, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-90; Faraglia B, 2003, CARCINOGENESIS, V24, P719, DOI 10.1093/carcin/bgg013; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Guha P, 2014, BREAST CANCER RES TR, V145, P5, DOI 10.1007/s10549-014-2912-z; Hao JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057495; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Heyder C, 2005, CLIN EXP METASTAS, V22, P99, DOI 10.1007/s10585-005-4335-z; Ho JN, 2010, MOL CANCER THER, V9, P825, DOI 10.1158/1535-7163.MCT-09-0904; Jayakumar R, 2012, FOOD CHEM, V134, P1580, DOI 10.1016/j.foodchem.2012.03.101; Jo M, 2013, FREE RADICAL BIO MED, V61, P453, DOI 10.1016/j.freeradbiomed.2013.04.032; Johnson KC, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.035931; Kanaya N, 2014, NUTR CANCER, V66, P242, DOI 10.1080/01635581.2014.863366; Kispert S, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12318; Kispert SE, 2014, AM J PHYSIOL-CELL PH, V307, pC951, DOI 10.1152/ajpcell.00218.2014; Lee CH, 2011, BREAST CANCER RES TR, V129, P331, DOI 10.1007/s10549-010-1209-0; Lee SJ, 2013, PLANTA MED; Li H, 2011, AM J PATHOL, V179, P452, DOI 10.1016/j.ajpath.2011.03.027; Liu S, 2013, ARTERIOSCL THROM VAS, V33, P1568, DOI 10.1161/ATVBAHA.112.300820; Liu S, 2012, J BIOL CHEM, V287, P24739, DOI 10.1074/jbc.M112.340216; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040480; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Mandal CC, 2010, BIOCHEM BIOPH RES CO, V402, P602, DOI 10.1016/j.bbrc.2010.10.063; McHowat J, 2011, AM J PHYSIOL-CELL PH, V300, pC825, DOI 10.1152/ajpcell.00502.2010; Momi N, 2013, ONCOGENE, V32, P1384, DOI 10.1038/onc.2012.163; Murin S, 2004, CHEST, V125, P1467, DOI 10.1378/chest.125.4.1467; Nicotera TM, 2009, PROSTATE, V69, P1270, DOI 10.1002/pros.20968; Nikolic DM, 2007, J BIOL CHEM, V282, P33405, DOI 10.1074/jbc.M704133200; Nishioka T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3055; Nyante SJ, 2014, BRIT J CANCER, V110, P2339, DOI 10.1038/bjc.2014.132; Pierce JP, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt359; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Radenkovic S, 2013, CELL BIOCH BIOPHYSIC; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Saab-Aoude S, 2013, BIOCHIMIE, V95, P903, DOI 10.1016/j.biochi.2012.12.008; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; Sun B, 2010, BIOCHEM PHARMACOL, V79, P1727, DOI 10.1016/j.bcp.2010.02.005; Talhout R, 2011, INT J ENV RES PUB HE, V8, P613, DOI 10.3390/ijerph8020613; Vadali S, 2014, J LEUKOCYTE BIOL, V96, P873, DOI 10.1189/jlb.2A0414-214R; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025436; Wang SX, 2012, NAT MED, V18, P902, DOI 10.1038/nm.2711; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wilkinson DS, 2013, PSYCHOPHARMACOLOGY, V225, P201, DOI 10.1007/s00213-012-2808-8; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	62	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143277	10.1371/journal.pone.0143277	http://dx.doi.org/10.1371/journal.pone.0143277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588686	Green Published, gold, Green Submitted			2022-12-27	WOS:000365251500049
J	Semple, BD; Noble-Haeusslein, LJ; Gooyit, M; Tercovich, KG; Peng, ZH; Nguyen, TT; Schroeder, VA; Suckow, MA; Chang, M; Raber, J; Trivedi, A				Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Gooyit, Major; Tercovich, Kayleen G.; Peng, Zhihong; Nguyen, Trung T.; Schroeder, Valerie A.; Suckow, Mark A.; Chang, Mayland; Raber, Jacob; Trivedi, Alpa			Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; GENE KNOCK-OUT; MATRIX METALLOPROTEINASES; CEREBROSPINAL-FLUID; HEMORRHAGIC TRANSFORMATION; HYPOXIA-ISCHEMIA; TISSUE INHIBITOR; MESSENGER-RNA; NEURONAL LOSS	The gelatinases, matrix metalloproteinases (MMP)-2 and MMP-9, are thought to be key mediators of secondary damage in adult animal models of brain injury. Moreover, an acute increase in these proteases in plasma and brain extracellular fluid of adult patients with moderate-to-severe traumatic brain injuries (TBIs) is associated with poorer clinical outcomes and mortality. Nonetheless, their involvement after TBI in the pediatric brain remains understudied. Using a murine model of TBI at postnatal day 21 (p21), approximating a toddler-aged child, we saw upregulation of active and pro-MMP-9 and MMP-2 by gelatin zymography at 48 h post-injury. We therefore investigated the role of gelatinases on long-term structural and behavioral outcomes after injury after acute inhibition with a selective gelatinase inhibitor, p-OH SB-3CT. After systemic administration, p-OH SB-3CT crossed the blood-brain barrier at therapeutically-relevant concentrations. TBI at p21 induced hyperactivity, deficits in spatial learning and memory, and reduced sociability when mice were assessed at adulthood, alongside pronounced tissue loss in key neuroanatomical regions. Acute and short-term post-injury treatment with p-OH SB-3CT did not ameliorate these long-term behavioral, cognitive, or neuropathological deficits as compared to vehicle-treated controls, suggesting that these deficits were independent of MMP-9 and MMP-2 upregulation. These findings emphasize the vulnerability of the immature brain to the consequences of traumatic injuries. However, early upregulation of gelatinases do not appear to be key determinants of long-term recovery after an early-life injury.	[Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Tercovich, Kayleen G.; Trivedi, Alpa] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94117 USA; [Semple, Bridgette D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3052, Australia; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil, San Francisco, CA 94143 USA; [Gooyit, Major; Peng, Zhihong; Nguyen, Trung T.; Chang, Mayland] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Div Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Div Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Radiat Med, Div Neurosci, Portland, OR 97201 USA	University of California System; University of California San Francisco; Royal Melbourne Hospital; University of Melbourne; University of California System; University of California San Francisco; University of Notre Dame; University of Notre Dame; University of Notre Dame; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Trivedi, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94117 USA.	alpa.mahuvakar@ucsf.edu	Tercovich, Kayleen/I-8941-2018; Peng, Zhihong/T-1359-2019	Tercovich, Kayleen/0000-0003-0450-8912; Peng, Zhihong/0000-0002-2764-4645; Suckow, Mark/0000-0001-7317-697X; Peng, Zhihong/0000-0002-3502-4657; Semple, Bridgette/0000-0002-2535-0491	National Institute of Neurological Disorders and Stroke [RO1NS077767, RO1NS050159]; Australian National Health and Medical Research Council [1052505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050159, R01NS077767] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	LJN received two grants from the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) with grant numbers RO1NS077767 and RO1NS050159. BDS received a CJ Martin Early Career Fellowship from the Australian National Health and Medical Research Council with award number 1052505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2008, SEMIN CELL DEV BIOL, V19, P42, DOI 10.1016/j.semcdb.2007.06.003; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asahi M, 2001, NEUROREPORT, V12, P3003, DOI 10.1097/00001756-200109170-00050; Bednarek N, 2012, PEDIATR RES, V71, P63, DOI 10.1038/pr.2011.3; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Chou SHY, 2011, TRANSL STROKE RES, V2, P600, DOI 10.1007/s12975-011-0117-x; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; Cui J, 2012, MOL NEURODEGENER, V7, P1750; Davis MJ, 2012, BEHAV BRAIN RES, V229, P21, DOI 10.1016/j.bbr.2011.12.037; Demestre M, 2005, J NEUROIMMUNOL, V159, P146, DOI 10.1016/j.jneuroim.2004.09.015; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dragun P, 2008, J PHYSIOL PHARMACOL, V59, P441; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Fager N, 2000, MECH DEVELOP, V98, P105, DOI 10.1016/S0925-4773(00)00437-8; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Fernandez Eva, 2011, Pharmaceutics, V3, P53, DOI 10.3390/pharmaceutics3010053; Gooyit M, 2013, J MED CHEM, V56, P8139, DOI 10.1021/jm401217d; Gooyit M, 2012, ACS CHEM NEUROSCI, V3, P730, DOI 10.1021/cn300062w; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Jia F, 2014, J NEUROTRAUM, V24, P24; Jiang XF, 2001, NEUROSCI LETT, V305, P41, DOI 10.1016/S0304-3940(01)01800-6; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; Kawai N, 2003, J NEUROTRAUM, V20, P649, DOI 10.1089/089771503322144563; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Konrad K, 2003, COGNITIVE BRAIN RES, V16, P425, DOI 10.1016/S0926-6410(03)00057-0; Lazarov O, 2006, J NEUROSCI, V26, P429, DOI 10.1523/JNEUROSCI.3961-05.2006; Lee M, 2005, ORG LETT, V7, P4463, DOI 10.1021/ol0517269; Lee M, 2007, CHEM BIOL DRUG DES, V70, P371, DOI 10.1111/j.1747-0285.2007.00577.x; Liu CL, 2014, TURK NEUROSURG, V24, P363, DOI 10.5137/1019-5149.JTN.8551-13.0; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lorente Leonardo, 2014, PLoS One, V9, pe94370, DOI 10.1371/journal.pone.0094370; Lu A, 2013, NEUROSCIENCE, V253, P361, DOI 10.1016/j.neuroscience.2013.08.068; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Muradashvili N, 2014, METAB BRAIN DIS, V29, P29; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Oh LYS, 1999, J NEUROSCI, V19, P8464; Omouendze PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071263; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Pardridge William M, 2005, NeuroRx, V2, P1, DOI 10.1602/neurorx.2.1.1; Pastrana E, 2006, J NEUROSCI, V26, P5347, DOI 10.1523/JNEUROSCI.1111-06.2006; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Ranasinghe HS, 2012, DEV NEUROSCI-BASEL, V34, P417, DOI 10.1159/000343257; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Semple BD, 2015, NEUROBIOL DIS, P74; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Strolin Benedetti M, 2005, Expert Opin Drug Metab Toxicol, V1, P447; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Vaillant C, 1999, J NEUROSCI, V19, P4994; Verslegers M, 2015, BRAIN STRUCT FUNCT, V220, P1601, DOI 10.1007/s00429-014-0747-3; Verslegers M, 2013, PROG NEUROBIOL, V105, P60, DOI 10.1016/j.pneurobio.2013.03.004; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yang M, 2011, CURR PROT NEUROSCI, V8; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zheng KB, 2013, NEUROL INDIA, V61, P606, DOI 10.4103/0028-3886.125258	89	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143386	10.1371/journal.pone.0143386	http://dx.doi.org/10.1371/journal.pone.0143386			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588471	Green Published, gold			2022-12-27	WOS:000365251500056
J	Sung, U; Sepehri-Rad, M; Piao, HH; Jin, L; Hughes, T; Cohen, LB; Baker, BJ				Sung, Uhna; Sepehri-Rad, Masoud; Piao, Hong Hua; Jin, Lei; Hughes, Thomas; Cohen, Lawrence B.; Baker, Bradley J.			Developing Fast Fluorescent Protein Voltage Sensors by Optimizing FRET Interactions	PLOS ONE			English	Article							ACTION-POTENTIALS; OPTICAL ELECTROPHYSIOLOGY; SENSING PHOSPHATASE; ELECTRICAL-ACTIVITY; DYNAMIC-RANGE; NEURONS; DOMAIN; GREEN; DIMERIZATION; SPIKING	FRET (Forster Resonance Energy Transfer)-based protein voltage sensors can be useful for monitoring neuronal activity in vivo because the ratio of signals between the donor and acceptor pair reduces common sources of noise such as heart beat artifacts. We improved the performance of FRET based genetically encoded Fluorescent Protein (FP) voltage sensors by optimizing the location of donor and acceptor FPs flanking the voltage sensitive domain of the Ciona intestinalis voltage sensitive phosphatase. First, we created 39 different "Nabi1" constructs by positioning the donor FP, UKG, at 8 different locations downstream of the voltage-sensing domain and the acceptor FP, mKO, at 6 positions upstream. Several of these combinations resulted in large voltage dependent signals and relatively fast kinetics. Nabi1 probes responded with signal size up to 11%Delta F/F for a 100 mV depolarization and fast response time constants both for signal activation (similar to 2ms) and signal decay (similar to 3ms). We improved expression in neuronal cells by replacing the mKO and UKG FRET pair with Clover (donor FP) and mRuby2 (acceptor FP) to create Nabi2 probes. Nabi2 probes also had large signals and relatively fast time constants in HEK293 cells. In primary neuronal culture, a Nabi2 probe was able to differentiate individual action potentials at 45 Hz.	[Sung, Uhna; Sepehri-Rad, Masoud; Piao, Hong Hua; Cohen, Lawrence B.; Baker, Bradley J.] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Jin, Lei; Cohen, Lawrence B.] Yale Univ, Sch Med, Dept Mol & Cellular Physiol, New Haven, CT USA; [Hughes, Thomas] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Korea Institute of Science & Technology (KIST); Yale University; Montana State University System; Montana State University Bozeman	Sung, U (corresponding author), Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea.	uhna.sung@gmail.com; lawrence.b.cohen@hotmail.com; bradley.baker19@gmail.com	Baker, Bradley/P-5047-2016	Baker, Bradley/0000-0003-4652-5585; Hughes, Thomas/0000-0002-8430-070X	National Institute of Health, USA [DC005259, U24NS057631]; World Class Institute program of the National Research Foundation of Korea [WCI 2009-003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS057631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC005259, R01DC005259] Funding Source: NIH RePORTER	National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class Institute program of the National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: This work was supported by: DC005259, and U24NS057631 from National Institute of Health, USA; www.nih.gov; the World Class Institute program of the National Research Foundation of Korea grant Number WCI 2009-003, www.nrf.re.kr/nrf_eng_cms/.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Akemann W, 2009, BIOPHYS J, V96, P3959, DOI 10.1016/j.bpj.2009.02.046; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Gong YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4674; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Jensen KK, 2001, BIOCHEMISTRY-US, V40, P938, DOI 10.1021/bi001765m; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Jung A, 2015, NEUROPHOTON IN PRESS, V2; Kotera I, 2010, ACS CHEM BIOL, V5, P215, DOI 10.1021/cb900263z; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; LOEW LM, 1985, BIOPHYS J, V47, P71, DOI 10.1016/S0006-3495(85)83878-9; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Perron A, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.005.2009; Piao HH, 2015, J NEUROSCI, V35, P372, DOI 10.1523/JNEUROSCI.3008-14.2015; Popovic MA, 2011, J PHYSIOL-LONDON, V589, P4167, DOI 10.1113/jphysiol.2011.209015; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Storace DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10212; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Tsutsui H, 2013, J PHYSIOL-LONDON, V591, P4427, DOI 10.1113/jphysiol.2013.257048; Tsutsui H, 2013, BIOPHYS J, V105, P108, DOI 10.1016/j.bpj.2013.05.051; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Villalba-Galea CA, 2013, J GEN PHYSIOL, V142, P543, DOI 10.1085/jgp.201310993; Vinkenborg JL, 2007, CHEMBIOCHEM, V8, P1119, DOI 10.1002/cbic.200700109; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zou P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5625	30	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0141585	10.1371/journal.pone.0141585	http://dx.doi.org/10.1371/journal.pone.0141585			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587834	gold, Green Published, Green Submitted			2022-12-27	WOS:000365251500004
J	Asadzadeh, M; Ahmad, S; Hagen, F; Meis, JF; Al-Sweih, N; Khan, Z				Asadzadeh, Mohammad; Ahmad, Suhail; Hagen, Ferry; Meis, Jacques F.; Al-Sweih, Noura; Khan, Ziauddin			Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis	PLOS ONE			English	Article							ANTIFUNGAL SUSCEPTIBILITY PROFILES; FLIGHT MASS-SPECTROMETRY; SENSU-LATO; GENETIC DIVERSITY; C-PARAPSILOSIS; IDENTIFICATION; METAPSILOSIS; DIFFERENTIATION; PREVALENCE; REVEALS	Candida parapsilosis has now emerged as the second or third most important cause of healthcare-associated Candida infections. Molecular studies have shown that phenotypically identified C. parapsilosis isolates represent a complex of three species, namely, C. parapsilosis, C. orthopsilosis and C. metapsilosis. Lodderomyces elongisporus is another species phenotypically closely related to the C. parapsilosis-complex. The aim of this study was to develop a simple, low cost multiplex (m) PCR assay for species-specific identification of C. parapsilosis complex isolates and to study genetic relatedness of C. orthopsilosis isolates in Kuwait. Species-specific amplicons from C. parapsilosis (171 bp), C. orthopsilosis (109 bp), C. metapsilosis (217 bp) and L. elongisporus (258 bp) were obtained in mPCR. Clinical isolates identified as C. parapsilosis (n = 380) by Vitek2 in Kuwait and an international collection of 27 C. parapsilosis complex and L. elongisporus isolates previously characterized by rDNA sequencing were analyzed to evaluate mPCR. Species-specific PCR and DNA sequencing of internal transcribed spacer (ITS) region of rDNA were performed to validate the results of mPCR. Fingerprinting of 19 clinical C. orthopsilosis isolates (including 4 isolates from a previous study) was performed by amplified fragment length polymorphism (AFLP) analysis. Phenotypically identified C. parapsilosis isolates (n = 380) were identified as C. parapsilosis sensu stricto (n = 361), C. orthopsilosis (n = 15), C. metapsilosis (n = 1) and L. elongisporus (n = 3) by mPCR. The mPCR also accurately detected all epidemiologically unrelated C. parapsilosis complex and L. elongisporus isolates. The 19 C. orthopsilosis isolates obtained from 16 patients were divided into 3 haplotypes based on ITS region sequence data. Seven distinct genotypes were identified among the 19 C. orthopsilosis isolates by AFLP including a dominant genotype (AFLP1) comprising 11 isolates recovered from 10 patients. A rapid, low-cost mPCR assay for detection and differentiation of C. parapsilosis, C. orthopsilosis, C. metapsilosis and L. elongisporus has been developed.	[Asadzadeh, Mohammad; Ahmad, Suhail; Al-Sweih, Noura; Khan, Ziauddin] Kuwait Univ, Fac Med, Dept Microbiol, Safat, Kuwait; [Hagen, Ferry; Meis, Jacques F.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Meis, Jacques F.] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands	Kuwait University; Canisius-Wilhelmina Hospital; Radboud University Nijmegen	Khan, Z (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Safat, Kuwait.	Zkhan@hsc.edu.kw	Meis, Jacques F/A-9241-2010; Hagen, Ferry/B-9044-2009; Ahmad, Suhail/AAJ-5456-2021	Meis, Jacques F/0000-0003-3253-6080; Hagen, Ferry/0000-0002-5622-1916; asadzadeh, Mohammad/0000-0002-9151-1505	College of Graduate Studies, Kuwait University;  [SRUL 02/13]	College of Graduate Studies, Kuwait University; 	The study was supported by College of Graduate Studies, Kuwait University and Research Core Facility Grant No. SRUL 02/13.	Ahmad S, 2004, INT J MED MICROBIOL, V294, P45, DOI 10.1016/j.ijmm.2004.01.002; Asadzadeh M, 2008, MYCOSES, V51, P318, DOI 10.1111/j.1439-0507.2008.01492.x; Asadzadeh M, 2009, J MED MICROBIOL, V58, P745, DOI 10.1099/jmm.0.008235-0; Barbedo LS, 2015, J MED MICROBIOL, V64, P7, DOI 10.1099/jmm.0.080655-0; Bonfietti LX, 2012, J MED MICROBIOL, V61, P1003, DOI 10.1099/jmm.0.037812-0; Canton E, 2011, ANTIMICROB AGENTS CH, V55, P5590, DOI 10.1128/AAC.00466-11; Chao QT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109376; Chen CY, 2015, J ANTIMICROB CHEMOTH, V70, P1531, DOI 10.1093/jac/dku540; Chen YC, 2010, DIAGN MICR INFEC DIS, V68, P284, DOI 10.1016/j.diagmicrobio.2010.07.004; Clinical and Laboratory standards Institute, 2012, M27S4 CLIN LAB STAND; Cornet M, 2011, J MOL DIAGN, V13, P12, DOI 10.1016/j.jmoldx.2010.11.014; De Carolis E, 2014, MED MYCOL, V52, P123, DOI 10.1093/mmy/myt009; Vercher MD, 2011, INT J MED MICROBIOL, V301, P531, DOI 10.1016/j.ijmm.2011.02.001; Feng XB, 2014, J CLIN MICROBIOL, V52, P1758, DOI 10.1128/JCM.00105-14; Feng XB, 2012, MYCOPATHOLOGIA, V173, P229, DOI 10.1007/s11046-011-9496-5; Gago S, 2014, MED MYCOL, V52, P470, DOI 10.1093/mmy/myu009; Garcia-Effron G, 2011, J CLIN MICROBIOL, V49, P3257, DOI 10.1128/JCM.00508-11; Ghosh AK, 2015, CLIN MICROBIOL INFEC, V21, P372, DOI 10.1016/j.cmi.2014.11.009; Hays C, 2011, J MED MICROBIOL, V60, P477, DOI 10.1099/jmm.0.026633-0; Hospenthal Duane R, 2006, Ann Clin Microbiol Antimicrob, V5, P1, DOI 10.1186/1476-0711-5-1; Illnait-Zaragozi MT, 2012, MYCOSES, V55, pe138, DOI 10.1111/j.1439-0507.2012.02168.x; Jamal WY, 2014, INT J INFECT DIS, V26, P167, DOI 10.1016/j.ijid.2014.05.031; Khan ZU, 2008, ANTON LEEUW INT J G, V94, P343, DOI 10.1007/s10482-008-9251-1; Khan ZU, 2010, ANTON LEEUW INT J G, V97, P253, DOI 10.1007/s10482-009-9406-8; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P374, DOI 10.1128/JCM.01790-07; Merseguel KB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0793-3; Mirhendi H, 2010, J MED MICROBIOL, V59, P414, DOI 10.1099/jmm.0.017293-0; ODDS FC, 1994, J CLIN MICROBIOL, V32, P1923, DOI 10.1128/JCM.32.8.1923-1929.1994; Oliveira VKP, 2014, PEDIATR NEONATOL, V55, P75, DOI 10.1016/j.pedneo.2013.07.006; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Pryszcz LP, 2014, GENOME BIOL EVOL, V6, P1069, DOI 10.1093/gbe/evu082; Riccombeni A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035750; Romeo O, 2012, DIAGN MICR INFEC DIS, V72, P234, DOI 10.1016/j.diagmicrobio.2011.12.002; Ruiz LD, 2013, MYCOPATHOLOGIA, V175, P231, DOI 10.1007/s11046-013-9616-5; Sahand IH, 2009, J MED MICROBIOL, V58, P1437, DOI 10.1099/jmm.0.011320-0; Sai SX, 2011, EUKARYOT CELL, V10, P578, DOI 10.1128/EC.00276-10; Silva AP, 2009, J CLIN MICROBIOL, V47, P2392, DOI 10.1128/JCM.02379-08; Souza ACR, 2012, J CLIN MICROBIOL, V50, P2310, DOI 10.1128/JCM.00303-12; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Tavanti A, 2007, J CLIN MICROBIOL, V45, P1455, DOI 10.1128/JCM.00243-07; Tavanti A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-203; Tay ST, 2009, J MED MICROBIOL, V58, P185, DOI 10.1099/jmm.0.004242-0; Trabasso P, 2015, MYCOPATHOLOGIA, V179, P53, DOI 10.1007/s11046-014-9830-9; Zhu YX, 2015, MYCOPATHOLOGIA, V179, P111, DOI 10.1007/s11046-014-9821-x	46	38	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142880	10.1371/journal.pone.0142880	http://dx.doi.org/10.1371/journal.pone.0142880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580965	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600065
J	Ben-Simhon, Z; Judeinstein, S; Trainin, T; Harel-Beja, R; Bar-Ya'akov, I; Borochov-Neori, H; Holland, D				Ben-Simhon, Zohar; Judeinstein, Sylvie; Trainin, Taly; Harel-Beja, Rotem; Bar-Ya'akov, Irit; Borochov-Neori, Hamutal; Holland, Doron			A "White" Anthocyanin-less Pomegranate (Punica granatum L.) Caused by an Insertion in the Coding Region of the Leucoanthocyanidin Dioxygenase (LDOX; ANS) Gene	PLOS ONE			English	Article							ONIONS ALLIUM-CEPA; FRUIT CHARACTERISTICS; PINK TRAIT; BIOSYNTHESIS; ARABIDOPSIS; SYNTHASE; EXPRESSION; MUTANT; ACCUMULATION; MUTATION	Color is an important determinant of pomegranate fruit quality and commercial value. To understand the genetic factors controlling color in pomegranate, chemical, molecular and genetic characterization of a "white" pomegranate was performed. This unique accession is lacking the typical pomegranate color rendered by anthocyanins in all tissues of the plant, including flowers, fruit (skin and arils) and leaves. Steady-state gene-expression analysis indicated that none of the analyzed "white" pomegranate tissues are able to synthesize mRNA corresponding to the PgLDOX gene (leucoanthocyanidin dioxygenase, also called ANS, anthocyanidin synthase), which is one of the central structural genes in the anthocyanin-biosynthesis pathway. HPLC analysis revealed that none of the "white" pomegranate tissues accumulate anthocyanins, whereas other flavonoids, corresponding to biochemical reactions upstream of LDOX, were present. Molecular analysis of the "white" pomegranate revealed the presence of an insertion and an SNP within the coding region of PgLDOX. It was found that the SNP does not change amino acid sequence and is not fully linked with the "white" phenotype in all pomegranate accessions from the collection. On the other hand, genotyping of pomegranate accessions from the collection and segregating populations for the "white" phenotype demonstrated its complete linkage with the insertion, inherited as a recessive single-gene trait. Taken together, the results indicate that the insertion in PgLDOX is responsible for the "white" anthocyanin-less phenotype. These data provide the first direct molecular, genetic and chemical evidence for the effect of a natural modification in the LDOX gene on color accumulation in a fruit-bearing woody perennial deciduous tree. This modification can be further utilized to elucidate the physiological role of anthocyanins in protecting the tree organs from harmful environmental conditions, such as temperature and UV radiation.	[Ben-Simhon, Zohar; Trainin, Taly; Harel-Beja, Rotem; Bar-Ya'akov, Irit; Holland, Doron] Agr Res Org, Newe Yaar Res Ctr, Unit Deciduous Fruit Tree Sci, IL-30095 Ramat Yishay, Israel; [Ben-Simhon, Zohar] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Judeinstein, Sylvie; Borochov-Neori, Hamutal] Southern Arava Res & Dev, IL-88820 Hevel Eilot, Israel	Technion Israel Institute of Technology	Holland, D (corresponding author), Agr Res Org, Newe Yaar Res Ctr, Unit Deciduous Fruit Tree Sci, POB 1021, IL-30095 Ramat Yishay, Israel.	vhhollan@volcani.agri.gov.il			Israeli Ministry of Agriculture & Rural Development; Jewish National Fund (KKL); JCA Charitable Foundation	Israeli Ministry of Agriculture & Rural Development; Jewish National Fund (KKL); JCA Charitable Foundation	The authors thank the Chief Scientist of the Israeli Ministry of Agriculture & Rural Development for financing the pomegranate breeding program. The authors also thank the Jewish National Fund (KKL) and the JCA Charitable Foundation for additional financial support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Appelhagen I, 2011, GENE, V484, P62, DOI 10.1016/j.gene.2011.05.031; Bassolino L, 2013, NEW PHYTOL, V200, P650, DOI 10.1111/nph.12524; Ben-Simhon Z, 2011, PLANTA, V234, P865, DOI 10.1007/s00425-011-1438-4; Borochov-Neori H, 2011, J AGR FOOD CHEM, V59, P5325, DOI 10.1021/jf2003688; Chagne D, 2008, GENOMICS, V92, P353, DOI 10.1016/j.ygeno.2008.07.008; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Debes MA, 2011, AM J BOT, V98, P2077, DOI 10.3732/ajb.1000373; Dick CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018230; Dressel A, 2009, PLANT BIOLOGY, V11, P204, DOI 10.1111/j.1438-8677.2008.00099.x; Feng YuZeng, 2006, China Fruits, P57; Fischer UA, 2011, FOOD CHEM, V127, P807, DOI 10.1016/j.foodchem.2010.12.156; Ghosh D, 2007, ASIA PAC J CLIN NUTR, V16, P200; GIL MI, 1995, J SCI FOOD AGR, V68, P77, DOI 10.1002/jsfa.2740680113; Gollop R, 2001, PLANT SCI, V161, P579, DOI 10.1016/S0168-9452(01)00445-9; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Guo CJ, 2003, NUTR RES, V23, P1719, DOI 10.1016/j.nutres.2003.08.005; Hajimahmoodi M, 2008, Pak J Biol Sci, V11, P1600, DOI 10.3923/pjbs.2008.1600.1604; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Hernandez F, 1999, EUR FOOD RES TECHNOL, V210, P39, DOI 10.1007/s002170050529; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Holland D., 2008, Chronica Horticulturae, V48, P12; Holland D., 2009, Horticultural Reviews, V35, P127; Hou DX, 2004, J BIOMED BIOTECHNOL, P321, DOI 10.1155/S1110724304403040; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Kim S, 2005, THEOR APPL GENET, V110, P573, DOI 10.1007/s00122-004-1875-6; Kim S, 2004, MOL GENET GENOMICS, V272, P411, DOI 10.1007/s00438-004-1076-7; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Kong JM, 2003, PHYTOCHEMISTRY, V64, P923, DOI 10.1016/S0031-9422(03)00438-2; Kotepong P, 2011, FUNCT PLANT BIOL, V38, P75, DOI 10.1071/FP10164; Kowalczyk E, 2003, POL J PHARMACOL, V55, P699; Levin G.M., 2006, POMEGRANATE ROADS SO; Li H, 2013, PLANTA, V238, P695, DOI 10.1007/s00425-013-1917-x; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Martens S, 2010, PHYTOCHEMISTRY, V71, P1040, DOI 10.1016/j.phytochem.2010.04.016; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Nakamura N., 2006, PLANT BIOTECHNOL, V23, P13, DOI DOI 10.5511/plantbiotechnology.23.13; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Niu SS, 2010, PLANTA, V231, P887, DOI 10.1007/s00425-009-1095-z; Ogundiwin EA, 2008, TREE GENET GENOMES, V4, P543, DOI 10.1007/s11295-007-0130-0; Ohno S, 2013, PLANTA, V238, P331, DOI 10.1007/s00425-013-1897-x; Ohno S, 2011, PLANTA, V234, P945, DOI 10.1007/s00425-011-1456-2; Ono NN, 2011, J INTEGR PLANT BIOL, V53, P800, DOI 10.1111/j.1744-7909.2011.01073.x; Opara LU, 2009, FOOD BIOPROCESS TECH, V2, P315, DOI 10.1007/s11947-008-0095-5; Ophir R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088998; Ozguven AI, 1997, ACTA HORTIC, P345; Pelletier MK, 1997, PLANT PHYSIOL, V113, P1437, DOI 10.1104/pp.113.4.1437; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Salvatierra A, 2013, PHYTOCHEMISTRY, V90, P25, DOI 10.1016/j.phytochem.2013.02.016; Sarkhosh A, 2006, SCI HORTIC-AMSTERDAM, V111, P24, DOI 10.1016/j.scienta.2006.07.033; Saud G, 2009, GENET RESOUR CROP EV, V56, P895, DOI 10.1007/s10722-009-9487-2; Schijlen EGW, 2004, PHYTOCHEMISTRY, V65, P2631, DOI 10.1016/j.phytochem.2004.07.028; Stover E, 2007, HORTSCIENCE, V42, P1088, DOI 10.21273/HORTSCI.42.5.1088; Szankowski I, 2009, PLANTA, V229, P681, DOI 10.1007/s00425-008-0864-4; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tsuda T, 2012, MOL NUTR FOOD RES, V56, P159, DOI 10.1002/mnfr.201100526; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Wilmouth RC, 2002, STRUCTURE, V10, P93, DOI 10.1016/S0969-2126(01)00695-5; Zamani Z, 2007, J HORTIC SCI BIOTECH, V82, P11, DOI 10.1080/14620316.2007.11512192; Zenoni S, 2011, PLANT J, V68, P11, DOI 10.1111/j.1365-313X.2011.04661.x; Zhang Y, 2013, CURR BIOL, V23, P1094, DOI 10.1016/j.cub.2013.04.072; Zhao XQ, 2015, J PLANT RES, V128, P687, DOI 10.1007/s10265-015-0717-8	70	48	56	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142777	10.1371/journal.pone.0142777	http://dx.doi.org/10.1371/journal.pone.0142777			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581077	gold, Green Submitted, Green Published			2022-12-27	WOS:000365154600059
J	Hung, WC; Chen, HJ; Lin, YT; Tsai, JC; Chen, CW; Lu, HH; Tseng, SP; Jheng, YY; Leong, KH; Teng, LJ				Hung, Wei-Chun; Chen, Hsiao-Jan; Lin, Yu-Tzu; Tsai, Jui-Chang; Chen, Chiao-Wei; Lu, Hsiao-Hung; Tseng, Sung-Pin; Jheng, Yao-Yu; Leong, Kin Hong; Teng, Lee-Jene			Skin Commensal Staphylococci May Act as Reservoir for Fusidic Acid Resistance Genes	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; CASSETTE CHROMOSOME MEC; ELONGATION-FACTOR-G; AUREUS; EPIDERMIDIS; IDENTIFICATION; FUSB; SEQUENCE; ISLANDS; SPP.	We analyzed the occurrence and mechanisms of fusidic acid resistance present in staphylococci isolated from 59 healthy volunteers. The fingers of the volunteers were screened for the presence of staphylococci, and the collected isolates were tested for resistance to fusidic acid. A total of 34 fusidic acid resistant staphylococcal strains (all were coagulase-negative) were isolated from 22 individuals (22/59, 37.3%). Examination of the resistance genes revealed that acquired fusB or fusC was present in Staphylococcus epidermidis, Staphylococcus capitis subsp. urealyticus, Staphylococcus hominis subsp. hominis, Staphylococcus warneri and Staphylococcus haemolyticus. Resistance islands (RIs) carrying fusB were found in S. epidermidis and S. capitis subsp. urealyticus, while staphylococcal chromosome cassette (SCC)-related structures harboring fusC were found in S. hominis subsp. hominis. Genotypic analysis of S. epidermidis and S. hominis subsp. hominis indicated that the fus elements were disseminated in diverse genetic strain backgrounds. The fusC elements in S. hominis subsp. hominis strains were highly homologous to SCCfusC in the epidemic sequence type (ST) 239/SCCmecIII methicillin-resistant S. aureus (MRSA) or the pseudo SCCmec in ST779 MRSA. The presence of acquired fusidic acid resistance genes and their genetic environment in commensal staphylococci suggested that the skin commensal staphylococci may act as reservoir for fusidic acid resistance genes.	[Hung, Wei-Chun] Kaohsiung Med Univ, Dept Microbiol & Immunol, Kaohsiung, Taiwan; [Chen, Hsiao-Jan; Lin, Yu-Tzu; Jheng, Yao-Yu; Leong, Kin Hong; Teng, Lee-Jene] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Tsai, Jui-Chang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Med, Taipei 10764, Taiwan; [Tsai, Jui-Chang] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Chen, Chiao-Wei; Lu, Hsiao-Hung] Taipei First Girls High Sch, Taipei, Taiwan; [Tseng, Sung-Pin] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Teng, Lee-Jene] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	Kaohsiung Medical University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; National Taiwan University; National Taiwan University Hospital	Teng, LJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	ljteng@ntu.edu.tw		Lin, Yu-Tzu/0000-0002-3815-6305; TSAI, JUI-CHANG/0000-0003-2723-6841; Tseng, sung-pin/0000-0001-8915-5268; TENG, LEE-JENE/0000-0003-0104-741X	National Science Council of Taiwan [NSC 100-2320-B-002-014-MY3]; Ministry of Science and Technology of Taiwan [MOST 103-2320-B-002-056-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan (NSC 100-2320-B-002-014-MY3) and from Ministry of Science and Technology of Taiwan (MOST 103-2320-B-002-056-MY3).	Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x; Besier S, 2003, MOL MICROBIOL, V47, P463, DOI 10.1046/j.1365-2958.2003.03307.x; Borg A, 2015, J BIOL CHEM, V290, P3440, DOI 10.1074/jbc.M114.611608; Castanheira M, 2010, ANTIMICROB AGENTS CH, V54, P3614, DOI 10.1128/AAC.01390-09; Castanheira M, 2010, J ANTIMICROB CHEMOTH, V65, P1353, DOI 10.1093/jac/dkq094; Chen HJ, 2015, J ANTIMICROB CHEMOTH, V70, P416, DOI 10.1093/jac/dku408; Chen HJ, 2013, ANTIMICROB AGENTS CH, V57, P5737, DOI 10.1128/AAC.01433-13; Chen HJ, 2011, ANTIMICROB AGENTS CH, V55, P5842, DOI 10.1128/AAC.00592-11; Chen HJ, 2010, ANTIMICROB AGENTS CH, V54, P4985, DOI 10.1128/AAC.00523-10; Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Coutant C, 1996, DIAGN MICR INFEC DIS, V25, P9, DOI 10.1016/0732-8893(96)00070-3; Cox G, 2012, P NATL ACAD SCI USA, V109, P2102, DOI 10.1073/pnas.1117275109; den Heijer CDJ, 2014, FUTURE MICROBIOL, V9, P737, DOI [10.2217/fmb.14.36, 10.2217/FMB.14.36]; Dobie D, 2004, ARCH DIS CHILD, V89, P74, DOI 10.1136/adc.2003.019695; Du X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062742; Ender M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-62; European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS; Guo XH, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120016; Hauschild T, 2008, J CLIN MICROBIOL, V46, P3875, DOI 10.1128/JCM.00810-08; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Jones RN, 2011, CLIN INFECT DIS, V52, pS477, DOI 10.1093/cid/cir163; Kinnevey PM, 2013, ANTIMICROB AGENTS CH, V57, P524, DOI 10.1128/AAC.01689-12; Koripella RK, 2012, J BIOL CHEM, V287, P30257, DOI 10.1074/jbc.M112.378521; Lin YT, 2014, ANTIMICROB AGENTS CH, V58, P1224, DOI 10.1128/AAC.01772-13; Liu D, 2006, LETT APPL MICROBIOL, V43, P325, DOI 10.1111/j.1472-765X.2006.01948.x; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mendes RE, 2012, ANTIMICROB AGENTS CH, V56, P4656, DOI 10.1128/AAC.00279-12; Norstrom T, 2007, ANTIMICROB AGENTS CH, V51, P4438, DOI 10.1128/AAC.00328-07; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; O'Brien FG, 2002, J ANTIMICROB CHEMOTH, V50, P313, DOI 10.1093/jac/dkf153; O'Neill AJ, 2007, ANTIMICROB AGENTS CH, V51, P1737, DOI 10.1128/AAC.01542-06; O'Neill AJ, 2007, J CLIN MICROBIOL, V45, P1505, DOI 10.1128/JCM.01984-06; O'Neill AJ, 2006, MOL MICROBIOL, V59, P664, DOI 10.1111/j.1365-2958.2005.04971.x; Piette A, 2009, VET MICROBIOL, V134, P45, DOI 10.1016/j.vetmic.2008.09.009; Planet PJ, 2013, MBIO, V4, DOI 10.1128/mBio.00889-13; Iorio NLP, 2012, DIAGN MICR INFEC DIS, V72, P32, DOI 10.1016/j.diagmicrobio.2011.09.017; Qin N, 2012, J BACTERIOL, V194, P4469, DOI 10.1128/JB.00827-12; Rolo J, 2012, J ANTIMICROB CHEMOTH, V67, P1333, DOI 10.1093/jac/dks068; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Wang JL, 2012, INT J ANTIMICROB AG, V40, P103, DOI 10.1016/j.ijantimicag.2012.03.010; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Yu DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087346; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058440, 10.1371/journal.pone.0066496]	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143106	10.1371/journal.pone.0143106	http://dx.doi.org/10.1371/journal.pone.0143106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581090	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600084
J	Ledo, A				Ledo, Alicia			Nature and Age of Neighbours Matter: Interspecific Associations among Tree Species Exist and Vary across Life Stages in Tropical Forests	PLOS ONE			English	Article							NEGATIVE DENSITY-DEPENDENCE; PLANT-COMMUNITIES; HABITAT ASSOCIATIONS; NEOTROPICAL FOREST; SPATIAL-PATTERNS; DIVERSITY; FACILITATION; COMPETITION; HYPOTHESES; CANOPY	Detailed information about interspecific spatial associations among tropical tree species is scarce, and hence the ecological importance of those associations may have been underestimated. However, they can play a role in community assembly and species diversity maintenance. This study investigated the spatial dependence between pairs of species. First, the spatial associations (spatial attraction and spatial repulsion) that arose between species were examined. Second, different sizes of trees were considered in order to evaluate whether the spatial relationships between species are constant or vary during the lifetime of individuals. Third, the consistency of those spatial associations with the species-habitat associations found in previous studies was assessed. Two different tropical ecosystems were investigated: a montane cloud forest and a lowland moist forest. The results showed that spatial associations among species exist, and these vary among life stages and species. The rarity of negative spatial interactions suggested that exclusive competition was not common in the studied forests. On the other hand, positive interactions were common, and the results of this study strongly suggested that habitat associations were not the only cause of spatial attraction among species. If this is true, habitat associations and density dependence are not the only mechanisms that explain species distribution and diversity; other ecological interactions, such as facilitation among species, may also play a role. These spatial associations could be important in the assembly of tropical tree communities and forest succession, and should be taken into account in future studies.	[Ledo, Alicia] Univ Aberdeen, Aberdeen, Scotland	University of Aberdeen	Ledo, A (corresponding author), Univ Aberdeen, Aberdeen, Scotland.	alicialedo@gmail.com			Universidad Politecnica de Madrid; FP7-PEOPLE-IEF Marie-Curie Action	Universidad Politecnica de Madrid; FP7-PEOPLE-IEF Marie-Curie Action	This research was funded through a PhD grant from the Universidad Politecnica de Madrid, and support of a FP7-PEOPLE-2013-IEF Marie-Curie Action.; This research was funded through a PhD grant from the Universidad Politecnica de Madrid, and finished thanks to the support of a FP7-PEOPLE-2013-IEF Marie-Curie Action. We are indebted to Wilder Caba Culquicondor for his help with the field work. I accept responsibility for all missing species identifications. Data from BCI were provided by the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the primary granting agencies that have supported the BCI plot. Thanks to Sonia Condes and Fernando Montes, supervisors of my PhD.	Bagchi R, 2011, ECOLOGY, V92, P1723, DOI 10.1890/11-0335.1; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1998, TROPICAL FOREST CENS; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hu YH, 2012, OIKOS, V121, P952, DOI 10.1111/j.1600-0706.2011.19831.x; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Illian J, 2008, STAT ANAL MODELLING; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kitajima K, 2005, ANN BOT-LONDON, V95, P535, DOI 10.1093/aob/mci051; Law R, 2000, ECOLOGY, V81, P2137, DOI 10.1890/0012-9658(2000)081[2137:ADSFNI]2.0.CO;2; Ledo A, 2013, J VEG SCI, V24, P1086, DOI 10.1111/jvs.12023; Ledo A, 2012, ACTA OECOL, V38, P49, DOI 10.1016/j.actao.2011.09.003; Ledo A, 2011, ECOL MODEL, V222, P580, DOI 10.1016/j.ecolmodel.2010.10.029; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Montgomery RA, 2002, OECOLOGIA, V131, P165, DOI 10.1007/s00442-002-0872-1; Pacala SW, 1998, AM NAT, V152, P729, DOI 10.1086/286203; PACALA SW, 1994, AM NAT, V143, P222, DOI 10.1086/285602; Pardos M, 2007, EUR J FOREST RES, V126, P37, DOI 10.1007/s10342-005-0090-6; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Scatena F.N., 2011, TROPICAL MONTANE CLO; Sheil D, 2003, TRENDS ECOL EVOL, V18, P18, DOI 10.1016/S0169-5347(02)00005-8; Uriarte M, 2012, ECOLOGY, V93, P191, DOI 10.1890/10-2422.1; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; Valiente-Banuet A, 2008, J ECOL, V96, P489, DOI 10.1111/j.1365-2745.2008.01357.x; Wiegand T, 2007, ECOLOGY, V88, P3088, DOI 10.1890/06-1350.1; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	41	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141387	10.1371/journal.pone.0141387	http://dx.doi.org/10.1371/journal.pone.0141387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581110	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600015
J	Markikou-Ouni, W; Drini, S; Bahi-Jaber, N; Chenik, M; Meddeb-Garnaoui, A				Markikou-Ouni, Wafa; Drini, Sima; Bahi-Jaber, Narges; Chenik, Mehdi; Meddeb-Garnaoui, Amel			Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation	PLOS ONE			English	Article							EXCRETED-SECRETED ANTIGENS; HOST IMMUNE-RESPONSE; NF-KAPPA-B; TYROSINE-PHOSPHATASE SHP-1; FACTOR-ALPHA PRODUCTION; VISCERAL LEISHMANIASIS; MAJOR INFECTION; T-CELLS; CUTANEOUS LEISHMANIASIS; PROTECTIVE IMMUNITY	Leishmania parasites and some molecules they secrete are known to modulate innate immune responses through effects on dendritic cells (DCs) and macrophages. Here, we characterized four Leishmania infantum potentially excreted/secreted recombinant proteins (LipESP) identified in our laboratory: Elongation Factor 1 alpha (LiEF-1 alpha), a proteasome regulatory ATPase (LiAAA-ATPase) and two novel proteins with unknown functions, which we termed LiP15 and LiP23, by investigating their effect on in vitro differentiation and maturation of human DCs and on cytokine production by DCs and monocytes. During DCs differentiation, LipESP led to a significant decrease in CD1a. LiP23 and LiEF-1 alpha, induced a decrease of HLA-DR and an increase of CD86 surface expression, respectively. During maturation, an up-regulation of HLA-DR and CD80 was found in response to LiP15, LiP23 and LiAAA-ATPase, while an increase of CD40 expression was only observed in response to LiP15. All LipESP induced an over-expression of CD86 with significant differences between proteins. These proteins also induced significant IL-12p70 levels in immature DCs but not in monocytes. The LipESP-induced IL-12p70 production was significantly enhanced by a co-treatment with IFN-gamma in both cell populations. TNF-alpha and IL-10 were induced in DCs and monocytes with higher levels observed for LiP15 and LiAAA-ATPase. However, LPS-induced cytokine production during DC maturation or in monocyte cultures was significantly down regulated by LipESP co-treatment. Our findings suggest that LipESP strongly interfere with DCs differentiation suggesting a possible involvement in mechanisms established by the parasite for its survival. These proteins also induce DCs maturation by up-regulating several costimulatory molecules and by inducing the production of proinflammatory cytokines, which is a prerequisite for T cell activation. However, the reduced ability of LipESP-stimulated DCs and monocytes to respond to lipopolysaccharide (LPS) that can be observed during human leishmaniasis, suggests that under certain circumstances LipESP may play a role in disease progression.	[Markikou-Ouni, Wafa; Drini, Sima; Bahi-Jaber, Narges; Chenik, Mehdi; Meddeb-Garnaoui, Amel] Inst Pasteur Tunis, Lab Med Parasitol Biotechnol & Biomol, Tunis, Tunisia; [Drini, Sima] Inst Pasteur, Unite Parasitol Mol & Signalisat, Paris, France; [Bahi-Jaber, Narges] UPSP EGEAL Inst Polytech LaSalle Beauvais, Beauvais, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Meddeb-Garnaoui, A (corresponding author), Inst Pasteur Tunis, Lab Med Parasitol Biotechnol & Biomol, Tunis, Tunisia.	amel.garnaoui@pasteur.rns.tn			Tunisian Ministry for research and technology [IMM23]; Tunisian Ministry for Research and Technology	Tunisian Ministry for research and technology; Tunisian Ministry for Research and Technology	Funding was provided by IMM23, Tunisian Ministry for research and technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Blood Transfusion Service of Tunis for blood samples and especially blood donors for the generous donation of their cells. This work was supported by the Tunisian Ministry for Research and Technology.	Adams EJ, 2014, CURR OPIN IMMUNOL, V26, P1, DOI 10.1016/j.coi.2013.09.005; Agallou M, 2011, VACCINE, V29, P5053, DOI 10.1016/j.vaccine.2011.04.089; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amprey JL, 2004, INFECT IMMUN, V72, P589, DOI 10.1128/IAI.72.1.589-592.2004; Argueta-Donohue J, 2008, EXP PARASITOL, V120, P1, DOI 10.1016/j.exppara.2008.04.002; Barhoumi M, 2011, PARASITE IMMUNOL, V33, P583, DOI 10.1111/j.1365-3024.2011.01320.x; Bourreau E, 2009, INFECT IMMUN, V77, P1465, DOI 10.1128/IAI.01398-08; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Campos-Martin Y, 2006, J IMMUNOL, V176, P6172, DOI 10.4049/jimmunol.176.10.6172; Carrillo E, 2008, VACCINE, V26, P1902, DOI 10.1016/j.vaccine.2008.01.042; Chamakh-Ayari R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092708; Chaudhary R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/947606; Chenik M, 2006, PARASITOLOGY, V132, P493, DOI 10.1017/S0031182005009546; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; Cuervo P, 2009, J PROTEOMICS, V73, P79, DOI 10.1016/j.jprot.2009.08.006; DebRoy S, 2010, EXP PARASITOL, V126, P582, DOI 10.1016/j.exppara.2010.06.011; Donovan MJ, 2007, PARASITE IMMUNOL, V29, P515, DOI 10.1111/j.1365-3024.2007.00970.x; ELON J, 1992, ISRAEL J MED SCI, V28, P847; Favali C, 2007, J LEUKOCYTE BIOL, V82, P1401, DOI 10.1189/jlb.0307187; Favila MA, 2014, J IMMUNOL, V192, P5863, DOI 10.4049/jimmunol.1203230; Felio K, 2009, J EXP MED, V206, P2497, DOI 10.1084/jem.20090898; Fernandes ACS, 2013, FEMS MICROBIOL LETT, V340, P117, DOI 10.1111/1574-6968.12080; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Garcia MR, 1997, EUR J IMMUNOL, V27, P1005, DOI 10.1002/eji.1830270430; Ghosh M, 2006, J INFECT DIS, V194, P294, DOI 10.1086/505228; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Jayakumar A, 2008, INFECT IMMUN, V76, P2138, DOI 10.1128/IAI.01252-07; Jebbari H, 2002, INFECT IMMUN, V70, P1023, DOI 10.1128/IAI.70.2.1023-1026.2002; Kadivar M R, 2000, East Mediterr Health J, V6, P879; Kasmar AG, 2011, J EXP MED, V208, P1741, DOI 10.1084/jem.20110665; Kawashima T, 2003, J IMMUNOL, V170, P5345, DOI 10.4049/jimmunol.170.11.5345; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Lambertz U, 2012, J LEUKOCYTE BIOL, V91, P887, DOI 10.1189/jlb.0611326; Lemesre JL, 2005, VACCINE, V23, P2825, DOI 10.1016/j.vaccine.2004.11.061; Liu D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00083; Lockridge JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021701; Mariotti S, 2002, EUR J IMMUNOL, V32, P3050, DOI 10.1002/1521-4141(200211)32:11<3050::AID-IMMU3050>3.0.CO;2-K; Markikou-Ouni W, 2012, CLIN EXP IMMUNOL, V169, P273, DOI 10.1111/j.1365-2249.2012.04611.x; Marovich MA, 2000, J IMMUNOL, V164, P5858, DOI 10.4049/jimmunol.164.11.5858; Matheoud D, 2013, CELL HOST MICROBE, V14, P15, DOI 10.1016/j.chom.2013.06.003; McDowell MA, 2002, INFECT IMMUN, V70, P3994, DOI 10.1128/IAI.70.8.3994-4001.2002; Nandan D, 2005, CLIN IMMUNOL, V114, P266, DOI 10.1016/j.clim.2004.07.017; Nandan D, 2003, BIOCHEM BIOPH RES CO, V302, P646, DOI 10.1016/S0006-291X(03)00216-X; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Naouar I, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/636039; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Pinedo-Cancino V, 2013, AM J TROP MED HYG, V88, P559, DOI 10.4269/ajtmh.12-0587; Pletinckx K, 2011, EUR J IMMUNOL, V41, P3479, DOI 10.1002/eji.201141631; Probst P, 1997, EUR J IMMUNOL, V27, P2634, DOI 10.1002/eji.1830271024; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; Rai AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031551; Revest M, 2008, VACCINE, V26, P6119, DOI 10.1016/j.vaccine.2008.09.005; Rosa R, 2005, EXP PARASITOL, V109, P106, DOI 10.1016/j.exppara.2004.11.008; Santarem N, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/85154; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Siddiqui S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00337; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Soong L, 2008, J IMMUNOL, V180, P4355, DOI 10.4049/jimmunol.180.7.4355; Soong L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00058; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Tejle K, 2008, FEMS MICROBIOL LETT, V279, P92, DOI 10.1111/j.1574-6968.2007.01013.x; Tsigankov P, 2013, J PROTEOME RES, V12, P3405, DOI 10.1021/pr4002492; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; VANNIERSANTOS MA, 1995, EUR J CELL BIOL, V67, P112; Von Stebut E, 2007, EUR J DERMATOL, V17, P115, DOI 10.1684/ejd.2007.0122; Wiethe C, 2008, J IMMUNOL, V180, P4371, DOI 10.4049/jimmunol.180.7.4371; Zahn S, 2010, EXP DERMATOL, V19, P924, DOI 10.1111/j.1600-0625.2010.01149.x	70	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143063	10.1371/journal.pone.0143063	http://dx.doi.org/10.1371/journal.pone.0143063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581100	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600076
J	Schopmeyer, SA; Lirman, D				Schopmeyer, Stephanie A.; Lirman, Diego			Occupation Dynamics and Impacts of Damselfish Territoriality on Recovering Populations of the Threatened Staghorn Coral, Acropora cervicornis	PLOS ONE			English	Article							REEF FISHES; CORALLIOPHILA-ABBREVIATA; POMACENTRUS-LIVIDUS; HURRICANE ALLEN; STABLE STATES; DISCOVERY BAY; RESOURCE USE; RESTORATION; MORTALITY; COMMUNITY	Large-scale coral reef restoration is needed to help recover structure and function of degraded coral reef ecosystems and mitigate continued coral declines. In situ coral propagation and reef restoration efforts have scaled up significantly in past decades, particularly for the threatened Caribbean staghorn coral, Acropora cervicornis, but little is known about the role that native competitors and predators, such as farming damselfishes, have on the success of restoration. Steep declines in A. cervicornis abundance may have concentrated the negative impacts of damselfish algal farming on a much lower number of coral prey/colonies, thus creating a significant threat to the persistence and recovery of depleted coral populations. This is the first study to document the prevalence of resident damselfishes and negative effects of algal lawns on A. cervicornis along the Florida Reef Tract (FRT). Impacts of damselfish lawns on A. cervicornis colonies were more prevalent (21.6% of colonies) than those of other sources of mortality (i.e., disease (1.6%), algal/sponge overgrowth (5.6%), and corallivore predation (7.9%)), and damselfish activities caused the highest levels of tissue mortality (34.6%) among all coral stressors evaluated. The probability of damselfish occupation increased as coral colony size and complexity increased and coral growth rates were significantly lower in colonies with damselfish lawns (15.4 vs. 29.6 cm per year). Reduced growth and mortality of existing A. cervicornis populations may have a significant effect on population dynamics by potentially reducing important genetic diversity and the reproductive potential of depleted populations. On a positive note, however, the presence of resident damselfishes decreased predation by other corallivores, such as Coralliophila and Hermodice, and may offset some negative impacts caused by algal farming. While most negative impacts of damselfishes identified in this study affected large individual colonies and <50% of the A. cervicornis population along the FRT, the remaining wild staghorn population, along with the rapidly increasing restored populations, continue to fulfill important functional roles on coral reefs by providing essential habitat and refuge to other reef organisms. Although the effects of damselfish predation are, and will continue to be, pervasive, successful restoration efforts and strategic coral transplantation designs may help overcome damselfish damage by rapidly increasing A. cervicornis cover and abundance while also providing important information to educate future conservation and management decisions.	[Schopmeyer, Stephanie A.; Lirman, Diego] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, Miami, FL 33149 USA	University of Miami	Schopmeyer, SA (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	sschopmeyer@rsmas.miami.edu		Schopmeyer, Stephanie/0000-0003-4717-465X	National Oceanic and Atmospheric Administration Coral Reef Conservation Program [NA13NOS482]	National Oceanic and Atmospheric Administration Coral Reef Conservation Program	This study was supported by National Oceanic and Atmospheric Administration Coral Reef Conservation Program Award Number NA13NOS482. Funding awarded to DL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axline-Minotti BA, 2003, THESIS; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; BELK MS, 1975, COPEIA, P603; Beukers JS, 1997, OECOLOGIA, V111, P50, DOI DOI 10.1007/S004420050419); Bohnsack JA, 1982, FISH FOOD HABITS STU, P258; BRAWLEY SH, 1982, B MAR SCI, V32, P595; Casey JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1032; Catano LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118764; CLARKE RD, 1977, MAR BIOL, V40, P277, DOI 10.1007/BF00390882; D'Antonio C, 2002, RESTOR ECOL, V10, P703, DOI 10.1046/j.1526-100X.2002.01051.x; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Engeman Richard M., 2009, P171; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; FOSTER SA, 1985, OECOLOGIA, V67, P499, DOI 10.1007/BF00790020; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gordon TAC, 2015, CORAL REEFS, V34, P13, DOI 10.1007/s00338-014-1229-z; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Griffin JN, 2015, RESTOR ECOL, V23, P197, DOI 10.1111/rec.12173; Grober-Dunsmore R, 2006, MAR ECOL PROG SER, V321, P123, DOI 10.3354/meps321123; HAYES JA, 1990, J EXP MAR BIOL ECOL, V142, P25, DOI 10.1016/0022-0981(90)90135-Y; Hernandez-Delgado EA, 2001, MEM 24 S REC NAT, P77; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Hixon Mark A., 1997, P230; HOGARTH WT, 2006, FED REGISTER, P26852; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; ITZKOWITZ M, 1977, J EXP MAR BIOL ECOL, V28, P217, DOI 10.1016/0022-0981(77)90093-4; Johnson M.E., 2011, CARIBBEAN ACROPORA R; Johnston L, 2014, CORAL REEFS, V33, P1047, DOI 10.1007/s00338-014-1176-8; Jones GP, 2006, MAR ECOL PROG SER, V328, P215, DOI 10.3354/meps328215; KAUFMAN L, 1981, PALEOBIOLOGY, V7, P527, DOI 10.1017/S0094837300025562; Kaufman L, 1997, P 3 INT COR REEF S, P559; KINZIE RA, 1973, B MAR SCI, V23, P93; KLUMPP DW, 1989, J EXP MAR BIOL ECOL, V125, P145, DOI 10.1016/0022-0981(89)90040-3; KNOWLTON N, 1981, NATURE, V294, P251, DOI 10.1038/294251a0; KNOWLTON N, 1992, AM ZOOL, V32, P674; Knowlton N, 1990, SMITHSON CONTR MAR S, V31, P1, DOI DOI 10.5479/SI.01960768.31.1; Lirman D, 2014, ECOL INDIC, V44, P120, DOI 10.1016/j.ecolind.2013.10.021; Lirman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107253; Lobel PS., 1980, B MAR SCI, V30, P273; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Miller M.A., 2010, P GAT COMP ENV WORKS; Miller S.L, 2008, P 11 INT COR REEF S; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Mumby PJ, 2012, MAR ECOL PROG SER, V445, P13, DOI 10.3354/meps09450; Munday PL, 2001, OECOLOGIA, V128, P585, DOI 10.1007/s004420100690; MYRBERG AA, 1974, AM ZOOL, V14, P81; Nemeth RS, 1998, ENVIRON BIOL FISH, V53, P129, DOI 10.1023/A:1007402104047; Omori M, 2010, MAR BIOL RES, V7, P3, DOI 10.1080/17451001003642317; POTTS DC, 1977, J EXP MAR BIOL ECOL, V28, P207, DOI 10.1016/0022-0981(77)90092-2; Powles H, 2000, ICES J MAR SCI, V57, P669, DOI 10.1006/jmsc.2000.0711; Precht WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010835; RISK MJ, 1982, OECOLOGIA, V52, P376, DOI 10.1007/BF00367962; ROBERTSON DR, 1981, ECOLOGY, V62, P1162, DOI 10.2307/1937280; Roby DD, 2003, CAN J ZOOL, V81, P250, DOI 10.1139/Z02-242; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; SAMMARCO PW, 1982, MAR ECOL PROG SER, V8, P53, DOI 10.3354/meps008053; SAMMARCO PW, 1986, J EXP MAR BIOL ECOL, V98, P1, DOI 10.1016/0022-0981(86)90072-9; Schopmeyer SA, 2012, RESTOR ECOL, V20, P696, DOI 10.1111/j.1526-100X.2011.00836.x; SHINN EA, 1976, ENVIRON GEOL, V1, P241, DOI 10.1007/BF02407510; Silbiger NJ, 2014, MAR ECOL PROG SER, V515, P33, DOI 10.3354/meps10999; Silverman J, 2014, GEOCHIM COSMOCHIM AC, V144, P72, DOI 10.1016/j.gca.2014.09.011; Sponaugle S, 1996, MAR FRESHWATER RES, V47, P433, DOI 10.1071/MF9960433; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; TUNNICLIFFE V, 1983, B MAR SCI, V33, P132; Vermeij MJA, 2015, MAR ECOL PROG SER, V528, P289, DOI 10.3354/meps11243; VINE PJ, 1974, MAR BIOL, V24, P131, DOI 10.1007/BF00389347; Wellenreuther M, 2002, J EXP MAR BIOL ECOL, V273, P61, DOI 10.1016/S0022-0981(02)00145-4; Wilkes AA, 2008, SOUTHEAST NAT, V7, P483, DOI 10.1656/1528-7092-7.3.483; WILLIAMS AH, 1978, J EXP MAR BIOL ECOL, V34, P197, DOI 10.1016/S0022-0981(78)80002-1; WILLIAMS AH, 1981, ECOLOGY, V62, P1107, DOI 10.2307/1937008; WILLIAMS AH, 1984, J EXP MAR BIOL ECOL, V75, P233, DOI 10.1016/0022-0981(84)90168-0; Williams DE, 2012, CORAL REEFS, V31, P369, DOI 10.1007/s00338-011-0847-y; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143	78	31	32	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141302	10.1371/journal.pone.0141302	http://dx.doi.org/10.1371/journal.pone.0141302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580977	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600013
J	Kong, XM; Zhang, XL; Xing, XY; Zhang, B; Hong, J; Yang, WY				Kong, Xiaomu; Zhang, Xuelian; Xing, Xiaoyan; Zhang, Bo; Hong, Jing; Yang, Wenying			The Association of Type 2 Diabetes Loci Identified in Genome-Wide Association Studies with Metabolic Syndrome and Its Components in a Chinese Population with Type 2 Diabetes	PLOS ONE			English	Article							BETA-CELL FUNCTION; ORAL GLUCOSE-TOLERANCE; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; COMMON VARIANTS; GLYCEMIC TRAITS; LIPID-LEVELS; PPAR-GAMMA	Metabolic syndrome (MetS) is prevalent in type 2 diabetes (T2D) patients. The comorbidity of MetS and T2D increases the risk of cardiovascular complications. The aim of the present study was to determine the T2D-related genetic variants that contribute to MetS-related components in T2D patients of Chinese ancestry. We successfully genotyped 25 genome wide association study validated T2D-related single nucleotide polymorphisms (SNPs) among 5,169 T2D individuals and 4,560 normal glycemic controls recruited from the Chinese National Diabetes and Metabolic Disorders Study (DMS). We defined MetS in this population using the harmonized criteria (2009) combined with the Chinese criteria for abdominal obesity. The associations between SNPs and MetS-related components, as well as the associations between SNPs and risk for T2D with or without MetS, were subjected to logistic regression analysis adjusted for age and sex. Results showed that the T2D risk alleles of rs243021 located near BCL11A, rs10830963 in MTNR1B, and rs2237895 in KCNQ1 were related to a lower risk for abdominal obesity in T2D patients (rs243021: 0.92 (0.84, 1.00), P = 4.42 x 10(-2); rs10830963: 0.92 (0.85, 1.00), P = 4.07 x 10(-2); rs2237895: 0.89 (0.82, 0.98), P = 1.29 x 10(-2)). The T2D risk alleles of rs972283 near KLF14 contributed to a higher risk of elevated blood pressure (1.10 (1.00, 1.22), P = 4.48 x 10(-2)), while the T2D risk allele of rs7903146 in TCF7L2 was related to a lower risk for elevated blood pressure (0.74 (0.61, 0.90), P = 2.56 x 10(-3)). The T2D risk alleles of rs972283 near KLF14 and rs11634397 near ZFAND6 were associated with a higher risk for elevated triglycerides (rs972283: 1.11 (1.02, 1.24), P = 1.46 x 10(-2); rs11634397: 1.14 (1.00, 1.29), P = 4.66 x 10(-2)), while the T2D risk alleles of rs780094 in GCKR and rs7903146 in TCF7L2 were related to a lower risk of elevated triglycerides (rs780094: 0.86 (0.80, 0.93), P = 1.35x 10-4; rs7903146: 0.82 (0.69, 0.98), P = 3.18 x 10(-2)). The genotype risk score of the 25 T2D-related SNPs was related to a lower risk for abdominal obesity (Ptrend = 1.29 x 10(-2)) and lower waist circumference (P = 2.20 x 10(-3)). Genetic variants of WFS1, CDKAL1, CDKN2BAS, TCF7L2, HHEX, KCNQ1, TSPAN8/LGR5, FTO, and TCF2 were associated with the risk for T2D with MetS, as well as the risk for development of T2D with at least one of the MetS components (P < 0.05). addition, genetic variants of BCL11A, GCKR, ADAMTS9, CDKAL1, KLF14, CDKN2BAS, TCF7L2, CDC123/CAMK1D, HHEX, MTNR1B, and KCNQ1 contributed to the risk for T2D without MetS (P < 0.05). In conclusion, these findings highlight the contribution of T2D-related genetic loci to MetS in a Chinese Han population. The study also provides insight into the pleotropic effects of genome-wide association loci of diabetes onmetabolic regulation.	[Kong, Xiaomu; Zhang, Xuelian; Xing, Xiaoyan; Zhang, Bo; Hong, Jing; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China	China-Japan Friendship Hospital	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.	ywying_1010@163.com	Zhang, Bo/ABE-8008-2020	Kong, Xiaomu/0000-0002-5920-4759; Yang, Wenying/0000-0002-7997-9404	Chinese Medical Association Foundation; Sanofi (China) Investment Company Limited; National 973 Program [2011CB504001]; China Postdoctoral Science Foundation [2012M520200]; Fogarty International Center of the National Institutes of Health [D43TW009107]	Chinese Medical Association Foundation; Sanofi (China) Investment Company Limited; National 973 Program(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Chinese National Diabetes and Metabolic Disorders Study was supported by grants from the Chinese Medical Association Foundation (http://en.cma.org.cn), Sanofi (China) Investment Company Limited (http://www.sanofi.cn/l/cn/zh/index.jsp) and the National 973 Program (2011CB504001) (http://www.973.gov.cn). XK was supported by Award Number 2012M520200 from China Postdoctoral Science Foundation Grant (http://res.chinapostdoctor.org.cn) and the Award Number D43TW009107 from Fogarty International Center of the National Institutes of Health (http://www.fic.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar SA, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-5; Ali O, 2013, WORLD J DIABETES, V4, P114, DOI 10.4239/wjd.v4.i4.114; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bao YQ, 2008, ATHEROSCLEROSIS, V201, P378, DOI 10.1016/j.atherosclerosis.2008.03.001; Bellia A, 2009, NUTR METAB CARDIOVAS, V19, P455, DOI 10.1016/j.numecd.2008.11.002; Bonnet F, 2013, DIABETOLOGIA, V56, P2414, DOI 10.1007/s00125-013-3021-y; Brunetti A, 2014, WORLD J DIABETES, V5, P128, DOI 10.4239/wjd.v5.i2.128; Chen X, 2012, J THROMB HAEMOST, V10, P1508, DOI 10.1111/j.1538-7836.2012.04815.x; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Cruz M, 2010, DIABETES-METAB RES, V26, P261, DOI 10.1002/dmrr.1082; de Assuncao TM, 2014, J BIOL CHEM, V289, P15798, DOI 10.1074/jbc.M113.544346; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Hossain S, 2014, DIABETES METAB SYNDR; Hotta K, 2011, J HUM GENET, V56, P647, DOI 10.1038/jhg.2011.74; Irwin DM, 2014, MOL PHYLOGENET EVOL, V70, P195, DOI 10.1016/j.ympev.2013.09.016; Jeong Seok Won, 2014, Genomics & Informatics, V12, P187, DOI 10.5808/GI.2014.12.4.187; Jonsson A, 2013, DIABETES, V62, P2978, DOI 10.2337/db12-1627; Karns R, 2011, EUR J HUM GENET, V19, P341, DOI 10.1038/ejhg.2010.178; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kong XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071399; Ling Y, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-66; Liu Y, 2009, DIABETOLOGIA, V52, P1315, DOI 10.1007/s00125-009-1375-y; Liu Y, 2011, J LIPID RES, V52, P354, DOI 10.1194/jlr.P007476; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Monda Keri L., 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P86; Mulder H, 2009, DIABETOLOGIA, V52, P1240, DOI 10.1007/s00125-009-1359-y; Peter I, 2012, OBESITY, V20, P1675, DOI 10.1038/oby.2012.11; Phillips CM, 2012, J NUTR BIOCHEM, V23, P239, DOI 10.1016/j.jnutbio.2010.11.020; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Pokharel DR, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0104-3; Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x; Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Rodriguez A, 2011, DIABET METAB SYND OB, V4, P1, DOI 10.2147/DMSOTT.S13457; Saadi H, 2008, DIABETES RES CLIN PR, V80, P392, DOI 10.1016/j.diabres.2008.01.008; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Sanghera DK, 2009, J HUM GENET, V54, P162, DOI 10.1038/jhg.2009.7; Sarzani R, 2008, J HUM HYPERTENS, V22, P373, DOI 10.1038/jhh.2008.8; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schleinitz D, 2010, HORM METAB RES, V42, P14, DOI 10.1055/s-0029-1233480; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shi H, 2012, ARCH MED RES, V43, P233, DOI 10.1016/j.arcmed.2012.03.006; Simonis-Bik AM, 2010, DIABETES, V59, P293, DOI 10.2337/db09-1048; Sjogren M, 2008, DIABETOLOGIA, V51, P2242, DOI 10.1007/s00125-008-1151-4; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sookoian S, 2011, CURR HYPERTENS REP, V13, P149, DOI 10.1007/s11906-010-0164-9; Stancakova A, 2014, REV ENDOCR METAB DIS, V15, P243, DOI 10.1007/s11154-014-9293-9; Stancakova A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Sun X, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/926713; Tan MC, 2014, SE ASIAN J TROP MED, V45, P226; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wang JJ, 2014, HUM IMMUNOL, V75, P342, DOI 10.1016/j.humimm.2014.01.008; Wang T, 2010, CHINESE MED J-PEKING, V123, P1852, DOI 10.3760/cma.j.issn.0366-6999.2010.14.005; Wang Yu-ping, 2013, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V30, P467, DOI 10.3760/cma.j.issn.1003-9406.2013.04.019; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yamagata K, 2011, BIOCHEM BIOPH RES CO, V407, P620, DOI 10.1016/j.bbrc.2011.03.083; Yang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100548; Yang LL, 2009, ARCH MED RES, V40, P89, DOI 10.1016/j.arcmed.2008.11.005; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yu W, 2012, DIABETOLOGIA, V55, P2655, DOI 10.1007/s00125-012-2636-8; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091790	75	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143607	10.1371/journal.pone.0143607	http://dx.doi.org/10.1371/journal.pone.0143607			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599349	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600093
J	Leclercq, A; Veillat, V; Loriot, S; Spuul, P; Madonna, F; Roques, X; Genot, E				Leclercq, Anne; Veillat, Veronique; Loriot, Sandrine; Spuul, Pirjo; Madonna, Francesco; Roques, Xavier; Genot, Elisabeth			A Methodology for Concomitant Isolation of Intimal and Adventitial Endothelial Cells from the Human Thoracic Aorta	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; PHENOTYPIC HETEROGENEITY; VASA VASORUM; IN-VITRO; ANEURYSMS; EXPRESSION; CULTURE	Background Aortic diseases are diverse and involve a multiplicity of biological systems in the vascular wall. Aortic dissection, which is usually preceded by aortic aneurysm, is a leading cause of morbidity and mortality in modern societies. Although the endothelium is now known to play an important role in vascular diseases, its contribution to aneurysmal aortic lesions remains largely unknown. The aim of this study was to define a reliable methodology for the isolation of aortic intimal and adventitial endothelial cells in order to throw light on issues relevant to endothelial cell biology in aneurysmal diseases. Methodology/Principal Findings We set up protocols to isolate endothelial cells from both the intima and the adventitia of human aneurysmal aortic vessel segments. Throughout the procedure, analysis of cell morphology and endothelial markers allowed us to select an endothelial fraction which after two rounds of expansion yielded a population of >90% pure endothelial cells. These cells have the features and functionalities of freshly isolated cells and can be used for biochemical studies. The technique was successfully used for aortic vessel segments of 20 patients and 3 healthy donors. Conclusions/Significance This simple and highly reproducible method allows the simultaneous preparation of reasonably pure primary cultures of intimal and adventitial human endothelial cells, thus providing a reliable source for investigating their biology and involvement in both thoracic aneurysms and other aortic diseases.	[Leclercq, Anne; Veillat, Veronique; Loriot, Sandrine; Spuul, Pirjo; Genot, Elisabeth] Univ Bordeaux, Bordeaux, France; [Leclercq, Anne; Veillat, Veronique; Spuul, Pirjo; Genot, Elisabeth] INSERM, U1045, Bordeaux, France; [Leclercq, Anne] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Loriot, Sandrine] SFR TransBioMed, Bordeaux, France; [Madonna, Francesco; Roques, Xavier] Hop Haut LEveque, Serv Chirurg Cardiaque & Vasc, Pessac, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Leclercq, A (corresponding author), Univ Bordeaux, Bordeaux, France.	anne_leclercq@yahoo.com; elisabeth.genot@inserm.fr	leclercq, anne/AAA-1233-2020; Spuul, Pirjo/A-7211-2015; Genot, Elisabeth/G-8031-2014	Spuul, Pirjo/0000-0001-9410-721X; 	Fondation Lefoulon-Delalande; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche [ANR-2010-BLAN-1237-01]	Fondation Lefoulon-Delalande; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by Fondation Lefoulon-Delalande (to AL), Fondation pour la Recherche Medicale (to AL), and Agence Nationale de la Recherche, ANR-2010-BLAN-1237-01 (to EG).	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; ANTONOV AS, 1986, ATHEROSCLEROSIS, V59, P1, DOI 10.1016/0021-9150(86)90027-4; ARCINIEGAS E, 1992, J CELL SCI, V103, P521; Azuma K, 2009, BIOCHEM BIOPH RES CO, V380, P620, DOI 10.1016/j.bbrc.2009.01.135; Bachetti T, 2000, PHARMACOL RES, V42, P9, DOI 10.1006/phrs.1999.0655; Bijman MNA, 2006, MOL CANCER THER, V5, P2348, DOI 10.1158/1535-7163.MCT-06-0242; Borges LF, 2005, CELL TISSUE RES, V320, P551, DOI 10.1007/s00441-005-1108-6; Borges LF, 2010, HISTOPATHOLOGY, V57, P917, DOI 10.1111/j.1365-2559.2010.03719.x; Borges LF, 2009, HUM PATHOL, V40, P306, DOI 10.1016/j.humpath.2008.08.002; Deissler H, 2006, INT J MOL MED, V18, P577; Fan LM, 2014, CIRCULATION, V129, P2661, DOI 10.1161/CIRCULATIONAHA.113.005062; Forte A, 2013, HISTOL HISTOPATHOL, V28, P795, DOI 10.14670/HH-28.795; Frid Maria G, 2004, Paediatr Respir Rev, V5 Suppl A, pS253, DOI 10.1016/S1526-0542(04)90048-6; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Gingras M, 2009, J AM SOC HYPERTENS, V3, P166, DOI 10.1016/j.jash.2009.03.002; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; HEWETT PW, 1993, IN VITRO CELL DEV-AN, V29A, P325; Hillebrand M, 2014, CLIN CARDIOL, V37, P672, DOI 10.1002/clc.22320; Holifield B, 1996, J CLIN INVEST, V97, P814, DOI 10.1172/JCI118481; IMCKE E, 1991, ARCH DERMATOL RES, V283, P149, DOI 10.1007/BF00372054; Jimenez N, 2013, CYTOTECHNOLOGY, V65, P1, DOI 10.1007/s10616-012-9459-9; Jondeau G, 2011, HEART, V97, P1206, DOI 10.1136/hrt.2010.212100; Kessler K, 2014, CARDIOVASC RES, V104, P147, DOI 10.1093/cvr/cvu196; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153; Majesky MW, 2011, CIRC RES, V108, P528, DOI 10.1161/CIRCRESAHA.111.240861; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Muller AM, 2002, EXP MOL PATHOL, V73, P171, DOI 10.1006/exmp.2002.2446; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; Mulligan-Kehoe MJ, 2014, CIRCULATION, V129, P2557, DOI 10.1161/CIRCULATIONAHA.113.007189; Osada H, 2013, EUR J CARDIO-THORAC, V43, pE82, DOI 10.1093/ejcts/ezs640; Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Pyeritz RE, 2014, CURR OPIN CARDIOL, V29, P97, DOI 10.1097/HCO.0000000000000023; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; REPIN VS, 1984, ATHEROSCLEROSIS, V50, P35, DOI 10.1016/0021-9150(84)90006-6; Ritman EL, 2007, CARDIOVASC RES, V75, P649, DOI 10.1016/j.cardiores.2007.06.020; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Saratzis A, 2014, HEART, V100, P916, DOI 10.1136/heartjnl-2013-305130; SCHOR AM, 1983, J CELL SCI, V62, P267; SCOTT PAE, 1993, J CELL SCI, V105, P269; Shen YH, 2012, ANN THORAC SURG, V93, P1524, DOI 10.1016/j.athoracsur.2012.01.063; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802; Suzuki T, 2011, J AM COLL CARDIOL, V58, P775, DOI 10.1016/j.jacc.2010.01.079; TOKUNAGA O, 1989, AM J PATHOL, V135, P967; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Wessa P, 2012, SPEARMAN RANK CORREL; WOLINSKY H, 1967, CIRC RES, V20, P99, DOI 10.1161/01.RES.20.1.99; WOLINSKY H, 1969, CIRC RES, V25, P677, DOI 10.1161/01.RES.25.6.677	56	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143144	10.1371/journal.pone.0143144	http://dx.doi.org/10.1371/journal.pone.0143144			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599408	Green Published, gold			2022-12-27	WOS:000365862600032
J	Robbins, HA; Fennell, CE; Gillison, M; Xiao, WH; Guo, YS; Wentz, A; Kirk, GD; Mehta, SH; D'Souza, G				Robbins, Hilary A.; Fennell, Christina E.; Gillison, Maura; Xiao, Weihong; Guo, Yingshi; Wentz, Alicia; Kirk, Gregory D.; Mehta, Shruti H.; D'Souza, Gypsyamber			Prevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject Drugs	PLOS ONE			English	Article							HPV INFECTION; SEXUAL-BEHAVIORS; MEN; EPIDEMIOLOGY; CLEARANCE; WOMEN; HEAD	Background Human papillomavirus (HPV) causes most oropharyngeal cancers in the United States. Oral HPV prevalence is associated with immunosuppression, and drug use can be immunosuppressive, but the epidemiology of oral HPV among people who use drugs is not well described. Methods We enrolled men and women with a current or prior history of injection drug use in this cross-sectional sub-study within the AIDS Linked to the Intravenous Experience (ALIVE) cohort. We tested oral rinse samples for 37 types of HPV DNA and collected self-reported risk factor information. We compared oral HPV prevalence across categories using chisquared statistics and multivariable logistic regression. Results Among 199 subjects, 32% were HIV-positive (median CD4 count 384 cells/mu L), 90% were Black, 56% had less than a high school education, 17% had recently used injection drugs, and the median age was 54 years. Most had performed oral sex (82%) but had fewer than 5 lifetime partners (58%). The prevalence of any oral HPV was 29%, and of any oncogenic oral HPV was 13%. Oral HPV prevalence was high among both heterosexual men (30%) and women (20%). After adjustment, odds of oral HPV were increased among HIV-positive individuals with a low CD4 count (<350 cells/mu l, aOR = 2.7, 95% CI = 1.2-6.4, vs. HIV-negative individuals), but not among HIV-positive individuals with a higher CD4 cell count. Odds were also elevated for those who had recently performed oral sex on a woman (aOR = 2.2, 95% CI = 1.01-4.6) and, even after this adjustment, among bisexual/lesbian females (aOR = 5.6, 95% CI = 1.4-23, vs. heterosexual females). Oral HPV prevalence was not associated with vaginal sex, performing oral sex on a man, or recent drug use. Conclusions Recent drug use was not associated with oral HPV prevalence in our study. However, despite modest numbers of sexual partners, the prevalence of oral HPV among this largely Black population with lower socioeconomic status was high.	[Robbins, Hilary A.; Wentz, Alicia; Kirk, Gregory D.; Mehta, Shruti H.; D'Souza, Gypsyamber] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Fennell, Christina E.] Spelman Coll, Atlanta, GA 30314 USA; [Gillison, Maura; Xiao, Weihong; Guo, Yingshi] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Spelman College; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	D'Souza, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	gdsouza2@jhu.edu		Robbins, Hilary/0000-0001-6041-6866	National Institute of Dental and Craniofacial Research [R01DE021395]; National Institute on Drug Abuse [NIDA] [R01DA12568, U01DA036297]; Johns Hopkins Center for AIDS Research [P30AI094189]; Cancer Epidemiology, Prevention, and Control training grant (National Cancer Institute) [T32CA009314]; NATIONAL CANCER INSTITUTE [T32CA009314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, K24AI118591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012568, U01DA036297] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Drug Abuse [NIDA](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Johns Hopkins Center for AIDS Research; Cancer Epidemiology, Prevention, and Control training grant (National Cancer Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by R01DE021395 (National Institute of Dental and Craniofacial Research), R01DA12568 (National Institute on Drug Abuse [NIDA]), U01DA036297 (NIDA), and P30AI094189 (Johns Hopkins Center for AIDS Research). H.A. Robbins was supported by the Cancer Epidemiology, Prevention, and Control training grant (National Cancer Institute T32CA009314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenor M, 2015, ANN INTERN MED, V163, P99, DOI 10.7326/M14-2108; Antonsson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091761; Beachler DC, 2015, AM J EPIDEMIOL, V181, P40, DOI 10.1093/aje/kwu247; Beachler DC, 2013, CURR OPIN ONCOL, V25, P503, DOI 10.1097/CCO.0b013e32836242b4; Beachler DC, 2013, J INFECT DIS, V208, P330, DOI 10.1093/infdis/jit170; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Broutian TR, 2011, J CLIN VIROL, V50, P270, DOI 10.1016/j.jcv.2010.12.005; Chaturvedi AK, 2015, CANCER RES, V75, P2468, DOI 10.1158/0008-5472.CAN-14-2843; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chung CH, 2014, ORAL ONCOL, V50, P364, DOI 10.1016/j.oraloncology.2013.09.003; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; D'Souza Gypsyamber, 2014, Cancers (Basel), V6, P1691, DOI 10.3390/cancers6031691; D'Souza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086023; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2011, CANCER EPIDEM BIOMAR, V20, P172, DOI 10.1158/1055-9965.EPI-10-0682; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Mooij SH, 2013, AIDS, V27, P2117, DOI 10.1097/QAD.0b013e328362395c; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ortiz AP, 2014, P R HEALTH SCI J, V33, P190; Phelan DF, 2009, SEX TRANSM DIS, V36, P149, DOI 10.1097/OLQ.0b013e31818d3df3; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; Read TRH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049324; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Wu Xiaocheng, 2012, Morbidity and Mortality Weekly Report, V61, P258	31	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143698	10.1371/journal.pone.0143698	http://dx.doi.org/10.1371/journal.pone.0143698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600158	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600105
J	Roizenblatt, S; Souza, AL; Palombini, L; Godoy, LM; Tufik, S; Bittencourt, LRA				Roizenblatt, Suely; Souza, Altay L.; Palombini, Luciana; Godoy, Luciana M.; Tufik, Sergio; Bittencourt, Lia Rita A.			Musculoskeletal Pain as a Marker of Health Quality. Findings from the Epidemiological Sleep Study among the Adult Population of Sao Paulo City	PLOS ONE			English	Article							GENERAL-POPULATION; PORTUGUESE VERSION; PREVALENCE; BRAZIL; ASSOCIATION; VALIDATION; COMPLAINTS; INSOMNIA; FATIGUE; BURDEN	Background We are witnessing the growth of urban populations, particularly in the developing world. Sao Paulo, the largest city in South America, continues to grow, and this growth is dramatically effecting the environment and human health. The aim of this study was to estimate the point prevalence of chronic pain in Sao Paulo city dwellers and to explore the influence of aspects related to urbanicity. Methods A two-stage cluster randomized sample included 1100 individuals of the city of Sao Paulo, representing the population proportionally in terms of gender, age and social classes in 2007. For this observational cross-sectional study, the household sample was interviewed using validated questionnaires for sociodemographic aspects, the Beck inventories for anxiety and depression, the WHOQoL-REF for quality of life, the Chalder Fatigue Scale. Musculoskeletal pain was defined as diffuse pain or pain located in the back, joints or limbs. Data regarding sleep complaints and polysomnography were obtained from the Epidemiologic Sleep Study conducted in Sao Paulo city in 2007. Results The prevalence estimate of chronic musculoskeletal pain was approximately 27%, with a female/male ratio of approximately 2.6/1. The predictors were being in the age-range of 3039 years, low socioeconomic and schooling levels, obesity, sedentarism, fatigue, non-restorative sleep, daytime sleepiness, poor sleep quality, poor life quality, anxiety and depression symptoms. Psychological wellbeing was the main discriminator between responders with chronic musculoskeletal pain and the controls, followed by depression for the participants with poor psychological wellbeing, and fatigue, for the remaining ones. Insomnia syndrome was the third-level discriminator for those with fatigue, whereas sleep quality for those without fatigue. Conclusions Musculoskeletal pain was frequently reported by Sao Paulo city dwellers and its correlates with psychological and sleep aspects are suggestive of a response to urbanicity. Trial Registration ClinicalTrials.gov NCT00596713	[Roizenblatt, Suely] Univ Fed Sao Paulo, Dept Internal Med, Sao Paulo, Brazil; [Souza, Altay L.; Palombini, Luciana; Godoy, Luciana M.; Tufik, Sergio; Bittencourt, Lia Rita A.] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Roizenblatt, S (corresponding author), Univ Fed Sao Paulo, Dept Med, Ave Angelica 1996,Cj 101, BR-01228200 Sao Paulo, SP, Brazil.	suely.roizenblatt@unifesp.br	Bittencourt, Lia/C-6551-2012	Bittencourt, Lia/0000-0001-7738-0927; Roizenblatt, Suely/0000-0003-3474-4481	Associacao Fundo de Incentivo a Pesquisa (AFIP); Sao Paulo Research Foundation (FAPESP) through the Research, Innovation and Dissemination Centers (RIDC) [98/14303-3]	Associacao Fundo de Incentivo a Pesquisa (AFIP); Sao Paulo Research Foundation (FAPESP) through the Research, Innovation and Dissemination Centers (RIDC)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Associacao Fundo de Incentivo a Pesquisa (AFIP) and the Sao Paulo Research Foundation (FAPESP) through the Research, Innovation and Dissemination Centers (RIDC - #98/14303-3 to ST).	Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879; [Anonymous], 2001, MANUAL VERSAO PORTUG; Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020; Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009; Bittencourt LRA SR, 2005, LAB SONO ESTRUTURA F; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Castro LS, 2013, ANN NEUROL, V74, P537, DOI 10.1002/ana.23945; Cho HJ, 2007, J PSYCHOSOM RES, V62, P301, DOI 10.1016/j.jpsychores.2006.10.018; Cintra F, 2012, SLEEP MED, V13, P577, DOI 10.1016/j.sleep.2011.12.016; Croft P BF, 2010, CHRONIC PAIN EPIDEMI, P1; Dominick CH, 2012, PAIN, V153, P293, DOI 10.1016/j.pain.2011.09.018; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Hauser W, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-352, 10.1186/1471-2458-14-353]; Kamaleri Y, 2008, PAIN, V138, P41, DOI 10.1016/j.pain.2007.11.002; Lavigne GJ, 2010, PAIN, V148, P6, DOI 10.1016/j.pain.2009.10.013; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Moraes W, 2013, SLEEP MED, V14, P312, DOI 10.1016/j.sleep.2012.11.010; Naughton F, 2007, PAIN, V127, P243, DOI 10.1016/j.pain.2006.08.019; Pires MLN, 2007, BRAZ J MED BIOL RES, V40, P1505, DOI 10.1590/S0100-879X2007001100011; Poleshuck EL, 2008, PAIN, V136, P235, DOI 10.1016/j.pain.2008.04.003; Salazar A, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130144; Santos-Silva R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030085; Santos-Silva R, 2010, SLEEP MED, V11, P520, DOI 10.1016/j.sleep.2009.12.011; Santos-Silva R, 2009, SLEEP MED, V10, P679, DOI 10.1016/j.sleep.2008.11.001; Smith MT, 2007, SLEEP, V30, P494, DOI 10.1093/sleep/30.4.494; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006; Tripp Dean A, 2006, Pain Res Manag, V11, P225; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; van Hecke O, 2013, BRIT J ANAESTH, V111, P13, DOI 10.1093/bja/aet123; Wong WS, 2012, J PSYCHOSOM RES, V73, P28, DOI 10.1016/j.jpsychores.2012.04.011	34	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142726	10.1371/journal.pone.0142726	http://dx.doi.org/10.1371/journal.pone.0142726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7DU	26600201	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600016
J	Rothe, M; Kleeberg, A; Gruneberg, B; Friese, K; Perez-Mayo, M; Hupfer, M				Rothe, Matthias; Kleeberg, Andreas; Grueneberg, Bjoern; Friese, Kurt; Perez-Mayo, Manuel; Hupfer, Michael			Sedimentary Sulphur: Iron Ratio Indicates Vivianite Occurrence: A Study from Two Contrasting Freshwater Systems	PLOS ONE			English	Article							PHOSPHORUS RETENTION; HYDROGEN-SULFIDE; LAKE-SEDIMENTS; EUTROPHICATION; REDUCTION; MOBILIZATION; MINERALS; RELEASE; MATTER; FORMS	An increasing number of studies constrain the importance of iron for the long-term retention of phosphorus (P) under anoxic conditions, i.e. the formation of reduced iron phosphate minerals such as vivianite (Fe-3(PO4)(2)center dot 8H(2)O). Much remains unknown about vivianite formation, the factors controlling its occurrence, and its relevance for P burial during early sediment diagenesis. To study the occurrence of vivianite and to assess its relevance for P binding, surface sediments of two hydrologically contrasting waters were analysed by heavy-liquid separation and subsequent powder X-ray diffraction. In Lake Arendsee, vivianite was present in deeper sediment horizons and not in the uppermost layers with a sharp transition between vivianite and non-vivianite bearing layers. In contrast, in lowland river Lower Havel vivianite was present in the upper sediment layers and not in deeper horizons with a gradual transition between non-vivianite and vivianite bearing layers. In both waters, vivianite occurrence was accompanied by the presence of pyrite (FeS2). Vivianite formation was favoured by an elevated iron availability through a lower degree of sulphidisation and was present at a molar ratio of total sulphur to reactive iron smaller than 1.1, only. A longer lasting burden of sediments by organic matter, i.e. due to eutrophication, favours the release of sulphides, and the formation of insoluble iron sulphides leading to a lack of available iron and to less or no vivianite formation. This weakening in sedimentary P retention, representing a negative feedback mechanism (P release) in terms of water quality, could be partly compensated by harmless Fe amendments.	[Rothe, Matthias; Kleeberg, Andreas; Hupfer, Michael] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Chem Analyt & Biogeochem, Berlin, Germany; [Rothe, Matthias] Humboldt Univ, Dept Geog, D-10099 Berlin, Germany; [Grueneberg, Bjoern] Brandenburg Univ Technol Cottbus Senftenberg, Dept Freshwater Conservat, Bad Saarow Pieskow, Germany; [Friese, Kurt] Helmholtz Ctr Environm Res, UFZ Dept Lake Res, Magdeburg, Germany; [Perez-Mayo, Manuel] Univ Bremen, Inst Environm Phys, D-28359 Bremen, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin; Brandenburg University of Technology Cottbus; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bremen	Rothe, M (corresponding author), State Lab Berlin Brandenburg, Kleinmachnow, Germany.	rothe@igb-berlin.de	Friese, Kurt/E-1395-2012	Friese, Kurt/0000-0002-7769-0818; Perez Mayo, Manuel/0000-0002-6003-649X	Deutsche Forschungsgemeinschaft of the German Federal Ministry of Education and Research [HU 740/5-1, 033L041A]	Deutsche Forschungsgemeinschaft of the German Federal Ministry of Education and Research	The study was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) within the project "RedoxPhos" (Grant Number: HU 740/5-1) (MH AK) and the framework programme Research for Sustainable Development (Grant Number: 033L041A) of the German Federal Ministry of Education and Research (http://www.bmbf.de/) within the research project NITROLIMIT (BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN JM, 1976, WATER RES, V10, P329, DOI 10.1016/0043-1354(76)90175-5; BERNER RA, 1981, J SEDIMENT PETROL, V51, P359, DOI 10.1306/212F7C7F-2B24-11D7-8648000102C1865D; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; Cosmidis J, 2014, GEOCHIM COSMOCHIM AC, V126, P78, DOI 10.1016/j.gca.2013.10.037; DEVITRE RR, 1988, GEOCHIM COSMOCHIM AC, V52, P1601, DOI 10.1016/0016-7037(88)90229-3; Dijkstra N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101139; DUNNETTE DA, 1985, WATER RES, V19, P875, DOI 10.1016/0043-1354(85)90146-0; Einsele W, 1936, ARCH HYDROBIOL, V29, P664; Findlay DL, 1998, J PALEOLIMNOL, V19, P41, DOI 10.1023/A:1007906611087; Gachter R, 2003, LIMNOL OCEANOGR, V48, P929; Gruneberg B, 2015, BIOGEOCHEMISTRY, V123, P185, DOI 10.1007/s10533-014-0062-3; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; HORDIJK CA, 1989, WATER RES, V23, P853, DOI 10.1016/0043-1354(89)90009-2; Howarth RW, 1992, SULPHUR CYCLING ON T; Hsu TW, 2014, J ASIAN EARTH SCI, V89, P88, DOI 10.1016/j.jseaes.2014.03.027; Hupfer M, 2000, WATER RES, V34, P859, DOI 10.1016/S0043-1354(99)00229-8; Hupfer M, 1995, AQUAT SCI, V57, P305, DOI 10.1007/BF00878395; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; Hyacinthe C, 2004, MAR CHEM, V91, P227, DOI 10.1016/j.marchem.2004.04.006; Jilbert T, 2013, GEOCHIM COSMOCHIM AC, V107, P155, DOI 10.1016/j.gca.2013.01.005; Kleeberg A, 2013, WATER RES, V47, P1491, DOI 10.1016/j.watres.2012.12.014; Kleeberg A, 2012, J SOIL SEDIMENT, V12, P1593, DOI 10.1007/s11368-012-0590-1; Lalonde K, 2012, NATURE, V483, P198, DOI 10.1038/nature10855; Lehtoranta J, 2009, AMBIO, V38, P303, DOI 10.1579/09-A-656.1; LIKENS GE, 1989, HYDROBIOLOGIA, V176, P331, DOI 10.1007/BF00026568; Losher A, 1989, THESIS; Marz C, 2008, MAR GEOL, V255, P118, DOI 10.1016/j.margeo.2008.05.013; Meinikmann K, 2015, J HYDROL, V524, P214, DOI 10.1016/j.jhydrol.2015.02.031; MORSE JW, 1987, EARTH-SCI REV, V24, P1, DOI 10.1016/0012-8252(87)90046-8; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; MURRAY TE, 1995, CAN J FISH AQUAT SCI, V52, P1190, DOI 10.1139/f95-115; NEMBRINI GP, 1983, GEOCHIM COSMOCHIM AC, V47, P1459, DOI 10.1016/0016-7037(83)90304-6; NRIAGU JO, 1972, GEOCHIM COSMOCHIM AC, V36, P459, DOI 10.1016/0016-7037(72)90035-X; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; PSENNER R, 1984, Archiv fuer Hydrobiologie Supplement, V70, P111; Robbins J.A., 1978, BIOGEOCHEMISTRY LEAD, V1A, P285; Roden EE, 1997, ARCH HYDROBIOL, V139, P347; Rothe M, 2014, BIOGEOSCIENCES, V11, P5169, DOI 10.5194/bg-11-5169-2014; Ruban V, 1999, J ENVIRON MONITOR, V1, P51, DOI 10.1039/a807778i; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; Slomp CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062386; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; SMOLDERS A, 1993, AQUAT BOT, V46, P247, DOI 10.1016/0304-3770(93)90005-H; Sondergaard M, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 1, P184; Stumm W, 1981, AQUATIC CHEMISTRY AN; WILLIAMS JDH, 1980, SOIL SCI SOC AM J, V44, P462, DOI 10.2136/sssaj1980.03615995004400030004x; Withers PJA, 2014, SUSTAINABILITY-BASEL, V6, P5853, DOI 10.3390/su6095853; Zak D, 2006, BIOGEOCHEMISTRY, V80, P109, DOI 10.1007/s10533-006-0003-x	49	35	38	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143737	10.1371/journal.pone.0143737	http://dx.doi.org/10.1371/journal.pone.0143737			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599406	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600113
J	Zhang, YX; Gao, TS; Hu, SY; Lin, B; Yan, DC; Xu, ZY; Zhang, ZJ; Mao, YL; Mao, HM; Wang, LT; Wang, GS; Xiong, YZ; Zuo, B				Zhang, Yunxia; Gao, Tengsen; Hu, Shanyao; Lin, Bin; Yan, Dechao; Xu, Zaiyan; Zhang, Zijun; Mao, Yuanliang; Mao, Huimin; Wang, Litong; Wang, Guoshui; Xiong, Yuanzhu; Zuo, Bo			The Functional SNPs in the 5 ' Regulatory Region of the Porcine PPARD Gene Have Significant Association with Fat Deposition Traits	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-DELTA; COLORECTAL-CANCER; BACKFAT THICKNESS; CANDIDATE GENES; SUS-SCROFA; FATNESS; EXPRESSION; GROWTH; LOCI; DIFFERENTIATION	Peroxisome proliferator-activated receptor delta (PPARD) is a key regulator of lipid metabolism, insulin sensitivity, cell proliferation and differentiation. In this study, we identified two Single Nucleotide Polymorphisms (SNPs, g.1015 A>G and g.1018 T>C) constituting four haplotypes (GT, GC, AC and AT) in the 5' regulatory region of porcine PPARD gene. Functional analysis of the four haplotypes showed that the transcriptional activity of the PPARD promoter fragment carrying haplotype AC was significantly lower than that of the other haplotypes in 3T3-L1, C2C12 and PK-15 cells, and haplotype AC had the lowest binding capacities to the nuclear extracts. Transcription factor 7-like 2 (TCF7L2) enhanced the transcription activities of promoter fragments of PPARD gene carrying haplotypes GT, GC and AT in C2C12 and 3T3-L1 cells, and increased the protein expression of PPARD gene in C2C12 myoblasts. TCF7L2 differentially bound to the four haplotypes, and the binding capacity of TCF7L2 to haplotype AC was the lowest. There were significant associations between -655A/G and fat deposition traits in three pig populations including the Large White x Meishan F-2 pigs, France and American Large White pigs. Pigs with genotype GG had significantly higher expression of PPARD at both mRNA and protein level than those with genotype AG. These results strongly suggested that the SNPs in 5' regulatory region of PPARD genes had significant impact on pig fat deposition traits.	[Zhang, Yunxia; Gao, Tengsen; Hu, Shanyao; Lin, Bin; Yan, Dechao; Xu, Zaiyan; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Minist Agr, Key Lab Swine Genet & Breeding, Wuhan, Peoples R China; [Zhang, Yunxia; Gao, Tengsen; Hu, Shanyao; Lin, Bin; Yan, Dechao; Xu, Zaiyan; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Minist Educ, Key Lab Agr Anim Genet & Breeding, Wuhan, Peoples R China; [Zhang, Zijun; Mao, Yuanliang; Mao, Huimin; Wang, Litong; Wang, Guoshui] Tianpeng Grp, Jiangshan, Zhejiang, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Zuo, B (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Vet Med, Minist Agr, Key Lab Swine Genet & Breeding, Wuhan, Peoples R China.	zuobo@mail.hzau.edu.cn			Key National High Technology Development Project of China [2011AA100301]; National Key Technology Support Program of China [2014BAD20B01]; Agricultural Innovation Fund of Hubei Province [2007-620]; Fundamental Research Funds for the Central Universities [2014PY038]; Key Project of Science and Technology of Zhejiang Province [2014C02010]	Key National High Technology Development Project of China; National Key Technology Support Program of China(National Key Technology R&D Program); Agricultural Innovation Fund of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Project of Science and Technology of Zhejiang Province	The study was financially supported by the Key National High Technology Development Project of China (Grant No. 2011AA100301), the National Key Technology Support Program of China (Grant No. 2014BAD20B01), the Agricultural Innovation Fund of Hubei Province (Grant No. 2007-620), the Fundamental Research Funds for the Central Universities (Grant No. 2014PY038) and the Key Project of Science and Technology of Zhejiang Province (Grant No. 2014C02010). The last funder is Tianpeng Group. The funder provided support in the form of salaries for authors [ZZ, YM, HM, LW, GW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai H, 2012, ANIM GENET, V43, P383, DOI 10.1111/j.1365-2052.2011.02282.x; Ali FY, 2006, AM J RESP CELL MOL, V34, P242, DOI 10.1165/rcmb.2005-0289OC; Andrulionyte L, 2006, DIABETES, V55, P2148, DOI 10.2337/db05-1629; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Archbold HC, 2012, ACTA PHYSIOL, V204, P74, DOI 10.1111/j.1748-1716.2011.02293.x; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bastie C, 2000, J BIOL CHEM, V275, P38768, DOI 10.1074/jbc.M006450200; Bidanel JP, 2001, GENET SEL EVOL, V33, P289, DOI 10.1051/gse:2001120; Burch LR, 2010, J CLIN ENDOCR METAB, V95, P1830, DOI 10.1210/jc.2009-1201; Burch LR, 2009, J CLIN ENDOCR METAB, V94, P2587, DOI 10.1210/jc.2009-0392; Chen LH, 2014, PPAR RES, V2014, DOI 10.1155/2014/653017; de Koning DJ, 1999, GENETICS, V152, P1679; Demeure O, 2005, J ANIM SCI, V83, P1979; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Duan YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075925; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Gondret F, 2012, J ANIM BREED GENET, V129, P316, DOI 10.1111/j.1439-0388.2011.00965.x; Grarup N, 2007, DIABETOLOGIA, V50, P1201, DOI 10.1007/s00125-007-0668-2; Grimaldi PA, 2001, PROG LIPID RES, V40, P269, DOI 10.1016/S0163-7827(01)00005-4; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Higashiyama H, 2007, HISTOCHEM CELL BIOL, V127, P485, DOI 10.1007/s00418-007-0279-5; Huang H, 2011, GENET MOL RES, V10, P3090, DOI 10.4238/2011.December.14.2; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Kim DJ, 2006, CELL DEATH DIFFER, V13, P53, DOI 10.1038/sj.cdd.4401713; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Leibowitz MD, 2000, FEBS LETT, V473, P333, DOI 10.1016/S0014-5793(00)01554-4; Liu GJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/903947; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meidtner K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-76; Neher MD, 2012, PPAR RES, V2012, DOI 10.1155/2012/728461; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Pesant M, 2006, CARDIOVASC RES, V69, P440, DOI 10.1016/j.cardiores.2005.10.019; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Qiao RM, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0089-5; Rattink AP, 2000, MAMM GENOME, V11, P656, DOI 10.1007/s003350010117; Ren J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002043; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Su Yu-Hong, 2002, Acta Genetica Sinica, V29, P681; Tanaka M, 2006, ANIM GENET, V37, P10, DOI 10.1111/j.1365-2052.2005.01362.x; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Thamer C, 2008, J CLIN ENDOCR METAB, V93, P1497, DOI 10.1210/jc.2007-1209; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xiong YZ, 1999, PRINCIPLE METHOD SWI; Xu ZY, 2010, MOL BIOL REP, V37, P3609, DOI 10.1007/s11033-010-0010-9; Zhang HJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P25, DOI 10.1016/j.abb.2007.01.028; Zuo B, 2004, ASIAN AUSTRAL J ANIM, V17, P1350, DOI 10.5713/ajas.2004.1350; [左波 Zuo Bo], 2003, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V34, P139	51	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143734	10.1371/journal.pone.0143734	http://dx.doi.org/10.1371/journal.pone.0143734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599230	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600111
J	Bourceret, A; Leyval, C; de Fouquet, C; Cebron, A				Bourceret, Amelia; Leyval, Corinne; de Fouquet, Chantal; Cebron, Aurelie			Mapping the Centimeter-Scale Spatial Variability of PAHs and Microbial Populations in the Rhizosphere of Two Plants	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BACTERIAL COMMUNITY STRUCTURE; CREOSOTE-CONTAMINATED SOIL; POLLUTED SOIL; PHENANTHRENE DEGRADATION; DEGRADING BACTERIA; FUNGAL COMMUNITIES; BIODEGRADATION; PHYTOREMEDIATION; HETEROGENEITY	Rhizoremediation uses root development and exudation to favor microbial activity. Thus it can enhance polycyclic aromatic hydrocarbon (PAH) biodegradation in contaminated soils. Spatial heterogeneity of rhizosphere processes, mainly linked to the root development stage and to the plant species, could explain the contrasted rhizoremediation efficiency levels reported in the literature. Aim of the present study was to test if spatial variability in the whole plant rhizosphere, explored at the centimetre-scale, would influence the abundance of microorganisms (bacteria and fungi), and the abundance and activity of PAH-degrading bacteria, leading to spatial variability in PAH concentrations. Two contrasted rhizospheres were compared after 37 days of alfalfa or ryegrass growth in independent rhizotron devices. Almost all spiked PAHs were degraded, and the density of the PAH-degrading bacterial populations increased in both rhizospheres during the incubation period. Mapping of multi-parametric data through geostatistical estimation (kriging) revealed that although root biomass was spatially structured, PAH distribution was not. However a greater variability of the PAH content was observed in the rhizosphere of alfalfa. Yet, in the ryegrass-planted rhizotron, the Gram-positive PAH-degraders followed a reverse depth gradient to root biomass, but were positively correlated to the soil pH and carbohydrate concentrations. The two rhizospheres structured the microbial community differently: a fungus-to-bacterium depth gradient similar to the root biomass gradient only formed in the alfalfa rhizotron.	[Bourceret, Amelia; Leyval, Corinne; Cebron, Aurelie] Fac Sci & Technol, CNRS, LIEC, UMR7360, F-54506 Vandoeuvre Les Nancy, France; [Bourceret, Amelia; Leyval, Corinne; Cebron, Aurelie] Univ Lorraine, Fac Sci & Technol, LIEC, UMR7360, F-54506 Vandoeuvre Les Nancy, France; [de Fouquet, Chantal] Ecole Natl Super Mines, Ctr Geosci Geostat, MINES ParisTech, F-77305 Fontainebleau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Cebron, A (corresponding author), Fac Sci & Technol, CNRS, LIEC, UMR7360, Bd Aiguillettes,BP70239, F-54506 Vandoeuvre Les Nancy, France.	aurelie.cebron@univ-lorraine.fr			Agence Nationale de la Recherche [ANR-13-JSV7-0007_01]; French national Research Agency through the laboratory of Excellence ARBRE [ANR-11-LABX-0002-01]	Agence Nationale de la Recherche(French National Research Agency (ANR)); French national Research Agency through the laboratory of Excellence ARBRE(French National Research Agency (ANR))	This study was funded by the Agence Nationale de la Recherche (ANR-13-JSV7-0007_01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Agence Nationale de la Recherche (ANR-13-JSV7-0007_01). The authors thank the GISFI (www.gisfi.fr) for soil providing, David Billet, Florence Coste and Genevieve Magnin and interns Maximilien Jeanvoine and Paul Dessaint for technical assistance. Carbohydrate analyses were performed by Jacqueline Marchand belonging to the PTEF facility that is supported by the French national Research Agency through the laboratory of Excellence ARBRE (ANR-11-LABX-0002-01). The authors also thank Annie Buchwalter for editing English language.	Allard AS, 2000, INT BIODETER BIODEGR, V46, P43, DOI 10.1016/S0964-8305(00)00050-0; Amellal N, 2001, BIODEGRADATION, V12, P49, DOI 10.1023/A:1011909107858; Anderson TA, 1993, ENVIRON SCI TECHNOL, V27, P2631; APRILL W, 1990, CHEMOSPHERE, V20, P253, DOI 10.1016/0045-6535(90)90100-8; Baudoin E, 2002, APPL SOIL ECOL, V19, P135, DOI 10.1016/S0929-1393(01)00185-8; Becker JM, 2006, MICROB ECOL, V51, P220, DOI 10.1007/s00248-005-0002-9; Bengtsson G, 2009, RISK ANAL, V29, P48, DOI 10.1111/j.1539-6924.2008.01128.x; Bengtsson G, 2013, MICROB ECOL, V65, P91, DOI 10.1007/s00248-012-0112-0; Bengtsson G, 2010, ENVIRON POLLUT, V158, P2865, DOI 10.1016/j.envpol.2010.06.010; Binet P, 2001, ORG GEOCHEM, V32, P217, DOI 10.1016/S0146-6380(00)00168-6; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Cebron A, 2008, J MICROBIOL METH, V73, P148, DOI 10.1016/j.mimet.2008.01.009; Cebron A, 2013, ENVIRON POLLUT, V177, P98, DOI 10.1016/j.envpol.2013.01.043; Cebron A, 2011, ENVIRON MICROBIOL, V13, P722, DOI 10.1111/j.1462-2920.2010.02376.x; Cebron A, 2009, APPL ENVIRON MICROB, V75, P6322, DOI 10.1128/AEM.02862-08; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; Chiapusio G, 2007, PLANT SOIL, V294, P103, DOI 10.1007/s11104-007-9234-4; Chiles J.-P., 2012, GEOSTATISTICS MODELI; Choudhary VR, 2000, LANGMUIR, V16, P7031, DOI 10.1021/la991714u; Corgie SC, 2004, APPL ENVIRON MICROB, V70, P3552, DOI 10.1128/AEM.70.6.3552-3557.2004; Corgie SC, 2003, PLANT SOIL, V257, P143, DOI 10.1023/A:1026278424871; Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b; D'Orazio V, 2013, CLEAN-SOIL AIR WATER, V41, P377, DOI 10.1002/clen.201100653; de Fouquet C, 2011, EUR J SOIL SCI, V62, P454, DOI 10.1111/j.1365-2389.2011.01374.x; De Fouquet C, 2010, P CONS SALZB; De Fouquet C, 2011, AM SOC MECH ENG, P1307; Demougeot-Renard H, 2004, ENVIRON SCI TECHNOL, V38, P5120, DOI 10.1021/es0351084; Demougeot-Renard H, 2004, J ENVIRON QUAL, V33, P1694, DOI 10.2134/jeq2004.1694; Faucheux C, 2008, CHARACTERISATION HYD, P961; Felske A, 1998, APPL ENVIRON MICROB, V64, P4581; Gerhardt KE, 2009, PLANT SCI, V176, P20, DOI 10.1016/j.plantsci.2008.09.014; Hafner S, 2014, PLANT SOIL, V380, P101, DOI 10.1007/s11104-014-2059-z; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hertenberger G, 2002, J PLANT NUTR SOIL SC, V165, P557, DOI 10.1002/1522-2624(200210)165:5<557::AID-JPLN1111557>3.0.CO;2-G; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; Hinsinger P, 2005, NEW PHYTOL, V168, P293, DOI 10.1111/j.1469-8137.2005.01512.x; Hybholt TK, 2011, ENVIRON POLLUT, V159, P1085, DOI 10.1016/j.envpol.2011.02.028; Johnsen AR, 2014, FEMS MICROBIOL ECOL, V88, P84, DOI 10.1111/1574-6941.12272; Joner EJ, 2002, SOIL BIOL BIOCHEM, V34, P859, DOI 10.1016/S0038-0717(02)00018-4; Joner EJ, 2003, ENVIRON SCI TECHNOL, V37, P2371, DOI 10.1021/es020196y; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Khan S, 2009, J SOIL SEDIMENT, V9, P482, DOI 10.1007/s11368-009-0061-5; Kuiper I, 2004, MOL PLANT MICROBE IN, V17, P6, DOI 10.1094/MPMI.2004.17.1.6; Kumar R, 2006, CURR SCI INDIA, V91, P885; Ling WT, 2013, J SOIL SEDIMENT, V13, P677, DOI 10.1007/s11368-013-0655-9; Liste HH, 2006, CHEMOSPHERE, V62, P1411, DOI 10.1016/j.chemosphere.2005.05.018; Liste HH, 2000, CHEMOSPHERE, V40, P7, DOI 10.1016/S0045-6535(99)00216-7; Louvel B, 2011, INT BIODETER BIODEGR, V65, P947, DOI 10.1016/j.ibiod.2011.07.003; Lueders T, 2004, ENVIRON MICROBIOL, V6, P60, DOI 10.1046/j.1462-2920.2003.00535.x; Ma B, 2012, ENVIRON POLLUT, V162, P413, DOI 10.1016/j.envpol.2011.10.034; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Mukherjee S, 2014, ISME J, V8, P2131, DOI 10.1038/ismej.2014.151; Oliveira V, 2014, MOL ECOL, V23, P1392, DOI 10.1111/mec.12559; Ouvrard S, 2011, INT J PHYTOREMEDIAT, V13, P245, DOI 10.1080/15226514.2011.568546; Phillips LA, 2008, SOIL BIOL BIOCHEM, V40, P3054, DOI 10.1016/j.soilbio.2008.09.006; Reid BJ, 2000, ENVIRON SCI TECHNOL, V34, P3174, DOI 10.1021/es990946c; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Shann JR, 1994, INFLUENCE PLANT SPEC; Siciliano SD, 2003, APPL ENVIRON MICROB, V69, P483, DOI 10.1128/AEM.69.1.483-489.2003; Soleimani M, 2010, CHEMOSPHERE, V81, P1084, DOI 10.1016/j.chemosphere.2010.09.034; Storey S, 2014, J APPL MICROBIOL, V117, P74, DOI 10.1111/jam.12518; Styrishave B, 2012, WATER AIR SOIL POLL, V223, P969, DOI 10.1007/s11270-011-0916-4; Sun BQ, 2013, J SOIL SEDIMENT, V13, P1161, DOI 10.1007/s11368-013-0712-4; Tejeda-Agredano MC, 2013, SOIL BIOL BIOCHEM, V57, P830, DOI 10.1016/j.soilbio.2012.08.008; Thion C, 2012, FEMS MICROBIOL ECOL, V82, P169, DOI 10.1111/j.1574-6941.2012.01414.x; Torneman N, 2008, ENVIRON TOXICOL CHEM, V27, P1039, DOI 10.1897/07-440.1; Tunega D, 2009, J COLLOID INTERF SCI, V330, P244, DOI 10.1016/j.jcis.2008.10.056; VANCURA V., 1965, "Plant Microbes Relationships" Proc. Symp. Prague., V1963, P21, DOI 10.1007/BF01377686; Villanneau EJ, 2013, ENVIRON CHEM LETT, V11, P99, DOI 10.1007/s10311-013-0401-y; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Yang CH, 2000, APPL ENVIRON MICROB, V66, P345, DOI 10.1128/AEM.66.1.345-351.2000	72	18	18	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142851	10.1371/journal.pone.0142851	http://dx.doi.org/10.1371/journal.pone.0142851			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599438	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900041
J	Islam, T; Manna, M; Reddy, MK				Islam, Tahmina; Manna, Mrinalini; Reddy, Malireddy K.			Glutathione Peroxidase of Pennisetum glaucum (PgGPx) Is a Functional Cd2+ Dependent Peroxiredoxin that Enhances Tolerance against Salinity and Drought Stress	PLOS ONE			English	Article							THIOREDOXIN PEROXIDASE; SUPEROXIDE-DISMUTASE; MOLECULAR CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; 2-CYS PEROXIREDOXIN; LIPID-PEROXIDATION; HELIANTHUS-ANNUUS; ESCHERICHIA-COLI; REDOX-TRANSDUCER	Reactive oxygen species (ROS) arise in the plant system due to inevitable influence of various environmental stimuli. Glutathione peroxidases are one of the important ROS scavengers inside the cell. A glutathione peroxidase (PgGPx) gene was previously found from Pennisetum glauccum abiotic stressed cDNA library. Enzyme kinetics data revealed that PgGPx possessed preference towards thioredoxin rather than glutathione as electron donor and thus belongs to the functional peroxiredoxin group. Moreover, its activity was found to be dependent on divalent cations, especially Cd2+ and homology model showed the presence of Cd2+ binding site in the protein. Site directed mutagenesis study of PgGPx protein revealed the vital role of two conserved Cysteine residues for its enzymatic activity and structural folding. Expression analysis suggested that PgGPx transcript is highly up-regulated in response to salinity and drought stresses. When expressed ectopically, PgGPx showed enhanced tolerance against multiple abiotic stresses in prokaryotic E. coli and model plant, rice. Transgenic rice plants showed lesser accumulation of MDA and H2O2; and higher accumulation of proline as compared to wild type (WT) plants in response to both salinity and drought stresses that clearly indicates suppression of lipid peroxidation and ROS generation in transgenic lines. Moreover, transgenic plants maintained better photosynthesis efficiency and higher level of antioxidant enzyme activity as compared to WT plants under stress conditions. These results clearly indicate the imperative role of PgGPx in cellular redox homeostasis under stress conditions, leading to the maintenance of membrane integrity and increased tolerance towards oxidative stress.	[Islam, Tahmina; Manna, Mrinalini; Reddy, Malireddy K.] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi 110067, India; [Islam, Tahmina] Univ Dhaka, Dept Bot, Dhaka 1000, Bangladesh	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Dhaka	Islam, T (corresponding author), Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	subarna.islam@gmail.com	Islam, Tahmina/AAU-9539-2021	Islam, Tahmina/0000-0002-0542-0050	International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India; Department of Biotechnology, Government of India; CSIR; ICGEB	International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); ICGEB(Department of Biotechnology (DBT) India)	Funded by International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India and Department of Biotechnology, Government of India. MM acknowledges CSIR for providing Pre-doctoral and SRF fellowship.; MKR acknowledges International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India. TI acknowledges ICGEB and MM acknowledges CSIR for providing Pre-doctoral and SRF fellowship, respectively.	Agrawal GK, 2002, GENE, V283, P227, DOI 10.1016/S0378-1119(01)00854-X; Brigelius-Flohe R, 2003, BIOFACTORS, V17, P93, DOI 10.1002/biof.5520170110; Chen SR, 2004, PLANT PHYSIOL, V135, P1630, DOI 10.1104/pp.103.038091; CRIQUI MC, 1992, PLANT MOL BIOL, V18, P623, DOI 10.1007/BF00040684; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Depege N, 1998, EUR J BIOCHEM, V253, P445, DOI 10.1046/j.1432-1327.1998.2530445.x; Finkemeier I, 2005, J BIOL CHEM, V280, P12168, DOI 10.1074/jbc.M413189200; Gaber A, 2012, PLANT CELL PHYSIOL, V53, P1596, DOI 10.1093/pcp/pcs100; Ghiani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099239; Ghosh A, 2014, PLANT J, V80, P93, DOI 10.1111/tpj.12621; Hazebrouck S, 2000, J BIOL CHEM, V275, P28715, DOI 10.1074/jbc.M004985200; Herbette S, 2002, EUR J BIOCHEM, V269, P2414, DOI 10.1046/j.1432-1033.2002.02905.x; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; HOLLAND D, 1993, PLANT MOL BIOL, V21, P923, DOI 10.1007/BF00027124; Islam T, 2015, PLANT MOL BIOL REP, P1; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; JOHNSON RR, 1995, PLANT MOL BIOL, V28, P113, DOI 10.1007/BF00042043; Jung BG, 2002, J BIOL CHEM, V277, P12572, DOI 10.1074/jbc.M110791200; Kadota Y, 2005, BIOCHEM BIOPH RES CO, V336, P1259, DOI 10.1016/j.bbrc.2005.09.004; Karan R, 2009, FUNCT INTEGR GENOMIC, V9, P411, DOI 10.1007/s10142-009-0119-x; Koh CS, 2007, J MOL BIOL, V370, P512, DOI 10.1016/j.jmb.2007.04.031; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Li WJ, 2000, BBA-GENE STRUCT EXPR, V1493, P225, DOI 10.1016/S0167-4781(00)00152-4; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Milla MAR, 2002, PLANT PHYSIOL, V130, P1706, DOI 10.1104/pp.009969; Mishra RN, 2007, PLANT MOL BIOL, V64, P713, DOI 10.1007/s11103-007-9193-4; Mullineaux PM, 1998, PLANT J, V13, P375, DOI 10.1046/j.1365-313X.1998.00052.x; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Pareek, 2015, BIO-PROTOCOL, V5, pE1440, DOI [10.21769/BioProtoc.1440, DOI 10.21769/BIOPROTOC.1440]; Passaia G, 2013, PLANT SCI, V208, P93, DOI 10.1016/j.plantsci.2013.03.017; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pulido P, 2010, J EXP BOT, V61, P4043, DOI 10.1093/jxb/erq218; Ramos J, 2009, NEW PHYTOL, V181, P103, DOI 10.1111/j.1469-8137.2008.02629.x; Roeckel-Drevet P, 1998, PHYSIOL PLANTARUM, V103, P385, DOI 10.1034/j.1399-3054.1998.1030312.x; Rouhier N, 2005, FREE RADICAL BIO MED, V38, P1413, DOI 10.1016/j.freeradbiomed.2004.07.037; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Roxas VP, 1997, NAT BIOTECHNOL, V15, P988, DOI 10.1038/nbt1097-988; Sairam RK, 2005, BIOL PLANTARUM, V49, P85, DOI 10.1007/s10535-005-5091-2; Sreenivasulu N, 2004, J PLANT PHYSIOL, V161, P467, DOI 10.1078/0176-1617-01112; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tanaka T, 2005, J BIOL CHEM, V280, P42078, DOI 10.1074/jbc.M508622200; Turan S, 2013, PROTOPLASMA, V250, P209, DOI 10.1007/s00709-012-0395-5; Wang LJ, 2006, PLANT SCI, V170, P685, DOI 10.1016/j.plantsci.2005.09.005; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Yoshida S, 1971, INT RICE RES I; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Zhai CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073989; Zhang HX, 2008, PLANTA, V227, P465, DOI 10.1007/s00425-007-0632-x	53	35	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143344	10.1371/journal.pone.0143344	http://dx.doi.org/10.1371/journal.pone.0143344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600014	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900097
J	Ladoni, M; Kravchenko, AN; Robertson, GP				Ladoni, Moslem; Kravchenko, Alexandra N.; Robertson, G. Phillip			Topography Mediates the Influence of Cover Crops on Soil Nitrate Levels in Row Crop Agricultural Systems	PLOS ONE			English	Article							AVAILABLE NITROGEN; CORN YIELD; CEREAL RYE; MANAGEMENT; LANDSCAPE; VARIABILITY; MIXTURES; RESIDUES; RECOVERY; BENEFITS	Supplying adequate amounts of soil N for plant growth during the growing season and across large agricultural fields is a challenge for conservational agricultural systems with cover crops. Knowledge about cover crop effects on N comes mostly from small, flat research plots and performance of cover crops across topographically diverse agricultural land is poorly understood. Our objective was to assess effects of both leguminous (red clover) and non-leguminous (winter rye) cover crops on potentially mineralizable N (PMN) and NO3- -N levels across a topographically diverse landscape. We studied conventional, low-input, and organic managements in corn-soybean-wheat rotation. The rotations of low-input and organic managements included rye and red clover cover crops. The managements were implemented in twenty large undulating fields in Southwest Michigan starting from 2006. The data collection and analysis were conducted during three growing seasons of 2011, 2012 and 2013. Observational micro-plots with and without cover crops were laid within each field on three contrasting topographical positions of depression, slope and summit. Soil samples were collected 4-5 times during each growing season and analyzed for NO3- -N and PMN. The results showed that all three managements were similar in their temporal and spatial distributions of NO3- -N. Red clover cover crop increased NO3- -N by 35% on depression, 20% on slope and 32% on summit positions. Rye cover crop had a significant 15% negative effect on NO3- -N in topographical depressions but not in slope and summit positions. The magnitude of the cover crop effects on soil mineral nitrogen across topographically diverse fields was associated with the amount of cover crop growth and residue production. The results emphasize the potential environmental and economic benefits that can be generated by implementing site-specific topography-driven cover crop management in row-crop agricultural systems.	[Ladoni, Moslem] Climate Corp, San Francisco, CA USA; [Kravchenko, Alexandra N.; Robertson, G. Phillip] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Robertson, G. Phillip] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA	Michigan State University; Michigan State University	Kravchenko, AN (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.	kravche1@msu.edu	Robertson, G Philip/H-3885-2011; Farmaha, Bhupinder/ABH-1387-2020	Robertson, G Philip/0000-0001-9771-9895; 	United States Department of Agriculture [2011-68002-30190]; United States Department of Agriculture Ecosystem service program [2010-65615-20614]; US National Science Foundation LTER Program [DEB 1027253]; LTER; Division Of Environmental Biology [1027253] Funding Source: National Science Foundation	United States Department of Agriculture(United States Department of Agriculture (USDA)); United States Department of Agriculture Ecosystem service program; US National Science Foundation LTER Program; LTER; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this research was provided in part by the United States Department of Agriculture, Award No. 2011-68002-30190 "Cropping Systems Coordinated Agricultural Project (CAP): Climate Change, Mitigation and Adaptation in Corn-based Cropping Systems" (AK), the United States Department of Agriculture Ecosystem service program, Award No. 2010-65615-20614 (AK), and by the US National Science Foundation LTER Program (DEB 1027253) (GPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank LTER support personnel for managing the experimental fields and helping with sampling and data collection.	Addiscott TM, 2005, NITRATE, AGRICULTURE AND THE ENVIRONMENT, P1, DOI 10.1079/9780851999135.0001; Andraski TW, 2005, AGRON J, V97, P1239, DOI 10.2134/agronj2005.0052; Asagi N, 2009, PLANT SOIL, V322, P251, DOI 10.1007/s11104-009-9913-4; Bair KE, 2008, HORTSCIENCE, V43, P875, DOI 10.21273/HORTSCI.43.3.875; Chan C, 2007, CAN J SOIL SCI, V87, P495, DOI 10.4141/CJSS07022; Collins HP, 2007, AGRON J, V99, P27, DOI 10.2134/agronj2005.0357; Corre MD, 2002, SOIL BIOL BIOCHEM, V34, P445, DOI 10.1016/S0038-0717(01)00198-5; Cueto-Wong JA, 2001, J SUSTAIN AGR, V17, P27, DOI 10.1300/J064v17n04_04; Dabney SM, 2001, COMMUN SOIL SCI PLAN, V32, P1221, DOI 10.1081/CSS-100104110; Dharmakeerthi RS, 2005, SOIL SCI SOC AM J, V69, P453, DOI 10.2136/sssaj2005.0453; Fageria NK, 2007, J PLANT NUTR, V30, P691, DOI 10.1080/01904160701289529; Garten CT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001918; Groffman P.M., 1999, STANDARD SOIL METHOD, P272; Havlin JL, 1996, SOIL FERTILITY FERTI; Haynes RJ, 1997, BIOL FERT SOILS, V25, P130, DOI 10.1007/s003740050292; Jiang P, 2004, AGRON J, V96, P252, DOI 10.2134/agronj2004.0252; Kay BD, 2006, SOIL SCI SOC AM J, V70, P1210, DOI 10.2136/sssaj2005.0039; Kramberger B, 2009, EUR J AGRON, V31, P103, DOI 10.1016/j.eja.2009.05.006; Kravchenko AN, 2005, AGRON J, V97, P514, DOI 10.2134/agronj2005.0514; Kuo S, 2002, AGRON J, V94, P501; Ladoni M, 2015, SOIL SCI SO IN PRESS; Lawson A, 2013, RENEW AGR FOOD SYST, V28, P59, DOI 10.1017/S1742170512000014; Mirsky SB, 2009, AGRON J, V101, P1589, DOI 10.2134/agronj2009.0130; Mulvaney RL, 1996, SSSA BOOK SER 3, V5; Munoz JD, 2014, AGR ECOSYST ENVIRON, V189, P229, DOI [10.1016/j.agee., 10.1016/j.agee.2014.03.045]; Munoz JD, 2012, GEOMORPHOLOGY, V179, P197, DOI 10.1016/j.geomorph.2012.08.011; Robertson G.P., 2015, ECOLOGY AGR LANDSCAP, P1; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Ruffo ML, 2004, AGRON J, V96, P800, DOI 10.2134/agronj2004.0800; Sainju UM, 2001, AGRON J, V93, P878, DOI 10.2134/agronj2001.934878x; Sainju UM, 2008, AGRON J, V100, P619, DOI 10.2134/agronj2007.0236; Schomberg HH, 2004, BIOL FERT SOILS, V40, P398, DOI 10.1007/s00374-004-0795-6; Soon YK, 2005, CAN J SOIL SCI, V85, P579, DOI 10.4141/S04-072; Starovoytov A, 2010, AGRON J, V102, P895, DOI 10.2134/agronj2009.0402; Tonitto C, 2006, AGR ECOSYST ENVIRON, V112, P58, DOI 10.1016/j.agee.2005.07.003; Wortman SE, 2012, AGRON J, V104, P1425, DOI 10.2134/agronj2012.0185; Zotarelli L, 2009, AGRON J, V101, P252, DOI 10.2134/agronj2008.0033x	37	21	21	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143358	10.1371/journal.pone.0143358	http://dx.doi.org/10.1371/journal.pone.0143358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600462	Green Published, gold			2022-12-27	WOS:000365853900098
J	Liu, LX; Li, H; Guo, ZZ; Ma, XF; Cao, N; Zheng, YQ; Geng, SN; Duan, YJ; Han, G; Du, GJ				Liu, Linxin; Li, Hong; Guo, Zhenzhen; Ma, Xiaofang; Cao, Ning; Zheng, Yaqiu; Geng, Shengnan; Duan, Yongjian; Han, Guang; Du, Gangjun			The Combination of Three Natural Compounds Effectively Prevented Lung Carcinogenesis by Optimal Wound Healing	PLOS ONE			English	Article							PANAX-NOTOGINSENG; STEM-CELLS; CANCER CELLS; IN-VITRO; TUMORIGENESIS; ACTIVATION; THERAPY; INFLAMMATION; DEBRIDEMENT; MECHANISM	The tumor stroma has been described as "normal wound healing gone awry". We explored whether the restoration of a wound healing-like microenvironment may facilitate tumor healing. Firstly, we screened three natural compounds (shikonin, notoginsenoside R1 and aconitine) from wound healing agents and evaluated the efficacies of wound healing microenvironment for limiting single agent-elicited carcinogenesis and two-stage carcinogenesis. The results showed that three compounds used alone could promote wound healing but had unfavorable efficacy to exert wound healing, and that the combination of three compounds made up treatment disadvantage of a single compound in wound healing and led to optimal wound healing. Although individual treatment with these agents may prevent cancer, they were not effective for the treatment of established tumors. However, combination treatment with these three compounds almost completely prevented urethane-induced lung carcinogenesis and reduced tumor burden. Different from previous studies, we found that urethane-induced lung carcinogenesis was associated with lung injury independent of pulmonary inflammation. LPS-induced pulmonary inflammation did not increase lung carcinogenesis, whereas decreased pulmonary inflammation by macrophage depletion promoted lung carcinogenesis. In addition, urethane damaged wound healing in skin excision wound model, reversed lung carcinogenic efficacy by the combination of three compounds was consistent with skin wound healing. Further, the combination of these three agents reduced the number of lung cancer stem cells (CSCs) by inducing cell differentiation, restoration of gap junction intercellular communication (GJIC) and blockade of the epithelial-to-mesenchymal transition (EMT). Our results suggest that restoration of a wound healing microenvironment represents an effective strategy for cancer prevention.	[Liu, Linxin; Li, Hong; Guo, Zhenzhen; Ma, Xiaofang; Cao, Ning; Zheng, Yaqiu; Geng, Shengnan; Han, Guang; Du, Gangjun] Henan Univ, Coll Pharm, Inst Pharm, Kaifeng 475004, Henan Provice, Peoples R China; [Duan, Yongjian] Henan Univ, Dept Oncol, Hosp Affiliated 1, Kaifeng 475001, Henan Provice, Peoples R China	Henan University; Henan University	Han, G (corresponding author), Henan Univ, Coll Pharm, Inst Pharm, Kaifeng 475004, Henan Provice, Peoples R China.	Hang@henu.edu.cn; 724200@henu.edu.cn			National Natural Science Foundation of China [81173094, 81373974, 81472745]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81173094, 81373974, 81472745).; The authors thank Prof. Ming Bai and Prof. Ming-San Miao for generous assistance. We thank AJE (American Journal Experts) for editing the manuscript. This work was supported by National Natural Science Foundation of China (No. 81173094, 81373974, 81472745).	Andujar I, 2013, EUR J PHARM SCI, V49, P637, DOI 10.1016/j.ejps.2013.05.018; Andujar I, 2013, PLANTA MED, V79, P1685, DOI 10.1055/s-0033-1350934; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Du GJ, 2013, EUR J PHARMACOL, V715, P395, DOI 10.1016/j.ejphar.2013.04.031; Du Juan, 2013, Molecules, V18, P757, DOI 10.3390/molecules18010757; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; Fu M, 2007, BIOCHEM BIOPH RES CO, V354, P929, DOI 10.1016/j.bbrc.2007.01.082; Grimwade D, 2010, CANCER TREAT RES, V145, P219, DOI 10.1007/978-0-387-69259-3_13; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Ho PL, 2012, NAT REV UROL, V9, P583, DOI 10.1038/nrurol.2012.142; Hong SJ, 2009, PHYTOTHER RES, V23, P677, DOI 10.1002/ptr.2705; Huang L, 2014, BIOINFORMATICS, V30, P228, DOI 10.1093/bioinformatics/btu278; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ke Q, 2013, HUM MOL GENET, V22, P2221, DOI 10.1093/hmg/ddt074; Kisley LR, 2002, CARCINOGENESIS, V23, P1653, DOI 10.1093/carcin/23.10.1653; Madhok BM, 2013, INT WOUND J, V10, P247, DOI 10.1111/iwj.12045; Maeda TM, 2014, CLIN EXP DERMATOL, V39, P911, DOI 10.1111/ced.12454; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Papageorgiou VP, 2008, CURR MED CHEM, V15, P3248, DOI 10.2174/092986708786848532; Paranjape AN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-785; Piccoli C, 2012, FREE RADICAL BIO MED, V52, P916, DOI 10.1016/j.freeradbiomed.2011.12.018; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song IY, 2015, SEMIN CANCER BIOL, V32, P32, DOI 10.1016/j.semcancer.2014.03.006; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Sun DQ, 2007, CARCINOGENESIS, V28, P1859, DOI 10.1093/carcin/bgm079; Tang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102967; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Wang B, 2011, GENOME MED, V3, DOI 10.1186/gm225; Wang CZ, 2009, PHYTOTHER RES, V23, P6, DOI 10.1002/ptr.2383; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052706; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yoshikawa M, 1997, CHEM PHARM BULL, V45, P1039, DOI 10.1248/cpb.45.1039; Yunhe F., 2012, J PHARM, V689, P255, DOI DOI 10.1016/J.EJPHAR.2012.05.038; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zyuz'kov GN, 2012, B EXP BIOL MED+, V153, P847, DOI 10.1007/s10517-012-1841-2	35	27	27	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143438	10.1371/journal.pone.0143438	http://dx.doi.org/10.1371/journal.pone.0143438			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599445	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900122
J	Phillips, C; Zeringue, AL; McDonald, JR; Eisen, SA; Ranganathan, P				Phillips, Christopher; Zeringue, Angelique L.; McDonald, Jay R.; Eisen, Seth A.; Ranganathan, Prabha			Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; VETERANS; THERAPY; SCORES; RISK	The objective of this retrospective cohort study was to determine the effect of tumor necrosis factor inhibitor (TNFi) therapy on the risk of head and neck cancer (HNC) recurrence or HNC-attributable death in patients with rheumatoid arthritis (RA). RA patients with HNC were assembled from the US national Veterans' Affairs (VA) administrative databases, and diagnoses confirmed and data collected by electronic medical record review. The cohort was divided into those treated with non-biologic disease-modifying anti-rheumatic drugs (nbDMARDs) versus TNF inhibitors (TNFi) after a diagnosis of HNC. Likelihood of a composite endpoint of recurrence or HNC-attributable death was determined by Cox proportional hazards regression. Of 180 patients with RA and HNC, 31 were treated with TNFi and 149 with nbDMARDs after the diagnosis of HNC. Recurrence or HNC-attributable death occurred in 5/31 (16.1%) patients in the TNFi group and 44/149 (29.5%) patients in the nbDMARD group (p = 0.17); it occurred in 2/16 (13%) patients who received TNFi in the year prior to HNC diagnosis but not after. Overall stage at diagnosis (p = 0.03) and stage 4 HNC (HR 2.49 [CI 1.06-5.89]; p = 0.04) were risk factors for recurrence or HNC-attributable death; treatment with radiation or surgery was associated with a lower risk (HR 0.35 [CI 0.17-0.74]; p = 0.01 and HR 0.39 [CI 0.20-0.76]; p = 0.01 respectively). Treatment with TNFi was not a risk factor for recurrence or HNC-attributable death (HR 0.75; CI 0.31-1.85; p = 0.54). We conclude that treatment with TNFi may be safe in patients with RA and HNC, especially as the time interval between HNC treatment and non-recurrence increases. In this study, TNF inhibition was not associated with an increase in recurrence or HNC-attributable death.	[Phillips, Christopher; Zeringue, Angelique L.; McDonald, Jay R.; Eisen, Seth A.; Ranganathan, Prabha] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Zeringue, Angelique L.; McDonald, Jay R.; Eisen, Seth A.] St Louis Vet Affairs Med Ctr, St Louis, MO USA	Washington University (WUSTL)	Ranganathan, P (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.	prangana@dom.wustl.edu		Eisen, Seth/0000-0001-7746-6624; Zeringue, Angelique/0000-0003-3654-4109	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service project [IAF 06-026]	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service project	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service project number IAF 06-026.	Amari W, 2011, RHEUMATOLOGY, V50, P1431, DOI 10.1093/rheumatology/ker113; Askling J, 2011, PHARMACOEPIDEM DR S, V20, P119, DOI 10.1002/pds.2046; Engel SH, 2008, LARYNGOSCOPE, V118, P450, DOI 10.1097/MLG.0b013e31815abf4c; Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291; Hashibe M, 2012, HEAD NECK; Jan JC, 2011, J ORAL MAXIL SURG, V69, P396, DOI 10.1016/j.joms.2010.05.017; Kim L, 2010, ONCOLOGY-NY, V24, P915; Mariette X, 2011, ANN RHEUM DIS, V70, P1895, DOI 10.1136/ard.2010.149419; Park HJ, 2012, DISCOV MED, V13, P229; Rahman N, 2010, JCR-J CLIN RHEUMATOL, V16, P197, DOI 10.1097/RHU.0b013e3181df8932; Rousseau A, 2009, REV STOMATOL CHIR, V110, P306, DOI 10.1016/j.stomax.2009.07.002; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Singh JA, 2004, ARTHRIT RHEUM-ARTHR, V51, P952, DOI 10.1002/art.20827; Urba S, 2012, ORAL ONCOL, V48, P723, DOI 10.1016/j.oraloncology.2012.02.016; Zitelli KB, 2013, CUTIS, V92, P35	15	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143286	10.1371/journal.pone.0143286	http://dx.doi.org/10.1371/journal.pone.0143286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599370	Green Submitted, gold, Green Published			2022-12-27	WOS:000365853900085
J	Sulu, RJ; Eriksson, H; Schwarz, AM; Andrew, NL; Orirana, G; Sukulu, M; Oeta, J; Harohau, D; Sibiti, S; Toritela, A; Beare, D				Sulu, Reuben J.; Eriksson, Hampus; Schwarz, Anne-Maree; Andrew, Neil L.; Orirana, Grace; Sukulu, Meshach; Oeta, Janet; Harohau, Daykin; Sibiti, Stephen; Toritela, Andrew; Beare, Douglas			Livelihoods and Fisheries Governance in a Contemporary Pacific Island Setting	PLOS ONE			English	Article							SHELL MONEY PRODUCTION; MARINE RESOURCES; INCOME DIVERSIFICATION; SOCIOECONOMIC-FACTORS; ECONOMIC CONTEXT; MANAGEMENT; STRATEGIES; SECURITY; POLICY; FISH	Inshore marine resources play an important role in the livelihoods of Pacific Island coastal communities. However, such reliance can be detrimental to inshore marine ecosystems. Understanding the livelihoods of coastal communities is important for devising relevant and effective fisheries management strategies. Semi-structured household interviews were conducted with householders in Langalanga Lagoon, Solomon Islands, to understand household livelihoods and resource governance in fishing-dependent communities. Households were engaged in a diverse range of livelihoods. Fishing, shell money production and gardening were the most important livelihoods. Proximity to an urban centre influenced how households accessed some livelihoods. Perceptions of management rules varied and different reasons were cited for why rules were broken, the most common reason being to meet livelihood needs. Current models of inshore small-scale fisheries management that are based on the notion of community-based resource management may not work in locations where customary management systems are weak and livelihoods are heavily reliant on marine resources. An important step for fisheries management in such locations should include elucidating community priorities through participatory development planning, taking into consideration livelihoods as well as governance and development aspirations.	[Sulu, Reuben J.; Schwarz, Anne-Maree; Orirana, Grace; Sukulu, Meshach; Oeta, Janet; Harohau, Daykin; Sibiti, Stephen] WorldFish, Honiara, Solomon Islands; [Eriksson, Hampus; Andrew, Neil L.; Beare, Douglas] WorldFish, George Town, Malaysia; [Eriksson, Hampus; Andrew, Neil L.] Univ Wollongong, ANCORS, Wollongong, NSW, Australia; [Toritela, Andrew] Malaita Prov Fisheries Div, Auki, Malaita Provinc, Solomon Islands	CGIAR; Worldfish; CGIAR; Worldfish; University of Wollongong	Sulu, RJ (corresponding author), WorldFish, Honiara, Solomon Islands.	r.sulu@cgiar.org	andrew, neil/AAG-6360-2020	andrew, neil/0000-0002-2337-8722	European Union Action [DCI-ENV/2011/221352]; Australian Centre for International Agricultural Research [FIS/2012/074]; CGIAR Research Programs - Aquatic Agricultural Systems and Climate Change Agriculture and Food Security; European Commission [DCI-ENV/2011/221352]; CGIAR Research Programs-Aquatic Agricultural Systems and Climate Change Agriculture and Food Security	European Union Action; Australian Centre for International Agricultural Research; CGIAR Research Programs - Aquatic Agricultural Systems and Climate Change Agriculture and Food Security; European Commission(European CommissionEuropean Commission Joint Research Centre); CGIAR Research Programs-Aquatic Agricultural Systems and Climate Change Agriculture and Food Security	This study was funded by the European Union Action (http://ec.europa.eu/development), 'Implementing an ecosystem approach to fisheries (EAF) in small-scale tropical marine fisheries' (DCI-ENV/2011/221352), the Australian Centre for International Agricultural Research (www.aciar.gov.au) project FIS/2012/074, 'Improving Community-based Fisheries Management in Pacific Island Countries', and the CGIAR Research Programs - Aquatic Agricultural Systems and Climate Change Agriculture and Food Security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the people of Langalanga who willingly participated in this study which was supported by funding from the European Commission (DCI-ENV/2011/221352), Australian Center for International Agricultural Research (FIS/2012/074) and the CGIAR Research Programs-Aquatic Agricultural Systems and Climate Change Agriculture and Food Security. We also acknowledge the academic editor and two anonymous reviewers whose suggestions greatly improved the manuscript.	Abernethy KE, 2014, GLOBAL ENVIRON CHANG, V28, P309, DOI 10.1016/j.gloenvcha.2014.07.008; Adams T, 1998, OCEAN COAST MANAGE, V40, P127, DOI 10.1016/S0964-5691(98)00041-6; Albert JA, 2014, CONTRIBUTION NEARSHO, P1, DOI [10.1371/journal.pone.0115386, DOI 10.1371/JOURNAL.PONE.0115386]; Allen M. G., 2006, SOLOMON ISLANDS SMAL, V4; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Andersen A. B., 2013, AAS201306; Armitage D, 2005, ENVIRON MANAGE, V35, P703, DOI 10.1007/s00267-004-0076-z; Aswani S, 2005, REV FISH BIOL FISHER, V15, P285, DOI 10.1007/s11160-005-4868-x; Barrett CB, 2001, FOOD POLICY, V26, P367, DOI 10.1016/S0306-9192(01)00017-3; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Bender A, 2002, ECON DEV CULT CHANGE, V50, P427, DOI 10.1086/340802; Berkes F, 1998, MT RES DEV, V18, P19, DOI 10.2307/3673865; Brewer TD, 2009, BIOL CONSERV, V142, P1797, DOI 10.1016/j.biocon.2009.03.021; Bunce M, 2009, GLOBAL ENVIRON CHANG, V19, P213, DOI 10.1016/j.gloenvcha.2008.11.005; Burke L., 2011, REEFS RISK REVISITED; Cinner J, 2005, ECOL SOC, V10; Cinner JE, 2006, ENVIRON CONSERV, V33, P73, DOI 10.1017/S0376892906002748; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner JE, 2005, CONSERV BIOL, V19, P1714, DOI 10.1111/j.1523-1739.2005.00209.x-i1; Cinner JE, 2007, BIOL CONSERV, V140, P201, DOI 10.1016/j.biocon.2007.08.008; Clarke P, 2010, ENVIRON CONSERV, V37, P98, DOI 10.1017/S0376892910000354; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cohen PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073383; CONNELL J, 1977, OCEANIA, V48, P81, DOI 10.1002/j.1834-4461.1977.tb01326.x; COOPER M, 1971, OCEANIA, V41, P266, DOI 10.1002/j.1834-4461.1971.tb01167.x; Cooper Matthew, 1972, OCEANIA, V43, P113, DOI DOI 10.1002/J.1834-4461.1972.TB00322.X; Curtis M, 2004, J DEV SOC TRANSFORM, V1, P37; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Evans M, 2001, B WORLD HEALTH ORGAN, V79, P856; Faradatolo D, 2008, THESIS; Fidali-Hickie K., 2005, PACIFIC VOICES EQUIT, P27; Foale S., 2004, ASIA PAC VIEWP, V45, P373; Foale S, 2011, FISH FISH, V12, P357, DOI 10.1111/j.1467-2979.2010.00395.x; Geheb K, 1997, AFR AFFAIRS, V96, P73, DOI 10.1093/oxfordjournals.afraf.a007822; Goto A., 1996, SENRI ETHNOL STUD, V42, P11; Govan H, 2013, SOLOMON ISLANDS ESSE; Guo P, 1996, LANDSCAPE MEMORY HIS, P189; Hardy PY, 2013, ENVIRON DEV, V8, P38, DOI 10.1016/j.envdev.2013.04.009; HUBER ME, 1994, MAR POLLUT BULL, V29, P69, DOI 10.1016/0025-326X(94)90428-6; Jennings S., 1996, Fisheries Management and Ecology, V3, P335, DOI 10.1046/j.1365-2400.1996.d01-155.x; Johannes RE, 1998, OCEAN COAST MANAGE, V40, P165, DOI 10.1016/S0964-5691(98)00046-5; Johannes RE., 2002, SPC TRADITIONAL MARI, V14, P3; Jones C, 2014, AAS201430 CGIAR RES, pAAs; Jupiter Stacy D., 2014, Pacific Conservation Biology, V20, P165; Kronen M., 2010, SPC WOMEN FISHERIES, V21, P3; Kronen M, 2007, HUM ECOL, V35, P195, DOI 10.1007/s10745-006-9084-3; Kuster C, 2006, FISHERIES MANAG ECOL, V13, P177, DOI 10.1111/j.1365-2400.2006.00492.x; Labrosse P, 2006, OCEAN COAST MANAGE, V49, P203, DOI 10.1016/j.ocecoaman.2006.02.006; Lane MB, 2006, OCEAN COAST MANAGE, V49, P421, DOI 10.1016/j.ocecoaman.2006.03.011; Marschke M., 2006, ECOL SOC, V11, P42; Mauli S, 2009, THESIS; Mills D, 2011, J INT DEV, V23, P308, DOI 10.1002/jid.1638; Mills DJ, 2011, SMALL-SCALE FISHERIES MANAGEMENT: FRAMEWORKS AND APPROACHES FOR THE DEVELOPING WORLD, P1, DOI 10.1079/9781845936075.0001; Morand P, 2012, CLIMATIC CHANGE, V115, P463, DOI 10.1007/s10584-012-0492-7; Ostrom E., 1990, GOVERNING COMMONS EV; OTTO T, 1992, OCEANIA, V62, P264, DOI 10.1002/j.1834-4461.1992.tb00357.x; Pauly D., 1994, TRADITIONAL MARINE R, V3, P7; POLUNIN NVC, 1984, SENRI ETHNOLOGICAL S, V17, P267; Pomeroy RS, 1995, OCEAN COAST MANAGE, V27, P143, DOI 10.1016/0964-5691(95)00042-9; R Core Team, 2020, R LANG ENV STAT COMP; REARDON T, 1992, J DEV STUD, V28, P264, DOI 10.1080/00220389208422232; Sarch M-T, 2000, P 10 BIENN C INT I F; Schwarz A. M., 2013, AAS201318 CGIAR RES; Sievanen L, 2005, OCEAN COAST MANAGE, V48, P297, DOI 10.1016/j.ocecoaman.2005.04.015; Snowdon W, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-53; Solomon Islands National Statistics Office, 2011, REP 2009 POP HOUS CE, V1; Swindale A., 2006, FHI 360FANTA; Thorne-Lyman A. L., 2010, J NUTR, P1, DOI [10.3945/jn.109.110809.of, DOI 10.3945/JN.109.110809.OF]; Torlesse H, 2003, J NUTR, V133, P1320; Turner RA, 2007, CORAL REEFS, V26, P997, DOI 10.1007/s00338-007-0238-6; Warren-Rhodes K, 2011, ENVIRON CONSERV, V38, P485, DOI 10.1017/S0376892911000373; World Bank, 2000, VOIC VILL COMP STUD; World Bank/FAO/WorldFish Center, 2010, HIDD HARV GLOB CONTR	74	34	35	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143516	10.1371/journal.pone.0143516	http://dx.doi.org/10.1371/journal.pone.0143516			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599412	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900136
J	de Gracia, P; Gallego, BI; Rojas, B; Ramirez, AI; de Hoz, R; Salazar, JJ; Trivino, A; Ramirez, JM				de Gracia, Pablo; Gallego, Beatriz I.; Rojas, Blanca; Ramirez, Ana I.; de Hoz, Rosa; Salazar, Juan J.; Trivino, Alberto; Ramirez, Jose M.			Automatic Counting of Microglial Cells in Healthy and Glaucomatous Mouse Retinas	PLOS ONE			English	Article							ELEVATED INTRAOCULAR-PRESSURE; NERVOUS-SYSTEM; IMAGE-ANALYSIS; ADULT ALBINO; RAT MODEL; QUANTIFICATION; PROLIFERATION; ACTIVATION; EXPRESSION; RESPONSES	Proliferation of microglial cells has been considered a sign of glial activation and a hallmark of ongoing neurodegenerative diseases. Microglia activation is analyzed in animal models of different eye diseases. Numerous retinal samples are required for each of these studies to obtain relevant data of statistical significance. Because manual quantification of microglial cells is time consuming, the aim of this study was develop an algorithm for automatic identification of retinal microglia. Two groups of adult male Swiss mice were used: age-matched controls (naive, n = 6) and mice subjected to unilateral laser-induced ocular hypertension (lasered; n = 9). In the latter group, both hypertensive eyes and contralateral untreated retinas were analyzed. Retinal whole mounts were immunostained with anti Iba-1 for detecting microglial cell populations. A new algorithm was developed in MATLAB for microglial quantification; it enabled the quantification of microglial cells in the inner and outer plexiform layers and evaluates the area of the retina occupied by Iba-1+ microglia in the nerve fiber-ganglion cell layer. The automatic method was applied to a set of 6,000 images. To validate the algorithm, mouse retinas were evaluated both manually and computationally; the program correctly assessed the number of cells (Pearson correlation R = 0.94 and R = 0.98 for the inner and outer plexiform layers respectively). Statistically significant differences in glial cell number were found between naive, lasered eyes and contralateral eyes (P<0.05, naive versus contralateral eyes; P<0.001, naive versus lasered eyes and contralateral versus lasered eyes). The algorithm developed is a reliable and fast tool that can evaluate the number of microglial cells in naive mouse retinas and in retinas exhibiting proliferation. The implementation of this new automatic method can enable faster quantification of microglial cells in retinal pathologies.	[de Gracia, Pablo] St Josephs Hosp, Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Gallego, Beatriz I.; Rojas, Blanca; Ramirez, Ana I.; de Hoz, Rosa; Salazar, Juan J.; Trivino, Alberto; Ramirez, Jose M.] Univ Complutense Madrid, Inst Invest Oftalmol Ramon Castroviejo, Madrid, Spain; [Gallego, Beatriz I.; Ramirez, Ana I.; de Hoz, Rosa; Salazar, Juan J.] Univ Complutense Madrid, Fac Opt & Optometria, Madrid, Spain; [Rojas, Blanca; Trivino, Alberto; Ramirez, Jose M.] Univ Complutense Madrid, Fac Med, Madrid, Spain	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid	de Gracia, P (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA.	pablodegracia@gmail.com	De Hoz, Rosa/ABF-9295-2020; ROJAS, BLANCA/V-8292-2017; Alberto, Trivino/ABG-2416-2020; Ramírez, Ana I/ABF-4789-2021; De Gracia, Pablo/B-2786-2017; Salazar, Juan J/L-6887-2014	De Hoz, Rosa/0000-0002-1581-087X; Ramírez, Ana I/0000-0002-2656-4723; Salazar, Juan J/0000-0001-5480-5902; De Gracia, Pablo/0000-0003-4319-2797	Science Foundation Arizona [BSP 0529-13]; (ISCIII) Institute of Health Carlos III (Spanish Ministry of Economy and Competitiveness); PN I-D+i; ISCIII, General Subdirection of Networks and Cooperative Research Centers; FEDER European program;  [SAF2014-53779-R]	Science Foundation Arizona; (ISCIII) Institute of Health Carlos III (Spanish Ministry of Economy and Competitiveness); PN I-D+i; ISCIII, General Subdirection of Networks and Cooperative Research Centers; FEDER European program(European Commission); 	This material is based upon works supported by Science Foundation Arizona under Grant No. BSP 0529-13. This work was also supported by the Network of Ophthalmology RETICs: "Prevention, early detection and treatment of chronic degenerative and prevalent eye disease" from the (ISCIII) Institute of Health Carlos III (Spanish Ministry of Economy and Competitiveness). This work was supported in part by the PN I-D+i 2008-2011; ISCIII, General Subdirection of Networks and Cooperative Research Centers; by the FEDER European program; by the SAF2014-53779-R: neuroinflammation in glaucoma: sequencing of glial and blood-retinal barrier damage. The role of encapsulated NSAIDs in PLGA microparticles as a neuroprotective treatment (Spanish Ministry of Economy and Competitiveness).	Aihara M, 2003, EXP EYE RES, V77, P681, DOI 10.1016/j.exer.2003.08.011; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Alyassin MA, 2009, LAB CHIP, V9, P3364, DOI 10.1039/b911882a; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Bandekar N, 2011, IEEE ENG MED BIO, P5997, DOI 10.1109/IEMBS.2011.6091482; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Bartels PH, 1996, EUR UROL, V30, P234; Biggerstaff J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-16; Bizrah M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-169; Bjornsson CS, 2008, J NEUROSCI METH, V170, P165, DOI 10.1016/j.jneumeth.2007.12.024; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; de Hoz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083733; Drouyer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003931; Elkabes S, 1996, J NEUROSCI, V16, P2508; Forero MG, 2012, J MICROSC-OXFORD, V246, P202, DOI 10.1111/j.1365-2818.2012.03608.x; Forero MG, 2010, CYTOM PART A, V77A, P371, DOI 10.1002/cyto.a.20877; Forero MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005441; Forero MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010557; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; GIULIAN D, 1988, J NEUROSCI, V8, P4707; Grunwald JE, 2005, INVEST OPHTH VIS SCI, V46, P1033, DOI 10.1167/iovs.04-1050; Hamilton PW, 1998, ANAL QUANT CYTOL, V20, P443; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Hopkins AM, 2014, J NEUROSCI METH, V228, P100, DOI 10.1016/j.jneumeth.2014.03.006; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Inman DM, 2011, GLAUCOMA CURRENT CLI, P26; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kandel E. R., 2001, PRINCIPIOS NEUROCIEN, P19; Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003; Kloss CUA, 1997, J NEUROSCI RES, V49, P248; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Lam TT, 2003, INVEST OPHTH VIS SCI, V44, P638, DOI 10.1167/iovs.02-0255; LEWIS GP, 1992, J NEUROSCI, V12, P3968; Li HQ, 2004, IEEE T BIO-MED ENG, V51, P246, DOI 10.1109/TBME.2003.820400; Madeira MH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/673090; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Nedzved A, 2005, Rocz Akad Med Bialymst, V50, P284; Ortin-Martinez A, 2010, INVEST OPHTH VIS SCI, V51, P3171, DOI 10.1167/iovs.09-4861; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Plog BA, 2014, J NEUROSCI METH, V229, P44, DOI 10.1016/j.jneumeth.2014.04.001; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rojas B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-133; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Sanchez CI, 2009, MED IMAGE ANAL, V13, P650, DOI 10.1016/j.media.2009.05.005; Sharma R, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-13; Sociedad Europea de Glaucoma, 2008, TERM PAUT GIAUC; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Tezel G, 2009, INVEST OPHTH VIS SCI, V50, P1001, DOI 10.1167/iovs.08-2717; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Wang L, 2002, INVEST OPHTH VIS SCI, V43, P1088; Wang X, 2000, BRAIN RES, V878, P136, DOI 10.1016/S0006-8993(00)02727-X; Wang X, 2000, EXP BRAIN RES, V132, P476, DOI 10.1007/s002210000360; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wong ST, 2003, J NEUROSCI METH, V123, P1, DOI 10.1016/S0165-0270(02)00318-7; Xiao BG, 1998, J NEUROL SCI, V157, P1, DOI 10.1016/S0022-510X(98)00049-5; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	62	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143278	10.1371/journal.pone.0143278	http://dx.doi.org/10.1371/journal.pone.0143278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580208	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600106
J	Einfinger, K; Badrnya, S; Furtmuller, M; Handschuh, D; Lindner, H; Geiger, M				Einfinger, Katrin; Badrnya, Sigrun; Furtmueller, Margareta; Handschuh, Daniela; Lindner, Herbert; Geiger, Margarethe			Phospholipid Binding Protein C Inhibitor (PCI) Is Present on Microparticles Generated In Vitro and In Vivo	PLOS ONE			English	Article							PLATELET-DERIVED MICROPARTICLES; PROCOAGULANT ACTIVITIES; MYOCARDIAL-INFARCTION; ACTIVATED PLATELETS; TISSUE KALLIKREIN; ESCHERICHIA-COLI; HEPARIN-BINDING; HUMAN-PLASMA; ROCK-I; MEMBRANE	Protein C inhibitor is a secreted, non-specific serine protease inhibitor with broad protease reactivity. It binds glycosaminoglycans and anionic phospholipids, which can modulate its activity. Anionic phospholipids, such as phosphatidylserine are normally localized to the inner leaflet of the plasma membrane, but are exposed on activated and apoptotic cells and on plasma membrane-derived microparticles. In this report we show by flow cytometry that microparticles derived from cultured cells and activated platelets incorporated protein C inhibitor during membrane blebbing. Moreover, protein C inhibitor is present in/on microparticles circulating in normal human plasma as judged from Western blots, ELISAs, flow cytometry, and mass spectrometry. These plasma microparticles are mainly derived from megakaryocytes. They seem to be saturated with protein C inhibitor, since they do not bind added fluorescence-labeled protein C inhibitor. Heparin partially removed microparticle-bound protein C inhibitor, supporting our assumption that protein C inhibitor is bound via phospholipids. To assess the biological role of microparticle-bound protein C inhibitor we performed protease inhibition assays and co-precipitated putative binding partners on microparticles with anti-protein C inhibitor IgG. As judged from amidolytic assays microparticle-bound protein C inhibitor did not inhibit activated protein C or thrombin, nor did microparticles modulate the activity of exogenous protein C inhibitor. Among the proteins co-precipitating with protein C inhibitor, complement factors, especially complement factor 3, were most striking. Taken together, our data do not support a major role of microparticle-associated protein C inhibitor in coagulation, but rather suggest an interaction with proteins of the complement system present on these phospholipid vesicles.	[Einfinger, Katrin; Furtmueller, Margareta; Handschuh, Daniela; Geiger, Margarethe] Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Badrnya, Sigrun] Med Univ Vienna, Dept Physiol, Ctr Physiol & Pharmacol, Vienna, Austria; [Lindner, Herbert] Med Univ Innsbruck, Bioctr, Div Clin Biochem, A-6020 Innsbruck, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Innsbruck	Geiger, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Vasc Biol & Thrombosis Res, Vienna, Austria.	margarethe.geiger@meduniwien.ac.at		Furtmuller, Margareta/0000-0002-2572-6401; Geiger, Margarethe/0000-0003-2021-5319	Austrian Science Fund (FWF) [P20248-B09, P22792-B11]; Austrian Science Fund (FWF) [P 22792] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants P20248-B09 and P22792-B11 (both to MG) from the Austrian Science Fund (FWF). Web site: www.fwf.ac.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnitz R, 2006, PROTEOMICS, V6, P865, DOI 10.1002/pmic.200500054; Assinger A, 2014, ARTERIOSCL THROM VAS, V34, P801, DOI 10.1161/ATVBAHA.114.303287; Baumgartner P, 2007, J CELL BIOL, V179, P793, DOI 10.1083/jcb.200707165; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Biro E, 2005, J THROMB HAEMOST, V3, P2754, DOI 10.1111/j.1538-7836.2005.01646.x; Biro E, 2003, J THROMB HAEMOST, V1, P2561, DOI 10.1046/j.1538-7836.2003.00456.x; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Dasgupta SK, 2009, BLOOD, V113, P1332, DOI 10.1182/blood-2008-07-167148; Dasgupta SK, 2012, CIRCULATION, V125, P1664, DOI 10.1161/CIRCULATIONAHA.111.068833; Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5; ECKE S, 1992, J BIOL CHEM, V267, P7048; Ecke S, 1997, EUR J BIOCHEM, V248, P475, DOI 10.1111/j.1432-1033.1997.00475.x; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; ESPANA F, 1990, THROMB RES, V59, P593, DOI 10.1016/0049-3848(90)90418-C; Flaumenhaft R, 2006, BLOOD CELL MOL DIS, V36, P182, DOI 10.1016/j.bcmd.2005.12.019; Flaumenhaft R, 2009, BLOOD, V113, P1112, DOI 10.1182/blood-2008-06-163832; GEIGER M, 1991, J BIOL CHEM, V266, P11851; Geiger M, 2007, THROMB HAEMOSTASIS, V97, P343, DOI 10.1160/TH06-09-0488; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gris JC, 1996, THROMB HAEMOSTASIS, V76, P38; Hussein MNA, 2008, THROMB RES, V121, P865, DOI 10.1016/j.thromres.2007.08.005; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; Kolbel T, 2006, J VASC SURG, V43, P935, DOI 10.1016/j.jvs.2006.01.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURELL M, 1992, J CLIN INVEST, V89, P1094, DOI 10.1172/JCI115689; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje; Nishioka J, 1998, J BIOL CHEM, V273, P11281, DOI 10.1074/jbc.273.18.11281; Nojima J, 2001, CLIN CHEM, V47, P1008; Perez-Casal M, 2005, BLOOD, V105, P1515, DOI 10.1182/blood-2004-05-1896; PRATT CW, 1992, J BIOL CHEM, V267, P8789; Prendes MJ, 1999, BLOOD, V94, P1300, DOI 10.1182/blood.V94.4.1300.416k26_1300_1312; PRIGLINGER U, 1994, J BIOL CHEM, V269, P14705; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Rank A, 2010, THROMB RES, V126, pE255, DOI 10.1016/j.thromres.2010.07.012; Rehault SM, 2005, BBA-PROTEINS PROTEOM, V1748, P57, DOI 10.1016/j.bbapap.2004.12.003; REZAIE AR, 1995, J BIOL CHEM, V270, P25336, DOI 10.1074/jbc.270.43.25336; Rieger D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101794; Robert S, 2009, J THROMB HAEMOST, V7, P190, DOI 10.1111/j.1538-7836.2008.03200.x; Sarg B, 2013, MOL CELL PROTEOMICS, V12, P2640, DOI 10.1074/mcp.M112.024109; SATTA N, 1994, J IMMUNOL, V153, P3245; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; SEIFFERT D, 1992, THROMB HAEMOSTASIS, V68, P657; Siljander PRM, 2011, THROMB RES, V127, pS30, DOI 10.1016/S0049-3848(10)70152-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Stavenuiter F, 2013, THROMB HAEMOSTASIS, V109, P229, DOI 10.1160/TH12-08-0622; Steppich B, 2005, THROMB HAEMOSTASIS, V93, P35, DOI 10.1160/TH04-06-0393; Suzuki K, 2008, J THROMB HAEMOST, V6, P2017, DOI 10.1111/j.1538-7836.2008.03181.x; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; SUZUKI K, 1983, J BIOL CHEM, V258, P163; TANS G, 1991, BLOOD, V77, P2641; Terrisse AD, 2010, J THROMB HAEMOST, V8, P2810, DOI 10.1111/j.1538-7836.2010.04088.x; Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414; Wahlmuller FC, 2014, THROMB HAEMOSTASIS, V111, P41, DOI 10.1160/TH13-06-0478	61	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143137	10.1371/journal.pone.0143137	http://dx.doi.org/10.1371/journal.pone.0143137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580551	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600090
J	Heremans, E; Nackaerts, E; Vervoort, G; Vercruysse, S; Broeder, S; Strouwen, C; Swinnen, SP; Nieuwboer, A				Heremans, Elke; Nackaerts, Evelien; Vervoort, Griet; Vercruysse, Sarah; Broeder, Sanne; Strouwen, Carolien; Swinnen, Stephan P.; Nieuwboer, Alice			Amplitude Manipulation Evokes Upper Limb Freezing during Handwriting in Patients with Parkinson's Disease with Freezing of Gait	PLOS ONE			English	Article							MOTOR BLOCKS; DIAGNOSIS; VARIABILITY; PATTERNS; DISORDER; ONSET; LIFE	Background Recent studies show that besides freezing of gait (FOG), many people with Parkinson's disease (PD) also suffer from freezing in the upper limbs (FOUL). Up to now, it is unclear which task constraints provoke and explain upper limb freezing. Objective To investigate whether upper limb freezing and other kinematic abnormalities during writing are provoked by (i) gradual changes in amplitude or by (ii) sustained amplitude generation in patients with and without freezing of gait. Methods Thirty-four patients with PD, including 17 with and 17 without FOG, performed a writing task on a touch-sensitive writing tablet requiring writing at constant small and large size as well as writing at gradually increasing and decreasing size. Patients of both groups were matched for disease severity, tested while 'on' medication and compared to healthy age-matched controls. Results Fifty upper limb freezing episodes were detected in 10 patients, including 8 with and 2 without FOG. The majority of the episodes occurred when participants had to write at small or gradually decreasing size. The occurrence of FOUL and the number of FOUL episodes per patient significantly correlated with the occurrence and severity of FOG. Patients with FOUL also showed a significantly smaller amplitude in the writing parts outside the freezing episodes. Conclusions Corroborating findings of gait research, the current study supports a core problem in amplitude control underlying FOUL, both in maintaining as well as in flexibly adapting the cycle size.	[Heremans, Elke; Nackaerts, Evelien; Vervoort, Griet; Broeder, Sanne; Strouwen, Carolien; Nieuwboer, Alice] Katholieke Univ Leuven, Neuromotor Rehabil Res Grp, Dept Rehabil Sci, Leuven, Belgium; [Vercruysse, Sarah] Hasselt Univ, Ctr Stat, Hasselt, Belgium; [Swinnen, Stephan P.] Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Dept Kinesiol, Leuven, Belgium	KU Leuven; Hasselt University; KU Leuven	Heremans, E (corresponding author), Katholieke Univ Leuven, Neuromotor Rehabil Res Grp, Dept Rehabil Sci, Leuven, Belgium.	elke.heremans@faber.kuleuven.be	; Nieuwboer, Alice/F-5643-2013	VERCRUYSSE, Sarah/0000-0001-7928-1981; Broeder, Sanne/0000-0002-0891-3264; Nackaerts, Evelien/0000-0002-6580-4902; Nieuwboer, Alice/0000-0003-1193-6229; Strouwen, Carolien/0000-0002-0008-0915	Research Foundation - Flanders (FWO) [G.0906.11]	Research Foundation - Flanders (FWO)(FWO)	The project was funded by the Research Foundation - Flanders (FWO) (project G.0906.11). EH is a Postdoctoral Researcher and EN a Research Assistant at the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Barbe MT, 2014, J NEUROL, V261, P330, DOI 10.1007/s00415-013-7199-1; Brichetto G, 2006, CLIN REHABIL, V20, P31, DOI 10.1191/0269215506cr913oa; Broeder S, 2014, NEUROSCIENCE, V263, P193, DOI 10.1016/j.neuroscience.2014.01.019; Brown MJN, 2015, J NEUROL, V262, P41, DOI 10.1007/s00415-014-7514-5; Chee R, 2009, BRAIN, V132, P2151, DOI 10.1093/brain/awp053; Cohen RG, 2014, J PARKINSON DIS, V4, P111, DOI 10.3233/JPD-130221; Cowie D, 2012, MOVEMENT DISORD, V27, P492, DOI 10.1002/mds.23990; Coxon JP, 2010, CEREB CORTEX, V20, P2368, DOI 10.1093/cercor/bhp306; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Heremans E, 2013, J NEURAL TRANSM, V120, P543, DOI 10.1007/s00702-012-0964-y; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Knobl P, 2012, J NEUROL NEUROSUR PS, V83, P98, DOI 10.1136/jnnp-2011-300869; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Nackaerts E, 2015, NEUROREHABI IN PRESS; Naismith SL, 2010, J CLIN NEUROSCI, V17, P984, DOI 10.1016/j.jocn.2009.12.006; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Nieuwboer A, 2009, EUR J NEUROSCI, V29, P1422, DOI 10.1111/j.1460-9568.2009.06681.x; Nonnekes J, 2014, J NEUROL, V261, P1763, DOI 10.1007/s00415-014-7422-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perez-Lloret S, 2014, JAMA NEUROL, V71, P884, DOI 10.1001/jamaneurol.2014.753; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Popovic MB, 2008, TOHOKU J EXP MED, V216, P317, DOI 10.1620/tjem.216.317; Robles-Garcia V, 2015, J APPL BIOMECH, V31, P189, DOI 10.1123/jab.2013-0319; Rosenblum S, 2013, J NEUROL, V260, P2357, DOI 10.1007/s00415-013-6996-x; Schaafsma JD, 2003, EUR J NEUROL, V10, P391, DOI 10.1046/j.1468-1331.2003.00611.x; Serbruyns L, 2015, CORTEX, V65, P128, DOI 10.1016/j.cortex.2015.01.003; Shine JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052602; Smulders K, 2015, MOVEMENT DISORD, V30, P1090, DOI 10.1002/mds.26133; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Vercruysse S, 2014, CEREB CORTEX, V24, P3154, DOI 10.1093/cercor/bht170; Vercruysse S, 2014, NEUROSCI BIOBEHAV R, V43, P213, DOI 10.1016/j.neubiorev.2014.04.010; Vercruysse S, 2012, MOVEMENT DISORD, V27, P254, DOI 10.1002/mds.24015; Walker RW, 2014, EXPERT REV MED DEVIC, V11, P243, DOI 10.1586/17434440.2014.900437; Williams AJ, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/595378; Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014; Ziv I, 1999, ACTA NEUROL SCAND, V99, P106, DOI 10.1111/j.1600-0404.1999.tb00666.x	43	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142874	10.1371/journal.pone.0142874	http://dx.doi.org/10.1371/journal.pone.0142874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580556	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600063
J	Kapkowski, M; Siudyga, T; Sitko, R; Lelatko, J; Szade, J; Balin, K; Klimontko, J; Bartczak, P; Polanski, J				Kapkowski, Maciej; Siudyga, Tomasz; Sitko, Rafal; Lelatko, Jozef; Szade, Jacek; Balin, Katarzyna; Klimontko, Joanna; Bartczak, Piotr; Polanski, Jaroslaw			Catalytic Gas-Phase Glycerol Processing over SiO2-, Cu-, Ni- and Fe- Supported Au Nanoparticles	PLOS ONE			English	Article							DEHYDRATION; OXIDATION; ACID; ACROLEIN; OXIDES	In this study, we investigated different metal pairings of Au nanoparticles (NPs) as potential catalysts for glycerol dehydration for the first time. All of the systems preferred the formation of hydroxyacetone (HYNE). Although the bimetallics that were tested, i.e., Au NPs supported on Ni, Fe and Cu appeared to be more active than the Au/SiO2 system, only Cu supported Au NPs gave high conversion (ca. 63%) and selectivity (ca. 70%) to HYNE.	[Kapkowski, Maciej; Sitko, Rafal; Bartczak, Piotr; Polanski, Jaroslaw] Univ Silesia, Inst Chem, PL-40006 Katowice, Poland; [Siudyga, Tomasz] Silesian Tech Univ, Dept Chem, PL-44100 Gliwice, Poland; [Lelatko, Jozef] Univ Silesia, Inst Mat Sci, PL-41500 Chorzow, Poland; [Szade, Jacek; Balin, Katarzyna; Klimontko, Joanna] Univ Silesia, A Chelkowski Inst Phys, Silesian Ctr Educ & Interdisciplinary Res, PL-41500 Chorzow, Poland	University of Silesia in Katowice; Silesian University of Technology; University of Silesia in Katowice; University of Silesia in Katowice	Polanski, J (corresponding author), Univ Silesia, Inst Chem, Szkolna 9, PL-40006 Katowice, Poland.	polanski@us.edu.pl	Balin, Katarzyna/D-6225-2017; Bartczak, Piotr/V-9520-2018; Szade, Jacek/W-6169-2018	Balin, Katarzyna/0000-0002-1811-3033; Bartczak, Piotr/0000-0002-2035-8654; Lelatko, Jozef/0000-0003-1868-5426; Szade, Jacek/0000-0003-2083-4275; Sitko, Rafal/0000-0002-0469-5159; Polanski, Jaroslaw/0000-0001-7361-2671; Kapkowski, Maciej/0000-0003-1425-4522	National Research and Development Center (NCBiR) [PBS2/A5/40/2014]; DoktoRIS - Scholarship program for innovative Silesia; European Union	National Research and Development Center (NCBiR); DoktoRIS - Scholarship program for innovative Silesia; European Union(European Commission)	The research was financed by the National Research and Development Center (NCBiR) under Grant ORGANOMET No: PBS2/A5/40/2014. Author Maciej Kapkowski expresses his appreciation for the support of the DoktoRIS - Scholarship program for innovative Silesia, which is co-financed by the European Union within the framework of the ESF.; The research was co-financed by the National Research and Development Center (NCBiR) under Grant ORGANOMET No: PBS2/A5/40/2014. Author Maciej Kapkowski expresses his appreciation for the support of the DoktoRIS-Scholarship program for innovative Silesia, which is co-financed by the European Union within the framework of the ESF.	Alhanash A, 2010, APPL CATAL A-GEN, V378, P11, DOI 10.1016/j.apcata.2010.01.043; Atia H, 2008, J CATAL, V258, P71, DOI 10.1016/j.jcat.2008.05.027; Behr A, 2008, GREEN CHEM, V10, P13, DOI 10.1039/b710561d; Besson M, 2014, CHEM REV, V114, P1827, DOI 10.1021/cr4002269; Bujak P, 2012, J CATAL, V295, P15, DOI 10.1016/j.jcat.2012.06.023; Carrettin S, 2003, PHYS CHEM CHEM PHYS, V5, P1329, DOI 10.1039/b212047j; Carrettin S, 2002, CHEM COMMUN, P696, DOI 10.1039/b201112n; Chai SH, 2014, RSC ADV, V4, P4619, DOI 10.1039/c3ra46511j; Chin CW, 2006, AICHE J, V52, P3543, DOI 10.1002/aic.10951; de Oliveira AS, 2011, CHEM ENG J, V168, P765, DOI 10.1016/j.cej.2010.09.029; de Sousa FF, 2013, CHEM ENG J, V228, P442, DOI 10.1016/j.cej.2013.04.106; Deleplanque J, 2010, CATAL TODAY, V157, P351, DOI 10.1016/j.cattod.2010.04.012; Della Pina C, 2012, CHEM SOC REV, V41, P350, DOI 10.1039/c1cs15089h; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; Hughes MD, 2005, NATURE, V437, P1132, DOI 10.1038/nature04190; Kapkowski M, 2014, J CATAL, V319, P110, DOI 10.1016/j.jcat.2014.08.003; Katryniok B, 2013, ACS CATAL, V3, P1819, DOI 10.1021/cs400354p; Katryniok B, 2011, GREEN CHEM, V13, P1960, DOI 10.1039/c1gc15320j; Korzec M, 2014, J CATAL, V313, P1, DOI 10.1016/j.jcat.2014.02.008; Li CJ, 2008, P NATL ACAD SCI USA, V105, P13197, DOI 10.1073/pnas.0804348105; Massa M, 2013, J CATAL, V307, P170, DOI 10.1016/j.jcat.2013.07.022; Nguyen NH, 2011, J POLYM SCI POL CHEM, V49, P4241, DOI 10.1002/pola.24866; Okudera H, 2003, THIN SOLID FILMS, V434, P62, DOI 10.1016/S0040-6090(03)00535-2; PAGLIARO M, 2010, FUTURE GLYCEROL; Philippe S, 2013, CONCEPTS NANOCATALYS; Rao GS, 2014, J MOL CATAL A-CHEM, V395, P486, DOI 10.1016/j.molcata.2014.09.018; Rao KS, 2005, J COLLOID INTERF SCI, V289, P125, DOI 10.1016/j.jcis.2005.02.019; Sharma RV, 2014, APPL CATAL A-GEN, V477, P147, DOI 10.1016/j.apcata.2014.03.007; Skaff H, 2004, NAN SCI TEC, P29; Stosic D, 2014, CATAL TODAY, V226, P167, DOI 10.1016/j.cattod.2013.11.047; Villa A, 2015, CATAL SCI TECHNOL, V5, P55, DOI 10.1039/c4cy00976b; Zhang Y, 2012, CHEM REV, V112, P2467, DOI 10.1021/cr200260m	32	4	4	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142668	10.1371/journal.pone.0142668	http://dx.doi.org/10.1371/journal.pone.0142668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580400	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600055
J	Liberman, MC; Liberman, LD; Maison, SF				Liberman, M. Charles; Liberman, Leslie D.; Maison, Stephane F.			Chronic Conductive Hearing Loss Leads to Cochlear Degeneration	PLOS ONE			English	Article							STEM AUDITORY NUCLEI; OLIVOCOCHLEAR INNERVATION; AFFERENT INFLUENCES; SYNAPTIC RIBBONS; ACOUSTIC INJURY; RISK-FACTORS; CAT COCHLEA; OTITIS; AGE; IMPAIRMENT	Synapses between cochlear nerve terminals and hair cells are the most vulnerable elements in the inner ear in both noise-induced and age-related hearing loss, and this neuropathy is exacerbated in the absence of efferent feedback from the olivocochlear bundle. If age-related loss is dominated by a lifetime of exposure to environmental sounds, reduction of acoustic drive to the inner ear might improve cochlear preservation throughout life. To test this, we removed the tympanic membrane unilaterally in one group of young adult mice, removed the olivocochlear bundle in another group and compared their cochlear function and innervation to age-matched controls one year later. Results showed that tympanic membrane removal, and the associated threshold elevation, was counterproductive: cochlear efferent innervation was dramatically reduced, especially the lateral olivocochlear terminals to the inner hair cell area, and there was a corresponding reduction in the number of cochlear nerve synapses. This loss led to a decrease in the amplitude of the suprathreshold cochlear neural responses. Similar results were seen in two cases with conductive hearing loss due to chronic otitis media. Outer hair cell death was increased only in ears lacking medial olivocochlear innervation following olivocochlear bundle cuts. Results suggest the novel ideas that 1) the olivocochlear efferent pathway has a dramatic use-dependent plasticity even in the adult ear and 2) a component of the lingering auditory processing disorder seen in humans after persistent middle-ear infections is cochlear in origin.	[Liberman, M. Charles; Maison, Stephane F.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Liberman, M. Charles; Liberman, Leslie D.; Maison, Stephane F.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Liberman, M. Charles; Maison, Stephane F.] Harvard Program Speech & Hearing Biosci & Technol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Maison, SF (corresponding author), Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA.	stephane_maison@meei.harvard.edu			National Institute on Deafness and Other Communication Disorders (NIDCD) [R01 DC 0188, P30 DC 05209]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000188, P30DC005209] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research was supported by grants from the National Institute on Deafness and Other Communication Disorders (NIDCD): R01 DC 0188 (MCL) and P30 DC 05209 (MCL) (http://www.nidcd.nih.gov/Pages/default.aspx).	Chhan D, 2013, 36 ANN MIDW M ASS RE, V36, P66; CODY AR, 1982, HEARING RES, V6, P291, DOI 10.1016/0378-5955(82)90061-2; COLEMAN JR, 1979, EXP NEUROL, V64, P553, DOI 10.1016/0014-4886(79)90231-0; CONLEE JW, 1983, J COMP NEUROL, V217, P216, DOI 10.1002/cne.902170208; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Darrow KN, 2006, NAT NEUROSCI, V9, P1474, DOI 10.1038/nn1807; Darrow KN, 2006, J COMP NEUROL, V498, P403, DOI 10.1002/cne.21050; Deal JA, 2015, AM J EPIDEMIOL, V181, P680, DOI 10.1093/aje/kwu333; Deggouj N, 2012, B-ENT, V8, P105; DUBNO JR, 1984, J ACOUST SOC AM, V76, P87, DOI 10.1121/1.391011; Flores EN, 2015, CURR BIOL, V25, P606, DOI 10.1016/j.cub.2015.01.009; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Genther DJ, 2015, J GERONTOL A-BIOL, V70, P85, DOI 10.1093/gerona/glu094; GOYCOOLEA MV, 1986, LARYNGOSCOPE, V96, P1391; Gravel JS, 2006, EAR HEARING, V27, P353, DOI 10.1097/01.aud.0000224727.45342.e9; Guinan J.J., 1996, COCHLEA EDITED, P435; Guinan JJ, 2010, CURR OPIN OTOLARYNGO, V18, P447, DOI 10.1097/MOO.0b013e32833e05d6; Jesic SD, 2012, OTOL NEUROTOL, V33, P934, DOI 10.1097/MAO.0b013e318259b885; Joglekar S, 2010, ACTA OTO-LARYNGOL, V130, P472, DOI 10.3109/00016480903311252; Kandler K, 2005, TRENDS NEUROSCI, V28, P290, DOI 10.1016/j.tins.2005.04.007; Katano Hiroaki, 2005, Nihon Jibiinkoka Gakkai Kaiho, V108, P533; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kokko E, 1974, Acta Otolaryngol Suppl, V327, P1; Kolo ES, 2012, INDIAN J OTOLARYNGOL, V64, P59, DOI 10.1007/s12070-011-0251-5; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Larsen E, 2010, HEARING RES, V260, P70, DOI 10.1016/j.heares.2009.11.011; Liberman LD, 2011, J NEUROSCI, V31, P801, DOI 10.1523/JNEUROSCI.3389-10.2011; Liberman MC, 2014, J NEUROSCI, V34, P4599, DOI 10.1523/JNEUROSCI.4923-13.2014; LIBERMAN MC, 1980, HEARING RES, V3, P189, DOI 10.1016/0378-5955(80)90046-5; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; Liberman MC, 2015, HEAR RES IN PRESS; Luntz M, 2013, ACTA OTO-LARYNGOL, V133, P1173, DOI 10.3109/00016489.2013.814154; Maison SF, 2002, J NEUROSCI, V22, P10838; Maison SF, 2000, J NEUROSCI, V20, P4701, DOI 10.1523/JNEUROSCI.20-12-04701.2000; Maison SF, 2003, J COMP NEUROL, V455, P406, DOI 10.1002/cne.10490; Mehta RP, 2006, OTOL NEUROTOL, V27, P136, DOI 10.1097/01.mao.0000176177.17636.53; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Mick P, 2014, OTOLARYNG HEAD NECK, V150, P378, DOI 10.1177/0194599813518021; Pennie RA, 1998, CAN FAM PHYSICIAN, V44, P1850; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; RAJAN R, 1988, J NEUROPHYSIOL, V60, P569, DOI 10.1152/jn.1988.60.2.569; ROSEN S, 1962, ANN OTO RHINOL LARYN, V71, P727, DOI 10.1177/000348946207100313; Ruel J, 2007, HEARING RES, V227, P19, DOI 10.1016/j.heares.2006.08.017; Ruggles D, 2012, CURR BIOL, V22, P1417, DOI 10.1016/j.cub.2012.05.025; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; SCHUKNECHT H F, 1955, J Laryngol Otol, V69, P75, DOI 10.1017/S0022215100050465; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207; Snell KB, 2000, J ACOUST SOC AM, V107, P1615, DOI 10.1121/1.428446; Sumner CJ, 2005, J NEUROPHYSIOL, V94, P4234, DOI 10.1152/jn.00401.2005; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; TUCCI DL, 1985, J COMP NEUROL, V238, P371, DOI 10.1002/cne.902380402; TUCCI DL, 1987, ANN OTO RHINOL LARYN, V96, P343, DOI 10.1177/000348948709600321; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; Voss SE, 2001, J ACOUST SOC AM, V110, P1432, DOI 10.1121/1.1394195; Walton JP, 2010, HEARING RES, V264, P63, DOI 10.1016/j.heares.2010.03.002; Warr WB, 1986, ORG EFFERENT FIBERS; WEBSTER DB, 1979, ANN OTO RHINOL LARYN, V88, P684, DOI 10.1177/000348947908800515; Yehudai N, 2015, INT J PEDIATR OTORHI, V79, P26, DOI 10.1016/j.ijporl.2014.10.025; Yin YB, 2014, JARO-J ASSOC RES OTO, V15, P571, DOI 10.1007/s10162-014-0462-z	62	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142341	10.1371/journal.pone.0142341	http://dx.doi.org/10.1371/journal.pone.0142341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580411	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600046
J	Wang, QL; Yu, SS; Dong, YW				Wang, Qing-lin; Yu, Shan-shan; Dong, Yun-wei			Parental Effect of Long Acclimatization on Thermal Tolerance of Juvenile Sea Cucumber Apostichopus japonicus	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; OXYGEN-CONSUMPTION; HEAT-SHOCK-PROTEIN-70 HSP70; LABEO-ROHITA; TEMPERATURE; GROWTH; RESPONSES; EVOLUTIONARY; EXPRESSION; SELENKA	To evaluate the thermal resistance of marine invertebrates to elevated temperatures under scenarios of future climate change, it is crucial to understand parental effect of long acclimatization on thermal tolerance of offspring. To test whether there is parental effect of long acclimatization, adult sea cucumbers (Apostichopus japonicus) from the same broodstock were transplanted southward and acclimatized at high temperature in field mesocosms. Four groups of juvenile sea cucumbers whose parents experienced different durations of high temperature acclimatization were established. Upper thermal limits, oxygen consumption and levels of heat shock protein mRNA of juveniles was determined to compare thermal tolerance of individuals from different groups. Juvenile sea cucumbers whose parents experienced high temperature could acquire high thermal resistance. With the increase of parental exposure duration to high temperature, offspring became less sensitive to high temperature, as indicated by higher upper thermal limits (LT50), less seasonal variations of oxygen consumption, and stable oxygen consumption rates between chronic and acute thermal stress. The relatively high levels of constitutive expression of heat-shock proteins should contribute to the high thermal tolerance. Together, these results indicated that the existence of a parental effect of long acclimatization would increase thermal tolerance of juveniles and change the thermal sensitivity of sea cucumber to future climate change.	[Wang, Qing-lin; Yu, Shan-shan; Dong, Yun-wei] Xiamen Univ, Coll Marine & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Wang, Qing-lin] Chinese Acad Fishery Sci, Beidaihe Cent Expt Stn, Qinhuangdao, Peoples R China	Xiamen University; Chinese Academy of Fishery Sciences; Beidaihe Central Experiment Station, CAFS	Dong, YW (corresponding author), Xiamen Univ, Coll Marine & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	dongyw@xmu.edu.cn	Dong, Yunwei/C-4617-2011	Dong, Yunwei/0000-0003-4550-2322	National Basic Research Program of China [2013CB956500]; Nature Science funds for Distinguished Young Scholars of Fujian Province, China [2011J06017]; National Natural Science Foundation of China [41276126, 41476115]; Fundamental Research 457 Funds for the Central Universities; Program for New Century Excellent Talents in University of Fujian Province; China Postdoctoral Science Foundation [2013M541862]; open funds of Scientific Observing and Experimental Station of South China Sea Fishery Resources and Environment, Ministry of Agriculture, P. R. China [SSCS-201207]; Fundamental Research Funds for the Central Universities	National Basic Research Program of China(National Basic Research Program of China); Nature Science funds for Distinguished Young Scholars of Fujian Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research 457 Funds for the Central Universities; Program for New Century Excellent Talents in University of Fujian Province(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); open funds of Scientific Observing and Experimental Station of South China Sea Fishery Resources and Environment, Ministry of Agriculture, P. R. China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from National Basic Research Program of China (2013CB956500), Nature Science funds for Distinguished Young Scholars of Fujian Province, China (2011J06017), National Natural Science Foundation of China (41276126, 41476115), the Fundamental Research 457 Funds for the Central Universities and Program for New Century Excellent Talents in University of Fujian Province, the China Postdoctoral Science Foundation (2013M541862), and the open funds of Scientific Observing and Experimental Station of South China Sea Fishery Resources and Environment, Ministry of Agriculture, P. R. China (SSCS-201207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors sincerely appreciate Prof. George Somero for his valuable discussions. This work was supported by grants from National Basic Research Program of China (2013CB956500), Nature Science funds for Distinguished Young Scholars of Fujian Province, China (2011J06017), National Natural Science Foundation of China (41276126, 41476115), the Fundamental Research Funds for the Central Universities, and Program for New Century Excellent Talents in University of Fujian Province, the China Postdoctoral Science Foundation (2013M541862), the open funds of Scientific Observing and Experimental Station of South China Sea Fishery Resources and Environment, Ministry of Agriculture, P. R. China (SSCS-201207).	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Baker SC, 1996, J FISH BIOL, V48, P1123, DOI 10.1006/jfbi.1996.0115; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Chatterjee N, 2004, J THERM BIOL, V29, P265, DOI 10.1016/j.jtherbio.2004.05.001; Crill WD, 1996, EVOLUTION, V50, P1205, DOI [10.2307/2410661, 10.1111/j.1558-5646.1996.tb02361.x]; Das T, 2005, J THERM BIOL, V30, P378, DOI 10.1016/j.jtherbio.2005.03.001; Dong YW, 2011, MAR BIOL, V158, P1223, DOI 10.1007/s00227-011-1642-6; Dong YW, 2008, BIOL BULL-US, V215, P173, DOI 10.2307/25470698; Dong YW, 2008, FISHERIES SCI, V74, P573, DOI 10.1111/j.1444-2906.2008.01560.x; Dong YW, 2008, AQUACULTURE, V275, P329, DOI 10.1016/j.aquaculture.2007.12.006; Dong YW, 2006, AQUACULTURE, V255, P514, DOI 10.1016/j.aquaculture.2005.12.013; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ferrer A, 2014, ENTOMOL EXP APPL, V151, P11, DOI 10.1111/eea.12163; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; HOFMANN GE, 1995, J EXP BIOL, V198, P1509; Hutchison V, 1976, THERMAL ECOLOGY, P10; Ji TT, 2008, AQUACULTURE, V283, P180, DOI 10.1016/j.aquaculture.2008.07.006; Laxminarayana A, 2005, SPC BECHE DE MER INF, V22, P48, DOI DOI 10.1038/415987A; LEROI AM, 1994, P NATL ACAD SCI USA, V91, P1917, DOI 10.1073/pnas.91.5.1917; Lesser MP, 2010, COMP BIOCHEM PHYS A, V156, P541, DOI 10.1016/j.cbpa.2010.04.012; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Meng XL, 2009, AQUACULTURE, V294, P314, DOI 10.1016/j.aquaculture.2009.06.015; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mislan KAS, 2014, GLOBAL ECOL BIOGEOGR, V23, P744, DOI 10.1111/geb.12160; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pigliucci M., 2001, SYN ECO EVO; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Runcie DE, 2012, MOL ECOL, V21, P4547, DOI 10.1111/j.1365-294X.2012.05717.x; Selvakumar S, 2005, COMP BIOCHEM PHYS A, V140, P209, DOI 10.1016/j.cbpb.2005.01.008; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Strange KT, 2002, AM MIDL NAT, V148, P120, DOI 10.1674/0003-0031(2002)148[0120:TTAGDI]2.0.CO;2; Thor P, 2014, GLOBAL CHANGE BIOL; Tomanek L, 2003, BIOL BULL-US, V205, P276, DOI 10.2307/1543291; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Tomanek L, 2008, PHYSIOL BIOCHEM ZOOL, V81, P709, DOI 10.1086/590163; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wan C, 2014, CHINA FISHERY STAT Y; Wang QL, 2013, AQUAC RES, V44, P1550, DOI 10.1111/j.1365-2109.2012.03162.x; Wang QL, 2011, AQUACULT INT, V19, P1165, DOI 10.1007/s10499-011-9436-x; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wu ZZ, 2007, MAR ENV SCI, V26, P84; Yang HS, 2005, AQUAC RES, V36, P1085, DOI 10.1111/j.1365-2109.2005.01325.x; Zhang Q, 1998, FARMING TECHNIQUES S	47	10	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143372	10.1371/journal.pone.0143372	http://dx.doi.org/10.1371/journal.pone.0143372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580550	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600117
J	Burger, D; Dolivo, G; Wedekind, C				Burger, Dominik; Dolivo, Guillaume; Wedekind, Claus			Ejaculate Characteristics Depend on Social Environment in the Horse (Equus caballus)	PLOS ONE			English	Article							SPERM COMPETITION; SEXUAL SELECTION; HAREM SIZE; TESTOSTERONE LEVELS; RISK; STALLIONS; SPERMATOGENESIS; METAANALYSES; FREEZABILITY; INVESTMENT	Sperm competition theory predicts semen characteristics to be affected by the social environment. We used the polygamous horse (Equus caballus) to experimentally study within-subject plasticity in response to different social environments. Stallions were sequentially exposed, over a period of 8 weeks each, to other stallions and then singly to mares, or vice versa (in adjacent boxes separated by grills). Ejaculates were collected to determine semen characteristics. Highest sperm numbers were found in stallions that were first exposed to other stallions and then to mares, while lowest sperm numbers were observed in stallions that had been exposed to mares but not yet to other stallions. One of three sperm velocity measures (curvilinear velocity) was consistently elevated in stallions that were first exposed to stallions and then to mares. Sperm number after exposure to mares and curvilinear sperm velocity after exposure to stallions were both positively correlated to average blood testosterone levels during the corresponding period of exposure. We conclude that ejaculate characteristics are plastic traits affected by the social environment in horses.	[Burger, Dominik; Dolivo, Guillaume] Agroscope, Swiss Inst Equine Med, Avenches, Switzerland; [Burger, Dominik; Dolivo, Guillaume] Univ Bern, Avenches, Switzerland; [Wedekind, Claus] Univ Lausanne, Biophore, Dept Ecol & Evolut, Lausanne, Switzerland	Swiss Federal Research Station Agroscope; University of Bern; University of Lausanne	Wedekind, C (corresponding author), Univ Lausanne, Biophore, Dept Ecol & Evolut, Lausanne, Switzerland.	claus.wedekind@unil.ch	Wedekind, Claus/S-3353-2016	Wedekind, Claus/0000-0001-6143-4716	Swiss Institute of Equine Medicine Research	Swiss Institute of Equine Medicine Research	This work was supported by the Swiss Institute of Equine Medicine Research to DB (http://ismequine.ch/wp/?lang=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R. P., 2011, Equine reproduction, Volume 1, P881; Arundell KL, 2014, ANIM BEHAV, V87, P231, DOI 10.1016/j.anbehav.2013.11.005; Aurich C, 1999, REPROD DOMEST ANIM, V34, P405, DOI 10.1111/j.1439-0531.1999.tb01393.x; Ball MA, 1998, J THEOR BIOL, V194, P251, DOI 10.1006/jtbi.1998.0756; Bauer C, 2006, VETERINARMEDIZINISCH, P89; BERNDTSON WE, 1977, J ANIM SCI, V44, P818, DOI 10.2527/jas1977.445818x; Birkhead TR, 1998, SPERM COMPETITION SE; Bribiescas RG, 2001, YEARB PHYS ANTHROPOL, V44, P148, DOI 10.1002/ajpa.10025; Burger D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0407; delBarco-Trillo J, 2004, NATURE, V431, P446, DOI 10.1038/nature02845; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Firman RC, 2013, EVOLUTION, V67, P3061, DOI 10.1111/evo.12164; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Gasparini C, 2009, BIOL LETTERS, V5, P792, DOI 10.1098/rsbl.2009.0413; GEBAUER MR, 1974, J ANIM SCI, V39, P737, DOI 10.2527/jas1974.394737x; Gleason ED, 2009, FRONT NEUROENDOCRIN, V30, P460, DOI 10.1016/j.yfrne.2009.04.009; Gomendio M, 2011, P ROY SOC B-BIOL SCI, V278, P3135, DOI 10.1098/rspb.2011.0275; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Hirschenhauser K, 2006, ANIM BEHAV, V71, P265, DOI 10.1016/j.anbehav.2005.04.014; Janett F, 2006, THERIOGENOLOGY, V65, P1737, DOI 10.1016/j.theriogenology.2005.09.017; Janett F, 2003, ANIM REPROD SCI, V77, P213, DOI 10.1016/S0378-4320(03)00039-3; Janett F, 2009, ANIM REPROD SCI, V115, P88, DOI 10.1016/j.anireprosci.2008.11.011; Johnson L, 1997, THERIOGENOLOGY, V48, P1199, DOI 10.1016/S0093-691X(97)00353-1; Kaseda Y, 1996, APPL ANIM BEHAV SCI, V47, P163, DOI 10.1016/0168-1591(95)00675-3; Kelly CD, 2011, BIOL REV, V86, P863, DOI 10.1111/j.1469-185X.2011.00175.x; Khalil AM, 1998, J VET MED SCI, V60, P643, DOI 10.1292/jvms.60.643; Khalil AM, 2009, J VET MED SCI, V71, P1075, DOI 10.1292/jvms.71.1075; Kimura K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-264; Koyama S, 2000, PHYSIOL BEHAV, V71, P415, DOI 10.1016/S0031-9384(00)00361-9; Lacava RV, 2011, HORM BEHAV, V59, P51, DOI 10.1016/j.yhbeh.2010.10.003; Lemaitre JF, 2012, J EVOLUTION BIOL, V25, P1216, DOI 10.1111/j.1420-9101.2012.02511.x; Lemaitre JF, 2011, P ROY SOC B-BIOL SCI, V278, P1171, DOI 10.1098/rspb.2010.1828; Linklater WL, 2000, BIOL REV, V75, P1, DOI 10.1017/S0006323199005411; Lupold S, 2013, EVOLUTION, V67, P3052, DOI 10.1111/evo.12132; MACRIDES F, 1975, SCIENCE, V189, P1104, DOI 10.1126/science.1162363; McDonnell S. M., 2011, Equine reproduction, Volume 1, P1385; McDonnell S. M., 1995, BIOLOGICAL REPROD, V1, P577; McDonnell SM, 2000, ANIM REPROD SCI, V60, P211, DOI 10.1016/S0378-4320(00)00136-6; Moatt JP, 2014, PHYSIOL BEHAV, V131, P111, DOI 10.1016/j.physbeh.2014.04.027; MOORE MC, 1991, HORM BEHAV, V25, P154, DOI 10.1016/0018-506X(91)90048-M; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Petrulis A, 2013, HORM BEHAV, V63, P723, DOI 10.1016/j.yhbeh.2013.03.011; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Ramm SA, 2009, P ROY SOC B-BIOL SCI, V276, P745, DOI 10.1098/rspb.2008.1296; Rudolfsen G, 2006, P ROY SOC B-BIOL SCI, V273, P325, DOI 10.1098/rspb.2005.3305; Smith CC, 2011, BIOL LETTERS, V7, P733, DOI 10.1098/rsbl.2011.0286; Stich K, 2002, THERIOGENOLOGY, V58, P397; Thompson JA, 2004, THERIOGENOLOGY, V62, P1607, DOI 10.1016/j.theriogenology.2004.03.015; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	52	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143185	10.1371/journal.pone.0143185	http://dx.doi.org/10.1371/journal.pone.0143185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599821	Green Published, gold			2022-12-27	WOS:000365862600034
J	Ju, ZH; Wang, CF; Wang, XG; Yang, CH; Sun, Y; Jiang, Q; Wang, F; Li, MJ; Zhong, JF; Huang, JM				Ju, Zhihua; Wang, Changfa; Wang, Xiuge; Yang, Chunhong; Sun, Yan; Jiang, Qiang; Wang, Fei; Li, Mengjiao; Zhong, Jifeng; Huang, Jinming			Role of an SNP in Alternative Splicing of Bovine NCF4 and Mastitis Susceptibility	PLOS ONE			English	Article							NADPH OXIDASE COMPONENTS; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; MAMMARY-GLAND; DAIRY-CATTLE; PX DOMAIN; DISEASE; CELLS; GENE; NEUTROPHIL	Neutrophil cytosolic factor 4 (NCF4) is component of the nicotinamide dinucleotide phosphate oxidase complex, a key factor in biochemical pathways and innate immune responses. In this study, splice variants and functional single-nucleotide polymorphism (SNP) of NCF4 were identified to determine the variability and association of the gene with susceptibility to bovine mastitis characterized by inflammation. A novel splice variant, designated as NCF4-TV and characterized by the retention of a 48 bp sequence in intron 9, was detected in the mammary gland tissues of infected cows. The expression of the NCF4-reference main transcript in the mastitic mammary tissues was higher than that in normal tissues. A novel SNP, g. 18174 A>G, was also found in the retained 48 bp region of intron 9. To determine whether NCF4-TV could be due to the g. 18174 A>G mutation, we constructed two mini-gene expression vectors with the wild-type or mutant NCF4 g. 18174 A>G fragment. The vectors were then transiently transfected into 293T cells, and alternative splicing of NCF4 was analyzed by reverse transcription-PCR and sequencing. Mini-gene splicing assay demonstrated that the aberrantly spliced NCF4-TV with 48 bp retained fragment in intron 9 could be due to g. 18174 A>G, which was associated with milk somatic count score and increased risk of mastitis infection in cows. NCF4 expression was also regulated by alternative splicing. This study proposes that NCF4 splice variants generated by functional SNP are important risk factors for mastitis susceptibility in dairy cows.	[Ju, Zhihua; Wang, Changfa; Wang, Xiuge; Yang, Chunhong; Sun, Yan; Jiang, Qiang; Wang, Fei; Li, Mengjiao; Zhong, Jifeng; Huang, Jinming] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan 250131, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences	Ju, ZH (corresponding author), Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan 250131, Shandong, Peoples R China.	juzhihua283@163.com; huangjinm@sina.com		wang, changfa/0000-0002-5186-1703	National Natural Science Foundation of China [31371255, 31271328, 31401050]; Major Project of National Transgenics in China [2014ZX08007-001]; National Cow Industrial Technology System Program [CARS-37]; Cow Innovation Team of the Shandong Province Modern Agricultural Industry Technology System [SDAIT-12-011-02]; Natural Science Foundation of Shandong Province [ZR2013CQ035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of National Transgenics in China; National Cow Industrial Technology System Program; Cow Innovation Team of the Shandong Province Modern Agricultural Industry Technology System; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by grants from the National Natural Science Foundation of China (31371255, 31271328, and 31401050), the Major Project of National Transgenics in China (2014ZX08007-001), the National Cow Industrial Technology System Program (CARS-37), the Cow Innovation Team of the Shandong Province Modern Agricultural Industry Technology System (SDAIT-12-011-02), and the Natural Science Foundation of Shandong Province (ZR2013CQ035).	Anderson KE, 2008, BLOOD, V112, P5202, DOI 10.1182/blood-2008-04-149450; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Buckley Rebecca H, 2004, Paediatr Respir Rev, V5 Suppl A, pS225, DOI 10.1016/S1526-0542(04)90043-7; Caminsky Natasha, 2014, F1000Res, V3, P282, DOI 10.12688/f1000research.5654.1; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Gao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084355; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Gustafson HL, 2014, AM J HEMATOL, V89, P639, DOI 10.1002/ajh.23709; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Hua J, 2001, INFLAMM RES, V50, P156, DOI 10.1007/s000110050740; Huang JM, 2011, GENET MOL RES, V10, P3199, DOI 10.4238/2011.December.21.1; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Ju ZH, 2012, MOL BIOL REP, V39, P4155, DOI 10.1007/s11033-011-1198-z; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim YM, 2014, CELL SIGNAL, V26, P784, DOI 10.1016/j.cellsig.2013.12.005; Lim KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/pnas.1101135108; Ma J. S., 2014, J APPL MATH, V2014, P1, DOI DOI 10.1155/2014/304202; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Olsson LM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2299; Palhais B, 2015, NUCLEIC ACIDS RES, V43, P4627, DOI 10.1093/nar/gkv275; Tejedor JR, 2015, RNA, V21, P1187, DOI 10.1261/rna.049890.115; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rupp R, 1999, J DAIRY SCI, V82, P2198, DOI 10.3168/jds.S0022-0302(99)75465-2; Ryan BM, 2014, INT J CANCER, V134, P1399, DOI 10.1002/ijc.28457; Sordillo LM, 1997, J DAIRY SCI, V80, P1851, DOI 10.3168/jds.S0022-0302(97)76121-6; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Tarazona-Santos E, 2013, MOL BIOL EVOL, V30, P2157, DOI 10.1093/molbev/mst119; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-630; Wang XG, 2012, IMMUNOGENETICS, V64, P807, DOI 10.1007/s00251-012-0639-8; Wientjes FB, 2001, BIOCHEM BIOPH RES CO, V289, P382, DOI 10.1006/bbrc.2001.5982; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Zhan Y, 2004, J CELL BIOCHEM, V92, P795, DOI 10.1002/jcb.20084; Zhang ZJ, 2015, MICROBIOL RES, V174, P24, DOI 10.1016/j.micres.2015.03.005	40	15	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143705	10.1371/journal.pone.0143705	http://dx.doi.org/10.1371/journal.pone.0143705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600390	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600107
J	Bain, PA; Papanicolaou, A; Kumar, A				Bain, Peter A.; Papanicolaou, Alexie; Kumar, Anupama			Identification of Putative Nuclear Receptors and Steroidogenic Enzymes in Murray-Darling Rainbowfish (Melanotaenia fluviatilis) Using RNA-Seq and De Novo Transcriptome Assembly	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; MINNOW PIMEPHALES-PROMELAS; PERSONAL CARE PRODUCTS; WASTE-WATER TREATMENT; KILLIFISH FUNDULUS-HETEROCLITUS; ENDOCRINE-DISRUPTING CHEMICALS; ESFENVALERATE PULSE-EXPOSURE; REPORTER GENE ASSAY; GENOME DUPLICATION; ENVIRONMENTAL CONTAMINATION	Murray-Darling rainbowfish (Melanotaenia fluviatilis [Castelnau, 1878]; Atheriniformes: Melanotaeniidae) is a small-bodied teleost currently under development in Australasia as a test species for aquatic toxicological studies. To date, efforts towards the development of molecular biomarkers of contaminant exposure have been hindered by the lack of available sequence data. To address this, we sequenced messenger RNA from brain, liver and gonads of mature male and female fish and generated a high-quality draft transcriptome using a de novo assembly approach. 149,742 clusters of putative transcripts were obtained, encompassing 43,841 non-redundant protein-coding regions. Deduced amino acid sequences were annotated by functional inference based on similarity with sequences from manually curated protein sequence databases. The draft assembly contained protein-coding regions homologous to 95.7% of the complete cohort of predicted proteins from the taxonomically related species, Oryzias latipes (Japanese medaka). The mean length of rainbowfish protein-coding sequences relative to their medaka homologues was 92.1%, indicating that despite the limited number of tissues sampled a large proportion of the total expected number of protein-coding genes was captured in the study. Because of our interest in the effects of environmental contaminants on endocrine pathways, we manually curated subsets of coding regions for putative nuclear receptors and steroidogenic enzymes in the rainbowfish transcriptome, revealing 61 candidate nuclear receptors encompassing all known subfamilies, and 41 putative steroidogenic enzymes representing all major steroidogenic enzymes occurring in teleosts. The transcriptome presented here will be a valuable resource for researchers interested in biomarker development, protein structure and function, and contaminant-response genomics in Murray-Darling rainbowfish.	[Bain, Peter A.; Kumar, Anupama] CSIRO, Div Land & Water, Urrbrae, SA, Australia; [Papanicolaou, Alexie] CSIRO, Div Land & Water, Black Mt, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Bain, PA (corresponding author), CSIRO, Div Land & Water, Urrbrae, SA, Australia.	peter.bain@csiro.au	Bain, Peter/A-9067-2013; Papanicolaou, Alexie/A-1618-2011; Kumar, Anu/E-9643-2011	Bain, Peter/0000-0002-0159-8417; Papanicolaou, Alexie/0000-0002-3635-6848; Kumar, Anu/0000-0002-3175-9867	Commonwealth Scientific and Industrial Research Organisation Division of Land and Water Capability Development Theme [R-00325-14-012]; BRAEMBL/NCISF in St Lucia, QLD, Australia	Commonwealth Scientific and Industrial Research Organisation Division of Land and Water Capability Development Theme; BRAEMBL/NCISF in St Lucia, QLD, Australia	The study was supported by the Commonwealth Scientific and Industrial Research Organisation Division of Land and Water Capability Development Theme, project R-00325-14-012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Hai Doan and Debra Gonzago for the maintenance of laboratory fish stocks and the provision of suitable specimens, and to Adrienne Gregg for assistance with RNA extractions. We gratefully acknowledge the support of the BRAEMBL/NCISF in St Lucia, QLD, Australia and the use of the High Performance Computing cluster "Barrine" to complete this research. Hosting of the web interface for JAMp annotations is gratefully provided through the National eResearch Collaboration Tools and Resources (NeCTAR) scheme, part of the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Andreasen EA, 2002, MOL PHARMACOL, V62, P234, DOI 10.1124/mol.62.2.234; Ankley GT, 2007, ENVIRON TOXICOL CHEM, V26, P1214, DOI 10.1897/06-428R.1; Ankley GT, 2002, TOXICOL SCI, V67, P121, DOI 10.1093/toxsci/67.1.121; [Anonymous], 2014, R LANG ENV STAT COMP; Arukwe A, 1997, ENVIRON HEALTH PERSP, V105, P418, DOI 10.2307/3433339; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Australian Bureau of Statistics [ABS], 2014, GROSS VAL IRR AGR PR; Bain PA, 2015, AQUAT TOXICOL, V163, P97, DOI 10.1016/j.aquatox.2015.03.021; Bain PA, 2015, GEN COMP ENDOCR, V212, P84, DOI 10.1016/j.ygcen.2015.01.024; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; BARRY MJ, 1995, ENVIRON TOXIC WATER, V10, P267, DOI 10.1002/tox.2530100406; BARRY MJ, 1995, AQUAT TOXICOL, V32, P115, DOI 10.1016/0166-445X(94)00084-4; BARRY MJ, 1995, ARCH ENVIRON CON TOX, V28, P459, DOI 10.1007/BF00211628; Bhatia H, 2014, ENVIRON TOXICOL CHEM, V33, P1098, DOI 10.1002/etc.2524; Bhatia H, 2014, AQUAT TOXICOL, V149, P103, DOI 10.1016/j.aquatox.2014.01.025; Bhatia H, 2013, ENVIRON TOXICOL CHEM, V32, P2335, DOI 10.1002/etc.2304; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BUCHELI TD, 1995, CRIT REV ENV SCI TEC, V25, P201, DOI 10.1080/10643389509388479; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Callard GV, 2001, J STEROID BIOCHEM, V79, P305, DOI 10.1016/S0960-0760(01)00147-9; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosnefroy A, 2012, TOXICOL SCI, V125, P439, DOI 10.1093/toxsci/kfr297; Cotter KA, 2015, AQUAT TOXICOL, V159, P184, DOI 10.1016/j.aquatox.2014.12.012; Cotter KA, 2013, GEN COMP ENDOCR, V194, P217, DOI 10.1016/j.ygcen.2013.09.014; Denslow ND, 1999, ECOTOXICOLOGY, V8, P385, DOI 10.1023/A:1008986522208; Diotel N, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00137; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Ellestad LE, 2014, ENVIRON SCI TECHNOL, V48, P8179, DOI 10.1021/es501428u; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Filby AL, 2005, BIOL REPROD, V73, P648, DOI 10.1095/biolreprod.105.039701; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Gelinas D, 1998, MOL CELL ENDOCRINOL, V138, P81, DOI 10.1016/S0303-7207(98)00015-X; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greytak SR, 2007, GEN COMP ENDOCR, V150, P174, DOI 10.1016/j.ygcen.2006.07.017; Guyomard Rene, 2012, BMC Genet, V13, P15, DOI 10.1186/1471-2156-13-15; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Haggstrom Stannered, 2014, WIKIVERSITY J MED; Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8; Halm S, 2002, AQUAT TOXICOL, V60, P285, DOI 10.1016/S0166-445X(02)00011-5; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hansson MC, 2003, GENE, V303, P197, DOI 10.1016/S0378-1119(02)01178-2; Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; HOLDWAY DA, 1994, AQUAT TOXICOL, V28, P169, DOI 10.1016/0166-445X(94)90032-9; Holdway DA, 2008, ENVIRON TOXICOL, V23, P253, DOI 10.1002/tox.20329; Hook SE, 2014, ENVIRON SCI TECHNOL, V48, P3504, DOI 10.1021/es405322s; Hook SE, 2014, AQUAT TOXICOL, V146, P247, DOI 10.1016/j.aquatox.2013.11.001; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Jobling S, 2002, BIOL REPROD, V66, P272, DOI 10.1095/biolreprod66.2.272; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karchner SI, 2005, BIOCHEM J, V392, P153, DOI 10.1042/BJ20050713; Karchner SI, 1999, J BIOL CHEM, V274, P33814, DOI 10.1074/jbc.274.47.33814; Kasprzyk-Hordern B, 2009, WATER RES, V43, P363, DOI 10.1016/j.watres.2008.10.047; Katsu Y, 2007, ENVIRON SCI TECHNOL, V41, P3368, DOI 10.1021/es062797l; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kookana RS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0586; Kumar A, 1998, ENVIRON TOXICOL CHEM, V17, P1799, DOI [10.1002/etc.5620170920, 10.1897/1551-5028(1998)017&lt;1799:PTTTER&gt;2.3.CO;2]; Kumar A, 2012, EP12292 CSIRO; LaLone CA, 2012, ENVIRON TOXICOL CHEM, V31, P611, DOI 10.1002/etc.1729; Lange A, 2012, AQUAT TOXICOL, V109, P250, DOI 10.1016/j.aquatox.2011.09.004; Leaver MJ, 2005, ENDOCRINOLOGY, V146, P3150, DOI 10.1210/en.2004-1638; Legler J, 2002, ENVIRON SCI TECHNOL, V36, P4410, DOI 10.1021/es010323a; LEITZ T, 1987, GEN COMP ENDOCR, V66, P145, DOI 10.1016/0016-6480(87)90359-5; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077292; Liu GL, 2005, ENVIRON TOXICOL CHEM, V24, P2260, DOI 10.1897/04-405R.1; Liu JL, 2013, ENVIRON INT, V59, P208, DOI 10.1016/j.envint.2013.06.012; Liu NY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-597; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margiotta-Casaluci L, 2013, GEN COMP ENDOCR, V191, P202, DOI 10.1016/j.ygcen.2013.06.017; Martin J, 2012, J HAZARD MATER, V239, P40, DOI 10.1016/j.jhazmat.2012.04.068; Martyniuk CJ, 2013, GEN COMP ENDOCR, V194, P264, DOI 10.1016/j.ygcen.2013.09.019; Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI [10.1897/1551-5028(2001)020&lt;0297:EPOCDI&gt;2.0.CO;2, 10.1002/etc.5620200210]; Miyagawa S, 2014, ENVIRON SCI TECHNOL, V48, P5254, DOI 10.1021/es5002659; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Noaksson E, 2003, GEN COMP ENDOCR, V134, P273, DOI 10.1016/S0016-6480(03)00267-3; Ogino Y, 2009, ENDOCRINOLOGY, V150, P5415, DOI 10.1210/en.2009-0523; Overturf MD, 2014, AQUAT TOXICOL, V148, P152, DOI 10.1016/j.aquatox.2014.01.012; Pakdel F, 2000, ENDOCRINOLOGY, V141, P571, DOI 10.1210/en.141.2.571; Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Patino R, 2000, GEN COMP ENDOCR, V120, P314, DOI 10.1006/gcen.2000.7566; Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001; Petit FG, 1999, EUR J BIOCHEM, V259, P385, DOI 10.1046/j.1432-1327.1999.00072.x; PIFERRER F, 1994, J EXP ZOOL, V270, P255, DOI 10.1002/jez.1402700304; Pinto PIS, 2012, GENE, V503, P18, DOI 10.1016/j.gene.2012.04.081; Pollino CA, 2002, ENVIRON TOXICOL, V17, P138, DOI 10.1002/tox.10043; Pollino CA, 2002, ECOTOX ENVIRON SAFE, V52, P180, DOI 10.1006/eesa.2002.2190; Pollino CA, 2007, ENVIRON TOXICOL CHEM, V26, P2171, DOI 10.1897/06-603R.1; Pollino CA, 2009, ECOTOX ENVIRON SAFE, V72, P1265, DOI 10.1016/j.ecoenv.2009.01.012; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; REID HP, 1995, WATER RES, V29, P2010, DOI 10.1016/0043-1354(95)00007-8; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Sabo-Attwood T, 2004, MOL CELL ENDOCRINOL, V218, P107, DOI 10.1016/j.mce.2003.12.007; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; Sanderson JT, 2002, TOXICOL APPL PHARM, V182, P44, DOI 10.1006/taap.2002.9420; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Seo JS, 2006, BIOCHEM BIOPH RES CO, V346, P213, DOI 10.1016/j.bbrc.2006.05.123; Shanthanagouda AH, 2013, COMP BIOCHEM PHYS C, V157, P162, DOI 10.1016/j.cbpc.2012.11.004; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Svensson J, 2014, AQUAT TOXICOL, V147, P84, DOI 10.1016/j.aquatox.2013.12.013; Svensson J, 2013, ENVIRON SCI TECHNOL, V47, P2043, DOI 10.1021/es304305k; Tan NS, 1996, MOL CELL ENDOCRINOL, V120, P177, DOI 10.1016/0303-7207(96)03836-1; Udy DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134738; Urushitani H, 2003, MOL CELL ENDOCRINOL, V203, P41, DOI 10.1016/S0303-7207(03)00118-7; Vajda AM, 2015, ENVIRON TOXICOL CHEM, V34, P1078, DOI 10.1002/etc.2895; Villeneuve DL, 2007, TOXICOL SCI, V98, P395, DOI 10.1093/toxsci/kfm124; Watson JD, 2014, TOXICOL APPL PHARM, V274, P445, DOI 10.1016/j.taap.2013.12.004; Whitehead SA, 2006, BEST PRACT RES CL EN, V20, P45, DOI 10.1016/j.beem.2005.09.003; Williams ND, 2000, ENVIRON TOXICOL, V15, P165, DOI 10.1002/1522-7278(2000)15:3<165::AID-TOX3>3.0.CO;2-Q; Woods M, 2011, ENVIRON TOXICOL CHEM, V30, P2620, DOI 10.1002/etc.660; Xia ZF, 1999, GEN COMP ENDOCR, V113, P360, DOI 10.1006/gcen.1999.7196; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yamaguchi A, 2005, AQUAT TOXICOL, V72, P239, DOI 10.1016/j.aquatox.2004.12.011; Yu Y, 2013, SCI TOTAL ENVIRON, V442, P310, DOI 10.1016/j.scitotenv.2012.10.001; Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	134	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142636	10.1371/journal.pone.0142636	http://dx.doi.org/10.1371/journal.pone.0142636			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599404	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900032
J	Bertille, N; Pons, G; Khoshnood, B; Fournier-Charriere, E; Chalumeau, M				Bertille, Nathalie; Pons, Gerard; Khoshnood, Babak; Fournier-Charriere, Elisabeth; Chalumeau, Martin			Symptomatic Management of Fever in Children: A National Survey of Healthcare Professionals' Practices in France	PLOS ONE			English	Article							PEDIATRIC EMERGENCY-DEPARTMENT; CLINICAL-PRACTICE GUIDELINES; CROSS-SECTIONAL SURVEY; WEB-BASED SURVEY; GENERAL-PRACTITIONERS; PRESCHOOL-CHILDREN; CHILDHOOD FEVER; SELF-CARE; DRUG-USE; PHYSICIANS	Despite the production and dissemination of recommendations related to managing fever in children, this symptom saturates the practices of primary healthcare professionals (HPs). Data on parent practices related to fever are available, but data on HPs' practices are limited. We studied HPs' practices, determinants of practices and concordance with recommendations in France. We conducted a national cross-sectional observational study between 2007 and 2008 among French general practitioners, primary care pediatricians and pharmacists. HPs were asked to include 5 consecutive patients aged 1 month to 12 years with acute fever. HPs completed a questionnaire about their practices for the current fever episode. We used a multilevel logistic regression model to assess the joint effects of patient-and HP-level variables associated with this behavior. In all, 1,534 HPs (participation rate 13%) included 6,596 children (mean age 3.7 +/- 2.7 years). Physicians measured the temperature of 40% of children. Primary HPs recommended drug treatment for 84% of children (including monotherapy for 92%) and physical treatment for 62% (including all recommended physical treatments for 7%). HPs gave written advice or a pamphlet for 13% of children. Significant practice variations were associated with characteristics of the child (age, fever level and diagnosis) and HP (profession and experience). In France, despite the production and dissemination of national recommendations for managing fever in children, primary HPs' observed practices differed greatly from current recommendations, which suggests potential targets for continuing medical education.	[Bertille, Nathalie; Khoshnood, Babak; Chalumeau, Martin] Paris Descartes Univ, Obstet Perinatal & Pediat Epidemiol Res Team Epop, Sorbonne Paris Cite CRESS, Inserm,U1153,Ctr Epidemiol & Stat, Paris, France; [Bertille, Nathalie] Univ Paris 06, Sorbonne Univ, Paris, France; [Bertille, Nathalie; Chalumeau, Martin] Hop Necker Enfants Malad, AP HP, Dept Gen Pediat, Paris, France; [Pons, Gerard] Paris Descartes Univ, Grp Hosp Cochin Broca Hotel Dieu, AP HP, Clin Pharmacol, Paris, France; [Pons, Gerard] INSERM, Pediat Epilepsies & Brain Plast U663, Paris, France; [Fournier-Charriere, Elisabeth] Hop Bicetre, AP HP, Pain Ctr, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Bertille, N (corresponding author), Paris Descartes Univ, Obstet Perinatal & Pediat Epidemiol Res Team Epop, Sorbonne Paris Cite CRESS, Inserm,U1153,Ctr Epidemiol & Stat, Paris, France.	nathalie.bertille@inserm.fr	Chalumeau, Martin/F-4293-2017; Khoshnood, Babak/N-9096-2017	Chalumeau, Martin/0000-0001-8175-3706; Khoshnood, Babak/0000-0002-4031-4915; Bertille, Nathalie/0000-0001-7159-2646	Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie and Ecole Doctorale (Sorbonne Universites, UPMC Univ Paris) [393]; Sanofi Aventis	Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie and Ecole Doctorale (Sorbonne Universites, UPMC Univ Paris); Sanofi Aventis(Sanofi-Aventis)	NB is supported by educational grants from Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie and Ecole Doctorale 393 (Sorbonne Universites, UPMC Univ Paris 06). EFC and GP received honoraria from Sanofi Aventis. MC belongs to the Assistance Publique-Hopitaux de Paris, which has received research grants from Sanofi Aventis. This does not alter our adherence to PLOS ONE policies on sharingdata and materials. We have no patents, products in development or marketed products to declare.	Agence nationale de securite du medicament et des produits de sante, 2005, MIS POINT PRIS CHARG; Al-Eissa YA, 2001, SAUDI MED J, V22, P124; Bardage C, 2013, HEALTH POLICY, V110, P76, DOI 10.1016/j.healthpol.2012.12.006; Bertille N, 2015, ACTA PAEDIA IN PRESS; Bertille N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083469; Bettinelli A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-51; Betz MG, 2006, EUR J EMERG MED, V13, P129, DOI 10.1097/01.mej.0000194401.15335.c7; Blacklock C, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656810; Bocquet A, 2005, ARCH PEDIATRIE, V12, P1688, DOI 10.1016/j.arcped.2005.06.014; Boivin JM, 2007, ARCH PEDIATRIE, V14, P322, DOI 10.1016/j.arcped.2006.12.018; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cavazos JM, 2008, ALIMENT PHARM THER, V28, P789, DOI 10.1111/j.1365-2036.2008.03791.x; Chiappini E, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-210; Chiappini E, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-97; Crocetti M, 2001, PEDIATRICS, V107, P1241, DOI 10.1542/peds.107.6.1241; Deligne J, 2007, PHARMACOEPIDEM DR S, V16, P812, DOI 10.1002/pds.1422; Demir F, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-40; El Khoury AC, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-95; ESKERUD JR, 1993, PHARM WORLD SCI, V15, P156, DOI 10.1007/BF01880558; ESKERUD JR, 1993, PHARM WORLD SCI, V15, P161, DOI 10.1007/BF01880559; Grimaldi-Bensouda L, 2010, EUR J CLIN PHARMACOL, V66, P831, DOI 10.1007/s00228-010-0832-3; Impicciatore P, 1998, PREV MED, V27, P268, DOI 10.1006/pmed.1998.0262; Karwowska Anna, 2002, CJEM, V4, P394; Langer T, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-41; Lava SAG, 2013, BRIT J CLIN PHARMACO, V75, P236, DOI 10.1111/j.1365-2125.2012.04311.x; Lava SAG, 2012, CLIN THER, V34, P250, DOI 10.1016/j.clinthera.2011.12.002; Martinot A, 2008, ARCH PEDIATRIE, V15, P656, DOI 10.1016/S0929-693X(08)71865-7; Matziou V, 2008, INT J NURS STUD, V45, P829, DOI 10.1016/j.ijnurstu.2006.04.021; MAY A, 1992, PEDIATRICS, V90, P851; McCullough H N, 1998, Paediatr Child Health, V3, P246; McIntyre J, 2011, ARCH DIS CHILD, V96, P1173, DOI 10.1136/archdischild-2011-301094; Mikaeloff Y, 2008, BRIT J CLIN PHARMACO, V65, P203, DOI 10.1111/j.1365-2125.2007.02997.x; Nash DR, 2002, ARCH PEDIAT ADOL MED, V156, P1114, DOI 10.1001/archpedi.156.11.1114; *NAT I HLTH CLIN E, 2007, FEV ILLN CHILDR ASS; Poirier MP, 2010, CLIN PEDIATR, V49, P530, DOI 10.1177/0009922809355312; Poirier MP, 2000, PEDIATR EMERG CARE, V16, P9, DOI 10.1097/00006565-200002000-00003; Pruvost I, 2012, ARCH PEDIATRIE, V19, P248, DOI 10.1016/j.arcped.2011.12.013; Roque F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1276; Sokal E, FIEVRE CHEZ ENFANT P; Sullivan JE, 2011, PEDIATRICS, V127, P580, DOI 10.1542/peds.2010-3852; Taveras EM, 2004, PEDIATR EMERG CARE, V20, P579, DOI 10.1097/01.pec.0000139739.46591.dd; Thompson M, 2008, BRIT J GEN PRACT, V58, P236, DOI 10.3399/bjgp08X279689; Ulinski T, 2004, EUR J PEDIATR, V163, P148, DOI 10.1007/s00431-003-1392-7; Vigier Rv, 2003, PAEDIATRICA, V14, P28; Walsh AM, 2005, J ADV NURS, V49, P453, DOI 10.1111/j.1365-2648.2004.03318.x	45	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143230	10.1371/journal.pone.0143230	http://dx.doi.org/10.1371/journal.pone.0143230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599740	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900079
J	Erdoes, G; Lippuner, C; Kocsis, I; Schiff, M; Stucki, M; Carrel, T; Windecker, S; Eberle, B; Stueber, F; Book, M				Erdoes, Gabor; Lippuner, Christoph; Kocsis, Istvan; Schiff, Marcel; Stucki, Monika; Carrel, Thierry; Windecker, Stephan; Eberle, Balthasar; Stueber, Frank; Book, Malte			Technical Approach Determines Inflammatory Response after Surgical and Transcatheter Aortic Valve Replacement	PLOS ONE			English	Article							CARDIOPULMONARY BYPASS; ON-PUMP; HIGH-RISK; SURGERY; IMPLANTATION; STENOSIS; CALCIFICATION; INTERLEUKIN-6; MYOCARDIUM; SYSTEM	Objective To investigate the periprocedural inflammatory response in patients with isolated aortic valve stenosis undergoing surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) with different technical approaches. Material and Methods Patients were prospectively allocated to one of the following treatments: SAVR using conventional extracorporeal circulation (CECC, n = 47) or minimized extracorporeal circulation (MECC, n = 15), or TAVI using either transapical (TA, n = 15) or transfemoral (TF, n = 24) access. Exclusion criteria included infection, pre-procedural immunosuppressive or antibiotic drug therapy and emergency indications. We investigated interleukin (IL)-6, IL-8, IL-10, human leukocyte antigen (HLA-DR), white blood cell count, high-sensitivity C-reactive protein (hs-CRP) and soluble L-selectin (sCD62L) levels before the procedure and at 4, 24, and 48 h after aortic valve replacement. Data are presented for group interaction (p-values for inter-group comparison) as determined by the Greenhouse-Geisser correction. Results SAVR on CECC was associated with the highest levels of IL-8 and hs-CRP (p<0.017, and 0.007, respectively). SAVR on MECC showed the highest descent in levels of HLA-DR and sCD62L (both p<0.001) in the perioperative period. TA-TAVI showed increased intraprocedural concentration and the highest peak of IL-6 (p = 0.017). Significantly smaller changes in the inflammatory markers were observed in TF-TAVI. Conclusion Surgical and interventional approaches to aortic valve replacement result in inflammatory modulation which differs according to the invasiveness of the procedure. As expected, extracorporeal circulation is associated with the most marked pro-inflammatory activation, whereas TF-TAVI emerges as the approach with the most attenuated inflammatory response. Factors such as the pre-treatment patient condition and the extent of myocardial injury also significantly affect inflammatory biomarker patterns. Accordingly, TA-TAVI is to be classified not as an interventional but a true surgical procedure, with inflammatory biomarker profiles comparable to those found after SAVR. Our study could not establish an obvious link between the extent of the periprocedural inflammatory response and clinical outcome parameters.	[Erdoes, Gabor; Lippuner, Christoph; Schiff, Marcel; Stucki, Monika; Eberle, Balthasar; Stueber, Frank; Book, Malte] Univ Bern, Inselspital, Univ Hosp Bern, Dept Anesthesiol & Pain Med, CH-3010 Bern, Switzerland; [Lippuner, Christoph; Schiff, Marcel; Stueber, Frank; Book, Malte] Univ Bern, Inselspital, Univ Hosp Bern, Dept Clin Res,Anesthesiol Grp, CH-3010 Bern, Switzerland; [Kocsis, Istvan] Semmelweis Univ, Dept Obstet & Gynecol 2, Budapest, Hungary; [Carrel, Thierry] Univ Bern, Inselspital, Univ Hosp Bern, Dept Cardiovasc Surg,Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland; [Windecker, Stephan] Univ Bern, Inselspital, Univ Hosp Bern, Dept Cardiol,Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Semmelweis University; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Erdoes, G (corresponding author), Univ Bern, Inselspital, Univ Hosp Bern, Dept Anesthesiol & Pain Med, CH-3010 Bern, Switzerland.	gabor.erdoes@insel.ch	Carrel, Thierry/AAI-5910-2021	Lippuner, Christoph/0000-0003-2872-9381				Abdelbaky A, 2015, ATHEROSCLEROSIS, V238, P165, DOI 10.1016/j.atherosclerosis.2014.11.026; Amonn K, 2013, EUR J CARDIO-THORAC, V43, P34, DOI 10.1093/ejcts/ezs173; Bical OM, 2006, EUR J CARDIO-THORAC, V29, P699, DOI 10.1016/j.ejcts.2006.01.053; Biglioli P, 2003, EUR J CARDIO-THORAC, V24, P260, DOI 10.1016/S1010-7940(03)00295-1; Blume ED, 1997, CIRCULATION, V96, P352; Bone RC, 1992, ACCP SCCM CONS C COM; Buellesfeld L, 2010, EUR HEART J, V31, P984, DOI 10.1093/eurheartj/ehp570; CRUICKSHANK AM, 1990, CLIN SCI, V79, P161, DOI 10.1042/cs0790161; Dahl JS, 2013, AM J CARDIOL, V112, P1433, DOI 10.1016/j.amjcard.2013.06.015; Dweck MR, 2013, EUR HEART J, V34, P1567, DOI 10.1093/eurheartj/eht034; Dybdahl B, 2004, EUR J CARDIO-THORAC, V25, P985, DOI 10.1016/j.ejcts.2004.03.002; Eppinger MJ, 1996, J THORAC CARDIOV SUR, V112, P1301, DOI 10.1016/S0022-5223(96)70144-7; Erdoes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053045; FAIST E, 1986, ARCH SURG-CHICAGO, V121, P1000; Fitzgerald DC, 2015, INNOVATIONS; Gessler P, 2003, J THORAC CARDIOV SUR, V126, P718, DOI 10.1016/S0022-5223(03)00685-8; Goetzenich A, 2011, THORAC CARDIOV SURG, V59, P465, DOI 10.1055/s-0031-1280370; Husser O, 2013, JACC-CARDIOVASC INTE, V6, P487, DOI 10.1016/j.jcin.2013.02.006; Issitt RW, 2008, ANN THORAC SURG, V86, P627, DOI 10.1016/j.athoracsur.2008.03.015; Jongman RM, 2014, SHOCK, V42, P121, DOI 10.1097/SHK.0000000000000190; Kiaii Bob, 2012, Innovations (Phila), V7, P23, DOI 10.1097/IMI.0b013e3182552ade; Kobayashi Y, 2010, ASAIO J, V56, P309, DOI 10.1097/MAT.0b013e3181e03d6c; Krumsdorf U, 2012, J INVASIVE CARDIOL, V24, P282; KUKIELKA GL, 1995, CIRCULATION, V92, P1866, DOI 10.1161/01.CIR.92.7.1866; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; Lindman BR, 2015, HEART, V101, P537, DOI 10.1136/heartjnl-2014-307057; Lindman BR, 2014, J AM COLL CARDIOL, V63, P1090, DOI 10.1016/j.jacc.2013.10.057; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Mahoney CB, 2000, PERFUSION-UK, V15, P467, DOI 10.1177/026765910001500510; Onorati F, 2010, EUR J CARDIO-THORAC, V37, P897, DOI 10.1016/j.ejcts.2009.11.010; Remadi JP, 2004, J THORAC CARDIOV SUR, V128, P436, DOI 10.1016/j.jtcvs.2004.01.041; Schewel D, 2015, CATHETER CARDIO INTE, V85, P502, DOI 10.1002/ccd.25295; Sinning JM, 2012, EUR HEART J, V33, P1459, DOI 10.1093/eurheartj/ehs002; SPERTINI O, 1992, J IMMUNOL METHODS, V156, P115, DOI 10.1016/0022-1759(92)90017-N; Stahli BE, 2012, J INVASIVE CARDIOL, V24, P407; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Walther T, 2011, SEMIN THORAC CARDIOV, V23, P55, DOI 10.1053/j.semtcvs.2011.05.006; Wan IYP, 2004, J THORAC CARDIOV SUR, V127, P1624, DOI 10.1016/j.jtcvs.2003.10.043; Wan S, 1996, J THORAC CARDIOV SUR, V112, P806, DOI 10.1016/S0022-5223(96)70068-5; Yutzey KE, 2014, CALCIFIC AORTIC VALV, P2387	40	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143089	10.1371/journal.pone.0143089	http://dx.doi.org/10.1371/journal.pone.0143089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599610	Green Published, gold			2022-12-27	WOS:000365853900063
J	Hudson, LN; Blagoderov, V; Heaton, A; Holtzhausen, P; Livermore, L; Price, BW; van der Walt, S; Smith, VS				Hudson, Lawrence N.; Blagoderov, Vladimir; Heaton, Alice; Holtzhausen, Pieter; Livermore, Laurence; Price, Benjamin W.; van der Walt, Stefan; Smith, Vincent S.			Inselect: Automating the Digitization of Natural History Collections	PLOS ONE			English	Article							MUSEUM COLLECTIONS	The world's natural history collections constitute an enormous evidence base for scientific research on the natural world. To facilitate these studies and improve access to collections, many organisations are embarking on major programmes of digitization. This requires automated approaches to mass-digitization that support rapid imaging of specimens and associated data capture, in order to process the tens of millions of specimens common to most natural history collections. In this paper we present Inselect-a modular, easy-to-use, cross-platform suite of open-source software tools that supports the semi-automated processing of specimen images generated by natural history digitization programmes. The software is made up of a Windows, Mac OS X, and Linux desktop application, together with command-line tools that are designed for unattended operation on batches of images. Blending image visualisation algorithms that automatically recognise specimens together with workflows to support post-processing tasks such as barcode reading, label transcription and metadata capture, Inselect fills a critical gap to increase the rate of specimen digitization.	[Hudson, Lawrence N.; Blagoderov, Vladimir; Heaton, Alice; Livermore, Laurence; Price, Benjamin W.; Smith, Vincent S.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Holtzhausen, Pieter; van der Walt, Stefan] Univ Stellenbosch, Div Appl Math, ZA-7600 Stellenbosch, South Africa; [van der Walt, Stefan] Univ Calif Berkeley, Berkeley Inst Data Sci, Berkeley, CA 94720 USA	Natural History Museum London; Stellenbosch University; University of California System; University of California Berkeley	Hudson, LN (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	l.hudson@nhm.ac.uk	Smith, Vincent/AAK-7335-2020; Livermore, Laurence/H-8062-2019; Price, Benjamin/Y-5971-2019; Hudson, Lawrence/H-2918-2013	Smith, Vincent/0000-0001-5297-7452; Livermore, Laurence/0000-0002-7341-1842; Price, Benjamin/0000-0001-5497-4087; Hudson, Lawrence/0000-0003-4072-7469	SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 Integrating Activities Programme [312253]; Natural Environment Research Council [NE/H02185X/1] Funding Source: researchfish; NERC [NE/H02185X/1] Funding Source: UKRI	SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 Integrating Activities Programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research received support from the SYNTHESYS Project, http://www.synthesys.info/, which is financed by European Community Research Infrastructure Action under the FP7 Integrating Activities Programme (Grant agreement number 312253).	Arino AH, 2010, BIODIVERS INFORM, V7, P81, DOI [10.17161/bi.v7i2.3991, DOI 10.17161/BI.V7I2.3991]; Beaman RS, 2012, ZOOKEYS, P7, DOI 10.3897/zookeys.209.3313; Beck J, 2007, J APPL ECOL, V44, P672, DOI 10.1111/j.1365-2664.2007.01291.x; Blagoderov V, 2012, ZOOKEYS, P133, DOI 10.3897/zookeys.209.3178; Brooks SJ, 2014, INT J BIOMETEOROL, V58, P1749, DOI 10.1007/s00484-013-0780-6; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Dietrich C, 2012, ZOOKEYS, P165, DOI 10.3897/zookeys.209.3571; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Holovachov O, 2014, J CONSERV MUS STUD, V12, DOI 10.5334/jcms.1021218; Lister AM, 2011, TRENDS ECOL EVOL, V26, P153, DOI 10.1016/j.tree.2010.12.009; Mantle BL, 2012, ZOOKEYS, P147, DOI 10.3897/zookeys.209.3169; Nelson G, 2012, ZOOKEYS, P19, DOI 10.3897/zookeys.209.3135; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Rocha LA, 2014, SCIENCE, V344, P814, DOI 10.1126/science.344.6186.814; Schmidt S, 2012, ZOOKEYS, P183, DOI 10.3897/zookeys.209.3115; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715	17	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143402	10.1371/journal.pone.0143402	http://dx.doi.org/10.1371/journal.pone.0143402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599208	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900109
J	Kanatsou, S; Fearey, BC; Kuil, LE; Lucassen, PJ; Harris, AP; Seckl, JR; Krugers, H; Joels, M				Kanatsou, Sofia; Fearey, Brenna C.; Kuil, Laura E.; Lucassen, Paul J.; Harris, Anjanette P.; Seckl, Jonathan R.; Krugers, Harm; Joels, Marian			Overexpression of Mineralocorticoid Receptors Partially Prevents Chronic Stress-Induced Reductions in Hippocampal Memory and Structural Plasticity	PLOS ONE			English	Article							CHRONIC PSYCHOSOCIAL STRESS; LONG-TERM POTENTIATION; DENTATE GYRUS; ADULT NEUROGENESIS; RECOGNITION MEMORY; LIFE STRESS; GLUCOCORTICOID-RECEPTORS; HORMONE CORTICOSTERONE; PYRAMIDAL NEURONS; CHRONIC RESTRAINT	Exposure to chronic stress is a risk factor for cognitive decline and psychopathology in genetically predisposed individuals. Preliminary evidence in humans suggests that mineralocorticoid receptors (MRs) may confer resilience to these stress-related changes. We specifically tested this idea using a well-controlled mouse model for chronic stress in combination with transgenic MR overexpression in the forebrain. Exposure to unpredictable stressors for 21 days in adulthood reduced learning and memory formation in a low arousing hippocampus-dependent contextual learning task, but enhanced stressful contextual fear learning. We found support for a moderating effect of MR background on chronic stress only for contextual memory formation under low arousing conditions. In an attempt to understand potentially contributing factors, we studied structural plasticity. Chronic stress altered dendritic morphology in the hippocampal CA3 area and reduced the total number of double-cortin- positive immature neurons in the infrapyramidal blade of the dentate gyrus. The latter reduction was absent in MR overexpressing mice. We therefore provide partial support for the idea that overexpression of MRs may confer resilience to the effects of chronic stress on hippocampus-dependent function and structural plasticity.	[Kanatsou, Sofia; Fearey, Brenna C.; Joels, Marian] Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Kuil, Laura E.; Lucassen, Paul J.; Krugers, Harm] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Harris, Anjanette P.; Seckl, Jonathan R.] Univ Edinburgh, Endocrinol Unit, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Edinburgh	Kanatsou, S (corresponding author), Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	s.kanatsou@gmail.com	Lucassen, Paul/ABA-3113-2020; Joëls, Marian/P-6415-2016; harris, Anjanette/D-8008-2011	Lucassen, Paul/0000-0001-9708-9133; Fearey, Brenna/0000-0002-2649-7727; Joels, Marian/0000-0002-4826-6209	ALW grant from the Netherlands Organization for Scientific Research NWO [821-02-007]	ALW grant from the Netherlands Organization for Scientific Research NWO	SFK was supported by ALW grant # 821-02-007 from the Netherlands Organization for Scientific Research NWO. The funding source had no involvement in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Alfarez DN, 2003, EUR J NEUROSCI, V17, P1928, DOI 10.1046/j.1460-9568.2003.02622.x; Bagot RC, 2009, NEUROBIOL LEARN MEM, V92, P292, DOI 10.1016/j.nlm.2009.03.004; Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Bogdan R, 2012, AM J PSYCHIAT, V169, P515, DOI 10.1176/appi.ajp.2011.11060855; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Cornelisse S, 2011, NEUROPSYCHOPHARMACOL, V36, P2720, DOI 10.1038/npp.2011.162; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; DeRijk RH, 2008, EUR J PHARMACOL, V585, P492, DOI 10.1016/j.ejphar.2008.03.012; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gass P, 2000, EMBO REP, V1, P447, DOI 10.1093/embo-reports/kvd088; Gould E, 1997, J NEUROSCI, V17, P2492; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; Hu P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046224; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; Joels M, 2012, PHARMACOL REV, V64, P901, DOI 10.1124/pr.112.005892; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Klok MD, 2011, J PSYCHIATR RES, V45, P871, DOI 10.1016/j.jpsychires.2010.12.002; Krugers HJ, 1997, HIPPOCAMPUS, V7, P427, DOI 10.1002/(SICI)1098-1063(1997)7:4<427::AID-HIPO8>3.3.CO;2-L; Kuningas M, 2007, NEUROPSYCHOPHARMACOL, V32, P1295, DOI 10.1038/sj.npp.1301260; Lai M, 2007, EUR J NEUROSCI, V25, P1832, DOI 10.1111/j.1460-9568.2007.05427.x; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Marlatt MW, 2010, BRAIN RES, V1341, P93, DOI 10.1016/j.brainres.2010.03.086; McEwen BS, 2004, EUR NEUROPSYCHOPHARM, V14, pS497, DOI 10.1016/j.euroneuro.2004.09.008; McKittrick CR, 2000, SYNAPSE, V36, P85, DOI 10.1002/(SICI)1098-2396(200005)36:2<85::AID-SYN1>3.0.CO;2-Y; Mitra R, 2009, BIOL PSYCHIAT, V66, P686, DOI 10.1016/j.biopsych.2009.04.016; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Naninck EFG, 2015, HIPPOCAMPUS, V25, P309, DOI 10.1002/hipo.22374; OITZL MS, 1994, EUR J NEUROSCI, V6, P1072, DOI 10.1111/j.1460-9568.1994.tb00604.x; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Oomen CA, 2014, WIRES COGN SCI, V5, P573, DOI 10.1002/wcs.1304; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Otte C, 2007, NEUROPSYCHOPHARMACOL, V32, P232, DOI 10.1038/sj.npp.1301217; Otte C, 2015, NEUROPSYCHOPHARMACOL, V40, P386, DOI 10.1038/npp.2014.181; Pugh CR, 1997, BEHAV NEUROSCI, V111, P503, DOI 10.1037/0735-7044.111.3.503; Reagan LP, 2004, P NATL ACAD SCI USA, V101, P2179, DOI 10.1073/pnas.0307294101; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Sandi C, 2006, NEUROBIOL AGING, V27, P128, DOI 10.1016/j.neurobiolaging.2005.01.006; Schwabe L, 2013, BIOL PSYCHIAT, V74, P801, DOI 10.1016/j.biopsych.2013.06.001; Schwabe L, 2010, J COGNITIVE NEUROSCI, V22, P1362, DOI 10.1162/jocn.2009.21278; Smith DM, 2006, J NEUROSCI, V26, P3154, DOI 10.1523/JNEUROSCI.3234-05.2006; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Vogel S, 2015, BIOL PSYCHIAT, VS0006-3223, P00124; Vogel S, 2015, NEUROPSYCHOPHARMACOL, V40, P947, DOI 10.1038/npp.2014.271; Wang XD, 2013, NAT NEUROSCI, V16, P706, DOI 10.1038/nn.3395; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Wright RL, 2005, STRESS, V8, P151, DOI 10.1080/10253890500156663; Zhou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026220; Zhou M, 2010, NEUROBIOL LEARN MEM, V94, P530, DOI 10.1016/j.nlm.2010.09.005; Zhou M, 2009, EUR J NEUROSCI, V30, P1559, DOI 10.1111/j.1460-9568.2009.06951.x	70	22	23	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142012	10.1371/journal.pone.0142012	http://dx.doi.org/10.1371/journal.pone.0142012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600250	Green Published, gold			2022-12-27	WOS:000365853900019
J	Kim, HJ; Cho, JC				Kim, Hye-Jin; Cho, Jae-Chang			Genotypic Diversity and Population Structure of Vibrio vulnificus Strains Isolated in Taiwan and Korea as Determined by Multilocus Sequence Typing	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; REAL-TIME PCR; WOUND-INFECTION; ENVIRONMENTAL STRAINS; STATISTICAL TESTS; GENETIC-VARIATION; COASTAL WATERS; POLYMORPHISM; OYSTERS; VIRULENCE	The genetic diversity and population structure of Vibrio vulnificus isolates from Korea and Taiwan were investigated using PCR-based assays targeting putative virulence-related genes and multilocus sequence typing (MLST). BOX-PCR genomic fingerprinting identified 52 unique genotypes in 84 environmental and clinical V. vulnificus isolates. The majority (>50%) of strains had pathogenic genotypes for all loci tested; moreover, many environmental strains had pathogenic genotypes. Although significant (p < 0.05) inter-relationships among the genotypes were observed, the association between genotype and strain source (environmental or clinical) was not significant, indicating that genotypic characteristics alone are not sufficient to predict the isolation source or the virulence of a given V. vulnificus strain and vice versa. MLST revealed 23-35 allelic types per locus analyzed, resulting in a total of 44 unique sequence types (STs). Two major monophyletic groups (lineages A and B) corresponding to the two known lineages of V. vulnificus were observed; lineage A had six STs that were exclusively environmental, whereas lineage B had STs from both environmental and clinical sources. Pathogenic and nonpathogenic genotypes predominated in MLST lineages B and A, respectively. In addition, V. vulnificus was shown to be in linkage disequilibrium (p < 0.05), although two different recombination tests (PHI and Sawyer's tests) detected significant evidence of recombination. Tajima's D test also indicated that V. vulnificus might be comprised of recently sub-divided lineages. These results suggested that the two lineages revealed by MLST correspond to two distinct ecotypes of V. vulnificus.	[Kim, Hye-Jin; Cho, Jae-Chang] Hankuk Univ Foreign Studies, Inst Environm Sci, Yongin, South Korea; [Kim, Hye-Jin; Cho, Jae-Chang] Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin, South Korea; [Cho, Jae-Chang] Solana Informat, San Diego, CA USA	Hankuk University Foreign Studies; Hankuk University Foreign Studies	Cho, JC (corresponding author), Hankuk Univ Foreign Studies, Inst Environm Sci, Yongin, South Korea.	chojc@hufs.ac.kr			Gyunggi Regional Research Center [GRRCHUFS-2013-B02]; Hankuk University of Foreign Studies [HUFS-2014]; National Research Foundation of Korea [NRF-2012R1A1A2004270]; Korea Environmental Industry and Technology Institute (GAIA) [20130005501]; GRRC [GRRCHUFS-2013-B02]; HUFS [HUFS-2014]; NRF [NRF-2012R1A1A2004270]; KEITI (GAIA) [20130005501]	Gyunggi Regional Research Center; Hankuk University of Foreign Studies; National Research Foundation of Korea(National Research Foundation of Korea); Korea Environmental Industry and Technology Institute (GAIA); GRRC; HUFS; NRF; KEITI (GAIA)	This work was supported by a research grant from the Gyunggi Regional Research Center (program no. GRRCHUFS-2013-B02) and Hankuk University of Foreign Studies (program no. HUFS-2014). H-J Kim was supported in part by the National Research Foundation of Korea (grant no. NRF-2012R1A1A2004270) and Korea Environmental Industry and Technology Institute (GAIA project no. 20130005501).; We thank K-H Lee, JD Oliver, and H-C Wong for providing Vibrio vulnificus strains. This work was supported by a research grant from the GRRC (program no. GRRCHUFS-2013-B02) and HUFS (program no. HUFS-2014). H-J Kim was supported in part by the NRF (grant no. NRF-2012R1A1A2004270) and KEITI (GAIA project no. 20130005501).	ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Baizabal-Ramirez Oscar, 2011, Rev Med Inst Mex Seguro Soc, V49, P433; Baker-Austin C, 2012, FOOD MICROBIOL, V30, P17, DOI 10.1016/j.fm.2011.09.002; Franca JCB, 2013, AN BRAS DERMATOL, V88, P424, DOI 10.1590/abd1806-4841.20131780; Bier N, 2013, APPL ENVIRON MICROB, V79, P3570, DOI 10.1128/AEM.00477-13; Biosca EG, 1997, APPL ENVIRON MICROB, V63, P1460, DOI 10.1128/AEM.63.4.1460-1466.1997; BIOSCA EG, 1991, J FISH DIS, V14, P103, DOI 10.1111/j.1365-2761.1991.tb00581.x; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Bisharat N, 1999, LANCET, V354, P1421, DOI 10.1016/S0140-6736(99)02471-X; Bisharat N, 2007, INFECT GENET EVOL, V7, P685, DOI 10.1016/j.meegid.2007.07.007; Bogard RW, 2007, APPL ENVIRON MICROB, V73, P7501, DOI 10.1128/AEM.01551-07; BOYD EF, 1994, P NATL ACAD SCI USA, V91, P1280, DOI 10.1073/pnas.91.4.1280; Broza YY, 2007, J CLIN MICROBIOL, V45, P2951, DOI 10.1128/JCM.00236-07; Broza YY, 2012, INT J FOOD MICROBIOL, V153, P436, DOI 10.1016/j.ijfoodmicro.2011.12.011; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cazorla C, 2011, EMERG INFECT DIS, V17, P136, DOI 10.3201/eid1701.100603; CDC, 2007, SUMM HUM VIBR IS REP; CHAO A, 1984, SCAND J STAT, V11, P265; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Chatzidaki-Livanis M, 2006, APPL ENVIRON MICROB, V72, P6136, DOI 10.1128/AEM.00341-06; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Chu Chaeshin, 2011, Osong Public Health Res Perspect, V2, P51, DOI 10.1016/j.phrp.2011.05.002; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohen ALV, 2007, APPL ENVIRON MICROB, V73, P5553, DOI 10.1128/AEM.00635-07; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; den Bakker HC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-277; Do T, 2009, MICROBIOL-SGM, V155, P2593, DOI 10.1099/mic.0.027284-0; Drake SL, 2010, FOODBORNE PATHOG DIS, V7, P97, DOI 10.1089/fpd.2009.0362; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Gonzalez-Escalona N, 2007, APPL ENVIRON MICROB, V73, P7494, DOI 10.1128/AEM.00738-07; Gordon KV, 2008, APPL ENVIRON MICROB, V74, P1704, DOI 10.1128/AEM.01100-07; GRAY LD, 1987, J INFECT DIS, V155, P236, DOI 10.1093/infdis/155.2.236; GRAY LD, 1985, INFECT IMMUN, V48, P62, DOI 10.1128/IAI.48.1.62-72.1985; Gutacker M, 2003, APPL ENVIRON MICROB, V69, P3203, DOI 10.1128/AEM.69.6.3203-3212.2003; Han F, 2010, LETT APPL MICROBIOL, V51, P234, DOI 10.1111/j.1472-765X.2010.02887.x; Han FF, 2009, FOODBORNE PATHOG DIS, V6, P1251, DOI 10.1089/fpd.2009.0343; HANE BG, 1993, ELECTROPHORESIS, V14, P967, DOI 10.1002/elps.11501401154; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; HOLLIS DG, 1976, J CLIN MICROBIOL, V3, P425; Horseman MA, 2011, INT J INFECT DIS, V15, pE157, DOI 10.1016/j.ijid.2010.11.003; Hsueh PR, 2004, EMERG INFECT DIS, V10, P1363, DOI 10.3201/eid1008.040047; HUDSON RR, 1994, J EVOLUTION BIOL, V7, P535, DOI 10.1046/j.1420-9101.1994.7050535.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Inoue Y, 2008, J DERMATOL, V35, P129, DOI 10.1111/j.1346-8138.2008.00432.x; Jeong Hye Sook, 2011, Osong Public Health Res Perspect, V2, P8, DOI 10.1016/j.phrp.2011.04.008; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones JL, 2013, INT J FOOD MICROBIOL, V167, P322, DOI 10.1016/j.ijfoodmicro.2013.09.017; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; JUKES T H, 1969, P21; Kaysner CA, 2001, VIBRIO, P405; KCDC, 2010, KCDCS ANN REP 2007; Keymer DP, 2011, APPL ENVIRON MICROB, V77, P537, DOI 10.1128/AEM.02062-10; Kim HJ, 2012, FOOD CONTROL, V23, P491, DOI 10.1016/j.foodcont.2011.08.019; Kim KY, 1999, J MICROBIOL BIOTECHN, V9, P78; Kim MS, 2001, AQUACULTURE, V193, P199, DOI 10.1016/S0044-8486(00)00495-6; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Kim YR, 2003, BIOCHEM BIOPH RES CO, V304, P405, DOI 10.1016/S0006-291X(03)00613-2; Kotetishvili M, 2003, J CLIN MICROBIOL, V41, P2191, DOI 10.1128/JCM.41.5.2191-2196.2003; Lee JH, 2007, J MICROBIOL, V45, P146; Lee JH, 2004, INFECT IMMUN, V72, P4905, DOI 10.1128/IAI.72.8.4905-4910.2004; Lee JH, 2001, J MICROBIOL BIOTECHN, V11, P302; Lee SH, 2013, JPN J INFECT DIS, V66, P331, DOI 10.7883/yoken.66.331; Robles AL, 2013, J WATER HEALTH, V11, P700, DOI 10.2166/wh.2013.160; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; Martin DP, 2011, MOL ECOL RESOUR, V11, P943, DOI 10.1111/j.1755-0998.2011.03026.x; Matui T, 2004, ARCH DERMATOL, V140, P888, DOI 10.1001/archderm.140.7.888; MCPHERSON VL, 1991, MICROBIOS, V67, P141; Miller MC, 2007, APPL ENVIRON MICROB, V73, P3695, DOI 10.1128/AEM.02735-06; Motes ML, 1998, APPL ENVIRON MICROB, V64, P1459; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nightingale KK, 2005, J BACTERIOL, V187, P5537, DOI 10.1128/JB.187.16.5537-5551.2005; Nilsson WB, 2003, J CLIN MICROBIOL, V41, P442, DOI 10.1128/JCM.41.1.442-446.2003; Oishi Hirotaka, 2006, Kansenshogaku Zasshi, V80, P680; OLIVER JD, 1982, APPL ENVIRON MICROB, V44, P1404, DOI 10.1128/AEM.44.6.1404-1414.1982; Oliver JD, 2005, EPIDEMIOL INFECT, V133, P383, DOI 10.1017/S0950268805003894; Oliver JD, 1989, VIBRIO VULNIFICUS; Osaka K, 2004, EPIDEMIOL INFECT, V132, P993, DOI 10.1017/S0950268804002407; Panicker G, 2004, CAN J MICROBIOL, V50, P911, DOI 10.1139/W04-085; Paranjpye RN, 2005, INFECT IMMUN, V73, P1411, DOI 10.1128/IAI.73.3.1411-1422.2005; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Park KH, 2007, EXP MOL MED, V39, P673, DOI 10.1038/emm.2007.73; PENMAN AD, 1995, SOUTHERN MED J, V88, P531, DOI 10.1097/00007611-199505000-00004; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Rademaker J. L. W., 1998, MOL MICROBIAL ECOLOG, P1; Rademaker JLW, 2000, INT J SYST EVOL MICR, V50, P665, DOI 10.1099/00207713-50-2-665; Reynaud Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083357; Roig FJ, 2010, APPL ENVIRON MICROB, V76, P1328, DOI 10.1128/AEM.01042-09; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Ruppert J, 2004, EUR J CLIN MICROBIOL, V23, P912, DOI 10.1007/s10096-004-1241-2; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Shao CP, 2000, INFECT IMMUN, V68, P3569, DOI 10.1128/IAI.68.6.3569-3573.2000; Shapiro RL, 1998, J INFECT DIS, V178, P752, DOI 10.1086/515367; SIMONSEN KL, 1995, GENETICS, V141, P413; SIMPSON LM, 1987, INFECT IMMUN, V55, P269, DOI 10.1128/IAI.55.1.269-272.1987; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiaville PC, 2011, INFECT IMMUN, V79, P1194, DOI 10.1128/IAI.01031-10; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TISON DL, 1982, APPL ENVIRON MICROB, V44, P640, DOI 10.1128/AEM.44.3.640-646.1982; Torres L, 2002, EUR J CLIN MICROBIOL, V21, P537, DOI 10.1007/s10096-002-0767-4; Tsao CH, 2013, J INFECT DEV COUNTR, V7, P533, DOI 10.3855/jidc.3008; Vickery MCL, 2007, J MICROBIOL METH, V68, P376, DOI 10.1016/j.mimet.2006.02.018; Vinuesa P, 1998, APPL ENVIRON MICROB, V64, P2096; Warner E, 2008, APPL ENVIRON MICROB, V74, P80, DOI 10.1128/AEM.01434-07; Wong HC, 2004, APPL ENVIRON MICROB, V70, P5153, DOI 10.1128/AEM.70.9.5153-5158.2004; Wood RR, 2012, J APPL MICROBIOL, V113, P172, DOI 10.1111/j.1365-2672.2012.05306.x; World Health Organization and Food and Agriculture Organization of the United Nations, 2005, RISK ASS VIBR VULN R; WRIGHT AC, 1990, INFECT IMMUN, V58, P1769, DOI 10.1128/IAI.58.6.1769-1773.1990; WRIGHT AC, 1981, INFECT IMMUN, V34, P503, DOI 10.1128/IAI.34.2.503-507.1981; Yokochi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055219; YOSHIDA SI, 1985, INFECT IMMUN, V47, P446, DOI 10.1128/IAI.47.2.446-451.1985; Zaidenstein R, 2008, EMERG INFECT DIS, V14, P1875, DOI 10.3201/eid1412.080499	123	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142657	10.1371/journal.pone.0142657	http://dx.doi.org/10.1371/journal.pone.0142657			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599487	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900033
J	Zhang, X; Zhang, YL; Liu, XF; Fang, AJ; Li, PL; Li, ZW; Liu, T; Yang, YM; Du, LT; Wang, CX				Zhang, Xin; Zhang, Yanli; Liu, Xinfeng; Fang, Aiju; Li, Peilong; Li, Zewu; Liu, Tong; Yang, Yongmei; Du, Lutao; Wang, Chuanxin			MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin	PLOS ONE			English	Article							DOWN-REGULATION; RESISTANCE; MULTICENTER; SENSITIVITY; EXPRESSION; SIGNATURES; CARCINOMA; CELLS; HEAD	Resistance to cisplatin-based chemotherapy is a major cause of treatment failure in advanced bladder cancer (BC) patients. There is increasing evidence that microRNAs are involved in the development and progression of BC. However, little is known about the function of microRNAs in predicting the effect of adjuvant chemotherapy on BC survival and regulating response to cisplatin. To address this issue, we employed RT-qPCR to evaluate the clinical significance of miR-203 expression in 108 tissues of BC patients receiving cisplatin-based adjuvant chemotherapy, and performed in vitro studies to explore chemotherapeutic sensitivity to cisplatin in miR-203 overexpressing BC cells. We found miR-203 levels were significantly lower in BC progression group than non-progression group (P<0.001). ROC curve analysis illustrated miR-203 could significantly distinguish progressed patients from those without progression (P<0.001), yielding an area under the ROC curve of 0.839 (95% CI, 0.756-0.903). Moreover, low miR-203 expression correlated with shortened progression free survival (PFS) and overall survival (OS) of BC patients, and was an independent prognostic factor. Overexpression of miR-203 in 5637 and T24 BC cells could decrease cell viability, enhance cisplatin cytotoxicity, and promote apoptosis. Western blotting and luciferase reporter assay showed Bcl-w and Survivin were direct downstream targets of miR-203. There was also a significant inverse association between miR-203 and Bcl-w or Survivin expression in BC tissues (r=-0.781, -0.740, both P<0.001). In conclusion, decreased miR-203 predicts progression and poor prognosis for BC patients treated with cisplatin-based chemotherapy while miR-203 overexpression can enhance cisplatin sensitization by promoting apoptosis via directly targeting Bcl-w and Survivin.	[Zhang, Xin; Li, Peilong; Li, Zewu; Liu, Tong; Yang, Yongmei; Du, Lutao; Wang, Chuanxin] Shandong Univ, Dept Clin Lab, Qilu Hosp, Jinan 250100, Peoples R China; [Zhang, Yanli; Liu, Xinfeng] Traff Hosp Shandong Prov, Dept Clin Lab, Jinan, Peoples R China; [Fang, Aiju] Traff Hosp Shandong Prov, Dept Pathol, Jinan, Peoples R China	Shandong University	Wang, CX (corresponding author), Shandong Univ, Dept Clin Lab, Qilu Hosp, Jinan 250100, Peoples R China.	cxwang@sdu.edu.cn		Li, Peilong/0000-0002-7441-6514	National Natural Science Foundation of China [81271916, 81301506]; Natural Science Foundation of Shandong Province [ZR2013HQ063]; Doctoral Program of Higher Education of China [20130131120067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (http://www.nsfc. gov.cn/) to CW (No. 81271916); National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to XZ (No. 81301506); Natural Science Foundation of Shandong Province (http://www.sdnsf.gov.cn/portal/) to XZ (ZR2013HQ063); and Doctoral Program of Higher Education of China (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) to XZ (No. 20130131120067).	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Chen XN, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0070-3; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Drayton RM, 2014, CLIN CANCER RES, V20, P1990, DOI 10.1158/1078-0432.CCR-13-2805; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; He JG, 2013, J SURG ONCOL, V108, P121, DOI 10.1002/jso.23315; Jamali Z, 2015, ORAL ONCOL, V51, P321, DOI 10.1016/j.oraloncology.2015.01.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kumar B, 2012, MOL CANCER THER, V11, P1988, DOI 10.1158/1535-7163.MCT-12-0167; Li H, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-8; Li JA, 2011, CANCER LETT, V304, P52, DOI 10.1016/j.canlet.2011.02.003; Li NW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128886; Li ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116170; Nordentoft I, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-40; Phatak P, 2015, ONCOGENE; Roberts JT, 2006, ANN ONCOL, V17, pV118, DOI 10.1093/annonc/mdj965; Saini S, 2011, CANCER PREV RES, V4, P1698, DOI 10.1158/1940-6207.CAPR-11-0267; Shariat SF, 2009, CLIN CANCER RES, V15, P7012, DOI 10.1158/1078-0432.CCR-08-2554; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Sternberg CN, 2013, EUR UROL, V63, P58, DOI 10.1016/j.eururo.2012.08.010; Tian HW, 2012, J BIOMED NANOTECHNOL, V8, P633, DOI 10.1166/jbn.2012.1419; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vinall RL, 2012, INT J CANCER, V130, P2526, DOI 10.1002/ijc.26256; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Herr HW, 2007, J UROLOGY, V177, P437, DOI 10.1016/j.juro.2006.09.027; Wang F, 2013, FEBS LETT, V587, P488, DOI 10.1016/j.febslet.2013.01.016; Wang XD, 2001, GENE DEV, V15, P2922; Wu XF, 2013, CANCER PREV RES, V6, P196, DOI 10.1158/1940-6207.CAPR-12-0276; Yin JH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-71; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhou YF, 2014, MOL ONCOL, V8, P83, DOI 10.1016/j.molonc.2013.09.004	36	8	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143441	10.1371/journal.pone.0143441	http://dx.doi.org/10.1371/journal.pone.0143441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599571	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900123
J	Yin, L; Zheng, LJ; Jiang, X; Liu, WB; Han, F; Cao, J; Liu, JY				Yin, Li; Zheng, Li-juan; Jiang, Xiao; Liu, Wen-bin; Han, Fei; Cao, Jia; Liu, Jin-yi			Effects of Low-Dose Diethylstilbestrol Exposure on DNA Methylation in Mouse Spermatocytes	PLOS ONE			English	Article							ENDOCRINE DISRUPTING CHEMICALS; POTENTIAL TUMOR-SUPPRESSOR; RETINOID-X-RECEPTOR; GERM-CELLS; INCREASED EXPRESSION; BREAST-CANCER; LUNG-CANCER; IN-UTERO; APOPTOSIS; GROWTH	Evidence from previous studies suggests that the male reproductive system can be disrupted by fetal or neonatal exposure to diethylstilbestrol (DES). However, the molecular basis for this effect remains unclear. To evaluate the effects of DES on mouse spermatocytes and to explore its potential mechanism of action, the levels of DNA methyltransferases (DNMTs) and DNA methylation induced by DES were detected. The results showed that low doses of DES inhibited cell proliferation and cell cycle progression and induced apoptosis in GC-2 cells, an immortalized mouse pachytene spermatocyte-derived cell line, which reproduces primary cells responses to E2. Furthermore, global DNA methylation levels were increased and the expression levels of DNMTs were altered in DES-treated GC-2 cells. A total of 141 differentially methylated DNA sites were detected by microarray analysis. Rxra, an important component of the retinoic acid signaling pathway, and mybph, a RhoA pathway-related protein, were found to be hypermethylated, and Prkcd, an apoptosis-related protein, was hypomethylated. These results showed that low-dose DES was toxic to spermatocytes and that DNMT expression and DNA methylation were altered in DES-exposed cells. Taken together, these data demonstrate that DNA methylation likely plays an important role in mediating DES-induced spermatocyte toxicity in vitro.	[Yin, Li; Zheng, Li-juan; Jiang, Xiao; Liu, Wen-bin; Han, Fei; Cao, Jia; Liu, Jin-yi] Third Mil Med Univ, Coll Prevent Med, Inst Toxicol, Chongqing, Peoples R China; [Zheng, Li-juan] Gansu Peoples Hosp, Lanzhou, Peoples R China	Army Medical University	Liu, JY (corresponding author), Third Mil Med Univ, Coll Prevent Med, Inst Toxicol, Chongqing, Peoples R China.	jinyiliutmmu@163.com	liu, wen/HGE-3071-2022; Han, Fei/AAH-2028-2020; Han, Fei/AAG-9260-2020	Han, Fei/0000-0002-0265-5487	Key Program of National Natural Science Foundation of China [81030052]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: Funded by Key Program of National Natural Science Foundation of China, No. 81030052.	Ahuja HS, 2003, J BIOL REG HOMEOS AG, V17, P29; Bromberg KD, 2007, CANCER RES, V67, P8172, DOI 10.1158/0008-5472.CAN-07-0045; Chappell J, 2013, GENE DEV, V27, P725, DOI 10.1101/gad.211300.112; Choi KJ, 2014, J BIOSCIENCES, V39, P97, DOI 10.1007/s12038-013-9406-8; Choudhry S, 2012, J UROLOGY, V188, P1450, DOI 10.1016/j.juro.2012.03.047; De Souza AP, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-15; Dyachenko OV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P77, DOI 10.1134/S0006297914020011; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Haddad R, 2013, TOXICOL APPL PHARM, V266, P27, DOI 10.1016/j.taap.2012.10.018; Harris RM, 2012, MATURITAS, V72, P108, DOI 10.1016/j.maturitas.2012.03.002; Heng K, 2012, INT J ANDROL, V35, P353, DOI 10.1111/j.1365-2605.2011.01231.x; Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa1013961; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Pharmaceuticals, 2012, IARC MONOGR EVAL CAR, V100, P1; Jaworska J, 2014, P NATL ACAD SCI USA, V111, pE2110, DOI 10.1073/pnas.1322118111; Jin Q, 2007, IN VIVO, V21, P593; Kalfa N, 2011, FERTIL STERIL, V95, P2574, DOI 10.1016/j.fertnstert.2011.02.047; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kanome T, 2007, ONCOGENE, V26, P5991, DOI 10.1038/sj.onc.1210423; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kim E, 2010, J NEUROPHYSIOL, V104, P3439, DOI 10.1152/jn.00525.2010; Klip H, 2002, LANCET, V359, P1102, DOI 10.1016/S0140-6736(02)08152-7; Krick S, 2008, P NATL ACAD SCI USA, V105, P14106, DOI 10.1073/pnas.0801146105; Kuang E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003007; Kubalak SW, 2002, DEVELOPMENT, V129, P733; Kuzbari O, 2013, REPROD TOXICOL, V37, P24, DOI 10.1016/j.reprotox.2013.01.005; LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003; LEE MS, 1993, SCIENCE, V260, P1117, DOI 10.1126/science.8388124; Li Y, 2014, ENVIRON HEALTH PERSP, V122, P262, DOI 10.1289/ehp.1307351; Li YL, 2011, REPROD TOXICOL, V31, P26, DOI 10.1016/j.reprotox.2010.09.007; Liu WB, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.366; Liu WB, 2014, INT J CANCER, V134, P1311, DOI 10.1002/ijc.28472; Liu XZ, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300053; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; Nair R, 2003, J BIOL CHEM, V278, P6470, DOI 10.1074/jbc.M209319200; Newbold Retha R, 2008, Fertil Steril, V89, pe55, DOI 10.1016/j.fertnstert.2008.01.062; Reed CE, 2013, BIRTH DEFECTS RES C, V99, P134, DOI 10.1002/bdrc.21035; Roig MB, 2009, CELL DEATH DIFFER, V16, P230, DOI 10.1038/cdd.2008.145; Rosenauer A, 1998, CANCER RES, V58, P5110; Ruden DM, 2005, HUM MOL GENET, V14, pR149, DOI 10.1093/hmg/ddi103; Sakurai Y, 2001, BIOL PHARM BULL, V24, P973, DOI 10.1248/bpb.24.973; Sales LB, 2013, TOXICOL IN VITRO, V27, P1634, DOI 10.1016/j.tiv.2013.04.005; Sato K, 2009, ENDOCR J, V56, P131, DOI 10.1507/endocrj.K08E-239; Schenkel AR, 2007, CELL COMMUN ADHES, V14, P227, DOI 10.1080/15419060701755966; Shi JF, 2012, BIOCHEM BIOPH RES CO, V427, P47, DOI 10.1016/j.bbrc.2012.08.144; Smith JM, 2004, DEV DYNAM, V230, P366, DOI 10.1002/dvdy.20053; Song N, 2011, ACTA HISTOCHEM CYTOC, V44, P183, DOI 10.1267/ahc.11027; Subauste AR, 2010, DIFFERENTIATION, V80, P140, DOI 10.1016/j.diff.2010.05.006; Subramaniam D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00080; Sun DJY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089696; Takashima S, 2009, BIOL REPROD, V81, P155, DOI 10.1095/biolreprod.108.074708; Uanschou C, 2013, PLANT CELL, V25, P4924, DOI 10.1105/tpc.113.118521; Virtanen HE, 2012, MOL CELL ENDOCRINOL, V355, P208, DOI 10.1016/j.mce.2011.11.015; Volle DH, 2009, J CLIN INVEST, V119, P3752, DOI 10.1172/JCI38521; Woo S, 2012, J CELL BIOL, V198, P941, DOI 10.1083/jcb.201203012; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Wu X, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096230; Xia L, 2013, J PROTEOME RES, V12, P4280, DOI 10.1021/pr400089v; Xu Chen, 2014, Zhonghua Nan Ke Xue, V20, P387; Yamashita S, 2006, CURR PHARM DESIGN, V12, P1505, DOI 10.2174/138161206776389840; Zamudio NM, 2008, REPRODUCTION, V136, P131, DOI 10.1530/REP-07-0576; Zhang HY, 2014, AM J PHYSIOL-CELL PH, V306, pC648, DOI 10.1152/ajpcell.00351.2013	62	7	7	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143143	10.1371/journal.pone.0143143	http://dx.doi.org/10.1371/journal.pone.0143143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588706	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500033
J	Chang, YJ; Shen, EL; Wen, LY; Yu, JJ; Zhu, DY; Zhao, Q				Chang, Yujie; Shen, Erli; Wen, Liuying; Yu, Jingjuan; Zhu, Dengyun; Zhao, Qian			Seed-Specific Expression of the Arabidopsis AtMAP18 Gene Increases both Lysine and Total Protein Content in Maize	PLOS ONE			English	Article							AMINO-ACIDS; ENDOSPERM; ZEIN; QUALITY; MUTANT; CYTOSKELETON; OPAQUE-2; ENCODES; GROWTH; PLANTS	Lysine is the most limiting essential amino acid for animal nutrition in maize grains. Expression of naturally lysine-rich protein genes can increase the lysine and protein contents in maize seeds. AtMAP18 from Arabidopsis thaliana encoding a microtubule-associated protein with high-lysine content was introduced into the maize genome with the seed-specific promoter F128. The protein and lysine contents of different transgenic offspring were increased prominently in the six continuous generations investigated. Expression of AtMAP18 increased both zein and non-zein protein in the transgenic endosperm. Compared with the wild type, more protein bodies were observed in the endosperm of transgenic maize. These results implied that, as a cytoskeleton binding protein, AtMAP18 facilitated the formation of protein bodies, which led to accumulation of both zein and non-zein proteins in the transgenic maize grains. Furthermore, F1 hybrid lines with high lysine, high protein and excellent agronomic traits were obtained by hybridizing T-6 transgenic offspring with other wild type inbred lines. This article provides evidence supporting the use of cytoskeleton-associated proteins to improve the nutritional value of maize.	[Chang, Yujie; Shen, Erli; Wen, Liuying; Yu, Jingjuan; Zhu, Dengyun; Zhao, Qian] China Agr Univ, Coll Biol Sci, State Key Lab Agr Biotechnol, Beijing 100094, Peoples R China	China Agricultural University	Zhao, Q (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agr Biotechnol, Beijing 100094, Peoples R China.	zhaoqian@cau.edu.cn			National Natural Science Foundation [31171258]; Ministry of Agriculture of China for Transgenic Research [2014ZX08009-003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China for Transgenic Research	This work was supported by National Natural Science Foundation (Grant No. 31171258) and the projects (No. 2014ZX08009-003) from the Ministry of Agriculture of China for Transgenic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Sai-Ming Samuel Sun (The Chinese University of Hong Kong) for providing the vector pSB130. This work was supported by National Natural Science Foundation (Grant No. 31171258) and the projects (No. 2014ZX08009-003) from the Ministry of Agriculture of China for Transgenic Research.	Abe S, 2003, PLANT PHYSIOL BIOCH, V41, P125, DOI 10.1016/S0981-9428(02)00016-5; Azama K, 2003, PLANTA, V217, P628, DOI 10.1007/s00425-003-1016-5; Azevedo RA, 2010, AMINO ACIDS, V39, P979, DOI 10.1007/s00726-010-0576-5; Clore AM, 1996, PLANT CELL, V8, P2003, DOI 10.2307/3870408; Coleman CE, 1997, P NATL ACAD SCI USA, V94, P7094, DOI 10.1073/pnas.94.13.7094; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; Galili G, 2013, PLANT BIOTECHNOL J, V11, P211, DOI 10.1111/pbi.12025; Gibbon BC, 2005, TRENDS GENET, V21, P227, DOI 10.1016/j.tig.2005.02.009; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Hournard NM, 2007, PLANT BIOTECHNOL J, V5, P605, DOI 10.1111/j.1467-7652.2007.00265.x; Huang SL, 2007, PLANT J, V51, P406, DOI 10.1111/j.1365-313X.2007.03153.x; Jia M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-60; Kirma M, 2012, J EXP BOT, V63, P4995, DOI 10.1093/jxb/ers119; Lang ZH, 2004, PLANT SCI, V166, P1227, DOI 10.1016/j.plantsci.2003.12.036; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060543; Lopez-Valenzuela JA, 2004, PLANT PHYSIOL, V135, P1784, DOI 10.1104/pp.104.042259; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matheka Jonathan M, 2013, BMC Res Notes, V6, P448, DOI 10.1186/1756-0500-6-448; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; Pan YL, 2015, PLANTA, V241, P57, DOI 10.1007/s00425-014-2164-5; Prasanna BM, 2001, CURRENT SCI, V81, P25; Prasanna BM, 2001, CURRENT SCI, V81, P10; Reyes AR, 2009, PLANT MOL BIOL, V69, P81, DOI 10.1007/s11103-008-9409-2; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; TSAI CY, 1974, CEREAL CHEM, V51, P825; Tuteja N, 2012, J BIOSCIENCES, V37, P167, DOI 10.1007/s12038-012-9187-5; Wang G, 2011, GENETICS, V189, P1281, DOI 10.1534/genetics.111.133967; Wang MZ, 2013, INT J MOL SCI, V14, P9459, DOI 10.3390/ijms14059459; Wang X, 2007, PLANT CELL, V19, P877, DOI 10.1105/tpc.106.048579; Wenefrida I, 2013, J AGR FOOD CHEM, V61, P11702, DOI 10.1021/jf4016812; Wenefrida Ida, 2009, Recent Pat DNA Gene Seq, V3, P219; Wu YR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00240; Wu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032850; Wu YR, 2011, GENETICS, V188, P1019, DOI 10.1534/genetics.111.131078; Yu Jingjuan, 2005, Food and Nutrition Bulletin, V26, P427; Yuan LL, 2014, PLANT PHYSIOL, V164, P119, DOI 10.1104/pp.113.230961; Yue J, 2014, INT J MOL SCI, V15, P5350, DOI 10.3390/ijms15045350; Zhu L, 2013, PLANT CELL, V25, P851, DOI 10.1105/tpc.113.110528	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142952	10.1371/journal.pone.0142952	http://dx.doi.org/10.1371/journal.pone.0142952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580206	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600070
J	Reynolds, CD; Smith, GD; Jefferson, TS; Lugo, JN				Reynolds, Conner D.; Smith, Gregory D.; Jefferson, Taylor S.; Lugo, Joaquin N.			Comparison of Equivalence between Two Commercially Available S499-Phosphorylated FMRP Antibodies in Mice	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; LHERMITTE-DUCLOS-DISEASE; SOMA SIZE; PTEN; DELETION; PHOSPHORYLATION; TRANSLATION; VALIDATION; DEFICITS	Fragile X syndrome (FXS) develops from excessive trinucleotide CGG repeats in the 5'-untranslated region at Xq27.3 of the Fmr-1 gene, which functionally silences its expression and prevents transcription of its protein. This disorder is the most prominent form of heritable intellectual deficiency, affecting roughly 1 in 5,000 males and 1 in 10,000 females globally. Antibody specificity and selectivity are essential for investigating changes in intracellular protein signaling and phosphorylation status of the Fragile X Mental Retardation Protein (FMRP). Currently, both PhosphoSolutions (R) and abcam (R) produce commercially available S499-phosphorylated FMRP specific antibodies. The antibody from PhosphoSolutions (R) has been validated in previous studies; however, the antibody from abcam (R) antibody has yet to receive similar validation. This study aims to determine whether these two antibodies are true equivalents through western blot analysis of both NS-Pten knockout (KO) and Fmr-1 KO mice strains. We prepared hippocampal synaptosomal preparations and probed the samples using total FMRP, abcam (R) phosphorylated FMRP, and PhosphoSolutions (R) phosphorylated FMRP antibodies. We found that there was a significant increase in phosphorylated FMRP levels using the abcam (R) and PhosphoSolutions (R) antibodies in the NS-Pten KO mice compared to wildtype mice. However, there was much more variability using the abcam (R) antibody. Furthermore, there was a band present in the Fmr-1 KO for the phosphorylated FMRP site using the abcam (R) antibody for western blotting but not for the PhosphoSolutions (R) antibody. Our findings strongly suggest that the antibody from abcam (R) is neither specific nor selective for its advertised targeted substrate, S499-phosphorylated FMRP.	[Reynolds, Conner D.; Jefferson, Taylor S.; Lugo, Joaquin N.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [Smith, Gregory D.; Lugo, Joaquin N.] Baylor Univ, Inst Biomed Sci, Waco, TX 76798 USA	Baylor University; Baylor University	Lugo, JN (corresponding author), Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA.	joaquin_lugo@baylor.edu		Reynolds, Conner/0000-0001-6320-1131	NIH NINDS [NS088776]; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS088776] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by the NIH NINDS: NS088776 [http://www.ninds.nih.gov/] and the Epilepsy Foundation [http://www.epilepsyfoundation.org/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bartley CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096956; Bernard P. B., 2013, NEUROBIOL DIS; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Fatemi SH, 2011, ANAT REC, V294, P1635, DOI 10.1002/ar.21299; Fatemi SH, 2010, SCHIZOPHR RES, V124, P246, DOI 10.1016/j.schres.2010.07.017; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Hawkins M, 2011, EUR J HUM GENET, V19, P10, DOI 10.1038/ejhg.2010.135; Hersh JH, 2011, PEDIATRICS, V127, P994, DOI 10.1542/peds.2010-3500; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lugo JN, 2008, J NEUROCHEM, V106, P1929, DOI 10.1111/j.1471-4159.2008.05508.x; Lugo JN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00027; Lugo JN, 2013, LEARN MEMORY, V20, P670, DOI 10.1101/lm.032839.113; Owonikoko TK, 2013, ASCO AM SOC CLIN ONC; Parada LF, 2012, CURR OPIN NEUROBIOL; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Stoevesandt O, 2013, NAT BIOTECHNOL, V31, P889, DOI 10.1038/nbt.2712; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x	25	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143134	10.1371/journal.pone.0143134	http://dx.doi.org/10.1371/journal.pone.0143134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580204	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600088
J	Bonnevie, ED; Galesso, D; Secchieri, C; Cohen, I; Bonassar, LJ				Bonnevie, Edward D.; Galesso, Devis; Secchieri, Cynthia; Cohen, Itai; Bonassar, Lawrence J.			Elastoviscous Transitions of Articular Cartilage Reveal a Mechanism of Synergy between Lubricin and Hyaluronic Acid	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURIZATION; BOUNDARY-LUBRICATING ABILITY; SYNOVIAL-FLUID; RECOMBINANT LUBRICIN; PROTEOGLYCAN 4; CONTACT AREA; LOW-FRICTION; OSTEOARTHRITIS; PREVENTION; SURFACES	When lubricated by synovial fluid, articular cartilage provides some of the lowest friction coefficients found in nature. While it is known that macromolecular constituents of synovial fluid provide it with its lubricating ability, it is not fully understood how two of the main molecules, lubricin and hyaluronic acid, lubricate and interact with one another. Here, we develop a novel framework for cartilage lubrication based on the elastoviscous transition to show that lubricin and hyaluronic acid lubricate by distinct mechanisms. Such analysis revealed nonspecific interactions between these molecules in which lubricin acts to concentrate hyaluronic acid near the tissue surface and promotes a transition to a low friction regime consistent with the theory of viscous boundary lubrication. Understanding the mechanics of synovial fluid not only provides insight into the progression of diseases such as arthritis, but also may be applicable to the development of new biomimetic lubricants.	[Bonnevie, Edward D.; Bonassar, Lawrence J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Galesso, Devis; Secchieri, Cynthia] Fidia Farmaceut SpA, Dept Res & Dev, Padua, Italy; [Cohen, Itai] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Bonassar, Lawrence J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA	Cornell University; Cornell University; Cornell University	Bonassar, LJ (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	lb244@cornell.edu	Bonassar, Lawrence J/C-2103-2016	Bonassar, Lawrence J/0000-0003-1094-6433; Galesso, Devis/0000-0002-1193-8067; Cohen, Itai/0000-0001-9218-043X	National Science Foundation; Fidia Farmaceutici SpA; National Science Foundation [DMR-1056662]; NSF MRSEC program [DMR-1120296]; National Institutes of Health [1S10RR025502-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025502] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Fidia Farmaceutici SpA; National Science Foundation(National Science Foundation (NSF)); NSF MRSEC program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by the National Science Foundation Graduate Research Fellowship Program (EDB) and Fidia Farmaceutici SpA and partially supported by the National Science Foundation under award No. DMR-1056662 (IC). Facilities and instruments used in this study were also supported by the NSF MRSEC program (DMR-1120296), and the National Institutes of Health (1S10RR025502-01). Coauthors Galesso and Secchieri are employees of Fidia Farmaceutici SpA and were involved in experimental design, material preparation, and manuscript preparation.	Abubacker S, 2016, ANN BIOMED ENG, V44, P1128, DOI 10.1007/s10439-015-1390-8; Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040; BALAZS EA, 1993, J RHEUMATOL, V20, P3; BALAZS EA, 1967, ARTHRITIS RHEUM, V10, P357, DOI 10.1002/art.1780100407; Banquy X, 2014, ADV FUNCT MATER, V24, P3152, DOI 10.1002/adfm.201302959; Bonnevie ED, 2012, J BIOMECH, V45, P1036, DOI 10.1016/j.jbiomech.2011.12.019; Bonnevie ED, 2011, TRIBOL LETT, V41, P83, DOI 10.1007/s11249-010-9687-0; Bonnevie ED, 2014, J BIOMECH, V47, P2183, DOI 10.1016/j.jbiomech.2013.10.028; Burris DL, 2009, TRIBOL LETT, V35, P17, DOI 10.1007/s11249-009-9438-2; Caligaris M, 2008, OSTEOARTHR CARTILAGE, V16, P1220, DOI 10.1016/j.joca.2008.02.020; Cui Z, 2015, BONE, V74, P37, DOI 10.1016/j.bone.2014.12.065; Das S, 2013, BIOMACROMOLECULES, V14, P1669, DOI 10.1021/bm400327a; Dunn AC, 2014, TRIBOL LETT, V54, P59, DOI 10.1007/s11249-014-0308-1; Elsaid KA, 2005, ARTHRITIS RHEUM-US, V52, P1746, DOI 10.1002/art.21038; Finelli I, 2011, BIORHEOLOGY, V48, P263, DOI 10.3233/BIR-2011-0596; Finelli I, 2009, MACROMOL BIOSCI, V9, P646, DOI 10.1002/mabi.200900009; Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304; GIBBS DA, 1968, BIOPOLYMERS, V6, P777, DOI 10.1002/bip.1968.360060603; Gleghorn JP, 2008, J BIOMECH, V41, P1910, DOI 10.1016/j.jbiomech.2008.03.043; Gleghorn JP, 2009, J ORTHOP RES, V27, P771, DOI 10.1002/jor.20798; Greene GW, 2011, P NATL ACAD SCI USA, V108, P5255, DOI 10.1073/pnas.1101002108; Hersey MD, 1914, J WASH ACAD SCI, V4, P542; Hyun K, 2002, J NON-NEWTON FLUID, V107, P51, DOI 10.1016/S0377-0257(02)00141-6; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Jay GD, 1998, J BIOMED MATER RES, V40, P414, DOI 10.1002/(SICI)1097-4636(19980605)40:3<414::AID-JBM11>3.0.CO;2-J; Jay GD, 2009, CHARACTERIZATION BOV; Jay GD, 2009, CHEM SERFACE ACTIVIT; Jay GD, 2007, ARTHRITIS RHEUM-US, V56, P3662, DOI 10.1002/art.22974; Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550; Jones ARC, 2007, J ORTHOP RES, V25, P283, DOI 10.1002/jor.20325; Krishnan R, 2004, J ORTHOP RES, V22, P565, DOI 10.1016/j.orthres.2003.07.002; Kwiecinski JJ, 2011, OSTEOARTHR CARTILAGE, V19, P1356, DOI 10.1016/j.joca.2011.07.019; LAI WM, 1978, J BIOMECH ENG-T ASME, V100, P169, DOI 10.1115/1.3426208; LINN F C, 1968, Journal of Biomechanics, V1, P193, DOI 10.1016/0021-9290(68)90004-3; Majd SE, 2014, LANGMUIR, V30, P14566, DOI 10.1021/la504345c; McCutchen C. W., 1962, WEAR, V5, P1, DOI [10.1016/0043-1648(62)90176-X, DOI 10.1016/0043-1648(62)90176-X]; Park JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112684; RAGAN C, 1949, J CLIN INVEST, V28, P56, DOI 10.1172/JCI102053; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; SWANN DA, 1974, ANN RHEUM DIS, V33, P318, DOI 10.1136/ard.33.4.318; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; Teeple E, 2011, AM J SPORT MED, V39, P164, DOI 10.1177/0363546510378088; Unsworth A, 1991, Proc Inst Mech Eng H, V205, P163, DOI 10.1243/PIME_PROC_1991_205_287_02; Waller KA, 2013, P NATL ACAD SCI USA, V110, P5852, DOI 10.1073/pnas.1219289110; Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005; Worden K, 2007, MECH SYST SIGNAL PR, V21, P514, DOI 10.1016/j.ymssp.2005.09.004; Yakubov GE, 2009, LANGMUIR, V25, P2313, DOI 10.1021/la8018666	47	80	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143415	10.1371/journal.pone.0143415	http://dx.doi.org/10.1371/journal.pone.0143415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599797	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600063
J	Johansson, A; Alfredsson, J; Eriksson, N; Wallentin, L; Siegbahn, A				Johansson, Asa; Alfredsson, Jenny; Eriksson, Niclas; Wallentin, Lars; Siegbahn, Agneta			Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							ARTERY-DISEASE; LINKAGE PHASE; INFLAMMATION; DETERMINANT; INFARCTION; OUTCOMES; TRAITS; TESTS; SERUM	Introduction Acute coronary syndrome (ACS) is a major cause of mortality worldwide. We have previously shown that increased interleukin-10 (IL-10) levels are associated with poor outcome in ACS patients. Method We performed a genome-wide association study in 2864 ACS patients and 408 healthy controls, to identify genetic variants associated with IL-10 levels. Then haplotype analyses of the identified loci were done and comparisons to levels of IL-10 and other known ACS related biomarkers. Results Genetic variants at the ABO blood group locus associated with IL-10 levels (top SNP: rs676457, P = 4.4 x 10(-10)) were identified in the ACS patients. Haplotype analysis, using SNPs tagging the four main ABO antigens (A1, A2, B and O), showed that O and A2 homozygous individuals, or O/A2 heterozygotes have much higher levels of IL-10 compared to individuals with other antigen combinations. In the ACS patients, associations between ABO antigens and von Willebrand factor (VWF, P = 9.2 x 10(-13)), and soluble tissue factor (sTF, P = 8.6 x 10(-4)) were also found. In the healthy control cohort, the associations with VWF and sTF were similar to those in ACS patients (P = 1.2 x 10(-15) and P = 1.0 x 10(-5) respectively), but the healthy cohort showed no association with IL-10 levels (P>0.05). In the ACS patients, the O antigen was also associated with an increased risk of cardiovascular death, all causes of death, and recurrent myocardial infarction (odds ratio [OR] = 1.24-1.29, P = 0.029-0.00067). Conclusion Our results suggest that the ABO antigens play important roles, not only for the immunological response in ACS patients, but also for the outcome of the disease.	[Johansson, Asa] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Eriksson, Niclas; Wallentin, Lars; Siegbahn, Agneta] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Alfredsson, Jenny; Siegbahn, Agneta] Uppsala Univ, Clin Chem, Dept Med Sci, Uppsala, Sweden; [Alfredsson, Jenny; Siegbahn, Agneta] Uppsala Univ, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	Johansson, A (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	asa.johansson@igp.uu.se	Johansson, Åsa/AAG-6799-2021; Johansson, Åsa/G-5270-2011	Johansson, Åsa/0000-0002-2915-4498; Johansson, Åsa/0000-0002-2915-4498	Swedish Research Council; Swedish Heart and Lung foundation; Goran Gustafssons Foundation; Swedish Society for Medical Research (SSMF); Kjell och Marta Beijers Foundation; Marcus Borgstrom Foundation; Ake Wiberg Foundation; Vleugels Foundation; Uppsala University; Swedish Research Council (VR-RFI) [80576801, 70374401]; Science for Life Laboratory-Sweden (SciLifeLab)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); Goran Gustafssons Foundation; Swedish Society for Medical Research (SSMF); Kjell och Marta Beijers Foundation; Marcus Borgstrom Foundation; Ake Wiberg Foundation; Vleugels Foundation; Uppsala University; Swedish Research Council (VR-RFI)(Swedish Research Council); Science for Life Laboratory-Sweden (SciLifeLab)	This study was supported by grants from the Swedish Research Council and the Swedish Heart and Lung foundation (AS). AJ is funded by the Swedish research council, the Goran Gustafssons Foundation, the Swedish Society for Medical Research (SSMF), the Kjell och Marta Beijers Foundation, the Marcus Borgstrom Foundation, the Ake Wiberg Foundation and the Vleugels Foundation.; Genotyping was performed by the SNP & SEQ Technology Platform in Uppsala, which is supported by Uppsala University, Science for Life Laboratory-Sweden (SciLifeLab) and the Swedish Research Council (VR-RFI, Contracts 80576801 and 70374401).	Alkout AM, 2000, J INFECT DIS, V181, P1364, DOI 10.1086/315375; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Dean L., 2005, BLOOD CELLS IT CONTA; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; GILL JC, 1987, BLOOD, V69, P1691; Goh L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-415; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; Hosoi E, 2008, J MED INVESTIG, V55, P174, DOI 10.2152/jmi.55.174; James SK, 2005, AM HEART J, V149, P619, DOI 10.1016/j.ahj.2004.08.026; Januszkiewicz L, 2013, POL ARCH MED WEWN, V123, P460; Johnston N, 2006, AM J CARDIOL, V97, P640, DOI 10.1016/j.amjcard.2005.09.123; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Malarstig A, 2008, HEART, V94, P724, DOI 10.1136/hrt.2007.119271; Malarstig A, 2007, THROMB RES, V119, P467, DOI 10.1016/j.thromres.2006.05.001; Malarstig A, 2006, ARTERIOSCL THROM VAS, V26, P1667, DOI 10.1161/01.ATV.0000222908.78873.36; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; O'Donnell J, 2002, ARTERIOSCL THROM VAS, V22, P335, DOI 10.1161/hq0202.103997; O'Donnell J, 2001, TRANSFUSION MED, V11, P343, DOI 10.1046/j.1365-3148.2001.00315.x; Oldgren J, 2005, J INTERN MED, V258, P420, DOI 10.1111/j.1365-2796.2005.01562.x; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000118; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sarode R, 2000, BRIT J HAEMATOL, V109, P857, DOI 10.1046/j.1365-2141.2000.02113.x; SCHACHTER H, 1971, BIOCHEM BIOPH RES CO, V45, P1011, DOI 10.1016/0006-291X(71)90438-4; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Storry J R, 2009, Immunohematology, V25, P48; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 1999, LANCET, V354, P701; Wolpin BM, 2010, THROMB HAEMOSTASIS, V104, P962, DOI 10.1160/TH10-05-0312	35	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142518	10.1371/journal.pone.0142518	http://dx.doi.org/10.1371/journal.pone.0142518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600159	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600012
J	Jung, M; Mody, M; Saito, DN; Tomoda, A; Okazawa, H; Wada, Y; Kosaka, H				Jung, Minyoung; Mody, Maria; Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka			Sex Differences in the Default Mode Network with Regard to Autism Spectrum Traits: A Resting State fMRI Study	PLOS ONE			English	Article							LOW-FREQUENCY OSCILLATIONS; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; QUOTIENT AQ; GENDER-DIFFERENCES; AMPLITUDE; SCHIZOPHRENIA; ACTIVATION; MOTION; CORTEX	Autism spectrum traits exist on a continuum and are more common in males than in females, but the basis for this sex difference is unclear. To this end, the present study draws on the extreme male brain theory, investigating the relationship between sex difference and the default mode network (DMN), both known to be associated with autism spectrum traits. Resting-state functional magnetic resonance imaging (MRI) was carried out in 42 females (mean age +/- standard deviation, 22.4 +/- 4.2 years) and 43 males (mean age +/- standard deviation, 23.8 +/- 3.9 years) with typical development. Using a combination of different analyses (viz., independent component analysis (ICA), fractional amplitude of low-frequency fluctuation (fALFF), regional homogeneity (ReHo), and seed-based analyses), we examined sex differences in the DMN and the relationship to autism spectrum traits as measured by autism-spectrum quotient (AQ) scores. We found significant differences between female and male subjects in DMN brain regions, with seed-based analysis revealing a significant negative correlation between default-mode resting state functional connectivity of the anterior medial prefrontal cortex seed (aMPFC) and AQ scores in males. However, there were no relationships between DMN sex differences and autism spectrum traits in females. Our findings may provide important insight into the skewed balance of functional connectivity in males compared to females that could serve as a potential biomarker of the degree of autism spectrum traits in line with the extreme male brain theory.	[Jung, Minyoung; Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Univ Fukui, Res Ctr Child Mental Dev, Eiheiji, Fukui, Japan; [Jung, Minyoung; Mody, Maria] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Osaka Univ, United Grad Sch Child Dev, Dept Child Dev, Dev Emot Intelligence,Div Dev Higher Brain Funct, Eiheiji, Fukui, Japan; [Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Kanazawa Univ, Eiheiji, Fukui, Japan; [Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Hamamatsu Univ Sch Med, Eiheiji, Fukui, Japan; [Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Chiba Univ, Eiheiji, Fukui, Japan; [Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Univ Fukui, Eiheiji, Fukui, Japan; [Saito, Daisuke N.; Okazawa, Hidehiko] Univ Fukui, Biomed Imaging Res Ctr, Eiheiji, Fukui, Japan; [Wada, Yuji; Kosaka, Hirotaka] Univ Fukui, Fac Med Sci, Dept Neuropsychiat, Eiheiji, Fukui, Japan	University of Fukui; Harvard University; Massachusetts General Hospital; Osaka University; University of Fukui; University of Fukui; University of Fukui	Kosaka, H (corresponding author), Univ Fukui, Res Ctr Child Mental Dev, Eiheiji, Fukui, Japan.	hirotaka@u-fukui.ac.jp	Okazawa, Hidehiko/B-2795-2016; Okazawa, Hidehiko/I-2488-2019; Kosaka, Hirotaka/AFG-5500-2022; Mody, Maria/Q-6662-2017	Okazawa, Hidehiko/0000-0001-7046-3383; Okazawa, Hidehiko/0000-0001-7046-3383; Kosaka, Hirotaka/0000-0003-2210-5025; Jung, Minyoung/0000-0001-9188-0549	Japan Society for the Promotion of Science [26118505]; Grants-in-Aid for Scientific Research [26118505, 15K12720] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded in part by Research Fellowships for Young Scientists and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (26118505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003622; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0102251; Baron-cohen S, 2004, THE EMPATHY QUOTIENT; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Constantino JN, 2003, J AM ACAD CHILD PSY, V42, P458, DOI 10.1097/01.CHI.0000046811.95464.21; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Di Martino A, 2013, BIOL PSYCHIAT, V74, P623, DOI 10.1016/j.biopsych.2013.02.011; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Falquez R, 2014, FRONT BEHAV NEUROSCI, V8, P1, DOI 10.3389/fnbeh.2014.00165; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frith U., 1991, AUTISM ASPERGER SYND; Fujisawa TX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136427; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hadjikhani N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.113; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Hong JY, 2013, J NEUROSCI, V33, P11994, DOI 10.1523/JNEUROSCI.5733-12.2013; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Inuggi A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00156; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Jung M, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-35; Kirkovski M, 2013, J AUTISM DEV DISORD, V43, P2584, DOI 10.1007/s10803-013-1811-1; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; Lai CH, 2012, J AFFECT DISORDERS, V142, P180, DOI 10.1016/j.jad.2012.04.021; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Lai MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001544; Lee MR, 2014, NEUROPSYCHOLOGIA, V53, P257, DOI 10.1016/j.neuropsychologia.2013.11.022; Libero LE, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-50; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rudie JD, 2012, NEURON, V75, P904, DOI 10.1016/j.neuron.2012.07.010; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shukla DK, 2010, NEUROSCI LETT, V476, P46, DOI 10.1016/j.neulet.2010.03.080; Skuse DH, 2000, PEDIATR RES, V47, P9, DOI 10.1203/00006450-200001000-00006; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Wijngaarden-Cremers PJM, 2014, J AUTISM DEV DISORD, V44, P627, DOI 10.1007/s10803-013-1913-9; von dem Hagen EAH, 2013, SOC COGN AFFECT NEUR, V8, P694, DOI 10.1093/scan/nss053; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Wang LQ, 2011, NEUROSCI LETT, V488, P275, DOI 10.1016/j.neulet.2010.11.046; Weissman-Fogel I, 2010, HUM BRAIN MAPP, V31, P1713, DOI 10.1002/hbm.20968; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	71	22	24	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143126	10.1371/journal.pone.0143126	http://dx.doi.org/10.1371/journal.pone.0143126			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600385	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600030
J	Tang, YF; Zhang, C; Cao, SX; Wang, X; Qi, HY				Tang, Yufan; Zhang, Chong; Cao, Songxiao; Wang, Xiao; Qi, Hongyan			The Effect of CmLOXs on the Production of Volatile Organic Compounds in Four Aroma Types of Melon (Cucumis melo)	PLOS ONE			English	Article							LIPOXYGENASE GENE-EXPRESSION; SOLID-PHASE MICROEXTRACTION; VAR. MAKUWA MAKINO; MALUS X DOMESTICA; ETHYLENE BIOSYNTHESIS; RIPENING KIWIFRUIT; FLAVOR COMPOUNDS; BRANCHED-CHAIN; FUJI APPLES; FRUIT	Lipoxygenases (LOXs) play important role in the synthesis of volatile organic compounds (VOCs), which influence the aroma of fruit. In this study, we elucidate that there is a positive relationship between LOXs activity and VOC production in melon (Cucumis melo), and CmLOX genes are involved in fruit aroma generation in melon. To this end, we tested four aroma types of melon that feature a thin pericarp: two aromatic cultivars of the oriental melons (C. melo var. makuwa Makino), 'Yu Meiren' (YMR) and 'Cui Bao' (CB); a non-aromatic oriental pickling melon (C. melo var. conomon), 'Shao Gua' (SHAO); and a non-aromatic snake melon (C. melo L. var. flexuosus Naud), 'Cai Gua' (CAI). A principal component analysis (PCA) revealed that the aromas of SHAO and CAI are similar in nature because their ester contents are lower than those of YMR and CB. Ethyl acetate, benzyl acetate, (E, Z)-2, 6-nonadienal and menthol are four principal volatile compounds that affect the aromatic characteristics of these four types of melons. The LOX activity and total ester content in YMR were the highest among the examined melon varieties. The expression patterns of 18 CmLOX genes were found to vary based on the aromatic nature of the melon. Four of them were highly expressed in YMR. Moreover, we treated the fruit disks of YMR with LOX substrates (linoleic acid and linolenic acid) and LOX inhibitors (n-propyl gallate and nordihydroguariaretic acid). Substrate application promoted LOX activity and induced accumulation of hexanal, (2E)-nonenal and straight-chain esters, such as ethyl acetate. In contrast, LOX inhibitors decreased the levels of these compounds. The effect of CmLOXs in the biosynthesis of esters in melons are discussed.	[Tang, Yufan; Zhang, Chong; Cao, Songxiao; Wang, Xiao; Qi, Hongyan] Shenyang Agr Univ, Coll Hort, Key Lab Protected Hort, Minist Educ & Liaoning Prov, Shenyang 110161, Liaoning Provin, Peoples R China	Shenyang Agricultural University	Qi, HY (corresponding author), Shenyang Agr Univ, Coll Hort, Shenyang 110161, Liaoning Provin, Peoples R China.	hyqiaaa@126.com			National Natural Science Foundation of China [31272154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (31272154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmann S, 2010, PLANT CELL ENVIRON, V33, P2028, DOI 10.1111/j.1365-3040.2010.02203.x; Altisent R, 2009, J AGR FOOD CHEM, V57, P4305, DOI 10.1021/jf803930j; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Araguez I, 2013, BIOTECHNOL J, V8, P1144, DOI 10.1002/biot.201300113; Aubert C, 2004, J AGR FOOD CHEM, V52, P4522, DOI 10.1021/jf049777s; Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; Baysal T, 2007, ENZYME MICROB TECH, V40, P491, DOI 10.1016/j.enzmictec.2006.11.025; Beaulieu JC, 2001, J AGR FOOD CHEM, V49, P1345, DOI 10.1021/jf0005768; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burger Y, 2006, ISR J PLANT SCI, V54, P233, DOI 10.1560/IJPS_54_3_233; Gonzalez-Mas MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022016; Chen GP, 2004, PLANT PHYSIOL, V136, P2641, DOI 10.1104/pp.104.041608; Cheong KW, 2010, FOOD RES INT, V43, P1267, DOI 10.1016/j.foodres.2010.03.001; Defilippi BG, 2005, J AGR FOOD CHEM, V53, P3133, DOI 10.1021/jf047892x; Dixon J, 2000, NEW ZEAL J CROP HORT, V28, P155, DOI 10.1080/01140671.2000.9514136; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; Dunemann F, 2012, MOL BREEDING, V29, P609, DOI 10.1007/s11032-011-9577-7; Echeverria G, 2004, POSTHARVEST BIOL TEC, V31, P217, DOI 10.1016/j.postharvbio.2003.09.003; El Hadi MAM, 2013, MOLECULES, V18, P8200, DOI 10.3390/molecules18078200; El-Sharkawy I, 2005, PLANT MOL BIOL, V59, P345, DOI 10.1007/s11103-005-8884-y; Ezura H, 2008, PLANT SCI, V175, P121, DOI 10.1016/j.plantsci.2008.02.004; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Golding JB, 1999, J AGR FOOD CHEM, V47, P1646, DOI 10.1021/jf980906c; Gonda I, 2010, J EXP BOT, V61, P1111, DOI 10.1093/jxb/erp390; Jin YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101730; Jordan MJ, 2001, J AGR FOOD CHEM, V49, P5929, DOI 10.1021/jf010954o; Khanom MM, 2008, POSTHARVEST BIOL TEC, V50, P18, DOI 10.1016/j.postharvbio.2008.02.015; Kourkoutas D, 2006, FOOD CHEM, V97, P95, DOI 10.1016/j.foodchem.2005.03.026; Kunsong C, 2003, J FRUIT SCI, V6, P002; Lalel HJD, 2003, POSTHARVEST BIOL TEC, V27, P323, DOI 10.1016/S0925-5214(02)00117-5; Lara I, 2006, POSTHARVEST BIOL TEC, V39, P19, DOI 10.1016/j.postharvbio.2005.09.001; Lara I, 2003, POSTHARVEST BIOL TEC, V29, P29, DOI 10.1016/S0925-5214(02)00230-2; Li M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-444; Li Y, 2011, J HORTIC SCI BIOTECH, V86, P517, DOI 10.1080/14620316.2011.11512798; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Liu WW, 2012, POSTHARVEST BIOL TEC, V67, P75, DOI 10.1016/j.postharvbio.2011.12.015; Ma YK, 2007, FOOD SCI TECHNOL INT, V13, P259, DOI 10.1177/1082013207081776; Mandal S, 2014, FOOD CHEM, V146, P394, DOI 10.1016/j.foodchem.2013.08.100; Manriquez D, 2006, PLANT MOL BIOL, V61, P675, DOI 10.1007/s11103-006-0040-9; Maul F, 2000, J FOOD SCI, V65, P1228, DOI 10.1111/j.1365-2621.2000.tb10270.x; Obando-Ulloa JM, 2008, POSTHARVEST BIOL TEC, V49, P27, DOI 10.1016/j.postharvbio.2007.11.004; Obando-Ulloa JM, 2010, FOOD CHEM, V118, P815, DOI 10.1016/j.foodchem.2009.05.068; Oliveira I, 2011, FOOD CHEM, V128, P667, DOI 10.1016/j.foodchem.2011.03.084; Ortiz A, 2010, FOOD CHEM, V123, P698, DOI 10.1016/j.foodchem.2010.05.037; Perry PL, 2009, FLAVOUR FRAG J, V24, P341, DOI 10.1002/ffj.1947; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Portnoy V, 2008, PLANT MOL BIOL, V66, P647, DOI 10.1007/s11103-008-9296-6; Rowan DD, 2009, J AGR FOOD CHEM, V57, P7953, DOI 10.1021/jf901678v; Sanchez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038992; Sanz C, 1996, AROMA BIOCH FRUITS V, P125; Senesi E, 2002, J SCI FOOD AGR, V82, P655, DOI 10.1002/jsfa.1087; Shalit M, 2001, J AGR FOOD CHEM, V49, P794, DOI 10.1021/jf001075p; Shalit M, 2000, ACTA HORTIC, P455, DOI 10.17660/ActaHortic.2000.510.72; Song J, 2003, POSTHARVEST BIOL TEC, V30, P113, DOI 10.1016/S0925-5214(03)00098-X; Ties P, 2012, J FOOD SCI, V77, pC830, DOI 10.1111/j.1750-3841.2012.02775.x; Tijet N, 2001, ARCH BIOCHEM BIOPHYS, V386, P281, DOI 10.1006/abbi.2000.2218; Tijskens LMM, 2009, POSTHARVEST BIOL TEC, V51, P320, DOI 10.1016/j.postharvbio.2008.06.001; Umate P, 2011, PLANT SIGNAL BEHAV, V6, P335, DOI 10.4161/psb.6.3.13546; Urruty L, 2002, J AGR FOOD CHEM, V50, P3129, DOI 10.1021/jf0116799; Visai C, 1997, SCI HORTIC-AMSTERDAM, V70, P15, DOI 10.1016/S0304-4238(97)00032-0; Vogt J, 2013, TREE GENET GENOMES, V9, P1493, DOI 10.1007/s11295-013-0653-5; Wyllie SG, 2000, J AGR FOOD CHEM, V48, P3493, DOI 10.1021/jf0001841; Zhang B, 2006, J EXP BOT, V57, P3825, DOI 10.1093/jxb/erl151; Zhang B, 2010, J AGR FOOD CHEM, V58, P6157, DOI 10.1021/jf100172e; Zhang B, 2009, J AM SOC HORTIC SCI, V134, P472, DOI 10.21273/JASHS.134.4.472; Zhang B, 2009, J AGR FOOD CHEM, V57, P2875, DOI 10.1021/jf9000378; Zhang C, 2014, SCI HORTIC-AMSTERDAM, V170, P94, DOI 10.1016/j.scienta.2014.03.005; Zhu SH, 2006, POSTHARVEST BIOL TEC, V42, P41, DOI 10.1016/j.postharvbio.2006.05.004	69	23	26	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143567	10.1371/journal.pone.0143567	http://dx.doi.org/10.1371/journal.pone.0143567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599669	Green Submitted, gold, Green Published			2022-12-27	WOS:000365862600086
J	Tedeschi, LO				Tedeschi, Luis O.			Integrating Genomics with Nutrition Models to Improve the Prediction of Cattle Performance and Carcass Composition under Feedlot Conditions	PLOS ONE			English	Article							4 SIMULATION-MODELS; BEEF-CATTLE; BODY-COMPOSITION; DYNAMIC-MODEL; COMPUTER-MODEL; LEPTIN GENE; GROWTH; ASSOCIATION; QUALITY; EFFICIENCY	Cattle body composition is difficult to model because several factors affect the composition of the average daily gain (ADG) of growing animals. The objective of this study was to identify commercial single nucleotide polymorphism (SNP) panels that could improve the predictability of days on feed (DOF) to reach a target United States Department of Agriculture (USDA) grade given animal, diet, and environmental information under feedyard conditions. The data for this study was comprised of crossbred heifers (n = 681) and steers (n = 836) from commercial feedyards. Eleven molecular breeding value (MBV) scores derived from SNP panels of candidate gene polymorphisms and two-leptin gene SNP (UASMS2 and E2FB) were evaluated. The empty body fat (EBF) and the shrunk body weight (SBW) at 28% EBF (AFSBW) were computed by the Cattle Value Discovery System (CVDS) model using hip height (EBFHH and AFSBW(HH)) or carcass traits (EBFCT and AFSBW(CT)) of the animals. The DOFHH was calculated when AFSBW(HH) and ADG(HH) were used and DOFCT was calculated when AFSBW(CT) and ADG(CT) were used. The CVDS estimates dry matter required (DMR) by individuals fed in groups when observed ADG and AFSBW are provided. The AFSBW(CT) was assumed more accurate than the AFSBW(HH) because it was computed using carcass traits. The difference between AFSBW(CT) and AFSBW(HH), DOFCT and DOFHH, and DMR and dry matter intake (DMI) were regressed on the MBV scores and leptin gene SNP to explain the variation. Our results indicate quite a large range of correlations among MBV scores and model input and output variables, but MBV ribeye area was the most strongly correlated with the differences in DOF, AFSBW, and DMI by explaining 8, 13.2 and 6.5%, respectively, of the variation. This suggests that specific MBV scores might explain additional variation of input and output variables used by nutritional models in predicting individual animal performance.	[Tedeschi, Luis O.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Tedeschi, LO (corresponding author), Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.	luis.tedeschi@tamu.edu			Texas A&M AgriLife Research [Hatch 09123]	Texas A&M AgriLife Research	This work was supported by Texas A&M AgriLife Research Hatch 09123.	Anele UY, 2014, J ANIM SCI, V92, P2660, DOI 10.2527/jas.2014-7557; [Anonymous], 2014, R LANG ENV STAT COMP; ARNOLD RN, 1991, AGR SYST, V35, P401, DOI 10.1016/0308-521X(91)90117-S; ARNOLD RN, 1991, AGR SYST, V36, P17, DOI 10.1016/0308-521X(91)90106-K; Baker MJ, 2006, J ANIM SCI, V84, P2666, DOI 10.2527/jas.2006-006; Beef Improvement Federation, 2010, GUIDELINES UNIFORM B, V9, P1; Bibby J., 1977, PREDICTION IMPROVED; Bourg B, 2007, P 2 INT S EN PROT ME; Bourg BM., 2007, THESIS; Buchanan FC, 2002, GENET SEL EVOL, V34, P105, DOI [10.1051/gse:2001006, 10.1186/1297-9686-34-1-105]; Cruz GD, 2011, J ANIM SCI, V89, P1640, DOI 10.2527/jas.2010-3416; Davidson A.C., 1997, BOOTSTRAP METHODS TH; DeVuyst EA, 2011, J ANIM SCI, V89, P1260, DOI 10.2527/jas.2009-2372; DIMARCO ON, 1989, AGR SYST, V29, P247, DOI 10.1016/0308-521X(89)90055-3; Efron B, 1998, INTRO BOOTSTRAP; Federation of Animal Science Societies, 2010, GUID CAR US AGR AN R; FOX DG, 1984, J ANIM SCI, V58, P725, DOI 10.2527/jas1984.583725x; FOX DG, 1988, J ANIM SCI, V66, P1475; Fox DG, 2004, ANIM FEED SCI TECH, V112, P29, DOI 10.1016/j.anifeedsci.2003.10.006; Garrett WN, 1978, J ANIM SCI S1, V47, P417; Greenwood PL, 2013, J ANIM SCI, V91, P5912, DOI 10.2527/jas.2013-6960; Guiroy PJ, 2001, J ANIM SCI, V79, P1983; Hoch T, 2004, AGR SYST, V81, P1, DOI 10.1016/j.agsy.2003.08.005; Kachman SD, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-30; KEELE JW, 1992, J ANIM SCI, V70, P841, DOI 10.2527/1992.703841x; Khatib H, 2009, J DAIRY SCI, V92, P6186, DOI 10.3168/jds.2009-2439; Kilpatrick DJ, 1999, AGR SYST, V61, P95, DOI 10.1016/S0308-521X(99)00040-2; Kirschten DP, 2006, P JOINT ANN M AM SOC; Kirschten DP, 2007, P JOINT ANN M AM SOC; Kononoff PJ, 2005, J ANIM SCI, V83, P927; Lancaster PA, 2009, J ANIM SCI, V87, P3887, DOI 10.2527/jas.2009-2041; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lusk JL, 2007, J ANIM SCI, V85, pCP6, DOI 10.2527/jas.2006-665; MacNeil MD, 2010, J ANIM SCI, V88, P517, DOI 10.2527/jas.2009-2022; Moore MC, 2012, J ANIM SCI, V90, P5143, DOI 10.2527/jas.2012-5550; National Research Council, 2000, NUTR REQ BEEF CATTL; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; Nkrumah JD, 2009, P JOINT ANN M AM SOC; OLTJEN JW, 1986, J ANIM SCI, V62, P86, DOI 10.2527/jas1986.62186x; Rincon G, 2009, ANIM GENET, V40, P878, DOI 10.1111/j.1365-2052.2009.01934.x; Schenkel FS, 2005, J ANIM SCI, V83, P2009; Sharma A, 2015, ASIAN AUSTRAL J ANIM, V28, P1371, DOI 10.5713/ajas.14.0715; Tedeschi LO, 2010, MODELLING NUTRIENT DIGESTION AND UTILISATION IN FARM ANIMALS, P91; Tedeschi LO, 2006, AGR SYST, V89, P225, DOI 10.1016/j.agsy.2005.11.004; Tedeschi LO, 2006, J ANIM SCI, V84, P767, DOI 10.2527/2006.843767x; Tedeschi LO, 2004, AGR SYST, V79, P171, DOI 10.1016/S0308-521X(03)00070-2; Tedeschi LO, 2010, P 3 INT S EN PROT ME; Tedford JL, 2014, J ANIM SCI, V92, P3685, DOI 10.2527/jas.2014-7739; Vasconcelos JT, 2007, J ANIM SCI, V85, P2772, DOI 10.2527/jas.2007-0261; Vasconcelos J. T., 2007, Professional Animal Scientist, V23, P340; Wang YP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002459; Williams CB, 2010, J ANIM SCI, V88, P2523, DOI 10.2527/jas.2009-2655; Williams CB, 2006, J ANIM SCI, V84, P1310, DOI 10.2527/2006.8461310x; WILLIAMS CB, 1995, J ANIM SCI, V73, P2903; Woronuk GN, 2012, ANIM GENET, V43, P608, DOI 10.1111/j.1365-2052.2012.02320.x	55	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143483	10.1371/journal.pone.0143483	http://dx.doi.org/10.1371/journal.pone.0143483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599759	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600070
J	Yue, YP; Huang, W; Liang, JJ; Guo, J; Ji, J; Yao, YL; Zheng, MZ; Cai, ZJ; Lu, LR; Wang, JL				Yue, Yinpu; Huang, Wei; Liang, Jingjing; Guo, Jing; Ji, Jian; Yao, Yunliang; Zheng, Mingzhu; Cai, Zhijian; Lu, Linrong; Wang, Jianli			IL4I1 Is a Novel Regulator of M2 Macrophage Polarization That Can Inhibit T Cell Activation via L-Tryptophan and Arginine Depletion and IL-10 Production	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; MONONUCLEAR PHAGOCYTES; ALTERNATIVE ACTIVATION; IL-4-INDUCED GENE-1; DENDRITIC CELLS; IN-VIVO; PROLIFERATION; STAT6; INFECTIONS; CATABOLISM	Interleukin 4-induced gene-1 (IL4I1) was initially described as an early IL-4-inducible gene in B cells. IL4I1 protein can inhibit T cell proliferation by releasing its enzymatic catabolite, H2O2, and this effect is associated with transient down-regulation of T cell CD3 receptor-zeta (TCR zeta) expression. Herein, we show that IL4I1 contributes to the regulation of macrophage programming. We found that expression of IL4I1 increased during bone marrow-derived macrophage (BMDM) differentiation, expression of IL4I1 is much higher in primary macrophages than monocytes, and IL4I1 expression in BMDMs could be induced by Th1 and Th2 cytokines in two different patterns. Gene expression analysis revealed that overexpression of IL4I1 drove the expression of M2 markers (Fizz1, Arg1, YM-1, MR) and inhibited the expression of M1-associated cytokines. Conversely, knockdown of IL4I1 by siRNA resulted in opposite effects, and also attenuated STAT-3 and STAT-6 phosphorylation. Furthermore, IL4I1 produced by macrophages catalyzed L-tryptophan degradation, while levo-1-methyl-tryptophan (L-1-MT), but not dextro-1-methyl-tryptophan, partially rescued IL4I1-dependent inhibition of T cell activation. Other inhibitors, such as diphenylene iodonium (DPI), an anti-IL-10Ra blocking antibody, and a nitric oxide synthase inhibitor, NG-monomethyl-L-arginine, also had this effect. Overall, our findings indicate that IL4I1 promotes an enhanced M2 functional phenotype, which is most likely associated with the phosphorylation of STAT-6 and STAT-3. Moreover, DPI, L-1-MT, NG-monomethyl-L-arginine, and anti-IL-10Ra blocking antibody were all found to be effective IL4I1 inhibitors in vitro.	[Yue, Yinpu; Huang, Wei; Liang, Jingjing; Guo, Jing; Yao, Yunliang; Zheng, Mingzhu; Cai, Zhijian; Lu, Linrong; Wang, Jianli] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Linrong] Zhejiang Univ, Sch Med, Program Mol & Cellular Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Ji, Jian] Zhejiang Univ, Minist Educ, Key Lab Anim Mol Nutr, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Yao, Yunliang] Huzhou Teachers Coll, Sch Med, Dept Microbiol & Immunol, Huzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Huzhou University	Lu, LR (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.	lu_linrong@zju.edu.cn; jlwang@zju.edu.cn	Zheng, Mingzhu/AAF-6010-2019; Liang, Jingjing/AAO-6865-2020; Zheng, Mingzhu/AAC-7818-2022	Liang, Jingjing/0000-0002-6766-4747; Zheng, Mingzhu/0000-0002-9399-9225; Lu, Linrong/0000-0002-0171-4115	Public Welfare Technology Application Research Project of Zhejiang Province [2013C33155]	Public Welfare Technology Application Research Project of Zhejiang Province	This work was supported by grants from the Public Welfare Technology Application Research Project of Zhejiang Province (2013C33155).	Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Carbonnelle-Puscian A, 2009, LEUKEMIA, V23, P952, DOI 10.1038/leu.2008.380; Chu CC, 1997, P NATL ACAD SCI USA, V94, P2507, DOI 10.1073/pnas.94.6.2507; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lasoudris F, 2011, EUR J IMMUNOL, V41, P1629, DOI 10.1002/eji.201041119; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marquet J, 2010, EUR J IMMUNOL, V40, P2557, DOI 10.1002/eji.201040428; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mason JM, 2004, J IMMUNOL, V173, P4561, DOI 10.4049/jimmunol.173.7.4561; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNN DH, 1993, CANCER RES, V53, P2603; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Munn DH, 1996, J IMMUNOL, V156, P523; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Puiffe ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054589; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stutz AM, 2003, J IMMUNOL, V170, P1789, DOI 10.4049/jimmunol.170.4.1789; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9	35	50	57	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142979	10.1371/journal.pone.0142979	http://dx.doi.org/10.1371/journal.pone.0142979			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599209	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600023
J	Benedeti, PD; da Silva, LG; de Paula, EM; Shenkoru, T; Marcondes, MI; Monteiro, HF; Amorati, B; Yeh, Y; Poulson, SR; Faciola, AP				Benedeti, Pedro Del Bianco; da Silva, Lorrayny Galoro; de Paula, Eduardo Marostegan; Shenkoru, Teshome; Marcondes, Marcos Inacio; Monteiro, Hugo Fernando; Amorati, Brad; Yeh, Yenling; Poulson, Simon Roger; Faciola, Antonio Pinheiro			Effects of Partial Replacement of Corn with Glycerin on Ruminal Fermentation in a Dual-Flow Continuous Culture System	PLOS ONE			English	Article							IN-VITRO FERMENTATION; VOLATILE FATTY-ACIDS; RUMEN FERMENTATION; CRUDE GLYCERIN; NUTRIENT DIGESTIBILITY; PURINE DERIVATIVES; BLOOD METABOLITES; FEEDING GLYCEROL; SOYBEAN-MEAL; DIETS	The objective of this study was to evaluate the effects of partially replacing dry ground corn with glycerin on ruminal fermentation using a dual-flow continuous culture system. Six fermenters (1,223 +/- 21 ml) were used in a replicated 3x3 Latin square arrangement with three periods of 10 d each, with 7 d for diet adaptation and 3 d for sample collections. All diets contained 75% concentrate and three dietary glycerin levels (0, 15, and 30% on dry matter basis), totaling six replicates per treatment. Fermenters were fed 72 g of dry matter/d equally divided in two meals/d, at 0800 and 2000 h. Solid and liquid dilution rates were adjusted daily to 5.5 and 11%/h, respectively. On d 8, 9, and 10, samples of 500 ml of solid and liquid digesta effluent were mixed, homogenized, and stored at -20 degrees C. Subsamples of 10 ml were collected and preserved with 0.2 mL of a 50% H2SO4 solution for later determination of NH3-N and volatile fatty acids. Microbial biomass was isolated from fermenters for chemical analysis at the end of each experimental period. Data were analyzed using the MIXED procedure in SAS with alpha = 0.05. Glycerin levels did not affect apparent digestibility of DM (P-Lin. = 0.13; P-Quad. = 0.40), OM (P-Lin. = 0.72; P-Quad. = 0.15), NDF (P-Lin. = 0.38; P-Quad. = 0.50) and ADF (P-Lin. = 0.91; P-Quad. = 0.18). Also, glycerin inclusion did not affect true digestibility of DM (P-Lin. = 0.35; P-Quad. = 0.48), and OM (P-Lin. = 0.08; P-Quad. = 0.19). Concentrations of propionate (P < 0.01) and total volatile fatty acids (P < 0.01) increased linearly and concentrations of acetate (P < 0.01), butyrate (P = 0.01), iso-valerate (P < 0.01), and total branched-chain volatile fatty acids, as well as the acetate: propionate ratio (P < 0.01) decreased with glycerin inclusion. Linear increases on NH3-N concentration in digesta effluent (P < 0.01) and on NH3-N flow (P < 0.01) were observed due to glycerin inclusion in the diets. Crude protein digestibility (P = 0.04) and microbial N flow (P = 0.04) were greater in the control treatment compared with the other treatments and responded quadratically with glycerin inclusion. Furthermore, the inclusion of glycerin linearly decreased (P = 0.02) non-ammonia N flow. Glycerin levels did not affect the flows of total N (P-Lin. = 0.79; P-Quad. = 0.35), and dietary N (P-Lin. = 0.99; P-Quad. = 0.07), as well as microbial efficiency (P-Lin. = 0.09; P-Quad. = 0.07). These results suggest that partially replacing dry ground corn with glycerin may change ruminal fermentation, by increasing total volatile fatty acids, and propionate concentration without affecting microbial efficiency, which may improve glucogenic potential of beef cattle diets.	[Benedeti, Pedro Del Bianco; da Silva, Lorrayny Galoro; de Paula, Eduardo Marostegan; Shenkoru, Teshome; Monteiro, Hugo Fernando; Amorati, Brad; Yeh, Yenling; Faciola, Antonio Pinheiro] Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA; [Benedeti, Pedro Del Bianco; Marcondes, Marcos Inacio] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Monteiro, Hugo Fernando] Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil; [Poulson, Simon Roger] Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Universidade Federal de Vicosa; Universidade Estadual de Maringa; Nevada System of Higher Education (NSHE); University of Nevada Reno	Faciola, AP (corresponding author), Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA.	afaciola@cabnr.unr.edu	Monteiro, Hugo/ADT-8240-2022; de Paula, Eduardo Marostegan/S-8509-2019; Faciola, Antonio/AAF-3865-2019; da Silva, Lorrayny Galoro/H-2312-2019; Faciola, Antonio/U-4800-2018; Del Bianco Benedeti, Pedro/C-3120-2016; Marcondes, Marcos/AAH-7553-2020	de Paula, Eduardo Marostegan/0000-0002-1891-6303; Faciola, Antonio/0000-0003-0935-6233; da Silva, Lorrayny Galoro/0000-0002-7843-1623; Faciola, Antonio/0000-0003-0935-6233; Del Bianco Benedeti, Pedro/0000-0003-2515-8974; Marcondes, Marcos/0000-0003-4843-2809	National Institute of Food and Agriculture (NIFA) [1003089]; Brazilian National Council for Scientific and Technological Development (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES)	National Institute of Food and Agriculture (NIFA); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by the National Institute of Food and Agriculture (NIFA), Project number: 1003089, the Brazilian National Council for Scientific and Technological Development (CNPq), and Coordination for the Improvement of Higher Education Personnel (CAPES). The funding agencies had no role in the study design, data collection, and analyses, decision to publish, or preparation of the manuscript.	AOAC, 2007, OFFICIAL METHODS ANA, V18th; Avila JS, 2011, ANIM FEED SCI TECH, V166-67, P265, DOI 10.1016/j.anifeedsci.2011.04.016; Avila-Stagno J, 2014, BRIT J NUTR, V111, P829, DOI 10.1017/S0007114513003206; Bach A, 2008, J ANIM SCI, V86, P1364, DOI 10.2527/jas.2007-0736; Bargo F, 2003, J DAIRY SCI, V86, P1330, DOI 10.3168/jds.S0022-0302(03)73718-7; Barton L, 2013, LIVEST SCI, V155, P53, DOI 10.1016/j.livsci.2013.04.010; Benedeti PDB, 2014, LIVEST SCI, V165, P51, DOI 10.1016/j.livsci.2014.04.027; BERGMAN EN, 1968, AM J PHYSIOL, V215, P874; BERGNER H, 1995, ARCH ANIM NUTR, V48, P245, DOI 10.1080/17450399509381845; Calsamiglia S, 1996, J ANIM SCI, V74, P1375; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chanjula P, 2014, ASIAN AUSTRAL J ANIM, V27, P365, DOI 10.5713/ajas.2013.13494; DAVIS CS, 1989, APPL STAT-J ROY ST C, V38, P535, DOI 10.2307/2347751; DeFrain JM, 2004, J DAIRY SCI, V87, P4195, DOI 10.3168/jds.S0022-0302(04)73564-X; DIJKSTRA J, 1994, LIVEST PROD SCI, V39, P61, DOI 10.1016/0301-6226(94)90154-6; DONKIN S., 2008, REV BRAS ZOOTECN, V37, P280, DOI DOI 10.1590/S1516-35982008001300032; El-Nor SA, 2010, ANIM FEED SCI TECH, V162, P99, DOI 10.1016/j.anifeedsci.2010.09.012; Fuentes MC, 2009, J DAIRY SCI, V92, P4456, DOI 10.3168/jds.2008-1722; GOETSCH AL, 1987, ANIM FEED SCI TECH, V18, P151, DOI 10.1016/0377-8401(87)90044-7; Griswold KE, 2003, J ANIM SCI, V81, P329; Hales KE, 2013, J ANIM SCI, V91, P4277, DOI 10.2527/jas.2013-6341; HOOVER WH, 1976, J ANIM SCI, V43, P528, DOI 10.2527/jas1976.432528x; Kijora C, 1998, ARCH ANIM NUTR, V51, P341, DOI 10.1080/17450399809381931; Krueger NA, 2010, BIORESOURCE TECHNOL, V101, P8469, DOI 10.1016/j.biortech.2010.06.010; Mach N, 2009, J ANIM SCI, V87, P632, DOI 10.2527/jas.2008-0987; NRC (National Research Council), 2000, NUTR REQ BEEF CATTL, DOI DOI 10.17226/19014; Owens F.N., 1988, RUMINANT ANIMAL DIGE, P145; Ramos MH, 2012, J ANIM SCI, V90, P892, DOI 10.2527/jas.2011-4099; REMOND B, 1993, ANIM FEED SCI TECH, V41, P121, DOI 10.1016/0377-8401(93)90118-4; Rico DE, 2012, J DAIRY SCI, V95, P3310, DOI 10.3168/jds.2011-5059; Schoonmaker JP, 2004, J ANIM SCI, V82, P137; Schroder A., 1999, INT RAP C GOSF REG I, P241; Shin JH, 2012, J DAIRY SCI, V95, P4006, DOI 10.3168/jds.2011-5121; SMITH SB, 1984, J NUTR, V114, P792, DOI 10.1093/jn/114.4.792; Soder KJ, 2013, J DAIRY SCI, V96, P3228, DOI 10.3168/jds.2012-6307; Stewart CS., 1997, RUMEN MICROBIAL ECOS, P10, DOI [10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-1453-7_2]; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Versemann B.A., 2008, J ANIM SCI, V86, P478; Wanapat M, 1999, ASIAN AUSTRAL J ANIM, V12, P904, DOI 10.5713/ajas.1999.904; Wang C, 2009, LIVEST SCI, V121, P15, DOI 10.1016/j.livsci.2008.05.010; WELLER RA, 1974, BRIT J NUTR, V32, P341, DOI 10.1079/BJN19740087; Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C; WINDSCHITL PM, 1988, J ANIM SCI, V66, P2948	44	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143201	10.1371/journal.pone.0143201	http://dx.doi.org/10.1371/journal.pone.0143201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599015	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900076
J	Burbelo, PD; Klimavicz, JS; Deeks, SG; Kovacs, JA; Ragheb, JA				Burbelo, Peter D.; Klimavicz, James S.; Deeks, Steve G.; Kovacs, Joseph A.; Ragheb, Jack A.			Lack of Evidence for Molecular Mimicry in HIV-Infected Subjects	PLOS ONE			English	Article							LUCIFERASE IMMUNOPRECIPITATION SYSTEMS; COMMON IMMUNOLOGICAL EPITOPE; ANTIERYTHROPOIETIN ANTIBODIES; POSITIVE INDIVIDUALS; AUTOIMMUNE-DISEASE; AUTOANTIBODIES; IMMUNODEFICIENCY; ANEMIA; QUANTIFICATION; ERYTHROPOIETIN	Previous studies in HIV patients have reported autoantibodies to several human proteins, including erythropoietin (EPO), interferon-alpha (IFN-alpha), interleukin-2 (IL-2), and HLA-DR, as potential mediators of anemia or immunosuppression. The etiology of these autoantibodies has been attributed to molecular mimicry between HIV epitopes and self-proteins. Here, the Luciferase Immunoprecipitation System (LIPS) was used to investigate the presence of such autoantibodies in HIV-infected adults. High levels of antibodies to HIV proteins such as capsid (p24), matrix (p17), envelope (gp41), and reverse transcriptase (RT) were detected using LIPS in both untreated and anti-retroviral-treated HIV-infected individuals but not in uninfected controls. LIPS readily detected anti-EPO autoantibodies in serum samples from subjects with presumptive pure red cell aplasia but not in any of the samples from HIV-infected or uninfected individuals. Similarly, subjects with HIV lacked autoantibodies to IFN-alpha, IL-2, HLA-DR and the immunoglobulin lambda light chain; all purported targets of molecular mimicry. While molecular mimicry between pathogen proteins and self-proteins is a commonly proposed mechanism for autoantibody production, the findings presented here indicate such a process is not common in HIV disease.	[Burbelo, Peter D.; Klimavicz, James S.] Natl Inst Dent & Craniofacial Res, Dent Clin Res Core, NIH, Bethesda, MD 20892 USA; [Deeks, Steve G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kovacs, Joseph A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Ragheb, Jack A.] US FDA, Off Biol Prod, OPQ, CDER, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); US Food & Drug Administration (FDA)	Burbelo, PD (corresponding author), Natl Inst Dent & Craniofacial Res, Dent Clin Res Core, NIH, Bethesda, MD 20892 USA.	burbelop@nidcr.nih.gov	Kovacs, Joseph/AAU-6105-2021	Kovacs, Joseph/0000-0002-5191-9880; Deeks, Steven/0000-0001-6371-747X; Klimavicz, James/0000-0002-3439-1906	Divisions of Intramural Research, National Institute of Dental and Craniofacial Research; NIH Clinical Center; CDER, Food and Drug Administration, Foundation for AIDS Research (amFAR); Delaney AIDS Research Enterprise (DARE) [U19AI096109]; UCSF/Gladstone Institute of Virology & Immunology CFAR [P30 AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U19AI096109] Funding Source: NIH RePORTER	Divisions of Intramural Research, National Institute of Dental and Craniofacial Research; NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); CDER, Food and Drug Administration, Foundation for AIDS Research (amFAR); Delaney AIDS Research Enterprise (DARE); UCSF/Gladstone Institute of Virology & Immunology CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Divisions of Intramural Research, National Institute of Dental and Craniofacial Research, the NIH Clinical Center, and the CDER, Food and Drug Administration, Foundation for AIDS Research (amFAR), the Delaney AIDS Research Enterprise (DARE, U19AI096109), the UCSF/Gladstone Institute of Virology & Immunology CFAR (P30 AI027763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atassi MZ, 2008, AUTOIMMUNITY, V41, P123, DOI 10.1080/08916930801929021; BOST KL, 1988, IMMUNOLOGY, V65, P611; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Burbelo PD, 2007, BIOCHEM BIOPH RES CO, V352, P889, DOI 10.1016/j.bbrc.2006.11.140; Burbelo PD, 2015, TRANSL RES, V165, P325, DOI 10.1016/j.trsl.2014.08.006; Burbelo PD, 2014, J INFECT DIS, V209, P1613, DOI 10.1093/infdis/jit667; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Chen YH, 1997, IMMUNOL LETT, V55, P15, DOI 10.1016/S0165-2478(96)02644-2; Chen YH, 1997, MOL IMMUNOL, V34, P1259, DOI 10.1016/S0161-5890(98)00011-X; Ching KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032001; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; GOLDING H, 1989, J CLIN INVEST, V83, P1430, DOI 10.1172/JCI114034; Hoesel W, 2004, J IMMUNOL METHODS, V294, P101, DOI 10.1016/j.jim.2004.08.017; Liu E, 2007, CLIN IMMUNOL, V125, P120, DOI 10.1016/j.clim.2007.08.005; Maksyutov A. Z., 2002, Molekulyarnaya Biologiya (Moscow), V36, P447; Mendoza D, 2012, BLOOD, V119, P4645, DOI 10.1182/blood-2011-10-381996; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Rose NR, 2000, CELL MOL LIFE SCI, V57, P542, DOI 10.1007/PL00000716; Sheikh V, 2014, AIDS, V28, P31, DOI 10.1097/QAD.0000000000000006; SILVESTRIS F, 1995, CLIN IMMUNOL IMMUNOP, V75, P197, DOI 10.1006/clin.1995.1072; Sipsas NV, 1999, J INFECT DIS, V180, P2044, DOI 10.1086/315156; SLOAND EM, 1991, JAMA-J AM MED ASSOC, V266, P2861, DOI 10.1001/jama.266.20.2861; Tacey R, 2003, J IMMUNOL METHODS, V283, P317, DOI 10.1016/j.jim.2003.09.003; Tsiakalos A, 2011, J INFECT DIS, V204, P902, DOI 10.1093/infdis/jir433; Tsiakalos A, 2010, J INFECTION, V60, P238, DOI 10.1016/j.jinf.2009.12.013; Tzioufas AG, 1997, ARTHRITIS RHEUM-US, V40, P2212, DOI 10.1002/art.1780401216; Wu G, 2004, AM J KIDNEY DIS, V44, P264, DOI 10.1053/j.ajkd.2004.04.031; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zandman-Goddard Gisele, 2002, Autoimmunity Reviews, V1, P329, DOI 10.1016/S1568-9972(02)00086-1	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0127662	10.1371/journal.pone.0127662	http://dx.doi.org/10.1371/journal.pone.0127662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599070	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900001
J	Dammers, C; Gremer, L; Reiss, K; Klein, AN; Neudecker, P; Hartmann, R; Sun, N; Demuth, HU; Schwarten, M; Willbold, D				Dammers, Christina; Gremer, Lothar; Reiss, Kerstin; Klein, Antonia N.; Neudecker, Philipp; Hartmann, Rudolf; Sun, Na; Demuth, Hans-Ulrich; Schwarten, Melanie; Willbold, Dieter			Structural Analysis and Aggregation Propensity of Pyroglutamate A beta(3-40) in Aqueous Trifluoroethanol	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDES; ALZHEIMERS-DISEASE BRAIN; A-BETA; NMR-SPECTROSCOPY; CHEMICAL-SHIFTS; MOUSE MODEL; IN-VITRO; PROTEIN; IDENTIFICATION; A-BETA-40	A hallmark of Alzheimer's disease (AD) is the accumulation of extracellular amyloid-beta (A beta) plaques in the brains of patients. N-terminally truncated pyroglutamate-modified A beta (pEA beta) has been described as a major compound of A beta species in senile plaques. pEA beta is more resistant to degradation, shows higher toxicity and has increased aggregation propensity and beta-sheet stabilization compared to non-modified A beta. Here we characterized recombinant pEA beta(3-40) in aqueous trifluoroethanol (TFE) solution regarding its aggregation propensity and structural changes in comparison to its non-pyroglutamate-modified variant A beta (1-40). Secondary structure analysis by circular dichroism spectroscopy suggests that pEA beta(3-40) shows an increased tendency to form beta-sheet-rich structures in 20% TFE containing solutions where A beta(1-40) forms alpha-helices. Aggregation kinetics of pEA beta(3-40) in the presence of 20% TFE monitored by thioflavin-T (ThT) assay showed a typical sigmoidal aggregation in contrast to A beta(1-40), which lacks ThT positive structures under the same conditions. Transmission electron microscopy confirms that pEA beta(3-40) aggregated to large fibrils and high molecular weight aggregates in spite of the presence of the helix stabilizing co-solvent TFE. High resolution NMR spectroscopy of recombinantly produced and uniformly isotope labeled [U-N-15 ]-pEA beta(3-40) in TFE containing solutions indicates that the pyroglutamate formation affects significantly the N-terminal region, which in turn leads to decreased monomer stability and increased aggregation propensity.	[Dammers, Christina; Gremer, Lothar; Reiss, Kerstin; Klein, Antonia N.; Neudecker, Philipp; Hartmann, Rudolf; Sun, Na; Schwarten, Melanie; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany; [Gremer, Lothar; Neudecker, Philipp; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Demuth, Hans-Ulrich] Fraunhofer Inst Cell Therapy & Immunol, Dept Drug Design & Target Validat, D-06120 Halle, Saale, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Fraunhofer Gesellschaft	Willbold, D (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany.	d.willbold@fz-juelich.de	Schwarten, Melanie/G-6407-2013; Sun, Na/ABC-7810-2020; Neudecker, Philipp/G-5265-2013; Neudecker, Philipp/AAP-9005-2020; Hartmann, Rudolf/H-9345-2017; Gremer, Lothar/H-9128-2013; Willbold, Dieter/A-6280-2013	Schwarten, Melanie/0000-0001-8920-9668; Sun, Na/0000-0003-0155-1763; Neudecker, Philipp/0000-0002-0557-966X; Neudecker, Philipp/0000-0002-0557-966X; Hartmann, Rudolf/0000-0001-7807-6273; Gremer, Lothar/0000-0001-7065-5027; Willbold, Dieter/0000-0002-0065-7366; Dammers, Christina/0000-0001-5650-090X	International NRW Research School BioStruct - Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich Heine University of Dusseldorf; Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf; Portfolio Technology and Medicine; Portfolio Drug Research; Helmholtz-Validierungsfonds of the "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft"	International NRW Research School BioStruct - Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich Heine University of Dusseldorf; Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf; Portfolio Technology and Medicine; Portfolio Drug Research; Helmholtz-Validierungsfonds of the "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft"	We gratefully acknowledge support of CD from the International NRW Research School BioStruct, granted by the Ministry of Innovation, Science and Research of the State North Rhine-Westphalia, the Heinrich Heine University of Dusseldorf, and the Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf. DW was supported by grants from the "Portfolio Technology and Medicine", the "Portfolio Drug Research" and the Helmholtz-Validierungsfonds of the "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Matthias Stoldt, Justin Lecher and Maren Thomaier are highly acknowledged for fruitful discussions. We gratefully acknowledge support of CD from the International NRW Research School BioStruct, granted by the Ministry of Innovation, Science and Research of the State North Rhine-Westphalia, the Heinrich Heine University of Dusseldorf, and the Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf. The authors acknowledge access to the Julich-Dusseldorf Biomolecular NMR Cent. DW was supported by grants from the "Portfolio Technology and Medicine", the "Portfolio Drug Research" and the Helmholtz-Validierungsfonds of the "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft".	Amani S, 2014, BIOCHEM ENG J, V91, P120, DOI 10.1016/j.bej.2014.08.004; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Ballard C, 2011, CAN J PSYCHIAT, V56, P589, DOI 10.1177/070674371105601004; Bayer TA, 2014, ACTA NEUROPATHOL, V127, P787, DOI 10.1007/s00401-014-1287-x; Chen YR, 2006, J BIOCHEM, V139, P733, DOI 10.1093/jb/mvj083; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Cummins PM, 1998, BBA-PROTEIN STRUCT M, V1429, P1, DOI 10.1016/S0167-4838(98)00248-9; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; Dammers C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139710; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Gil-Caballero S, 2014, J BIOMOL NMR, V60, P1, DOI 10.1007/s10858-014-9847-x; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Gunn AP, 2010, INT J BIOCHEM CELL B, V42, P1915, DOI 10.1016/j.biocel.2010.08.015; Gupta P, 2014, BIOCHEM BIOPH RES CO, V449, P126, DOI 10.1016/j.bbrc.2014.04.160; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Jawhar S, 2011, J BIOL CHEM, V286, P38825, DOI 10.1074/jbc.R111.288308; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Khan MV, 2014, INT J BIOL MACROMOL, V70, P606, DOI 10.1016/j.ijbiomac.2014.07.027; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kumar S, 2009, BIOCHEMISTRY-US, V48, P6441, DOI 10.1021/bi900682w; Marinelli P, 2013, INT J MOL SCI, V14, P17830, DOI 10.3390/ijms140917830; Meissner JN, 2015, J ALZHEIMERS DIS, V45, P471, DOI 10.3233/JAD-142868; Mischo A, 2012, CHEMBIOCHEM, V13, P1421, DOI 10.1002/cbic.201200178; MORI H, 1992, J BIOL CHEM, V267, P17082; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Perez-Garmendia R, 2013, CURR NEUROPHARMACOL, V11, P491, DOI 10.2174/1570159X11311050004; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2012, J NEUROCHEM, V121, P774, DOI 10.1111/j.1471-4159.2012.07707.x; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; Shao HY, 1999, J MOL BIOL, V285, P755, DOI 10.1006/jmbi.1998.2348; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Sun N, 2012, J PEPT SCI, V18, P691, DOI 10.1002/psc.2456; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	53	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143647	10.1371/journal.pone.0143647	http://dx.doi.org/10.1371/journal.pone.0143647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600248	Green Published, gold			2022-12-27	WOS:000365853900151
J	Davin, A; Monti, MC; Polito, L; Vaccaro, R; Abbondanza, S; Gnesi, M; Villani, S; Guaita, A				Davin, Annalisa; Monti, Maria Cristina; Polito, Letizia; Vaccaro, Roberta; Abbondanza, Simona; Gnesi, Marco; Villani, Simona; Guaita, Antonio			Influence of Serotonin Transporter Gene Polymorphisms and Adverse Life Events on Depressive Symptoms in the Elderly: A Population-Based Study	PLOS ONE			English	Article							5-HTTLPR POLYMORPHISM; AFFECTIVE-DISORDERS; MAJOR DEPRESSION; AGE-DIFFERENCES; OLDER-ADULTS; ASSOCIATION; SUSCEPTIBILITY; DEMENTIA; ONSET; METAANALYSIS	Background Depression is common in the elderly. The role of genetic and environmental factors in modulating depressive symptoms is not clear. Methods We evaluated the influence of serotonin transporter gene polymorphisms and recent adverse life events on depressive symptoms in an elderly Italian population. We used data from "InveCe.Ab", a population-based study of 1321 subjects aged 70-74 years. We used the 15-item Geriatric Depression Scale (GDS) to assess depressive symptoms-a GDS score >= 5 points (GDS >= 5) indicated the presence of clinically relevant symptoms-and performed 5-HTTLPR and rs25531 genotyping to obtain the triallelic polymorphism of the serotonin transporter. We used the Geriatric Adverse Life Events Scale to measure adverse life events, and logistic regression models to evaluate the role of genotype and recent adverse life events in depressive symptoms, controlling for potential confounders and independent predictors. Results Two hundred subjects (15.76%) had a GDS >= 5. The 5-HTTLPR triallelic polymorphism was significantly associated with GDS >= 5. Only S'S' carriers showed an increased risk of depressive symptoms (ORadj = 1.81, p = .022); one extra adverse life event increased this risk by 14%(p = .061) independently of genotype. Other factors significantly related to GDS >= 5 were: female gender (ORadj = 2.49, p < .001), age (ORadj = 1.19, p = .007), a history of depression (ORadj = 4.73, p < .001), and comorbidity (ORadj = 1.23, p = .001). One extra adverse life event increased the risk of depressive symptoms by 57%(p = .005) only in the L'L' carriers, while antidepressant intake was directly related to GDS >= 5 in the L'S' carriers (ORadj = 2.46, p = .036) and borderline significant in the S'S' carriers (ORadj = 2.41, p = .081). Discussion The S'S' genotype and recent exposure to adverse life events were independently associated with depressive symptoms. The S'S' genotype, compared with the environment, exerted a predominant effect on depressive symptoms, suggesting that it reduces the efficacy of antidepressant therapy. We conclude that genetics may be an important risk factor for depressive symptoms in late adulthood.	[Davin, Annalisa; Polito, Letizia; Vaccaro, Roberta; Abbondanza, Simona; Guaita, Antonio] Golgi Cenci Fdn, Abbiategrasso, Italy; [Monti, Maria Cristina; Gnesi, Marco; Villani, Simona] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Sect Biostat & Clin Epidemiol, I-27100 Pavia, Italy; [Vaccaro, Roberta] C Golgi Geriatr Inst, Abbiategrasso, Italy	University of Pavia	Davin, A (corresponding author), Golgi Cenci Fdn, Abbiategrasso, Italy.	a.davin@golgicenci.it	Davin, Annalisa/AAB-8602-2022; Guaita, Antonio/Q-1787-2019; Vaccaro, Roberta/AAK-8117-2020	Davin, Annalisa/0000-0002-5597-7586; Guaita, Antonio/0000-0003-3954-5932; Gnesi, Marco/0000-0001-6022-6325; /0000-0003-2517-6515; Abbondanza, Simona/0000-0002-6042-7298; Monti, Maria Cristina/0000-0003-1586-527X				Aldwin CM, 1996, J GERONTOL B-PSYCHOL, V51, pP179, DOI 10.1093/geronb/51B.4.P179; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; [Anonymous], 2007, DSM 4 T MANUALE DIAG; Bjorklof GH, 2013, DEMENT GERIATR COGN, V35, P121, DOI 10.1159/000346633; Blazer DG, 2005, PSYCHOL MED, V35, P1241, DOI 10.1017/S0033291705004411; Bogdan R, 2014, J CHILD PSYCHOL PSYC, V55, P448, DOI 10.1111/jcpp.12142; Brown SM, 2006, COGN AFFECT BEHAV NE, V6, P44, DOI 10.3758/CABN.6.1.44; Buber I, 2011, COMP POPUL STUD, V36, P103, DOI 10.4232/10.CPoS-2011-02en; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Cho HJ, 2005, MOL PSYCHIATR, V10, P771, DOI 10.1038/sj.mp.4001663; Choi S, 2014, PSYCHIAT Q; Chou KL, 2008, J AFFECT DISORDERS, V106, P191, DOI 10.1016/j.jad.2007.05.028; Cicirelli VG, 2009, J GERONTOL B-PSYCHOL, V64, P24, DOI 10.1093/geronb/gbn024; Cohen-Woods S, 2013, PSYCHOL MED, V43, P673, DOI 10.1017/S0033291712001286; Cole MG, 2008, AM J GERIAT PSYCHIAT, V16, P435, DOI 10.1097/JGP.0b013e318162f174; CONWELL Y, 1993, J AM GERIATR SOC, V41, P38, DOI 10.1111/j.1532-5415.1993.tb05945.x; Costafreda SG, 2013, J AFFECT DISORDERS, V150, P96, DOI 10.1016/j.jad.2013.02.028; de Craen AJM, 2003, INT J GERIATR PSYCH, V18, P63, DOI 10.1002/gps.773; Devanand DP, 2002, AM J GERIAT PSYCHIAT, V10, P265; Diniz BS, 2014, DEPRESS ANXIETY, V31, P787, DOI 10.1002/da.22226; Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Fabbri C, 2014, CAN J PSYCHIAT, V59, P62, DOI 10.1177/070674371405900202; Favaro A, 2014, PSYCHIAT RES-NEUROIM, V223, P157, DOI 10.1016/j.pscychresns.2014.05.006; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Furlong RA, 1998, AM J MED GENET, V81, P58, DOI 10.1002/(SICI)1096-8628(19980207)81:1<58::AID-AJMG11>3.0.CO;2-V; Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555; Guaita A, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-98; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Heils A, 1996, J NEUROCHEM, V66, P2621; Hoehe MR, 1998, AM J MED GENET, V81, P1, DOI 10.1002/(SICI)1096-8628(19980207)81:1<1::AID-AJMG1>3.0.CO;2-2; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Janzing JGE, 2002, INT J GERIATR PSYCH, V17, P1, DOI 10.1002/gps.526; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Knight BG, 2007, AGING MENT HEALTH, V11, P538, DOI 10.1080/13607860601086561; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Luijendijk HJ, 2008, ARCH GEN PSYCHIAT, V65, P1394, DOI 10.1001/archpsyc.65.12.1394; Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033; Luppa M, 2013, INT PSYCHOGERIATR, V25, P292, DOI 10.1017/S1041610212001688; Mast BT, 2008, BIOL PSYCHIAT, V64, P320, DOI 10.1016/j.biopsych.2008.01.025; Mazure CM, 2002, AM J GERIAT PSYCHIAT, V10, P297, DOI 10.1176/appi.ajgp.10.3.297; McHugh RK, 2010, DRUG ALCOHOL DEPEN, V108, P1, DOI 10.1016/j.drugalcdep.2009.11.017; Mendlewicz J, 2004, EUR J HUM GENET, V12, P377, DOI 10.1038/sj.ejhg.5201149; Mezuk B, 2012, INT J GERIATR PSYCH, V27, P879, DOI 10.1002/gps.2807; Narasimhan S, 2012, PHARMACOGENOMICS, V13, P441, DOI [10.2217/PGS.12.1, 10.2217/pgs.12.1]; Nolen-Hoeksema S, 2002, PSYCHOL AGING, V17, P116, DOI 10.1037//0882-7974.17.1.116; Ornstein K, 2014, INT J AGING HUM DEV, V78, P133, DOI 10.2190/AG.78.2.c; Parker GB, 2015, J AFFECT DISORDERS, V182, P91, DOI 10.1016/j.jad.2015.04.041; Peerenboom L, 2015, J AFFECT DISORDERS, V182, P26, DOI 10.1016/j.jad.2015.04.033; Polito L, 2015, J SLEEP RES, V24, P215, DOI 10.1111/jsr.12248; Power T, 2010, NEUROBIOL AGING, V31, P886, DOI 10.1016/j.neurobiolaging.2008.06.006; Regan CO, 2013, INT J GERIATR PSYCH, V28, P1280, DOI 10.1002/gps.3955; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Schwarzbach M, 2014, INT J GERIATR PSYCH, V29, P1, DOI 10.1002/gps.3971; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Starkstein SE, 2008, INT REV PSYCHIATR, V20, P382, DOI 10.1080/09540260802094480; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014; Wancata J, 2006, ACTA PSYCHIAT SCAND, V114, P398, DOI 10.1111/j.1600-0447.2006.00888.x; Way BM, 2010, PSYCHOSOM MED, V72, P107, DOI 10.1097/PSY.0b013e3181ce6a7d; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Whitbourne S., 2011, HDB PSYCHOL AGING, P311, DOI [DOI 10.1016/B978-0-12-380882-0.00020-6, 10.1016/B978-0-12-380882-0.00020-6]; Yan XY, 2011, J INT MED RES, V39, P1142, DOI 10.1177/147323001103900402; Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588	70	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143395	10.1371/journal.pone.0143395	http://dx.doi.org/10.1371/journal.pone.0143395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26598970	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900107
J	Peci, A; Winter, AL; Warshawsky, B; Booth, TF; Eshaghi, A; Li, AM; Perusini, S; Olsha, R; Marchand-Austin, A; Kristjanson, E; Gubbay, JB				Peci, Adriana; Winter, Anne-Luise; Warshawsky, Bryna; Booth, Tim F.; Eshaghi, AliReza; Li, Aimin; Perusini, Stephen; Olsha, Romy; Marchand-Austin, Alex; Kristjanson, Erik; Gubbay, Jonathan B.			Epidemiology of Enterovirus D68 in Ontario	PLOS ONE			English	Article							PCR	In August 2014, children's hospitals in Kansas City, Missouri and Chicago, Illinois notified the Centers for Disease Control and Prevention (CDC) about increased numbers of pediatric patients hospitalized with severe respiratory illness (SRI). In response to CDC reports, Public Health Ontario Laboratories (PHOL) launched an investigation of patients being tested for enterovirus D-68 (EV-D68) in Ontario, Canada. The purpose of this investigation was to enhance our understanding of EV-D68 epidemiology and clinical features. Data for this study included specimens submitted for EV-D68 testing at PHOL from September 1, 2014 to October 31, 2014. Comparisons were made between patients who tested positive for the virus (cases) and those testing negative (controls). EV-D68 was identified in 153/907 (16.8%) of patients tested. In the logistic regression model adjusting for age, sex, setting and time to specimen collection, individuals younger than 20 years of age were more likely to be diagnosed with EV-D68 compared to those 20 and over, with peak positivity at ages 5-9 years. Cases were not more likely to be hospitalized than controls. Cases were more likely to be identified in September than October (OR 8.07; 95% CI 5.15 to 12.64). Routine viral culture and multiplex PCR were inadequate methods to identify EV-D68 due to poor sensitivity and inability to differentiate EV-D68 from other enterovirus serotypes or rhinovirus. Testing for EV-D68 in Ontario from July to December, 2014 detected the presence of EV-D68 virus among young children during September-October, 2014, with most cases detected in September. There was no difference in hospitalization status between cases and controls. In order to better understand the epidemiology of this virus, surveillance for EV-D68 should include testing of symptomatic individuals from all treatment settings and patient age groups, with collection and analysis of comprehensive clinical and epidemiological data.	[Peci, Adriana; Eshaghi, AliReza; Li, Aimin; Perusini, Stephen; Olsha, Romy; Marchand-Austin, Alex; Kristjanson, Erik; Gubbay, Jonathan B.] Publ Hlth Ontario Lab, Toronto, ON, Canada; [Winter, Anne-Luise; Warshawsky, Bryna] Publ Hlth Ontario, Toronto, ON, Canada; [Booth, Tim F.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	Public Health Agency of Canada	Peci, A (corresponding author), Publ Hlth Ontario Lab, 661 Univ Ave, Toronto, ON, Canada.	adriana.peci@oahpp.ca	Gubbay, Jonathan/Q-8580-2019	Gubbay, Jonathan/0000-0003-0026-3786; Eshaghi, Alireza/0000-0001-5150-483X; Marchand-Austin, Alex/0000-0001-5932-2037	GlaxoSmith Kline Inc; Hoffman-La Roche Ltd; Pfizer Inc	GlaxoSmith Kline Inc(GlaxoSmithKline); Hoffman-La Roche Ltd; Pfizer Inc(Pfizer)	The authors of this manuscript have the following competing interests: Dr. Gubbay has received research grants from GlaxoSmith Kline Inc, and Hoffman-La Roche Ltd to study antiviral resistance in influenza, and from Pfizer Inc, to conduct microbiological surveillance of Streptococcus pneumonia. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Other co-authors have no conflict of interest to declare.	CDC, 2014, ENT D68 US; CDC, 2014, ENT D68 EV D68 2014; CDC, 2014, SUMM FIND INV AC FLA; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Jaramillo-Gutierrez G, 2013, J VIROL METHODS, V190, P53, DOI 10.1016/j.jviromet.2013.02.010; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Lang M, 2014, EUROSURVEILLANCE; Lauinger IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036005; Leshem E, 2015, MMWR-MORBID MORTAL W, V63, P1243; MEIJER A, 2014, EUROSURVEILLANCE, V19, P2011; MMWR, 2008, CLUST AC RESP ILLN A; National Collaborating Centre for Infectious Diseases (NCCID), DIS DEBR EV D68; Nelson R, 2014, LANCET RESP MED, V2, P791, DOI 10.1016/S2213-2600(14)70190-0; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2010, J CLIN VIROL, V49, P73, DOI 10.1016/j.jcv.2010.06.022; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Opanda SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102866; Rahamat-Langendoen J, 2011, J CLIN VIROL, V52, P103, DOI 10.1016/j.jcv.2011.06.019; Robinson JL, 2014, CAN J INFECT DIS MED, V25, P296, DOI 10.1155/2014/201846; Sherwood MDGS, 2014, BC MED J, V56, P495; Todd AK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-103; Waghmare A, 2015, BLOOD, V125, P1724, DOI 10.1182/blood-2014-12-616516	23	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142841	10.1371/journal.pone.0142841	http://dx.doi.org/10.1371/journal.pone.0142841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599365	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900040
J	Stephens, D; Diesing, M				Stephens, David; Diesing, Markus			Towards Quantitative Spatial Models of Seabed Sediment Composition	PLOS ONE			English	Article							EUROPEAN CONTINENTAL-SHELF; SORTED BEDFORMS; SAND TRANSPORT; RANDOM FORESTS; GRAIN-SIZE; CLASSIFICATION; REGRESSION; INTERPOLATION; BACKSCATTER; COMMUNITIES	There is a need for fit-for-purpose maps for accurately depicting the types of seabed substrate and habitat and the properties of the seabed for the benefits of research, resource management, conservation and spatial planning. The aim of this study is to determine whether it is possible to predict substrate composition across a large area of seabed using legacy grain-size data and environmental predictors. The study area includes the North Sea up to approximately 58.44 degrees N and the United Kingdom's parts of the English Channel and the Celtic Seas. The analysis combines outputs from hydrodynamic models as well as optical remote sensing data from satellite platforms and bathymetric variables, which are mainly derived from acoustic remote sensing. We build a statistical regression model to make quantitative predictions of sediment composition (fractions of mud, sand and gravel) using the random forest algorithm. The compositional data is analysed on the additive log-ratio scale. An independent test set indicates that approximately 66% and 71% of the variability of the two log-ratio variables are explained by the predictive models. A EUNIS substrate model, derived from the predicted sediment composition, achieved an overall accuracy of 83% and a kappa coefficient of 0.60. We demonstrate that it is feasible to spatially predict the seabed sediment composition across a large area of continental shelf in a repeatable and validated way. We also highlight the potential for further improvements to the method.	[Stephens, David; Diesing, Markus] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England	Centre for Environment Fisheries & Aquaculture Science	Stephens, D (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England.	davesteps@gmail.com	Diesing, Markus/D-6868-2011	Diesing, Markus/0000-0003-4331-7553	project DEVOTES (Development of innovative tools for understanding marine biodiversity and assessing good Environmental Status) - EU FP7 [308392]	project DEVOTES (Development of innovative tools for understanding marine biodiversity and assessing good Environmental Status) - EU FP7	This work was made possible through funding from the project DEVOTES (Development of innovative tools for understanding marine biodiversity and assessing good Environmental Status) funded by the EU FP7 (grant agreement no. 308392), www.devotes-project.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO; Aldridge JN, 2015, CONT SHELF RES, V108, P121, DOI 10.1016/j.csr.2015.03.004; Alpaydin E., 2010, INTRO MACHINE LEARNI; [Anonymous], 2002, INTRO STAT R; Anthony D, 2002, MAR GEOL, V182, P247, DOI 10.1016/S0025-3227(01)00245-6; Astrium OceanWise, 2011, CREAT HIGH RES DIG E; Bekkby T, 2009, MAR GEOD, V32, P379, DOI 10.1080/01490410903297816; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Boero F, 2015, J SEA RES, V101, P12, DOI 10.1016/j.seares.2014.07.008; Bradwell T, 2008, EARTH-SCI REV, V88, P207, DOI 10.1016/j.earscirev.2008.01.008; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; British Geological Survey, 2014, BGS LEG PART SIZ AN; Buhl-Mortensen P, 2009, ICES J MAR SCI, V66, P2026, DOI 10.1093/icesjms/fsp200; Calvert J, 2015, ICES J MAR SCI, V72, P1498, DOI 10.1093/icesjms/fsu223; Campbell N, 2009, ICES J MAR SCI, V66, P2052, DOI 10.1093/icesjms/fsp176; Capuzzo E, 2015, GLOB CHANG BIOL; Chan JCW, 2008, REMOTE SENS ENVIRON, V112, P2999, DOI 10.1016/j.rse.2008.02.011; Chapman DS, 2010, J BIOGEOGR, V37, P37, DOI 10.1111/j.1365-2699.2009.02186.x; Clark CD, 2012, QUATERNARY SCI REV, V44, P112, DOI 10.1016/j.quascirev.2010.07.019; Coggan R, 2012, ESTUAR COAST SHELF S, V111, P118, DOI 10.1016/j.ecss.2012.06.017; Coggan RA, 2012, ELSEV INSIGHT, P471, DOI 10.1016/B978-0-12-385140-6.00033-5; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Connor D.W., 2006, UKSEAMAP MAPPING SEA, V3rd ed.; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dartnell P, 2004, PHOTOGRAMM ENG REM S, V70, P1081, DOI 10.14358/PERS.70.9.1081; Diesing M, 2006, CONT SHELF RES, V26, P902, DOI 10.1016/j.csr.2006.02.009; Diesing M, 2015, J SEA RES, V100, P62, DOI 10.1016/j.seares.2014.10.013; Diesing M, 2014, CONT SHELF RES, V84, P107, DOI 10.1016/j.csr.2014.05.004; Diesing M, 2009, ESTUAR COAST SHELF S, V83, P647, DOI 10.1016/j.ecss.2009.05.018; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; FOLK RL, 1954, J GEOL, V62, P344, DOI 10.1086/626171; Goff JA, 2005, CONT SHELF RES, V25, P461, DOI 10.1016/j.csr.2004.09.019; Goff JA, 2004, MAR GEOL, V209, P147, DOI 10.1016/j.margeo.2004.05.030; Gohin F, 2005, REMOTE SENS ENVIRON, P95; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hasan RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097339; Hasan RC, 2012, REMOTE SENS-BASEL, V4, P3427, DOI 10.3390/rs4113427; Hasan RC, 2012, ESTUAR COAST SHELF S, V97, P1, DOI 10.1016/j.ecss.2011.10.004; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hengl T., 2009, PRACTICAL GUIDE GEOS, DOI DOI 10.1016/0277-9390(86)90082-8; Holt JT, 2001, J GEOPHYS RES-OCEANS, V106, P14015, DOI 10.1029/2000JC000304; Huang Z, 2008, POW EN SOC GEN M CON, P1; Ierodiaconou D, 2011, CONT SHELF RES, V31, pS28, DOI 10.1016/j.csr.2010.01.012; Isaaks E.H, 1989, INTRO APPL GEOSTATIS; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Jenkins J, 2014, SEABED SUBSTRATES DA; Johnson H D, 1996, SEDIMENTARY ENV PROC, P232; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Kursa M. B., 2010, J STAT SOFTW, V36; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; LEVINS R, 1966, AM SCI, V54, P421; Li J, 2014, ENVIRON MODELL SOFTW, V53, P173, DOI 10.1016/j.envsoft.2013.12.008; Li J, 2011, CONT SHELF RES, V31, P1365, DOI 10.1016/j.csr.2011.05.015; Long D, 2006, BGS DETAILED EXPLANA; Lucieer V, 2013, ESTUAR COAST SHELF S, V117, P94, DOI 10.1016/j.ecss.2012.11.001; Lundblad E., 2006, GEOD, V29, P89, DOI [10.1080/01490410600738021, DOI 10.1080/01490410600738021]; Marsh I, 2009, APPL ACOUST, V70, P1269, DOI 10.1016/j.apacoust.2008.07.012; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Ojeda GY, 2004, ESTUAR COAST SHELF S, V59, P399, DOI 10.1016/j.ecss.2003.09.012; Oliveira S, 2012, FOREST ECOL MANAG, V275, P117, DOI 10.1016/j.foreco.2012.03.003; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Perkins TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112951; PINGREE RD, 1979, J MAR BIOL ASSOC UK, V59, P497, DOI 10.1017/S0025315400042806; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R Core Team, 2021, R LANGUAGE ENV STAT; Rattray A, 2009, ESTUAR COAST SHELF S, V84, P237, DOI 10.1016/j.ecss.2009.06.023; Rooper CN, 2007, CONT SHELF RES, V27, P947, DOI 10.1016/j.csr.2006.12.006; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Schwarzer K, 2003, MAR GEOL, V194, P79, DOI 10.1016/S0025-3227(02)00700-4; Simons DG, 2009, APPL ACOUST, V70, P1258, DOI 10.1016/j.apacoust.2008.07.013; Stephens D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093950; Sternberg RW, 1999, J SEA RES, V41, P55, DOI 10.1016/S1385-1101(98)00037-9; STIVE MJF, 1995, MAR GEOL, V126, P235, DOI 10.1016/0025-3227(95)00080-I; Strong JA, 2012, J MAPS, V8, P129, DOI 10.1080/17445647.2012.680746; Valerius J., 2014, TRANSNATIONAL DATABA; van der Molen J, 2002, CONT SHELF RES, V22, P2739, DOI 10.1016/S0278-4343(02)00124-3; van Heteren S., 2015, COLLABORATIVE KNOWLE, P154, DOI [DOI 10.4018/978-1-4666-6567-5.CH008, 10.4018/978-1-4666-6567-5.ch008]; Van Landeghem KJJ, 2009, BOREAS, V38, P119, DOI 10.1111/j.1502-3885.2008.00041.x; Visser H, 2006, ENVIRON MODELL SOFTW, V21, P346, DOI 10.1016/j.envsoft.2004.11.013; WARWICK RM, 1980, MAR ECOL PROG SER, V3, P97, DOI 10.3354/meps003097; Weltje GJ, 2006, GEOL SOC SPEC PUBL, V264, P79, DOI 10.1144/GSL.SP.2006.264.01.07; Wilson AM, 2008, ESTUAR COAST SHELF S, V80, P193, DOI 10.1016/j.ecss.2008.06.011; Woodroffe C.D, 2003, COASTS FORM PROCESS; Zhi H, 2014, MAR GEOL, V357, P37, DOI 10.1016/j.margeo.2014.07.012	85	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142502	10.1371/journal.pone.0142502	http://dx.doi.org/10.1371/journal.pone.0142502			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600040	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900026
J	Vanlandewijck, M; Lebouvier, T; Mae, MA; Nahar, K; Hornemann, S; Kenkel, D; Cunha, SI; Lennartsson, J; Boss, A; Heldin, CH; Keller, A; Betsholtz, C				Vanlandewijck, Michael; Lebouvier, Thibaud; Mae, Maarja Andaloussi; Nahar, Khayrun; Hornemann, Simone; Kenkel, David; Cunha, Sara I.; Lennartsson, Johan; Boss, Andreas; Heldin, Carl-Henrik; Keller, Annika; Betsholtz, Christer			Functional Characterization of Germline Mutations in PDGFB and PDGFRB in Primary Familial Brain Calcification	PLOS ONE			English	Article							BASAL GANGLIA CALCIFICATION; GROWTH-FACTOR; RECEPTOR; BETA; PERICYTES; MECHANISM; CELLS; ACTIVATION; DEFICIENT; INDUCTION	Primary Familial Brain Calcification (PFBC), a neurodegenerative disease characterized by progressive pericapillary calcifications, has recently been linked to heterozygous mutations in PDGFB and PDGFRB genes. Here, we functionally analyzed several of these mutations in vitro. All six analyzed PDGFB mutations led to complete loss of PDGF-B function either through abolished protein synthesis or through defective binding and/or stimulation of PDGF-R beta. The three analyzed PDGFRB mutations had more diverse consequences. Whereas PDGF-R beta autophosphorylation was almost totally abolished in the PDGFRB L658P mutation, the two sporadic PDGFRB mutations R987W and E1071V caused reductions in protein levels and specific changes in the intensity and kinetics of PLC. activation, respectively. Since at least some of the PDGFB mutations were predicted to act through haploinsufficiency, we explored the consequences of reduced Pdgfb or Pdgfrb transcript and protein levels in mice. Heterozygous Pdgfb or Pdgfrb knockouts, as well as double Pdgfb(+/-); Pdgfrb(+/-) mice did not develop brain calcification, nor did Pdgfrb(redeye/redeye) mice, which show a 90% reduction of PDGFR beta protein levels. In contrast, Pdgfb(ret/ret) mice, which have altered tissue distribution of PDGF-B protein due to loss of a proteoglycan binding motif, developed brain calcifications. We also determined pericyte coverage in calcification-prone and non-calcification-prone brain regions in Pdgfb(ret/ret) mice. Surprisingly and contrary to our hypothesis, we found that the calcification-prone brain regions in Pdgfb(ret/ret) mice model had a higher pericyte coverage and a more intact blood-brain barrier (BBB) compared to non-calcification-prone brain regions. While our findings provide clear evidence that loss-of-function mutations in PDGFB or PDGFRB cause PFBC, they also demonstrate species differences in the threshold levels of PDGF-B/PDGF-R beta signaling that protect against small-vessel calcification in the brain. They further implicate region-specific susceptibility factor(s) in PFBC pathogenesis that are distinct from pericyte and BBB deficiency.	[Vanlandewijck, Michael; Lebouvier, Thibaud; Mae, Maarja Andaloussi; Nahar, Khayrun; Cunha, Sara I.; Betsholtz, Christer] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Hornemann, Simone] Univ Zurich, Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Kenkel, David; Boss, Andreas] Univ Zurich, Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; [Cunha, Sara I.; Lennartsson, Johan; Heldin, Carl-Henrik] Uppsala Univ, Sci Life Lab, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Keller, Annika] Univ Zurich, Univ Zurich Hosp, Div Neurosurg, CH-8091 Zurich, Switzerland; [Vanlandewijck, Michael] Karolinska Inst, Novum, ICMC, SE-14157 Stockholm, Sweden	Uppsala University; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Ludwig Institute for Cancer Research; Uppsala University; University of Zurich; University Zurich Hospital; Karolinska Institutet	Betsholtz, C (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Dag Hammarskjolds Vag 20, S-75185 Uppsala, Sweden.	Christer.Betsholtz@igp.uu.se	Lebouvier, Thibaud/G-7053-2018; Boss, Andreas/A-7484-2014; Andaloussi Mäe, Maarja/AAA-9215-2022	Lebouvier, Thibaud/0000-0002-4386-6045; Keller, Annika/0000-0003-1466-3633; Vanlandewijck, Michael/0000-0002-0709-7808	European Research Council [294556 BBBARRIER]; Swedish Research Council; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; Leducq Foundation; Uppsala University; Swiss National Science Foundation; Synapsis Foundation	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Leducq Foundation(Leducq Foundation); Uppsala University; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Synapsis Foundation	Work in Christer Betholtz's group was funded by: the European Research Council (Advanced grant no 294556 BBBARRIER) (http://erc.europa.eu); the Swedish Research Council (http://www.vr.se); the Swedish Cancer Foundation (https://www.cancerfonden.se); the Knut and Alice Wallenberg Foundation (https://www.wallenberg.com); a transatlantic network grant (Sphingonet) from the Leducq Foundation (https://www.fondationleducq.org/network/sphingosine-1-phosphate-in-neurovascular-biology-and-disease-sphingonet/); and Uppsala University (http://www.uu.se/en). Work in Annika Keller's group was funded by the Swiss National Science Foundation (http://www.snf.ch/en) and The Synapsis Foundation (http://www.alzheimer-synapsis.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cecilia Olsson, Helene Leksell, Pia Peterson, and Jana Chmielniakova for technical assistance. This work was funded by the European Research Council (Advanced grant no 294556 BBBARRIER), the Swedish Research Council, the Swedish Cancer Foundation, the Knut and Alice Wallenberg Foundation, a transatlantic network grant (Sphingonet) from the Leducq Foundation, and Uppsala University to CB, and the Swiss National Science Foundation and The Synapsis Foundation to AK.	ANDERSSON M, 1992, J BIOL CHEM, V267, P11260; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arts FA, 2015, J CELL MOL MED, V19, P239, DOI 10.1111/jcmm.12443; Cheung YH, 2013, AM J HUM GENET, V92, P996, DOI 10.1016/j.ajhg.2013.04.026; Delacour A, 1850, ANN MED PSYCHOL; Goswami R, 2012, CLIN ENDOCRINOL, V77, P200, DOI 10.1111/j.1365-2265.2012.04353.x; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; Jadeja S, 2013, INVEST OPHTH VIS SCI, V54, P3569, DOI 10.1167/iovs.12-11125; Kakita A, 2004, ATHEROSCLEROSIS, V174, P17, DOI 10.1016/j.atherosclerosis.2003.12.039; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; KOBAYASHI S, 1987, ACTA NEUROPATHOL, V73, P62, DOI 10.1007/BF00695503; Lee JW, 2013, CLIN GENET, V84, P340, DOI 10.1111/cge.12238; Legati A, 2015, NAT GENET, V47, P579, DOI 10.1038/ng.3289; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu YW, 2013, CIRC RES, V112, pE99, DOI 10.1161/CIRCRESAHA.111.300543; Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001; Martignetti JA, 2013, AM J HUM GENET, V92, P1001, DOI 10.1016/j.ajhg.2013.04.024; McArthur GA, 2005, J CLIN ONCOL, V23, P866, DOI 10.1200/JCO.2005.07.088; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7; Nicolas G, 2014, EUR J HUM GENET, V22, P1236, DOI 10.1038/ejhg.2014.9; Nicolas G, 2014, J MOL NEUROSCI, V53, P171, DOI 10.1007/s12031-014-0265-z; Nicolas G, 2013, BRAIN, V136, P3395, DOI 10.1093/brain/awt255; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; OSTMAN A, 1992, J CELL BIOL, V118, P509, DOI 10.1083/jcb.118.3.509; Ruusala A, 1998, J CELL SCI, V111, P111; Saleem S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-156; Sanchez-Contreras M, 2014, HUM MUTAT, V35, P964, DOI 10.1002/humu.22582; Schindelin J., 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, DOI 10.1038/NMETH.2019]; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tsai WH, 1985, COMPUTER VISION; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; WESTERMARK B, 1990, P NATL ACAD SCI USA, V87, P128, DOI 10.1073/pnas.87.1.128; Wider C, 2009, J NEUROL, V256, P839, DOI 10.1007/s00415-009-5025-6	48	61	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143407	10.1371/journal.pone.0143407	http://dx.doi.org/10.1371/journal.pone.0143407			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599395	Green Submitted, gold, Green Published			2022-12-27	WOS:000365853900111
J	Wibaux, A; Thota, P; Mastej, J; Prince, DL; Carty, N; Johnson, P				Wibaux, Anne; Thota, Priyaleela; Mastej, Jozef; Prince, Daniel L.; Carty, Neal; Johnson, Peter			Antimicrobial Activity of a Novel Vascular Access Film Dressing Containing Chlorhexidine Gluconate	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CATHETER-RELATED INFECTIONS; BLOOD-STREAM INFECTIONS; PREVENTION; SKIN; COLONIZATION; HOSPITALS; ADHESIVE; DEVICES; ADULTS	Background Covering insertion sites with chlorhexidine impregnated dressings has been proven to be clinically effective in reducing catheter related blood stream infections (CR-BSI). Two chlorhexidine gluconate (CHG)-impregnated dressings are commercially available, a polyurethane foam disk and a film dressing containing a chlorhexidine gluconate-impregnated gel pad. While both have demonstrated efficacy in clinical settings, the major drawback of high cost and impaired IV insertion site visibility limits their usage. A new, simple film dressing containing CHG within its adhesive layer is now available. The objective of this study was to test the in vitro antimicrobial efficacy of the new dressing in comparison to the CHG-impregnated gel dressing. Methods Quantitative aliquots of suspensions (concentration of 1.0x10(6) to 5.0x10(6) cfu/sample) of clinically relevant challenge organisms (Staphylococcus species, gram-negative bacilli, Candida albicans) were incubated in contact with the new CHG-containing film dressing, a placebo version of the same (negative control) and the commercially available CHG-impregnated gel dressing (positive control). Serial dilutions of the surviving organisms were quantified using the pour plate after 1, 3, 5, and 7 days of incubation in order to calculate an antimicrobial log(10) reduction for each organism/dressing combination at each point in time. Results The new CHG-containing film dressing delivered greater than 5.0 log(10) reduction throughout the 7 days on all aerobic gram-negative bacilli and Staphylococcus species tested. As of day 1 the CHG-containing film dressing provided greater than 5.0 log(10) reduction on Candida albicans. There were no statistically significant differences in the log10 reduction between the two dressings tested. Conclusion The new CHG-containing film dressing was found to be as effective as the chlorhexidine gluconate-impregnated gel dressing on clinically relevant microbes.	[Wibaux, Anne; Thota, Priyaleela; Carty, Neal; Johnson, Peter] Vanc Med Technol, Chicago, IL 60606 USA; [Mastej, Jozef; Prince, Daniel L.] Gibraltar Labs Inc, Fairfield, NJ 07004 USA		Wibaux, A (corresponding author), Vanc Med Technol, 20 N Wacker Dr,Suite 2240, Chicago, IL 60606 USA.	anne.wibaux@averydennison.com		Carty, Neal/0000-0003-1329-4506	Vancive Medical TechnologiesTM, an Avery Dennison business	Vancive Medical TechnologiesTM, an Avery Dennison business	This work was supported by Vancive Medical TechnologiesTM, an Avery Dennison business. The funders had a role in study design, data analysis, decision to publish, and preparation of the manuscript. The funders had no role in the data collection.	Bashir MH, 2012, AM J INFECT CONTROL, V40, P344, DOI 10.1016/j.ajic.2011.03.030; Carty N, 2014, J ANTIMICROB CHEMOTH, V69, P2224, DOI 10.1093/jac/dku096; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Davies Julian, 2006, Can J Infect Dis Med Microbiol, V17, P287; Denton GW, 2001, DISINFECTION STERILI, P321; Exline MC, 2013, CRIT CARE, V17, DOI 10.1186/cc12551; Garland JS, 2001, PEDIATRICS, V107, P1431, DOI 10.1542/peds.107.6.1431; Karpanen TJ, 2011, J ANTIMICROB CHEMOTH, V66, P1777, DOI 10.1093/jac/dkr191; Kaye KS, 2008, CLIN INFECT DIS, V46, P1568, DOI 10.1086/587673; Levy I, 2005, PEDIATR INFECT DIS J, V24, P676, DOI 10.1097/01.inf.0000172934.98865.14; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mann TJ, 2001, ANAESTH INTENS CARE, V29, P600, DOI 10.1177/0310057X0102900606; Marchaim D, 2010, CLIN MICROBIOL INFEC, V16, P747, DOI 10.1111/j.1469-0691.2009.02934.x; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Palmore TN, 2013, CLIN INFECT DIS, V57, P1593, DOI 10.1093/cid/cit531; Poole M D, 1993, Ear Nose Throat J, V72, P433; Popovich KJ, 2012, INFECT CONT HOSP EP, V33, P889, DOI 10.1086/667371; Pujol M, 2007, J HOSP INFECT, V67, P22, DOI 10.1016/j.jhin.2007.06.017; Safdar N, 2014, CRIT CARE MED, V42, P1703, DOI 10.1097/CCM.0000000000000319; Shah H, 2013, NEUROHOSPITALIST, V3, P144, DOI 10.1177/1941874413476043; Tattevin P, 2012, CLIN INFECT DIS, V55, P781, DOI 10.1093/cid/cis527; Timsit JF, 2012, AM J RESP CRIT CARE, V186, P1272, DOI 10.1164/rccm.201206-1038OC; Timsit JF, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-34; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Ye X, 2011, AM J INFECT CONTROL, V39, P647, DOI 10.1016/j.ajic.2010.11.008; Zingg Walter, 2009, Int J Antimicrob Agents, V34 Suppl 4, pS38, DOI 10.1016/S0924-8579(09)70565-5	27	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143035	10.1371/journal.pone.0143035	http://dx.doi.org/10.1371/journal.pone.0143035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599087	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900059
J	Yamashiro, K; Sato, D; Onishi, H; Sugawara, K; Nakazawa, S; Shimojo, H; Akatsuka, K; Nakata, H; Maruyama, A				Yamashiro, Koya; Sato, Daisuke; Onishi, Hideaki; Sugawara, Kazuhiro; Nakazawa, Sho; Shimojo, Hirofumi; Akatsuka, Kosuke; Nakata, Hiroki; Maruyama, Atsuo			Skill-Specific Changes in Somatosensory Nogo Potentials in Baseball Players	PLOS ONE			English	Article							EVOKED POTENTIALS; ERP COMPONENTS; GO; PERFORMANCE; EXERCISE; SPEED; TASKS; P300	Athletic training is known to induce neuroplastic alterations in specific somatosensory circuits, which are reflected by changes in somatosensory evoked potentials and event-related potentials. The aim of this study was to clarify whether specific athletic training also affects somatosensory Nogo potentials related to the inhibition of movements. The Nogo potentials were recorded at nine cortical electrode positions (Fz, Cz, Pz, F3, F4, C3, C4, P3 and P4) in 12 baseball players (baseball group) and in 12 athletes in sports, such as track and field events and swimming, that do not require response inhibition, such as batting for training or performance (sports group). The Nogo potentials and Go/Nogo reaction times (Go/Nogo RTs) were measured under a somatosensory Go/Nogo paradigm in which subjects were instructed to rapidly push a button in response to stimulus presentation. The Nogo potentials were obtained by subtracting the Go trial from the Nogo trial. The peak Nogo-N2 was significantly shorter in the baseball group than that in the sports group. In addition, the amplitude of Nogo-N2 in the frontal area was significantly larger in the baseball group than that in the sports group. There was a significant positive correlation between the latency of Nogo-N2 and Go/Nogo RT. Moreover, there were significant correlations between the Go/Nogo RT and both the amplitude of Nogo-N2 and Nogo-P3 (i.e., amplitude of the Nogo-potentials increases with shorter RT). Specific athletic training regimens may induce neuroplastic alterations in sensorimotor inhibitory processes.	[Yamashiro, Koya; Sato, Daisuke; Onishi, Hideaki; Sugawara, Kazuhiro; Shimojo, Hirofumi; Maruyama, Atsuo] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Yamashiro, Koya; Sato, Daisuke; Nakazawa, Sho; Shimojo, Hirofumi; Maruyama, Atsuo] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Japan; [Onishi, Hideaki; Sugawara, Kazuhiro] Niigata Univ Hlth & Welf, Dept Phys Theraphy, Niigata, Japan; [Akatsuka, Kosuke] Kurume Natl Coll Technol, Dept Liberal Arts, Fukuoka, Japan; [Nakata, Hiroki] Nara Womens Univ, Dept HealthSci, Fac Human Life & Environm, Nara 630, Japan	Niigata University; Niigata University; Niigata University; Nara Womens University	Yamashiro, K (corresponding author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan.	yamashiro@nuhw.ac.jp	Shimojo, Hirofumi/AAP-2794-2021		Japan Society for the Promotion of Science (JSPS); Niigata University of Health and Welfare	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Niigata University of Health and Welfare	This study was supported by a Grant-in-aid for young scientists (B) from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-aid for Advanced Research from Niigata University of Health and Welfare.	Band GPH, 2003, PSYCHOL RES-PSYCH FO, V67, P266, DOI 10.1007/s00426-002-0127-0; Bulut S, 2003, INT J NEUROSCI, V113, P315, DOI 10.1080/00207450390162119; DESMEDT JE, 1977, J PHYSIOL-LONDON, V271, P761, DOI 10.1113/jphysiol.1977.sp012025; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Eimer M, 2003, EXP BRAIN RES, V151, P24, DOI 10.1007/s00221-003-1437-1; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Filipovic SR, 2000, EXP BRAIN RES, V132, P411, DOI 10.1007/s002210000349; Hashimoto I, 2004, CLIN NEUROPHYSIOL, V115, P435, DOI 10.1016/S1388-2457(03)00340-7; Iwadate M, 2005, EXP BRAIN RES, V160, P528, DOI 10.1007/s00221-004-2125-5; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Kida N, 2005, COGNITIVE BRAIN RES, V22, P257, DOI 10.1016/j.cogbrainres.2004.09.003; Kida T, 2004, COGNITIVE BRAIN RES, V19, P33, DOI 10.1016/j.cogbrainres.2003.10.016; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Lavric A, 2004, EUR J NEUROSCI, V20, P2483, DOI 10.1111/j.1460-9568.2004.03683.x; Murakami T, 2008, CLIN NEUROPHYSIOL, V119, P2862, DOI 10.1016/j.clinph.2008.09.002; Nakamoto H, 2008, BRAIN RES, V1189, P179, DOI 10.1016/j.brainres.2007.10.096; Nakata H, 2005, EXP BRAIN RES, V162, P293, DOI 10.1007/s00221-004-2195-4; Nakata H, 2004, CLIN NEUROPHYSIOL, V115, P361, DOI 10.1016/j.clinph.2003.09.013; Nakata H, 2014, J PHYSIOL SCI, V64, P233, DOI 10.1007/s12576-014-0320-0; Nakata H, 2012, EUR J APPL PHYSIOL, V112, P207, DOI 10.1007/s00421-011-1973-5; Nakata H, 2009, NEUROREPORT, V20, P1149, DOI 10.1097/WNR.0b013e32832f81d6; Smith JL, 2006, INT J PSYCHOPHYSIOL, V61, P121, DOI 10.1016/j.ijpsycho.2005.07.013; Thomas NG, 1996, MED SCI SPORT EXER, V28, P473, DOI 10.1097/00005768-199604000-00012; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Vallesi A, 2009, NEUROPSYCHOLOGIA, V47, P577, DOI 10.1016/j.neuropsychologia.2008.10.018; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Yamanaka K, 2002, EXP BRAIN RES, V142, P301, DOI 10.1007/s00221-001-0943-2; Yamashiro K, 2013, EXP BRAIN RES, V225, P197, DOI 10.1007/s00221-012-3361-8	29	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142581	10.1371/journal.pone.0142581	http://dx.doi.org/10.1371/journal.pone.0142581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600391	Green Published, gold			2022-12-27	WOS:000365853900028
J	Duque-Afonso, J; Smith, KS; Cleary, ML				Duque-Afonso, Jesus; Smith, Kevin S.; Cleary, Michael L.			Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice	PLOS ONE			English	Article							ACUTE-LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR; LEUCINE-ZIPPER; TRANSACTIVATION DOMAINS; ANTIAPOPTOTIC ACTIVITY; GENE; E2A; TRANSFORMATION; APOPTOSIS; FUSION	Chromosomal translocations are driver mutations of human cancers, particularly leukemias. They define disease subtypes and are used as prognostic markers, for minimal residual disease monitoring and therapeutic targets. Due to their low incidence, several translocations and their biological consequences remain poorly characterized. To address this, we engineered mouse strains that conditionally express E2A-HLF, a fusion oncogene from the translocation t(17; 19) associated with 1% of pediatric B-cell precursor ALL. Conditional oncogene activation and expression were directed to the B-cell compartment by the Cre driver promoters CD19 or Mb1 (Iga, CD79a), or to the hematopoietic stem cell compartment by the Mx1 promoter. E2A-HLF expression in B-cell progenitors induced hyposplenia and lymphopenia, whereas expression in hematopoietic stem/progenitor cells was embryonic lethal. Increased cell death was detected in E2A-HLF expressing cells, suggesting the need for cooperating genetic events that suppress cell death for B-cell oncogenic transformation. E2A-HLF/Mb1. Cre aged mice developed a fatal myeloproliferative-like disorder with low frequency characterized by leukocytosis, anemia, hepatosplenomegaly and organ-infiltration by mature myelocytes. In conclusion, we have developed conditional E2A-HLF knock-in mice, which provide an experimental platform to study cooperating genetic events and further elucidate translational biology in cross-species comparative studies.	[Duque-Afonso, Jesus; Smith, Kevin S.; Cleary, Michael L.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Cleary, ML (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	mcleary@stanford.edu			German Research Foundation (Deutsche Forschungsgemeinschaft) [DU 1287/2-1]; Lucile Packard Foundation for Children's Health; Child Health Research Institute; Stanford NIH-NCATS-CTSA [UL1 TR001085]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Lucile Packard Foundation for Children's Health; Child Health Research Institute; Stanford NIH-NCATS-CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding: JDA was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, ref. DU 1287/2-1). MLC was supported by the Lucile Packard Foundation for Children's Health, the Child Health Research Institute and the Stanford NIH-NCATS-CTSA grant #UL1 TR001085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altura RA, 1998, BLOOD, V92, P1397, DOI 10.1182/blood.V92.4.1397.416k19_1397_1405; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; DEDERA DA, 1993, CELL, V74, P833, DOI 10.1016/0092-8674(93)90463-Z; Duque-Afonso J, 2015, J CLIN INVEST, V125, P3667, DOI 10.1172/JCI81158; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Hirose K, 2010, BLOOD, V116, P962, DOI 10.1182/blood-2009-09-244673; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Honda H, 1999, BLOOD, V93, P2780; HUNGER SP, 1992, GENE DEV, V6, P1608, DOI 10.1101/gad.6.9.1608; HUNGER SP, 1994, BLOOD, V83, P2970, DOI 10.1182/blood.V83.10.2970.2970; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Inaba T, 1996, NATURE, V382, P541, DOI 10.1038/382541a0; INABA T, 1994, MOL CELL BIOL, V14, P3403, DOI 10.1128/MCB.14.5.3403; Inukai T, 2007, LEUKEMIA, V21, P288, DOI 10.1038/sj.leu.2404496; Inukai T, 1998, MOL CELL BIOL, V18, P6035, DOI 10.1128/MCB.18.10.6035; Inukai T, 2005, BLOOD, V105, P4437, DOI 10.1182/blood-2004-08-2976; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; Okuya M, 2010, J BIOL CHEM, V285, P1850, DOI 10.1074/jbc.M109.023762; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; RAIMONDI SC, 1991, BLOOD, V77, P2016; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Roberts KG, 2015, NAT REV CLIN ONCOL, V12, P344, DOI 10.1038/nrclinonc.2015.38; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seidel MG, 2001, ONCOGENE, V20, P5718, DOI 10.1038/sj.onc.1204591; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith KS, 2002, MOL CELL BIOL, V22, P7678, DOI 10.1128/MCB.22.21.7678-7688.2002; Smith KS, 1999, MOL CELL BIOL, V19, P4443; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Yamasaki N, 2010, ONCOGENE, V29, P1963, DOI 10.1038/onc.2009.475; YOSHIHARA T, 1995, MOL CELL BIOL, V15, P3247; Zhang X, 2012, LEUKEMIA, V26, P2483, DOI 10.1038/leu.2012.139; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	44	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143216	10.1371/journal.pone.0143216	http://dx.doi.org/10.1371/journal.pone.0143216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588248	Green Submitted, gold, Green Published			2022-12-27	WOS:000365251500039
J	Zheng, J; Hu, ZH; Guan, XL; Dou, DQ; Bai, G; Wang, Y; Guo, YT; Li, W; Leng, PS				Zheng, Jian; Hu, Zenghui; Guan, Xuelian; Dou, Dequan; Bai, Guo; Wang, Yu; Guo, Yingtian; Li, Wei; Leng, Pingsheng			Transcriptome Analysis of Syringa oblata Lindl. Inflorescence Identifies Genes Associated with Pigment Biosynthesis and Scent Metabolism	PLOS ONE			English	Article							EXPRESSION ANALYSIS; CHALCONE SYNTHASE; FLORAL SCENT; ANTHOCYANIN BIOSYNTHESIS; DIFFERENTIAL EXPRESSION; TEMPORAL EXPRESSION; GENOME ANNOTATION; RNA-SEQ; ARABIDOPSIS; R2R3-MYB	Syringa oblata Lindl. is a woody ornamental plant with high economic value and characteristics that include early flowering, multiple flower colors, and strong fragrance. Despite a long history of cultivation, the genetics and molecular biology of S. oblata are poorly understood. Transcriptome and expression profiling data are needed to identify genes and to better understand the biological mechanisms of floral pigments and scents in this species. Nine cDNA libraries were obtained from three replicates of three developmental stages: inflorescence with enlarged flower buds not protruded, inflorescence with corolla lobes not displayed, and inflorescence with flowers fully opened and emitting strong fragrance. Using the Illumina RNA-Seq technique, 319,425,972 clean reads were obtained and were assembled into 104,691 final unigenes (average length of 853 bp), 41.75% of which were annotated in the NCBI non-redundant protein database. Among the annotated unigenes, 36,967 were assigned to gene ontology categories and 19,956 were assigned to eukaryoticorthologous groups. Using the Kyoto Encyclopedia of Genes and Genomes pathway database, 12,388 unigenes were sorted into 286 pathways. Based on these transcriptomic data, we obtained a large number of candidate genes that were differentially expressed at different flower stages and that were related to floral pigment biosynthesis and fragrance metabolism. This comprehensive transcriptomic analysis provides fundamental information on the genes and pathways involved in flower secondary metabolism and development in S. oblata, providing a useful database for further research on S. oblata and other plants of genus Syringa.	[Zheng, Jian; Hu, Zenghui; Guan, Xuelian; Dou, Dequan; Bai, Guo; Wang, Yu; Guo, Yingtian; Leng, Pingsheng] Beijing Agr Univ, Coll Landscape Architecture, Beijing 102206, Peoples R China; [Zheng, Jian] Beijing Engn Res Ctr Rural Landscape Planning & D, Beijing 102206, Peoples R China; [Li, Wei] Qingdao Agr Univ, Coll Landscape Architecture & Forestry, Qingdao 266100, Peoples R China	Beijing University of Agriculture; Qingdao Agricultural University	Leng, PS (corresponding author), Beijing Agr Univ, Coll Landscape Architecture, Beijing 102206, Peoples R China.	zhengjian770116@163.com	Guo, Yingtian/GLT-2017-2022		Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD20154043]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality [CITIDHT20150503]; Building Project of Beijing Laboratory of Urban and Rural Ecological Environment [PXM2015-014207-000014]	Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality; Building Project of Beijing Laboratory of Urban and Rural Ecological Environment	Funding: Funding was provided by The Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT& The Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality (CIT& The Building Project of Beijing Laboratory of Urban and Rural Ecological Environment (PXM2015-014207-000014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Ben Zvi MM, 2008, PLANT BIOTECHNOL J, V6, P403, DOI 10.1111/j.1467-7652.2008.00329.x; Brautigam A, 2011, J EXP BOT, V62, P3093, DOI 10.1093/jxb/err029; Cardoso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046021; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; [崔洪霞 Cui Hongxia], 2004, [植物研究, Bulletin of Botanical Research], V24, P141; Deng MingHua, 2012, African Journal of Biotechnology, V11, P2389; Dudareva N, 1996, PLANT CELL, V8, P1137, DOI 10.1105/tpc.8.7.1137; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Elomaa P, 2003, PLANT PHYSIOL, V133, P1831, DOI 10.1104/pp.103.026039; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Feng LG, 2014, PLANT PHYSIOL BIOCH, V75, P80, DOI 10.1016/j.plaphy.2013.12.006; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Ge XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087693; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Guitton Y, 2010, PHYSIOL PLANTARUM, V138, P150, DOI 10.1111/j.1399-3054.2009.01315.x; Hao RJ, 2014, BIOCHEM SYST ECOL, V54, P23, DOI 10.1016/j.bse.2013.12.007; Hatayama M, 2006, PLANT BIOTECHNOL, V23, P273; Hendel-Rahmanim K, 2007, PLANTA, V226, P1491, DOI 10.1007/s00425-007-0582-3; Hu K, 2010, THESIS, P63; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; [回瑞华 Hui Ruihua], 2002, [质谱学报, Journal of Chinese Mass Spectrometry Society], V23, P210; Iwashina Tsukasa, 2001, Journal of Japanese Botany, V76, P166; [黄金霞 Jinxia Huang], 2006, [植物学通报, Chinese Bulletin of Botany], V23, P321; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kunu W., 2012, African Journal of Biotechnology, V11, P12702; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085480; Li ZuGuang, 2006, Journal of Zhejiang Forestry College, V23, P159; Liu DF, 2013, PLOS ONE, V9; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muhlemann JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040381; Nagegowda DA, 2010, FEBS LETT, V584, P2965, DOI 10.1016/j.febslet.2010.05.045; Nakatsuka A, 2003, PLANT SCI, V165, P759, DOI 10.1016/S0168-9452(03)00254-1; Nakatsuka T, 2005, PLANT SCI, V168, P1309, DOI 10.1016/j.plantsci.2005.01.009; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ogata J., 2004, PLANT BIOTECHNOL, V21, P367, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.21.367; Pelletier MK, 1996, PLANT PHYSIOL, V111, P339, DOI 10.1104/pp.111.1.339; Pelletier MK, 1997, PLANT PHYSIOL, V113, P1437, DOI 10.1104/pp.113.4.1437; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Spitzer-Rimon B, 2012, PLANT CELL, V24, P5089, DOI 10.1105/tpc.112.105247; Spitzer-Rimon B, 2010, PLANT CELL, V22, P1961, DOI 10.1105/tpc.109.067280; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Svenson SE, 2014, AM NURSERYMAN, V214, P38; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Togami J, 2011, PLANT BIOTECHNOL-NAR, V28, P231, DOI 10.5511/plantbiotechnology.11.0106b; Verdonk JC, 2005, PLANT CELL, V17, P1612, DOI 10.1105/tpc.104.028837; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yamagishi M, 2010, PLANT CELL PHYSIOL, V51, P463, DOI 10.1093/pcp/pcq011; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yuan YW, 2013, CURR OPIN PLANT BIOL, V16, P422, DOI 10.1016/j.pbi.2013.05.004; [张辉秀 Zhang Huixiu], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P790; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhao J, 2012, KOREAN J HORTIC SCI, V30, P617, DOI 10.7235/hort.2012.12055; Zhou L, 2011, AFR J BIOTECHNOL, V10, P1275	65	31	35	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142542	10.1371/journal.pone.0142542	http://dx.doi.org/10.1371/journal.pone.0142542			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587670	Green Published, gold			2022-12-27	WOS:000365251500011
J	Kamarajan, C; Pandey, AK; Chorlian, DB; Manz, N; Stimus, AT; Anokhin, AP; Bauer, LO; Kuperman, S; Kramer, J; Bucholz, KK; Schuckit, MA; Hesselbrock, VM; Porjesz, B				Kamarajan, Chella; Pandey, Ashwini K.; Chorlian, David B.; Manz, Niklas; Stimus, Arthur T.; Anokhin, Andrey P.; Bauer, Lance O.; Kuperman, Samuel; Kramer, John; Bucholz, Kathleen K.; Schuckit, Marc A.; Hesselbrock, Victor M.; Porjesz, Bernice			Deficient Event-Related Theta Oscillations in Individuals at Risk for Alcoholism: A Study of Reward Processing and Impulsivity Features	PLOS ONE			English	Article							FEEDBACK-RELATED NEGATIVITY; CURRENT SOURCE DENSITY; MEDIAL FRONTAL-CORTEX; AUDITORY ODDBALL TASK; GAMMA BAND RESPONSE; SCHOOL-AGE CHILDREN; FAMILY-HISTORY; BRAIN OSCILLATIONS; SEX-DIFFERENCES; DEVELOPMENTAL-CHANGES	Background Individuals at high risk to develop alcoholism often manifest neurocognitive deficits as well as increased impulsivity. Event-related oscillations (EROs) have been used to effectively measure brain (dys) function during cognitive tasks in individuals with alcoholism and related disorders and in those at risk to develop these disorders. The current study examines ERO theta power during reward processing as well as impulsivity in adolescent and young adult subjects at high risk for alcoholism. Methods EROs were recorded during a monetary gambling task (MGT) in 12-25 years old participants (N = 1821; males = 48%) from high risk alcoholic families (HR, N = 1534) and comparison low risk community families (LR, N = 287) from the Collaborative Study on the Genetics of Alcoholism (COGA). Impulsivity scores and prevalence of externalizing diagnoses were also compared between LR and HR groups. Results HR offspring showed lower theta power and decreased current source density (CSD) activity than LR offspring during loss and gain conditions. Younger males had higher theta power than younger females in both groups, while the older HR females showed more theta power than older HR males. Younger subjects showed higher theta power than older subjects in each comparison. Differences in topography (i.e., frontalization) between groups were also observed. Further, HR subjects across gender had higher impulsivity scores and increased prevalence of externalizing disorders compared to LR subjects. Conclusions As theta power during reward processing is found to be lower not only in alcoholics, but also in HR subjects, it is proposed that reduced reward-related theta power, in addition to impulsivity and externalizing features, may be related in a predisposition to develop alcoholism and related disorders.	[Kamarajan, Chella; Pandey, Ashwini K.; Chorlian, David B.; Manz, Niklas; Stimus, Arthur T.; Porjesz, Bernice] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Anokhin, Andrey P.; Bucholz, Kathleen K.] Washington Univ, Sch Med, St Louis, MO USA; [Bauer, Lance O.; Hesselbrock, Victor M.] Univ Connecticut, Ctr Hlth, Farmington, CT USA; [Kuperman, Samuel; Kramer, John] Univ Iowa, Iowa City, IA USA; [Schuckit, Marc A.] Univ Calif San Diego, San Diego, CA 92103 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Washington University (WUSTL); University of Connecticut; University of Iowa; University of California System; University of California San Diego	Kamarajan, C (corresponding author), Suny Downstate Med Ctr, Brooklyn, NY 11203 USA.	kam@hbnl.downstate.edu	Kamarajan, Chella/C-5671-2019; Pandey, Ashwini Kumar/D-6788-2013; Manz, Niklas/A-3234-2009	Kamarajan, Chella/0000-0003-2291-6880; Pandey, Ashwini Kumar/0000-0002-2688-7901; Manz, Niklas/0000-0003-1483-915X; Anokhin, Andrey/0000-0001-8158-6346; Kuperman, Samuel/0000-0002-5995-1981	NIH grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U10AA008401]; National Institute on Drug Abuse (NIDA); NIAAA [AA05524]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA003510, R37AA005524, R01AA005524, U10AA008401, F31AA005524] Funding Source: NIH RePORTER	NIH grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	NIH grant U10AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (http://www.niaaa.nih.gov/) and the National Institute on Drug Abuse (NIDA)(http://www.drugabuse.gov/) (BP, VMH), and grant AA05524 (BP) from NIAAA (http://www.niaaa.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We continue to be inspired by our memories of Henri Begleiter and Theodore Reich, founding PI and Co-PI of COGA, and also owe a debt of gratitude to other past organizers of COGA, including Ting-Kai Li, currently a consultant with COGA, P. Michael Conneally, Raymond Crowe, and Wendy Reich, for their critical contributions. This study is supported by NIH grant U10AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), and grant AA05524 (PI: Bernice Porjesz) from NIAAA.	ALEXANDER JE, 1994, INT J PSYCHOPHYSIOL, V17, P35, DOI 10.1016/0167-8760(94)90053-1; Barratt ES., 1985, MOTIVATION EMOTION P, P137, DOI DOI 10.1371/JOURNAL.PONE.0129139; Bas ~ar E, 1999, BRAIN FUNCTION OSCIL; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basar E, 1999, NEUROSCI LETT, V259, P165, DOI 10.1016/S0304-3940(98)00934-3; Basar E, 2015, INT J PSYCHOPHYSIOL; Basar E., 1999, BRAIN FUNCTION OSCIL, VI; Basar E, 2008, BRAIN RES, V1235, P172, DOI 10.1016/j.brainres.2008.06.103; Basar Erol, 2013, Dialogues Clin Neurosci, V15, P291; Basar Erol, 2013, Suppl Clin Neurophysiol, V62, P303; Basar-Eroglu C, 2001, INT J PSYCHOPHYSIOL, V39, P167, DOI 10.1016/S0167-8760(00)00140-9; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; BEGLEITER H, 1987, ALCOHOL, V4, P315, DOI 10.1016/0741-8329(87)90029-2; Begleiter H, 1995, ALCOHOL HEALTH RES W, V19, P228; BEGLEITER H, 1984, SCIENCE, V225, P1493, DOI 10.1126/science.6474187; Bell MA, 2012, J COGN DEV, V13, P281, DOI 10.1080/15248372.2012.691143; Benegal V, 1995, PSYCHIATR GENET, V5, P149, DOI 10.1097/00041444-199524000-00001; BERMAN SM, 1993, ALCOHOL, V10, P69, DOI 10.1016/0741-8329(93)90055-S; Bernat EM, 2011, J ABNORM PSYCHOL, V120, P352, DOI 10.1037/a0022124; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Boord Peter R., 2007, Journal of Integrative Neuroscience, V6, P205, DOI 10.1142/S0219635207001416; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; CHATRIAN GE, 1988, J CLIN NEUROPHYSIOL, V5, P183, DOI 10.1097/00004691-198804000-00005; Chorlian DB, 2015, BEHAV BRAIN RES, V292, P342, DOI 10.1016/j.bbr.2015.06.020; Chuang CC, 2014, BIOMED OPT EXPRESS, V5, P2503, DOI 10.1364/BOE.5.002503; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P806, DOI 10.1016/S1388-2457(01)00488-6; COHEN HL, 1994, ALCOHOL, V11, P583, DOI 10.1016/0741-8329(94)90087-6; Cohen HL, 1997, BIOL PSYCHIAT, V42, P57, DOI 10.1016/S0006-3223(96)00221-1; Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056; Cottencin O, 2009, EUR PSYCHIAT, V24, P195, DOI 10.1016/j.eurpsy.2008.12.003; Courehesne E, 1990, ISSUES EVENT RELATED; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Cservenka A, 2014, PSYCHIAT RES-NEUROIM, V221, P210, DOI 10.1016/j.pscychresns.2013.12.004; Cservenka A, 2012, ALCOHOL CLIN EXP RES, V36, P604, DOI 10.1111/j.1530-0277.2011.01650.x; Cuijpers P, 1999, ADDICTION, V94, P1489, DOI 10.1046/j.1360-0443.1999.941014895.x; Davies PL, 2004, DEV NEUROPSYCHOL, V25, P355, DOI 10.1207/s15326942dn2503_6; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; de Greck M, 2009, HUM BRAIN MAPP, V30, P1691, DOI 10.1002/hbm.20634; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Dick DM, 2013, TWIN RES HUM GENET, V16, P661, DOI 10.1017/thg.2013.20; Dick DM, 2010, ADDICT BIOL, V15, P217, DOI 10.1111/j.1369-1600.2009.00190.x; DREJER K, 1985, ALCOHOL CLIN EXP RES, V9, P498, DOI 10.1111/j.1530-0277.1985.tb05590.x; Dustman RE, 1999, CLIN NEUROPHYSIOL, V110, P1399, DOI 10.1016/S1388-2457(99)00102-9; Ecuyer-Dab I, 2004, COGNITION, V91, P221, DOI 10.1016/j.cognition.2003.09.007; Edenberg HJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S2; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fein G, 2008, DRUG ALCOHOL DEPEN, V92, P141, DOI 10.1016/j.drugalcdep.2007.07.017; Field AP, 1988, NEWSLETTER MATH STAT, V6, P13; Foroud T, 2000, ALCOHOL CLIN EXP RES, V24, P933, DOI 10.1097/00000374-200007000-00001; Freunberger R, 2007, BRAIN RES BULL, V71, P593, DOI 10.1016/j.brainresbull.2006.11.014; Freunberger R, 2011, BRAIN RES, V1375, P93, DOI 10.1016/j.brainres.2010.12.048; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Garcia-Garcia M, 2008, BIOL PSYCHOL, V79, P307, DOI 10.1016/j.biopsycho.2008.07.006; Gasbarri A, 2006, BEHAV BRAIN RES, V168, P177, DOI 10.1016/j.bbr.2005.07.034; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P100, DOI 10.1016/0013-4694(88)90205-2; Gehring W.J., 2004, ERRORS CONFLICTS BRA; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Geier C, 2009, PHARMACOL BIOCHEM BE, V93, P212, DOI 10.1016/j.pbb.2009.01.021; Giancola PR, 1996, ALCOHOL CLIN EXP RES, V20, P740, DOI 10.1111/j.1530-0277.1996.tb01680.x; Gilmore CS, 2012, BRAIN BEHAV, V2, P796, DOI 10.1002/brb3.95; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; Guntekin B, 2007, NEUROSCI LETT, V424, P94, DOI 10.1016/j.neulet.2007.07.052; Guntekin B, 2007, INT J PSYCHOPHYSIOL, V65, P294, DOI 10.1016/j.ijpsycho.2007.03.009; Guntekin B, 2007, INT J PSYCHOPHYSIOL, V64, P91, DOI 10.1016/j.ijpsycho.2006.07.003; Haas L F, 2003, J Neurol Neurosurg Psychiatry, V74, P9, DOI 10.1136/jnnp.74.1.9; Hammerer D, 2012, DEV PSYCHOL, V48, P862, DOI 10.1037/a0027342; Hammerer D, 2011, J COGNITIVE NEUROSCI, V23, P579, DOI 10.1162/jocn.2010.21475; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Hall JR, 2007, PSYCHOL SCI, V18, P326, DOI 10.1111/j.1467-9280.2007.01899.x; Hardie TL, 2008, AM J ADDICTION, V17, P319, DOI 10.1080/10550490802139010; Harper J, 2014, CLIN NEUROPHYSIOL, V125, P124, DOI 10.1016/j.clinph.2013.06.025; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Hauser TU, 2015, NEUROIMAGE, V104, P347, DOI 10.1016/j.neuroimage.2014.09.018; Herting MM, 2011, NEUROIMAGE, V54, P2582, DOI 10.1016/j.neuroimage.2010.10.030; Hill SY, 1999, BIOL PSYCHIAT, V46, P970, DOI 10.1016/S0006-3223(99)00032-3; HJORTH B, 1991, J CLIN NEUROPHYSIOL, V8, P391, DOI 10.1097/00004691-199110000-00004; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Holguin SR, 1999, BIOL PSYCHIAT, V46, P281, DOI 10.1016/S0006-3223(98)00247-9; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Jausovec N, 2008, INTELLIGENCE, V36, P383, DOI 10.1016/j.intell.2007.09.002; Jausovec N, 2009, NEUROIMAGE, V45, P198, DOI 10.1016/j.neuroimage.2008.11.013; Javadi AH, 2014, J COGNITIVE NEUROSCI, V26, P2670, DOI 10.1162/jocn_a_00677; Javadi AH, 2014, NEUROPSYCHOLOGIA, V56, P280, DOI 10.1016/j.neuropsychologia.2014.01.021; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P651, DOI 10.1111/j.1469-8986.1989.tb03167.x; Jones KA, 2004, INT J PSYCHOPHYSIOL, V53, P75, DOI 10.1016/j.ijpsycho.2004.02.004; Jones KA, 2006, CLIN NEUROPHYSIOL, V117, P2128, DOI 10.1016/j.clinph.2006.02.028; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kamarajan C, 2006, BIOL PSYCHIAT, V59, P625, DOI 10.1016/j.biopsych.2005.08.017; Kamarajan C, 2005, BIOL PSYCHOL, V69, P353, DOI 10.1016/j.biopsycho.2004.08.004; Kamarajan C, 2004, INT J PSYCHOPHYSIOL, V51, P155, DOI 10.1016/j.ijpsycho.2003.09.004; Kamarajan C, 2008, BRAIN RES, V1235, P45, DOI 10.1016/j.brainres.2008.06.051; Kamarajan C, 2015, INT J PSYCHOPHYSIOL, V98, P182, DOI 10.1016/j.ijpsycho.2015.09.005; Kamarajan C, 2015, INT J PSYCHOPHYSIOL, V97, P310, DOI 10.1016/j.ijpsycho.2014.10.013; Kamarajan C, 2012, HUM BRAIN MAPP, V33, P1019, DOI 10.1002/hbm.21267; Kamarajan C, 2010, J PSYCHIATR RES, V44, P576, DOI 10.1016/j.jpsychires.2009.11.019; Kamarajan C, 2009, BEHAV BRAIN RES, V197, P62, DOI 10.1016/j.bbr.2008.08.011; Karakas S, 2000, NEUROSCI LETT, V285, P45, DOI 10.1016/S0304-3940(00)01022-3; Kayser J, 2014, INT J PSYCHOPHYSIOL, V91, P104, DOI 10.1016/j.ijpsycho.2013.12.003; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Klimesch W, 2006, CEREB CORTEX, V16, P280, DOI 10.1093/cercor/bhi107; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; Klimesch W, 1997, NEUROSCI LETT, V238, P9, DOI 10.1016/S0304-3940(97)00771-4; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2001, CLIN NEUROPHYSIOL, V112, P1174, DOI 10.1016/S1388-2457(01)00545-4; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; Knyazev GG, 2008, CLIN NEUROPHYSIOL, V119, P556, DOI 10.1016/j.clinph.2007.11.041; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Knyazev GG, 2010, EMOTION, V10, P678, DOI 10.1037/a0019175; Kolev V, 2002, CLIN NEUROPHYSIOL, V113, P901, DOI 10.1016/S1388-2457(02)00106-2; Koob GF, 2013, CURR TOP BEHAV NEURO, V13, P3, DOI 10.1007/7854_2011_129; Kovacevic S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043957; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; KUPERMAN S, 1995, ELECTROEN CLIN NEURO, V94, P462, DOI 10.1016/0013-4694(94)00312-9; Ladouceur CD, 2007, DEVELOPMENTAL SCI, V10, P874, DOI 10.1111/j.1467-7687.2007.00639.x; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Liu Y, 2014, PSYCHOPHYSIOLOGY; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; Marco-Pallares J, 2008, NEUROPSYCHOLOGIA, V46, P241, DOI 10.1016/j.neuropsychologia.2007.07.016; Marinkovic K, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00121; MATOUSEK M, 1973, ELECTROEN CLIN NEURO, V35, P603, DOI 10.1016/0013-4694(73)90213-7; Matousek M., 1973, AUTOMATION CLIN ELEC, P75; Mennes M, 2008, PSYCHOPHYSIOLOGY; Mizuhara H, 2007, NEUROIMAGE, V36, P232, DOI 10.1016/j.neuroimage.2007.02.026; Mohr PNC, 2010, NEUROSCI BIOBEHAV R, V34, P678, DOI 10.1016/j.neubiorev.2009.05.010; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; NUNEZ P L, 1989, Brain Topography, V2, P141, DOI 10.1007/BF01128851; Nunez P.L, 1981, ELECT FIELDS BRAIN N; NUNEZ PL, 1991, J CLIN NEUROPHYSIOL, V8, P397, DOI 10.1097/00004691-199110000-00005; Nurnberger JI, 2004, ARCH GEN PSYCHIAT, V61, P1246, DOI 10.1001/archpsyc.61.12.1246; OBOYLE M, 1993, PERS INDIV DIFFER, V14, P609, DOI 10.1016/0191-8869(93)90156-W; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; OCONNOR S, 1986, PROG NEURO-PSYCHOPH, V10, P211, DOI 10.1016/0278-5846(86)90075-8; OCONNOR S, 1987, ALCOHOL, V4, P323; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Padmanabhapillai A, 2006, INT J PSYCHOPHYSIOL, V60, P15, DOI 10.1016/j.ijpsycho.2005.03.026; Padmanabhapillai A, 2006, INT J PSYCHOPHYSIOL, V62, P262, DOI 10.1016/j.ijpsycho.2006.05.012; Pandey AK., 2012, J ADDICT RES THER, V7, P3844, DOI [DOI 10.4172/2155-6105.S7-001, 10.4172/2155-6105.S7-001]; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; POLICH J, 1994, PSYCHOL BULL, V115, P55, DOI 10.1037/0033-2909.115.1.55; PORJESZ B, 1987, ALCOHOL, V4, P283, DOI 10.1016/0741-8329(87)90024-3; Porjesz B, 2005, CLIN NEUROPHYSIOL, V116, P993, DOI 10.1016/j.clinph.2004.12.016; Porjesz B, 1996, INT CONGR SER, V1099, P539; Porjesz Bernice, 2007, ScientificWorldJournal, V7, P131; Prescott CA, 2002, ALCOHOL RES HEALTH, V26, P264; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Ramachandran G, 1996, ALCOHOL CLIN EXP RES, V20, P9, DOI 10.1111/j.1530-0277.1996.tb01035.x; Ramsey SE, 1997, J STUD ALCOHOL, V58, P606, DOI 10.15288/jsa.1997.58.606; Rangaswamy M, 2007, INT J PSYCHOPHYSIOL, V63, P3, DOI 10.1016/j.ijpsycho.2006.10.003; Rangaswamy Madhavi, 2014, Handb Clin Neurol, V125, P383, DOI 10.1016/B978-0-444-62619-6.00023-9; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; RICE JP, 1995, ALCOHOL CLIN EXP RES, V19, P1018, DOI 10.1111/j.1530-0277.1995.tb00983.x; Rohrbaugh JW, 1997, INT J PSYCHOPHYSIOL, V25, P111, DOI 10.1016/S0167-8760(96)00714-3; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Romer D, 2009, NEUROPSYCHOLOGIA, V47, P2916, DOI 10.1016/j.neuropsychologia.2009.06.019; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; SAUNDERS JT, 1973, AM J ORTHOPSYCHIAT, V43, P789, DOI 10.1111/j.1939-0025.1973.tb00851.x; SCHACTER DL, 1977, BIOL PSYCHOL, V5, P47, DOI 10.1016/0301-0511(77)90028-X; Schmiedt C, 2005, COGNITIVE BRAIN RES, V25, P936, DOI 10.1016/j.cogbrainres.2005.09.015; Schmiedt-Fehr C, 2011, CLIN NEUROPHYSIOL, V122, P1156, DOI 10.1016/j.clinph.2010.10.045; Segalowitz SJ, 2010, BRAIN COGNITION, V72, P86, DOI 10.1016/j.bandc.2009.10.003; Segalowitz SJ, 2008, DEVELOPMENTAL PSYCHOPHYSIOLOGY: THEORY, SYSTEMS, AND METHODS, P1; Shen X, 2005, INT J NEUROSCI, V115, P1631, DOI 10.1080/00207450590958484; SHER KJ, 1991, J ABNORM PSYCHOL, V100, P427, DOI 10.1037/0021-843X.100.4.427; SHER KJ, 1994, J ABNORM PSYCHOL, V103, P92, DOI 10.1037/0021-843X.103.1.92; Silverman I, 2007, ARCH SEX BEHAV, V36, P261, DOI 10.1007/s10508-006-9168-6; Spadoni AD, 2013, AM J DRUG ALCOHOL AB, V39, P356, DOI 10.3109/00952990.2013.818680; Squeglia LM, 2014, PSYCHOL MED, V44, P2775, DOI 10.1017/S0033291714000609; Srinivasan R, 1999, INT J BIOELECTROMAGN, V1, P102, DOI DOI 10.1109/IEMBS.1988.95290; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Stice E, 2014, PSYCHOL ADDICT BEHAV, V28, P805, DOI 10.1037/a0034460; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Stoltenberg SF, 2008, ADDICT BEHAV, V33, P252, DOI 10.1016/j.addbeh.2007.09.004; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tenke CE, 2012, CLIN NEUROPHYSIOL, V123, P2328, DOI 10.1016/j.clinph.2012.06.005; Toyomaki A, 2005, NEUROREPORT, V16, P1865, DOI 10.1097/01.wnr.0000185962.96217.36; Trujillo LT, 2007, CLIN NEUROPHYSIOL, V118, P645, DOI 10.1016/j.clinph.2006.11.009; Van der Stelt O, 1998, ALCOHOL, V15, P119, DOI 10.1016/S0741-8329(97)00106-7; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Wackermann J, 1998, ELECTROEN CLIN NEURO, V107, P415, DOI 10.1016/S0013-4694(98)00090-X; Wang KM, 1999, BRAIN TOPOGR, V12, P19, DOI 10.1023/A:1022225522447; Wetherill RR, 2012, BRAIN RES, V1432, P66, DOI 10.1016/j.brainres.2011.11.013; WHIPPLE SC, 1991, ALCOHOL, V8, P321, DOI 10.1016/0741-8329(91)90497-K; Yener GG, 2007, INT J PSYCHOPHYSIOL, V64, P46, DOI 10.1016/j.ijpsycho.2006.07.006; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yordanova J, 1998, J PSYCHOPHYSIOL, V12, P113; Yordanova J, 1997, EVOKED POTENTIAL, V104, P418, DOI 10.1016/S0168-5597(97)00054-3; Yordanova J, 2006, NEUROIMAGE, V32, P940, DOI 10.1016/j.neuroimage.2006.03.056; Yordanova J, 2009, J PSYCHOPHYSIOL, V23, P174, DOI 10.1027/0269-8803.23.4.174; Yordanova J, 2008, DEVELOPMENTAL PSYCHOPHYSIOLOGY: THEORY, SYSTEMS, AND METHODS, P15; Yordanova JY, 1996, ELECTROEN CLIN NEURO, V99, P527; Yu RJ, 2006, NEUROREPORT, V17, P1649, DOI 10.1097/01.wnr.0000236866.39328.1d; Yun L., 2013, INT J SIGNAL P, V65, P245; Yurgelun-Todd DA, 2006, NEUROSCI LETT, V406, P194, DOI 10.1016/j.neulet.2006.07.046	212	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142659	10.1371/journal.pone.0142659	http://dx.doi.org/10.1371/journal.pone.0142659			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580209	Green Published, gold			2022-12-27	WOS:000365154600054
J	Moreno, P; Lara-Chica, M; Soler-Torronteras, R; Caro, T; Medina, M; Alvarez, A; Salvatierra, A; Munoz, E; Calzado, MA				Moreno, Paula; Lara-Chica, Maribel; Soler-Torronteras, Rafael; Caro, Teresa; Medina, Manuel; Alvarez, Antonio; Salvatierra, Angel; Munoz, Eduardo; Calzado, Marco A.			The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer	PLOS ONE			English	Article							MURINE HOMOLOGS; PROLIFERATION; TUMORIGENESIS; PROGRESSION; INHIBITION; PHENOTYPE; SURVIVAL; HIF	Objectives Lung cancer is the leading cause of cancer-related deaths worldwide. Overall 5-year survival has shown little improvement over the last decades. Seven in absentia homolog (SIAH) proteins are E3 ubiquitin ligases that mediate proteasomal protein degradation by poly-ubiquitination. Even though SIAH proteins play a key role in several biological processes, their role in human cancer remains controversial. The aim of the study was to document SIAH2 expression pattern at different levels (mRNA, protein level and immunohistochemistry) in human non-small cell lung cancer (NSCLC) samples compared to surrounding healthy tissue from the same patient, and to analyse the association with clinicopathological features. Materials and Methods One hundred and fifty-two samples from a patient cohort treated surgically for primary lung cancer were obtained for the study. Genic and protein expression levels of SIAH2 were analysed and compared with clinic-pathologic variables. Results The present study is the first to analyze the SIAH2 expression pattern at different levels (RNA, protein expression and immunohistochemistry) in non-small cell lung cancer (NSCLC). We found that SIAH2 protein expression is significantly enhanced in human lung adenocarcinoma (ADC) and squamous cell lung cancer (SCC). Paradoxically, non-significant changes at RNA level were found, suggesting a post-traductional regulatory mechanism. More importantly, an increased correlation between SIAH2 expression and tumor grade was detected, suggesting that this protein could be used as a prognostic biomarker to predict lung cancer progression. Likewise, SIAH2 protein expression showed a strong positive correlation with fluorodeoxyglucose (2-deoxy-2(F-18) fluoro-D-glucose) uptake in primary NSCLC, which may assist clinicians in stratifying patients at increased overall risk of poor survival. Additionally, we described an inverse correlation between the expression of SIAH2 and the levels of one of its substrates, the serine/threonine kinase DYRK2. Conclusions Our results provide insight into the potential use of SIAH2 as a novel target for lung cancer treatment.	[Moreno, Paula; Lara-Chica, Maribel; Soler-Torronteras, Rafael; Munoz, Eduardo; Calzado, Marco A.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, E-14004 Cordoba, Spain; [Caro, Teresa; Medina, Manuel] Univ Cordoba, Dept Pathol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, E-14004 Cordoba, Spain; [Alvarez, Antonio; Salvatierra, Angel] Hosp Univ Reina Sofia, Thorac Surg & Lung Transplantat Unit, Cordoba 14004, Spain	Universidad de Cordoba; Universidad de Cordoba	Calzado, MA (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, E-14004 Cordoba, Spain.	mcalzado@uco.es	Salvatierra, Angel/E-4530-2015; Munoz, Eduardo/I-5225-2012; Calzado, Marco A./S-2295-2019; Alvarez, Antonio/AAM-6126-2021; Lara Chica, Maribel/GRF-0887-2022; Calzado, Marco/E-9046-2016	Munoz, Eduardo/0000-0001-8478-5842; Calzado, Marco A./0000-0002-5338-535X; Alvarez, Antonio/0000-0003-1531-9543; Calzado, Marco/0000-0002-5338-535X; MORENO, PAULA/0000-0003-4403-7035; Caro Cuenca, Teresa/0000-0003-4838-8684; Lara-Chica, Maribel/0000-0003-2908-9929	Ministerio de Economia y Competitividad MICINN [SAF2010-17122]; Consejeria de Salud (Junta de Andalucia) [PI-0650-2010, PI-0246-2013]; Instituto de Salud Carlos III [PIE14/00005]	Ministerio de Economia y Competitividad MICINN(Spanish Government); Consejeria de Salud (Junta de Andalucia)(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Ministerio de Economia y Competitividad MICINN (SAF2010-17122) to MAC, Consejeria de Salud (Junta de Andalucia) (PI-0650-2010) to MAC, Consejeria de Salud (Junta de Andalucia) (PI-0246-2013) to MAC, and Instituto de Salud Carlos III, Award Number: PIE14/00005 (FLEXI-MET) to MAC.	Ahmed AU, 2008, JNCI-J NATL CANCER I, V100, P1606, DOI 10.1093/jnci/djn365; Behling KC, 2011, BREAST CANCER RES TR, V129, P717, DOI 10.1007/s10549-010-1254-8; Brauckhoff A, 2011, J HEPATOL, V55, P1049, DOI 10.1016/j.jhep.2011.02.019; Bruzzoni-Giovanelli H, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-10; Butler CA, 2006, RESP MED, V100, P1642, DOI 10.1016/j.rmed.2005.12.006; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Chan P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2828; Confalonieri S, 2009, ONCOGENE, V28, P2959, DOI 10.1038/onc.2009.156; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Erridge SC, 2007, NAT CLIN PRACT ONCOL, V4, P570, DOI 10.1038/ncponc0932; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Holloway AJ, 1997, GENOMICS, V41, P160, DOI 10.1006/geno.1997.4642; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2009, CANCER RES, V69, P8835, DOI 10.1158/0008-5472.CAN-09-1676; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kim H, 2004, J AM SOC NEPHROL, V15, P2042, DOI 10.1097/01.ASN.0000133490.00348.59; Kramer OH, 2013, LEUKEMIA, V27, P792, DOI 10.1038/leu.2012.284; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Malz M, 2012, INT J CANCER, V131, P2016, DOI 10.1002/ijc.27473; Manser R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004699.pub2; Moller A, 2009, ONCOGENE, V28, P289, DOI 10.1038/onc.2008.382; Muller S, 2014, ONCOTARGET, V5, P3184; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Perez M, 2012, J MOL CELL BIOL, V4, P316, DOI 10.1093/jmcb/mjs047; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Qi JF, 2013, CELL BIOCHEM BIOPHYS, V67, P15, DOI 10.1007/s12013-013-9636-2; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Schmidt RL, 2007, CANCER RES, V67, P11798, DOI 10.1158/0008-5472.CAN-06-4471; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Wong CSF, 2013, CANCER RES, V73, P2400, DOI 10.1158/0008-5472.CAN-12-4348; Wong CSF, 2012, CANCER RES, V72, P1694, DOI 10.1158/0008-5472.CAN-11-3310; Yoshibayashi H, 2007, ONCOL REP, V17, P549	38	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143376	10.1371/journal.pone.0143376	http://dx.doi.org/10.1371/journal.pone.0143376			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580787	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600118
J	Burri, A; Ogata, S; Livshits, G; Williams, F				Burri, Andrea; Ogata, Soshiro; Livshits, Gregory; Williams, Frances			The Association between Chronic Widespread Musculoskeletal Pain, Depression and Fatigue Is Genetically Mediated	PLOS ONE			English	Article							LONDON FIBROMYALGIA EPIDEMIOLOGY; RISK-FACTORS; DEHYDROEPIANDROSTERONE REPLACEMENT; WOMEN; POPULATION; TWIN; DHEA; PREVALENCE; STEROIDS; INSULIN	Background Chronic widespread muscoloskeletal pain (CWP) is prevalent in the general population and associated with high health care costs, so understanding the risk factors for chronic pain is important for both those affected and for society. In the present study we investigated the underlying etiological structure of CWP to understand better the association between the major clinical features of fatigue, depression and dihydroepiandrosterone sulphate (DHEAS) using a multivariate twin design. Methodology/Principle Findings Data were available in 463 UK female twin pairs including CWP status and information on depression, chronic fatigue and serum DHEAS levels. High to moderate heritabilities for all phenotypes were obtained (42.58% to 74.24%). The highest phenotypic correlation was observed between fatigue and CWP (r = 0.45), and the highest genetic correlation between CWP and fatigue (r(g) = 0.78). Structural equation modeling revealed the AE Cholesky model to provide the best model of the observed data. In this model, two additive genetic factors could be detected loading heavily on CWP-A2 explaining 40% of the variance and A3 20%. The factor loading heaviest on DHEAS showed only a small loading on the other phenotypes and none on fatigue at all. Furthermore, one distinct non-shared environmental factor loading specifically on CWP-but not on any of the other phenotypes-could be detected suggesting that the association between CWP and the other phenotypes is due only to genetic factors. Conclusions/Significance Our results suggest that CWP and its associated features share a genetic predisposition but that they are relatively distinct in their environmental determinants.	[Burri, Andrea; Livshits, Gregory; Williams, Frances] Kings Coll London, Dept Twin Res & Genet Epidemiol, St Thomas Hosp, London WC2R 2LS, England; [Burri, Andrea] Univ Zurich, Dept Psychol, CH-8050 Zurich, Switzerland; [Ogata, Soshiro] Osaka Univ, Dept Hlth Promot Sci, Grad Sch Med, Suita, Osaka 565087, Japan; [Livshits, Gregory] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Zurich; Osaka University; Tel Aviv University; Sackler Faculty of Medicine	Burri, A (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, St Thomas Hosp, London WC2R 2LS, England.	a.burri@psychologie.uzh.ch	Livshits, Gregory/AAG-7051-2019	Livshits, Gregory/0000-0003-3766-7493; Williams, Frances/0000-0002-2998-2744; Burri, Andrea/0000-0002-4705-3551	Wellcome Trust; European Community; National Institute for Health Research (NIHR); Swiss National Science Foundation; Swisslife Jubilaumsstiftung; Pain Research Foundation; Arthritis Research UK; Versus Arthritis [20682] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swisslife Jubilaumsstiftung; Pain Research Foundation; Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	This work was supported by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. Additionally, AB reports an Ambizione personal career fellowship by the Swiss National Science Foundation. AB also acknowledges a research grant support from the Swisslife Jubilaumsstiftung. FW has grant support from the Pain Research Foundation and Arthritis Research UK.	Aaron LA, BEST PRACT RES CLIN, V17, P563; Abeles AM, 2007, ANN INTERN MED, V146, P726, DOI 10.7326/0003-4819-146-10-200705150-00006; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Bhui K, 1997, BRIT J HOSP MED, V58, P145; Bradley LA, 2000, CURR RHEUMATOL REP, V2, P31; Bradley Laurence A, 2005, Curr Pain Headache Rep, V9, P79, DOI 10.1007/s11916-005-0042-3; Burri A, 2015, PAIN; Burri A, 2015, TWIN RES HUM GENET, V18, P188, DOI 10.1017/thg.2015.7; Burri A, 2014, J SEX MED, V11, P2772, DOI 10.1111/jsm.12651; Casale R, 2011, BEST PRACT RES CL RH, V25, P241, DOI 10.1016/j.berh.2011.01.016; Cleare AJ, 2004, PSYCHONEUROENDOCRINO, V29, P724, DOI 10.1016/S0306-4530(03)00104-5; Croft P, 2002, J MUSCULOSKELET PAIN, V10, P191, DOI 10.1300/J094v10n01_15; Freitas RPD, 2012, J BACK MUSCULOSKELET, V25, P245, DOI 10.3233/BMR-2012-0331; Dessein PH, 1999, PAIN, V83, P313, DOI 10.1016/S0304-3959(99)00113-X; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Erosheva EA, 2002, AM STAT, V56, P273, DOI 10.1198/000313002579; Finckh A, 2005, J RHEUMATOL, V32, P1336; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gupta A, 2004, ARTHRITIS RES THER, V6, P98, DOI 10.1186/ar1176; Guymer EK, 2002, RHEUM DIS CLIN N AM, V28, P367, DOI 10.1016/S0889-857X(01)00007-2; Hartkamp A, 2008, ANN RHEUM DIS, V67, P91, DOI 10.1136/ard.2007.071563; Hotopf M, 1997, J PSYCHOSOM RES, V43, P1, DOI 10.1016/S0022-3999(97)00115-3; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; Hur YM, 2008, TWIN RES HUM GENET, V11, P306, DOI 10.1375/twin.11.3.306; Kato K, 2009, PSYCHOL MED, V39, P497, DOI 10.1017/S0033291708003784; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Kato K, 2006, ARTHRITIS RHEUM-US, V54, P1682, DOI 10.1002/art.21798; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Livshits G, 2015, PAIN; Lovas K, 2003, J CLIN ENDOCR METAB, V88, P1112, DOI 10.1210/jc.2002-020769; Markkula R, 2009, EUR J PAIN, V13, P744, DOI 10.1016/j.ejpain.2008.09.007; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; MORALES AJ, 1994, J CLIN ENDOCR METAB, V78, P1360, DOI 10.1210/jc.78.6.1360; Nestler JE, 2002, J CLIN ENDOCR METAB, V87, P682, DOI 10.1210/jc.87.2.682; Ogata S, 2014, J EPIDEMIOL, V24, P31, DOI 10.2188/jea.JE20130070; Pamuk ON, 2009, CLIN RHEUMATOL, V28, P561, DOI 10.1007/s10067-009-1087-1; Papageorgiou AC, 2002, ANN RHEUM DIS, V61, P1071, DOI 10.1136/ard.61.12.1071; Peters MJ, 2013, ANN RHEUM DIS, V72, P427, DOI 10.1136/annrheumdis-2012-201742; Plomin R., 2013, BEHAV GENET; Posthuma D, 2010, HANDBOOK OF BEHAVIOR GENETICS, P47, DOI 10.1007/978-0-387-76727-7_4; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Rohrbeck J, 2007, BRIT J GEN PRACT, V57, P109; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Spencer NFL, 1996, EXP GERONTOL, V31, P393, DOI 10.1016/0531-5565(95)02033-0; Staud Roland, 2009, Curr Rheumatol Rep, V11, P433; Straub RH, 2002, J ENDOCRINOL, V175, P467, DOI 10.1677/joe.0.1750467; van Rensburg SJ, 2001, BRAIN RES BULL, V55, P319, DOI 10.1016/S0361-9230(01)00478-6; Virkki LM, 2010, ARTHRIT CARE RES, V62, P118, DOI 10.1002/acr.20022; Walker JG, 2007, CLIN RHEUMATOL, V26, P671, DOI 10.1007/s10067-006-0450-8; White KP, 1999, J RHEUMATOL, V26, P880; White KP, 1999, J RHEUMATOL, V26, P885; Williams FMK, 2010, RHEUMATOLOGY, V49, P1753, DOI 10.1093/rheumatology/keq170; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1996, J RHEUMATOL, V23, P1407; Yildiz BO, 2006, FERTIL STERIL, V86, P1688, DOI 10.1016/j.fertnstert.2006.05.045	58	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0140289	10.1371/journal.pone.0140289	http://dx.doi.org/10.1371/journal.pone.0140289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599910	Green Accepted, Green Published, gold			2022-12-27	WOS:000365862600002
J	Cheng, H; Liu, L; Yu, WM; Zhang, H; Luo, DZ; Zheng, GY				Cheng, Hui; Liu, Li; Yu, Weimin; Zhang, Hong; Luo, Dianzhong; Zheng, Guoyan			Comparison of 2.5D and 3D Quantification of Femoral Head Coverage in Normal Control Subjects and Patients with Hip Dysplasia	PLOS ONE			English	Article							FEMOROACETABULAR IMPINGEMENT; PERIACETABULAR OSTEOTOMY; RADIOGRAPHIC ANALYSIS; ACETABULAR COVERAGE; PELVIC RADIOGRAPHS; RADIATION-EXPOSURE; CANCER-RISKS; CT; RELIABILITY; VERSION	Hip dysplasia is characterized by insufficient femoral head coverage (FHC). Quantification of FHC is of importance as the underlying goal of the surgery to treat hip dysplasia is to restore a normal acetabular morphology and thereby to improve FHC. Unlike a pure 2D X-ray radiograph-based measurement method or a pure 3D CT-based measurement method, previously we presented a 2.5D method to quantify FHC from a single anteriorposterior (AP) pelvic radiograph. In this study, we first quantified and compared 3D FHC between a normal control group and a patient group using a CT-based measurement method. Taking the CT-based 3D measurements of FHC as the gold standard, we further quantified the bias, precision and correlation between the 2.5D measurements and the 3D measurements on both the control group and the patient group. Based on digitally reconstructed radiographs (DRRs), we investigated the influence of the pelvic tilt on the 2.5D measurements of FHC. The intraclass correlation coefficients (ICCs) for absolute agreement was used to quantify interobserver reliability and intraobserver reproducibility of the 2.5D measurement technique. The Pearson correlation coefficient, r, was used to determine the strength of the linear association between the 2.5D and the 3D measurements. Student's t-test was used to determine whether the differences between different measurements were statistically significant. Our experimental results demonstrated that both the interobserver reliability and the intraobserver reproducibility of the 2.5D measurement technique were very good (ICCs > 0.8). Regression analysis indicated that the correlation was very strong between the 2.5D and the 3D measurements (r = 0.89, p < 0.001). Student's t-test showed that there were no statistically significant differences between the 2.5D and the 3D measurements of FHC on the patient group (p > 0.05). The results of this study provided convincing evidence demonstrating the validity of the 2.5D measurements of FHC from a single AP pelvic radiograph and proved that it could serve as a surrogate for 3D CT-based measurements. Thus it may be possible to use this method to avoid a CT scan for the purpose of estimating 3D FHC in diagnosis and post-operative treatment evaluation of patients with hip dysplasia.	[Cheng, Hui; Zhang, Hong; Luo, Dianzhong] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthopaed Surg, Div Joint Surg, Beijing, Peoples R China; [Cheng, Hui; Liu, Li; Yu, Weimin; Zheng, Guoyan] Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland	Chinese People's Liberation Army General Hospital; University of Bern	Zheng, GY (corresponding author), Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland.	guoyan.zheng@ieee.org	, Guoyan/M-3617-2018; Zheng, Guoyan/C-8079-2014	, Guoyan/0000-0003-4173-0379; Cheng, Hui/0000-0003-2137-2041	Sino-Swiss Science and Technology Cooperation Program [EG 11-032014]	Sino-Swiss Science and Technology Cooperation Program	This work was partially supported by Sino-Swiss Science and Technology Cooperation Program, EG 11-032014 (GZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2012, SKELETAL RADIOL, V41, P1411, DOI 10.1007/s00256-012-1368-7; Clohisy JC, 2008, J BONE JOINT SURG AM, V90A, P47, DOI 10.2106/JBJS.H.00756; Collier MB, 2003, J BONE JOINT SURG AM, V85A, P2410, DOI 10.2106/00004623-200312000-00020; Cooperman D, 2013, J PEDIATR ORTHOPED, V33, pS2, DOI 10.1097/BPO.0b013e3182770a8d; COOPERMAN DR, 1983, CLIN ORTHOP RELAT R, P79; Dandachli W, 2008, J BONE JOINT SURG BR, V90B, P1428, DOI 10.1302/0301-620X.90B11.20073; Engesaeter IO, 2012, SKELETAL RADIOL, V41, P775, DOI 10.1007/s00256-011-1283-3; Flohr TG, 2005, RADIOLOGY, V235, P756, DOI 10.1148/radiol.2353040037; GANZ R, 1988, CLIN ORTHOP RELAT R, P26; HARRIS WH, 1986, CLIN ORTHOP RELAT R, P20; KLAUE K, 1988, CLIN ORTHOP RELAT R, P15; Kleinerman RA, 2006, PEDIATR RADIOL, V36, P121, DOI 10.1007/s00247-006-0191-5; KONISHI N, 1993, J BONE JOINT SURG AM, V75A, P1318, DOI 10.2106/00004623-199309000-00007; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lembeck B, 2005, ACTA ORTHOP, V76, P517, DOI 10.1080/17453670510041501; Liu L., 2014, COMPUTER ASSISTED PL, P643; Liu L, 2015, MED ENG PHY IN PRESS; Morvan J, 2013, J RHEUMATOL, V40, P1583, DOI 10.3899/jrheum.121544; MURPHY SB, 1995, J BONE JOINT SURG AM, V77A, P985, DOI 10.2106/00004623-199507000-00002; Nepple JJ, 2014, AM J SPORT MED, V42, P2393, DOI 10.1177/0363546514542797; Nho JH, 2012, J BONE JOINT SURG BR, V94B, P32, DOI 10.1302/0301-620X.94B1.27621; Pedersen DR, 2004, J PEDIATR ORTHOPED, V24, P156, DOI 10.1097/01241398-200403000-00004; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; STEEL HH, 1977, CLIN ORTHOP RELAT R, P116; Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P782, DOI 10.1007/s11999-008-0141-7; Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P1633, DOI 10.1007/s11999-008-0242-3; Tannast M, 2005, CLIN ORTHOP RELAT R, P182, DOI 10.1097/01.blo.0000167669.26068.c5; Tannast M, 2008, J ORTHOP RES, V26, P1199, DOI 10.1002/jor.20653; Wiberg G., 1939, ACTA CHIR SCAND, V83, P53; Zheng G, 2007, COMPUT METH PROG BIO, V87, P36, DOI 10.1016/j.cmpb.2007.02.010	31	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143498	10.1371/journal.pone.0143498	http://dx.doi.org/10.1371/journal.pone.0143498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599869	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600071
J	Faruque, MRI; Hossain, MI; Misran, N; Singh, M; Islam, MT				Faruque, M. R. I.; Hossain, M. I.; Misran, N.; Singh, M.; Islam, M. T.			Metamaterial-Embedded Low SAR PIFA for Cellular Phone	PLOS ONE			English	Article							ANTENNA	A metamaterial-embedded planar inverted-F antenna (PIFA) is proposed in this study for cellular phone applications. A dual-band PIFA is designed to operate both GSM 900 MHz and DCS 1800 MHz. The ground plane of a conventional PIFA is modified using a planar one-dimensional metamaterial array. The investigation is performed using the Finite Integration Technique (FIT) of CST Microwave Studio. The performance of the developed antenna was measured in an anechoic chamber. The specific absorption rate (SAR) values are calculated considering two different holding positions: cheek and tilt. The SAR values are measured using COMOSAR measurement system. Good agreement is observed between the simulated and measured data. The results indicate that the proposed metamaterial-embedded antenna produces significantly lower SAR in the human head compared to the conventional PIFA. Moreover, the modified antenna substrate leads to slight improvement of the antenna performances.	[Faruque, M. R. I.; Hossain, M. I.] Univ Kebangsaan Malaysia, Space Sci Ctr ANGKASA, Bangi 43600, Selangor, Malaysia; [Misran, N.; Singh, M.; Islam, M. T.] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Faruque, MRI (corresponding author), Univ Kebangsaan Malaysia, Space Sci Ctr ANGKASA, Bangi 43600, Selangor, Malaysia.	rashedgen@yahoo.com	Islam, Mohammad Tariqul/E-6380-2012; Faruque, Mohammad Rashed Iqbal/Q-5957-2019; Misran, Norbahiah/U-1666-2019; Hossain, Ikbal/AAS-7099-2021; Islam, Mohammad Tariqul/M-7377-2016	Islam, Mohammad Tariqul/0000-0002-4929-3209; Faruque, Mohammad Rashed Iqbal/0000-0003-4086-7672; Misran, Norbahiah/0000-0002-6142-8591; Hossain, Ikbal/0000-0002-3985-5255; Islam, Mohammad Tariqul/0000-0002-4929-3209	Research Universiti Grant, Dana Lonjakan Penerbitan [DLP-2014-003]	Research Universiti Grant, Dana Lonjakan Penerbitan	This work was supported by the Research Universiti Grant, Dana Lonjakan Penerbitan, grant No. DLP-2014-003.	[Anonymous], 1996, 96326 FCC; Barroso JJ, 2010, J ELECTROMAGNET WAVE, V24, P1563, DOI 10.1163/156939310792149759; Bonev I. B., 2011, Proceedings of the 2011 International Conference on Electromagnetics in Advanced Applications & IEEE-APS Topical Conference on Antennas & Propagation in Wireless Communications (ICEAA 2011), P769, DOI 10.1109/ICEAA.2011.6046443; Ebrahimi-Ganjeh MA, 2007, PROG ELECTROMAGN RES, V77, P225, DOI 10.2528/PIER07081804; Faruque MRI, 2013, MEAS SCI REV, V13, P70, DOI 10.2478/msr-2013-0011; Faruque MRI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109947; Goldsmith JR, 1996, SCI TOTAL ENVIRON, V180, P3, DOI 10.1016/0048-9697(95)04914-2; Hossain MI, 2015, PROG BIOPHYS MOL BIO, V119, P103, DOI 10.1016/j.pbiomolbio.2015.03.008; Hossain MI, 2015, APPL COMPUT ELECTROM, V30, P792; Hossain M. I., 2014, Advanced Materials Research, V974, P288, DOI 10.4028/www.scientific.net/AMR.974.288; Hossain MI, 2015, MATERIALS, V8, P57, DOI 10.3390/ma8010057; Islam MT, 2012, PROG ELECTROMAGN RES, V128, P121, DOI 10.2528/PIER12030105; Kahng S, 2014, J ELECTR ENG TECHNOL, V9, P622, DOI 10.5370/JEET.2014.9.2.622; Kusuma AH, 2011, PROG ELECTROMAGN RES, V112, P23, DOI 10.2528/PIER10101802; Kwak SI, 2007, 2007 EUROPEAN MICROWAVE CONFERENCE, VOLS 1-4, P937; McKinlay AF, 2004, HEALTH PHYS, V87, P171; Moulder JE, 2005, INT J RADIAT BIOL, V81, P189, DOI 10.1080/09553000500091097; NICOLSON AM, 1970, IEEE T INSTRUM MEAS, VIM19, P377, DOI 10.1109/TIM.1970.4313932; Panagamuwa Chinthana J., 2007, 2007 Loughborough Antennas and Propagation Conference, P261, DOI 10.1109/LAPC.2007.367479; Seker S, 2003, IEEE INT S EL COMP E; WHO, 2014, CELL PHON US CAN INC	21	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142663	10.1371/journal.pone.0142663	http://dx.doi.org/10.1371/journal.pone.0142663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599584	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900034
J	Li, ZW; Sun, F; Zhang, YH; Chen, H; He, NN; Chen, H; Song, PH; Wang, Y; Yan, S; Zheng, SS				Li, Zhiwei; Sun, Fei; Zhang, Yaohui; Chen, Hao; He, Ningning; Chen, Hui; Song, Penghong; Wang, Yan; Yan, Sheng; Zheng, Shusen			Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects	PLOS ONE			English	Article							ONSET DIABETES-MELLITUS; KIDNEY-TRANSPLANT RECIPIENTS; SOLID-ORGAN TRANSPLANTATION; IMMUNOSUPPRESSIVE DRUGS; LIVER-TRANSPLANTATION; COTRANSPORTER SGLT1; RISK-FACTORS; TRANSPORT; HYPERINSULINEMIA; INTESTINE	Background The use of the immunosuppressive drug tacrolimus (TAC) is related to new onset diabetes after transplantation. Herein, we examined the effect of intraperitoneal administered TAC on intestinal glucose absorption in mice. Methods Animals received low, medium, or high dose TAC (0.5, 1, or 5 mg/kg/d, respectively), or 0.9% saline solution (control) for 14 days. Oral glucose tolerance test (OGTT), insulin concentration test, and serum TAC concentration measurements was performed after 14 days of TAC exposure. Plasma insulin was assessed and electrogenic glucose absorption were measured by the sodium-dependent increase of the short-circuit current. Expression levels of the glucose transporters sodium glucose co-transporter (SGLT) 1, glucose transporter (GLUT) 2, and GLUT5 were also determined. Results Oral glucose absorption assessed by OGTT was significantly enhanced in the low, medium, and high groups. Serum insulin was elevated in the medium and high group compared with the control. Moreover, glucose-induced Isc was significantly higher in TAC administrated groups, which indicates that SGLT1 activity increased. Transcription levels and protein abundance of SGLT1 in the experimental groups also increased compared with the control. Conclusions TAC induced insulin resistance and strengthened intestinal glucose absorption by increasing the activity and expression of the glucose transporter, SGLT1.	[Li, Zhiwei; Sun, Fei; Zhang, Yaohui; Chen, Hao; He, Ningning; Chen, Hui; Song, Penghong; Wang, Yan; Yan, Sheng; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Shusen] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn		Sun, Fei/0000-0002-2499-6864	Public Welfare Technology Application Research Plan of Zhejiang [2015C33117]; National ST Major Project [2012ZX10002017]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81121002]	Public Welfare Technology Application Research Plan of Zhejiang; National ST Major Project; Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Public Welfare Technology Application Research Plan of Zhejiang (no. 2015C33117), National S&T Major Project (no. 2012ZX10002017) and Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No. 81121002).	Abe T, 2014, TRANSPL P, V46, P865, DOI 10.1016/j.transproceed.2013.12.027; Balakrishnan A, 2008, SURGERY, V143, P813, DOI 10.1016/j.surg.2008.03.018; Chen QJ, 2015, RENAL FAILURE, V37, P601, DOI 10.3109/0886022X.2015.1007833; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; Dong M, 2012, DIABETIC MED, V29, pE1, DOI 10.1111/j.1464-5491.2012.03617.x; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Hjelmesaeth J, 2006, KIDNEY INT, V69, P588, DOI 10.1038/sj.ki.5000116; Hjelmesth J, 2005, CURR DIABETES REV, V1, P1, DOI 10.2174/1573399052952604; Kesiraju S, 2014, TRANSPL IMMUNOL, V30, P52, DOI 10.1016/j.trim.2013.10.006; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Kisielinski K, 2002, CLIN EXP MED, V2, P131, DOI 10.1007/s102380200018; Lankarani KB, 2014, EXP CLIN TRANSPLANT, V12, P46, DOI 10.6002/ect.2013.0047; Larsen JL, 2006, TRANSPLANTATION, V82, P466, DOI 10.1097/01.tp.0000229384.22217.15; Malinowski M, 2011, TRANSPL INT, V24, P184, DOI 10.1111/j.1432-2277.2010.01167.x; Malinowski M, 2009, ANN TRANSPL, V14, P38; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Pereira MJ, 2014, J CLIN ENDOCR METAB, V99, pE1885, DOI 10.1210/jc.2014-1266; Pham PTT, 2007, ENDOCRIN METAB CLIN, V36, P873, DOI 10.1016/j.ecl.2007.07.007; Rexhepaj R, 2011, PFLUG ARCH EUR J PHY, V462, P489, DOI 10.1007/s00424-011-0987-5; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Shirazi-Beechey SP, 2011, P NUTR SOC, V70, P185, DOI 10.1017/S0029665111000103; Stockmann M, 2002, TRANSPLANT P, V34, P1449, DOI 10.1016/S0041-1345(02)02924-X; Storset E, 2015, TRANSPLANTATION, V99, P2158, DOI 10.1097/TP.0000000000000708; Sui WG, 2008, TRANSPL IMMUNOL, V20, P95, DOI 10.1016/j.trim.2008.07.003; Valderhaug TG, 2011, DIABETOLOGIA, V54, P1341, DOI 10.1007/s00125-011-2105-9; Valderhaug TG, 2012, TRANSPLANTATION, V94, P714, DOI 10.1097/TP.0b013e31825f4434; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x; Xavier GD, 2012, DIABETOLOGIA, V55, P2667, DOI 10.1007/s00125-012-2600-7; Yan S, 2013, OBES SURG, V23, P1361, DOI 10.1007/s11695-013-0954-7; Yanchar NL, 1996, TRANSPLANTATION, V61, P630, DOI 10.1097/00007890-199602270-00019; Yu SF, 2006, TRANSPLANTATION, V81, P46, DOI 10.1097/01.tp.0000188118.34633.bf	34	24	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143405	10.1371/journal.pone.0143405	http://dx.doi.org/10.1371/journal.pone.0143405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599323	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900110
J	Lixandru, BE; Cotar, AI; Straut, M; Usein, CR; Cristea, D; Ciontea, S; Tatu-Chitoiu, D; Codita, I; Rafila, A; Nica, M; Buzea, M; Baicus, A; Ghita, MC; Nistor, I; Tuchilus, C; Indreas, M; Antohe, F; Glasner, C; Grundmann, H; Jasir, A; Damian, M				Lixandru, Brandusa Elena; Cotar, Ani Ioana; Straut, Monica; Usein, Codruta Romanita; Cristea, Dana; Ciontea, Simona; Tatu-Chitoiu, Dorina; Codita, Irina; Rafila, Alexandru; Nica, Maria; Buzea, Mariana; Baicus, Anda; Ghita, Mihaela Camelia; Nistor, Irina; Tuchilus, Cristina; Indreas, Marina; Antohe, Felicia; Glasner, Corinna; Grundmann, Hajo; Jasir, Aftab; Damian, Maria			Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey	PLOS ONE			English	Article							BETA-LACTAMASE; PSEUDOMONAS-AERUGINOSA; ENTEROBACTERIACEAE; PLASMID; SPREAD; RESISTANCE; EMERGENCE; OUTBREAK; STRAINS; TURKEY	This study presents the first characterization of carbapenem-non-susceptible Klebsiella pneumoniae isolates by means of a structured six-month survey performed in Romania as part of an Europe-wide investigation. Klebsiella pneumoniae clinical isolates from different anatomical sites were tested for antibiotic susceptibility by phenotypic methods and confirmed by PCR for the presence of four carbapenemase genes. Genome macrorestriction fingerprinting with XbaI was used to analyze the relatedness of carbapenemase-producing Klebsiella pneumoniae isolates collected from eight hospitals. Among 75 non-susceptible isolates, 65 were carbapenemase producers. The most frequently identified genotype was OXA-48 (n = 51 isolates), eight isolates were positive for bla(NDM-1) gene, four had the bla(KPC-2) gene, whereas two were positive for bla(VIM-1). The analysis of PFGE profiles of OXA-48 and NDM-1 producing K. pneumoniae suggests inter-hospitals and regional transmission of epidemic clones. This study presents the first description of K. pneumoniae strains harbouring blaKPC-2 and blaVIM-1 genes in Romania. The results of this study highlight the urgent need for the strengthening of hospital infection control measures in Romania in order to curb the further spread of the antibiotic resistance.	[Lixandru, Brandusa Elena; Cotar, Ani Ioana; Straut, Monica; Usein, Codruta Romanita; Cristea, Dana; Ciontea, Simona; Tatu-Chitoiu, Dorina; Codita, Irina; Damian, Maria] Cantacuzino Natl Inst Res Dev Microbiol & Immunol, Bucharest, Romania; [Cotar, Ani Ioana; Jasir, Aftab] European Ctr Dis Prevent & Control ECDC, European Programme Publ Hlth Microbiol Training E, Stockholm, Sweden; [Rafila, Alexandru] Matei Bals Natl Inst Infect Dis, Bucharest, Romania; [Nica, Maria] Victor Babes Hosp Infect & Trop Dis, Bucharest, Romania; [Buzea, Mariana] Elias Emergency Univ Hosp, Bucharest, Romania; [Baicus, Anda] Emergency Univ Hosp Bucharest, Bucharest, Romania; [Ghita, Mihaela Camelia] Fundeni Clin Inst, Bucharest, Romania; [Nistor, Irina] Grigore Alexandrescu Emergency Children Hosp, Bucharest, Romania; [Tuchilus, Cristina] St Spiridon Emergency Clin Hosp, Iasi, Romania; [Indreas, Marina] Bacau Cty Emergency Hosp, Bacau, Romania; [Antohe, Felicia] Nicolae Simionescu Inst Cellular Biol & Pathol, Bucharest, Romania; [Glasner, Corinna; Grundmann, Hajo] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 GZ Groningen, Netherlands	Cantacuzino Institute Bucharest; European Centre for Disease Prevention & Control; National Institute for Infectious Diseases "Matei Bals"; Victor Babes National Institute of Pathology; Institutul Clinic Fundeni; Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; University of Groningen	Cotar, AI (corresponding author), Cantacuzino Natl Inst Res Dev Microbiol & Immunol, Splaiul Independentei 103, Bucharest, Romania.	aniioana@gmail.com	ANTOHE, Felicia/B-9860-2011; Codita, Irina/K-1057-2016; Cotar, Ani Ioana/AAV-3624-2021	Codita, Irina/0000-0002-0892-3120; ANTOHE, Felicia/0000-0002-3325-2867; Codita, Irina/0000-0002-2834-365X; Cotar, Ani Ioana/0000-0003-3770-8515	Romanian Ministry of Education and Research [PN 0922]	Romanian Ministry of Education and Research(Ministry of Education and Research - Romania)	The results presented in this work were supported by the Romanian Ministry of Education and Research, PN 0922 grant "Modernization the diagnosis of infectious diseases and improvement their surveillance through applications based on identifying the molecular mechanisms of resistance to antibiotics and antivirals and of genetic structures involved in the dissemination of resistance phenotype", coordinated by Monica Straut.	[Anonymous], 2002, OFFICIAL J EUROPEAN; Berger S, 2013, ANTIMICROB AGENTS CH, V57, P4064, DOI 10.1128/AAC.02550-12; Bogaerts P, 2011, ANTIMICROB AGENTS CH, V55, P3036, DOI 10.1128/AAC.00049-11; Bratu S, 2005, J ANTIMICROB CHEMOTH, V56, P128, DOI 10.1093/jac/dki175; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07; Carrer A, 2010, ANTIMICROB AGENTS CH, V54, P1369, DOI 10.1128/AAC.01312-09; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P2420, DOI 10.1128/AAC.01452-10; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; EUCAST, 2013, EUCAST GUIDELINES DE; Gheorghe I, 2014, J MED MICROBIOL, V63, P1303, DOI 10.1099/jmm.0.074039-0; Glasner C, 2013, Euro Surveill, V18, DOI 10.2807/1560-7917.ES2013.18.28.20525; Grundmann H, 2010, EUROSURVEILLANCE, V15, P22; Hansen DS, 2004, J CLIN MICROBIOL, V42, P3665, DOI 10.1128/jcm.42.8.3665-3669.2004; Mavroidi A, 2000, J ANTIMICROB CHEMOTH, V46, P1041, DOI 10.1093/jac/46.6.1041; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Peirano G, 2011, DIAGN MICR INFEC DIS, V71, P106, DOI 10.1016/j.diagmicrobio.2011.06.013; Pitart C, 2011, ANTIMICROB AGENTS CH, V55, P4398, DOI 10.1128/AAC.00329-11; Pitout JDD, 2005, J CLIN MICROBIOL, V43, P3129, DOI 10.1128/JCM.43.7.3129-3135.2005; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; PulseNet, 2013, STANDARD OPERATING P; Shin SY, 2012, J MED MICROBIOL, V61, P239, DOI 10.1099/jmm.0.037036-0; Struelens MJ, 2010, EUROSURVEILLANCE, V15, P9; Szekely E, 2013, INT J MED MICROBIOL, V303, P697, DOI 10.1016/j.ijmm.2013.10.001; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356; Wang XD, 2009, J MED MICROBIOL, V58, P1196, DOI 10.1099/jmm.0.008094-0	31	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143214	10.1371/journal.pone.0143214	http://dx.doi.org/10.1371/journal.pone.0143214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599338	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900077
J	Lv, XG; Shi, YF; Xu, X; Wei, YL; Wang, HM; Zhang, XB; Wu, JL				Lv, Xiang-guang; Shi, Yong-feng; Xu, Xia; Wei, Yan-lin; Wang, Hui-mei; Zhang, Xiao-bo; Wu, Jian-li			Oryza sativa Chloroplast Signal Recognition Particle 43 (OscpSRP43) Is Required for Chloroplast Development and Photosynthesis	PLOS ONE			English	Article							HARVESTING COMPLEX-II; YELLOW COLORING 1; CHLOROPHYLL BIOSYNTHESIS; GENETIC-ANALYSIS; ANKYRIN REPEAT; MUTANT REVEALS; LEAF MUTANT; PROTEIN; REDUCTASE; DOMAIN	A rice chlorophyll-deficient mutant w67 was isolated from an ethyl methane sulfonate (EMS)-induced IR64 (Oryza sativa L. ssp. indica) mutant bank. The mutant exhibited a distinct yellow-green leaf phenotype in the whole plant growth duration with significantly reduced levels of chlorophyll and carotenoid, impaired chloroplast development and lowered capacity of photosynthesis compared with the wild-type IR64. Expression of a number of genes associated with chlorophyll metabolism, chloroplast biogenesis and photosynthesis was significantly altered in the mutant. Genetic analysis indicated that the yellow-green phenotype was controlled by a single recessive nuclear gene located on the short arm of chromosome 3. Using map-based strategy, the mutation was isolated and predicted to encode a chloroplast signal recognition particle 43 KD protein (cpSRP43) with 388 amino acid residuals. A single base substitution from A to T at position 160 resulted in a premature stop codon. OscpSRP43 was constitutively expressed in various organs with the highest level in the leaf. Functional complementation could rescue the mutant phenotype and subcellular localization showed that the cpSRP43:GFP fusion protein was targeted to the chloroplast. The data suggested that Oryza sativa cpSRP43 (OscpSRP43) was required for the normal development of chloroplasts and photosynthesis in rice.	[Lv, Xiang-guang; Shi, Yong-feng; Xu, Xia; Wei, Yan-lin; Wang, Hui-mei; Zhang, Xiao-bo; Wu, Jian-li] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Wu, JL (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	beishangd@163.com		xiang guang, lu/0000-0001-9588-1717; wang, hui mei/0000-0002-8353-8978	National High Technology Research and Development Program of China [2014AA10A603, 2012AA101102]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (Nos. 2014AA10A603 and 2012AA101102).	Agne B, 2010, PLANT PHYSIOL, V153, P1016, DOI 10.1104/pp.110.158048; Agne B, 2009, J BIOL CHEM, V284, P8661, DOI 10.1074/jbc.M804235200; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asakura Y, 2004, PLANT CELL, V16, P201, DOI 10.1105/tpc.014787; Asakura Y, 2008, PLANT J, V56, P1007, DOI 10.1111/j.1365-313X.2008.03659.x; Barry CS, 2012, PLANT PHYSIOL, V159, P1086, DOI 10.1104/pp.112.197483; Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; Belcher S, 2015, BBA-BIOENERGETICS, V1847, P1004, DOI 10.1016/j.bbabio.2015.02.014; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Christ B, 2014, J PLANT GROWTH REGUL, V33, P4, DOI 10.1007/s00344-013-9392-y; Dong H, 2013, PLANT PHYSIOL, V162, P1867, DOI 10.1104/pp.113.217604; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Holdermann I, 2012, NAT STRUCT MOL BIOL, V19, P260, DOI 10.1038/nsmb.2196; Huang QN, 2016, J INTEGR PLANT BIOL, V58, P12, DOI 10.1111/jipb.12372; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Jia T, 2015, PLANT J, V81, P586, DOI 10.1111/tpj.12753; Jiang Q, 2014, PLANT SCI, V215, P172, DOI 10.1016/j.plantsci.2013.11.003; Kim S, 2013, PLANT CELL, V25, P4984, DOI 10.1105/tpc.113.119172; Kirst H, 2012, PLANT PHYSIOL, V160, P2251, DOI 10.1104/pp.112.206672; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kumar AM, 2000, PLANT PHYSIOL, V122, P49, DOI 10.1104/pp.122.1.49; Kumar KK, 2005, PLANT MOL BIOL REP, V23, P67, DOI 10.1007/BF02772648; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Lee KH, 2003, J BIOL CHEM, V278, P36794, DOI 10.1074/jbc.M304457200; Lee S, 2005, PLANT MOL BIOL, V57, P805, DOI 10.1007/s11103-005-2066-9; Lin YP, 2014, PLANT J, V80, P14, DOI 10.1111/tpj.12611; Lu Y. J., 1992, Chinese Journal of Rice Science, V6, P47; McCormac AC, 2001, PLANT J, V25, P549, DOI 10.1046/j.1365-313x.2001.00986.x; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; PARHAM R, 1995, ANAL BIOCHEM, V231, P164, DOI 10.1006/abio.1995.1516; Piskozub M, 2015, J BIOENERG BIOMEMBR, V47, P265, DOI 10.1007/s10863-014-9598-0; Sakuraba Y, 2013, BIOCHEM BIOPH RES CO, V430, P32, DOI 10.1016/j.bbrc.2012.11.050; Sato Y, 2009, PLANT J, V57, P120, DOI 10.1111/j.1365-313X.2008.03670.x; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Shi DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080107; Shi YF, 2009, SCI CHINA SER C, V52, P885, DOI 10.1007/s11427-009-0109-1; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Thomas H, 2014, J EXP BOT, V65, P3889, DOI 10.1093/jxb/eru037; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Vothknecht UC, 2012, J EXP BOT, V63, P1699, DOI 10.1093/jxb/err357; Wang PR, 2010, PLANT PHYSIOL, V153, P994, DOI 10.1104/pp.110.158477; Wang Q, 2004, PLANT PHYSIOL, V136, P3594, DOI 10.1104/pp.104.049841; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Zhang LG, 2012, PLANT CELL, V24, P3695, DOI 10.1105/tpc.112.103606; Zhou KN, 2013, PLANTA, V237, P279, DOI 10.1007/s00425-012-1756-1	51	23	29	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143249	10.1371/journal.pone.0143249	http://dx.doi.org/10.1371/journal.pone.0143249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600124	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900081
J	Rosa, RG; Roehrig, C; de Oliveira, RP; Maccari, JG; Antoonio, ACP; Castro, PD; Neto, FLD; Balzano, PD; Teixeira, C				Rosa, Regis Goulart; Roehrig, Cintia; de Oliveira, Roselaine Pinheiro; Maccari, Jucara Gasparetto; Pecanha Antonio, Ana Carolina; Castro, Priscylla de Souza; Dexheimer Neto, Felippe Leopoldo; Balzano, Patricia de Campos; Teixeira, Cassiano			Comparison of Unplanned Intensive Care Unit Readmission Scores: A Prospective Cohort Study	PLOS ONE			English	Article							MORTALITY AFTER-DISCHARGE; WORKLOAD INDEX; ORGAN DYSFUNCTION/FAILURE; RISK-FACTORS; OUTCOMES; STABILITY; ICU; VALIDATION; PREDICTORS; FAILURE	Purpose Early discharge from the intensive care unit (ICU) may constitute a strategy of resource consumption optimization; however, unplanned readmission of hospitalized patients to an ICU is associated with a worse outcome. We aimed to compare the effectiveness of the Stability and Workload Index for Transfer score (SWIFT), Sequential Organ Failure Assessment score (SOFA) and simplified Therapeutic Intervention Scoring System (TISS-28) in predicting unplanned ICU readmission or unexpected death in the first 48 hours after discharge from the ICU. Methods We conducted a prospective cohort study in a single tertiary hospital in southern Brazil. All adult patients admitted to the ICU for more than 24 hours from January 2008 to December 2009 were evaluated. SWIFT, SOFA and TISS-28 scores were calculated on the day of discharge from the ICU. A stepwise logistic regression was conducted to evaluate the effectiveness of these scores in predicting unplanned ICU readmission or unexpected death in the first 48 hours after discharge from the ICU. Moreover, we conducted a direct accuracy comparison among SWIFT, SOFA and TISS-28 scores. Results A total of 1,277 patients were discharged from the ICU during the study period. The rate of unplanned ICU readmission or unexpected death in the first 48 hours after discharge from the ICU was 15% (192 patients). In the multivariate analysis, age (P = 0.001), length of ICU stay (P = 0.01), cirrhosis (P = 0.03), SWIFT (P = 0.001), SOFA (P = 0.01) and TISS-28 (P<0.001) constituted predictors of unplanned ICU readmission or unexpected death. The SWIFT, SOFA and TISS-28 scores showed similar predictive accuracy (AUC values were 0.66, 0.65 and 0.74, respectively; P = 0.58). Conclusions SWIFT, SOFA and TISS-28 on the day of discharge from the ICU have only moderate accuracy in predicting ICU readmission or death. The present study did not find any differences in accuracy among the three scores.	[Rosa, Regis Goulart; Roehrig, Cintia; de Oliveira, Roselaine Pinheiro; Maccari, Jucara Gasparetto; Pecanha Antonio, Ana Carolina; Castro, Priscylla de Souza; Dexheimer Neto, Felippe Leopoldo; Balzano, Patricia de Campos; Teixeira, Cassiano] Hosp Moinhos Vento, Dept Crit Care, Porto Alegre, RS, Brazil; [de Oliveira, Roselaine Pinheiro; Teixeira, Cassiano] UFCSPA, Sch Med, Porto Alegre, RS, Brazil	Universidade Federal de Ciencias da Saude de Porto Alegre	Rosa, RG (corresponding author), Hosp Moinhos Vento, Dept Crit Care, Porto Alegre, RS, Brazil.	regisgoulartrosa@gmail.com	Teixeira, Cassiano/V-8764-2019; Rosa, Regis/V-2859-2017; Rosa, Regis Goulart/P-6422-2019	Rosa, Regis/0000-0001-7881-9866; 				Campos RA, 2011, MED INTENSIVA, V35, P150, DOI 10.1016/j.medin.2010.12.012; Angus DC, 1998, CRIT CARE MED, V26, P1779, DOI 10.1097/00003246-199811000-00008; [Anonymous], 2008, FED REG; Badawi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048758; Beck DH, 2002, INTENS CARE MED, V28, P1287, DOI 10.1007/s00134-002-1412-5; Brown SES, 2012, AM J RESP CRIT CARE, V185, P955, DOI 10.1164/rccm.201109-1720OC; Campbell AJ, 2008, BRIT J ANAESTH, V100, P656, DOI 10.1093/bja/aen069; Capuzzo M, 2010, CURR OPIN CRIT CARE, V16, P499, DOI 10.1097/MCC.0b013e32833cb874; Chandra S, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2011.05.003; Chen LM, 1998, CRIT CARE MED, V26, P1834, DOI 10.1097/00003246-199811000-00025; Daly K, 2001, BRIT MED J, V322, P1274, DOI 10.1136/bmj.322.7297.1274; Gajic O, 2008, CRIT CARE MED, V36, P676, DOI 10.1097/CCM.0B013E318164E3B0; Giakoumidakis K, 2014, ANN THORAC MED, V9, P8, DOI 10.4103/1817-1737.124412; Hosein FS, 2013, CRIT CARE, V17, DOI 10.1186/cc12747; Kastrup M, 2013, CRIT CARE MED, V41, P1608, DOI 10.1097/CCM.0b013e31828a217b; Kramer AA, 2012, CRIT CARE MED, V40, P3, DOI 10.1097/CCM.0b013e31822d751e; Moreno R, 1997, INTENS CARE MED, V23, P640, DOI 10.1007/s001340050387; Moreno R, 2001, INTENS CARE MED, V27, P999, DOI 10.1007/s001340100966; Oakes DF, 2014, J BRAS PNEUMOL, V40, P73, DOI 10.1590/S1806-37132014000100011; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; Rosenberg AL, 2001, CRIT CARE MED, V29, P511, DOI 10.1097/00003246-200103000-00008; Smith L, 1999, INTENS CARE MED, V25, P1061, DOI 10.1007/s001340051012; Timmers Tim K, 2014, World J Crit Care Med, V3, P74, DOI 10.5492/wjccm.v3.i4.74; Timmers TK, 2014, CRIT CARE NURS Q, V37, P125, DOI 10.1097/CNQ.0000000000000011; Vincent JL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0813-0; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; ZIMMERMAN JE, 1994, CRIT CARE MED, V22, P1373, DOI 10.1097/00003246-199409000-00005	28	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143127	10.1371/journal.pone.0143127	http://dx.doi.org/10.1371/journal.pone.0143127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600463	Green Published, gold			2022-12-27	WOS:000365853900067
J	Thrane, S; Janitzek, CM; Agerbaek, MO; Ditlev, SB; Resende, M; Nielsen, MA; Theander, TG; Salanti, A; Sander, AF				Thrane, Susan; Janitzek, Christoph M.; Agerbaek, Mette O.; Ditlev, Sisse B.; Resende, Mafalda; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali; Sander, Adam F.			A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; PLASMODIUM-FALCIPARUM PARASITES; STREPTAVIDIN MONOMER; PROTEIN; ANTIBODIES; INDUCTION; ADHESION; DELIVERY; BINDING	Placental malaria caused by Plasmodium falciparum is a major cause of mortality and severe morbidity. Clinical testing of a soluble protein-based vaccine containing the parasite ligand, VAR2CSA, has been initiated. VAR2CSA binds to the human receptor chondroitin sulphate A (CSA) and is responsible for sequestration of Plasmodium falciparum infected erythrocytes in the placenta. It is imperative that a vaccine against malaria in pregnancy, if administered to women before they become pregnant, can induce a strong and long lasting immune response. While most soluble protein-based vaccines have failed during clinical testing, virus-like particle (VLP) based vaccines (e.g., the licensed human papillomavirus vaccines) have demonstrated high efficacy, suggesting that the spatial assembly of the vaccine antigen is a critical parameter for inducing an optimal long-lasting protective immune response. We have developed a VLP vaccine display platform by identifying regions of the HPV16 L1 coat protein where a biotin acceptor site (AviTag (TM)) can be inserted without compromising VLP-assembly. Subsequent biotinylation of Avi-L1 VLPs allow us to anchor monovalent streptavidin (mSA)-fused proteins to the biotin, thereby obtaining a dense and repetitive VLP-display of the vaccine antigen. The mSA-VAR2CSA antigen was delivered on the Avi-L1 VLP platform and tested in C57BL/6 mice in comparison to two soluble protein-based vaccines consisting of naked VAR2CSA and mSA-VAR2CSA. The mSA-VAR2CSA Avi-L1 VLP and soluble mSA-VAR2CSA vaccines induced higher antibody titers than the soluble naked VAR2CSA vaccine after three immunizations. The VAR2CSA Avi-L1 VLP vaccine induced statistically significantly higher endpoint titres compared to the soluble mSA-VAR2CSA vaccine, after 1st and 2nd immunization; however, this difference was not statistically significant after 3rd immunization. Importantly, the VLP-VAR2CSA induced antibodies were functional in inhibiting the binding of parasites to CSA. This study demonstrates that the described Avi-L1 VLP-platform may serve as a versatile system for facilitating optimal VLP-display of large and complex vaccine antigens.	[Thrane, Susan; Janitzek, Christoph M.; Agerbaek, Mette O.; Ditlev, Sisse B.; Resende, Mafalda; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali; Sander, Adam F.] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Thrane, Susan; Janitzek, Christoph M.; Agerbaek, Mette O.; Ditlev, Sisse B.; Resende, Mafalda; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali; Sander, Adam F.] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Sander, AF (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.	adamsander@gmail.com	Theander, Thor/F-6714-2015	Theander, Thor/0000-0002-3509-7514; Thrane, Susan/0000-0001-6596-3527; Agerbaek, Mette Orskov/0000-0001-5865-2034; Nielsen, Morten Agertoug/0000-0003-2668-4992; Bertelsen, Adam Frederik Sander/0000-0002-8782-7830; Salanti, Ali/0000-0003-2207-5575; Ditlev, Sisse Bolm/0000-0003-4417-9711; Janitzek, Christoph Mikkel/0000-0001-6529-9355	Bill and Melinda Gates Foundation [APP178218]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The project was funded through a grant from Bill and Melinda Gates Foundation Grant ID APP178218 [http://www.gatesfoundation.org]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Bill and Melinda Gates foundation for financial support.	Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2007, CURRENT PROTOCOLS CE, V26, P1, DOI DOI 10.1002/0471143030.CB2601S37; Cardone G, 2014, MATURATION HUMAN PAP; Chackerian B, 2002, J IMMUNOL, V169, P6120, DOI 10.4049/jimmunol.169.11.6120; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; De Vincenzo R, 2014, INT J WOMENS HEALTH, V6, P999, DOI 10.2147/IJWH.S50365; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Hartman TK, 2010, ANN TROP PAEDIATR, V30, P271, DOI 10.1179/146532810X12858955921032; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Koho T, 2015, EUR J PHARM BIOPHARM, V96, P22, DOI 10.1016/j.ejpb.2015.07.002; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Lechner F, 2002, INTERVIROLOGY, V45, P212, DOI 10.1159/000067912; Lim KH, 2013, BIOTECHNOL BIOENG, V110, P57, DOI 10.1002/bit.24605; Lim KH, 2011, BIOCHEMISTRY-US, V50, P8682, DOI 10.1021/bi2010366; Moyle PM, 2013, CHEMMEDCHEM, V8, P360, DOI 10.1002/cmdc.201200487; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nielsen MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135406; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Peacey M, 2007, BIOTECHNOL BIOENG, V98, P968, DOI 10.1002/bit.21518; Safaeian M, 2013, CANCER PREV RES, V6, P1242, DOI 10.1158/1940-6207.CAPR-13-0203; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Schiller J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004254; Schmiegelow C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053794; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Tuikuendam N, 2015, DEV VACCINES PREVENT, P1; World Health Organization, 2013, NATURE	36	42	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143071	10.1371/journal.pone.0143071	http://dx.doi.org/10.1371/journal.pone.0143071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599509	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900062
J	Zembe, YZ; Townsend, L; Thorson, A; Silberschmidt, M; Ekstrom, AM				Zembe, Yanga Z.; Townsend, Loraine; Thorson, Anna; Silberschmidt, Margrethe; Ekstrom, Anna Mia			Intimate Partner Violence, Relationship Power Inequity and the Role of Sexual and Social Risk Factors in the Production of Violence among Young Women Who Have Multiple Sexual Partners in a Peri-Urban Setting in South Africa	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; ADOLESCENT GIRLS; HIV; PREVENTION; ATTITUDES; MEN	Introduction This paper aims to assess the extent and correlates of intimate partner violence (IPV), explore relationship power inequity and the role of sexual and social risk factors in the production of violence among young women aged 16-24 reporting more than one partner in the past three months in a peri-urban setting in the Western Cape, South Africa. Recent estimates suggest that every six hours a woman is killed by an intimate partner in South Africa, making IPV a leading public health problem in the country. While there is mounting evidence that levels of IPV are high in peri-urban settings in South Africa, not much is known about how it manifests among women who engage in concomitantly high HIV risk behaviours such as multiple sexual partnering, transactional sex and age mixing. We know even less about how such women negotiate power and control if exposed to violence in such sexual networks. Methods Two hundred and fifty nine women with multiple sexual partners, residing in a predominantly Black peri-urban community in the Western Cape, South Africa, were recruited into a bio-behavioural survey using Respondent Driven Sampling (RDS). After the survey, focus group discussions and individual interviews were conducted among young women and men to understand the underlying factors informing their risk behaviours and experiences of violence. Findings 86% of the young women experienced IPV in the past 12 months. Sexual IPV was significantly correlated with sex with a man who was 5 years or older than the index female partner (OR 1.7, 95% CI 1.0-3.2) and transactional sex with most recent casual partner (OR 2.1, 95% CI 1.1-3.8). Predictably, women experienced high levels of relationship power inequity. However, they also identified areas in their controlling relationships where they shared decision making power. Discussion Levels of IPV among young women with multiple sexual partners were much higher than what is reported among women in the general population and shown to be associated with sexual risk taking. Interventions targeting IPV need to address sexual risk taking as it heightens vulnerability to violence.	[Zembe, Yanga Z.; Townsend, Loraine] Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Zembe, Yanga Z.; Thorson, Anna; Ekstrom, Anna Mia] Karolinska Inst, Dept Publ Hlth Sci Global Hlth, Stockholm, Sweden; [Zembe, Yanga Z.; Thorson, Anna; Ekstrom, Anna Mia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Silberschmidt, Margrethe] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Copenhagen	Zembe, YZ (corresponding author), Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa.	yanga.zembe@mrc.ac.za	Fazli, Ghazal/AAE-8320-2022	Thorson, Anna/0000-0002-8703-6561	International Development Research Centre (IDRC); Health Economics HIV/AIDS Research Division (HEARD) at the University of Kwazulu Natal; Centers for Disease Control and Prevention (CDC); Fogarty AIDS International Training and Research Program (AITRP); IDRC/HEARD	International Development Research Centre (IDRC); Health Economics HIV/AIDS Research Division (HEARD) at the University of Kwazulu Natal; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty AIDS International Training and Research Program (AITRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); IDRC/HEARD	The International Development Research Centre (IDRC) and the Health Economics HIV/AIDS Research Division (HEARD) at the University of Kwazulu Natal funded the development and implementation of the qualitative study. The Centers for Disease Control and Prevention (CDC) funded the data collection activities of the quantitative component and the Fogarty AIDS International Training and Research Program (AITRP) funded the manuscript preparation activities. The IDRC/HEARD funders contributed insights to the interpretation of the findings of the qualitative component of this manuscript, through two symposiums that were held wherein the lead author shared the preliminary findings of the study with the funders and other donor recipients who were participants at the symposiums. The IDRC/HEARD funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The CDC and the ARTRP had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrahams Naeemah, 2006, Violence Vict, V21, P247; Abrahams N, 2009, VIOLENCE VICTIMS, V24, P546, DOI 10.1891/0886-6708.24.4.546; Burn SM, 2009, SEX ROLES, V60, P779, DOI 10.1007/s11199-008-9581-5; Chopra M, 2009, JAIDS-J ACQ IMM DEF, V51, P72, DOI 10.1097/QAI.0b013e31819907de; Dunkle K, 2006, AIDS, V20, P2017; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Graham K, 2014, DRUG ALCOHOL REV, V33, P393, DOI 10.1111/dar.12153; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hindin MJ, 2003, B WORLD HEALTH ORGAN, V81, P501; Hunter M, 2005, CULT HEALTH SEX, V7, P209, DOI 10.1080/13691050412331293458; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kabeer Naila., 2005, GENDER DEV, V13, P13, DOI [10.1080/13552070512331332273, DOI 10.1080/13552070512331332273]; Kalichman SC, 2010, ALCOHOL RES HLTH, V33; Kim J, 2002, SOC SCI MED, V54, P1243, DOI 10.1016/S0277-9536(01)00093-4; Leclerc-Madlala S, 2008, INTERGENERATIONAL AG; Luke N, 2002, CROSS GENERATIONAL S; Luke N, 2005, INT FAMILY PLANNING, V31, P1; Machisa M, 2011, WAR HOME FINDINGS GE; Norman R, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-32; Petersen I, 2005, CHILD ABUSE NEGLECT, V29, P1233, DOI 10.1016/j.chiabu.2005.02.012; Pettifor AE, 2004, EMERGING INFECT DIS, V10; Pitpitan EV, 2012, SOC SCI MED, V75, P1417, DOI 10.1016/j.socscimed.2012.06.020; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Santelli JS, 2001, FAM PLANN PERSPECT, V33, P200, DOI 10.2307/2673782; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Shields N, 2008, CHILD ABUSE NEGLECT, V32, P589, DOI 10.1016/j.chiabu.2007.07.010; SHISANA O, 2005, S AFRICAN NATL HIV P; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Singh K, 2010, AIDS BEHAV, V14, P200, DOI 10.1007/s10461-009-9572-8; South African Police Services, 2012, CRIM MBEKW WC APR MA; South African Police Services, 2006, SAF AND SEC; Statistics South Africa, 2012, 030141105 STAT S AFR; Townsend L, 2011, AIDS BEHAV, V15, P132, DOI 10.1007/s10461-010-9680-5; Walker L, 2005, CULT HEALTH SEX, V7, P225, DOI 10.1080/13691050410001713215; Weir SS, 2008, TROP MED INT HEALTH, V13, P801, DOI 10.1111/j.1365-3156.2008.02057.x; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; WHO, 2005, MULT STUD WOM HLTH D; Wilson HW, 2012, PSYCHOL VIOLENCE, V2, P194, DOI 10.1037/a0027265; Wood K, 1997, Gend Dev, V5, P41; Zembe YZ, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-28; Zembe YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051998	44	40	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0139430	10.1371/journal.pone.0139430	http://dx.doi.org/10.1371/journal.pone.0139430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599394	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900003
J	Zhao, HF; Feng, L; Jiang, WD; Liu, Y; Jiang, J; Wu, P; Zhao, J; Kuang, SY; Tang, L; Tang, WN; Zhang, YA; Zhou, XQ				Zhao, Hua-Fu; Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Wu, Pei; Zhao, Juan; Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng; Zhang, Yong-An; Zhou, Xiao-Qiu			Flesh Shear Force, Cooking Loss, Muscle Antioxidant Status and Relative Expression of Signaling Molecules (Nrf2, Keap1, TOR, and CK2) and Their Target Genes in Young Grass Carp (Ctenopharyngodon idella) Muscle Fed with Graded Levels of Choline	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; WATER-HOLDING CAPACITY; COD GADUS-MORHUA; ATLANTIC SALMON; GROWTH-PERFORMANCE; ENZYME-ACTIVITIES; DIETARY CHOLINE; JUVENILE JIAN; VAR. JIAN; VITAMIN-E	Six groups of grass carp (average weight 266.9 +/- 0.6 g) were fed diets containing 197, 385, 770, 1082, 1436 and 1795 mg choline/kg, for 8 weeks. Fish growth, and muscle nutrient (protein, fat and amino acid) content of young grass carp were significantly improved by appropriate dietary choline. Furthermore, muscle hydroxyproline concentration, lactate content and shear force were improved by optimum dietary choline supplementation. However, the muscle pH value, cooking loss and cathepsins activities showed an opposite trend. Additionally, optimum dietary choline supplementation attenuated muscle oxidative damage in grass carp. The muscle antioxidant enzyme (catalase and glutathione reductase did not change) activities and glutathione content were enhanced by optimum dietary choline supplementation. Muscle cooking loss was negatively correlated with antioxidant enzyme activities and glutathione content. At the gene level, these antioxidant enzymes, as well as the targets of rapamycin, casein kinase 2 and NF-E2-related factor 2 transcripts in fish muscle were always up-regulated by suitable choline. However, suitable choline significantly decreased Kelch-like ECH-associated protein 1 a (Keap1a) and Kelch-like ECH-associated protein 1 b (Keap1b) mRNA levels in muscle. In conclusion, suitable dietary choline enhanced fish flesh quality, and the decreased cooking loss was due to the elevated antioxidant status that may be regulated by Nrf2 signaling.	[Zhao, Hua-Fu; Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Wu, Pei; Zhao, Juan; Zhou, Xiao-Qiu] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Wu, Pei; Zhou, Xiao-Qiu] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu 611130, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Wu, Pei; Zhou, Xiao-Qiu] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, China Minist Educ, Chengdu 611130, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu 610066, Peoples R China; [Zhang, Yong-An] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhou, XQ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China.	xqzhouqq@tom.com	Jun, Jiang/CAE-8962-2022; jiang, jun/GWC-9329-2022; liu, yang/HHY-8583-2022	Zhang, Yong-An/0000-0002-9956-3879	National Basic Research Program of China (973 Program) [2014CB138600]; National Department Public Benefit Research Foundation (Agriculture) of China [201003020]; Science and Technology Support Programme of Sichuan Province of China [2014NZ0003]; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2012NC0007, 2013NC0045]; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2015CC0011]; Natural Science Foundation for Young Scientists of Sichuan Province [2014JQ0007]; Sichuan Province Research Foundation for Basic Research [2013JY0082]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Department Public Benefit Research Foundation (Agriculture) of China; Science and Technology Support Programme of Sichuan Province of China; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Natural Science Foundation for Young Scientists of Sichuan Province; Sichuan Province Research Foundation for Basic Research	This research was financially supported by the National Basic Research Program of China (973 Program) (2014CB138600), National Department Public Benefit Research Foundation (Agriculture) of China (201003020), Science and Technology Support Programme of Sichuan Province of China (2014NZ0003), Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2012NC0007, 2013NC0045), the Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2015CC0011), Natural Science Foundation for Young Scientists of Sichuan Province (2014JQ0007) and Sichuan Province Research Foundation for Basic Research (2013JY0082). The authors would like to thank the personnel of these teams for their kind assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2013, FOOD CHEM, V140, P238, DOI 10.1016/j.foodchem.2013.02.042; Alirezaei M., 2012, COMP CLIN PATHOL, V23, P161, DOI [10.1007/s00580-012-1589-0, DOI 10.1007/S00580-012-1589-0]; Armenteros M, 2009, MEAT SCI, V83, P104, DOI 10.1016/j.meatsci.2009.04.007; ASGHAR A, 1991, J SCI FOOD AGR, V57, P31, DOI 10.1002/jsfa.2740570104; Atli G, 2010, ECOTOX ENVIRON SAFE, V73, P1884, DOI 10.1016/j.ecoenv.2010.09.005; Belal IEH, 2005, BIORESOURCE TECHNOL, V96, P395, DOI 10.1016/j.biortech.2003.11.030; Bjorlykke GA, 2011, FOOD CHEM, V127, P1706, DOI 10.1016/j.foodchem.2011.02.045; Blaszczyk I, 2010, BIOL TRACE ELEM RES, V133, P60, DOI 10.1007/s12011-009-8412-z; Brinker A, 2011, AQUACULTURE, V310, P350, DOI 10.1016/j.aquaculture.2010.09.041; Cai DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105504; Chen SR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053662, 10.1371/journal.pone.0056380]; Craig SR, 1997, AQUACULTURE, V151, P259, DOI 10.1016/S0044-8486(96)01479-2; Deng YP, 2014, AQUACULTURE, V434, P66, DOI 10.1016/j.aquaculture.2014.07.026; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388; Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818; Feng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069974; Flores-Mateo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105881; Fuentes A, 2010, FOOD CHEM, V119, P1514, DOI 10.1016/j.foodchem.2009.09.036; Gan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115129; GARDINER JE, 1974, J PHYSIOL-LONDON, V239, P459, DOI 10.1113/jphysiol.1974.sp010578; Geurden I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083162; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Godiksen H, 2009, FOOD CHEM, V113, P889, DOI 10.1016/j.foodchem.2008.08.012; Grattagliano I, 2000, J NUTR, V130, P2131, DOI 10.1093/jn/130.9.2131; He HJ, 2014, FOOD CHEM, V156, P394, DOI 10.1016/j.foodchem.2014.01.118; Hernandez MD, 2009, FOOD CHEM, V114, P237, DOI 10.1016/j.foodchem.2008.09.045; Hultmann L, 2007, FOOD CHEM, V104, P1687, DOI 10.1016/j.foodchem.2007.03.030; Hultmann L, 2012, FOOD CHEM, V134, P1399, DOI 10.1016/j.foodchem.2012.03.038; Ilcol YO, 2003, EUR J BIOCHEM, V270, P991, DOI 10.1046/j.1432-1033.2003.03472.x; Jiang J, 2009, AQUACULT NUTR, V15, P409, DOI 10.1111/j.1365-2095.2008.00605.x; Jiang WD, 2014, AQUAT TOXICOL, V155, P301, DOI 10.1016/j.aquatox.2014.07.003; Jiang WD, 2010, FOOD CHEM, V120, P692, DOI 10.1016/j.foodchem.2009.10.062; Jiang WD, 2009, AQUAC RES, V40, P955, DOI 10.1111/j.1365-2109.2009.02191.x; Johnston IA, 1999, AQUACULTURE, V177, P99, DOI 10.1016/S0044-8486(99)00072-1; Johnston IA, 2006, AQUACULTURE, V256, P323, DOI 10.1016/j.aquaculture.2006.02.048; Kamireddy N, 2011, J FOOD SCI, V76, pS233, DOI 10.1111/j.1750-3841.2011.02121.x; Khan MA, 2004, AQUAC RES, V35, P1277, DOI 10.1111/j.1365-2109.2004.01150.x; Khan N, 2011, PAK J ZOOL, V43, P1177; Larsson T, 2014, AQUACULTURE, V426, P288, DOI 10.1016/j.aquaculture.2014.01.034; Larsson T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039219; Li SH, 2008, FOOD CHEM, V111, P879, DOI 10.1016/j.foodchem.2008.04.072; Li XY, 2014, FISH PHYSIOL BIOCHEM, V40, P673, DOI 10.1007/s10695-013-9875-6; Liu DS, 2013, FOOD CHEM, V140, P105, DOI 10.1016/j.foodchem.2013.02.034; Lomiwes D, 2014, MEAT SCI, V96, P646, DOI 10.1016/j.meatsci.2013.08.022; Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]; Mai KS, 2009, AQUACULTURE, V289, P124, DOI 10.1016/j.aquaculture.2009.01.016; Martinez I, 2011, FOOD CHEM, V126, P140, DOI 10.1016/j.foodchem.2010.10.090; Matthews JO, 2001, J ANIM SCI, V79, P967; Mehta AK, 2009, EUR J CLIN INVEST, V39, P934, DOI 10.1111/j.1365-2362.2009.02190.x; Menezes C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114233; Mercado N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088168; Morkore T, 2003, J FOOD SCI, V68, P1492, DOI 10.1111/j.1365-2621.2003.tb09672.x; Nieto N, 2007, J HEPATOL, V46, P330, DOI 10.1016/j.jhep.2006.09.010; Ogino C, 1970, Bull. Jap. Soc. scient. Fish., V36, P1140; Okouchi M, 2006, CURR NEUROVASC RES, V3, P249, DOI 10.2174/156720206778792876; Olsen BB, 2012, INT J ONCOL, V41, P1967, DOI 10.3892/ijo.2012.1635; Olsson GB, 2003, LEBENSM-WISS TECHNOL, V36, P125, DOI 10.1016/S0023-6438(02)00205-0; Ossani G, 2007, FRONT BIOSCI-LANDMRK, V12, P1174, DOI 10.2741/2135; Pacelli C, 2010, J NUTR, V140, P1072, DOI 10.3945/jn.109.116673; Pearce KL, 2011, MEAT SCI, V89, P111, DOI 10.1016/j.meatsci.2011.04.007; Periago Ma.J., 2005, Aquaculture, V249, P175, DOI 10.1016/j.aquaculture.2005.02.047; POSTON HA, 1991, PROG FISH CULT, V53, P220, DOI 10.1577/1548-8640(1991)053&lt;0220:CROSUR&gt;2.3.CO;2; Qiao H, 2009, J VASC RES, V46, P15, DOI 10.1159/000135661; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Repetto MG, 2010, EXP MOL PATHOL, V88, P143, DOI 10.1016/j.yexmp.2009.11.002; Rhee JS, 2013, AQUAT TOXICOL, V132, P182, DOI 10.1016/j.aquatox.2013.02.013; Richard L, 2011, BRIT J NUTR, V106, P825, DOI 10.1017/S0007114511001115; RUMSEY GL, 1991, AQUACULTURE, V95, P107, DOI 10.1016/0044-8486(91)90077-K; Salmeron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075349; Seiliez I, 2011, GEN COMP ENDOCR, V172, P363, DOI 10.1016/j.ygcen.2011.03.026; Shay KP, 2012, BBA-MOL CELL RES, V1823, P1102, DOI 10.1016/j.bbamcr.2012.04.002; Sinha AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095319; Skipnes D, 2007, J FOOD ENG, V80, P1078, DOI 10.1016/j.jfoodeng.2006.08.015; Sriket C., 2014, International Food Research Journal, V21, P433; Tang QQ, 2013, BIOL TRACE ELEM RES, V155, P370, DOI 10.1007/s12011-013-9785-6; Utrera M, 2014, MEAT SCI, V96, P812, DOI 10.1016/j.meatsci.2013.09.006; Venugopal PB, 1985, METHODS VITAMIN ASSA, P555; Venugopal V, 1996, FOOD REV INT, V12, P175, DOI 10.1080/87559129609541074; Wang B, 2015, FOOD CHEM, V167, P91, DOI 10.1016/j.foodchem.2014.06.091; Wang DaoZun, 1995, Journal of Fisheries of China, V19, P133; Wang ZG, 2009, POULTRY SCI, V88, P1096, DOI 10.3382/ps.2008-00207; Wu P, 2014, FISH SHELLFISH IMMUN, V38, P374, DOI 10.1016/j.fsi.2014.03.032; Wu P, 2011, AQUACULTURE, V317, P107, DOI 10.1016/j.aquaculture.2011.03.042; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Wu YP, 2015, AQUAC RES, V46, P2360, DOI 10.1111/are.12392; ZEISEL SH, 1981, ANNU REV NUTR, V1, P95, DOI 10.1146/annurev.nu.01.070181.000523; Zhang JF, 2004, CHEMOSPHERE, V55, P167, DOI 10.1016/j.chemosphere.2003.10.048; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]; Zhou QC, 2013, AQUACULTURE, V392, P142, DOI 10.1016/j.aquaculture.2013.01.026	89	21	22	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142915	10.1371/journal.pone.0142915	http://dx.doi.org/10.1371/journal.pone.0142915			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600252	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900046
J	Cheng, CY; Tu, WL; Wang, SH; Tang, PC; Chen, CF; Chen, HH; Lee, YP; Chen, SE; Huang, SY				Cheng, Chuen-Yu; Tu, Wei-Lin; Wang, Shih-Han; Tang, Pin-Chi; Chen, Chih-Feng; Chen, Hsin-Hsin; Lee, Yen-Pai; Chen, Shuen-Ei; Huang, San-Yuan			Annotation of Differential Gene Expression in Small Yellow Follicles of a Broiler-Type Strain of Taiwan Country Chickens in Response to Acute Heat Stress	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; EGG-PRODUCTION; GRANULOSA-CELLS; GROWTH-FACTOR; ACTIVATION; PROTEIN; HSP25; IDENTIFICATION; NEUTROPHIL; CAVEOLAE	This study investigated global gene expression in the small yellow follicles (6-8 mm diameter) of broiler-type B strain Taiwan country chickens (TCCs) in response to acute heat stress. Twelve 30-wk-old TCC hens were divided into four groups: control hens maintained at 25 degrees C and hens subjected to 38 degrees C acute heat stress for 2 h without recovery (H2R0), with 2-h recovery (H2R2), and with 6-h recovery (H2R6). Small yellow follicles were collected for RNA isolation and microarray analysis at the end of each time point. Results showed that 69, 51, and 76 genes were upregulated and 58, 15, 56 genes were downregulated after heat treatment of H2R0, H2R2, and H2R6, respectively, using a cutoff value of two-fold or higher. Gene ontology analysis revealed that these differentially expressed genes are associated with the biological processes of cell communication, developmental process, protein metabolic process, immune system process, and response to stimuli. Upregulation of heat shock protein 25, interleukin 6, metallopeptidase 1, and metalloproteinase 13, and downregulation of type II alpha 1 collagen, discoidin domain receptor tyrosine kinase 2, and Kruppel-like factor 2 suggested that acute heat stress induces proteolytic disintegration of the structural matrix and inflamed damage and adaptive responses of gene expression in the follicle cells. These suggestions were validated through gene expression, using quantitative real-time polymerase chain reaction. Functional annotation clarified that interleukin 6-related pathways play a critical role in regulating acute heat stress responses in the small yellow follicles of TCC hens.	[Cheng, Chuen-Yu; Tu, Wei-Lin; Wang, Shih-Han; Tang, Pin-Chi; Chen, Chih-Feng; Lee, Yen-Pai; Chen, Shuen-Ei; Huang, San-Yuan] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan; [Tang, Pin-Chi; Chen, Chih-Feng; Chen, Shuen-Ei; Huang, San-Yuan] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Tang, Pin-Chi; Chen, Chih-Feng; Chen, Shuen-Ei; Huang, San-Yuan] Natl Chung Hsing Univ, Ctr Integrat & Evolutionary Galliformes Genom, iEGG Ctr, Taichung 40227, Taiwan; [Chen, Hsin-Hsin] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Huang, San-Yuan] Natl Chung Hsing Univ, Ctr Nanosci & Nanotechnol, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Chen, SE (corresponding author), Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan.	shueneic@dragon.nchu.edu.tw; syhuang@dragon.nchu.edu.tw	Wang, Shih-Han/HGA-7092-2022; Chen, Shuen-Ei/AAE-3574-2019; Chen, Shuen-Ei/B-2341-2019	Chen, Shuen-Ei/0000-0003-1737-2591	Ministry of Science and Technology (NSC) [102-2321-B-005-013, 101-2311-B-005-008-MY3]; Ministry of Science and Technology (MOST) [103-2321-B-005-010]; Ministry of Education (under the ATU plan), Executive Yuan, Taiwan	Ministry of Science and Technology (NSC); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Ministry of Education (under the ATU plan), Executive Yuan, Taiwan	This study was supported in part by grants from Ministry of Science and Technology (NSC# 102-2321-B-005-013, MOST# 103-2321-B-005-010, and NSC# 101-2311-B-005-008-MY3), and the Ministry of Education (under the ATU plan), Executive Yuan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajakaiye JJ, 2011, VET ARHIV, V81, P119; Beaupre CE, 1997, BIOL REPROD, V56, P1570, DOI 10.1095/biolreprod56.6.1570; Beckham JT, 2010, LASER SURG MED, V42, P752, DOI 10.1002/lsm.20983; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; Chao CH, 2001, POULTRY SCI, V80, P535, DOI 10.1093/ps/80.5.535; Chen CF, 2007, THERIOGENOLOGY, V68, P1305, DOI 10.1016/j.theriogenology.2007.08.032; Cray C, 2009, COMPARATIVE MED, V59, P517; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; EMERY DA, 1984, POULTRY SCI, V63, P2027, DOI 10.3382/ps.0632027; EVANS MI, 1988, GENE DEV, V2, P116, DOI 10.1101/gad.2.1.116; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Hernandez AG, 2003, REPRODUCTION, V125, P683, DOI 10.1530/rep.0.1250683; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Johnson AL, 2009, GEN COMP ENDOCR, V163, P12, DOI 10.1016/j.ygcen.2008.11.012; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Kang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-352; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Katoh Y, 2004, FEBS LETT, V565, P28, DOI 10.1016/j.febslet.2003.12.085; Kim HJ, 2010, PLOS ONE, V6; Knight J, 2012, AMBIO, V41, P206, DOI 10.1007/s13280-011-0178-9; Kuo YM, 2005, THERIOGENOLOGY, V64, P1490, DOI 10.1016/j.theriogenology.2005.03.020; KUSHNER I, 1993, PERSPECT BIOL MED, V36, P611; Lee YP, 2007, BRIT POULTRY SCI, V48, P113, DOI 10.1080/00071660701261302; Li C, 2011, POULTRY SCI, V90, P1028, DOI 10.3382/ps.2010-01144; Liang GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086894; Lindner RA, 2000, EUR J BIOCHEM, V267, P1923, DOI 10.1046/j.1432-1327.2000.01188.x; Liu Y, 2006, CELL STRESS CHAPERON, V11, P379, DOI 10.1379/CSC-210.1; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; Mason SW, 1997, EMBO J, V16, P163, DOI 10.1093/emboj/16.1.163; Matsumoto H, 2010, COMP BIOCHEM PHYS A, V157, P68, DOI 10.1016/j.cbpa.2010.04.019; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; New M, 2011, PHILOS T R SOC A, V369, P6, DOI 10.1098/rsta.2010.0303; Onagbesan O, 2009, ANIM REPROD SCI, V111, P121, DOI 10.1016/j.anireprosci.2008.09.017; Park CH, 2004, J INVEST DERMATOL, V123, P1012, DOI 10.1111/j.0022-202X.2004.23487.x; Rogers RS, 1985, J APPL PHYSIOL, V118, P98, DOI DOI 10.1152/JAPPLPHYSI0L.00286.2014; Ross EA, 2006, BLOOD, V107, P1178, DOI 10.1182/blood-2005-07-2692; Rozenboim I, 2007, POULTRY SCI, V86, P1760, DOI 10.1093/ps/86.8.1760; Saha SK, 2007, CELL PHYSIOL BIOCHEM, V19, P67, DOI 10.1159/000099193; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; SAS, 2010, SAS STAT US GUID VER; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Star L, 2008, POULTRY SCI, V87, P1022, DOI 10.3382/ps.2007-00142; Tan TQ, 2010, CELL BIOL INT, V34, P769, DOI 10.1042/CBI20090244; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Yen TTH, 2014, PROTEIN PEPTIDE LETT, V21, P306, DOI 10.2174/09298665113206660115; VANMIERT ASJPAM, 1995, VET QUART, V17, P41, DOI 10.1080/01652176.1995.9694530; Wang SH, 2013, THERIOGENOLOGY, V79, P374, DOI 10.1016/j.theriogenology.2012.10.010; Woessner JF, 1998, CONNECT TISSUE RES, V39, P69, DOI 10.3109/03008209809023913; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Zhu GY, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114249	55	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143418	10.1371/journal.pone.0143418	http://dx.doi.org/10.1371/journal.pone.0143418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587838	Green Submitted, gold, Green Published			2022-12-27	WOS:000365251500060
J	Ayme, L; Jolivet, P; Nicaud, JM; Chardot, T				Ayme, Laure; Jolivet, Pascale; Nicaud, Jean-Marc; Chardot, Thierry			Molecular Characterization of the Elaeis guineensis Medium-Chain Fatty Acid Diacylglycerol Acyltransferase DGAT1-1 by Heterologous Expression in Yarrowia lipolytica	PLOS ONE			English	Article							N-TERMINAL FRAGMENT; ARABIDOPSIS-THALIANA; TRIACYLGLYCEROL BIOSYNTHESIS; LIPID-ACCUMULATION; BINDING-SITES; OIL CONTENT; KEY ENZYME; YEAST; CLONING; IDENTIFICATION	Diacylglycerol acyltransferases (DGAT) are involved in the acylation of sn-1,2-diacylglycerol. Palm kernel oil, extracted from Elaeis guineensis (oil palm) seeds, has a high content of medium-chain fatty acids mainly lauric acid (C12:0). A putative E. guineensis diacylglycerol acyltransferase gene (EgDGAT1-1) is expressed at the onset of lauric acid accumulation in the seed endosperm suggesting that it is a determinant of medium-chain triacylglycerol storage. To test this hypothesis, we thoroughly characterized EgDGAT1-1 activity through functional complementation of a Yarrowia lipolytica mutant strain devoid of neutral lipids. EgDGAT1-1 expression is sufficient to restore triacylglycerol accumulation in neosynthesized lipid droplets. A comparative functional study with Arabidopsis thaliana DGAT1 highlighted contrasting substrate specificities when the recombinant yeast was cultured in lauric acid supplemented medium. The EgDGAT1-1 expressing strain preferentially accumulated medium-chain triacylglycerols whereas AtDGAT1 expression induced long-chain triacylglycerol storage in Y. lipolytica. EgDGAT1-1 localized to the endoplasmic reticulum where TAG biosynthesis takes place. Reestablishing neutral lipid accumulation in the Y. lipolytica mutant strain did not induce major reorganization of the yeast microsomal proteome. Overall, our findings demonstrate that EgDGAT1-1 is an endoplasmic reticulum DGAT with preference for medium-chain fatty acid substrates, in line with its physiological role in palm kernel. The characterized EgDGAT1-1 could be used to promote medium-chain triacylglycerol accumulation in microbial-produced oil for industrial chemicals and cosmetics.	[Ayme, Laure; Jolivet, Pascale; Chardot, Thierry] INRA, UMR1318, Inst Jean Pierre Bourgin Saclay Plant Sci, F-78026 Versailles, France; [Ayme, Laure; Jolivet, Pascale; Chardot, Thierry] AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, Versailles, France; [Ayme, Laure; Jolivet, Pascale; Chardot, Thierry] AgroParisTech, Micalis, INRA UMR1319, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chardot, T (corresponding author), INRA, UMR1318, Inst Jean Pierre Bourgin Saclay Plant Sci, F-78026 Versailles, France.	thierry.chardot@versailles.inra.fr	NICAUD, Jean-marc/ABA-9076-2021	Chardot, Thierry/0000-0001-6689-6151	French Government [ANR-11-BTBR-0003]	French Government	This work is carried out within ProBio3 project ANR-11-BTBR-0003, selected in Investissements d'Avenir Program, with financial support from French Government, managed by Research National Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah C, 2014, J PROTEOMICS, V108, P354, DOI 10.1016/j.jprot.2014.05.028; Ayme L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092237; Barth G, 2003, TOP CURR GENET, V2, P227; Beopoulos A, 2012, APPL MICROBIOL BIOT, V93, P1523, DOI 10.1007/s00253-011-3506-x; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Blein-Nicolas M, 2013, MOL BIOL EVOL, V30, P1368, DOI 10.1093/molbev/mst050; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Cao Heping, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-249; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; DEVSHONY S, 1992, J AM OIL CHEM SOC, V69, P595, DOI 10.1007/BF02636115; Dong SB, 2014, GENE, V542, P16, DOI 10.1016/j.gene.2014.03.028; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; FOLCH J, 1957, J BIOL CHEM, V226, P497; Froissard M, 2009, FEMS YEAST RES, V9, P428, DOI 10.1111/j.1567-1364.2009.00483.x; Gallart-Ayala H, 2013, ANAL CHIM ACTA, V796, P75, DOI 10.1016/j.aca.2013.08.006; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Guo ZM, 2001, J LIPID RES, V42, P1282; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hobbs DH, 1999, FEBS LETT, V452, P145, DOI 10.1016/S0014-5793(99)00646-8; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; KATAVIC V, 1995, PLANT PHYSIOL, V108, P399, DOI 10.1104/pp.108.1.399; Klug L, 2014, BBA-MOL CELL BIOL L, V1841, P215, DOI 10.1016/j.bbalip.2013.11.005; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Liang MH, 2013, PROG LIPID RES, V52, P395, DOI 10.1016/j.plipres.2013.05.002; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Lopes JLS, 2014, BBA-BIOMEMBRANES, V1838, P3145, DOI 10.1016/j.bbamem.2014.08.017; Hernandez ML, 2012, PLANT PHYSIOL, V160, P215, DOI 10.1104/pp.112.201541; Manas-Fernandez A, 2009, LIPIDS, V44, P555, DOI 10.1007/s11745-009-3303-9; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Metzger JO, 2009, EUR J LIPID SCI TECH, V111, P865, DOI 10.1002/ejlt.200900130; Mlickova K, 2004, APPL ENVIRON MICROB, V70, P3918, DOI 10.1128/AEM.70.7.3918-3924.2004; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pan X, 2013, J BIOL CHEM, V288, P24173, DOI 10.1074/jbc.M113.475699; Papanikolaou S, 2002, APPL MICROBIOL BIOT, V58, P308, DOI 10.1007/s00253-001-0897-0; Routaboul JM, 1999, PLANT PHYSIOL BIOCH, V37, P831, DOI 10.1016/S0981-9428(99)00115-1; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siloto RMP, 2008, BIOCHEM BIOPH RES CO, V373, P350, DOI 10.1016/j.bbrc.2008.06.031; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Spanova M, 2010, J BIOL CHEM, V285, P6127, DOI 10.1074/jbc.M109.074229; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Turchetto-Zolet AC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-263; Weselake RJ, 2008, J EXP BOT, V59, P3543, DOI 10.1093/jxb/ern206; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Xu JY, 2008, PLANT BIOTECHNOL J, V6, P799, DOI 10.1111/j.1467-7652.2008.00358.x; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	62	24	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143113	10.1371/journal.pone.0143113	http://dx.doi.org/10.1371/journal.pone.0143113			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581109	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600085
J	Azar, M; Riehm, KE; McKay, D; Thombs, BD				Azar, Marleine; Riehm, Kira E.; McKay, Dean; Thombs, Brett D.			Transparency of Outcome Reporting and Trial Registration of Randomized Controlled Trials Published in the Journal of Consulting and Clinical Psychology	PLOS ONE			English	Article							CONSORT STATEMENT; MEDICAL JOURNALS; EXPLANATION; BIAS; PROTOCOLS; THERAPY; EDITORS	Background Confidence that randomized controlled trial (RCT) results accurately reflect intervention effectiveness depends on proper trial conduct and the accuracy and completeness of published trial reports. The Journal of Consulting and Clinical Psychology (JCCP) is the primary trials journal amongst American Psychological Association (APA) journals. The objectives of this study were to review RCTs recently published in JCCP to evaluate (1) adequacy of primary outcome analysis definitions; (2) registration status; and, (3) among registered trials, adequacy of outcome registrations. Additionally, we compared results from JCCP to findings from a recent study of top psychosomatic and behavioral medicine journals. Methods Eligible RCTs were published in JCCP in 2013-2014. For each RCT, two investigators independently extracted data on (1) adequacy of outcome analysis definitions in the published report, (2) whether the RCT was registered prior to enrolling patients, and (3) adequacy of outcome registration. Results Of 70 RCTs reviewed, 12 (17.1%) adequately defined primary or secondary outcome analyses, whereas 58 (82.3%) had multiple primary outcome analyses without statistical adjustment or undefined outcome analyses. There were 39 (55.7%) registered trials. Only two trials registered prior to patient enrollment with a single primary outcome variable and time point of assessment. However, in one of the two trials, registered and published outcomes were discrepant. No studies were adequately registered as per Standard Protocol Items: Recommendation for Interventional Trials guidelines. Compared to psychosomatic and behavioral medicine journals, the proportion of published trials with adequate outcome analysis declarations was significantly lower in JCCP (17.1% versus 32.9%; p = 0.029). The proportion of registered trials in JCCP (55.7%) was comparable to behavioral medicine journals (52.6%; p = 0.709). Conclusions The quality of published outcome analysis definitions and trial registrations in JCCP is suboptimal. Greater attention to proper trial registration and outcome analysis definition in published reports is needed.	[Azar, Marleine; Riehm, Kira E.; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Azar, Marleine; Riehm, Kira E.; Thombs, Brett D.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [McKay, Dean] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; Fordham University; McGill University; McGill University; McGill University; McGill University; McGill University	Thombs, BD (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	brett.thombs@mcgill.ca		McKay, Dean/0000-0003-1158-5043	CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships - Master's Award; Arthritis Society	CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships - Master's Award(Canadian Institutes of Health Research (CIHR)); Arthritis Society	Although this study was not supported by any sources of funding, individual authors are supported by funding agencies. Marleine Azar is supported by a CIHR Frederick Banting and Charles Best Canadian Graduate Scholarships - Master's Award (http://cihr-irsc.gc.ca). Dr. Brett Thombs receives support from an Investigator Award from the Arthritis Society (http://www.arthritis.ca/page.aspx?pid=1068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; APA, 2015, J CONSULTING CLIN PS; APA, 2015, J ABNORMAL PSYCHOL; Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; Arthur A, 2003, EDITORIAL MODIFICATI; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brice A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6170; CHALMERS I, 1985, BRIT MED J, V290, P1002, DOI 10.1136/bmj.290.6473.1002; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cook JM, 2007, SCI REV MENTAL HLTH, V5; Cooper H, 2008, AM PSYCHOL, V63, P839, DOI 10.1037/0003-066X.63.9.839; Creed F, 2011, J PSYCHOSOM RES, V70, P203, DOI 10.1016/j.jpsychores.2011.01.011; Dal-Re R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1323; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Enkin M.W., 2007, BIAS RANDOMIZED CONT; Friedmen LM, 2010, FUNDAMENTALS OF CLINICAL TRIALS, FOURTH EDITION, P1; Kaplan RM, 2002, ANN BEHAV MED, V24, P167, DOI 10.1207/S15324796ABM2403_01; KOREN G, 1991, JAMA-J AM MED ASSOC, V266, P1824, DOI 10.1001/jama.266.13.1824; Luborsky L, 1999, CLIN PSYCHOL-SCI PR, V6, P95, DOI 10.1093/clipsy/6.1.95; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Milette K, 2011, J PSYCHOSOM RES, V70, P205, DOI 10.1016/j.jpsychores.2010.09.015; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Murray GD, 2000, STAT METHODS MED RES, V9, P17, DOI 10.1191/096228000670253839; Nezu AM, 2011, J CONSULT CLIN PSYCH, V79, P1, DOI 10.1037/a0022353; Olthuis JV, 2014, J CONSULT CLIN PSYCH, V82, P1005, DOI 10.1037/a0037027; Page MJ, 2013, J CLIN EPIDEMIOL, V66, P524, DOI 10.1016/j.jclinepi.2012.10.010; Page MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000035.pub2; Pocock SJ, 1997, CONTROL CLIN TRIALS, V18, P530, DOI 10.1016/S0197-2456(97)00008-1; Riehm KE, 2015, J PSYCHOSOMATIC RES; Rogers K, 2014, J CONSULT CLIN PSYCH, V82, P361, DOI 10.1037/a0035744; Saquib N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4313; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Sheps DS, 2003, PSYCHOSOM MED, V65, P499, DOI 10.1097/01.PSY.0000082398.68127.9B; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Song Fujian, 2014, PLoS One, V9, pe110418, DOI 10.1371/journal.pone.0110418; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; Wager E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5248	41	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142894	10.1371/journal.pone.0142894	http://dx.doi.org/10.1371/journal.pone.0142894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26581079	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600066
J	Traverso, G; Ciccarelli, G; Schwartz, S; Hughes, T; Boettcher, T; Barman, R; Langer, R; Swiston, A				Traverso, G.; Ciccarelli, G.; Schwartz, S.; Hughes, T.; Boettcher, T.; Barman, R.; Langer, R.; Swiston, A.			Physiologic Status Monitoring via the Gastrointestinal Tract	PLOS ONE			English	Article							CORE TEMPERATURE; SYSTEM; PHONOCARDIOGRAM; VALIDATION; EXTRACTION	Reliable, real-time heart and respiratory rates are key vital signs used in evaluating the physiological status in many clinical and non-clinical settings. Measuring these vital signs generally requires superficial attachment of physically or logistically obtrusive sensors to subjects that may result in skin irritation or adversely influence subject performance. Given the broad acceptance of ingestible electronics, we developed an approach that enables vital sign monitoring internally from the gastrointestinal tract. Here we report initial proof-of-concept large animal (porcine) experiments and a robust processing algorithm that demonstrates the feasibility of this approach. Implementing vital sign monitoring as a stand-alone technology or in conjunction with other ingestible devices has the capacity to significantly aid telemedicine, optimize performance monitoring of athletes, military service members, and first-responders, as well as provide a facile method for rapid clinical evaluation and triage.	[Traverso, G.; Barman, R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gastroenterol, Boston, MA USA; [Traverso, G.; Barman, R.; Langer, R.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Traverso, G.; Barman, R.; Langer, R.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Ciccarelli, G.; Schwartz, S.; Hughes, T.; Boettcher, T.; Swiston, A.] MIT, Lincoln Lab, Bioengn Syst & Technol, Lexington, MA 02420 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT)	Langer, R (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	rlanger@mit.edu; albert.swiston@ll.mit.edu	Traverso, Carlo Giovanni/ABC-9065-2020	Traverso, Carlo Giovanni/0000-0001-7851-4077; Barman, Ross/0000-0002-0370-6354	Department of the Air Force [FA8721-05-C-0002]; Office of the Assistant Secretary of Defense for Research and Engineering; NIH grant [EB000244, T32DK7191-38-S1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244, R01EB000244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F31ES027304, F32ES027306] Funding Source: NIH RePORTER	Department of the Air Force; Office of the Assistant Secretary of Defense for Research and Engineering; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The MIT Lincoln Laboratory portion of this work was sponsored by the Department of the Air Force under Air Force Contract #FA8721-05-C-0002. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the United States Government. The MIT Campus portion of this work was sponsored by the Office of the Assistant Secretary of Defense for Research and Engineering. This work was funded in part by NIH grant EB000244 (to R.L.) and NIH grant T32DK7191-38-S1 (to G.T.).; The MIT Lincoln Laboratory portion of this work was sponsored by the Department of the Air Force under Air Force Contract #FA8721-05-C-0002. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the United States Government. The MIT Campus portion of this work was sponsored by the Office of the Assistant Secretary of Defense for Research and Engineering. This work was funded in part by NIH grant EB000244 (to R.L.) and NIH grant T32DK7191-38-S1 (to G.T.). We would like to thank Pentax for providing the endoscopic equipment used for this research, and in particular Mr. Mike Fina for facilitating access to the equipment. We also thank Kari Siegle for her excellent graphics support, and Monica Siddalls and Robert Marini for their excellent veterinary support.	Beekley MD, 2007, MIL MED, V172, P592, DOI 10.7205/MILMED.172.6.592; Chen YH, 2011, IEEE ENG MED BIO, P1957, DOI 10.1109/IEMBS.2011.6090552; Deswysen AC, 2013, CONTACT DERMATITIS, V69, P379, DOI 10.1111/cod.12137; Egdell P, 2008, EMERG MED J, V25, P745, DOI 10.1136/emj.2007.054965; Emmanuel Babatunde S., 2012, Journal of Medical Engineering & Technology, V36, P303, DOI 10.3109/03091902.2012.684831; Kahn CM, 2010, MERCK VET MANUAL; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lee J, 2011, PHYSIOL MEAS, V32, P1763, DOI 10.1088/0967-3334/32/11/S04; Lopez-Herce J, 2011, INTENS CARE MED, V37, P147, DOI 10.1007/s00134-010-2006-2; Maqbool S, 2009, DIGEST DIS SCI, V54, P2167, DOI 10.1007/s10620-009-0899-9; McKenzie JE, 2004, J THERM BIOL, V29, P605, DOI 10.1016/j.jtherbio.2004.08.020; Muhammad G, 2008, SIGN PROC INF TECHN; O'Brien C, 1998, MED SCI SPORT EXER, V30, P468, DOI 10.1097/00005768-199803000-00020; Rabiner L., 2011, THEORY APPL DIGITAL; Rafiei H, 2013, INT WOUND J, V10, P116, DOI 10.1111/j.1742-481X.2011.00915.x; RANGAYYAN RM, 1988, CRIT REV BIOMED ENG, V15, P211; SAKAI A, 1971, CARDIOVASC RES, V5, P358, DOI 10.1093/cvr/5.3.358; Wang A, 2013, GASTROINTEST ENDOSC, V78, P805, DOI 10.1016/j.gie.2013.06.026; Welles AP, 2013, MIL MED, V178, P1141, DOI 10.7205/MILMED-D-12-00538	19	20	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141666	10.1371/journal.pone.0141666	http://dx.doi.org/10.1371/journal.pone.0141666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580216	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600018
J	Wang, L; Wang, ZL; Yuan, YH; Cai, R; Niu, C; Yue, TL				Wang, Ling; Wang, Zhouli; Yuan, Yahong; Cai, Rui; Niu, Chen; Yue, Tianli			Identification of Key Factors Involved in the Biosorption of Patulin by Inactivated Lactic Acid Bacteria (LAB) Cells	PLOS ONE			English	Article							APPLE JUICE; WALL COMPONENTS; YEAST; ADSORPTION; REDUCTION; MECHANISM; CONTAMINATION; METHYLATION; INDUSTRY; REMOVAL	The purpose of this study was to identify the key factors involved in patulin adsorption by heat-inactivated lactic acid bacteria (LAB) cells. For preventing bacterial contamination, a sterilization process was involved in the adsorption process. The effects of various physical, chemical, and enzymatic pre-treatments, simultaneous treatments, and post-treatments on the patulin adsorption performances of six LAB strains were evaluated. The pre-treated cells were characterized by scanning electron microscopy (SEM). Results showed that the removal of patulin by viable cells was mainly based on adsorption or degradation, depending on the specific strain. The adsorption abilities were widely increased by NaOH and esterification pre-treatments, and reduced by trypsin, lipase, iodate, and periodate pre-treatments. Additionally, the adsorption abilities were almost maintained at pH 2.2-4.0, and enhanced significantly at pH 4.0-6.0. The effects of sodium and magnesium ions on the adsorption abilities at pH 4 were slight and strain-specific. A lower proportion of patulin was released from the strain with higher adsorption ability. Analyses revealed that the physical structure of peptidoglycan was not a principal factor. Vicinal OH and carboxyl groups were not involved in patulin adsorption, while alkaline amino acids, thiol and ester compounds were important for patulin adsorption. Additionally, besides hydrophobic interaction, electrostatic interaction also participated in patulin adsorption, which was enhanced with the increase in pH (4.0-6.0).	[Wang, Ling; Wang, Zhouli; Yuan, Yahong; Cai, Rui; Niu, Chen; Yue, Tianli] Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Yue, TL (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China.	yuetl305@nwsuaf.edu.cn	Cai, Rui/GRO-1869-2022; yue, tianli/AEY-3384-2022	yue, tianli/0000-0002-4768-5831	National Natural Science Foundation of China [31371814]; Science and Technology Research and Development Program of Shaanxi Province, China [2014K13-15]; Basic Research Program of Science and Technology [2013FY113400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research and Development Program of Shaanxi Province, China; Basic Research Program of Science and Technology	This work has been supported by National Natural Science Foundation of China (31371814); Science and Technology Research and Development Program of Shaanxi Province, China (2014K13-15); Basic Research Program of Science and Technology (2013FY113400).	Acar J, 1998, Z LEBENSM UNTERS F A, V207, P328, DOI 10.1007/s002170050341; Al-Degs YS, 2008, DYES PIGMENTS, V77, P16, DOI 10.1016/j.dyepig.2007.03.001; Ramirez JAA, 2014, CARBOHYD POLYM, V114, P416, DOI 10.1016/j.carbpol.2014.08.020; Banik S, 2003, BIORESOURCE TECHNOL, V87, P155, DOI 10.1016/S0960-8524(02)00169-4; Bermejo-Barrera P, 1999, J ANAL ATOM SPECTROM, V14, P1893, DOI 10.1039/a903924d; Bintsis T, 2000, J SCI FOOD AGR, V80, P637, DOI 10.1002/(SICI)1097-0010(20000501)80:6<637::AID-JSFA603>3.0.CO;2-1; Bissessur J, 2001, J FOOD PROTECT, V64, P1216, DOI 10.4315/0362-028X-64.8.1216; Burgi H, 2001, THYROID, V11, P449, DOI 10.1089/105072501300176408; Chen FL, 2004, J HETEROCYCLIC CHEM, V41, P697, DOI 10.1002/jhet.5570410507; COPE AC, 1965, J ORG CHEM, V30, P2163, DOI 10.1021/jo01018a011; Das SK, 2008, COLLOID SURFACE B, V65, P30, DOI 10.1016/j.colsurfb.2008.02.020; Fliege R, 2000, CHEM RES TOXICOL, V13, P363, DOI 10.1021/tx9901478; Fuchs S, 2008, FOOD CHEM TOXICOL, V46, P1398, DOI 10.1016/j.fct.2007.10.008; Geciova J, 2002, INT DAIRY J, V12, P541, DOI 10.1016/S0958-6946(02)00038-9; Guo C, 2012, LETT APPL MICROBIOL, V55, P453, DOI 10.1111/j.1472-765x.2012.03314.x; Guo CX, 2013, SPECTROSC SPECT ANAL, V33, P672, DOI 10.3964/j.issn.1000-0593(2013)03-0672-05; Guo CX, 2013, FOOD CONTROL, V32, P99, DOI 10.1016/j.foodcont.2012.11.009; Guo CX, 2012, J FOOD PROTECT, V75, P585, DOI 10.4315/0362-028X.JFP-11-323; Hatab S, 2012, J APPL MICROBIOL, V112, P892, DOI 10.1111/j.1365-2672.2012.05279.x; Hatab S, 2012, J FOOD SCI, V77, pM238, DOI 10.1111/j.1750-3841.2011.02615.x; Hawar S, 2013, FOOD CONTROL, V34, P502, DOI 10.1016/j.foodcont.2013.05.023; HONDA S, 1989, ANAL BIOCHEM, V177, P62, DOI 10.1016/0003-2697(89)90014-6; Joyce E, 2003, ULTRASON SONOCHEM, V10, P315, DOI 10.1016/S1350-4177(03)00101-9; Lahtinen SJ, 2004, FOOD ADDIT CONTAM A, V21, P158, DOI [10.1080/02652030310001639521, 10.1080/02646830020032300]; Leiros HKS, 2004, PROTEIN SCI, V13, P1056, DOI 10.1110/ps.03498604; Lemke SL, 1998, J AGR FOOD CHEM, V46, P3789, DOI 10.1021/jf9709461; Moake MM, 2005, COMPR REV FOOD SCI F, V4, P8, DOI 10.1111/j.1541-4337.2005.tb00068.x; Nadeem R, 2008, J HAZARD MATER, V150, P335, DOI 10.1016/j.jhazmat.2007.04.110; Park DL, 2002, ADV EXP MED BIOL, V504, P277; PAUL TR, 1994, INFECT IMMUN, V62, P1542, DOI 10.1128/IAI.62.5.1542-1550.1994; Puel O, 2010, TOXINS, V2, P613, DOI 10.3390/toxins2040613; Reddy KRN, 2010, TOXIN REV, V29, P3, DOI 10.3109/15569541003598553; Riteni A, 2003, J AGR FOOD CHEM, V51, P6086, DOI 10.1021/jf034523c; Svendsen A, 2000, BBA-PROTEIN STRUCT M, V1543, P223, DOI 10.1016/S0167-4838(00)00239-9; Topcu A, 2010, INT J FOOD MICROBIOL, V139, P202, DOI 10.1016/j.ijfoodmicro.2010.03.006; Trezl L, 2003, MOL CELL BIOCHEM, V244, P167, DOI 10.1023/A:1022499621630; van Bokhorst-van de Veen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039053; Wang L, 2015, FOOD CONTROL, V50, P104, DOI 10.1016/j.foodcont.2014.08.041; Yuan Y, 2014, LETT APPL MICROBIOL, V59, P604, DOI 10.1111/lam.12315; Yue TL, 2011, J FOOD PROTECT, V74, P149, DOI 10.4315/0362-028X.JFP-10-326; Zou ZY, 2012, FOOD SCI BIOTECHNOL, V21, P1677, DOI 10.1007/s10068-012-0223-x	41	8	10	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143431	10.1371/journal.pone.0143431	http://dx.doi.org/10.1371/journal.pone.0143431			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581099	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600121
J	Grassi, E; Zapparoli, E; Molineris, I; Provero, P				Grassi, Elena; Zapparoli, Ettore; Molineris, Ivan; Provero, Paolo			Total Binding Affinity Profiles of Regulatory Regions Predict Transcription Factor Binding and Gene Expression in Human Cells	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; EMBRYONIC STEM-CELLS; CHIP-SEQ; GENOME; DATABASE; OCCUPANCY; MOUSE; MODEL	Transcription factors regulate gene expression by binding regulatory DNA. Understanding the rules governing such binding is an essential step in describing the network of regulatory interactions, and its pathological alterations. We show that describing regulatory regions in terms of their profile of total binding affinities for transcription factors leads to increased predictive power compared to methods based on the identification of discrete binding sites. This applies both to the prediction of transcription factor binding as revealed by ChIP-seq experiments and to the prediction of gene expression through RNA-seq. Further significant improvements in predictive power are obtained when regulatory regions are defined based on chromatin states inferred from histone modification data.	[Grassi, Elena; Zapparoli, Ettore; Molineris, Ivan; Provero, Paolo] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Provero, Paolo] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy	University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Provero, P (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.	paolo.provero@unito.it	Grassi, Elena/AAB-3099-2020; Provero, Paolo/AAC-1930-2019; Zapparoli, Ettore/AAN-1951-2020	Grassi, Elena/0000-0003-1066-927X; Zapparoli, Ettore/0000-0003-4170-7902; Molineris, Ivan/0000-0003-2102-0804	Italian Ministry of University and Research	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant to PP by the Italian Ministry of University and Research (http://www.istruzione.it/) under the PRIN 2010-2011 call, and by funding to the Graduate School of Biomedical Sciences and Oncology of the University of Turin by the same Italian Ministry of University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113; Budden DM, 2014, BRIEFINGS BIOINFORMA; Carey V, 2014, ROC UTILITIES ROC UA; Cheng C, 2012, NUCLEIC ACIDS RES, V40, P553, DOI 10.1093/nar/gkr752; Claeys M, 2012, BIOINFORMATICS, V28, P1931, DOI 10.1093/bioinformatics/bts293; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Grassi E, 2015, MATRIXRIDER OBTAIN T; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Liu X, 2002, J MOL BIOL, V323, P1, DOI 10.1016/S0022-2836(02)00894-X; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Molineris I, 2011, MOL BIOL EVOL, V28, P2173, DOI 10.1093/molbev/msr027; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Shannon P, 2015, MOTIFDB ANNOTATED CO; Tan G, 2015, TFBSTOOLS SOFTWARE P; Tan G, 2014, JASPAR2014 DATA PACK; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Tibshirani R, 2015, BOOTSTRAP FUNCTIONS; Ward LD, 2008, BIOINFORMATICS, V24, pI165, DOI 10.1093/bioinformatics/btn154; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xie Z, 2010, BIOINFORMATICS, V26, P287, DOI 10.1093/bioinformatics/btp631	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143627	10.1371/journal.pone.0143627	http://dx.doi.org/10.1371/journal.pone.0143627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599758	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600096
J	Meadows, DN; Bahous, RH; Best, AF; Rozen, R				Meadows, Danielle N.; Bahous, Renata H.; Best, Ana F.; Rozen, Rima			High Dietary Folate in Mice Alters Immune Response and Reduces Survival after Malarial Infection	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY; TUMOR-NECROSIS-FACTOR; NEURAL-TUBE DEFECTS; FOLIC-ACID; CEREBRAL MALARIA; METABOLISM; EXPRESSION; GENE; SUPPLEMENTATION; FORTIFICATION	Malaria is a significant global health issue, with nearly 200 million cases in 2013 alone. Parasites obtain folate from the host or synthesize it de novo. Folate consumption has increased in many populations, prompting concerns regarding potential deleterious consequences of higher intake. The impact of high dietary folate on the host's immune function and response to malaria has not been examined. Our goal was to determine whether high dietary folate would affect response to malarial infection in a murine model of cerebral malaria. Mice were fed control diets (CD, recommended folate level for rodents) or folic acid-supplemented diets (FASD, 10x recommended level) for 5 weeks before infection with Plasmodium berghei ANKA. Survival, parasitemia, numbers of immune cells and other infection parameters were assessed. FASD mice had reduced survival (p<0.01, Cox proportional hazards) and higher parasitemia (p<0.01, joint model of parasitemia and survival) compared with CD mice. FASD mice had lower numbers of splenocytes, total T cells, and lower numbers of specific T and NK cell sub-populations, compared with CD mice (p<0.05, linear mixed effects). Increased brain TNF alpha immunoreactive protein (p<0.01, t-test) and increased liver Abca1 mRNA (p<0.01, t-test), a modulator of TNF alpha, were observed in FASD mice; these variables correlated positively (r(s) = 0.63, p = 0.01). Bcl-xl/Bak mRNA was increased in liver of FASD mice (p<0.01, t-test), suggesting reduced apoptotic potential. We conclude that high dietary folate increases parasite replication, disturbs the immune response and reduces resistance to malaria in mice. These findings have relevance for malaria-endemic regions, when considering anti-folate anti-malarials, food fortification or vitamin supplementation programs.	[Meadows, Danielle N.; Bahous, Renata H.; Rozen, Rima] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada; [Best, Ana F.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Rozen, Rima] McGill Univ, Dept Pediat, Ctr Hlth, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; McGill University	Rozen, R (corresponding author), McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada.	rima.rozen@mcgill.ca	Rozen, Rima/AAE-9294-2020	Best, Ana/0000-0002-4467-1725	Canadian Institutes of Health Research [MOP 43232]; Fonds de recherche du Quebec-Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by a Canadian Institutes of Health Research grant to RR (MOP 43232). The McGill University Health Centre Research Institute is supported by a Centres grant from the Fonds de recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GUID DAIL IR FOL AC; Boulet SL, 2008, BIRTH DEFECTS RES A, V82, P527, DOI 10.1002/bdra.20468; Britto Jéssica Carrilho, 2014, Rev. Bras. Hematol. Hemoter., V36, P275, DOI 10.1016/j.bjhh.2014.03.018; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Carter JY, 2005, AM J TROP MED HYG, V73, P166, DOI 10.4269/ajtmh.2005.73.166; Castilla C, 2006, ENDOCRINOLOGY, V147, P4960, DOI 10.1210/en.2006-0502; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P513; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Christensen KE, 2015, AM J CLIN NUTR, V101, P646, DOI 10.3945/ajcn.114.086603; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Dzinjalamala FK, 2005, AM J TROP MED HYG, V72, P267, DOI 10.4269/ajtmh.2005.72.267; EUROCAT, 2015, FOL AC MAND FORT; Garcia-Crespo D, 2009, J NUTR, V139, P488, DOI 10.3945/jn.108.095661; GRAU GE, 1989, IMMUNOL REV, V112, P49, DOI 10.1111/j.1600-065X.1989.tb00552.x; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Hansen DS, 2007, CURR OPIN IMMUNOL, V19, P416, DOI 10.1016/j.coi.2007.07.011; Haque A, 2011, INFECT IMMUN, V79, P1882, DOI 10.1128/IAI.01210-10; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Hood AT, 1996, BLOOD, V87, P1600, DOI 10.1182/blood.V87.4.1600.bloodjournal8741600; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Kalmbach RD, 2008, AM J CLIN NUTR, V88, P763, DOI 10.1093/ajcn/88.3.763; Kicska GA, 2003, J INFECT DIS, V188, P1776, DOI 10.1086/379373; Knock E, 2006, CANCER RES, V66, P10349, DOI 10.1158/0008-5472.CAN-06-2477; Knock E, 2011, J NUTR BIOCHEM, V22, P1022, DOI 10.1016/j.jnutbio.2010.07.015; Krawinkel MB, 2014, EUR J CLIN NUTR, V68, P719, DOI 10.1038/ejcn.2014.45; Lawrance AK, 2009, GUT, V58, P805, DOI 10.1136/gut.2007.143107; Leclerc D, 2013, MOL NUTR FOOD RES, V57, P686, DOI 10.1002/mnfr.201200212; LEVANDER OA, 1995, J PARASITOL, V81, P99, DOI 10.2307/3284013; Li DQ, 2005, AM J CLIN NUTR, V82, P188, DOI 10.1093/ajcn/82.1.188; McDowell Margaret A, 2008, NCHS Data Brief, P1; MCGILCHRIST CA, 1991, BIOMETRICS, V47, P461, DOI 10.2307/2532138; Meadows DN, 2014, HUM MUTAT, V35, P594, DOI 10.1002/humu.22533; Mikael LG, 2013, BIRTH DEFECTS RES A, V97, P47, DOI 10.1002/bdra.23092; Mikael LG, 2006, CIRC RES, V98, P564, DOI 10.1161/01.RES.0000204825.66410.0b; Morris MS, 2010, AM J CLIN NUTR, V91, P1733, DOI 10.3945/ajcn.2009.28671; Muller IB, 2013, MOL BIOCHEM PARASIT, V188, P63, DOI 10.1016/j.molbiopara.2013.02.008; Mulenga M, 2006, AM J TROP MED HYG, V74, P986, DOI 10.4269/ajtmh.2006.74.986; Nzila A, 2005, TRENDS PARASITOL, V21, P334, DOI 10.1016/j.pt.2005.05.008; Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002; Nzila A, 2014, J ANTIMICROB CHEMOTH, V69, P323, DOI 10.1093/jac/dkt394; Oakes D, 1998, LIFETIME DATA ANAL, V4, P209, DOI 10.1023/A:1009689630516; Pandya AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026780; Pfeiffer CM, 2012, J NUTR, V142, P886, DOI 10.3945/jn.111.156919; Pickell L, 2009, BIRTH DEFECTS RES A, V85, P531, DOI 10.1002/bdra.20575; Pinheiro J, 2015, NLME LINEAR NONLINEA; Protiva P, 2011, CANCER PREV RES, V4, P530, DOI 10.1158/1940-6207.CAPR-10-0143; R Core Team, 2013, R LANG ENV STAT COMP; Reeves PG, 1997, J NUTR, V127, pS838; Rizopoulos D, 2010, J STAT SOFTW, V35, P1; ROTH EF, 1988, J LAB CLIN MED, V111, P35; Rudin W, 1997, AM J PATHOL, V150, P257; Sepehr E, 2003, J NUTR, V133, P1347; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Spence PJ, 2012, CURR OPIN IMMUNOL, V24, P444, DOI 10.1016/j.coi.2012.05.003; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Therneau T.M., 2000, MODELING SURVIVAL DA; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Troen AM, 2006, J NUTR, V136, P189, DOI 10.1093/jn/136.1.189; Valera-Gran D, 2014, JAMA PEDIATR, V168, DOI 10.1001/jamapediatrics.2014.2611; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson RD, 2007, J OBSTET GYNAECOL CA, V29, P1003, DOI 10.1016/S1701-2163(16)32685-8; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; YING Z, 1994, J MULTIVARIATE ANAL, V50, P17, DOI 10.1006/jmva.1994.1031	68	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143738	10.1371/journal.pone.0143738	http://dx.doi.org/10.1371/journal.pone.0143738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599510	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600114
J	Schabrun, SM; Burns, E; Hodges, PW				Schabrun, Siobhan M.; Burns, Emma; Hodges, Paul W.			New Insight into the Time-Course of Motor and Sensory System Changes in Pain	PLOS ONE			English	Article							TONIC MUSCLE PAIN; ELECTRICAL-STIMULATION; PERIPHERAL INPUT; CORTEX; EXCITABILITY; INHIBITION; POTENTIALS; PARAMETERS; LORAZEPAM; HUMANS	Background Pain-related interactions between primary motor (M1) and primary sensory (S1) cortex are poorly understood. In particular, the time-course over which S1 processing and corticomotor output are altered in association with muscle pain is unclear. We aimed to examine the temporal profile of altered processing in S1 and altered corticomotor output with finer temporal resolution than has been used previously. Methods In 10 healthy individuals we recorded somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) in separate sessions at multiple time-points before, during and immediately after pain induced by hypertonic saline infusion in a hand muscle, and at 15 and 25 minutes follow-up. Results Participants reported an average pain intensity that was less in the session where SEPs were recorded (SEPs: 4.0 +/- 1.6; MEPs: 4.9 +/- 2.3). In addition, the time taken for pain to return to zero once infusion of hypertonic saline ceased was less for participants in the SEP session (SEPs: 4.7 +/- 3.8 mins; MEPs 9.4 +/- 7.4 mins). Both SEPs and MEPs began to reduce almost immediately after pain reached 5/10 following hypertonic saline injection and were significantly reduced from baseline by the second (SEPs) and third (MEPs) recording blocks during pain. Both parameters remained suppressed immediately after pain had resolved and at 15 and 25 minutes after the resolution of pain. Conclusions These data suggest S1 processing and corticomotor output may be co-modulated in association with muscle pain. Interestingly, this is in contrast to previous observations. This discrepancy may best be explained by an effect of the SEP test stimulus on the corticomotor pathway. This novel finding is critical to consider in experimental design and may be potentially useful to consider as an intervention for the management of pain.	[Schabrun, Siobhan M.; Burns, Emma] Univ Western Sydney, Brain Rehabil & Neuroplast Unit, Sch Sci & Hlth, Penrith, NSW 2751, Australia; [Hodges, Paul W.] Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld 4062, Australia	Western Sydney University; University of Queensland	Schabrun, SM (corresponding author), Univ Western Sydney, Brain Rehabil & Neuroplast Unit, Sch Sci & Hlth, Campbelltown Campus,Locked Bag 1797, Penrith, NSW 2751, Australia.	s.schabrun@westernsydney.edu.au	Hodges, Paul W/B-6578-2008	Hodges, Paul W/0000-0002-1206-9107; Schabrun, Siobhan/0000-0002-9083-3107	National Health and Medical Research Council of Australia [ID631612, ID1002190]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	SMS is supported by a Clinical Research Fellowship (ID631612) and PWH by a Senior Principal Research Fellowship (ID1002190), both from the National Health and Medical Research Council of Australia.	Andrews RK, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-51; ASANUMA H, 1984, J NEUROPHYSIOL, V52, P212, DOI 10.1152/jn.1984.52.2.212; ASANUMA H, 1980, EXP BRAIN RES, V38, P349; Chipchase LS, 2011, CLIN NEUROPHYSIOL, V122, P456, DOI 10.1016/j.clinph.2010.07.025; Chipchase L, 2012, CLIN NEUROPHYSIOL, V123, P1698, DOI 10.1016/j.clinph.2012.05.003; Chipchase LS, 2011, ARCH PHYS MED REHAB, V92, P1423, DOI 10.1016/j.apmr.2011.01.011; Coppieters MW, 2006, ARCH PHYS MED REHAB, V87, P1412, DOI 10.1016/j.apmr.2006.06.012; DARIANSMITH C, 1990, J COMP NEUROL, V299, P47, DOI 10.1002/cne.902990104; Di Lazzaro V, 2000, CLIN NEUROPHYSIOL, V111, P794, DOI 10.1016/S1388-2457(99)00314-4; Eichstaedt KE, 2013, NEUROREHABILITATION, V32, P693, DOI 10.3233/NRE-130893; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; KANEKO T, 1994, J COMP NEUROL, V345, P161, DOI 10.1002/cne.903450202; KANEKO T, 1994, J COMP NEUROL, V345, P172, DOI 10.1002/cne.903450203; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; Martin PG, 2008, J PHYSIOL-LONDON, V586, P1277, DOI 10.1113/jphysiol.2007.140426; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Rossi S, 2003, CLIN NEUROPHYSIOL, V114, P1351, DOI 10.1016/S1388-2457(03)00073-7; Rushton DN, 2003, MED ENG PHYS, V25, P75, DOI 10.1016/S1350-4533(02)00040-1; SAKAMOTO T, 1987, BRAIN RES, V413, P360, DOI 10.1016/0006-8993(87)91029-8; Schabrun SM, 2013, NEUROSCIENCE, V235, P159, DOI 10.1016/j.neuroscience.2012.12.072; Schabrun SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051298; Schabrun SM, 2012, J PAIN, V13, P187, DOI 10.1016/j.jpain.2011.10.013; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Vance CGT, 2014, PAIN MANAG, V4, P197, DOI [10.2217/pmt.14.13, 10.2217/PMT.14.13]; Ziemann U, 1998, NEUROLOGY, V51, P1320, DOI 10.1212/WNL.51.5.1320; Ziemann U, 1996, EXP BRAIN RES, V109, P127	26	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142857	10.1371/journal.pone.0142857	http://dx.doi.org/10.1371/journal.pone.0142857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599632	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600020
J	Dai, HP; Ehrentraut, S; Nagel, S; Eberth, S; Pommerenke, C; Dirks, WG; Geffers, R; Kalavalapalli, S; Kaufmann, M; Meyer, C; Faehnrich, S; Chen, SN; Drexler, HG; MacLeod, RAF				Dai, Haiping; Ehrentraut, Stefan; Nagel, Stefan; Eberth, Sonja; Pommerenke, Claudia; Dirks, Wilhelm G.; Geffers, Robert; Kalavalapalli, Srilaxmi; Kaufmann, Maren; Meyer, Corrina; Faehnrich, Silke; Chen, Suning; Drexler, Hans G.; MacLeod, Roderick A. F.			Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; REED-STERNBERG CELLS; GRAY ZONE LYMPHOMA; HODGKINS-LYMPHOMA; IN-VITRO; MUTATIONS; FREQUENT; SOCS-1; REL	Primary mediastinal B-Cell lymphoma (PMBL) is a recently defined entity comprising similar to 2-10% non-Hodgkin lymphomas (NHL). Unlike most NHL subtypes, PMBL lacks recurrent gene rearrangements to serve as biomarkers or betray target genes. While druggable, late chemotherapeutic complications warrant the search for new targets and models. Well characterized tumor cell lines provide unlimited material to serve as preclinical resources for verifiable analyses directed at the discovery of new biomarkers and pathological targets using high throughput microarray technologies. The same cells may then be used to seek intelligent therapies directed at clinically validated targets. Four cell lines have emerged as potential PMBL models: FARAGE, KARPAS-1106P, MEDB-1 and U-2940. Transcriptionally, PMBL cell lines cluster near c(lassical)-HL and B-NHL examples showing they are related but separate entities. Here we document genomic alterations therein, by cytogenetics and high density oligonucleotide/SNP microarrays and parse their impact by integrated global expression profiling. PMBL cell lines were distinguished by moderate chromosome rearrangement levels undercutting cHL, while lacking oncogene translocations seen in B-NHL. In total 61 deletions were shared by two or more cell lines, together with 12 amplifications (>= 4x) and 72 homozygous regions. Integrated genomic and transcriptional profiling showed deletions to be the most important class of chromosome rearrangement. Lesions were mapped to several loci associated with PMBL, e.g. 2p15 (REL/COMMD1), 9p24 (JAK2, CD274), 16p13 (SOCS1, LITAF, CIITA); plus new or tenuously associated loci: 2p16 (MSH6), 6q23 (TNFAIP3), 9p22 (CDKN2A/B), 20p12 (PTPN1). Discrete homozygous regions sometimes substituted focal deletions accompanied by gene silencing implying a role for epigenetic or mutational inactivation. Genomic amplifications increasing gene expression or gene-activating rearrangements were respectively rare or absent. Our findings highlight biallelic deletions as a major class of chromosomal lesion in PMBL cell lines, while endorsing the latter as preclinical models for hunting and testing new biomarkers and actionable targets.	[Dai, Haiping; Ehrentraut, Stefan; Nagel, Stefan; Eberth, Sonja; Pommerenke, Claudia; Dirks, Wilhelm G.; Kaufmann, Maren; Meyer, Corrina; Faehnrich, Silke; Drexler, Hans G.; MacLeod, Roderick A. F.] Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Braunschweig, Germany; [Dai, Haiping; Chen, Suning] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou, Jiangsu, Peoples R China; [Geffers, Robert] Helmholtz Ctr Infect Res, Dept Genome Anal, HZI, Braunschweig, Germany; [Kalavalapalli, Srilaxmi] Univ Florida, Gainesville, FL USA	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Soochow University - China; Helmholtz Association; Helmholtz-Center for Infection Research; State University System of Florida; University of Florida	MacLeod, RAF (corresponding author), Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Braunschweig, Germany.	rml@dsmz.de		Dirks, Wilhelm/0000-0001-9781-0998				Bartuzi P, 2013, BBA-MOL BASIS DIS, V1832, P2315, DOI 10.1016/j.bbadis.2013.09.014; BENBASSAT H, 1992, LEUKEMIA LYMPHOMA, V6, P513, DOI 10.3109/10428199209053591; Bertolo C, 2013, BRIT J HAEMATOL, V162, P621, DOI 10.1111/bjh.12440; Boleti E, 2007, HEMATOL ONCOL, V25, P157, DOI 10.1002/hon.818; Carbone A, 2014, ANN HEMATOL, V93, P1263, DOI 10.1007/s00277-014-2116-y; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Drexler HG, 2015, LEUKEMIA RES, V39, P18, DOI 10.1016/j.leukres.2014.11.002; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Dunleavy K, 2015, BLOOD, V125, P33, DOI 10.1182/blood-2014-05-575092; Eberle FC, 2011, HAEMATOL-HEMATOL J, V96, P558, DOI 10.3324/haematol.2010.033167; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Guiter C, 2004, BLOOD, V104, P543, DOI 10.1182/blood-2003-10-3545; Gunawardana J, 2014, NAT GENET, V46, P329, DOI 10.1038/ng.2900; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Hao YS, 2014, CLIN CANCER RES, V20, P2674, DOI 10.1158/1078-0432.CCR-13-3007; Joos S, 1996, BLOOD, V87, P1571, DOI 10.1182/blood.V87.4.1571.bloodjournal8741571; Kimm LR, 2007, GENE CHROMOSOME CANC, V46, P1090, DOI 10.1002/gcc.20495; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; MacLeod RAF, 2008, CURR MED CHEM, V15, P339, DOI 10.2174/092986708783497319; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Melzner I, 2006, INT J CANCER, V118, P1941, DOI 10.1002/ijc.21485; Melzner I, 2005, BLOOD, V105, P2535, DOI 10.1182/blood-2004-09-3701; Mestre C, 2005, LEUKEMIA, V19, P1082, DOI 10.1038/sj.leu.2403741; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mitelman F., 1995, INT SYSTEM HUMAN CYT; Moller P, 2001, INT J CANCER, V92, P348, DOI 10.1002/ijc.1211; Moreno BH, 2015, BRIT J CANCER, V112, P1421, DOI 10.1038/bjc.2015.124; NACHEVA E, 1994, BLOOD, V84, P3422, DOI 10.1182/blood.V84.10.3422.bloodjournal84103422; Ritz O, 2013, ONCOTARGET, V4, P1093, DOI 10.18632/oncotarget.1149; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Sambade C, 2006, INT J CANCER, V118, P555, DOI 10.1002/ijc.21417; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Taskinen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091031; Tiacci E, 2012, BLOOD, V120, P4609, DOI 10.1182/blood-2012-05-428896; Twa DDW, 2014, BLOOD, V123, P2062, DOI 10.1182/blood-2013-10-535443; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; Weniger MA, 2007, GENE CHROMOSOME CANC, V46, P406, DOI 10.1002/gcc.20420; Wessendorf S, 2007, LEUKEMIA, V21, P2463, DOI 10.1038/sj.leu.2404919; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Zhou J, 2011, ONCOGENE, V30, P1892, DOI 10.1038/onc.2010.575	52	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0139663	10.1371/journal.pone.0139663	http://dx.doi.org/10.1371/journal.pone.0139663			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599546	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900005
J	Ding, XX; Wang, QM; Chang, PJ; Li, J; Savini, G; Huang, JH; Huang, SH; Zhao, YY; Liao, N; Lin, L; Yu, XY; Zhao, YE				Ding, Xixia; Wang, Qinmei; Chang, Pingjun; Li, Jin; Savini, Giacomo; Huang, Jinhai; Huang, Shenghai; Zhao, Yinying; Liao, Na; Lin, Lei; Yu, Xiaoyu; Zhao, Yun-e			The Repeatability Assessment of Three-Dimensional Capsule-Intraocular Lens Complex Measurements by Means of High-Speed Swept-Source Optical Coherence Tomography	PLOS ONE			English	Article							IN-VIVO; ANTERIOR SEGMENT; CATARACT-SURGERY; DECENTRATION; SILICONE; TILT; AGREEMENT; ADHESION; BIOMETRY; PURKINJE	Purpose To rebuild the three-dimensional (3-D) model of the anterior segment by high-speed swept-source optical coherence tomography (SSOCT) and evaluate the repeatability of measurement for the parameters of capsule-intraocular lens (C-IOL) complex. Methods Twenty-two pseudophakic eyes from 22 patients were enrolled. Three continuous SSOCT measurements were performed in all eyes and the tomograms obtained were used for 3-D reconstruction. The output data were used to evaluate the measurement repeatability. The parameters included postoperative aqueous depth (PAD), the area and diameter of the anterior capsule opening (Area and D), IOL tilt (IOL-T), horizontal, vertical, and space decentration of the IOL, anterior capsule opening, and IOL-anterior capsule opening. Results PAD, IOL-T, Area, D, and all decentration measurements showed high repeatability. Repeated measure analysis showed there was no statistically significant difference among the three continuous measurements (all P>.05). Pearson correlation analysis showed high correlation between each pair of them (all r>0.90, P<0.001). ICCs were all more than 0.9 for all parameters. The 95% LoAs of all parameters were narrow for comparison of three measurements, which showed high repeatability for three measurements. Conclusion SSOCT is available to be a new method for the 3-D measurement of C-IOL complex after cataract surgery. This method presented high repeatability in measuring the parameters of the C-IOL complex.	[Ding, Xixia; Wang, Qinmei; Chang, Pingjun; Li, Jin; Huang, Jinhai; Huang, Shenghai; Zhao, Yinying; Liao, Na; Lin, Lei; Yu, Xiaoyu; Zhao, Yun-e] Wenzhou Med Univ, Sch Optometry, Wenzhou, Zhejiang, Peoples R China; [Ding, Xixia; Wang, Qinmei; Chang, Pingjun; Li, Jin; Huang, Jinhai; Huang, Shenghai; Zhao, Yinying; Liao, Na; Lin, Lei; Yu, Xiaoyu; Zhao, Yun-e] Wenzhou Med Univ, Ophthalmol & Eye Hosp, Wenzhou, Zhejiang, Peoples R China; [Ding, Xixia; Wang, Qinmei; Chang, Pingjun; Li, Jin; Huang, Jinhai; Huang, Shenghai; Zhao, Yinying; Liao, Na; Lin, Lei; Yu, Xiaoyu; Zhao, Yun-e] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Savini, Giacomo] GB Bietti Fdn IRCCS, Rome, Italy	Wenzhou Medical University; Wenzhou Medical University; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia	Zhao, YE (corresponding author), Wenzhou Med Univ, Sch Optometry, Wenzhou, Zhejiang, Peoples R China.	zye@mail.eye.ac.cn	Huang, Jinhai/ABH-4519-2020; Savini, Giacomo/J-9196-2018	Savini, Giacomo/0000-0003-0075-3582	Foundation of National Nature Science Foundation of China [80213050]; Zhejiang Provincial Natural Science Foundation of China [LY13H120005]; Italian Ministry of Health; Fondazione Roma	Foundation of National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission)	This study was supported by research grants from Foundation of National Nature Science Foundation of China (Grant No. 80213050 to Yun-e Zhao); and Zhejiang Provincial Natural Science Foundation of China (LY13H120005 to JL). The contribution of the G.B. Fondazione Bietti IRCCS in this paper was supported by the Italian Ministry of Health and by Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ale JB, 2011, NEPAL J OPHTHALMOL, V3, P68, DOI 10.3126/nepjoph.v3i1.4281; Apple DJ, 2000, SURV OPHTHALMOL, V45, pS5; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen Q, 2014, EYE CONTACT LENS, V40, P37, DOI 10.1097/ICL.0000000000000005; de Castro A, 2007, J CATARACT REFR SURG, V33, P418, DOI 10.1016/j.jcrs.2006.10.054; Grulkowski I, 2009, OPT EXPRESS, V17, P4842, DOI 10.1364/OE.17.004842; Hayashi H, 2002, OPHTHALMOLOGY, V109, P1427, DOI 10.1016/S0161-6420(02)01112-0; Hayashi K, 1997, OPHTHALMOLOGY, V104, P793, DOI 10.1016/S0161-6420(97)30231-0; Hoffer KJ, 2011, OPHTHALMOLOGY, V118, P1484, DOI 10.1016/j.ophtha.2011.03.009; Kumar DA, 2011, AM J OPHTHALMOL, V151, P406, DOI 10.1016/j.ajo.2010.09.013; Marcantonio JM, 2000, INVEST OPHTH VIS SCI, V41, P1130; Marcos S, 2014, OPHTHALMOLOGY, V121, P45, DOI 10.1016/j.ophtha.2013.06.025; Nagata T, 1998, J CATARACT REFR SURG, V24, P367, DOI 10.1016/S0886-3350(98)80325-8; Nishi O, 1998, OPHTHALMIC SURG LAS, V29, P587; Nishi O, 2002, J CATARACT REFR SURG, V28, P431, DOI 10.1016/S0886-3350(01)01094-X; Nishi Y, 2010, J CATARACT REFR SURG, V36, P1529, DOI 10.1016/j.jcrs.2010.03.043; Nixon DR, 2006, AM J OPHTHALMOL, V142, P557, DOI 10.1016/j.ajo.2006.05.049; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P472, DOI 10.1111/j.1600-0420.2007.00879.x; Ortiz S, 2013, BIOMED OPT EXPRESS, V4, P387, DOI 10.1364/BOE.4.000387; Ortiz S, 2010, OPT EXPRESS, V18, P2782, DOI 10.1364/OE.18.002782; Oshika T, 1998, BRIT J OPHTHALMOL, V82, P549, DOI 10.1136/bjo.82.5.549; Sacu S, 2005, J CATARACT REFR SURG, V31, P330, DOI 10.1016/j.jcrs.2004.04.057; Savini G, 2013, J REFRACT SURG, V29, P121, DOI 10.3928/1081597X-20130117-07; Tao AZ, 2013, INVEST OPHTH VIS SCI, V54, P6991, DOI 10.1167/iovs.13-12849; Wang XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059109; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Zemaitiene Reda, 2004, Medicina (Kaunas), V40, P721; Zhao MT, 2010, OPT EXPRESS, V18, P8923, DOI 10.1364/OE.18.008923; Zhao YY, 2013, AM J OPHTHALMOL, V155, P484, DOI 10.1016/j.ajo.2012.08.019	29	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142556	10.1371/journal.pone.0142556	http://dx.doi.org/10.1371/journal.pone.0142556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600254	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900027
J	Kanda, E; Muneyuki, T; Suwa, K; Nakajima, K				Kanda, Eiichiro; Muneyuki, Toshitaka; Suwa, Kaname; Nakajima, Kei			Effects of Weight Loss Speed on Kidney Function Differ Depending on Body Mass Index in Nondiabetic Healthy People: A Prospective Cohort	PLOS ONE			English	Article							OBESITY-RELATED GLOMERULOPATHY; METABOLIC SYNDROME; RISK; DISEASE; CKD; ASSOCIATION; PROGRESSION; OVERWEIGHT; DECLINE; GENDER	Background Obesity is associated with diabetes mellitus and cardiovascular diseases. However, it has been reported that weight loss is associated with incident chronic kidney disease (CKD) in healthy males. The purpose of this prospective cohort study is to investigate the effects of weight loss on kidney function in healthy people in terms of body mass index (BMI) and gender. Methods A total of 8447 nondiabetic healthy people were enrolled in the Saitama Cardiometabolic Disease and Organ Impairment Study, Japan. Relationships between estimated glomerular filtration rate (eGFR) change, BMI, and BMI change were evaluated using 3D-scatter plots with spline and generalized additive models (GAMs) adjusted for baseline characteristics. Results The subjects were stratified into four groups according to BMI. The mean +/- standard deviations for males and females were, respectively, 40.11 +/- 9.49, and 40.3 +/- 9.71 years for age and 76.39 +/- 17.72 and 71.49 +/- 18.4 ml/min/1.73m(2) for eGFR. GAMs showed that a decreasing BMI change (<-1 kg/m(2)/year) was associated with a decreasing eGFR change in males with high normal BMIs (22 kg/m(2)<= BMI<25 kg/m(2)). A decreasing BMI change (<-2 kg/m(2)/year) was associated with an increasing eGFR change in overweight males (25 kg/m(2)<= BMI). Among underweight females (BMI<18.5 kg/m(2)), decreasing BMI was observed with decreasing eGFR. Conclusions These findings suggest that the benefit and risk of weight loss in relation to kidney function differs depending on BMI and weight loss speed, especially in males.	[Kanda, Eiichiro] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan; [Kanda, Eiichiro] Tokyo Med & Dent Univ, Ctr Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan; [Muneyuki, Toshitaka] Funabashi City Rehabil Hosp, Dept Rehabil, Funabashi, Chiba, Japan; [Suwa, Kaname] Saitama Hlth Promot Corp, Hiki, Saitama, Japan; [Nakajima, Kei] Kuki Gen Hosp, Dept Metab, Kuki, Saitama, Japan	Tokyo Medical & Dental University (TMDU)	Kanda, E (corresponding author), Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan.	tokyo.kyosai.kanda@gmail.com	Nakajima, Kei/AAF-2801-2019	Nakajima, Kei/0000-0002-1788-3896				Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Bernieh B, 2010, SAUDI J KIDNEY DIS T, V21, P898; Chen HM, 2008, AM J KIDNEY DIS, V52, P58, DOI 10.1053/j.ajkd.2008.02.303; Cheng HT, 2012, J CLIN ENDOCR METAB, V97, P1268, DOI 10.1210/jc.2011-2658; Dittmann K, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-87; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Grubbs V, 2014, AM J KIDNEY DIS, V63, P590, DOI 10.1053/j.ajkd.2013.10.055; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Liu YF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/745410; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Morales E, 2003, AM J KIDNEY DIS, V41, P319, DOI 10.1053/ajkd.2003.50039; Muneyuki T, 2013, OPEN J ENDOCR METAB, V3, P144, DOI DOI 10.4236/0JEMD.2013.32022]; Muneyuki T, 2013, KIDNEY INT, V84, P1254, DOI 10.1038/ki.2013.222; Nagel G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-177; Navarro-Diaz M, 2006, J AM SOC NEPHROL, V17, pS213, DOI 10.1681/ASN.2006080917; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Neugarten J, 2013, ADV CHRONIC KIDNEY D, V20, P390, DOI 10.1053/j.ackd.2013.05.004; Noori N, 2011, AM J KIDNEY DIS, V57, P130, DOI 10.1053/j.ajkd.2010.10.003; Panwar B, 2015, KIDNEY INT, V87, P1216, DOI 10.1038/ki.2014.384; Rogacev KS, 2011, NEW ENGL J MED, V365, P1745, DOI 10.1056/NEJMc1110239; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; Neto AS, 2009, J NEPHROL, V22, P637; Shen WW, 2010, CLIN J AM SOC NEPHRO, V5, P1401, DOI 10.2215/CJN.01370210; Straznicky NE, 2011, J HYPERTENS, V29, P553, DOI 10.1097/HJH.0b013e3283418875; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tokashiki K, 2009, CLIN EXP NEPHROL, V13, P55, DOI 10.1007/s10157-008-0085-y; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Tsuboi N, 2013, CLIN EXP NEPHROL, V17, P379, DOI 10.1007/s10157-012-0719-y; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488	34	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143434	10.1371/journal.pone.0143434	http://dx.doi.org/10.1371/journal.pone.0143434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599331	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900120
J	Matsuda, M; Bonatti, R; Marquezini, MV; Garcia, MLB; Santos, UP; Braga, ALF; Alves, MR; Saldiva, PHN; Monteiro, MLR				Matsuda, Monique; Bonatti, Rodolfo; Marquezini, Monica V.; Garcia, Maria L. B.; Santos, Ubiratan P.; Braga, Alfesio L. F.; Alves, Milton R.; Saldiva, Paulo H. N.; Monteiro, Mario L. R.			Lacrimal Cytokines Assessment in Subjects Exposed to Different Levels of Ambient Air Pollution in a Large Metropolitan Area	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; DRY EYE PATIENTS; TEAR CYTOKINES; OCULAR SURFACE; INFLAMMATORY MARKERS; DISEASE; IMPACT; INDUCE; CONJUNCTIVITIS; INTERLEUKIN-6	Background Air pollution is one of the most environmental health concerns in the world and has serious impact on human health, particularly in the mucous membranes of the respiratory tract and eyes. However, ocular hazardous effects to air pollutants are scarcely found in the literature. Design Panel study to evaluate the effect of different levels of ambient air pollution on lacrimal film cytokine levels of outdoor workers from a large metropolitan area. Methods Thirty healthy male workers, among them nineteen professionals who work on streets (taxi drivers and traffic controllers, high pollutants exposure, Group 1) and eleven workers of a Forest Institute (Group 2, lower pollutants exposure compared to group 1) were evaluated twice, 15 days apart. Exposure to ambient PM2.5 (particulate matter equal or smaller than 2.5 mu m) was 24 hour individually collected and the collection of tears was performed to measure interleukins (IL) 2, 4, 5 and 10 and interferon gamma (IFN-gamma) levels. Data from both groups were compared using Student's t test or Mann-Whitney test for cytokines. Individual PM2.5 levels were categorized in tertiles (lower, middle and upper) and compared using one-way ANOVA. Relationship between PM2.5 and cytokine levels was evaluated using generalized estimating equations (GEE). Results PM2.5 levels in the three categories differed significantly (lower: <= 22 mu g/m(3); middle: 23-37.5 mu g/m(3); upper: >37.5 mu g/m(3); p<0.001). The subjects from the two groups were distributed unevenly in the lower category (Group 1 = 8%; Group 2 = 92%), the middle category (Group 1 = 89%; Group 2 = 11%) and the upper category (Group 1 = 100%). A significant relationship was found between IL-5 and IL-10 and PM2.5 levels of the group 1, with an average decrease of 1.65 pg/mL of IL-5 level and of 0.78 pg/mL of IL-10 level in tear samples for each increment of 50 mu g/m(3) of PM2.5 (p = 0.01 and p = 0.003, respectively). Conclusion High levels of PM2.5 exposure is associated with decrease of IL-5 and IL-10 levels suggesting a possible modulatory action of ambient air pollution on ocular surface immune response.	[Matsuda, Monique; Bonatti, Rodolfo; Alves, Milton R.; Monteiro, Mario L. R.] Univ Sao Paulo, Sch Med, Lab Invest Ophthalmol LIM 33, Sao Paulo, SP, Brazil; [Marquezini, Monica V.; Garcia, Maria L. B.; Braga, Alfesio L. F.; Saldiva, Paulo H. N.] Univ Sao Paulo, Sch Med, Lab Expt Air Pollut LPAE, Sao Paulo, SP, Brazil; [Santos, Ubiratan P.] Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Heart Inst InCor, Sao Paulo, SP, Brazil; [Braga, Alfesio L. F.] Univ Catolica Santos, Environm Exposure & Risk Assessment Grp, Collect Hlth Postgrad Program, Santos, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Catolica de Santos	Matsuda, M (corresponding author), Univ Sao Paulo, Sch Med, Lab Invest Ophthalmol LIM 33, Sao Paulo, SP, Brazil.	moniquematsuda@yahoo.com.br	Saldiva, Paulo HN/D-7385-2012; Santos, Ubiratan/H-7862-2012; MONTEIRO, MARIO L R/C-8891-2012; Matsuda, Monique/J-4646-2013; Braga, Alfésio L. F./G-6920-2012; Bonatti, Rodolfo/AAP-2778-2021	Saldiva, Paulo HN/0000-0003-2005-8253; Santos, Ubiratan/0000-0003-4919-884X; MONTEIRO, MARIO L R/0000-0002-7281-2791; Matsuda, Monique/0000-0003-4451-9712; Braga, Alfésio L. F./0000-0003-3254-3029; Bonatti, Rodolfo/0000-0001-9912-2582	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brasilia, Brazil [555223/2006-0, 306487/2011-0]; FAPESP/PPSUS, Sao Paulo, Brazil [2014/50110-0]; CNPq; FAPESP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP/PPSUS, Sao Paulo, Brazil; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding: We thank the support grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (555223/2006-0 and 306487/2011-0), Brasilia, Brazil (http://www.cnpq.br/) and FAPESP/PPSUS (2014/50110-0), Sao Paulo, Brazil (http://www.fapesp.br/) to PHNS and MLRM. The CNPq and FAPESP have provided the funds for the purchase of materials for sample collection and analysis.	Acera A, 2008, OPHTHALMIC RES, V40, P315, DOI 10.1159/000150445; [Anonymous], 2006, Lancet, V368, P1302; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Boehm N, 2011, INVEST OPHTH VIS SCI, V52, P7725, DOI 10.1167/iovs.11-7266; Brucker N, 2013, SCI TOTAL ENVIRON, V463, P884, DOI 10.1016/j.scitotenv.2013.06.098; Cancado JE, 2006, ENVIRON HEALTH PERSP, V114, P725, DOI 10.1289/ehp.8485; Cançado José Eduardo Delfini, 2006, J. bras. pneumol., V32, pS5, DOI 10.1590/S1806-37132006000800003; Carreno E, 2010, ACTA OPHTHALMOL, V88, pe250, DOI 10.1111/j.1755-3768.2010.01978.x; Chang CJ, 2012, INVEST OPHTH VIS SCI, V53, P429, DOI 10.1167/iovs.11-8253; DAS M, 1991, ANN OCCUP HYG, V35, P347, DOI 10.1093/annhyg/35.3.347; de Miranda RM, 2012, AIR QUAL ATMOS HLTH, V5, P63, DOI 10.1007/s11869-010-0124-1; Toledo Giovana Iara Ferreira Moser de, 2011, Rev. bras. epidemiol., V14, P445, DOI 10.1590/S1415-790X2011000300009; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Gupta SK, 2002, OPHTHALMOLOGICA, V216, P368, DOI 10.1159/000066183; Hagan S, 2013, OCUL SURF, V11, P219, DOI 10.1016/j.jtos.2013.04.004; Handelsman Y, 2015, ENDOCR PRACT, V21, P1, DOI [10.4158/EP15672.GLSUPPL, 10.4158/EP15672.GL]; Jacquemin B, 2015, ENV HLTH PERSPECT; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee H, 2013, FREE RADICAL BIO MED, V63, P78, DOI 10.1016/j.freeradbiomed.2013.05.006; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Leonardi A, 2006, CLIN EXP ALLERGY, V36, P777, DOI 10.1111/j.1365-2222.2006.02499.x; Leonardi A, 2006, GRAEF ARCH CLIN EXP, V244, P1240, DOI 10.1007/s00417-006-0285-7; Liu JF, 2010, MOL VIS, V16, P2931; Malerbi FK, 2012, ENVIRON RES, V112, P199, DOI 10.1016/j.envres.2011.11.010; Matsuda M, 2013, J CLIN EXPT CARDIOLO, V4, P255; Na KS, 2012, INVEST OPHTH VIS SCI, V53, P5443, DOI 10.1167/iovs.11-9417; Narayanan S, 2006, INVEST OPHTH VIS SCI, V47, P2445, DOI 10.1167/iovs.05-1364; Novaes P, 2007, ENVIRON HEALTH PERSP, V115, P1753, DOI 10.1289/ehp.10363; Novaes P, 2010, ENVIRON RES, V110, P372, DOI 10.1016/j.envres.2010.03.003; Perez L, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13129; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Roszkowska AM, 2013, CURR EYE RES, V38, P335, DOI 10.3109/02713683.2012.745880; Rummenie VT, 2008, CYTOKINE, V43, P200, DOI 10.1016/j.cyto.2008.05.011; Sanchez-Carrillo CI, 2003, EPIDEMIOLOGY, V14, P536, DOI 10.1097/01.ede.0000081801.90352.bf; Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380; Saxena R, 2003, ACTA OPHTHALMOL SCAN, V81, P491, DOI 10.1034/j.1600-0420.2003.00119.x; Tau J, 2013, INVEST OPHTH VIS SCI, V54, P4759, DOI 10.1167/iovs.12-10541; Torricelli AA, 2013, CORNEA; Tsai DH, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-24; Uchino E, 2006, CYTOKINE, V33, P36, DOI 10.1016/j.cyto.2005.11.013; Uchio E, 2000, CLIN EXP ALLERGY, V30, P103; VanDerMeid KR, 2012, INVEST OPHTH VIS SCI, V53, P1512, DOI 10.1167/iovs.11-7627; Versura P, 1999, OPHTHALMOLOGICA, V213, P103, DOI 10.1159/000027401; Williams LA, 2009, ENVIRON HEALTH PERSP, V117, P373, DOI 10.1289/ehp.11580; Yin XJJ, 2004, TOXICOL SCI, V77, P263, DOI 10.1093/toxsci/kfh035; Yoon KC, 2007, CORNEA, V26, P431, DOI 10.1097/ICO.0b013e31803dcda2; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	47	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143131	10.1371/journal.pone.0143131	http://dx.doi.org/10.1371/journal.pone.0143131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588473	gold, Green Submitted, Green Published			2022-12-27	WOS:000365251500032
J	Baranyi, A; Amouzadeh-Ghadikolai, O; Rothenhausler, HB; Theokas, S; Robier, C; Baranyi, M; Koppitz, M; Reicht, G; Hlade, P; Meinitzer, A				Baranyi, Andreas; Amouzadeh-Ghadikolai, Omid; Rothenhaeusler, Hans-Bernd; Theokas, Simon; Robier, Christoph; Baranyi, Maria; Koppitz, Michael; Reicht, Gerhard; Hlade, Peter; Meinitzer, Andreas			Nitric Oxide-Related Biological Pathways in Patients with Major Depression	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; L-ARGININE; SYMMETRIC DIMETHYLARGININE; CARDIOVASCULAR MORTALITY; ENDOTHELIAL DYSFUNCTION; PLASMA-CONCENTRATIONS; CORONARY-ANGIOGRAPHY; LUDWIGSHAFEN RISK; AMINO-ACIDS; DISEASE	Background Major depression is a well-known risk factor for cardiovascular diseases and increased mortality following myocardial infarction. However, biomarkers of depression and increased cardiovascular risk are still missing. The aim of this prospective study was to evaluate, whether nitric-oxide (NO) related factors for endothelial dysfunction, such as global arginine bioavailability, arginase activity, L-arginine/ADMA ratio and the arginine metabolites asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) might be biomarkers for depression-induced cardiovascular risk. Methods In 71 in-patients with major depression and 48 healthy controls the Global Arginine Bioavailability Ratio (GABR), arginase activity (arginine/ornithine ratio), the L-arginine/ADMA ratio, ADMA, and SDMA were determined by high-pressure liquid chromatography. Psychiatric and laboratory assessments were obtained at baseline at the time of in-patient admittance and at the time of hospital discharge. Results The ADMA concentrations in patients with major depression were significantly elevated and the SDMA concentrations were significantly decreased in comparison with the healthy controls. Even after a first improvement of depression, ADMA and SDMA levels remained nearly unchanged. In addition, after a first improvement of depression at the time of hospital discharge, a significant decrease in arginase activity, an increased L-arginine/ADMA ratio and a trend for increased global arginine bioavailability were observed. Conclusions Our study results are evidence that in patients with major depression ADMA and SDMA might be biomarkers to indicate an increased cardiovascular threat due to depression-triggered NO reduction. GABR, the L-arginine/ADMA ratio and arginase activity might be indicators of therapy success and increased NO production after remission.	[Baranyi, Andreas; Rothenhaeusler, Hans-Bernd; Theokas, Simon; Baranyi, Maria; Koppitz, Michael] Med Univ Graz, Dept Psychiat, Graz, Austria; [Baranyi, Andreas] ARU Cambridge, Inst Int Management Practice, Cambridge, England; [Amouzadeh-Ghadikolai, Omid; Robier, Christoph; Reicht, Gerhard; Hlade, Peter] Hosp Bros St John God, Graz, Austria; [Robier, Christoph; Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Medical University of Graz; Medical University of Graz	Baranyi, A (corresponding author), Med Univ Graz, Dept Psychiat, Graz, Austria.	andreas.baranyi@klinikum-graz.at		Baranyi, Andreas/0000-0003-2389-1945; Rothenhausler, Hans-Bernd/0000-0002-8857-8557				Asif M, 2013, CURR ALZHEIMER RES, V10, P347, DOI 10.2174/1567205011310040001; Bajaj JS, 2013, J HEPATOL, V58, P38, DOI 10.1016/j.jhep.2012.08.005; Baranyi A, 2014, PSYCHOSOM MED, V76, P197, DOI 10.1097/PSY.0000000000000042; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boger RH, 1998, ATHEROSCLEROSIS, V136, P67, DOI 10.1016/S0021-9150(97)00183-4; Chao TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071675; COOKE JP, 1991, J CLIN INVEST, V88, P1663, DOI 10.1172/JCI115481; Demas GE, 1999, J NEUROSCI, V19; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Frisch C, 2000, J NEUROSCI, V20, P6694, DOI 10.1523/JNEUROSCI.20-17-06694.2000; Gallagher D, 2012, J AFFECT DISORDERS, V142, P132, DOI 10.1016/j.jad.2012.04.012; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Kielstein H, 2015, NEPHROL DIAL TRANSPL, V30, P1699, DOI 10.1093/ndt/gfv253; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lorin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064796; Lundman P, 2001, J AM COLL CARDIOL, V38, P111, DOI 10.1016/S0735-1097(01)01318-3; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Meinitzer A, 2007, CLIN CHIM ACTA, V384, P141, DOI 10.1016/j.cca.2007.07.006; Meinitzer A, 2007, CLIN CHEM, V53, P273, DOI 10.1373/clinchem.2006.076711; Meinitzer A, 2011, CLIN CHEM, V57, P112, DOI 10.1373/clinchem.2010.150854; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; Mommersteeg PMC, 2015, PSYCHOSOM MED, V77, P292, DOI 10.1097/PSY.0000000000000162; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Nemeth Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135498; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Rajapakse NW, 2009, CLIN EXP PHARMACOL P, V36, P249, DOI 10.1111/j.1440-1681.2008.05123.x; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; Schwarz EL, 2005, CLIN CHIM ACTA, V354, P83, DOI 10.1016/j.cccn.2004.11.016; Selley ML, 2004, J AFFECT DISORDERS, V80, P249, DOI 10.1016/S0165-0327(03)00135-6; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Snyder SH, 2000, AM J PSYCHIAT, V157, P1738, DOI 10.1176/appi.ajp.157.11.1738; Sourij H, 2011, ATHEROSCLEROSIS, V218, P220, DOI 10.1016/j.atherosclerosis.2011.04.041; Stewart JC, 2012, CIRCULATION, V126, P410, DOI 10.1161/CIRCULATIONAHA.112.094946; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Tsao PS, 1996, CIRCULATION, V94, P1682, DOI 10.1161/01.CIR.94.7.1682; VALLANCE P, 1992, LANCET, V339, P572; Wei JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102986; Winkelmann B. R., 2001, PHARMACOGENOMICS S1, V2, P1; Wolf A, 1997, J AM COLL CARDIOL, V29, P479, DOI 10.1016/S0735-1097(97)00523-8	43	38	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143397	10.1371/journal.pone.0143397	http://dx.doi.org/10.1371/journal.pone.0143397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581044	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600120
J	Dillehay, TD; Ocampo, C; Saavedra, J; Sawakuchi, AO; Vega, RM; Pino, M; Collins, MB; Cummings, LS; Arregui, I; Villagran, XS; Hartmann, GA; Mella, M; Gonzalez, A; Dix, G				Dillehay, Tom D.; Ocampo, Carlos; Saavedra, Jose; Sawakuchi, Andre Oliveira; Vega, Rodrigo M.; Pino, Mario; Collins, Michael B.; Cummings, Linda Scott; Arregui, Ivan; Villagran, Ximena S.; Hartmann, Gelvam A.; Mella, Mauricio; Gonzalez, Andrea; Dix, George			New Archaeological Evidence for an Early Human Presence at Monte Verde, Chile	PLOS ONE			English	Article							LAKE DISTRICT; SOUTH-AMERICA; ISLA GRANDE; CALIBRATION; COMPLEX; BRAZIL; AREA	Questions surrounding the chronology, place, and character of the initial human colonization of the Americas are a long-standing focus of debate. Interdisciplinary debate continues over the timing of entry, the rapidity and direction of dispersion, the variety of human responses to diverse habitats, the criteria for evaluating the validity of early sites, and the differences and similarities between colonization in North and South America. Despite recent advances in our understanding of these issues, archaeology still faces challenges in defining interdisciplinary research problems, assessing the reliability of the data, and applying new interpretative models. As the debates and challenges continue, new studies take place and previous research reexamined. Here we discuss recent exploratory excavation at and interdisciplinary data from the Monte Verde area in Chile to further our understanding of the first peopling of the Americas. New evidence of stone artifacts, faunal remains, and burned areas suggests discrete horizons of ephemeral human activity in a sandur plain setting radiocarbon and luminescence dated between at least similar to 18,500 and 14,500 cal BP. Based on multiple lines of evidence, including sedimentary proxies and artifact analysis, we present the probable anthropogenic origins and wider implications of this evidence. In a non-glacial cold climate environment of the south-central Andes, which is challenging for human occupation and for the preservation of hunter-gatherer sites, these horizons provide insight into an earlier context of late Pleistocene human behavior in northern Patagonia.	[Dillehay, Tom D.] Vanderbilt Univ, Dept Anthropol, Nashville, TN 37235 USA; [Dillehay, Tom D.] Univ Austral Chile, Valdivia, Chile; [Dillehay, Tom D.] Univ Catolic Temuco, Temuco, Chile; [Ocampo, Carlos; Saavedra, Jose; Arregui, Ivan] Fdn Wulaia & Soc Chilena Arqueol, Santiago, Chile; [Sawakuchi, Andre Oliveira] Univ Sao Paulo, Inst Geociencias, Dept Geol Sedimentar & Ambiental, BR-01498 Sao Paulo, Brazil; [Vega, Rodrigo M.; Pino, Mario] Univ Austral Chile, Inst Ciencias Tierra, Valdivia, Chile; [Collins, Michael B.] SW Texas State Univ, San Marcos, TX 78666 USA; [Cummings, Linda Scott] PaleoRes Inst Inc, Golden, CO USA; [Villagran, Ximena S.] Univ Sao Paulo, Museu Arqueol & Etnol, Sao Paulo, Brazil; [Hartmann, Gelvam A.] Observ Nacl, Rio De Janeiro, RJ, Brazil; [Hartmann, Gelvam A.] Univ Sao Paulo, Dept Geofis, Inst Astron Geofis & Ciencias Atmosfer, Sao Paulo, Brazil; [Mella, Mauricio] Serv Nacl Geol & Mineria, Oficina Tecn, Puerto Montt, Chile; [Gonzalez, Andrea] Univ SEKA, Fac Estudios Patrimonio Cultural & Educ, Santiago, Chile; [Dix, George] Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada	Vanderbilt University; Universidad Austral de Chile; Universidade de Sao Paulo; Universidad Austral de Chile; Texas State University System; Texas State University San Marcos; Universidade de Sao Paulo; Universidade de Sao Paulo; Carleton University	Dillehay, TD (corresponding author), Vanderbilt Univ, Dept Anthropol, 221 Kirkland Hall, Nashville, TN 37235 USA.	tom.d.dillehay@vanderbilt.edu	Dix, George R./AAK-4186-2020; San Martín, Rodrigo Manuel Vega/P-1700-2019; Villagran, Ximena Suarez/S-5429-2019; Pino, Mario/GPP-7219-2022; Sawakuchi, André O/D-1445-2013; González-Ramírez, Andrea/P-1140-2019; González Ríos, Andrea/HGU-7618-2022; Sawakuchi, Andre/AAE-8328-2019; Villagran, Ximena S/I-6342-2012; Hartmann, Gelvam/K-4856-2012	Dix, George R./0000-0002-6826-0111; San Martín, Rodrigo Manuel Vega/0000-0002-3866-0341; Villagran, Ximena Suarez/0000-0001-8630-2015; González-Ramírez, Andrea/0000-0002-8319-0078; Sawakuchi, Andre/0000-0001-5016-2428; Villagran, Ximena S/0000-0001-8630-2015; Hartmann, Gelvam/0000-0001-6078-3893	National Council of Monuments, Chile; National Geographic Society; Vanderbilt University; SERNAGEOMIN, Chile; Instituto de Geociencias, Universidad Austral de Chile; Instituto de Astronomia, Geofisica e Ciencias Atmosfericas; Instituto de Geociencias, Universidade de Sao Paulo, Brasil	National Council of Monuments, Chile; National Geographic Society(National Geographic Society); Vanderbilt University; SERNAGEOMIN, Chile; Instituto de Geociencias, Universidad Austral de Chile; Instituto de Astronomia, Geofisica e Ciencias Atmosfericas; Instituto de Geociencias, Universidade de Sao Paulo, Brasil	This research was funded by the National Council of Monuments, Chile, the National Geographic Society, Vanderbilt University, SERNAGEOMIN, Chile, Instituto de Geociencias, Universidad Austral de Chile, Instituto de Astronomia, Geofisica e Ciencias Atmosfericas, Instituto de Geociencias, Universidade de Sao Paulo, Brasil. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of only travel, salary, field and laboratory costs for some authors [MP, CO, JS, RV, LSC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The Paleo Research Institute provided analytical services for only the pollen and phytolith studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimola G, 2014, J LITHIC STUD, V1, P5, DOI 10.2218/jls.v1i2.1125; Battaglia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071390; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; Boeda E, 2013, PALEOAMERICAN ODYSSE; Boeda E, 2014, ANTIQUITY, V88, P927, DOI 10.1017/S0003598X00050845; Bryan AL, 2003, QUATERN INT, V109, P175, DOI 10.1016/S1040-6182(02)00211-2; Bryan AL., 1986, NEW EVIDENCE PLEISTO, P1; Buylaert JP, 2012, BOREAS, V41, P435, DOI 10.1111/j.1502-3885.2012.00248.x; Buylaert JP, 2011, GEOCHRONOMETRIA, V38, P432, DOI 10.2478/s13386-011-0047-0; Casamiquela R., 1989, MONTE VERDE LATE PLE, P205; Chauchat C., 2006, PREHISTORIA COSTA NO; Chlachula J, 2004, QUATERN INT, p[101, 80]; Chlachula J, 2011, BOREAS, V40, P146, DOI 10.1111/j.1502-3885.2010.00166.x; Collins M. B., 1997, MONTE VERDE LATE PLE, VII, P383; Collins MB, 2014, CAMBRIDGE WORLD PREH, V2, P903; Denton GH, 1999, GEOGR ANN A, V81A, P167, DOI 10.1111/1468-0459.00057; Dillehay T. D, 1989, PALEOENVIRONMENT SIT, VI; Dillehay T. D., 1989, PALAEOENVIRONMENT SI, VI, P133; Dillehay T. D., 1997, ARCHAEOLOGICAL CONTE, VII; DILLEHAY TD, 1988, NATURE, V332, P150, DOI 10.1038/332150a0; Dillehay TD, 2008, QUATERNARY RES, V77, P418; DILLEHAY TD, 2000, NEW PREHISTORY SETTL; Dillehay TD, 2014, ANTIQUITY, V88, P941, DOI DOI 10.1017/S0003598X00050857; Dillehay TD, 1981, UN INT CIENC PREH PR, P58; Dillehay TD, 1989, MONTE VERDE, P183; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Graf KE, 2013, PALEOAMERICAN ODYSSE; HAYNES V, 1973, SCIENCE, V181, P305, DOI 10.1126/science.181.4097.305; Heusser CJ, 1999, GEOGR ANN A, V81A, P231, DOI 10.1111/1468-0459.00058; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Jenkins DL, 2013, PALEOAMERICAN ODYSSE, P485; Lahaye C, 2013, J ARCHAEOL SCI, V40, P2840, DOI 10.1016/j.jas.2013.02.019; McAvoy J.M., 1997, RES REPORT SERIES; Meltzer D. J., 2009, 1 PEOPLES NEW WORLD; Meltzer DJ, 1997, AM ANTIQUITY, V62, P659, DOI 10.2307/281884; Moreno PI, 1999, GEOGR ANN A, V81A, P285, DOI 10.1111/1468-0459.00059; Morrow JE, 1999, AM ANTIQUITY, V64, P215, DOI 10.2307/2694275; Murray AS, 2003, RADIAT MEAS, V37, P377, DOI 10.1016/S1350-4487(03)00053-2; Neves WA, 2005, P NATL ACAD SCI USA, V102, P18309, DOI 10.1073/pnas.0507185102; Parenti F., 2001, GISEMENT QUATERNAIRE; Pierson T.C., 2005, US GEOLOGICAL SURVEY, P4; Pino M., 1989, MONTE VERDE, VI, P89; Politis G., 2014, SERIE MONOGRAFICO IN, V5; Richardson III J. B., 1978, EARLY MAN AM CIRCUMP, V1, P274; RITTER DF, 1995, PROCESS GEOMORPHOLOG; Skoglund P, 2015, NATURE; Stanford D. J., 2013, ATLANTIC ICE ORIGIN; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Vialou D., 2011, PEUPLEMENTS PREHISTO; Vilhena Vialou A., 2005, PREHISTORIA MATO GRO, VI; Waters M. R., 2013, PALEOAMERICAN ODYSSE, P541; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855	53	100	101	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141923	10.1371/journal.pone.0141923	http://dx.doi.org/10.1371/journal.pone.0141923			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CW7CD	26580202	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600027
J	Duursma, RA				Duursma, Remko A.			Plantecophys - An R Package for Analysing and Modelling Leaf Gas Exchange Data	PLOS ONE			English	Article							INSTANTANEOUS TRANSPIRATION EFFICIENCY; VAPOR-PRESSURE DEFICIT; STOMATAL CONDUCTANCE; MESOPHYLL CONDUCTANCE; ATMOSPHERIC CO2; RESPONSE CURVES; PHOTOSYNTHESIS; TEMPERATURE; CARBON; WATER	Here I present the R package 'plantecophys', a toolkit to analyse and model leaf gas exchange data. Measurements of leaf photosynthesis and transpiration are routinely collected with portable gas exchange instruments, and analysed with a few key models. These models include the Farquhar-von Caemmerer-Berry (FvCB) model of leaf photosynthesis, the Ball-Berry models of stomatal conductance, and the coupled leaf gas exchange model which combines the supply and demand functions for CO2 in the leaf. The 'plantecophys' R package includes functions for fitting these models to measurements, as well as simulating from the fitted models to aid in interpreting experimental data. Here I describe the functionality and implementation of the new package, and give some examples of its use. I briefly describe functions for fitting the FvCB model of photosynthesis to measurements of photosynthesis-CO2 response curves ('A-C-i curves'), fitting Ball-Berry type models, modelling C3 photosynthesis with the coupled photosynthesis-stomatal conductance model, modelling C4 photosynthesis, numerical solution of optimal stomatal behaviour, and energy balance calculations using the Penman-Monteith equation. This open-source package makes technically challenging calculations easily accessible for many users and is freely available on CRAN.	[Duursma, Remko A.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia	Western Sydney University	Duursma, RA (corresponding author), Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia.	r.duursma@westernsydney.edu.au						Ball J.T., 1987, PROGR PHOTOSYNTHESIS, P221, DOI [10.1007/978-94-017-0519-6_48, DOI 10.1007/978-94-017-0519-6_48]; Barton CVM, 2012, GLOBAL CHANGE BIOL, V18, P585, DOI 10.1111/j.1365-2486.2011.02526.x; Bonan GB, 2014, GEOSCI MODEL DEV, V7, P2193, DOI 10.5194/gmd-7-2193-2014; Buckley TN, 2014, PLANT CELL ENVIRON, V37, P2707, DOI 10.1111/pce.12343; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Cowan I R, 1977, Symp Soc Exp Biol, V31, P471; De Kauwe MG, 2015, GEOSCI MODEL DEV, V8, P431, DOI 10.5194/gmd-8-431-2015; Duursma RA, 2012, GEOSCI MODEL DEV, V5, P919, DOI 10.5194/gmd-5-919-2012; Duursma RA, CODE REPOSITORY GENE, DOI DOI 10.5281/ZENODO.32026; Duursma RA, 2014, AGR FOREST METEOROL, V189, P2, DOI 10.1016/j.agrformet.2013.12.007; Duursma RA, 2013, AGR FOREST METEOROL, V168, P168, DOI 10.1016/j.agrformet.2012.09.005; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Gu LH, 2010, PLANT CELL ENVIRON, V33, P1852, DOI 10.1111/j.1365-3040.2010.02192.x; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; LEUNING R, 1990, AUST J PLANT PHYSIOL, V17, P159, DOI 10.1071/PP9900159; LEUNING R, 1989, PLANT CELL ENVIRON, V12, P669, DOI 10.1111/j.1365-3040.1989.tb01236.x; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Lin YS, 2015, NAT CLIM CHANGE, V5, P459, DOI [10.1038/nclimate2550, 10.1038/NCLIMATE2550]; Lin YS, 2012, TREE PHYSIOL, V32, P219, DOI 10.1093/treephys/tpr141; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; MCDERMITT DK, 1989, ANN SCI FOREST, V46, pS416, DOI 10.1051/forest:19890593; Medlyn B, TUMBARUMBA GAS EXCHA, DOI [10.6084/m9.figshare.1538079, DOI 10.6084/M9.FIGSHARE.1538079]; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1167, DOI 10.1046/j.1365-3040.2002.00891.x; Medlyn BE, 2007, TREE PHYSIOL, V27, P1687, DOI 10.1093/treephys/27.12.1687; Medlyn BE, 2013, AGR FOREST METEOROL, V182, P200, DOI 10.1016/j.agrformet.2013.04.019; Medlyn BE, 2011, GLOBAL CHANGE BIOL, V17, P2134, DOI 10.1111/j.1365-2486.2010.02375.x; Pearcey R.W., 1989, PLANT PHYSL ECOLOGY; Peltoniemi MS, 2012, TREE PHYSIOL, V32, P510, DOI 10.1093/treephys/tps023; R Core Team, 2021, R LANGUAGE ENV STAT; Ritz C, 2008, USE R, P1; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; SHARKEY TD, 1982, PLANT PHYSIOL, V69, P657, DOI 10.1104/pp.69.3.657; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Tholen D, 2012, PLANT CELL ENVIRON, V35, P2087, DOI 10.1111/j.1365-3040.2012.02538.x; von Caemmerer S, 2000, BIOCH MODELS LEAF PH; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Wang YP, 1998, AGR FOREST METEOROL, V91, P89, DOI 10.1016/S0168-1923(98)00061-6; WULLSCHLEGER SD, 1993, J EXP BOT, V44, P907, DOI 10.1093/jxb/44.5.907	41	237	240	8	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143346	10.1371/journal.pone.0143346	http://dx.doi.org/10.1371/journal.pone.0143346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581080	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600111
J	Levenson, RM; Krupinski, EA; Navarro, VM; Wasserman, EA				Levenson, Richard M.; Krupinski, Elizabeth A.; Navarro, Victor M.; Wasserman, Edward A.			Pigeons (Columba livia) as Trainable Observers of Pathology and Radiology Breast Cancer Images	PLOS ONE			English	Article							CATEGORIZATION; PATTERNS; BEHAVIOR; SHAPE	Pathologists and radiologists spend years acquiring and refining their medically essential visual skills, so it is of considerable interest to understand how this process actually unfolds and what image features and properties are critical for accurate diagnostic performance. Key insights into human behavioral tasks can often be obtained by using appropriate animal models. We report here that pigeons (Columba livia)-which share many visual system properties with humans-can serve as promising surrogate observers of medical images, a capability not previously documented. The birds proved to have a remarkable ability to distinguish benign from malignant human breast histopathology after training with differential food reinforcement; even more importantly, the pigeons were able to generalize what they had learned when confronted with novel image sets. The birds' histological accuracy, like that of humans, was modestly affected by the presence or absence of color as well as by degrees of image compression, but these impacts could be ameliorated with further training. Turning to radiology, the birds proved to be similarly capable of detecting cancer-relevant microcalcifications on mammogram images. However, when given a different (and for humans quite difficult) task-namely, classification of suspicious mammographic densities (masses)-the pigeons proved to be capable only of image memorization and were unable to successfully generalize when shown novel examples. The birds' successes and difficulties suggest that pigeons are well-suited to help us better understand human medical image perception, and may also prove useful in performance assessment and development of medical imaging hardware, image processing, and image analysis tools.	[Levenson, Richard M.] Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Navarro, Victor M.; Wasserman, Edward A.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Krupinski, Elizabeth A.] Emory Univ, Coll Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA	University of California System; University of California Davis; University of Iowa; Emory University	Levenson, RM (corresponding author), Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA.	levenson@ucdavis.edu; ed-wasserman@uiowa.edu						Abbey C., 2010, HDB MED IMAGE PERCEP, P240; Badano A, 2015, J DIGIT IMAGING, V28, P41, DOI 10.1007/s10278-014-9721-0; Bailey JH, 2014, ACAD RADIOL, V21, P859, DOI 10.1016/j.acra.2013.11.022; Barrett H H, 2004, FDN IMAGE SCI; BHATT RS, 1988, J EXP PSYCHOL ANIM B, V14, P219, DOI 10.1037/0097-7403.14.3.219; BLOUGH DS, 1982, SCIENCE, V218, P397, DOI 10.1126/science.7123242; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Colucci PG, 2015, ACAD RADIOL, V22, P247, DOI 10.1016/j.acra.2014.09.014; Cook RG, 1997, J EXP PSYCHOL ANIM B, V23, P417, DOI 10.1037/0097-7403.23.4.417; Cook RG, 2005, PSYCHON B REV, V12, P350, DOI 10.3758/BF03196384; Cook RG, 2015, PSYCHOL LEARN MOTIV, V63; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Evans KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064366; Gallas BD, 2012, ACAD RADIOL, V19, P463, DOI 10.1016/j.acra.2011.12.016; Gibson BM, 2007, CURR BIOL, V17, P336, DOI 10.1016/j.cub.2006.12.025; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Horvath G, 2008, INTEGR CANCER THER, V7, P76, DOI 10.1177/1534735408319058; Huber L, 2000, Q J EXP PSYCHOL-B, V53, P341, DOI 10.1080/027249900750001347; Krupinski EA, 1996, ACAD RADIOL, V3, P137, DOI 10.1016/S1076-6332(05)80381-2; Krupinski EA, 2014, REP MED IMAGING, V4, P5; Krupinski EA, 2008, MED PHYS, V35, P645, DOI 10.1118/1.2830376; Krupinski EA, 2014, HEALTHCARE, V2, P94, DOI 10.3390/healthcare2010094; Krupinski Elizabeth A, 2012, J Pathol Inform, V3, P17, DOI 10.4103/2153-3539.95129; Kupinski M, 2010, HDB MED IMAGE PERCEP, P251; Lazareva OF, 2006, PERCEPT PSYCHOPHYS, V68, P711, DOI 10.3758/BF03193695; Levenson R, 2008, ARCH PATHOL LAB MED, V132, P748, DOI 10.1043/1543-2165(2008)132[748:PTMBIM]2.0.CO;2; Mahoney AM, 2011, PAN AFR MED J, V9; Naseem M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1312-z; Orel SG, 1999, RADIOLOGY, V211, P845, DOI 10.1148/radiology.211.3.r99jn31845; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Saunders R, 2010, HDB MED IMAGE PERCEP, P157; Shamshuddin S, 2014, CLIN RADIOL, V69, pE373, DOI 10.1016/j.crad.2014.04.002; Shimizu T, 1999, BEHAV BRAIN RES, V98, P183, DOI 10.1016/S0166-4328(98)00083-7; Shimizu T, 2010, BRAIN BEHAV EVOLUT, V75, P204, DOI 10.1159/000314283; Soto FA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00122; Soto FA, 2012, COGN AFFECT BEHAV NE, V12, P220, DOI 10.3758/s13415-011-0070-x; Troje NF, 1999, VISION RES, V39, P353, DOI 10.1016/S0042-6989(98)00153-9; VERHAVE T, 1966, AM PSYCHOL, V21, P109, DOI 10.1037/h0023273; Wagner RF, 2002, ACAD RADIOL, V9, P1264, DOI 10.1016/S1076-6332(03)80560-3; Wasserman Edward A., 2012, P191; WATANABE S, 1995, J EXP ANAL BEHAV, V63, P165, DOI 10.1901/jeab.1995.63-165; Wei H, 2014, COLOR RES APPL; Weinstein RS, 2012, APMIS, V120, P256, DOI 10.1111/j.1600-0463.2011.02866.x	44	47	52	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141357	10.1371/journal.pone.0141357	http://dx.doi.org/10.1371/journal.pone.0141357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581091	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600014
J	Szabo, DJ; Noer, A; Nagymihaly, R; Josifovska, N; Andjelic, S; Vereb, Z; Facsko, A; Moe, MC; Petrovski, G				Szabo, Dora Julia; Noer, Agate; Nagymihaly, Richard; Josifovska, Natasha; Andjelic, Sofija; Vereb, Zoltan; Facsko, Andrea; Moe, Morten C.; Petrovski, Goran			Long-Term Cultures of Human Cornea Limbal Explants Form 3D Structures Ex Vivo - Implications for Tissue Engineering and Clinical Applications	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; ADHESION MOLECULE CD44; ANATOMICAL STRUCTURE; EXPRESSION; PHENOTYPE; TRANSPLANTATION; ABCG2; NICHE	Long-term cultures of cornea limbal epithelial stem cells (LESCs) were developed and characterized for future tissue engineering and clinical applications. The limbal tissue explants were cultivated and expanded for more than 3 months in medium containing serum as the only growth supplement and without use of scaffolds. Viable 3D cell outgrowth from the explants was observed within 4 weeks of cultivation. The outgrowing cells were examined by immunofluorescent staining for putative markers of stemness (ABCG2, CK15, CK19 and Vimentin), proliferation (p63 alpha, Ki-67), limbal basal epithelial cells (CK8/18) and differentiated cornea epithelial cells (CK3 and CK12). Morphological and immunostaining analyses revealed that long-term culturing can form stratified 3D tissue layers with a clear extracellular matrix deposition and organization (collagen I, IV and V). The LESCs showed robust expression of p63a, ABCG2, and their surface marker fingerprint (CD117/c-kit, CXCR4, CD146/MCAM, CD166/ALCAM) changed over time compared to short-term LESC cultures. Overall, we provide a model for generating stem cell-rich, long-standing 3D cultures from LESCs which can be used for further research purposes and clinical transplantation.	[Szabo, Dora Julia; Nagymihaly, Richard; Josifovska, Natasha; Vereb, Zoltan; Facsko, Andrea; Petrovski, Goran] Univ Szeged, Stem Cells & Eye Res Lab, Dept Ophthalmol, Fac Med, Szeged, Hungary; [Noer, Agate; Moe, Morten C.] Oslo Univ Hosp, Ctr Eye Res, Dept Ophthalmol, Oslo, Norway; [Noer, Agate; Moe, Morten C.] Univ Oslo, Oslo, Norway; [Andjelic, Sofija] Univ Med Ctr, Hosp Eye, Ljubljana, Slovenia	Szeged University; University of Oslo; University of Oslo; University Medical Centre Ljubljana	Petrovski, G (corresponding author), Univ Szeged, Stem Cells & Eye Res Lab, Dept Ophthalmol, Fac Med, Szeged, Hungary.	petrovski.goran@med.u-szeged.hu	Vereb, Zoltan/I-6356-2019; Vereb, Zoltan/AAR-4092-2020	Vereb, Zoltan/0000-0002-9518-2155; Petrovski, Goran/0000-0003-2905-9252; Josifovska, Natasha/0000-0002-3898-9729; Noer, Agate/0000-0003-0329-916X	EU COST Action BM1302 travel grant; South-East Norway regional health authority, Helse Sor-Ost RHF, Norway	EU COST Action BM1302 travel grant; South-East Norway regional health authority, Helse Sor-Ost RHF, Norway	DJS has been supported by an EU COST Action BM1302 travel grant to perform part of the experiments at the host site at the Norwegian Center for Stem Cell Research / Center for Eye Research, University of Oslo, Norway. AN is supported by The South-East Norway regional health authority, Helse Sor-Ost RHF, Norway.; DJS has been supported by an EU COST Action BM1302 travel grant to perform part of the experiments at the host site at the Norwegian Center for Stem Cell Research / Center for Eye Research, University of Oslo, Norway. AN is supported by The South-East Norway regional health authority, Helse Sor-Ost RHF, Norway. We like to thank Charlotte L. Ness, Kristiane Haug Berg and staff at the Center for Eye Research, Department of Ophthalmology, Oslo University Hospital for their technical support and input.	Albert R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047187; Ambrose WM, 2009, J BIOMED MATER RES B, V90B, P818, DOI 10.1002/jbm.b.31351; Andjelic S, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/232659; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Chang CY, 2008, INVEST OPHTH VIS SCI, V49, P5279, DOI 10.1167/iovs.07-1260; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346; Ghoubay-Benallaoua D, 2011, MOL VIS, V17, P341; Gore A, 2014, CORNEA, V33, P65, DOI 10.1097/ICO.0000000000000002; Huang MH, 2015, CELL TISSUE RES, V359, P547, DOI 10.1007/s00441-014-2032-4; Joseph A, 2004, BRIT J OPHTHALMOL, V88, P393, DOI 10.1136/bjo.2003.018481; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Levis HJ, 2013, CURR EYE RES, V38, P41, DOI 10.3109/02713683.2012.725799; Lopez-Paniagua M, 2013, CURR EYE RES, V38, P537, DOI 10.3109/02713683.2013.767350; Lv Z, 2015, J IMMUNOL, DOI [10.4049/jimmunol.1401719, DOI 10.4049/JIMMUN0L.1401719]; McCracken MN, 2015, CLIN CANCER RES, V21, P3597, DOI 10.1158/1078-0432.CCR-14-2520; Merjava S, 2011, INVEST OPHTH VIS SCI, V52, P787, DOI 10.1167/iovs.10-5489; Merjava S, 2011, HISTOL HISTOPATHOL, V26, P323, DOI 10.14670/HH-26.323; Mi SL, 2010, TISSUE ENG PT A, V16, P2091, DOI 10.1089/ten.TEA.2009.0748; Michel M, 1996, J CELL SCI, V109, P1017; Nubile M, 2013, MOL VIS, V19, P516; Oldenborg Per-Arne, 2013, ISRN Hematol, V2013, P614619, DOI 10.1155/2013/614619; Pathak M, 2013, ACTA OPHTHALMOL, V91, P769, DOI 10.1111/j.1755-3768.2012.02521.x; Pellegrini G, 2014, STEM CELLS, V32, P26, DOI 10.1002/stem.1517; Priya CG, 2013, MICROSC RES TECHNIQ, V76, P242, DOI 10.1002/jemt.22159; Shandadfar A, 2012, EXP EYE RES, V97, P1, DOI 10.1016/j.exer.2012.01.013; Shanmuganathan VA, 2007, BRIT J OPHTHALMOL, V91, P514, DOI 10.1136/bjo.2006.102640; Utheim TP, 2009, INVEST OPHTH VIS SCI, V50, P5165, DOI 10.1167/iovs.08-2884; Yu FSX, 1998, INVEST OPHTH VIS SCI, V39, P710; Zhu SN, 1997, BRIT J OPHTHALMOL, V81, P80, DOI 10.1136/bjo.81.1.80	31	18	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143053	10.1371/journal.pone.0143053	http://dx.doi.org/10.1371/journal.pone.0143053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580800	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600073
J	Khalid, T; Aggio, R; White, P; Costello, B; Persad, R; Al-Kateb, H; Jones, P; Probert, CS; Ratcliffe, N				Khalid, Tanzeela; Aggio, Raphael; White, Paul; Costello, Ben De Lacy; Persad, Raj; Al-Kateb, Huda; Jones, Peter; Probert, Chris S.; Ratcliffe, Norman			Urinary Volatile Organic Compounds for the Detection of Prostate Cancer	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; DIGITAL RECTAL EXAMINATION; OLFACTORY DETECTION; TOTAL PSA; MASS-SPECTROMETRY; EARLY-DIAGNOSIS; MARKER; ANTIGEN; NG/ML; SARCOSINE	The aim of this work was to investigate volatile organic compounds (VOCs) emanating from urine samples to determine whether they can be used to classify samples into those from prostate cancer and non-cancer groups. Participants were men referred for a trans-rectal ultrasound-guided prostate biopsy because of an elevated prostate specific antigen (PSA) level or abnormal findings on digital rectal examination. Urine samples were collected from patients with prostate cancer (n = 59) and cancer-free controls (n = 43), on the day of their biopsy, prior to their procedure. VOCs from the headspace of basified urine samples were extracted using solid-phase micro-extraction and analysed by gas chromatography/mass spectrometry. Classifiers were developed using Random Forest (RF) and Linear Discriminant Analysis (LDA) classification techniques. PSA alone had an accuracy of 62-64% in these samples. A model based on 4 VOCs, 2,6-dimethyl-7-octen-2-ol, pentanal, 3-octanone, and 2-octanone, was marginally more accurate 63-65%. When combined, PSA level and these four VOCs had mean accuracies of 74% and 65%, using RF and LDA, respectively. With repeated double cross-validation, the mean accuracies fell to 71% and 65%, using RF and LDA, respectively. Results from VOC profiling of urine headspace are encouraging and suggest that there are other metabolomic avenues worth exploring which could help improve the stratification of men at risk of prostate cancer. This study also adds to our knowledge on the profile of compounds found in basified urine, from controls and cancer patients, which is useful information for future studies comparing the urine from patients with other disease states.	[Khalid, Tanzeela] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Aggio, Raphael; Probert, Chris S.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [White, Paul; Costello, Ben De Lacy; Al-Kateb, Huda; Jones, Peter; Ratcliffe, Norman] Univ W England, Inst Biosensor Technol, Bristol BS16 1QY, Avon, England; [Persad, Raj] North Bristol NHS Trust, Bristol Urol Inst, Bristol, Avon, England	Imperial College London; University of Liverpool; University of West England; North Bristol NHS Trust	Probert, CS (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	Chris.Probert@liverpool.ac.uk	de Lacy Costello, Ben/ABG-2043-2021; De Lacy Costello, Ben/I-8259-2019; Khalid, Tanzeela/AAX-3520-2020	de Lacy Costello, Ben/0000-0003-2999-6801; Khalid, Tanzeela/0000-0003-3503-7762; Probert, Christopher/0000-0003-4550-0239; ALKATEB, HUDA/0000-0002-8194-8906	Rotary club; Ralph Shackman Trust, Woodfines Llp, Lockton House, Clarendon Road, Cambridge [CB28FH]	Rotary club; Ralph Shackman Trust, Woodfines Llp, Lockton House, Clarendon Road, Cambridge	This work was funded by the Rotary club, https://www.rotary.org/en. Additional funding was provided by the Ralph Shackman Trust, Woodfines Llp, Lockton House, Clarendon Road, Cambridge, CB28FH. No official URL is available though registration details of the charity can be found at: http://opencharities.org/charities/287406. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggio R, 2011, BIOINFORMATICS, V27, P2316, DOI 10.1093/bioinformatics/btr379; Anderssen E, 2006, CHEMOMETR INTELL LAB, V84, P69, DOI 10.1016/j.chemolab.2006.04.021; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Asimakopoulos AD, 2014, PROSTATE CANCER P D, V17, P206, DOI 10.1038/pcan.2014.11; Bensalah K, 2007, EUR UROL, V52, P1601, DOI 10.1016/j.eururo.2007.09.036; Boots AW, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/027108; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; Catalona WJ, 2000, UROLOGY, V56, P255, DOI 10.1016/S0090-4295(00)00637-3; Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452; CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3; Chun FKH, 2007, WORLD J UROL, V25, P131, DOI 10.1007/s00345-007-0146-y; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Delen D, 2009, EXPERT SYST, V26, P100, DOI 10.1111/j.1468-0394.2008.00480.x; Elliker KR, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-22; Filipiak W, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-17; Filzmoser P, 2009, J CHEMOMETR, V23, P160, DOI 10.1002/cem.1225; Garattini S, 2010, NEW ENGL J MED, V363, P794, DOI 10.1056/NEJMc1005498; Groskopf J, 2006, CLIN CHEM, V52, P1089, DOI 10.1373/clinchem.2005.063289; Herwig R, 2008, EUR J CLIN INVEST, V38, P430, DOI 10.1111/j.1365-2362.2008.01953.x; Hessels D, 2007, CLIN CANCER RES, V13, P5103, DOI 10.1158/1078-0432.CCR-07-0700; Horvath G, 2008, INTEGR CANCER THER, V7, P76, DOI 10.1177/1534735408319058; Jentzmik F, 2010, EUR UROL, V58, P12, DOI 10.1016/j.eururo.2010.01.035; Killick E, 2013, SCI REP-UK, P3; Klecka W. R., 1980, DISCRIMINANT ANAL; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Kwiatkowski MK, 1998, UROLOGY, V52, P360, DOI 10.1016/S0090-4295(98)00245-3; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; Lazzeri M, 2013, EUR UROL, V63, P986, DOI 10.1016/j.eururo.2013.01.011; Leman ES, 2007, UROLOGY, V69, P714, DOI 10.1016/j.urology.2007.01.097; Lughezzani G, 2014, EUR UROL, V66, P906, DOI 10.1016/j.eururo.2013.12.005; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Mills GA, 2001, J CHROMATOGR B, V753, P259, DOI 10.1016/S0378-4347(00)00554-5; Morgan R, 2011, CLIN CANCER RES, V17, P1090, DOI 10.1158/1078-0432.CCR-10-2410; Naughton CK, 2000, J UROLOGY, V164, P388, DOI 10.1016/S0022-5347(05)67367-3; NCI (NCIN), CANC MORT MAL ICD10; NCI NCIN, 2013, CANC INC MAL ICD10 C; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Pickel D, 2004, APPL ANIM BEHAV SCI, V89, P107, DOI 10.1016/j.applanim.2004.04.008; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Roine A, 2014, J UROLOGY, V192, P230, DOI 10.1016/j.juro.2014.01.113; Roobol MJ, 2010, EUR UROL, V58, P475, DOI 10.1016/j.eururo.2010.06.039; Rosenberg LH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-468; Schostak M, 2009, J UROLOGY, V181, P343, DOI 10.1016/j.juro.2008.08.119; Schroder FH, 2010, NEW ENGL J MED, V363, P4; Silva CL, 2011, BRIT J CANCER, V105, P1894, DOI 10.1038/bjc.2011.437; Silva CL, 2012, TALANTA, V89, P360, DOI 10.1016/j.talanta.2011.12.041; Smith S, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037022; Smith S, 2010, IEEE SENS J, V10, P92, DOI 10.1109/JSEN.2009.2035771; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Struys EA, 2010, ANN CLIN BIOCHEM, V47, P282, DOI 10.1258/acb.2010.009270; Taverna G, 2014, THE JOURNAL OF UROLO, pe546; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tomlins SA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001970; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Wu H, 2011, ANAL BIOANAL CHEM, V401, P635, DOI 10.1007/s00216-011-5098-9; Zhang Shucha, 2014, Methods Mol Biol, V1198, P265, DOI 10.1007/978-1-4939-1258-2_17	59	91	91	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143283	10.1371/journal.pone.0143283	http://dx.doi.org/10.1371/journal.pone.0143283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599280	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600044
J	Shamaa, OR; Mitra, S; Gavrilin, MA; Wewers, MD				Shamaa, Obada R.; Mitra, Srabani; Gavrilin, Mikhail A.; Wewers, Mark D.			Monocyte Caspase-1 Is Released in a Stable, Active High Molecular Weight Complex Distinct from the Unstable Cell Lysate-Activated Caspase-1	PLOS ONE			English	Article							INTERLEUKIN-1-BETA-CONVERTING ENZYME; IL-1-BETA-CONVERTING ENZYME; NLRP3 INFLAMMASOME; CYSTEINE PROTEASE; ASC; IL-1-BETA; DEATH; ICE; K+; PURIFICATION	Mononuclear phagocytes utilize caspase-1 activation as a means to respond to danger signals. Although caspase-1 was discovered using highly concentrated cell extracts that spontaneously activate caspase-1, it is now clear that in live cell models caspase-1 activation occurs in the process of its cellular release and is not an intracellular event. Therefore, we compared the characteristics of caspase-1 activation in the cell lysate model to that of caspase-1 that is released in response to exogenous inflammasome activation. Whereas both models generated active caspase-1, the cell-lysate induced caspase-1 required highly concentrated cell lysates and had a short half-life (similar to 15 min) whereas, the activation induced released caspase-1 required 2-3 log fold fewer cells and was stable for greater than 12 h. Both forms were able to cleave proIL-1beta but unexpectedly, the released activity was unable to be immunodepleted by caspase-1 antibodies. Size exclusion chromatography identified two antigenic forms of p20 caspase-1 in the activation induced released caspase-1: one at the predicted size of tetrameric, p20/p10 caspase-1 and the other at >200 kDa. However, only the high molecular weight form had stable functional activity. These results suggest that released caspase-1 exists in a unique complex that is functionally stable and protected from immunodepletion whereas cell-extract generated active caspase-1 is rapidly inhibited in the cytosolic milieu.	[Shamaa, Obada R.; Mitra, Srabani; Gavrilin, Mikhail A.; Wewers, Mark D.] Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Wexner Med Ctr,Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Wewers, MD (corresponding author), Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Wexner Med Ctr,Davis Heart & Lung Res Inst, 473 W 12th Ave,201 DHLRI, Columbus, OH 43210 USA.	wewers.2@osu.edu	Wewers, Mark/AAB-6202-2021	Gavrilin, Mikhail/0000-0003-2003-768X	National Institute of Heart Lung and Blood [HL076278, HL102724]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102724, R01HL076278] Funding Source: NIH RePORTER	National Institute of Heart Lung and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Heart Lung and Blood, grants HL076278 and HL102724 supported this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdelaziz DH, 2011, J BIOL CHEM, V286, P3203, DOI 10.1074/jbc.M110.197681; AYALA JM, 1994, J IMMUNOL, V153, P2592; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; BLACK RA, 1988, J BIOL CHEM, V263, P9437; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Ghonime MG, 2012, BIOCHEM BIOPH RES CO, V425, P384, DOI 10.1016/j.bbrc.2012.07.102; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Labbe K, 2011, PROG INFLAMM RES SER, P17, DOI 10.1007/978-3-0348-0148-5_2; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; MILLER DK, 1993, J BIOL CHEM, V268, P18062; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; RAMAGE P, 1995, J BIOL CHEM, V270, P9378, DOI 10.1074/jbc.270.16.9378; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Rayamajhi Manira, 2013, Methods Mol Biol, V1040, P85, DOI 10.1007/978-1-62703-523-1_7; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Swaan PW, 2001, PHARMACEUT RES, V18, P1083, DOI 10.1023/A:1010958406364; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; WEWERS MD, 1988, J CLIN INVEST, V82, P1260, DOI 10.1172/JCI113724; Wewers MD, 1997, J IMMUNOL, V159, P5964; Wewers MD, 2004, P NATL ACAD SCI USA, V101, P10241, DOI 10.1073/pnas.0403971101; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900	45	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142203	10.1371/journal.pone.0142203	http://dx.doi.org/10.1371/journal.pone.0142203			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599267	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600008
J	Zhong, J; Shi, QQ; Zhu, MM; Shen, J; Wang, HH; Ma, D; Miao, CH				Zhong, Jing; Shi, Qi-Qing; Zhu, Min-Min; Shen, Jian; Wang, Hui-Hui; Ma, Duan; Miao, Chang-Hong			MFHAS1 Is Associated with Sepsis and Stimulates TLR2/NF-kappa B Signaling Pathway Following Negative Regulation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; INFLAMMATORY RESPONSE SYNDROME; ACUTE KIDNEY INJURY; MITOCHONDRIAL DYSFUNCTION; MASL1; RECOGNITION; BIOMARKERS; CELLS; SIRS; TLR	Malignant fibrous histiocytoma amplified sequence 1 (MFHAS1) has a potential immunoregulatory role dependent on Toll-like receptors (TLRs). TLR2, associated with deleterious systemic inflammation, cardiac dysfunction, and acute kidney injury, acts synergistically in sepsis. The role of MFHAS1 in targeting TLR2 involved in sepsis has not been examined thus far. This study aimed to examine the relationship of MFHAS1 and sepsis, and the effect of MFHAS1 on the TLR2 signaling pathway. Blood samples were collected from eight sepsis patients after surgery and eight patients undergoing selective surgery to determine blood MFHAS1 levels. HEK 293 cells, RAW 264.7 macrophages and THP-1 monocytes were used to confirm the effect of MFHAS1 on TLR2 signaling pathway. Our study showed that blood MFHAS1 was significantly elevated in septic patients, and MFHAS1 was more increased in mononuclear cells from septic patients. Pam3CSK4 (TLR2 ligand) was found to induce MFHAS1 production in RAW 264.7 murine macrophages and THP-1 human monocytes in a time-dependent manner. MFHAS1 has dual effects on TLR2 signaling pathway and inflammation, i.e., inhibitory effect at 6 hours, and then stimulatory effect after 24 hours through the activation of TLR2/NF-kappa B signaling pathway, and MFHAS1 induced the phosphorylation of JNK and p38 after TLR2 stimulation.	[Zhong, Jing; Zhu, Min-Min; Shen, Jian; Wang, Hui-Hui; Miao, Chang-Hong] Fudan Univ, Shanghai Canc Ctr, Dept Anesthesiol, Shanghai 200433, Peoples R China; [Zhong, Jing; Zhu, Min-Min; Shen, Jian; Wang, Hui-Hui; Miao, Chang-Hong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Shi, Qi-Qing] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Ma, Duan] Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Dept Biochem & Mol Biol,Key Lab Mol Med,Minist Ed, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Ma, D (corresponding author), Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Dept Biochem & Mol Biol,Key Lab Mol Med,Minist Ed, Shanghai 200433, Peoples R China.	duanma@fudan.edu.cn; miaochh@aliyun.com	Zhong, Jing/AAD-2291-2020; Ma, Duan/I-8330-2014; wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022	Zhong, Jing/0000-0002-8764-0187; 	Ministry of Education of the People's Republic of China [20110071110044]; Shanghai Municipal Commission of Health and Family Planning [20144Y0173]	Ministry of Education of the People's Republic of China(Ministry of Education, China); Shanghai Municipal Commission of Health and Family Planning	This study was funded by grants from Ministry of Education of the People's Republic of China No. 20110071110044; URL: http://www.moe.gov.cn/ to CHM and the Shanghai Municipal Commission of Health and Family Planning No. 20144Y0173; URL: http://www.wsjsw.gov.cn/wsj/ to JZ.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balk RA, 2014, VIRULENCE, V5, P20, DOI 10.4161/viru.27135; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004; Brightbill HD, 2000, IMMUNOLOGY, V101, P1, DOI 10.1046/j.1365-2567.2000.00093.x; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dihanich S, 2014, FEBS J, V281, P261, DOI 10.1111/febs.12593; Dihanich S, 2012, BIOCHEM SOC T, V40, P1090, DOI 10.1042/BST20120127; Dumache R, 2015, ANAL CELL PATHOL, V2015, P1, DOI 10.1155/2015/186716; Dupuy AM, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-22; Ferrer R, 2009, AM J RESP CRIT CARE, V180, P861, DOI 10.1164/rccm.200812-1912OC; Fijen, 2000, Eur J Intern Med, V11, P89, DOI 10.1016/S0953-6205(00)00068-6; Foley NM, 2015, MILITARY MED RES, V2, pCP10, DOI 10.1186/s40779-014-0029-7; Gomez HG, 2014, CRIT CARE MED, V42, P771, DOI 10.1097/CCM.0000000000000100; Gong Y, 2014, ANESTHESIOLOGY, V121, P1236, DOI 10.1097/ALN.0000000000000470; Hoang M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115428; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Kojic Dubravka, 2015, World J Exp Med, V5, P50, DOI 10.5493/wjem.v5.i2.50; Kumkhaek C, 2013, BLOOD, V121, P3216, DOI 10.1182/blood-2011-10-385252; Li Y, 2015, IRAN J KIDNEY DIS, V9, P202; Ma J, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/984825; Marik PE, 2012, J TRAUMA ACUTE CARE, V73, P801, DOI 10.1097/TA.0b013e318265cf87; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Peng Y, 2015, RENAL FAILURE, V37, P694, DOI 10.3109/0886022X.2015.1011499; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rosenthal M, 2015, MINERVA ANESTESIOLOG; Sakabe T, 1999, CANCER RES, V59, P511; Schorr CA, 2014, TRENDS MOL MED, V20, P192, DOI 10.1016/j.molmed.2014.02.001; Sellge G, 2015, SEMIN IMMUNOL, V27, P75, DOI 10.1016/j.smim.2015.03.009; Sharawy N, 2015, J SURG RES, V194, P520, DOI 10.1016/j.jss.2014.12.014; Shibata T, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.585901; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Weng WH, 2004, CANCER GENET CYTOGEN, V150, P27, DOI 10.1016/j.cancergencyto.2003.08.009; Yao YM, 2015, METHODS MOL BIOL, V1237, P5, DOI 10.1007/978-1-4939-1776-1_2; Zheng GL, 2015, J RES MED SCI, V20, P185; Zhong J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001423	41	20	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143662	10.1371/journal.pone.0143662	http://dx.doi.org/10.1371/journal.pone.0143662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599367	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600102
J	Aguera, Z; Romero, X; Arcelus, J; Sanchez, I; Riesco, N; Jimenez-Murcia, S; Gonzalez-Gomez, J; Granero, R; Custal, N; de Bernabe, MMG; Tarrega, S; Banos, RM; Botella, C; de la Torre, R; Fernandez-Garcia, JC; Fernandez-Real, JM; Fruhbeck, G; Gomez-Ambrosi, J; Tinahones, FJ; Crujeiras, AB; Casanueva, FF; Menchon, JM; Fernandez-Aranda, F				Agueera, Zaida; Romero, Xandra; Arcelus, Jon; Sanchez, Isabel; Riesco, Nadine; Jimenez-Murcia, Susana; Gonzalez-Gomez, Jana; Granero, Roser; Custal, Nuria; de Bernabe, Monica Montserrat-Gil; Tarrega, Salome; Banos, Rosa M.; Botella, Cristina; de la Torre, Rafael; Fernandez-Garcia, Jose C.; Fernandez-Real, Jose M.; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Tinahones, Francisco J.; Crujeiras, Ana B.; Casanueva, Felipe F.; Menchon, Jose M.; Fernandez-Aranda, Fernando			Changes in Body Composition in Anorexia Nervosa: Predictors of Recovery and Treatment Outcome	PLOS ONE			English	Article							FAT DISTRIBUTION; WEIGHT-GAIN; BIOELECTRICAL-IMPEDANCE; ENERGY-EXPENDITURE; ADOLESCENTS; WOMEN; WATER; BIA	The restoration of body composition (BC) parameters is considered to be one of the most important goals in the treatment of patients with anorexia nervosa (AN). However, little is known about differences between AN diagnostic subtypes [restricting (AN-R) and binge/purging (AN-BP)] and weekly changes in BC during refeeding treatment. Therefore, the main objectives of our study were twofold: 1) to assess the changes in BC throughout nutritional treatment in an AN sample and 2) to analyze predictors of BC changes during treatment, as well as predictors of treatment outcome. The whole sample comprised 261 participants [118 adult females with AN (70 AN-R vs. 48 AN-BP), and 143 healthy controls]. BC was measured weekly during 15 weeks of day-hospital treatment using bioelectrical impedance analysis (BIA). Assessment measures also included the Eating Disorders Inventory-2, as well as a number of other clinical indices. Overall, the results showed that AN-R and AN-BP patients statistically differed in all BC measures at admission. However, no significant timexgroup interaction was found for almost all BC parameters. Significant timexgroup interactions were only found for basal metabolic rate (p =.041) and body mass index (BMI) (p =.035). Multiple regression models showed that the best predictors of pre-post changes in BC parameters (namely fat-free mass, muscular mass, total body water and BMI) were the baseline values of BC parameters. Stepwise predictive logistic regressions showed that only BMI and age were significantly associated with outcome, but not with the percentage of body fat. In conclusion, these data suggest that although AN patients tended to restore all BC parameters during nutritional treatment, only AN-BP patients obtained the same fat mass values as healthy controls. Put succinctly, the best predictors of changes in BC were baseline BC values, which did not, however, seem to influence treatment outcome.	[Agueera, Zaida; Romero, Xandra; Sanchez, Isabel; Riesco, Nadine; Jimenez-Murcia, Susana; Custal, Nuria; de Bernabe, Monica Montserrat-Gil; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Hosp Bellvitge, IDIBELL, Dept Psychiat, Barcelona, Spain; [Agueera, Zaida; Jimenez-Murcia, Susana; Granero, Roser; Banos, Rosa M.; Botella, Cristina; de la Torre, Rafael; Fernandez-Garcia, Jose C.; Fernandez-Real, Jose M.; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Tinahones, Francisco J.; Crujeiras, Ana B.; Casanueva, Felipe F.; Fernandez-Aranda, Fernando] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Arcelus, Jon] Univ Loughborough, Ctr Res Eating Disorders, Loughborough, Leics, England; [Jimenez-Murcia, Susana; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Gonzalez-Gomez, Jana] Marques de Valdecilla Publ Fdn Res Inst FMV IFIMA, Santander, Spain; [Granero, Roser; Tarrega, Salome] Univ Autonoma Barcelona, Dept Psychobiol & Methodol, E-08193 Barcelona, Spain; [de Bernabe, Monica Montserrat-Gil] Univ Hosp Bellvitge, Dietet & Nutr Unit, Barcelona, Spain; [Banos, Rosa M.] Univ Valencia, Dept Personal Evaluat & Psychol Treatment, Valencia, Spain; [Botella, Cristina] Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain; [de la Torre, Rafael] IMIM Hosp Mar Med Res Inst, Neurosci Res Program, Human Pharmacol & Clin Neurosci Res Grp, Barcelona, Spain; [Fernandez-Garcia, Jose C.; Tinahones, Francisco J.] Hosp Clin Univ Virgen Victoria, Dept Diabet Endocrinol & Nutr, Malaga, Spain; [Fernandez-Real, Jose M.] Hosp Dr Josep Trueta, IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Fruehbeck, Gema; Gomez-Ambrosi, Javier] Univ Navarra, Univ Navarra Clin, Dept Endocrinol & Nutr, E-31080 Pamplona, Spain; [Crujeiras, Ana B.; Casanueva, Felipe F.] Complejo Hosp Univ Santiago, Div Endocrine, Santiago De Compostela, Spain; [Menchon, Jose M.] CIBER Salud Mental CIBERSAM, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Loughborough University; University of Barcelona; Hospital Universitario Marques de Valdecilla (HUMV); Autonomous University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Valencia; Universitat Jaume I; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital Virgen de la Victoria; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Navarra; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Fernandez-Aranda, F (corresponding author), Univ Hosp Bellvitge, IDIBELL, Dept Psychiat, Barcelona, Spain.	ffernandez@bellvitgehospital.cat	Gómez-Ambrosi, Javier/D-2984-2017; Larrea, Salomé Tárrega/AAE-2684-2020; Fernandez-Aranda, Fernando/L-9762-2014; García, José Carlos Fernández/X-3910-2019; Botella, Cristina/F-9230-2010; Tárrega, Salomé/D-8876-2011; Granero, Roser/S-3529-2019; Díaz, Isabel M Sánchez/G-7277-2017; Riesco, Nadine/L-1114-2014; Fernández-Real, Jose Manuel/AGH-3599-2022; Tinahones, Francisco José/AAB-2882-2020; García, José Carlos Fernández/B-3723-2013; Fernandez-Garcia, Jose Carlos/B-5312-2013; JIMENEZ-MURCIA, SUSANA/L-9786-2014; AGÜERA, ZAIDA/K-9771-2014; de la Torre, Rafael/D-3561-2018; Crujeiras, Ana/ABA-8866-2021; BAÑOS, ROSA MARIA/C-6077-2011; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Granero, Roser/F-9492-2016; Menchon, Jose/A-5242-2009	Gómez-Ambrosi, Javier/0000-0001-5601-1604; Larrea, Salomé Tárrega/0000-0002-5820-6795; Fernandez-Aranda, Fernando/0000-0002-2968-9898; García, José Carlos Fernández/0000-0003-2308-2865; Botella, Cristina/0000-0001-8783-6959; Tárrega, Salomé/0000-0002-5820-6795; Díaz, Isabel M Sánchez/0000-0001-5874-8204; Riesco, Nadine/0000-0002-6336-4907; Fernández-Real, Jose Manuel/0000-0002-7442-9323; García, José Carlos Fernández/0000-0003-2308-2865; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; AGÜERA, ZAIDA/0000-0003-4453-4939; de la Torre, Rafael/0000-0002-6765-1866; Crujeiras, Ana/0000-0003-4392-0301; BAÑOS, ROSA MARIA/0000-0003-0626-7665; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Granero, Roser/0000-0001-6308-3198; Arcelus, Jon/0000-0002-3805-0180; Tinahones, Francisco J/0000-0001-6871-4403; Romero, Xandra/0000-0003-4276-9793; Menchon, Jose/0000-0002-6231-6524	Instituto de Salud Carlos III [ISCIII] [FIS PI11/00210, FIS PI14/00290]; Fondos Europeos de Desarrollo Regional (FEDER) funds; Servicio Andaluz de Salud (SAS) [B-0033-2014]; Instituto de Salud Carlos III [Ministerio de de Economia y Competitividad] [PSI2011-28349]	Instituto de Salud Carlos III [ISCIII](Instituto de Salud Carlos IIIEuropean Commission); Fondos Europeos de Desarrollo Regional (FEDER) funds; Servicio Andaluz de Salud (SAS); Instituto de Salud Carlos III [Ministerio de de Economia y Competitividad]	The study was supported by Instituto de Salud Carlos III [ISCIII; FIS PI11/00210, FIS PI14/00290 and Ministerio de de Economia y Competitividad (PSI2011-28349)] and co-funded by Fondos Europeos de Desarrollo Regional (FEDER) funds - a way to build Europe. Jose C. Fernandez-Garcia is the recipient of a research contract from Servicio Andaluz de Salud (SAS) (B-0033-2014). CIBERobn and CIBERSAM are both initiatives of ISCIII.	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, V5th; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Bossu C, 2007, AM J PHYSIOL-ENDOC M, V292, pE132, DOI 10.1152/ajpendo.00241.2006; BREWERTON TD, 1995, INT J EAT DISORDER, V17, P413, DOI 10.1002/1098-108X(199505)17:4<413::AID-EAT2260170414>3.0.CO;2-0; Browning LM, 2011, OBESITY FACTS, V4, P9, DOI 10.1159/000324546; Bruni V, 2011, J PEDIATR ADOL GYNEC, V24, P347, DOI 10.1016/j.jpag.2011.06.004; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dalle Grave R, 2008, COMPR PSYCHIAT, V49, P346, DOI 10.1016/j.comppsych.2007.12.007; De Alvaro MTG, 2007, EUR J ENDOCRINOL, V157, P473, DOI 10.1530/EJE-07-0459; DEMPSEY DT, 1984, AM J CLIN NUTR, V40, P260, DOI 10.1093/ajcn/40.2.260; El Ghoch M, 2014, NUTRIENTS, V6, P3895, DOI 10.3390/nu6093895; El Ghoch M, 2014, AM J CLIN NUTR, V99, P771, DOI 10.3945/ajcn.113.078816; Garner D.M., 1998, INVENTARIO TRASTORNO; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Iketani T, 1999, INT J EAT DISORDER, V26, P275, DOI 10.1002/(SICI)1098-108X(199911)26:3&lt;275::AID-EAT4&gt;3.0.CO;2-I; KAYE WH, 1986, AM J CLIN NUTR, V44, P435, DOI 10.1093/ajcn/44.4.435; KRAHN DD, 1993, J AM DIET ASSOC, V93, P434, DOI 10.1016/0002-8223(93)92291-5; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Kyle UG, 2001, NUTRITION, V17, P534, DOI 10.1016/S0899-9007(01)00555-X; Lowe B, 2001, PSYCHOL MED, V31, P881, DOI 10.1017/S003329170100407X; Martinoli R, 2003, ACTA DIABETOL, V40, pS203, DOI 10.1007/s00592-003-0066-2; Marzola E, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-290; Mayer L, 2005, AM J CLIN NUTR, V81, P1286; Mika C, 2004, J NUTR, V134, P3026, DOI 10.1093/jn/134.11.3026; Misra M, 2003, AM J CLIN NUTR, V77, P1361, DOI 10.1093/ajcn/77.6.1361; Orphanidou CI, 1997, AM J CLIN NUTR, V65, P1034, DOI 10.1093/ajcn/65.4.1034; Polito A, 1998, EUR J CLIN NUTR, V52, P655, DOI 10.1038/sj.ejcn.1600618; Probst M, 2001, AM J CLIN NUTR, V73, P190; Probst M, 1996, BRIT J NUTR, V76, P639, DOI 10.1079/BJN19960072; Saladino CF, 2014, J EAT DISORD, V2, DOI 10.1186/s40337-014-0034-y; SALISBURY JJ, 1995, INT J EAT DISORDER, V17, P337, DOI 10.1002/1098-108X(199505)17:4&lt;337::AID-EAT2260170405&gt;3.0.CO;2-Q; Scalfi L, 2002, EUR J CLIN NUTR, V56, P15, DOI 10.1038/sj.ejcn.1601290; Terra X, 2013, INT J EAT DISORDER, V46, P855, DOI 10.1002/eat.22166; Yamashita S, 2010, INT J EAT DISORDER, V43, P365, DOI 10.1002/eat.20700	35	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143012	10.1371/journal.pone.0143012	http://dx.doi.org/10.1371/journal.pone.0143012			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600309	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900057
J	Newport, C; Wallis, G; Siebeck, UE				Newport, Cait; Wallis, Guy; Siebeck, Ulrike E.			Same/Different Abstract Concept Learning by Archerfish (Toxotes chatareus)	PLOS ONE			English	Article							MATCHING-TO-SAMPLE; ODD-ITEM SEARCH; PIGEONS; DISCRIMINATION; COMPLEX; INFORMATION; SAMENESS; GOLDFISH; STARTS	While several phylogenetically diverse species have proved capable of learning abstract concepts, previous attempts to teach fish have been unsuccessful. In this report, the ability of archerfish (Toxotes chatareus) to learn the concepts of sameness and difference using a simultaneous two-item discrimination task was tested. Six archerfish were trained to either select a pair of same or different stimuli which were presented simultaneously. Training consisted of a 2-phase approach. Training phase 1: the symbols in the same and different pair did not change, thereby allowing the fish to solve the test through direct association. The fish were trained consecutively with four different sets of stimuli to familiarize them with the general procedure before moving on to the next training phase. Training phase 2: six different symbols were used to form the same or different pairs. After acquisition, same/different concept learning was tested by presenting fish with six novel stimuli (transfer test). Five fish successfully completed the first training phase. Only one individual passed the second training phase, however, transfer performance was consistent with chance. This individual was given further training using 60 training exemplars but the individual was unable to reach the training criterion. We hypothesize that archerfish are able to solve a limited version of the same/different test by learning the response to each possible stimulus configuration or by developing a series of relatively simple choice contingencies. We conclude that the simultaneous two-item discrimination task we describe cannot be successfully used to test the concepts of same and different in archerfish. In addition, despite considerable effort training archerfish using several tests and training methods, there is still no evidence that fish can learn an abstract concept-based test.	[Newport, Cait; Siebeck, Ulrike E.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Newport, Cait] Univ Oxford, Dept Zool, Oxford, England; [Wallis, Guy] Univ Queensland, Ctr Sensorimotor Performance, Sch Human Movement Studies, Brisbane, Qld, Australia	University of Queensland; University of Oxford; University of Queensland	Newport, C (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	caitlin.newport@zoo.ox.ac.uk	Siebeck, Ulrike E/J-6190-2014; Wallis, Guy/G-2342-2011	Siebeck, Ulrike E/0000-0003-2024-1568; Wallis, Guy/0000-0003-1601-1540	Australian Research Council [FT100100020, DP140100431]; European Union [659684]	Australian Research Council(Australian Research Council); European Union(European Commission)	This study was funded by the Australian Research Council (GW: FT100100020; UES: DP140100431) and the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement (CN: 659684). The contents of this study reflect only the authors' views and not the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avargues-Weber A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1907; Ben-Tov M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7476; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Bisazza A, 2014, ANIM COGN, V17, P1413, DOI 10.1007/s10071-014-0759-7; Blaisdell AP, 2005, LEARN BEHAV, V33, P67; BLOUGH DS, 1986, BEHAV RES METH INSTR, V18, P413, DOI 10.3758/BF03201403; BLOUGH DS, 1989, J EXP PSYCHOL ANIM B, V15, P14, DOI 10.1037/0097-7403.15.1.14; Bodily KD, 2008, J EXP PSYCHOL ANIM B, V34, P178, DOI 10.1037/0097-7403.34.1.178; CARTER DE, 1978, J EXP ANAL BEHAV, V29, P565, DOI 10.1901/jeab.1978.29-565; CHAUSSEIL M, 1991, ETHOLOGY, V87, P28; Cook RG, 2003, BEHAV PROCESS, V62, P125, DOI 10.1016/S0376-6357(03)00022-6; Gierszewski S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057363; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GOLDMAN M, 1979, J EXP ANAL BEHAV, V31, P259, DOI 10.1901/jeab.1979.31-259; HERRNSTEIN RJ, 1964, SCIENCE, V146, P549, DOI 10.1126/science.146.3643.549; KASTAK D, 1994, ANIM LEARN BEHAV, V22, P427, DOI 10.3758/BF03209162; Katz JS, 2007, COMP COGN BEHAV REV, V2, P79, DOI 10.3819/ccbr.2008.20005; Katz JS, 2006, J EXP PSYCHOL ANIM B, V32, P80, DOI 10.1037/0097-7403.32.1.80; Katz JS, 2002, J EXP PSYCHOL ANIM B, V28, P358, DOI 10.1037//0097-7403.28.4.358; Krupczynski P, 2013, J EXP BIOL, V216, P3450, DOI 10.1242/jeb.088856; LUBOW RE, 1974, J EXP ANAL BEHAV, V21, P475, DOI 10.1901/jeab.1974.21-475; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Mercado E, 2000, BEHAV PROCESS, V50, P79, DOI 10.1016/S0376-6357(00)00100-5; Miller AM, 2013, ANIM BEHAV, V85, P339, DOI 10.1016/j.anbehav.2012.11.002; Newport C, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00039; Newport C, 2013, ANIM BEHAV, V86, P1265, DOI 10.1016/j.anbehav.2013.09.031; PEPPERBERG IM, 1987, ANIM LEARN BEHAV, V15, P423, DOI 10.3758/BF03205051; PREMACK D, 1983, ANNU REV PSYCHOL, V34, P351, DOI 10.1146/annurev.ps.34.020183.002031; Premack D., 1978, COGNITIVE PROCESS, P423; Reinel C, 2014, J EXP BIOL, V217, P2866, DOI 10.1242/jeb.105510; Rischawy I, 2013, J EXP BIOL, V216, P3096, DOI 10.1242/jeb.087734; Schluessel V, 2012, ANIM COGN, V15, P525, DOI 10.1007/s10071-012-0480-3; Scholtyssek C, 2013, ANIM COGN, V16, P915, DOI 10.1007/s10071-013-0624-0; Schuster S, 2012, CURR OPIN NEUROBIOL, V22, P279, DOI 10.1016/j.conb.2011.12.004; WILSON B, 1985, Q J EXP PSYCHOL-B, V37, P313, DOI 10.1080/14640748508401173; Young ME, 1997, J EXP PSYCHOL ANIM B, V23, P491, DOI 10.1037/0097-7403.23.4.491; ZENTALL T, 1974, J EXP PSYCHOL, V102, P393, DOI 10.1037/h0035970; ZERBOLIO DJ, 1983, ANIM LEARN BEHAV, V11, P341, DOI 10.3758/BF03199786	38	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143401	10.1371/journal.pone.0143401	http://dx.doi.org/10.1371/journal.pone.0143401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599071	Green Published, gold			2022-12-27	WOS:000365853900108
J	Semple, SJ; Stockman, JK; Pitpitan, EV; Strathdee, SA; Chavarin, CV; Mendoza, DV; Aarons, GA; Patterson, TL				Semple, Shirley J.; Stockman, Jamila K.; Pitpitan, Eileen V.; Strathdee, Steffanie A.; Chavarin, Claudia V.; Mendoza, Doroteo V.; Aarons, Gregory A.; Patterson, Thomas L.			Prevalence and Correlates of Client-Perpetrated Violence against Female Sex Workers in 13 Mexican Cities	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; INJECTION-DRUG USE; HARD-TO-REACH; RISK-FACTORS; U.S. BORDER; CONDOM USE; HIV RISK; STRUCTURAL VIOLENCE; ALCOHOL-CONSUMPTION; ANDHRA-PRADESH	Background Globally, client-perpetrated violence against female sex workers (FSWs) has been associated with multiple health-related harms, including high-risk sexual behavior and increased exposure to HIV/STIs. This study examined correlates of client-perpetrated sexual, physical, and economic violence (e.g., robbery) against FSWs in 13 cities throughout Mexico. Methods FSWs (N = 1,089) who were enrolled in a brief, evidence-based, sexual risk reduction intervention for FSWs (Mujer Segura) were interviewed about their work context, including experiences of violence perpetrated by clients, sexual risk and substance use practices, financial need, and social supports. Three broad categories of factors (sociodemographic, work context, behavioral and social characteristics of FSWs) were examined as correlates of sexual, physical, and economic violence. Results The prevalence of different types of client-perpetrated violence against FSWs in the past 6 months was: sexual (11.7%), physical (11.8%), economic (16.9%), and any violence (22.6%). Greater financial need, self-identification as a street worker, and lower perceived emotional support were independently associated with all three types of violence. Alcohol use before or during sex with clients in the past month was associated with physical and sexual violence. Using drugs before or during sex with clients, injection drug use in the past month, and population size of city were associated with sexual violence only, and FSWs' alcohol use score (AUDIT-C) was associated with economic violence only. Conclusions Correlates of client-perpetrated violence encompassed sociodemographic, work context, and behavioral and social factors, suggesting that approaches to violence prevention for FSWs must be multi-dimensional. Prevention could involve teaching FSWs strategies for risk avoidance in the workplace (e.g., avoiding use of alcohol with clients), enhancement of FSWs' community-based supports, development of interventions that deliver an anti-violence curriculum to clients, and programs to address FSWs' financial need by increasing their economic opportunities outside of the sex trade.	[Semple, Shirley J.; Stockman, Jamila K.; Chavarin, Claudia V.; Aarons, Gregory A.; Patterson, Thomas L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Pitpitan, Eileen V.; Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Mendoza, Doroteo V.] Mexican Fdn Family Planning Mexfam, Evaluat & Res Dept, Mexico City 14000, DF, Mexico	University of California System; University of California San Diego; University of California System; University of California San Diego	Patterson, TL (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	tpatterson@ucsd.edu	Stockman, Jamila/AAK-8960-2020; Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X	National Institutes of Health [R01 MH087054, K01 DA036447, K01 DA031593, R01 HD077891]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD077891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA036447, K01DA031593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health, grants R01 MH087054 (TLP), K01 DA036447 (EVP), and K01 DA031593 and R01 HD077891 (JKS). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Abas M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-204; Alexander H, 2001, RES SEX WORK, V4, P20; Argento E, 2011, AIDS CARE, V23, P69, DOI 10.1080/09540121.2010.498868; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Beletsky L, 2013, J URBAN HEALTH, V90, P284, DOI 10.1007/s11524-012-9741-3; Betts, 2001, RES SEX WORK, V4, P29; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bucardo J, 2005, DRUG ALCOHOL DEPEN, V79, P281, DOI 10.1016/j.drugalcdep.2005.02.003; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Castaneda X, 1996, CULT MED PSYCHIAT, V20, P229, DOI 10.1007/BF00115863; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Choi SYP, 2008, SEX TRANSM DIS, V35, P141, DOI 10.1097/OLQ.0b013e31815407c3; Church S, 2001, BMJ-BRIT MED J, V322, P524, DOI 10.1136/bmj.322.7285.524; Cler-Cunningham L., 2001, RES SEX WORK, V4, P25; Decker MR, 2012, SEX TRANSM INFECT, V88, P278, DOI 10.1136/sextrans-2011-050171; Decker MR, 2010, SEX TRANSM INFECT, V86, P236, DOI 10.1136/sti.2009.037846; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Deering KN, 2013, SEX TRANSM DIS, V40, P168, DOI 10.1097/OLQ.0b013e31827df174; Devries K, 2011, SOC SCI MED, V73, P79, DOI 10.1016/j.socscimed.2011.05.006; Du Mont J, 2004, WOMEN HEALTH, V39, P79, DOI 10.1300/j013v39n03_06; El-Bassel N, 2001, AIDS PATIENT CARE ST, V15, P41, DOI 10.1089/108729101460092; Farley M, 1998, WOMEN HEALTH, V27, P37, DOI 10.1300/J013v27n03_03; Farley Melissa, 2005, Transcult Psychiatry, V42, P242, DOI 10.1177/1363461505052667; George A, 2011, J INFECT DIS, V204, pS1235, DOI 10.1093/infdis/jir542; Goldenberg SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072982; Gu J, 2014, AIDS BEHAV, V18, pS181, DOI 10.1007/s10461-013-0434-z; Hong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062290; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Javidi H, 2012, INT J OCCUP ENV MED, V3, P2; Karandikar S, 2010, J INTERPERS VIOLENCE, V25, P257, DOI 10.1177/0886260509334393; Katsulis Y, 2015, VIOLENCE AGAINST WOM, V21, P571, DOI 10.1177/1077801214545283; Kinnell H., 2001, RES SEX WORK, V4, P22; Li JCM, 2013, INT J OFFENDER THER, V57, P613, DOI 10.1177/0306624X12438365; Loza O, 2010, J ADOLESCENT HEALTH, V46, P37, DOI 10.1016/j.jadohealth.2009.06.011; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mbonye M, 2014, AJAR-AFR J AIDS RES, V13, P145, DOI 10.2989/16085906.2014.927779; Nolan JJ, 2004, J CRIM JUST, V32, P547, DOI 10.1016/j.jcrimjus.2004.08.002; O'Doherty T, 2011, VIOLENCE AGAINST WOM, V17, P944, DOI 10.1177/1077801211412917; Odinokova V, 2014, INT J DRUG POLICY, V25, P96, DOI 10.1016/j.drugpo.2013.06.008; Okal J, 2011, AIDS CARE, V23, P612, DOI 10.1080/09540121.2010.525605; Olufunmilayo IF, 2014, AFR HEALTH SCI, V14, P299, DOI 10.4314/ahs.v14i2.4; Panchanadeswaran S, 2008, INT J DRUG POLICY, V19, P106, DOI 10.1016/j.drugpo.2007.11.013; Pandiyan Kasthuri, 2012, Indian J Psychiatry, V54, P349, DOI 10.4103/0019-5545.104822; Pando MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054147; Patterson TL, 2008, AM J PUBLIC HEALTH, V98, P2051, DOI 10.2105/AJPH.2007.130096; Patterson TL, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-105; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Platt L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002836; Platt L, 2011, SEX TRANSM INFECT, V87, P377, DOI 10.1136/sti.2011.049544; Raphael J, 2004, VIOLENCE AGAINST WOM, V10, P126, DOI 10.1177/1077801203260529; Reed E, 2010, PUBLIC HEALTH REP, V125, P81, DOI 10.1177/00333549101250S412; Navarro JR, 2012, REV PANAM SALUD PUBL, V31, P388, DOI 10.1590/S1020-49892012000500006; Robertson AM, 2014, J SEX RES, V51, P711, DOI 10.1080/00224499.2012.757283; Romero-Daza Nancy, 2003, Med Anthropol, V22, P233; Roxburgh A, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-24; Sarkar K, 2008, J HEALTH POPUL NUTR, V26, P223; Schwitters A, 2015, AIDS BEHAV, V19, pS68, DOI 10.1007/s10461-014-0957-y; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Servin AE, 2015, J APPL RES CHILD, V6; Shaghaghi A, 2011, HEALTH PROMOT PERSPE, V1, P86, DOI 10.5681/hpp.2011.009; Shannon K, 2008, AIDS CARE, V20, P235, DOI 10.1080/09540120701561270; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; Strathdee SA, 2012, ANN EPIDEMIOL, V22, P426, DOI 10.1016/j.annepidem.2012.04.002; Strathdee SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019048; Suresh G., 2009, J CONTEMP CRIM JUST, V25, P186, DOI [https://doi.org/10.1177/1043986209333590, DOI 10.1177/1043986209333590]; Surratt H, 2007, AIDS CARE, V19, P1274, DOI 10.1080/09540120701426490; Surratt HL, 2012, AIDS CARE, V24, P553, DOI 10.1080/09540121.2011.630342; Ulibarri MD, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/631479; Ulibarri MD, 2014, VIOLENCE AGAINST WOM, V20, P427, DOI 10.1177/1077801214528582; Ulibarri MD, 2011, AIDS BEHAV, V15, P179, DOI 10.1007/s10461-009-9595-1; Valera RJ, 2001, AM J HEALTH BEHAV, V25, P50, DOI 10.5993/AJHB.25.1.6; Witte SS, 2010, J PREV INTERV COMMUN, V38, P89, DOI 10.1080/10852351003640625; Zhang C, 2013, PSYCHOL HEALTH MED, V18, P330, DOI 10.1080/13548506.2012.712705	80	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143317	10.1371/journal.pone.0143317	http://dx.doi.org/10.1371/journal.pone.0143317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599083	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900092
J	Weinberger, J; Jimenez-Heredia, R; Schaller, S; Suessner, S; Sunzenauer, J; Reindl-Schwaighofer, R; Weiss, R; Winkler, S; Gabriel, C; Danzer, M; Oberbauer, R				Weinberger, Johannes; Jimenez-Heredia, Raul; Schaller, Susanne; Suessner, Susanne; Sunzenauer, Judith; Reindl-Schwaighofer, Roman; Weiss, Richard; Winkler, Stephan; Gabriel, Christian; Danzer, Martin; Oberbauer, Rainer			Immune Repertoire Profiling Reveals that Clonally Expanded B and T Cells Infiltrating Diseased Human Kidneys Can Also Be Tracked in Blood	PLOS ONE			English	Article							ANTIGEN RECEPTOR; GENERATION; IMMUNOGLOBULIN; DIVERSITY; ORGAN	Recent advances in high-throughput sequencing allow for the competitive analysis of the human B and T cell immune repertoire. In this study we compared Immunoglobulin and T cell receptor repertoires of lymphocytes found in kidney and blood samples of 10 patients with various renal diseases based on next-generation sequencing data. We used Biomed-2 primer panels and ImmunExplorer software to sequence, analyze and compare complementarity determining regions and V-(D)-J elements. While generally an individual's renal receptor repertoire is different from the repertoire present in blood, 94% (30/32) of the lymphocytes with clonal expansion in kidney can also be traced in blood however, not all of these clonotypes are equally abundant. Summarizing the data of all analyzed patients, 68% of highly expanded T cell clonotypes and 30% of the highly expanded B cell clonotypes that have infiltrated the kidney can be found amongst the five most abundant clonotypes in blood. In addition, complementarity determining region 3 sequences of the immunoglobulin heavy chains are on average more diverse than T cell receptor beta chains. Immune repertoire analysis of tissue infiltrating B and T cells adds new approaches to the assessment of adaptive immune response in kidney diseases. Our data suggest that expanded clonotypes in the tissues might be traceable in blood samples in the course of treatment or the natural history of the disease.	[Weinberger, Johannes; Jimenez-Heredia, Raul; Suessner, Susanne; Gabriel, Christian; Danzer, Martin] Ludwig Boltzmann Inst Expt & Clin Traumatol, Linz, Austria; [Weinberger, Johannes; Jimenez-Heredia, Raul; Suessner, Susanne; Gabriel, Christian; Danzer, Martin] Red Cross Transfus Serv Upper Austria, Dept Immunogenet, Linz, Austria; [Schaller, Susanne; Winkler, Stephan] Univ Appl Sci Upper Austria, Bioinformat Res Grp, Hagenberg, Austria; [Sunzenauer, Judith; Reindl-Schwaighofer, Roman; Oberbauer, Rainer] KH Elisabethinen, Dept Internal Med 3, Linz, Austria; [Sunzenauer, Judith; Reindl-Schwaighofer, Roman; Oberbauer, Rainer] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria; [Weiss, Richard] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Ludwig Boltzmann Institute; Ordensklinikum Linz Elisabethinen; Medical University of Vienna; Salzburg University	Danzer, M (corresponding author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Linz, Austria.	martin.danzer@o.roteskreuz.at; rainer.oberbauer@meduniwien.ac.at	Weiss, Richard/N-7279-2013; Gabriel, Christian/A-1689-2014	Weiss, Richard/0000-0003-3185-7253; Gabriel, Christian/0000-0003-2043-9320; Jimenez Heredia, Raul/0000-0002-1406-0608	Austrian Science Funds [P25726]; European Regional Development Funds [DAABAA_00720]	Austrian Science Funds(Austrian Science Fund (FWF)); European Regional Development Funds(European Commission)	This work was supported by Austrian Science Funds P25726 (https://www.fwf.ac.at/en/) and European Regional Development Funds DAABAA_00720 (http://ec.europa.eu/regional_policy/en/funding/erdf/).	Abul K, 2014, CELLULAR MOL IMMUNOL; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Anders HJ, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-138; Batal I, 2015, J AM SOC NEPHROLOGY; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158; Brown K, 2007, AM J PATHOL, V171, P1915, DOI 10.2353/ajpath.2007.070396; Cheng JL, 2011, P NATL ACAD SCI USA, V108, P5560, DOI 10.1073/pnas.1101148108; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Dziubianau M, 2013, AM J TRANSPLANT, V13, P2842, DOI 10.1111/ajt.12431; Emerson RO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111943; Fernandez-Ruiz M, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.3; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gonzalez D, 2007, BLOOD, V110, P3112, DOI 10.1182/blood-2007-02-069625; Hershberg U, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0239; Holcomb CL, 2014, TISSUE ANTIGENS, V83, P32, DOI 10.1111/tan.12269; Klarenbeek PL, 2012, ANN RHEUM DIS, V71, P1088, DOI 10.1136/annrheumdis-2011-200612; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lewis M, 2008, IMMUNOL CELL BIOL, V86, P226, DOI 10.1038/sj.icb.7100132; Li DR, 2014, IMMUNOL LETT, V162, P170, DOI 10.1016/j.imlet.2014.08.012; Morris H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010760; NeudoerfI C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00046; Niklas N, 2014, CELL IMMUNOL, V288, P31, DOI 10.1016/j.cellimm.2014.02.001; Ochsenreither S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-35; Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Salou M, 2015, ANN CLIN TRANSL NEUR, V2, P609, DOI 10.1002/acn3.199; Schaller S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0687-9; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Silva HM, 2012, MOL MED, V18, P733, DOI 10.2119/molmed.2011.00281; SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6; Six A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00413; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Sun CY, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/954292; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020	41	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143125	10.1371/journal.pone.0143125	http://dx.doi.org/10.1371/journal.pone.0143125			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600245	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900066
J	Bae, MN; Kim, SH; Kim, YO; Jin, DC; Song, HC; Choi, EJ; Kim, YL; Kim, YS; Kang, SW; Kim, NH; Yang, CW; Kim, YK				Bae, Myoung Nam; Kim, Su Hyun; Kim, Young Ok; Jin, Dong Chan; Song, Ho Chul; Choi, Euy Jin; Kim, Yong-Lim; Kim, Yon-Su; Kang, Shin-Wook; Kim, Nam-Ho; Yang, Chul Woo; Kim, Yong Kyun			Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; KIDNEY-DISEASE; ANEMIA; INDEX; HEMOGLOBIN; RESISTANCE; OUTCOMES; REGISTRY; THERAPY; COHORT	Erythropoiesis-stimulating agent (ESA) responsiveness has been reported to be associated with increased mortality in hemodialysis (HD) patients. ESA requirement to obtain the same hemoglobin (Hb) level is different between HD and peritoneal dialysis (PD) patients. In this study, we investigated the impact of ESA responsiveness on mortality between both HD and PD patients. Prevalent HD and PD patients were selected from the Clinical Research Center registry for end-stage renal disease, a prospective cohort study in Korea. ESA responsiveness was estimated using an erythropoietin resistant index (ERI) (U/kg/week/g/dL). Patients were divided into three groups by tertiles of ERI. ESA responsiveness was also assessed based on a combination of ESA dosage and hemoglobin (Hb) levels. The primary outcome was all-cause mortality. A total of 1,594 HD and 876 PD patients were included. The median ESA dose and ERI were lower in PD patients compared with HD patients (ESA dose: 4000 U/week vs 6000 U/week, respectively. P<0.001, ERI: 7.0 vs 10.4 U/kg/week/g/dl, respectively. P<0.001). The median follow-up period was 40 months. In HD patients, the highest ERI tertile was significantly associated with higher risk for all-cause mortality (HR 1.96, 95% CI, 1.07 to 3.59, P = 0.029). HD patients with high-dose ESA and low Hb levels (ESA hypo-responsiveness) had a significantly higher risk of all-cause mortality (HR 2.24, 95% CI, 1.16 to 4.31, P = 0.016). In PD patients, there was no significant difference in all-cause mortality among the ERI groups (P = 0.247, log-rank test). ESA hypo-responsiveness was not associated with all-cause mortality (HR = 1.75, 95% CI, 0.58 to 5.28, P = 0.319). Our data showed that ESA hypo-responsiveness was associated with an increased risk of all-cause mortality in HD patients. However, in PD patients, ESA hypo-responsiveness was not related to all-cause mortality. These finding suggest the different prognostic value of ESA responsiveness between HD and PD patients.	[Bae, Myoung Nam; Kim, Young Ok; Jin, Dong Chan; Song, Ho Chul; Choi, Euy Jin; Yang, Chul Woo; Kim, Yong Kyun] Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Su Hyun] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Kim, Yon-Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Kim, Yong Kyun] Catholic Univ Korea, MRC Cell Death Dis Res Ctr, Seoul, South Korea	Catholic University of Korea; Chung Ang University; Chung Ang University Hospital; Kyungpook National University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Chonnam National University; Catholic University of Korea	Kim, YK (corresponding author), Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea.	drkimyk@catholic.ac.kr			Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020).	Al-Hilali N, 2007, MED PRIN PRACT, V16, P63, DOI 10.1159/000096143; [Anonymous], 2006, AM J KIDNEY DIS, DOI [10.1053/j.ajkd.2006.03.051, DOI 10.1053/J.AJKD.2006.03.051.MEDLINE]; Blake PG, 2011, PERITON DIALYSIS INT, V31, P218, DOI 10.3747/pdi.2011.00026; Chung S, 2012, HEMODIAL INT, V16, P181, DOI 10.1111/j.1542-4758.2011.00644.x; Coronel F, 2003, J NEPHROL, V16, P697; Cotter DJ, 2004, SEMIN DIALYSIS, V17, P181, DOI 10.1111/j.0894-0959.2004.17317.x; DEPAEPE MBJ, 1983, KIDNEY INT, V23, P744, DOI 10.1038/ki.1983.88; Duong U, 2012, AM J NEPHROL, V35, P198, DOI 10.1159/000335685; Frank H, 2004, KIDNEY INT, V66, P832, DOI 10.1111/j.1523-1755.2004.00810.x; Fukuma S, 2012, AM J KIDNEY DIS, V59, P108, DOI 10.1053/j.ajkd.2011.07.014; GOLDBERG N, 1992, AM HEART J, V124, P424, DOI 10.1016/0002-8703(92)90608-X; HALSTENSON CE, 1991, CLIN PHARMACOL THER, V50, P702, DOI 10.1038/clpt.1991.210; Kaysen GA, 2006, AM J KIDNEY DIS, V47, P157, DOI 10.1053/j.ajkd.2005.09.013; Kim YK, 2014, PERITON DIALYSIS INT, V34, P383, DOI 10.3747/pdi.2013.00008; KORBET SM, 1993, KIDNEY INT, V43, pS111; Locatelli Francesco, 2007, Ther Clin Risk Manag, V3, P433; Lopez-Gomez JM, 2008, KIDNEY INT, V74, pS75, DOI 10.1038/ki.2008.523; MACDOUGALL IC, 1990, LANCET, V335, P489, DOI 10.1016/0140-6736(90)90733-L; McFarlane PA, 2010, KIDNEY INT, V78, P215, DOI 10.1038/ki.2010.108; Ogawa T, 2014, INT UROL NEPHROL, V46, P151, DOI 10.1007/s11255-013-0494-z; Parfrey PS, 2009, CLIN J AM SOC NEPHRO, V4, P755, DOI 10.2215/CJN.02730608; Rao A, 2013, NEPHRON CLIN PRACT, V125, P183, DOI 10.1159/000360029; Rattanasompattikul M, 2013, NEPHROL DIAL TRANSPL, V28, P1936, DOI 10.1093/ndt/gfs368; Sklar AH, 1998, NEW ENGL J MED, V339, P2023; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; Suttorp MM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-200; Vega A, 2014, RENAL FAILURE, V36, P1073, DOI 10.3109/0886022X.2014.917937; Wetmore JB, 2015, AM J NEPHROL, V41, P354, DOI 10.1159/000431335	28	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143348	10.1371/journal.pone.0143348	http://dx.doi.org/10.1371/journal.pone.0143348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588085	Green Published, gold, Green Submitted			2022-12-27	WOS:000365251500054
J	Tam, SY; Lilla, JN; Chen, CC; Kalesnikoff, J; Tsai, M				Tam, See-Ying; Lilla, Jennifer N.; Chen, Ching-Cheng; Kalesnikoff, Janet; Tsai, Mindy			RabGEF1/Rabex-5 Regulates TrkA-Mediated Neurite Outgrowth and NMDA-Induced Signaling Activation in NGF-Differentiated PC12 Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEURONAL DEVELOPMENT; NUCLEOTIDE EXCHANGE; MAST-CELLS; RABEX-5; KINASE; RECEPTORS; ENDOSOMES; UBIQUITIN; RAC	Nerve growth factor (NGF) binds to its cognate receptor TrkA and induces neuronal differentiation by activating distinct downstream signal transduction events. RabGEF1 (also known as Rabex-5) is a guanine nucleotide exchange factor for Rab5, which regulates early endosome fusion and vesicular trafficking in endocytic pathways. Here, we used the antisense (AS) expression approach to induce an NGF-dependent sustained knockdown of RabGEF1 protein expression in stable PC12 transfectants. We show that RabGEF1 is a negative regulator of NGF-induced neurite outgrowth and modulates other cellular and signaling processes that are activated by the interaction of NGF with TrkA receptors, such as cell cycle progression, cessation of proliferation, and activation of NGF-mediated downstream signaling responses. Moreover, RabGEF1 can bind to Rac1, and the activation of Rac1 upon NGF treatment is significantly enhanced in AS transfectants, suggesting that RabGEF1 is a negative regulator of NGF-induced Rac1 activation in PC12 cells. Furthermore, we show that RabGEF1 can also interact with NMDA receptors by binding to the NR2B subunit and its associated binding partner SynGAP, and negatively regulates activation of nitric oxide synthase activity induced by NMDA receptor stimulation in NGF-differentiated PC12 cells. Our data suggest that RabGEF1 is a negative regulator of TrkA-dependent neuronal differentiation and of NMDA receptor-mediated signaling activation in NGF-differentiated PC12 cells.	[Tam, See-Ying; Lilla, Jennifer N.; Chen, Ching-Cheng; Kalesnikoff, Janet; Tsai, Mindy] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Tam, SY (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	stam@stanford.edu		Tsai, Mindy/0000-0002-8421-4721	National Institutes of Health (NIH) [AI-23990]; Department of Pathology, Stanford University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023990, R01AI023990] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology, Stanford University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported in part by National Institutes of Health (NIH) grant AI-23990 (to Stephen J. Galli) and the Department of Pathology, Stanford University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Arundine M, 2003, BRAIN RES, V976, P149, DOI 10.1016/S0006-8993(03)02568-X; Bucci C, 2014, MEMBRANES, V4, P642, DOI 10.3390/membranes4040642; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grimes ML, 1996, J NEUROSCI, V16, P7950; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kalesnikoff J, 2006, P NATL ACAD SCI USA, V103, P2659, DOI 10.1073/pnas.0511191103; Kalesnikoff J, 2007, BLOOD, V109, P5308, DOI 10.1182/blood-2007-01-067363; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Lamoureux P, 1997, J CELL SCI, V110, P635; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Mori Y, 2013, J BIOL CHEM, V288, P9835, DOI 10.1074/jbc.M112.427591; Nguyen LK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-52; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Obara Y, 2009, J BIOL CHEM, V284, P23564, DOI 10.1074/jbc.M109.027821; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SPAARGAREN M, 1991, J BIOL CHEM, V266, P1733; Stratmann H, 2010, CELL SIGNAL, V22, P1124, DOI 10.1016/j.cellsig.2010.03.007; Tam SY, 2004, NAT IMMUNOL, V5, P844, DOI 10.1038/ni1093; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wang L, 2011, MOL BIOL CELL, V22, P3853, DOI 10.1091/mbc.E11-03-0277; XIONG LM, 1992, P NATL ACAD SCI USA, V89, P5356, DOI 10.1073/pnas.89.12.5356; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	55	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142935	10.1371/journal.pone.0142935	http://dx.doi.org/10.1371/journal.pone.0142935			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588713	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500025
J	Ye, P; Zhang, MZ; Fan, SQ; Zhang, TW; Fu, HH; Su, XY; Gavine, PR; Liu, Q; Yin, XL				Ye, Peng; Zhang, Meizhuo; Fan, Shuqiong; Zhang, Tianwei; Fu, Haihua; Su, Xinying; Gavine, Paul R.; Liu, Qiang; Yin, Xiaolu			Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis	PLOS ONE			English	Article							KINASE-ACTIVITY; MET; INHIBITOR; AMPLIFICATION; SENSITIVITY; EXPRESSION; THERAPY; GROWTH; CELLS	Current drug development efforts on gastric cancer are directed against several molecular targets driving the growth of this neoplasm. Intra-tumoral biomarker heterogeneity however, commonly observed in gastric cancer, could lead to biased selection of patients. MET, ATM, FGFR2, and HER2 were profiled on gastric cancer biopsy samples. An innovative pathological assessment was performed through scoring of individual biopsies against whole biopsies from a single patient to enable heterogeneity evaluation. Following this, false negative risks for each biomarker were estimated in silico. 166 gastric cancer cases with multiple biopsies from single patients were collected from Shanghai Renji Hospital. Following pre-set criteria, 56 similar to 78% cases showed low, 15 similar to 35% showed medium and 0 similar to 11% showed high heterogeneity within the biomarkers profiled. If 3 biopsies were collected from a single patient, the false negative risk for detection of the biomarkers was close to 5% (exception for FGFR2: 12.2%). When 6 biopsies were collected, the false negative risk approached 0%. Our study demonstrates the benefit of multiple biopsy sampling when considering personalized healthcare biomarker strategy, and provides an example to address the challenge of intra-tumoral biomarker heterogeneity using alternative pathological assessment and statistical methods.	[Ye, Peng; Fan, Shuqiong; Zhang, Tianwei; Fu, Haihua; Su, Xinying; Gavine, Paul R.; Yin, Xiaolu] AstraZeneca R&D, Asia & Emerging Markets iMed, Shanghai, Peoples R China; [Zhang, Meizhuo] AstraZeneca R&D, Res & Dev Informat, Shanghai, Peoples R China; [Liu, Qiang] Shanghai Jiao Tong Univ, Dept Pathol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China	AstraZeneca; AstraZeneca; Shanghai Jiao Tong University	Liu, Q (corresponding author), Shanghai Jiao Tong Univ, Dept Pathol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China.	liuq1963@sohu.com; lucy.yin@astrazeneca.com	Liu, Qiang/HHZ-3181-2022		AstraZeneca	AstraZeneca(AstraZeneca)	Funding: AstraZeneca has sponsored this study. The funder provided support in the form of salaries for authors [PY, MZ, SF, TZ, HF, XS, PG and XY] and provided facility and resources for completing this study. The specific roles of these authors are articulated in the "author contributions" section.	Bang YJ, 2010, LANCET, V376, P1302; Cunningham D, 2013, J CLIN ON S IN PRESS, V31; DEARETXABALA X, 1989, CANCER, V63, P791, DOI 10.1002/1097-0142(19890215)63:4<791::AID-CNCR2820630431>3.0.CO;2-W; Feng Y, 2011, CANCER DISCOV, V1, P550, DOI 10.1158/2159-8290.CD-11-0289; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gavine PR, 2015, MOL ONCOL, V9, P323, DOI 10.1016/j.molonc.2014.08.015; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gilardini Montani MS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-95; Guo XN, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B42; Inskip HM, 1999, BRIT J CANCER, V79, P1304, DOI 10.1038/sj.bjc.6690209; Kim HS, 2013, PATHOBIOLOGY, V80, P127, DOI 10.1159/000346034; Kubota E, 2014, CELL CYCLE, V13, P2129, DOI 10.4161/cc.29212; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee J, 2013, DISCOV MED, V16, P7; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Min A, 2013, MOL CANCER THER, V12, P865, DOI 10.1158/1535-7163.MCT-12-0950; NALDINI L, 1991, ONCOGENE, V6, P501; Pourhoseingholi Mohamad Amin, 2015, Gastroenterol Hepatol Bed Bench, V8, P19; Power DG, 2010, CANCER TREAT REV, V36, P384, DOI 10.1016/j.ctrv.2010.01.005; Reimers MS, 2013, GASTROENTEROL REP, V1, P166, DOI 10.1093/gastro/got022; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Su X, 2014, BRIT J CANCER, V110, P967, DOI 10.1038/bjc.2013.802; Tai WY, 2010, J CONTROL RELEASE, V146, P264, DOI 10.1016/j.jconrel.2010.04.009; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Yang JY, 2012, CELL BIOCHEM BIOPHYS, V62, P221, DOI 10.1007/s12013-011-9286-1; Ye QQ, 2014, PATHOL ONCOL RES, V20, P931, DOI 10.1007/s12253-014-9776-8; YONEMURA Y, 1992, ANAL CELL PATHOL, V4, P61	29	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143207	10.1371/journal.pone.0143207	http://dx.doi.org/10.1371/journal.pone.0143207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587992	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500037
J	Box-Steffensmeier, JM; Cunha, RC; Varbanov, RA; Hoh, YS; Knisley, ML; Holmes, MA				Box-Steffensmeier, Janet M.; Cunha, Raphael C.; Varbanov, Roumen A.; Hoh, Yee Shwen; Knisley, Margaret L.; Holmes, Mary Alice			Survival Analysis of Faculty Retention and Promotion in the Social Sciences by Gender	PLOS ONE			English	Article							RESEARCH PRODUCTIVITY; ACADEMIC CAREERS; SEX-DIFFERENCES; WOMEN; SCIENTISTS; UNIVERSITY	Background Recruitment and retention of talent is central to the research performance of universities. Existing research shows that, while men are more likely than women to be promoted at the different stages of the academic career, no such difference is found when it comes to faculty retention rates. Current research on faculty retention, however, focuses on careers in science, technology, engineering, and mathematics (STEM). We extend this line of inquiry to the social sciences. Methods We follow 2,218 tenure-track assistant professors hired since 1990 in seven social science disciplines at nineteen U.S. universities from time of hire to time of departure. We also track their time to promotion to associate and full professor. Using survival analysis, we examine gender differences in time to departure and time to promotion. Our methods account for censoring and unobserved heterogeneity, as well as effect heterogeneity across disciplines and cohorts. Results We find no statistically significant differences between genders in faculty retention. However, we do find that men are more likely to be granted tenure than women. When it comes to promotion to full professor, the results are less conclusive, as the effect of gender is sensitive to model specification. Conclusions The results corroborate previous findings about gender patterns in faculty retention and promotion. They suggest that advances have been made when it comes to gender equality in retention and promotion, but important differences still persist.	[Box-Steffensmeier, Janet M.; Cunha, Raphael C.; Hoh, Yee Shwen; Holmes, Mary Alice] Ohio State Univ, Dept Polit Sci, Columbus, OH 43210 USA; [Varbanov, Roumen A.] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Knisley, Margaret L.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	University System of Ohio; Ohio State University; State University System of Florida; Florida State University; Case Western Reserve University	Box-Steffensmeier, JM (corresponding author), Ohio State Univ, Dept Polit Sci, Columbus, OH 43210 USA.	steffensmeier.2@osu.edu	Box-Steffensmeier, Janet/AAF-7634-2019	Box-Steffensmeier, Janet/0000-0002-0878-6269; Coutinho da Cunha, Raphael/0000-0002-2415-3867				Adamo SA, 2013, BIOSCIENCE, V63, P43, DOI 10.1525/bio.2013.63.1.9; ALLISON PD, 1974, AM SOCIOL REV, V39, P596, DOI 10.2307/2094424; Box-Steffensmeier JanetM., 2004, EVENT HIST MODELING; BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.2307/2334776; CLEMENTE F, 1973, AM J SOCIOL, V79, P409, DOI 10.1086/225553; Collins L.H., 1998, CAREER STRATEGIES WO, P45; Duch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051332; FOX MF, 1983, SOC STUD SCI, V13, P285, DOI 10.1177/030631283013002005; GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.2307/2333825; GMELCH WH, 1986, RES HIGH EDUC, V24, P266, DOI 10.1007/BF00992075; Gordon SE, 2014, J GEN PHYSIOL, V144, P1, DOI 10.1085/jgp.201411240; Groeneveld S, 2012, EQUAL DIVERS INCL, V31, P646, DOI 10.1108/02610151211263487; Hancock KJ, 2013, INT STUD PERSPECT, V14, P507, DOI 10.1111/insp.12002; Hesli VL, 2011, PS-POLIT SCI POLIT, V44, P393, DOI 10.1017/S1049096511000242; HOUGAARD P, 1991, J APPL PROBAB, V28, P695, DOI 10.2307/3214503; Hougaard P, 1995, Lifetime Data Anal, V1, P255; Jaschik S., 2014, INSIDE HIGHER ED; June A. W., 2012, CHRONICLE HIGHER ED; Junn J, 2012, ANAL DATA TENURE USC; Kaminski D, 2012, SCIENCE, V335, P864, DOI 10.1126/science.1214844; Kirwan Institute for the Study of Race and Ethnicity Ohio State University, 2013, STAT SCI IMPL BIAS R; Klein JP, 2005, SURVIVAL ANAL TECHNI; Laube H., 2007, NATL WOMENS STUDIES, V19, P87; LONG JS, 1993, AM SOCIOL REV, V58, P703, DOI 10.2307/2096282; Maliniak D, 2013, INT ORGAN, V67, P889, DOI 10.1017/S0020818313000209; Miller J, 2000, TEACH SOCIOL, V28, P283, DOI 10.2307/1318580; Morrison E, 2011, REV HIGH EDUC, V34, P525, DOI 10.1353/rhe.2011.0017; National Academy of Sciences (US) National Academy of Engineering (US) and Institute of Medicine (US) Committee on Maximizing the Potential of Women in Academic Science and Engineering, 2007, BIAS BARR FULF POT W; National Science Foundation, 2015, ADVANCE INCR PART AD; Philipsen M.I., 2010, HELPING FACULTY FIND; Preston AE., 2004, LEAVING SCI; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Sabatier M, 2010, APPL ECON, V42, P2053, DOI 10.1080/00036840701765338; Sanz-Menendez L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077028; Sinclair L, 2000, PERS SOC PSYCHOL B, V26, P1329, DOI 10.1177/0146167200263002; Smith-Doerr Laurel, 2004, WOMENS WORK GENDER E; Suitor J.J., 2001, GEND ISSUES, V19, P50, DOI [https://doi.org/10.1007/s12147-001-1007-4, DOI 10.1007/S12147-001-1007-4, 10.1007/s12147-001-1007-4]; Texas A&M University, 2015, STRIDE PROGR; Therneau T.M., 2000, MODELING SURVIVAL DA; University of California Davis, 2015, ADVANCE PROGR; University of Michigan, 2015, ADVANCE PROGR; Valian V., 1999, WHY SO SLOW ADV WOME, V1 1st; Washington State University, 2015, ADV WSU; Weisshaar K, 2014, ANN M AM SOC ASS; Welch S., 2014, CHRONICLE HIGHER ED; Wickware P, 1997, NATURE, V390, P202, DOI 10.1038/36639; Wolfinger NH, 2008, J HIGH EDUC-UK, V79, P388, DOI 10.1353/jhe.0.0015; Xie Y, 1998, AM SOCIOL REV, V63, P847, DOI 10.2307/2657505	48	34	34	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143093	10.1371/journal.pone.0143093	http://dx.doi.org/10.1371/journal.pone.0143093			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26580565	Green Submitted, gold, Green Published			2022-12-27	WOS:000365154600081
J	Turner, CB; Blount, ZD; Lenski, RE				Turner, Caroline B.; Blount, Zachary D.; Lenski, Richard E.			Replaying Evolution to Test the Cause of Extinction of One Ecotype in an Experimentally Evolved Population	PLOS ONE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; KEY INNOVATION; RISK; COMPETITION; ADAPTATION; PREDATION; GROWTH	In a long-term evolution experiment with Escherichia coli, bacteria in one of twelve populations evolved the ability to consume citrate, a previously unexploited resource in a glucose-limited medium. This innovation led to the frequency-dependent coexistence of citrate-consuming (Cit(+)) and non-consuming (Cit(-)) ecotypes, with Cit(-) bacteria persisting on the exogenously supplied glucose as well as other carbon molecules released by the Cit+ bacteria. After more than 10,000 generations of coexistence, however, the Cit(-) lineage went extinct; cells with the Cit(-) phenotype dropped to levels below detection, and the Cit(-) clade could not be detected by molecular assays based on its unique genotype. We hypothesized that this extinction was a deterministic outcome of evolutionary change within the population, specifically the appearance of a more-fit Cit(+) ecotype that competitively excluded the Cit(-) ecotype. We tested this hypothesis by re-evolving the population from a frozen population sample taken within 500 generations of the extinction and from another sample taken several thousand generations earlier, in each case for 500 generations and with 20-fold replication. To our surprise, the Cit(-) type did not go extinct in any of these replays, and Cit(-) cells also persisted in a single replicate that was propagated for 2,500 generations. Even more unexpectedly, we showed that the Cit(-) ecotype could reinvade the Cit(+) population after its extinction. Taken together, these results indicate that the extinction of the Cit(-) ecotype was not a deterministic outcome driven by competitive exclusion by the Cit(+) ecotype. The extinction also cannot be explained by demographic stochasticity alone, as the population size of the Cit(-) ecotype should have been many thousands of cells even during the daily transfer events. Instead, we infer that the extinction must have been caused by a rare chance event in which some aspect of the experimental conditions was inadvertently perturbed.	[Turner, Caroline B.; Lenski, Richard E.] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA; [Turner, Caroline B.; Lenski, Richard E.] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Turner, Caroline B.; Blount, Zachary D.; Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Blount, Zachary D.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Lenski, RE (corresponding author), Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA.	lenski@msu.edu	Blount, Zachary/L-3130-2019	Lenski, Richard/0000-0002-1064-8375; Blount, Zachary/0000-0001-5153-0034; Turner, Caroline B./0000-0003-1347-518X	Environmental Protection Agency Science to Achieve Results Fellowship [FP-917112-01-0]; Michigan State University Distinguished Graduate Student Fellowship; National Science Foundation [DEB-1019989]; John Templeton Foundation; Biocomputational Evolution in Action Consortium (BEACON) Center for the Study of Evolution in Action (National Science Foundation Cooperative Agreement) [DBI-0939454]; Division Of Environmental Biology [1451740] Funding Source: National Science Foundation	Environmental Protection Agency Science to Achieve Results Fellowship; Michigan State University Distinguished Graduate Student Fellowship; National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Biocomputational Evolution in Action Consortium (BEACON) Center for the Study of Evolution in Action (National Science Foundation Cooperative Agreement); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by an Environmental Protection Agency Science to Achieve Results Fellowship (http://www.epa.gov/, FP-917112-01-0) and a Michigan State University Distinguished Graduate Student Fellowship (www.msu.edu) to C.B. T., a National Science Foundation grant (http://www.nsf.gov/, DEB-1019989) to R.E.L., a grant from the John Templeton Foundation (https://www.templeton.org/) to R.E.L. and Z.D.B., and the Biocomputational Evolution in Action Consortium (BEACON) Center for the Study of Evolution in Action (National Science Foundation Cooperative Agreement DBI-0939454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; BENGTSSON J, 1995, OECOLOGIA, V101, P397, DOI 10.1007/BF00329418; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; HELLING RB, 1987, GENETICS, V116, P349; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Koser SA, 1924, J BACTERIOL, V9, P59, DOI 10.1128/JB.9.1.59-77.1924; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Maddamsetti R, 2015, GENETICS, V200, P619, DOI 10.1534/genetics.115.176677; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; Pos KM, 1998, J BACTERIOL, V180, P4160, DOI 10.1128/JB.180.16.4160-4165.1998; Reddy C., 2007, METHODS GEN MOL MICR; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schoener TW, 2001, NATURE, V412, P183, DOI 10.1038/35084071; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; Turner CB, 2015, BIORXIV, DOI [10.1101/020958, DOI 10.1101/020958]; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Wootton JT, 2013, ECOLOGY, V94, P2117, DOI 10.1890/12-1828.1; Yedid G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037233; Yedid G, 2009, AM NAT, V173, pE139, DOI 10.1086/597228	28	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142050	10.1371/journal.pone.0142050	http://dx.doi.org/10.1371/journal.pone.0142050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581098	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600033
J	Wawruszak, A; Luszczki, JJ; Grabarska, A; Gumbarewicz, E; Dmoszynska-Graniczka, M; Polberg, K; Stepulak, A				Wawruszak, Anna; Luszczki, Jarogniew J.; Grabarska, Aneta; Gumbarewicz, Ewelina; Dmoszynska-Graniczka, Magdalena; Polberg, Krzysztof; Stepulak, Andrzej			Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; PHASE-II TRIAL; VALPROIC ACID; GENE-EXPRESSION; LUNG-CANCER; INDUCED APOPTOSIS; ANTICANCER DRUGS; ORAL VORINOSTAT; CYCLE ARREST; TUMOR-GROWTH	Histone deacetylase inhibitors (HDIs) are promising anticancer drugs, which inhibit proliferation of a wide variety of cancer cells including breast carcinoma cells. In the present study, we investigated the influence of valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA, vorinostat), alone or in combination with cisplatin (CDDP) on proliferation, induction of apoptosis and cell cycle progression in MCF7, T47D and MDA-MB-231 human breast carcinoma cell lines. The type of interaction between HDIs and CDDP was determined by an isobolographic analysis. The isobolographic analysis is a very precise and rigorous pharmacodynamic method, to determine the presence of synergism, addition or antagonism between different drugs with using variety of fixed dose ratios. Our experiments show that the combinations of CDDP with SAHA or VPA at a fixed-ratio of 1: 1 exerted additive interaction in the viability of MCF7 cells, while in T47D cells there was a tendency to synergy. In contrast, sub-additive (antagonistic) interaction was observed for the combination of CDDP with VPA in MDA-MB-231 "triple-negative" (i.e. estrogen receptor negative, progesterone receptor negative, and HER-2 negative) human breast cancer cells, whereas combination of CDDP with SAHA in the same MDA-MB-231 cell line yielded additive interaction. Additionally, combined HDIs/CDDP treatment resulted in increase in apoptosis and cell cycle arrest in all tested breast cancer cell lines in comparison with a single therapy. In conclusion, the additive interaction of CDDP with SAHA or VPA suggests that HDIs could be combined with CDDP in order to optimize treatment regimen in some human breast cancers.	[Wawruszak, Anna; Grabarska, Aneta; Gumbarewicz, Ewelina; Dmoszynska-Graniczka, Magdalena; Stepulak, Andrzej] Med Univ Lublin, Dept Biochem & Mol Biol, Lublin, Poland; [Luszczki, Jarogniew J.] Med Univ Lublin, Dept Pathophysiol, Lublin, Poland; [Luszczki, Jarogniew J.] Inst Rural Hlth, Isobolog Anal Lab, Lublin, Poland; [Polberg, Krzysztof; Stepulak, Andrzej] MSW Hosp, Dept Otolaryngol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Institute of Rural Health in Lublin, Poland	Wawruszak, A (corresponding author), Med Univ Lublin, Dept Biochem & Mol Biol, Lublin, Poland.	anna.wawruszak@umlub.pl	Luszczki, Jarogniew J./U-7035-2018; Luszczki, Jarogniew/AAB-1113-2020	Luszczki, Jarogniew J./0000-0002-3059-0393; Luszczki, Jarogniew/0000-0002-3059-0393; Dmoszynska-Graniczka, Magdalena/0000-0002-6248-0930; Grabarska, Aneta/0000-0002-3823-1467; Stepulak, Andrzej/0000-0002-1872-394X; Wawruszak, Anna/0000-0003-2388-4577	Medical University of Lublin [DS440/2014-2015]	Medical University of Lublin	The study was supported by Medical University of Lublin DS440/2014-2015 grant.	Andreopoulou E, 2015, EXPERT OPIN PHARMACO, V16, P983, DOI 10.1517/14656566.2015.1032246; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Biswas SK, 2004, MOL CANCER THER, V3, P327; Blaheta RA, 2007, BRIT J CANCER, V96, P1699, DOI 10.1038/sj.bjc.6603777; Blaheta RA, 2002, MED RES REV, V22, P492, DOI 10.1002/med.10017; Botrugno OA, 2009, CANCER LETT, V280, P134, DOI 10.1016/j.canlet.2009.02.027; Catalano MG, 2005, J CLIN ENDOCR METAB, V90, P1383, DOI 10.1210/jc.2004-1355; Chiao MT, 2013, AUTOPHAGY, V9, P1509, DOI 10.4161/auto.25664; Chien CW, 2011, TOXICOL APPL PHARM, V257, P59, DOI 10.1016/j.taap.2011.08.018; Dawood S, 2008, J CLIN ONCOL, V26, P4891, DOI 10.1200/JCO.2007.14.1168; Denis I, 2014, ONCOTARGET, V5, P11641, DOI 10.18632/oncotarget.2604; Dodurga Y, 2014, MOL BIOL REP, V41, P4595, DOI 10.1007/s11033-014-3330-3; Eastman A, 2009, MECH ACTION CISPLATI; Erlich RB, 2009, CANCER CHEMOTH PHARM, V63, P381, DOI 10.1007/s00280-008-0747-1; Feng D, 2013, PLOS ONE, V8; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Fortunati N, 2008, CANCER LETT, V259, P156, DOI 10.1016/j.canlet.2007.10.006; Galanis E, 2009, J CLIN ONCOL, V27, P2052, DOI 10.1200/JCO.2008.19.0694; Gan CP, 2012, HEAD NECK-J SCI SPEC, V34, P344, DOI 10.1002/hed.21734; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Grabovsky Y, 2004, J PHARMACOL EXP THER, V310, P981, DOI 10.1124/jpet.104.067264; GRECO WR, 1995, PHARMACOL REV, V47, P331; Heerboth S, 2014, GENET EPIGENETICS, V6, P9, DOI 10.4137/GEG.S12270; Hiriyan J, 2015, ANTICANCER RES, V35, P229; Hirsch CL, 2004, FEBS LETT, V570, P37, DOI 10.1016/j.febslet.2004.06.018; Isakoff SJ, 2015, J CLIN ONCOL, V33, P1902, DOI 10.1200/JCO.2014.57.6660; Jiang W, 2014, INT UROL NEPHROL, V46, P941, DOI 10.1007/s11255-013-0609-6; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kim MS, 2003, CANCER RES, V63, P7291; Knutson A, 2010, ONCOL REP, V112, P3044; Kramer OH, 2014, TRENDS PHARMACOL SCI, V35, P501, DOI 10.1016/j.tips.2014.08.001; Lakshmaiah KC, 2014, J CANCER RES THER, V10, P469, DOI 10.4103/0973-1482.137937; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lee YJ, 2012, INT J MED SCI, V9, P881, DOI 10.7150/ijms.5011; Li GF, 2012, GENET MOL RES, V11, P77, DOI 10.4238/2012.January.13.1; Lin CT, 2008, CANCER SCI, V99, P1218, DOI 10.1111/j.1349-7006.2008.00793.x; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; Luszczki JJ, 2007, N-S ARCH PHARMACOL, V375, P105, DOI 10.1007/s00210-007-0144-z; Luszczki JJ, 2006, N-S ARCH PHARMACOL, V374, P51, DOI 10.1007/s00210-006-0100-3; Luszczki JJ, 2004, N-S ARCH PHARMACOL, V369, P434, DOI 10.1007/s00210-004-0867-z; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Nighat N, 2010, CANCER CHEMOTH PHARM, V66, P625, DOI [10.1007/s00280-010-1324-y, DOI 10.1007/S00280-010-1324-Y]; Pizarro AM, 2009, BIOCHIMIE, V91, P1198, DOI 10.1016/j.biochi.2009.03.017; Prater J, 2015, J CANC RES CLIN ONCO; Richardson P, 2008, LEUKEMIA LYMPHOMA, V49, P502, DOI 10.1080/10428190701817258; Shah RD, 2013, J CELL BIOCHEM, V114, P854, DOI 10.1002/jcb.24422; Shen J, 2007, BIOCHEM PHARMACOL, V73, P1901, DOI 10.1016/j.bcp.2007.03.009; Sidana A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/180363; Sun GC, 2015, J CANCER, V6, P996, DOI 10.7150/jca.12135; Sun PC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-76; Suzuki M, 2009, CANCER CHEMOTH PHARM, V64, P1115, DOI 10.1007/s00280-009-0969-x; Tallarida RJ., 2000, DRUG SYNERGISM DOSE; Tallarida RJ, 2007, PHARMACOL THERAPEUT, V113, P197, DOI 10.1016/j.pharmthera.2006.08.002; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Travaglini L, 2009, INT J BIOCHEM CELL B, V41, P225, DOI 10.1016/j.biocel.2008.08.019; Tzao C, 2014, DIS ESOPHAGUS, V27, P693, DOI 10.1111/dote.12127; Vafaiyan Z, 2015, IRAN J BASIC MED SCI, V18, P700; Vansteenkiste J, 2008, INVEST NEW DRUG, V26, P483, DOI 10.1007/s10637-008-9131-6; Viet C, 2014, PLOS ONE, V9; Vijayaraghavalu S, 2013, MOL PHARMACEUT, V10, P337, DOI 10.1021/mp3004622; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Xu Y, 2015, INT J CLIN EXP PATHO, V8, P8291; Yang H, 2015, BRIT J CANCER, V112, P112, DOI 10.1038/bjc.2014.547; Yang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079734; Zhang L, 2012, MOL CELL BIOCHEM, V361, P39, DOI 10.1007/s11010-011-1085-x; Zhou Y, 2014, ONCOL LETT, V7, P203, DOI 10.3892/ol.2013.1666	67	46	47	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143013	10.1371/journal.pone.0143013	http://dx.doi.org/10.1371/journal.pone.0143013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580554	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600072
J	Xu, SY; Wang, DY; Zhou, DS; Lin, Y; Che, LQ; Fang, ZF; Wu, D				Xu, Shengyu; Wang, Dingyue; Zhou, Dongsheng; Lin, Yan; Che, Lianqiang; Fang, Zhengfeng; Wu, De			Reproductive Hormone and Transcriptomic Responses of Pituitary Tissue in Anestrus Gilts Induced by Nutrient Restriction	PLOS ONE			English	Article							GROWTH; GENE; OVULATION; ACTIVATION; RECEPTOR; GPR54	The onset of estrus is a critical sign of female sexual maturity. The pituitary plays a vital role in this process by the secretion of reproductive hormones. To investigate the effects of nutrient restriction on reproductive function and the underlying mechanisms involved, deep RNA sequencing of pituitary gland tissue was carried out to determine the differentially expressed genes (DEGs) between gilts in normal estrus, and gilts in which anestrus was induced by nutrient restriction. Gilts which had gone through two estrus cycles were fed a normal (CON, 2.86kg/d, n = 10) or nutrient restricted (NR, 1kg/d, n = 10) diet. The NR gilts experienced another three estrus cycles, but did not express estrus symptoms at the anticipated 6th and 7th cycles. Body weight gain in NR gilts was significantly decreased by nutrient restriction. Gilts were considered as anestrus when blood progesterone concentrations lower than 1.0 ng/mL from three consecutive blood samples were recorded. Circulating concentrations of progesterone (< 1.0 ng/mL vs. 2.1 ng/mL) and estradiol (208.6 ng/mL vs. 371.8 ng/mL) were significantly lower in the NR gilts than in the CON gilts. Between 5,360,000 and 5,370,000 sequence reads per sample from the CON and NR gilts' pituitaries were obtained and mapped to the porcine genome. Analysis of read counts revealed 185 DEGs. Expression of selected genes was validated by the use of quantitative real-time RTPCR. Bioinformatic analysis identified that the genes identified were enriched in the GO terms "neuroactive ligand-receptor interaction", "GnRH signaling pathway" and "immune response system". Our findings provide a new perspective for understanding the nutrient restriction-induced reproductive impairment at the pituitary transcriptional level, and how this is linked to hormone secretion. Moreover, the transcriptomic changes in anestrus gilts associated with nutrient restriction could be a resource for targeted studies of genes and pathways potentially involved in the regulation of reproductive function and animal health.	[Wu, De] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Minist Educ, Yaan 625014, Peoples R China; Sichuan Agr Univ, Inst Anim Nutr, Yaan 625014, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Wu, D (corresponding author), Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Minist Educ, Yaan 625014, Peoples R China.	pig2pig@sina.com.cn			National Natural Science Foundation of P.R. China [30871804]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; Program form Feed Industry and Technology Research Institute of Sichuan Province [2013NZ0054]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program form Feed Industry and Technology Research Institute of Sichuan Province	This work was supported by National Natural Science Foundation (30871804) of P.R. China, Program for Changjiang Scholars and Innovative Research Team in University (IRT13083) and Program form Feed Industry and Technology Research Institute of Sichuan Province (2013NZ0054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JD, 1987, J ANIM SCI, V65, P508, DOI 10.2527/jas1987.652508x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BERGENDAHL M, 1991, BIOL REPROD, V44, P413, DOI 10.1095/biolreprod44.3.413; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; BOOTH PJ, 1994, J ANIM SCI, V72, P2415, DOI 10.2527/1994.7292415x; BOYAR RM, 1978, ANNU REV MED, V29, P509; Breen SM, 2012, ANIM REPROD SCI, V132, P193, DOI 10.1016/j.anireprosci.2012.05.013; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Castellano JM, 2009, PEPTIDES, V30, P139, DOI 10.1016/j.peptides.2008.06.007; Colledge WH, 2004, TRENDS ENDOCRIN MET, V15, P448, DOI 10.1016/j.tem.2004.09.008; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; de la Iglesia HO, 2006, ENDOCRINOLOGY, V147, P1148, DOI 10.1210/en.2005-1311; DYCK GW, 1979, CAN J ANIM SCI, V59, P649, DOI 10.4141/cjas79-084; Fasler-Kan E, 2013, XENOTRANSPLANTATION, V20, P469, DOI 10.1111/xen.12070; Ge XJ, 2007, J RES ADOLESCENCE, V17, P767, DOI 10.1111/j.1532-7795.2007.00546.x; Hillier SG, 2001, MOL CELL ENDOCRINOL, V179, P39, DOI 10.1016/S0303-7207(01)00469-5; HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51, DOI 10.1016/0303-7207(94)90278-X; Hirose M, 2013, ANIM SCI J, V84, P693, DOI 10.1111/asj.12061; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loisel F, 2015, DOMEST ANIM ENDOCRIN, V53, P35, DOI 10.1016/j.domaniend.2015.04.005; Macklon NS, 2001, ARCH MED RES, V32, P595, DOI 10.1016/S0188-4409(01)00327-7; Mastorakos G, 2010, ANN NY ACAD SCI, V900, P65; Mekchay S, 2003, GENET SEL EVOL, V35, pS83, DOI 10.1051/gse:2003018; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; National Research Council, 1998, NUTR REQ SWIN, Vtenth; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; POMERANTZ SH, 1987, GAMETE RES, V17, P267, DOI 10.1002/mrd.1120170310; ROZEBOOM DW, 1993, J ANIM SCI, V71, P426, DOI 10.2527/1993.712426x; Smit LS, 1996, MOL ENDOCRINOL, V10, P519, DOI 10.1210/me.10.5.519; Stouffer RL, 2007, FRONT BIOSCI, V12, P297, DOI 10.2741/2065; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tena-Sempere M, 2006, HUM REPROD UPDATE, V12, P631, DOI 10.1093/humupd/dml023; Viswanathan G, 2014, J CLIN ENDOCR METAB, V99, pE1050, DOI 10.1210/jc.2013-3062; Zhou DS, 2014, MOL BIOL REP, V41, P4733, DOI 10.1007/s11033-014-3344-x	37	7	8	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143219	10.1371/journal.pone.0143219	http://dx.doi.org/10.1371/journal.pone.0143219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580562	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600099
J	de Andrade, JNBM; Tang, JN; Hensley, MT; Vandergriff, A; Cores, J; Henry, E; Allen, TA; Caranasos, TG; Wang, ZG; Zhang, TX; Zhang, JY; Cheng, K				de Andrade, James N. B. M.; Tang, Junnan; Hensley, Michael Taylor; Vandergriff, Adam; Cores, Jhon; Henry, Eric; Allen, Tyler A.; Caranasos, Thomas George; Wang, Zegen; Zhang, Tianxia; Zhang, Jinying; Cheng, Ke			Rapid and Efficient Production of Coronary Artery Ligation and Myocardial Infarction in Mice Using Surgical Clips	PLOS ONE			English	Article							ATHEROSCLEROSIS; INDUCTION; MODEL	Aims The coronary artery ligation model in rodents mimics human myocardial infarction (MI). Normally mechanical ventilation and prolonged anesthesia period are needed. Recently, a method has been developed to create MI by popping-out the heart (without ventilation) followed by immediate suture ligation. Mortality is high due to the time-consuming suture ligation process while the heart is exposed. We sought to improve this method and reduce mortality by rapid coronary ligation using a surgical clip instead of a suture. Methods and Results Mice were randomized into 3 groups: clip MI (CMI), suture MI (SMI), or sham (SHAM). In all groups, heart was manually exposed without intubation through a small incision on the chest wall. Unlike the conventional SMI method, mice in the CMI group received a metal clip on left anterior descending artery (LAD), quickly dispensed by an AutoSuture Surgiclip T. The CMI method took only 1/3 of ligation time of the standard SMI method and improved post-MI survival rate. TTC staining and Masson's trichrome staining revealed a similar degree of infarct size in the SMI and CMI groups. Echocardiograph confirmed that both SMI and CMI groups had a similar reduction of ejection fraction and fraction shortening over the time. Histological analysis showed that the numbers of CD68(+) macrophages and apoptotic cells (TUNEL-positive) are indistinguishable between the two groups. Conclusion This new method, taking only less than 3 minutes to complete, represents an efficient myocardial infarction model in rodents.	[de Andrade, James N. B. M.; Tang, Junnan; Hensley, Michael Taylor; Vandergriff, Adam; Cores, Jhon; Henry, Eric; Allen, Tyler A.; Zhang, Tianxia; Cheng, Ke] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA; [de Andrade, James N. B. M.; Tang, Junnan; Hensley, Michael Taylor; Vandergriff, Adam; Cores, Jhon; Henry, Eric; Allen, Tyler A.; Zhang, Tianxia; Cheng, Ke] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC USA; [Vandergriff, Adam; Cores, Jhon; Henry, Eric; Cheng, Ke] Univ North Carolina Chapel Hill & North Carolina, Joint Dept Biomed Engn, Raleigh, NC USA; [Tang, Junnan; Zhang, Jinying] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China; [Caranasos, Thomas George] Univ N Carolina, Div Cardiothorac Surg, Chapel Hill, NC USA; [Wang, Zegen; Cheng, Ke] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Peoples R China	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Zhengzhou University; University of North Carolina; University of North Carolina Chapel Hill; Soochow University - China	Zhang, JY (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China.	jyzhang@zzu.edu.cn; ke_cheng@ncsu.edu	Caranasos, Thomas/AAK-4580-2021; Cheng, Ke/HCH-8846-2022	Caranasos, Thomas/0000-0002-4347-0219; Vandergriff, Adam/0000-0001-7614-4834; Allen, Tyler/0000-0002-8729-6339	American Heart Association [12BGIA12040477]; National Institute of Health; NC State University Chancellor's Faculty Excellence Program; National Natural Science Foundation of China [H020381370216, 81570274]; Science and Technology Innovation Team Support Project of Henan Province [14IRTSTHN018]; Innovation Team of Science and Technology Project of Henan Province; China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123920] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NC State University Chancellor's Faculty Excellence Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Team Support Project of Henan Province; Innovation Team of Science and Technology Project of Henan Province; China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from American Heart Association 12BGIA12040477, National Institute of Health, NC State University Chancellor's Faculty Excellence Program, and National Natural Science Foundation of China H020381370216, Science and Technology Innovation Team Support Project of Henan Province 14IRTSTHN018, Innovation Team of Science and Technology Project of Henan Province and National Natural Science Foundation of China 81570274. Junnan Tang is supported by China Scholarship Council.	Ahmad F, 2014, J AM COLL CARDIOL, V64, P696, DOI 10.1016/j.jacc.2014.04.068; Ahn D, 2004, AM J PHYSIOL-HEART C, V286, pH1201, DOI 10.1152/ajpheart.00862.2003; Borst O, 2011, CELL PHYSIOL BIOCHEM, V28, P1, DOI 10.1159/000331708; Cheng K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001260; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Curaj A, 2015, JOVE-J VIS EXP, DOI 10.3791/52197; Degabriele NM, 2004, EXP PHYSIOL, V89, P497, DOI 10.1113/expphysiol.2004.027276; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Li JF, 2015, CIRC RES, V116, P70, DOI 10.1161/CIRCRESAHA.116.304472; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Muthuramu I, 2014, JOVE-J VIS EXP, DOI 10.3791/52206; Patten RD, 1998, AM J PHYSIOL, V274, P1812; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Vandergriff AC, 2014, BIOMATERIALS, V35, P8528, DOI 10.1016/j.biomaterials.2014.06.031; Virag JAI, 2011, JOVE-J VIS EXP, DOI 10.3791/2581; Wu YW, 2011, JOVE-J VIS EXP, DOI 10.3791/2464; Xu ZB, 2014, JOVE-J VIS EXP, DOI 10.3791/51329	19	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143221	10.1371/journal.pone.0143221	http://dx.doi.org/10.1371/journal.pone.0143221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599500	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600039
J	Kjellberg, MA; Lonnfors, M; Slotte, JP; Mattjus, P				Kjellberg, Matti A.; Lonnfors, Max; Slotte, J. Peter; Mattjus, Peter			Metabolic Conversion of Ceramides in HeLa Cells - A Cholesteryl Phosphocholine Delivery Approach	PLOS ONE			English	Article							AKT KINASE; SPHINGOMYELIN; APOPTOSIS; MEMBRANE; CHANNELS; ACID; SYNTHASE; DIHYDROCERAMIDE; SPHINGOSINE; DEGRADATION	Ceramides can be delivered to cultured cells without solvents in the form of complexes with cholesteryl phosphocholine. We have analysed the delivery of three different radiolabeled D-erythro-ceramides (C6-Cer, C10-Cer and C16-Cer) to HeLa cells, and followed their metabolism as well as the cell viability. We found that all three ceramides were successfully taken up by HeLa cells when complexed to CholPC in an equimolar ratio, and show that the ceramides show different rates of cellular uptake and metabolic fate. The C6-Cer had the highest incorporation rate, followed by C10-Cer and C16-Cer, respectively. The subsequent effect on cell viability strongly correlated with the rate of incorporation, where C6-Cer had the strongest apoptotic effects. Low-dose (1 mu M) treatment with C6-Cer favoured conversion of the precursor to sphingomyelin, whereas higher concentrations (25-100 mu M) yielded increased conversion to C6-glucosylceramide. Similar results were obtained for C10-Cer. In the lower-dose C16-Cer experiments, most of the precursor was degraded, whereas at high-dose concentrations the precursor remained un-metabolized. Using this method, we demonstrate that ceramides with different chain lengths clearly exhibit varying rates of cellular uptake. The cellular fate of the externally delivered ceramides are clearly connected to their rate of incorporation and their subsequent effects on cell viability may be in part determined by their chain length.	[Kjellberg, Matti A.; Lonnfors, Max; Slotte, J. Peter; Mattjus, Peter] Abo Akad Univ, Fac Sci & Engn, Biochem, Turku, Finland	Abo Akademi University	Mattjus, P (corresponding author), Abo Akad Univ, Fac Sci & Engn, Biochem, Turku, Finland.	pmattjus@abo.fi	Mattjus, Peter/ABE-3596-2021; Mattjus, Peter/AAQ-7531-2021	Mattjus, Peter/0000-0001-8991-5933; 	Academy of Finland; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation	This work was funded by Academy of Finland, the Sigrid Juselius Foundation and Magnus Ehrnrooth Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2002, TRENDS IMMUNOL, V23, P1, DOI 10.1016/S1471-4906(01)02091-9; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bleicher RJ, 2002, BBA-MOL CELL BIOL L, V1585, P172, DOI 10.1016/S1388-1981(02)00338-4; Chapman JV, 2010, BIOCHEM PHARMACOL, V80, P308, DOI 10.1016/j.bcp.2010.04.001; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Ledesma MD, 2011, J NEUROCHEM, V116, P779, DOI 10.1111/j.1471-4159.2010.07034.x; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Ferreira NS, 2014, JIMD REP, V12, P71, DOI 10.1007/8904_2013_246; Gotoh M, 2006, CHEM BIODIVERS, V3, P198, DOI 10.1002/cbdv.200690023; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062; Grullich C, 2000, J BIOL CHEM, V275, P8650, DOI 10.1074/jbc.275.12.8650; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Koivusalo M, 2004, BIOPHYS J, V86, P923, DOI 10.1016/S0006-3495(04)74168-5; Koivusalo M, 2007, MOL BIOL CELL, V18, P5113, DOI 10.1091/mbc.E07-04-0330; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Kolesnick RN, 2002, TRENDS BIOCHEM SCI, V24, P224; Leppimaki P, 1998, BIOCHEM J, V335, P285, DOI 10.1042/bj3350285; Lin CF, 2006, CURR MED CHEM, V13, P1609, DOI 10.2174/092986706777441986; Lonnfors M, 2013, LANGMUIR, V29, P2319, DOI 10.1021/la3051324; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao ZH, 2010, J BIOL CHEM, V285, P29078, DOI 10.1074/jbc.M110.105296; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Michel C, 1997, FEBS LETT, V416, P153, DOI 10.1016/S0014-5793(97)01187-3; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2008, J LIPID RES, V49, P2356, DOI 10.1194/jlr.M800158-JLR200; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Nybond S, 2005, BBA-BIOMEMBRANES, V1718, P61, DOI 10.1016/j.bbamem.2005.10.009; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Ohvo H, 1997, BBA-LIPID LIPID MET, V1349, P131, DOI 10.1016/S0005-2760(97)00126-4; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Perera MN, 2012, BBA-BIOMEMBRANES, V1818, P1291, DOI 10.1016/j.bbamem.2012.02.010; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; PORN MI, 1995, BIOCHEM J, V308, P269; PORN MI, 1990, BIOCHEM J, V271, P121, DOI 10.1042/bj2710121; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Shabbits JA, 2003, BBA-BIOMEMBRANES, V1612, P98, DOI 10.1016/S0005-2736(03)00108-1; SINGH I, 1983, J LIPID RES, V24, P662; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Smyth M J, 1997, Adv Pharmacol, V41, P133, DOI 10.1016/S1054-3589(08)61057-1; Smyth MJ, 1996, BIOCHEM J, V316, P25, DOI 10.1042/bj3160025; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Sukumaran P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061290; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Sun W, 2010, J BIOL CHEM, V285, P8995, DOI 10.1074/jbc.M109.069203; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Zhang Y, 2011, J LIPID RES, V52, P771, DOI 10.1194/jlr.M012880; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	66	10	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143385	10.1371/journal.pone.0143385	http://dx.doi.org/10.1371/journal.pone.0143385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599810	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600059
J	Arvidsson, S; Pilebro, B; Westermark, P; Lindqvist, P; Suhr, OB				Arvidsson, Sandra; Pilebro, Bjorn; Westermark, Per; Lindqvist, Per; Suhr, Ole B.			Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; MYOCARDIAL INVOLVEMENT; STANDARDS COMMITTEE; RECOMMENDATIONS; POLYNEUROPATHY; DIAGNOSIS; AGE; ECHOCARDIOGRAPHY; QUANTIFICATION; HYPERTROPHY	Purpose Transthyretin V30M (ATTR V30M) amyloidosis is a phenotypically diverse disease with symptoms ranging from predominant neuropathy to exclusive cardiac manifestations. The aims of this study were to determine the dispersion of the two types of fibrils found in Swedish ATTR V30M patients - Type A consisting of a mixture of truncated and full length ATTR fibrils and type B fibrils consisting of full length fibrils, and to estimate the severity of cardiac dysfunction in relation to fibril composition and sex. Material and Methods Echocardiographic data were analysed in 107 Swedish ATTR V30M patients with their fibril composition determined as either type A or type B. Measurements of left ventricular (LV) dimensions and evaluation of systolic and diastolic function including speckle tracking derived strain were performed. Patients were grouped according to fibril type and sex. Multivariate linear regression was utilised to determine factors of significant impact on LV thickness. Results There was no significant difference in proportions of the two types of fibrils between men and women. In patients with type A fibrils, women had significantly lower median septal (p = 0.007) and posterior wall thicknesses (p = 0.010), lower median LV mass indexed to height (p = 0.008), and higher septal strain (p = 0.037), as compared to males. These differences were not apparent in patients with type B fibrils. Multiple linear regression analysis revealed that fibril type, sex and age all had significant impact on LV septal thickness. Conclusion This study demonstrates a clear difference between sexes in the severity of amyloid heart disease in ATTR V30M amyloidosis patients. Even though type A fibrils were associated with more advanced amyloid heart disease compared to type B, women with type A fibrils generally developed less cardiac infiltration than men. The differences may explain the better outcome for liver transplanted late-onset female patients compared to males.	[Arvidsson, Sandra; Lindqvist, Per] Umea Univ, Dept Clin Physiol, Ctr Heart, Umea, Sweden; [Pilebro, Bjorn] Umea Univ, Dept Cardiol, Ctr Heart, Umea, Sweden; [Arvidsson, Sandra; Pilebro, Bjorn; Suhr, Ole B.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Westermark, Per] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Lindqvist, Per] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University; Umea University; Uppsala University; Umea University	Arvidsson, S (corresponding author), Umea Univ, Dept Clin Physiol, Ctr Heart, Umea, Sweden.	sandra.gustavsson@umu.se	LIndqvist, Per/AAK-1377-2021; Pilebro, Björn/AFS-1030-2022; Pilebro, Björn/AHE-8710-2022	Suhr, Ole/0000-0002-1175-2369	Swedish Heart-Lung Foundation; Umea University [VLL 365301]; Vasterbotten County Council/ALF [VLL 365301]; Heart Foundation of Northern Sweden; spearhead grant from Umea County	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Umea University; Vasterbotten County Council/ALF; Heart Foundation of Northern Sweden; spearhead grant from Umea County	This study was supported by grants from the Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se/) [PL, OBS], from a regional agreement between Umea University and Vasterbotten County Council/ALF [VLL 365301 for funding of SA], the Heart Foundation of Northern Sweden (http://www.hjartfonden.com/) [SA], and a spearhead grant from Umea County [OBS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 1976, Acta Med Scand Suppl, V590, P1; Ando Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-31; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Connors LH, 2009, AM HEART J, V158, P607, DOI 10.1016/j.ahj.2009.08.006; Deschepper CF, 2007, HYPERTENSION, V49, P401, DOI 10.1161/01.HYP.0000256279.49882.d8; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Foppa Murilo, 2005, Cardiovasc Ultrasound, V3, P17, DOI 10.1186/1476-7120-3-17; Gustafsson S, 2012, TRANSPLANTATION, V93, P1017, DOI 10.1097/TP.0b013e31824b3749; HOLMGREN G, 1994, J MED GENET, V31, P351, DOI 10.1136/jmg.31.5.351; Hornsten R, 2010, AMYLOID, V17, P63, DOI 10.3109/13506129.2010.483114; Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Ihse E, 2011, J MOL MED, V89, P171, DOI 10.1007/s00109-010-0695-1; Ikeda S, 2002, NEUROLOGY, V58, P1001, DOI 10.1212/WNL.58.7.1001; Koike H, 2012, AMYLOID, V19, P55, DOI 10.3109/13506129.2012.674580; Koike H, 2009, J NEUROL SCI, V287, P178, DOI 10.1016/j.jns.2009.07.028; Kyle RA, 1996, AM J MED, V101, P395, DOI 10.1016/S0002-9343(96)00229-X; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Ng B, 2005, ARCH INTERN MED, V165, P1425, DOI 10.1001/archinte.165.12.1425; Okamoto S, 2011, AMYLOID, V18, P200, DOI 10.3109/13506129.2011.615872; Okamoto S, 2009, LIVER TRANSPLANT, V15, P1229, DOI 10.1002/lt.21817; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rapezzi C, 2005, ARCH INTERN MED, V165, P2429, DOI 10.1001/archinte.165.20.2429; Rapezzi C, 2008, AMYLOID, V15, P40, DOI 10.1080/13506120701815373; Rapezzi C, 2013, EUR HEART J, V34, P520, DOI 10.1093/eurheartj/ehs123; Rapezzi C, 2011, JACC-CARDIOVASC IMAG, V4, P659, DOI 10.1016/j.jcmg.2011.03.016; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Suhr OB, 2006, AMYLOID, V13, P154, DOI 10.1080/13506120600876849; Svedenhag J, 2014, CLIN PHYSL FUNCT IMA; Tasaki M, 2013, INT J CARDIOL, V170, P69, DOI 10.1016/j.ijcard.2013.10.033; Taylor AL, 2015, CURR HEART FAIL REP; Westermark P, 2006, ACTA HISTOCHEM, V108, P209, DOI 10.1016/j.acthis.2006.03.011	34	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143456	10.1371/journal.pone.0143456	http://dx.doi.org/10.1371/journal.pone.0143456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600306	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900127
J	Hotegni, VNF; Lommen, WJM; Agbossou, EK; Struik, PC				Hotegni, V. Nicodeme Fassinou; Lommen, Willemien J. M.; Agbossou, Euloge K.; Struik, Paul C.			Trade-Offs of Flowering and Maturity Synchronisation for Pineapple Quality	PLOS ONE			English	Article							FRUIT-QUALITY; HETEROGENEITY; TEMPERATURE; GROWTH; YIELD	In the pineapple sector of Benin, poor fruit quality prevents pineapple producers to enter the European market. We investigated effects of common cultural practices, flowering and maturity synchronisation, (1) to quantify the trade-offs of flowering and maturity synchronisation for pineapple quality and the proportion of fruits exportable to European markets, and (2) to determine the effect of harvesting practice on quality attributes. Four on-farm experiments were conducted during three years using cultivars Sugarloaf and Smooth Cayenne. A split-split plot design was used in each experiment, with flowering induction practice as main factor (artificial or natural flowering induction), maturity induction practice as split factor (artificial or natural maturity induction) and harvesting practice as the split-split factor (farmers' harvest practice or individual fruit harvesting at optimum maturity). Artificial flowering induction gave fruits with lower infructescence weight, higher ratio crown: infructescence length, and a lower proportion of fruits exportable to European markets than natural flowering induction. The costs of the improvements by natural flowering induction were huge: the longer durations from planting to flowering induction and harvesting, the higher number of harvestings of the fruits increasing the labour cost and the lower proportion of plants producing fruits compared with crops from artificially flowering-induced plants. Artificial maturity induction decreased the total soluble solids concentration in the fruits compared with natural maturity induction thus decreasing the proportion of fruits exportable to European markets, at a benefit of only a slightly shorter time from flowering induction to harvesting. Harvesting individual fruits at optimum maturity gave fruits with higher total soluble solids in naturally maturity induced fruits compared with the farmers' harvest practice. Given the huge costs of natural flowering induction, options to use artificial flowering induction effectively for obtaining high fruit quality are discussed.	[Hotegni, V. Nicodeme Fassinou; Lommen, Willemien J. M.; Struik, Paul C.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands; [Hotegni, V. Nicodeme Fassinou; Agbossou, Euloge K.] Univ Abomey Calavi, Fac Sci Agron, Cotonou, Benin	Wageningen University & Research; University of Abomey Calavi	Lommen, WJM (corresponding author), Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands.	Willemien.Lommen@wur.nl		FASSINOU HOTEGNI, V. Nicodeme/0000-0001-5826-3688; Lommen, Willemien J.M./0000-0003-3254-6879	North-South Interdisciplinary Research and Education Fund (INREF) of Wageningen University and Research Centre; Netherlands Organisation for International Cooperation in Higher Education (NUFFIC) [NFP-PhD/CF7551/2011]	North-South Interdisciplinary Research and Education Fund (INREF) of Wageningen University and Research Centre; Netherlands Organisation for International Cooperation in Higher Education (NUFFIC)	The authors are thankful to the North-South Interdisciplinary Research and Education Fund (INREF) of Wageningen University and Research Centre and the Netherlands Organisation for International Cooperation in Higher Education (NUFFIC) for their financial support through the Co-Innovation for Quality in African Foods Chains (CoQA) Programme and the Netherlands Fellowship Programme (NFP-PhD/CF7551/2011), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hatab A, 2013, INT FOOD AGRIBUS MAN, V16, P77; Achigan-Dako EG, 2014, BIOTECHNOL AGRON SOC, V18, P49; Adams SR, 2001, ANN BOT-LONDON, V88, P869, DOI 10.1006/anbo.2001.1524; Adikaram N., 2012, Crop post-harvest: science and technology. Volume 3: perishables, P143; Aggelopoulou KD, 2010, PRECIS AGRIC, V11, P538, DOI 10.1007/s11119-009-9146-9; [Anonymous], 1936, J R STAT SOC B, DOI DOI 10.2307/2983678; [Anonymous], 2013, GENSTAT WINDOWS; Bartholomew D.P., 1994, HDB ENV PHYSL FRUIT, P243; Bartholomew Duane P., 2003, P167, DOI 10.1079/9780851995038.0167; Chen CC, 2000, J AM SOC HORTIC SCI, V125, P558, DOI 10.21273/JASHS.125.5.558; Chuenboonngarm N., 2007, Kasetsart Journal, Natural Sciences, V41, P205; Codex Alimentarius, 2005, 1821993 COD AL; CROCHON M, 1981, FRUITS, V36, P409; Devadas VS, 2005, ACTA HORTIC, P185, DOI 10.17660/ActaHortic.2005.666.17; FAO, 2012, STAT DAT; FERNANDEZ GCJ, 1992, HORTSCIENCE, V27, P297, DOI 10.21273/HORTSCI.27.4.297; FRIEND DJC, 1979, BOT GAZ, V140, P280, DOI 10.1086/337086; Gbaguidi A. A., 2015, International Journal of Biological and Chemical Sciences, V9, P1050, DOI 10.4314/ijbcs.v9i2.40; Gonzalez R, 2008, DATA ANAL EXPT DESIG; Hepton Anthony, 2003, P109, DOI 10.1079/9780851995038.0109; Hotegni VNF, 2012, ACTA HORTIC, V928, P47; Hotegni VNF, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00798; Hotegni VNF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00670; Hotegni VNF, 2014, INT FOOD AGRIBUS MAN, V17, P139; Kerns K. R., 1936, NEW PHYTOL, V35, P305, DOI [10.1111/j.1469-8137.1936.tb06884.x, DOI 10.1111/J.1469-8137.1936.TB06884.X]; Malezieux Eric, 2003, P143, DOI 10.1079/9780851995038.0143; MOSS GI, 1976, AUST J AGR RES, V27, P399, DOI 10.1071/AR9760399; Muasyal RM, 2006, NJAS-WAGEN J LIFE SC, V54, P5, DOI 10.1016/S1573-5214(06)80001-1; Neven D, 2009, WORLD DEV, V37, P1802, DOI 10.1016/j.worlddev.2008.08.026; Norman J., 1978, ACTA HORTIC, V84, P191; ONAHA A, 1983, J JPN SOC HORTIC SCI, V52, P280, DOI 10.2503/jjshs.52.280; Paull RE, 1996, SCI HORTIC-AMSTERDAM, V66, P59, DOI 10.1016/0304-4238(96)00905-3; Cunha Getúlio Augusto Pinto da, 2005, Bragantia, V64, P499, DOI 10.1590/S0006-87052005000400001; Py C, 1987, PINEAPPLE CULTIVATIO; Reardon T., 1999, INT FOOD AGRIBUS MAN, V2, P421, DOI DOI 10.1016/S1096-7508(01)00035-0; REID MS, 1991, PLANT HORMONE ETHYLE, P215; Royer A., 2012, African Journal of Agricultural Research, V7, P5344; Saltveit ME, 1999, POSTHARVEST BIOL TEC, V15, P279, DOI 10.1016/S0925-5214(98)00091-X; SHEWFELT RL, 1990, J FOOD QUALITY, V13, P37, DOI 10.1111/j.1745-4557.1990.tb00004.x; SIDERIS C. P., 1938, GROWTH, V2, P181; SINGLETO.VL, 1965, J FOOD SCI, V30, P19, DOI 10.1111/j.1365-2621.1965.tb00255.x; Trienekens J, 2008, INT J PROD ECON, V113, P107, DOI 10.1016/j.ijpe.2007.02.050; Vorley B, 2004, OECD AGR PROP GROWTH; Wassman R, 1991, PINEAPPLE FIELD DAY, P37; Wijesinghe W. A. J. P., 2002, Tropical Agricultural Research and Extension, V5, P53; Zuniga-Arias G, 2009, TRENDS FOOD SCI TECH, V20, P168, DOI 10.1016/j.tifs.2009.01.059; [No title captured]	47	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143290	10.1371/journal.pone.0143290	http://dx.doi.org/10.1371/journal.pone.0143290			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599545	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900087
J	Katz, J; Chemla, E; Pallier, C				Katz, Jonah; Chemla, Emmanuel; Pallier, Christophe			An Attentional Effect of Musical Metrical Structure	PLOS ONE			English	Article							RHYTHM PERCEPTION; NONMUSICIANS; POTENTIALS; MUSICIANS; BEAT	Theories of metrical structure postulate the existence of several degrees of beat strength. While previous work has clearly established that humans are sensitive to the distinction between strong beats and weak ones, there is little evidence for a more fine grained distinction between intermediate levels. Here, we present experimental data showing that attention can be allocated to an intermediate level of beat strength. Comparing the effects of short exposures to 6/8 and 3/4 metrical structures on a tone detection task, we observe that subjects respond differently to beats of intermediate strength than to weak beats.	[Katz, Jonah] W Virginia Univ, Morgantown, WV 26506 USA; [Katz, Jonah] IEC, Inst Jean Nicod, EHESS, CNRS, Paris, France; [Chemla, Emmanuel] IEC, Lab Sci Cognit & Psycholinguist, EHESS, CNRS, Paris, France; [Pallier, Christophe] Neurospin Ctr, CEA, INSERM, Cognit Neuroimaging Unit,U992, Gif Sur Yvette, France	West Virginia University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Katz, J (corresponding author), W Virginia Univ, Dept World Languages Literatures & Linguist, Chitwood Hall,POB 6298, Morgantown, WV 26506 USA.	katzlinguist@gmail.com	Christophe, PALLIER/C-4755-2014	Christophe, PALLIER/0000-0002-3324-666X; Chemla, Emmanuel/0000-0002-8423-5880; Katz, Jonah/0000-0002-1057-7052	European Research Council under the European Union [324115-FRONTSEM]; Euryi grant from the European Science Foundation ('Presupposition: A Formal Pragmatic Approach');  [ANR-10-IDEX-0001-02 PSL*];  [ANR-10-LABX-0087 IEC]	European Research Council under the European Union(European Research Council (ERC)); Euryi grant from the European Science Foundation ('Presupposition: A Formal Pragmatic Approach'); ; 	The research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007- 2013)/ERC Grant Agreement No. 324115-FRONTSEM (PI: Schlenker) and was also supported by a Euryi grant from the European Science Foundation ('Presupposition: A Formal Pragmatic Approach'). Research was conducted at Institut d'Etudes Cognitives (ENS), which is supported by grants ANR-10-IDEX-0001-02 PSL* and ANR-10-LABX-0087 IEC.; Many thanks to Isabelle Brunet, Anne-Caroline Fievet and Paul Marty for their assistance with technical aspects and data collection, and to Philippe Schlenker for crucial suggestions from the start. We are also very grateful to Peter Pfordresher, Bruno Repp, and Mari Riess Jones for detailed critiques of earlier drafts of this paper. The research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007- 2013)/ERC Grant Agreement No. 324115-FRONTSEM(PI: Schlenker) and was also supported by a Euryi grant from the European Science Foundation ('Presupposition: A Formal Pragmatic Approach'). Research was conducted at Institut d'Etudes Cognitives (ENS), which is supported by grants ANR-10-IDEX-0001-02 PSL* and ANR-10-LABX-0087 IEC.	Bolger D, 2013, ACTA PSYCHOL, V142, P238, DOI 10.1016/j.actpsy.2012.11.012; DAWE LA, 1995, PERCEPT PSYCHOPHYS, V57, P905, DOI 10.3758/BF03206805; Escoffier N, 2010, ACTA PSYCHOL, V135, P12, DOI 10.1016/j.actpsy.2010.04.005; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; Jongsma MLA, 2004, BIOL PSYCHOL, V66, P129, DOI 10.1016/j.biopsycho.2003.10.002; Large E. W., 1994, Connection Science, V6, P177, DOI 10.1080/09540099408915723; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Lerdahl F, 1983, MUSIC PERCEPT, P229, DOI 10.2307/40285257; London J., 2012, HEARING TIME; MATT J, 1992, J EXP PSYCHOL LEARN, V18, P810, DOI 10.1037/0278-7393.18.4.810; PALMER C, 1990, J EXP PSYCHOL HUMAN, V16, P728, DOI 10.1037/0096-1523.16.4.728; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Penel A, 2005, MUSIC PERCEPT, V22, P371, DOI 10.1525/mp.2005.22.3.371; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Repp BH, 2010, ATTEN PERCEPT PSYCHO, V72, P1390, DOI 10.3758/APP.72.5.1390; Vuust P, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01111; Witek MAG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094446	20	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0140895	10.1371/journal.pone.0140895	http://dx.doi.org/10.1371/journal.pone.0140895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CX7AW	26600180	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900009
J	Kerkum, YL; Buizer, AI; van den Noort, JC; Becher, JG; Harlaar, J; Brehm, MA				Kerkum, Yvette L.; Buizer, Annemieke I.; van den Noort, Josien C.; Becher, Jules G.; Harlaar, Jaap; Brehm, Merel-Anne			The Effects of Varying Ankle Foot Orthosis Stiffness on Gait in Children with Spastic Cerebral Palsy Who Walk with Excessive Knee Flexion	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; ENERGY-EXPENDITURE; JOINT KINEMATICS; EFFICIENCY; MOMENTS; STROKE; REPRODUCIBILITY; CONFIGURATIONS; INDIVIDUALS; RELIABILITY	Rigid Ankle-Foot Orthoses (AFOs) are commonly prescribed to counteract excessive knee flexion during the stance phase of gait in children with cerebral palsy (CP). While rigid AFOs may normalize knee kinematics and kinetics effectively, it has the disadvantage of impeding push-off power. A spring-like AFO may enhance push-off power, which may come at the cost of reducing the knee flexion less effectively. Optimizing this trade-off between enhancing push-off power and normalizing knee flexion in stance is expected to maximize gait efficiency. This study investigated the effects of varying AFO stiffness on gait biomechanics and efficiency in children with CP who walk with excessive knee flexion in stance. Fifteen children with spastic CP (11 boys, 10 +/- 2 years) were prescribed with a ventral shell spring-hinged AFO (vAFO). The hinge was set into a rigid, or spring-like setting, using both a stiff and flexible performance. At baseline (i.e. shoes-only) and for each vAFO, a 3D-gait analysis and 6-minute walk test with breath-gas analysis were performed at comfortable speed. Lower limb joint kinematics and kinetics were calculated. From the 6-minute walk test, walking speed and the net energy cost were determined. A generalized estimation equation (p<0.05) was used to analyze the effects of different conditions. Compared to shoes-only, all vAFOs improved the knee angle and net moment similarly. Ankle power generation and work were preserved only by the spring-like vAFOs. All vAFOs decreased the net energy cost compared to shoes-only, but no differences were found between vAFOs, showing that the effects of spring-like vAFOs to promote push-off power did not lead to greater reductions in walking energy cost. These findings suggest that, in this specific group of children with spastic CP, the vAFO stiffness that maximizes gait efficiency is primarily determined by its effect on knee kinematics and kinetics rather than by its effect on push-off power.	[Kerkum, Yvette L.; Buizer, Annemieke I.; van den Noort, Josien C.; Becher, Jules G.; Harlaar, Jaap; Brehm, Merel-Anne] Vrije Univ Amsterdam Med Ctr, MOVE Res Inst Amsterdam, Dept Rehabil Med, Amsterdam, Netherlands; [Brehm, Merel-Anne] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Kerkum, YL (corresponding author), Vrije Univ Amsterdam Med Ctr, MOVE Res Inst Amsterdam, Dept Rehabil Med, Amsterdam, Netherlands.	y.kerkum@vumc.nl	Brehm, Merel-Anne/K-8638-2017; Becher, Jules/AAE-2246-2020; Brehm, Merel-Anne/AAK-7419-2020; Buizer, Annemieke/G-9500-2016; van den Noort, Josien/ABG-7503-2021	Brehm, Merel-Anne/0000-0002-3425-4661; Brehm, Merel-Anne/0000-0002-3425-4661; Buizer, Annemieke/0000-0001-5662-2843; van den Noort, Josien/0000-0002-2305-498X; KERKUM, Yvette/0000-0001-6694-8804; Harlaar, Jaap/0000-0003-2889-271X; van den Noort, Josien/0000-0001-5753-4183	Johanna KinderFonds [2009/0055-357]; Phelps Stichting voor Spastici [2010001]; Stichting Rotterdams Kinderrevalidatie Fonds Adriaanstichting [00.02.10-2009/0055]	Johanna KinderFonds; Phelps Stichting voor Spastici; Stichting Rotterdams Kinderrevalidatie Fonds Adriaanstichting	Funding was provided by Johanna KinderFonds (2009/0055-357) (http://www.johannakinderfonds.nl); Phelps Stichting voor Spastici (2010001) (http://phelps-stichting.nl); and Stichting Rotterdams Kinderrevalidatie Fonds Adriaanstichting (00.02.10-2009/0055) (http://www.kinderfondsadriaan.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballaz L, 2010, CLIN BIOMECH, V25, P944, DOI 10.1016/j.clinbiomech.2010.06.011; Bennett BC, 2005, ARCH PHYS MED REHAB, V86, P2189, DOI 10.1016/j.apmr.2005.05.012; Bregman DJJ, 2012, GAIT POSTURE, V35, P148, DOI 10.1016/j.gaitpost.2011.08.026; Bregman DJJ, 2009, GAIT POSTURE, V30, P144, DOI 10.1016/j.gaitpost.2009.05.012; Bregman DJJ, 2011, OPTIMAL ANKLE FOOT O; Brehm MA, 2008, J REHABIL MED, V40, P529, DOI 10.2340/16501977-0209; Brehm MA, 2008, GAIT POSTURE, V27, P196, DOI 10.1016/j.gaitpost.2007.03.012; Brehm MA, 2007, DEV MED CHILD NEUROL, V49, P45, DOI 10.1017/S0012162207000114; Brehm MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115200; Buckon CE, 2004, DEV MED CHILD NEUROL, V46, P590; Buckon CE, 2001, DEV MED CHILD NEUROL, V43, P371, DOI 10.1017/S0012162201000706; Campbell J, 1978, Orthop Clin North Am, V9, P374; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chen G, 2008, J BIOMECH, V41, P877, DOI 10.1016/j.jbiomech.2007.10.017; Collins S. H., 2015, NATURE; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Davids JR, 2007, J AM ACAD ORTHOP SUR, V15, P178, DOI 10.5435/00124635-200703000-00008; Desloovere K, 2006, GAIT POSTURE, V24, P142, DOI 10.1016/j.gaitpost.2006.08.003; Esposito ER, 2014, CLIN ORTHOP RELAT R, V472, P3026, DOI 10.1007/s11999-014-3661-3; Farris DJ, 2015, J NEUROENG REHABIL, V12; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; Harper NG, 2014, CLIN BIOMECH, V29, P877, DOI 10.1016/j.clinbiomech.2014.07.005; Kamp FA, 2014, GAIT POSTURE, V40, P209, DOI 10.1016/j.gaitpost.2014.03.187; Kerkum YL, 2014, GAIT POSTURE, V39, pS136; Kerkum YL, 2015, CLIN BIOMECHANICS; Kerkum YL, 2014, J APPL BIOMECH, V30, P728, DOI 10.1123/jab.2014-0046; Kerkum YL, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-17; Kobayashi T, 2015, CLIN BIOMECH, V30, P775, DOI 10.1016/j.clinbiomech.2015.06.014; Kobayashi T, 2013, GAIT POSTURE, V37, P457, DOI 10.1016/j.gaitpost.2012.07.028; Kobayashi T, 2011, GAIT POSTURE, V33, P721, DOI 10.1016/j.gaitpost.2011.02.005; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; Leteneur S, 2009, CLIN BIOMECH, V24, P190, DOI 10.1016/j.clinbiomech.2008.10.005; Leteneur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055256; Maltais D, 2001, MED SCI SPORT EXER, V33, P320; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Peterson CL, 2011, CLIN BIOMECH, V26, P859, DOI 10.1016/j.clinbiomech.2011.04.010; Rogozinski BM, 2009, J BONE JOINT SURG AM, V91A, P2440, DOI 10.2106/JBJS.H.00965; ROSE J, 1990, DEV MED CHILD NEUROL, V32, P333; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; Scholtes VA, 2007, SPASTICITY TEST CLIN; Schwartz MH, 2006, GAIT POSTURE, V24, P14, DOI 10.1016/j.gaitpost.2005.06.014; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Singer ML, 2014, CLIN BIOMECH, V29, P1077, DOI 10.1016/j.clinbiomech.2014.09.001; Smits DW, 2010, DEV NEUROREHABIL, V13, P258, DOI 10.3109/17518421003705698; Steinwender G, 2001, GAIT POSTURE, V13, P78, DOI 10.1016/S0966-6362(00)00103-X; Thomas SS, 2009, DEV MED CHILD NEUROL, V51, P615, DOI 10.1111/j.1469-8749.2008.03214.x; van den Noort JC, 2010, ARCH PHYS MED REHAB, V91, P615, DOI 10.1016/j.apmr.2009.12.022; Van Gestel L, 2008, DEV MED CHILD NEUROL, V50, P63, DOI 10.1111/j.1469-8749.2007.02014.x; Voorman JM, 2007, ARCH PHYS MED REHAB, V88, P871, DOI 10.1016/j.apmr.2007.04.002; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Wingstrand M, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-327; WU G, 1995, J BIOMECH, V28, P1257, DOI 10.1016/0021-9290(95)00017-C; ZATSIORSKY VM, 2002, HUMAN KINETICS; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	54	50	50	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142878	10.1371/journal.pone.0142878	http://dx.doi.org/10.1371/journal.pone.0142878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600039	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900045
J	Khazai, B; Luo, YT; Rosenberg, S; Wingrove, J; Budoff, MJ				Khazai, Bahram; Luo, Yanting; Rosenberg, Steven; Wingrove, James; Budoff, Matthew J.			Coronary Atherosclerotic Plaque Detected by Computed Tomographic Angiography in Subjects with Diabetes Compared to Those without Diabetes	PLOS ONE			English	Article							ARTERY-DISEASE; HEART-DISEASE; RISK-FACTORS; INSULIN-RESISTANCE; PROGNOSTIC VALUE; CALCIUM; PREVALENCE; ADULTS; CALCIFICATION; EPIDEMIOLOGY	Objectives Little data are available regarding coronary plaque composition and semi-quantitative scores in individuals with diabetes; the extent to which diabetes may affect the presence and extent of Coronary Artery Calcium (CAC) needs more evaluation. Considering that this information may be of great value in formulating preventive interventions in this population, we compared these findings in individuals with diabetes to those without. Methods Multi-Detector Computed Tomographic (MDCT) images of 861 consecutive patients with diabetes who were referred to Los Angeles Biomedical Research Institute from January 2000 to September 2012, were evaluated using a 15-coronary segment model. All 861 patients underwent calcium scoring and from these; 389 had coronary CT angiography (CTA). CAC score was compared to 861 age, sex and ethnicity matched controls without diabetes after adjustment for Body Mass Index (BMI), family history of coronary artery disease, hyperlipidemia, hypertension and smoking. Segment Involvement Score (SIS; the total number of segments with any plaque), Segment Stenosis Score (SSS; the sum of maximal stenosis score per segment), Total Plaque Score (TPS; the sum of the plaque amount per segment) and plaque compositionwere compared to 389 age, sex and ethnicity matched controls without diabetes after adjustment for BMI, family history of coronary artery disease, hyperlipidemia, hypertension and smoking. Results Diabetes was positively correlated to the presence and extent of CAC (P<0.0001 for both). SIS, SSS and TPS were significantly higher in those with diabetes (P<0.0001). Number of mixed and calcified plaques were significantly higher in those with diabetes (P = 0.018 and P<0.001 respectively) but there was no significant difference in the number of non-calcified plaques between the two groups (P = 0.398). Conclusions Patients with diabetes have higher CAC and semi-quantitative coronary plaque scores compared to the age, gender and ethnicity matched controls without diabetes after adjustment for cardiovascular risk factors. Since mixed plaque is associated with worse long-term clinical outcomes, these findings support more aggressive preventive measures in this population.	[Khazai, Bahram] Univ Miami, Miller Sch Med, Dept Cardiol, Miami, FL 33136 USA; [Luo, Yanting; Budoff, Matthew J.] Univ Calif Los Angeles, Sch Med, Harbor UCLA, Dept Cardiol,Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Rosenberg, Steven; Wingrove, James] CardioDx Inc, Palo Alto, CA USA	University of Miami; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lundquist Institute	Khazai, B (corresponding author), Univ Miami, Miller Sch Med, Dept Cardiol, Miami, FL 33136 USA.	bahram_khazaee@yahoo.com	Budoff, Matthew/ABD-5175-2021	Budoff, Matthew/0000-0002-9616-1946	Endocrinology, Metabolism and Nutrition training Grant [T32 DK007571]; CardioDx, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007571] Funding Source: NIH RePORTER	Endocrinology, Metabolism and Nutrition training Grant; CardioDx, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This material was supported by the Endocrinology, Metabolism and Nutrition training Grant (T32 DK007571) to Los Angeles Biomedical Research Institute in support of endocrinology fellowship training for Bahram Khazai. CardioDx, Inc. provided support in the form of salaries for authors Steven Rosenberg and James Wingrove, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank other investigators, the staff, and the participants in this study for their valuable contributions. This material is the result of work supported by the Endocrinology, Metabolism and Nutrition training Grant (T32 DK007571) to Los Angeles Biomedical Research Institute.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; [Anonymous], 1998, Diabetes Care, V21, P179; Austen WG, 1975, CIRCULATION, V51, P5; Budoff MJ, 2005, AM HEART J, V149, P695, DOI 10.1016/j.ahj.2004.07.034; Budoff MJ, 2003, DIABETES CARE, V26, P541, DOI 10.2337/diacare.26.2.541; Budoff MJ, 1996, CIRCULATION, V93, P898, DOI 10.1161/01.CIR.93.5.898; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Cheng Victor Y, 2009, J Cardiovasc Comput Tomogr, V3, P312, DOI 10.1016/j.jcct.2009.07.001; Choi TY, 2013, ACAD RADIOL, V20, P202, DOI 10.1016/j.acra.2012.09.017; Elkeles RS, 2008, EUR HEART J, V29, P2244, DOI 10.1093/eurheartj/ehn279; Forrest KYZ, 2000, ATHEROSCLEROSIS, V148, P159, DOI 10.1016/S0021-9150(99)00217-8; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hoff JA, 2003, J AM COLL CARDIOL, V41, P1008, DOI 10.1016/S0735-1097(02)02975-3; Khaleeli E, 2001, AM HEART J, V141, P637, DOI 10.1067/mhj.2001.113224; KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750, DOI 10.1016/0002-9149(87)91086-1; Lloyd CE, 1996, ARTERIOSCL THROM VAS, V16, P720, DOI 10.1161/01.ATV.16.6.720; MARGOLIS JR, 1973, AM J CARDIOL, V32, P1, DOI 10.1016/S0002-9149(73)80079-7; Mielke CH, 2001, DIABETES RES CLIN PR, V53, P55, DOI 10.1016/S0168-8227(01)00239-X; Olson JC, 2000, DIABETES, V49, P1571, DOI 10.2337/diabetes.49.9.1571; Orchard TJ, 2003, DIABETES CARE, V26, P1374, DOI 10.2337/diacare.26.5.1374; Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161; Pagali SR, 2010, J CARDIOVASC COMPUT, V4, P312, DOI 10.1016/j.jcct.2010.05.018; PALUMBO PJ, 1976, DIABETES, V25, P566, DOI 10.2337/diabetes.25.7.566; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; RUMBERGER JA, 1995, CIRCULATION, V91, P1363, DOI 10.1161/01.CIR.91.5.1363; Russo V, 2010, CIRC-CARDIOVASC IMAG, V3, P351, DOI 10.1161/CIRCIMAGING.109.880625; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Soedamah-Muthu SS, 2004, DIABETES CARE, V27, P530, DOI 10.2337/diacare.27.2.530; Starkman HS, 2003, DIABETES CARE, V26, P433, DOI 10.2337/diacare.26.2.433; The sixth report of the Joint National Committee, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; Weiss RA, 2001, ARTERIOSCL THROM VAS, V21, P1561; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Williams KV, 2000, DIABETES, V49, P626, DOI 10.2337/diabetes.49.4.626	36	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143187	10.1371/journal.pone.0143187	http://dx.doi.org/10.1371/journal.pone.0143187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600086	Green Published, gold			2022-12-27	WOS:000365853900073
J	Leidinger, P; Backes, C; Rheinheimer, S; Keller, A; Meese, E				Leidinger, Petra; Backes, Christina; Rheinheimer, Stefanie; Keller, Andreas; Meese, Eckart			Towards Clinical Applications of Blood-Borne miRNA Signatures: The Influence of the Anticoagulant EDTA on miRNA Abundance	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; QUALITY RNA; TNF-ALPHA; STABILIZATION; COLLECTION; SAMPLES	Background Circulating microRNAs (miRNAs) from blood are increasingly recognized as biomarker candidates for human diseases. Clinical routine settings frequently include blood sampling in tubes with EDTA as anticoagulant without considering the influence of phlebotomy on the overall miRNA expression pattern. We collected blood samples from six healthy individuals each in an EDTA blood collection tube. Subsequently, the blood was transferred into PAXgene (TM) tubes at three different time points, i.e. directly (0 min), 10 min, and 2 h after phlebotomy. As control blood was also directly collected in PAXgene (TM) blood RNA tubes that contain a reagent to directly lyse blood cells and stabilize their content. For all six blood donors at the four conditions (24 samples) we analyzed the abundance of 1,205 miRNAs by human Agilent miRNA V16 microarrays. Results While we found generally a homogenous pattern of the miRNA abundance in all 24 samples, the duration of the EDTA treatment appears to influence the miRNA abundance of specific miRNAs. The most significant changes are observed after longer EDTA exposition. Overall, the impact of the different blood sample conditions on the miRNA pattern was substantially lower than intra-individual variations. While samples belonging to one of the six individuals mostly cluster together, there was no comparable clustering for any of the four tested blood sampling conditions. The most affected miRNA was miR-769-3p that was not detected in any of the six PAXgene blood samples, but in all EDTA 2h samples. Accordingly, hsa-miR-769-3p was also the only miRNA that showed a significantly different abundance between the 4 blood sample conditions by an ANOVA analysis (Benjamini-Hochberg adjusted p-value of 0.003). Validation by qRT-PCR confirmed this finding. Conclusion The pattern of blood-borne miRNA abundance is rather homogenous between the four tested blood sample conditions of six blood donors. There was a clustering between the miRNA profiles that belong to a specific blood donor, but not between any of the four tested blood sampling conditions. The results show a limited overall impact of the blood sampling conditions on the miRNA pattern. Notwithstanding, the abundance of single miRNAs can be significantly altered by different blood sampling conditions.	[Leidinger, Petra; Rheinheimer, Stefanie; Meese, Eckart] Univ Saarland, Sch Med, Dept Human Genet, D-66421 Homburg, Germany; [Backes, Christina; Keller, Andreas] Univ Saarland, Dept Clin Bioinformat, D-66123 Saarbrucken, Germany	Saarland University; Saarland University	Meese, E (corresponding author), Univ Saarland, Sch Med, Dept Human Genet, Bldg 60, D-66421 Homburg, Germany.	hgemee@uks.eu	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895	HOMFOR (Homburger Forschungsforderung)	HOMFOR (Homburger Forschungsforderung)	This study was funded by HOMFOR 2013 (Homburger Forschungsforderung).	Asare AL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-474; Beekman Johanna M., 2009, Journal of Pharmacological and Toxicological Methods, V59, P44, DOI 10.1016/j.vascn.2008.10.003; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; FREEMAN R, 1990, LANCET, V336, P312, DOI 10.1016/0140-6736(90)91848-5; Girardi C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/296747; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kim JH, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-76; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Nagler M, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-19; Pahl A, 2002, CLIN CHEM, V48, P2251; Ple H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050746; Pogue AI, 2010, NEUROSCI LETT, V476, P18, DOI 10.1016/j.neulet.2010.03.054; Rainen L, 2002, CLIN CHEM, V48, P1883; REDL H, 1992, CLIN CHIM ACTA, V205, P149, DOI 10.1016/S0009-8981(05)80010-5; RICHES P, 1992, J IMMUNOL METHODS, V153, P125, DOI 10.1016/0022-1759(92)90314-J; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Tanner MA, 2002, CLIN LAB HAEMATOL, V24, P337, DOI 10.1046/j.1365-2257.2002.00474.x; Viprey VF, 2012, ANAL BIOCHEM, V421, P566, DOI 10.1016/j.ab.2011.10.022; Yoshizawa M, 2011, INT J MOL SCI, V12, P9265, DOI 10.3390/ijms12129265	23	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143321	10.1371/journal.pone.0143321	http://dx.doi.org/10.1371/journal.pone.0143321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599228	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900093
J	Mahmud, SM; Bozat-Emre, S; Hammond, G; Elliott, L; Van Caeseele, P				Mahmud, Salaheddin M.; Bozat-Emre, Songul; Hammond, Gregory; Elliott, Lawrence; Van Caeseele, Paul			Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?	PLOS ONE			English	Article							ADMINISTRATIVE DATA; A H1N1; CHILDREN; MANITOBA; HOSPITALIZATION; METAANALYSIS; DATABASE	Background The extent to which A(H1N1) pdm09 influenza vaccines prevented hospital admissions with pneumonia and influenza (P&I) during the 2009 pandemic remains poorly understood. We evaluated the effectiveness of the A(H1N1) pdm09 and seasonal influenza vaccines (TIV) used during the 2009 mass vaccination campaign in Manitoba (Canada) in preventing P&I hospitalization. Methods A population-based record-linkage nested case-control study. Cases (N = 1,812) were persons hospitalized with influenza (ICD-10: J09-J11) or pneumonia (ICD-10: J12-J18) during the study period. Age-, gender-and area of residence-matched controls (N = 7,915) were randomly sampled from Manitoba's Population Registry. Information on receipt of A(H1N1) pdm09 vaccine and TIV was obtained from the Manitoba Immunization Monitoring System, a province-wide vaccine registry. Results Overall, the adjuvanted A(H1N1) pdm09 vaccine was 27% (95% CI 13-39%) effective against P& I hospitalization >= 14 days following administration. Effectiveness seemed lower among older (>= 65 years) adults (10%; -16-30%), particularly when compared to under-5 children (58%; 30-75%). The number-needed-to-vaccinate to prevent 1 P& I admission was lowest among < 4 year-olds (928) and >= 65 years (1,721). VE against hospitalization with laboratory-confirmed A(H1N1) pdm09 was 70% (39-85%) overall and (91%; 62-98%) >= 14 days following vaccination. Discussion Our data suggest that the adjuvanted A(H1N1)pdm09 vaccine was effective in preventing about 55-60% of P&I hospitalizations among children and younger adults who were at much higher risk of infection. Unfortunately, the vaccine was less effective among 65 or older adults. Despite that the vaccine still had a significant population-based impact especially among the very young (<5) and the older (>= 65 years).	[Mahmud, Salaheddin M.; Bozat-Emre, Songul; Elliott, Lawrence] Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada; [Hammond, Gregory; Elliott, Lawrence; Van Caeseele, Paul] Univ Manitoba, Med Microbiol, Winnipeg, MB, Canada; [Hammond, Gregory] Univ Manitoba, Med, Winnipeg, MB, Canada; [Mahmud, Salaheddin M.; Elliott, Lawrence] Winnipeg Reg Hlth Author, Winnipeg, MB, Canada; [Van Caeseele, Paul] Cadham Prov Lab, Winnipeg, MB, Canada; [Mahmud, Salaheddin M.; Bozat-Emre, Songul; Elliott, Lawrence; Van Caeseele, Paul] Manitoba Hlth, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Mahmud, SM (corresponding author), Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada.	Salah.mahmud@gmail.com			investigator-initiated grant from GSK Biologicals to the International Centre of Infectious Disease, Winnipeg, Canada	investigator-initiated grant from GSK Biologicals to the International Centre of Infectious Disease, Winnipeg, Canada	This work was funded by an investigator-initiated grant from GSK Biologicals to the International Centre of Infectious Disease, Winnipeg, Canada. Funders had no role in designing or conducting the study or in the decision to submit the results for publication. GSK: http://www.gsk.ca/english/index.html. International Centre of Infectious Disease: http://www.icid.com/.	[Anonymous], VACCINES; Baxter R, 2010, J INFECT DIS, V201, P186, DOI 10.1086/649568; Canadian Institute for Health Information, 2009, ICD 10 CA INT STAT C; Canadian Institute for Health Information, 2006, CAN CLASS HLTH INT; Dublin S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2137; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Emborg HD, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7901; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Gilca R, 2011, PEDIATRICS, V128, pE1084, DOI 10.1542/peds.2010-3492; Gilmour H, 2010, H1N1 VACCINATION HLT, V21; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Hadler JL, 2012, J INFECT DIS, V206, P49, DOI 10.1093/infdis/jis306; Hardy JR, 2004, PHARMACOEPIDEM DR S, V13, P749, DOI 10.1002/pds.935; Hills, 1993, STAT MODELS EPIDEMIO; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Kozyrskyj AL, 1998, ANN PHARMACOTHER, V32, P1152, DOI 10.1345/aph.18117; LeBlanc JJ, 2009, J CLIN MICROBIOL, V47, P3805, DOI 10.1128/JCM.01344-09; Lix L, 2006, DEFINING VALIDATING; Mahmud S, 2011, VACCINE, V29, P7975, DOI 10.1016/j.vaccine.2011.08.068; Mahmud SM, 2012, EMERG INFECT DIS, V18, P801, DOI 10.3201/eid1805.111596; Mahmud SM, 2010, CAN MED ASSOC J, V182, P1522, DOI 10.1503/cmaj.100488; Manitoba H, 2010, H1N1 FLU MANITOBA MA; Manzoli L, 2012, HUM VACC IMMUNOTHER, V8, P851, DOI 10.4161/hv.19917; Manzoli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024384; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Roberts JD, 1996, J CLIN EPIDEMIOL, V49, P51, DOI 10.1016/0895-4356(95)00522-6; ROBERTS JD, 1994, AM J PUBLIC HEALTH, V84, P1666, DOI 10.2105/AJPH.84.10.1666; Robinson JR, 1997, MED CARE, V35, P932, DOI 10.1097/00005650-199709000-00006; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; Simpson CR, 2010, HEALTH TECHNOL ASSES, V14, P323, DOI 10.3310/hta14340-05; Singh H, 2009, AM J GASTROENTEROL, V104, P3015, DOI 10.1038/ajg.2009.574; Steens A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-196; Thompson LH, 2012, CAN J INFECT DIS MED, V23, P65, DOI 10.1155/2012/484693; Viboud C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000259; Wong K, 2012, ARCH INTERN MED, V172, P484, DOI 10.1001/archinternmed.2011.2038; Yin JK, 2011, INFLUENZA OTHER RESP, V5, P299, DOI 10.1111/j.1750-2659.2011.00229.x	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142754	10.1371/journal.pone.0142754	http://dx.doi.org/10.1371/journal.pone.0142754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600435	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900039
J	Naczk, AM; Kolanowska, M				Naczk, Aleksandra M.; Kolanowska, Marta			Glacial Refugia and Future Habitat Coverage of Selected Dactylorhiza Representatives (Orchidaceae)	PLOS ONE			English	Article							INCARNATA/MACULATA COMPLEX ORCHIDACEAE; PLASTID DNA VARIATION; SPECIES DISTRIBUTION; POLYPLOID EVOLUTION; CLIMATE-CHANGE; GENETIC DIFFERENTIATION; POTENTIAL DISTRIBUTIONS; DECEPTIVE POLLINATION; TERRESTRIAL ORCHID; QUATERNARY REFUGIA	The intensively discussed taxonomic complexity of the Dactylorhiza genus is probably correlated with its migration history during glaciations and interglacial periods. Previous studies on past processes affecting the current distribution of Dactylorhiza species as well as the history of the polyploid complex formation were based only on molecular data. In the present study the ecological niche modeling (ENM) technique was applied in order to describe the distribution of potential refugia for the selected Dactylorhiza representatives during the Last Glacial Maximum. Additionally, future changes in their potential habitat coverage were measured with regard to three various climatic change scenarios. The maximum entropy method was used to create models of suitable niche distribution. A database of Dactylorhiza localities was prepared on the grounds of information collected from literature and data gathered during field works. Our research indicated that the habitats of majority of the studied taxa will decrease by 2080, except for D. incarnata var. incarnata, for which suitable habitats will increase almost two-fold in the global scale. Moreover, the potential habitats of some taxa are located outside their currently known geographical ranges, e.g. the Aleutian Islands, the western slopes of the Rocky Mountains, Newfoundland, southern Greenland and Iceland. ENM analysis did not confirm that the Balkans, central Europe or central Russia served as the most important refugia for individual representatives of the Dactylorhiza incarnata/maculata complex. Our study rather indicated that the Black Sea coast, southern Apennines and Corsica were the main areas characterized by habitats suitable for most of the taxa.	[Naczk, Aleksandra M.] Univ Gdansk, Dept Mol Evolut, PL-80308 Gdansk, Poland; [Kolanowska, Marta] Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80308 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Kolanowska, M (corresponding author), Univ Gdansk, Dept Plant Taxon & Nat Conservat, Wita Stwosza 59, PL-80308 Gdansk, Poland.	martakolanowska@wp.pl	Kolanowska, Marta/AAR-3107-2020	Kolanowska, Marta/0000-0001-5347-5403; Naczk, Aleksandra M./0000-0001-7731-4487	Polish Ministry of Science and Higher Education [NN 303 5491]; Foundation For Polish Science (Fundacja na rzecz Nauki Polskiej, FNP); European Social Fund	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation For Polish Science (Fundacja na rzecz Nauki Polskiej, FNP); European Social Fund(European Social Fund (ESF))	The present study was financially supported by the Polish Ministry of Science and Higher Education (grant no. NN 303 5491) and The Foundation For Polish Science (Fundacja na rzecz Nauki Polskiej, FNP). The publication is financed from European Social Fund as a part of the project "Educators for the elite-integrated training program for PhD students, post-docs and professors as academic teachers at University of Gdansk" within the framework of Human Capital Operational Programme, Action IV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to express our gratitude to Professors Dariusz L. Szlachetko and Marek S. Zietara for their valuable comments on the manuscript. This paper was prepared thanks to the support of The Foundation For Polish Science (Fundacja na rzecz Nauki Polskiej, FNP) and The Polish Ministry of Science and Higher Education (grant no. NN 303 5491). We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank National Center for Atmospheric Research for producing and making available their model output. For CMIP the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Adamowski Wojciech, 1995, Wiadomosci Botaniczne, V39, P105; Averyanov L., 1990, ORCHID BIOL REV PERS, VV, P159; Barredo J. I., 2015, Bulletin OEPP, V45, P273, DOI 10.1111/epp.12208; BATEMAN R M, 1989, Watsonia, V17, P319; Bateman RM, 2003, BOT J LINN SOC, V142, P1, DOI 10.1046/j.1095-8339.2003.00157.x; Baumann H., 2006, ORCHIDEEN EUROPAS AN; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Bernardos S, 2006, ACTA BOT GALLICA, V153, P273, DOI 10.1080/12538078.2006.10515546; Boex J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02118; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; BUSBY JR, 1986, AUST J ECOL, V11, P1, DOI 10.1111/j.1442-9993.1986.tb00912.x; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Clague JJ, 2002, QUATERNARY SCI REV, V21, P71, DOI 10.1016/S0277-3791(01)00070-1; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Coops NC, 2011, ECOL MODEL, V222, P2119, DOI 10.1016/j.ecolmodel.2011.03.033; Cozzolino S, 2005, P ROY SOC B-BIOL SCI, V272, P1271, DOI 10.1098/rspb.2005.3069; Cribb P.J., 2003, ORCHID CONSERVATION, P1; Delforge P, 2005, GUIDE ORCHIDEES EURO; Delforge P, 1995, ORCHIDS BRITAIN EURO; Devos N, 2006, MOL PHYLOGENET EVOL, V38, P767, DOI 10.1016/j.ympev.2005.11.013; Devos N, 2005, MOL PHYLOGENET EVOL, V36, P568, DOI 10.1016/j.ympev.2005.04.014; Devos N, 2003, PLANT SYST EVOL, V243, P85, DOI 10.1007/s00606-003-0068-0; DUFRENE M, 1991, PLANT SYST EVOL, V175, P55, DOI 10.1007/BF00942145; Elenga H, 2000, J BIOGEOGR, V27, P621, DOI 10.1046/j.1365-2699.2000.00430.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ferro VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107792; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Freeman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082404; Glennon KL, 2012, EVOL ECOL, V26, P909, DOI 10.1007/s10682-011-9539-x; Godsoe W, 2013, AM J BOT, V100, P496, DOI 10.3732/ajb.1200275; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Gormley KSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068263; Grant V., 1981, PLANT SPECIATION; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; HADLEY G, 1970, NEW PHYTOL, V69, P1015, DOI 10.1111/j.1469-8137.1970.tb02481.x; Hedren M., 1996, Watsonia, V21, P113; Hedren M, 2003, MOL ECOL, V12, P2669, DOI 10.1046/j.1365-294X.2003.01930.x; Hedren M, 1996, NORD J BOT, V16, P253, DOI 10.1111/j.1756-1051.1996.tb00225.x; Hedren M, 2001, AM J BOT, V88, P1868, DOI 10.2307/3558363; Hedren M, 2001, PLANT SYST EVOL, V229, P23, DOI 10.1007/s006060170016; Hedren M, 1996, PLANT SYST EVOL, V201, P31, DOI 10.1007/BF00989050; HEDREN M, 2002, J EUROPAISCHER ORCHI, V34, P707; Hedren M, 2008, MOL ECOL, V17, P5075, DOI 10.1111/j.1365-294X.2008.03965.x; Hedren M, 2007, AM J BOT, V94, P1205, DOI 10.3732/ajb.94.7.1205; Hedren M, 2012, NORD J BOT, V30, P257, DOI 10.1111/j.1756-1051.2012.01321.x; Hedren M, 2011, BIOL J LINN SOC, V104, P107, DOI 10.1111/j.1095-8312.2011.01708.x; Hedren Mikael, 2001, Lindleyana, V16, P17; Hedren M, 2009, ANN BOT-LONDON, V104, P527, DOI 10.1093/aob/mcp102; Hedren M, 2009, NORD J BOT, V27, P69, DOI 10.1111/j.1756-1051.2009.00274.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; HESLOP HARRISON J., 1951, SVENSK BOT TIDSKR, V45, P608; HESLOP-HARRISON J., 1954, BER GEOBOT FORSCHUNGSINST RUBEL ZURICH, V1953, P53; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hopkins DM, 1982, PALEOECOLOGY BERINGI; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1; JAGIELLO M, 1986, FRAGM FLORIST GEOBOT, V31, P385; Janeckova P, 2006, BIOL CONSERV, V129, P40, DOI 10.1016/j.biocon.2005.09.045; Khanum R, 2013, ACTA OECOL, V49, P23, DOI 10.1016/j.actao.2013.02.007; Kim SJ, 2003, CLIM DYNAM, V20, P635, DOI 10.1007/s00382-002-0292-2; Kolanowska M, 2015, ACTA SOC BOT POL, V84, P97, DOI 10.5586/asbp.2014.030; Kolanowska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077352; LAMMI A, 1995, OECOLOGIA, V101, P500, DOI 10.1007/BF00329430; Lammi A, 2003, ANN BOT FENN, V40, P331; Laport RG, 2013, J TORREY BOT SOC, V140, P349, DOI 10.3159/TORREY-D-13-00009.1; Lewis W. H., 1980, Polyploidy. Biological relevance. Part I. Polyploidy and plant evolution., P103; Malm JU, 2002, BIOL J LINN SOC, V77, P23, DOI 10.1046/j.1095-8312.1999.00079.x; McCullagh P, 1989, GEN LINEAR MODELS; McIntyre PJ, 2012, AM J BOT, V99, P655, DOI 10.3732/ajb.1100466; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Minasiewicz J, 2004, ACTA BOT CASSUB, V4, P139; Naczk AM, 2015, BOT J LINN SOC, V178, P121, DOI 10.1111/boj.12267; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Nordal I, 1998, BOT J LINN SOC, V128, P105, DOI 10.1111/j.1095-8339.1998.tb02110.x; Nordstrom S, 2008, PLANT SYST EVOL, V276, P73, DOI 10.1007/s00606-008-0084-1; Nordstrom S, 2009, NORD J BOT, V27, P548, DOI 10.1111/j.1756-1051.2009.00548.x; Nordstrom S, 2009, BIOL J LINN SOC, V97, P52, DOI 10.1111/j.1095-8312.2008.01183.x; Palme AE, 2003, MOL ECOL, V12, P201, DOI 10.1046/j.1365-294X.2003.01724.x; Pedersen HA, 1998, NORD J BOT, V18, P289, DOI 10.1111/j.1756-1051.1998.tb01881.x; Pedersen HA, 1998, NORD J BOT, V18, P15, DOI 10.1111/j.1756-1051.1998.tb01091.x; Pedersen HAE, 2002, NORD J BOT, V22, P641, DOI 10.1111/j.1756-1051.2002.tb01921.x; Pedersen HAE, 2001, NORD J BOT, V21, P177, DOI 10.1111/j.1756-1051.2001.tb01355.x; Pedersen HAE, 2009, BOT J LINN SOC, V159, P396, DOI 10.1111/j.1095-8339.2009.00954.x; Pellegrino G, 2009, BIOLOGIA, V64, P893, DOI 10.2478/s11756-009-0175-7; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pillon Y, 2006, BIOL CONSERV, V129, P4, DOI 10.1016/j.biocon.2005.06.036; Pillon Y, 2007, TAXON, V56, P1185, DOI 10.2307/25065911; Pridgeon A., 2001, GENERA ORCHIDACEAR 1, V2; Pridgeon Alec M., 1997, Lindleyana, V12, P89; Reinhard HR, 1985, MITT BL ARBEITSKR HE, V17, P321; Rendell S, 2002, MOL ECOL, V11, P69, DOI 10.1046/j.0962-1083.2001.01413.x; Schiemann K, 2000, PLANT SYST EVOL, V225, P119, DOI 10.1007/BF00985462; Schmitt T, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-22; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shipunov AB, 2004, AM J BOT, V91, P1419, DOI 10.3732/ajb.91.9.1419; Songer Melissa, 2012, International Journal of Ecology, P1; Stahlberg D, 2008, PLANT SYST EVOL, V273, P107, DOI 10.1007/s00606-008-0035-x; Stahlberg D, 2010, BIOL J LINN SOC, V101, P503, DOI 10.1111/j.1095-8312.2010.01505.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Szalchetko DL, 1996, STORCZYKI POLSKI; Taberlet P, 2002, SCIENCE, V297, P2009, DOI 10.1126/science.297.5589.2009; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Toth JP, 2013, J INSECT CONSERV, V17, P245, DOI 10.1007/s10841-012-9503-2; TREMBLAY RL, 1992, CAN J BOT, V70, P642, DOI 10.1139/b92-083; TYTECA D, 2004, BER ARBEITSKR HEIM O, V21, P4; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083; Varela S, 2011, PALAEOGEOGR PALAEOCL, V310, P451, DOI 10.1016/j.palaeo.2011.07.021; Velasquez-Tibata J, 2013, REG ENVIRON CHANGE, V13, P235, DOI 10.1007/s10113-012-0329-y; Voth W., 1978, LINZER BIOL BEITR, V10, P179; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Wang WG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111587; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Weisrock DW, 2000, MOL PHYLOGENET EVOL, V14, P152, DOI 10.1006/mpev.1999.0689; Weiss S, 2007, PHYLOGEOGRAPHY SO EU; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wotavova K, 2004, BIOL CONSERV, V118, P271, DOI 10.1016/j.biocon.2003.09.005	133	8	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143478	10.1371/journal.pone.0143478	http://dx.doi.org/10.1371/journal.pone.0143478			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599630	Green Published, gold			2022-12-27	WOS:000365853900133
J	Shi, YK; Li, JL; Zhang, SC; Wang, MZ; Yang, SJ; Li, N; Wu, G; Liu, W; Liao, GQ; Cai, KC; Chen, L; Zheng, MZ; Yu, P; Wang, XW; Liu, YP; Guo, QS; Nie, LG; Liu, JW; Han, XH				Shi, Yuankai; Li, Junling; Zhang, Shucai; Wang, Mengzhao; Yang, Shujun; Li, Ning; Wu, Gang; Liu, Wei; Liao, Guoqing; Cai, Kaican; Chen, Liang'an; Zheng, Meizhen; Yu, Ping; Wang, Xiuwen; Liu, Yunpeng; Guo, Qisen; Nie, Ligong; Liu, Jiwei; Han, Xiaohong			Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DRIVER MUTATIONS; SMOKERS VARIES; GENE-MUTATIONS; KINASE DOMAIN; NEVER-SMOKERS; OPEN-LABEL; GEFITINIB; SENSITIVITY; FREQUENCY	Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation frequency on lung adenocarcinoma is still limited to retrospective studies. The PIONEER study (NCT01185314) is a prospective molecular epidemiology study in Asian patients with newly diagnosed advanced lung adenocarcinoma, aiming to prospectively analyze EGFR mutation status in IIIB/IV treatment-naive lung adenocarcinomas in Asia. We report the mainland China subset results. Eligible patients (similar to 20 yrs old, IIIB/IV adenocarcinoma and treatment-naive) were registered in 17 hospitals in mainland China. EGFR was tested for mutations by amplification refractory mutation system using biopsy samples. Demographic and clinical characteristics were collected for subgroup analyses. A total of 747 patients were registered. Successful EGFR mutation analysis was performed in 741, with an overall mutation rate of 50.2%. The EGFR active mutation rate is 48.0% (with 1.3% of combined active and resistance mutations). Tobacco use (>30 pack-year vs. 0-10 pack-year, OR 0.27, 95% CI: 0.17-0.42) and regional lymph nodes involvement (N3 vs. N0, OR 0.47, 95% CI: 0.29-0.76) were independent predictors of EGFR mutation in multivariate analysis. However, even in regular smokers, the EGFR mutation frequency was 35.3%. The EGFR mutation frequency was similar between diverse biopsy sites and techniques. The overall EGFR mutation frequency of the mainland China subset was 50.2%, independently associated with the intensity of tobacco use and regional lymph nodes involvement. The relatively high frequency of EGFR mutations in the mainland China subset suggest that any effort to obtain tissue sample for EGFR mutation testing should be encouraged.	[Shi, Yuankai; Li, Junling; Han, Xiaohong] Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100021, Peoples R China; [Shi, Yuankai; Li, Junling; Han, Xiaohong] Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing 100021, Peoples R China; [Zhang, Shucai] Capital Med Univ, Beijing Chest Hosp, Dept Med Oncol, Beijing 1011429, Peoples R China; [Wang, Mengzhao] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Respirat Med, Beijing 100005, Peoples R China; [Wang, Mengzhao] Peking Union Med Coll, Beijing 100005, Peoples R China; [Yang, Shujun] Henan Canc Hosp, Dept Med Oncol, Zhengzhou 450008, Henan Province, Peoples R China; [Li, Ning] Guangzhou Chest Hosp, Dept Med Oncol, Guangzhou 510095, Guangdong, Peoples R China; [Wu, Gang] Huazhong Univ Sci & Technol, Ctr Canc, Union Hosp, Tongji Med Coll, Wuhan 430030, Hubei Province, Peoples R China; [Liu, Wei] Hebei Med Univ, Dept Med Oncol, Hosp 4, Shijiazhuang 050035, Hebei Province, Peoples R China; [Liao, Guoqing] Chinese Peoples Liberat Army, Hosp 309, Dept Med Oncol, Beijing 100091, Peoples R China; [Cai, Kaican] Southern Med Univ, Nanfang Hosp, Dept Med Oncol, Guangzhou 510515, Guangdong, Peoples R China; [Chen, Liang'an] Chinese Peoples Liberat Army Gen Hosp, Dept Respirat Med, Beijing 100853, Peoples R China; [Zheng, Meizhen] Liaoning Canc Hosp, Dept Med Oncol, Shenyang 110042, Liaoning Provin, Peoples R China; [Yu, Ping] Sichuan Canc Hosp, Dept Med Oncol, Chengdu 610041, Sichuan Provinc, Peoples R China; [Wang, Xiuwen] Shandong Univ, Qilu Hosp, Dept Med Oncol, Jinan 250012, Shandong, Peoples R China; [Liu, Yunpeng] China Med Univ, Dept Med Oncol, Hosp 1, Shenyang 110001, Liaoning Provin, Peoples R China; [Guo, Qisen] Shandong Canc Hosp, Dept Med Oncol, Jinan 250117, Shandong, Peoples R China; [Nie, Ligong] Peking Univ, Dept Respirat Med, Hosp 1, Beijing 100034, Peoples R China; [Liu, Jiwei] Dalian Med Univ, Dept Med Oncol, Affiliated Hosp 1, Dalian 116011, Liaoning Provin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhengzhou University; Huazhong University of Science & Technology; Hebei Medical University; Southern Medical University - China; Chinese People's Liberation Army General Hospital; Shandong University; China Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Peking University; Dalian Medical University	Shi, YK (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China.	syuankai@cicams.ac.cn	han, xiao/HDN-9782-2022	Chen, Liang-an/0000-0002-1829-3134	AstraZeneca; Chinese National Major Project for New Drug Innovation [2008ZX09312, 2012ZX09303012-001]; Research Special Fund for Public Welfare Industry of Health [200902002-1]	AstraZeneca(AstraZeneca); Chinese National Major Project for New Drug Innovation; Research Special Fund for Public Welfare Industry of Health	This study was funded by AstraZeneca and partly supported by Chinese National Major Project for New Drug Innovation (2008ZX09312, 2012ZX09303012-001) and Research Special Fund for Public Welfare Industry of Health (200902002-1).	Arcila ME, 2013, MOL CANCER THER, V12, P220, DOI 10.1158/1535-7163.MCT-12-0620; Chou TY, 2005, CLIN CANCER RES, V11, P3750, DOI 10.1158/1078-0432.CCR-04-1981; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li H, 2013, LUNG CANCER, V79, P8, DOI 10.1016/j.lungcan.2012.09.018; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Na Im Il, 2011, ISRN Oncol, V2011, P756265, DOI 10.5402/2011/756265; Oxnard GR, 2013, J THORAC ONCOL, V8, P179, DOI 10.1097/JTO.0b013e3182779d18; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sasaki H, 2007, LUNG CANCER, V58, P324, DOI 10.1016/j.lungcan.2007.06.024; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Sun YH, 2010, ACTA PHARMACOL SIN, V31, P647, DOI 10.1038/aps.2010.43; Wu SG, 2008, EUR RESPIR J, V32, P924, DOI 10.1183/09031936.00167407; Yasuda H, 2012, LANCET ONCOL, V13, pE23, DOI 10.1016/S1470-2045(11)70129-2; Zhang Y, 2012, CLIN CANCER RES, V18, P1947, DOI 10.1158/1078-0432.CCR-11-2511; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	24	105	135	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143515	10.1371/journal.pone.0143515	http://dx.doi.org/10.1371/journal.pone.0143515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599344	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900135
J	Summers, CF; Gulliford, CM; Carlson, CH; Lillis, JA; Carlson, MO; Cadle-Davidson, L; Gent, DH; Smart, CD				Summers, Carly F.; Gulliford, Colwyn M.; Carlson, Craig H.; Lillis, Jacquelyn A.; Carlson, Maryn O.; Cadle-Davidson, Lance; Gent, David H.; Smart, Christine D.			Identification of Genetic Variation between Obligate Plant Pathogens Pseudoperonospora cubensis and P-humuli Using RNA Sequencing and Genotyping-By-Sequencing	PLOS ONE			English	Article							DOWNY MILDEW; CAUSAL AGENT; MATING-TYPE; OOMYCETE; SEQ; SNPS; PERONOSPORALES; DISCOVERY; INFESTANS	RNA sequencing (RNA-seq) and genotyping-by-sequencing (GBS) were used for single nucleotide polymorphism (SNP) identification from two economically important obligate plant pathogens, Pseudoperonospora cubensis and P. humuli. Twenty isolates of P. cubensis and 19 isolates of P. humuli were genotyped using RNA-seq and GBS. Principle components analysis (PCA) of each data set showed genetic separation between the two species. Additionally, results supported previous findings that P. cubensis isolates from squash are genetically distinct from cucumber and cantaloupe isolates. A PCA-based procedure was used to identify SNPs correlated with the separation of the two species, with 994 and 4,231 PCA-correlated SNPs found within the RNA-seq and GBS data, respectively. The corresponding unigenes (n = 800) containing these potential species-specific SNPs were then annotated and 135 putative pathogenicity genes, including 3 effectors, were identified. The characterization of genes containing SNPs differentiating these two closely related downy mildew species may contribute to the development of improved detection and diagnosis strategies and improve our understanding of host specificity pathways.	[Summers, Carly F.; Carlson, Maryn O.; Smart, Christine D.] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA; [Gulliford, Colwyn M.] Cornell Univ, Cornell Lab Accelerator Based Sci & Educ, Ithaca, NY USA; [Carlson, Craig H.] Cornell Univ, Hort Sect, Sch Integrat Plant Sci, Geneva, NY USA; [Lillis, Jacquelyn A.; Cadle-Davidson, Lance] USDA ARS, Grape Genet Res Unit, Geneva, NY USA; [Gent, David H.] Oregon State Univ, USDA ARS, Forage Seed & Cereal Res Unit, Corvallis, OR 97331 USA; [Gent, David H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Cornell University; Cornell University; Cornell University; United States Department of Agriculture (USDA); Oregon State University; United States Department of Agriculture (USDA); Oregon State University	Smart, CD (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA.	cds14@cornell.edu	Carlson, Craig H/O-9716-2017	Smart, Christine/0000-0003-4162-9502; Carlson, Craig/0000-0003-2050-5455; Myers, Jacquelyn/0000-0002-5005-028X	United States Department of Agriculture Organic Research and Extension Initiative (NIFA) [2012-51300-20006]; National Institutes of Health [1S10OD010693-01]; NSF Graduate Research Fellowship [DGE-1144153]; ARS [ARS-0425016] Funding Source: Federal RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010693] Funding Source: NIH RePORTER	United States Department of Agriculture Organic Research and Extension Initiative (NIFA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided through the United States Department of Agriculture Organic Research and Extension Initiative (http://nifa.usda.gov/funding-opportunity/organic-agriculture-research-and-extension-initiative; NIFA contract no. 2012-51300-20006) and National Institutes of Health (http://www.nih.gov/; grant 1S10OD010693-01). Funding for C.F. Summers was also provided through an NSF Graduate Research Fellowship (www.nsfgrfp.org; DGE-1144153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergey CM, 2012, VCF TAB TO FASTA; Burkhardt A, 2015, MOL PLANT MICROBE IN, V28, P298, DOI 10.1094/MPMI-09-14-0300-FI; Chee HY, 2006, PLANT DIS, V90, P1283, DOI 10.1094/PD-90-1283; Choi YJ, 2005, MYCOL RES, V109, P841, DOI 10.1017/S0953756205002534; Cohen Y, 2013, PLANT DIS, V97, P292, DOI 10.1094/PDIS-10-12-0911-PDN; Cohen Y, 2003, PHYTOPARASITICA, V31, P458, DOI 10.1007/BF02979739; Cohen Y, 2015, PHYTOPATHOLOGY, V105, P998, DOI 10.1094/PHYTO-11-14-0334-FI; Cohen Y, 2012, EUR J PLANT PATHOL, V132, P577, DOI 10.1007/s10658-011-9902-3; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; De Wit P, 2015, MOL ECOL, V24, P2310, DOI 10.1111/mec.13165; Ellis J, 2006, PLANT CELL, V18, P523, DOI 10.1105/tpc.105.040584; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Flier WG, 2002, MYCOL RES, V106, P848, DOI 10.1017/S0953756202006123; Gent DH, 2008, PLANT DIS, V92, P463, DOI 10.1094/PDIS-92-3-0463; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Goodwin SB, 1999, MYCOLOGIA, V91, P796, DOI 10.2307/3761533; Hall GS, 1996, PLANT PATHOL, V45, P1009, DOI 10.1046/j.1365-3059.1996.d01-191.x; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Johnson JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127013; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Laloe D, 2012, GENETIC INTERPRETATI, P1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lebeda A, 2002, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.2002.588.20; Lebeda A., 2011, European Journal of Plant Pathology, V129, P157, DOI 10.1007/s10658-010-9658-1; Li XR, 2012, GENOME RES, V22, P2436, DOI 10.1101/gr.140277.112; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng SW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S7; Mitchell MN, 2011, PHYTOPATHOLOGY, V101, P805, DOI 10.1094/PHYTO-10-10-0270; Northeast hop alliance, 2012, NYSP HOPS ED; Palti J, 1981, DOWNY MILDEWS, P45; Panabieres F, 2005, FUNGAL GENET BIOL, V42, P611, DOI 10.1016/j.fgb.2005.03.002; Paritosh K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-396; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quesada-Ocampo LM, 2012, PLANT DIS, V96, P1459, DOI 10.1094/PDIS-11-11-0943-RE; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; R Core Team, 2016, R FDN STAT COMP; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Riethmuller A, 2002, MYCOLOGIA, V94, P834, DOI 10.2307/3761698; Runge F, 2012, PLANT DIS, V96, P55, DOI 10.1094/PDIS-01-11-0035; Runge F, 2011, EUR J PLANT PATHOL, V129, P147, DOI 10.1007/s10658-010-9650-9; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savory EA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035796, 10.1371/journal.pone.0034701]; SKOTLAND CB, 1983, PLANT DIS, V67, P1183, DOI 10.1094/PD-67-1183; Studholme DJ, 2011, ANNU REV PHYTOPATHOL, V49, P87, DOI 10.1146/annurev-phyto-072910-095408; Summers CF, 2015, CAN J PLANT PATHOL, V37, P315, DOI 10.1080/07060661.2015.1053989; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thines M, 2014, EUR J PLANT PATHOL, V138, P431, DOI 10.1007/s10658-013-0366-5; Thomas A, 2014, PHYTOPATHOLOGY, V104, P118; THOMAS CE, 1987, PHYTOPATHOLOGY, V77, P1621, DOI 10.1094/Phyto-77-1621; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto-Alalibo TA, 2007, MOL PLANT MICROBE IN, V20, P781, DOI 10.1094/MPMI-20-7-0781; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Vidal RO, 2012, GENET MOL BIOL, V35, P331, DOI 10.1590/S1415-47572012000200014; Voglmayr H, 1998, FUNGAL GENET BIOL, V25, P181, DOI 10.1006/fgbi.1998.1097; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199	65	21	21	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143665	10.1371/journal.pone.0143665	http://dx.doi.org/10.1371/journal.pone.0143665			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599440	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900154
J	Ehrentraut, H; Ehrentraut, SF; Boehm, O; El Aissati, S; Foltz, F; Goelz, L; Goertz, D; Kebir, S; Weisheit, C; Wolf, M; Meyer, R; Baumgarten, G				Ehrentraut, Heidi; Ehrentraut, Stefan Felix; Boehm, Olaf; El Aissati, Sakina; Foltz, Fabian; Goelz, Lina; Goertz, David; Kebir, Sied; Weisheit, Christina; Wolf, Michael; Meyer, Rainer; Baumgarten, Georg			Tlr4 Deficiency Protects against Cardiac Pressure Overload Induced Hyperinflammation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RECEPTOR 4-DEFICIENT MICE; GENE-EXPRESSION; IN-VIVO; HYPERTROPHY; HEART; INFLAMMATION; ACTIVATION; MONOCYTES; IMMUNITY	Transverse aortic constriction provokes a pro-inflammatory reaction and results in cardiac hypertrophy. Endogenous ligands contribute to cardiac hypertrophy via toll-like receptor (TLR)4 binding. A lack of TLR4 signaling diminishes hypertrophy and inflammation. Wild type mice undergoing aortic constriction respond to a lipopolysaccharide second-hit stimulus with hyper-inflammation. The objective of this study was to assess whether other second-hit challenges utilizing TLR ligands provoke a comparable inflammatory reaction, and to find out whether this response is absent in TLR4 deficient mice. Assuming that cardiac stress alters the expression of pattern recognition receptors we analyzed the effects of transverse aortic constriction and second-hit virulence factor treatment on TLR expression, as well as cytokine regulation. Wild type and Tlr4(-/-) mice were subjected to three days of TAC and subsequently confronted with gram-positive TLR2 ligand lipoteichoic acid (LTA, 15mg/g bodyweight) or synthetic CpG-oligo-desoxynucleotide 1668 thioate (20 nmol/kg bodyweight, 30 min after D-galactosamin desensitization) signaling via TLR9. Hemodynamic measurements and organ preservation were performed 6 h after stimulation. Indeed, the study revealed a robust enhancement of LTA induced pattern recognition receptor and cytokine mRNA expression and a LTA-dependent reduction of hemodynamic pressure in TAC wild typemice. Second-Hit treatment with CpG-ODNs led to similar results. However, second-hit effects were abolished in Tlr4(-/-) mice. In total, these data indicate for the first time that cardiac stress increases the inflammatory response towards both, gram-negative and gram-positive, TLR ligands as well as bacterial DNA. The decrease of the inflammatory response upon TLR2 and -9 ligand challenge in TAC Tlr4(-/-) mice demonstrates that a lack of TLR4 signaling does not only prevent left ventricular hypertrophy but also protects the mice from a cardiac stress induced hyperinflammatory reaction.	[Ehrentraut, Heidi; Ehrentraut, Stefan Felix; Boehm, Olaf; El Aissati, Sakina; Foltz, Fabian; Goertz, David; Kebir, Sied; Weisheit, Christina; Baumgarten, Georg] Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, D-53105 Bonn, Germany; [El Aissati, Sakina] Marienhaus Klinikum, Bad Neuenahr Ahrweiler, Germany; [Foltz, Fabian] Asklepios Klin St Augustin, St Augustin, Germany; [Goelz, Lina; Wolf, Michael] Univ Bonn, Polyclin Orthodont, D-53111 Bonn, Germany; [Goelz, Lina; Wolf, Michael; Meyer, Rainer] Univ Hosp Bonn, Inst Physiol 2, D-53115 Bonn, Germany; [Goelz, Lina] HELIOS Med Ctr Siegburg, Klin Orthopadie & Unfallchirurg, Siegburg, Germany; [Kebir, Sied] Univ Bonn Med Ctr, Dept Neurol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn	Ehrentraut, H (corresponding author), Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, Sigmund Freud Str 25, D-53105 Bonn, Germany.	heidi.ehrentraut@ukb.uni-bonn.com	Kebir, Sied/ABD-8792-2021; Weisheit, Christina/V-2507-2018; Meyer, Rainer/H-5871-2013	Kebir, Sied/0000-0002-0678-5852; Weisheit, Christina/0000-0002-7647-1613; Ehrentraut, Stefan/0000-0001-5747-6737	Deutsche Forschungsgemeinschaft [BA 1725/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by BA 1725/3-1, Deutsche Forschungsgemeinschaft (http://dfg.de/). GB received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2000, J ENDOTOXIN RES, V6, P383, DOI 10.1177/09680519000060050901; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baumgarten G, 2002, CIRCULATION, V105, P2192, DOI 10.1161/01.CIR.0000015608.37608.18; Baumgarten G, 2001, J INFECT DIS, V183, P1617, DOI 10.1086/320712; Baumgarten G, 2006, BASIC RES CARDIOL, V101, P427, DOI 10.1007/s00395-006-0597-0; Boehm O, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/217297; Boehm O, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-33; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Ehrentraut H, 2011, EUR J HEART FAIL, V13, P602, DOI 10.1093/eurjhf/hfr035; Ehrentraut SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044531; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Ifrim DC, 2014, CLIN VACCINE IMMUNOL, V21, P534, DOI 10.1128/CVI.00688-13; Jiang DS, 2014, HYPERTENSION, V63, P96, DOI 10.1161/HYPERTENSIONAHA.113.01506; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Li T, 2009, J HYPERTENS, V27, P1084, DOI 10.1097/HJH.0b013e3283293c93; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Matsuda S, 2015, J ATHEROSCLER THROMB; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; ROCKMAN HA, 1994, AM J PHYSIOL, V266, pH2468, DOI 10.1152/ajpheart.1994.266.6.H2468; Stapel H, 2006, EUR J HEART FAIL, V8, P665, DOI 10.1016/j.ejheart.2006.03.005; Valparaiso AP, 2014, J SURG RES; Weisheit C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112710; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266	26	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142921	10.1371/journal.pone.0142921	http://dx.doi.org/10.1371/journal.pone.0142921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588247	gold, Green Published, Green Submitted			2022-12-27	WOS:000365251500023
J	Negash, C; Whiting, SJ; Henry, CJ; Belachew, T; Hailemariam, TG				Negash, Canaan; Whiting, Susan J.; Henry, Carol J.; Belachew, Tefera; Hailemariam, Tewodros G.			Association between Maternal and Child Nutritional Status in Hula, Rural Southern Ethiopia: A Cross Sectional Study	PLOS ONE			English	Article							GROWTH; DETERMINANTS; EDUCATION; HEALTH; CARE	Background Maternal and child under nutrition is highly prevalent in low-income and middle-income countries, resulting in substantial increases in mortality and overall disease burden. The aim of this baseline survey was to determine the association between selected maternal characteristics, maternal nutritional status and children's nutritional status. Methods and Findings A survey with a cross sectional design was conducted between September and October 2012 in Hula, Ethiopia. The study subjects were 197 mothers of children between the ages of 6 and 23 months. Weight and height (mothers) or recumbent length (children) were measured using calibrated, standardized techniques. Seven percent of children were below -2 weight for height Z score (WHZ), 11.5% were below -2 height for age Z score (HAZ) and 9.9% were below -2 weight for age Z score (WAZ). Maternal anthropometrics were associated with child nutritional status in the bivariate analysis. Maternal BMI (r = 0.16 P = 0.02) and educational status (r = 0.25 P = 0.001) were correlated with WHZ of children while maternal height (r = 0.2 P = 0.007) was correlated with HAZ of children. After multivariate analysis, children whose mothers had salary from employment had a better WHZ score (P = 0.001) and WAZ score (P<0.001). Both maternal BMI and maternal height were associated with WHZ (P = 0.04) and HAZ (P = 0.01) score of children. Conclusion Having a mother with better nutritional status and salaried employment is a benefit for the nutritional status of the child. The interrelationship between maternal and child nutritional status stresses the value of improving maternal nutritional status as this should improve both maternal and child health outcomes. Therefore strategies to improve nutritional status of children should also include improving the nutritional status of the mother and empowering her financially.	[Negash, Canaan; Hailemariam, Tewodros G.] Wolaita Sodo Univ, Sch Publ Hlth, Wolaita, Ethiopia; [Whiting, Susan J.; Henry, Carol J.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada; [Belachew, Tefera] Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia	University of Saskatchewan; Jimma University	Negash, C (corresponding author), Wolaita Sodo Univ, Sch Publ Hlth, Wolaita, Ethiopia.	canaanb00@gmail.com	Hailemariam, Tewodros Getachew/AAI-2914-2020; Belachew, Tefera/AAO-5877-2020	Hailemariam, Tewodros Getachew/0000-0001-6013-2767; 	Canadian Department of Foreign Affairs, Trade and Development, International Development Research Centre (IDRC) Canadian International Food Security Research Fund (CIFSRF)	Canadian Department of Foreign Affairs, Trade and Development, International Development Research Centre (IDRC) Canadian International Food Security Research Fund (CIFSRF)	Funding: Financial support was provided by the Canadian Department of Foreign Affairs, Trade and Development, International Development Research Centre (IDRC) Canadian International Food Security Research Fund (CIFSRF), http://www.idrc.ca/EN/Pages/default.aspx). The funders had no role in decision to publish or preparation of the manuscript.	Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; Ajieroh V, 2009, QUANTITATIVE ANAL DE; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Ethiopian Society of Population Studies, 2008, MAT HLTH CAR SEEK BE; Fabunmi TM, 2013, INT J CHILD HEALTH N, V2, P39, DOI 10.6000/1929-4247.2013.02.01.7; Felisbino-Mendes MS, 2014, PLOS ONE, V9; Frost MB, 2005, SOC SCI MED, V60, P395, DOI 10.1016/j.socscimed.2004.05.010; Gewa CA, 2012, MATERN CHILD NUTR, V8, P275, DOI 10.1111/j.1740-8709.2011.00322.x; Girma W., 2002, DETERMINANTS NUTR ST; [ICFI Ethiopia Demographic and Health Survey Central AS], 2011, ICF I ETH DEM HLTH S; Kabubo-Mariara J, 2009, J AFR ECON, V18, P363, DOI 10.1093/jae/ejn024; Lamontagne JF, 1998, SOC SCI MED, V46, P403, DOI 10.1016/S0277-9536(97)00184-6; Lander RL, 2012, CAD SAUDE PUBLICA, V28, P2177, DOI 10.1590/S0102-311X2012001100017; Lourenco BH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-265; Negash C, 2014, FOOD NUTR BULL, V35, P480, DOI 10.1177/156482651403500409; Shuhaimi F., 2012, Asian Journal of Clinical Nutrition, V4, P53, DOI 10.3923/ajcn.2012.53.66; Wamani H., 2007, BMC Pediatrics, V7; World Bank, CHILD MALN	19	43	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142301	10.1371/journal.pone.0142301	http://dx.doi.org/10.1371/journal.pone.0142301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW8LQ	26588687	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500009
J	Shingleton, JR; Hemann, MT				Shingleton, Jennifer R.; Hemann, Michael T.			The Chromatin Regulator CHD8 Is a Context-Dependent Mediator of Cell Survival in Murine Hematopoietic Malignancies	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMOSOME-POSITIVE LEUKEMIAS; AUTISM SPECTRUM DISORDERS; HISTONE H1 RECRUITMENT; DE-NOVO MUTATIONS; TARGETED THERAPY; BURKITT-LYMPHOMA; SUPPRESSION; RESISTANCE; CANCER	Aberrant chromatin regulation is a frequent driver of leukemogenesis. Mutations in chromatin regulators often result in more stem-like cells that seed a bulk leukemic population. Inhibitors targeting these proteins represent an emerging class of therapeutics, and identifying further chromatin regulators that promote disease progression may result in additional drug targets. We identified the chromatin-modifying protein CHD8 as necessary for cell survival in a mouse model of BCR-Abl+ B-cell acute lymphoblastic leukemia. This disease has a poor prognosis despite treatment with kinase inhibitors targeting BCR-Abl. Although implicated as a risk factor in autism spectrum disorder and a tumor suppressor in prostate and lung cancer, the mechanism of CHD8's activity is still unclear and has never been studied in the context of hematopoietic malignancies. Here we demonstrate that depletion of CHD8 in B-ALL cells leads to cell death. While multiple B cell malignancies were dependent on CHD8 expression for survival, T cell malignancies displayed milder phenotypes upon CHD8 knockdown. In addition, ectopic expression of the Notch1 intracellular domain in a T cell malignancy partially alleviated the detrimental effect of CHD8 depletion. Our results demonstrate that CHD8 has a context-dependent role in cell survival, and its inhibition may be an effective treatment for B lymphoid malignancies.	[Shingleton, Jennifer R.; Hemann, Michael T.] MIT, Koch Inst Integrated Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hemann, MT (corresponding author), MIT, Koch Inst Integrated Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hemann@mit.edu			Ludwig Foundation for Cancer research; NSF graduate Fellowship	Ludwig Foundation for Cancer research; NSF graduate Fellowship(National Science Foundation (NSF))	This work was funded by the Ludwig Foundation for Cancer research (http://www.ludwigcancerresearch.org). JRS was funded by by an NSF graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Liu-Dumlao T, 2012, CURR ONCOL REP, V14, P387, DOI 10.1007/s11912-012-0247-7; Meacham CE, 2008, GENE DEV, P483; Menon T, 2010, MOL ENDOCRINOL, V24, P1165, DOI 10.1210/me.2009-0421; Mullighan CG, 2008, GENE DEV, V22, P1411, DOI 10.1101/gad.1673908; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nie J, 2014, CANCER LETT, V354, P12, DOI 10.1016/j.canlet.2014.08.010; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez-Paredes M, 2009, NUCLEIC ACIDS RES, V37, P2449, DOI 10.1093/nar/gkp101; Sakamoto I, 2000, J BIOL CHEM, V275, P32871, DOI 10.1074/jbc.M004089200; Sawada G, 2013, ONCOL REP, V30, P1137, DOI 10.3892/or.2013.2597; Subtil-Rodrfguez A, 2013, NUCLEIC ACIDS RES, P1; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tahara T, 2014, GASTROENTEROLOGY, V146, P530, DOI 10.1053/j.gastro.2013.10.060; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	38	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143275	10.1371/journal.pone.0143275	http://dx.doi.org/10.1371/journal.pone.0143275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588464	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500048
J	Fernandez, AB; Panza, GA; Cramer, B; Chatterjee, S; Jayaraman, R; Wu, WC				Fernandez, Antonio B.; Panza, Gregory A.; Cramer, Benjamin; Chatterjee, Saurav; Jayaraman, Ramya; Wu, Wen-Chih			Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SUBRETINAL DRUSENOID DEPOSITS; ENDOTHELIAL GROWTH-FACTOR; BEAVER DAM EYE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PREVALENCE; EPIDEMIOLOGY; THERAPIES; MORTALITY; MODEL	Background Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness in people over 65 years old in the United States and has been associated with cardiovascular risk and decreased survival. There is conflicting data, however, regarding the contribution of AMD to the prediction of stroke. Aim To determine whether AMD is a risk indicator for incident stroke in a meta-analysis of available prospective and retrospective cohort studies published in the English literature. Methods We performed a systematic literature search of all studies published in English with Pub Med and other databases from 1966 to August 2014, reporting stroke incidence in patients with macular degeneration. Two investigators independently extracted the data. A random effects model was used to report Odds ratios (OR), with corresponding 95% confidence intervals (CI). Meta-regression using a mixed linear model was used to understand potential heterogeneity amongst studies. Results We identified 9 studies that reported stroke incidence in patients with and without early AMD (N = 1,420,978). No significant association was found between early AMD with incident stroke. Combined, these 9 studies demonstrated random effects (OR, 1.12; CI, 0.86-1.47; I-2 = 96%). Meta-regression on baseline covariates of age, sex, and year of publication did not significantly relate to heterogeneity. Conclusions We found no significant relationship between AMD and incident stroke. Further studies are needed to clarify other causes of decreased survival in patients with AMD.	[Fernandez, Antonio B.; Panza, Gregory A.] Hartford Hosp, Div Cardiol, Hartford, CT 06115 USA; [Fernandez, Antonio B.] Univ Connecticut, Sch Med, Farmington, CT USA; [Panza, Gregory A.] Univ Connecticut, Dept Kinesiol, Storrs, CT USA; [Cramer, Benjamin] Quinnipiac Univ, Frank H Netter Sch Med, Hamden, CT USA; [Chatterjee, Saurav] Mt Sinai Hlth Syst, St Lukes Roosevelt Hosp, New York, NY USA; [Jayaraman, Ramya] St Vincents Med Ctr, Dept Med, Bridgeport, CT USA; [Wu, Wen-Chih] Brown Univ, Alpert Med Sch, Med Serv, Providence VA Med Ctr, Providence, RI 02912 USA; [Wu, Wen-Chih] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA	Hartford Hospital; University of Connecticut; University of Connecticut; Quinnipiac University; Icahn School of Medicine at Mount Sinai; Mount Sinai St. Luke's; Mount Sinai West; St. Vincent's Medical Center; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Fernandez, AB (corresponding author), Hartford Hosp, Div Cardiol, Hartford, CT 06115 USA.	antoinefemandezt@hotmail.com	Jayaraman, Ramya/AAM-1518-2021					A Martillo Miguel, 2012, Med Hypothesis Discov Innov Ophthalmol, V1, P37; Alexander SL, 2007, OPHTHALMOLOGY, V114, P2174, DOI 10.1016/j.ophtha.2007.09.017; Chakravarthy U, 2007, OPHTHALMOLOGY, V114, P1157, DOI 10.1016/j.ophtha.2006.09.022; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Fernandez AB, 2012, OPHTHALMOLOGY, V119, P765, DOI 10.1016/j.ophtha.2011.09.044; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; FRIEDMAN E, 1995, OPHTHALMOLOGY, V102, P640, DOI 10.1016/S0161-6420(95)30974-8; Friedman E, 1997, AM J OPHTHALMOL, V124, P677, DOI 10.1016/S0002-9394(14)70906-7; Hogg RE, 2007, OPHTHALMOLOGY, V115; Hu CC, 2010, STROKE, V41, P613, DOI 10.1161/STROKEAHA.109.571000; Ikram MK, 2012, STROKE, V43, P1681, DOI 10.1161/STROKEAHA.112.654632; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2008, AM J OPHTHALMOL, V145, P317, DOI 10.1016/j.ajo.2007.09.008; Knudtson MD, 2006, ARCH OPHTHALMOL-CHIC, V124, P243, DOI 10.1001/archopht.124.2.243; Liao DP, 2008, OPEN OPHTHALMOL J, V2, P37, DOI 10.2174/1874364100802010037; Lip PL, 2001, OPHTHALMOLOGY, V108, P705, DOI 10.1016/S0161-6420(00)00663-1; Nguyen-Khoa BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1280, DOI 10.1001/archopht.126.9.1280; Pumariega NM, 2011, OPHTHALMOLOGY, V118, P1619, DOI 10.1016/j.ophtha.2011.01.029; Ross RD, 1998, AM J OPHTHALMOL, V125, P71, DOI 10.1016/S0002-9394(99)80237-2; Saade C, 2014, CLIN EXP OPHTHALMOL, V42, P865, DOI 10.1111/ceo.12353; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Smith RT, 2009, AM J OPHTHALMOL, V148, P733, DOI 10.1016/j.ajo.2009.06.028; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun C, 2009, OPHTHALMOLOGY, V116, P1913, DOI 10.1016/j.ophtha.2009.03.046; Tan JSL, 2008, BRIT J OPHTHALMOL, V92, P509, DOI 10.1136/bjo.2007.131706; Verhoeff F H, 1937, Trans Am Ophthalmol Soc, V35, P262; Voutilainen-Kaunisto RM, 2002, DIABETES CARE, V20, P1672; Wieberdink RG, 2011, STROKE, V42, P2138, DOI 10.1161/STROKEAHA.111.616359; Wong TY, 2009, AM J OPHTHALMOL, V148, P327, DOI 10.1016/j.ajo.2009.05.012; Wong TY, 2006, ANN INTERN MED, V145, P98, DOI 10.7326/0003-4819-145-2-200607180-00007; Xu LN, 2013, RETINA-J RET VIT DIS, V33, P1850, DOI 10.1097/IAE.0b013e31828991b2; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P1775, DOI 10.1016/j.ophtha.2010.01.027	35	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142968	10.1371/journal.pone.0142968	http://dx.doi.org/10.1371/journal.pone.0142968			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580396	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600071
J	Bonnemains, L; Odille, F; Meyer, C; Hossu, G; Felblinger, J; Vuissoz, PA				Bonnemains, Laurent; Odille, Freddy; Meyer, Christophe; Hossu, Gabriella; Felblinger, Jacques; Vuissoz, Pierre-Andre			Is High Temporal Resolution Achievable for Paediatric Cardiac Acquisitions during Several Heart Beats? Illustration with Cardiac Phase Contrast Cine-MRI	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; TIME-RESOLVED MRI; RECONSTRUCTION; DOPPLER; ECHOCARDIOGRAPHY; MOTION; FIELD	Background During paediatric cardiac Cine-MRI, data acquired during cycles of different lengths must be combined. Most of the time, Feinstein's model is used to project multiple cardiac cycles of variable lengths into a mean cycle. Objective To assess the effect of Feinstein projection on temporal resolution of Cine-MRI. Methods 1/The temporal errors during Feinstein's projection were computed in 306 cardiac cycles fully characterized by tissue Doppler imaging with 6-phase analysis (from a population of 7 children and young adults). 2/The effects of these temporal errors on tissue velocities were assessed by simulating typical tissue phase mapping acquisitions and reconstructions. 3/Myocardial velocities curves, extracted from high-resolution phase-contrast cine images, were compared for the 6 volunteers with lowest and highest heart rate variability, within a population of 36 young adults. Results 1/The mean of temporal misalignments was 30 ms over the cardiac cycle but reached 60 ms during early diastole. 2/During phase contrast MRI simulation, early diastole velocity peaks were diminished by 6.1 cm/s leading to virtual disappearance of isovolumic relaxation peaks. 3/The smoothing and erasing of isovolumic relaxation peaks was confirmed on tissue phase mapping velocity curves, between subjects with low and high heart rate variability (p = 0.05). Conclusions Feinstein cardiac model creates temporal misalignments that impair high temporal resolution phase contrast cine imaging when beat-to-beat heart rate is changing.	[Bonnemains, Laurent] CHU Strasbourg, Dept Cardiol, F-67000 Strasbourg, France; [Bonnemains, Laurent] CHU Nancy, Dept Cardiol, Nancy, France; [Bonnemains, Laurent; Odille, Freddy; Meyer, Christophe; Hossu, Gabriella; Felblinger, Jacques; Vuissoz, Pierre-Andre] INSERM, U947, Nancy, France; [Bonnemains, Laurent; Odille, Freddy; Meyer, Christophe; Felblinger, Jacques; Vuissoz, Pierre-Andre] Univ Lorraine, IADI, Nancy, France; [Hossu, Gabriella; Felblinger, Jacques] CHU Nancy, Clin Invest Ctr, CIC IT 1433, Nancy, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; CHU de Nancy	Bonnemains, L (corresponding author), CHU Strasbourg, Dept Cardiol, F-67000 Strasbourg, France.	laurent.bonnemains@inserm.fr	Felblinger, Jacques/ABG-2033-2021; Hossu, Gabriela/ABG-2470-2021; Vuissoz, Pierre-André/Y-8259-2019; Odille, Freddy/H-7650-2019; bonnemains, laurent/A-3394-2013	Felblinger, Jacques/0000-0002-9245-6595; Hossu, Gabriela/0000-0003-1178-9097; Vuissoz, Pierre-André/0000-0003-3519-1743; Odille, Freddy/0000-0001-5260-8905; bonnemains, laurent/0000-0002-5194-1762				Bezanson J., 2012, ARXIV12095145CS; Biglino G, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-57; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Calcagno C, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-42; Espe EKS, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-82; Feinstein JA, 1997, JMRI-J MAGN RESON IM, V7, P794, DOI 10.1002/jmri.1880070505; Kellman P, 2009, MAGN RESON MED, V62, P1557, DOI 10.1002/mrm.22153; Kowalik GT, 2015, MAGN RESON MED, V73, P749, DOI 10.1002/mrm.25183; Larson AC, 2004, MAGN RESON MED, V51, P93, DOI 10.1002/mrm.10664; Lindqvist P, 2005, ECHOCARDIOGR-J CARD, V22, P305, DOI 10.1111/j.1540-8175.2005.04023.x; Meyer C, 2014, J CARDIOVASCULAR MAG, V16; Meyer C, 2014, MAGN RESON MATER PHY, V27, P211, DOI 10.1007/s10334-013-0405-4; Mistretta CA, 2006, MAGN RESON MED, V55, P30, DOI 10.1002/mrm.20772; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; R Core Team, 2020, R LANG ENV STAT COMP; Schaeffter T, 2001, MAGNET RESON MED, V46, P1238, DOI 10.1002/mrm.1322; Sengupta PP, 2007, J AM COLL CARDIOL, V49, P899, DOI 10.1016/j.jacc.2006.07.075; Siegel RJ, 1956, NONPARAMETRIC STAT B; Siest G, 1998, CLIN CHEM LAB MED, V36, P35, DOI 10.1515/CCLM.1998.007; Tsao J, 2012, J MAGN RESON IMAGING, V36, P543, DOI 10.1002/jmri.23640; Voss A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118308; WEISSLER AM, 1968, CIRCULATION, V37, P149, DOI 10.1161/01.CIR.37.2.149; Winkelmann S, 2007, IEEE T MED IMAGING, V26, P68, DOI 10.1109/TMI.2006.885337; Xue H, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-102; Zhang S, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-39	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143744	10.1371/journal.pone.0143744	http://dx.doi.org/10.1371/journal.pone.0143744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599755	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600116
J	Daneshjoo, A; Abu Osman, NA; Sahebozamani, M; Yusof, A				Daneshjoo, Abdolhamid; Abu Osman, Noor Azuan; Sahebozamani, Mansour; Yusof, Ashril			Analysis of Jumping-Landing Manoeuvers after Different Speed Performances in Soccer Players	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; LOWER-EXTREMITY BIOMECHANICS; INJURY PREVENTION; LEG; STRENGTH; RISK; RELIABILITY; KINEMATICS; CAPACITIES; DOMINANT	Purpose Running at high speed and sudden change in direction or activity stresses the knee. Surprisingly, not many studies have investigated the effects of sprinting on knee's kinetics and kinematics of soccer players. Hence, this study is aimed to investigate indices of injury risk factors of jumping-landing maneuvers performed immediately after sprinting in male soccer players. Methods Twenty-three collegiate male soccer players (22.1 +/- 1.7 years) were tested in four conditions; vertical jump (VJ), vertical jump immediately after slow running (VJSR), vertical jump immediately after sprinting (VJFR) and double horizontal jump immediately after sprinting (HJFR). The kinematics and kinetics data were measured using Vicon motion analyzer (100Hz) and two Kistler force platforms (1000Hz), respectively. Results For knee flexion joint angle, (p = 0.014, eta = 0.15) and knee valgus moment (p = 0.001, eta = 0.71) differences between condition in the landing phase were found. For knee valgus joint angle, a main effect between legs in the jumping phase was found (p = 0.006, eta = 0.31), which suggests bilateral deficit existed between the right and left lower limbs. Conclusion In brief, the important findings were greater knee valgus moment and less knee flexion joint angle proceeding sprint (HJFR & VJFR) rather than no sprint condition (VJ) present an increased risk for knee injuries. These results seem to suggest that running and sudden subsequent jumping-landing activity experienced during playing soccer may negatively change the knee valgus moment. Thus, sprinting preceding a jump task may increase knee risk factors such as moment and knee flexion joint angle.	[Daneshjoo, Abdolhamid; Sahebozamani, Mansour] Shahid Bahonar Univ Kerman, Fac Phys Educ & Sport Sci, Dept Sports Injuries & Correct Exercises, Kerman, Iran; [Abu Osman, Noor Azuan] Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Yusof, Ashril] Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia	Shahid Bahonar University of Kerman (SBUK); Universiti Malaya; Universiti Malaya	Daneshjoo, A (corresponding author), Shahid Bahonar Univ Kerman, Fac Phys Educ & Sport Sci, Dept Sports Injuries & Correct Exercises, Kerman, Iran.	daneshjoo.hamid@mail.com	Sahebozamani, Mansour/ABH-2181-2022; Daneshjoo, Abdolhamid/B-3225-2013; ABU OSMAN, NOOR AZUAN/B-9265-2010; YUSOF, ASHRIL/B-8252-2010	Daneshjoo, Abdolhamid/0000-0002-6197-2300; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; YUSOF, ASHRIL/0000-0002-8117-6440	UM/MOHE/HIR [D000014-16001]	UM/MOHE/HIR	This study was supported by UM/MOHE/HIR Project No. D000014-16001. The authors are grateful to Dr. Mohammadtaghi Amiri-Khorasani and Nafiseh Khalaj for their expert guidance during the early stage of this project and Dr. Jos Vanrenterghem for his valuable comments.	Adams G., 1999, EXERCISE PHYSL LAB M, V3; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; [Anonymous], 2005, INT J SPORT STUD, DOI DOI 10.5432/IJSHS.3.272; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bahr R, 2003, BRIT J SPORT MED, V37, P384, DOI 10.1136/bjsm.37.5.384; BERNS GS, 1992, J ORTHOP RES, V10, P167, DOI 10.1002/jor.1100100203; Besier TF, 2001, MED SCI SPORT EXER, V33, P1168; Christou M, 2006, J STRENGTH COND RES, V20, P783, DOI 10.1519/00124278-200611000-00010; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daneshjoo A, 2013, BIOL SPORT, V30, P281, DOI [10.5604/20831862.1077554, 10.5604/20881862.1077554]; Daneshjoo A, 2013, J HUM KINET, V36, P45, DOI [10.2478/hukin-2013-0005, 10.2478/hukin-2013-0074]; Daneshjoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050979; DEVITA P, 1992, MED SCI SPORT EXER, V24, P108; Durall CJ, 2011, J SPORT REHABIL, V20, P406, DOI 10.1123/jsr.20.4.406; Fauno P, 2006, INT J SPORTS MED, V27, P75, DOI 10.1055/s-2005-837485; Fedie R, 2012, SPORT BIOMECH, V9, P165; Fong CM, 2011, J ATHL TRAINING, V46, P5, DOI 10.4085/1062-6050-46.1.5; Fousekis K, 2010, J SPORT SCI MED, V9, P364; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hewett TE, 2006, AM J SPORT MED, V34, P490, DOI 10.1177/0363546505282619; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hootman JM, 2012, J ATHL TRAINING, V47, P589, DOI 10.4085/1062-6050-47.5.06; Iga J, 2009, SCAND J MED SCI SPOR, V19, P714, DOI 10.1111/j.1600-0838.2008.00822.x; Kimura Y, 2012, BRIT J SPORT MED, V46, P207, DOI 10.1136/bjsm.2010.080861; Lin HC, 2010, J SPORT SCI MED, V9, P472; Little T, 2006, J STRENGTH COND RES, V20, P203; Lockie RG, 2013, J SPORT SCI MED, V12, P88; Maulder P, 2005, PHYS THER SPORT, V6, P74, DOI 10.1016/j.ptsp.2005.01.001; McLean SG, 2005, CLIN BIOMECH, V20, P863, DOI 10.1016/j.clinbiomech.2005.05.007; Nagano A, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-20; Niu WX, 2011, HUM MOVEMENT SCI, V30, P614, DOI 10.1016/j.humov.2010.10.010; Orsi AD, 2015, COMPUT METHOD BIOMEC, P1; Pallant J, 2007, SPSS SURVIVAL MANUAL, P263; Rahnama N., 2009, SPORT SCI HLTH, V5, P9, DOI [DOI 10.1007/S11332-009-0070-1, 10.1007/s11332-009-0070-1]; Schiltz M, 2009, J ATHL TRAINING, V44, P39, DOI 10.4085/1062-6050-44.1.39; Sell TC, 2007, J ORTHOP RES, V25, P1589, DOI 10.1002/jor.20459; Shultz SJ, 2007, CLIN J SPORT MED, V17, P357, DOI 10.1097/JSM.0b013e31811df950; van der Harst JJ, 2007, CLIN BIOMECH, V22, P674, DOI 10.1016/j.clinbiomech.2007.02.007; Wang LI, 2011, J SPORT SCI MED, V10, P151; Wannop JW, 2012, J APPL BIOMECH, V28, P665, DOI 10.1123/jab.28.6.665; Wong P, 2005, BRIT J SPORT MED, V39, P473, DOI 10.1136/bjsm.2004.015511; Yu B, 2006, CLIN BIOMECH, V21, P297, DOI 10.1016/j.clinbiomech.2005.11.003	42	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143323	10.1371/journal.pone.0143323	http://dx.doi.org/10.1371/journal.pone.0143323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599336	Green Published, gold			2022-12-27	WOS:000365862600050
J	Jozwiak, B; Orczykowska, M; Dziubinski, M				Jozwiak, Bertrand; Orczykowska, Magdalena; Dziubinski, Marek			Fractional Generalizations of Maxwell and Kelvin-Voigt Models for Biopolymer Characterization	PLOS ONE			English	Article							VISCOELASTIC MODELS; MOLECULAR-WEIGHT; CROSS-LINKS; CALCULUS; BEHAVIOR; RELAXATION; MODULUS; STARCH	The paper proposes a fractional generalization of the Maxwell and Kelvin-Voigt rheological models for a description of dynamic behavior of biopolymer materials. It was found that the rheological models of Maxwell-type do not work in the case of modeling of viscoelastic solids, and the model which significantly better describes the nature of changes in rheological properties of such media is the modified fractional Kelvin-Voigt model with two built-in springpots (MFKVM2). The proposed model was used to describe the experimental data from the oscillatory and creep tests of 3% (w/v) kuzu starch pastes, and to determine the values of their rheological parameters as a function of pasting time. These parameters provide a lot of additional information about structure and viscoelastic properties of the medium in comparison to the classical analysis of dynamic curves G' and G '' and shear creep compliance J(t). It allowed for a comprehensive description of a wide range of properties of kuzu starch pastes, depending on the conditions of pasting process.	[Jozwiak, Bertrand; Orczykowska, Magdalena; Dziubinski, Marek] Lodz Univ Technol, Fac Proc & Environm Engn, Lodz, Poland	Lodz University of Technology	Jozwiak, B (corresponding author), Lodz Univ Technol, Fac Proc & Environm Engn, Lodz, Poland.	bertrand.jozwiak@dokt.p.lodz.pl	Orczykowska, Magdalena/P-1472-2019; Dziubinski, Marek/P-4524-2019; Jóźwiak, Bertrand/AAW-3024-2021	Orczykowska, Magdalena/0000-0002-0109-2563; Dziubinski, Marek/0000-0002-7765-1106; Jozwiak, Bertrand/0000-0003-2977-5670				Alcoutlabi M, 1998, POLYMER, V39, P6269, DOI 10.1016/S0032-3861(98)00168-2; [Anonymous], 1980, VISCOELASTIC PROPERT; BAGLEY RL, 1986, J RHEOL, V30, P133, DOI 10.1122/1.549887; Cho K, 1996, POLYMER, V37, P813, DOI 10.1016/0032-3861(96)87258-2; Crawford R.J., 1998, PLASTICS ENG; Deshpande AP, 2010, RHEOLOGY OF COMPLEX FLUIDS, P87, DOI 10.1007/978-1-4419-6494-6_4; Dziubinski M, 2014, FUNDAMENTALS FLUID T; Dziubinski M, 2014, SOFT MATER, V12, P420, DOI 10.1080/1539445X.2014.957837; Fancey KS, 2005, J MATER SCI, V40, P4827, DOI 10.1007/s10853-005-2020-x; Friedrich C, 1999, RHEOL SER, V8, P429; HOLMES LA, 1966, J PHYS CHEM-US, V70, P2714, DOI 10.1021/j100881a002; Kilbas A.A., 2006, THEORY APPL FRACTION; Kilpimaa S, 2015, J IND ENG CHEM, V21, P1354, DOI 10.1016/j.jiec.2014.06.006; Lagaros ND., 2013, DESIGN OPTIMIZATION, DOI [10.4018/978-1-4666-2029-2, DOI 10.4018/978-1-4666-2029-2]; Lakes R, 2009, VISCOELASTIC MATERIALS, P1, DOI 10.1017/CBO9780511626722; Lakes R.S., 1998, CRC MEC ENG SER; Larson RG, 2003, J RHEOL, V47, P809, DOI 10.1122/1.1567750; Lefebvre J, 2003, J CEREAL SCI, V38, P257, DOI 10.1016/S0733-5210(03)00025-0; Lewandowski R, 2010, COMPUT STRUCT, V88, P1, DOI 10.1016/j.compstruc.2009.09.001; Liu CY, 2006, POLYMER, V47, P4461, DOI 10.1016/j.polymer.2006.04.054; Liu HZ, 2003, ULTRASON, P933; Ma HY, 2011, MACROMOL CHEM PHYS, V212, P252, DOI 10.1002/macp.201000503; Makris N, 2009, RHEOL ACTA, V48, P815, DOI 10.1007/s00397-009-0374-8; Orczykowska M, 2014, STARCH-STARKE, V66, P707, DOI 10.1002/star.201300265; Pritz T, 2003, J SOUND VIB, V265, P935, DOI 10.1016/S0022-460X(02)01530-4; Pruska-Kedzior A, 2006, APLICATION PHENOMENO; Schiessel H, 1995, J PHYS A-MATH GEN, V28, P6567, DOI 10.1088/0305-4470/28/23/012; Sen M, 1999, POLYMER, V40, P2969, DOI 10.1016/S0032-3861(98)00251-1; STEIN AD, 1992, J CHEM PHYS, V96, P3269, DOI 10.1063/1.461972; STIASSNIE M, 1979, APPL MATH MODEL, V3, P300, DOI 10.1016/S0307-904X(79)80063-3; Telis VRN, 2012, CONTEMP FOOD ENG, P1, DOI 10.1201/b12048; Tschoegl N.W., 1989, PHENOMENOLOGICAL THE; Ward I.M., 2012, MECH PROPERTIES SOLI; Worstell J., 2014, DIMENSIONAL ANAL PRA; Xu YJ, 2015, COMPOS STRUCT, V123, P35, DOI 10.1016/j.compstruct.2014.12.031; Yasar F, 2007, J FOOD ENG, V81, P187, DOI 10.1016/j.jfoodeng.2006.10.022	36	22	23	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143090	10.1371/journal.pone.0143090	http://dx.doi.org/10.1371/journal.pone.0143090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599756	gold, Green Published			2022-12-27	WOS:000365862600028
J	Aelvoet, SA; Pascual-Brazo, J; Libbrecht, S; Reumers, V; Gijsbers, R; Van den Haute, C; Baekelandt, V				Aelvoet, Sarah-Ann; Pascual-Brazo, Jesus; Libbrecht, Sarah; Reumers, Veerle; Gijsbers, Rik; Van den Haute, Chris; Baekelandt, Veerle			Long-Term Fate Mapping Using Conditional Lentiviral Vectors Reveals a Continuous Contribution of Radial Glia-Like Cells to Adult Hippocampal Neurogenesis in Mice	PLOS ONE			English	Article							NEURAL STEM-CELLS; REPORTER GENES; NEURONS; BRAIN; MULTIPOTENT; MIGRATION; MRI; PROGENITORS; ASTROCYTES; EXPRESSION	Newborn neurons are generated throughout life in two neurogenic regions, the subventricular zone and the hippocampal dentate gyrus. Stimulation of adult neurogenesis is considered as an attractive endogenous repair mechanism to treat different neurological disorders. Although tremendous progress has been made in our understanding of adult hippocampal neurogenesis, important questions remain unanswered, regarding the identity and the behavior of neural stem cells in the dentate gyrus. We previously showed that conditional Cre-Flex lentiviral vectors can be used to label neural stem cells in the subventricular zone and to track the migration of their progeny with non-invasive bioluminescence imaging. Here, we applied these Cre-Flex lentiviral vectors to study neurogenesis in the dentate gyrus with bioluminescence imaging and histological techniques. Stereotactic injection of the Cre-Flex vectors into the dentate gyrus of transgenic Nestin-Cre mice resulted in specific labeling of the nestin-positive neural stem cells. The labeled cell population could be detected with bioluminescence imaging until 9 months post injection, but no significant increase in the number of labeled cells over time was observed with this imaging technique. Nevertheless, the specific labeling of the nestin-positive neural stem cells, combined with histological analysis at different time points, allowed detailed analysis of their neurogenic potential. This long-term fate mapping revealed that a stable pool of labeled nestin-positive neural stem cells continuously contributes to the generation of newborn neurons in the mouse brain until 9 months post injection. In conclusion, the Cre-Flex technology is a valuable tool to address remaining questions regarding neural stem cell identity and behavior in the dentate gyrus.	[Aelvoet, Sarah-Ann; Pascual-Brazo, Jesus; Libbrecht, Sarah; Reumers, Veerle; Baekelandt, Veerle] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Dept Neurosci, Leuven, Flanders, Belgium; [Gijsbers, Rik; Van den Haute, Chris] Katholieke Univ Leuven, Leuven Viral Vector Core, Leuven, Flanders, Belgium	KU Leuven; KU Leuven	Baekelandt, V (corresponding author), Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Dept Neurosci, Leuven, Flanders, Belgium.	veerle.baekelandt@med.kuleuven.be	Baekelandt, Veerle/ABB-9736-2020	Baekelandt, Veerle/0000-0001-8966-2921; Libbrecht, Sarah/0000-0002-0612-0869	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen); European FP7 HEALTH-F2-278850 project (INMiND); FWO Research Foundation FWO [G.0484.08]; IWT [SBO/130065 MIRIAD]; KU Leuven (IMIR program financing) [PF/10/017]; KU Leuven (SCIL program financing) [PF/10/019]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European FP7 HEALTH-F2-278850 project (INMiND); FWO Research Foundation FWO; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven (IMIR program financing); KU Leuven (SCIL program financing)	SA was financially supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen, http://www.iwt.be). This work was financially supported by the European FP7 project HEALTH-F2-2011-278850 (INMiND, http://cordis.europa.eu/fp7), the FWO Research Foundation FWO (project G.0484.08 and PhD scholarship to SL, http://www.fwo.be), the IWT (SBO/130065 MIRIAD) and the KU Leuven (IMIR program financing PF/10/017 (http://www.kuleuven.be/imir) and SCIL program financing PF/10/019 (http://www.kuleuven.be/scil).	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; Baekelandt V, 2003, GENE THER, V10, P1933, DOI 10.1038/sj.gt.3302094; BAYER SA, 1985, ANN NY ACAD SCI, V457, P163, DOI 10.1111/j.1749-6632.1985.tb20804.x; Bellenchi GC, 2013, J NEUROCHEM, V124, P159, DOI 10.1111/jnc.12084; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Couillard-Despres S, 2011, EUR J NEUROSCI, V33, P1037, DOI 10.1111/j.1460-9568.2011.07601.x; DeCarolis NA, 2013, HIPPOCAMPUS, V23, P708, DOI 10.1002/hipo.22130; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deroose CM, 2006, MOL THER, V14, P423, DOI 10.1016/j.ymthe.2006.05.007; Deroose CM, 2009, CURR GENE THER, V9, P212, DOI 10.2174/156652309788488596; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Geraerts M, 2006, HUM GENE THER, V17, P635, DOI 10.1089/hum.2006.17.635; Guglielmetti C, 2014, NEUROIMAGE, V86, P99, DOI 10.1016/j.neuroimage.2013.07.080; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lemberger T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-4; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Massoud TF, 2008, AM J NEURORADIOL, V29, P409, DOI 10.3174/ajnr.A0863; Mezzanotte L, 2013, CONTRAST MEDIA MOL I, V8, P505, DOI 10.1002/cmmi.1549; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nieman BJ, 2010, NEUROIMAGE, V50, P456, DOI 10.1016/j.neuroimage.2009.12.107; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; Pascual-Brazo J, 2014, CURR PHARM DESIGN, V20, P3763, DOI 10.2174/13816128113196660739; Reumers V, 2008, STEM CELLS, V26, P2382, DOI 10.1634/stemcells.2007-1062; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rueger MA, 2010, J NEUROSCI, V30, P6454, DOI 10.1523/JNEUROSCI.6092-09.2010; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shapiro EM, 2006, NEUROIMAGE, V32, P1150, DOI 10.1016/j.neuroimage.2006.04.219; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sumner JP, 2009, NEUROIMAGE, V44, P671, DOI 10.1016/j.neuroimage.2008.07.050; Sun MY, 2014, J COMP NEUROL, V522, P1191, DOI 10.1002/cne.23497; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vande Velde G, 2012, NEUROIMAGE, V62, P367, DOI 10.1016/j.neuroimage.2012.04.040; Vandeputte C, 2014, NEUROBIOL DIS, V69, P144, DOI 10.1016/j.nbd.2014.05.014; Vreys R, 2010, NEUROIMAGE, V49, P2094, DOI 10.1016/j.neuroimage.2009.10.034	53	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143772	10.1371/journal.pone.0143772	http://dx.doi.org/10.1371/journal.pone.0143772			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600383	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900158
J	Idewaki, Y; Iwase, M; Fujii, H; Ohkuma, T; Ide, H; Kaizu, S; Jodai, T; Kikuchi, Y; Hirano, A; Nakamura, U; Kubo, M; Kitazono, T				Idewaki, Yasuhiro; Iwase, Masanori; Fujii, Hiroki; Ohkuma, Toshiaki; Ide, Hitoshi; Kaizu, Shinako; Jodai, Tamaki; Kikuchi, Yohei; Hirano, Atsushi; Nakamura, Udai; Kubo, Michiaki; Kitazono, Takanari			Association of Genetically Determined Aldehyde Dehydrogenase 2 Activity with Diabetic Complications in Relation to Alcohol Consumption in Japanese Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; CHRONIC KIDNEY-DISEASE; MICROVASCULAR COMPLICATIONS; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; RISK-FACTORS; POLYMORPHISM; MEN; RETINOPATHY	Aldehyde dehydrogenase 2 (ALDH2) detoxifies aldehyde produced during ethanol metabolism and oxidative stress. A genetic defect in this enzyme is common in East Asians and determines alcohol consumption behaviors. We investigated the impact of genetically determined ALDH2 activity on diabetic microvascular and macrovascular complications in relation to drinking habits in Japanese patients with type 2 diabetes mellitus. An ALDH2 single-nucleotide polymorphism (rs671) was genotyped in 4,400 patients. Additionally, the relationship of clinical characteristics with ALDH2 activity (ALDH2 *1/*1 active enzyme activity vs. *1/*2 or *2/*2 inactive enzyme activity) and drinking habits (lifetime abstainers vs. former or current drinkers) was investigated cross-sectionally (n = 691 in *1/*1 abstainers, n = 1,315 in abstainers with *2, n = 1,711 in *1/*1 drinkers, n = 683 in drinkers with *2). The multiple logistic regression analysis for diabetic complications was adjusted for age, sex, current smoking habits, leisure-time physical activity, depressive symptoms, diabetes duration, body mass index, hemoglobin A(1c), insulin use, high-density lipoprotein cholesterol, systolic blood pressure and renin-angiotensin system inhibitors use. Albuminuria prevalence was significantly lower in the drinkers with *2 than that of other groups (odds ratio [95% confidence interval (CI)]: *1/*1 abstainers as the referent, 0.94 [0.76-1.16] in abstainers with *2, 1.00 [0.80-1.26] in *1/*1 drinkers, 0.71 [0.54-0.93] in drinkers with *2). Retinal photocoagulation prevalence was also lower in drinkers with ALDH2 *2 than that of other groups. In contrast, myocardial infarction was significantly increased in ALDH2 *2 carriers compared with that in ALDH2 *1/*1 abstainers (odds ratio [95% CI]: *1/*1 abstainers as the referent, 2.63 [1.28-6.13] in abstainers with *2, 1.89 [0.89-4.51] in *1/*1 drinkers, 2.35 [1.06-5.79] in drinkers with *2). In summary, patients with type 2 diabetes and ALDH2 *2 displayed a lower microvascular complication prevalence associated with alcohol consumption but a higher macrovascular complication prevalence irrespective of alcohol consumption.	[Idewaki, Yasuhiro; Iwase, Masanori; Fujii, Hiroki; Ohkuma, Toshiaki; Ide, Hitoshi; Kaizu, Shinako; Jodai, Tamaki; Kikuchi, Yohei; Hirano, Atsushi; Nakamura, Udai; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Idewaki, Yasuhiro; Iwase, Masanori] Hakujyuji Hosp, Ctr Diabet, Fukuoka, Japan; [Fujii, Hiroki] Kyushu Dent Univ, Sch Oral Hlth Sci, Div Gen Internal Med, Kitakyushu, Fukuoka, Japan; [Ohkuma, Toshiaki] Kyushu Univ, Grad Sch Med Sci, Ctr Cohort Studies, Div Res Management, Fukuoka 812, Japan; [Hirano, Atsushi; Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	Kyushu University; Kyushu Dental University; Kyushu University; RIKEN	Iwase, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan.	iwase@intmed2.med.kyushu-u.ac.jp	Kubo, Michiaki/N-7947-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan [23249037, 23659353]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23249037, 23659353]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by Grants-in-Aid for Scientific Research (no. 23249037 and no. 23659353) for M.I. from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Beulens JWJ, 2008, DIABETOLOGIA, V51, P1631, DOI 10.1007/s00125-008-1091-z; CAMARGO CA, 1989, STROKE, V20, P1611, DOI 10.1161/01.STR.20.12.1611; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Dunkler D, 2015, KIDNEY INT, V87, P784, DOI 10.1038/ki.2014.370; Evert AB, 2014, DIABETES CARE, V37, pS120, DOI 10.2337/dc14-S120; Guo JM, 2013, CELL RES, V23, P915, DOI 10.1038/cr.2013.69; Guo YJ, 2010, ATHEROSCLEROSIS, V211, P545, DOI 10.1016/j.atherosclerosis.2010.03.030; Harjutsalo V, 2014, DIABETIC MED, V31, P156, DOI 10.1111/dme.12307; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Jo SA, 2007, CLIN CHIM ACTA, V382, P43, DOI 10.1016/j.cca.2007.03.016; Kaizu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098768; Kato I, 2003, J CLIN EPIDEMIOL, V56, P196, DOI 10.1016/S0895-4356(02)00578-4; Kikuchi Y, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000063; Lee CC, 2010, DIABETIC MED, V27, P1130, DOI 10.1111/j.1464-5491.2010.03080.x; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Morita K, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-132; Nagasawa H, 2007, EUR J NEUROL, V14, P428, DOI 10.1111/j.1468-1331.2007.01700.x; Ohkuma T, 2013, DIABETOLOGIA, V56, P70, DOI 10.1007/s00125-012-2746-3; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; STOLINE MR, 1981, AM STAT, V35, P134, DOI 10.2307/2683979; Suzuki Y, 1996, DIABETOLOGIA, V39, P1115; Takagi S, 2002, HYPERTENS RES, V25, P677; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Tsuchihashi-Makaya M, 2009, HYPERTENS RES, V32, P207, DOI 10.1038/hr.2009.3; Wang Y, 2013, J HUM HYPERTENS, V27, P181, DOI 10.1038/jhh.2012.15; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yokoyama A, 1998, CARCINOGENESIS, V19, P1383, DOI 10.1093/carcin/19.8.1383; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258	34	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143288	10.1371/journal.pone.0143288	http://dx.doi.org/10.1371/journal.pone.0143288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599441	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900086
J	Mensah, LB; Davison, C; Fan, SJ; Morris, JF; Goberdhan, DCI; Wilson, C				Mensah, Lawrence B.; Davison, Claire; Fan, Shih-Jung; Morris, John F.; Goberdhan, Deborah C. I.; Wilson, Clive			Fine-Tuning of PI3K/AKT Signalling by the Tumour Suppressor PTEN Is Required for Maintenance of Flight Muscle Function and Mitochondrial Integrity in Ageing Adult Drosophila melanogaster	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; OXIDATIVE STRESS; PARKINSONS-DISEASE; ENERGY-METABOLISM; NERVOUS-SYSTEM; CELL-GROWTH; PROTEIN; PATHWAY; SIZE; NEURODEGENERATION	Insulin/insulin-like growth factor signalling (IIS), acting primarily through the PI3-kinase (PI3K)/AKT kinase signalling cassette, plays key evolutionarily conserved regulatory roles in nutrient homeostasis, growth, ageing and longevity. The dysfunction of this pathway has been linked to several age-related human diseases including cancer, Type 2 diabetes and neurodegenerative disorders. However, it remains unclear whether minor defects in IIS can independently induce the age-dependent functional decline in cells that accompany some of these diseases or whether IIS alters the sensitivity to other aberrant signalling. We identified a novel hypomorphic allele of PI3K's direct antagonist, Phosphatase and tensin homologue on chromosome 10 (Pten), in the fruit fly, Drosophila melanogaster. Adults carrying combinations of this allele, Pten(5), combined with strong loss-of-function Pten mutations exhibit subtle or no increase in mass, but are highly susceptible to a wide range of stresses. They also exhibit dramatic upregulation of the oxidative stress response gene, GstD1, and a progressive loss of motor function that ultimately leads to defects in climbing and flight ability. The latter phenotype is associated with mitochondrial disruption in indirect flight muscles, although overall muscle structure appears to be maintained. We show that the phenotype is partially rescued by muscle-specific expression of the Bcl-2 homologue Buffy, which in flies, maintains mitochondrial integrity, modulates energy homeostasis and suppresses cell death. The flightless phenotype is also suppressed by mutations in downstream IIS signalling components, including those in the mechanistic Target of Rapamycin Complex 1 (mTORC1) pathway, suggesting that elevated IIS is responsible for functional decline in flight muscle. Our data demonstrate that IIS levels must be precisely regulated by Pten in adults to maintain the function of the highly metabolically active indirect flight muscles, offering a new system to study the in vivo roles of IIS in the maintenance of mitochondrial integrity and adult ageing.	[Mensah, Lawrence B.; Davison, Claire; Fan, Shih-Jung; Morris, John F.; Goberdhan, Deborah C. I.; Wilson, Clive] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	University of Oxford	Wilson, C (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Le Gros Clark Bldg,South Parks Rd, Oxford OX1 3QX, England.	clive.wilson@dpag.ox.ac.uk			BBSRC [96/G10924, 43/C16865, BB-L007096-1]; BBSRC [BB/L007096/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L007096/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Some of the work was funded by BBSRC grants 96/G10924, 43/C16865, and and BB-L007096-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Alex Whitworth, Dept. of Biomedical Sciences, University of Sheffield, UK. Ernst Hafen, Universitat Zurich, currently at MIDATA COOP-Project, Switzerland, Hugo Stocker, ETH Zurich, Switzerland, Duojia D.J. Pan, Dept. of Molecular Biology and Genetics, Johns Hopkins University, USA, Judith Lengyel, Dept. of Molecular Biology, University of California, USA, Thomas Neufeld, College of Biological Sciences, University of Minnesota, USA and the Bloomington Stock Centre for fly stocks. We are also grateful to Chris Parkin, Mohan Masih and Lynne Scott for technical assistance. Some of the work was funded by BBSRC grants 96/G10924, 43/C16865 and BB-L007096-1.	Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bononi A, 2013, CELL DEATH DIFFER, V20, P1631, DOI 10.1038/cdd.2013.77; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Brown HLD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044888; Cauchi RJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000265; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Doumanis J, 2007, CELL DEATH DIFFER, V14, P907, DOI 10.1038/sj.cdd.4402082; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Goberdhan DCI, 2002, DEV GENES EVOL, V212, P196, DOI 10.1007/s00427-002-0226-3; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hatano T, 2012, MOVEMENT DISORD, V27, P1613, DOI 10.1002/mds.25241; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hosamani R, 2013, ARCH INSECT BIOCHEM, V83, P25, DOI 10.1002/arch.21094; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Kondo M, 2005, MECH AGEING DEV, V126, P642, DOI 10.1016/j.mad.2004.11.012; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Monserrate JP, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-63; Nepal O, 2011, Kathmandu Univ Med J (KUMJ), V9, P35; Oldham S, 2002, DEVELOPMENT, V129, P4103; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Patel PH, 2006, J CELL SCI, V119, P4285, DOI 10.1242/jcs.03199; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Quinn L, 2003, EMBO J, V22, P3568, DOI 10.1093/emboj/cdg355; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Rzezniczak TZ, 2011, ANAL BIOCHEM, V419, P345, DOI 10.1016/j.ab.2011.08.023; Shamoto-Nagai M, 2003, J NEUROSCI RES, V74, P589, DOI 10.1002/jnr.10777; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tsubouchi A, 2009, DEVELOPMENT, V136, P3757, DOI 10.1242/dev.042135; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Vereshchagina N, 2008, J CELL SCI, V121, P3383, DOI 10.1242/jcs.035220; Vincent A, 2012, HUM MOL GENET, V21, P1760, DOI 10.1093/hmg/ddr609; Wang C, 2007, J NEUROSCI, V27, P8563, DOI 10.1523/JNEUROSCI.0218-07.2007; Wang LQ, 2011, J NEUROSCI, V31, P2868, DOI 10.1523/JNEUROSCI.3410-10.2011; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	59	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143818	10.1371/journal.pone.0143818	http://dx.doi.org/10.1371/journal.pone.0143818			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599788	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900163
J	Chen, HH; Sun, AH; Ojcius, DM; Hu, WL; Ge, YM; Lin, XA; Li, LJ; Pan, JP; Yan, J				Chen, Hong-Hu; Sun, Ai-Hua; Ojcius, David M.; Hu, Wei-Lin; Ge, Yu-Mei; Lin, Xu'ai; Li, Lan-Juan; Pan, Jian-Ping; Yan, Jie			Eosinophils from Murine Lamina Propria Induce Differentiation of Naive T Cells into Regulatory T Cells via TGF-beta 1 and Retinoic Acid	PLOS ONE			English	Article							DENDRITIC CELLS; REG-CELLS; GENERATION; FOXP3; QUANTIFICATION; INTESTINE; RESPONSES; T(H)17; HEALTH	Treg cells play a crucial role in immune tolerance, but mechanisms that induce Treg cells are poorly understood. We here have described eosinophils in lamina propria (LP) that displayed high aldehyde dehydrogenase (ALDH) activity, a rate-limiting step during all-trans retinoic acid (ATRA) synthesis, and expressed TGF-beta 1 mRNA and high levels of ATRA. Co-incubation assay confirmed that LP eosinophils induced the differentiation of naive T cells into Treg cells. Differentiation promoted by LP eosinophils were inhibited by blocked either TGF-beta 1 or ATRA. Peripheral blood (PB) eosinophils did not produce ATRA and could not induce Treg differentiation. These data identifies LP eosinophils as effective inducers of Treg cell differentiation through a mechanism dependent on TGF-beta 1 and ATRA.	[Chen, Hong-Hu; Hu, Wei-Lin; Lin, Xu'ai; Li, Lan-Juan; Yan, Jie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Hong-Hu; Hu, Wei-Lin; Ge, Yu-Mei; Lin, Xu'ai; Li, Lan-Juan; Yan, Jie] Zhejiang Univ, Sch Med, State Key Lab Diag & Treatment Infect Dis, Div Basic Med Microbiol,Affiliated Hosp 1, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Hong-Hu; Hu, Wei-Lin; Ge, Yu-Mei; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, Dept Med Microbiol & Parasitol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Hong-Hu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China; [Sun, Ai-Hua] Zhejiang Med Coll, Fac Basic Med, Hangzhou 310053, Zhejiang, Peoples R China; [Ojcius, David M.] Univ Calif, Hlth Sci Res Inst & Mol Cell Biol, Merced, CA 95343 USA; [Pan, Jian-Ping] Zhejiang Univ City Coll, Sch Med, Dept Clin Med, Hangzhou 310015, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention; University of California System; University of California Merced; Zhejiang University City College	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; jppan@zucc.edu.cn; med_bp@zju.edu.cn	Ojcius, David/ABE-6557-2020		National Natural Science Foundation of China [30872325, 81261160321, 81171534]; National Key Lab for Diagnosis and Treatment of Infectious Diseases of China [2013-032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Lab for Diagnosis and Treatment of Infectious Diseases of China	This work was supported by grants (30872325, 81261160321 and 81171534) from the National Natural Science Foundation of China and a grant (2013-032) from the National Key Lab for Diagnosis and Treatment of Infectious Diseases of China.	Ali R, 2012, ANAL CHIM ACTA, V725, P57, DOI 10.1016/j.aca.2012.03.003; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Maloy KJ, 2005, NAT IMMUNOL, V6, P1071, DOI 10.1038/ni1105-1071; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Oluwole SF, 2004, CELL BIOCHEM BIOPHYS, P27; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rook GA, 2013, P NATL ACAD SCI USA, V110, P18360, DOI 10.1073/pnas.1313731110; Rothenberg ME, 2001, IMMUNOL REV, V179, P139, DOI 10.1034/j.1600-065X.2001.790114.x; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255	29	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142881	10.1371/journal.pone.0142881	http://dx.doi.org/10.1371/journal.pone.0142881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587591	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500019
J	Knauf, S; Barnett, U; Maciej, P; Klapproth, M; Ndao, I; Frischmann, S; Fischer, J; Zinner, D; Liu, H				Knauf, Sascha; Barnett, Ulrike; Maciej, Peter; Klapproth, Matthias; Ndao, Ibrahima; Frischmann, Sieghard; Fischer, Julia; Zinner, Dietmar; Liu, Hsi			High Prevalence of Antibodies against the Bacterium Treponema pallidum in Senegalese Guinea Baboons (Papio papio)	PLOS ONE			English	Article							YAWS; INFECTION; SYPHILIS; PHYLOGEOGRAPHY	The bacterium Treponema pallidum is known to cause syphilis (ssp. pallidum), yaws (ssp. pertenue), and endemic syphilis (ssp. endemicum) in humans. Nonhuman primates have also been reported to be infected with the bacterium with equally versatile clinical manifestations, from severe skin ulcerations to asymptomatic. At present all simian strains are closely related to human yaws-causing strains, an important consideration for yaws eradication. We tested clinically healthy Guinea baboons (Papio papio) at Parc National Niokolo Koba in south eastern Senegal for the presence of anti-T. pallidum antibodies. Since T. pallidum infection in this species was identified 50 years ago, and there has been no attempt to treat non-human primates for infection, it was hypothesized that a large number of West African baboons are still infected with simian strains of the yaws-bacterium. All animals were without clinical signs of treponematoses, but 18 of 20 (90%) baboons tested positive for antibodies against T. pallidum based on treponemal tests. Yet, Guinea baboons seem to develop no clinical symptoms, though it must be assumed that infection is chronic or comparable to the latent stage in human yaws infection. The non-active character is supported by the low anti-T. pallidum serum titers in Guinea baboons (median = 1: 2,560) versus serum titers that are found in genital-ulcerated olive baboons with active infection in Tanzania (range of medians among the groups of initial, moderate, and severe infected animals = 1: 15,360 to 1: 2.097e+7). Our findings provide evidence for simian infection with T. pallidum in wild Senegalese baboons. Potentially, Guinea baboons in West Africa serve as a natural reservoir for human infection, as the West African simian strain has been shown to cause sustainable yaws infection when inoculated into humans. The present study pinpoints an area where further research is needed to support the currently on-going second WHO led yaws eradication campaign with its goal to eradicate yaws by 2020.	[Knauf, Sascha] German Primate Ctr, Leibniz Inst Primate Res, Pathol Unit, Work Grp Neglected Trop Dis, Gottingen, Germany; [Barnett, Ulrike; Maciej, Peter; Klapproth, Matthias; Fischer, Julia; Zinner, Dietmar] German Primate Ctr, Leibniz Inst Primate Res, Cognit Ethol Lab, Gottingen, Germany; [Ndao, Ibrahima] Direct Parc Natl Niokolo Koba, Tambacounda, Senegal; [Frischmann, Sieghard] Mast Diagnost GmbH, Reinfeld, Germany; [Liu, Hsi] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA	Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Centers for Disease Control & Prevention - USA	Knauf, S (corresponding author), German Primate Ctr, Leibniz Inst Primate Res, Pathol Unit, Work Grp Neglected Trop Dis, Gottingen, Germany.	sknauf@dpz.eu	Knauf, Sascha/F-1661-2017; Fischer, Julia/B-6674-2008	Knauf, Sascha/0000-0001-5744-4946; Fischer, Julia/0000-0002-5807-0074	Mast Diagnostica GmbH	Mast Diagnostica GmbH	Funding: The funder (Mast Diagnostica GmbH) provided support in the form of salaries for authors [SF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P189; Baylet R, 1971, Bull Soc Pathol Exot Filiales, V64, P842; Baylet R, 1971, Bull Soc Pathol Exot Filiales, V64, P836; Carlson JA, 2011, AM J DERMATOPATH, V33, P433, DOI 10.1097/DAD.0b013e3181e8b587; Delobel J, 2010, INT J MOL SCI, V11, P4601, DOI 10.3390/ijms11114601; FRIBOURG-BLANC A, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P54; Fribourg-Blanc A, 1969, Primates Med, V3, P113; GALATLUONG A, 2006, DEV PRIMATOL, P105; Harper K, 2013, DEV PRIMATOLOGY PROG, V38, P189; Harper KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050882; HAUSFATER G, 1976, BEHAVIOUR, V56, P44, DOI 10.1163/156853976X00299; Knauf S, 2012, VET PATHOL, V49, P292, DOI 10.1177/0300985811402839; Knauf S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003637; Knauf S, 2013, EMERG INFECT DIS, V19, P2058, DOI 10.3201/eid1912.130863; MAGNUSON HJ, 1956, MEDICINE, V35, P33, DOI 10.1097/00005792-195602000-00002; Marks M, 2015, LANCET INFECT DIS, V15, P1220, DOI 10.1016/S1473-3099(15)00136-X; Marks M, 2015, BRIT MED BULL, V113, P91, DOI 10.1093/bmb/ldu037; Maurice J, 2012, LANCET, V379, P1377, DOI 10.1016/S0140-6736(12)60581-9; Mitja O, 2013, LANCET, V381, P763, DOI 10.1016/S0140-6736(12)62130-8; Patzelt A, 2014, P NATL ACAD SCI USA, V111, P14740, DOI 10.1073/pnas.1405811111; Peeling RW, 2004, B WORLD HEALTH ORGAN, V82, P439; Peterman TA, 2015, EXPERT REV ANTI-INFE, V13, P161, DOI 10.1586/14787210.2015.990384; Salazar JC, 2002, MICROBES INFECT, V4, P1133, DOI 10.1016/S1286-4579(02)01638-6; SMITH JL, 1971, BRIT J VENER DIS, V47, P226; Teunis PFM, 2012, STAT MED, V31, P2240, DOI 10.1002/sim.5322; Zinner D, 2013, AM J PHYS ANTHROPOL, V150, P133, DOI 10.1002/ajpa.22185; Zinner D, 2011, DEV PRIMATOL-PROG PR, P267, DOI 10.1007/978-1-4419-7403-7_7; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83; Zobanikova M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002172	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143100	10.1371/journal.pone.0143100	http://dx.doi.org/10.1371/journal.pone.0143100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588087	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500030
J	Kreinest, M; Goller, S; Rauch, G; Frank, C; Gliwitzky, B; Wolfl, CG; Matschke, S; Munzberg, M				Kreinest, Michael; Goller, Sarah; Rauch, Geraldine; Frank, Christian; Gliwitzky, Bernhard; Woelfl, Christoph G.; Matschke, Stefan; Muenzberg, Matthias			Application of Cervical Collars - An Analysis of Practical Skills of Professional Emergency Medical Care Providers	PLOS ONE			English	Article							HARD COLLAR; SPINE; IMMOBILIZATION; EPIDEMIOLOGY; ORTHOSES; INJURY; MOTION	Background/Objective The application of a cervical collar is a standard procedure in trauma patients in emergency medicine. It is often observed that cervical collars are applied incorrectly, resulting in reduced immobilization of the cervical spine. The objective of this study was to analyze the practical skills of trained professional rescue personnel concerning the application of cervical collars. Material and Methods Within emergency medical conferences, n = 104 voluntary test subjects were asked to apply a cervical collar to a training doll, wherein each step that was performed received an evaluation. Furthermore, personal and occupational data of all study participants were collected using a questionnaire. Results The test subjects included professional rescue personnel (80.8%) and emergency physicians (12.5%). The average occupational experience of all study participants in pre-clinical emergency care was 11.1 +/- 8.9 years. Most study participants had already attended a certified training on trauma care (61%) and felt "very confident" in handling a cervical collar (84%). 11% applied the cervical collar to the training doll without errors. The most common error consisted of incorrect adjustment of the size of the cervical collar (66%). No association was found between the correct application of the cervical collar and the occupational group of the test subjects (trained rescue personnel vs. emergency physicians) or the participation in certified trauma courses. Conclusion Despite pronounced subjective confidence regarding the application of cervical collars, this study allows the conclusion that there are general deficits in practical skills when cervical collars are applied. A critical assessment of the current training contents on the subject of trauma care must, therefore, be demanded.	[Kreinest, Michael; Goller, Sarah; Woelfl, Christoph G.; Matschke, Stefan; Muenzberg, Matthias] BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthoped, Ludwigshafen, Germany; [Kreinest, Michael; Goller, Sarah; Frank, Christian; Gliwitzky, Bernhard; Woelfl, Christoph G.; Muenzberg, Matthias] PHTLS Europe Res Grp, Offenbach Queich, Germany; [Rauch, Geraldine] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Frank, Christian] Mittelbaden Clin, Dept Orthoped & Trauma Surg, Baden Baden, Germany	Ruprecht Karls University Heidelberg	Munzberg, M (corresponding author), BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthoped, Ludwigshafen, Germany.	matthias.muenzberg@bgu-ludwigshafen.de	Kreinest, Michael/ABI-7282-2020					Bell KM, 2009, SPINE J, V9, P225, DOI 10.1016/j.spinee.2008.03.010; Ben-Galim P, 2010, J TRAUMA, V69, P447, DOI 10.1097/TA.0b013e3181be785a; Bhamra Js, 2012, Open Orthop J, V6, P548, DOI 10.2174/1874325001206010548; Bouland AJ, 2013, J EMERG MED, V45, pE117, DOI 10.1016/j.jemermed.2013.03.046; Clarke A, 2010, ACTA ORTHOP BELG, V76, P413; Deasy C, 2011, INJURY, V42, P841, DOI 10.1016/j.injury.2011.06.191; Del Rossi Gianluca, 2004, Spine J, V4, P619; Fredo HL, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-85; Goutcher CM, 2005, BRIT J ANAESTH, V95, P344, DOI 10.1093/bja/aei190; Ivancic PC, 2013, EUR SPINE J, V22, P169, DOI 10.1007/s00586-012-2552-0; James CY, 2004, J ATHL TRAINING, V39, P138; Lemyze M, 2011, EMERG MED J, V28, P532, DOI 10.1136/emj.2010.106625; Mobbs RJ, 2002, ANZ J SURG, V72, P389, DOI 10.1046/j.1445-2197.2002.02462.x; Muenzberg M, 2013, EUR J TRAUMA EMERG S, V39, P517, DOI 10.1007/s00068-013-0316-0; Oliver M, 2012, INJURY, V43, P1296, DOI 10.1016/j.injury.2012.04.021; Papadopoulos MC, 1999, BRIT MED J, V319, P171, DOI 10.1136/bmj.319.7203.171; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f	17	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143409	10.1371/journal.pone.0143409	http://dx.doi.org/10.1371/journal.pone.0143409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587650	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500059
J	Zhou, D; Liu, XM; Sun, Y; Ma, L; Shen, B; Zhu, CL				Zhou, Dan; Liu, Xianmiao; Sun, Yan; Ma, Lei; Shen, Bo; Zhu, Changliang			Genomic Analysis of Detoxification Supergene Families in the Mosquito Anopheles sinensis	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CYTOCHROME-P450 GENE SUPERFAMILY; RED FLOUR BEETLE; INSECTICIDE-RESISTANCE; DROSOPHILA-MELANOGASTER; MALARIA VECTOR; CULEX-QUINQUEFASCIATUS; DIPTERA-CULICIDAE; AEDES-AEGYPTI; MOLECULAR CHARACTERIZATION	Anopheles sinensis is an important malaria vector in China and other Southeast Asian countries, and the emergence of insecticide resistance in this mosquito poses a serious threat to the efficacy of malaria control programs. The recently published An. sinensis genome and transcriptome provide an opportunity to understand the molecular mechanisms of insecticide resistance. Analysis of the An. sinensis genome revealed 174 detoxification genes, including 93 cytochrome P450s (P450s), 31 glutathione-S-transferases (GSTs), and 50 choline/carboxylesterases (CCEs). The gene number was similar to that in An. gambiae, but represented a decrease of 29% and 42% compared with Aedes aegypti and Culex quinquefasciatus, respectively. The considerable contraction in gene number in Anopheles mosquitoes mainly occurred in two detoxification supergene families, P450s and CCEs. The available An. sinensis transcriptome was also re-analyzed to further identify key resistance-associated detoxification genes. Among 174 detoxification genes, 124 (71%) were detected. Several candidate genes overexpressed in a deltamethrin-resistant strain (DR-strain) were identified as belonging to the CYP4 or CYP6 family of P450s and the Delta GST class. These generated data provide a basis for identifying the resistance-associated genes of An. sinensis at the molecular level.	[Zhou, Dan; Liu, Xianmiao; Sun, Yan; Ma, Lei; Shen, Bo; Zhu, Changliang] Nanjing Med Univ, Dept Pathogen Biol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Shen, B (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing 210029, Jiangsu, Peoples R China.	shenbo@njmu.edu.cn; clzhu@njmu.edu.cn			National Institutes of Health of US (NIH) [2R01AI075746]; National Natural Science Foundation of China [81171610, 81301458]; National S & T Major Program [2012ZX10004-219, 2012ZX10004-220]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075746] Funding Source: NIH RePORTER	National Institutes of Health of US (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health of US (NIH) (Grant No. 2R01AI075746), the National Natural Science Foundation of China (Grant No. 81171610 and 81301458), the National S & T Major Program (Grant No. 2012ZX10004-219 and 2012ZX10004-220) and Priority Academic Program Development of Jiangsu Higher Education Institutions.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Avicor SW, 2014, PROTEIN J, V33, P457, DOI 10.1007/s10930-014-9580-z; Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162; Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Blackburn AC, 1998, CYTOGENET CELL GENET, V83, P109, DOI 10.1159/000015145; Brock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060324; Cha DJ, 2015, EVOL DEV, V17, P109, DOI 10.1111/ede.12111; Chanda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024336; Chang Kyu-Sik, 2013, Osong Public Health Res Perspect, V4, P76, DOI 10.1016/j.phrp.2013.02.001; Chen WP, 2014, GENOME BIOL EVOL, V6, P1620, DOI 10.1093/gbe/evu132; Choochote W, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-36; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djegbe I, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-409; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; Edi CV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004236; Erickson SM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000529; Feng LF, 2014, AQUAT TOXICOL, V149, P126, DOI 10.1016/j.aquatox.2014.02.004; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Field LM, 2002, PEST MANAG SCI, V58, P889, DOI 10.1002/ps.552; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; Hassan MM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-46; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang HZ, 2012, ANAL BIOCHEM, V431, P77, DOI 10.1016/j.ab.2012.09.011; Huchard E, 2006, P R SOC B, V273, P2595, DOI 10.1098/rspb.2006.3621; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Kang S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-151; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125362; Kiang KM, 2013, ARCH DIS CHILDHOOD-E, V98, P7, DOI 10.1136/archdischild-2011-301530; Kim JI, 2006, INSECT MOL BIOL, V15, P513, DOI 10.1111/j.1365-2583.2006.00666.x; Kozaki T, 2008, ARCH INSECT BIOCHEM, V67, P130, DOI 10.1002/arch.20229; Kwiatkowska RM, 2013, GENE, V519, P98, DOI 10.1016/j.gene.2013.01.036; Lee DW, 2006, BBA-GEN SUBJECTS, V1760, P125, DOI 10.1016/j.bbagen.2005.10.009; Li F, 2002, GENOME, V45, P1134, DOI 10.1139/G02-085; Li F, 2004, INSECT BIOCHEM MOLEC, V34, P397, DOI 10.1016/j.ibmb.2004.02.001; Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018; Ma YJ, 2008, MOL ECOL RESOUR, V8, P1059, DOI 10.1111/j.1755-0998.2008.02154.x; MEIKLE DB, 1990, J INSECT PHYSIOL, V36, P93, DOI 10.1016/0022-1910(90)90179-J; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; MOUCHES C, 1986, SCIENCE, V233, P778, DOI 10.1126/science.3755546; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; OLSON PF, 1990, EMBO J, V9, P1219, DOI 10.1002/j.1460-2075.1990.tb08229.x; Omura T, 2010, J BIOCHEM, V147, P297, DOI 10.1093/jb/mvq001; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; PASTEUR N, 1981, BIOCHEM GENET, V19, P909, DOI 10.1007/BF00504256; Patarroyo MA, 2012, EXPERT REV VACCINES, V11, P1249, DOI [10.1586/ERV.12.91, 10.1586/erv.12.91]; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Qin Q, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-92; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Raymond M, 1998, PHILOS T R SOC B, V353, P1707, DOI 10.1098/rstb.1998.0322; Reddy BPN, 2012, BIOINFORMATION, V8, P430, DOI 10.6026/97320630008430; Riveron JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-817; Rueda LM, 2011, TROP BIOMED, V28, P181; SAAD M, 1994, GENETICA, V94, P43, DOI 10.1007/BF01429219; Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Seong KM, 2012, INSECT MOL BIOL, V21, P149, DOI 10.1111/j.1365-2583.2011.01118.x; Shi HX, 2012, GENOMICS, V100, P327, DOI 10.1016/j.ygeno.2012.07.010; Shi LN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003928; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; TANG AH, 1994, J BIOL CHEM, V269, P27876; Temeyer KB, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0577-4; Tene BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061408; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Vaughan A, 1997, BIOCHEM J, V325, P359, DOI 10.1042/bj3250359; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang DQ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-164; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wongtrakul J, 2010, J MED ENTOMOL, V47, P162, DOI 10.1603/ME09132; Xing GL, 2014, J BIOL CHEM, V289, P31867, DOI 10.1074/jbc.M114.574897; Xu TL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-54; Yan LZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-609; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; Yu QY, 2008, INSECT BIOCHEM MOLEC, V38, P1158, DOI 10.1016/j.ibmb.2008.08.002; Zhang YX, 2014, INSECT BIOCHEM MOLEC, V46, P25, DOI 10.1016/j.ibmb.2014.01.004; Zhao PC, 2013, INSECT BIOCHEM MOLEC, V43, P260, DOI 10.1016/j.ibmb.2012.12.005; Zhou D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-42, 10.1186/1471-2164-15-573]; Zhou SS, 2007, ZHONGGUO JI SHENG CH, V25, P439; Zhou WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056604; Zhu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-174; Zhu G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0582-7	93	23	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143387	10.1371/journal.pone.0143387	http://dx.doi.org/10.1371/journal.pone.0143387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588704	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500057
J	Hadi, LA; Di Vito, C; Marfia, G; Ferraretto, A; Tringali, C; Viani, P; Riboni, L				Hadi, Loubna Abdel; Di Vito, Clara; Marfia, Giovanni; Ferraretto, Anita; Tringali, Cristina; Viani, Paola; Riboni, Laura			Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells	PLOS ONE			English	Article							CHRONIC INTESTINAL INFLAMMATION; SPHINGOLIPID METABOLISM; BREFELDIN-A; SPHINGOSINE-1-PHOSPHATE; PREVENTION; GROWTH; OVEREXPRESSION; ACCUMULATION; TRAFFICKING; ACTIVATION	The plant flavonoid luteolin exhibits different biological effects, including anticancer properties. Little is known on the molecular mechanisms underlying its actions in colorectal cancer (CRC). Here we investigated the effects of luteolin on colon cancer cells, focusing on the balance between ceramide and sphingosine-1-phosphate (S1P), two sphingoid mediators with opposite roles on cell fate. Using cultured cells, we found that physiological concentrations of luteolin induce the elevation of ceramide, followed by apoptotic death of colon cancer cells, but not of differentiated enterocytes. Pulse studies revealed that luteolin inhibits ceramide anabolism to complex sphingolipids. Further experiments led us to demonstrate that luteolin induces an alteration of the endoplasmic reticulum (ER)-Golgi flow of ceramide, pivotal to its metabolic processing to complex sphingolipids. We report that luteolin exerts its action by inhibiting both Akt activation, and sphingosine kinase (SphK) 2, with the consequent reduction of S1P, an Akt stimulator. S1P administration protected colon cancer cells from luteolin-induced apoptosis, most likely by an intracellular, receptor-independent mechanism. Overall this study reveals for the first time that the dietary flavonoid luteolin exerts toxic effects on colon cancer cells by inhibiting both S1P biosynthesis and ceramide traffic, suggesting its dietary introduction/supplementation as a potential strategy to improve existing treatments in CRC.	[Hadi, Loubna Abdel; Di Vito, Clara; Tringali, Cristina; Viani, Paola; Riboni, Laura] Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy; [Marfia, Giovanni] Univ Milan, Lab Expt Neurosurg & Cell Therapy, Fdn IRCCS Ca Granda, Osped Maggiore Policlin Milan,Neurosurg Unit, Milan, Italy; [Ferraretto, Anita] Univ Milan, LITA Segrate, Dept Biomed Sci Hlth, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan	Riboni, L (corresponding author), Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy.	laura.riboni@unimi.it	Tringali, Cristina Alessandra/Q-7259-2017; Di Vito, Clara/ABC-3385-2020; Marfia, Giovanni/AAB-8702-2020; VIANI, PAOLA/Q-5955-2017; Riboni, Laura/R-4281-2017; Marfia, Giovanni/N-4650-2014; Ferraretto, Anita/L-3543-2016	Tringali, Cristina Alessandra/0000-0002-0632-6197; Di Vito, Clara/0000-0001-7248-1710; Marfia, Giovanni/0000-0002-5849-7000; VIANI, PAOLA/0000-0002-5728-6631; Riboni, Laura/0000-0002-4149-8226; Marfia, Giovanni/0000-0002-5849-7000; Ferraretto, Anita/0000-0002-3637-5002; Abdel Hadi, loubna/0000-0002-5271-0798				Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Ferraretto A, 2007, ANTICANCER RES, V27, P3919; Galadari S, 2015, APOPTOSIS, V20, P689, DOI 10.1007/s10495-015-1109-1; Garcia-Barros M, 2014, BBA-MOL CELL BIOL L, V1841, P773, DOI 10.1016/j.bbalip.2013.09.007; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Giussani P, 2009, J BIOL CHEM, V284, P5088, DOI 10.1074/jbc.M808934200; Gjoni E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110875; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Gustin DJ, 2013, BIOORG MED CHEM LETT, V23, P4608, DOI 10.1016/j.bmcl.2013.06.030; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heringdorf DMZ, 2003, FEBS LETT, V554, P443, DOI 10.1016/S0014-5793(03)01219-5; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Le Scolan E, 2005, BLOOD, V106, P1808, DOI 10.1182/blood-2004-12-4832; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Meng AM, 2004, EXP CELL RES, V292, P385, DOI 10.1016/j.yexcr.2003.10.001; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Muller R, 2010, TUMOR BIOL, V31, P341, DOI 10.1007/s13277-010-0043-7; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nagahashi Masayuki, 2014, Advances in Biological Regulation, V54, P112, DOI 10.1016/j.jbior.2013.10.001; Nemoto S, 2009, J BIOL CHEM, V284, P10422, DOI 10.1074/jbc.M900735200; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; Oskouian B, 2007, CELL CYCLE, V6, P522, DOI 10.4161/cc.6.5.3903; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Patwardhan NN, 2015, J MED CHEM, V58, P1879, DOI 10.1021/jm501760d; Pericleous M, 2013, J GASTROINTEST ONCOL, V4, P409, DOI 10.3978/j.issn.2078-6891.2013.003; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Pyne S, 2011, TRENDS MOL MED, V17, P463, DOI 10.1016/j.molmed.2011.03.002; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; Ravishankar D, 2013, INT J BIOCHEM CELL B, V45, P2821, DOI 10.1016/j.biocel.2013.10.004; Riboni L, 2000, METHOD ENZYMOL, V311, P656; Riboni L, 2010, ADV EXP MED BIOL, V688, P24; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Scalbert Augustin, 2000, Journal of Nutrition, V130, p2073S; Selzner M, 2001, CANCER RES, V61, P1233; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tan SSL, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.21; Lopez PJT, 2014, CLIN MED INSIGHTS-GA, V7, P33, DOI 10.4137/CGast.S14039; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; Vogt D, 2014, BIOORGAN MED CHEM, V22, P5354, DOI 10.1016/j.bmc.2014.07.044; Xiao M, 2014, BIOMED ENVIRON SCI, V27, P197, DOI 10.3967/bes2014.040; Yester JW, 2011, CANCER METAST REV, V30, P577, DOI 10.1007/s10555-011-9305-0	58	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143384	10.1371/journal.pone.0143384	http://dx.doi.org/10.1371/journal.pone.0143384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580959	Green Published, gold			2022-12-27	WOS:000365154600119
J	Nishigori, N; Matsumoto, M; Koyama, F; Hayakawa, M; Hatakeyayama, K; Ko, S; Fujimura, Y; Nakajima, Y				Nishigori, Naoto; Matsumoto, Masanori; Koyama, Fumikazu; Hayakawa, Masaki; Hatakeyayama, Kinta; Ko, Saiho; Fujimura, Yoshihiro; Nakajima, Yoshiyuki			von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; HEPATIC VENOOCCLUSIVE DISEASE; METASTATIC COLORECTAL-CANCER; FACTOR MULTIMERS; PATHOLOGICAL RESPONSE; VONWILLEBRAND-FACTOR; PLASMA-LEVELS; BEVACIZUMAB; FLUOROURACIL; LEUCOVORIN	Oxaliplatin-based chemotherapy is widely used to treat advanced colorectal cancer (CRC). Sinusoidal obstruction syndrome (SOS) due to oxaliplatin is a serious type of chemotherapy- associated liver injury (CALI) in CRC patients. SOS is thought to be caused by the sinusoidal endothelial cell damage, which results in the release of unusually-large von Willebrand factor multimers (UL-VWFMs) from endothelial cells. To investigate the pathophysiology of CALI after oxaliplatin-based chemotherapy, we analyzed plasma concentration of von Willebrand factor (VWF) and the distribution of VWFMs in CRC patients. Twenty-three patients with advanced CRC who received oxaliplatin-based chemotherapy with (n = 6) and without (n = 17) bevacizumab were analyzed. CALI (n = 6) and splenomegaly (n = 9) were found only in patients who did not treated with bevacizumab. Plasma VWF antigen (VWF: Ag) and serum aspartate aminotransferase (AST) levels increased after chemotherapy only in patients without bevacizumab. VWFM analysis in patients who did not receive bevacizumab showed the presence of UL-VWFMs and absence of high molecular weight VWFMs during chemotherapy, especially in those with CALI. In addition, plasma VWF: Ag and AST levels increased after chemotherapy in patients with splenomegaly (n = 9), but not in patients without splenomegaly (n = 14). Histological findings in the liver tissue of patients who did not receive bevacizumab included sinusoidal dilatation and microthrombi in the sinusoids. Many microthrombi were positive for both anti-IIb/IIIa and anti-VWF antibodies. Plasma UL-VWFM levels might be increased by damage to endothelial cells as a result of oxaliplatin-based chemotherapy. Bevacizumab could prevent CALI and splenomegaly through inhibition of VWF-rich platelet thrombus formation.	[Nishigori, Naoto; Koyama, Fumikazu; Ko, Saiho; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 634, Japan; [Matsumoto, Masanori; Hayakawa, Masaki; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan; [Hatakeyayama, Kinta] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara 634, Japan	Nara Medical University; Nara Medical University; Nara Medical University	Matsumoto, M (corresponding author), Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan.	mmatsumo@naramed-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan [H26-063]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22591069]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25461456] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from the Ministry of Health, Labor, and Welfare of Japan (H26-063) to MM and YF, from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22591069) to MM, and from the Takeda Science Foundation to MM, YF, and NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer AT, 2015, BLOOD, V125, P3153, DOI 10.1182/blood-2014-08-595686; BUDDE U, 1990, THROMB HAEMOSTASIS, V63, P312; Budde U, 2002, SEMIN THROMB HEMOST, V28, P173, DOI 10.1055/s-2002-27820; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Furlan M, 1996, ANN HEMATOL, V72, P341, DOI 10.1007/s002770050184; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iguchi A, 2001, BONE MARROW TRANSPL, V27, P1173, DOI 10.1038/sj.bmt.1703061; Jung EJ, 2012, ANTICANCER RES, V32, P3357; Kato S, 2006, TRANSFUSION, V46, P1444, DOI 10.1111/j.1537-2995.2006.00914.x; Kishi Y, 2010, ANN SURG ONCOL, V17, P2870, DOI 10.1245/s10434-010-1166-1; Klinger M, 2009, EJSO-EUR J SURG ONC, V35, P515, DOI 10.1016/j.ejso.2008.12.013; Lenting PJ, 2015, BLOOD, V125, P2019, DOI 10.1182/blood-2014-06-528406; MANNUCCI PM, 1977, LANCET, V1, P869; Matsumoto M, 2007, BONE MARROW TRANSPL, V40, P251, DOI 10.1038/sj.bmt.1705724; Matsumoto M, 2005, PATHOPHYSIOL HAEMO T, V34, P35, DOI 10.1159/000088546; Matsushita K, 2005, BLOOD, V105, P207, DOI 10.1182/blood-2004-04-1519; MCDONALD GB, 1984, HEPATOLOGY, V4, P116, DOI 10.1002/hep.1840040121; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Overman MJ, 2010, J CLIN ONCOL, V28, P2549, DOI 10.1200/JCO.2009.27.5701; Park YD, 2002, BONE MARROW TRANSPL, V29, P789, DOI 10.1038/sj.bmt.1703544; Perez-Rodriguez A, 2011, EUR J HAEMATOL, V87, P448, DOI 10.1111/j.1600-0609.2011.01664.x; Ribero D, 2007, CANCER-AM CANCER SOC, V110, P2761, DOI 10.1002/cncr.23099; Robinson S, 2011, SURG ONCOL, V20, P57, DOI 10.1016/j.suronc.2009.10.002; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Rubbia-Brandt L, 2004, ANN ONCOL, V15, P460, DOI 10.1093/annonc/mdh095; Rubbia-Brandt L, 2010, HISTOPATHOLOGY, V56, P430, DOI 10.1111/j.1365-2559.2010.03511.x; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; Schwarz RE, 2013, HPB, V15, P106, DOI 10.1111/j.1477-2574.2012.00558.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Uemura M, 2005, BLOOD, V106, P922, DOI 10.1182/blood-2005-01-0152; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392	34	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143136	10.1371/journal.pone.0143136	http://dx.doi.org/10.1371/journal.pone.0143136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580395	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600089
J	Yang, FX; Zhu, GF				Yang, Fengxi; Zhu, Genfa			Digital Gene Expression Analysis Based on De Novo Transcriptome Assembly Reveals New Genes Associated with Floral Organ Differentiation of the Orchid Plant Cymbidium ensifolium	PLOS ONE			English	Article							MADS-BOX GENES; RNA-SEQ; FLOWER DEVELOPMENT; EVOLUTION; ARABIDOPSIS; ROLES; DIVERSITY	Cymbidium ensifolium belongs to the genus Cymbidium of the orchid family. Owing to its spectacular flower morphology, C. ensifolium has considerable ecological and cultural value. However, limited genetic data is available for this non-model plant, and the molecular mechanism underlying floral organ identity is still poorly understood. In this study, we characterize the floral transcriptome of C. ensifolium and present, for the first time, extensive sequence and transcript abundance data of individual floral organs. After sequencing, over 10 Gb clean sequence data were generated and assembled into 111,892 unigenes with an average length of 932.03 base pairs, including 1,227 clusters and 110,665 singletons. Assembled sequences were annotated with gene descriptions, gene ontology, clusters of orthologous group terms, the Kyoto Encyclopedia of Genes and Genomes, and the plant transcription factor database. From these annotations, 131 flowering-associated unigenes, 61 CONSTANS-LIKE (COL) unigenes and 90 floral homeotic genes were identified. In addition, four digital gene expression libraries were constructed for the sepal, petal, labellum and gynostemium, and 1,058 genes corresponding to individual floral organ development were identified. Among them, eight MADS-box genes were further investigated by full-length cDNA sequence analysis and expression validation, which revealed two APETALA1/AGL9-like MADS-box genes preferentially expressed in the sepal and petal, two AGAMOUS-like genes particularly restricted to the gynostemium, and four DEF-like genes distinctively expressed in different floral organs. The spatial expression of these genes varied distinctly in different floral mutant corresponding to different floral morphogenesis, which validated the specialized roles of them in floral patterning and further supported the effectiveness of our in silico analysis. This dataset generated in our study provides new insights into the molecular mechanisms underlying floral patterning of Cymbidium and supports a valuable resource for molecular breeding of the orchid plant.	[Yang, Fengxi; Zhu, Genfa] Guangdong Acad Agr Sci, Guangdong Key Lab Ornamental Plant Germplasm Inno, Environm Hort Res Inst, Guangzhou 510640, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences	Zhu, GF (corresponding author), Guangdong Acad Agr Sci, Guangdong Key Lab Ornamental Plant Germplasm Inno, Environm Hort Res Inst, Guangzhou 510640, Guangdong, Peoples R China.	genfazhu@163.com			Strategic Emerging Industries of Guangdong Province [2012A020800003]; National Natural Science Foundation of China [31471915]; Agriculture common key technology research [2011A020102007]	Strategic Emerging Industries of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture common key technology research	This research was supported by grants from the Strategic Emerging Industries of Guangdong Province (2012A020800003), the National Natural Science Foundation of China (31471915), and Agriculture common key technology research (2011A020102007).	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Cai J, 2015, NAT GENET, V47, P304, DOI 10.1038/ng0315-304a; Chang YY, 2010, PLANT PHYSIOL, V152, P837, DOI 10.1104/pp.109.147116; Chou ML, 2013, PLANTA, V237, P1425, DOI 10.1007/s00425-013-1850-z; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; da Silva JAT, 2014, SCI HORTIC-AMSTERDAM, V175, P74, DOI 10.1016/j.scienta.2014.05.008; De Paolo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102155; Du Puy D., 1988, THE GENUS CYMBIDIUM; Gravendeel B, 2004, PHILOS T ROY SOC B, V359, P1523, DOI 10.1098/rstb.2004.1529; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Hsu HF, 2002, PLANT CELL PHYSIOL, V43, P1198, DOI 10.1093/pcp/pcf143; Huang JiaPing, 1998, Journal of Beijing Forestry University, V20, P38; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim SY, 2007, PLANT SCI, V172, P319, DOI 10.1016/j.plantsci.2006.09.009; Konishi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2621; Li XY, 2013, INT J NANOMED, V8, P23, DOI 10.2147/IJN.S38507; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; LIU ZJ, 2006, CHINESE CYMBIDIUM PL; Mondragon-Palomino M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-81; Pan ZJ, 2014, NEW PHYTOL, V202, P1024, DOI 10.1111/nph.12723; Rajkumari JD, 2005, J GENET, V84, P81, DOI 10.1007/BF02715895; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Schauser L, 2005, J MOL EVOL, V60, P229, DOI 10.1007/s00239-004-0144-2; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai WC, 2010, ACTA HORTIC, V878, P115, DOI 10.17660/ActaHortic.2010.878.12; Tsai WC, 2005, PLANT CELL PHYSIOL, V46, P1125, DOI 10.1093/pcp/pci125; Tsai WC, 2004, PLANT CELL PHYSIOL, V45, P831, DOI 10.1093/pcp/pch095; Tsai WC, 2014, J SYST EVOL, V52, P397, DOI 10.1111/jse.12010; Wang HZ, 2011, PLANT SYST EVOL, V293, P101, DOI 10.1007/s00606-011-0429-z; Wang SY, 2011, PLANT CELL PHYSIOL, V52, P563, DOI 10.1093/pcp/pcr015; Wang Y, 2014, PLANT CELL TISS ORG, V116, P297, DOI 10.1007/s11240-013-0404-1; Yukawa T, 2002, BOT J LINN SOC, V138, P383, DOI 10.1046/j.1095-8339.2002.00038.x; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082	40	14	17	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142434	10.1371/journal.pone.0142434	http://dx.doi.org/10.1371/journal.pone.0142434			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580566	gold, Green Submitted, Green Published			2022-12-27	WOS:000365154600047
J	Catherine, C; Lee, SW; Ju, JW; Kim, HC; Shin, HI; Kim, YJ; Kim, DM				Catherine, Christy; Lee, Seung-Won; Ju, Jung Won; Kim, Ho-Cheol; Shin, Hyun-Il; Kim, Yu Jung; Kim, Dong-Myung			Cell-Free Expression and In Situ Immobilization of Parasite Proteins from Clonorchis sinensis for Rapid Identification of Antigenic Candidates	PLOS ONE			English	Article							VITRO EXPRESSION; HIGH-THROUGHPUT; WHEAT-GERM; CONSTRUCTION; SYSTEM; MICROARRAYS; MALARIA	Progress towards genetic sequencing of human parasites has provided the groundwork for a post-genomic approach to develop novel antigens for the diagnosis and treatment of parasite infections. To fully utilize the genomic data, however, high-throughput methodologies are required for functional analysis of the proteins encoded in the genomic sequences. In this study, we investigated cell-free expression and in situ immobilization of parasite proteins as a novel platform for the discovery of antigenic proteins. PCR-amplified parasite DNA was immobilized on microbeads that were also functionalized to capture synthesized proteins. When the microbeads were incubated in a reaction mixture for cell-free synthesis, proteins expressed from the microbead-immobilized DNA were instantly immobilized on the same microbeads, providing a physical linkage between the genetic information and encoded proteins. This approach of in situ expression and isolation enables streamlined recovery and analysis of cell-free synthesized proteins and also allows facile identification of the genes coding antigenic proteins through direct PCR of the microbead-bound DNA.	[Catherine, Christy; Lee, Seung-Won; Kim, Ho-Cheol; Kim, Dong-Myung] Chungnam Natl Univ, Dept Fine Chem Engn & Appl Chem, Daejeon 305764, South Korea; [Ju, Jung Won; Shin, Hyun-Il; Kim, Yu Jung] Natl Inst Hlth, Div Malaria & Parasit Dis, Osong 361951, South Korea	Chungnam National University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH)	Kim, DM (corresponding author), Chungnam Natl Univ, Dept Fine Chem Engn & Appl Chem, Daejeon 305764, South Korea.	dmkim@cnu.ac.kr		Ju, Jung-Won/0000-0001-5248-6995; Kim, Dong-Myung/0000-0001-7875-0694	Korea National Institute of Health [2013-E54003-00]; National Research Foundation of Korea [2014M3C1A3051473]	Korea National Institute of Health; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the grants from the Korea National Institute of Health (http://www.nih.go.kr/NIH/eng/main.jsp; grant no. 2013-E54003-00) and National Research Foundation of Korea (www.nrf.re.kr; grant no. 2014M3C1A3051473).	Angenendt P, 2006, MOL CELL PROTEOMICS, V5, P1658, DOI 10.1074/mcp.T600024-MCP200; Barik S., 2012, Molecular and Cellular Pharmacology, V4, P91; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Carlson ED, 2011, BIOTECHNOL ADV, V30, P1185, DOI DOI 10.1016/J.BI0TECHADV.2011.09.016; Catherine C, 2013, BIOTECHNOL ADV, V31, P797, DOI 10.1016/j.biotechadv.2013.04.009; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Kim TW, 2006, J BIOTECHNOL, V126, P554, DOI 10.1016/j.jbiotec.2006.05.014; Kim TW, 2006, PROTEIN EXPRES PURIF, V45, P249, DOI 10.1016/j.pep.2005.09.010; Lee KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034429; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Paul S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks940; Quertinmont LT, 2015, CHEM COMMUN, V51, P122, DOI 10.1039/c4cc08240k; Rui E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-192; Rungpragayphan S, 2003, FEBS LETT, V540, P147, DOI 10.1016/S0014-5793(03)00251-5; Rungpragayphan S, 2002, J MOL BIOL, V318, P395, DOI 10.1016/S0022-2836(02)00094-3; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Tsuboi T, 2010, ACTA TROP, V114, P171, DOI 10.1016/j.actatropica.2009.10.024; Wu W, 2012, PARASITOL RES, V111, P1879, DOI 10.1007/s00436-012-3152-y	21	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143597	10.1371/journal.pone.0143597	http://dx.doi.org/10.1371/journal.pone.0143597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599101	Green Submitted, gold, Green Published			2022-12-27	WOS:000365862600092
J	Jang, SJ; Hsieh, CA; Huang, HL; Juang, JMJ; Chou, HH; Tsao, CY; Wu, TY; Ko, YL				Jang, Shih-Jung; Hsieh, Chien-An; Huang, Hsuan-Li; Juang, Jyh-Ming Jimmy; Chou, Hsin-Hua; Tsao, Chueh-Yung; Wu, Tien-Yu; Ko, Yu-Lin			Feasibility and Clinical Outcomes of Peripheral Drug-Coated Balloon in High-Risk Patients with Femoropopliteal Disease	PLOS ONE			English	Article							IN-STENT RESTENOSIS; PROXIMAL POPLITEAL ARTERIES; PACLITAXEL-ELUTING BALLOON; SUBINTIMAL ANGIOPLASTY; TASC C; LONG; LESIONS; IMPLANTATION; IMPACT; CLASSIFICATION	Background Clinical outcomes of the drug-coated balloon (DCB) procedure in high-risk patients with femoropopliteal (FP) disease have not been investigated sufficiently. Methods This retrospective, single-center study analyzed 87 patients (39% dialysis) and 97 affected legs (64% critical limb ischemia [CLI]) that underwent DCB for symptomatic FP disease from March 2013 to September 2014. Risk stratification was based on FeDCLIP (female, diabetes, dialysis, CLI, lesion length >150 mm and poor runoff) score. The DCB outcomes among the different risk groups were compared and factors predicting restenosis were analyzed during follow-up. Results Most of study participants (84%) were moderate to high-risk patients. The procedural success rate was 100% and the 30-day major adverse vascular event rate was 2.1%. The mean lesion length was 178 +/- 106 mm and the mean follow-up time was 428 +/- 145 (range 50-782) days. The binary restenosis-free and clinically driven target lesion revascularization (CD-TLR)-free rates at 12 months were 77.5% and 84.3%, respectively, for all participants. No significant differences were observed in 1-year binary restenosis and CD-TLR rates in the low-, moderate-, and high-risk groups (60%, 84%, and 73%: p = 0.396; 78%, 89%, and 80%: p = 0.635, respectively). In multivariate analysis, lesion length > 150 mm (Hazard ratio [HR]: 8.00, 95% confidence interval (CI) 1.12 to 55.6, p = 0.038) and Rutherford class 6 (HR: 7.09, 95% CI, 1.15 to 43.5, p = 0.034) were identified as independent predictors of binary restenosis. Conclusions Despite general comorbidities and advanced limb ischemia, 1-year outcomes of DCB in high-risk patients with FP disease were effective. The DCB procedure holds promise to improve vessel patency; however, lesion length >150 mm and major tissue loss were independent predictors for binary restenosis after the treatment.	[Jang, Shih-Jung; Hsieh, Chien-An; Huang, Hsuan-Li; Chou, Hsin-Hua; Wu, Tien-Yu; Ko, Yu-Lin] Taipei Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Chou, Hsin-Hua; Ko, Yu-Lin] Tzuchi Univ, Sch Med, Hualien, Taiwan; [Juang, Jyh-Ming Jimmy] Natl Taiwan Univ Hosp, Dept Internal Med, Cardiovasc Ctr, Taipei 100, Taiwan; [Juang, Jyh-Ming Jimmy] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Juang, Jyh-Ming Jimmy] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Tsao, Chueh-Yung] Chang Gang Univ, Dept Ind & Business Management, Taoyuan, Taiwan	Tzu Chi University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung University	Huang, HL (corresponding author), Taipei Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	huang304@gmail.com	Huang, Hsuan-Li/AAS-9530-2021; Chou, Hsin Hua/AAU-8756-2021; Huang, Hsuan Li/ABD-2244-2020	Huang, Hsuan-Li/0000-0001-7640-7702; Chou, Hsin Hua/0000-0001-5871-555X; Juang, Jyh-Ming Jimmy/0000-0003-4767-7636				Armstrong EJ, 2014, J ENDOVASC THER, V21, P34, DOI 10.1583/13-4399MR.1; Ban DT, 2010, J VASC SURG, V51, P1406, DOI 10.1016/j.jvs.2010.01.062; Bosiers M, 2011, J VASC SURG, V54, P1042, DOI 10.1016/j.jvs.2011.03.272; Chalmers N, 2013, CARDIOVASC INTER RAD, V36, P353, DOI 10.1007/s00270-012-0492-z; Davaine JM, 2012, EUR J VASC ENDOVASC, V44, P432, DOI 10.1016/j.ejvs.2012.07.015; Fanelli F, 2014, CARDIOVASC INTER RAD, V37, P898, DOI 10.1007/s00270-014-0904-3; Iida O, 2009, CIRC J, V73, P2143, DOI 10.1253/circj.CJ-09-0166; Laird JR, 2012, J ENDOVASC THER, V19, P1, DOI 10.1583/11-3627.1; Laird JR, 2012, J AM COLL CARDIOL, V59, P24, DOI 10.1016/j.jacc.2011.09.037; Laird JR, 2012, CATHETER CARDIO INTE, V80, P852, DOI 10.1002/ccd.23475; Laxdal E, 2003, EUR J VASC ENDOVASC, V25, P578, DOI 10.1053/ejvs.2002.1899; Liistro F, 2014, J ENDOVASC THER, V21, P1, DOI 10.1583/13-4420R.1; Mewissen MW, 2009, J ENDOVASC THER, V16, P63, DOI 10.1583/08-2658.1; Micari A, 2012, JACC-CARDIOVASC INTE, V5, P331, DOI 10.1016/j.jcin.2011.11.010; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026; Scheinert D, 2014, JACC-CARDIOVASC INTE, V7, P11, DOI 10.1016/j.jcin.2013.05.022; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Sidhu R, 2010, VASC ENDOVASC SURG, V44, P633, DOI 10.1177/1538574410376453; Soga Y, 2011, J VASC SURG, V54, P1058, DOI 10.1016/j.jvs.2011.03.286; Soga Y, 2010, J VASC SURG, V52, P608, DOI 10.1016/j.jvs.2010.03.050; Tepe G, 2015, CIRCULATION, V131, P495, DOI 10.1161/CIRCULATIONAHA.114.011004; Tosaka A, 2012, J AM COLL CARDIOL, V59, P16, DOI 10.1016/j.jacc.2011.09.036; Virga V, 2014, JACC-CARDIOVASC INTE, V7, P411, DOI 10.1016/j.jcin.2013.11.020; Werk M, 2012, CIRC-CARDIOVASC INTE, V5, P831, DOI 10.1161/CIRCINTERVENTIONS.112.971630; Zeller T, 2014, J ENDOVASC THER, V21, P359, DOI 10.1583/13-4630MR.1	26	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143658	10.1371/journal.pone.0143658	http://dx.doi.org/10.1371/journal.pone.0143658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599128	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600101
J	Karimian, G; Kirschbaum, M; Veldhuis, ZJ; Bomfati, F; Porte, RJ; Lisman, T				Karimian, Golnar; Kirschbaum, Marc; Veldhuis, Zwanida J.; Bomfati, Fernanda; Porte, Robert J.; Lisman, Ton			Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice	PLOS ONE			English	Article							NF-KAPPA-B; LIPID-PEROXIDATION; HEPATOCYTE APOPTOSIS; HEPATIC STEATOSIS; DOWN-REGULATION; RISK-FACTOR; STEATOHEPATITIS; REGENERATION; INFLAMMATION; EXPRESSION	Background and Aim The progression of non-alcoholic fatty liver disease (NAFLD) likely involves a 'multiple hit' mechanism. We hypothesized that partial hepatectomy, a procedure performed frequently in patients with NAFLD, would accelerate the progression of disease. Methods C57BL/6JolaHsd mice were fed a choline-deficient L-amino acid-defined diet (CD-AA) or a choline-sufficient L-amino acid-defined control diet (CS-AA). Part of the mice in the CD-AA group received a diet enriched in vitamin E (similar to 20 mg /day). Two weeks after the start of the diet, mice underwent a partial hepatectomy or a sham operation. Results In the CD-AA group, NAFLD activity scores were significantly higher at 7 days after partial hepatectomy compared to the sham operated mice (3.7 +/- 1.3 vs. 1.8 +/- 0.7; P<0.05). In addition, TBARS, a measure for oxidative stress, in liver tissue of the CD-AA group were significantly higher at day 1, 3 and 7 after partial hepatectomy compared to the sham operated mice (P<0.05). Vitamin E therapy significantly reduced TBARS level at day 7 after partial hepatectomy compared to the CD-AA diet group (P<0.05). Vitamin E suppletion reduced NAFLD activity score at day 7 after partial hepatectomy compared to the CD-AA group (2.3 +/- 0.8 vs. 3.8 +/- 1.0; P<0.05). Conclusion Partial hepatectomy accelerates the progression of NAFLD. Disease progression induced by partial hepatectomy is substantially attenuated by vitamin E.	[Karimian, Golnar; Kirschbaum, Marc; Veldhuis, Zwanida J.; Bomfati, Fernanda] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Surg Res Lab, Groningen, Netherlands; [Porte, Robert J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands; [Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Surg Res Lab, Groningen, Netherlands; [Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Karimian, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Surg Res Lab, Groningen, Netherlands.	golnar.karimian@gmail.com		Lisman, Ton/0000-0002-3503-7140	Netherlands Organization for scientific research (VIDI) [917.11.304]	Netherlands Organization for scientific research (VIDI)(Netherlands Organization for Scientific Research (NWO))	This project was supported by the Netherlands Organization for scientific research (VIDI, 917.11.304; T.L.).	Albano E, 2005, ALIMENT PHARM THER, V22, P71, DOI 10.1111/j.1365-2036.2005.02601.x; Albano E, 2005, GUT, V54, P987, DOI 10.1136/gut.2004.057968; Cho JY, 2006, SURGERY, V139, P508, DOI 10.1016/j.surg.2005.09.007; Cho SW, 2008, ANN SURG ONCOL, V15, P2795, DOI 10.1245/s10434-008-0090-0; Day CP, 2012, DIGEST DIS, V30, P69, DOI 10.1159/000341128; de Meijer VE, 2010, BRIT J SURG, V97, P1331, DOI 10.1002/bjs.7194; DeAngelis RA, 2005, HEPATOLOGY, V42, P1148, DOI 10.1002/hep.20879; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hardwick RN, 2010, DRUG METAB DISPOS, V38, P2293, DOI 10.1124/dmd.110.035006; Hsieh HF, 2008, AM J SURG, V196, P346, DOI 10.1016/j.amjsurg.2007.09.051; Hugenholtz GCG, 2013, THROMB HAEMOSTASIS, V109, P948, DOI 10.1160/TH12-12-0930; Iwai M, 2001, CYTOKINE, V13, P60, DOI 10.1006/cyto.2000.0797; Kamada Y, 2007, J HEPATOL, V47, P556, DOI 10.1016/j.jhep.2007.03.020; Kele PG, 2013, LIVER INT, V33, P469, DOI 10.1111/liv.12089; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Lo Sasso G, 2010, HEPATOLOGY, V51, P1334, DOI 10.1002/hep.23436; Morris EM, 2011, ANTIOXID REDOX SIGN, V15, P485, DOI 10.1089/ars.2010.3795; Oliveira CPMS, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-9; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Ronco MT, 2002, MOL MED, V8, P808, DOI 10.1007/BF03402085; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; Sydor S, 2013, LAB INVEST, V93, P20, DOI 10.1038/labinvest.2012.142; Tevar AD, 2010, J AM COLL SURGEONS, V210, P515, DOI 10.1016/j.jamcollsurg.2010.01.020; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Zhang YKJ, 2010, TOXICOL APPL PHARM, V245, P326, DOI 10.1016/j.taap.2010.03.016	32	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143121	10.1371/journal.pone.0143121	http://dx.doi.org/10.1371/journal.pone.0143121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600128	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600029
J	Luo, XM; Xu, B; Zhou, ML; Bao, YY; Zhou, SH; Fan, J; Lu, ZJ				Luo, Xing-Mei; Xu, Bin; Zhou, Min-Li; Bao, Yang-Yang; Zhou, Shui-Hong; Fan, Jun; Lu, Zhong-Jie			Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GLUCOSE-UPTAKE; CANCER CELLS; GLOTTIC CANCER; HEP-2 CELLS; NECK-CANCER; GLUCOSE-TRANSPORTER-1; AKT; HEAD; ACTIVATION	In the present study, we investigated the role of GLUT-1 and PI3K/Akt signaling in radioresistance of laryngeal carcinoma xenografts. Volume, weight, radiosensitization, and the rate of inhibition of tumor growth in the xenografts were evaluated in different groups. Apoptosis was evaluated by TUNEL assay. In addition, mRNA and protein levels of GLUT-1, p-Akt, and PI3K in the xenografts were measured. Treatment with LY294002, wortmannin, wortmannin plus GLUT-1 AS-ODN, and LY294002 plus GLUT-1 AS-ODN after X-ray irradiation significantly reduced the size and weight of the tumors, rate of tumor growth, and apoptosis in tumors compared to that observed in the 10-Gy group (p<0.05). In addition, mRNA and protein expression of GLUT-1, p-Akt, and PI3K was downregulated. The E/O values of LY294002, LY294002 plus GLUT-1 AS-ODN, wortmannin, and wortmannin plus GLUT-1 AS-ODN were 2.7, 1.1, 1.8, and 1.8, respectively. Taken together, these data indicate that GLUT-1 AS-ODN as well as the inhibitors of PI3K/Akt signaling may act as radiosensitizers of laryngeal carcinoma in vivo.	[Luo, Xing-Mei; Xu, Bin; Zhou, Min-Li; Bao, Yang-Yang; Zhou, Shui-Hong] Zhejiang Univ, Affiliated Hosp 1, Dept Otolaryngol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Fan, Jun] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Zhong-Jie] Zhejiang Univ, Affiliated Hosp 1, Dept Radiotherapy, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhou, SH (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Otolaryngol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	zhouyunzhoush@163.com			National Natural Science Foundation of China [81172562, 81372903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81172562 and 81372903).	Bao YY, 2015, ONCOL REP, V34, P1805, DOI 10.3892/or.2015.4158; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Chen XH, 2013, MOL MED REP, V8, P1695, DOI 10.3892/mmr.2013.1740; Doki Y, 2005, SURGERY, V137, P536, DOI 10.1016/j.surg.2005.01.008; Eckert AW, 2012, ORAL MAXILLOFAC SURG, V16, P189, DOI 10.1007/s10006-012-0335-8; Fan JA, 2010, CANCER BIOTHER RADIO, V25, P521, DOI 10.1089/cbr.2010.0784; Han MW, 2012, HEAD NECK-J SCI SPEC, V34, P1395, DOI 10.1002/hed.21945; Heavey S, 2014, CANCER TREAT REV, V40, P445, DOI 10.1016/j.ctrv.2013.08.006; Huang XQ, 2014, INT J CLIN EXP PATHO, V7, P1651; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Ke CC, 2013, EUR J NUCL MED MOL I, V40, P61, DOI 10.1007/s00259-012-2242-5; Kim JH, 2013, INT J MOL SCI, V14, P17304, DOI 10.3390/ijms140917304; Koukourakis MI, 2010, INT J RADIAT ONCOL, V77, P9, DOI 10.1016/j.ijrobp.2009.04.060; Lei Y, 2013, INT J RADIAT BIOL, V89, P1079, DOI 10.3109/09553002.2013.825058; Luna-Ortiz K, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-101; Luo XM, 2010, J INT MED RES, V38, P1885, DOI 10.1177/147323001003800601; Melstrom LG, 2008, PANCREAS, V37, P426, DOI 10.1097/MPA.0b013e3181735ccb; Pedersen MWB, 2001, NEOPLASIA, V3, P80, DOI 10.1038/sj.neo.7900133; Pellini R, 2008, HEAD NECK-J SCI SPEC, V30, P372, DOI 10.1002/hed.20709; Perri F, 2015, HEAD NECK-J SCI SPEC, V37, P763, DOI 10.1002/hed.23837; Rashmi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092948; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Santoro R, 2014, EUR ARCH OTO-RHINO-L, V271, P777, DOI 10.1007/s00405-013-2583-0; Shimanishi M, 2013, J ORAL PATHOL MED, V42, P382, DOI 10.1111/jop.12028; Shin SJ, 2014, EUR J PHARMACOL, V743, P17, DOI 10.1016/j.ejphar.2014.09.013; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; Tateya I, 2006, EUR ARCH OTO-RHINO-L, V263, P144, DOI 10.1007/s00405-005-0978-2; van der Molen L, 2013, RADIOTHER ONCOL, V106, P364, DOI 10.1016/j.radonc.2013.03.005; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Volker HU, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-18; Wang KR, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-294; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xia Y, 1996, AIZHENG, V15, P8; Xu YY, 2014, INT J CLIN EXP PATHO, V7, P3938; Yan SX, 2013, INT J MED SCI, V10, P1375, DOI 10.7150/ijms.6855; Yang X, 2015, TUMOR BIOL, V36, P383, DOI 10.1007/s13277-014-2617-2; Zhou SH, 2009, HEAD NECK-J SCI SPEC, V31, P1624, DOI 10.1002/hed.21137	38	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143306	10.1371/journal.pone.0143306	http://dx.doi.org/10.1371/journal.pone.0143306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600164	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600047
J	Pellegrin, M; Aubert, JF; Bouzourene, K; Amstutz, C; Mazzolai, L				Pellegrin, Maxime; Aubert, Jean-Francois; Bouzourene, Karima; Amstutz, Catherine; Mazzolai, Lucia			Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects	PLOS ONE			English	Article							E-DEFICIENT MICE; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; HYPERCHOLESTEROLEMIC MICE; CARDIAC REHABILITATION; INFLAMMATORY MARKERS; PRIMARY PREVENTION; KNOCKOUT MICE; T-CELLS; PLAQUE	We have previously demonstrated that exercise training prevents the development of Angiotensin (Ang) II-induced atherosclerosis and vulnerable plaques in Apolipoprotein E-deficient (ApoE(-/-)) mice. In this report, we investigated whether exercise attenuates progression and promotes stability in pre-established vulnerable lesions. To this end, ApoE(-/-) mice with already established Ang II-mediated advanced and vulnerable lesions (2-kidney, 1-clip [2K1C] renovascular hypertension model), were subjected to sedentary (SED) or voluntary wheel running training (EXE) regimens for 4 weeks. Mean blood pressure and plasma renin activity did not significantly differ between the two groups, while total plasma cholesterol significantly decreased in 2K1C EXE mice. Aortic plaque size was significantly reduced by 63% in 2K1C EXE compared to SED mice. Plaque stability score was significantly higher in 2K1C EXE mice than in SED ones. Aortic ICAM-1 mRNA expression was significantly down-regulated following EXE. Moreover, EXE significantly down-regulated splenic proinflammatory cytokines IL-18, and IL-1 beta mRNA expression while increasing that of antiinflammatory cytokine IL-4. Reduction in plasma IL-18 levels was also observed in response to EXE. There was no significant difference in aortic and splenic Th1/Th2 and M1/M2 polarization markers mRNA expression between the two groups. Our results indicate that voluntary EXE is effective in slowing progression and promoting stabilization of preexisting Ang II-dependent vulnerable lesions by ameliorating systemic inflammatory state. Our findings support a therapeutic role for voluntary EXE in patients with established atherosclerosis.	[Pellegrin, Maxime; Aubert, Jean-Francois; Bouzourene, Karima; Amstutz, Catherine; Mazzolai, Lucia] Univ Lausanne Hosp, Div Angiol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Pellegrin, M (corresponding author), Univ Lausanne Hosp, Div Angiol, Lausanne, Switzerland.	maxime.pellegrin@chuv.ch						Ajijola OA, 2009, ANTIOXID REDOX SIGN, V11, P15, DOI 10.1089/ars.2008.2092; Apostolakis Stavros, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P150, DOI 10.2174/187152508783955006; Fukao K, 2010, J ATHEROSCLER THROMB, V17, P1226, DOI 10.5551/jat.4788; Goldhammer E, 2005, INT J CARDIOL, V100, P93, DOI 10.1016/j.ijcard.2004.08.073; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Kadoglou NPE, 2011, J VASC RES, V48, P347, DOI 10.1159/000321174; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Kyaw T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060430; Lavie CJ, 2011, PROG CARDIOVASC DIS, V53, P397, DOI 10.1016/j.pcad.2011.02.008; Lawler PR, 2011, AM HEART J, V162, P571, DOI 10.1016/j.ahj.2011.07.017; Li NL, 2013, THROMB HAEMOSTASIS, V109, P980, DOI 10.1160/TH12-11-0819; Liu Z, 2013, BRIT J PHARMACOL, V169, P1795, DOI 10.1111/bph.12246; Mazzolai L, 2004, HYPERTENSION, V44, P277, DOI 10.1161/01.HYP.0000140269.55873.7b; Meissner M, 2011, ATHEROSCLEROSIS, V218, P323, DOI 10.1016/j.atherosclerosis.2011.06.040; Napoli C, 2006, P NATL ACAD SCI USA, V103, P10479, DOI 10.1073/pnas.0602774103; Nussberger J, 2008, HYPERTENSION, V51, P1306, DOI 10.1161/HYPERTENSIONAHA.108.110932; Okabe T, 2007, CARDIOVASC RES, V74, P537, DOI 10.1016/j.cardiores.2007.02.019; Pedersen BK, 2006, ESSAYS BIOCHEM, V42, P105, DOI 10.1042/bse0420105; Pellegrin M, 2013, J CLIN EXP CARDIOLOG; Pellegrin M, 2007, ATHEROSCLEROSIS, V190, P35, DOI 10.1016/j.atherosclerosis.2006.02.001; Pellegrin M, 2009, MED SCI SPORT EXER, V41, P2128, DOI 10.1249/MSS.0b013e3181a8d530; Pellegrin M, 2009, HYPERTENSION, V53, P782, DOI 10.1161/HYPERTENSIONAHA.108.128165; Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010; Perez-Terzic CM, 2012, PM&R, V4, P867, DOI 10.1016/j.pmrj.2012.10.003; Pinto A, 2012, CURR PHARM DESIGN, V18, P4326, DOI 10.2174/138161212802481192; Qamar A, 2012, CURR OPIN LIPIDOL, V23, P548, DOI 10.1097/MOL.0b013e328359b0a6; Ramachandran S, 2005, ATHEROSCLEROSIS, V178, P33, DOI 10.1016/j.atherosclerosis.2004.08.010; Ribeiro F, 2012, INT J SPORTS MED, V33, P192, DOI 10.1055/s-0031-1297959; She ZG, 2009, CIRC RES, V104, P1160, DOI 10.1161/CIRCRESAHA.108.192229; Shin HS, 2014, J ETHNOPHARMACOL, V153, P142, DOI 10.1016/j.jep.2014.01.039; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Spence AL, 2013, J PHYSIOL-LONDON, V591, P1265, DOI 10.1113/jphysiol.2012.247387; Thijssen DHJ, 2012, CLIN SCI, V122, P311, DOI 10.1042/CS20110469; Tse K, 2013, INT IMMUNOL, V25, P615, DOI 10.1093/intimm/dxt043; Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6; Xu SW, 2011, ARCH BIOCHEM BIOPHYS, V515, P72, DOI 10.1016/j.abb.2011.08.006	37	10	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143536	10.1371/journal.pone.0143536	http://dx.doi.org/10.1371/journal.pone.0143536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600018	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600080
J	Pisani, F; Settanni, P; Rosito, S; Mola, MG; Iorio, R; Tortorella, C; Ruggieri, M; Trojano, M; Svelto, M; Frigeri, A; Nicchia, GP				Pisani, Francesco; Settanni, Paolo; Rosito, Stefania; Mola, Maria Grazia; Iorio, Raffaele; Tortorella, Carla; Ruggieri, Maddalena; Trojano, Maria; Svelto, Maria; Frigeri, Antonio; Nicchia, Grazia Paola			Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection	PLOS ONE			English	Article							ANTI-AQUAPORIN-4 ANTIBODIES; DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; BINDING; MARKER; IGG; NMO; SPECIFICITY; MUSCLE; ASSAYS	Serological markers of Nuromyelitis Optica (NMO), an autoimmune disorder of the central nervous system, are autoantibodies targeting the astrocytic water channel aquaporin-4 (AQP4). We have previously demonstrated that the main epitopes for these autoantibodies (AQP4-IgG) are generated by the supramolecular arrangement of AQP4 tetramers into an Orthogonal Array of Particles (OAPs). Many tests have been developed to detect AQP4-IgG in patient sera but several procedural issues affect OAP assembly and consequently test sensitivity. To date, the protein based ELISA test shows the lowest sensitivity while representing a valid alternative to the more sensitive cell based assay (CBA), which, however, shows economic, technical and interpretation problems. Here we have developed a high perfomance ELISA in which native OAPs are used as the molecular target. To this aim a native size exclusion chromatography method has been developed to isolate integral, highly pure and AQP4-IgG-recognized OAPs from rat brain. These OAPs were immobilized and oriented on a plastic plate by a sandwich approach and 139 human sera were tested, including 67 sera from NMO patients. The OAP-ELISA showed a 99% specificity and a higher sensitivity (91%) compared to the CBA test. A comparative analysis revealed an end-point titer three orders of magnitude higher than the commercial ELISA and six times higher than our in-house CBA test. We show that CNS-extracted OAPs are crucial elements in order to perform an efficient AQP4-IgG test and the OAP-ELISA developed represents a valid alternative to the CBA currently used.	[Pisani, Francesco; Settanni, Paolo; Rosito, Stefania; Mola, Maria Grazia; Svelto, Maria; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy; [Pisani, Francesco; Settanni, Paolo; Rosito, Stefania; Mola, Maria Grazia; Svelto, Maria; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Ctr Excellence Comparat Genom, I-70126 Bari, Italy; [Tortorella, Carla; Ruggieri, Maddalena; Trojano, Maria; Frigeri, Antonio] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, I-70126 Bari, Italy; [Iorio, Raffaele] Univ Cattolica Sacro Cuore, Inst Neurol, Dept Geriatr Neurosci & Orthoped, I-00168 Rome, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Frigeri, A (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, I-70126 Bari, Italy.	antonio.frigeri@uniba.it	Iorio, Raffaele/E-1236-2014; PISANI, Francesco/AAC-1749-2019; Mola, Maria Grazia/I-3507-2019; Iorio, Raffaele/HDN-3072-2022; frigeri, Antonio/AAC-6336-2022; tortorella, carla/J-2557-2012	Iorio, Raffaele/0000-0002-6270-0956; PISANI, Francesco/0000-0001-8511-117X; Mola, Maria Grazia/0000-0002-4421-9237; Iorio, Raffaele/0000-0002-6270-0956; Trojano, Maria/0000-0002-6329-8946; tortorella, carla/0000-0001-9037-7300	Italian Ministry of University and Research MIUR, FIRB [RBFR12SJA8]; Apulian Region funding PON [01_01297]	Italian Ministry of University and Research MIUR, FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Apulian Region funding PON	This work was financially supported by: Italian Ministry of University and Research MIUR, FIRB project RBFR12SJA8 to GPN and Apulian Region funding PON project 01_01297 to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apiwattanakul M, 2012, J NEUROL SCI, V320, P118, DOI 10.1016/j.jns.2012.07.014; Bergamaschi R, 2004, NEUROL SCI, V25, pS364, DOI 10.1007/s10072-004-0342-0; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Fazio R, 2009, MULT SCLER J, V15, P1153, DOI 10.1177/1352458509106851; Frigeri A, 2004, FASEB J, V18, P905, DOI 10.1096/fj.03-0987fje; Fryer JP, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000011; Hayakawa S, 2008, J NEUROIMMUNOL, V196, P181, DOI 10.1016/j.jneuroim.2008.03.009; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Isobe N, 2012, MULT SCLER J, V18, P1541, DOI 10.1177/1352458512443917; Jarius S, 2012, J NEUROL SCI, V320, P32, DOI 10.1016/j.jns.2012.06.002; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Jarius S, 2013, BRAIN PATHOL, V23, P661, DOI 10.1111/bpa.12084; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Kampylafka EI, 2011, J AUTOIMMUN, V36, P221, DOI 10.1016/j.jaut.2011.01.004; Kim W, 2012, MULT SCLER J, V18, P578, DOI 10.1177/1352458511424590; Kim YJ, 2012, J CLIN LAB ANAL, V26, P184, DOI 10.1002/jcla.21508; Kimbrough DJ, 2012, MULT SCLER RELAT DIS, V1, P180, DOI 10.1016/j.msard.2012.06.002; Kremer L, 2014, MULT SCLER J, V20, P843, DOI 10.1177/1352458513507822; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Nicchia GP, 2008, J NEUROCHEM, V105, P2156, DOI 10.1111/j.1471-4159.2008.05302.x; Nicchia GP, 2010, NEUROSCIENCE, V168, P903, DOI 10.1016/j.neuroscience.2010.02.008; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Pisani F, 2014, J BIOL CHEM, V289, P30578, DOI 10.1074/jbc.M114.582221; Pisani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079185; Pisani F, 2011, GLIA, V59, P1923, DOI 10.1002/glia.21234; Pisani F, 2011, J BIOL CHEM, V286, P9216, DOI 10.1074/jbc.M110.123000; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rossi A, 2010, J BIOL CHEM, V285, P4562, DOI 10.1074/jbc.M109.069245; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Waters P, 2008, Int MS J, V15, P99; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	39	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143679	10.1371/journal.pone.0143679	http://dx.doi.org/10.1371/journal.pone.0143679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599905	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600104
J	Shin, SJ; Ko, KJ; Kim, TS; Ryoo, HS; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Choi, HY; Jeon, SS				Shin, Seung Jea; Ko, Kwang Jin; Kim, Tae Sun; Ryoo, Hyun Soo; Sung, Hyun Hwan; Jeon, Hwang Gyun; Jeong, Byong Chang; Seo, Seong Il; Lee, Hyun Moo; Choi, Han Yong; Jeon, Seong Soo			Trends in the Use of Nephron-Sparing Surgery over 7 Years: An Analysis Using the RENAL Nephrometry Scoring System	PLOS ONE			English	Article							RADICAL NEPHRECTOMY; IMPACT	Objective To analyze trends in the use of partial nephrectomy, we evaluated which individual factors of renal nephrometry score (RNS) influenced the operative approach bi-annually from 2008 to 2014. Materials and Methods We performed a retrospective review of renal cell carcinoma treated by surgery in 2008, 2010, 2012, and 2014. The complexity of renal masses was measured using the R.E.N.A.L. nephrometry scoring system with CT or MRI. Group comparison in terms of operation year and surgical type (partial nephrectomy versus radical nephrectomy) was performed. We developed a nomogram to quantitate the likelihood of selecting partial nephrectomy over radical nephrectomy. Results A total of 1106 cases (237 in 2008, 225 in 2010, 292 in 2012, and 352 in 2014) were available for the study. Over the study period, the proportion of partial nephrectomies performed increased steadily from 21.5% in 2008 to 66.5% in 2014 (p < 0.05). Furthermore, use of partial nephrectomy increased steadily in all RNS complexity groups (low, moderate, and high) (p < 0.05). In the analysis of individual components of RNS, values of the R and N components increased statistically by year in the partial nephrectomy group (p < 0.05). Average AUC was 0.920. Conclusions The proportion of partial nephrectomies performed sharply increased over the study period. Additionally, over the study period, more partial nephrectomies were performed for renal masses of larger size and closer to the collecting system and main renal vessels. A nomogram developed based on this recent data set provides significant predictive value for surgical decision making.	[Shin, Seung Jea; Ko, Kwang Jin; Kim, Tae Sun; Ryoo, Hyun Soo; Sung, Hyun Hwan; Jeon, Hwang Gyun; Jeong, Byong Chang; Seo, Seong Il; Lee, Hyun Moo; Choi, Han Yong; Jeon, Seong Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, SS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea.	seongsoo.jeon@samsung.com	Ko, Kwang/AFO-2587-2022; sung, hh/O-6246-2014; Ko, Kwang Jin/AAH-7455-2019	Ko, Kwang/0000-0003-1085-1266; 	Korean Urologic Oncology Society [12-02]	Korean Urologic Oncology Society	The research was supported in part by the Korean Urologic Oncology Society Grant 12-02.	Becker F, 2006, EUR UROL, V49, P1058, DOI 10.1016/j.eururo.2006.03.003; Dulabon LM, 2010, CANCER-AM CANCER SOC, V116, P2316, DOI 10.1002/cncr.24965; Heuer R, 2010, EUR UROL, V57, P223, DOI 10.1016/j.eururo.2009.10.023; Hwang EC, 2013, KOREAN J UROL, V54, P283, DOI 10.4111/kju.2013.54.5.283; Kim SP, 2011, J UROLOGY, V186, P1779, DOI 10.1016/j.juro.2011.07.041; Kim SP, 2012, J UROL IN PRESS; Krebs RK, 2014, UROL INT, V92, P449, DOI 10.1159/000355609; Kutikov A, 2011, EUR UROL, V60, P241, DOI 10.1016/j.eururo.2011.03.029; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Lane BR, 2011, J UROLOGY, V186, P1229, DOI 10.1016/j.juro.2011.05.081; Lane BR, 2010, J UROLOGY, V184, P1286, DOI 10.1016/j.juro.2010.06.011; Leslie S, 2014, EUR UROL, V66, P884, DOI 10.1016/j.eururo.2014.03.010; Monn MF, 2014, J ENDOUROL, V28, P1006, DOI 10.1089/end.2014.0166; Montag S, 2011, J ENDOUROL, V25, P1925, DOI 10.1089/end.2011.0217; Poon SA, 2013, J UROLOGY, V190, P464, DOI 10.1016/j.juro.2013.02.094; ROBSON CJ, 1969, J UROLOGY, V101, P297, DOI 10.1016/S0022-5347(17)62331-0; Rosevear HM, 2012, BJU INT, V109, P700, DOI 10.1111/j.1464-410X.2011.10452.x; Satasivam P, 2012, BJU INT, V109, P1341, DOI 10.1111/j.1464-410X.2011.10595.x; Thompson RH, 2009, J UROLOGY, V181, P993, DOI 10.1016/j.juro.2008.11.017; Touijer K, 2010, EUR UROL, V57, P214, DOI 10.1016/j.eururo.2009.10.019; Weight CJ, 2011, J UROLOGY, V186, P1223, DOI 10.1016/j.juro.2011.05.052	21	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0141709	10.1371/journal.pone.0141709	http://dx.doi.org/10.1371/journal.pone.0141709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599436	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600005
J	Wiecek, M; Maciejczyk, M; Szymura, J; Szygula, Z; Kantorowicz, M				Wiecek, Magdalena; Maciejczyk, Marcin; Szymura, Jadwiga; Szygula, Zbigniew; Kantorowicz, Malgorzata			Changes in Non-Enzymatic Antioxidants in the Blood Following Anaerobic Exercise in Men and Women	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; VASTUS LATERALIS MUSCLE; HUMAN SKELETAL-MUSCLE; SPRINT EXERCISE; FIBER-TYPE; ENZYME-ACTIVITIES; FREE-RADICALS; WINGATE TEST; VITAMIN-E; PLASMA	Purpose The aim of this study was to compare changes in total oxidative status (TOS), total antioxidative capacity (TAC) and the concentration of VitA, VitE, VitC, uric acid (UA), reduced (GSH) and oxidized glutathione (GSSG) in blood within 24 hours following anaerobic exercise (AnEx) among men and women. Methods 10 women and 10 men performed a 20-second bicycle sprint (AnEx). Concentrations of oxidative stress indicators were measured before AnEx and 3, 15 and 30 minutes and 1 hour afterwards. UA, GSH and GSSH were also measured 24 hours after AnEx. Lactate and H+ concentrations were measured before and 3 minutes after AnEx. Results The increase in lactate and H+ concentrations following AnEx was similar in both sexes. Changes in the concentrations of all oxidative stress indicators were significant and did not differ between men and women. In both sexes, TOS, TAC, TOS/ TAC and VitA and VitE concentrations were the highest 3 minutes, VitC concentration was the highest 30 minutes, and UA concentration was the highest 1 hour after AnEx. GSH concentration was significantly lower than the initial concentration from 15 minutes to 24 hour after AnEx. GSSG concentration was significantly higher, while the GSH/ GSSG ratio was significantly lower than the initial values 1 hour and 24 hour after AnEx. Conclusions With similar changes in lactate and H+ concentrations, AnEx induces the same changes in TAC, TOS, TOS/ TAC and non-enzymatic antioxidants of low molecular weight in men and women. Oxidative stress lasted at least 24 hours after AnEx.	[Wiecek, Magdalena; Maciejczyk, Marcin] Univ Phys Educ, Fac Phys Educ & Sport, Dept Physiol & Biochem, Krakow, Poland; [Szymura, Jadwiga] Univ Phys Educ, Dept Clin Rehabil, Fac Motor Rehabil, Krakow, Poland; [Szygula, Zbigniew] Univ Phys Educ, Fac Phys Educ & Sport, Dept Sports Med & Human Nutr, Krakow, Poland; [Kantorowicz, Malgorzata] Univ Phys Educ, Fac Phys Educ & Sport, Krakow, Poland		Wiecek, M (corresponding author), Univ Phys Educ, Fac Phys Educ & Sport, Dept Physiol & Biochem, Krakow, Poland.	magdalena.wiecek@awf.krakow.pl	Więcek, Magdalena/P-8276-2018; Magdalena, Wiecek/U-2339-2019; Maciejczyk, Marcin/E-1211-2017; Szymura, Jadwiga/V-6413-2018	Więcek, Magdalena/0000-0002-5390-3049; Magdalena, Wiecek/0000-0002-5390-3049; Maciejczyk, Marcin/0000-0002-9505-4081; Szymura, Jadwiga/0000-0003-4594-7954; Szygula, Zbigniew/0000-0002-6685-6579; Kantorowicz, Malgorzata/0000-0002-4913-9930	Faculty of Physical Education and Sport, University of Physical Education in Krakow, Poland [21/BS/IFC/2011]	Faculty of Physical Education and Sport, University of Physical Education in Krakow, Poland	The research was carried out under a statutory research of the Faculty of Physical Education and Sport, University of Physical Education in Krakow, Poland (grant 21/BS/IFC/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MED SCI SPORT EXER S, V29, P89, DOI DOI 10.1097/00005768-199706001-00018; Baker JS, 2004, EUR J APPL PHYSIOL, V92, P321, DOI 10.1007/s00421-004-1090-9; Berzosa C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/540458; Bloomer RJ, 2009, RES SPORTS MED, V17, P1, DOI 10.1080/15438620802678289; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; Cuevas MJ, 2005, FREE RADICAL RES, V39, P431, DOI 10.1080/10715760500072149; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Durackova Z, 2010, PHYSIOL RES, V59, P459, DOI 10.33549/physiolres.931844; Dybek T, 2012, BIOL SPORT, V29, P39, DOI 10.5604/20831862.979854; ESBJORNSSON M, 1993, INT J SPORTS MED, V14, P257, DOI 10.1055/s-2007-1021174; Esbjornsson-Liljedahl M, 2002, J APPL PHYSIOL, V93, P1075, DOI 10.1152/japplphysiol.00732.1999; Esbjornsson-Liljedahl M, 1999, J APPL PHYSIOL, V87, P1326, DOI 10.1152/jappl.1999.87.4.1326; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Fuentes T, 2012, EUR J APPL PHYSIOL, V112, P1917, DOI 10.1007/s00421-011-2164-0; GREEN HJ, 1984, J NEUROL SCI, V65, P323, DOI 10.1016/0022-510X(84)90095-9; Groussard C, 2003, EUR J APPL PHYSIOL, V89, P14, DOI 10.1007/s00421-002-0767-1; Groussard C, 2003, CAN J APPL PHYSIOL, V28, P79, DOI 10.1139/h03-007; Ilhan N, 2004, ARCH MED RES, V35, P294, DOI 10.1016/j.arcmed.2004.03.006; Inbar O, 1996, WINGATE ANAEROBIC TE, P35; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Karabulut A., 2011, J US CHINA MEDICAL S, V8, P150; Kurkcu R, 2010, BIOL SPORT, V27, P177, DOI 10.5604/20831862.919350; Laurent CM, 2007, EUR J APPL PHYSIOL, V100, P645, DOI 10.1007/s00421-007-0454-3; Michailidis Y, 2007, MED SCI SPORT EXER, V39, P1107, DOI 10.1249/01.mss.0b013e318053e7ba; Morales-Alamo D, 2014, FREE RADICAL RES, V48, P30, DOI 10.3109/10715762.2013.825043; Morales-Alamo D, 2013, J APPL PHYSIOL, V114, P566, DOI 10.1152/japplphysiol.01246.2012; Morales-Alamo D, 2012, J APPL PHYSIOL, V113, P917, DOI 10.1152/japplphysiol.00415.2012; Podgorski T, 2006, POLISH J SPORT MED, V22, P215; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Quindry J, 2011, INT J SPORT NUTR EXE, V21, P462, DOI 10.1123/ijsnem.21.6.462; Rutkowski M, 2012, INT J OCCUP MED ENV, V25, P105, DOI 10.2478/S13382-012-0022-x; Sacheck JM, 2001, NUTRITION, V17, P809, DOI 10.1016/S0899-9007(01)00639-6; Sakano N, 2009, J CLIN BIOCHEM NUTR, V44, P185, DOI 10.3164/jcbn.08-252; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Szponar L, 2012, ALBUM PHOTOGRAPHS FO; Taito S, 2013, CLIN PHYSIOL FUNCT I, V33, P241, DOI 10.1111/cpf.12007; Toft I, 2003, MUSCLE NERVE, V28, P101, DOI 10.1002/mus.10373; Vincent S, 2004, EUR J APPL PHYSIOL, V91, P15, DOI 10.1007/s00421-003-0957-5; WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3; Weber GL, 2000, EUR J APPL PHYSIOL, V82, P255, DOI 10.1007/s004210000214; Wiecek M, 2015, PHYSIOL RES, V64, P93, DOI 10.33549/physiolres.932744	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143499	10.1371/journal.pone.0143499	http://dx.doi.org/10.1371/journal.pone.0143499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600020	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600072
J	Zhao, J; Qiu, ZN; Ruan, BP; Kang, SJ; He, L; Zhang, S; Dong, GJ; Hu, J; Zeng, DL; Zhang, GH; Gao, ZY; Ren, DY; Hu, XM; Chen, G; Guo, LB; Qian, Q; Zhu, L				Zhao, Juan; Qiu, Zhennan; Ruan, Banpu; Kang, Shujing; He, Lei; Zhang, Sen; Dong, Guojun; Hu, Jiang; Zeng, Dali; Zhang, Guangheng; Gao, Zhenyu; Ren, Deyong; Hu, Xingming; Chen, Guang; Guo, Longbiao; Qian, Qian; Zhu, Li			Functional Inactivation of Putative Photosynthetic Electron Acceptor Ferredoxin C2 (FdC2) Induces Delayed Heading Date and Decreased Photosynthetic Rate in Rice	PLOS ONE			English	Article							PHOTOSYSTEM-I; PHYTOCHROMOBILIN SYNTHASE; CHLOROPHYLL SYNTHESIS; MULTICOPPER OXIDASES; ARABIDOPSIS; SYSTEM; GENE; FLOW; REDUCTASE; MUTANTS	Ferredoxin (Fd) protein as unique electron acceptor, involved in a variety of fundamental metabolic and signaling processes, which is indispensable for plant growth. The molecular mechanisms of Fd such as regulation of electron partitioning, impact of photosynthetic rate and involvement in the carbon fixing remain elusive in rice. Here we reported a heading date delay and yellowish leaf 1 (hdy1) mutant derived from Japonica rice cultivar "Nipponbare" subjected to EMS treatment. In the paddy field, the hdy1 mutant appeared at a significantly late heading date and had yellow-green leaves during the whole growth stage. Further investigation indicated that the abnormal phenotype of hdy1 was connected with depressed pigment content and photosynthetic rate. Genetic analysis results showed that the hdy1 mutant phenotype was caused by a single recessive nuclear gene mutation. Map-based cloning revealed that OsHDY1 is located on chromosome 3 and encodes an ortholog of the AtFdC2 gene. Complementation and overexpression, transgenic plants exhibited the mutant phenotype including head date, leaf color and the transcription levels of the FdC2 were completely rescued by transformation with OsHDY1. Real-time PCR revealed that the expression product of OsHDY1 was detected in almost all of the organs except root, whereas highest expression levels were observed in seeding new leaves. The lower expression levels of HDY1 and content of iron were detected in hdy1 than WT's. The FdC2:: GFP was detected in the chloroplasts of rice. Real-time PCR results showed that the expression of many photosynthetic electron transfer related genes in hdy1 were higher than WT. Our results suggest that OsFdC2 plays an important role in photosynthetic rate and development of heading date by regulating electron transfer and chlorophyll content in rice.	[Zhao, Juan; Qiu, Zhennan; Ruan, Banpu; Kang, Shujing; He, Lei; Zhang, Sen; Dong, Guojun; Hu, Jiang; Zeng, Dali; Zhang, Guangheng; Gao, Zhenyu; Ren, Deyong; Hu, Xingming; Chen, Guang; Guo, Longbiao; Qian, Qian; Zhu, Li] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Zhu, L (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.	zhuli05@caas.cn	Lei, He/N-8316-2014; qian, qian/AAH-8708-2021; Zhu, Li/AAH-9693-2021	Lei, He/0000-0001-9642-6804; Gao, Zhenyu/0000-0003-4808-2511	National Natural Science Foundation of China [31171532, 31371606]; Ministry of Agriculture of China [2014ZX08001-003, 2014ZX08001-002]; Central Level and Scientific Research Institutes for the basic research and development special fund business [2015RG001-2]; Chinese 863 Program [2012AA10A302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Central Level and Scientific Research Institutes for the basic research and development special fund business; Chinese 863 Program(National High Technology Research and Development Program of China)	The work was supported by The National Natural Science Foundation of China (Grant Nos. 31171532; 31371606), http://www.nsfc.gov.cn/. LZ; The Transgenic Plant Research and Commercialization Project of the Ministry of Agriculture of China (Grant No. 2014ZX08001-003, 2014ZX08001-002), http://www.moa.gov.cn/, LZ; The Central Level and Scientific Research Institutes for the basic research and development special fund business (Grant No. 2015RG001-2), http://www.most.gov.cn/, LZ; and The Chinese 863 Program (Grant No. 2012AA10A302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; ARNON DI, 1975, P NATL ACAD SCI USA, V72, P4961, DOI 10.1073/pnas.72.12.4961; ARNON DI, 1979, FEBS LETT, V102, P133, DOI 10.1016/0014-5793(79)80944-8; Asai K, 2002, DEVELOPMENT, V129, P265; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Chiu FY, 2010, J BIOL CHEM, V285, P5056, DOI 10.1074/jbc.M109.075747; Coschigano KT, 1998, PLANT CELL, V10, P741, DOI 10.1105/tpc.10.5.741; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Goss T, 2014, CURR PROTEIN PEPT SC, V15, P385, DOI 10.2174/1389203715666140327113733; Gothandam KM, 2005, PLANT MOL BIOL, V58, P421, DOI 10.1007/s11103-005-5702-5; Hajirezaei MR, 2002, PLANT J, V29, P281, DOI 10.1046/j.0960-7412.2001.01209.x; Hamdani S, 2015, J PLANT PHYSIOL, V177, P128, DOI 10.1016/j.jplph.2014.12.019; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Hanke GT, 2008, PLANT CELL ENVIRON, V31, P1017, DOI 10.1111/j.1365-3040.2008.01814.x; Hase Toshiharu, 2006, V24, P477; Higuchi-Takeuchi M, 2011, PLANT PHYSIOL, V157, P96, DOI 10.1104/pp.111.181248; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Izawa T, 2000, PLANT J, V22, P391, DOI 10.1046/j.1365-313X.2000.00753.x; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Jones SM, 2015, CELL MOL LIFE SCI, V72, P869, DOI 10.1007/s00018-014-1826-6; Jung KH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000164; Kang SJ, 2015, CROP SCI, V55, P284, DOI 10.2135/cropsci2014.03.0185; Kimata-Ariga Y, 2000, EMBO J, V19, P5041, DOI 10.1038/sj.emboj.7593319; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Kondou Y, 2009, PLANT J, V57, P883, DOI 10.1111/j.1365-313X.2008.03733.x; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lintala M, 2007, PLANT J, V49, P1041, DOI 10.1111/j.1365-313X.2006.03014.x; Lintala M, 2012, PLANT J, V70, P809, DOI 10.1111/j.1365-313X.2012.04930.x; Lintala M, 2009, PLANT J, V57, P1103, DOI 10.1111/j.1365-313X.2008.03753.x; [Liu Bing 刘兵], 2013, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V52, P112; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Msilini N, 2013, J PLANT PHYSIOL, V170, P1400, DOI 10.1016/j.jplph.2013.05.004; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Ogiso-Tanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075959; Palatnik JF, 2003, PLANT J, V35, P332, DOI 10.1046/j.1365-313X.2003.01809.x; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; SOLOMON EI, 1993, SCIENCE, V259, P1575, DOI 10.1126/science.8384374; Tapken Wiebke, 2015, Plant Signal Behav, V10, pe1046666, DOI 10.1080/15592324.2015.1046666; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Voss I, 2011, J BIOL CHEM, V286, P50, DOI 10.1074/jbc.M110.161562; Wang PY, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-201; Wang QX, 2015, MOL PLANT, V8, P946, DOI 10.1016/j.molp.2015.02.014; Wherland S, 2014, J BIOL INORG CHEM, V19, P541, DOI 10.1007/s00775-013-1080-7; Yu CC, 2014, BIOCHEM BIOPH RES CO, V450, P1575, DOI 10.1016/j.bbrc.2014.07.043; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07663; Zhao J, 2015, NEW PHYTOL; Zhu L, 2011, PLANT MOL BIOL, V77, P475, DOI 10.1007/s11103-011-9825-6	50	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143361	10.1371/journal.pone.0143361	http://dx.doi.org/10.1371/journal.pone.0143361			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26598971	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600056
J	Cael, BB				Cael, B. B.			The Good, the Bad, and the Tiny: A Simple, Mechanistic-Probabilistic Model of Virus-Nutrient Colimitation in Microbes	PLOS ONE			English	Article							MARINE-BACTERIA; PHYTOPLANKTON; SEA; ABUNDANCE; PHOTOSYNTHESIS; MORTALITY; DYNAMICS; PHYSICS; MOTION; OCEAN	For phytoplankton and other microbes, nutrient receptors are often the passages through which viruses invade. This presents a bottom-up vs. top-down, co-limitation scenario; how do these would-be-hosts balance minimizing viral susceptibility with maximizing uptake of limiting nutrient(s)? This question has been addressed in the biological literature on evolutionary timescales for populations, but a shorter timescale, mechanistic perspective is lacking, and marine viral literature suggests the strong influence of additional factors, e.g. host size; while the literature on both nutrient uptake and host-virus interactions is expansive, their intersection, of ubiquitous relevance to marine environments, is understudied. I present a simple, mechanistic model from first principles to analyze the effect of this co-limitation scenario on individual growth, which suggests that in environments with high risk of viral invasion or spatial/temporal heterogeneity, an individual host's growth rate may be optimized with respect to receptor coverage, producing top-down selective pressure on short timescales. The model has general applicability, is suggestive of hypotheses for empirical exploration, and can be extended to theoretical studies of more complex behaviors and systems.	[Cael, B. B.] MIT, Cambridge, MA 02139 USA; [Cael, B. B.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution	Cael, BB (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bcaelb@mit.edu			Massachusetts Institute of Technology Charles Vest Presidential Fellowship	Massachusetts Institute of Technology Charles Vest Presidential Fellowship	This work was supported by the Massachusetts Institute of Technology Charles Vest Presidential Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal PP., 1972, METALLOGRAPHY, V5, P97, DOI [DOI 10.1016/0026-0800(72)90048-1, 10.1016/0026-0800(72)90048-1]; Beardall J, 2001, AQUAT SCI, V63, P44, DOI 10.1007/PL00001344; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BIENFANG PK, 1984, MAR ECOL PROG SER, V14, P297, DOI 10.3354/meps014297; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Boras JA, 2009, ENVIRON MICROBIOL, V11, P1181, DOI 10.1111/j.1462-2920.2008.01849.x; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Chapman-McQuiston E, 2008, BIOPHYS J, V94, P4525, DOI 10.1529/biophysj.107.120212; Clausznitzer D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003870; Corinaldesi C, 2003, APPL ENVIRON MICROB, V69, P2664, DOI 10.1128/AEM.69.5.2664-2673.2003; Cotton F. A., 1999, ADV INORGANIC CHEM, V5; Cussler E. L, 2009, DIFFUSION MASS TRANS; Danovaro R, 2011, FEMS MICROBIOL REV, V35, P993, DOI 10.1111/j.1574-6976.2010.00258.x; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FALKOWSKI PG, 1994, PHOTOSYNTH RES, V39, P235, DOI 10.1007/BF00014586; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; GEHRING K, 1987, J BACTERIOL, V169, P2103, DOI 10.1128/jb.169.5.2103-2106.1987; Guixa-Boixereu N, 1999, APPL ENVIRON MICROB, V65, P1949; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Hoyland-Kroghsbo NM, 2013, MBIO, V4, DOI 10.1128/mBio.00362-12; JENNINGS BR, 1988, P ROY SOC LOND A MAT, V419, P137, DOI 10.1098/rspa.1988.0100; KarpBoss L, 1996, OCEANOGR MAR BIOL, V34, P71; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Kirchman DL, 2010, MICROBIAL ECOLOGY OC, V36; Mann NH, 2003, FEMS MICROBIOL REV, V27, P17, DOI 10.1016/S0168-6445(03)00016-0; MARANGER R, 1995, MAR ECOL PROG SER, V121, P217, DOI 10.3354/meps121217; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; May R.M., 2001, STABILITY COMPLEXITY, V6; MCCARTHY JJ, 1979, SCIENCE, V203, P670, DOI 10.1126/science.203.4381.670; Menge DNL, 2009, J THEOR BIOL, V257, P104, DOI 10.1016/j.jtbi.2008.10.032; MURRAY AG, 1992, MAR ECOL PROG SER, V89, P103, DOI 10.3354/meps089103; North RL, 2007, LIMNOL OCEANOGR, V52, P315, DOI 10.4319/lo.2007.52.1.0315; Payet JP, 2008, J MARINE SYST, V74, P933, DOI 10.1016/j.jmarsys.2007.11.002; PRICE NM, 1991, LIMNOL OCEANOGR, V36, P1071, DOI 10.4319/lo.1991.36.6.1071; PRICE NM, 1994, LIMNOL OCEANOGR, V39, P520, DOI 10.4319/lo.1994.39.3.0520; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Redner S, 2001, GUIDE 1 PASSAGE PROC; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Roland Clift, 2005, BUBBLES DROPS PARTIC; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Rothenberg E, 2011, BIOPHYS J, V100, P2875, DOI 10.1016/j.bpj.2011.05.014; Saito MA, 2008, LIMNOL OCEANOGR, V53, P266, DOI 10.4319/lo.2008.53.1.0266; SCHNEIDER H, 1993, J BACTERIOL, V175, P2809, DOI 10.1128/JB.175.10.2809-2817.1993; Schrodinger E, 1915, PHYS Z, V16, P289; Son K, 2014, B AM PHYS SOC, V59; Son K, 2013, B AM PHYS SOC, V58; Steward GF, 1996, MAR ECOL PROG SER, V131, P287, DOI 10.3354/meps131287; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Strom SL, 2007, LIMNOL OCEANOGR, V52, P1480, DOI 10.4319/lo.2007.52.4.1480; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1992, MAR ECOL PROG SER, V87, P105, DOI 10.3354/meps087105; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Weitz JS, 2012, F1000 BIOL REPORTS, V4; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Williams R. G., 2011, OCEAN DYNAMICS CARBO, DOI 10.1017/cbo9780511977817	60	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143299	10.1371/journal.pone.0143299	http://dx.doi.org/10.1371/journal.pone.0143299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600042	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900089
J	Field, MA; Cho, V; Andrews, TD; Goodnow, CC				Field, Matthew A.; Cho, Vicky; Andrews, T. Daniel; Goodnow, Chris C.			Reliably Detecting Clinically Important Variants Requires Both Combined Variant Calls and Optimized Filtering Strategies	PLOS ONE			English	Article							READ ALIGNMENT; WHOLE-GENOME; GENERATION; EXOME; BIOINFORMATICS; PERFORMANCE; FRAMEWORK; MUTATIONS; DISCOVERY; PIPELINES	A diversity of tools is available for identification of variants from genome sequence data. Given the current complexity of incorporating external software into a genome analysis infrastructure, a tendency exists to rely on the results from a single tool alone. The quality of the output variant calls is highly variable however, depending on factors such as sequence library quality as well as the choice of short-read aligner, variant caller, and variant caller filtering strategy. Here we present a two-part study first using the high quality 'genome in a bottle' reference set to demonstrate the significant impact the choice of aligner, variant caller, and variant caller filtering strategy has on overall variant call quality and further how certain variant callers outperform others with increased sample contamination, an important consideration when analyzing sequenced cancer samples. This analysis confirms previous work showing that combining variant calls of multiple tools results in the best quality resultant variant set, for either specificity or sensitivity, depending on whether the intersection or union, of all variant calls is used respectively. Second, we analyze a melanoma cell line derived from a control lymphocyte sample to determine whether software choices affect the detection of clinically important melanoma risk-factor variants finding that only one of the three such variants is unanimously detected under all conditions. Finally, we describe a cogent strategy for implementing a clinical variant detection pipeline; a strategy that requires careful software selection, variant caller filtering optimizing, and combined variant calls in order to effectively minimize false negative variants. While implementing such features represents an increase in complexity and computation the results offer indisputable improvements in data quality.	[Field, Matthew A.; Cho, Vicky; Andrews, T. Daniel; Goodnow, Chris C.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia; [Cho, Vicky] Australian Natl Univ, Australian Phen Facil, Canberra, ACT, Australia; [Field, Matthew A.; Andrews, T. Daniel] Australian Natl Univ, Natl Computat Infrastruct, Canberra, ACT, Australia; [Goodnow, Chris C.] St Vincents Hosp, Garvan Inst Med Res, Immunol Res Program, Immunogen Grp, Darlinghurst, NSW 2010, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Australian National University; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Field, MA (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia.	matt.field@anu.edu.au	Goodnow, Christopher C/V-8108-2018; Andrews, Dan/ABG-4815-2020	Goodnow, Christopher C/0000-0001-5296-6155; Field, Matthew/0000-0003-0788-6513; Andrews, Dan/0000-0003-3922-6376	National Institutes of Health [U19 AII00627]; National Health and Medical Research Council [585490]; National Collaborative Research Infrastructure Strategy (Australia); Melanoma Institute of Australia; Bioplatforms Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Collaborative Research Infrastructure Strategy (Australia)(Australian GovernmentDepartment of Industry, Innovation and Science); Melanoma Institute of Australia; Bioplatforms Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been in part funded by grants from the National Institutes of Health (Author: CCG; URL: www.nih.gov; Grant ID: U19 AII00627), the National Health and Medical Research Council (Author: CCG; URL: https://www.nhmrc.gov.au/; Grant ID: Australia Fellowship 585490), the National Collaborative Research Infrastructure Strategy (Australia), the Melanoma Institute of Australia (Author: MAF; URL: www.melanoma.org.au/), and Bioplatforms Australia (Author: MAF; URL: www.bioplatforms.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; Brownstein CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r53; BURNET M, 1965, BRIT MED J, V1, P338, DOI 10.1136/bmj.1.5431.338; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cantarel BL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-104; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0089-z; Field MA, 2015, BIOINFORMATICS, V31, P2377, DOI 10.1093/bioinformatics/btv135; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guan YF, 2012, CHIN J CANCER, V31, P463, DOI 10.5732/cjc.012.10216; Highnam G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7275; Jeck WR, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12238; Jia PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038470; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Liu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075619; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376; Nagy R, 2004, ONCOGENE, V23, P6445, DOI 10.1038/sj.onc.1207714; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Parla JS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r97; Pirooznia M, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-14; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Ramos EM, 2014, AM J MED GENET C, V166, P93, DOI 10.1002/ajmg.c.31386; Ratan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055089; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sadedin SP, 2012, BIOINFORMATICS, V28, P1525, DOI 10.1093/bioinformatics/bts167; Shang J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/309650; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Thomas A, 2013, ANN ONCOL, V24, P577, DOI 10.1093/annonc/mds478; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wilmott JS, 2015, PATHOLOGY, V47, P683, DOI 10.1097/PAT.0000000000000324; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Yi M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku392; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	53	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143199	10.1371/journal.pone.0143199	http://dx.doi.org/10.1371/journal.pone.0143199			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600436	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000365853900075
J	Mensen, A; Poryazova, R; Huegli, G; Baumann, CR; Schwartz, S; Khatami, R				Mensen, Armand; Poryazova, Rositsa; Huegli, Gordana; Baumann, Christian R.; Schwartz, Sophie; Khatami, Ramin			The Roles of Dopamine and Hypocretin in Reward: A Electroencephalographic Study	PLOS ONE			English	Article							FEEDBACK-RELATED NEGATIVITY; MEDIAL PREFRONTAL CORTEX; PARKINSONS-DISEASE; PREDICTION ERRORS; NARCOLEPSY; CATAPLEXY; MODULATION; BRAIN; EEG; ANTICIPATION	The proper functioning of the mesolimbic reward system is largely dependent on the neurotransmitter dopamine. Recent evidence suggests that the hypocretin system has significant projections to this reward system. We examined the distinct effects of reduced dopamine or reduced hypocretin levels on reward activity in patients with Parkinson's disease, dopamine deficient, as well as patients with narcolepsy-cataplexy, hypocretin depleted, and healthy controls. Participants performed a simple game-like task while high-density electroencephalography was recorded. Topography and timing of event-related potentials for both reward cue, and reward feedback was examined across the entire dataset. While response to reward cue was similar in all groups, two distinct time points were found to distinguish patients and controls for reward feedback. Around 160ms both patient groups had reduced ERP amplitude compared to controls. Later at 250ms, both patient groups also showed a clear event-related potential (ERP), which was absent in controls. The initial differences show that both patient groups show a similar, blunted response to reward delivery. The second potential corresponds to the classic feedback-related negativity (FRN) potential which relies on dopamine activity and reflects reward prediction-error signaling. In particular the mismatch between predicted reward and reward subsequently received was significantly higher in PD compared to NC, independent of reward magnitude and valence. The intermediate FRN response in NC highlights the contribution of hypocretin in reward processing, yet also shows that this is not as detrimental to the reward system as in Parkinson's. Furthermore, the inability to generate accurate predictions in NC may explain why hypocretin deficiency mediates cataplexy triggered by both positive and negative emotions.	[Mensen, Armand; Huegli, Gordana; Khatami, Ramin] Clin Barmelweid, Dept Sleep Med, CH-5017 Aargau, Switzerland; [Poryazova, Rositsa; Baumann, Christian R.] Univ Zurich Hosp, Dept Neurol, CH-8006 Zurich, Switzerland; [Schwartz, Sophie] Univ Geneva, Dept Neurosci, CH-1211 Geneva, Switzerland	University of Zurich; University Zurich Hospital; University of Geneva	Khatami, R (corresponding author), Clin Barmelweid, Dept Sleep Med, CH-5017 Aargau, Switzerland.	Ramin.Khatami@Barmelweid.ch		Baumann, Christian/0000-0003-3417-1978; Schwartz, Sophie/0000-0001-7718-4053	Swiss National Science Foundation [32003B_124763/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation. Grant ID: 32003B_124763/1.	Aarts E, 2012, NEUROIMAGE, V59, P3339, DOI 10.1016/j.neuroimage.2011.11.073; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Baker TE, 2009, CEREB CORTEX, V19, P1708, DOI 10.1093/cercor/bhn223; Bassetti C, 1997, SLEEP, V20, P630, DOI 10.1093/sleep/20.8.630; Biehl SC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-107; Bismark AW, 2013, PSYCHOPHYSIOLOGY, V50, P125, DOI 10.1111/j.1469-8986.2012.01490.x; Bortoletto M, 2011, INT J PSYCHOPHYSIOL, V81, P312, DOI 10.1016/j.ijpsycho.2011.07.017; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Calipari ES, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00054; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Delazer M, 2011, NEUROPSYCHOLOGY, V25, P477, DOI 10.1037/a0022357; Donamayor N, 2012, NEUROIMAGE, V62, P17, DOI 10.1016/j.neuroimage.2012.04.038; Donamayor N, 2011, HUM BRAIN MAPP, V32, P2228, DOI 10.1002/hbm.21184; Eckart C, 2012, NEUROIMAGE; Ferdinand NK, 2012, J NEUROSCI, V32, P12087, DOI 10.1523/JNEUROSCI.1410-12.2012; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GOTHAM AM, 1986, LANCET, V2, P970; Hauser TU, 2014, NEUROIMAGE, V84, P159, DOI 10.1016/j.neuroimage.2013.08.028; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Holroyd CB, 2009, COGN AFFECT BEHAV NE, V9, P59, DOI 10.3758/CABN.9.1.59; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Korotkova TM, 2003, J NEUROSCI, V23, P7; MacDonald PA, 2011, BRAIN, V134, P1447, DOI 10.1093/brain/awr075; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Mantini D, 2010, BRAIN TOPOGR, V23, P150, DOI 10.1007/s10548-009-0132-3; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Mensen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085978; Mensen A, 2013, NEUROIMAGE, V67, P111, DOI 10.1016/j.neuroimage.2012.10.027; Mensen Armand, 2015, EEG PERMUTATION TEST, DOI [10.5281/zenodo.14787, DOI 10.5281/ZENODO.14787]; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; Oishi Y, 2013, J NEUROSCI, V33, P9743, DOI 10.1523/JNEUROSCI.0499-13.2013; Overeem S, 2011, SLEEP MED, V12, P12, DOI 10.1016/j.sleep.2010.05.010; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Ponz A, 2010, ANN NEUROL, V67, P190, DOI 10.1002/ana.21825; Rossion B, VISION RES IN PRESS; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sato JR, 2010, NEUROIMAGE, V50, P1416, DOI 10.1016/j.neuroimage.2010.01.075; Schultz A, 2004, ACTA ANAESTH SCAND, V48, P27, DOI 10.1111/j.1399-6576.2004.00258.x; Talmi D, 2013, J NEUROSCI, V33, P8264, DOI 10.1523/JNEUROSCI.5695-12.2013; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; van der Vegt JPM, 2013, BRAIN, V136, P1192, DOI 10.1093/brain/awt027; van Wouwe NC, 2012, NEUROPSYCHOLOGIA, V50, P583, DOI 10.1016/j.neuropsychologia.2011.12.012; Voon V, 2010, NEURON, V65, P135, DOI 10.1016/j.neuron.2009.12.027; Walsh MM, 2011, P NATL ACAD SCI USA, V108, P19048, DOI 10.1073/pnas.1117189108; Zinbarg RE, 2010, J ABNORM PSYCHOL, V119, P307, DOI 10.1037/a0017552	49	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142432	10.1371/journal.pone.0142432	http://dx.doi.org/10.1371/journal.pone.0142432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599765	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000365853900025
J	Mu, QJ; Li, HL; Yao, Y; Liu, SC; Yin, CG; Ma, XZ				Mu, Qing-Jie; Li, Hong-Li; Yao, Yuan; Liu, Shi-Chao; Yin, Chong-Gao; Ma, Xue-Zhen			Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; SURVIVAL; PROGRESSION; PROMOTES; CELLS; KINASE; MIGRATION	Background Chromodomain helicase/ATPase DNA-binding protein 1-like gene (CHD1L), also known as ALC1 (amplified in liver cancer 1 gene), is a new oncogene amplified in many solid tumors. Whether this gene plays a role in invasion and metastasis of breast cancer is unknown. Methods Immunohistochemistry was performed to detect the expression of CHD1L in patients with invasive ductal carcinoma and normal mammary glands. Chemotaxis, wound healing, and Transwell invasion assays were also performed to examine cell migration and invasion. Western blot analysis was conducted to detect the expression of CHD1L, MMP-2, MMP-9, pAkt/Akt, pARK5/ARK5, and pmTOR/mTOR. Moreover, ELISA was carried out to detect the expression levels of MMP-2 and MMP-9. Nude mice xenograft model was used to detect the invasion and metastasis of breast cancer cell lines. Results CHD1L overexpression was observed in 112 of 268 patients (41.8%). This overexpression was associated with lymph node metastasis (P = 0.008), tumor differentiation (P = 0.020), distant metastasis (P = 0.026), MMP-2 (P = 0.035), and MMP-9 expression (P = 0.022). In the cell experiment, reduction of CHD1L inhibited the invasion and metastasis of breast cancer cells by mediating MMP-2 and MMP-9 expression. CHD1L knockdown via siRNA suppressed EGF-induced pAkt, pARK5, and pmTOR. This knockdown inhibited the metastasis of breast cancer cells into the lungs of SCID mice. Conclusions CHD1L promoted the invasion and metastasis of breast cancer cells via the PI3K/Akt/ARK5/mTOR/MMP signaling pathway. This study identified CHD1L as a potential anti-metastasis target for therapeutic intervention in breast cancer.	[Mu, Qing-Jie] Qing Dao Univ, Qingdao, Peoples R China; [Mu, Qing-Jie] Weifang Med Univ, Clin Dept, Weifang, Peoples R China; [Li, Hong-Li] Weifang Med Univ, Med Res Ctr, Weifang 261053, Peoples R China; [Yao, Yuan] Qing Dao Univ, Affiliated Hosp, Qing Dao 260003, Peoples R China; [Liu, Shi-Chao; Ma, Xue-Zhen] Qing Dao Univ, Affiliated Hosp 2, Qing Dao Tumor Hosp, Qing Dao Cent Hosp, Qing Dao 260042, Peoples R China; [Yin, Chong-Gao] Weifang Med Univ, Coll Nursing, Weifang 261053, Peoples R China	Qingdao University; Weifang Medical University; Weifang Medical University; Qingdao University; Qingdao University; Weifang Medical University	Yin, CG (corresponding author), Weifang Med Univ, Coll Nursing, Weifang 261053, Peoples R China.	wfyinchg@163.com; maxuezhen1968@126.com			National Scientific Foundation of China [81402389]; Natural Science Foundation of Shandong Province [ZR2015HL065]; Foundation of Shandong Educational Committee [J12LK03, J13LK03]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Foundation of Shandong Educational Committee	This work was supported by the National Scientific Foundation of China (81402389), the Natural Science Foundation of Shandong Province (ZR2015HL065), and the Foundation of Shandong Educational Committee (J12LK03 and J13LK03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao BP, 2013, DISCOV MED, V16, P137; Castaneda CA, 2010, CANCER METAST REV, V29, P751, DOI 10.1007/s10555-010-9261-0; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen LL, 2009, HEPATOLOGY, V50, P122, DOI 10.1002/hep.22933; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Chien CS, 2010, MOL CELL BIOCHEM, V333, P169, DOI 10.1007/s11010-009-0217-z; Grunt TW, 2013, CURR CANCER DRUG TAR, V13, P188; He WP, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-437; Ji XP, 2013, J SURG RES, V185, P84, DOI 10.1016/j.jss.2013.05.008; Jiang Hao, 2009, J Exp Ther Oncol, V8, P25; Li HL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0162-x; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031251; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Mukherjee D, 2013, AM J CANCER RES, V3, P46; Rasheed SAK, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0337-x; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Tian F, 2013, TUMOR BIOL, V34, P3687, DOI 10.1007/s13277-013-0951-4; Wang J, 2015, ONCOTARGET, V6, P1618, DOI 10.18632/oncotarget.2730; Wang XF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/894386; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Yan BA, 2010, J CELL BIOCHEM, V111, P1114, DOI 10.1002/jcb.22797; Yin CG, 2013, BREAST CANCER RES TR, V142, P297, DOI 10.1007/s10549-013-2737-1	25	19	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143030	10.1371/journal.pone.0143030	http://dx.doi.org/10.1371/journal.pone.0143030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599012	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900058
J	Sola-Gines, M; Cameron-Veas, K; Badiola, I; Dolz, R; Majo, N; Dahbi, G; Viso, S; Mora, A; Blanco, J; Piedra-Carrasco, N; Gonzalez-Lopez, JJ; Migura-Garcia, L				Sola-Gines, Marc; Cameron-Veas, Karla; Badiola, Ignacio; Dolz, Roser; Majo, Natalia; Dahbi, Ghizlane; Viso, Susana; Mora, Azucena; Blanco, Jorge; Piedra-Carrasco, Nuria; Gonzalez-Lopez, Juan Jose; Migura-Garcia, Lourdes			Diversity of Multi-Drug Resistant Avian Pathogenic Escherichia coli (APEC) Causing Outbreaks of Colibacillosis in Broilers during 2012 in Spain	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; MOLECULAR EPIDEMIOLOGY; POULTRY PRODUCTS; PUBLIC-HEALTH; RISK-FACTORS; O78 STRAINS; VIRULENCE; PLASMIDS; ANIMALS; SPREAD	Avian pathogenic Escherichia coli (APEC) are the major cause of colibacillosis in poultry production. In this study, a total of 22 E. coli isolated from colibacillosis field cases and 10 avian faecal E. coli (AFEC) were analysed. All strains were characterised phenotypically by susceptibility testing and molecular typing methods such as pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST). The presence of 29 virulence genes associated to APEC and human extraintestinal pathogenic E. coli (ExPEC) was also evaluated. For cephalosporin resistant isolates, cephalosporin resistance genes, plasmid location and replicon typing was assessed. Avian isolates belonged to 26 O:H serotypes and 24 sequence types. Out of 22 APEC isolates, 91% contained the virulence genes predictors of APEC; iutA, hlyF, iss, iroN and ompT. Of all strains, 34% were considered ExPEC. PFGE analysis demonstrated a high degree of genetic polymorphism. All strains were multi-resistant, including those isolated from healthy animals. Eleven strains were resistant to cephalosporins; six contained bla(CTX-M-14), two bla(SHV-12), two bla(CMY-2) and one bla(SHV-2). Two strains harboured qnrA, and two qnrA together with aac(6')-Ib-cr. Additionally, the emergent clone O25b:H4-B2-ST131 was isolated from a healthy animal which harboured bla(CMY-2) and qnrS genes. Cephalosporin resistant genes were mainly associated to the presence of IncK replicons. This study demonstrates a very diverse population of multi-drug resistant E. coli containing a high number of virulent genes. The E. coli population among broilers is a reservoir of resistance and virulence-associated genes that could be transmitted into the community through the food chain. More epidemiological studies are necessary to identify clonal groups and resistance mechanisms with potential relevance to public health.	[Sola-Gines, Marc; Cameron-Veas, Karla; Badiola, Ignacio; Dolz, Roser; Majo, Natalia; Migura-Garcia, Lourdes] IRTA, CReSA, Barcelona, Spain; [Majo, Natalia] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Cerdanyola Del, Spain; [Dahbi, Ghizlane; Viso, Susana; Mora, Azucena; Blanco, Jorge] Univ Santiago de Compostela, Fac Vet, Dept Microbiol & Parasitol, Lab Referencia E Coli, Lugo, Spain; [Piedra-Carrasco, Nuria; Gonzalez-Lopez, Juan Jose] Univ Autonoma Barcelona, Hosp Vall Hebron, Microbiol Serv, E-08193 Barcelona, Spain	IRTA; Autonomous University of Barcelona; Universidade de Santiago de Compostela; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Migura-Garcia, L (corresponding author), IRTA, CReSA, Campus UAB, Barcelona, Spain.	lourdes.migura@irta.cat	Masferrer, Natàlia Majó/AAV-3696-2021; Migura-Garcia, Lourdes/E-3560-2016; González-López, Juanjo/C-5366-2014; Gutiérrez, Azucena Mora/F-4612-2016; ALVAREZ, JORGE BLANCO/C-7161-2013	Migura-Garcia, Lourdes/0000-0003-2935-928X; González-López, Juanjo/0000-0003-2419-5909; Gutiérrez, Azucena Mora/0000-0002-0785-5795; ALVAREZ, JORGE BLANCO/0000-0003-0264-4136; Viso, Susana/0000-0003-2530-1961	Ministerio de Economia y Competitividad (Espana) [AGL2011-28836, AGL2013-47852-R]; Conselleria de Cultura, Educacion e Ordenacion Universitaria [CN2012/303, EM2014/001]; Xunta de Galicia [CN2012/303, EM2014/001]; European Regional Development Fund, ERDF [CN2012/303, EM2014/001]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA); European Social Fund; Ministerio de Economia y Competitividad (Gobierno de Espana) [AGL2013-47852-R, AGL2011- 28836]	Ministerio de Economia y Competitividad (Espana); Conselleria de Cultura, Educacion e Ordenacion Universitaria; Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Regional Development Fund, ERDF(European Commission); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Social Fund(European Social Fund (ESF)); Ministerio de Economia y Competitividad (Gobierno de Espana)	This work was partially supported by the grants AGL2011-28836 and AGL2013-47852-R from the Ministerio de Economia y Competitividad (Espana) and grants CN2012/303 and EM2014/001 (Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia and the European Regional Development Fund, ERDF). Work from LMG is supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the grants AGL2011- 28836 and AGL2013-47852-R from the Ministerio de Economia y Competitividad (Gobierno de Espana) and grants CN2012/303 and EM2014/001 (Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia and the European Regional Development Fund, ERDF).; MSG is a Ph.D. student registered with the Universidad Autonoma de Barcelona. Work from LMG is supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) and the European Social Fund.	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Blanco JE, 1998, VET MICROBIOL, V61, P229, DOI 10.1016/S0378-1135(98)00182-5; Blanco M, 2009, J ANTIMICROB CHEMOTH, V63, P1135, DOI 10.1093/jac/dkp122; Bortolaia V, 2010, ANTIMICROB AGENTS CH, V54, P1623, DOI 10.1128/AAC.01361-09; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chen X, 2012, ANTIMICROB AGENTS CH, V56, P3423, DOI 10.1128/AAC.06191-11; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute (CLSI), 2008, AUSTRALIA; Coelho A, 2011, J ANTIMICROB CHEMOTH, V66, P517, DOI 10.1093/jac/dkq491; Coelho A, 2009, J ANTIMICROB CHEMOTH, V64, P862, DOI 10.1093/jac/dkp264; CollignOn P, 2013, EMERG INFECT DIS, V19, P1339, DOI [10.3201/eid1908.120681, 10.3201/eid.1908.120681]; Coque T M, 2008, Euro Surveill, V13; Cortes P, 2010, APPL ENVIRON MICROB, V76, P2799, DOI 10.1128/AEM.02421-09; de Campos TA, 2008, PESQUI VET BRASIL, V28, P533, DOI 10.1590/S0100-736X2008001000015; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dziva F, 2013, INFECT IMMUN, V81, P838, DOI 10.1128/IAI.00585-12; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Gross WB, 1991, DIS POULTRY, P138; Guinee P. A. M., 1981, Laboratory diagnosis in neonatal calf and pig diarrhoea, P126; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Heininger A, 1999, J CLIN MICROBIOL, V37, P2479, DOI 10.1128/JCM.37.8.2479-2482.1999; Johnson JR, 2007, EMERG INFECT DIS, V13, P838, DOI 10.3201/eid1306.061576; Johnson JR, 2003, ANTIMICROB AGENTS CH, V47, P2161, DOI 10.1128/AAC.47.7.2161-2168.2003; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Lopez-Cerero L, 2014, J ANTIMICROB CHEMOTH, V69, P809, DOI 10.1093/jac/dkt405; Maluta RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105016; Manges AR, 2012, CLIN INFECT DIS, V55, P712, DOI 10.1093/cid/cis502; Mora Azucena, 2013, Vet Microbiol, V167, P506, DOI 10.1016/j.vetmic.2013.08.007; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; MORLEY AJ, 1984, AVIAN DIS, V28, P238, DOI 10.2307/1590147; Nakazato G, 2009, PESQUI VET BRASIL, V29, P479, DOI 10.1590/S0100-736X2009000700001; Novais A, 2012, ANTIMICROB AGENTS CH, V56, P3973, DOI 10.1128/AAC.00475-12; Ozawa M, 2010, J VET MED SCI, V72, P1517, DOI 10.1292/jvms.10-0174; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pires-dos-Santos T, 2013, VET MICROBIOL, V162, P873, DOI 10.1016/j.vetmic.2012.11.008; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Schouler C, 2012, J CLIN MICROBIOL, V50, P1673, DOI 10.1128/JCM.05057-11; Sola-Gines M, 2015, APPL ENVIRON MICROB, V81, P3604, DOI 10.1128/AEM.04252-14; Wang Y, 2010, AVIAN PATHOL, V39, P297, DOI 10.1080/03079457.2010.495742; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	51	60	63	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143191	10.1371/journal.pone.0143191	http://dx.doi.org/10.1371/journal.pone.0143191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600205	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900074
J	Zahawi, RA; Duran, G; Kormann, U				Zahawi, Rakan A.; Duran, Guillermo; Kormann, Urs			Sixty-Seven Years of Land-Use Change in Southern Costa Rica	PLOS ONE			English	Article							RAIN-FOREST VEGETATION; LOS-TUXTLAS; COUNTRYSIDE BIOGEOGRAPHY; LANDSCAPE CHANGES; SPECIES RICHNESS; NATURAL-HISTORY; BIRD ABUNDANCE; LIVE FENCES; DEFORESTATION; FRAGMENTATION	Habitat loss and fragmentation of forests are among the biggest threats to biodiversity and associated ecosystem services in tropical landscapes. We use the vicinity of the Las Cruces Biological Station in southern Costa Rica as a regional case study to document seven decades of land-use change in one of the most intensively studied sites in the Neotropics. Though the premontane wet forest was largely intact in 1947, a wave of immigration in 1952 initiated rapid changes over a short period. Overall forest cover was reduced during each time interval analyzed (1947-1960, 1960-1980, 1980-1997, 1997-2014), although the vast majority of forest loss (> 90%) occurred during the first two time intervals (1947-1960, 1960-1980) with an annual deforestation rate of 2.14% and 3.86%, respectively. The rate dropped to < 2% thereafter and has been offset by forest recovery in fallow areas more recently, but overall forest cover has continued to decline. Approximately 27.9% of the study area is forested currently. Concomitantly, the region shifted from a single contiguous forest to a series of progressively smaller forest fragments with each successive survey. A strong reduction in the amount of core habitat was paralleled by an increased proportion of edge habitat, due to the irregular shape of many forest fragments. Structural connectivity, however, remains high, with an expansive network of > 100 km of linear strips of vegetation within a 3 km radius of the station, which may facilitate landscape-level movement for some species. Despite the extent of forest loss, a substantial number of regional landscape-level studies over the past two decades have demonstrated the persistence of many groups of organisms such as birds and mammals. Nonetheless, the continued decline in the quantity and quality of remaining habitat (similar to 30% of remaining forest is secondary), as well as the threat of an extinction debt (or time lag in species loss), may result in the extirpation of additional species if more proactive conservation measures are not taken to reverse current trends-a pattern that reflects many other tropical regions the world over.	[Zahawi, Rakan A.] Org Trop Studies, Las Cruces Biol Stn, San Vito De Coto Brus, Costa Rica; [Duran, Guillermo] Univ Nacl Costa Rica, Ctr Recursos Hidr Ctr Amer & Caribe, Sede Chorotega, Liberia, Costa Rica; [Kormann, Urs] Univ Gottingen, Dept Agroecol, D-37077 Gottingen, Germany	Universidad Nacional Costa Rica; University of Gottingen	Zahawi, RA (corresponding author), Org Trop Studies, Las Cruces Biol Stn, Apartado 73-8257, San Vito De Coto Brus, Costa Rica.	zahawi@ots.ac.cr	; Zahawi, Rakan/N-1028-2014	Duran Sanabria, Guillermo A./0000-0002-1944-9524; Zahawi, Rakan/0000-0002-5678-2967	Deutsche Forschungsgemeinschaft; Organization for Tropical Studies	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Organization for Tropical Studies	The Organization for Tropical Studies provided funds for data analysis and data acquisition (RZ). The Deutsche Forschungsgemeinschaft provided financial assistance for data analysis (UK).	Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Anchukaitis KJ, 2005, PALAEOGEOGR PALAEOCL, V221, P35, DOI 10.1016/j.palaeo.2005.02.003; Austin George T., 1996, Tropical Lepidoptera, V7, P21; Babin N, 2015, AGROECOL SUST FOOD, V39, P99, DOI 10.1080/21683565.2014.960549; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Barnett JR, 2008, CONSERV GENET, V9, P1403, DOI 10.1007/s10592-007-9463-3; Borgella R, 2005, ECOL APPL, V15, P1062, DOI 10.1890/04-0352; Brockett CD, 2002, LAT AM RES REV, V37, P7; Brosi BJ, 2007, ECOL APPL, V17, P418, DOI 10.1890/06-0029; Brosi BJ, 2009, BIOL CONSERV, V142, P414, DOI 10.1016/j.biocon.2008.11.003; Calvo-Alvarado J, 2009, FOREST ECOL MANAG, V258, P931, DOI 10.1016/j.foreco.2008.10.035; Cayuela L, 2006, FOREST ECOL MANAG, V226, P208, DOI 10.1016/j.foreco.2006.01.047; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Clement RM, 2001, HOLOCENE, V11, P419, DOI 10.1191/095968301678302850; Cole-Christensen D, 1997, PLACE RAIN FOREST; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Diaz A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8101; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; EDELMAN M, 1994, HISPANIC AM HIST REV, V74, P445, DOI 10.2307/2517892; Estrada A, 2000, BIODIVERS CONSERV, V9, P1399, DOI 10.1023/A:1008935016046; Estrada A, 1997, BIODIVERS CONSERV, V6, P19, DOI 10.1023/A:1018328930981; Estrada A, 2001, ECOGRAPHY, V24, P94, DOI 10.1034/j.1600-0587.2001.240111.x; Ewers RM, 2007, CONSERV BIOL, V21, P926, DOI 10.1111/j.1523-1739.2007.00720.x; Ewers RM, 2013, ECOL LETT, V16, P1221, DOI 10.1111/ele.12160; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAO, 2020, GLOBAL FOREST RESOUR; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Frishkoff LO, 2014, SCIENCE, V345, P1343, DOI 10.1126/science.1254610; Fuchs EJ, 2003, CONSERV BIOL, V17, P149, DOI 10.1046/j.1523-1739.2003.01140.x; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gloor M, 2012, BIOGEOSCIENCES, V9, P5407, DOI 10.5194/bg-9-5407-2012; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hadley AS, 2014, ECOLOGY, V95, P2202, DOI 10.1890/13-0929.1; Hadley AS, 2009, BIOL LETTERS, V5, P207, DOI 10.1098/rsbl.2008.0691; HARRISON S, 1991, INTERCIENCIA, V16, P83; Holdridge L.R., 1971, FOREST ENV TROPICAL; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; Huth T, 2012, BIOTROPICA, V44, P661, DOI 10.1111/j.1744-7429.2012.00863.x; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Killeen TJ, 2008, ECOL SOC, V13; Laurance SGW, 2004, CONSERV BIOL, V18, P1099, DOI 10.1111/j.1523-1739.2004.00268.x; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Leon MC, 2006, AGROFOREST SYST, V68, P15, DOI 10.1007/s10457-005-5831-5; Lindell CA, 2006, ANIM CONSERV, V9, P445, DOI 10.1111/j.1469-1795.2006.00060.x; Lindquist E. J., 2012, Global forest land-use change 1990-2005; Manger WF, 1992, COLONIZATION SO FRON; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Mendenhall CD, 2014, ECOLOGY, V95, P856, DOI 10.1890/12-2017.1; Mendenhall CD, 2011, P NATL ACAD SCI USA, V108, P16313, DOI 10.1073/pnas.1111687108; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Meyfroidt P, 2013, CURR OPIN ENV SUST, V5, P438, DOI 10.1016/j.cosust.2013.04.003; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pacheco J, 2006, REV BIOL TROP, V54, P219; Pulido-Santacruz P, 2011, AGROFOREST SYST, V81, P15, DOI 10.1007/s10457-010-9331-x; Reid JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090573; Rickert E., 2005, THESIS; Rosero-Bixby L, 1998, POPUL ENVIRON, V20, P149, DOI 10.1023/A:1023319327838; Ruiz-Gutierrez V, 2008, ECOL APPL, V18, P838, DOI 10.1890/07-1090.1; Ryan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098351; SADER SA, 1988, BIOTROPICA, V20, P11, DOI 10.2307/2388421; Sanchez- Azofeifa G. A., 2000, QUANTIFYING SUSTAINA, P473; Santos BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012625; Santos-Barrera G, 2008, REV BIOL TROP, V56, P755; SAUER JD, 1979, TURRIALBA, V29, P255; Schlaepfer MA, 2001, CONSERV BIOL, V15, P1079, DOI 10.1046/j.1523-1739.2001.0150041079.x; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Volpe NL, 2014, ECOL APPL, V24, P2122, DOI 10.1890/13-2168.1; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]	74	56	56	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143554	10.1371/journal.pone.0143554	http://dx.doi.org/10.1371/journal.pone.0143554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599325	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900144
J	Douze, K; Wurz, S; Henshilwood, CS				Douze, Katja; Wurz, Sarah; Henshilwood, Christopher Stuart			Techno-Cultural Characterization of the MIS 5 (c. 105-90 Ka) Lithic Industries at Blombos Cave, Southern Cape, South Africa	PLOS ONE			English	Article							MIDDLE STONE-AGE; DIEPKLOOF ROCK SHELTER; MODERN HUMAN-BEHAVIOR; HOWIESONS POORT; WESTERN CAPE; ADDITIONAL EVIDENCE; KLASIES RIVER; SEQUENCE; SYMBOLISM; BAY	Blombos Cave is well known as an important site for understanding the evolution of symbolically mediated behaviours among Homo sapiens during the Middle Stone Age, and during the Still Bay in particular. The lower part of the archaeological sequence (M3 phase) contains 12 layers dating to MIS 5 with ages ranging from 105 to 90 ka ago (MIS 5c to 5b) that provide new perspectives on the technological behaviour of these early humans. The new data obtained from our extensive technological analysis of the lithic material enriches our currently limited knowledge of this time period in the Cape region. By comparing our results with previously described lithic assemblages from sites south of the Orange River, we draw new insights on the extent of the techno-cultural ties between these sites and the M3 phase at Blombos Cave and highlight the importance of this phase within the Middle Stone Age cultural stratigraphy.	[Douze, Katja; Wurz, Sarah] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Douze, Katja] Univ Bordeaux, UMR 5199, Anthropol, Prehist Actuel,Culture,Environm, Talence, France; [Douze, Katja] Univ Witwatersrand, Ctr Excellence Palaeosci, Johannesburg, South Africa; [Wurz, Sarah; Henshilwood, Christopher Stuart] Univ Bergen, Inst Archaeol Hist Culture & Relig, Bergen, Norway	University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand; University of Bergen	Douze, K (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa.	douzekatja@gmail.com	Henshilwood, Christopher S/K-3806-2014	Henshilwood, Christopher S/0000-0002-2818-293X; Douze, Katja/0000-0001-9997-1605; Wurz, Sarah/0000-0002-0949-5391	Department of Science and Technology/National Research Foundation Center of Excellence in Palaeosciences; CSH's SARChI (South African Research Chairs Initiative) Research Chair; National Research Foundation; African Origins Platform; National Research Foundation/Department of Science and Technology at the University of the Witwatersrand, South Africa; University of Bergen, Norway	Department of Science and Technology/National Research Foundation Center of Excellence in Palaeosciences; CSH's SARChI (South African Research Chairs Initiative) Research Chair; National Research Foundation; African Origins Platform; National Research Foundation/Department of Science and Technology at the University of the Witwatersrand, South Africa; University of Bergen, Norway	The support of the Department of Science and Technology/National Research Foundation Center of Excellence in Palaeosciences (http://ancient-earth.co.za/about/) toward this research is hereby acknowledged by KD. Opinions expressed and conclusions arrived at, are those of the author and are not necessarily to be attributed to the CoE in Palaeosciences. KD's funding was also provided by CSH's SARChI (South African Research Chairs Initiative) Research Chair. SW's contribution is based on the research partly supported by the National Research Foundation (http://www.nrf.ac.za/) and by the African Origins Platform. Any opinion, finding and conclusion or recommendation expressed in this material is that of the author(s) and the National Research Foundation does not accept any liability in this regard. Financial support for the Blombos Cave project was provided to CSH by a National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa and by the University of Bergen, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, ANAL LITHIQUE IND MO; Avery G., 2008, S AFRI ARCHAEOL SOC, V10, P66, DOI [10.2307/40650020, DOI 10.2307/40650020]; Beaumont P, 2001, J HUM EVOL, V40; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Conard NJ, 2004, S AFR ARCHAEOL BULL, V59, P12, DOI 10.2307/3889318; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; D'Errico F, 2001, ANTIQUITY, V75, P309, DOI 10.1017/S0003598X00060968; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; Dibble HL, 2005, AM ANTIQUITY, V70, P545, DOI 10.2307/40035313; Douglass MJ, 2008, AM ANTIQUITY, V73, P513, DOI 10.2307/25470502; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; HENSHILWOOD CS, 2004, SCIENCE, P304; Inizan Marie -Louise, 1999, PRE HIST PIERRE TAIL; Kandel AW, 2016, J ARCHAEOL METHOD TH, V23, P623, DOI 10.1007/s10816-015-9254-y; Langejans GHJ, 2014, PALAEOECO A, V32, P19; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P27; Lombard M, 2012, S AFR ARCHAEOL BULL, V67, P123; Mackay A, 2014, J HUM EVOL, V72, P26, DOI 10.1016/j.jhevol.2014.03.003; Marean C. W., 2008, GOODWIN SERIES, V10, P90; McNabb J., 2009, BAR INT SERIES; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Pelegrin J., 1988, TECHNOLOGIE PREHISTO, V25, P55; Pelegrin J., 1993, USE TOOLS HUMAN NONH, P303; Pigeot N., 1991, PALEO, P167, DOI [10.3406/PAL.1991.1046, DOI 10.3406/PAL.1991.1046]; Pigeot N., 1987, B SOC PREHISTORIQUE, V84, P358; Porraz G, 2015, S AFR ARCH IN PRESS; Porraz G, 2014, TRANSITIONS RUPTURES, P155; Porraz G, 2013, J ARCHAEOL SCI, V40, P3542, DOI 10.1016/j.jas.2013.02.024; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Reynolds SC, 2003, S AFR J SCI, V99, P286; Sampson C.G., 1974, STONE AGE ARCHAEOLOG; Singer R., 1982, MIDDLE STONE AGE KLA; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Thompson E, 2010, J HUM EVOL, V59, P358, DOI 10.1016/j.jhevol.2010.07.009; Thompson JC, 2011, J HUM EVOL, V60, P746, DOI 10.1016/j.jhevol.2011.01.013; Tixier J., 1978, THESIS; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Volman T.P., 1984, P169; Volman T.P., 1981, THESIS; Wadley L, 2007, J HUM EVOL, V52, P681, DOI 10.1016/j.jhevol.2007.01.002; Wadley L, 2015, AZANIA, V50, P155, DOI 10.1080/0067270X.2015.1039236; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Will M, 2013, J HUM EVOL, V64, P518, DOI 10.1016/j.jhevol.2013.02.012; Wurz S, 2002, J ARCHAEOL SCI, V29, P1001, DOI 10.1006/jasc.2001.0799; Wurz S., 2000, MIDDLE STONE AGE KLA; Wurz S, 2013, CURR ANTHROPOL, V54, pS305, DOI 10.1086/673283; Wurz S, 2012, QUATERN INT, V270, P61, DOI 10.1016/j.quaint.2011.06.032	56	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142151	10.1371/journal.pone.0142151	http://dx.doi.org/10.1371/journal.pone.0142151			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CW7CD	26580219	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600036
J	Ghosh, SS; Righi, S; Krieg, R; Kang, L; Carl, D; Wang, J; Massey, HD; Sica, DA; Gehr, TWB; Ghosh, S				Ghosh, Siddhartha S.; Righi, Samuel; Krieg, Richard; Kang, Le; Carl, Daniel; Wang, Jing; Massey, H. Davis; Sica, Domenic A.; Gehr, Todd W. B.; Ghosh, Shobha			High Fat High Cholesterol Diet (Western Diet) Aggravates Atherosclerosis, Hyperglycemia and Renal Failure in Nephrectomized LDL Receptor Knockout Mice: Role of Intestine Derived Lipopolysaccharide	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; EPITHELIAL TIGHT JUNCTION; TRANSGENIC EXPRESSION; INSULIN SENSITIVITY; MURINE MACROPHAGES; INDUCED OBESITY; RISK-FACTOR; RATS ROLE; CURCUMIN; INFLAMMATION	A high fat meal, frequently known as western diet (WD), exacerbates atherosclerosis and diabetes. Both these diseases are frequently associated with renal failure. Recent studies have shown that lipopolysaccharide (LPS) leaks into the circulation from the intestine in the setting of renal failure and after WD. However, it is not clear how renal function and associated disorders are affected by LPS. This study demonstrates that circulatory LPS exacerbates renal insufficiency, atherosclerosis and glucose intolerance. Renal insufficiency was induced by 2/3 nephrectomy in LDL receptor knockout mice. Nx animals were given normal diet (Nx) or WD (Nx+WD). The controls were sham operated animals on normal diet (control) and WD (WD). To verify if LPS plays a role in exaggerating renal insufficiency, polymyxin (PM), a known LPS antagonist, and curcumin (CU), a compound known to ameliorate chronic kidney disease (CKD), was given to Nx animals on western diet (Nx+WD+PM and Nx+WD+CU, respectively). Compared to control, all other groups displayed increased circulatory LPS. The Nx+WD cohort had the highest levels of LPS. Nx group had significant renal insufficiency and glucose intolerance but not atherosclerosis. WD had intense atherosclerosis and glucose intolerance but it did not show signs of renal insufficiency. Compared to other groups, Nx+WD had significantly higher cytokine expression, macrophage infiltration in the kidney, renal insufficiency, glucose intolerance and atherosclerosis. PM treatment blunted the expression of cytokines, deterioration of renal function and associated disorders, albeit not to the levels of Nx, and was significantly inferior to CU. PM is a non-absorbable antibiotic with LPS binding properties, hence its beneficial effect can only be due to its effect within the GI tract. We conclude that LPS may not cause renal insufficiency but can exaggerate kidney failure and associated disorders following renal insufficiency.	[Ghosh, Siddhartha S.; Righi, Samuel; Carl, Daniel; Sica, Domenic A.; Gehr, Todd W. B.] Virginia Commonwealth Univ, Div Nephrol, Richmond, VA 23284 USA; [Krieg, Richard] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Wang, Jing; Ghosh, Shobha] Virginia Commonwealth Univ, Div Pulm Med, Richmond, VA USA; [Massey, H. Davis] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Kang, Le] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Ghosh, SS (corresponding author), Virginia Commonwealth Univ, Div Nephrol, Richmond, VA 23284 USA.	ssghosh@vcu.edu	Kang, Le/ABD-1116-2022	Kang, Le/0000-0003-4262-2329	Jeffress Foundation	Jeffress Foundation	This work was supported by Jeffress Foundation.	ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Al-Sadi R, 2013, J IMMUNOL, V190, P6596, DOI 10.4049/jimmunol.1201876; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; Bentata Y, 2014, AM J CARDIOVASC DIS, V4, P26; Bie JH, 2011, AM J PHYSIOL-REG I, V301, pR967, DOI 10.1152/ajpregu.00277.2011; Bie JH, 2010, J BIOL CHEM, V285, P13630, DOI 10.1074/jbc.M109.069781; Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Buzello M, 2003, J AM SOC NEPHROL, V14, P311, DOI 10.1097/01.ASN.0000045048.71975.FC; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Davies B, 2011, LANCET INFECT DIS, V11, P65, DOI 10.1016/S1473-3099(10)70220-6; Davies MR, 2005, J AM SOC NEPHROL, V16, P917, DOI 10.1681/ASN.2004100835; Decleves AE, 2013, KIDNEY INT; Dempe JS, 2013, MOL NUTR FOOD RES, V57, P1543, DOI 10.1002/mnfr.201200113; Deng H, 2013, J BIOL CHEM, V288, P3897, DOI 10.1074/jbc.M112.424390; Dutta D, 2013, J DIABETES; EMMELOT CH, 1980, J HYG-CAMBRIDGE, V84, P331, DOI 10.1017/S0022172400026851; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Ghosh SS, 2012, AM J PHYSIOL-RENAL, V302, pF439, DOI 10.1152/ajprenal.00356.2010; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Ghosh SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108577; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hasan ST, 2014, ATHEROSCLEROSIS, V232, P40, DOI 10.1016/j.atherosclerosis.2013.10.016; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; HENRICSON BE, 1993, INFECT IMMUN, V61, P2325, DOI 10.1128/IAI.61.6.2325-2333.1993; Hirohashi N, 1996, INFECT IMMUN, V64, P1011, DOI 10.1128/IAI.64.3.1011-1015.1996; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112; Kovesdy CP, 2013, AM J CLIN NUTR, V97, P1163, DOI 10.3945/ajcn.112.036418; Kubotera N, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/954956; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Liu Z, 2013, J IMMUNOL, V191, P857, DOI 10.4049/jimmunol.1300790; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Mak RH, 2007, CURR OPIN NEPHROL HY, V16, P27, DOI 10.1097/MNH.0b013e3280117ce7; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Nguyen S, 2007, CURR OPIN NEPHROL HY, V16, P71, DOI 10.1097/MNH.0b013e32802ef4b6; Niwa T, 2013, EXPERT OPIN THER TAR, V17, P1287, DOI 10.1517/14728222.2013.829456; Odermatt A, 2011, AM J PHYSIOL-RENAL, V301, pF919, DOI 10.1152/ajprenal.00068.2011; Pavkov ME, 2012, CLIN J AM SOC NEPHRO, V7, P78, DOI 10.2215/CJN.07610711; Soetikno V, 2011, MOL NUTR FOOD RES, V55, P1655, DOI 10.1002/mnfr.201100080; Sun PP, 2009, KIDNEY INT, V76, pS20, DOI 10.1038/ki.2009.403; Terawaki H, 2010, THER APHER DIAL, V14, P477, DOI 10.1111/j.1744-9987.2010.00815.x; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Vaziri ND, 2012, NEPHROL DIAL TRANSPL, V27, P2686, DOI 10.1093/ndt/gfr624; Veniant MM, 2001, ARTERIOSCL THROM VAS, V21, P1567, DOI 10.1161/hq1001.097780; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang Y, 2009, INT J FOOD MICROBIOL, V136, P71, DOI 10.1016/j.ijfoodmicro.2009.09.001; West MA, 2008, J TRAUMA, V65, P893, DOI 10.1097/TA.0b013e3181877fde; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yamamoto S, 2011, ARTERIOSCL THROM VAS, V31, P2856, DOI 10.1161/ATVBAHA.111.237198; ZHANG XK, 1993, J EXP MED, V177, P511, DOI 10.1084/jem.177.2.511; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	60	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141109	10.1371/journal.pone.0141109	http://dx.doi.org/10.1371/journal.pone.0141109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580567	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600011
J	Miyamoto, K; Suzuki, KT; Suzuki, M; Sakane, Y; Sakuma, T; Herberg, S; Simeone, A; Simpson, D; Jullien, J; Yamamoto, T; Gurdon, JB				Miyamoto, Kei; Suzuki, Ken-ichi T.; Suzuki, Miyuki; Sakane, Yuto; Sakuma, Tetsushi; Herberg, Sarah; Simeone, Angela; Simpson, David; Jullien, Jerome; Yamamoto, Takashi; Gurdon, J. B.			The Expression of TALEN before Fertilization Provides a Rapid Knock-Out Phenotype in Xenopus laevis Founder Embryos	PLOS ONE			English	Article							TARGETED GENE DISRUPTION; EFFECTOR NUCLEASES; ZINC-FINGER; TROPICALIS; CRISPR/CAS9; TRANSCRIPTION; OOCYTES; SYSTEM; DNA; MUTAGENESIS	Recent advances in genome editing using programmable nucleases have revolutionized gene targeting in various organisms. Successful gene knock-out has been shown in Xenopus, a widely used model organism, although a system enabling less mosaic knock-out in founder embryos (F0) needs to be explored in order to judge phenotypes in the F0 generation. Here, we injected modified highly active transcription activator-like effector nuclease (TALEN) mRNA to oocytes at the germinal vesicle (GV) stage, followed by in vitro maturation and intracytoplasmic sperm injection, to achieve a full knock-out in F0 embryos. Unlike conventional injection methods to fertilized embryos, the injection of TALEN mRNA into GV oocytes allows expression of nucleases before fertilization, enabling them to work from an earlier stage. Using this procedure, most of developed embryos showed full knock-out phenotypes of the pigmentation gene tyrosinase and/or embryonic lethal gene pax6 in the founder generation. In addition, our method permitted a large 1 kb deletion. Thus, we describe nearly complete gene knock-out phenotypes in Xenopus laevis F0 embryos. The presented method will help to accelerate the production of knock-out frogs since we can bypass an extra generation of about 1 year in Xenopus laevis. Meantime, our method provides a unique opportunity to rapidly test the developmental effects of disrupting those genes that do not permit growth to an adult able to reproduce. In addition, the protocol shown here is considerably less invasive than the previously used host transfer since our protocol does not require surgery. The experimental scheme presented is potentially applicable to other organisms such as mammals and fish to resolve common issues of mosaicism in founders.	[Miyamoto, Kei; Herberg, Sarah; Simeone, Angela; Simpson, David; Jullien, Jerome; Gurdon, J. B.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England; [Suzuki, Ken-ichi T.; Suzuki, Miyuki; Sakane, Yuto; Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Dept Math & Life Sci, Grad Sch Sci, Higashihiroshima 724, Japan	University of Cambridge; Hiroshima University	Miyamoto, K (corresponding author), Kinki Univ, Lab Mol Dev Biol, Fac Biol Oriented Sci & Technol, Wakayama, Japan.	kmiyamo@waka.kindai.ac.jp; suzuk107@hiroshima-u.ac.jp	Sakuma, Tetsushi/A-7615-2013; jerome, jullien/K-5565-2019; Suzuki, Ken-ichi T/G-2864-2019; jullien, jerome/AAC-1887-2022; Yamamoto, Takashi/U-4790-2017	Sakuma, Tetsushi/0000-0003-0396-1563; jerome, jullien/0000-0002-7868-0021; Suzuki, Ken-ichi T/0000-0002-4502-831X; Yamamoto, Takashi/0000-0002-6516-2903; Suzuki, Miyuki/0000-0002-7284-7505; Miyamoto, Kei/0000-0003-2912-6777; GURDON, JOHN/0000-0002-5621-3799	Wellcome Trust [RG69899]; Herchel Smith Postdoctoral Fellowship; Japan Society for the Promotion of Science (JSPS KAKENHI Grant) [25124708]; Biotechnology and Biological Sciences Research Council [BBS/B/14647] Funding Source: researchfish; Wellcome Trust [101050/Z/13/Z] Funding Source: researchfish; Grants-in-Aid for Scientific Research [26290070] Funding Source: KAKEN	Wellcome Trust(Wellcome TrustEuropean Commission); Herchel Smith Postdoctoral Fellowship; Japan Society for the Promotion of Science (JSPS KAKENHI Grant)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by grants from the Wellcome Trust to JBG (RG69899, http://www.wellcome.ac.uk/). This work is supported by Herchel Smith Postdoctoral Fellowship to KM (grant number is not available, http://www.herchelsmith.cam.ac.uk/fellowships/). This work is also supported by the Japan Society for the Promotion of Science to KTS (JSPS KAKENHI Grant Number 25124708, https://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Carroll D, 2014, METHODS, V69, P137, DOI 10.1016/j.ymeth.2014.03.026; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Hagmann M, 1996, BIOL CHEM H-S, V377, P239, DOI 10.1515/bchm3.1996.377.4.239; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hashimoto S, 2009, J REPROD DEVELOP, V55, P1, DOI 10.1262/jrd.20127; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Herberg S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14236; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hulstrand AM, 2010, METHODS, V51, P75, DOI 10.1016/j.ymeth.2009.12.015; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Ishibashi S, 2012, BIOL OPEN, V1, P1273, DOI 10.1242/bio.20123228; James-Zorn C, 2013, NUCLEIC ACIDS RES, V41, pD865, DOI 10.1093/nar/gks1025; Jullien J, 2014, MOL CELL, V55, P524, DOI 10.1016/j.molcel.2014.06.024; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Miyamoto K, 2015, JOVE-J VIS EXP, DOI 10.3791/52496; Miyamoto K, 2013, SCIENCE, V341, P1002, DOI 10.1126/science.1240376; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakajima K, 2015, BIOL OPEN, V4, P180, DOI 10.1242/bio.201410009; Nakayama T., 2015, DEV BIOL; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Rungger-Brandle E, 2010, DEV NEUROBIOL, V70, P764, DOI 10.1002/dneu.20816; Sakane Y, 2014, DEV GROWTH DIFFER, V56, P108, DOI 10.1111/dgd.12105; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Shirogane Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2252; Suzuki KT, 2013, BIOL OPEN, V2, P448, DOI 10.1242/bio.20133855; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wang FQ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0006-1; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108	36	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142946	10.1371/journal.pone.0142946	http://dx.doi.org/10.1371/journal.pone.0142946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580070	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600069
J	Taboada, S; Riesgo, A; Bas, M; Arnedo, MA; Cristobo, J; Rouse, GW; Avila, C				Taboada, Sergi; Riesgo, Ana; Bas, Maria; Arnedo, Miquel A.; Cristobo, Javier; Rouse, Greg W.; Avila, Conxita			Bone-Eating Worms Spread: Insights into Shallow-Water Osedax (Annelida, Siboglinidae) from Antarctic, Subantarctic, and Mediterranean Waters	PLOS ONE			English	Article							MESSINIAN SALINITY CRISIS; DWARF MALES; BACTERIAL ENDOSYMBIONTS; PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; TEMPORAL VARIATION; SOUTHERN-OCEAN; NORTH-ATLANTIC; MIXED MODELS; DNA	Osedax, commonly known as bone-eating worms, are unusual marine annelids belonging to Siboglinidae and represent a remarkable example of evolutionary adaptation to a specialized habitat, namely sunken vertebrate bones. Usually, females of these animals live anchored inside bone owing to a ramified root system from an ovisac, and obtain nutrition via symbiosis with Oceanospirillales gamma-proteobacteria. Since their discovery, 26 Osedax operational taxonomic units (OTUs) have been reported from a wide bathymetric range in the Pacific, the North Atlantic, and the Southern Ocean. Using experimentally deployed and naturally occurring bones we report here the presence of Osedax deceptionensis at very shallow-waters in Deception Island (type locality; Antarctica) and at moderate depths near South Georgia Island (Subantarctic). We present molecular evidence in a new phylogenetic analysis based on five concatenated genes (28S rDNA, Histone H3, 18S rDNA, 16S rDNA, and cytochrome c oxidase I-COI-), using Maximum Likelihood and Bayesian inference, supporting the placement of O. deceptionensis as a separate lineage (Clade VI) although its position still remains uncertain. This phylogenetic analysis includes a new unnamed species (O. 'mediterranea') recently discovered in the shallow-water Mediterranean Sea belonging to Osedax Clade I. A timeframe of the diversification of Osedax inferred using a Bayesian framework further suggests that Osedax diverged from other siboglinids during the Middle Cretaceous (ca. 108 Ma) and also indicates that the most recent common ancestor of Osedax extant lineages dates to the Late Cretaceous (ca. 74.8 Ma) concomitantly with large marine reptiles and teleost fishes. We also provide a phylogenetic framework that assigns newly-sequenced Osedax endosymbionts of O. deceptionensis and O. 'mediterranea' to ribospecies Rs1. Molecular analysis for O. deceptionensis also includes a COI-based haplotype network indicating that individuals from Deception Island and the South Georgia Island (ca. 1,600 km apart) are clearly the same species, confirming the well-developed dispersal capabilities reported in other congeneric taxa. In addition, we include a complete description of living features and morphological characters (including scanning and transmission electron microscopy) of O. deceptionensis, a species originally described from a single mature female, and compare it to information available for other congeneric OTUs.	[Taboada, Sergi; Riesgo, Ana; Bas, Maria; Arnedo, Miquel A.; Avila, Conxita] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Taboada, Sergi; Riesgo, Ana; Bas, Maria; Arnedo, Miquel A.; Avila, Conxita] Univ Barcelona, Fac Biol, Biodivers Res Inst IrBIO, Barcelona, Spain; [Cristobo, Javier] IEO, Ctr Oceanog Gijon, Gijon, Spain; [Rouse, Greg W.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Barcelona; University of Barcelona; Spanish Institute of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography	Taboada, S (corresponding author), Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain.	sergiotab@gmail.com	Rouse, Greg W/F-2611-2010; Rouse, Gregory/AAW-1494-2021; Arnedo, Miquel/E-9086-2011; Cristobo, Javier/M-1949-2014; Avila, Conxita/B-9466-2008; Taboada, Sergi/AAB-9390-2021; Riesgo, Ana/E-3341-2014	Rouse, Greg W/0000-0001-9036-9263; Rouse, Gregory/0000-0001-9036-9263; Arnedo, Miquel/0000-0003-1402-4727; Cristobo, Javier/0000-0002-7725-4055; Avila, Conxita/0000-0002-5489-8376; Taboada, Sergi/0000-0003-1669-1152; Riesgo, Ana/0000-0002-7993-1523; Bas, Maria/0000-0001-8553-6557	Spanish Government through the research project ACTIQUIM-II [CTM2010-17415/ANT]; National Science Foundation Office of Polar Programs [1043749]; Spanish Government through the environmental association S'Agulla Educacio Mediambiental	Spanish Government through the research project ACTIQUIM-II; National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Spanish Government through the environmental association S'Agulla Educacio Mediambiental	This research received support from the Spanish Government, through the research project ACTIQUIM-II (CTM2010-17415/ANT) and through the environmental association S'Agulla Educacio Mediambiental. G.W. Rouse thanks the captain and crew of RVIB Nathaniel B. Palmer Chief Scientist N.G. Wilson and the science participants during the cruise NBP13-03. This work was supported by award #1043749 from the National Science Foundation Office of Polar Programs to N.G. Wilson, G.W. Rouse and R.S. Burton.	Ahumada-Sempoal MA, 2013, PROG OCEANOGR, V118, P61, DOI 10.1016/j.pocean.2013.07.030; Amon DJ, 2014, ZOOL SCR, V43, P405, DOI 10.1111/zsc.12057; Bardet Nathalie, 1994, Historical Biology, V7, P313; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; Colgan DJ, 2000, ZOOL SCR, V29, P29, DOI 10.1046/j.1463-6409.2000.00021.x; Dahlgren TG, 2006, CAH BIOL MAR, V47, P385; Danise S, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0072; DRUMMOND AJ, 2010, GENEIOUS V5 5; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Friedman M, 2009, P NATL ACAD SCI USA, V106, P5218, DOI 10.1073/pnas.0808468106; Fujikura K, 2006, ZOOL SCI, V23, P733, DOI 10.2108/zsj.23.733; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; Glover AG, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1390; Glover AG, 2005, P ROY SOC B-BIOL SCI, V272, P2587, DOI 10.1098/rspb.2005.3275; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Goffredi SK, 2014, ISME J, V8, P908, DOI 10.1038/ismej.2013.201; Goffredi SK, 2005, ENVIRON MICROBIOL, V7, P1369, DOI 10.1111/j.1462-2920.2005.00824.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Higgs ND, 2012, HIST BIOL, V24, P269, DOI 10.1080/08912963.2011.621167; Higgs ND, 2011, BIOL BULL-US, V221, P307, DOI 10.1086/BBLv221n3p307; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hipsley CA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-151; Jolivet L, 2006, SEDIMENT GEOL, V188, P9, DOI 10.1016/j.sedgeo.2006.02.004; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katz S, 2013, INVERTEBR BIOL, V132, P368, DOI 10.1111/ivb.12037; Katz S, 2011, BIOL BULL-US, V220, P128, DOI 10.1086/BBLv220n2p128; Katz S, 2010, J MORPHOL, V271, P1272, DOI 10.1002/jmor.10873; Kiel S, 2013, PALAEONTOL Z, V87, P161, DOI 10.1007/s12542-012-0158-9; Kiel S, 2011, NATURWISSENSCHAFTEN, V98, P51, DOI 10.1007/s00114-010-0740-5; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; LENAERS G, 1989, J MOL EVOL, V29, P40, DOI 10.1007/BF02106180; Lenn YD, 2003, DEEP-SEA RES PT II, V50, P1665, DOI 10.1016/S0967-0645(03)00085-7; Li YN, 2015, MOL PHYLOGENET EVOL, V85, P221, DOI 10.1016/j.ympev.2015.02.008; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Little CTS, 1999, GEOLOGY, V27, P1027, DOI 10.1130/0091-7613(1999)027<1027:LCHVCF>2.3.CO;2; Miyamoto N, 2013, NATURWISSENSCHAFTEN, V100, P285, DOI 10.1007/s00114-013-1024-7; Morris SC, 2008, ACTA PALAEONTOL POL, V53, P135; Nelson K, 2000, SYMBIOSIS, V28, P1; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2014, TRACER V1 6; Rambaut A., 2006, FIGTREE V1 3 1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouse GW, 2008, BIOL BULL-US, V214, P67, DOI 10.2307/25066661; Rouse GW, 2015, CURR BIOL, V25, P236, DOI 10.1016/j.cub.2014.11.032; Rouse GW, 2011, BIOL LETTERS, V7, P736, DOI 10.1098/rsbl.2011.0202; Rouse GW, 2009, MAR BIOL, V156, P395, DOI 10.1007/s00227-008-1091-z; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Salathe RM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-189; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taboada S, 2015, MAR ECOL; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; Tresguerres M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0625; Verducci M, 2009, PALAEOGEOGR PALAEOCL, V280, P371, DOI 10.1016/j.palaeo.2009.06.024; Vrijenhoek RC, 2008, MOL ECOL, V17, P4535, DOI 10.1111/j.1365-294X.2008.03937.x; Vrijenhoek RC, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-74; Worsaae K, 2010, J MORPHOL, V271, P127, DOI 10.1002/jmor.10786	64	14	15	0	193	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140341	10.1371/journal.pone.0140341	http://dx.doi.org/10.1371/journal.pone.0140341			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581105	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600006
J	Bongers, MN; Schabel, C; Thomas, C; Raupach, R; Notohamiprodjo, M; Nikolaou, K; Bamberg, F				Bongers, Malte N.; Schabel, Christoph; Thomas, Christoph; Raupach, Rainer; Notohamiprodjo, Mike; Nikolaou, Konstantin; Bamberg, Fabian			Comparison and Combination of Dual-Energy- and Iterative-Based Metal Artefact Reduction on Hip Prosthesis and Dental Implants	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ORTHOPEDIC IMPLANTS; CT; RECONSTRUCTIONS; IMAGES	Purpose To compare and combine dual-energy based and iterative metal artefact reduction on hip prosthesis and dental implants in CT. Material and Methods A total of 46 patients (women: 50%, mean age: 63+/-15years) with dental implants or hip prostheses (n = 30/20) were included and examined with a second-generation Dual Source Scanner. 120kV equivalent mixed-images were derived from reconstructions of the 100/Sn140kV source images using no metal artefact reduction (NOMAR) and iterative metal artefact reduction (IMAR). We then generated monoenergetic extrapolations at 130keV from source images without IMAR (DEMAR) or from source images with IMAR, (IMAR + DEMAR). The degree of metal artefact was quantified for NOMAR, IMAR, DEMAR and IMAR+DEMAR using a Fourier-based method and subjectively rated on a five point Likert scale by two independent readers. Results In subjects with hip prosthesis, DEMAR and IMAR resulted in significantly reduced artefacts compared to standard reconstructions (33% vs. 56%; for DEMAR and IMAR; respectively, p<0.005), but the degree of artefact reduction was significantly higher for IMAR (all p<0.005). In contrast, in subjects with dental implants only IMAR showed a significant reduction of artefacts whereas DEMAR did not (71%, vs. 8% p<0.01 and p = 0.1; respectively). Furthermore, the combination of IMAR with DEMAR resulted in additionally reduced artefacts (Hip prosthesis: 47%, dental implants 18%; both p<0.0001). Conclusion IMAR allows for significantly higher reduction of metal artefacts caused by hip prostheses and dental implants, compared to a dual energy based method. The combination of DE-source images with IMAR and subsequent monoenergetic extrapolation provides an incremental benefit compared to both single methods.	[Bongers, Malte N.; Schabel, Christoph; Notohamiprodjo, Mike; Nikolaou, Konstantin; Bamberg, Fabian] Univ Hosp Tubingen, Dept Diagnost & Intervent Radiol, D-72076 Tubingen, Germany; [Thomas, Christoph] Univ Hosp Dusseldorf, Dept Diagnost & Intervent Radiol, D-40225 Dusseldorf, Germany; [Raupach, Rainer] Siemens AG, Healthcare Sect, D-91301 Forchheim, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Siemens AG; Siemens Germany	Bongers, MN (corresponding author), Univ Hosp Tubingen, Dept Diagnost & Intervent Radiol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	malte.bongers@med.uni-tuebingen.de	Artzner, Christoph/GLS-9305-2022		Siemens Healthcare, Germany; Siemens AG	Siemens Healthcare, Germany(Siemens AG); Siemens AG(Siemens AG)	The study was supported by a research grant from Siemens Healthcare, Germany. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis or decision to publish. Coauthor Rainer Raupach (RR) is employed by Siemens AG. Siemens AG provided support in the form of salary for author RR, but did not have any additional role in the study design, data collection and analysis or decision to publish. The specific role of this author is articulated in the 'author contributions' section.	Bamberg F, 2011, EUR RADIOL, V21, P1424, DOI 10.1007/s00330-011-2062-1; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Dong Y, 2016, EUR SPINE J, V25, P1754, DOI 10.1007/s00586-015-4053-4; Filograna L, 2015, SKELETAL RADIOL, V44, P1287, DOI 10.1007/s00256-015-2155-z; Grant KL, 2014, INVEST RADIOL, V49, P586, DOI 10.1097/RLI.0000000000000060; Han SC, 2014, AM J ROENTGENOL, V203, P788, DOI 10.2214/AJR.13.10980; Kuchenbecker S, 2015, MED PHYS, V42, P1023, DOI 10.1118/1.4905106; Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087; Mangold S, 2014, INVEST RADIOL, V49, P788, DOI 10.1097/RLI.0000000000000083; Meyer E, 2012, MED PHYS, V39, P1904, DOI 10.1118/1.3691902; Meyer E, 2010, MED PHYS, V37, P5482, DOI 10.1118/1.3484090; Morsbach F, 2013, EUR RADIOL, V23, P2687, DOI 10.1007/s00330-013-2885-z; Morsbach F, 2013, RADIOLOGY, V268, P237, DOI 10.1148/radiol.13122089; Mouton A, 2013, J X-RAY SCI TECHNOL, V21, P193, DOI 10.3233/XST-130372; Subhas N, 2014, SKELETAL RADIOL, V43, P1729, DOI 10.1007/s00256-014-1987-2; Taljanovic MS, 2003, RADIOGRAPHICS, V23, P1295, DOI 10.1148/rg.235035059; Teixeira PAG, 2014, SKELETAL RADIOL, V43, P1237, DOI 10.1007/s00256-014-1923-5; White Lawrence M, 2002, Semin Musculoskelet Radiol, V6, P5, DOI 10.1055/s-2002-23160; Zhou CS, 2011, ACAD RADIOL, V18, P1252, DOI 10.1016/j.acra.2011.05.009	19	60	60	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143584	10.1371/journal.pone.0143584	http://dx.doi.org/10.1371/journal.pone.0143584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600188	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600089
J	Floren, A; Kruger, D; Muller, T; Dittrich, M; Rudloff, R; Hoppe, B; Linsenmair, KE				Floren, Andreas; Krueger, Dirk; Mueller, Tobias; Dittrich, Marcus; Rudloff, Renate; Hoppe, Bjoern; Linsenmair, Karl Eduard			Diversity and Interactions of Wood-Inhabiting Fungi and Beetles after Deadwood Enrichment	PLOS ONE			English	Article							FOREST MANAGEMENT; NORWAY SPRUCE; BARK BEETLES; SPECIES RICHNESS; ECOLOGY; RARE; ESTABLISHMENT; METAANALYSIS; COMMUNITIES; ASSEMBLAGES	Freshly cut beech deadwood was enriched in the canopy and on the ground in three cultural landscapes in Germany (Swabian Alb, Hainich-Dun, Schorfheide-Chorin) in order to analyse the diversity, distribution and interaction of wood-inhabiting fungi and beetles. After two years of wood decay 83 MOTUs (Molecular Operational Taxonomic Units) from 28 wood samples were identified. Flight Interception Traps (FITs) installed adjacent to the deadwood enrichments captured 29.465 beetles which were sorted to 566 species. Geographical 'region' was the main factor determining both beetle and fungal assemblages. The proportions of species occurring in all regions were low. Statistic models suggest that assemblages of both taxa differed between stratum and management praxis but their strength varied among regions. Fungal assemblages in Hainich-Dun, for which the data was most comprehensive, discriminated unmanaged from extensively managed and age-class forests (even-aged timber management) while canopy communities differed not from those near the ground. In contrast, the beetle assemblages at the same sites showed the opposite pattern. We pursued an approach in the search for fungus-beetle associations by computing cross correlations and visualize significant links in a network graph. These correlations can be used to formulate hypotheses on mutualistic relationships for example in respect to beetles acting as vectors of fungal spores.	[Floren, Andreas; Linsenmair, Karl Eduard] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany; [Krueger, Dirk; Rudloff, Renate; Hoppe, Bjoern] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, D-06120 Halle, Saale, Germany; [Mueller, Tobias; Dittrich, Marcus] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97074 Wurzburg, Germany	University of Wurzburg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Wurzburg	Floren, A (corresponding author), Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany.	floren@biozentrum.uni-wuerzburg.de; bjoern.hoppe@ufz.de	Linsenmair, Karl Eduard/Q-2268-2018; Müller, Tobias/A-8952-2008; Kruger, Dirk/C-3316-2012	Linsenmair, Karl Eduard/0000-0002-2132-8721; Kruger, Dirk/0000-0002-7305-5104; Hoppe, Bjorn/0000-0001-8689-4911	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [LI 150/22-1, KR 3587/3-2]; Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"; Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (grants LI 150/22-1 and KR 3587/3-2) and also supported through the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103416; Bassler C, 2014, J APPL ECOL, V51, P939, DOI 10.1111/1365-2664.12267; Bassler C, 2010, FUNGAL BIOL-UK, V114, P129, DOI 10.1016/j.funbio.2009.11.001; Baum Sebastian, 2003, Mycological Progress, V2, P141, DOI 10.1007/s11557-006-0052-5; Biedermann PHW, 2013, FEMS MICROBIOL ECOL, V83, P711, DOI 10.1111/1574-6941.12026; Blaser S, 2013, FOREST ECOL MANAG, V304, P42, DOI 10.1016/j.foreco.2013.04.043; Chessel D., 2012, PACKAGE ADE4 ANAL EC; Doyle J. J., 1987, PHYTOCHEM B, P11; Dray S, 2014, COMP SCI DATA ANAL S, P289; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Floren A, 2014, FOREST ECOL MANAG, V323, P57, DOI 10.1016/j.foreco.2014.03.028; Garbelotto M, 2013, ANNU REV PHYTOPATHOL, V51, P39, DOI 10.1146/annurev-phyto-082712-102225; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Giordano L, 2013, MYCOL PROG, V12, P127, DOI 10.1007/s11557-012-0822-1; Gossner MM, 2013, FOREST ECOL MANAG, V302, P404, DOI 10.1016/j.foreco.2013.03.039; Gruppe Axel, 2008, P383; Halme P, 2013, BIOL CONSERV, V168, P24, DOI 10.1016/j.biocon.2013.08.034; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hiscox J, 2015, ISME J, V9, P2246, DOI 10.1038/ismej.2015.38; Hoppe B, 2016, FUNGAL DIVERS, V77, P367, DOI 10.1007/s13225-015-0341-x; Hoppe B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088141; Jonsson MT, 2008, J ECOL, V96, P1065, DOI 10.1111/j.1365-2745.2008.01411.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Klausnitzer Bernhard, 2011, Berichte der Naturforschenden Gesellschaft Oberlausitz, V19, P47; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Kohler F, 2000, LOBF SCHRIFTENREIH B, P1; Lachat T, 2012, ECOL INDIC, V23, P323, DOI 10.1016/j.ecolind.2012.04.013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassauce A, 2011, ECOL INDIC, V11, P1027, DOI 10.1016/j.ecolind.2011.02.004; Leach JG, 1937, J AGRIC RES, V55, P0129; Leather SR, 2014, INSECT CONSERV DIVER, V7, P314, DOI 10.1111/icad.12055; Lindblad I, 1998, NORD J BOT, V18, P243, DOI 10.1111/j.1756-1051.1998.tb01877.x; Lonsdale D, 2008, EUR J FOREST RES, V127, P1, DOI 10.1007/s10342-007-0182-6; Molina R, 2008, MYCOL RES, V112, P613, DOI 10.1016/j.mycres.2007.12.005; Moller G, 2009, THESIS; Muller J, 2007, EUR J FOREST RES, V126, P513, DOI 10.1007/s10342-007-0173-7; Oksanen J, 2013, MULTIVARIATE ANAL EC; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Pazoutova S, 2010, FUNGAL ECOL, V3, P392, DOI 10.1016/j.funeco.2010.07.002; Persson Y, 2011, FUNGAL ECOL, V4, P262, DOI 10.1016/j.funeco.2011.01.005; Persson Y, 2009, MICROB ECOL, V58, P651, DOI 10.1007/s00248-009-9520-1; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; Purahong W, 2015, FUNG ECOL UNPUB; Purahong W, 2014, J ENVIRON MANAGE, V139, P109, DOI 10.1016/j.jenvman.2014.02.031; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Schauer F, 1999, MYCOSES, V42, P12, DOI 10.1111/j.1439-0507.1999.tb04521.x; Schigel D. S., 2012, Mycology - An International Journal on Fungal Biology, V3, P258; Schmidl Juergen, 2004, Naturschutz und Landschaftsplanung, V36, P202; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Six DL, 2003, CAN J FOREST RES, V33, P1815, DOI 10.1139/X03-107; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Strid Y, 2014, FUNGAL ECOL, V7, P47, DOI 10.1016/j.funeco.2013.09.003; Ulyshen MD, 2016, BIOL REV, V91, P70, DOI 10.1111/brv.12158; Ulyshen MD, 2013, METHODS ECOL EVOL, V4, P345, DOI 10.1111/2041-210x.12012; Unterseher M, 2006, MYCOL RES, V110, P169, DOI 10.1016/j.mycres.2005.08.002; van der Wal A, 2015, ECOLOGY, V96, P124, DOI 10.1890/14-0242.1; Vindstad OPL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099624; Weslien J, 2011, J ANIM ECOL, V80, P1155, DOI 10.1111/j.1365-2656.2011.01860.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yousuf F, 2014, AUSTRAL ENTOMOL, V53, P298, DOI 10.1111/aen.12077; Zanzot JW, 2010, ENVIRON ENTOMOL, V39, P415, DOI 10.1603/EN09261	64	16	19	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143566	10.1371/journal.pone.0143566	http://dx.doi.org/10.1371/journal.pone.0143566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599572	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600085
J	Gao, C; Wang, N; Guo, XQ; Ziegler, JT; Taylor, KD; Xiang, AH; Hai, Y; Kridel, SJ; Nadler, JL; Kandeel, F; Raffel, LJ; Chen, YDI; Norris, JM; Rotter, JI; Watanabe, RM; Wagenknecht, LE; Bowden, DW; Speliotes, EK; Goodarzi, MO; Langefeld, CD; Palmer, ND				Gao, Chuan; Wang, Nan; Guo, Xiuqing; Ziegler, Julie T.; Taylor, Kent D.; Xiang, Anny H.; Hai, Yang; Kridel, Steven J.; Nadler, Jerry L.; Kandeel, Fouad; Raffel, Leslie J.; Chen, Yii-Der I.; Norris, Jill M.; Rotter, Jerome I.; Watanabe, Richard M.; Wagenknecht, Lynne E.; Bowden, Donald W.; Speliotes, Elizabeth K.; Goodarzi, Mark O.; Langefeld, Carl D.; Palmer, Nicholette D.			A Comprehensive Analysis of Common and Rare Variants to Identify Adiposity Loci in Hispanic Americans: The IRAS Family Study (IRASFS)	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN SENSITIVITY; BLOOD-PRESSURE; LIPOPROTEIN-LIPASE; ABDOMINAL FAT; HIP RATIO; HIGH-RISK; METAANALYSIS; GENE; RESISTANCE	Obesity is growing epidemic affecting 35% of adults in the United States. Previous genome-wide association studies (GWAS) have identified numerous loci associated with obesity. However, the majority of studies have been completed in Caucasians focusing on total body measures of adiposity. Here we report the results from genome-wide and exome chip association studies focusing on total body measures of adiposity including body mass index (BMI), percent body fat (PBF) and measures of fat deposition including waist circumference (WAIST), waist-hip ratio (WHR), subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) in Hispanic Americans (n(max) = 1263) from the Insulin Resistance Atherosclerosis Family Study (IRASFS). Five SNPs from two novel loci attained genome-wide significance (P<5.00x10(-8)) in IRASFS. A missense SNP in the isocitrate dehydrogenase 1 gene (IDH1) was associated with WAIST (rs34218846, MAF = 6.8%, P-DOM = 1.62x10(-8)). This protein is postulated to play an important role in fat and cholesterol biosynthesis as demonstrated in cell and knock-out animal models. Four correlated intronic SNPs in the Zinc finger, GRF-type containing 1 gene (ZGRF1; SNP rs1471880, MAF = 48.1%, PDOM = 1.00x10(-8)) were strongly associated with WHR. The exact biological function of ZGRF1 and the connection with adiposity remains unclear. SNPs with p-values less than 5.00x10(-6) from IRASFS were selected for replication. Meta-analysis was computed across seven independent Hispanic-American cohorts (n(max) = 4156) and the strongest signal was rs1471880 (P-DOM = 8.38x10(-6)) in ZGRF1 with WAIST. In conclusion, a genome-wide and exome chip association study was conducted that identified two novel loci (IDH1 and ZGRF1) associated with adiposity. While replication efforts were inconclusive, when taken together with the known biology, IDH1 and ZGRF1 warrant further evaluation.	[Gao, Chuan] Wake Forest Sch Med, Mol Genet & Genom Program, Winston Salem, NC 27157 USA; [Gao, Chuan; Bowden, Donald W.; Palmer, Nicholette D.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Gao, Chuan; Wang, Nan; Ziegler, Julie T.; Langefeld, Carl D.; Palmer, Nicholette D.] Wake Forest Sch Med, Ctr Publ Hlth Genom, Winston Salem, NC USA; [Wang, Nan; Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Physiol & Biophys, Los Angeles, CA 90033 USA; [Wang, Nan; Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Guo, Xiuqing; Taylor, Kent D.; Hai, Yang; Chen, Yii-Der I.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Guo, Xiuqing; Taylor, Kent D.; Hai, Yang; Chen, Yii-Der I.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Ziegler, Julie T.; Langefeld, Carl D.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Xiang, Anny H.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Kridel, Steven J.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Nadler, Jerry L.] Eastern Virginia Med Sch, Dept Internal Med, Strelitz Diabet Ctr, Norfolk, VA 23501 USA; [Kandeel, Fouad] Beckman Res Inst City Hope, Dept Diabet & Metab Dis Res, Duarte, CA USA; [Raffel, Leslie J.; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Med Genet Res Inst, Los Angeles, CA 90048 USA; [Norris, Jill M.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Wagenknecht, Lynne E.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Bowden, Donald W.; Palmer, Nicholette D.] Wake Forest Sch Med, Ctr Diabet Res, Winston Salem, NC USA; [Bowden, Donald W.; Palmer, Nicholette D.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Speliotes, Elizabeth K.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Speliotes, Elizabeth K.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA	Wake Forest University; Wake Forest University; Wake Forest University; University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Wake Forest University; Kaiser Permanente; Wake Forest University; Eastern Virginia Medical School; City of Hope; Beckman Research Institute of City of Hope; Cedars Sinai Medical Center; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Wake Forest University; Wake Forest University; Wake Forest University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cedars Sinai Medical Center	Gao, C (corresponding author), Wake Forest Sch Med, Mol Genet & Genom Program, Winston Salem, NC 27157 USA.	nallred@wakehealth.edu	Goodarzi, Mark/AAH-7106-2021; Rotter, Jerome/AAY-6598-2021; Hai, Yang/AAB-2650-2020	Goodarzi, Mark/0000-0001-6364-5103; Hai, Yang/0000-0002-9420-0614; Xiang, Anny/0000-0003-2786-1268	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK097524, DK087914, DK085175, DK061628, DK063491, DK081350]; National Institute for Heart, Lung, and Blood Disorders (NHLBI) [HL060944, HL061019, HL060919, HL047887, HL047889, HL047890, HL47902, HL088457, HL069794, HL055798]; National Human Genome Research Institute (NHGRI) [HG007112]; National Center for Advancing Translational Science [UL1TR000124]; Department of Internal Medicine at the University of Michigan; National Institutes of Health (NIH) through National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),; National Institute for Heart, Lung, and Blood Disorders (NHLBI); National Human Genome Research Institute (NHGRI); NATIONAL CANCER INSTITUTE [R01CA161503] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055798, U01HL047890, U01HL047902, R01HL061019, U01HL047887, R01HL060919, U01HL047889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087914, R01DK061628, P30DK034933, R01DK085175, P30DK063491, R01DK106621, R00DK081350, R21DK097524, K99DK081350] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Heart, Lung, and Blood Disorders (NHLBI); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Advancing Translational Science; Department of Internal Medicine at the University of Michigan; National Institutes of Health (NIH) through National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),; National Institute for Heart, Lung, and Blood Disorders (NHLBI); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): DK097524, DK087914, DK085175, DK061628, DK063491, DK081350, and DK087914; the National Institute for Heart, Lung, and Blood Disorders (NHLBI): HL060944, HL061019, HL060919, HL047887, HL047889, HL047890, HL47902, HL060944, HL061019, HL088457, HL069794, and HL055798; the National Human Genome Research Institute (NHGRI): HG007112, and HG007112; and the National Center for Advancing Translational Science UL1TR000124. The provision of genotyping data was supported in part by funds from the Department of Internal Medicine at the University of Michigan. Computational resources were provided, in part, by the Wake Forest School of Medicine Center for Public Health Genomics.; This research was supported by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute for Heart, Lung, and Blood Disorders (NHLBI), and the National Human Genome Research Institute (NHGRI). The authors would like to acknowledge the members of the GUARDIAN Consortium. The authors thank the other investigators, the staff, and the participants of the studies for their valuable contributions.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Black MH, 2008, DIABETES, V57, P1048, DOI 10.2337/db07-0848; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Buchanan TA, 2000, DIABETES, V49, P782, DOI 10.2337/diabetes.49.5.782; Cheng LSC, 2001, CIRCULATION, V104, P1255, DOI 10.1161/hc3601.096729; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002705; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Going SB, 2011, AM J PREV MED, V41, pS77, DOI 10.1016/j.amepre.2011.07.006; Goodarzi MO, 2014, OBESITY, V22, P1157, DOI 10.1002/oby.20639; Goodarzi MO, 2005, DIABETES, V54, P1222, DOI 10.2337/diabetes.54.4.1222; Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214; Goodarzi MO, 2003, GENET MED, V5, P322, DOI 10.1097/01.GIM.0000076971.55421.AD; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Henkin L, 2003, ANN EPIDEMIOL, V13, P211, DOI 10.1016/S1047-2797(02)00412-X; Hindorff LA, CATALOG OF PUBLISHED; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Lafontan M, 2003, TRENDS PHARMACOL SCI, V24, P276, DOI 10.1016/S0165-6147(03)00132-9; Li X, 2009, OBESITY, V17, P729, DOI 10.1038/oby.2008.593; Liu CT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003681; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Nam WS, 2012, BBA-MOL BASIS DIS, V1822, P1181, DOI 10.1016/j.bbadis.2012.04.003; Narkiewicz K, 2006, NEPHROL DIAL TRANSPL, V21, P264, DOI 10.1093/ndt/gfi290; Norris JM, 2005, INT J OBESITY, V29, P67, DOI 10.1038/sj.ijo.0802793; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Shu YH, 2009, J CLIN ENDOCR METAB, V94, P4094, DOI 10.1210/jc.2008-2751; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Wagenknecht LE, 2003, DIABETES, V52, P2490, DOI 10.2337/diabetes.52.10.2490; Wagenknecht Lynne E., 1995, Annals of Epidemiology, V5, P464, DOI 10.1016/1047-2797(95)00062-3; Wang Y, 2000, DIABETES, V49, pA204; Watanabe RM, 2007, DIABETES, V56, P1481, DOI 10.2337/db06-1682; Xiang AH, 2001, CIRCULATION, V103, P78; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401	53	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0134649	10.1371/journal.pone.0134649	http://dx.doi.org/10.1371/journal.pone.0134649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599207	Green Published, gold			2022-12-27	WOS:000365862600001
J	Haack, IA; Derkow, K; Riehn, M; Rentinck, MN; Kuhl, AA; Lehnardt, S; Schott, E				Haack, Ira An; Derkow, Katja; Riehn, Mathias; Rentinck, Marc-Nicolas; Kuehl, Anja A.; Lehnardt, Seija; Schott, Eckart			The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis	PLOS ONE			English	Article							SINUSOIDAL ENDOTHELIAL-CELLS; DENDRITIC CELLS; KUPFFER CELLS; LIVER; ACTIVATION; ANTIGEN; MICE; INDUCTION; HEPATOCYTES; IMMUNITY	Background The role of regulatory CD4 T cells (Treg) in immune-mediated liver disease is still under debate. It remains disputed whether Treg suppress T cell-mediated hepatitis in vivo and whether hepatic regulatory T cells are functional in patients with autoimmune hepatitis. Methods We used TF-OVA mice, which express ovalbumin in hepatocytes, to investigate the impact of Treg in a model of autoimmune hepatitis. Treg isolated from inflamed livers of TF-OVA mice were tested for their functionality in vitro. By employing double transgenic TF-OVAxDEREG (DEpletion of REGulatory T cells) mice we analyzed whether Treg-depletion aggravates autoimmune inflammation in the liver in vivo. Results CD25+ Foxp3+ CD4 T cells accumulated in the liver in the course of CD8 T cell-mediated hepatitis. Treg isolated from inflamed livers were functional to suppress CD8 T-cell proliferation in vitro. Depletion of Treg in TF-OVAxDEREG mice dramatically amplified T cell-mediated hepatitis. Repeated administration of antigen-specific CD8 T cells led to a second wave of inflammation only after depletion of Treg. Conclusion Our data add to the evidence for an important role of Treg in autoimmune hepatitis and show that Treg reduce the severity of T-cell mediated hepatitis in vivo. They constitute a key immune cell population that actively maintains a tolerogenic milieu in the liver and protects the liver against repeated inflammatory challenges.	[Haack, Ira An; Rentinck, Marc-Nicolas; Schott, Eckart] Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; [Derkow, Katja; Lehnardt, Seija] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Riehn, Mathias] Helmholtz Ctr Infect Res Braunschweig, Model Syst Infect & Immun, Braunschweig, Germany; [Kuehl, Anja A.] Charite, Res Ctr ImmunoSci, Dept Med Gastroenterol Infect Dis & Rheumatol 1, D-13353 Berlin, Germany; [Lehnardt, Seija] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Lehnardt, Seija] Charite, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schott, E (corresponding author), Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany.	eckart.schott@charite.de	Lehnardt, Seija/AAA-4113-2022	Riehn, Mathias/0000-0001-8737-5566; Kuhl, Anja/0000-0003-2293-5387	Deutsche Forschungsgemeinschaft [SFB633]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The project was funded by the Deutsche Forschungsgemeinschaft, SFB633. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; Bertolino P, 2001, J IMMUNOL, V166, P5430, DOI 10.4049/jimmunol.166.9.5430; BERTOLINO P, 1995, EUR J IMMUNOL, V25, P1932, DOI 10.1002/eji.1830250721; Bochtler P, 2008, HEPATOLOGY, V48, P1954, DOI 10.1002/hep.22559; Bottcher JP, 2013, CELL REP, V3, P779, DOI 10.1016/j.celrep.2013.02.008; Burghardt S, 2013, J IMMUNOL, V191, P5574, DOI 10.4049/jimmunol.1300826; Carambia A, 2014, J HEPATOL, V61, P594, DOI 10.1016/j.jhep.2014.04.027; de Boer YS, 2014, GASTROENTEROLOGY, V147, P443, DOI 10.1053/j.gastro.2014.04.022; Derkow K, 2007, HEPATOLOGY, V46, P1155, DOI 10.1002/HEP.21796; Derkow K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021847; Dunham RM, 2013, J IMMUNOL, V190, P2009, DOI 10.4049/jimmunol.1201937; Erhardt A, 2007, HEPATOLOGY, V45, P475, DOI 10.1002/hep.21498; Foureau DM, 2014, CLIN EXPT IMMUNOLOGY; Grant CR, 2014, HEPATOLOGY, V59, P1007, DOI 10.1002/hep.26583; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Kido M, 2008, GASTROENTEROLOGY, V135, P1333, DOI 10.1053/j.gastro.2008.06.042; Kondo Y, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/810939; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; Kruse N, 2009, HEPATOLOGY, V50, P1904, DOI 10.1002/hep.23191; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lapierre P, 2013, HEPATOLOGY, V57, P217, DOI 10.1002/hep.26023; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Liu H, 2013, TRANSPL P, V45, P1853, DOI 10.1016/j.transproceed.2013.03.015; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Longhi MS, 2005, J AUTOIMMUN, V25, P63, DOI 10.1016/j.jaut.2005.05.001; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Luth S, 2008, J CLIN INVEST, V118, P3403, DOI 10.1172/JCI32132; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Oo YH, 2010, J IMMUNOL, V184, P2886, DOI 10.4049/jimmunol.0901216; Peiseler M, 2012, J HEPATOL, V57, P125, DOI 10.1016/j.jhep.2012.02.029; Plitas G, 2008, HEPATOLOGY, V47, P1343, DOI 10.1002/hep.22167; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Stross L, 2012, HEPATOLOGY, V56, P873, DOI 10.1002/hep.25765; Taubert R, 2014, J HEPATOL, V61, P1106, DOI 10.1016/j.jhep.2014.05.034; Tay SS, 2014, J IMMUNOL, V193, P2087, DOI 10.4049/jimmunol.1400037; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Vergani D, 2008, WORLD J GASTROENTERO, V14, P3306, DOI 10.3748/wjg.14.3306; Wei HX, 2008, J IMMUNOL, V181, P7221, DOI 10.4049/jimmunol.181.10.7221; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Wuensch SA, 2006, J IMMUNOL, V177, P1689, DOI 10.4049/jimmunol.177.3.1689; Wuensch SA, 2010, HEPATOLOGY, V52, P1068, DOI 10.1002/hep.23745; You Q, 2008, HEPATOLOGY, V48, P978, DOI 10.1002/hep.22395; Zierden M, 2010, GASTROENTEROLOGY, V139, P975, DOI 10.1053/j.gastro.2010.05.075	48	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143715	10.1371/journal.pone.0143715	http://dx.doi.org/10.1371/journal.pone.0143715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599014	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600109
J	Hu, XS; Zhang, L; Shi, YK; Zhou, CC; Liu, XQ; Wang, D; Song, Y; Li, Q; Feng, JF; Qin, SK; Xv, N; Zhou, JY; Zhang, L; Hu, CH; Zhang, SC; Luo, RC; Wang, J; Tan, FL; Wang, YX; Ding, LM; Sun, Y				Hu, Xingsheng; Zhang, Li; Shi, Yuankai; Zhou, Caicun; Liu, Xiaoqing; Wang, Dong; Song, Yong; Li, Qiang; Feng, Jifeng; Qin, Shukui; Xv, Nong; Zhou, Jianying; Zhang, Li; Hu, Chunhong; Zhang, Shucai; Luo, Rongcheng; Wang, Jie; Tan, Fenlai; Wang, Yinxiang; Ding, Lieming; Sun, Yan			The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study	PLOS ONE			English	Article							OPEN-LABEL; 1ST-LINE TREATMENT; PHASE-IV; ERLOTINIB; GEFITINIB; TRIAL; ADENOCARCINOMA; INHIBITORS; MUTATIONS; THERAPY	Background Icotinib is a small molecule targeting epidermal growth factor receptor tyrosine kinase, which shows non-inferior efficacy and better safety comparing to gefitinib in previous phase III trial. The present study was designed to further evaluate the efficacy and safety of icotinib in patients with advanced non-small-cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy. Methods Patients with NSCLC progressing after one or two lines of chemotherapy were enrolled to receive oral icotinib (125mg tablet, three times per day). The primary endpoint was progression-free survival. The secondary endpoints included overall survival, objective response rate, time to progression, quality of life and safety. Results From March 16, 2010 to October 9, 2011, 128 patients from 15 centers nationwide were enrolled, in which 124 patients were available for efficacy evaluation and 127 patients were evaluable for safety. The median progression-free survival and time to progression were 5.0 months (95% CI 2.9-6.6 m) and 5.4 months (95% CI 3.1-7.9 m), respectively. The objective response rate and disease control rate were 25.8% and 67.7% respectively. Median overall survival exceeded 17.6 months (95% CI 14.2 m-NA) according to censored data. Further follow-up of overall survival is ongoing. The most frequent treatment-related adverse events were rash (26%, 33/127), diarrhea (12.6%, 16/127) and elevation of transaminase (15.7%, 20/127). Conclusions In general, this study showed similar efficacy and numerically better safety when compared with that in ICOGEN trial, further confirming the efficacy and safety of icotinib in treating patients with advanced NSCLC previously treated with chemotherapy. Trial Registration ClinicalTrials.gov NCT02486354	[Hu, Xingsheng; Shi, Yuankai; Sun, Yan] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Hu, Xingsheng; Shi, Yuankai; Sun, Yan] Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing 100021, Peoples R China; [Zhang, Li] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Caicun] Tongji Univ, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; [Liu, Xiaoqing] Acad Mil Med Sci, Dept Pulm Oncol, Ctr Canc, Hosp 307, Beijing, Peoples R China; [Wang, Dong] Third Mil Med Univ Peoples Liberat Army, Affiliated Hosp 3, Chongqing, Peoples R China; [Song, Yong] Nanjing Mil Gen Hosp, Nanjing, Jiangsu, Peoples R China; [Li, Qiang] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China; [Feng, Jifeng] Jiangsu Prov Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Qin, Shukui] Nanjing Bayi Hosp Peoples Liberat Army, Nanjing, Jiangsu, Peoples R China; [Xv, Nong; Zhou, Jianying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Li] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Hu, Chunhong] Second Xiangya Hosp, Changsha, Hunan, Peoples R China; [Zhang, Shucai] Capital Med Univ, Beijing TB & Thorac Tumor Res Inst, Beijing Chest Hosp, Beijing, Peoples R China; [Luo, Rongcheng] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Jie] Beijing Canc Hosp, Beijing, Peoples R China; [Tan, Fenlai; Wang, Yinxiang; Ding, Lieming] Betta Pharmaceut Co Ltd, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sun Yat Sen University; Tongji University; Academy of Military Medical Sciences - China; Naval Medical University; Nanjing Medical University; Nanjing University of Chinese Medicine; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; Southern Medical University - China; Peking University	Sun, Y (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China.	suny@csco.org.cn			Betta Pharmaceuticals Co, Ltd.	Betta Pharmaceuticals Co, Ltd.	This study was funded by Betta Pharmaceuticals Co, Ltd. The funder provided funding and organizational support and collected the data, and also provided support in the form of salaries for authors [Fenlai Tan, Yinxiang Wang, and Lieming Ding], the specific roles of these authors are articulated in the 'author contributions' section.	CELLA DF, 1995, LUNG CANCER-J IASLC, V12, P199, DOI 10.1016/0169-5002(95)00450-F; Cersosimo RJ, 2006, EXPERT OPIN DRUG SAF, V5, P469, DOI 10.1517/14740338.5.3.469; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Cohen MH, 2005, ONCOLOGIST, V10, P461, DOI 10.1634/theoncologist.10-7-461; Gemma Akihiko, 2009, Journal of Nippon Medical School, V76, P4; Heigener DF, 2011, LUNG CANCER, V74, P274, DOI 10.1016/j.lungcan.2011.02.017; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hu SJ, 2012, BIOORG MED CHEM LETT, V22, P6301, DOI 10.1016/j.bmcl.2012.06.067; Hu XS, 2014, LUNG CANCER, V86, P207, DOI 10.1016/j.lungcan.2014.08.014; KIM ES, 2008, GEFITINIB VERSUS DOC, V372, P1809; Maemondo M, 2012, J THORAC ONCOL, V7, P1417, DOI 10.1097/JTO.0b013e318260de8b; Makris D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-150; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nguyen KSH, 2012, BIOL-TARGETS THER, V6, P337, DOI 10.2147/BTT.S26558; Reck M, 2010, J THORAC ONCOL, V5, P1616, DOI 10.1097/JTO.0b013e3181f1c7b0; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shi YK, 2013, LANCET ONCOL, V14, P953, DOI 10.1016/S1470-2045(13)70355-3; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Tsuboi M, 2006, MED ONCOL, V23, P161, DOI 10.1385/MO:23:2:161; Wang HP, 2011, CHINESE MED J-PEKING, V124, P1933, DOI 10.3760/cma.j.issn.0366-6999.2011.13.003; Yang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057528; Zhao QO, 2011, LUNG CANCER, V73, P195, DOI 10.1016/j.lungcan.2010.11.007; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	26	8	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142500	10.1371/journal.pone.0142500	http://dx.doi.org/10.1371/journal.pone.0142500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599904	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600011
J	Lagana, A; Veneziano, D; Spata, T; Tang, R; Zhu, H; Mohler, PJ; Kilic, A				Lagana, Alessandro; Veneziano, Dario; Spata, Tyler; Tang, Richard; Zhu, Hua; Mohler, Peter J.; Kilic, Ahmet			Identification of General and Heart-Specific miRNAs in Sheep (Ovis aries)	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; TARGETED DELETION; MIR-17-92 CLUSTER; ANIMAL-MODELS; EMERGING ROLE; MICRORNAS; EXPRESSION; BIOGENESIS; EVOLUTION; DYSREGULATION	MicroRNAs (miRNAs or miRs) are small regulatory RNAs crucial for modulation of signaling pathways in multiple organs. While the link between miRNAs and heart disease has grown more readily apparent over the past three years, these data are primarily limited to small animal models or cell-based systems. Here, we performed a high-throughput RNA sequencing (RNAseq) analysis of left ventricle and other tissue from a pre-clinical ovine model. We identified 172 novel miRNA precursors encoding a total of 264 mature miRNAs. Notably, 84 precursors were detected in both the left ventricle and other tissues. However, 10 precursors, encoding 11 mature sequences, were specific to the left ventricle. Moreover, the total 168 novel miRNA precursors included 22 non-conserved ovine-specific sequences. Our data identify and characterize novel miRNAs in the left ventricle of sheep, providing fundamental new information for our understanding of protein regulation in heart and other tissues.	[Lagana, Alessandro; Veneziano, Dario] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Veneziano, Dario] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Spata, Tyler; Tang, Richard; Zhu, Hua; Kilic, Ahmet] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Dept Internal Med, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Catania; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lagana, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	alessandro.lagana@mssm.edu; ahmet.kilic@osumc.edu		Zhu, Hua/0000-0001-7136-7326				Abdellatif M, 2010, CIRC RES, V106, P16, DOI 10.1161/CIRCRESAHA.109.212183; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreassen R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-482; Barozai MYK, 2012, MOL BIOL REP, V39, P6259, DOI 10.1007/s11033-012-1446-x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Carmi S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002317; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chistiakov DA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/354517; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Danielson LS, 2013, FASEB J, V27, P1460, DOI 10.1096/fj.12-221994; de Wit E, 2009, GENOME RES, V19, P2064, DOI 10.1101/gr.093781.109; Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Dixon JA, 2009, CIRC-HEART FAIL, V2, P262, DOI 10.1161/CIRCHEARTFAILURE.108.814459; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedlander MR, 2008, NAT BIOTECHNOL; Friedlander MR, 2012, NUCLEIC ACIDS RES, P40; Galio L, 2013, PHYSIOL GENOMICS, V45, P151, DOI 10.1152/physiolgenomics.00091.2012; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Han MY, 2012, CARDIOVASC RES, V93, P645, DOI 10.1093/cvr/cvs001; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Kim W, 2011, HEART VESSELS, V26, P342, DOI 10.1007/s00380-010-0022-3; Kim WG, 2003, INT J ARTIF ORGANS, V26, P1; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krombach GA, 2005, INVEST RADIOL, V40, P14; Lagana Alessandro, 2010, J RNAi Gene Silencing, V6, P379; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li C, 2013, BMC MED GENOMICS, P6; Li M, 2010, PLOS ONE; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li SC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S14; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Liu XJ, 2015, CELL METAB, V21, P584, DOI 10.1016/j.cmet.2015.02.014; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; Locatelli Paola, 2011, ILAR J, V52, pE16; Mahon NG, 2004, J CARD FAIL, V10, P273, DOI 10.1016/j.cardfail.2003.11.001; Marco A, 2012, SILENCE, V3, P3, DOI [10.1186/1758-907X-3-3, DOI 10.1186/1758-907X-3-3]; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; McGahon MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065809; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Metpally Raghu Prasad Rao, 2013, Frontiers in Genetics, V4, P20, DOI 10.3389/fgene.2013.00020; Moainie SL, 2002, ANN THORAC SURG, V74, P753, DOI 10.1016/S0003-4975(02)03827-4; Monnet E, 2005, ANN THORAC SURG, V79, P1445, DOI 10.1016/j.athoracsur.2004.04.002; Muroya S, 2013, J ANIMAL; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Oliveira-Carvalho V, 2013, DNA CELL BIOL, V32, P8, DOI 10.1089/dna.2012.1787; Oz MC, 2001, J CARD FAIL, V7, P18, DOI 10.1054/jcaf.2001.26654; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Sheng XH, 2011, MOL BIOL REP, V38, P3161, DOI 10.1007/s11033-010-9987-3; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Spata T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/938047; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Vacchi-Suzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052442; Vacchi-Suzzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040395; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang XH, 2014, CARDIOVASC RES, V102, P385, DOI 10.1093/cvr/cvu044; WEAVER ME, 1986, CARDIOVASC RES, V20, P907, DOI 10.1093/cvr/20.12.907; Wei Z, 2011, INT J BIOL SCI; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Wong SSY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036121; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018	88	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143313	10.1371/journal.pone.0143313	http://dx.doi.org/10.1371/journal.pone.0143313			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599010	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600049
J	Liang, WH; Fang, L; Xiang, D; Hu, Y; Feng, H; Chang, LJ; Zhang, TZ				Liang, Wenhua; Fang, Lei; Xiang, Dan; Hu, Yan; Feng, Hao; Chang, Lijing; Zhang, Tianzhen			Transcriptome Analysis of Short Fiber Mutant Ligon lintless-1 (Li-1) Reveals Critical Genes and Key Pathways in Cotton Fiber Elongation and Leaf Development	PLOS ONE			English	Article							CELL ELONGATION; MOLECULAR CHARACTERIZATION; IN-VITRO; EXPRESSION; WALL; GROWTH; TEMPERATURE; GENOMICS; KINETICS; ETHYLENE	For efficient spinning and superior fabric production, long fiber length is a desired trait for cotton production. To unveil the molecular basis of the cotton fiber length regulation, a short fiber mutant, Ligon lintless-1 (Li-1), is selected to compare with its corresponding wild type (WT). Li-1 is a monogenic dominant cotton mutant causing extremely short fibers (<6mm) on mature seeds with visible pleiotropic effects on vegetative growth and development. In this research, we compared the transcriptome of fiber bearing ovules at 1 DPA, 3 DPA, 8 DPA and leaf between Li1 mutant and WT. A total of 7,852 differentially expressed genes (DEGs) were detected in ovules and leaves, which mainly participated in sugar, secondary metabolite and lipid metabolism pathways based on KEGG analysis. The common DEGs at 1 DPA and 3 DPA were involved in the responses to endogenous stimulus, signal transduction and long-chain fatty acid biosynthesis. For 3 DPA, 8 DPA and leaf, the common DEGs were involved in the responses to auxin and receptor kinases related pathway. Further analysis showed that 37 genes involved in very-long-chain fatty acid biosynthesis were suppressed in Li1 mutant during fiber fast elongation development. Most of the DEGs involved in cell wall metabolism, such cellulose synthase, expansin family, and glycosyl hydrolase were differentially expressed at 3 DPA and 8 DPA. Our results provide new insights into the mechanisms of fiber elongation, and offer novel genes as potential objects for fiber length improvement.	[Liang, Wenhua; Fang, Lei; Xiang, Dan; Hu, Yan; Feng, Hao; Chang, Lijing; Zhang, Tianzhen] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Cotton Hybrid R&D Engn Ctr, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, TZ (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Cotton Hybrid R&D Engn Ctr, Nanjing 210095, Jiangsu, Peoples R China.	cotton@njau.edu.cn			Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 program; JCIC-MCP project	Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 program(Ministry of Education, China - 111 Project); JCIC-MCP project	This work was financially supported in part by grants from the Priority Academic Program Development of Jiangsu Higher Education Institutions, the 111 program, and the JCIC-MCP project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CF, 2007, MOL GENET GENOMICS, V278, P539, DOI 10.1007/s00438-007-0270-9; Andrews S., 2010, FASTQC QUALITY CONTR; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Basra AS, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P47; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Bolton JJ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/659301; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Davidonis GH, 2004, AGRON J, V96, P42, DOI 10.2134/agronj2004.0042; Ding MQ, 2014, GENE, V535, P273, DOI 10.1016/j.gene.2013.11.017; Gilbert MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095554; Gilbert MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-403; GORDON A., 2011, FASTX TOOLKIT COMPUT; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Hamann T, 2009, PLANT J, V57, P1015, DOI 10.1111/j.1365-313X.2008.03744.x; He XC, 2008, J EXP BOT, V59, P2687, DOI 10.1093/jxb/ern127; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Hinchliffe DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-445; Hinchliffe DJ, 2011, CROP SCI, V51, P1683, DOI 10.2135/cropsci2010.10.0569; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; JENSEN WA, 1968, PLANTA, V79, P346, DOI 10.1007/BF00386917; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karaca M, 2002, J HERED, V93, P221, DOI 10.1093/jhered/93.3.221; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; KOHEL RJ, 1992, CROP SCI, V32, P733, DOI 10.2135/cropsci1992.0011183X003200030031x; KOHEL RJ, 1972, CROP SCI, V12, P66, DOI 10.2135/cropsci1972.0011183X001200010022x; KOHEL RJ, 1974, CROP SCI, V14, P471, DOI 10.2135/cropsci1974.0011183X001400030040x; KOHEL RJ, 1993, CROP SCI, V33, P1036, DOI 10.2135/cropsci1993.0011183X003300050032x; Kunst L, 2000, BIOCHEM SOC T, V28, P651, DOI 10.1042/BST0280651; Lassner MW, 1996, PLANT CELL, V8, P281, DOI 10.1105/tpc.8.2.281; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee J, 2010, PLANTA, V232, P1191, DOI 10.1007/s00425-010-1246-2; Li L, 2007, J EXP BOT, V58, P3227, DOI 10.1093/jxb/erm167; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Li YL, 2003, SCI CHINA SER C, V46, P235, DOI 10.1360/03yc9025; Liakatas A, 1998, J AGR SCI-CAMBRIDGE, V130, P463, DOI 10.1017/S0021859698005413; Liu K, 2012, GENOMICS, V100, P42, DOI 10.1016/j.ygeno.2012.04.007; Ma JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049244; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; NAITHANI SC, 1982, PHYSIOL PLANTARUM, V54, P225, DOI 10.1111/j.1399-3054.1982.tb06330.x; Naoumkina M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-155; NARBUTH EV, 1990, J HERED, V81, P131; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Rong JK, 2005, THEOR APPL GENET, V111, P1137, DOI 10.1007/s00122-005-0041-0; SCHUBERT AM, 1973, CROP SCI, V13, P704, DOI 10.2135/cropsci1973.0011183X001300060035x; SCHUBERT AM, 1976, CROP SCI, V16, P539, DOI 10.2135/cropsci1976.0011183X001600040026x; SEAGULL RW, 1986, CAN J BOT, V64, P1373, DOI 10.1139/b86-188; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; THAKER VS, 1989, FIELD CROP RES, V22, P129, DOI 10.1016/0378-4290(89)90063-4; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thyssen GN, 2014, THEOR APPL GENET, V127, P2183, DOI 10.1007/s00122-014-2372-1; TIWARI SC, 1995, CAN J BOT, V73, P746, DOI 10.1139/b95-081; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; WILLISON JHM, 1977, PROTOPLASMA, V92, P21, DOI 10.1007/BF01280198; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t	60	13	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143503	10.1371/journal.pone.0143503	http://dx.doi.org/10.1371/journal.pone.0143503			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600249	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600074
J	Lyons, C; Raustad, N; Bustos, MA; Shiaris, M				Lyons, Casandra; Raustad, Nicole; Bustos, Mario A.; Shiaris, Michael			Incidence of Type II CRISPR1-Cas Systems in Enterococcus Is Species-Dependent	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPLETE GENOME SEQUENCE; CAS SYSTEMS; PATHOGENICITY ISLAND; IMMUNE-SYSTEM; FAECALIS; FAECIUM; CASSELIFLAVUS; RESISTANCE; VIRULENCE	CRISPR-Cas systems, which obstruct both viral infection and incorporation of mobile genetic elements by horizontal transfer, are a specific immune response common to prokaryotes. Antiviral protection by CRISPR-Cas comes at a cost, as horizontally-acquired genes may increase fitness and provide rapid adaptation to habitat change. To date, investigations into the prevalence of CRISPR have primarily focused on pathogenic and clinical bacteria, while less is known about CRISPR dynamics in commensal and environmental species. We designed PCR primers and coupled these with DNA sequencing of products to detect and characterize the presence of cas1, a universal CRISPR-associated gene and proxy for the Type II CRISPR1-Cas system, in environmental and non-clinical Enterococcus isolates. CRISPR1-cas1 was detected in approximately 33% of the 275 strains examined, and differences in CRISPR1 carriage between species was significant. Incidence of cas1 in E. hirae was 73%, nearly three times that of E. faecalis (23.6%) and 10 times more frequent than in E. durans (7.1%). Also, this is the first report of CRISPR1 presence in E. durans, as well as in the plant-associated species E. casseliflavus and E. sulfureus. Significant differences in CRISPR1-cas1 incidence among Enterococcus species support the hypothesis that there is a tradeoff between protection and adaptability. The differences in the habitats of enterococcal species may exert varying selective pressure that results in a species-dependent distribution of CRISPR-Cas systems.	[Lyons, Casandra; Raustad, Nicole; Bustos, Mario A.; Shiaris, Michael] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	Shiaris, M (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	michael.shiaris@umb.edu		Lyons, Casandra/0000-0002-6900-0311	National Science Foundation [IOS -0847691 8]; National Science Foundation Research Experiences for Undergraduates [DBI-1062748]; National Institutes of Health Bridges to Baccalaureate Program [2R25GM075306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075306] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Research Experiences for Undergraduates(National Science Foundation (NSF)); National Institutes of Health Bridges to Baccalaureate Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (IOS -0847691 8) (http://www.nsf.gov), the National Science Foundation Research Experiences for Undergraduates (DBI-1062748) (http://www.nsf.gov), and the National Institutes of Health Bridges to the Baccalaureate Program (2R25GM075306) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; BLAIMONT B, 1995, MICROB ECOL HEALTH D, V8, P87, DOI 10.3109/08910609509140084; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Burley KM, 2012, J ENDODONT, V38, P1511, DOI 10.1016/j.joen.2012.07.004; Devriese LA, 2002, J APPL MICROBIOL, V92, P821, DOI 10.1046/j.1365-2672.2002.01586.x; Duerkop B.A., 2014, ENTEROCOCCI COMMENSA; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garcia-Gutierrez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131935; Gilmore MS, 2013, CURR OPIN MICROBIOL, V16, P10, DOI 10.1016/j.mib.2013.01.006; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Halliday E, 2011, ENVIRON SCI TECHNOL, V45, P370, DOI 10.1021/es102747s; Holzel C, 2014, MICROB DRUG RESIST, V20, P177, DOI 10.1089/mdr.2013.0108; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Katyal I, 2013, MICROB ECOL, V66, P182, DOI 10.1007/s00248-013-0217-0; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Lebreton F, 2013, MBIO, V4, DOI 10.1128/mBio.00534-13; Levin BR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001171; Lindenstrauss AG, 2011, SYST APPL MICROBIOL, V34, P553, DOI 10.1016/j.syapm.2011.05.002; Liu Y, 2014, VET MICROBIOL, V170, P352, DOI 10.1016/j.vetmic.2014.02.037; Low JR, 2015, EYE; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Magni C, 2012, J BACTERIOL, V194, P550, DOI 10.1128/JB.06415-11; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MARTINEZMURCIA AJ, 1991, FEMS MICROBIOL LETT, V80, P69; MUNDT JO, 1968, J BACTERIOL, V95, P2005, DOI 10.1128/JB.95.6.2005-2009.1968; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Narciso-Schiavon JL, 2015, ANN HEPATOL, V14, P270, DOI 10.1016/S1665-2681(19)30791-4; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Palmer KL, 2010, CURR OPIN MICROBIOL, V13, P632, DOI 10.1016/j.mib.2010.08.004; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pieniz S, 2015, FOOD CONTROL, V51, P49, DOI 10.1016/j.foodcont.2014.11.012; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Rozen S, 2000, Methods Mol Biol, V132, P365; Santagati M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00095; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shiwa Y, 2014, DNA RES, V21, P369, DOI 10.1093/dnares/dsu003; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; VAUGHAN DH, 1979, INT J SYST BACTERIOL, V29, P204, DOI 10.1099/00207713-29-3-204; Yasuda M, 2010, WATER RES, V44, P3982, DOI 10.1016/j.watres.2010.05.007	47	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143544	10.1371/journal.pone.0143544	http://dx.doi.org/10.1371/journal.pone.0143544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600384	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600081
J	Tsai, CC; Wu, SB; Chang, PC; Wei, YH				Tsai, Chieh-Chih; Wu, Shi-Bei; Chang, Pei-Chen; Wei, Yau-Huei			Alteration of Connective Tissue Growth Factor (CTGF) Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy	PLOS ONE			English	Article							THYROID-ASSOCIATED OPHTHALMOPATHY; OXIDATIVE STRESS; FIBROSIS; CELLS; PATHOGENESIS; INDUCTION; INSIGHTS; COLLAGEN; INDUCER	Graves' ophthalmopathy (GO) is a disfiguring and sometimes blinding disease, which is characterized by inflammation and swelling of orbital tissues, with fibrosis and adipogenesis being predominant features. The aim of this study is to investigate whether the expression levels of fibrosis-related genes, especially that of connective tissue growth factor (CTGF), are altered in orbital fibroblasts of patients with GO. The role of oxidative stress in the regulation of CTGF expression in GO orbital fibroblasts is also examined. By a SYBR Green-based real time quantitative PCR (RT-QPCR), we demonstrated that the mRNA expression levels of fibronectin, apolipoprotein J, and CTGF in cultured orbital fibroblasts from patients with GO were significantly higher than those of age-matched normal controls (p = 0.007, 0.037, and 0.002, respectively). In addition, the protein expression levels of fibronectin, apolipoprotein J, and CTGF analyzed by Western blot were also significantly higher in GO orbital fibroblasts (p = 0.046, 0.032, and 0.008, respectively) as compared with the control. Furthermore, after treatment of orbital fibroblasts with a sub-lethal dose of hydrogen peroxide (200 mu M H2O2), we found that the H2O2-induced increase of CTGF expression was more pronounced in the GO orbital fibroblasts as compared with those in normal controls (20% vs. 7%, p = 0.007). Importantly, pre-incubation with antioxidants including N-acetylcysteine (NAC) and vitamin C, respectively, resulted in significant attenuation of the induction of CTGF in GO orbital fibroblasts in response to H2O2 (p = 0.004 and 0.015, respectively). Taken together, we suggest that oxidative stress plays a role in the alteration of the expression of CTGF in GO orbital fibroblasts that may contribute to the pathogenesis and progression of GO. Antioxidants may be used in combination with the therapeutic agents for effective treatment of GO.	[Tsai, Chieh-Chih] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei 112, Taiwan; [Tsai, Chieh-Chih] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Wu, Shi-Bei; Wei, Yau-Huei] Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan; [Chang, Pei-Chen] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wei, Yau-Huei] Mackay Med Coll, Dept Med, New Taipei 252, Taiwan; [Wei, Yau-Huei] Mackay Med Coll, Inst Biomed Sci, New Taipei 252, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Medical College	Wei, YH (corresponding author), Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan.	joeman@ym.edu.tw	Wei, Yau-Huei/ABA-6841-2021; Tsai, Chieh-Chih/ABE-6364-2021; TMU, barry0110/AAV-4030-2021	Wei, Yau-Huei/0000-0002-6429-2546; Tsai, Chieh-Chih/0000-0002-4411-3387; 	Ministry of Science and Technology (MOST), Executive Yuan, Taiwan [MOST 103-2314-B-075-074, MOST 103-2321-B-715-001, MOST 104-2314-B-075 -056 -MY2]; Taipei Veterans General Hospital, Taiwan [V103-C-194]	Ministry of Science and Technology (MOST), Executive Yuan, Taiwan; Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This study was supported by grants (MOST 103-2314-B-075-074, MOST 103-2321-B-715-001, and MOST 104-2314-B-075 -056 -MY2) from the Ministry of Science and Technology (MOST), Executive Yuan, Taiwan to authors CCT and YHW. This study was also supported by grant (V103-C-194) from Taipei Veterans General Hospital, Taiwan to author CCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shady M, 2000, LIVER, V20, P296, DOI 10.1034/j.1600-0676.2000.020004296.x; Aragno M, 2008, ENDOCRINOLOGY, V149, P380, DOI 10.1210/en.2007-0877; Bartley GB, 1996, OPHTHALMOLOGY, V103, P958, DOI 10.1016/S0161-6420(96)30579-4; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Dammeier J, 1998, J BIOL CHEM, V273, P18185, DOI 10.1074/jbc.273.29.18185; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Folger PA, 2001, INVEST OPHTH VIS SCI, V42, P2534; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Guo P, 2006, J HYPERTENS, V24, P1097, DOI 10.1097/01.hjh.0000226200.73065.5d; Han R, 2005, J IMMUNOL, V174, P3072, DOI 10.4049/jimmunol.174.5.3072; He SK, 2008, INVEST OPHTH VIS SCI, V49, P4078, DOI 10.1167/iovs.07-1302; Hondur A, 2008, CURR EYE RES, V33, P421, DOI 10.1080/02713680802123532; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Iyer P, 2012, INVEST OPHTH VIS SCI, V53, P4952, DOI 10.1167/iovs.12-9681; Kazim M, 2002, ARCH OPHTHALMOL-CHIC, V120, P380; Kim H, 2010, INVEST OPHTH VIS SCI, V51, P3061, DOI 10.1167/iovs.09-4257; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8; LAWRENCE DA, 1995, KIDNEY INT, V47, pS19; Lin CS, 2012, INT J MOL SCI, V13, P11228, DOI 10.3390/ijms130911228; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Ma B, 2014, BIOCHEM BIOPH RES CO, V447, P689, DOI 10.1016/j.bbrc.2014.04.068; Marcocci C, 2011, NEW ENGL J MED, V364, P1920, DOI 10.1056/NEJMoa1012985; Matsuda S, 2006, JPN J OPHTHALMOL, V50, P229, DOI 10.1007/s10384-005-0317-6; Naik V, 2008, THYROID, V18, P967, DOI 10.1089/thy.2007.0403; Park SK, 2001, BIOCHEM BIOPH RES CO, V284, P966, DOI 10.1006/bbrc.2001.5058; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Shih MJ, 2006, J CLIN ENDOCR METAB, V91, P1159, DOI 10.1210/jc.2005-1877; Sisco M, 2008, WOUND REPAIR REGEN, V16, P661, DOI 10.1111/j.1524-475X.2008.00416.x; Smith TJ, 2005, CLIN EXP IMMUNOL, V141, P388, DOI 10.1111/j.1365-2249.2005.02824.x; Smith TJ, 2002, THYROID, V12, P197, DOI 10.1089/105072502753600133; Sobral LM, 2011, J PERIODONTOL, V82, P642, DOI 10.1902/jop.2010.100510; Tall EG, 2010, INVEST OPHTH VIS SCI, V51, P5002, DOI 10.1167/iovs.09-5110; Tsai CC, 2010, EYE, V24, P1520, DOI 10.1038/eye.2010.31; Tsai CC, 2009, EYE, V23, P1725, DOI 10.1038/eye.2008.310; Tsai CC, 2013, MOL VIS, V19, P927; Tsai CC, 2011, MOL VIS, V17, P2782; Yokoi H, 2001, AM J KIDNEY DIS, V38, pS134, DOI 10.1053/ajkd.2001.27422; Yoon JS, 2012, INVEST OPHTH VIS SCI, V53, P5921, DOI 10.1167/iovs.12-9646; Zarkovic M, 2012, J THROID RES, V2012, DOI 10.1155/2012/302537; Zhang JY, 2014, CURR EYE RES, V39, P53, DOI 10.3109/02713683.2013.833245; Zhao SX, 2011, J ENDOCRINOL, V210, P369, DOI 10.1530/JOE-11-0162	42	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143514	10.1371/journal.pone.0143514	http://dx.doi.org/10.1371/journal.pone.0143514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599235	Green Submitted, gold, Green Published			2022-12-27	WOS:000365862600078
J	Hall, CM; Busch, JD; Shippy, K; Allender, CJ; Kaestli, M; Mayo, M; Sahl, JW; Schupp, JM; Colman, RE; Keim, P; Currie, BJ; Wagner, DM				Hall, Carina M.; Busch, Joseph D.; Shippy, Kenzie; Allender, Christopher J.; Kaestli, Mirjam; Mayo, Mark; Sahl, Jason W.; Schupp, James M.; Colman, Rebecca E.; Keim, Paul; Currie, Bart J.; Wagner, David M.			Diverse Burkholderia Species Isolated from Soils in the Southern United States with No Evidence of B. pseudomallei	PLOS ONE			English	Article							CEPACIA COMPLEX; GENETIC DIVERSITY; MELIOIDOSIS; EPIDEMIOLOGY; IDENTIFICATION; AMPLIFICATION; THAILANDENSIS; SURVEILLANCE; CENOCEPACIA; INFECTION	The global distribution of the soil-dwelling bacterium Burkholderia pseudomallei, causative agent of melioidosis, is poorly understood. We used established culturing methods developed for B. pseudomallei to isolate Burkholderia species from soil collected at 18 sampling sites in three states in the southern United States (Arizona (n = 4), Florida (n = 7), and Louisiana (n = 7)). Using multi-locus sequence typing (MLST) of seven genes, we identified 35 Burkholderia isolates from these soil samples. All species belonged to the B. cepacia complex (Bcc), including B. cenocepacia, B. cepacia, B. contaminans, B. diffusa, B. metallica, B. seminalis, B. vietnamiensis and two unnamed members of the Bcc. The MLST analysis provided a high level of resolution among and within these species. Despite previous clinical cases within the U.S. involving B. pseudomallei and its close phylogenetic relatives, we did not isolate any of these taxa. The Bcc contains a number of opportunistic pathogens that cause infections in cystic fibrosis patients. Interestingly, we found that B. vietnamiensis was present in soil from all three states, suggesting it may be a common component in southern U.S. soils. Most of the Burkholderia isolates collected in this study were from Florida (30/35; 86%), which may be due to the combination of relatively moist, sandy, and acidic soils found there compared to the other two states. We also investigated one MLST gene, recA, for its ability to identify species within Burkholderia. A 365bp fragment of recA recovered nearly the same species-level identification as MLST, thus demonstrating its cost effective utility when conducting environmental surveys for Burkholderia. Although we did not find B. pseudomallei, our findings document that other diverse Burkholderia species are present in soils in the southern United States.	[Hall, Carina M.; Busch, Joseph D.; Shippy, Kenzie; Allender, Christopher J.; Sahl, Jason W.; Keim, Paul; Wagner, David M.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Kaestli, Mirjam; Mayo, Mark; Currie, Bart J.] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Schupp, James M.; Colman, Rebecca E.; Keim, Paul] Translat Genom Res Inst, Flagstaff, AZ 86001 USA	Northern Arizona University; Charles Darwin University; Menzies School of Health Research; Translational Genomics Research Institute	Wagner, DM (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, 1395 S Knoles Dr, Flagstaff, AZ 86011 USA.	Dave.Wagner@nau.edu	Colman, Rebecca/AAI-2112-2019	Colman, Rebecca/0000-0002-6854-2100; , Jason/0000-0002-2497-0138; Wagner, David/0000-0003-2684-6007; , Mirjam/0000-0002-6053-5141	Chemical Biological Technologies Directorate from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency [HDTRA1-12-C-0066]	Chemical Biological Technologies Directorate from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency	This work was supported by the Chemical Biological Technologies Directorate contract HDTRA1-12-C-0066 to DMW from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency (www.dtra.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; [Anonymous], 1998, SOILDATA V 0 PROGR C; ASHDOWN LR, 1979, PATHOLOGY, V11, P293, DOI 10.3109/00313027909061954; Bachmann HS, 2003, PHARMACOGENETICS, V13, P759, DOI 10.1097/00008571-200312000-00006; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Baldwin A, 2005, J CLIN MICROBIOL, V43, P4665, DOI 10.1128/JCM.43.9.4665-4673.2005; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Biggins JB, 2012, J AM CHEM SOC, V134, P13192, DOI 10.1021/ja3052156; Birnie E, 2015, FUTURE MICROBIOL, V10, P275, DOI [10.2217/FMB.14.113, 10.2217/fmb.14.113]; Cesarini S, 2009, LETT APPL MICROBIOL, V49, P580, DOI 10.1111/j.1472-765X.2009.02709.x; Chantratita N, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000182; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; DELAMBALLERIE X, 1992, RES MICROBIOL, V143, P785, DOI 10.1016/0923-2508(92)90107-Y; Doker TJ, 2014, AM J TROP MED HYG, V91, P743, DOI 10.4269/ajtmh.14-0172; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Engelthaler DM, 2014, MBIO, V5, DOI 10.1128/mBio.01464-14; Engelthaler DM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001347; Environmental Systems Research Institute, 2013, ESRI ARCMAP; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; Gee JE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-54; GILLIS M, 1995, INT J SYST BACTERIOL, V45, P274, DOI 10.1099/00207713-45-2-274; Ginther JL, 2015, PLOS NEGLEC IN RPESS; Glass MB, 2009, AM J TROP MED HYG, V80, P1023, DOI 10.4269/ajtmh.2009.80.1023; Glass MB, 2006, INT J SYST EVOL MICR, V56, P2171, DOI 10.1099/ijs.0.63991-0; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Inglis TJJ, 2004, EPIDEMIOL INFECT, V132, P813, DOI 10.1017/s0950268804002663; Jacobs JL, 2008, APPL ENVIRON MICROB, V74, P3121, DOI 10.1128/AEM.01941-07; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kaestli M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000364; Lee YA, 2007, PHYTOPATHOLOGY, V97, P195, DOI 10.1094/PHYTO-97-2-0195; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002105; LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153; LiPuma JJ, 2003, SEMIN RESP CRIT CARE, V24, P681, DOI 10.1055/s-2004-815664; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Martina P, 2013, J CLIN MICROBIOL, V51, P339, DOI 10.1128/JCM.02500-12; Nei M, 2000, MOL EVOLUTION PHYLOG, Vxiv; NELSON MJK, 1986, APPL ENVIRON MICROB, V52, P383, DOI 10.1128/AEM.52.2.383-384.1986; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; O'Sullivan LA, 2005, LETT APPL MICROBIOL, V41, P8, DOI 10.1111/j.1472-765X.2005.01758.x; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; Price EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071647; Sarovich DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030789; Stewart T, 2011, EMERG INFECT DIS, V17, P1286, DOI 10.3201/eid1707.100661; Stopnisek N, 2014, ENVIRON MICROBIOL, V16, P1503, DOI 10.1111/1462-2920.12211; TABLAN OC, 1993, INFECT CONT HOSP EP, V14, P124, DOI 10.2307/30148474; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trung TT, 2011, T ROY SOC TROP MED H, V105, P346, DOI 10.1016/j.trstmh.2011.03.004; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Weisskopf L, 2011, APPL ENVIRON MICROB, V77, P7715, DOI 10.1128/AEM.05845-11; Wiersinga WJ, 2015, EMERG INFECT DIS, V21, P40, DOI 10.3201/eid2101.140762	56	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143254	10.1371/journal.pone.0143254	http://dx.doi.org/10.1371/journal.pone.0143254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600238	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900082
J	Li, RH; Jiang, XT; Jin, DH; Dhaubhadel, S; Bian, SM; Li, XY				Li, Ruihua; Jiang, Xiaotong; Jin, Donghao; Dhaubhadel, Sangeeta; Bian, Shaomin; Li, Xuyan			Identification of 14-3-3 Family in Common Bean and Their Response to Abiotic Stress	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; GENE FAMILY; COMPREHENSIVE ANALYSIS; ISOFORM SPECIFICITY; ARABIDOPSIS HOMOLOG; SIGNAL-TRANSDUCTION; DROUGHT TOLERANCE; ROOT-GROWTH; PROTEIN; RICE	14-3-3s are a class of conserved regulatory proteins ubiquitously found in eukaryotes, which play important roles in a variety of cellular processes including response to diverse stresses. Although much has been learned about 14-3-3s in several plant species, it remains unknown in common bean. In this study, 9 common bean 14-3-3s (PvGF14s) were identified by exhaustive data mining against the publicly available common bean genomic database. A phylogenetic analysis revealed that each predicted PvGF14 was clustered with two GmSGF14 paralogs from soybean. Both epsilon-like and non-epsilon classes of PvGF14s were found in common bean, and the PvGF14s belonging to each class exhibited similar gene structure. Among 9 PvGF14s, only 8 are transcribed in common bean. Expression patterns of PvGF14s varied depending on tissue type, developmental stage and exposure of plants to stress. A protein-protein interaction study revealed that PvGF14a forms dimer with itself and with other PvGF14 isoforms. This study provides a first comprehensive look at common bean 14-3-3 proteins, a family of proteins with diverse functions in many cellular processes, especially in response to stresses.	[Li, Ruihua; Jiang, Xiaotong; Jin, Donghao; Bian, Shaomin; Li, Xuyan] Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China; [Dhaubhadel, Sangeeta] Agr & Agri Food Canada, Southern Crop Protect & Food Res Ctr, London, ON, Canada	Jilin University; Agriculture & Agri Food Canada	Bian, SM (corresponding author), Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China.	shmbian@jlu.edu.cn; xuyanli@jlu.edu.cn			National Natural Science Foundation of China [31300253]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 31300253), http://www.nsfc.gov.cn/.	Aksamit A, 2005, PLANT CELL PHYSIOL, V46, P1635, DOI 10.1093/pcp/pci179; Alsterfjord M, 2004, PLANT CELL PHYSIOL, V45, P1202, DOI 10.1093/pcp/pch136; Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; BRANDT J, 1992, PLANT J, V2, P815, DOI 10.1046/j.1365-313X.1992.t01-18-00999.x; Campo S, 2012, J EXP BOT, V63, P983, DOI 10.1093/jxb/err328; Catala R, 2014, PLANT CELL, V26, P3326, DOI 10.1105/tpc.114.127605; Chang IF, 2009, PROTEOMICS, V9, P2967, DOI 10.1002/pmic.200800445; Chen F, 2006, DNA RES, V13, P53, DOI 10.1093/dnares/dsl001; Chen Q, 2015, PLANT CELL PHYSIOL, V56, P1144, DOI 10.1093/pcp/pcv038; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; DEVETTEN NC, 1994, PLANT PHYSIOL, V106, P1593, DOI 10.1104/pp.106.4.1593; Dobra J, 2015, PLANT SCI, V231, P52, DOI 10.1016/j.plantsci.2014.11.005; Ferl RJ, 2002, GENOME BIOL, V3; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Gokirmak T, 2010, CURR OPIN PLANT BIOL, V13, P527, DOI 10.1016/j.pbi.2010.06.001; HIRSCH S, 1992, FEBS LETT, V296, P222, DOI 10.1016/0014-5793(92)80384-S; Ho SL, 2013, PLANT MOL BIOL, V81, P347, DOI 10.1007/s11103-012-0006-z; JARILLO JA, 1994, PLANT MOL BIOL, V25, P693, DOI 10.1007/BF00029607; Jaspert N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00096; Kinoshita T, 2002, PLANT CELL PHYSIOL, V43, P1359, DOI 10.1093/pcp/pcf167; Kumar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123236; LAUGHNER B, 1994, PLANT PHYSIOL, V105, P1457, DOI 10.1104/pp.105.4.1457; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Li MY, 2012, PLANT CELL REP, V31, P369, DOI 10.1007/s00299-011-1172-1; Li XY, 2012, PLANT J, V71, P239, DOI 10.1111/j.1365-313X.2012.04986.x; Li XY, 2011, PLANTA, V233, P569, DOI 10.1007/s00425-010-1315-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LU GH, 1992, P NATL ACAD SCI USA, V89, P11490, DOI 10.1073/pnas.89.23.11490; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Paul AL, 2005, MOL BIOL CELL, V16, P1735, DOI 10.1091/mbc.E04-09-0839; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; Pedrosa A, 2003, THEOR APPL GENET, V106, P205, DOI 10.1007/s00122-002-1138-3; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Porcel R, 2006, MICROB ECOL, V52, P575, DOI 10.1007/s00248-006-9015-2; Rosenquist M, 2001, PLANT PHYSIOL, V127, P142, DOI 10.1104/pp.127.1.142; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 2002, PLANT MOL BIOL, V50, P1011, DOI 10.1023/A:1021289127519; Sehnke PC, 2002, PLANT CELL, V14, pS339, DOI 10.1105/tpc.010430; Shanko AV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1320, DOI 10.1023/B:BIRY.0000011653.46422.c3; Sun GL, 2011, FUNCT INTEGR GENOMIC, V11, P627, DOI 10.1007/s10142-011-0242-3; Sun XL, 2014, PLANT CELL PHYSIOL, V55, P99, DOI 10.1093/pcp/pct161; Swatek KN, 2011, J PROTEOME RES, V10, P4076, DOI 10.1021/pr200263m; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Tian FX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123225; van Kleeff PJM, 2014, J EXP BOT, V65, P5877, DOI 10.1093/jxb/eru338; Vysotskii DA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22672; Wang XQ, 2009, PROTEOMICS, V9, P4529, DOI 10.1002/pmic.200900062; Xu WF, 2006, ANN BOT-LONDON, V98, P965, DOI 10.1093/aob/mcl189; Xu WF, 2013, PLANT PHYSIOL, V163, P1817, DOI 10.1104/pp.113.224758; Xu WF, 2012, PLANT CELL ENVIRON, V35, P1393, DOI 10.1111/j.1365-3040.2012.02497.x; Yan JQ, 2004, PLANT CELL PHYSIOL, V45, P1007, DOI 10.1093/pcp/pch115; Yang XH, 2006, PLANT PHYSIOL, V142, P820, DOI 10.1104/pp.106.083642; Yang ZP, 2014, PLANT PHYSIOL BIOCH, V80, P121, DOI 10.1016/j.plaphy.2014.03.034; Yao Y, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1003, DOI 10.1134/S000629790709012X; Yao Y, 2007, J BIOCHEM MOL BIOL, V40, P349; Yuan SX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1328-4; Zhang ZT, 2010, J EXP BOT, V61, P3331, DOI 10.1093/jxb/erq155; Zhou HP, 2014, PLANT CELL, V26, P1166, DOI 10.1105/tpc.113.117069	62	19	23	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143280	10.1371/journal.pone.0143280	http://dx.doi.org/10.1371/journal.pone.0143280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599110	Green Published, gold			2022-12-27	WOS:000365853900084
J	McInnes, AM; Khoosal, A; Murrell, B; Merkle, D; Lacerda, M; Nyengera, R; Coetzee, JC; Edwards, LC; Ryan, PG; Rademan, J; van der Westhuizen, JJ; Pichegru, L				McInnes, Alistair M.; Khoosal, Arjun; Murrell, Ben; Merkle, Dagmar; Lacerda, Miguel; Nyengera, Reason; Coetzee, Janet C.; Edwards, Loyd C.; Ryan, Peter G.; Rademan, Johan; van der Westhuizen, Jan J.; Pichegru, Lorien			Recreational Fish-Finders-An Inexpensive Alternative to Scientific Echo-Sounders for Unravelling the Links between Marine Top Predators and Their Prey	PLOS ONE			English	Article							PENGUINS SPHENISCUS-DEMERSUS; SOUTH-AFRICA; ROBBEN ISLAND; SEABIRDS; SCHOOLS; INDICATORS; FISHERIES; ZONE	Studies investigating how mobile marine predators respond to their prey are limited due to the challenging nature of the environment. While marine top predators are increasingly easy to study thanks to developments in bio-logging technology, typically there is scant information on the distribution and abundance of their prey, largely due to the specialised nature of acquiring this information. We explore the potential of using single-beam recreational fish-finders (RFF) to quantify relative forage fish abundance and draw inferences of the prey distribution at a fine spatial scale. We compared fish school characteristics as inferred from the RFF with that of a calibrated scientific split-beam echo-sounder (SES) by simultaneously operating both systems from the same vessel in Algoa Bay, South Africa. Customized open-source software was developed to extract fish school information from the echo returns of the RFF. For schools insonified by both systems, there was close correspondence between estimates of mean school depth (R-2 = 0.98) and school area (R-2 = 0.70). Estimates of relative school density (mean volume backscattering strength; S-v) measured by the RFF were negatively biased through saturation of this system given its smaller dynamic range. A correction factor applied to the RFF-derived density estimates improved the comparability between the two systems. Relative abundance estimates using all schools from both systems were congruent at scales from 0.5 km to 18 km with a strong positive linear trend in model fit estimates with increasing scale. Although absolute estimates of fish abundance cannot be derived from these systems, they are effective at describing prey school characteristics and have good potential for mapping forage fish distribution and relative abundance. Using such relatively inexpensive systems could greatly enhance our understanding of predator-prey interactions.	[McInnes, Alistair M.; Ryan, Peter G.] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa; [Khoosal, Arjun] Univ Cape Town, Inst Infect Dis & Mol Med, Computat Biol Grp, ZA-7925 Cape Town, South Africa; [Murrell, Ben] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Merkle, Dagmar; Coetzee, Janet C.; Rademan, Johan; van der Westhuizen, Jan J.] Dept Agr Forestry & Fisheries, Branch Fisheries Management, Cape Town, South Africa; [Lacerda, Miguel] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Nyengera, Reason; Pichegru, Lorien] Nelson Mandela Metropolitan Univ, Dept Zool, DST NRF Ctr Excellence, Percy Fitzpatrick Inst African Ornithol, Port Elizabeth, South Africa; [Edwards, Loyd C.] Raggy Charters, Port Elizabeth, South Africa	National Research Foundation - South Africa; University of Cape Town; University of Cape Town; University of California System; University of California San Diego; University of Cape Town; National Research Foundation - South Africa; Nelson Mandela University	McInnes, AM (corresponding author), Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa.	amcinnes3@gmail.com	Murrell, Ben/AAM-1188-2021	Coetzee, Janet/0000-0002-2382-7815; Pichegru, Lorien/0000-0003-3815-9845; Murrell, Ben/0000-0002-0393-4445	Department of Science and Technology-National Research Foundation Centre of Excellence; African Penguin Species Champion project of the Charl van der Merwe Trust; Responsible Fisheries Alliance; Raggy Charters	Department of Science and Technology-National Research Foundation Centre of Excellence; African Penguin Species Champion project of the Charl van der Merwe Trust; Responsible Fisheries Alliance; Raggy Charters	This work was supported by the Department of Science and Technology-National Research Foundation Centre of Excellence grant to the Percy FitzPatrick Institute of African Ornithology at the University of Cape Town http://www.fitzpatrick.uct.ac.za/: AMM; The African Penguin Species Champion project of the Charl van der Merwe Trust: LP; and The Responsible Fisheries Alliance http://www.rfalliance.org.za/: LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Loyd C. Edwards is employed by Raggy Charters. Raggy Charters provided support in the form of salary for author LCE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Brierley AS, 2015, CURR BIOL, V25, P75, DOI 10.1016/j.cub.2014.10.062; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Coetzee J, 2000, AQUAT LIVING RESOUR, V13, P1, DOI 10.1016/S0990-7440(00)00139-X; Coetzee JC, 2008, AFR J MAR SCI, V30, P205, DOI 10.2989/AJMS.2008.30.2.1.551; Coetzee JC, 2010, CLAIM PICHEGRU MARIN; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377; Crawford RJM, 2006, BIOL CONSERV, V132, P119, DOI 10.1016/j.biocon.2006.03.019; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Foote KG, 1981, FISH RES, V1, P129, DOI [10.1016/0165-7836(81)90015-1, DOI 10.1016/0165-7836(81)90015-1]; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Harding AMA, 2007, ECOLOGY, V88, P2024, DOI 10.1890/06-1695.1; IUCN, IUCN RED LIST THREAT; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Korneliussen RJ, 2008, ICES J MAR SCI, V65, P982, DOI 10.1093/icesjms/fsn052; Lawson GL, 2001, ICES J MAR SCI, V58, P275, DOI 10.1006/jmsc.2000.1009; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Montevecchi WA, 1993, BIRDS MONITORS ENV C; Mori Y, 1998, J ZOOL, V245, P279, DOI 10.1111/j.1469-7998.1998.tb00102.x; PIATT JF, 1990, STUD AVIAN BIOL, V14, P36; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; Pichegru L, 2012, BIOL CONSERV, V156, P117, DOI 10.1016/j.biocon.2011.12.013; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; PIVORUNAS A, 1979, AM SCI, V67, P432; R Development Core Team, 2014, R LANG ENV STAT COMP; RICKLEFS RE, 1985, J ANIM ECOL, V54, P883, DOI 10.2307/4385; ROEL BA, 1991, S AFR J MARINE SCI, V11, P267, DOI 10.2989/025776191784287655; Ropert-Coudert Yan, 2000, Polar Bioscience, V13, P101; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Weill A, 1993, AQUAT LIVING RESOUR, V6, P255, DOI 10.1051/alr:1993026; Weller F, 2014, ECOL MODEL, V277, P38, DOI 10.1016/j.ecolmodel.2014.01.013; Wilson R.P., 1990, P181; Wilson RP, 2010, AQUAT BIOL, V8, P193, DOI 10.3354/ab00230; WILSON RP, 1986, ARDEA, V74, P211; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; WILSON RP, 1985, MAR ECOL PROG SER, V25, P219, DOI 10.3354/meps025219; Zeileis A, 2014, R PACKAGE ZOO	45	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0140936	10.1371/journal.pone.0140936	http://dx.doi.org/10.1371/journal.pone.0140936			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600300	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900010
J	Peng, M; Ding, YL; Yu, L; Deng, YL; Lai, WS; Hu, Y; Zhang, HW; Wu, XQ; Fan, H; Ding, H; Wu, YL; Tao, GS				Peng, Mei; Ding, Yiling; Yu, Ling; Deng, Yali; Lai, Weisi; Hu, Yun; Zhang, Hongwen; Wu, Xianqing; Fan, Hong; Ding, Hui; Wu, Yilin; Tao, Guangshi			Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm	PLOS ONE			English	Article							HYDATIDIFORM MOLE; MANAGEMENT; DIAGNOSIS; DISEASE; S-1; UFT	Although 5-fluorouracil (5-Fu) combination chemotherapy provides a satisfactory therapeutic response in patients with gestational trophoblastic neoplasms (GTNs), it has severe side effects. The current study analyzed the therapeutic effects and side effects of tegafur plus actinomycin D (Act-D) vs. 5-Fu plus Act-D for the treatment of GTNs based on controlled historical records. A total of 427 GTN cases that received tegafur and Act-D combination chemotherapy at the Second Xiangya Hospital of XiangYa Medical School between August 2003 and July 2013 were analyzed based on historical data. A total of 393 GTN cases that received 5-Fu plus Act-D between August 1993 and July 2003 at the same hospital were also analyzed, which constituted the control group. The therapeutic effects, toxicity and side effects after chemotherapy were compared between the groups. The overall response rate was 90.63% in the tegafur+Act-D group (tegafur group) and 92.37% in the 5-Fu+Act-D group (5-Fu group); these rates were not significantly different (P > 0.05). However, the incidence rates of myelosuppression (white blood cell decline), gastrointestinal reactions (nausea, vomiting, dental ulcer, and diarrhea), skin lesions and phlebitis were lower in the tegafur group than in the 5-Fu group (P < 0.05). The results of this study may provide useful data for the clinical application of tegafur in GTN treatment.	[Peng, Mei; Ding, Yiling; Yu, Ling; Deng, Yali; Lai, Weisi; Hu, Yun; Zhang, Hongwen; Wu, Xianqing; Fan, Hong; Ding, Hui; Wu, Yilin; Tao, Guangshi] Cent S Univ, Dept Obstet & Gynaecol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China	Central South University	Ding, YL (corresponding author), Cent S Univ, Dept Obstet & Gynaecol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.	dingylcn@yeah.net						Ajani JA, 2005, J CLIN ONCOL, V24, P663; Berkowitz RS, 2002, NOVAKS GYNECOLOGY, P1353; Cao J, 2007, WORLD PHARM NEWSLETT, P38; Chalouhi GE, 2009, AM J OBSTET GYNECOL, P643; Chen XQ, 2003, NEW PHARM, P673; Eiriksson L, 2012, GYNECOL ONCOL, V124, P553, DOI 10.1016/j.ygyno.2011.10.036; Feng YJ, 2010, OBSTET GYNECOLOGY 8; Goldstein DP, 2012, HEMATOL ONCOL CLIN N, V26, P111, DOI 10.1016/j.hoc.2011.10.007; Komatsu T, 2001, CLIN CANCER RES, V7, P675; LI MC, 1971, ANN INTERN MED, V74, P102, DOI 10.7326/0003-4819-74-1-102; LI MC, 1956, P SOC EXP BIOL MED, V93, P361; Li ZY, 2009, CLIN ONCOLOGY, Vl14, P1022; Malet-Martino M, 2002, ONCOLOGIST, V7, P288, DOI 10.1634/theoncologist.7-4-288; Manopunya M, 2012, ASIAN PAC J CANCER P, V13, P387, DOI 10.7314/APJCP.2012.13.1.387; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Ngan HYS, 2002, INT J GYNECOL OBSTET, V77, P285; Ngan S, 2007, CURR OPIN ONCOL, V19, P486, DOI 10.1097/CCO.0b013e3282dc94e5; Organization W.H, 1979, WHO HDB REP RES CANC; Rodriguez N, 2010, EXPERT OPIN PHARMACO, V11, P3027, DOI 10.1517/14656566.2010.512288; Shi YF, 2006, HYDATID MOLE CHORIOC; Shi YF, 2000, CHINESE J CLIN OBSTE, V1, P29; Song HZ, 2004, DIAGNOSIS TREATMENT; Soper JT, 2004, GYNECOL ONCOL, V93, P575, DOI 10.1016/j.ygyno.2004.05.013; Sun Y, 2001, ONCOLOGY INTERNAL ME, P523; Takayama K, 2008, RESPIROLOGY, V13, P103, DOI 10.1111/j.1440-1843.2007.01190.x; Tsuburaya A, 2014, LANCET ONCOL, V15, P886, DOI 10.1016/S1470-2045(14)70025-7; Wan XR, 2002, CHINESE J PRACTICAL, V17, P398; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196; Wang FM, 2007, PRACTICAL J CANC, P77; WANG SL, 1991, CHINESE MED J-PEKING, V104, P156; Zhao YF, 2007, CHINESE CLIN ONCOLOG, V12, P699; Zhou JC, 2003, PRACTICAL TUMOR INTE; Zhou JC, CLIN APPL ANTITUMOR; Zhou X, 2012, ONCOL LETT, V3, P659, DOI 10.3892/ol.2011.542	34	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143531	10.1371/journal.pone.0143531	http://dx.doi.org/10.1371/journal.pone.0143531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599757	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900138
J	Silva, DF; de Almeida, MM; Chaves, CG; Braz, AL; Gomes, MA; Pinho-da-Silva, L; Pesquero, JL; Andrade, VA; Leite, MD; de Albuquerque, JGF; Araujo, IGA; Nunes, XP; Barbosa, JM; Cruz, JD; Correia, ND; de Medeiros, IA				Silva, Darizy Flavia; de Almeida, Monica Moura; Chaves, Cinthia Guedes; Braz, Ana Leticia; Gomes, Maria Aparecida; Pinho-da-Silva, Leidiane; Pesquero, Jorge Luiz; Andrade, Viviane Aguiar; Leite, Maria de Fatima; Ferreira de Albuquerque, Jose George; Albuquerque Araujo, Islania Giselia; Nunes, Xirley Pereira; Barbosa-Filho, Jose Maria; Cruz, Jader dos Santos; Correia, Nadja de Azevedo; de Medeiros, Isac Almeida			TRPM8 Channel Activation Induced by Monoterpenoid Rotundifolone Underlies Mesenteric Artery Relaxation	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; PIPERITENONE OXIDE; VASCULAR-TONE; SMOOTH-MUSCLE; ION-CHANNEL; MENTHOL; COLD; CALCIUM; THERMOSENSATION; LOCALIZATION	In this study, our aims were to investigate transient receptor potential melastatin-8 channels (TRPM8) involvement in rotundifolone induced relaxation in the mesenteric artery and to increase the understanding of the role of these thermosensitive TRP channels in vascular tissue. Thus, message and protein levels of TRPM8 were measured by semi-quantitative PCR and western blotting in superior mesenteric arteries from 12 week-old Spague-Dawley (SD) rats. Isometric tension recordings evaluated the relaxant response in mesenteric rings were also performed. Additionally, the intracellular Ca2+ changes in mesenteric artery myocytes were measured using confocal microscopy. Using PCR and western blotting, both TRPM8 channel mRNA and protein expression was measured in SD rat mesenteric artery. Rotundifolone and menthol induced relaxation in the isolated superior mesenteric artery from SD rats and improved the relaxant response induced by cool temperatures. Also, this monoterpene induced an increase in transient intracellular Ca2+. These responses were significantly attenuated by pretreatment with capsazepine or BCTC, both TRPM8 channels blockers. The response induced by rotundifolone was not significantly attenuated by ruthenium red, a non-selective TRP channels blocker, or following capsaicin-mediated desensitization of TRPV1. Our findings suggest that rotundifolone induces relaxation by activating TRPM8 channels in rat superior mesenteric artery, more selectively than menthol, the classic TRPM8 agonist, and TRPM8 channels participates in vasodilatory pathways in isolated rat mesenteric arteries.	[Silva, Darizy Flavia] Univ Fed Bahia UFBA, Dept Bioregulacao, BR-40110902 Salvador, BA, Brazil; [de Almeida, Monica Moura; Chaves, Cinthia Guedes; Braz, Ana Leticia; Ferreira de Albuquerque, Jose George; Albuquerque Araujo, Islania Giselia; Barbosa-Filho, Jose Maria; Correia, Nadja de Azevedo; de Medeiros, Isac Almeida] Univ Fed Paraiba UFPB, Dept Ciencias Farmaceut, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Gomes, Maria Aparecida; Pinho-da-Silva, Leidiane; Pesquero, Jorge Luiz; Andrade, Viviane Aguiar; Leite, Maria de Fatima; Cruz, Jader dos Santos] Univ Fed Minas Gerais, Dept Fisiol & Biofis, BR-31270901 Belo Horizonte, MG, Brazil; [Nunes, Xirley Pereira] Univ Fed Vale Sao Francisco, Nucleo Estudos & Pesquisas Plantas Med, BR-56304205 Petrolina, PE, Brazil	Universidade Federal da Paraiba; Universidade Federal de Minas Gerais; Universidade Federal do Vale do Sao Francisco	Silva, DF (corresponding author), Univ Fed Bahia UFBA, Dept Bioregulacao, BR-40110902 Salvador, BA, Brazil.	darizy@gmail.com	Cruz, Jader/AAO-5284-2020; de Medeiros, Isac Almeida/C-5784-2013; Silva, Darizy Flávia/AAV-9772-2020; Filho, Jose Maria Barbosa/B-3951-2010; de Fatima Leite, Maria/AAK-2555-2021; Nunes, Xirley/F-6272-2014	Cruz, Jader/0000-0003-1365-2318; de Medeiros, Isac Almeida/0000-0001-8783-4806; Filho, Jose Maria Barbosa/0000-0002-9567-4096; Pesquero, Jorge/0000-0002-1460-9226; Braz de Sousa, Ana Leticia/0000-0003-0576-1047; Nunes, Xirley/0000-0002-9714-8575; Giselia Albuquerque Araujo, Islania/0000-0002-3584-898X	Fundacao de Amparo a pesquisa do estado da Bahia (FAPESB); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a pesquisa do estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DFS was supported by Fundacao de Amparo a pesquisa do estado da Bahia (FAPESB-http://www.fapesb.ba.gov.br). JSC was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - www.fapemig.br). IAM and MFL were supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R. N., 1996, Fitoterapia, V67, P334; Amato A, 2014, EUR J PHARMACOL, V745, P129, DOI 10.1016/j.ejphar.2014.10.012; Bai VU, 2010, INT J ONCOL, V36, P443, DOI 10.3892/ijo_00000518; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Calixto JB, 2005, PHARMACOL THERAPEUT, V106, P179, DOI 10.1016/j.pharmthera.2004.11.008; Cheang WS, 2013, EUR J PHARMACOL, V702, P79, DOI 10.1016/j.ejphar.2013.01.028; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Filosa JA, 2013, J CARDIOVASC PHARM, V61, P113, DOI 10.1097/FJC.0b013e318279ba42; Guedes DN, 2004, BRAZ J MED BIOL RES, V37, P1881, DOI 10.1590/S0100-879X2004001200014; Guedes DN, 2002, PLANTA MED, V68, P700, DOI 10.1055/s-2002-33795; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Lahlou S, 2001, PLANTA MED, V67, P638, DOI 10.1055/s-2001-17352; Leite MF, 2003, P NATL ACAD SCI USA, V100, P2975, DOI 10.1073/pnas.0536590100; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Reading SA, 2005, AM J PHYSIOL-HEART C, V288, pH2055, DOI 10.1152/ajpheart.00861.2004; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Silva DF, 2011, BASIC CLIN PHARMACOL, V109, P465, DOI 10.1111/j.1742-7843.2011.00749.x; Sokabe Takaaki, 2009, Communicative & Integrative Biology, V2, P170; Sousa PJC, 1997, BRAZ J MED BIOL RES, V30, P787, DOI 10.1590/S0100-879X1997000600014; Tanaka Y, 1999, BRIT J PHARMACOL, V128, P1602, DOI 10.1038/sj.bjp.0702954; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Zholos A, 2010, BRIT J PHARMACOL, V159, P1559, DOI 10.1111/j.1476-5381.2010.00649.x; Zuker CS, 2002, NATURE, V416, P27, DOI 10.1038/416027a	50	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143171	10.1371/journal.pone.0143171	http://dx.doi.org/10.1371/journal.pone.0143171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599698	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900072
J	Singh, GKS; Balzer, BWR; Kelly, PJ; Paxton, K; Hawke, CI; Handelsman, DJ; Steinbeck, KS				Singh, Gurmeet K. S.; Balzer, Ben W. R.; Kelly, Patrick J.; Paxton, Karen; Hawke, Catherine I.; Handelsman, David J.; Steinbeck, Katharine S.			Urinary Sex Steroids and Anthropometric Markers of Puberty - A Novel Approach to Characterising Within-Person Changes of Puberty Hormones	PLOS ONE			English	Article							MASS-SPECTROMETRY ASSAY; SELF-ASSESSMENT; REFERENCE INTERVALS; TESTOSTERONE LEVELS; CHINESE BOYS; GIRLS; ADOLESCENTS; CHILDREN; ESTRADIOL; PATTERN	Background/Aims The longitudinal relationships of within-individual hormone and anthropometric changes during puberty have not ever been fully described. The objectives of this study were to demonstrate that 3 monthly urine collection was feasible in young adolescents and to utilise liquid chromatography-tandem mass spectrometry assay methods for serum and urine testosterone (T), estradiol (E2) and luteinizing hormone (LH) in adolescents by relating temporal changes in urine and serum hormones over 12 months to standard measures of pubertal development. Methods A community sample of 104 adolescents (57 female) was studied over 12 months with annual anthropometric assessment, blood sampling and self-rated Tanner staging and urine collected every 3 months. Serum and urine sex steroids (T, E2) were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and LH by immunoassay. Results A high proportion (92%) of scheduled samples were obtained with low attrition rate of 6.7% over the 12 months. Urine hormone measurements correlated cross-sectionally and longitudinally with age, anthropometry and Tanner stage. Conclusion We have developed a feasible and valid sampling methodology and measurements for puberty hormones in urine, which allows a sampling frequency by which individual pubertal progression in adolescents can be described in depth.	[Singh, Gurmeet K. S.; Handelsman, David J.] Univ Sydney, ANZAC Res Inst, Camperdown, NSW, Australia; [Singh, Gurmeet K. S.] Univ Teknol MARA, Fac Pharm, Selangor, Malaysia; [Balzer, Ben W. R.; Steinbeck, Katharine S.] Childrens Hosp Westmead, Acad Dept Adolescent Med, Westmead, NSW, Australia; [Balzer, Ben W. R.; Steinbeck, Katharine S.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney Med Sch, Camperdown, NSW, Australia; [Kelly, Patrick J.] Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Camperdown, NSW, Australia; [Paxton, Karen; Hawke, Catherine I.] Univ Sydney, Sch Rural Hlth, Sydney Med Sch, Camperdown, NSW, Australia	University of Sydney; ANZAC Research Institute; Universiti Teknologi MARA; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Steinbeck, KS (corresponding author), Childrens Hosp Westmead, Acad Dept Adolescent Med, Westmead, NSW, Australia.	kate.steinbeck@health.nsw.gov.au	Research Institute, ANZAC/CAE-9030-2022; Surindar Singh, Gurmeet Kaur/ABA-7801-2020; Handelsman, David/AAR-9580-2021; Steinbeck, Kate/AAX-6197-2020; Ekanayake, Kanchana/P-8817-2016	Surindar Singh, Gurmeet Kaur/0000-0003-4223-9557; Kelly, Patrick/0000-0002-5015-0977; Handelsman, David/0000-0002-4200-7476; Paxton, Karen/0000-0001-7537-3731; Balzer, Ben/0000-0001-7116-2339	Australian National Health and Medical Research Council (NHMRC) Project [1003312]	Australian National Health and Medical Research Council (NHMRC) Project(National Health and Medical Research Council (NHMRC) of Australia)	The ARCHER study is supported by the Australian National Health and Medical Research Council (NHMRC) Project Grant #1003312. (KSS, CIH, DJH) www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Balzer BWR, 2015, EUR J PEDIATR, V174, P289, DOI 10.1007/s00431-014-2475-3; BIRO FM, 1995, J PEDIATR-US, V127, P100, DOI 10.1016/S0022-3476(95)70265-2; Biro FM, 2014, J CLIN ENDOCR METAB, V99, P3829, DOI 10.1210/jc.2013-4528; Bonat S, 2002, PEDIATRICS, V110, P743, DOI 10.1542/peds.110.4.743; Bordini B, 2011, PEDIATR REV, V32, P281, DOI 10.1542/pir.32-7-281; BREMNER WJ, 1983, J CLIN ENDOCR METAB, V56, P1278, DOI 10.1210/jcem-56-6-1278; Courant F, 2010, J CLIN ENDOCR METAB, V95, P82, DOI 10.1210/jc.2009-1140; Desmangles JC, 2006, J PEDIATR ENDOCR MET, V19, P213; Dorn L. D., 2006, APPL DEV SCI, V10, P30, DOI [10.1207/s1532480xads1001_3, DOI 10.1207/S1532480XADS1001_3]; Duke SA, 2014, J ADOLESCENT HEALTH, V55, P315, DOI 10.1016/j.jadohealth.2014.05.007; Handelsman DJ, 2013, J CLIN ENDOCR METAB, V98, P3971, DOI 10.1210/jc.2013-3375; Harwood DT, 2009, CLIN CHIM ACTA, V409, P78, DOI 10.1016/j.cca.2009.09.003; Hergenroeder AC, 1999, J ADOLESCENT HEALTH, V24, P201, DOI 10.1016/S1054-139X(98)00110-4; Ji CY, 2001, AM J HUM BIOL, V13, P35, DOI 10.1002/1520-6300(200101/02)13:1<35::AID-AJHB1005>3.0.CO;2-E; Kaitz M, 2012, DEV PSYCHOBIOL, V54, P113, DOI 10.1002/dev.20580; Kettaneh A, 2005, DIABETES METAB, V31, P534, DOI 10.1016/S1262-3636(07)70228-8; Konforte D, 2013, CLIN CHEM, V59, P1215, DOI 10.1373/clinchem.2013.204123; Kushnir MM, 2008, AM J CLIN PATHOL, V129, P530, DOI 10.1309/LC03BHQ5XJPJYEKG; Kushnir MM, 2010, MASS SPECTROM REV, V29, P480, DOI 10.1002/mas.20264; Laron Zvi, 2010, Pediatr Endocrinol Rev, V7, P256; Lee PA, 2006, PEDIAT ENDOCRINOLOGY, P273; Marceau K, 2011, DEV PSYCHOL, V47, P1389, DOI 10.1037/a0023838; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Mouritsen A, 2014, HORM RES PAEDIAT, V82, P12, DOI 10.1159/000358560; NIELSEN CT, 1986, ACTA ENDOCRINOL-COP, V113, P98; Rasmussen AR, 2015, PEDIATRICS, V135, P86, DOI 10.1542/peds.2014-0793; Rosner W, 2013, J CLIN ENDOCR METAB, V98, P1376, DOI 10.1210/jc.2012-3780; Sikaris K, 2005, J CLIN ENDOCR METAB, V90, P5928, DOI 10.1210/jc.2005-0962; Singh GKS, 2015, ANN CLIN BIOCHEM, V52, P665, DOI 10.1177/0004563215580385; Singh GKS, 2014, DRUG TEST ANAL, V6, P336, DOI 10.1002/dta.1481; Sivananthan T, 2012, ASIAN J ANDROL, V14, P476, DOI 10.1038/aja.2012.2; Steinbeck K, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-143; Sun Y, 2012, ANN HUM BIOL, V39, P461, DOI 10.3109/03014460.2012.712156; Taieb J, 2003, CLIN CHEM, V49, P1381, DOI 10.1373/49.8.1381	37	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143555	10.1371/journal.pone.0143555	http://dx.doi.org/10.1371/journal.pone.0143555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599397	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900145
J	Houston, F; Goldmann, W; Foster, J; Gonzalez, L; Jeffrey, M; Hunter, N				Houston, Fiona; Goldmann, Wilfred; Foster, James; Gonzalez, Lorenzo; Jeffrey, Martin; Hunter, Nora			Comparative Susceptibility of Sheep of Different Origins, Breeds and PRNP Genotypes to Challenge with Bovine Spongiform Encephalopathy and Scrapie	PLOS ONE			English	Article							DISEASE-ASSOCIATED PRP; PRION PROTEIN; GENE HAPLOTYPES; ORAL INFECTION; HOST GENOTYPE; POLYMORPHISMS; AGENT; BSE; ACCUMULATION; INOCULATION	Sheep are natural hosts of the prion disease, scrapie. They are also susceptible to experimental challenge with various scrapie strains and with bovine spongiform encephalopathy (BSE), which affects cattle and has been accidentally transmitted to a range of other species, including man. Incidence and incubation period of clinical disease in sheep following inoculation is controlled by the PRNP gene, which has different alleles defined on the basis of polymorphisms, particularly at codons 136, 154 and 171, although other codons are associated with survival time, and the exact responses of the sheep may be influenced by other breed-related differences. Here we report the results of a long term single study of experimental scrapie and BSE susceptibility of sheep of Cheviot, Poll Dorset and Suffolk breeds, originating from New Zealand and of a wide range of susceptible and resistant PRNP genotypes. Responses were compared with those of sheep from a closed Cheviot flock of UK origin (Roslin Cheviot flock). The unusually long observation period (6-8 years for most, but up to 12 years for others) allows us to draw robust conclusions about rates of survival of animals previously regarded as resistant to infection, particularly PRNP heterozygotes, and is the most comprehensive such study reported to date. BSE inoculation by an intracerebral route produced disease in all genotype groups with differing incubation periods, although M112T and L141F polymorphisms seemed to give some protection. Scrapie isolate SSBP/1, which has the shortest incubation period in sheep with at least one VRQ PRNP allele, also produced disease following sub-cutaneous inoculation in ARQ/ARQ animals of New Zealand origin, but ARQ/ARQ sheep from the Roslin flock survived the challenge. Our results demonstrate that the links between PRNP genotype and clinical prion disease in sheep are much less secure than previously thought, and may break down when, for example, a different breed of sheep is moved into a new flock.	[Houston, Fiona; Goldmann, Wilfred; Foster, James; Hunter, Nora] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Gonzalez, Lorenzo; Jeffrey, Martin] Anim & Plant Hlth Agcy APHA Lasswade, Penicuik, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Hunter, N (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.	nora.hunter@roslin.ed.ac.uk	González, Lorenzo/A-5325-2010	González, Lorenzo/0000-0003-4199-4526	Department of the Environment, Food and Rural Affairs (UK) [SE1432]; Biotechnology and Biological Research Council (UK), Institute Strategic Grant [BB/J004332/1]; BBSRC [BBS/E/A/00001651, BBS/E/D/20251968, BBS/E/D/05241340, BBS/E/D/20251967] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/A/00001651, BBS/E/A/00001656, BBS/E/D/20251967, BBS/E/I/00001128, BBS/E/D/20251968, BBS/E/D/05241340] Funding Source: researchfish	Department of the Environment, Food and Rural Affairs (UK)(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Research Council (UK), Institute Strategic Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Department of the Environment, Food and Rural Affairs (UK), SE1432 (https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs) (to NH); and Biotechnology and Biological Research Council (UK), Institute Strategic Grant BB/J004332/1 (http://www.bbsrc.ac.uk) (to NH FH JF WG). The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andreoletti O, 2006, J GEN VIROL, V87, P1043, DOI 10.1099/vir.0.81318-0; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Begara-McGorum I, 2002, J COMP PATHOL, V127, P59, DOI 10.1053/jcpa.2002.0558; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Chianini F, 2013, VET IMMUNOL IMMUNOP, V152, P348, DOI 10.1016/j.vetimm.2013.01.005; Dawson M, 1998, VET REC, V142, P623; Dawson M, 2008, VET RES, V39, DOI 10.1051/vetres:2007064; Diaz C, 2005, J GEN VIROL, V86, P849, DOI 10.1099/vir.0.80412-0; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Foster JD, 2001, VET REC, V148, P165, DOI 10.1136/vr.148.6.165; Goldmann W, 2005, J APPL MICROBIOL, V98, P1294, DOI 10.1111/j.1365-2672.2005.02568.x; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Gonzalez L, 2014, J COMP PATHOL, V150, P57, DOI 10.1016/j.jcpa.2013.10.001; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gonzalez L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-55; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; Haase B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-15; Houston EF, 2002, J GEN VIROL, V83, P1247, DOI 10.1099/0022-1317-83-5-1247; Houston F, 2003, NATURE, V423, P498, DOI 10.1038/423498a; HUNTER N, 1994, ARCH VIROL, V137, P171, DOI 10.1007/BF01311184; Hunter N, 2012, J VIROL, V86, P11856, DOI 10.1128/JVI.01573-12; IKEDA T, 1995, J GEN VIROL, V76, P2577, DOI 10.1099/0022-1317-76-10-2577; Jeffrey M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091026; Laegreid WW, 2008, J VIROL, V82, P10318, DOI 10.1128/JVI.00710-08; Martin S, 2005, J GEN VIROL, V86, P839, DOI 10.1099/vir.0.80364-0; McGovern G, 2015, J COMP PATHOL, V152, P28, DOI 10.1016/j.jcpa.2014.09.004; Migliore S, 2012, J GEN VIROL, V93, P450, DOI 10.1099/vir.0.035469-0; O'Neill GT, 2005, J ANIM BREED GENET, V122, P86, DOI 10.1111/j.1439-0388.2005.00520.x; Ronzon F, 2006, BIOCHEM BIOPH RES CO, V350, P872, DOI 10.1016/j.bbrc.2006.09.137; Saijo E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003692; Saunders GC, 2009, J GEN VIROL, V90, P2569, DOI 10.1099/vir.0.012724-0; Simmons HA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-8; Tan BC, 2012, J GEN VIROL, V93, P2749, DOI 10.1099/vir.0.039008-0; Vaccari G, 2007, J VIROL, V81, P7306, DOI 10.1128/JVI.02880-06; Vrentas CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043060; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; Zhang L, 2004, ANIM GENET, V35, P457, DOI 10.1111/j.1365-2052.2004.01204.x	41	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143251	10.1371/journal.pone.0143251	http://dx.doi.org/10.1371/journal.pone.0143251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587837	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500044
J	Enenkel, M; See, L; Karner, M; Alvarez, M; Rogenhofer, E; Baraldes-Vallverdu, C; Lanusse, C; Salse, N				Enenkel, Markus; See, Linda; Karner, Mathias; Alvarez, Monica; Rogenhofer, Edith; Baraldes-Vallverdu, Carme; Lanusse, Candela; Salse, Nuria			Food Security Monitoring via Mobile Data Collection and Remote Sensing: Results from the Central African Republic	PLOS ONE			English	Article								The Central African Republic is one of the world's most vulnerable countries, suffering from chronic poverty, violent conflicts and weak disaster resilience. In collaboration with Doctors without Borders/Medecins Sans Frontieres (MSF), this study presents a novel approach to collect information about socio-economic vulnerabilities related to malnutrition, access to resources and coping capacities. The first technical test was carried out in the North of the country (sub-prefecture Kabo) in May 2015. All activities were aimed at the investigation of technical feasibility, not at operational data collection, which requires a random sampling strategy. At the core of the study is an open-source Android application named SATIDA COLLECT that facilitates rapid and simple data collection. All assessments were carried out by local MSF staff after they had been trained for one day. Once a mobile network is available, all assessments can easily be uploaded to a database for further processing and trend analysis via MSF in-house software. On one hand, regularly updated food security assessments can complement traditional large-scale surveys, whose completion can take up to eight months. Ideally, this leads to a gain in time for disaster logistics. On the other hand, recording the location of every assessment via the smart phones' GPS receiver helps to analyze and display the coupling between drought risk and impacts over many years. Although the current situation in the Central African Republic is mostly related to violent conflict it is necessary to consider information about drought risk, because climatic shocks can further disrupt the already vulnerable system. SATIDA COLLECT can easily be adapted to local conditions or other applications, such as the evaluation of vaccination campaigns. Most importantly, it facilitates the standardized collection of information without pen and paper, as well as straightforward sharing of collected data with the MSF headquarters or other aid organizations.	[Enenkel, Markus] Vienna Univ Technol, Dept Geodesy & Geoinformat, A-1040 Vienna, Austria; [See, Linda; Karner, Mathias] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Alvarez, Monica; Baraldes-Vallverdu, Carme; Lanusse, Candela; Salse, Nuria] Doctors Borders Med Sans Frontieres MSF, Barcelona, Spain; [Rogenhofer, Edith] Doctors Borders Med Sans Frontieres MSF, Vienna, Austria	Technische Universitat Wien; International Institute for Applied Systems Analysis (IIASA)	Enenkel, M (corresponding author), Vienna Univ Technol, Dept Geodesy & Geoinformat, A-1040 Vienna, Austria.	markus.enenkel@geo.tuwien.ac.at			SATIDA (Satellite Technologies for Improved Drought-Risk Assessment); SATIDA within Austrian Space Applications Programme (ASAP10) of the Austrian Research Promotion Agency [4277353]	SATIDA (Satellite Technologies for Improved Drought-Risk Assessment); SATIDA within Austrian Space Applications Programme (ASAP10) of the Austrian Research Promotion Agency	This work was supported by (https://www.ffg.at/), grant number: 4277353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported and funded within the framework of SATIDA (Satellite Technologies for Improved Drought-Risk Assessment). SATIDA is a project within the Austrian Space Applications Programme (ASAP10) of the Austrian Research Promotion Agency (project number 4277353).	Aitamurto T, 2016, DIGIT JOURNAL, V4, P280, DOI 10.1080/21670811.2015.1034807; Anokwa Y, 2009, COMPUTER, V42, P97, DOI 10.1109/MC.2009.328; Barbier G, 2012, COMPUT MATH ORGAN TH, V18, P257, DOI 10.1007/s10588-012-9121-2; Brabham DC, 2014, AM J PREV MED, V46, P179, DOI 10.1016/j.amepre.2013.10.016; Brown M.E., 2008, FAMINE EARLY WARNING; Choi C, 2015, PREDICT FLU OUTBREAK; David Harvey TDK, 2013, ASTRON COMPUT, DOI [10.1016/j.ascom.2014.04.003, DOI 10.1016/J.ASC0M.2014.04.003]; Ericsson, 2014, SUBS AFR ER MOB REP; Famine Early Warning Systems Network (FEWSNET), 2014, IDPS FAC CRIS IPC PH; FAO/WFP, 2014, FAO WFP MARK FOOD SE; FAO/WFP, 2014, SPECIAL REPORT; Fienen MN, 2012, COMPUT GEOSCI-UK, V49, P164, DOI 10.1016/j.cageo.2012.06.015; Food and Agriculture Organization, 2009, FAO WFP JOINT GUID C; Goolsby R, 2010, ACM T INTEL SYST TEC, V1, DOI 10.1145/1858948.1858955; Hanjra MA, 2010, FOOD POLICY, V35, P365, DOI 10.1016/j.foodpol.2010.05.006; HOWE J, 2006, WIRED MAG, V14, P14; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Liu YY, 2011, HYDROL EARTH SYST SC, V15, P425, DOI 10.5194/hess-15-425-2011; Maidment RI, 2014, J GEOPHYS RES-ATMOS, V119, P10619, DOI 10.1002/2014JD021927; Meier Patrick, 2015, DIGITAL HUMANITARIAN; Mistelbauer T., 2014, GEOINFO SERIES, V40; Schepaschenko D, 2015, REMOTE SENS ENVIRON, V162, P208, DOI 10.1016/j.rse.2015.02.011; See L., 2013, International Journal of Geosciences, V4, P6; Sheffield J, 2014, B AM METEOROL SOC, V95, P861, DOI 10.1175/BAMS-D-12-00124.1; Tarnavsky E, 2014, J APPL METEOROL CLIM, V53, P2805, DOI 10.1175/JAMC-D-14-0016.1; UNICEF, 2013, IMPR CHILD NUTR THE; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1	27	19	19	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142030	10.1371/journal.pone.0142030	http://dx.doi.org/10.1371/journal.pone.0142030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581042	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000365154600032
J	Kim, M; Seo, H; Choi, Y; Yoo, I; Seo, M; Lee, CK; Kim, H; Ka, H				Kim, Mingoo; Seo, Heewon; Choi, Yohan; Yoo, Inkyu; Seo, Minseok; Lee, Chang-Kyu; Kim, Heebal; Ka, Hakhyun			Analysis of Stage-Specific Gene Expression Profiles in the Uterine Endometrium during Pregnancy in Pigs	PLOS ONE			English	Article							SECRETED PHOSPHOPROTEIN 1; MATERNAL-FETAL INTERFACE; PORCINE UTERUS; BINDING-PROTEIN; SPP1 GENE; IMPLANTATION; OSTEOPONTIN; MICROARRAY; TRANSPORT; SULFOTRANSFERASE	The uterine endometrium plays a critical role in regulating the estrous cycle and the establishment and maintenance of pregnancy in mammalian species. Many studies have investigated the expression and function of genes in the uterine endometrium, but the global expression pattern of genes and relationships among genes differentially expressed in the uterine endometrium during gestation in pigs remain unclear. Thus, this study investigated global gene expression profiles using microarray in pigs. Diverse transcriptome analyses including clustering, network, and differentially expressed gene (DEG) analyses were performed to detect endometrial gene expression changes during the different gestation stages. In total, 6,991 genes were found to be differentially expressed by comparing genes expressed on day (D) 12 of pregnancy with those on D15, D30, D60, D90 and D114 of pregnancy, and clustering analysis of detected DEGs distinguished 8 clusters. Furthermore, several pregnancy-related hub genes such as ALPPL2, RANBP17, NF1B, SPP1, and CST6 were discovered through network analysis. Finally, detected hub genes were technically validated by quantitative RT-PCR. These results suggest the complex network characteristics involved in uterine endometrial gene expression during pregnancy and indicate that diverse patterns of stage-specific gene expression and network connections may play a critical role in endometrial remodeling and in placental and fetal development to establish and maintenance of pregnancy in pigs.	[Kim, Mingoo; Seo, Heewon; Choi, Yohan; Yoo, Inkyu; Ka, Hakhyun] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Seo, Minseok; Kim, Heebal] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Lee, Chang-Kyu; Kim, Heebal] Seoul Natl Univ, Dept Anim Biotechnol, Seoul, South Korea; [Seo, Minseok; Kim, Heebal] C&K Genom, Seoul, South Korea	Yonsei University; Seoul National University (SNU); Seoul National University (SNU)	Ka, H (corresponding author), Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea.	hka@yonsei.ac.kr	Seo, Heewon/AAW-9481-2021; Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303	Next Generation BioGreen 21 Program [PJ01119103, PJ01110301]; National Research Foundation Grant - Korean Government, Republic of Korea [NRF-2012R1A2A2A01047079]; Rural Development Administration	Next Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); National Research Foundation Grant - Korean Government, Republic of Korea; Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Next Generation BioGreen 21 Program (#PJ01119103; #PJ01110301), Rural Development Administration, and by the National Research Foundation Grant funded by the Korean Government (#NRF-2012R1A2A2A01047079), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Next Generation BioGreen 21 Program (#PJ01119103; #PJ01110301), Rural Development Administration, and by the National Research Foundation Grant funded by the Korean Government (#NRF-2012R1A2A2A01047079), Republic of Korea.	Badinga L, 1999, BIOL REPROD, V61, P380, DOI 10.1095/biolreprod61.2.380; Bazer FW, 2014, DIFFERENTIATION, V87, P52, DOI 10.1016/j.diff.2013.11.005; Bazer FW, 2012, MOL CELL ENDOCRINOL, V354, P22, DOI 10.1016/j.mce.2011.08.026; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burghardt RC, 2002, CELLS TISSUES ORGANS, V172, P202, DOI 10.1159/000066969; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; DAVIS DL, 1993, J REPROD FERTIL, P143; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DWYER RJ, 1980, J REPROD FERTIL, V60, P187, DOI 10.1530/jrf.0.0600187; Erikson DW, 2009, BIOL REPROD, V81, P814, DOI 10.1095/biolreprod.109.078600; FIRST NL, 1979, J ANIM SCI, V48, P1407, DOI 10.2527/jas1979.4861407x; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Garlow JE, 2002, BIOL REPROD, V66, P718, DOI 10.1095/biolreprod66.3.718; GOLDSTEIN MH, 1980, BIOL REPROD, V22, P1168, DOI 10.1093/biolreprod/22.5.1168; Green J A, 2006, Soc Reprod Fertil Suppl, V62, P163; Han SH, 2012, MOL BIOL REP, V39, P7705, DOI 10.1007/s11033-012-1606-z; Hashizume K, 2007, J REPROD DEVELOP, V53, P1, DOI 10.1262/jrd.18123; Hernandez SC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104679; Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/biolreprod.103.020651; Ka H, 2000, BIOL REPROD, V62, P1772, DOI 10.1095/biolreprod62.6.1772; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Kim JG, 2002, DOMEST ANIM ENDOCRIN, V23, P493, DOI 10.1016/S0739-7240(02)00172-8; King AH, 2003, BIOL REPROD, V68, P2172, DOI 10.1095/biolreprod.102.012955; KNIGHT JW, 1977, J ANIM SCI, V44, P620, DOI 10.2527/jas1977.444620x; Knoll A, 1999, ANIM GENET, V30, P466, DOI 10.1046/j.1365-2052.1999.00498-5.x; Koch P, 2000, BIOCHEM BIOPH RES CO, V278, P241, DOI 10.1006/bbrc.2000.3788; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lee JH, 2010, J CELL BIOCHEM, V111, P195, DOI 10.1002/jcb.22689; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALATHY PV, 1990, MOL ENDOCRINOL, V4, P428, DOI 10.1210/mend-4-3-428; Marrable A.W., 1971, EMBRYONIC PIG CHRONO, V1st ed.; Molina-Navarro MM, 2013, INT J CARDIOL, V168, P2837, DOI 10.1016/j.ijcard.2013.03.192; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pan HY, 2006, ENDOCRINOLOGY, V147, P4904, DOI 10.1210/en.2006-0140; Rashev P, 2005, FOLIA BIOL-PRAGUE, V51, P121; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; RICHOUX V, 1989, ANAT REC, V223, P72, DOI 10.1002/ar.1092230111; ROBERTS RM, 1988, J REPROD FERTIL, V82, P875, DOI 10.1530/jrf.0.0820875; Ross JW, 2007, ENDOCRINOLOGY, V148, P4761, DOI 10.1210/en.2007-0599; Salamonsen LA, 1999, REV REPROD, V4, P11; Seo H, 2011, BIOL REPROD, V84, P279, DOI 10.1095/biolreprod.110.086934; Seo H, 2008, ENDOCRINOLOGY, V149, P6166, DOI 10.1210/en.2008-0354; Shim J, 2013, MOL REPROD DEV, V80, P570, DOI 10.1002/mrd.22192; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929; Spencer T E, 2007, Soc Reprod Fertil Suppl, V64, P379; Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Vallet JL, 1999, J ANIM SCI, V77, P1236; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	56	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143436	10.1371/journal.pone.0143436	http://dx.doi.org/10.1371/journal.pone.0143436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580069	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600123
J	Paknia, O; Schierwater, B				Paknia, Omid; Schierwater, Bernd			Global Habitat Suitability and Ecological Niche Separation in the Phylum Placozoa	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; TRICHOPLAX; REEF; DIVERSITY; PATTERNS; GENOME; AUC	The enigmatic placozoans, which hold a key position in the metazoan Tree of Life, have attracted substantial attention in many areas of biological and biomedical research. While placozoans have become an emerging model system, their ecology and particularly biogeography remain widely unknown. In this study, we use modelling approaches to explore habitat preferences, and distribution pattern of the placozoans phylum. We provide hypotheses for discrete ecological niche separation between genetic placozoan lineages, which may also help to understand biogeography patterns in other small marine invertebrates. We, here, used maximum entropy modelling to predict placozoan distribution using 20 environmental grids of 9.2 km(2) resolution. In addition, we used recently developed metrics of niche overlap to compare habitat suitability models of three genetic clades. The predicted distributions range from 55 degrees N to 44 degrees S and are restricted to regions of intermediate to warm sea surface temperatures. High concentrations of salinity and low nutrient concentrations appear as secondary factors. Tests of niche equivalency reveal the largest differences between placozoan clades I and III. Interestingly, the genetically well-separated clades I and V appear to be ecologically very similar. Our habitat suitability models predict a wider latitudinal distribution for placozoans, than currently described, especially in the northern hemisphere. With respect to biogeography modelling, placozoans show patterns somewhere between higher metazoan taxa and marine microorganisms, with the first group usually showing complex biogeographies and the second usually showing "no biogeography."	[Paknia, Omid; Schierwater, Bernd] TiHo Hannover, ITZ, Ecol & Evolut, Hannover, Germany; [Schierwater, Bernd] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Schierwater, Bernd] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Schierwater, Bernd] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	University of Veterinary Medicine Hannover, Foundation; Yale University; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH)	Paknia, O (corresponding author), TiHo Hannover, ITZ, Ecol & Evolut, Hannover, Germany.	omid.paknia@ecolevol.de			German Research Foundation [Schi-227/29-1]	German Research Foundation(German Research Foundation (DFG))	The study was supported by German Research Foundation grant Schi-227/29-1 to BS.; The study was supported by German Research Foundation grant Schi-227/29-1 to BS. We thank Michael Eitel for providing the placozoan geo-referenced data. OP thanks Babak Naimi for his technical assistance and comments on modelling.	Acevedo-Trejos E, 2013, GLOBAL ECOL BIOGEOGR, V22, P1060, DOI 10.1111/geb.12071; Aguilar M, 2012, ISME J, V6, P1506, DOI 10.1038/ismej.2012.12; [Anonymous], 2011, ECOLOGICAL NICHES GE; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Ball EE, 2010, MOL ECOL, V19, P2181, DOI 10.1111/j.1365-294X.2010.04618.x; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Bentlage B, 2013, GLOBAL ECOL BIOGEOGR, V22, P952, DOI 10.1111/geb.12049; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Cord A, 2011, ECOL APPL, V21, P3285, DOI 10.1890/11-0114.1; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Eitel M, 2010, MOL ECOL, V19, P2315, DOI 10.1111/j.1365-294X.2010.04617.x; Eitel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057131; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Glor RE, 2011, EVOLUTION, V65, P673, DOI 10.1111/j.1558-5646.2010.01177.x; Guidi L, 2011, J MORPHOL, V272, P371, DOI 10.1002/jmor.10922; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Keith SA, 2014, GLOBAL ECOL BIOGEOGR, V23, P517, DOI 10.1111/geb.12132; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; McClanahan TR, 2003, MAR ECOL PROG SER, V261, P135, DOI 10.3354/meps261135; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Naimi B, 2014, ECOGRAPHY, V37, P191, DOI 10.1111/j.1600-0587.2013.00205.x; Nakano H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05356; Navarro-Cerrillo RM, 2011, APPL VEG SCI, V14, P256, DOI 10.1111/j.1654-109X.2010.01112.x; Neustupa J, 2013, PLANT ECOL EVOL, V146, P279, DOI 10.5091/plecevo.2013.862; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Rivera-Ingraham GA, 2013, J EXP BIOL, V216, P2741, DOI 10.1242/jeb.081984; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; Schierwater B., 2013, SPEZIELLE ZOOLOGIE 1, P103; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schierwater B, 2009, INT J BIOCHEM CELL B, V41, P370, DOI 10.1016/j.biocel.2008.09.023; Schulze FE, 1883, ZOOL ANZ, V6, P92; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Voigt O, 2004, CURR BIOL, V14, pR944, DOI 10.1016/j.cub.2004.10.036; von der Chevallerie K., 2010, CAH BIOL MAR, V51, P212; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	49	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140162	10.1371/journal.pone.0140162	http://dx.doi.org/10.1371/journal.pone.0140162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580806	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600003
J	Panno, A; Lauriola, M; Pierro, A				Panno, Angelo; Lauriola, Marco; Pierro, Antonio			Regulatory Mode and Risk-Taking: The Mediating Role of Anticipated Regret	PLOS ONE			English	Article							INNER-CITY ADOLESCENTS; DECISION-MAKING; TASK BART; INDIVIDUAL-DIFFERENCES; SLEEP-DEPRIVATION; SENSATION SEEKING; BEHAVIORAL MEASURES; IMPULSIVE BEHAVIOR; D-AMPHETAMINE; ALCOHOL-USE	We propose that decision maker's regulatory mode affects risk-taking through anticipated regret. In the Study 1 either a locomotion or an assessment orientation were experimentally induced, and in the Studies 2 and 3 these different orientations were assessed as chronic individual differences. To assess risk-taking we used two behavioral measures of risk: BART and hot-CCT. The results show that experimentally induced assessment orientation-compared to locomotion-leads to decreased risk-taking through increased anticipated regret (Study 1). People chronically predisposed to be in the assessment state take less risk through increased anticipated regret (Study 2 and Study 3). Study 2 results also show a marginally non-significant indirect effect of chronic locomotion mode on BART through anticipated regret. Differently, Study 3 shows that people chronically predisposed to be in the locomotion state take greater risk through decreased anticipated regret, when play a dynamic risk task triggering stronger emotional arousal. Through all three studies, the average effect size for the relationship of assessment with anticipated regret was in the moderate-large range, whereas for risk-taking was in the moderate range. The average effect size for the relationship of locomotion with anticipated regret was in the moderate range, whereas for risk-taking was in the small-moderate range. These results increase our understanding of human behavior under conditions of risk obtaining novel insights into regulatory mode theory and decision science.	[Panno, Angelo] Univ Rome Tre, Expt Psychol Lab, Dept Educ, I-00146 Rome, Italy; [Lauriola, Marco; Pierro, Antonio] Univ Roma La Sapienza, Dept Social & Dev Psychol, I-00185 Rome, Italy	Roma Tre University; Sapienza University Rome	Panno, A (corresponding author), Univ Rome Tre, Expt Psychol Lab, Dept Educ, I-00146 Rome, Italy.	angelopanno@yahoo.it	Panno, Angelo/H-9019-2019	Panno, Angelo/0000-0002-6516-161X				Acheson A, 2008, EXP CLIN PSYCHOPHARM, V16, P113, DOI 10.1037/1064-1297.16.2.113; Acheson A, 2007, PHYSIOL BEHAV, V91, P579, DOI 10.1016/j.physbeh.2007.03.020; Aklin WM, 2005, BEHAV RES THER, V43, P215, DOI 10.1016/j.brat.2003.12.007; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; Appelt KC, 2011, JUDGM DECIS MAK, V6, P252; Avnet T, 2003, J EXP SOC PSYCHOL, V39, P525, DOI 10.1016/S0022-1031(03)00027-1; Bakker AB, 1997, J APPL SOC PSYCHOL, V27, P2001; Blais AR, 2006, JUDGM DECIS MAK, V1, P33; Borenstein M, 2009, COMPREHENSIVE METANA; Bornovalova MA, 2008, CHILD ABUSE NEGLECT, V32, P99, DOI 10.1016/j.chiabu.2007.04.009; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cesario J, 2008, PSYCHOL SCI, V19, P415, DOI 10.1111/j.1467-9280.2008.02102.x; Conner M, 2006, BRIT J HEALTH PSYCH, V11, P85, DOI 10.1348/135910705X40997; Connolly T, 2002, CURR DIR PSYCHOL SCI, V11, P212, DOI 10.1111/1467-8721.00203; Cooke R, 2007, ALCOHOL ALCOHOLISM, V42, P84, DOI 10.1093/alcalc/agl115; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Donati MA, 2014, J CLIN EXP NEUROPSYC, V36, P588, DOI 10.1080/13803395.2014.918091; Eich E, 2014, PSYCHOL SCI, V25, P3, DOI 10.1177/0956797613512465; Figner B, 2011, CURR DIR PSYCHOL SCI, V20, P211, DOI 10.1177/0963721411415790; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; GILOVICH T, 1995, PSYCHOL REV, V102, P379, DOI 10.1037/0033-295X.102.2.379; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2013, PSYCHOL SCI, V24, P1918, DOI 10.1177/0956797613480187; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Higgins ET, 1997, J PERS SOC PSYCHOL, V72, P515, DOI 10.1037/0022-3514.72.3.515; Higgins ET, 2003, ADV EXP SOC PSYCHOL, V35, P293, DOI 10.1016/S0065-2601(03)01005-0; Hunt MK, 2005, ASSESSMENT, V12, P416, DOI 10.1177/1073191105278740; Kahneman D., 2011, THINKING FAST SLOW; Killgore WDS, 2008, AVIAT SPACE ENVIR MD, V79, P867, DOI 10.3357/ASEM.2259.2008; Killgore WDS, 2007, PSYCHOL REP, V100, P613, DOI 10.2466/PRO.100.3.613-626; Knight F. H., 1921, UNCERTAINTY PROFIT; Kruglanski AW, 2000, J PERS SOC PSYCHOL, V79, P793, DOI 10.1037/0022-3514.79.5.793; Lauriola M, 2001, PERS INDIV DIFFER, V31, P215, DOI 10.1016/S0191-8869(00)00130-6; Lauriola M, 2014, J BEHAV DECIS MAKING, V27, P20, DOI 10.1002/bdm.1784; Lejuez CW, 2007, J CLIN CHILD ADOLESC, V36, P106, DOI 10.1207/s15374424jccp3601_11; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Li S, 2010, J GAMBL STUD, V26, P105, DOI 10.1007/s10899-009-9149-5; Lighthall NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006002; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; MacPherson L, 2010, ALCOHOL CLIN EXP RES, V34, P1400, DOI 10.1111/j.1530-0277.2010.01223.x; Mannetti L, 2009, EUR J SOC PSYCHOL, V39, P1120, DOI 10.1002/ejsp.601; Mellers BA, 2000, PSYCHOL BULL, V126, P910, DOI 10.1037/0033-2909.126.6.910; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Mellers BA, 2001, CURR DIR PSYCHOL SCI, V10, P210, DOI 10.1111/1467-8721.00151; Mischel W, 1996, SOCIAL PSYCHOL HDB B, P329; Mishra S, 2010, PERS INDIV DIFFER, V49, P616, DOI 10.1016/j.paid.2010.05.032; Molden DC, 2012, SOC PERSONAL PSYCHOL, V6, P156, DOI 10.1111/j.1751-9004.2011.00424.x; Nordgren LF, 2007, J BEHAV DECIS MAKING, V20, P533, DOI 10.1002/bdm.565; Panno A, 2014, INT J PSYCHOL, V49, P211, DOI 10.1002/ijop.12026; Panno A, 2013, COGNITION EMOTION, V27, P326, DOI 10.1080/02699931.2012.707642; Pierro A, 2008, J EXP SOC PSYCHOL, V44, P321, DOI 10.1016/j.jesp.2007.06.002; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Reed SC, 2010, HORM BEHAV, V58, P533, DOI 10.1016/j.yhbeh.2010.04.003; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Richard R, 1996, J BEHAV DECIS MAKING, V9, P185, DOI 10.1002/(SICI)1099-0771(199609)9:3<185::AID-BDM228>3.0.CO;2-5; Richard R, 1998, J APPL SOC PSYCHOL, V28, P1411, DOI 10.1111/j.1559-1816.1998.tb01684.x; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Schwarz N, 2000, COGNITION EMOTION, V14, P433, DOI 10.1080/026999300402745; Sheeran P, 1999, EUR J SOC PSYCHOL, V29, P349, DOI 10.1002/(SICI)1099-0992(199903/05)29:2/3<349::AID-EJSP931>3.0.CO;2-Y; Skeel RL, 2008, PSYCHOL ADDICT BEHAV, V22, P402, DOI 10.1037/0893-164X.22.3.402; SLOVIC P, 1972, J PERS SOC PSYCHOL, V22, P128, DOI 10.1037/h0032370; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Swogger MT, 2010, CRIM JUSTICE BEHAV, V37, P439, DOI 10.1177/0093854810361617; Tochkov K, 2009, JUDGM DECIS MAK, V4, P227; Wallsten TS, 2005, PSYCHOL REV, V112, P862, DOI 10.1037/0033-295X.112.4.862; Weber EU, 2009, ANNU REV PSYCHOL, V60, P53, DOI 10.1146/annurev.psych.60.110707.163633; White TL, 2007, EXP CLIN PSYCHOPHARM, V15, P599, DOI 10.1037/1064-1297.15.6.599; Zeelenberg M, 2004, ORGAN BEHAV HUM DEC, V93, P155, DOI 10.1016/j.obhdp.2003.10.001; Zeelenberg M, 1999, J BEHAV DECIS MAKING, V12, P93, DOI 10.1002/(SICI)1099-0771(199906)12:2<93::AID-BDM311>3.0.CO;2-S; Zeelenberg M, 1997, ORGAN BEHAV HUM DEC, V72, P63, DOI 10.1006/obhd.1997.2730; Zeelenberg M, 2007, J CONSUM PSYCHOL, V17, P3, DOI 10.1207/s15327663jcp1701_3	76	19	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143147	10.1371/journal.pone.0143147	http://dx.doi.org/10.1371/journal.pone.0143147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26580960	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600092
J	Young, AE; Choi, Y; Besen, E				Young, Amanda E.; Choi, YoonSun; Besen, Elyssa			An Exploration of the Factors Considered When Forming Expectations for Returning to Work following Sickness Absence Due to a Musculoskeletal Condition	PLOS ONE			English	Article							LOW-BACK-PAIN; RECOVERY EXPECTATIONS; TO-WORK; DISABILITY; INJURY	Introduction Workers' own expectations for returning to work following a period of sickness absence have been found to be one of the best predictors of future work status; however, there is a limited understanding of why people expect what they do. The current study was undertaken with the aim of determining what people take into consideration when forming their expectations for returning to work. Methods Thirty-four people (8 women, 26 men), who were off work due to a musculoskeletal condition, participated in one of 14 focus groups. Participants were aged 25 to 65 (M = 45, SD = 12.6), and all had been out of work for 3 months or less. Results All participants reported expecting to return to work, with the most common timeframe being approximately 30 days (Range = 1 day-12months). When explaining what they thought about when forming their expectations, participants referenced numerous considerations. Much of what was spoken about could be compartmentalized to reflect features of themselves, their condition, or their broader environmental contexts. Participant's subjective experience of these features influenced his or her expectations. Prominent themes included concerns about employability, a desire to get back to normal, no job to go back to, mixed emotions, re-injury concerns, the judgments of workplace stakeholders, being needed by their employer, waiting for input, until the money runs out, and working out what was in their best interest. Conclusions Indications are that many of the reported considerations are amenable to intervention, suggesting opportunities to assist workers in the process of returning to work.	[Young, Amanda E.; Choi, YoonSun; Besen, Elyssa] Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA 01748 USA	Liberty Mutual Research Institute for Safety	Young, AE (corresponding author), Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA 01748 USA.	amandae.young@libertymutual.com	Young, Amanda Ellen/HDN-1629-2022	Young, Amanda Ellen/0000-0002-7288-3469				Besen E, 2015, J OCCUP REHABIL, V25, P25, DOI 10.1007/s10926-014-9522-9; Brouwer S, 2010, J OCCUP REHABIL, V20, P104, DOI 10.1007/s10926-009-9214-z; Brouwer S, 2009, J OCCUP REHABIL, V19, P166, DOI 10.1007/s10926-009-9172-5; Bultmann U., 2013, HDB WORK DISABILITY, P149; CHEADLE A, 1994, AM J PUBLIC HEALTH, V84, P190, DOI 10.2105/AJPH.84.2.190; Dekkers-Sanchez PM, 2010, J REHABIL MED, V42, P544, DOI 10.2340/16501977-0544; Denzin N.K., 2013, LANDSCAPE QUALITATIV; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; Glassel A, 2011, J OCCUP REHABIL, V21, P167, DOI 10.1007/s10926-010-9277-x; Grunfeld EA, 2012, PSYCHO-ONCOLOGY, V21, P82, DOI 10.1002/pon.1874; Hammersley, 1992, WHAT IS WRONG ETHNOG; Heymans MW, 2006, J OCCUP REHABIL, V16, P685, DOI 10.1007/s10926-006-9058-8; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Iles RA, 2012, J REHABIL MED, V44, P781, DOI 10.2340/16501977-1019; Iles RA, 2009, J OCCUP REHABIL, V19, P25, DOI 10.1007/s10926-008-9161-0; Islam SS, 2001, AM J IND MED, V39, P84, DOI 10.1002/1097-0274(200101)39:1<84::AID-AJIM8>3.3.CO;2-K; Krause N, 2001, AM J IND MED, V40, P374, DOI 10.1002/ajim.1112; Lydell M, 2011, DISABIL REHABIL, V33, P1262, DOI 10.3109/09638288.2010.527029; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; Marhold C, 2002, J OCCUP REHABIL, V12, P65, DOI 10.1023/A:1015056429505; MAYER TG, 1995, SPINE, V20, P2060, DOI 10.1097/00007632-199509150-00021; Mitchell Laura A, 2009, Curr Opin Support Palliat Care, V3, P131, DOI 10.1097/SPC.0b013e32832b7de2; Ozegovic D, 2010, SPINE, V35, pE708, DOI 10.1097/BRS.0b013e3181d12432; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Shaw W. S., 2013, HDB WORK DISABILITY, P163; Shaw WS, 2005, DISABIL REHABIL, V27, P1269, DOI 10.1080/09638280500076269; Stewart AM, 2012, J OCCUP REHABIL, V22, P1, DOI 10.1007/s10926-011-9312-6; Udry J R, 1998, Inj Prev, V4, P94; van der Giezen AM, 2000, PAIN, V87, P285, DOI 10.1016/S0304-3959(00)00292-X; Young AE, 2015, DISABIL REHABIL, V37, P1808, DOI 10.3109/09638288.2014.979299	31	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143330	10.1371/journal.pone.0143330	http://dx.doi.org/10.1371/journal.pone.0143330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26580559	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600108
J	Chang, HT; Mishra, N; Lin, CC				Chang, Hsien-Tsung; Mishra, Nilamadhab; Lin, Chung-Chih			IoT Big-Data Centred Knowledge Granule Analytic and Cluster Framework for BI Applications: A Case Base Analysis	PLOS ONE			English	Article							INTERVAL TYPE-2; FUZZY; INTELLIGENCE; SYSTEMS; MODEL	The current rapid growth of Internet of Things (IoT) in various commercial and non-commercial sectors has led to the deposition of large-scale IoT data, of which the time-critical analytic and clustering of knowledge granules represent highly thought-provoking application possibilities. The objective of the present work is to inspect the structural analysis and clustering of complex knowledge granules in an IoT big-data environment. In this work, we propose a knowledge granule analytic and clustering (KGAC) framework that explores and assembles knowledge granules from IoT big-data arrays for a business intelligence (BI) application. Our work implements neuro-fuzzy analytic architecture rather than a standard fuzzified approach to discover the complex knowledge granules. Furthermore, we implement an enhanced knowledge granule clustering (e-KGC) mechanism that is more elastic than previous techniques when assembling the tactical and explicit complex knowledge granules from IoT big-data arrays. The analysis and discussion presented here show that the proposed framework and mechanism can be implemented to extract knowledge granules from an IoT big-data array in such a way as to present knowledge of strategic value to executives and enable knowledge users to perform further BI actions.	[Chang, Hsien-Tsung; Mishra, Nilamadhab; Lin, Chung-Chih] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan	Chang Gung University	Lin, CC (corresponding author), Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan.	cclin@mail.cgu.edu.tw	Mishra, Dr. Nilamadhab/I-3515-2014; Chang, Hsien-Tsung/E-7511-2012	Mishra, Dr. Nilamadhab/0000-0002-1330-4869; Chang, Hsien-Tsung/0000-0003-4987-5943	Ministry of Science and Technology, Taiwan [MOST 104-2218-E-182-005 -MY3, MOST 104-2221-E-182-069]; Chang Gung University [CMRPD3E0061]; Chang Gung Memorial Hospital of Chang Gung University [CMRPD3E0061]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung University; Chang Gung Memorial Hospital of Chang Gung University(Chang Gung Memorial Hospital)	Financial support was provided by the Ministry of Science and Technology, Taiwan, through Grants MOST 104-2218-E-182-005 -MY3, MOST 104-2221-E-182-069, and CMRPD3E0061 of Chang Gung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support provided by the Ministry of Science and Technology, through Grant MOST 104-2218-E-182-005 -MY3, MOST 104-2221-E-182-069 and the Chang Gung Memorial Hospital through CMRPD3E0061 of Chang Gung University is gratefully acknowledged. The authors also would like to express their deep appreciation to all anonymous reviewers for their kind comments.	Aggarwal C.C., 2012, MINING TEXT DATA, P77, DOI [DOI 10.1007/978-1-4614-3223-44, 10.1007/978-1-4614-3223-4, 10.1007/978-1-4614-3223-4_4, DOI 10.1007/978-1-4614-3223-4_4]; Al-Shayea Q. K., 2012, P 11 WSEAS INT C ART, P22; Al-Shayea Q. K., 2014, P WORLD C ENG, V1; Alelyani S, 2014, CH CRC DATA MIN KNOW, P29; [Anonymous], 2013, ARXIV13010159; Asemi A., 2014, P 3 INT C COMP ENG M; Bouveyron C, 2014, COMPUT STAT DATA AN, V71, P52, DOI 10.1016/j.csda.2012.12.008; Cai X., P 23 INT JOINT C ART, P2598; Cattelani L, 2014, COMP MED SY, P38, DOI 10.1109/CBMS.2014.35; Chen CLP, 2014, INFORM SCIENCES, V275, P314, DOI 10.1016/j.ins.2014.01.015; Chen Y., 2014, UNCERTAIN SUPPLY CHA, V2, P229; Comas DS, 2014, SOFT COMPUTING BUSIN, P267, DOI DOI 10.1007/978-3-642-53737-0_18; Davenport T., 2013, BIG DATA BIG COMPANI; Davenport T. H., 2013, MIT SLOAN MANAGEMENT, V54; Gaxiola F, 2014, INFORM SCIENCES, V260, P1, DOI 10.1016/j.ins.2013.11.006; Gayathri K. S., P 3 INT C SOFT COMP, P833; George G, 2014, ACAD MANAGE J, V57, P321, DOI 10.5465/amj.2014.4002; Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128; Kalaichelvi V, 2013, J INTELL FUZZY SYST, V25, P429, DOI 10.3233/IFS-120650; Kannan D, 2013, J CLEAN PROD, V47, P355, DOI 10.1016/j.jclepro.2013.02.010; Kar S, 2014, APPL SOFT COMPUT, V15, P243, DOI 10.1016/j.asoc.2013.10.014; Krishna Anand S., 2014, International Journal of Artificial Intelligence and Soft Computing, V4, P249, DOI 10.1504/IJAISC.2014.062822; Kuznetsov Sergei O., 2013, Formal Concept Analysis. 11th International Conference, ICFCA 2013. Proceedings, P254, DOI 10.1007/978-3-642-38317-5_17; Lemos A, 2011, IEEE T FUZZY SYST, V19, P91, DOI 10.1109/TFUZZ.2010.2087381; Lin YY, 2014, IEEE T IND ELECTRON, V61, P447, DOI 10.1109/TIE.2013.2248332; Lucia, 2013, MIL COMM INF SYST C, P1; Makridou G., 2013, INT J FINANCIAL ENG, V1, P35, DOI DOI 10.1504/IJFERM.2013.053707; Marquez-Chamorro A. E., EV COMP CEC 2013 IEE, P592; Mehta A., 2011, BIG DATA POWERING NE; Mishra N., 2014, SCI WORLD J; Mishra N., COMM PROBL SOLV ICCP, P124; Mishra N, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/172186; Ozkan G, 2014, APPL SOFT COMPUT, V24, P232, DOI 10.1016/j.asoc.2014.06.032; Park K., 2014, INT J DISTRIBUTED SE; Ren Q, 2014, INFORM SCIENCES, V255, P121, DOI 10.1016/j.ins.2013.06.010; Roostaee Razieh, 2012, International Journal of Fuzzy Systems Applications, V2, P1, DOI 10.4018/ijfsa.2012010101; Rouhani S, 2012, EXPERT SYST APPL, V39, P3764, DOI 10.1016/j.eswa.2011.09.074; Sheta AF, 2013, BUSINESS INTELLIGENC, P191, DOI DOI 10.1007/978-1-4471-4866-1_13; Silva AM, 2014, APPL SOFT COMPUT, V14, P194, DOI 10.1016/j.asoc.2013.03.022; Stefik M, 2014, PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON COLLABORATION TECHNOLOGIES AND SYSTEMS (CTS), P474, DOI 10.1109/CTS.2014.6867609; Subramanian K, 2013, IEEE CONF EVOL ADAPT, P48, DOI 10.1109/EAIS.2013.6604104; Wu DR, 2012, IEEE T FUZZY SYST, V20, P832, DOI 10.1109/TFUZZ.2012.2186818; Wu XD, 2014, IEEE T KNOWL DATA EN, V26, P97, DOI 10.1109/TKDE.2013.109; Yu MC, 2011, EXPERT SYST APPL, V38, P3416, DOI 10.1016/j.eswa.2010.08.127; Yuksel M. E., 2013, COMPUTATIONAL INTELL, P3; Zhang X., 2014, TRANSPORTATION RES C	46	5	5	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0141980	10.1371/journal.pone.0141980	http://dx.doi.org/10.1371/journal.pone.0141980			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600156	gold, Green Published			2022-12-27	WOS:000365862600006
J	Gutierrez, S; Tardaguila, J; Fernandez-Novales, J; Diago, MP				Gutierrez, Salvador; Tardaguila, Javier; Fernandez-Novales, Juan; Diago, Maria P.			Support Vector Machine and Artificial Neural Network Models for the Classification of Grapevine Varieties Using a Portable NIR Spectrophotometer	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; DISCRIMINATION; IDENTIFICATION; SPECTROSCOPY; WATER	The identification of different grapevine varieties, currently attended using visual ampelometry, DNA analysis and very recently, by hyperspectral analysis under laboratory conditions, is an issue of great importance in the wine industry. This work presents support vector machine and artificial neural network's modelling for grapevine varietal classification from in-field leaf spectroscopy. Modelling was attempted at two scales: site-specific and a global scale. Spectral measurements were obtained on the near-infrared (NIR) spectral range between 1600 to 2400 nm under field conditions in a non-destructive way using a portable spectrophotometer. For the site specific approach, spectra were collected from the adaxial side of 400 individual leaves of 20 grapevine (Vitis vinifera L.) varieties one week after veraison. For the global model, two additional sets of spectra were collected one week before harvest from two different vineyards in another vintage, each one consisting on 48 measurement from individual leaves of six varieties. Several combinations of spectra scatter correction and smoothing filtering were studied. For the training of the models, support vector machines and artificial neural networks were employed using the pre-processed spectra as input and the varieties as the classes of the models. The results from the pre-processing study showed that there was no influence whether using scatter correction or not. Also, a second-degree derivative with a window size of 5 Savitzky-Golay filtering yielded the highest outcomes. For the site-specific model, with 20 classes, the best results from the classifiers thrown an overall score of 87.25% of correctly classified samples. These results were compared under the same conditions with a model trained using partial least squares discriminant analysis, which showed a worse performance in every case. For the global model, a 6-class dataset involving samples from three different vineyards, two years and leaves monitored at post-veraison and harvest was also built up, reaching a 77.08% of correctly classified samples. The outcomes obtained demonstrate the capability of using a reliable method for fast, in-field, non-destructive grapevine varietal classification that could be very useful in viticulture and wine industry, either global or site-specific.	[Gutierrez, Salvador; Tardaguila, Javier; Fernandez-Novales, Juan; Diago, Maria P.] Univ La Rioja, CSIC, Inst Ciencias Vid & Vino, Logrono 26007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja	Diago, MP (corresponding author), Univ La Rioja, CSIC, Inst Ciencias Vid & Vino, Ctra Burgos Km 6, Logrono 26007, Spain.	mpaz.diago.santamaria@gmail.com	Fernández-Novales, Juan/K-7123-2015; Novales, Juan Fernández/ABG-2333-2021; Gutiérrez, Salvador/GLV-0302-2022; Tardaguila, Javier/K-3512-2012; Gutiérrez, Salvador/T-7637-2019; Diago, Maria P/R-9547-2018	Fernández-Novales, Juan/0000-0001-9973-2604; Novales, Juan Fernández/0000-0001-9973-2604; Tardaguila, Javier/0000-0002-6639-8723; Gutiérrez, Salvador/0000-0002-8205-9772; Diago, Maria P/0000-0003-4049-0879	Spanish Ministry of Economy and Competitiveness (MINECO) under INNGRAPE project [RTC-2014-3058-2]	Spanish Ministry of Economy and Competitiveness (MINECO) under INNGRAPE project	This work has received funding from the Spanish Ministry of Economy and Competitiveness (MINECO) under the INNGRAPE project (RTC-2014-3058-2).	ALTUBE H, 1991, VITIS, V30, P203; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Borchers H. W., 2015, PRACMA PRACTICAL NUM; Borrego J, 2002, AM J ENOL VITICULT, V53, P125; Canaza-Cayo AW, 2012, COMPUT ELECTRON AGR, V88, P141, DOI 10.1016/j.compag.2012.07.013; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Delwiche SR, 2004, J NEAR INFRARED SPEC, V12, P177, DOI 10.1255/jnirs.424; DHANOA MS, 1995, APPL SPECTROSC, V49, P765, DOI 10.1366/0003702953964615; Diago MP, 2013, COMPUT ELECTRON AGR, V99, P7, DOI 10.1016/j.compag.2013.08.021; Fernandes AM, 2015, J AGR SCI-CAMBRIDGE, V153, P455, DOI 10.1017/S0021859614000252; Fernandez-Cabanas VM, 2006, APPL SPECTROSC, V60, P17, DOI 10.1366/000370206775382839; Fernandez-Novales J, 2009, INT J FOOD SCI NUTR, V60, P265, DOI 10.1080/09637480903093116; Fu X, 2007, T ASABE, V50, P1355, DOI 10.13031/2013.23613; Galet P, 1979, PRACTICAL AMPELOGRAP; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Ivorra E, 2013, J FOOD ENG, V117, P342, DOI 10.1016/j.jfoodeng.2013.02.022; Jacquemoud S, 2001, P 8 INT S PHYS MEASU, P223; Kong WW, 2013, SENSORS-BASEL, V13, P8916, DOI 10.3390/s130708916; Li XL, 2008, BIOSYST ENG, V99, P313, DOI 10.1016/j.biosystemseng.2007.11.007; Li XL, 2007, J FOOD ENG, V81, P357, DOI 10.1016/j.jfoodeng.2006.10.033; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Pelabon C, 2013, ANN BOT-LONDON, V111, P935, DOI 10.1093/aob/mct050; Pelsy F, 2010, THEOR APPL GENET, V120, P1219, DOI 10.1007/s00122-009-1250-8; Perez-Marin D, 2010, J FOOD ENG, V99, P294, DOI 10.1016/j.jfoodeng.2010.03.002; Platt J., 1998, TECH REP; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sanchez MT, 2012, J FOOD ENG, V110, P102, DOI 10.1016/j.jfoodeng.2011.12.003; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sefc KM, 2001, MOLECULAR BIOLOGY & BIOTECHNOLOGY OF THE GRAPEVINE, P433; Stevens A., 2020, R PACKAG, P1; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Talens P, 2013, J FOOD ENG, V117, P272, DOI 10.1016/j.jfoodeng.2013.03.014; Vanloot P, 2014, COMPUT ELECTRON AGR, V102, P98, DOI 10.1016/j.compag.2014.01.009; Wang W, 2006, T ASABE, V49, P1607, DOI 10.13031/2013.22035; Werbos P., 1974, THESIS; Xie CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098522; Xu HR, 2009, J ZHEJIANG UNIV-SC B, V10, P126, DOI 10.1631/jzus.B0820200; Yang CW, 2011, J FOOD DRUG ANAL, V19, P9; Yang XL, 2015, SENSORS-BASEL, V15, P15578, DOI 10.3390/s150715578	42	34	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143197	10.1371/journal.pone.0143197	http://dx.doi.org/10.1371/journal.pone.0143197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600316	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600036
J	Ortega-Andrade, HM; Rojas-Soto, OR; Valencia, JH; de Los Monteros, AE; Morrone, JJ; Ron, SR; Cannatella, DC				Mauricio Ortega-Andrade, H.; Rojas-Soto, Octavio R.; Valencia, Jorge H.; Espinosa de los Monteros, Alejandro; Morrone, Juan J.; Ron, Santiago R.; Cannatella, David C.			Insights from Integrative Systematics Reveal Cryptic Diversity in Pristimantis Frogs (Anura: Craugastoridae) from the Upper Amazon Basin	PLOS ONE			English	Article							SPECIES DELIMITATION; HISTORICAL BIOGEOGRAPHY; PHYLOGENETIC ANALYSIS; CENTRAL-AMERICA; FOREST CANOPY; ELEUTHERODACTYLUS; LEPTODACTYLIDAE; EVOLUTION; DIVERSIFICATION; MITOCHONDRIAL	Pluralistic approaches to taxonomy facilitate a more complete appraisal of biodiversity, especially the diversification of cryptic species. Although species delimitation has traditionally been based primarily on morphological differences, the integration of new methods allows diverse lines of evidence to solve the problem. Robber frogs (Pristimantis) are exemplary, as many of the species show high morphological variation within populations, but few traits that are diagnostic of species. We used a combination of DNA sequences from three mitochondrial genes, morphometric data, and comparisons of ecological niche models (ENMs) to infer a phylogenetic hypothesis for the Pristimantis acuminatus complex. Molecular phylogenetic analyses revealed a close relationship between three new species-Pristimantis enigmaticus sp. nov., P. limoncochensis sp. nov. and P. omeviridis sp. nov.-originally confused with Pristimantis acuminatus. In combination with morphometric data and geographic distributions, several morphological characters such as degree of tympanum exposure, skin texture, ulnar/tarsal tubercles and sexual secondary characters (vocal slits and nuptial pads in males) were found to be useful for diagnosing species in the complex. Multivariate discriminant analyses provided a successful classification rate for 83-100% of specimens. Discriminant analysis of localities in environmental niche space showed a successful classification rate of 75-98%. Identity tests of ENMs rejected hypotheses of niche equivalency, although not strongly because the high values on niche overlap. Pristimantis acuminatus and P. enigmaticus sp. nov. are distributed along the lowlands of central-southern Ecuador and northern Peru, in contrast with P. limoncochensis sp. nov. and P. omeviridis sp. nov., which are found in northern Ecuador and southern Colombia, up to 1200 m in the upper Amazon Basin. The methods used herein provide an integrated framework for inventorying the greatly underestimated biodiversity in Amazonia.	[Mauricio Ortega-Andrade, H.; Rojas-Soto, Octavio R.] Inst Ecol AC, Lab Biogeog, Red Biol Evolutiva, Xalapa, Veracruz, Mexico; [Mauricio Ortega-Andrade, H.] Museo Ecuatoriano Ciencias Nat, Div Herpetol, Secc Vertebrados, Quito, Ecuador; [Mauricio Ortega-Andrade, H.] Fdn EcoCiencia, Programa Conservac Especies & Ecosistemas Amenaza, Quito, Ecuador; [Valencia, Jorge H.] Fdn Herpetol Gustavo Orces, Quito, Ecuador; [Espinosa de los Monteros, Alejandro] Inst Ecol AC, Red Biol Evolutiva, Xalapa, Veracruz, Mexico; [Morrone, Juan J.] Univ Nacl Autonoma Mexico, Fac Ciencias, Museo Zool Alfonso L Herrera, Dept Biol Evolutiva, Mexico City 04510, DF, Mexico; [Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Museo Zool, Dept Ciencias Biol, Quito, Ecuador; [Cannatella, David C.] Univ Texas Austin, Dept Integrat Biol & Biodivers Collect, Austin, TX 78712 USA	Instituto de Ecologia - Mexico; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico; Pontificia Universidad Catolica del Ecuador; University of Texas System; University of Texas Austin	Ortega-Andrade, HM (corresponding author), Inst Ecol AC, Lab Biogeog, Red Biol Evolutiva, Xalapa, Veracruz, Mexico.	biomauro@hotmail.com	Rojas-Soto, Octavio/Q-6252-2018; Espinosa de los Monteros, Alejandro/Q-6207-2018; Andrade, H. Mauricio Ortega/G-8245-2016; Morrone, Juan J./AAH-4325-2021; Ron, Santiago/J-4203-2019	Rojas-Soto, Octavio/0000-0002-0201-1454; Espinosa de los Monteros, Alejandro/0000-0002-7742-5977; Andrade, H. Mauricio Ortega/0000-0001-9464-3688; Ron, Santiago/0000-0001-6300-9350	Consejo Nacional de Ciencia y Tecnologia [275448/224620]; Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion; Richard Gilder Graduate School; Pontificia Universidad Catolica del Ecuador	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion; Richard Gilder Graduate School; Pontificia Universidad Catolica del Ecuador	Support was provided by Consejo Nacional de Ciencia y Tecnologia, No. 275448/224620 [http://www.conacyt.mx/] to HMOA; Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion [http://programasbecas.educacionsuperior.gob.ec/] to HMOA; Richard Gilder Graduate School [http://www.amnh.org/our-research/richard-gilder-graduate-school] to HMOA; Pontificia Universidad Catolica del Ecuador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Almendariz A, 2005, REV POLITECNICA, V26, P20; Barker MG, 2001, PLANT ECOL, V153, P23, DOI 10.1023/A:1017584130692; Barley AJ, 2013, EVOLUTION, V67, P3556, DOI 10.1111/evo.12219; BARVE N, 2008, TOOL PARTIAL ROC VER; Beirne D, 2011, FROGS YACHANA RESERV; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BOLT JR, 1985, BIOL J LINN SOC, V24, P83, DOI 10.1111/j.1095-8312.1985.tb00162.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Chessel D., 2004, R NEWS, V4, P5; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Christensen-Dalsgaard J, 2008, BRAIN RES BULL, V75, P365, DOI 10.1016/j.brainresbull.2007.10.044; Crawford AJ, 2003, MOL ECOL, V12, P2525, DOI 10.1046/j.1365-294X.2003.01910.x; Crawford AJ, 2005, MOL PHYLOGENET EVOL, V35, P536, DOI 10.1016/j.ympev.2005.03.006; Crawford AJ, 2013, MOL ECOL RESOUR, V13, P1005, DOI 10.1111/1755-0998.12054; Crawford AJ, 2010, HERPETOLOGICA, V66, P192, DOI 10.1655/09-018R1.1; Crump M.L., 1994, MEASURING MONITORING, P84, DOI DOI 10.1007/S10682-018-9929-4; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dixon J, 1975, MILLWAKEE PUBLIC MUS, V1975, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Duellman W.E., 2005, CUSCO AMAZONICO THE; Duellman W.E., 2009, TERRESTRIAL BREEDING; Duellman WE, 1999, PATTERNS OF DISTRIBU; Duellman William E., 1995, University of Kansas Science Bulletin, V55, P329; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Elmer KR, 2008, ZOOTAXA, P11, DOI 10.11646/zootaxa.1784.1.2; ESRI, 2010, ARCMAP 10 0; Florio AM, 2012, J EVOLUTION BIOL, V25, P1399, DOI 10.1111/j.1420-9101.2012.02528.x; Fouquet A, 2014, J BIOGEOGR, V41, P855, DOI 10.1111/jbi.12250; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046077; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guayasamin JM, 2006, HERPETOLOGICA, V62, P191, DOI 10.1655/05-40.1; Hedges SB, 2008, ZOOTAXA, P1; Heinicke MP, 2009, ZOOTAXA, P1; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hetherington TE, 1999, J COMP PHYSIOL A, V184, P395, DOI 10.1007/s003590050338; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, WORLDCLIM VERSION 1; Hooghiemstra H, 2001, INTRO BIOGEOGRAFIA L; Hu JH, 2012, NATURWISSENSCHAFTEN, V99, P553, DOI 10.1007/s00114-012-0933-1; IUCN, 2003, DIR EMPL CRIT LIST R; Jansen M, 2011, ZOOL SCR, V40, P567, DOI 10.1111/j.1463-6409.2011.00498.x; Jaramillo C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P317; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kohler J, 1998, STUD NEOTROP FAUNA E, V33, P93, DOI 10.1076/snfe.33.2.93.2158; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Lehr E, 2007, HERPETOLOGICA, V63, P94, DOI 10.1655/0018-0831(2007)63[94:ANSOAE]2.0.CO;2; Lehr E, 2007, ZOOL J LINN SOC-LOND, V149, P583, DOI 10.1111/j.1096-3642.2007.00270.x; Liao JC, 2008, ITAL J ZOOL, V75, P125, DOI 10.1080/11250000701878773; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; LYNCH J D, 1980, American Museum Novitates, P1; Lynch JD, 1997, U KANSAS NATURAL HIS, V23, P1, DOI DOI 10.5962/BHL.TITLE.7951; Lynch John D., 1997, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V21, P237; Lynch John D., 2005, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V29, P581; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; McCracken Shawn F., 2007, Phyllomedusa, V6, P23; McDiarmid R. W., 1994, MEASURING MONITORING; Miller M.A., 2010, P GAT COMP ENV WORKS; Moravec J, 2010, VERTEBRATE ZOOLOGY, V60, P10; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ortega-Andrade H Mauricio, 2013, PLoS One, V8, pe81837, DOI 10.1371/journal.pone.0081837; Ortega-Andrade HM, 2010, THESIS; OVASKA K, 1992, COPEIA, P569; Padial JM, 2008, ZOOL J LINN SOC-LOND, V152, P353, DOI 10.1111/j.1096-3642.2007.00341.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; Paez-Moscoso DJ, 2012, MOL PHYLOGENET EVOL, V65, P805, DOI 10.1016/j.ympev.2012.08.001; Pearman PB, 1997, CONSERV BIOL, V11, P1211, DOI 10.1046/j.1523-1739.1997.96202.x; PEARMAN PB, 1995, HERPETOLOGICA, V51, P325; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 1999, CONSERV BIOL, V13, P427, DOI 10.1046/j.1523-1739.1999.013002427.x; Peterson AT, 2011, MONOGRAPHS POPULATIO, P328, DOI [DOI 10.5860/CHOICE.49-6266, 10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rambaut A, 2013, TRACER VERSION 1 6; ROBERTSON JGM, 1986, ANIM BEHAV, V34, P773, DOI 10.1016/S0003-3472(86)80061-6; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; Rojas-Soto O, 2008, J FIELD ORNITHOLOGY, V79, P245; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Santos JC, 2009, PLOS BIOL, V7, P448, DOI 10.1371/journal.pbio.1000056; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SHREVE BENJAMIN, 1935, OCCAS PAPERS BOSTON SOC NAT HIST, V8, P209; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Smith SA, 2010, SYST BIOL, V59, P322, DOI 10.1093/sysbio/syq011; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; UICN [Union Internacional de Conservacion de la Naturaleza], 2012, CAT CRIT LIST ROJ UN; Urbina-C. Jose Nicolas, 2003, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V27, P105; Vigle Gregory O., 2008, Breviora, V514, P1, DOI 10.3099/0006-9698-514.1.1; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Williams RAJ, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-47; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zink RM, 1995, AUK, V112, P701; Zwickl D, 2006, THESIS	119	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143392	10.1371/journal.pone.0143392	http://dx.doi.org/10.1371/journal.pone.0143392			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600198	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600061
J	Carrillo, P; Medina-Sanchez, JM; Herrera, G; Duran, C; Segovia, M; Cortes, D; Salles, S; Korbee, N; Figueroa, FL; Mercado, JM				Carrillo, Presentacion; Medina-Sanchez, Juan M.; Herrera, Guillermo; Duran, Cristina; Segovia, Maria; Cortes, Dolores; Salles, Soluna; Korbee, Nathalie; Figueroa, Felix L.; Mercado, Jesus M.			Interactive Effect of UVR and Phosphorus on the Coastal Phytoplankton Community of the Western Mediterranean Sea: Unravelling Eco-Physiological Mechanisms	PLOS ONE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; ULTRAVIOLET-RADIATION; MARINE-PHYTOPLANKTON; PRIMARY PRODUCTIVITY; SOLAR-RADIATION; ALBORAN SEA; TAXONOMIC COMPOSITION; NUTRIENT LIMITATION; AMINO-ACIDS; LIGHT	Some of the most important effects of global change on coastal marine systems include increasing nutrient inputs and higher levels of ultraviolet radiation (UVR, 280-400 nm), which could affect primary producers, a key trophic link to the functioning of marine food webs. However, interactive effects of both factors on the phytoplankton community have not been assessed for the Mediterranean Sea. An in situ factorial experiment, with two levels of ultraviolet solar radiation (UVR+PAR vs. PAR) and nutrients (control vs. P-enriched), was performed to evaluate single and UVRxP effects on metabolic, enzymatic, stoichiometric and structural phytoplanktonic variables. While most phytoplankton variables were not affected by UVR, dissolved phosphatase (APA(EX)) and algal P content increased in the presence of UVR, which was interpreted as an acclimation mechanism of algae to oligotrophic marine waters. Synergistic UVRxP interactive effects were positive on photosynthetic variables (i.e., maximal electron transport rate, ETRmax), but negative on primary production and phytoplankton biomass because the pulse of P unmasked the inhibitory effect of UVR. This unmasking effect might be related to greater photodamage caused by an excess of electron flux after a P pulse (higher ETRmax) without an efficient release of carbon as the mechanism to dissipate the reducing power of photosynthetic electron transport.	[Carrillo, Presentacion; Medina-Sanchez, Juan M.; Herrera, Guillermo; Duran, Cristina] Univ Granada, Inst Agua, Granada, Spain; [Carrillo, Presentacion; Medina-Sanchez, Juan M.] Univ Granada, Fac Ciencias, Dept Ecol, Granada, Spain; [Segovia, Maria; Korbee, Nathalie; Figueroa, Felix L.] Univ Malaga, Fac Ciencias, Dept Ecol, E-29071 Malaga, Spain; [Cortes, Dolores; Salles, Soluna; Mercado, Jesus M.] Inst Espanol Oceanog Fuengirola, Ctr Oceanog Malaga, Malaga, Spain	University of Granada; University of Granada; Universidad de Malaga; Spanish Institute of Oceanography	Carrillo, P (corresponding author), Univ Granada, Inst Agua, Granada, Spain.	pcl@ugr.es	Mercado, Jesús M./B-1011-2008; Medina-Sánchez, Juan Manuel/A-4703-2013; Korbee, Nathalie/K-5995-2014; /ABH-3083-2020; Carrillo, Presentación/I-1601-2015; Lopez Figueroa, Felix Diego/K-7720-2014	Mercado, Jesús M./0000-0003-3291-1493; Medina-Sánchez, Juan Manuel/0000-0003-0991-9331; Korbee, Nathalie/0000-0002-9780-4915; Carrillo, Presentación/0000-0003-3794-4294; Duran Romero, Cristina/0000-0003-2382-4056; Lopez Figueroa, Felix Diego/0000-0003-3580-4693	Spanish Ministries of Science and Innovation [CGL2011-23681/BOS]; Consejeria de Innovacion, Ciencia y Empresa - Junta de Andalucia [CVI-02598]; Spanish government 'Formacion de Profesorado Universitario fellowship; Ministerio Ciencia e Innovacion [CGL2011-23681/BOS]; Spanish Government - Formacion de Profesorado Universitario Grant; Consejeria de Innovacion, Ciencia y Empresa-Junta de Andalucia [CVI-02598]	Spanish Ministries of Science and Innovation(Spanish Government); Consejeria de Innovacion, Ciencia y Empresa - Junta de Andalucia(Junta de Andalucia); Spanish government 'Formacion de Profesorado Universitario fellowship; Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Government - Formacion de Profesorado Universitario Grant; Consejeria de Innovacion, Ciencia y Empresa-Junta de Andalucia(Junta de Andalucia)	This research was supported by the Spanish Ministries of Science and Innovation (CGL2011-23681/BOS), Consejeria de Innovacion, Ciencia y Empresa - Junta de Andalucia' (Excelencia CVI-02598) and Spanish government 'Formacion de Profesorado Universitario fellowship to G. Herrera and C Duran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Ministerio Ciencia e Innovacion (CGL2011-23681/BOS), Consejeria de Innovacion, Ciencia y Empresa-Junta de Andalucia (Excelencia CVI-02598). GH and CD were supported by the Spanish Government - Formacion de Profesorado Universitario Grant. We thank the crew of the B/O F. de P.	Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bader MR, 2000, PHILOS T R SOC B, V355, P1433, DOI 10.1098/rstb.2000.0704; BADGER MR, 1985, ANNU REV PLANT PHYS, V36, P27, DOI 10.1146/annurev.arplant.36.1.27; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Beardall J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1257, DOI 10.1039/b9pp00034h; Bouchard JN, 2013, MAR BIOL, V160, P2547, DOI 10.1007/s00227-013-2247-z; Carrillo P, 2008, GLOBAL CHANGE BIOL, V14, P423, DOI 10.1111/j.1365-2486.2007.01496.x; Carrillo P, 2008, MICROB ECOL, V56, P350, DOI 10.1007/s00248-007-9353-8; Cloern JE, 2014, BIOGEOSCIENCES, V11, P2477, DOI 10.5194/bg-11-2477-2014; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; Doyle SA, 2005, LIMNOL OCEANOGR, V50, P1362, DOI 10.4319/lo.2005.50.5.1362; Duran C, 2014, MULTIPLE STRESSORS A; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Findlay S., 2003, AQUATIC ECOSYSTEMS I; Gallisai R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110762; Gao KS, 2007, PLANT PHYSIOL, V144, P54, DOI 10.1104/pp.107.098491; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Garcia-Gomez C, 2014, PHOTOCH PHOTOBIO SCI, V13, P1347, DOI 10.1039/c4pp00044g; Goyal A, 1996, P NATL ACAD SCI USA, V93, P3319, DOI 10.1073/pnas.93.8.3319; Grasshoff K, 1999, METHODS SEAWATER ANA; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hader DP, 2015, PHOTOCH PHOTOBIO SCI, V14, P108, DOI 10.1039/c4pp90035a; HELBLING EW, 1992, MAR ECOL PROG SER, V80, P89, DOI 10.3354/meps080089; Heraud P, 2005, J PHYCOL, V41, P1212, DOI 10.1111/j.1529-8817.2005.00149.x; Hessen DO, 2012, J EXP MAR BIOL ECOL, V411, P45, DOI 10.1016/j.jembe.2011.10.028; Hessen DO, 2008, DEEP-SEA RES PT II, V55, P2169, DOI 10.1016/j.dsr2.2008.05.013; Hudson JJ, 2000, NATURE, V406, P54, DOI 10.1038/35017531; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jahid IK, 2006, APPL ENVIRON MICROB, V72, P7043, DOI 10.1128/AEM.00924-06; JANSSON M, 1988, HYDROBIOLOGIA, V170, P157, DOI 10.1007/BF00024903; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; KANA TM, 1987, DEEP-SEA RES, V34, P497, DOI 10.1016/0198-0149(87)90002-1; KARENTZ D, 1991, J PHYCOL, V27, P326, DOI 10.1111/j.0022-3646.1991.00326.x; Korbee N, 2005, MAR BIOL, V146, P645, DOI 10.1007/s00227-004-1484-6; Korbee N, 2012, PHOTOCH PHOTOBIO SCI, V11, P1087, DOI 10.1039/c2pp05336e; Korbee N, 2010, LIMNOL OCEANOGR, V55, P899, DOI 10.4319/lo.2009.55.2.0899; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Krom MD, 2004, LIMNOL OCEANOGR, V49, P1582, DOI 10.4319/lo.2004.49.5.1582; Kulk G, 2011, J EXP MAR BIOL ECOL, V398, P63, DOI 10.1016/j.jembe.2010.12.011; Lawrenz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058137; Leu E, 2007, LIMNOL OCEANOGR, V52, P787, DOI 10.4319/lo.2007.52.2.0787; LIGNELL R, 1992, LIMNOL OCEANOGR, V37, P172, DOI 10.4319/lo.1992.37.1.0172; Llabres M, 2010, MAR ECOL PROG SER, V399, P27, DOI 10.3354/meps08332; Llebot C, 2010, J MARINE SYST, V83, P192, DOI 10.1016/j.jmarsys.2010.06.009; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Lubian LM, 1998, PHYCOLOGIA, V37, P16, DOI 10.2216/i0031-8884-37-1-16.1; LUDWIG LJ, 1971, PLANT PHYSIOL, V48, P712, DOI 10.1104/pp.48.6.712; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Marcoval MA, 2008, J PHOTOCH PHOTOBIO B, V91, P157, DOI 10.1016/j.jphotobiol.2008.03.002; Martinez-Lozano JA, 2011, INT J CLIMATOL, V31, P1554, DOI 10.1002/joc.2173; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; Medina-Sanchez JM, 2006, LIMNOL OCEANOGR, V51, P913; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Mercado JM, 2014, AQUAT BIOL, V22, P43, DOI 10.3354/ab00606; Mercado JM, 2008, J MARINE SYST, V71, P31, DOI 10.1016/j.jmarsys.2007.05.009; Mercado JM, 2007, PROG OCEANOGR, V74, P273, DOI 10.1016/j.pocean.2007.04.013; Mercado JM, 2006, ESTUAR COAST SHELF S, V69, P459, DOI 10.1016/j.ecss.2006.05.019; Mercado JM, 2005, SCI MAR, V69, P451, DOI 10.3989/scimar.2005.69n4451; Morales-Baquero R, 2006, LIMNOL OCEANOGR, V51, P830, DOI 10.4319/lo.2006.51.2.0830; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Neale PJ, 2014, AQUAT BIOL, V22, P25, DOI 10.3354/ab00587; Neale PJ, 2014, BIOGEOSCIENCES, V11, P2883, DOI 10.5194/bg-11-2883-2014; Olenina I., 2006, HELCON BALTIC SEA EN, P144; Peinado NK, 2004, J PHYCOL, V40, P248, DOI 10.1046/j.1529-8817.2004.03013.x; Petterson K, 1978, VERH INT VEREIN LIMN, V20, P226; Philippart CJM, 2011, J EXP MAR BIOL ECOL, V400, P52, DOI 10.1016/j.jembe.2011.02.023; Pinhassi J, 2006, AQUAT MICROB ECOL, V44, P241, DOI 10.3354/ame044241; Querol X, 2009, ATMOS CHEM PHYS, V9, P4575, DOI 10.5194/acp-9-4575-2009; Ramirez T, 2005, ESTUAR COAST SHELF S, V65, P654, DOI 10.1016/j.ecss.2005.07.012; RAVEN JA, 1981, CAN B FISH AQUAT SCI, P55; Ribes M, 1999, J PLANKTON RES, V21, P1077, DOI 10.1093/plankt/21.6.1077; Rijstenbil JW, 2002, J PLANKTON RES, V24, P1277, DOI 10.1093/plankt/24.12.1277; Segovia M, 2009, J PHYCOL, V45, P1116, DOI 10.1111/j.1529-8817.2009.00733.x; Sereda JM, 2011, HYDROBIOLOGIA, V665, P205, DOI 10.1007/s10750-011-0623-6; Shanklin J, 2010, NATURE, V465, P34, DOI 10.1038/465034a; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Sola Y, 2011, INT J CLIMATOL, V31, P1724, DOI 10.1002/joc.2194; SOMERVILLE CR, 1982, TRENDS BIOCHEM SCI, V7, P171, DOI 10.1016/0968-0004(82)90130-X; Sommaruga R, 2005, APPL ENVIRON MICROB, V71, P2154, DOI 10.1128/AEM.71.4.2154-2157.2005; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Tanaka T, 2004, LIMNOL OCEANOGR, V49, P1063, DOI 10.4319/lo.2004.49.4.1063; Tanaka T, 2011, BIOGEOSCIENCES, V8, P525, DOI 10.5194/bg-8-525-2011; Tanaka T, 2009, AQUAT MICROB ECOL, V56, P81, DOI 10.3354/ame01314; Tank SE, 2005, LIMNOL OCEANOGR, V50, P1345, DOI 10.4319/lo.2005.50.5.1345; Vadrucci M.R., 2007, TRANSITIONAL WATERS, V2, P83, DOI [10.1285/i1825229Xv1n2p83, DOI 10.1285/I1825229XV1N2P83]; van de Poll WH, 2009, PHOTOCH PHOTOBIO SCI, V8, P1295, DOI 10.1039/b904501e; Veen A, 1997, PLANT ECOL, V128, P28; VERITY PG, 1992, LIMNOL OCEANOGR, V37, P1434, DOI 10.4319/lo.1992.37.7.1434; Villafane VE, 2004, MAR ECOL PROG SER, V284, P23, DOI 10.3354/meps284023; Villafane VE, 2003, COMP SER PHOTOCHEM, V1, P357; Villafane VE, 2014, J EXP MAR BIOL ECOL, V459, P199, DOI 10.1016/j.jembe.2014.05.027; Xenopoulos MA, 2003, J PHYCOL, V39, P291, DOI 10.1046/j.1529-8817.2003.02125.x; Xenopoulos MA, 2002, ECOLOGY, V83, P423, DOI 10.1890/0012-9658(2002)083[0423:JEOURA]2.0.CO;2; Xu ZG, 2009, FUNCT PLANT BIOL, V36, P1057, DOI 10.1071/FP09092; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Zudaire L, 2001, J PHOTOCH PHOTOBIO B, V62, P26, DOI 10.1016/S1011-1344(01)00150-6	99	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142987	10.1371/journal.pone.0142987	http://dx.doi.org/10.1371/journal.pone.0142987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599583	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900053
J	Larsen, ME; Curry, L; Mastellos, N; Robb, C; Car, J; Middleton, LT				Larsen, Mark E.; Curry, Lisa; Mastellos, Nikolaos; Robb, Catherine; Car, Josip; Middleton, Lefkos T.			Development of the CHARIOT Research Register for the Prevention of Alzheimer's Dementia and Other Late Onset Neurodegenerative Diseases	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MILD COGNITIVE IMPAIRMENT; CROSS-SECTIONAL ANALYSIS; PRIMARY-CARE; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; HEALTH RESEARCH; RECRUITMENT; RECOMMENDATIONS	Background Identifying cognitively healthy people at high risk of developing dementia is an ever-increasing focus. These individuals are essential for inclusion in observational studies into the natural history of the prodromal and early disease stages and for interventional studies aimed at prevention or disease modification. The success of this research is dependent on having access to a well characterised, representative and sufficiently large population of individuals. Access to such a population remains challenging as clinical research has, historically, focussed on patients with dementia referred to secondary and tertiary services. The primary care system in the United Kingdom allows access to a true prodromal population prior to symptoms emerging and specialist referral. We report the development and recruitment rates of the CHARIOT register, a primary care-based recruitment register for research into the prevention of dementia. The CHARIOT register was designed specifically to support recruitment into observational natural history studies of pre-symptomatic or prodromal dementia stages, and primary or secondary prevention pharmaceutical trials or other prevention strategies for dementia and other cognitive problems associated with ageing. Methods Participants were recruited through searches of general practice lists across the west and central London regions. Invitations were posted to individuals aged between 60 and 85 years, without a diagnosis of dementia. Upon consent, a minimum data set of demographic and contact details was extracted from the patient's electronic health record. Results To date, 123 surgeries participated in the register, recruiting a total of 24,509 participants-a response rate of 22.3%. The age, gender and ethnicity profiles of participants closely match that of the overall eligible population. Higher response rates tended to be associated with larger practices (r = 0.34), practices with a larger older population (r = 0.27), less socioeconomically disadvantaged practices ( r = 0.68), and practices with a higher proportion of White patients (r = 0.82). Discussion Response rates are comparable to other registers reported in the literature, and indicate good interest and support for a research register and for participation in research for the prevention of age-related neurodegenerative diseases and dementia. We consider that the simplicity of the approach means that this system is easily scalable and replicable across the UK and internationally.	[Larsen, Mark E.; Mastellos, Nikolaos; Car, Josip] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Global eHlth Unit, London, England; [Curry, Lisa; Robb, Catherine; Middleton, Lefkos T.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Neuroepidemiol & Ageing Res Unit, London, England; [Car, Josip] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Imperial College London; Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Car, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Global eHlth Unit, London, England.	josip.car@imperial.ac.uk	Car, Josip/H-6755-2015	Car, Josip/0000-0001-8969-371X; Middleton, Lefkos/0000-0002-8615-3723	Janssen Pharmaceuticals; AstraZeneca; Zinfandel Pharmaceuticals; Takeda	Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); AstraZeneca(AstraZeneca); Zinfandel Pharmaceuticals; Takeda(Takeda Pharmaceutical Company Ltd)	The CHARIOT register was made possible with funding from Janssen Pharmaceuticals, AstraZeneca, Zinfandel Pharmaceuticals and Takeda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Beaton SJ, 2010, CONTEMP CLIN TRIALS, V31, P549, DOI 10.1016/j.cct.2010.08.005; Bell-Syer SEM, 2000, FAM PRACT, V17, P187, DOI 10.1093/fampra/17.2.187; Bower P, 2007, FAM PRACT, V24, P601, DOI 10.1093/fampra/cmm051; Bower P, 2009, FAM PRACT, V26, P391, DOI 10.1093/fampra/cmp037; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Department of Health, DEM CHALL AR ACT IMP; Douglas L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-546; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Gill TM, 2001, J AM GERIATR SOC, V49, P1039, DOI 10.1046/j.1532-5415.2001.49206.x; Health & Social Care Information Centre, QUAL OUTC FRAM; Hetherton J, 2004, PRIM HEALTH CARE RES, V5, P5, DOI DOI 10.1191/1463423604PC1680A]; Iliffe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-9; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; Khadjesari Z, 2013, BRIT J GEN PRACT, V63, pE706, DOI 10.3399/bjgp13X673720; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lyketsos CG, 2007, NEUROLOGY, V68, P1800; Mason VL, 2007, FAM PRACT, V24, P518, DOI 10.1093/fampra/cmm047; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; Olsson T, 2015, AD PD C 18 22 MARCH; Ousset P-J, 2014, J Prev Alzheimers Dis, V1, P40, DOI 10.14283/jpad.2014.19; Patel M.X., 2003, ADV PSYCHIAT TREAT, V9, P229, DOI [10.1192/apt.9.3.229, DOI 10.1192/APT.9.3.229]; Public Health England, NAT GEN PRACT PROF; Sano M, 2008, CLIN TRIALS, V5, P523, DOI 10.1177/1740774508096313; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sullivan F.M., 2011, TRIALS S1, V12, pA115, DOI DOI 10.1186/1745-6215-12-S1-A115; Vellas B, 2012, J NUTR HEALTH AGING, V16, P339, DOI 10.1007/s12603-012-0044-x; Wang YY, 2006, BRIT J GEN PRACT, V56, P830; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; World Health Organization, DEM CAS SET TRIPL 20	35	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141806	10.1371/journal.pone.0141806	http://dx.doi.org/10.1371/journal.pone.0141806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599631	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900015
J	Spencer, MD; Tyndall, AV; Davenport, MH; Argourd, L; Anderson, TJ; Eskes, GA; Friedenreich, CM; Hogan, DB; Leigh, R; Meshi, B; Smith, EE; Wilson, BJ; Wilton, SB; Poulin, MJ				Spencer, Matthew D.; Tyndall, Amanda V.; Davenport, Margie H.; Argourd, Laurie; Anderson, Todd J.; Eskes, Gail A.; Friedenreich, Christine M.; Hogan, David B.; Leigh, Richard; Meshi, Bernard; Smith, Eric E.; Wilson, Ben J.; Wilton, Stephen B.; Poulin, Marc J.			Cerebrovascular Responsiveness to Hypercapnia Is Stable over Six Months in Older Adults	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; TRANSCRANIAL DOPPLER ULTRASOUND; COGNITIVE FUNCTION; AEROBIC EXERCISE; CARBON-DIOXIDE; REACTIVITY; FITNESS; PERFORMANCE; POPULATION; VELOCITY	The primary purpose of this Brain in Motion (BIM) sub-study was to determine the 6-month stability of resting blood flow velocity and cerebrovascular responsiveness to a euoxic hypercapnic challenge in a group of physically inactive community dwelling men and men aged >= 55 yrs (range 55-92 yrs). At baseline and 6 months later 88 women (65 +/- 6 yr) and 78 men (67 +/- 7 yr) completed a hypercapnic challenge (step changes from resting end-tidal PCO2 ((PETCO2) to +1, +5 and +8 mmHg above rest) while cerebral blood flow velocity was assessed using transcranial Doppler ultrasound. Peak velocity of the middle cerebral artery (MCAv) was increased (p<0.05) at the second visit during rest (51 +/- 2 vs. 52 +/- 4); however, these differences were abolished (p>0.05) when MCAv was normalized to PETCO2. During hypercapnia, MCAv tended to be increased at follow-up, but this finding was absent when MCAv/PETCO2 was compared across time. Cerebrovascular reactivity (i.e., Delta MCAv/Delta PETCO2) was similar (p>0.05) between testing occasions regardless of the approach taken (i.e., considering only the lower step [from +1 to +5 mmHg]; the upper step [+5 to +8 mmHg]; or the complete test taken together). In conclusion, this study has shown that cerebral blood flow and cerebrovascular responsiveness to acute euoxic hypercapnia are stable in older, healthy adults over a 6-month period. Modest changes in MCAv over time must be viewed in the context of underlying differences in PETCO2, an important finding with implications for future studies considering cerebral blood flow velocity.	[Spencer, Matthew D.; Tyndall, Amanda V.; Davenport, Margie H.; Argourd, Laurie; Eskes, Gail A.; Leigh, Richard; Poulin, Marc J.] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Tyndall, Amanda V.; Davenport, Margie H.; Argourd, Laurie; Hogan, David B.; Smith, Eric E.; Poulin, Marc J.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Anderson, Todd J.; Wilton, Stephen B.; Poulin, Marc J.] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Anderson, Todd J.] Univ Calgary, Cumming Sch Med, Dept Cardiac Sci, Calgary, AB T2N 4N1, Canada; [Eskes, Gail A.] Dalhousie Univ, Fac Med, Dept Psychiat, Halifax, NS B3H 2E2, Canada; [Friedenreich, Christine M.] Canc Control Alberta, Alberta Hlth Serv, Dept Canc Epidemiol & Prevent Res, Calgary, AB T2S 3C3, Canada; [Friedenreich, Christine M.; Hogan, David B.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB T2N 4N1, Canada; [Friedenreich, Christine M.] Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Hogan, David B.; Leigh, Richard; Meshi, Bernard; Wilson, Ben J.] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB T2N 4N1, Canada; [Hogan, David B.; Smith, Eric E.; Poulin, Marc J.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Leigh, Richard] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada; [Poulin, Marc J.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; Dalhousie University; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Poulin, MJ (corresponding author), Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada.	poulin@ucalgary.ca	Smith, Eric E/C-5443-2012; Hogan, David Bryan/I-4360-2013	Smith, Eric E/0000-0003-3956-1668; Hogan, David Bryan/0000-0002-9462-5460; Eskes, Gail/0000-0001-5867-9616; Friedenreich, Christine/0000-0002-4783-1966	Eyes High Postdoctoral Fellowship - University of Calgary; Alberta Innovates - Health Solutions (AIHS) Postdoctoral Fellowship; Alzheimer Society of Canada Research Program doctoral award; Canadian Institutes for Health Research/Heart and Stroke Foundation of Canada - Focus on Stroke Postdoctoral Fellowship; Canadian Institutes for Health Research Operating Grant [MOP-93717]	Eyes High Postdoctoral Fellowship - University of Calgary; Alberta Innovates - Health Solutions (AIHS) Postdoctoral Fellowship; Alzheimer Society of Canada Research Program doctoral award; Canadian Institutes for Health Research/Heart and Stroke Foundation of Canada - Focus on Stroke Postdoctoral Fellowship; Canadian Institutes for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	MD Spencer was supported by an Eyes High Postdoctoral Fellowship awarded by the University of Calgary and an Alberta Innovates - Health Solutions (AIHS) Postdoctoral Fellowship. AV Tyndall was supported by an Alzheimer Society of Canada Research Program doctoral award. MH Davenport was supported by a Canadian Institutes for Health Research/Heart and Stroke Foundation of Canada - Focus on Stroke Postdoctoral Fellowship. CM Friedenreich holds an Alberta Innovates-Health Solutions Health Senior Scholar Award and the ACF Weekend to End Women's Cancers Breast Cancer Chair. EE Smith holds the Katthy Taylor Chair in Vascular Dementia. DB Hogan holds The Brenda Strafford Foundation Chair in Geriatric Medicine. MJP Holds The Brenda Strafford Foundation Chair in Alzheimer Research. This research was supported by a Canadian Institutes for Health Research Operating Grant (MOP-93717; PI, MJ Poulin; Co-Applicants and Collaborators, TJ Anderson, GA Eskes, CM Friedenreich, DB Hogan; R Leigh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to the participants in this study and to acknowledge the assistance provided by Brad Hanson, Grazyna Burek, Jacqueline Harrison, Tona Pitt and Kristin Sabourin. MD Spencer was supported by an Eyes High Postdoctoral Fellowship awarded by the University of Calgary and an Alberta Innovates-Health Solutions (AIHS) Postdoctoral Fellowship. AV Tyndall was supported by an Alzheimer Society of Canada Research Program doctoral award. MH Davenport was supported by a Canadian Institutes for Health Research/Heart and Stroke Foundation of Canada-Focus on Stroke Postdoctoral Fellowship. CM Friedenreich holds an Alberta Innovates-Health Solutions Health Senior Scholar Award and the ACF Weekend to End Women's Cancers Breast Cancer Chair. EE Smith holds the Katthy Taylor Chair in Vascular Dementia. DB Hogan holds The Brenda Strafford Foundation Chair in Geriatric Medicine. MJP Holds The Brenda Strafford Foundation Chair in Alzheimer Research. This research was supported by a Canadian Institutes for Health Research Operating Grant (MOP-93717; PI, MJ Poulin; Co-Applicants and Collaborators, TJ Anderson, GA Eskes, CM Friedenreich, DB Hogan; R Leigh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Ainslie PN, 2014, J APPL PHYSIOL, V117, P1081, DOI 10.1152/japplphysiol.00854.2014; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; ARTS MGJ, 1972, MED BIOL ENG, V10, P23, DOI 10.1007/BF02474565; Baker AB, 2003, EXP AGING RES, V29, P47, DOI 10.1080/03610730303706; Battisti-Charbonney A, 2011, J PHYSIOL-LONDON, V589, P3039, DOI 10.1113/jphysiol.2011.206052; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown AD, 2010, NEUROBIOL AGING, V31, P2047, DOI 10.1016/j.neurobiolaging.2008.11.002; Canadian Society for Exercise Physiology, 1996, PROF FITN LIF CONS R; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; Davenport MH, 2012, EXERC SPORT SCI REV, V40, P153, DOI 10.1097/JES.0b013e3182553430; Donald AE, 2008, J AM COLL CARDIOL, V51, P1959, DOI 10.1016/j.jacc.2008.02.044; Fierstra J, 2010, J NEUROL NEUROSUR PS, V81, P290, DOI 10.1136/jnnp.2009.188078; Galvin SD, 2010, ANAESTH INTENS CARE, V38, P710, DOI 10.1177/0310057X1003800415; Halani S, 2015, NEUROIMAGE, V110, P110, DOI 10.1016/j.neuroimage.2015.01.050; Hatab MR, 1997, ULTRASOUND MED BIOL, V23, P1025, DOI 10.1016/S0301-5629(97)00030-6; Ide Kojiro, 2003, Journal of Applied Physiology, V95, P129; Lambertsen CJ, 1998, J APPL PHYSIOL, V85, P386, DOI 10.1152/jappl.1998.85.2.386; LAUTT WW, 1989, MICROVASC RES, V37, P230, DOI 10.1016/0026-2862(89)90040-X; Mitsis GD, 2002, P ANN INT IEEE EMBS, P1341, DOI 10.1109/IEMBS.2002.1106418; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Paterson DH, 1999, MED SCI SPORT EXER, V31, P1813, DOI 10.1097/00005768-199912000-00018; Poulin MJ, 1996, J APPL PHYSIOL, V81, P1084, DOI 10.1152/jappl.1996.81.3.1084; Poulin MJ, 1996, STROKE, V27, P2244, DOI 10.1161/01.STR.27.12.2244; Poulin MJ, 1998, J APPL PHYSIOL, V85, P388, DOI 10.1152/jappl.1998.85.2.388; Przybylowski T, 2003, J PHYSIOL-LONDON, V548, P323, DOI 10.1113/jphysiol.2002.029678; Regan RE, 2014, BRAIN BEHAV, V4, P775, DOI 10.1002/brb3.275; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Schwertfeger N, 2006, J NEUROL SCI, V249, P135, DOI 10.1016/j.jns.2006.06.009; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Sobczyk O, 2014, NEUROIMAGE, V92, P56, DOI 10.1016/j.neuroimage.2014.01.051; Sobczyk O, 2015, J CEREBR BLOOD F MET, V35, P213, DOI 10.1038/jcbfm.2014.184; Stoquart-ElSankari S, 2007, J CEREBR BLOOD F MET, V27, P1563, DOI 10.1038/sj.jcbfm.9600462; Strohm J, 2014, RESP PHYSIOL NEUROBI, V197, P15, DOI 10.1016/j.resp.2014.03.003; Thomas BP, 2014, J CEREBR BLOOD F MET, V34, P242, DOI 10.1038/jcbfm.2013.194; Tyndall AV, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-21; Verbree J, 2014, J APPL PHYSIOL, V117, P1084, DOI 10.1152/japplphysiol.00651.2014; Viticchi G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.027; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wilson MH, 2011, J CEREBR BLOOD F MET, V31, P2019, DOI 10.1038/jcbfm.2011.81	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143059	10.1371/journal.pone.0143059	http://dx.doi.org/10.1371/journal.pone.0143059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599343	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900060
J	Yu, HF; Sui, YJ; Wang, YC; Sato, N; Frey, B; Xia, Z; Waldmann, TA; Berzofsky, J				Yu, Huifeng; Sui, Yongjun; Wang, Yichuan; Sato, Noriko; Frey, Blake; Xia, Zheng; Waldmann, Thomas A.; Berzofsky, Jay			Interleukin-15 Constrains Mucosal T Helper 17 Cell Generation: Influence of Mononuclear Phagocytes	PLOS ONE			English	Article							INTESTINAL DENDRITIC CELLS; IN-VITRO; IMMUNE-RESPONSES; IL-15; EXPRESSION; DIFFERENTIATION; SUBSETS; TH17; PATHWAYS; DISTINCT	Interleukin (IL)-15 has multiple roles in innate and adaptive immunity, especially regarding CD8(+) T cells and natural killer cells. However, the role of IL-15 in regulating differentiation of T helper cell subsets and mononuclear phagocytes (MPs) in different tissues in vivo is unknown. Here we report that IL-15 indirectly regulates Th17 but not other Th subsets in the intestinal lamina propria (LP), apparently through effects on MPs. Th17 cells in the LP were more prevalent in IL-15 KO mice than their wild-type counterparts, and less prevalent in IL-15 transgenic mice than their wild-type littermates, even co-caged. MPs from the LP of these mice were sufficient to mimic the in vivo finding in vitro by skewing of cocultured wild type OVA-specific CD4(+) T cells. However, production of IL-15 or lack thereof by these MPs was not sufficient to explain the skewing, as addition or blockade of IL- 15 in the cultures had no effect. Rather, a skewing of the relative proportion of CD11b(+), CD103(+) and double positive LP MP subsets in transgenic and KO could explain the differences in Th17 cells. Thus, IL-15 may influence MP subsets in the gut in a novel way that alters the frequency of LP Th17 cells.	[Yu, Huifeng; Sui, Yongjun; Wang, Yichuan; Frey, Blake; Xia, Zheng; Berzofsky, Jay] NIH, Vaccine Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Sato, Noriko] NCI, Mol Imaging Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Waldmann, Thomas A.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sui, YJ (corresponding author), NIH, Vaccine Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA.	suiy@niaid.nih.gov; berzofsj@mail.nih.gov	Sui, Yongjun/AAA-3228-2019; Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660; Sato, Noriko/0000-0002-9372-1725; Sui, Yongjun/0000-0002-1568-4607	National Cancer Institute (NCI) [ZO1 SC 004020]; NATIONAL CANCER INSTITUTE [Z01SC004020, ZIBBC010906] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Cancer Institute (NCI) intramural funding ZO1 SC 004020.	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Becker M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00326; Borger P, 1999, IMMUNOLOGY, V96, P207; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Fehniger TA, 2002, CYTOKINE GROWTH F R, V13, P169, DOI 10.1016/S1359-6101(01)00021-1; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Gross M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00254; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Imamichi H, 2008, EUR J IMMUNOL, V38, P1621, DOI 10.1002/eji.200737607; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jaensson-Gyllenback E, 2011, MUCOSAL IMMUNOL, V4, P438, DOI 10.1038/mi.2010.91; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim JJ, 1998, EUR J IMMUNOL, V28, P1089, DOI 10.1002/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lu J, 2002, CLIN CANCER RES, V8, P3877; Malamut G, 2010, J CLIN INVEST, V120, P2131, DOI 10.1172/JCI41344; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mann ER, 2013, IMMUNOL LETT, V150, P30, DOI 10.1016/j.imlet.2013.01.007; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Masuda A, 2000, J BIOL CHEM, V275, P29331, DOI 10.1074/jbc.M910290199; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mishra A, 2014, CLIN CANCER RES, V20, P2044, DOI 10.1158/1078-0432.CCR-12-3603; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Oh S, 2004, P NATL ACAD SCI USA, V101, P15154, DOI 10.1073/pnas.0406649101; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Pandiyan P, 2012, J IMMUNOL, V189, P4237, DOI 10.4049/jimmunol.1201476; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Raki M, 2006, GASTROENTEROLOGY, V131, P428, DOI 10.1053/j.gastro.2006.06.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Scott CL, 2015, MUCOSAL IMMUNOL, V8, P327, DOI 10.1038/mi.2014.70; Seder RA, 1996, J IMMUNOL, V156, P2413; Sin JI, 1998, EUR J IMMUNOL, V28, P3530, DOI 10.1002/(SICI)1521-4141(199811)28:11<3530::AID-IMMU3530>3.0.CO;2-C; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Terabe M, 2008, J IMMUNOL, V180, P7276, DOI 10.4049/jimmunol.180.11.7276; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Umemura M, 2001, J IMMUNOL, V167, P946, DOI 10.4049/jimmunol.167.2.946; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	74	133	135	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143001	10.1371/journal.pone.0143001	http://dx.doi.org/10.1371/journal.pone.0143001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600079	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900055
J	Ko, SY; Ko, HA; Chu, KH; Shieh, TM; Chi, TC; Chen, HI; Chang, WC; Chang, SS				Ko, Shun-Yao; Ko, Hshin-An; Chu, Kuo-Hsiung; Shieh, Tzong-Ming; Chi, Tzong-Cherng; Chen, Hong-I; Chang, Weng-Cheng; Chang, Shu-Shing			The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; REDUCE OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; NEUROBLASTOMA-CELLS; IN-VITRO; BETA; SIRT1; CYTOTOXICITY; RESVERATROL; NEUROTOXICITY	Amyloid precursor protein (APP) has been modified by beta and gamma-secretase that cause amyloid deposits (plaques) in neuronal cells. Glyceraldhyde-derived AGEs has been identified as a major source of neurotoxicity in Alzheimer's disease (AD). In a previous study, we demonstrated that glyceraldehyde-derived AGEs increase APP and A beta via ROS. Furthermore, the combination of AGEs and A beta has been shown to enhance neurotoxicity. In mice, APP expression is increased by tail vein injection of AGEs. This evidence suggests a correlation between AGEs and the development of AD. However, the role played by AGEs in the pathogenesis of AD remains unclear. In this report, we demonstrate that AGEs up-regulate APP processing protein (BACE and PS1) and Sirt1 expression via ROS, but do not affect the expression of downstream antioxidant genes HO-1 and NQO-1. Moreover, we found that AGEs increase GRP78 expression and enhance the cell death-related pathway p53, bcl-2/bax ratio, caspase 3. These results indicate that AGEs impair the neuroprotective effects of Sirt1 and lead to neuronal cell death via ER stress. Our findings suggest that AGEs increase ROS production, which stimulates downstream pathways related to APP processing, A beta production, Sirt1, and GRP78, resulting in the up-regulation of cell death related pathway. This in-turn enhances neuronal cell death, which leads to the development of AD.	[Ko, Shun-Yao; Chi, Tzong-Cherng; Chen, Hong-I; Chang, Weng-Cheng] Chang Jung Christian Univ, Grad Inst Med Sci, Coll Hlth Sci, Tainan, Taiwan; [Ko, Shun-Yao; Chi, Tzong-Cherng; Chen, Hong-I; Chang, Shu-Shing] Chang Jung Christian Univ, Innovate Res Ctr Med, Tainan, Taiwan; [Ko, Hshin-An] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan; [Chu, Kuo-Hsiung] Chang Jung Christian Univ, Dept Biosci Technol, Coll Hlth Sci, Tainan, Taiwan; [Shieh, Tzong-Ming] China Med Univ, Dept Dent Hyg, Taichung, Taiwan	Chang Jung Christian University; Chang Jung Christian University; National Chung Hsing University; Chang Jung Christian University; China Medical University Taiwan	Ko, SY (corresponding author), Chang Jung Christian Univ, Grad Inst Med Sci, Coll Hlth Sci, Tainan, Taiwan.	syko@mail.cjcu.edu.tw						Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Aso E, 2013, CURR ALZHEIMER RES, V10, P290, DOI 10.2174/15672050112099990128; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Choei H, 2004, ACTA NEUROPATHOL, V108, P189, DOI 10.1007/s00401-004-0871-x; Choi CW, 2011, PLANTA MED, V77, P374, DOI 10.1055/s-0030-1250370; Costa RO, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.011; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Deuther-Conrad W, 2001, NEUROSCI LETT, V312, P29, DOI 10.1016/S0304-3940(01)02174-7; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Gasic-Milenkovic J, 2001, Z GERONTOL GERIATR, V34, P457, DOI 10.1007/s003910170018; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Ghemrawi R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.69; Huang KP, 2015, MOL CELL ENDOCRINOL, V399, P178, DOI 10.1016/j.mce.2014.08.014; Huang KP, 2013, FREE RADICAL BIO MED, V65, P528, DOI 10.1016/j.freeradbiomed.2013.07.029; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333; Khan RS, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-3; Khan RS, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00063; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Ko SY, 2010, FREE RADICAL BIO MED, V49, P474, DOI 10.1016/j.freeradbiomed.2010.05.005; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee S, 2011, EXP EYE RES, V93, P204, DOI 10.1016/j.exer.2010.07.015; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Li JG, 2014, INT J MOL SCI, V15, P5928, DOI 10.3390/ijms15045928; Li YG, 2013, BIOCHEM BIOPH RES CO, V438, P270, DOI 10.1016/j.bbrc.2013.07.042; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039120; Liu T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03467; Loske C, 1998, J NEURAL TRANSM, V105, P1005, DOI 10.1007/s007020050108; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mruthinti S, 2006, NEUROSCIENCE, V142, P463, DOI 10.1016/j.neuroscience.2006.06.010; Mruthinti S, 2007, CURR ALZHEIMER RES, V4, P581, DOI 10.2174/156720507783018325; Munch G, 1997, BBA-MOL BASIS DIS, V1360, P17, DOI 10.1016/S0925-4439(96)00062-2; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Olivieri G, 2000, J NEUROCHEM, V74, P231, DOI 10.1046/j.1471-4159.2000.0740231.x; Olivieri G, 2001, J NEUROCHEM, V76, P224, DOI 10.1046/j.1471-4159.2001.00090.x; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Sato Takashi, 2006, Am J Alzheimers Dis Other Demen, V21, P197; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sun QR, 2014, BIOCHEM BIOPH RES CO, V447, P485, DOI 10.1016/j.bbrc.2014.04.019; Takeuchi M, 2000, J NEUROPATH EXP NEUR, V59, P1094, DOI 10.1093/jnen/59.12.1094; Takeuchi M, 2004, CURR ALZHEIMER RES, V1, P39, DOI 10.2174/1567205043480582; Uribarri J, 2014, AMINO ACIDS, V46, P301, DOI 10.1007/s00726-013-1502-4; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Wang MY, 2009, ACTA NEUROPATHOL, V118, P381, DOI 10.1007/s00401-009-0513-4; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Woltjer RL, 2003, J ALZHEIMERS DIS, V5, P467, DOI 10.3233/JAD-2003-5607; Xiong YY, 2013, DOSE-RESPONSE, V11, P270, DOI 10.2203/dose-response.12-005.Gao; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Ye QY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-82; Yuan D, 2014, INT J MOL SCI, V15, P13209, DOI 10.3390/ijms150813209; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou SS, 2014, TOXICOL LETT, V227, P113, DOI 10.1016/j.toxlet.2014.03.011	58	82	84	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143345	10.1371/journal.pone.0143345	http://dx.doi.org/10.1371/journal.pone.0143345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587989	gold, Green Published, Green Submitted			2022-12-27	WOS:000365251500053
J	Qian, D; Nan, Q; Yang, YM; Li, H; Zhou, YL; Zhu, JE; Bai, QF; Zhang, P; An, LZ; Xiang, Y				Qian, Dong; Nan, Qiong; Yang, Yueming; Li, Hui; Zhou, Yuelong; Zhu, Jingen; Bai, Qifeng; Zhang, Pan; An, Lizhe; Xiang, Yun			Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; ACTIN-BINDING PROTEIN; FILAMENT-SEVERING PROTEIN; F-ACTIN; BUNDLING PROTEIN; TERMINAL HALF; ARABIDOPSIS; CALCIUM; VILLIN; IDENTIFICATION	The villin/gelsolin/fragmin superfamily is a major group of Ca2+-dependent actin-binding proteins (ABPs) involved in various cellular processes. Members of this superfamily typically possess three or six tandem gelsolin-like (G) domains, and each domain plays a distinct role in actin filament dynamics. Although the activities of most G domains have been characterized, the biochemical function of the G3 domain remains poorly understood. In this study, we carefully compared the detailed biochemical activities of ABP29 (a new member of this family that contains the G1-G2 domains of lily ABP135) and ABP135(G1-G3) (which contains the G1-G3 domains of lily ABP135). In the presence of high Ca2+ levels in vitro (200 and 10 mu M), ABP135(G1-G3) exhibited greater actin severing and/or depolymerization and nucleating activities than ABP29, and these proteins had similar actin capping activities. However, in the presence of low levels of Ca2+ (41 nM), ABP135(G1-G3) had a weaker capping activity than ABP29. In addition, ABP29 inhibited F-actin depolymerization, as shown by dilution-mediated depolymerization assay, differing from the typical superfamily proteins. In contrast, ABP135(G1-G3) accelerated F-actin depolymerization. All of these results demonstrate that the G3 domain plays specific roles in regulating the activities of the lily villin/gelsolin/fragmin superfamily proteins.	[Qian, Dong; Nan, Qiong; Yang, Yueming; Li, Hui; Zhou, Yuelong; Zhu, Jingen; Zhang, Pan; An, Lizhe; Xiang, Yun] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China; [Bai, Qifeng] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Xiang, Y (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China.	xiangy@lzu.edu.cn	Bai, Qifeng/A-2950-2019; Yang, Xiaoming/GRJ-9483-2022	Bai, Qifeng/0000-0001-7296-6187; Xiang, Yun/0000-0002-5178-0700; Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program [2014CB954203]; National Natural Science Foundation of China [31270326, 30800079]; Natural Science Foundation for Distinguished Yong Scholars of Gansu Province [2013GS10064]; Program for New Century Excellent Talents in University [NCET-13-0264]; Fundamental Research Funds for the Central Universities [lzujbky-2013-243]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Distinguished Yong Scholars of Gansu Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding: This work was supported by the National Basic Research Program (2014CB954203), National Natural Science Foundation of China (31270326 and 30800079), the Natural Science Foundation for Distinguished Yong Scholars of Gansu Province (2013GS10064), the Program for New Century Excellent Talents in University (NCET-13-0264) and the Fundamental Research Funds for the Central Universities (lzujbky-2013-243).	BAZARI WL, 1988, P NATL ACAD SCI USA, V85, P4986, DOI 10.1073/pnas.85.14.4986; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Chen CY, 2002, PLANT CELL, V14, P2175, DOI 10.1105/tpc.003038; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; Fan XX, 2004, PLANT PHYSIOL, V136, P3979, DOI 10.1104/pp.104.046326; Friederich E, 1999, J BIOL CHEM, V274, P26751, DOI 10.1074/jbc.274.38.26751; Ghoshdastider U, 2013, CYTOSKELETON, V70, P775, DOI 10.1002/cm.21149; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Gunning PW, 2015, J CELL SCI, V128, P2009, DOI 10.1242/jcs.165563; Hampton CM, 2008, STRUCTURE, V16, P1882, DOI 10.1016/j.str.2008.09.015; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; Huang SJ, 2004, J BIOL CHEM, V279, P23364, DOI 10.1074/jbc.M312973200; Huang SJ, 2003, J BIOL CHEM, V278, P44832, DOI 10.1074/jbc.M306670200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jia HL, 2013, J BIOL CHEM, V288, P32277, DOI 10.1074/jbc.M113.483594; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Klaavuniemi T, 2008, J BIOL CHEM, V283, P26071, DOI 10.1074/jbc.M803618200; Klahre U, 2000, PLANT PHYSIOL, V122, P35, DOI 10.1104/pp.122.1.35; Kolappan SL, 2003, J MOL BIOL, V329, P85, DOI 10.1016/S0022-2836(03)00383-8; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Liu ZM, 2013, CYTOSKELETON, V70, P228, DOI 10.1002/cm.21103; Liu ZM, 2011, J BIOL CHEM, V286, P34051, DOI 10.1074/jbc.M111.237404; Ma BY, 2012, J BIOL CHEM, V287, P19008, DOI 10.1074/jbc.M111.281873; Maciver SK, 2000, FEBS LETT, V473, P71, DOI 10.1016/S0014-5793(00)01507-6; McGough AM, 2003, FEBS LETT, V552, P75, DOI 10.1016/S0014-5793(03)00932-3; Messerli MA, 2000, DEV BIOL, V222, P84, DOI 10.1006/dbio.2000.9709; Mittermann I, 2005, FEBS LETT, V579, P3807, DOI 10.1016/j.febslet.2005.05.066; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Nakayasu T, 1998, BIOCHEM BIOPH RES CO, V249, P61, DOI 10.1006/bbrc.1998.9088; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Peddada N, 2013, J BIOL CHEM, V288, P28266, DOI 10.1074/jbc.M113.463224; Pellieux C, 2003, J BIOL CHEM, V278, P29136, DOI 10.1074/jbc.M300598200; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; POPE B, 1995, BIOCHEMISTRY-US, V34, P1583, DOI 10.1021/bi00005a014; Pope BJ, 1997, BIOCHEMISTRY-US, V36, P15848, DOI 10.1021/bi972192p; Qin T, 2014, PLANT CELL, V26, P325, DOI 10.1105/tpc.113.119768; Qu XL, 2013, PLANT CELL, V25, P1803, DOI 10.1105/tpc.113.110940; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Staiger CJ, 2004, PLANT CYTOSKELETON C; Su H, 2007, J INTEGR PLANT BIOL, V49, P1183, DOI 10.1111/j.1672-9072.2007.00546.x; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; SUN HQ, 1994, J BIOL CHEM, V269, P9473; Vidali L, 2001, MOL BIOL CELL, V12, P2534, DOI 10.1091/mbc.12.8.2534; Vidali L, 1999, PROTOPLASMA, V209, P283, DOI 10.1007/BF01453456; Wang H, 2009, J BIOL CHEM, V284, P21265, DOI 10.1074/jbc.M109.019760; Wang T, 2008, MOL PLANT, V1, P1048, DOI 10.1093/mp/ssn073; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; YIN HL, 1988, J CELL BIOL, V106, P805, DOI 10.1083/jcb.106.3.805; Yokota E, 1999, PLANTA, V209, P264, DOI 10.1007/s004250050631; Yokota E, 2003, PLANT CELL PHYSIOL, V44, P1088, DOI 10.1093/pcp/pcg132; Zhang H, 2010, PLANT CELL, V22, P2749, DOI 10.1105/tpc.110.076257; Zhang Y, 2006, EMBO J, V25, P4458, DOI 10.1038/sj.emboj.7601323; Zheng YY, 2013, PLANT CELL, V25, P3405, DOI 10.1105/tpc.113.117820	60	4	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143174	10.1371/journal.pone.0143174	http://dx.doi.org/10.1371/journal.pone.0143174			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587673	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500035
J	Carter, JR; Taylor, S; Fraser, TS; Kucharski, CA; Dawson, JL; Fraser, MJ				Carter, James R.; Taylor, Samantha; Fraser, Tresa S.; Kucharski, Cheryl A.; Dawson, James L.; Fraser, Malcolm J., Jr.			Suppression of the Arboviruses Dengue and Chikungunya Using a Dual-Acting Group-I Intron Coupled with Conditional Expression of the Bax C-Terminal Domain	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; APOPTOTIC CELL-DEATH; GENE DRIVE SYSTEMS; HUMAN CANCER-CELLS; TRANSSPLICING RIBOZYMES; AEDES-ALBOPICTUS; TETRAHYMENA RIBOZYME; VIRUS-REPLICATION; MOSQUITO CELLS; CATALYTIC CORE	In portions of South Asia, vectors and patients co-infected with dengue (DENV) and chikungunya (CHIKV) are on the rise, with the potential for this occurrence in other regions of the world, for example the United States. Therefore, we engineered an antiviral approach that suppresses the replication of both arboviruses in mosquito cells using a single antiviral group I intron. We devised unique configurations of internal, external, and guide sequences that permit homologous recognition and splicing with conserved target sequences in the genomes of both viruses using a single trans-splicing Group I intron, and examined their effectiveness to suppress infections of DENV and CHIKV in mosquito cells when coupled with a proapoptotic 3' exon, Delta N Bax. RT-PCR demonstrated the utility of these introns in trans-splicing the Delta N Bax sequence downstream of either the DENV or CHIKV target site in transformed Aedes albopictus C6/36 cells, independent of the order in which the virus specific targeting sequences were inserted into the construct. This trans-splicing reaction forms DENV or CHIKV Delta N Bax RNA fusions that led to apoptotic cell death as evidenced by annexin V staining, caspase, and DNA fragmentation assays. TCID50-IFA analyses demonstrate effective suppression of DENV and CHIKV infections by our anti-arbovirus group I intron approach. This represents the first report of a dual-acting Group I intron, and demonstrates that we can target DENV and CHIKV RNAs in a sequence specific manner with a single, uniquely configured CHIKV/DENV dual targeting group I intron, leading to replication suppression of both arboviruses, and thus providing a promising single antiviral for the transgenic suppression of multiple arboviruses.	[Carter, James R.; Taylor, Samantha; Fraser, Tresa S.; Kucharski, Cheryl A.; Dawson, James L.; Fraser, Malcolm J., Jr.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	University of Notre Dame	Fraser, MJ (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	fraser.1@nd.edu	Fraser, Malcolm J/C-9100-2009; Dawson, James/GZH-1195-2022	Carter, James/0000-0001-6905-1082	US National Institutes of Health (NIH) [AI097554-04]; NIH/NIAID [AI097554]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097554] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US National Institutes of Health (NIH) grant AI097554-04 to MJF.; Our thanks to Dr. Thomas Cech (University of Colorado, Boulder) for the pTT1A3-T7 plasmid. Chikungunya virus strain 181/25 used in this study was a kind gift from Dr. Scott Weaver (UTMB). This research was supported by research grant NIH/NIAID AI097554 to MJF.	Adelman ZN, 2002, J VIROL, V76, P12925, DOI 10.1128/JVI.76.24.12925-12933.2002; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; Ayre BG, 1999, P NATL ACAD SCI USA, V96, P3507, DOI 10.1073/pnas.96.7.3507; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blankenberg FG, 2008, CANCER BIOL THER, V7, P1525, DOI 10.4161/cbt.7.10.6934; Byun J, 2003, RNA, V9, P1254, DOI 10.1261/rna.5450203; Campbell TB, 1996, BIOCHEMISTRY-US, V35, P11493, DOI 10.1021/bi960510z; Carter JR, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-111; Carter JR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-84; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CECH TR, 1991, CELL, V64, P667, DOI 10.1016/0092-8674(91)90494-J; Chursi S, 2014, AM J TROP MED HYG, V90, P410, DOI 10.4269/ajtmh.12-0681; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Coupe SA, 2004, J EXP BOT, V55, P59, DOI 10.1093/jxb/erh018; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Fauran P, 1996, B SOC PATHOL EXOT, V89, P163; Geske FJ, 2001, CELL DEATH DIFFER, V8, P182, DOI 10.1038/sj.cdd.4400786; Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419; Guo F, 2002, RNA, V8, P647, DOI 10.1017/S1355838202029011; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; Higgs S, 2010, J CLIN INVEST, V120, P657, DOI 10.1172/JCI42392; James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004; Jeong JS, 2008, CLIN CANCER RES, V14, P281, DOI 10.1158/1078-0432.CCR-07-1524; Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915; Johnson TH, 2005, P NATL ACAD SCI USA, V102, P10176, DOI 10.1073/pnas.0501498102; Jung HS, 2005, BIOTECHNOL LETT, V27, P567, DOI 10.1007/s10529-005-2883-6; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480; Kastanos E, 2004, BIOCHEM BIOPH RES CO, V322, P930, DOI 10.1016/j.bbrc.2004.07.203; Kohler U, 1999, J MOL BIOL, V285, P1935, DOI 10.1006/jmbi.1998.2447; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kwon BS, 2005, MOL THER, V12, P824, DOI 10.1016/j.ymthe.2005.06.096; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Liu QZ, 2011, APOPTOSIS, V16, P105, DOI 10.1007/s10495-010-0558-9; Maddox Nancy, 2011, MLO Med Lab Obs, V43, P44; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Morens DM, 2014, N ENGL J MED; Muhlenfeld K, 1998, ARCH PHARM, V331, P259; MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307; Nava VE, 1998, J VIROL, V72, P452, DOI 10.1128/JVI.72.1.452-459.1998; Nawtaisong P, 2015, VIROLOGY, V481, P223, DOI 10.1016/j.virol.2015.02.023; Nawtaisong P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-73; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nuckols JT, 2013, VECTOR-BORNE ZOONOT, V13, P103, DOI 10.1089/vbz.2012.1013; O'Brien IEW, 1998, EXP CELL RES, V241, P46, DOI 10.1006/excr.1998.4036; O'Neill K, 2015, P NATL ACAD SCI USA, V112, pE1152, DOI 10.1073/pnas.1424469112; Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Press AF, 2010, FRENCH RIVIERA SEES; Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130; Randolph SE, 2010, NAT REV MICROBIOL; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rogers CS, 2002, J CLIN INVEST, V110, P1783, DOI 10.1172/JCI200216481; RUDNICK A, 1965, SCIENCE, V149, P638, DOI 10.1126/science.149.3684.638; Ryu KJ, 2004, J MICROBIOL, V42, P361; Ryu KJ, 2003, J BIOCHEM MOL BIOL, V36, P538; Ryu KJ, 2003, MOL THER, V7, P386, DOI 10.1016/S1525-0016(02)00063-1; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Singh P, 2012, EPIDEMIOL INFECT, V140, P1337, DOI 10.1017/S0950268811001671; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; STROBEL SA, 1993, BIOCHEMISTRY-US, V32, P13593, DOI 10.1021/bi00212a027; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; Tang HL, 2012, MOL BIOL CELL, V23, P2240, DOI 10.1091/mbc.E11-11-0926; Thavara U, 2009, SE ASIAN J TROP MED, V40, P951; Toyota H, 2006, ANTICANCER RES, V26, P99; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Usui K, 2003, ONCOGENE, V22, P2655, DOI 10.1038/sj.onc.1206331; Van Bortel W, 2014, EURO SURVEILL, V19; VANDENHURK AF, 2009, VECTOR BORNE ZOONOTI; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Wang H, 2008, J GEN VIROL, V89, P2651, DOI 10.1099/vir.0.2008/005314-0; Watanabe T, 2000, P NATL ACAD SCI USA, V97, P8490, DOI 10.1073/pnas.150104097; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008	81	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0139899	10.1371/journal.pone.0139899	http://dx.doi.org/10.1371/journal.pone.0139899			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580561	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600002
J	Iwata, T; Ito, I; Niimi, A; Ikegami, K; Marumo, S; Tanabe, N; Nakaji, H; Kanemitsu, Y; Matsumoto, H; Kamei, J; Setou, M; Mishima, M				Iwata, Toshiyuki; Ito, Isao; Niimi, Akio; Ikegami, Koji; Marumo, Satoshi; Tanabe, Naoya; Nakaji, Hitoshi; Kanemitsu, Yoshihiro; Matsumoto, Hisako; Kamei, Junzo; Setou, Mitsutoshi; Mishima, Michiaki			Mechanical Stimulation by Postnasal Drip Evokes Cough	PLOS ONE			English	Article							RAPIDLY ADAPTING RECEPTORS; ALLERGIC RHINITIS; VARIANT ASTHMA; GUINEA-PIGS; AIRWAY RESPONSIVENESS; BRONCHIAL EPITHELIUM; MICE; CAPSAICIN; PLETHYSMOGRAPHY; INFLAMMATION	Cough affects all individuals at different times, and its economic burden is substantial. Despite these widespread adverse effects, cough research relies on animal models, which hampers our understanding of the fundamental cause of cough. Postnasal drip is speculated to be one of the most frequent causes of chronic cough; however, this is a matter of debate. Here we show that mechanical stimuli by postnasal drip cause chronic cough. We distinguished human cough from sneezes and expiration reflexes by airflow patterns. Cough and sneeze exhibited one-peak and two-peak patterns, respectively, in expiratory airflow, which were also confirmed by animal models of cough and sneeze. Transgenic mice with ciliary dyskinesia coughed substantially and showed postnasal drip in the pharynx; furthermore, their cough was completely inhibited by nasal airway blockade of postnasal drip. We successfully reproduced cough observed in these mice by injecting artificial postnasal drip in wild-type mice. These results demonstrated that mechanical stimulation by postnasal drip evoked cough. The findings of our study can therefore be used to develop new antitussive drugs that prevent the root cause of cough.	[Iwata, Toshiyuki; Ito, Isao; Niimi, Akio; Marumo, Satoshi; Tanabe, Naoya; Nakaji, Hitoshi; Kanemitsu, Yoshihiro; Matsumoto, Hisako; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Niimi, Akio] Nagoya City Univ, Grad Sch Med Sci, Dept Med Oncol & Immunol, Nagoya, Aichi, Japan; [Ikegami, Koji; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Kamei, Junzo] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol & Therapeut, Tokyo 142, Japan	Kyoto University; Nagoya City University; Hamamatsu University School of Medicine; Hoshi University	Ito, I (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	isaoito@kuhp.kyoto-u.ac.jp		Ito, Isao/0000-0003-3109-898X	Center for Women Researchers, Kyoto University; Japan Society for the Promotion of Science [20590896. II]	Center for Women Researchers, Kyoto University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Center for Women Researchers (http://www.cwr.kyoto-u.ac.jp/index.php), Kyoto University and by Japan Society for the Promotion of Science (http://www.jsps.go.jp/) Grant-in-Aid for Scientific Research number 20590896. II received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATSEL HL, 1975, AM J PHYSIOL, V229, P770, DOI 10.1152/ajplegacy.1975.229.3.770; BENNETT WD, 1990, J APPL PHYSIOL, V69, P1670, DOI 10.1152/jappl.1990.69.5.1670; Birrell MA, 2009, AM J RESP CRIT CARE, V180, P1042, DOI 10.1164/rccm.200905-0665OC; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Brozmanova M, 2006, PHYSIOL RES, V55, P577, DOI 10.33549/physiolres.930840; Canning BJ, 2004, J PHYSIOL-LONDON, V557, P543, DOI 10.1113/jphysiol.2003.057885; Chen LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059263; Dicpinigaitis PV, 2006, RESP PHYSIOL NEUROBI, V152, P356, DOI 10.1016/j.resp.2005.11.010; Fox AJ, 1996, NAT MED, V2, P814, DOI 10.1038/nm0796-814; French CT, 2005, CHEST, V127, P1991, DOI 10.1378/chest.127.6.1991; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Irwin RS, 1997, ARCH INTERN MED, V157, P1981, DOI 10.1001/archinte.157.17.1981; IRWIN RS, 1984, CHEST, V85, P346, DOI 10.1378/chest.85.3.346; Kamei J, 2007, EUR J PHARMACOL, V566, P181, DOI 10.1016/j.ejphar.2007.03.036; KAUFMAN MP, 1980, J APPL PHYSIOL, V48, P511, DOI 10.1152/jappl.1980.48.3.511; Korpaes J, 1979, COUGH OTHER RESP REF; Kunimoto K, 2012, CELL, V148, P189, DOI 10.1016/j.cell.2011.10.052; LALLOO UG, 1995, J APPL PHYSIOL, V79, P1082, DOI 10.1152/jappl.1995.79.4.1082; Leung Sum Yee, 2007, Cough, V3, P10, DOI 10.1186/1745-9974-3-10; Mazzone S. B., 2009, V187, P99, DOI 10.1007/978-3-540-79842-2_6; Miyahara S, 2005, J ALLERGY CLIN IMMUN, V116, P1020, DOI 10.1016/j.jaci.2005.08.020; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006; Morice AH, 2004, PULM PHARMACOL THER, V17, P343, DOI 10.1016/j.pupt.2004.09.005; Morikawa T, 1997, PHARMACOL RES, V35, P113, DOI 10.1006/phrs.1996.0122; Nakaya M, 2006, LAB INVEST, V86, P917, DOI 10.1038/labinvest.3700452; Niimi A, 2000, LANCET, V356, P564, DOI 10.1016/S0140-6736(00)02584-8; Niimi A, 2005, J ALLERGY CLIN IMMUN, V116, P565, DOI 10.1016/j.jaci.2005.07.010; Niimi A, 1998, EUR RESPIR J, V11, P1064, DOI 10.1183/09031936.98.11051064; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; OCONNELL F, 1994, AM J RESP CRIT CARE, V150, P374, DOI 10.1164/ajrccm.150.2.8049818; PACK RJ, 1981, J ANAT, V132, P71; Pecova R, 2005, J Physiol Pharmacol, V56 Suppl 4, P171; Plevkova J, 2006, PULM PHARMACOL THER, V19, P120, DOI 10.1016/j.pupt.2005.04.004; Poliacek Ivan, 2008, Cough, V4, P1, DOI 10.1186/1745-9974-4-1; Pratter MR, 2006, CHEST, V129, p63S, DOI 10.1378/chest.129.1_suppl.63S; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Sant'Ambrogio G, 2001, RESP PHYSIOL, V125, P33, DOI 10.1016/S0034-5687(00)00203-6; Satoh I, 1998, NEUROSCI RES, V32, P131, DOI 10.1016/S0168-0102(98)00075-3; SCAPPATICCI E, 1994, ANN THORAC SURG, V57, P119, DOI 10.1016/0003-4975(94)90378-6; Schroeder K, 2002, BRIT MED J, V324, P329, DOI 10.1136/bmj.324.7333.329; Simera M, 2010, EUR J MED RES, V15, P184; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Stephens RE, 2003, AM J PHYS MED REHAB, V82, P384, DOI 10.1097/00002060-200305000-00013; Swartz MA, 2001, P NATL ACAD SCI USA, V98, P6180, DOI 10.1073/pnas.111133298; Tschumperlin DJ, 2003, AM J RESP CELL MOL, V28, P142, DOI 10.1165/rcmb.2002-0121OC; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Widdicombe J, 2006, EUR RESPIR J, V28, P10, DOI 10.1183/09031936.06.00096905; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P55, DOI 10.1113/jphysiol.1954.sp005033; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P71, DOI 10.1113/jphysiol.1954.sp005034; Widdicome J, 2003, ANAT REC PART A, V270A, P2, DOI 10.1002/ar.a.10003; Zhang QL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-61	54	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141823	10.1371/journal.pone.0141823	http://dx.doi.org/10.1371/journal.pone.0141823			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581078	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600023
J	Journath, G; Hammar, N; Elofsson, S; Linnersjo, A; Vikstrom, M; Walldius, G; Krakau, I; Lindgren, P; de Faire, U; Hellenius, ML				Journath, Gunilla; Hammar, Niklas; Elofsson, Stig; Linnersjo, Anette; Vikstrom, Max; Walldius, Goran; Krakau, Ingvar; Lindgren, Peter; de Faire, Ulf; Hellenius, Mai-Lis			Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden	PLOS ONE			English	Article							HEART-DISEASE MORTALITY; RISK-FACTORS; CASE-FATALITY; FINLAND; DIET; ASSOCIATIONS; MORBIDITY; EDUCATION; REGISTER; DECREASE	Background In 1988, a cardiovascular prevention program which combined an individual and a population-based strategy was launched within primary health-care in Sollentuna, a municipality in Stockholm County. The aim of this study was to investigate time trends in the incidence of and mortality from acute myocardial infarction and all-cause mortality in Sollentuna compared with the rest of Stockholm County during a period of two decades following the implementation of a cardiovascular prevention program. Materials and Methods The average population in Sollentuna was 56,589 (49% men) and in Stockholm County (Sollentuna included) 1,795,504 (49% men) during the study period of 1987-2010. Cases of hospitalized acute myocardial infarction and death were obtained for the population of Sollentuna and the rest of Stockholm County using national registries of hospital discharges and deaths. Acute myocardial infarction incidence and mortality were estimated using the average population of Sollentuna and Stockholm in 1987-2010. Results During the observation period, the incidence of acute myocardial infarction decreased more in Sollentuna compared with the rest of Stockholm County in women (-22% vs. -7%; for difference in slope <0.05). There was a trend towards a greater decline in Sollentuna compared to the rest of Stockholm County in the incidence of acute myocardial infarction (in men), acute myocardial mortality, and all-cause mortality but the differences were not significant. Conclusion During a period of steep decline in acute myocardial infarction incidence and mortality in Stockholm County the municipality of Sollentuna showed a stronger trend in women possibly compatible with favorable influence of a cardiovascular prevention program.	[Journath, Gunilla; Hellenius, Mai-Lis] Karolinska Inst, Dept Med, Unit Cardiol, Stockholm, Sweden; [Hammar, Niklas] Karolinska Inst, Div Epidemiol, Inst Environm Med, Stockholm, Sweden; [Hammar, Niklas] AstraZeneca R&D, Molndal, Sweden; [Elofsson, Stig] Stockholm Univ, Dept Social Work, S-10691 Stockholm, Sweden; [Linnersjo, Anette] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Linnersjo, Anette; Vikstrom, Max; Walldius, Goran; de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, Stockholm, Sweden; [Krakau, Ingvar] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Lindgren, Peter] Karolinska Inst, MMC, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Lindgren, Peter] Swedish Inst Hlth Econ, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; AstraZeneca; Stockholm University; Stockholm County Council; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Journath, G (corresponding author), Karolinska Inst, Dept Med, Unit Cardiol, Stockholm, Sweden.	Gunilla.Journath@ki.se	Lindgren, Peter/AID-5379-2022; journath, Gunilla/AAU-9413-2020	Lindgren, Peter/0000-0002-8238-8189; journath, Gunilla/0000-0002-5286-2062	Swedish Society of Medicine [SLS-328481, SLS-407891]; Heart and Lung Foundation [20100473]; Stockholm County Council; Wallenberg Foundation; AstraZeneca RD; IVBAR AB	Swedish Society of Medicine; Heart and Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Wallenberg Foundation(European Commission); AstraZeneca RD(AstraZeneca); IVBAR AB	This study was supported by the Swedish Society of Medicine (SLS-328481, SLS-407891), (http://www.sls.se) Heart and Lung Foundation (20100473) (http://www.hjart-lungfonden.se). The prevention program was supported by the Stockholm County Council, (http://www.sll.se) and the Wallenberg Foundation, (http://www.wallenberg.com). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NH is employed by AstraZeneca R&D, Molndal. PL is employed by IVBAR AB. AstraZeneca R&D and IVBAR AB provided support in the form of salaries for authors NH and PL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; Berg J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-9; Bjorck L, 2011, J INTERN MED, V269, P452, DOI 10.1111/j.1365-2796.2010.02339.x; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; BJORKELUND C, 1991, Scandinavian Journal of Primary Health Care, V9, P89, DOI 10.3109/02813439109026590; Cowburn G, 2009, CARDIOVASCULAR DIS P; Dudas K, 2011, CIRCULATION, V123, P46, DOI 10.1161/CIRCULATIONAHA.110.964999; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fortmann SP, 2000, AM J EPIDEMIOL, V152, P316, DOI 10.1093/aje/152.4.316; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Hellenius M L, 1993, Scand J Prim Health Care, V11, P68, DOI 10.3109/02813439308994905; Hellenius ML, 1999, SCAND J PRIM HEALTH, V17, P111, DOI 10.1080/028134399750002746; Johansson I, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-40; Levi F, 2009, EUR J CARDIOV PREV R, V16, P333, DOI 10.1097/HJR.0b013e328325d67d; Lingfors H, 2003, SCAND J PRIM HEALTH, V21, P248, DOI 10.1080/02813430310003282; Lingfors H, 2002, SCAND J PRIM HEALTH, V20, P28, DOI 10.1080/028134302317282707; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Luepker RV, 1996, AM J EPIDEMIOL, V144, P351, DOI 10.1093/oxfordjournals.aje.a008936; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; *NAT BOARD HLTH WE, MYOC INF SWED 1987 2; National Board of Health and Welfare, ANN REPORT; National Board of Health and Welfare, CAUS OF DEATH; Nichols M., 2012, EUROPEAN CARDIOVASCU; Norberg M, 2012, SCAND J PUBLIC HEALT, V40, P135, DOI 10.1177/1403494812459471; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Rosen M, 2000, J INTERN MED, V248, P159, DOI 10.1046/j.1365-2796.2000.00716.x; Sydhoff Jenny, 2006, Lakartidningen, V103, P375; Unal B, 2005, J CLIN EPIDEMIOL, V58, P733, DOI 10.1016/j.jclinepi.2004.09.015; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Weinehall L, 1999, J EPIDEMIOL COMMUN H, V53, P243, DOI 10.1136/jech.53.4.243; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	36	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140201	10.1371/journal.pone.0140201	http://dx.doi.org/10.1371/journal.pone.0140201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580968	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600004
J	Pistorius, PA; Hindell, MA; Tremblay, Y; Rishworth, GM				Pistorius, Pierre A.; Hindell, Mark A.; Tremblay, Yann; Rishworth, Gavin M.			Weathering a Dynamic Seascape: Influences of Wind and Rain on a Seabird's Year-Round Activity Budgets	PLOS ONE			English	Article							CAPE GANNETS; ALGOA BAY; BEHAVIOR; PATTERNS; POPULATION; FLIGHT; FOOD; INFORMATION; GUILLEMOTS; DISPERSAL	How animals respond to varying environmental conditions is fundamental to ecology and is a question that has gained impetus due to mounting evidence indicating negative effects of global change on biodiversity. Behavioural plasticity is one mechanism that enables individuals and species to deal with environmental changes, yet for many taxa information on behavioural parameters and their capacity to change are lacking or restricted to certain periods within the annual cycle. This is particularly true for seabirds where year-round behavioural information is intrinsically challenging to acquire due to their reliance on the marine environment where they are difficult to study. Using data from over 13,000 foraging trips throughout the annual cycle, acquired using new-generation automated VHF technology, we described sex-specific, year-round activity budgets in Cape gannets. Using these data we investigated the role of weather (wind and rain) on foraging activity and time allocated to nest attendance. Foraging activity was clearly influenced by wind speed, wind direction and rainfall during and outside the breeding season. Generally, strong wind conditions throughout the year resulted in relatively short foraging trips. Birds spent longer periods foraging when rainfall was moderate. Nest attendance, which was sex-specific outside of the breeding season, was also influenced by meteorological conditions. Large amounts of rainfall (> 2.5 mm per hour) and strong winds (> 13 m s(-1)) resulted in gannets spending shorter amounts of time at their nests. We discuss these findings in terms of life history strategies and implications for the use of seabirds as bio-indicators.	[Pistorius, Pierre A.; Rishworth, Gavin M.] Nelson Mandela Metropolitan Univ, Percy FitzPatrick Inst, Dept Zool, DST NRF Ctr Excellence, ZA-6031 Summerstrand, South Africa; [Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Tremblay, Yann] Ctr Rech Halieut Mediterraneenne & Tropicale, Inst Rech Dev, UMR EME Exploited Marine Ecosyst 212, F-34203 Sete, France	National Research Foundation - South Africa; Nelson Mandela University; University of Tasmania; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Pistorius, PA (corresponding author), Nelson Mandela Metropolitan Univ, Percy FitzPatrick Inst, Dept Zool, DST NRF Ctr Excellence, ZA-6031 Summerstrand, South Africa.	ppistorius@nmmu.ac.za		Hindell, Mark/0000-0002-7823-7185; Pistorius, Pierre/0000-0001-6561-7069; Tremblay, Yann/0000-0002-4653-9269	National Research Foundation (NRF) of South Africa	National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This research was funded by the National Research Foundation (NRF) of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The National Research Foundation (NRF) of South Africa is thanked for funding this research. South African National Parks (SANParks) provided logistical support and accommodation on Bird Island. The field assistance of David Green and Maelle Connan is greatly appreciated. The South African Weather Service (SAWS) and Wayne Goschen are thanked for making meteorological data available to this project.	Ainley DG, 1977, ADAPTATIONS ANTARCTI, P669; Amelineau F, 2014, J EXP BIOL, V217, P876, DOI 10.1242/jeb.097915; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Barton K., 2013, MUMIN MULTIMODEL INF; Benvenuti S, 2002, POLAR BIOL, V25, P474, DOI 10.1007/s00300-002-0372-0; Burger A.E., 1990, Studies in Avian Biology, P71; Cairns D.K., 1992, Current Ornithology, V9, P37; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Crawford R.J.M., 2005, ROBERTS BIRDS SO AFR, P565; Crawford RJM, 2007, ICES J MAR SCI, V64, P169, DOI 10.1093/icesjms/fsl011; Daunt F, 2006, BEHAV ECOL SOCIOBIOL, V59, P381, DOI 10.1007/s00265-005-0061-4; Dehnhard N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079487; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Elliott KH, 2015, MAR BIOL, V162, P1739, DOI 10.1007/s00227-015-2701-1; Elliott KH, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0017-2; Finney SK, 1999, J AVIAN BIOL, V30, P23, DOI 10.2307/3677239; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Furness RW, 1996, ECOLOGY, V77, P1181, DOI 10.2307/2265587; GABRIELSEN GW, 1987, CONDOR, V89, P126, DOI 10.2307/1368766; Garthe S, 2009, MAR ECOL PROG SER, V391, P243, DOI 10.3354/meps08170; Goschen WS, 2012, AFR J MAR SCI, V34, P525, DOI 10.2989/1814232X.2012.749810; Green D, 2013, OSTRICH, V84, P123, DOI 10.2989/00306525.2013.830652; Green DB, 2015, MAR ECOL PROG SER, V537, P277, DOI 10.3354/meps11428; Green DB, 2015, ICES J MAR SCI, V72, P771, DOI 10.1093/icesjms/fsu203; Hamer KC, 1997, IBIS, V139, P31, DOI 10.1111/j.1474-919X.1997.tb04501.x; HANEY JC, 1994, AUK, V111, P427, DOI 10.2307/4088606; Harding AMA, 2007, MAR ECOL PROG SER, V352, P269, DOI 10.3354/meps07072; HATCH SA, 1987, AUK, V104, P450, DOI 10.2307/4087544; Hunt G.L. Jr, 1987, P7; Ismar SMH, 2011, WILSON J ORNITHOL, V123, P121, DOI 10.1676/10-072.1; Jaquemet S, 2008, ESTUAR COAST SHELF S, V80, P374, DOI 10.1016/j.ecss.2008.08.019; KLAGES NTW, 1994, OSTRICH, V65, P218, DOI 10.1080/00306525.1994.9639685; Kowalczyk ND, 2015, OECOLOGIA, V178, P967, DOI 10.1007/s00442-015-3294-6; Lewis S, 2006, OECOLOGIA, V147, P606, DOI 10.1007/s00442-005-0321-z; Lund U, 2012, CIRCSTATS CIRCULAR S; Mullers RHE, 2009, ICES J MAR SCI, V66, P2244, DOI 10.1093/icesjms/fsp210; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nelson J.B, 2002, THE ATLANTIC GANNET, V2nd; Nelson JB, 1978, SULIDAE GANNETS BOOB, P231; Nelson JB, 2005, CORMORANTS THEIR REL; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; O'Donoghue SH, 2010, AFR J MAR SCI, V32, P279, DOI 10.2989/1814232X.2010.501584; Patrick SC, 2014, OIKOS, V123, P33, DOI 10.1111/j.1600-0706.2013.00406.x; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; R Core Team, 2012, R LANG ENV STAT COMP; Ramirez I, 2013, MAR ECOL PROG SER, V476, P269, DOI 10.3354/meps10083; RANDALL R, 1979, OSTRICH, V50, P168, DOI 10.1080/00306525.1979.9634106; Reed TE, 2009, J ANIM ECOL, V78, P376, DOI 10.1111/j.1365-2656.2008.01503.x; Rishworth GM, 2015, MAR ECOL PROG SER, V530, P153, DOI 10.3354/meps11317; Rishworth GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116544; Rishworth GM, 2014, METHODS ECOL EVOL, V5, P854, DOI 10.1111/2041-210X.12213; Rishworth GM, 2014, AFR ZOOL, V49, P107, DOI 10.3377/004.049.0115; Sandvik H, 2008, GLOBAL CHANGE BIOL, V14, P703, DOI 10.1111/j.1365-2486.2007.01533.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schreiber E, 2001, BIOL MARINE BIRDS, P179; SCHREIBER RW, 1984, SCIENCE, V225, P713, DOI 10.1126/science.225.4663.713; Shoji A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017760; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Spruzen FL, 2002, POLAR BIOL, V25, P296, DOI 10.1007/s00300-001-0344-9; Stearns S.C., 1992, pi; Thiebault A, 2014, BEHAV ECOL, V25, P1302, DOI 10.1093/beheco/aru132; Thiebault A, 2014, AUK, V131, P595, DOI 10.1642/AUK-13-209.1; Tremblay Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088424; UTTLEY JD, 1994, IBIS, V136, P205, DOI 10.1111/j.1474-919X.1994.tb01086.x; Weidinger K, 1996, POLAR BIOL, V16, P339; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wolfaardt Anton C., 2012, Marine Ornithology, V40, P129	73	17	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142623	10.1371/journal.pone.0142623	http://dx.doi.org/10.1371/journal.pone.0142623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581108	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600051
J	Sarkar, S; Leo, BF; Carranza, C; Chen, S; Rivas-Santiago, C; Porter, AE; Ryan, MP; Gow, A; Chung, KF; Tetley, TD; Zhang, JF; Georgopoulos, PG; Ohman-Strickland, PA; Schwander, S				Sarkar, Srijata; Leo, Bey Fen; Carranza, Claudia; Chen, Shu; Rivas-Santiago, Cesar; Porter, Alexandra E.; Ryan, Mary P.; Gow, Andrew; Chung, Kian Fan; Tetley, Teresa D.; Zhang, Junfeng (Jim); Georgopoulos, Panos G.; Ohman-Strickland, Pamela A.; Schwander, Stephan			Modulation of Human Macrophage Responses to Mycobacterium tuberculosis by Silver Nanoparticles of Different Size and Surface Modification	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; HOST-DEFENSE; RECEPTOR; EXPRESSION; TOXICITY; CELL; ACTIVATION; EPITHELIUM	Exposure to silver nanoparticles (AgNP) used in consumer products carries potential health risks including increased susceptibility to infectious pathogens. Systematic assessments of antimicrobial macrophage immune responses in the context of AgNP exposure are important because uptake of AgNP by macrophages may lead to alterations of innate immune cell functions. In this study we examined the effects of exposure to AgNP with different particle sizes (20 and 110 nm diameters) and surface chemistry (citrate or polyvinlypyrrolidone capping) on cellular toxicity and innate immune responses against Mycobacterium tuberculosis (M.tb) by human monocyte-derived macrophages (MDM). Exposures of MDM to AgNP significantly reduced cellular viability, increased IL8 and decreased IL10 mRNA expression. Exposure of M.tb-infected MDM to AgNP suppressed M.tb-induced expression of IL1B, IL10, and TNFA mRNA. Furthermore, M.tb-induced IL-1 beta, a cytokine critical for host resistance to M.tb, was inhibited by AgNP but not by carbon black particles indicating that the observed immunosuppressive effects of AgNP are particle specific. Suppressive effects of AgNP on the M.tb-induced host immune responses were in part due to AgNP-mediated interferences with the TLR signaling pathways that culminate in the activation of the transcription factor NF-.B. AgNP exposure suppressed M.tb-induced expression of a subset of NF-.B mediated genes (CSF2, CSF3, IFNG, IL1A, IL1B, IL6, IL10, TNFA, NFKB1A). In addition, AgNP exposure increased the expression of HSPA1A mRNA and the corresponding stress-induced Hsp72 protein. Up-regulation of Hsp72 by AgNP can suppress M.tb-induced NF-kappa B activation and host immune responses. The observed ability of AgNP to modulate infectious pathogen-induced immune responses has important public health implications.	[Sarkar, Srijata; Rivas-Santiago, Cesar; Schwander, Stephan] Rutgers State Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA; [Leo, Bey Fen; Chen, Shu; Porter, Alexandra E.; Ryan, Mary P.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; [Leo, Bey Fen; Chen, Shu; Porter, Alexandra E.; Ryan, Mary P.] Univ London Imperial Coll Sci Technol & Med, London Ctr Nanotechnol, London, England; [Leo, Bey Fen] Univ Malaya, Dept Mech Engn, Kuala Lumpur, Malaysia; [Carranza, Claudia] Inst Nacl Enfermedades Resp, Dept Microbiol, Mexico City, DF, Mexico; [Gow, Andrew] Rutgers State Univ, Dept Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ USA; [Chung, Kian Fan; Tetley, Teresa D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Zhang, Junfeng (Jim)] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Zhang, Junfeng (Jim)] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Georgopoulos, Panos G.] Rutgers State Univ, Robert Wood Johnson Med Sch, Computat Chemodynam Lab, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Ohman-Strickland, Pamela A.] Rutgers State Univ, Sch Publ Hlth, Dept Biostat, Piscataway, NJ USA; [Schwander, Stephan] Rutgers State Univ, Sch Publ Hlth, Ctr Global Publ Hlth, Piscataway, NJ USA	Rutgers State University New Brunswick; Imperial College London; Imperial College London; University of London; University College London; Universiti Malaya; Rutgers State University New Brunswick; Imperial College London; Duke University; Duke University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schwander, S (corresponding author), Rutgers State Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA.	schwansk@sph.rutgers.edu	Rivas-Santiago, Cesar/L-8627-2019; Chung, Kian Fan/B-1872-2012; Leo, Bey Fen/AAA-1455-2020; Gow, Andrew/N-8566-2013; Zhang, Junfeng/AAJ-9183-2020; Leo, Bey/HHN-7701-2022; Leo, Bey Fen/C-4133-2017; Gow, Andrew/AAR-2309-2020; Tetley, Teresa D/B-3288-2016; Carranza, Cristina/K-9578-2016	Rivas-Santiago, Cesar/0000-0002-0504-2299; Chung, Kian Fan/0000-0001-7101-1426; Gow, Andrew/0000-0003-0876-5158; Zhang, Junfeng/0000-0003-3759-6672; Leo, Bey Fen/0000-0002-8075-0295; Gow, Andrew/0000-0003-0876-5158; 	National Institute of Environmental Health Sciences [5U19 ES019536, 5R01 ES02038202, P30ES005022]; European Research Council [257182]; Else Widdowson fellowship; MRC [G0700926] Funding Source: UKRI; NERC [NE/H012893/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES019536, P30ES005022, R01ES020382] Funding Source: NIH RePORTER; Medical Research Council [G0700926] Funding Source: researchfish; Natural Environment Research Council [NE/H012893/1] Funding Source: researchfish	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); European Research Council(European Research Council (ERC)European Commission); Else Widdowson fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the National Institute of Environmental Health Sciences http://www.niehs.nih.gov/: 5U19 ES019536, 5R01 ES02038202, P30ES005022; European Research Council http://erc.europa.eu/: 257182; and Else Widdowson fellowship.	Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Aueviriyavit S, 2012, BIOL TRACE ELEM RES, V149, P123, DOI 10.1007/s12011-012-9403-z; Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Beer C, 2012, TOXICOL LETT, V208, P286, DOI 10.1016/j.toxlet.2011.11.002; Bhatt KH, 2011, CLIN VACCINE IMMUNOL, V18, P994, DOI 10.1128/CVI.00541-10; Bieber J, 2003, ANN RHEUM DIS, V62, P1118, DOI 10.1136/ard.62.11.1118; BOTELHO DJ, 2015, NANOTOXICOLOGY, P1, DOI DOI 10.3109/17435390.2015.1038330; Boucher W, 2008, J UROLOGY, V179, P1598, DOI 10.1016/j.juro.2007.11.037; Bouwmeester H, 2011, ACS NANO, V5, P4091, DOI 10.1021/nn2007145; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Carranza C, 2006, AM J RESP CRIT CARE, V173, P238, DOI 10.1164/rccm.200503-411OC; Chairuangkitti P, 2013, TOXICOL IN VITRO, V27, P330, DOI 10.1016/j.tiv.2012.08.021; Chan ED, 2010, AM J RESP CRIT CARE, V182, P990, DOI 10.1164/rccm.201006-0861ED; Chase MA, 2007, J IMMUNOL, V179, P6318, DOI 10.4049/jimmunol.179.9.6318; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Davies PDO, 2006, T ROY SOC TROP MED H, V100, P291, DOI 10.1016/j.trstmh.2005.06.034; Diaz B, 2008, SMALL, V4, P2025, DOI 10.1002/smll.200800199; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Eom HJ, 2010, ENVIRON SCI TECHNOL, V44, P8337, DOI 10.1021/es1020668; Ferat-Osorio E, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-19; Foldbjerg R, 2012, TOXICOL SCI, V130, P145, DOI 10.1093/toxsci/kfs225; Foldbjerg R, 2011, ARCH TOXICOL, V85, P743, DOI 10.1007/s00204-010-0545-5; Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gopinath P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075104; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Grover A, 2014, IMMUNOLOGY, V142, P111, DOI 10.1111/imm.12236; Hanley C, 2009, NANOSCALE RES LETT, V4, P1409, DOI 10.1007/s11671-009-9413-8; Hussain S, 2012, WIRES NANOMED NANOBI, V4, P169, DOI 10.1002/wnan.166; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Huynh KA, 2011, ENVIRON SCI TECHNOL, V45, P5564, DOI 10.1021/es200157h; Imperiali FG, 2001, CLIN EXP IMMUNOL, V123, P435, DOI 10.1046/j.1365-2249.2001.01481.x; Ivask A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102108; Jacobs M, 2007, EUR CYTOKINE NETW, V18, P5; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Krishnan N, 2013, TUBERCULOSIS, V93, P538, DOI 10.1016/j.tube.2013.05.002; Krutzik SR, 2001, CURR OPIN IMMUNOL, V13, P104, DOI 10.1016/S0952-7915(00)00189-8; Ku KT, 2008, J AGR FOOD CHEM, V56, P8911, DOI 10.1021/jf8019369; Landsiedel R, 2010, ADV MATER, V22, P2601, DOI 10.1002/adma.200902658; Lee JH, 2012, NANOTOXICOLOGY, V6, P667, DOI 10.3109/17435390.2011.600840; Leo BF, 2013, ENVIRON SCI TECHNOL, V47, P11232, DOI 10.1021/es403377p; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Mayer A, 2009, TOXICOLOGY, V258, P139, DOI 10.1016/j.tox.2009.01.015; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Maynard AD, 2011, TOXICOL SCI, V120, pS109, DOI 10.1093/toxsci/kfq372; Mazarati A, 2011, EXP NEUROL, V232, P143, DOI 10.1016/j.expneurol.2011.08.012; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Munusamy P, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4926547; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Pai M, 2007, EXPERT REV ANTI-INFE, V5, P385, DOI 10.1586/14787210.5.3.385; Park S, 2007, INHAL TOXICOL, V19, P59, DOI 10.1080/08958370701493282; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; PRIETO J, 1994, CELL IMMUNOL, V156, P191, DOI 10.1006/cimm.1994.1164; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Rivas-Santiago CE, 2015, INFECT IMMUN, V83, P2507, DOI 10.1128/IAI.03018-14; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Rylance J, 2015, AM J RESP CELL MOL, V52, P584, DOI 10.1165/rcmb.2014-0188OC; Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380; Schanen BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062816; Schanen BC, 2009, ACS NANO, V3, P2523, DOI 10.1021/nn900403h; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Spano A, 2007, HISTOCHEM CELL BIOL, V127, P79, DOI 10.1007/s00418-006-0227-9; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; Tejamaya M, 2012, ENVIRON SCI TECHNOL, V46, P7011, DOI 10.1021/es2038596; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tolaymat TM, 2010, SCI TOTAL ENVIRON, V408, P999, DOI 10.1016/j.scitotenv.2009.11.003; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Wang X, 2014, SMALL, V10, P385, DOI 10.1002/smll.201301597; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Williams K, 2014, NANOTOXICOLOGY, V9, P1; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Yilma AN, 2013, INT J NANOMED, V8, P2421, DOI 10.2147/IJN.S44090; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082	88	26	27	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143077	10.1371/journal.pone.0143077	http://dx.doi.org/10.1371/journal.pone.0143077			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580078	gold, Green Submitted, Green Published			2022-12-27	WOS:000365154600078
J	Wang, XP; Liu, YL; Chen, HS; Mei, LY; He, CF; Jiang, L; Niu, ZJ; Sun, J; Luo, HJ; Li, JD; Feng, Y				Wang, Xueping; Liu, Yalan; Chen, Hongsheng; Mei, Lingyun; He, Chufeng; Jiang, Lu; Niu, Zhijie; Sun, Jie; Luo, Hunjin; Li, Jiada; Feng, Yong			LEF-1 Regulates Tyrosinase Gene Transcription In Vitro	PLOS ONE			English	Article							MELANOCYTE-SPECIFIC TRANSCRIPTION; OCULOCUTANEOUS ALBINISM; NEURAL CREST; FUNCTIONAL-ANALYSIS; MELANIN SYNTHESIS; MOLECULAR-BASIS; BETA-CATENIN; MICROPHTHALMIA; WNT; MOUSE	TYR, DCT and MITF are three important genes involved in maintaining the mature phenotype and producing melanin; they therefore participate in neural crest cell development into melanocytes. Previous studies have revealed that the Wnt signaling factor lymphoid enhancer-binding factor (LEF-1) can enhance DCT and MITF gene expression. However, whether LEF-1 also affects TYR gene expression remains unclear. In the present study, we found that LEF-1 regulated TYR transcription in vitro. LEF-1 overexpression increased TYR gene promoter activity, whereas LEF-1 knockdown by RNA interference significantly decreased TYR expression. Moreover, the core GTTTGAT sequence (-56 to -50) within the TYR promoter is essential for the effect of LEF-1 on TYR expression, and chromatin immunoprecipitation (ChIP) assay indicated that endogenous LEF-1 interacts with the TYR promoter. In addition, we observed a synergistic transactivation of the TYR promoter by LEF-1 and MITF. These data suggest that Wnt signaling plays an important role in regulating melanocyte development and differentiation.	[Wang, Xueping; Chen, Hongsheng; Mei, Lingyun; He, Chufeng; Jiang, Lu; Niu, Zhijie; Sun, Jie; Feng, Yong] Cent S Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China; [Liu, Yalan; Chen, Hongsheng; Mei, Lingyun; He, Chufeng; Jiang, Lu; Feng, Yong] Cent S Univ, Xiangya Hosp, Prov Key Lab Otolaryngol Crit Dis, Changsha, Hunan, Peoples R China; [Luo, Hunjin; Li, Jiada; Feng, Yong] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Sun, Jie] Xinjiang Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Urumqi, Peoples R China	Central South University; Central South University; Central South University; Xinjiang Medical University	Li, JD (corresponding author), Cent S Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China.	lijiada@sklmg.edu.cn; fengyong_hn@hotmail.com	Niu, Zhijie/GRS-2684-2022	Li, Jia-Da/0000-0002-4236-3518; Chen, Hongsheng/0000-0002-1373-6434	National Basic Research and Development Program of China (973 Program) [2014CB541702]; National Natural Science Foundation of China [81170923, 81470705, 81300833]; ministry of health of China [201302001]	National Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ministry of health of China	This study was supported by National Basic Research and Development Program of China (973 Program) (No. 2014CB541702, to Yong Feng), the National Natural Science Foundation of China (Nos. 81170923, 81470705 to Yong Feng; No. 81300833 to Lu Jiang), The public welfare industry research special fund projects of ministry of health of China (No. 201302001, to Yong Feng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amae S, 1998, BIOCHEM BIOPH RES CO, V247, P710, DOI 10.1006/bbrc.1998.8838; Barker N, 2000, ADV CANCER RES, V77, P1; BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; BUDD PS, 1995, GENOMICS, V29, P35, DOI 10.1006/geno.1995.1212; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cho M, 2009, BIOCHEM BIOPH RES CO, V390, P500, DOI 10.1016/j.bbrc.2009.09.124; Driskell RR, 2007, DEV BIOL, V305, P90, DOI 10.1016/j.ydbio.2007.01.038; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Fukunaga-Kalabis M, 2015, J INVEST DERMATOL, V135, P1521, DOI 10.1038/jid.2015.59; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Goding CR, 2000, GENE DEV, V14, P1712; Guo HY, 2012, BIOCHEM BIOPH RES CO, V420, P799, DOI 10.1016/j.bbrc.2012.03.077; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3799, DOI 10.1093/nar/19.14.3799; KOBAYASHI T, 1995, J CELL SCI, V108, P2301; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; KWON BS, 1993, J INVEST DERMATOL, V100, P134; Land EJ, 2004, METHOD ENZYMOL, V378, P88; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Metzeler KH, 2012, BLOOD, V120, P2118, DOI 10.1182/blood-2012-02-411827; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHIBAHARA S, 1991, J BIOL CHEM, V266, P15895; Singhi AD, 2014, MODERN PATHOL, V27, P1355, DOI 10.1038/modpathol.2014.40; SLOMINSKI A, 1989, PIGM CELL RES, V2, P109, DOI 10.1111/j.1600-0749.1989.tb00170.x; SLOMINSKI A, 1985, J CANCER RES CLIN, V109, P29, DOI 10.1007/BF01884251; SPRITZ RA, 1994, HUM MOL GENET, V3, P1469, DOI 10.1093/hmg/3.suppl_1.1469; TAKEDA A, 1990, J BIOL CHEM, V265, P17792; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; Wang HH, 2014, GENE, V538, P36, DOI 10.1016/j.gene.2014.01.026; Wang WJ, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/983981; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Xu SX, 2015, DNA CELL BIOL, V34, P69, DOI 10.1089/dna.2014.2590; Yamaguchi Y, 2008, FASEB J, V22, P1009, DOI 10.1096/fj.07-9475com; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058; YAVUZER U, 1995, ONCOGENE, V10, P123; Zhang H, 2012, FEBS LETT, V586, P4126, DOI 10.1016/j.febslet.2012.10.006; Zhou WB, 2010, MOL CELL BIOCHEM, V343, P231, DOI 10.1007/s11010-010-0518-2	48	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143142	10.1371/journal.pone.0143142	http://dx.doi.org/10.1371/journal.pone.0143142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580798	gold, Green Submitted, Green Published			2022-12-27	WOS:000365154600091
J	Yang, YL; Yen, CT; Pai, CH; Chen, HY; Yu, SL; Lin, CY; Hu, CY; Jou, ST; Lin, DT; Lin, SR; Lin, SW				Yang, Yung-Li; Yen, Ching-Tzu; Pai, Chen-Hsueh; Chen, Hsuan-Yu; Yu, Sung-Liang; Lin, Chien-Yu; Hu, Chung-Yi; Jou, Shiann-Tarng; Lin, Dong-Tsamn; Lin, Shu-Rung; Lin, Shu-Wha			A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							SURVIVAL; TEL; MICRORNA-223; PROTEIN; GENES; CELLS	Childhood acute lymphoblastic leukemia (ALL) with t(12;21), which results in expression of the ETV6/RUNX1 fusion gene, is the most common chromosomal lesion in precursor-B (pre-B) ALL. We identified 17 microRNAs that were downregulated in ETV6/RUNX1(+) compared with ETV6/RUNX1(-) clinical samples. Among these microRNAs, miR-181a-1 was the most significantly reduced (by similar to 75%; P < 0.001). Using chromatin immunoprecipitation, we demonstrated that ETV6/RUNX1 directly binds the regulatory region of MIR181A1, and knockdown of ETV6/RUNX1 increased miR-181a-1 level. We further showed that miR-181a (functional counterpart of miR-181a-1) could target ETV6/RUNX1 and cause a reduction in the level of the oncoprotein ETV6/RUNX1, cell growth arrest, an increase in apoptosis, and induction of cell differentiation in ETV6/RUNX1(+) cell line. Moreover, ectopic expression of miR-181a also resulted in decreased CD10 hyperexpression in ETV6/RUNX1(+) primary patient samples. Taken together, our results demonstrate that MIR181A1 and ETV6/RUNX1 regulate each other, and we propose that a double negative loop involving MIR181A1 and ETV6/RUNX1 may contribute to ETV6/RUNX1-driven arrest of differentiation in pre-B ALL.	[Yang, Yung-Li; Lin, Dong-Tsamn] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 10764, Taiwan; [Yang, Yung-Li; Jou, Shiann-Tarng; Lin, Dong-Tsamn] Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yen, Ching-Tzu; Pai, Chen-Hsueh; Yu, Sung-Liang; Hu, Chung-Yi; Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Clin Lab, Taipei 10764, Taiwan; [Yen, Ching-Tzu; Pai, Chen-Hsueh; Yu, Sung-Liang; Hu, Chung-Yi; Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Sci, Taipei 10764, Taiwan; [Yen, Ching-Tzu; Pai, Chen-Hsueh; Yu, Sung-Liang; Hu, Chung-Yi; Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Med Biotechnol, Taipei 10764, Taiwan; [Chen, Hsuan-Yu; Lin, Chien-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Dept Biosci Technol, Coll Sci, Taoyuan, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Ctr Nanotechnol, Coll Sci, Taoyuan, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Ctr Biomed Technol, Coll Sci, Taoyuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University	Lin, SR (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, Coll Sci, Taoyuan, Taiwan.	shurung@cycu.edu.tw; mtshuwha@ntu.edu.tw	Chen, Hsuan-Yu/AAE-8428-2019	HU, CHUNG-YI/0000-0002-6990-3297; Pai, Chen-Hsueh/0000-0001-5425-897X; YU, SUNG-LIANG/0000-0003-4535-9036; JOU, SHIANN-TANG/0000-0003-1483-0403; LIN, SHU-WHA/0000-0001-6748-5581; YANG, YUNG-LI/0000-0002-3598-7218	National Science Council of Taiwan [NSC 102-2320-B-002-028-MY3, NSC 99-2314-B-002-016-MY3, NSC 100-2632-M-033-001-MY3, NSC 101-2632-M-033-001-MY2, NSC 102-2632-M-033-001-MY3, NSC 102-2320-B-033 -003]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan, www.most.gov.tw/ (Grant No. NSC 102-2320-B-002-028-MY3, NSC 99-2314-B-002-016-MY3, NSC 100-2632-M-033-001-MY3, NSC 101-2632-M-033-001-MY2, NSC 102-2632-M-033-001-MY3, and NSC 102-2320-B-033 -003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Diakos C, 2007, BLOOD, V109, P2607, DOI 10.1182/blood-2006-04-019612; Diakos C, 2010, BLOOD, V116, P4885, DOI 10.1182/blood-2009-02-206706; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Fischer M, 2005, ONCOGENE, V24, P7579, DOI 10.1038/sj.onc.1208931; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gefen N, 2010, LEUKEMIA, V24, P89, DOI 10.1038/leu.2009.208; Guidez F, 2000, BLOOD, V96, P2557; Gunji H, 2004, BIOCHEM BIOPH RES CO, V322, P623, DOI 10.1016/j.bbrc.2004.07.169; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Kaindl U, 2014, LEUKEMIA, V28, P600, DOI 10.1038/leu.2013.345; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Lwin T, 2013, J CLIN INVEST, V123, P4612, DOI 10.1172/JCI64210; Mesquita D, 2010, REV BRAS REUMATOL, V50, P566, DOI 10.1590/S0482-50042010000500008; Morrow M, 2007, ONCOGENE, V26, P4404, DOI 10.1038/sj.onc.1210227; Musilova K, 2015, LEUKEMIA, V29, P1004, DOI 10.1038/leu.2014.351; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Pallasch CP, 2009, BLOOD, V114, P3255, DOI 10.1182/blood-2009-06-229898; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Roehle A, 2008, BRIT J HAEMATOL, V142, P732, DOI 10.1111/j.1365-2141.2008.07237.x; Schotte D, 2011, HAEMATOL-HEMATOL J, V96, P703, DOI 10.3324/haematol.2010.026138; Starkova J, 2007, CLIN CANCER RES, V13, P1726, DOI 10.1158/1078-0432.CCR-06-2569; Torrano V, 2011, BLOOD, V118, P4910, DOI 10.1182/blood-2011-05-354266; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang LL, 2001, ONCOGENE, V20, P3716, DOI 10.1038/sj.onc.1204479; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Yang YL, 2010, LEUKEMIA RES, V34, P18, DOI 10.1016/j.leukres.2009.07.023; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zaliova M, 2011, LEUKEMIA, V25, P313, DOI 10.1038/leu.2010.277	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142863	10.1371/journal.pone.0142863	http://dx.doi.org/10.1371/journal.pone.0142863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580398	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600062
J	Hart, ML; Meyer, A; Johnson, PJ; Ericsson, AC				Hart, Marcia L.; Meyer, Alexandra; Johnson, Philip J.; Ericsson, Aaron C.			Comparative Evaluation of DNA Extraction Methods from Feces of Multiple Host Species for Downstream Next-Generation Sequencing	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL-DNA; DATABASE	The gastrointestinal tract contains a vast community of microbes that to this day remain largely unculturable, making studies in this area challenging. With the newly affordable advanced sequencing technology, important breakthroughs in this exciting field are now possible. However, standardized methods of sample collection, handling, and DNA extraction have yet to be determined. To help address this, we investigated the use of 5 common DNA extraction methods on fecal samples from 5 different species. Our data show that the method of DNA extraction impacts DNA concentration and purity, successful NGS amplification, and influences microbial communities seen in NGS output dependent on the species of fecal sample and the DNA extraction method used. These data highlight the importance of careful consideration of DNA extraction method used when designing and interpreting data from cross species studies.	[Hart, Marcia L.; Ericsson, Aaron C.] Univ Missouri, Dept Vet Pathobiol, Comparat Med Program, Columbia, MO 65211 USA; [Meyer, Alexandra] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Johnson, Philip J.] Univ Missouri, Dept Vet Med & Surg, Columbia, MO USA; [Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Columbia, MO USA; [Ericsson, Aaron C.] Univ Missouri, Mutant Mouse Resource & Res Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ericsson, AC (corresponding author), Univ Missouri, Dept Vet Pathobiol, Comparat Med Program, Columbia, MO 65211 USA.	ericssona@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021	Ericsson, Aaron C./0000-0002-3053-7269	National Institutes of Health [NIH U42 OD010918-13, NIH T32 OD011126]; Mizzou Advantage, One Health Initiative; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011126, U42OD010918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizzou Advantage, One Health Initiative; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Studies were funded by grants from the National Institutes of Health (NIH U42 OD010918-13 and NIH T32 OD011126) to the University of Missouri Mutant Mouse Resource and Research Center (www.mmrrc.org) and a T32 training grant to the University of Missouri Comparative Medicine Program (cmp.missouri.edu). Funding was also provided by the Mizzou Advantage, One Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Ferrand J, 2014, J MICROBIOL METH, V105, P180, DOI 10.1016/j.mimet.2014.07.029; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hugenholtz P, 2002, GENOME BIOL, V3; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li M, 2003, J MICROBIOL METH, V54, P13, DOI 10.1016/S0167-7012(02)00260-9; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Strober W, 2013, TRENDS IMMUNOL, V34, P423, DOI 10.1016/j.it.2013.07.001; Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865	24	84	89	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143334	10.1371/journal.pone.0143334	http://dx.doi.org/10.1371/journal.pone.0143334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599606	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600052
J	Isdory, A; Mureithi, EW; Sumpter, DJT				Isdory, Augustino; Mureithi, Eunice W.; Sumpter, David J. T.			The Impact of Human Mobility on HIV Transmission in Kenya	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EPIDEMIC MODEL; RISK-FACTORS; INFECTION; MIGRATION; SPREAD; HIV/AIDS; DYNAMICS; HETEROGENEITY; ABSTINENCE	Disease spreads as a result of people moving and coming in contact with each other. Thus the mobility patterns of individuals are crucial in understanding disease dynamics. Here we study the impact of human mobility on HIV transmission in different parts of Kenya. We build an SIR metapopulation model that incorporates the different regions within the country. We parameterise the model using census data, HIV data and mobile phone data adopted to track human mobility. We found that movement between different regions appears to have a relatively small overall effect on the total increase in HIV cases in Kenya. However, the most important consequence of movement patterns was transmission of the disease from high infection to low prevalence areas. Mobility slightly increases HIV incidence rates in regions with initially low HIV prevalences and slightly decreases incidences in regions with initially high HIV prevalence. We discuss how regional HIV models could be used in public-health planning. This paper is a first attempt to model spread of HIV using mobile phone data, and we also discuss limitations to the approach.	[Isdory, Augustino; Mureithi, Eunice W.] Univ Dar Es Salaam, Dept Math, Dar Es Salaam, Tanzania; [Sumpter, David J. T.] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden	University of Dar es Salaam; Uppsala University	Isdory, A (corresponding author), Univ Dar Es Salaam, Dept Math, Dar Es Salaam, Tanzania.	lukwea@yahoo.com	Isdory, Augustino/ABC-6031-2020; Mureithi, Eunice/ABB-6114-2020		International Science Programme (ISP); International Science Programme (ISP) in Sweden	International Science Programme (ISP); International Science Programme (ISP) in Sweden	The authors received no specific funding for this work. However, the International Science Programme (ISP) sponsored the corresponding author in his visits from Tanzania to Uppsala University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the International Science Programme (ISP) in Sweden for the financial support. We also thank the PLOS One reviewers for their critical review and many useful suggestions on an earlier version of this Manuscript.	Abdulkarim UM, 2007, RES J APPL SCI, V2, P595; Amundsen EJ, 2004, EPIDEMIOL INFECT, V132, P1139, DOI 10.1017/S0950268804002997; ANDERSON RM, 1988, J ROY STAT SOC A STA, V151, P66, DOI 10.2307/2982185; Arino J, 2005, MATH MED BIOL, V22, P129, DOI 10.1093/imammb/dqi003; Arino J, 2007, MATH BIOSCI, V206, P46, DOI 10.1016/j.mbs.2005.09.002; Arino J, 2006, FIELDS I COMMUN, V48, P1; Barnett T, 2005, LANCET INFECT DIS, V5, P590, DOI 10.1016/S1473-3099(05)70219-X; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; Baryarama F, 2006, Comput Math Methods Med, V7, P27, DOI 10.1080/10273660600890057; Berman A., 1979, NONNEGATIVE MATRICES; Brewer TH, 1998, AIDS, V12, P1879, DOI 10.1097/00002030-199814000-00020; BWAYO J, 1994, ARCH INTERN MED, V154, P1391, DOI 10.1001/archinte.154.12.1391; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; CARSWELL JW, 1989, AIDS, V3, P759, DOI 10.1097/00002030-198911000-00013; Coast E, 2006, SOC SCI MED, V63, P1000, DOI 10.1016/j.socscimed.2006.03.009; Coffee M, 2007, AIDS, V21, P343, DOI 10.1097/QAD.0b013e328011dac9; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; David Z, 2015, DATABANK HOME CORPOR; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Farina L., 2000, PUR AP M-WI; FLINT JJ, 1974, WATER RESOUR RES, V10, P969, DOI 10.1029/WR010i005p00969; Goufo EFD, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/781028; Gualtieri AF, 2011, J LIFE SCI, V5, P503; Hargrove J, 2008, S AFR J SCI, V104, P53; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; HETHCOTE HW, 1987, MATH BIOSCI, V84, P85, DOI 10.1016/0025-5564(87)90044-7; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; HUANG WZ, 1992, SIAM J APPL MATH, V52, P835, DOI 10.1137/0152047; Kamwanga J, 2006, CORRIDORS HOPE SO AF; Keeling MJ, 2009, BRIT MED BULL, V92, P33, DOI 10.1093/bmb/ldp038; Keeling MJ, 2008, MODELING INFECT DIES; Kenya A.I.D.S., 2008, IND SURV 2007 NAIR K; Kenya S, 2013, COUNTRY COUNTIES KEN; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Korobeinikov A, 2006, B MATH BIOL, V68, P615, DOI 10.1007/s11538-005-9037-9; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Lima V, 2009, SOC SCI MED, V68, P1044, DOI 10.1016/j.socscimed.2008.12.043; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lu ZH, 2002, MATH COMPUT MODEL, V36, P1039, DOI 10.1016/S0895-7177(02)00257-1; LUI KJ, 1986, P NATL ACAD SCI USA, V83, P3051, DOI 10.1073/pnas.83.10.3051; Lurie M, 1997, HLTH TRANSITION R S3, V7, P17; Lurie MN, 2002, SEXUALLY TRANSMITTED, V30, P149, DOI [10.1097/00007435-200302000-00011, DOI 10.1097/00007435-200302000-00011]; Makinde OD, 2007, APPL MATH COMPUT, V184, P842, DOI 10.1016/j.amc.2006.06.074; Margevicius R., 2013, INVOLVE, V6, P127, DOI DOI 10.2140/INV0LVE.2013.6.127; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Mmbaga EJ, 2008, INT J INFECT DIS, V12, P519, DOI 10.1016/j.ijid.2008.02.007; Naresh R., 2011, WORLD J MODEL SIMUL, V7, P230; Nishiura H, 2010, INT J ENV RES PUB HE, V7, P291, DOI 10.3390/ijerph7010291; Ramjee G, 2002, SEX TRANSM DIS, V29, P44, DOI 10.1097/00007435-200201000-00008; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; Singh S, 2004, REPROD HEALTH MATTER, V12, P129, DOI 10.1016/S0968-8080(04)23118-4; Smith RJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S15; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; Tizzoni M, 2014, USE HUMAN MOBILITY P, DOI [10.1371/journal.pcbi.1003716, DOI 10.1371/JOURNAL.PCBI.1003716]; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vergu E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009371; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Williams B, ARXIV13043720; WILSON ME, 1995, EMERG INFECT DIS, V1, P39, DOI 10.3201/eid0102.950201; Xiao YN, 2013, J THEOR BIOL, V317, P271, DOI 10.1016/j.jtbi.2012.09.037; Zuma K, 2005, EPIDEMIOL INFECT, V133, P421, DOI 10.1017/S0950268804003607	66	22	23	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142805	10.1371/journal.pone.0142805	http://dx.doi.org/10.1371/journal.pone.0142805			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599277	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600019
J	Leung-Theung-Long, S; Gouanvic, M; Coupet, CA; Ray, A; Tupin, E; Silvestre, N; Marchand, JB; Schmitt, D; Hoffmann, C; Klein, M; Seegren, P; Huaman, MC; Cristillo, AD; Inchauspe, G				Leung-Theung-Long, Stephane; Gouanvic, Marie; Coupet, Charles-Antoine; Ray, Aurelie; Tupin, Emmanuel; Silvestre, Nathalie; Marchand, Jean-Baptiste; Schmitt, Doris; Hoffmann, Chantal; Klein, Murielle; Seegren, Philip; Huaman, Maria C.; Cristillo, Anthony D.; Inchauspe, Genevieve			A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates	PLOS ONE			English	Article							CD8(+) T-CELLS; OF-THE-ART; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE EFFICACY; VIRUS ANKARA; CYNOMOLGUS MACAQUES; RHESUS MACAQUES; IN-VIVO; INFECTION; BCG	Bacille Calmette-Guerin (BCG) vaccination of new born babies can protect children against tuberculosis (TB), but fails to protect adults consistently against pulmonary TB underlying the urgent need to develop novel TB vaccines. Majority of first generation TB vaccine candidates have relied on a very limited number of antigens typically belonging to the active phase of infection. We have designed a multi-antigenic and multiphasic vaccine, based on the Modified Vaccinia Ankara virus (MVA). Up to fourteen antigens representative of the three phases of TB infection (active, latent and resuscitation) were inserted into MVA. Using three different strains of mouse (BALB/c, C57BL/6 and C3H/HeN), we show that a single vaccination results in induction of both CD4 and CD8 T cells, displaying capacity to produce multiple cytokines together with cytolytic activity targeting a large array of epitopes. As expected, dominance of responses was linked to the mouse haplotype although for a given haplotype, responses specific of at least one antigen per phase could always be detected. Vaccination of non-human primates with the 14 antigens MVA-TB candidate resulted in broad and potent cellular-based immunogenicity. The remarkable plasticity of MVA opens the road to development of a novel class of highly complex recombinant TB vaccines to be evaluated in both prophylactic and therapeutic settings.	[Leung-Theung-Long, Stephane; Gouanvic, Marie; Coupet, Charles-Antoine; Ray, Aurelie; Tupin, Emmanuel; Inchauspe, Genevieve] Transgene SA, Dept Infect Dis, Lyon, France; [Silvestre, Nathalie; Marchand, Jean-Baptiste; Schmitt, Doris; Hoffmann, Chantal; Klein, Murielle] Transgene SA, Dept Smart Virus Lab, Illkirch Graffenstaden, France; [Seegren, Philip; Huaman, Maria C.; Cristillo, Anthony D.] Adv BioSci Labs Inc, Rockville, MD USA	Transgene SA; Transgene SA	Leung-Theung-Long, S (corresponding author), Transgene SA, Dept Infect Dis, Lyon, France.	leung_theung_long@transgene.fr		LEUNG-THEUNG-LONG, Stephane/0000-0001-5590-9666; Seegren, Philip/0000-0002-7153-4670	National Institute of Allergy and Infectious Diseases [R01-AI098911]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098911] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported in part by Award Number R01-AI098911 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. SL, MG, CC, AR, ET, NS, JM, DS, CH, MK and GI are paid employees of Transgene. PS, MCH and ADC are paid employees of Advanced BioScience Laboratories, Inc. Transgene has supported all in vitro experiments and mouse studies. Advanced BioScience Laboratories, Inc. has supported primate studies. The funders provided support in the form of salaries for authors [Transgene: SL, MG, CC, AR, ET, NS, JM, DS, CH, MK, GI; Advanced BioScience Laboratories, Inc.: PS, MCH, ADC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Baldwin SL, 2014, CLIN VACCINE IMMUNOL, V21, P1309, DOI 10.1128/CVI.00372-14; Baldwin SL, 2012, J IMMUNOL, V188, P2189, DOI 10.4049/jimmunol.1102696; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Boukhebza H, 2012, HUM VACC IMMUNOTHER, V8, P1746, DOI 10.4161/hv.21689; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; COCHRAN MA, 1985, J VIROL, V54, P30, DOI 10.1128/JVI.54.1.30-37.1985; Coler RN, 2013, J INFECT DIS, V207, P1242, DOI 10.1093/infdis/jis425; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cruz A, 2015, VACCINE, V33, P85, DOI 10.1016/j.vaccine.2014.11.013; da Costa C, 2015, INT J INFECT DIS, V32, P5, DOI 10.1016/j.ijid.2014.11.026; de Barra E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115161; Derrick SC, 2013, VACCINE, V31, P4641, DOI 10.1016/j.vaccine.2013.07.032; Foulds KE, 2012, CYTOM PART A, V81A, P360, DOI 10.1002/cyto.a.22008; Fournillier A, 2007, VACCINE, V25, P7339, DOI 10.1016/j.vaccine.2007.08.020; Gilbert SC, 2013, VACCINE, V31, P4241, DOI 10.1016/j.vaccine.2013.03.020; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Gupta RK, 2010, MICROBIOL-SGM, V156, P2714, DOI 10.1099/mic.0.037622-0; Hawn TR, 2014, MICROBIOL MOL BIOL R, V78, P650, DOI 10.1128/MMBR.00021-14; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Kolibab K, 2010, CLIN VACCINE IMMUNOL, V17, P793, DOI 10.1128/CVI.00006-10; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Malkevitch NV, 2006, VIROLOGY, V353, P83, DOI 10.1016/j.virol.2006.05.012; Martin P, 2004, J MED VIROL, V74, P397, DOI 10.1002/jmv.20189; Marx FM, 2014, CLIN INFECT DIS, V58, P1676, DOI 10.1093/cid/ciu186; McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Pitt JM, 2013, MICROB PATHOGENESIS, V58, P2, DOI 10.1016/j.micpath.2012.12.002; Remy-Ziller C, 2014, CLIN VACCINE IMMUNOL, V21, P147, DOI 10.1128/CVI.00678-13; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; Russell-Goldman E, 2008, INFECT IMMUN, V76, P4269, DOI 10.1128/IAI.01735-07; Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X; Schiroli C, 2015, INFECTION, V10, P10; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Smaill F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006843; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Verwaerde C, 2014, VACCINE, V32, P6240, DOI 10.1016/j.vaccine.2014.09.024; Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; WHO, 2014, GLOBAL TUBERCULOSIS; Woodworth JS, 2008, J IMMUNOL, V181, P8595, DOI 10.4049/jimmunol.181.12.8595; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30; Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09	50	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143552	10.1371/journal.pone.0143552	http://dx.doi.org/10.1371/journal.pone.0143552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599077	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600082
J	Sarfo, FS; Eberhardt, KA; Dompreh, A; Kuffour, EO; Soltau, M; Schachscheider, M; Drexler, JF; Eis-Hubinger, AM; Haussinger, D; Oteng-Seifah, EE; Bedu-Addo, G; Phillips, RO; Norman, B; Burchard, G; Feldt, T				Sarfo, Fred Stephen; Eberhardt, Kirsten Alexandra; Dompreh, Albert; Kuffour, Edmund Osei; Soltau, Mareike; Schachscheider, Marei; Drexler, Jan Felix; Eis-Hubinger, Anna Maria; Haeussinger, Dieter; Oteng-Seifah, Emelia Efua; Bedu-Addo, George; Phillips, Richard Odame; Norman, Betty; Burchard, Gerd; Feldt, Torsten			Helicobacter pylori Infection Is Associated with Higher CD4 T Cell Counts and Lower HIV-1 Viral Loads in ART-Naive HIV-Positive Patients in Ghana	PLOS ONE			English	Article							CD4/CD8 RATIO; IMMUNE-RESPONSE; THERAPY; COHORT; RISK; TUBERCULOSIS; INFLAMMATION; INDIVIDUALS; ERADICATION; PERSPECTIVE	Background Worldwide, there is a high co-endemicity of HIV and H. pylori infection and there is growing evidence that H. pylori co-infection is associated with parameters of HIV disease progression. The objective of this study was to investigate the prevalence of H. pylori infection, and the association with clinical, immunological and virological parameters in a large cohort of HIV-infected individuals and uninfected controls in a West African country. Methods HIV-patients (n = 1,095) and HIV-negative individuals (n = 107) were recruited at a university hospital in Ghana. H. pylori status was determined using stool antigen testing. HIV-related, clinical and socio-demographic parameters were recorded and analyzed according to H. pylori status. Results The prevalence of H. pylori infection was significantly lower in HIV-positive compared to HIV-negative individuals (51.5 vs. 88%, p<0.0001). In HIV patients, H. pylori prevalence decreased in parallel with CD4+ T cell counts. In ART-naive HIV-infected individuals, but not in those taking ART, H. pylori infection was associated with higher CD4 cell counts (312 vs. 189 cells/mu L, p<0.0001) and lower HIV-1 viral loads (4.92 vs. 5.21 log10 copies/mL, p = 0.006). The findings could not be explained by socio-demographic confounders or reported use of antibiotics. Having no access to tap water and higher CD4+ T cell counts were identified as risk factors for H. pylori infection. Conclusions H. pylori prevalence was inversely correlated with the degree of immunosuppression. In ART-naive individuals, H. pylori infection is associated with favorable immunological and virological parameters. The underlying mechanisms for this association are unclear and warrant investigation.	[Sarfo, Fred Stephen; Bedu-Addo, George; Phillips, Richard Odame; Norman, Betty] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Sarfo, Fred Stephen; Dompreh, Albert; Bedu-Addo, George; Phillips, Richard Odame; Norman, Betty] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Eberhardt, Kirsten Alexandra; Soltau, Mareike; Schachscheider, Marei; Burchard, Gerd; Feldt, Torsten] Bernhard Nocht Inst Trop Med, Clin Res Unit, Hamburg, Germany; [Kuffour, Edmund Osei; Haeussinger, Dieter] Univ Hosp Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Drexler, Jan Felix; Eis-Hubinger, Anna Maria] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Oteng-Seifah, Emelia Efua] Kumasi Ctr Collaborat Res, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Bernhard Nocht Institut fur Tropenmedizin; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Bonn; Kumasi Center for Collaborative Research	Feldt, T (corresponding author), Bernhard Nocht Inst Trop Med, Clin Res Unit, Hamburg, Germany.	Torsten.Feldt@med.uni-duesseldorf.de	Phillips, Richard Odame/ABD-5394-2021; Drexler, Jan Felix/GMW-5098-2022; Feldt, Torsten/ABF-5894-2021; Eberhardt, Kirsten/AAP-8440-2021	Phillips, Richard Odame/0000-0001-8992-0222; Eberhardt, Kirsten/0000-0002-1002-0326; Drexler, Jan Felix/0000-0002-3509-0232	German Federal Ministry of Education and Research [01KA1102]; MRC [MR/J01477X/1] Funding Source: UKRI; Medical Research Council [MR/J01477X/1] Funding Source: researchfish	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the German Federal Ministry of Education and Research [grant number 01KA1102]. The funders had no role in the design of the study and decision to publish these findings.	Aebischer T, 2010, HELICOBACTER, V15, P21, DOI 10.1111/j.1523-5378.2010.00777.x; Ahmed K. S., 2007, SMJ Singapore Medical Journal, V48, P543; Angin M, 2014, J INFECT DIS, V210, P899, DOI 10.1093/infdis/jiu188; Arnold IC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00010; Assimakopoulos SF, 2014, INFECTION; Bhan MK, 2002, J INFECT DIS, V186, P1857, DOI 10.1086/345762; Boyanova L, 2014, DIAGN MICR INFEC DIS, V79, P358, DOI 10.1016/j.diagmicrobio.2014.03.028; Bravo LE, 2003, J PEDIATR GASTR NUTR, V37, P614, DOI 10.1097/00005176-200311000-00021; Buggert M, 2014, J IMMUNOL, V192, P2099, DOI 10.4049/jimmunol.1302596; Burkey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P41, DOI 10.1097/QAI.0000000000000094; CHIBA N, 1992, AM J GASTROENTEROL, V87, P1716; DuBois S, 2005, AM J GASTROENTEROL, V100, P453, DOI 10.1111/j.1572-0241.2005.30252.x; Eberhardt KA, 2015, CLIN INFECT DIS, V61, P1615, DOI 10.1093/cid/civ577; EDWARDS PD, 1991, AM J GASTROENTEROL, V86, P1761; Erzin Y, 2004, HELICOBACTER, V9, P657, DOI 10.1111/j.1083-4389.2004.00280.x; Fabris P, 1997, DIGEST DIS SCI, V42, P289, DOI 10.1023/A:1018801532136; Gao L, 2009, EUR J CANCER, V45, P2860, DOI 10.1016/j.ejca.2009.04.015; Gisbert JP, 2007, HELICOBACTER, V12, P50, DOI 10.1111/j.1523-5378.2007.00576.x; Goll R, 2007, HELICOBACTER, V12, P185, DOI 10.1111/j.1523-5378.2007.00495.x; Goodwin CS, 1997, LANCET, V349, P265, DOI 10.1016/S0140-6736(96)07023-7; Khamri W, 2010, INFECT IMMUN, V78, P845, DOI 10.1128/IAI.00524-09; Khan A, 2012, J INFECT DEV COUNTR, V6, P251, DOI 10.3855/jidc.2312; Makristathis A, 2000, J CLIN MICROBIOL, V38, P3710, DOI 10.1128/JCM.38.10.3710-3714.2000; Mitchell P, 2007, INFECT IMMUN, V75, P810, DOI 10.1128/IAI.00228-06; Muller A, 2011, HELICOBACTER, V16, P26, DOI 10.1111/j.1523-5378.2011.00877.x; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Nevin DT, 2014, HELICOBACTER, V19, P323, DOI 10.1111/hel.12131; Panos GZ, 2007, AIDS RES HUM RETROV, V23, P709, DOI 10.1089/aid.2006.0174; Perry S, 2013, EPIDEMIOL INFECT, V141, P1232, DOI 10.1017/S0950268812001823; Perry S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008804; Romanelli F, 2007, AIDS PATIENT CARE ST, V21, P908, DOI 10.1089/apc.2006.0215; Rothenbacher D, 2000, J PEDIATR-US, V136, P744, DOI 10.1016/S0022-3476(00)77103-4; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Sayi A, 2009, J IMMUNOL, V182, P7085, DOI 10.4049/jimmunol.0803293; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Stevenson TH, 2000, APPL ENVIRON MICROB, V66, P723, DOI 10.1128/AEM.66.2.723-727.2000; Thomas JE, 2004, ARCH DIS CHILD, V89, P1149, DOI 10.1136/adc.2002.015313; UNAIDS, 2014, THE GAP REP	39	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143388	10.1371/journal.pone.0143388	http://dx.doi.org/10.1371/journal.pone.0143388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599971	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600060
J	Bernard, H; Desseyn, JL; Gottrand, F; Stahl, B; Bartke, N; Husson, MO				Bernard, Henry; Desseyn, Jean-Luc; Gottrand, Frederic; Stahl, Bernd; Bartke, Nana; Husson, Marie-Odile			Pectin- Derived Acidic Oligosaccharides Improve the Outcome of Pseudomonas aeruginosa Lung Infection in C57BL/6 Mice	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; IMMUNE-RESPONSE; GALACTO-OLIGOSACCHARIDES; BUTYRATE; CELLS; BIFIDOBACTERIA; POLARIZATION; ACTIVATION; MICROBIOTA; MONOCYTES	The administration of prebiotics as oligosaccharides (OS), by acting on intestinal microbiota, could modulate the immune and inflammatory response and represent a new strategy to improve the outcome of bacterial infection. The aim of this study was to determine whether pectin-derived acidic oligosaccharides (pAOS) could modulate the outcome of pulmonary P. aeruginosa (PA) infection in C57BL/6 mice, which develop a Th1 response to PA lung infection. Mice were randomized for 5 weeks to consume a control or a 5% pAOS diet and chronically infected by PA. Resistance to a second PA infection was also analyzed by reinfecting the surviving mice 2 weeks after the first infection. Compared with control mice, mice fed pAOS had reduced mortality (P<0.05). This improvement correlated with a better control of the inflammatory response with a lower neutrophil count on day 1 (P<0.05), a sustained neutrophil and macrophage recruitment on days 2 and 3 (P<0.01) a greater and sustained IL-10 release in lung (P<0.05) and a reduction of the Th1 response and M1 activation with a lower IFN-./IL-4 (P<0.01) and nos2/arg1 (P<0.05) ratios. These results coincided with a modulation of the intestinal microbiota as shown by an increased butyric acid concentration in feces (P<0.05). Moreover, pAOS decreased the bacterial load (P<0.01) in mice reinfected 2 weeks after the first infection, suggesting that pAOS could reduce pulmonary exacerbations. In conclusion, pAOS improved the outcome of PA infection in C57BL/6 mice by modulating the intestinal microbiota and the inflammatory and immune responses.	[Bernard, Henry; Desseyn, Jean-Luc; Gottrand, Frederic; Husson, Marie-Odile] Univ Lille, LIRIC UMR 995, INSERM, CHRU Lille,Fac Med, F-59045 Lille, France; [Stahl, Bernd; Bartke, Nana] Nutricia Res, NL-3584 CT Utrecht, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Danone Nutricia	Husson, MO (corresponding author), Univ Lille, LIRIC UMR 995, INSERM, CHRU Lille,Fac Med, Pl Verdun, F-59045 Lille, France.	mo.husson@orange.fr	Desseyn, Jean-Luc/M-5070-2018; gottrand, frederic/G-7370-2015	Desseyn, Jean-Luc/0000-0001-6876-8049; gottrand, frederic/0000-0002-5290-0436	French Association "Vaincre la Mucoviscidose" [2009/IC0916, 2010/IC1018]; Funder Nutritia Research	French Association "Vaincre la Mucoviscidose"; Funder Nutritia Research	The study was funded by grants from the French Association "Vaincre la Mucoviscidose": grant number 2009/IC0916, 2010/IC1018) for purchasing mice and materials, and Nutricia Research for providing the experimental diets. The Funder Nutritia Research provided also support in the form of the salary of H. B., but did not have any additional role in the study design, data collection and other analysis, decision to publish, or preparation of the manuscript. The specific roles of the two authors (N.B. and B.S.) of Nutritia Research are articulated in the 'author contributions' section.	Arslanoglu S, 2012, J Biol Regul Homeost Agents, V26, P49; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bernard H, 2015, J INFECT DIS, V211, P156, DOI 10.1093/infdis/jiu391; Brazova J, 2005, CLIN IMMUNOL, V115, P210, DOI 10.1016/j.clim.2005.01.013; Capitan-Canadas F, 2014, MOL NUTR FOOD RES, V58, P1098, DOI 10.1002/mnfr.201300497; Chuang L, 2007, J AGR FOOD CHEM, V55, P11080, DOI 10.1021/jf071786o; Duytschaever G, 2013, J CYST FIBROS, V12, P206, DOI 10.1016/j.jcf.2012.10.003; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Perez-Cobas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080201; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Ghadimi D, 2008, IMMUNOBIOLOGY, V213, P677, DOI 10.1016/j.imbio.2008.02.001; Giovannini M, 2014, J AM COLL NUTR, V10, P1; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Jensen PO, 2010, FEMS IMMUNOL MED MIC, V59, P292, DOI 10.1111/j.1574-695X.2010.00706.x; Kondratieva TK, 2000, CLIN EXP IMMUNOL, V121, P275, DOI 10.1046/j.1365-2249.2000.01222.x; Livingston M, 2010, IMMUNOL CELL BIOL, V88, P99, DOI 10.1038/icb.2009.71; Lohner S, 2014, NUTR REV, V72, P523, DOI 10.1111/nure.12117; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Moser C, 2005, APMIS, V113, P400, DOI 10.1111/j.1600-0463.2005.apm_142.x; Moser C, 1999, APMIS, V107, P1093, DOI 10.1111/j.1699-0463.1999.tb01514.x; Ni YF, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-33; Ortega-Gonzalez M, 2014, MOL NUTR FOOD RES, V58, P384, DOI 10.1002/mnfr.201300296; Pierre M, 2007, AM J PHYSIOL-LUNG C, V292, pL1422, DOI 10.1152/ajplung.00337.2006; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Saemann MD, 2000, FASEB J, V14, P2380; Schippa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061176; Scott KP, 2014, FEMS MICROBIOL ECOL, V87, P30, DOI 10.1111/1574-6941.12186; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; van Hoffen E, 2009, ALLERGY, V64, P484, DOI 10.1111/j.1398-9995.2008.01765.x; van't Land B, 2010, VACCINE, V28, P5711, DOI 10.1016/j.vaccine.2010.06.046; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vos AP, 2007, PEDIAT ALLERG IMM-UK, V18, P304, DOI 10.1111/j.1399-3038.2007.00515.x; Walton GE, 2012, BRIT J NUTR, V107, P1466, DOI 10.1017/S0007114511004697; Yang JY, 2013, ANAEROBE, V23, P74, DOI 10.1016/j.anaerobe.2013.06.012	38	14	15	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0139686	10.1371/journal.pone.0139686	http://dx.doi.org/10.1371/journal.pone.0139686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599638	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900006
J	De Franceschi, N; Peuhu, E; Parsons, M; Rissanen, S; Vattulainen, I; Salmi, M; Ivaska, J; Pouwels, J				De Franceschi, Nicola; Peuhu, Emilia; Parsons, Maddy; Rissanen, Sami; Vattulainen, Ilpo; Salmi, Marko; Ivaska, Johanna; Pouwels, Jeroen			Mutually Exclusive Roles of SHARPIN in Integrin Inactivation and NF-kappa B Signaling	PLOS ONE			English	Article							UBIQUITIN LIGASE; ACTIVATION; COMPLEX; PROTEIN; CANCER; CELLS; PTEN; CONTRIBUTES	SHANK-associated RH domain interactor (SHARPIN) inhibits integrins through interaction with the integrin alpha-subunit. In addition, SHARPIN enhances nuclear factor-kappaB (NF-kappa B) activity as a component of the linear ubiquitin chain assembly complex (LUBAC). However, it is currently unclear how regulation of these seemingly different roles is coordinated. Here, we show that SHARPIN binds integrin and LUBAC in a mutually exclusive manner. We map the integrin binding site on SHARPIN to the ubiquitin-like (UBL) domain, the same domain implicated in SHARPIN interaction with LUBAC component RNF31 (ring finger protein 31), and identify two SHARPIN residues (V267, L276) required for both integrin and RNF31 regulation. Accordingly, the integrin alpha-tail is capable of competing with RNF31 for SHARPIN binding in vitro. Importantly, the full SHARPIN RNF31-binding site contains residues (F263A/I272A) that are dispensable for SHARPIN-integrin interaction. Importantly, disrupting SHARPIN interaction with integrin or RNF31 abolishes SHARPIN-mediated regulation of integrin or NF-kappa B activity, respectively. Altogether these data suggest that the roles of SHARPIN in inhibiting integrin activity and supporting linear ubiquitination are (molecularly) distinct.	[De Franceschi, Nicola; Peuhu, Emilia; Ivaska, Johanna; Pouwels, Jeroen] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [De Franceschi, Nicola; Peuhu, Emilia; Ivaska, Johanna] VTT Tech Res Ctr Finland, Med Biotechnol, Turku, Finland; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Rissanen, Sami; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Vattulainen, Ilpo] Univ Southern Denmark, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Salmi, Marko] Univ Turku, MediCity Res Lab, Turku, Finland; [Salmi, Marko] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Ivaska, Johanna] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland	University of Turku; VTT Technical Research Center Finland; University of London; King's College London; Tampere University; University of Southern Denmark; University of Turku; University of Turku; University of Turku	Ivaska, J (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	johanna.ivaska@utu.fi; jpouwels@btk.fi	Vattulainen, Ilpo T/G-4224-2014; De Franceschi, Nicola/S-8194-2016; Parsons, Maddy/B-2203-2013	Vattulainen, Ilpo/0000-0001-7408-3214; De Franceschi, Nicola/0000-0002-7221-613X; Ivaska, Johanna/0000-0002-6295-6556; Peuhu, Emilia/0000-0003-4945-3046; Pouwels, Jeroen/0000-0002-5388-6103; Parsons, Maddy/0000-0002-2021-8379	FinPharma Doctoral Programme; Intrumentarium Foundation; Orion Research Foundation; Finsk-Norska Medicinska Stiftelsen; Magnus Ehrnrooth Foundation; Royal Society; Academy of Finland; Sigrid Juselius Foundation; European Research Council; Finnish Heart Foundation; Finnish Cancer Organizations; Finnish Cancer Institute; Instrumentarium Foundation	FinPharma Doctoral Programme; Intrumentarium Foundation; Orion Research Foundation; Finsk-Norska Medicinska Stiftelsen; Magnus Ehrnrooth Foundation; Royal Society(Royal Society of London); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Research Council(European Research Council (ERC)European Commission); Finnish Heart Foundation; Finnish Cancer Organizations; Finnish Cancer Institute; Instrumentarium Foundation	This work was supported by N.d.F. FinPharma Doctoral Programme (http://www.fpdp.fi/), Intrumentarium Foundation (http://www.instrufoundation.fi/), Orion Research Foundation (http://www.orion.fi/tutkimus/orionin-tutkimussaatio/), Finsk-Norska Medicinska Stiftelsen (http://www.foundationweb.net/finsknorska/), and the Magnus Ehrnrooth Foundation (http://pro.tsv.fi/magnusehrnrooth/English/); E.P. Academy of Finland Postdoc Grant (www.aka.fi); M.P. Royal Society (https://royalsociety.org/); M.S. Academy of Finland, the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation); J.I. Academy of Finland, European Research Council Starting Grant (http://erc.europa.eu/), The Finnish Heart Foundation (http://www.sydanliitto.fi/finnish-heart-association#.VdV8Z5fUPhU) and Finnish Cancer Organizations (www.cancer.fi); J.P. Finnish Cancer Institute (www.cancer.fi), Academy of Finland, Instrumentarium Foundation.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; De Franceschi N, 2014, TRAFFIC, V15, P104, DOI 10.1111/tra.12124; De Melo J, 2014, CELL SIGNAL, V26, P2749, DOI 10.1016/j.cellsig.2014.08.013; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Dubois SM, 2014, BLOOD, V123, P2199, DOI 10.1182/blood-2013-05-504019; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; He LZ, 2010, J CLIN INVEST, V120, P2094, DOI 10.1172/JCI40778; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Jung J, 2010, MOL CELL BIOCHEM, V340, P161, DOI 10.1007/s11010-010-0413-x; Landgraf K, 2010, MOL CELL BIOL, V30, P5764, DOI 10.1128/MCB.01645-09; Li J, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0444-3; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Liu JM, 2015, NAT STRUCT MOL BIOL, V22, P383, DOI 10.1038/nsmb.2999; Mameza MG, 2013, J BIOL CHEM, V288, P26697, DOI 10.1074/jbc.M112.424747; Milella M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00024; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pouwels J, 2013, CELL REP, V5, P619, DOI 10.1016/j.celrep.2013.10.011; QWARNSTROM EE, 1994, J BIOL CHEM, V269, P30765; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Rosales C, 1996, CANCER RES, V56, P2302; Sieber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029993; Stieglitz B, 2012, J BIOL CHEM, V287, P20823, DOI 10.1074/jbc.M112.359547; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Zhang YM, 2014, CANCER-AM CANCER SOC, V120, P3208, DOI 10.1002/cncr.28796	32	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143423	10.1371/journal.pone.0143423	http://dx.doi.org/10.1371/journal.pone.0143423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600301	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900116
J	Park, BY; Lee, H; Woo, S; Yoon, M; Kim, J; Hong, Y; Lee, HS; Park, EK; Hahm, JC; Kim, JW; Shin, SS; Kim, MY; Yoon, M				Park, Byung Young; Lee, Hyunghee; Woo, Sangee; Yoon, Miso; Kim, Jeongjun; Hong, Yeonhee; Lee, Hee Suk; Park, Eun Kyu; Hahm, Jong Cheon; Kim, Jin Woo; Shin, Soon Shik; Kim, Min-Young; Yoon, Michung			Reduction of Adipose Tissue Mass by the Angiogenesis Inhibitor ALS-L1023 from Melissa officinalis	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITION; COMPOSITION OB-X; INSULIN-RESISTANCE; GELATINASE-A; PPAR-ALPHA; MORUS-ALBA; OBESITY; GROWTH; EXPRESSION; ADIPOGENESIS	It has been suggested that angiogenesis modulates adipogenesis and obesity. This study was undertaken to determine whether ALS-L1023 (ALS) prepared by a two-step organic solvent fractionation from Melissa leaves, which exhibits antiangiogenic activity, can regulate adipose tissue growth. The effects of ALS on angiogenesis and extracellular matrix remodeling were measured using in vitro assays. The effects of ALS on adipose tissue growth were investigated in high fat diet-induced obese mice. ALS inhibited VEGF-and bFGF-induced endothelial cell proliferation and suppressed matrix metalloproteinase (MMP) activity in vitro. Compared to obese control mice, administration of ALS to obese mice reduced body weight gain, adipose tissue mass and adipocyte size without affecting appetite. ALS treatment decreased blood vessel density and MMP activity in adipose tissues. ALS reduced the mRNA levels of angiogenic factors (VEGF-A and FGF-2) and MMPs (MMP-2 and MMP-9), whereas ALS increased the mRNA levels of angiogenic inhibitors (TSP-1, TIMP-1, and TIMP-2) in adipose tissues. The protein levels of VEGF, MMP-2 and MMP-9 were also decreased by ALS in adipose tissue. Metabolic changes in plasma lipids, liver triglycerides, and hepatic expression of fatty acid oxidation genes occurred during ALS-induced weight loss. These results suggest that ALS, which has antiangiogenic and MMP inhibitory activities, reduces adipose tissue mass in nutritionally obese mice, demonstrating that adipose tissue growth can be regulated by angiogenesis inhibitors.	[Park, Byung Young; Kim, Jin Woo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Park, Byung Young; Lee, Hee Suk; Park, Eun Kyu; Hahm, Jong Cheon; Kim, Min-Young] AngioLab Inc, Daejeon, South Korea; [Lee, Hyunghee; Woo, Sangee; Yoon, Miso; Kim, Jeongjun; Hong, Yeonhee; Yoon, Michung] Mokwon Univ, Dept Biomed Engn, Daejeon, South Korea; [Shin, Soon Shik] Dong Eui Univ, Dept Formula Sci, Coll Oriental Med, Busan, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Mokwon University; Dong-Eui University	Kim, MY (corresponding author), AngioLab Inc, Daejeon, South Korea.	mykim@angiolab.co.kr; yoon60@mokwon.ac.kr	KIM, JIN WOO/C-1655-2011	KIM, JIN WOO/0000-0003-0767-1918	National Research Foundation of Korea Grant - Korea Government (MEST), Korea [2012R1A1A3002100, 2012R1A2A2A01004508, 2015R1A1A3A04001016]; AngioLab Inc	National Research Foundation of Korea Grant - Korea Government (MEST), Korea; AngioLab Inc	This work was supported by the National Research Foundation of Korea [http://www.nrf.re.kr/] Grants funded by the Korea Government (MEST) (2012R1A1A3002100, 2012R1A2A2A01004508, and 2015R1A1A3A04001016), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder AngioLab Inc provided support in the form of salaries for authors [HL SW MY JK] and reagent materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondzadeh S, 2003, J NEUROL NEUROSUR PS, V6, P625; [Anonymous], [No title captured]; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Blumenthal M, 2000, HERBAL MED EXPANDED, V123, P230; Bouloumie A, 2002, ANN ENDOCRINOL-PARIS, V63, P91; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Celletti FL, 2001, NAT MED, V7, P425, DOI 10.1038/86490; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Croissandeau G, 2002, BIOCHEM J, V364, P739, DOI 10.1042/BJ20011158; Demeulemeester D, 2005, BIOCHEM BIOPH RES CO, V329, P105, DOI 10.1016/j.bbrc.2005.01.103; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; GALARDY RE, 1994, CANCER RES, V54, P4715; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hong Y, 2011, PHARM BIOL, V49, P775, DOI 10.3109/13880209.2010.547208; Itoh T, 1998, CANCER RES, V58, P1048; Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045; Kim MY, 2010, INT J OBESITY, V34, P820, DOI 10.1038/ijo.2010.13; Kim YM, 2007, J MOL ENDOCRINOL, V38, P455, DOI 10.1677/jme.1.02165; Lee H, 2013, FOOD CHEM TOXICOL, V53, P402, DOI 10.1016/j.fct.2012.11.052; Li JP, 2002, AM J PHYSIOL-ENDOC M, V282, pE1334, DOI 10.1152/ajpendo.00516.2001; Lijnen HR, 2002, ARTERIOSCL THROM VAS, V22, P374, DOI 10.1161/hq0302.104522; Lijnen HR, 2001, THROMB HAEMOSTASIS, V85, P1111; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Miksztowicz V, 2014, NUTR METAB CARDIOVAS, V24, P294, DOI 10.1016/j.numecd.2013.08.007; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Rundhaug JE, 2003, CLIN CANCER RES, V9, P551; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; SILVERMAN KJ, 1988, BIOCHEM BIOPH RES CO, V153, P347, DOI 10.1016/S0006-291X(88)81229-4; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Valentino MA, 2010, CLIN PHARMACOL THER, V87, P652, DOI 10.1038/clpt.2010.57; Van Hul M, 2008, J THROMB HAEMOST, V6, P1198, DOI 10.1111/j.1538-7836.2008.02988.x; Van Hul M, 2011, ENDOCR J, V58, P101, DOI 10.1507/endocrj.K10E-267; Yoon M, 2011, PHARM BIOL, V49, P614, DOI 10.3109/13880209.2010.539617; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004	46	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141612	10.1371/journal.pone.0141612	http://dx.doi.org/10.1371/journal.pone.0141612			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599360	Green Published, gold			2022-12-27	WOS:000365853900013
J	Wang, CY; Shen, Y; Zhu, SB				Wang, Changyin; Shen, Ying; Zhu, Shaobo			Distribution Features of Skeletal Metastases: A Comparative Study between Pulmonary and Prostate Cancers	PLOS ONE			English	Article							BONE-SCAN; LUNG-CANCER; FLARE PHENOMENON; VERTEBRAL VEINS; SPECT; SCINTIGRAPHY; PREDICTORS	Bone scintigraphies are widely applied for detecting bone metastases. The aim of this study was to investigate distribution features of bone metastases in pulmonary and prostate cancers. Bone scintigraphies were performed in 460 patients with pulmonary cancer and 144 patients with prostate cancer. Patients were divided into three groups according to the total number of bone metastases: few bone metastases, moderate bone metastases, and extensive bone metastases. We compared the distribution of bone metastases in the two cancers, and analyzed the relationship between the distribution of metastatic lesions and their metastatic patterns. A total of 2279 and 2000 lesions of bone metastases were detected in 258 patients with pulmonary cancer and 102 patients with prostate cancer, respectively. In patients with few bone metastases, the distributions of metastatic lesions in the vertebrae (chi(2) = 16.0, P = 0.000) and thoracic bones (chi(2) = 20.7, P = 0.002) were significantly different between pulmonary and prostate cancers. In cases with moderate bone metastases, the distributions in the vertebrae (chi(2) = 6.6, P = 0.010), pelvis (chi(2) = 15.1 P = 0.000), and thoracic bones (chi(2) = 38.8, P = 0.000) were also significantly different between the two cancers. However, in patients with extensive bone metastases, the distributions were very similar. As the total number of bone metastases increased, their distribution in pulmonary cancer did not noticeably change, but the distribution in the vertebrae and thoracic bones of prostate cancer patients significantly changed. Accordingly, the distribution characteristics of bone metastases differed in pulmonary and prostate cancers, mainly in the early stages of metastasis.	[Wang, Changyin; Shen, Ying] Wuhan Univ, Zhongnan Hosp, Dept Nucl Med, Wuhan 430071, Hubei, Peoples R China; [Zhu, Shaobo] Wuhan Univ, Zhongnan Hosp, Dept Osteol, Wuhan 430071, Hubei, Peoples R China	Wuhan University; Wuhan University	Zhu, SB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Osteol, Wuhan 430071, Hubei, Peoples R China.	zhushaobo2000@163.com	Wang, Changyin/AAX-5904-2020	Wang, Changyin/0000-0002-8491-6272				Batson OV, 1940, ANN SURG, V112, P138, DOI 10.1097/00000658-194007000-00016; Brown MS, 2012, NUCL MED COMMUN, V33, P384, DOI 10.1097/MNM.0b013e3283503ebf; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Chao HS, 2009, CLIN NUCL MED, V34, P346, DOI 10.1097/RLU.0b013e3181a344df; Conti Giario, 2008, Arch Ital Urol Androl, V80, P59; Cook GJR, 2011, EUR J NUCL MED MOL I, V38, P7, DOI 10.1007/s00259-010-1576-0; DODDS PR, 1981, J UROLOGY, V126, P753, DOI 10.1016/S0022-5347(17)54735-7; Even-Sapir E, 2006, J NUCL MED, V47, P287; EVENSAPIR E, 1993, RADIOLOGY, V187, P193, DOI 10.1148/radiology.187.1.8451412; Gates GF, 1998, SEMIN NUCL MED, V28, P78, DOI 10.1016/S0001-2998(98)80020-2; Huang C. Y., 2006, MIDTAIWAN J MED, V11, P82; Inal A, 2014, WSPOLCZESNA ONKOL, V18, P106, DOI 10.5114/wo.2014.42725; Kakhki VRD, 2013, NUCL MED REV, V16, P66, DOI 10.5603/NMR.2013.0037; Lin K, 1999, CLIN NUCL MED, V24, P579, DOI 10.1097/00003072-199908000-00007; MORGAN JWM, 1990, UROLOGY, V36, P31, DOI 10.1016/0090-4295(90)80308-A; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Park JY, 2000, LUNG CANCER-J IASLC, V28, P55, DOI 10.1016/S0169-5002(99)00118-X; Picchio M, 2012, EUR J NUCL MED MOL I, V39, P13, DOI 10.1007/s00259-011-1920-z; Sharma P, 2012, SKELETAL RADIOL, V41, P843, DOI 10.1007/s00256-011-1304-2; Sugiura H, 2008, CLIN ORTHOP RELAT R, V466, P729, DOI 10.1007/s11999-007-0051-0; Sun JM, 2011, LUNG CANCER, V71, P89, DOI 10.1016/j.lungcan.2010.04.003; Takahashi Y, 2012, ANN NUCL MED, V26, P586, DOI 10.1007/s12149-012-0617-0; TOFE AJ, 1975, J NUCL MED, V16, P986; Wang CY, 2012, NUCL MED COMMUN, V33, P379, DOI 10.1097/MNM.0b013e3283504528; Wang CY, 2010, CHINESE GERMAN J CLI, V9, P435; WILSON MA, 1981, J NUCL MED, V22, P594	26	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143437	10.1371/journal.pone.0143437	http://dx.doi.org/10.1371/journal.pone.0143437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599401	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900121
J	Liu, XQ; Thungrat, K; Boothe, DM				Liu, Xiaoqiang; Thungrat, Kamoltip; Boothe, Dawn M.			Multilocus Sequence Typing and Virulence Profiles in Uropathogenic Escherichia coli Isolated from Cats in the United States	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ANTIMICROBIAL RESISTANCE; STRAINS; GENES; DOGS; IDENTIFICATION; GENOTYPES; HOST; DETERMINANTS; BACTEREMIA	The population structure, virulence, and antimicrobial resistance of uropathogenic E. coli (UPEC) from cats are rarely characterized. The aim of this study was to compare and characterize the UPEC isolated from cats in four geographic regions of USA in terms of their multilocus sequence typing (MLST), virulence profiles, clinical signs, antimicrobial resistance and phylogenetic grouping. The results showed that a total of 74 E. coli isolates were typed to 40 sequence types with 10 being novel. The most frequent phylogenetic group was B2 (n = 57). The most frequent sequence types were ST73 (n = 12) and ST83 (n = 6), ST73 was represented by four multidrug resistant (MDR) and eight non-multidrug resistant (SDR) isolates, and ST83 were significantly more likely to exhibit no drug resistant (NDR) isolates carrying the highest number of virulence genes. Additionally, MDR isolates were more diverse, and followed by SDR and NDR isolates in regards to the distribution of the STs. afa/draBC was the most prevalent among the 29 virulence-associated genes. Linking virulence profile and antimicrobial resistance, the majority of virulence-associated genes tested were more prevalent in NDR isolates, and followed by SDR and MDR isolates. Twenty (50%) MLST types in this study have previously been associated with human isolates, suggesting that these STs are potentially zoonotic. Our data enhanced the understanding of E. coli population structure and virulence association from cats. The diverse and various combinations of virulence-associated genes implied that the infection control may be challenging.	[Liu, Xiaoqiang] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Thungrat, Kamoltip; Boothe, Dawn M.] Auburn Univ, Coll Vet Med, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA	Northwest A&F University - China; Auburn University System; Auburn University	Liu, XQ (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	liuxiaoqiang142@163.com			Fundamental Research Funds for the Central Universities [QN2013029]; National Science Foundation of Shaanxi province [2014JM3071]; Morris Animal Foundation [D07-MS006]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation of Shaanxi province; Morris Animal Foundation	This study was supported by the Fundamental Research Funds for the Central Universities (no. QN2013029), National Science Foundation of Shaanxi province (no. 2014JM3071), and partially supported by grant D07-MS006 from Morris Animal Foundation.	Aly SA, 2012, CAN J MICROBIOL, V58, P1288, DOI 10.1139/w2012-105; Antao EM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-22; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Boerlin P, 2005, APPL ENVIRON MICROB, V71, P6753, DOI 10.1128/AEM.71.11.6753-6761.2005; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; CLSI, 2013, VET01A4 CLSI; Cooke NM, 2010, J CLIN MICROBIOL, V48, P1099, DOI 10.1128/JCM.02017-09; Feria C, 2001, FEMS MICROBIOL LETT, V202, P205, DOI 10.1016/S0378-1097(01)00310-X; Freitag T, 2005, VET MICROBIOL, V106, P79, DOI 10.1016/j.vetmic.2004.11.014; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jaureguy F, 2007, CLIN MICROBIOL INFEC, V13, P854, DOI 10.1111/j.1469-0691.2007.01775.x; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2008, J CLIN MICROBIOL, V46, P417, DOI 10.1128/JCM.00674-07; Johnson JR, 2006, CLIN INFECT DIS, V43, pE101, DOI 10.1086/508541; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 1998, J INFECT DIS, V177, P1120, DOI 10.1086/517409; Johnson JR, 2003, J CLIN MICROBIOL, V41, P337, DOI 10.1128/JCM.41.1.337-345.2003; Johnson JR, 2001, J INFECT DIS, V183, P1546; Johnson JR, 1996, J INFECT DIS, V173, P920, DOI 10.1093/infdis/173.4.920; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Karisik E, 2008, J ANTIMICROB CHEMOTH, V61, P54, DOI 10.1093/jac/dkm401; Koczura R, 2013, MICROB ECOL, V65, P84, DOI 10.1007/s00248-012-0101-3; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; LEBOUGUENEC C, 1992, J CLIN MICROBIOL, V30, P1189, DOI 10.1128/JCM.30.5.1189-1193.1992; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mitsumori K, 1998, FEMS IMMUNOL MED MIC, V21, P261; Moreno E, 2005, DIAGN MICR INFEC DIS, V53, P93, DOI 10.1016/j.diagmicrobio.2005.05.015; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Osugui L, 2014, VET MICROBIOL, V171, P242, DOI 10.1016/j.vetmic.2014.03.027; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Piatti G, 2008, J CLIN MICROBIOL, V46, P480, DOI 10.1128/JCM.01488-07; Platell JL, 2011, ANTIMICROB AGENTS CH, V55, P3782, DOI 10.1128/AAC.00306-11; Rijavec M, 2008, J MED MICROBIOL, V57, P1329, DOI 10.1099/jmm.0.2008/002543-0; Schierack P, 2006, APPL ENVIRON MICROB, V72, P6680, DOI 10.1128/AEM.02952-05; Tarchouna M, 2013, INT J INFECT DIS, V17, pE450, DOI 10.1016/j.ijid.2013.01.025; Tartof SY, 2005, J CLIN MICROBIOL, V43, P5860, DOI 10.1128/JCM.43.12.5860-5864.2005; Thungrat K, 2015, VET MICROBIOL, V179, P287, DOI 10.1016/j.vetmic.2015.06.012; Wagner S, 2014, VET MICROBIOL, V169, P171, DOI 10.1016/j.vetmic.2014.01.003; Wang XM, 2010, FEMS MICROBIOL LETT, V306, P15, DOI 10.1111/j.1574-6968.2010.01917.x; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu GH, 2012, VET MICROBIOL, V160, P197, DOI 10.1016/j.vetmic.2012.05.029; YAMAMOTO S, 1995, FEMS IMMUNOL MED MIC, V12, P85, DOI 10.1111/j.1574-695X.1995.tb00179.x; Yuri K, 1998, J VET MED SCI, V60, P287, DOI 10.1292/jvms.60.287; Zhao LX, 2009, UROLOGY, V74, P702, DOI 10.1016/j.urology.2009.01.042	44	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143335	10.1371/journal.pone.0143335	http://dx.doi.org/10.1371/journal.pone.0143335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587840	gold, Green Published, Green Submitted			2022-12-27	WOS:000365251500052
J	Ramsey, JS; Johnson, RS; Hoki, JS; Kruse, A; Mahoney, J; Hilf, ME; Hunter, WB; Hall, DG; Schroeder, FC; MacCoss, MJ; Cilia, M				Ramsey, John S.; Johnson, Richard S.; Hoki, Jason S.; Kruse, Angela; Mahoney, Jaclyn; Hilf, Mark E.; Hunter, Wayne B.; Hall, David G.; Schroeder, Frank C.; MacCoss, Michael J.; Cilia, Michelle			Metabolic Interplay between the Asian Citrus Psyllid and Its Profftella Symbiont: An Achilles' Heel of the Citrus Greening Insect Vector	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; HEMIPTERA PSYLLIDAE; STATISTICAL-MODEL; DISEASE; IDENTIFICATIONS; BIOSYNTHESIS; INFECTION; DATABASE; GENOME	'Candidatus Liberibacter asiaticus' (CLas), the bacterial pathogen associated with citrus greening disease, is transmitted by Diaphorina citri, the Asian citrus psyllid. Interactions among D. citri and its microbial endosymbionts, including 'Candidatus Profftella armatura', are likely to impact transmission of CLas. We used quantitative mass spectrometry to compare the proteomes of CLas(+) and CLas(-) populations of D. citri, and found that proteins involved in polyketide biosynthesis by the endosymbiont Profftella were up-regulated in CLas(+) insects. Mass spectrometry analysis of the Profftella polyketide diaphorin in D. citri metabolite extracts revealed the presence of a novel diaphorin-related polyketide and the ratio of these two polyketides was changed in CLas(+) insects. Insect proteins differentially expressed between CLas(+) and CLas(-) D. citri included defense and immunity proteins, proteins involved in energy storage and utilization, and proteins involved in endocytosis, cellular adhesion, and cytoskeletal remodeling which are associated with microbial invasion of host cells. Insight into the metabolic interdependence between the insect vector, its endosymbionts, and the citrus greening pathogen reveals novel opportunities for control of this disease, which is currently having a devastating impact on citrus production worldwide.	[Ramsey, John S.; Hoki, Jason S.; Kruse, Angela; Mahoney, Jaclyn; Schroeder, Frank C.; Cilia, Michelle] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Ramsey, John S.; Mahoney, Jaclyn; Cilia, Michelle] USDA ARS, Robert W Holley Ctr Agr & Hlth, Emerging Pests & Pathogens Res Unit, Ithaca, NY 14853 USA; [Johnson, Richard S.; MacCoss, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hoki, Jason S.; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Kruse, Angela; Cilia, Michelle] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY USA; [Hilf, Mark E.] USDA ARS, US Hort Res Lab, Subtrop Plant Pathol Res Unit, Ft Pierce, FL USA; [Hunter, Wayne B.; Hall, David G.] USDA ARS, US Hort Res Lab, Subtrop Insects & Hort Res Unit, Ft Pierce, FL USA	Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); University of Washington; University of Washington Seattle; Cornell University; Cornell University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Cilia, M (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	mic68@cornell.edu	hunter, wayne/AAB-9096-2020	hunter, wayne/0000-0001-8603-3337; Kruse, Angela/0000-0001-8776-2769; Schroeder, Frank/0000-0002-4420-0237	Citrus Research Board [5300-155, 5300-163]; USDA ARS project [6034-22320-001-00, 8062-22000-021-00]; ARS [ARS-0423113] Funding Source: Federal RePORTER	Citrus Research Board; USDA ARS project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by Citrus Research Board: http://citrusresearch.com/; Grant numbers: 5300-155, 5300-163, USDA ARS project numbers: 6034-22320-001-00 and 8062-22000-021-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dossi FCA, 2014, MICROB ECOL, V68, P881, DOI 10.1007/s00248-014-0463-9; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Cilia M, 2009, J Biomol Tech, V20, P201; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; HALARNKAR PP, 1989, COMP BIOCHEM PHYS B, V92, P227, DOI 10.1016/0305-0491(89)90270-8; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; JIANG YP, 1987, PHYTOPATHOLOGY, V77, P949, DOI 10.1094/Phyto-77-949; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Nachappa P, 2012, MOL GENET GENOMICS, V287, P803, DOI 10.1007/s00438-012-0713-9; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Slisz AM, 2012, J PROTEOME RES, V11, P4223, DOI 10.1021/pr300350x; Steele-Mortimer O, 2011, TRAFFIC, V12, P162, DOI 10.1111/j.1600-0854.2010.01137.x; Tetreau G, 2015, INSECT BIOCHEM MOLEC, V62, P127, DOI 10.1016/j.ibmb.2014.12.002; Tiwari S, 2011, ANN ENTOMOL SOC AM, V104, P297, DOI 10.1603/AN10128; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Zhou P, 1999, CHEM BIOL, V6, P577, DOI 10.1016/S1074-5521(99)80090-8	30	47	48	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140826	10.1371/journal.pone.0140826	http://dx.doi.org/10.1371/journal.pone.0140826			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580079	gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600008
J	Antonopoulos, GC; Steltner, B; Heisterkamp, A; Ripken, T; Meyer, H				Antonopoulos, Georgios C.; Steltner, Benjamin; Heisterkamp, Alexander; Ripken, Tammo; Meyer, Heiko			Tile-Based Two-Dimensional Phase Unwrapping for Digital Holography Using a Modular Framework	PLOS ONE			English	Article							ALGORITHM; RADAR; INTERFEROMETER; MICROSCOPY; MRI	A variety of physical and biomedical imaging techniques, such as digital holography, interferometric synthetic aperture radar (InSAR), or magnetic resonance imaging (MRI) enable measurement of the phase of a physical quantity additionally to its amplitude. However, the phase can commonly only be measured modulo 2 pi, as a so called wrapped phase map. Phase unwrapping is the process of obtaining the underlying physical phase map from the wrapped phase. Tile-based phase unwrapping algorithms operate by first tessellating the phase map, then unwrapping individual tiles, and finally merging them to a continuous phase map. They can be implemented computationally efficiently and are robust to noise. However, they are prone to failure in the presence of phase residues or erroneous unwraps of single tiles. We tried to overcome these shortcomings by creating novel tile unwrapping and merging algorithms as well as creating a framework that allows to combine them in modular fashion. To increase the robustness of the tile unwrapping step, we implemented a model-based algorithm that makes efficient use of linear algebra to unwrap individual tiles. Furthermore, we adapted an established pixel-based unwrapping algorithm to create a quality guided tile merger. These original algorithms as well as previously existing ones were implemented in a modular phase unwrapping C++ framework. By examining different combinations of unwrapping and merging algorithms we compared our method to existing approaches. We could show that the appropriate choice of unwrapping and merging algorithms can significantly improve the unwrapped result in the presence of phase residues and noise. Beyond that, our modular framework allows for efficient design and test of new tile-based phase unwrapping algorithms. The software developed in this study is freely available.	[Antonopoulos, Georgios C.; Steltner, Benjamin; Ripken, Tammo; Meyer, Heiko] Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany; [Heisterkamp, Alexander] Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany	Leibniz University Hannover	Antonopoulos, GC (corresponding author), Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany.	g.antonopoulos@lzh.de	Heisterkamp, Alexander/V-5376-2017	Heisterkamp, Alexander/0000-0001-8770-0859				Adi K, 2010, IEEE GEOSCI REMOTE S, V7, P704, DOI 10.1109/LGRS.2010.2046393; Ambale B, 2009, I S BIOMED IMAGING, P466, DOI 10.1109/ISBI.2009.5193085; Baldi A, 2001, APPL OPTICS, V40, P1187, DOI 10.1364/AO.40.001187; Chavez S, 2002, IEEE T MED IMAGING, V21, P966, DOI 10.1109/TMI.2002.803106; Chen CW, 2000, J OPT SOC AM A, V17, P401, DOI 10.1364/JOSAA.17.000401; Coppola G, 2010, OPT LETT, V35, P3390, DOI 10.1364/OL.35.003390; Costantini M, 1998, IEEE T GEOSCI REMOTE, V36, P813, DOI 10.1109/36.673674; CUSACK R, 1995, APPL OPTICS, V34, P781, DOI 10.1364/AO.34.000781; Dias JMB, 2002, IEEE T IMAGE PROCESS, V11, P408, DOI 10.1109/TIP.2002.999675; Egidi N, 2004, APPL MATH COMPUT, V148, P599, DOI 10.1016/S0096-3003(02)00920-7; Epple FM, 2014, PHASE UNWRAPPING SPE; Escobar HM, 2003, CYTOGENET GENOME RES, V101, P33, DOI 10.1159/000073415; Ferraro P, 2004, APPL PHYS LETT, V85, P2709, DOI 10.1063/1.1791735; Flannery BP, 1992, NUMERICAL RECIPES C, P24; Flynn TJ, 1997, J OPT SOC AM A, V14, P2692, DOI 10.1364/JOSAA.14.002692; Fornaro G, 1999, IEEE T GEOSCI REMOTE, V37, P2215, DOI 10.1109/36.789618; Friedlander B, 1996, IEEE T SIGNAL PROCES, V44, P2999, DOI 10.1109/78.553474; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE, V1st; GHIGLIA DC, 1987, J OPT SOC AM A, V4, P267, DOI 10.1364/JOSAA.4.000267; GHIGLIA DC, 1994, J OPT SOC AM A, V11, P107, DOI 10.1364/JOSAA.11.000107; Girshovitz P, 2013, OPT EXPRESS, V21, P5701, DOI 10.1364/OE.21.005701; Goldstein GL, 2013, SMART TEMPORAL PHASE; GOLDSTEIN RM, 1988, RADIO SCI, V23, P713, DOI 10.1029/RS023i004p00713; GRAHAM LC, 1974, P IEEE, V62, P763, DOI 10.1109/PROC.1974.9516; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Guennebaud G., 2010, EIGEN V3; Gutmann B, 2000, APPL OPTICS, V39, P4802, DOI 10.1364/AO.39.004802; Herraez MA, 2002, APPL OPTICS, V41, P7445, DOI 10.1364/AO.41.007445; Herraez MA, 2002, APPL OPTICS, V41, P7437, DOI 10.1364/AO.41.007437; Pham H, 2011, BIOMED OPT EXPRESS, V2, P1781, DOI 10.1364/BOE.2.001781; ITOH K, 1982, APPL OPTICS, V21, P2470, DOI 10.1364/AO.21.002470; Kalies S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124052; Kemper B, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3540674; Langley J, 2009, PHYS MED BIOL, V54, P5237, DOI 10.1088/0031-9155/54/17/011; Li C, 2009, PROG ELECTROMAGN RES, V95, P341, DOI 10.2528/PIER09070706; Liang ZP, 1996, IEEE T MED IMAGING, V15, P893, DOI 10.1109/42.544507; MARROQUIN JL, 1995, J OPT SOC AM A, V12, P2578, DOI 10.1364/JOSAA.12.002578; Memmolo P, 2012, OPT EXPRESS, V20, P17250, DOI 10.1364/OE.20.017250; Memmolo P, 2012, OPT EXPRESS, V20, P28485, DOI 10.1364/OE.20.028485; PRITT MD, 1994, IEEE T GEOSCI REMOTE, V32, P706, DOI 10.1109/36.297989; QUIROGA JA, 1994, APPL OPTICS, V33, P6725, DOI 10.1364/AO.33.006725; Robinson S, 2014, MAGN RESON MED, V72, P80, DOI 10.1002/mrm.24897; Saika Y, 2014, RECENT ADV ELECT COM, P23; SCHNARS U, 1994, APPL OPTICS, V33, P179, DOI 10.1364/AO.33.000179; Schofield MA, 2003, OPT LETT, V28, P1194, DOI 10.1364/OL.28.001194; STEPHENSON P, 1994, OPT ENG, V33, P3703, DOI 10.1117/12.181183; Stramaglia S, 1997, P SOC PHOTO-OPT INS, V3217, P4, DOI 10.1117/12.295591; Strand J, 1999, IEEE T IMAGE PROCESS, V8, P375, DOI 10.1109/83.748892; TOWERS DP, 1989, P SOC PHOTO-OPT INS, V1163, P95, DOI 10.1117/12.962786; TRIBOLET JM, 1977, IEEE T ACOUST SPEECH, V25, P170, DOI 10.1109/TASSP.1977.1162923; ZEBKER HA, 1992, IEEE T GEOSCI REMOTE, V30, P950, DOI 10.1109/36.175330; Zhong H, 2010, FUT COMP COMM ICFCC, V1, pV1	52	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143186	10.1371/journal.pone.0143186	http://dx.doi.org/10.1371/journal.pone.0143186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599984	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600035
J	Doetterl, S; Kearsley, E; Bauters, M; Hufkens, K; Lisingo, J; Baert, G; Verbeeck, H; Boeckx, P				Doetterl, Sebastian; Kearsley, Elizabeth; Bauters, Marijn; Hufkens, Koen; Lisingo, Janvier; Baert, Geert; Verbeeck, Hans; Boeckx, Pascal			Aboveground vs. Belowground Carbon Stocks in African Tropical Lowland Rainforest: Drivers and Implications	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; NUTRIENT LIMITATION; AMAZONIAN FORESTS; MATTER; NITROGEN; BIOMASS; STABILIZATION; PHOSPHORUS; GROWTH; FRACTIONATION	Background African tropical rainforests are one of the most important hotspots to look for changes in the upcoming decades when it comes to C storage and release. The focus of studying C dynamics in these systems lies traditionally on living aboveground biomass. Belowground soil organic carbon stocks have received little attention and estimates of the size, controls and distribution of soil organic carbon stocks are highly uncertain. In our study on lowland rainforest in the central Congo basin, we combine both an assessment of the aboveground C stock with an assessment of the belowground C stock and analyze the latter in terms of functional pools and controlling factors. Principal Findings Our study shows that despite similar vegetation, soil and climatic conditions, soil organic carbon stocks in an area with greater tree height (=larger aboveground carbon stock) were only half compared to an area with lower tree height (=smaller aboveground carbon stock). This suggests that substantial variability in the aboveground vs. belowground C allocation strategy and/or C turnover in two similar tropical forest systems can lead to significant differences in total soil organic C content and C fractions with important consequences for the assessment of the total C stock of the system. Conclusions/Significance We suggest nutrient limitation, especially potassium, as the driver for aboveground versus belowground C allocation. However, other drivers such as C turnover, tree functional traits or demographic considerations cannot be excluded. We argue that large and unaccounted variability in C stocks is to be expected in African tropical rain-forests. Currently, these differences in aboveground and belowground C stocks are not adequately verified and implemented mechanistically into Earth System Models. This will, hence, introduce additional uncertainty to models and predictions of the response of C storage of the Congo basin forest to climate change and its contribution to the terrestrial C budget.	[Doetterl, Sebastian; Kearsley, Elizabeth; Bauters, Marijn; Boeckx, Pascal] Univ Ghent, Isotope Biosci Lab ISOFYS, B-9000 Ghent, Belgium; [Hufkens, Koen] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Lisingo, Janvier] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; [Baert, Geert] Univ Ghent, Dept Appl Biosci, B-9000 Ghent, Belgium; [Kearsley, Elizabeth; Bauters, Marijn; Verbeeck, Hans] Univ Ghent, Computat & Appl Vegetat Ecol CAVElab, B-9000 Ghent, Belgium; [Doetterl, Sebastian] Univ Augsburg, Dept Geog, D-86159 Augsburg, Germany	Ghent University; Harvard University; Ghent University; Ghent University; University of Augsburg	Doetterl, S (corresponding author), Univ Ghent, Isotope Biosci Lab ISOFYS, B-9000 Ghent, Belgium.	Sebastian.Doetterl@Ugent.be		Bauters, Marijn/0000-0003-0978-6639; Hufkens, Koen/0000-0002-5070-8109; Doetterl, Sebastian/0000-0002-0986-891X; Verbeeck, Hans/0000-0003-1490-0168	Belgian Science Policy Office (BELSPO) [SD/AR/01A]; BELSPO Interuniversity Attraction Poles Programme IUAP project "SOGLO-Soils under Global change"	Belgian Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); BELSPO Interuniversity Attraction Poles Programme IUAP project "SOGLO-Soils under Global change"	This research is part of the COBIMFO project (Congo Basin integrated monitoring for forest carbon mitigation and biodiversity; contract no. SD/AR/01A) and was funded by the Belgian Science Policy Office (BELSPO). Further funding was given by the BELSPO Interuniversity Attraction Poles Programme IUAP project "SOGLO-Soils under Global change."	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; Aragao LEOC, 2009, BIOGEOSCIENCES, V6, P2759, DOI 10.5194/bg-6-2759-2009; Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Banin L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1179, DOI 10.1111/j.1466-8238.2012.00778.x; Batjes NH, 2008, GEODERMA, V146, P58, DOI 10.1016/j.geoderma.2008.05.006; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; Don A, 2009, J PLANT NUTR SOIL SC, V172, P53, DOI 10.1002/jpln.200700158; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Espeleta JF, 2007, ECOL MONOGR, V77, P377, DOI 10.1890/06-1257.1; Fanin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049990; Fanin N, 2011, SOIL BIOL BIOCHEM, V43, P1014, DOI 10.1016/j.soilbio.2011.01.018; Fernandez-Martinez M, 2015, NATURE CLIM CHANG, V4, P471; Field C. B., 2003, GLOBAL CARBON CYCLE, P1; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; Fisher JB, 2013, OECOLOGIA, V172, P889, DOI 10.1007/s00442-012-2522-6; Gilson P, 1956, NOTICE EXPLICATIVE C; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; IUSS Working Group WRB, 2014, WORLD SOIL RES REP, V106; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; John B, 2005, GEODERMA, V128, P63, DOI 10.1016/j.geoderma.2004.12.013; Kearsley E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3269; Kong AYY, 2010, SOIL SCI SOC AM J, V74, P1201, DOI 10.2136/sssaj2009.0346; Laudelout H, 1954, T 5 INT C SOIL SCI, V2, P267; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; McCormack ML, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00205; NADELHOFFER KJ, 1985, ECOLOGY, V66, P1377, DOI 10.2307/1939190; Nottingham AT, 2015, SOIL BIOL BIOCHEM, V80, P26, DOI 10.1016/j.soilbio.2014.09.012; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pansu M, 2006, HDB SOIL ANAL, DOI 10.1007/978-3-540-31211-6; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pichancourt JB, 2014, GLOBAL CHANGE BIOL, V20, P382, DOI 10.1111/gcb.12345; Priess J, 1999, PLANT ECOL, V143, P171, DOI 10.1023/A:1009844226078; Reyer CPO, 2015, J ECOL, V103, P5, DOI 10.1111/1365-2745.12337; Saiz G, 2012, GLOBAL CHANGE BIOL, V18, P1670, DOI 10.1111/j.1365-2486.2012.02657.x; Santiago LS, 2012, J ECOL, V100, P309, DOI 10.1111/j.1365-2745.2011.01904.x; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schulp CJE, 2008, FOREST ECOL MANAG, V256, P482, DOI 10.1016/j.foreco.2008.05.007; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Six J, 2014, SOIL BIOL BIOCHEM, V68, pA4, DOI 10.1016/j.soilbio.2013.06.014; United Nations, 2011, UN COLL PROGR RED EM; Verbeeck H, 2014, J TROP FOR SCI, V26, P409; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Wurzburger N, 2015, ECOLOGY, V96, P2137, DOI 10.1890/14-1362.1; Zanne AE, 2009, DRYAD DIGITAL REPOSI, V2009, DOI [10.5061/dryad.234, DOI 10.5061/DRYAD.234]	59	22	22	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143209	10.1371/journal.pone.0143209	http://dx.doi.org/10.1371/journal.pone.0143209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599231	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600038
J	Hu, LS; Ning, SL; Eschbacher, JM; Gaw, N; Dueck, AC; Smith, KA; Nakaji, P; Plasencia, J; Ranjbar, S; Price, SJ; Tran, N; Loftus, J; Jenkins, R; O'Neill, BP; Elmquist, W; Baxter, LC; Gao, F; Frakes, D; Karis, JP; Zwart, C; Swanson, KR; Sarkaria, J; Wu, T; Mitchell, JR; Li, J				Hu, Leland S.; Ning, Shuluo; Eschbacher, Jennifer M.; Gaw, Nathan; Dueck, Amylou C.; Smith, Kris A.; Nakaji, Peter; Plasencia, Jonathan; Ranjbar, Sara; Price, Stephen J.; Nhan Tran; Loftus, Joseph; Jenkins, Robert; O'Neill, Brian P.; Elmquist, William; Baxter, Leslie C.; Gao, Fei; Frakes, David; Karis, John P.; Zwart, Christine; Swanson, Kristin R.; Sarkaria, Jann; Wu, Teresa; Mitchell, J. Ross; Li, Jing			Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma	PLOS ONE			English	Article							DIFFUSION; GLIOMAS; VALIDATION; CLASSIFICATION; DELINEATION; NECROSIS; REGIONS	Background Genetic profiling represents the future of neuro-oncology but suffers from inadequate biopsies in heterogeneous tumors like Glioblastoma (GBM). Contrast-enhanced MRI (CE-MRI) targets enhancing core (ENH) but yields adequate tumor in only similar to 60% of cases. Further, CE-MRI poorly localizes infiltrative tumor within surrounding non-enhancing parenchyma, or brain-around-tumor (BAT), despite the importance of characterizing this tumor segment, which universally recurs. In this study, we use multiple texture analysis and machine learning (ML) algorithms to analyze multi-parametric MRI, and produce new images indicating tumor-rich targets in GBM. Methods We recruited primary GBM patients undergoing image-guided biopsies and acquired preoperative MRI: CE-MRI, Dynamic-Susceptibility-weighted-Contrast-enhanced-MRI, and Diffusion Tensor Imaging. Following image coregistration and region of interest placement at biopsy locations, we compared MRI metrics and regional texture with histologic diagnoses of high-vs low-tumor content (>= 80% vs <80% tumor nuclei) for corresponding samples. In a training set, we used three texture analysis algorithms and three ML methods to identify MRI-texture features that optimized model accuracy to distinguish tumor content. We confirmed model accuracy in a separate validation set. Results We collected 82 biopsies from 18 GBMs throughout ENH and BAT. The MRI-based model achieved 85% cross-validated accuracy to diagnose high-vs low-tumor in the training set (60 biopsies, 11 patients). The model achieved 81.8% accuracy in the validation set (22 biopsies, 7 patients). Conclusion Multi-parametric MRI and texture analysis can help characterize and visualize GBM's spatial histologic heterogeneity to identify regional tumor-rich biopsy targets.	[Hu, Leland S.; Ranjbar, Sara; Zwart, Christine; Wu, Teresa; Mitchell, J. Ross; Li, Jing] Mayo Clin, Dept Radiol, Phoenix, AZ 85054 USA; [Dueck, Amylou C.] Mayo Clin, Dept Biostat, Phoenix, AZ USA; [Swanson, Kristin R.] Mayo Clin, Dept Neurosurg, Phoenix, AZ USA; [Loftus, Joseph] Mayo Clin, Dept Canc & Cell Biol, Scottsdale, AZ USA; [Jenkins, Robert] Mayo Clin, Dept Pathol, Rochester, MN USA; [O'Neill, Brian P.] Mayo Clin, Dept Neurooncol, Rochester, MN USA; [Sarkaria, Jann] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Elmquist, William] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Nhan Tran] Translat Genom Res Inst, Dept Canc & Cell Biol, Phoenix, AZ USA; [Ning, Shuluo; Gaw, Nathan; Gao, Fei; Wu, Teresa; Li, Jing] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA; [Plasencia, Jonathan; Frakes, David] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA; [Eschbacher, Jennifer M.] Barrow Neurol Inst, Dept Pathol, Phoenix, AZ 85013 USA; [Smith, Kris A.; Nakaji, Peter] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Hu, Leland S.; Baxter, Leslie C.; Karis, John P.] Barrow Neurol Inst, Dept Radiol, Phoenix, AZ 85013 USA; [Price, Stephen J.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Translational Genomics Research Institute; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Barrow Neurological Institute; Barrow Neurological Institute; Barrow Neurological Institute; University of Cambridge	Hu, LS (corresponding author), Mayo Clin, Dept Radiol, Phoenix, AZ 85054 USA.	Hu.leland@mayo.edu	Ning, Shuluo/AAD-2426-2020; Ranjbar, Sara/AAA-4550-2020; Price, Stephen J/B-1068-2011	Price, Stephen J/0000-0002-7535-3009; Ranjbar, Sara/0000-0002-4344-1282; Baxter, Leslie/0000-0002-3971-863X	NATIONAL INSTITUTES OF HEALTH (NIH) - National Institute of Neurological Disorders and Stroke (NINDS) [NS082609]; Mayo Clinic Foundation; National Institute for Health Research [NIHR/CS/009/011] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS082609] Funding Source: NIH RePORTER	NATIONAL INSTITUTES OF HEALTH (NIH) - National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NATIONAL INSTITUTES OF HEALTH (NIH) - National Institute of Neurological Disorders and Stroke (NINDS) NS082609 (LSH): provided support for study design, data collection and analysis, preparation of the manuscript. Mayo Clinic Foundation (LSH): provided support for study design, data collection and analysis, preparation of the manuscript. National Science Foundation (NSF) DGE-1311230 (JP): provided support for data collection and analysis.	Agarwal S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001888; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Berens Michael E., 1999, Neoplasia (New York), V1, P208, DOI 10.1038/sj.neo.7900034; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Brown R, 2008, CLIN CANCER RES, V14, P2357, DOI 10.1158/1078-0432.CCR-07-1964; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dixon SJ, 2009, CHEMOMETR INTELL LAB, V95, P1, DOI 10.1016/j.chemolab.2008.07.010; Drabycz S, 2010, NEUROIMAGE, V49, P1398, DOI 10.1016/j.neuroimage.2009.09.049; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Eyal E, 2010, INVEST RADIOL, V45, P174, DOI 10.1097/RLI.0b013e3181d0a02f; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743; Hu LS, 2010, AM J NEURORADIOL, V31, P40, DOI 10.3174/ajnr.A1787; Hu LS, 2012, NEURO-ONCOLOGY, V14, P919, DOI 10.1093/neuonc/nos112; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; LaViolette PS, 2014, NEURO-ONCOLOGY, V16, P1599, DOI 10.1093/neuonc/nou142; Lin GC, 2010, COMPUT MED IMAG GRAP, V34, P251, DOI 10.1016/j.compmedimag.2009.11.001; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pafundi DH, 2013, NEURO-ONCOLOGY, V15, P1058, DOI 10.1093/neuonc/not002; Price SJ, 2006, AM J NEURORADIOL, V27, P1969; Roberts DW, 2011, J NEUROSURG, V114, P595, DOI 10.3171/2010.2.JNS091322; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Semmineh NB, 2015, MAGN RESON MED, V74, P772, DOI 10.1002/mrm.25435; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stadlbauer A, 2006, RADIOLOGY, V240, P803, DOI 10.1148/radiol.2403050937; Valdes PA, 2012, J NEUROPATH EXP NEUR, V71, P806, DOI 10.1097/NEN.0b013e31826775a1; Weber MA, 2010, INVEST RADIOL, V45, P755, DOI 10.1097/RLI.0b013e3181ec9db0; Yeung TPC, 2014, ACAD RADIOL, V21, P624, DOI 10.1016/j.acra.2014.01.015; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147	30	64	68	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0141506	10.1371/journal.pone.0141506	http://dx.doi.org/10.1371/journal.pone.0141506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599106	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600004
J	Pappalardo, AM; Federico, C; Sabella, G; Saccone, S; Ferrito, V				Pappalardo, Anna Maria; Federico, Concetta; Sabella, Giorgio; Saccone, Salvatore; Ferrito, Venera			A COI Nonsynonymous Mutation as Diagnostic Tool for Intraspecific Discrimination in the European Anchovy Engraulis encrasicolus (Linnaeus)	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; APHANIUS-FASCIATUS; SELECTION; VARIABILITY; NUCLEOTIDE; STRAIT; NORTH; TELEOSTEI	The European anchovy, Engraulis encrasicolus, is currently one of the principal target species for commercial fisheries in Europe. In this study, the mitochondrial Control Region (CR) and the Cytochrome Oxidase I (COI) mitochondrial gene were analyzed in 74 specimens of E. encrasicolus from four localities in the central Mediterranean. In both populations, the two markers revealed the presence of two main haplogroups, A and B, already detected in previous investigations of different classes of molecular markers. Both CR and COI markers consistently identified two haplogroups. The COI sequence analysis identified a non-synonymous transversion (T to G) at position 116 of the translated sequence, resulting in an amino acid change. All COI sequences of haplogroup A had an amino acid sequence with alanine in this position, while serine was present in the same position in haplogroup B. The two haplogroups A and B were also discriminated by the variable number of TACA elements at the 5'-end of the mitochondrial CR. The selection tests applied to the COI dataset revealed that codon 116 was not under positive selection, that seven amino acid changes were under purifying selection, and that two amino acids were under episodic positive selection.	[Pappalardo, Anna Maria; Federico, Concetta; Sabella, Giorgio; Saccone, Salvatore; Ferrito, Venera] Univ Catania, Dept Biol Geol & Environm Sci, Sec Anim Biol M La Greca, Catania, Italy	University of Catania	Ferrito, V (corresponding author), Univ Catania, Dept Biol Geol & Environm Sci, Sec Anim Biol M La Greca, Catania, Italy.	vferrito@unict.it	Sabella, Giorgio/R-9487-2019; Pappalardo, Anna Maria/AAD-3410-2019; Saccone, Salvatore/H-1548-2012; FEDERICO, Concetta/M-5553-2015	Saccone, Salvatore/0000-0001-7568-5823; Ferrito, Venera/0000-0001-5069-546X; FEDERICO, Concetta/0000-0002-0160-9040; SABELLA, Giorgio/0000-0002-2234-1901				Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basilone G, 2006, FISH OCEANOGR, V15, P271, DOI 10.1111/j.1365-2419.2005.00391.x; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Bonanno A, 2014, OCEAN SCI, V10, P759, DOI 10.5194/os-10-759-2014; Borrell YJ, 2012, ICES J MAR SCI, V69, P1357, DOI 10.1093/icesjms/fss129; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Castellana S, 2011, GENOME BIOL EVOL, V3, P1067, DOI 10.1093/gbe/evr040; Cuttitta A, 2015, FISH OCEANOGR, V24, P135, DOI 10.1111/fog.12098; Dalziel AC, 2006, J MOL EVOL, V62, P319, DOI 10.1007/s00239-005-0110-7; Erdogan Z, 2009, ACTA ADRIAT, V50, P77; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falcini F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123213; Ferrito V, 2013, MAR BIOL, V160, P3193, DOI 10.1007/s00227-013-2307-4; Fruciano C, 2014, BIOL J LINN SOC, V112, P387, DOI 10.1111/bij.12279; Grant WS, 2006, J HERED, V97, P571, DOI 10.1093/jhered/esl033; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Grant WS, 2005, GENETICA, V125, P293, DOI 10.1007/s10709-005-0717-z; Grueber CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089632; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova Petya P., 2006, Acta Adriatica, V47, P13; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kristoffersen JB, 2008, FISH RES, V91, P187, DOI 10.1016/j.fishres.2007.11.024; Lafuente JG, 2002, FISH OCEANOGR, V11, P31, DOI 10.1046/j.1365-2419.2002.00186.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Magoulas A, 1996, MOL BIOL EVOL, V13, P178, DOI 10.1093/oxfordjournals.molbev.a025554; Magoulas A, 2006, MOL PHYLOGENET EVOL, V39, P734, DOI 10.1016/j.ympev.2006.01.016; Mhlongo N, 2015, FISH OCEANOGR, V24, P1, DOI 10.1111/fog.12061; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pappalardo AM, 2008, J FISH BIOL, V72, P1154, DOI 10.1111/j.1095-8649.2007.01748.x; Pappalardo AM, 2015, J FISH BIOL, V87, P69, DOI 10.1111/jfb.12693; Pappalardo AM, 2015, HYDROBIOLOGIA, V749, P155, DOI 10.1007/s10750-014-2161-5; Pappalardo AM, 2015, FISH RES, V164, P153, DOI 10.1016/j.fishres.2014.11.004; Pappalardo AM, 2015, FOOD CONTROL, V57, P385, DOI 10.1016/j.foodcont.2015.03.038; Pappalardo AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025516; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Raab K, 2013, MAR ECOL PROG SER, V488, P233, DOI 10.3354/meps10408; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Robalo JI, 2012, ECOL EVOL, V2, P153, DOI 10.1002/ece3.77; Sanz N, 2008, ICES J MAR SCI, V65, P1635, DOI 10.1093/icesjms/fsn128; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Shaltout M, 2014, OCEANOLOGIA, V56, P411, DOI 10.5697/oc.56-3.411; Silva G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1093; Silva G, 2014, J BIOGEOGR, V41, P1171, DOI 10.1111/jbi.12275; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tomasco IH, 2014, GENE, V534, P371, DOI 10.1016/j.gene.2013.09.097; Tudela S, 2002, J MAR BIOL ASSOC UK, V82, P349, DOI 10.1017/S0025315402005568; Vinas J, 2014, ICES J MAR SCI, V71, P391, DOI 10.1093/icesjms/fst132; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Whitehead P.J.P., 1990, CHECKLIST FISHES E T, V1, P228; Whitehead PJP, 1988, FAO FISHERIES SYNOPS, V7; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Zardoya R, 2004, MOL ECOL, V13, P1785, DOI 10.1111/j.1365-294X.2004.02198.x; Zarraonaindia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042201; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	60	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143297	10.1371/journal.pone.0143297	http://dx.doi.org/10.1371/journal.pone.0143297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599908	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600046
J	Rabinovich-Toidman, P; Rabinovich-Nikitin, I; Ezra, A; Barbiro, B; Fogel, H; Slutsky, I; Solomon, B				Rabinovich-Toidman, Polina; Rabinovich-Nikitin, Inna; Ezra, Assaf; Barbiro, Beka; Fogel, Hilla; Slutsky, Inna; Solomon, Beka			Mutant SOD1 Increases APP Expression and Phosphorylation in Cellular and Animal Models of ALS	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; SOD1(G93A) MOUSE MODEL; INTRACELLULAR DOMAIN; DISEASE PROGRESSION; RELEASE PROBABILITY; FAMILIAL ALS; A-BETA; NEURONS; DYSFUNCTION	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease and it is the most common adult onset neurodegenerative disorder affecting motor neurons. There is currently no effective treatment for ALS and our understanding of the pathological mechanism is still far away from prevention and/or treatment of this devastating disease. Amyloid precursor protein (APP) is a transmembrane protein that undergoes processing either by beta-secretase or a-secretase, followed by gamma-secretase. In the present study, we show that APP levels, and aberrant phosphorylation, which is associated with enhanced beta-secretase cleavage, are increased in SOD1(G93A) ALS mouse model. Fluorescence resonance energy transfer (FRET) analysis suggests a close interaction between SOD1 and APP at hippocampal synapses. Notably, SOD1(G93A) mutation induces APP-SOD1 conformational changes, indicating a crosstalk between these two signaling proteins. Inhibition of APP processing via monoclonal antibody called BBS that blocks APP beta-secretase cleavage site, resulted in reduction of mutant SOD1(G93A) levels in animal and cellular models of ALS, significantly prolonged life span of SOD1(G93A) mice and diminished inflammation. Beyond its effect on toxic mutant SOD1(G93A), BBS treatment resulted in a reduction in the levels of APP, its processing product soluble APP beta and pro-apoptotic p53. This study demonstrates that APP and its processing products contribute to ALS pathology through several different pathways; thus BBS antibody could be a promising neuroprotective strategy for treatment of this disease.	[Rabinovich-Toidman, Polina; Rabinovich-Nikitin, Inna; Ezra, Assaf; Barbiro, Beka; Solomon, Beka] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Fogel, Hilla; Slutsky, Inna] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Solomon, B (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	beka@post.tau.ac.il		Rabinovich-Nikitin, Inna/0000-0001-5067-8803; Slutsky, Inna/0000-0002-0700-2266	NasVax Ltd.; Tel Aviv University	NasVax Ltd.; Tel Aviv University	Partial support was provided by NasVax Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funding source was internal Tel Aviv University funding.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Arbel M, 2005, P NATL ACAD SCI USA, V102, P7718, DOI 10.1073/pnas.0502427102; Bros-Facer V, 2014, HUM MOL GENET, V23, P4187, DOI 10.1093/hmg/ddu136; Bryson JB, 2012, HUM MOL GENET, V21, P3871, DOI 10.1093/hmg/dds215; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Coan G, 2015, NEURODEGENER DIS, V15, P301, DOI 10.1159/000433581; Fogel H, 2014, CELL REP, V7, P1560, DOI 10.1016/j.celrep.2014.04.024; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Koistinen H, 2006, MUSCLE NERVE, V34, P444, DOI 10.1002/mus.20612; Laviv T, 2010, NEURON, V67, P253, DOI 10.1016/j.neuron.2010.06.022; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Leigh P Nigel, 2007, Handb Clin Neurol, V82, P249, DOI 10.1016/S0072-9752(07)80016-9; Li QX, 2006, AGING CELL, V5, P153, DOI 10.1111/j.1474-9726.2006.00200.x; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; Mali Y, 2009, J MED CHEM, V52, P5442, DOI 10.1021/jm900631m; Martin LJ, 2000, NEUROBIOL DIS, V7, P613, DOI 10.1006/nbdi.2000.0314; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Ozaki T, 2006, BIOCHEM BIOPH RES CO, V351, P57, DOI 10.1016/j.bbrc.2006.09.162; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Rabinovich-Nikitin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046650; Rabinovich-Toidman P, 2012, NEURODEGENER DIS, V10, P30, DOI 10.1159/000334774; Ranganathan Srikanth, 2010, Open Pathol J, V4, P11; Sasaki S, 1999, ACTA NEUROPATHOL, V97, P463, DOI 10.1007/s004010051015; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Woolley SC, 2010, AMYOTROPH LATERAL SC, V11, P303, DOI 10.3109/17482961003727954; Xie YY, 2000, NEUROREPORT, V11, P697, DOI 10.1097/00001756-200003200-00009; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143420	10.1371/journal.pone.0143420	http://dx.doi.org/10.1371/journal.pone.0143420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600047	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600064
J	Wu, YG; Zhou, J; Li, YH; Zhou, YJ; Cui, YQ; Yang, G; Hong, Y				Wu, Yougen; Zhou, Juan; Li, Yinghua; Zhou, Yunjiao; Cui, Yunqing; Yang, Gong; Hong, Yang			Rap1A Regulates Osteoblastic Differentiation via the ERK and p38 Mediated Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR; MAP KINASE; CELL-PROLIFERATION; EXPRESSION; RUNX2; PATHWAY; TARGET; C2C12; BMP-2	Rap1A is a member of small G proteins belonging to the Ras family. Recently, an integration of human genome-wide association studies (GWAS) and gene expression profiling study revealed that single-nucleotide polymorphisms (SNPs) within human Rap1A were strongly associated with narrow neck width in women. However, the regulatory role of Rap1A in osteoblasts remains to be elucidated. Here we report that Rap1A is a key regulator in osteoblast differentiation. Rap1A expression and activity were gradually enhanced during the induced differentiation of multipotent mesenchymal progenitor cells (C2C12) and preosteoblastic cells (MC3T3-E1). Knockdown of endogenous Rap1A significantly inhibited the osteogenic marker gene expression and matrix mineralization in cells with osteogenesis. In addition, knockdown of endogenous Rap1A suppressed the activation of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK), while overexpression of Rap1A accelerated osteoblast differentiation and enhanced the phosphorylation of ERK and p38. Taken together, our study suggests that Rap1A regulates osteoblast differentiation through modulating the ERK/p38 signaling.	[Wu, Yougen; Zhou, Juan; Li, Yinghua; Zhou, Yunjiao; Cui, Yunqing; Yang, Gong; Hong, Yang] Fudan Univ, Peoples Hosp Shanghai 5, Cent Lab, Shanghai 200240, Peoples R China; [Yang, Gong] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai 200032, Peoples R China; [Yang, Gong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Hong, Yang] Fudan Univ, Peoples Hosp Shanghai 5, Dept Osteol, Shanghai 200240, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Yang, G (corresponding author), Fudan Univ, Peoples Hosp Shanghai 5, Cent Lab, Shanghai 200240, Peoples R China.	yanggong@fudan.edu.cn; hongyangcm@163.com		Wu, Yougen/0000-0002-1498-4085	Natural Science Foundation of Minhang District of Shanghai [2014MHZ055]	Natural Science Foundation of Minhang District of Shanghai	This work was supported by Natural Science Foundation of Minhang District of Shanghai, No. 2014MHZ055.	de Oliveira PT, 2003, J HISTOCHEM CYTOCHEM, V51, P633, DOI 10.1177/002215540305100509; Dorn A, 2012, CELL IMMUNOL, V276, P187, DOI 10.1016/j.cellimm.2012.05.008; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hsu YL, 2008, J BONE MINER RES, V23, P949, DOI 10.1359/JBMR.080219; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Huang YF, 2012, J BONE MINER RES, V27, P1093, DOI 10.1002/jbmr.1548; Kim JH, 2014, J CELL BIOL, V204, P1063, DOI 10.1083/jcb.201308102; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Lin KL, 2010, J BONE MINER RES, V25, P2489, DOI 10.1002/jbmr.159; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; Moon JS, 2014, J BONE MINER RES, V29, P1586, DOI 10.1002/jbmr.2197; Mundy C, 2014, J CELL PHYSIOL, V229, P672, DOI 10.1002/jcp.24491; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pizon V, 2000, ONCOGENE, V19, P6074, DOI 10.1038/sj.onc.1203984; Sayyah J, 2014, J BIOL CHEM, V289, P17689, DOI 10.1074/jbc.M113.536227; Sondag GR, 2014, J CELL PHYSIOL, V229, P955, DOI 10.1002/jcp.24512; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Xiang J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0125-x; Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12	26	35	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143777	10.1371/journal.pone.0143777	http://dx.doi.org/10.1371/journal.pone.0143777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599016	Green Published, gold, Green Submitted			2022-12-27	WOS:000365862600121
J	Bosse, JB; Tanneti, NS; Hogue, IB; Enquist, LW				Bosse, Jens B.; Tanneti, Nikhila S.; Hogue, Ian B.; Enquist, Lynn W.			Open LED Illuminator: A Simple and Inexpensive LED Illuminator for Fast Multicolor Particle Tracking in Neurons	PLOS ONE			English	Article							LIGHT-EMITTING-DIODES; MICROSCOPY	Dual-color live cell fluorescence microscopy of fast intracellular trafficking processes, such as axonal transport, requires rapid switching of illumination channels. Typical broad-spectrum sources necessitate the use of mechanical filter switching, which introduces delays between acquisition of different fluorescence channels, impeding the interpretation and quantification of highly dynamic processes. Light Emitting Diodes (LEDs), however, allow modulation of excitation light in microseconds. Here we provide a step-by-step protocol to enable any scientist to build a research-grade LED illuminator for live cell microscopy, even without prior experience with electronics or optics. We quantify and compare components, discuss our design considerations, and demonstrate the performance of our LED illuminator by imaging axonal transport of herpes virus particles with high temporal resolution.	[Bosse, Jens B.; Tanneti, Nikhila S.; Hogue, Ian B.; Enquist, Lynn W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Bosse, Jens B.; Tanneti, Nikhila S.; Hogue, Ian B.; Enquist, Lynn W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University	Enquist, LW (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	lenquist@princeton.edu	Bosse, Jens Bernhard/D-7336-2011	Bosse, Jens Bernhard/0000-0001-7252-5541; Hogue, Ian/0000-0002-1977-5573	National Institutes of Health [NS033506, NS060699]; Deutsche Forschungsgesellschaft [BO 4158/1-1]; American Cancer Society [PF-13-050-01-MPC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060699, R01NS033506, R37NS033506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (www.NIH.gov) grants NS033506 and NS060699 to LWE. JBB was supported by a Fellowship from the Deutsche Forschungsgesellschaft (www.dg.de) (BO 4158/1-1). IBH was supported by a fellowship from the American Cancer Society (www.cancer.org) (PF-13-050-01-MPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeanu DF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002146; [Anonymous], 2007, NAT PHOTONICS, V1, P23; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Baird T Regan, 2014, J Biomol Tech, V25, P48, DOI 10.7171/jbt.14-2502-001; Ball T., OPTICS IMAGING; Benavides JM, 2005, APPL OPTICS, V44, P4000, DOI 10.1364/AO.44.004000; Cole RW, 2008, MICROSC MICROANAL, V14, P243, DOI 10.1017/S1431927608080288; Curanovic Dusica, 2009, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2604s43; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diaz E, PROTOTYPING ILLUMINA; Edelstein Arthur D, 2014, J Biol Methods, V1; Hogue IB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004535; Moser C, 2006, J MICROSC-OXFORD, V222, P135, DOI 10.1111/j.1365-2818.2006.01581.x; Nishigaki T, 2006, BIOTECHNIQUES, V41, P191, DOI 10.2144/000112220; Pitrone PG, 2013, NAT METHODS, V10, P598, DOI 10.1038/nmeth.2507; Sato T, 2012, COLD SPRING HARB PRO, V2012; Schek H., 2015, BIOOPTICS WORLD; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Thorlabs, LED OUTP COMP SCAL M; thorlabs, MCPCB LED SPECTR; Wessels JT, 2012, CYTOM PART A, DOI [10.1002/cyto.a.22023/pdf, DOI 10.1002/CYTO.A.22023/PDF]	21	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143547	10.1371/journal.pone.0143547	http://dx.doi.org/10.1371/journal.pone.0143547			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600461	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900142
J	de Oliveira, AP; Bernardo, CR; Camargo, AVD; Ronchi, LS; Borim, AA; de Mattos, CCB; de Campos, E; Castiglioni, L; Netinho, JG; Cavasini, CE; Bestetti, RB; de Mattos, LC				de Oliveira, Amanda Priscila; Bernardo, Cassia Rubia; da Silveira Camargo, Ana Vitoria; Ronchi, Luiz Sergio; Borim, Aldenis Albaneze; Brandao de Mattos, Cinara Cassia; de Campos Junior, Eumildo; Castiglioni, Lilian; Netinho, Joao Gomes; Cavasini, Carlos Eugonio; Bestetti, Reinaldo Bulgarelli; de Mattos, Luiz Carlos			Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism	PLOS ONE			English	Article							CRUZI-ELICITED MYOCARDITIS; CHEMOKINE RECEPTOR EXPRESSION; HARDY-WEINBERG EQUILIBRIUM; TRYPANOSOMA-CRUZI; MONONUCLEAR-CELLS; IMMUNE-RESPONSES; T-CELLS; CARDIOMYOPATHY; HIV-1; INFECTION	The clinical manifestations of chronic Chagas disease include the cardiac form of the disease and the digestive form. Not all the factors that act in the variable clinical course of this disease are known. This study investigated whether the CCR5 Delta 32 (rs333) and CCR5 59029 A/G (promoter region-rs1799987) polymorphisms of the CCR5 gene are associated with different clinical forms of chronic Chagas disease and with the severity of left ventricular systolic dysfunction in patients with chronic Chagas heart disease (CCHD). The antibodies anti-T. cruzi were identified by ELISA. PCR and PCR-RFLP were used to identify the CCR5.32 and CCR5 59029 A/G polymorphisms. The chi-square test was used to compare variables between groups. There was a higher frequency of the AA genotype in patients with CCHD compared with patients with the digestive form of the disease and the control group. The results also showed a high frequency of the AG genotype in patients with the digestive form of the disease compared to the other groups. The results of this study show that the CCR5.32 polymorphism does not seem to influence the different clinical manifestations of Chagas disease but there is involvement of the CCR5 59029 A/G polymorphism in susceptibility to the different forms of chronic Chagas disease. Besides, these polymorphisms do not influence left ventricular systolic dysfunction in patients with CCHD.	[de Oliveira, Amanda Priscila; Bernardo, Cassia Rubia; da Silveira Camargo, Ana Vitoria; Brandao de Mattos, Cinara Cassia; de Mattos, Luiz Carlos] Fac Med Sao Jose do Rio Preto, Dept Biol Mol, Lab Imunogenet, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Ronchi, Luiz Sergio; Borim, Aldenis Albaneze; de Campos Junior, Eumildo; Netinho, Joao Gomes] Fac Med Sao Jose do Rio Preto, Dept Cirugia, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Borim, Aldenis Albaneze; de Campos Junior, Eumildo; Netinho, Joao Gomes] Hosp Base, Fundacao Fac Reg Med, Dept Cirurgia Geral, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Castiglioni, Lilian] Fac Med Sao Jose do Rio Preto, Dept Epidemiol & Saude Colet, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Cavasini, Carlos Eugonio] Fac Med Sao Jose do Rio Preto, Ctr Invest Microrganismos, Dept Doencas Dermatol Infecciosas & Parasitarias, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Bestetti, Reinaldo Bulgarelli] Fac Med Sao Jose do Rio Preto, Dept Cardiol & Cirurgia Cardiovasc, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil		de Mattos, LC (corresponding author), Fac Med Sao Jose do Rio Preto, Dept Biol Mol, Lab Imunogenet, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.	luiz.demattos@famerp.br	BRANDÃO, CINARA/B-3650-2008; de Mattos, Luiz Carlos/P-4005-2019; DE MATTOS, LUIZ CARLOS/F-6739-2010; de Mattos, Luiz Carlos/P-3574-2019; Bestetti, Reinaldo B./AAH-4658-2019; Castiglioni, Lilian/C-2687-2014	BRANDÃO, CINARA/0000-0002-4836-3113; de Mattos, Luiz Carlos/0000-0002-8572-8177; DE MATTOS, LUIZ CARLOS/0000-0002-8572-8177; Castiglioni, Lilian/0000-0002-9999-2673	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP] [2011/08075-4, 2011/19439-7, 2012/20735-2, 2012/05580-2]; Brazilian Ministry of Education Scholarship - Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior; Institutional Research Grant BAP-FAMERP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Ministry of Education Scholarship - Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior; Institutional Research Grant BAP-FAMERP	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP grant numbers #2011/08075-4 to LCM; #2011/19439-7 to AVSC; #2012/20735-2 to AVSC; #2012/05580-2 to CRB]; Brazilian Ministry of Education Scholarship - Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (to APO; AVSC; CRB) and Institutional Research Grant BAP-FAMERP to LC. The opinions, assumptions, and conclusions or recommendations expressed in this material are the responsibility of the authors and do not necessarily reflect the views of FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Machuca MA, 2014, HUM IMMUNOL, V75, P1210, DOI 10.1016/j.humimm.2014.09.023; Ayo CM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/284729; Bestetti RB, 2014, INT J CARDIOL, V176, P309, DOI 10.1016/j.ijcard.2014.07.112; Bestetti RB, 2011, INT J CARDIOL, V151, P205, DOI 10.1016/j.ijcard.2010.05.033; Bestetti RB, 2008, INT J CARDIOL, V131, P9, DOI 10.1016/j.ijcard.2008.05.024; Bonney KM, 2014, PARASITE, V21, DOI 10.1051/parasite/2014012; Brener Z, 1997, INT ARCH ALLERGY IMM, V114, P103, DOI 10.1159/000237653; Calzada JE, 2001, TISSUE ANTIGENS, V58, P154, DOI 10.1034/j.1399-0039.2001.580302.x; Corbett CEP, 2001, DIS COLON RECTUM, V44, P993, DOI 10.1007/BF02235488; Correa-Oliveira R, 1999, MEM I OSWALDO CRUZ, V94, P253, DOI 10.1590/S0074-02761999000700042; Coura JR, 2014, MEM I OSWALDO CRUZ, V109, P856, DOI 10.1590/0074-0276140236; Cunha-Neto E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/683230; Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032; da Silveira ABM, 2007, PARASITOLOGY, V134, P789, DOI 10.1017/S0031182007002296; da Silveira ABM, 2005, PARASITOLOGY, V131, P627, DOI 10.1017/S0031182005008061; dos Santos PVA, 2001, MICROBES INFECT, V3, P971, DOI 10.1016/S1286-4579(01)01461-7; Dutra Oscar P., 2006, Arq. Bras. Cardiol., V87, P223, DOI 10.1590/S0066-782X2006001500024; Dutra WO, 2009, MEM I OSWALDO CRUZ, V104, P208, DOI 10.1590/S0074-02762009000900027; Esper L, 2015, CURR OPIN INFECT DIS, V28, P246, DOI 10.1097/QCO.0000000000000157; Fernandez-Mestre MT, 2004, HUM IMMUNOL, V65, P725, DOI 10.1016/j.humimm.2004.05.002; Florez O, 2012, HUM IMMUNOL, V73, P852, DOI 10.1016/j.humimm.2012.04.005; Frade AF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-587; Gomes JAS, 2005, INFECT IMMUN, V73, P7960, DOI 10.1128/IAI.73.12.7960-7966.2005; Guedes PMM, 2010, VET IMMUNOL IMMUNOP, V138, P106, DOI 10.1016/j.vetimm.2010.06.010; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kimura A, 2014, GENE, V537, P357, DOI 10.1016/j.gene.2014.01.005; Li MY, 2008, GENET EPIDEMIOL, V32, P589, DOI 10.1002/gepi.20335; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Llorca Javier, 2005, Gac Sanit, V19, P321, DOI 10.1157/13078032; Lopes MP, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/678246; Machado Fabiana S, 2012, Front Biosci (Elite Ed), V4, P1743; Mack M, 1999, ARTHRITIS RHEUM, V42, P981, DOI 10.1002/1529-0131(199905)42:5<981::AID-ANR17>3.0.CO;2-4; Mangano A, 2001, TISSUE ANTIGENS, V58, P99, DOI 10.1034/j.1399-0039.2001.580207.x; Marino APMP, 2005, MEM I OSWALDO CRUZ, V100, P93, DOI 10.1590/S0074-02762005000900015; Marino APMP, 2004, CIRCULATION, V110, P1443, DOI 10.1161/01.CIR.0000141561.15939.EC; Martins Paulo Roberto Juliano, 2013, Rev. Bras. Hematol. Hemoter., V35, P180, DOI 10.5581/1516-8484.20130040; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Medeiros GA, 2009, MICROBES INFECT, V11, P264, DOI 10.1016/j.micinf.2008.11.012; Nogueira LG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001867; Oliveira AP, 2011, J VENOM ANIM TOXINS, V17, P264, DOI 10.1590/S1678-91992011000300005; Oliveira AP, 2014, INT J CARDIOL, V176, P520, DOI 10.1016/j.ijcard.2014.07.043; Pinazo MJ, 2015, ACTA TROP, V151, P16, DOI 10.1016/j.actatropica.2015.06.013; Ferreira LRP, 2014, WORLD J CARDIOL, V6, P782, DOI 10.4330/wjc.v6.i8.782; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Shieh B, 2000, INT IMMUNOL, V12, P1311, DOI 10.1093/intimm/12.9.1311; Steverding D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-317; Strasen J, 2014, CLIN RES CARDIOL, V103, P1, DOI 10.1007/s00392-013-0613-y; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; Talvani A, 2004, J INFECT DIS, V189, P214, DOI 10.1086/380803; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3; Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002; World Health Organization (WHO), CHAG DIS AM TRYP; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y	60	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141847	10.1371/journal.pone.0141847	http://dx.doi.org/10.1371/journal.pone.0141847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599761	Green Published, gold			2022-12-27	WOS:000365853900016
J	Follett, R; Strezov, V				Follett, Ria; Strezov, Vladimir			An Analysis of Citizen Science Based Research: Usage and Publication Patterns	PLOS ONE			English	Article							BIODIVERSITY; TOOL; REVEALS; BAY	The use of citizen science for scientific discovery relies on the acceptance of this method by the scientific community. Using the Web of Science and Scopus as the source of peer reviewed articles, an analysis of all published articles on "citizen science" confirmed its growth, and found that significant research on methodology and validation techniques preceded the rapid rise of the publications on research outcomes based on citizen science methods. Of considerable interest is the growing number of studies relying on the re-use of collected datasets from past citizen science research projects, which used data from either individual or multiple citizen science projects for new discoveries, such as for climate change research. The extent to which citizen science has been used in scientific discovery demonstrates its importance as a research approach. This broad analysis of peer reviewed papers on citizen science, that included not only citizen science projects, but the theory and methods developed to underpin the research, highlights the breadth and depth of the citizen science approach and encourages cross-fertilization between the different disciplines.	[Follett, Ria; Strezov, Vladimir] Macquarie Univ, Dept Environm Sci, N Ryde, NSW, Australia	Macquarie University	Follett, R (corresponding author), Macquarie Univ, Dept Environm Sci, N Ryde, NSW, Australia.	ria-maren.follett@students.mq.edu.au	Strezov, Vladimir/J-4827-2019	Strezov, Vladimir/0000-0002-9129-9284				Aguillo IF, 2012, SCIENTOMETRICS, V91, P343, DOI 10.1007/s11192-011-0582-8; [Anonymous], 2008, SHERMANS CREEK WATER; Bates AJ, 2014, GARDEN LANDSCAPE SCA; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Brohan P, 2009, B AM METEOROL SOC, V90, P219, DOI 10.1175/2008BAMS2522.1; Bruce E, 2014, APPL GEOGR, V54, P83, DOI 10.1016/j.apgeog.2014.06.014; Brzeski KE, 2013, J WILDLIFE MANAGE, V77, P1523, DOI 10.1002/jwmg.610; Bulleri F, 2014, MAR ECOL PROG SER, V506, P255, DOI 10.3354/meps10804; Citizen Science Association, 2015, CIT SCI THEOR PRACT; Clery D, 2011, SCIENCE, V333, P173, DOI 10.1126/science.333.6039.173; Cooper CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106508; Cox TE, 2012, ECOL APPL, V22, P1201, DOI 10.1890/11-1614.1; Crowston K, 2013, P ANN HICSS, P450, DOI 10.1109/HICSS.2013.413; Davies TK, 2012, WILDLIFE RES, V39, P696, DOI 10.1071/WR12092; Dhondt Andre A., 1997, AAAS Annual Meeting and Science Innovation Exposition, V163, pA18; Donnelly A, 2014, INT J BIOMETEOROL, V58, P1237, DOI 10.1007/s00484-013-0717-0; European Commission, 2013, GREEN PAP CIT SCI; Fahr Jakob, 2013, African Bat Conservation News, V30, P2; Faridani S, 2009, P 2009 IFAC WORKSH N; Gura Trisha, 2013, Nature, V496, P259; Hill A, 2012, ZOOKEYS, P219, DOI 10.3897/zookeys.209.3472; Hladka B, 2012, WEB SCI; Howard E, 2010, PSYCHE J ENTOMOLOGY, V2010; Hoyer MV, 2012, LAKE RESERV MANAGE, V28, P277, DOI 10.1080/07438141.2012.736016; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; IRWIN A, 1994, FUTURES, V26, P323, DOI 10.1016/0016-3287(94)90018-3; Jordan R, 2015, BIOSCIENCE, V65, P208, DOI 10.1093/biosci/biu217; Jun Yu, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P1157, DOI 10.1109/ICDM.2010.103; Kawrykow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031362; Kelemen-Finan Julia, 2013, Naturschutz und Landschaftsplanung, V45, P171; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; Lee T, 2006, ECOL SOC, V11; Lin AY-M, 2013, HDB HUMAN COMPUTATIO, P171; Lin HS, 2013, PUBLIC UNDERST SCI, V22, P941, DOI 10.1177/0963662511429412; McCormick S, 2012, ECOL SOC, V17, DOI 10.5751/ES-05263-170431; Meehan TD, 2013, J INSECT CONSERV, V17, P411, DOI 10.1007/s10841-012-9523-y; Michener WK, 2012, TRENDS ECOL EVOL, V27, P85, DOI 10.1016/j.tree.2011.11.016; Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278; Mori Emiliano, 2014, Quaderni del Museo Civico di Storia Naturale di Ferrara, V2, P91; Neylon C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000242; Rosevelt C, 2013, MAR POLLUT BULL, V71, P299, DOI 10.1016/j.marpolbul.2013.01.015; Rotman D., 2014, MOTIVATIONS AFFECTIN, DOI [10.9776/14054, DOI 10.9776/14054]; Sequeira AMM, 2014, ECOL EVOL, V4, P2103, DOI 10.1002/ece3.1094; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Simon Jirka D, ENVIROCAR CROWD SOUR; Smith AM, 2011, MON NOT R ASTRON SOC, V412, P1309, DOI 10.1111/j.1365-2966.2010.17994.x; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Suomela TE, 2014, CITIZEN SCI FRAMING; Theobald EJ, 2015, BIOL CONSERV, V181, P236, DOI 10.1016/j.biocon.2014.10.021; Thiel M, 2014, OCEANOGR MAR BIOL, V52, P257; Tian HD, 2011, P NATL ACAD SCI USA, V108, P14521, DOI 10.1073/pnas.1100189108; Toomey AH, 2013, HUM ECOL REV, V20, P50; Tschope O, 2013, TAXON, V62, P1248, DOI 10.12705/626.4; van Vliet AJH, 2014, INT J BIOMETEOROL, V58, P565, DOI 10.1007/s00484-014-0821-9; Weckel ME, 2010, J WILDLIFE MANAGE, V74, P1163, DOI 10.2193/2008-512; Wiersma YF, 2010, AVIAN CONSERV ECOL, V5; Wiggins A., 2011, Proceedings of the 2011 IEEE Seventh International Conference on e-Science Workshops (eScienceW 2011), P14, DOI 10.1109/eScienceW.2011.27; Wiggins Andrea, 2011, P HICSS, P1, DOI DOI 10.1109/HICSS.2011.207; Willett KW, 2013, MON NOT R ASTRON SOC, V435, P2835, DOI 10.1093/mnras/stt1458; Williams AC, 2014, IEEE INT CONF BIG DA; Yu J., 2012, IEEE 8 INT C E SCI, P1, DOI DOI 10.1109/ESCIENCE.2012.6404472; Zoouniverse, 2015, PUBL PAP	64	184	188	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143687	10.1371/journal.pone.0143687	http://dx.doi.org/10.1371/journal.pone.0143687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26600041	gold, Green Published, Green Submitted			2022-12-27	WOS:000365853900157
J	Martin, L; De Santis, R; Koczera, P; Simons, N; Haase, H; Heinbockel, L; Brandenburg, K; Marx, G; Schuerholz, T				Martin, Lukas; De Santis, Rebecca; Koczera, Patrick; Simons, Nadine; Haase, Hajo; Heinbockel, Lena; Brandenburg, Klaus; Marx, Gernot; Schuerholz, Tobias			The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis	PLOS ONE			English	Article							EXPRESSION; FAILURE; MODEL	Heparanase is an endo-beta-glucuronidase that cleaves heparan sulfate side chains from their proteoglycans. Thereby, heparanase liberates highly potent circulating heparan sulfate-fragments (HS-fragments) and triggers the fatal and excessive inflammatory response in sepsis. As a potential anti-inflammatory agent for sepsis therapy, peptide 19-2.5 belongs to the class of synthetic anti-lipopolysaccharide peptides; however, its activity is not restricted to Gram-negative bacterial infection. We hypothesized that peptide 19-2.5 interacts with heparanase and/or HS, thereby reducing the levels of circulating HS-fragments in murine and human sepsis. Our data indicate that the treatment of septic mice with peptide 19-2.5 compared to untreated control animals lowers levels of plasma heparanase and circulating HS-fragments and reduces heparanase activity. Additionally, mRNA levels of heparanase in heart, liver, lung, kidney and spleen are downregulated in septic mice treated with peptide 19-2.5 compared to untreated control animals. In humans, plasma heparanase level and activity are elevated in septic shock. The ex vivo addition of peptide 19-2.5 to plasma of septic shock patients decreases heparanase activity but not heparanase level. Isothermal titration calorimetry revealed a strong exothermic reaction between peptide 19-2.5 and heparanase and HS-fragments. However, a saturation character has been identified only in the peptide 19-2.5 and HS interaction. In conclusion, the findings of our current study indicate that peptide 19-2.5 interacts with heparanase, which is elevated in murine and human sepsis and consecutively attenuates the generation of circulating HS-fragments in systemic inflammation. Thus, peptide 19-2.5 seems to be a potential anti-inflammatory agent in sepsis.	[Martin, Lukas; De Santis, Rebecca; Koczera, Patrick; Simons, Nadine; Marx, Gernot; Schuerholz, Tobias] Univ Hosp RWTH, Dept Intens Care & Intermediate Care, Aachen, Germany; [Haase, Hajo] Berlin Inst Technol, Dept Food Chem & Toxicol, Berlin, Germany; [Heinbockel, Lena; Brandenburg, Klaus] Forschungszentrum Borstel, Div Biophys, Borstel, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Technical University of Berlin; Forschungszentrum Borstel	Schuerholz, T (corresponding author), Univ Hosp RWTH, Dept Intens Care & Intermediate Care, Aachen, Germany.	tschuerholz@ukaachen.de	Haase, Hajo/B-9280-2009; Martin, Lukas/Q-8917-2019; Schuerholz, Tobias/E-8071-2011	Haase, Hajo/0000-0002-1622-8718; Martin, Lukas/0000-0001-8650-5090; Schuerholz, Tobias/0000-0003-3830-3499	Astellas Pharma; Bayer Vital; Astra-Zeneca; B. Braun Melsungen; BBraun; Edwards Life Sciences; Serumwerke Bernburg; Hutchinson Technology; Baxter	Astellas Pharma(Astellas Pharmaceuticals); Bayer Vital(Bayer AG); Astra-Zeneca(AstraZeneca); B. Braun Melsungen; BBraun; Edwards Life Sciences; Serumwerke Bernburg; Hutchinson Technology; Baxter	KB has a patent for the structure of the synthetic antimicrobial peptide 19-2.5 (Aspidasept, Brandenburg Antiinfektiva, Borstel, Germany): Patent-No: PCT/EP2009/002565, and is chief scientific officer of Brandenburg Antiinfektiva GmbH. TS received travel grants and lecture fees from Astellas Pharma, and lecture fees from Bayer Vital, Astra-Zeneca and B. Braun Melsungen, and is chief medical officer of Brandenburg Antiinfektiva GmbH. GM has received honoraria for consulting or lecturing and restricted research grants from the following companies: BBraun, Edwards Life Sciences, Serumwerke Bernburg, Hutchinson Technology, and Baxter. The competing interests do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chen GP, 2004, BIOCHEMISTRY-US, V43, P4971, DOI 10.1021/bi0356552; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Goode KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109596; Gutsmann T, 2010, ANTIMICROB AGENTS CH, V54, P3817, DOI 10.1128/AAC.00534-10; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Heinbockel L, 2015, INNATE IMMUN-LONDON, V21, P305, DOI 10.1177/1753425914535957; Heinbockel L, 2013, ANTIMICROB AGENTS CH, V57, P1480, DOI 10.1128/AAC.02066-12; Hu ZS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085765; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Kaconis Y, 2011, BIOPHYS J, V100, P2652, DOI 10.1016/j.bpj.2011.04.041; Krepstakies M, 2012, J INFECT DIS, V205, P1654, DOI 10.1093/infdis/jis273; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Lerner I, 2008, CLIN CANCER RES, V14, P668, DOI 10.1158/1078-0432.CCR-07-1866; Lygizos MI, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.153; Martin L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127584; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Nelson A, 2014, ACTA ANAESTH SCAND, V58, P36, DOI 10.1111/aas.12223; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12; Schmidt EP, 2014, J BIOL CHEM, V289, P8194, DOI 10.1074/jbc.M113.539452; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Schuerholz T, 2013, CRIT CARE, V17, DOI 10.1186/cc11920; Shafat I, 2007, NEOPLASIA, V9, P909, DOI 10.1593/neo.07673; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; van Griensven M, 2002, SHOCK, V18, P445, DOI 10.1097/00024382-200211000-00010; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Zanotti S, 2002, EXPERT OPIN INV DRUG, V11, P1061, DOI 10.1517/13543784.11.8.1061; Zhang LJ, 2006, EXPERT OPIN PHARMACO, V7, P653, DOI 10.1517/14656566.7.6.653	31	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143583	10.1371/journal.pone.0143583	http://dx.doi.org/10.1371/journal.pone.0143583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600070	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900146
J	Shen, HS; Dai, GC; Luo, MY; Duan, CJ; Cai, WL; Liang, D; Wang, XH; Zhu, DY; Li, WR; Qiu, JP				Shen, Hesong; Dai, Guochao; Luo, Mingyue; Duan, Chaijie; Cai, Wenli; Liang, Dan; Wang, Xinhua; Zhu, Dongyun; Li, Wenru; Qiu, Jianping			Image Quality and Radiation Dose of CT Coronary Angiography with Automatic Tube Current Modulation and Strong Adaptive Iterative Dose Reduction Three-Dimensional (AIDR3D)	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; COMPUTED-TOMOGRAPHY; RECONSTRUCTION TECHNIQUES; 3D	Purpose To investigate image quality and radiation dose of CT coronary angiography (CTCA) scanned using automatic tube current modulation (ATCM) and reconstructed by strong adaptive iterative dose reduction three-dimensional (AIDR3D). Methods Eighty-four consecutive CTCA patients were collected for the study. All patients were scanned using ATCM and reconstructed with strong AIDR3D, standard AIDR3D and filtered back-projection (FBP) respectively. Two radiologists who were blinded to the patients' clinical data and reconstruction methods evaluated image quality. Quantitative image quality evaluation included image noise, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). To evaluate image quality qualitatively, coronary artery is classified into 15 segments based on the modified guidelines of the American Heart Association. Qualitative image quality was evaluated using a 4-point scale. Radiation dose was calculated based on dose-length product. Results Compared with standard AIDR3D, strong AIDR3D had lower image noise, higher SNR and CNR, their differences were all statistically significant (P<0.05); compared with FBP, strong AIDR3D decreased image noise by 46.1%, increased SNR by 84.7%, and improved CNR by 82.2%, their differences were all statistically significant (P<0.05 or 0.001). Segments with diagnostic image quality for strong AIDR3D were 336 (100.0%), 486 (96.4%), and 394 (93.8%) in proximal, middle, and distal part respectively; whereas those for standard AIDR3D were 332 (98.8%), 472 (93.7%), 378 (90.0%), respectively; those for FBP were 217 (64.6%), 173 (34.3%), 114 (27.1%), respectively; total segments with diagnostic image quality in strong AIDR3D (1216, 96.5%) were higher than those of standard AIDR3D (1182, 93.8%) and FBP (504, 40.0%); the differences between strong AIDR3D and standard AIDR3D, strong AIDR3D and FBP were all statistically significant (P<0.05 or 0.001). The mean effective radiation dose was (2.55 +/- 1.21) mSv. Conclusion Compared with standard AIDR3D and FBP, CTCA with ATCM and strong AIDR3D could significantly improve both quantitative and qualitative image quality.	[Shen, Hesong; Luo, Mingyue; Liang, Dan; Wang, Xinhua; Zhu, Dongyun; Li, Wenru; Qiu, Jianping] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Hesong] Chongqing Canc Inst, Dept Radiol, Chongqing, Peoples R China; [Dai, Guochao] First Peoples Hosp Kashi Area, Imaging Ctr, Xinjiang, Peoples R China; [Duan, Chaijie] Tsinghua Univ, Grad Sch,Shenzhen, Biomed Engn Res Ctr, Shenzhen, Guangdong, Peoples R China; [Cai, Wenli] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Cai, Wenli] Harvard Univ, Sch Med, Boston, MA USA	Sun Yat Sen University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Luo, MY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China.	myluo720@163.com	Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	National Natural Science Foundation of China [81230035]; Guangdong Provincial Science and Technology Programs [2013B051000016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Programs	This study was supported by the National Natural Science Foundation of China (81230035), (http://www.nsfc.gov.cn/); and Guangdong Provincial Science and Technology Programs (2013B051000016), (http://pro.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittencourt MS, 2011, INT J CARDIOVAS IMAG, V27, P1081, DOI 10.1007/s10554-010-9756-3; Buchmann RF, 2014, J COMPUT ASSIST TOMO, V38, P786, DOI 10.1097/RCT.0000000000000122; Chen MY, 2013, INT J CARDIOVAS IMAG, V29, P1167, DOI 10.1007/s10554-013-0190-1; Elojeimy S, 2010, RADIAT PROT DOSIM, V141, P43, DOI 10.1093/rpd/ncq138; Feger S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125943; Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7; Gordic S, 2015, EUR RADIOL; Gosling O, 2010, HEART, V96, P922, DOI 10.1136/hrt.2010.195909; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Hausleiter J, 2009, JAMA-J AM MED ASSOC, V301, P500, DOI 10.1001/jama.2009.54; Joemai RMS, 2013, AM J ROENTGENOL, V201, P1291, DOI 10.2214/AJR.12.9780; Juri H, 2013, J COMPUT ASSIST TOMO, V37, P426, DOI 10.1097/RCT.0b013e3182830aa9; Kim M, 2014, KOREAN J RADIOL, V15, P195, DOI 10.3348/kjr.2014.15.2.195; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285; Matsuki M, 2013, ACTA RADIOL, V54, P869, DOI 10.1177/0284185113488576; Moscariello A, 2011, EUR RADIOL, V21, P2130, DOI 10.1007/s00330-011-2164-9; Rybicki FJ, 2008, INT J CARDIOVAS IMAG, V24, P535, DOI 10.1007/s10554-008-9308-2; Shen JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065025; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Tatsugami F, 2012, BRIT J RADIOL, V85, pE378, DOI 10.1259/bjr/10084599; Tomizawa N, 2012, J CARDIOVASC COMPUT, V6, P318, DOI 10.1016/j.jcct.2012.02.009; Yamada Y, 2012, EUR J RADIOL, V81, P4185, DOI 10.1016/j.ejrad.2012.07.013; Yamashiro T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105735; Yoo RE, 2013, INT J CARDIOVAS IMAG, V29, P669, DOI 10.1007/s10554-012-0113-6; Zhang LJ, 2015, EUR RADIOL; Zheng MW, 2015, ACAD RADIOL, V22, P195, DOI 10.1016/j.acra.2014.07.025	27	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142185	10.1371/journal.pone.0142185	http://dx.doi.org/10.1371/journal.pone.0142185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599111	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900022
J	Waszczuk, MA; Brown, HM; Eley, TC; Lester, KJ				Waszczuk, Monika A.; Brown, Hannah M.; Eley, Thalia C.; Lester, Kathryn J.			Attentional Control Theory in Childhood: Enhanced Attentional Capture by Non-Emotional and Emotional Distractors in Anxiety and Depression	PLOS ONE			English	Article							DSM-IV DISORDERS; WORKING-MEMORY; COGNITIVE VULNERABILITY; EXECUTIVE FUNCTION; THREAT; SYMPTOMS; CHILDREN; PERFORMANCE; PREVALENCE; IMPAIRMENTS	Attentional control theory (ACT) proposes that anxiety is associated with executive functioning deficits. The theory has been widely investigated in adults. The current study tested whether symptoms of childhood anxiety and depression were associated with experimentally measured attentional control in the context of non-emotional and emotional stimuli. Sixty-one children (mean age = 9.23 years, range = 8.39-10.41) reported their trait anxiety and depression symptoms and completed three visual search tasks. The tasks used a variant of an irrelevant singleton paradigm and measured attentional capture by task-irrelevant non-emotional (color) and emotional (facial expressions) distractors. Significant attentional capture by both non-emotional and emotional distractors was observed, and was significantly correlated with trait anxiety and symptoms of depression. The strength of relationship between attentional capture and the symptoms did not differ significantly for non-emotional and emotional distractors. The results suggest that symptoms of childhood anxiety and depression are associated with poorer attentional control both in the presence of emotional and non-emotional stimuli, supporting ACT in younger populations. This attentional deficit in the context of non-emotional information might be as central to childhood internalizing symptoms as attentional biases often observed on tasks investigating processing of emotional stimuli.	[Waszczuk, Monika A.; Brown, Hannah M.; Eley, Thalia C.; Lester, Kathryn J.] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Lester, Kathryn J.] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of London; King's College London; University of Sussex	Lester, KJ (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	k.lester@sussex.ac.uk	Waszczuk, Monika/AAP-7716-2020		Medical Research Council [MR/J011762/1]; Alexander von Humboldt Foundation; Leverhulme Foundation [RPG-210]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development; MRC [MR/J011762/1] Funding Source: UKRI; Economic and Social Research Council [1013456] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Leverhulme Foundation; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London(General Electric); John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The present work was funded by Medical Research Council grant MR/J011762/1 to Dr. Kathryn Lester and Prof. Thalia Eley. Monika Waszczuk was supported by The Alexander von Humboldt Foundation. This work is also supported by the Leverhulme Foundation [RPG-210 to Thalia Eley]. This paper represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Development of the MacBrain Face Stimulus Set was overseen by Nim Tottenham and supported by the John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development. Please contact Nim Tottenham at tott0006@tc.umn.edu for more information concerning the stimulus set. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACAP, 2007, J AM ACAD CHILD ADOL, V46; Angold A, 1995, INT J METHOD PSYCH, V5, P237; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Callinan S, 2014, COGNITIVE THERAPY RE, P1; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Eisenberg N, 2001, CHILD DEV, V72, P1112, DOI 10.1111/1467-8624.00337; Esterman M, 2013, J INT NEUROPSYCH SOC, V19, P835, DOI 10.1017/S135561771300057X; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Eysenck MW, 2011, PERS INDIV DIFFER, V50, P955, DOI 10.1016/j.paid.2010.08.019; Finch A J Jr, 1974, J Abnorm Child Psychol, V2, P67, DOI 10.1007/BF00919356; Gregory AM, 2007, AM J PSYCHIAT, V164, P301, DOI 10.1176/appi.ajp.164.2.301; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hughes C, 2011, J EXP CHILD PSYCHOL, V108, P663, DOI 10.1016/j.jecp.2010.06.005; Jacobs RH, 2008, CLIN PSYCHOL REV, V28, P759, DOI 10.1016/j.cpr.2007.10.006; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; Lester KJ, 2011, J BEHAV THER EXP PSY, V42, P298, DOI 10.1016/j.jbtep.2011.01.001; Lonigan CJ, 2009, J ABNORM CHILD PSYCH, V37, P387, DOI 10.1007/s10802-008-9284-y; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Moran TP, 2014, COGN AFFECT BEHAV NE, P1, DOI [10.3758/, DOI 10.3758/]; Moser JS, 2012, EMOTION, V12, P213, DOI 10.1037/a0026156; Muris P, 2008, CHILD PSYCHIAT HUM D, V39, P455, DOI 10.1007/s10578-008-0101-1; Muris P, 2008, COGNITION EMOTION, V22, P395, DOI 10.1080/02699930701843450; Muris P, 2007, BEHAV RES THER, V45, P997, DOI 10.1016/j.brat.2006.07.010; PAPAY JP, 1978, J ABNORM CHILD PSYCH, V6, P115, DOI 10.1007/BF00915787; Peers PV, 2009, EMOTION, V9, P140, DOI 10.1037/a0014507; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Reinholdt-Dunne ML, 2009, BEHAV RES THER, V47, P410, DOI 10.1016/j.brat.2009.01.012; Roughan L, 2011, LEARN INDIVID DIFFER, V21, P759, DOI 10.1016/j.lindif.2011.07.011; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Salemink E, 2012, BEHAV RES THER, V50, P40, DOI 10.1016/j.brat.2011.10.006; Scott A, 2001, Popul Trends, P6; Shipstead Z, 2012, J APPL RES MEM COGN, V1, P185, DOI 10.1016/j.jarmac.2012.06.003; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Spielberger C, 1973, PRELIMINARY TEST MAN; Susa G, 2012, COGNITION EMOTION, V26, P1069, DOI 10.1080/02699931.2011.638910; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Wass SV, 2012, DEV REV, V32, P360, DOI 10.1016/j.dr.2012.07.001; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Zavos HMS, 2010, J AFFECT DISORDERS, V124, P45, DOI 10.1016/j.jad.2009.10.030	54	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141535	10.1371/journal.pone.0141535	http://dx.doi.org/10.1371/journal.pone.0141535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599268	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000365853900012
J	Louis, M; Hofmann, K; Broemer, M				Louis, Marcell; Hofmann, Kay; Broemer, Meike			Evolutionary Loss of Activity in De-Ubiquitylating Enzymes of the OTU Family	PLOS ONE			English	Article							OVARIAN TUMOR GENE; DROSOPHILA-MELANOGASTER; CELL-DEATH; PROTEASES; PROTEINS; SEQUENCE; DOMAIN; DEUBIQUITINASES; GENERATION; OOGENESIS	Understanding function and specificity of de-ubiquitylating enzymes (DUBs) is a major goal of current research, since DUBs are key regulators of ubiquitylation events and have been shown to be mutated in human diseases. Most DUBs are cysteine proteases, relying on a catalytic triad of cysteine, histidine and aspartate to cleave the isopeptide bond between two ubiquitin units in a poly-ubiquitin chain. We have discovered that the two Drosophila melanogaster homologues of human OTUD4, CG3251 and Otu, contain a serine instead of a cysteine in the catalytic OTU (ovarian tumor) domain. DUBs that are serine proteases instead of cysteine-or metallo-proteases have not been described. In line with this, neither CG3251 nor Otu protein were active to cleave ubiquitin chains. Re-introduction of a cysteine in the catalytic center did not render the enzymes active, indicating that further critical features for ubiquitin binding or cleavage have been lost in these proteins. Sequence analysis of OTUD4 homologues from various other species showed that within this OTU subfamily, loss of the catalytic cysteine has occurred frequently in presumably independent events, as well as gene duplications or triplications, suggesting DUB-independent functions of OTUD4 proteins. Using an in vivo RNAi approach, we show that CG3251 might function in the regulation of Inhibitor of Apoptosis (IAP)-antagonist-induced apoptosis, presumably in a DUB-independent manner.	[Louis, Marcell; Broemer, Meike] German Ctr Neurodegenerat Dis DZNE, LiMeS, D-53115 Bonn, Germany; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Cologne	Broemer, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, LiMeS, Carl Troll Str 31, D-53115 Bonn, Germany.	meike.broemer@dzne.de			Deutsche Forschungsgemeinschaft (DFG) [BR 3442/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding: This work was supported by Deutsche Forschungsgemeinschaft (DFG) (BR 3442/2-1) to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; Fernando MDA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004117; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Glenn LE, 2001, MECH DEVELOP, V102, P181, DOI 10.1016/S0925-4773(01)00314-8; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KING RC, 1988, BIOESSAYS, V8, P18, DOI 10.1002/bies.950080106; KING RC, 1986, DEV GENET, V7, P1, DOI 10.1002/dvg.1020070102; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Leulier F, 2006, CELL DEATH DIFFER, V13, P1663, DOI 10.1038/sj.cdd.4401868; Lu R, 2013, TRENDS BIOCHEM SCI, V38, P546, DOI 10.1016/j.tibs.2013.08.002; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Nanao MH, 2004, EMBO REP, V5, P783, DOI 10.1038/sj.embor.7400201; Ponting CP, 1997, TRENDS BIOCHEM SCI, V22, P51, DOI 10.1016/S0968-0004(96)30049-2; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; RODESCH C, 1995, GENETICS, V141, P191; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASS GL, 1993, GENETICS, V133, P253; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Seetharam Arun, 2012, BMC Res Notes, V5, P670, DOI 10.1186/1756-0500-5-670; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STEINHAUER WR, 1989, MOL CELL BIOL, V9, P5726, DOI 10.1128/MCB.9.12.5726; STROUD RM, 1974, SCI AM, V231, P74, DOI 10.1038/scientificamerican0774-74; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Zhao Y, 2015, EMBO J, V34, P1687, DOI 10.15252/embj.201490497	36	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143227	10.1371/journal.pone.0143227	http://dx.doi.org/10.1371/journal.pone.0143227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588485	Green Published, gold			2022-12-27	WOS:000365251500040
J	Mazur, A; Welker, KM; Peng, B				Mazur, Allan; Welker, Keith M.; Peng, Bin			Does the Biosocial Model Explain the Emergence of Status Differences in Conversations among Unacquainted Men?	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; AGGRESSIVE-BEHAVIOR; TESTOSTERONE; DOMINANCE; HYPOTHESIS	Fifteen triads of unacquainted men conversed for ten minutes while stress was measured in real time by pulse rate and thumb blood volume (TBV). Salivary measures of testosterone (T), cortisol (C), and the stress-related enzyme alpha-amylase (AA) were measured at the beginning and end of the session. Fully or partially transitive status hierarchies formed in 14 triads. (Highest ranked man was scored 1, lowest 3, with ties allowed.) Ten of the triads participated in Study 1, where nothing was at stake in the casual conversation. Five additional triads were run in Study 2, intended to introduce competition by offering a $20 reward to the man afterward chosen as having led the conversation. Most results from the two studies are similar, suggesting that the $20 reward had little effect. Combining studies, pulse and TBV show that conversation is more stressful than watching a video beforehand. Within the conversation, speaking turns are more stressful than listening turns, especially among the lowest ranked men, less so among those higher in rank. This supports a stress-based mechanism for status allocation among humans. Apparently, human speech is a form of status signaling, homologous with nonlinguistic status signals used by other primates, as posited by the "biosocial model." The biosocial model also posits that a physiological substrate (T, C, and AA) is related to dominance or status. Predicted effects are not replicated here, except for an inverse relationship between the stress enzyme AA and status. The mostly null results, obtained from conversations where there was little or nothing at stake, suggest that T and C (and their interaction) are not relevant to emergent status in the absence of serious competition.	[Mazur, Allan] Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA; [Welker, Keith M.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA; [Peng, Bin] Syracuse Univ, Dept Econ, Syracuse, NY 13244 USA	Syracuse University; University of Massachusetts System; University of Massachusetts Boston; Syracuse University	Mazur, A (corresponding author), Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA.	amazur@syr.edu	Peng, Bin/AAG-6796-2020					Aiken L. S., 1991, MULTIPLE REGRESSION; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Bales R, 1953, WORKING PAPERS THEOR; Batrinos ML, 2012, INT J ENDOCRINOL MET, V10, P563, DOI 10.5812/ijem.3661; BERGER J, 1972, AM SOCIOL REV, V37, P241, DOI 10.2307/2093465; BRINKERHOFF DB, 1984, J SOC BIOL STRUCT, V7, P159, DOI 10.1016/S0140-1750(84)80007-X; Burnham T, 2007, P ROYAL SOC B; Carre JM, 2008, HORM BEHAV, V54, P403, DOI 10.1016/j.yhbeh.2008.04.008; Carre JM, 2013, PSYCHONEUROENDOCRINO, V38, P2034, DOI 10.1016/j.psyneuen.2013.03.008; Chen FR, 2015, PSYCHONEUROENDOCRINO, V51, P188, DOI 10.1016/j.psyneuen.2014.09.027; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; FISEK MH, 1970, SOCIOMETRY, V33, P327, DOI 10.2307/2786161; Fiske SusanT., 2010, HDB SOCIAL PSYCHOL, V5th ed., P941, DOI DOI 10.1002/9780470561119.SOCPSY002026; Garson, 2013, HIERARCHICAL LINEAR; Giles GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113618; Goffman E., 1967, INTERACTION RITUAL E; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Granger DA, 2012, J ADOLESCENCE, V35, P1081, DOI 10.1016/j.adolescence.2012.01.005; Homans G.C., 1961, SOCIAL BEHAV ITS ELE; Jaccard J., 2003, INTERACTION EFFECTS; Kenny DA, 2002, J PERS SOC PSYCHOL, V83, P126, DOI 10.1037/0022-3514.83.1.126; Koski J, 2015, SOCIAL NEUROSCIENCE; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Maner JK, 2008, PSYCHOL SCI, V19, P764, DOI 10.1111/j.1467-9280.2008.02154.x; Manson J, 2004, PLOS ONE, V9, DOI [10.1371/journal.pone.0113135, DOI 10.1371/J0URNAL.P0NE.0113135]; Mast MS, 2002, HUM COMMUN RES, V28, P420, DOI 10.1111/j.1468-2958.2002.tb00814.x; MAZUR A, 1985, SOC FORCES, V64, P377; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; MAZUR A, 1984, AM J SOCIOL, V90, P125, DOI 10.1086/228050; Mazur A, 2015, HDB EVOLUTION SOC; Mazur A., 2005, BIOSOCIOLOGY DOMINAN; Mazur A, 2014, BIOL PSYCHOL, V96, P72, DOI 10.1016/j.biopsycho.2013.11.015; Mehta PH, 2015, CURR OPIN BEHAV SCI, V3, P163, DOI 10.1016/j.cobeha.2015.04.008; Mehta PH, 2015, PSYCHONEUROENDOCRINO, V56, P88, DOI 10.1016/j.psyneuen.2015.02.023; Mehta PH, 2010, HORM BEHAV, V58, P898, DOI 10.1016/j.yhbeh.2010.08.020; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Olmstead N, 2014, NEUROSCIENCE; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Scherbaum CA, 2009, ORGAN RES METHODS, V12, P347, DOI 10.1177/1094428107308906; Sherman GD, J PERSONALI IN PRESS; Stanton SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007543; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Zilioli S, 2014, BIOL PSYCHOL, V103, P54, DOI 10.1016/j.biopsycho.2014.07.022	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142941	10.1371/journal.pone.0142941	http://dx.doi.org/10.1371/journal.pone.0142941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW8LQ	26588849	Green Published, gold			2022-12-27	WOS:000365251500026
J	Preethirani, PL; Isloor, S; Sundareshan, S; Nuthanalakshmi, V; Deepthikiran, K; Sinha, AY; Rathnamma, D; Prabhu, KN; Sharada, R; Mukkur, TK; Hegde, NR				Preethirani, P. L.; Isloor, Shrikrishna; Sundareshan, S.; Nuthanalakshmi, V.; Deepthikiran, K.; Sinha, Akhauri Y.; Rathnamma, D.; Prabhu, K. Nithin; Sharada, R.; Mukkur, Trilochan K.; Hegde, Nagendra R.			Isolation, Biochemical and Molecular Identification, and In-Vitro Antimicrobial Resistance Patterns of Bacteria Isolated from Bubaline Subclinical Mastitis in South India	PLOS ONE			English	Article							SOMATIC-CELL COUNT; COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYMERASE-CHAIN-REACTION; INTRAMAMMARY INFECTION; OXACILLIN RESISTANCE; ANTIBIOTIC-RESISTANCE; CLINICAL MASTITIS; D-GLUCOSAMINIDASE; BOVINE MASTITIS; UDDER HEALTH	Buffaloes are the second largest source of milk. Mastitis is a major impediment for milk production, but not much information is available about bubaline mastitis, especially subclinical mastitis. The aim of this study was to (a) investigate the application of various tests for the diagnosis of bubaline subclinical mastitis, (b) identify the major bacteria associated with it, and (c) evaluate the antibiotic resistance pattern of the bacteria. To this end, 190 quarter milk samples were collected from 57 domesticated dairy buffaloes from organized (64 samples) and unorganized (126 samples) sectors. Of these, 48.4%, 40.0%, 45.8%, 61.1%, and 61.6% were positive for subclinical mastitis by somatic cell count, electrical conductivity, California mastitis test, bromothymol blue test, and N-acetyl glucosaminidase test, respectively. As compared to the gold standard of somatic cell count, California mastitis test performed the best. However, a combination of the two methods was found to be the best option. Microbiological evaluation, both by biochemical methods as well as by monoplex and multiplex polymerase chain reaction, revealed that coagulase-negative staphylococci were the most predominant (64.8%) bacteria, followed by streptococci (18.1%), Escherichia coli (9.8%) and Staphylococcus aureus (7.3%). Most of the pathogens were resistant to multiple antibiotics, especially to beta-lactam antibiotics. We propose that California mastitis test be combined with somatic cell count for diagnosis of subclinical mastitis in domestic dairy buffaloes. Further, our results reveal high resistance of the associated bacteria to the beta-lactam class of antibiotics, and a possible major role of coagulase-negative staphylococci in causing the disease in India.	[Preethirani, P. L.; Isloor, Shrikrishna; Sundareshan, S.; Nuthanalakshmi, V.; Deepthikiran, K.; Rathnamma, D.; Prabhu, K. Nithin; Sharada, R.] Karnataka Vet Anim & Fisheries Sci Univ, Dept Microbiol, Hebbal, Bengaluru, India; [Sinha, Akhauri Y.; Hegde, Nagendra R.] Ella Fdn, Genome Valley, Hyderabad, Andhra Pradesh, India; [Mukkur, Trilochan K.] Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Perth, WA 6845, Australia	Curtin University	Hegde, NR (corresponding author), Ella Fdn, Genome Valley, Hyderabad, Andhra Pradesh, India.	hegden@ellafoundation.org	Hegde, Nagendra R/H-3132-2019	Hegde, Nagendra R/0000-0001-5260-2159	Department of Biotechnology, Government of India [BT/Indo-US/04/06/2009]; Department of Innovation, Industry, Science and Research, Government of Australia [BF040038]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Innovation, Industry, Science and Research, Government of Australia	Funding: This work was funded in part by a grant from the Department of Biotechnology (BT/Indo-US/04/06/2009), Government of India (www.dbtindia.nic.in), to NRH and SI, and from the Department of Innovation, Industry, Science and Research (BF040038), Government of Australia (www.industry.gov.au), to TKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W. M., 2008, Global Veterinaria, V2, P41; Ali MA, 2011, J ANIM PLANT SCI-PAK, V21, P477; [Anonymous], 1995, BOVINE UDDER MASTITI; Bachaya H. A., 2005, Pakistan Veterinary Journal, V25, P134; Barrow G.I., 1993, COWAN STEELS MANUAL, V3rd; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bjork S, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-12; Bosshard PP, 2004, J CLIN MICROBIOL, V42, P2065, DOI 10.1128/JCM.42.5.2065-2073.2004; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Ceron-Munoz M, 2002, J DAIRY SCI, V85, P2885, DOI 10.3168/jds.S0022-0302(02)74376-2; Charaya G, 2014, VET WORLD, V7, P980, DOI 10.14202/vetworld.2014.980-985; Clinical and Laboratory Standards Institute, 2010, PERF STAND ANT SUSC; Collee JG, 1996, MACKIE MCCARTNEY PRA; Contreras A, 1999, SMALL RUMINANT RES, V31, P203, DOI 10.1016/S0921-4488(98)00147-3; Daly P, 2002, LETT APPL MICROBIOL, V34, P222, DOI 10.1046/j.1472-765x.2002.01074.x; de Medeiros ES, 2011, J VET DIAGN INVEST, V23, P793, DOI 10.1177/1040638711407882; De Vliegher S, 2012, J DAIRY SCI, V95, P1025, DOI 10.3168/jds.2010-4074; Dhakal IP, 2006, J VET MED B, V53, P81, DOI 10.1111/j.1439-0450.2006.00918.x; Dhakal IP, 2007, J VET MED SCI, V69, P1241, DOI 10.1292/jvms.69.1241; El-Ashker M, 2015, J DAIRY SCI, V98, P7450, DOI 10.3168/jds.2015-9432; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Food and Agriculture Organization, 2014, IMP MAST SMALL SCAL, V13, P10; Guha A, 2012, ASIAN AUSTRAL J ANIM, V25, P353, DOI 10.5713/ajas.2011.11426; Hegde R, 2011, THESIS; Hegde R, 2013, INDIAN J MICROBIOL, V53, P315, DOI 10.1007/s12088-012-0336-1; Hogan J., 1999, LAB HDB BOVINE MASTI; Jeykumar M, 2013, VET WORLD, V6, P354, DOI 10.5455/vetworld.2013.354-356; Joshi L.R., 2014, INT J APPL SCI BIOTE, V2, P29, DOI DOI 10.3126/IJASBT.V2I1.9861; Kalmus P, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-4; Khan A. Z., 2005, Pakistan Veterinary Journal, V25, P9; Khudaier B. Y., 2014, Basrah Journal of Veterinary Research, V13, P235; KITCHEN BJ, 1976, J DAIRY RES, V43, P491, DOI 10.1017/S0022029900016071; Koop G, 2012, J DAIRY SCI, V95, P7200, DOI 10.3168/jds.2012-5747; Koop G, 2012, J DAIRY SCI, V95, P5075, DOI 10.3168/jds.2012-5615; Kumar R, 2011, MICROB PATHOGENESIS, V51, P31, DOI 10.1016/j.micpath.2011.03.006; Kumar S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-186; Kurjogi M. M., 2014, INT SCH RES NOT, V2014, P1, DOI DOI 10.1155/2014/968076; Leitner G, 2004, J DAIRY RES, V71, P311, DOI 10.1017/S0022029904000305; Leitner G, 2007, J DAIRY RES, V74, P186, DOI 10.1017/S0022029906002299; Li XR, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-31; MCDONALD TJ, 1976, AM J VET RES, V37, P377; McDougall S, 2014, NEW ZEAL VET J, V62, P136, DOI 10.1080/00480169.2013.865294; Mitra M, 1995, INDIAN VET J, V72, P1310; Moroni P, 2006, J DAIRY SCI, V89, P998, DOI 10.3168/jds.S0022-0302(06)72165-8; Moroni P, 2005, PREV VET MED, V69, P163, DOI 10.1016/j.prevetmed.2004.10.013; NAGAHATA H, 1987, CAN J VET RES, V51, P126; National Academy of Agricultural Sciences, 2013, MAST MAN DAIR AN; Odierno L, 2006, J DAIRY SCI, V89, P3886, DOI 10.3168/jds.S0022-0302(06)72431-6; Pamuk S., 2010, KOCATEPE VET J, V3, P7; Persson Y, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-15; Pieterse R, 2010, BRAZ J MICROBIOL, V41, P542, DOI 10.1590/S1517-83822010000300003; Pottumarthy S, 2005, DIAGN MICR INFEC DIS, V51, P57, DOI 10.1016/j.diagmicrobio.2004.08.002; Prabhu KN, 2013, INDIAN J BIOTECHNOL, V12, P208; Pyorala S, 2003, VET RES, V34, P565, DOI 10.1051/vetres:2003026; Radostits OM, 2000, TXB DIS CATTLE SHEEP, V9th; Ramesha K. P., 2014, Indian Dairyman, V66, P94; Ranjan R, 2010, VET WORLD, V3, P17; Reneau JK, 2001, P NATL MAST COUNC RE, P18; Rovai M, 2014, J DAIRY SCI, V97, P5393, DOI 10.3168/jds.2014-7988; Ruegg PL, 2012, VET CLIN N AM-FOOD A, V28, P149, DOI 10.1016/j.cvfa.2012.03.001; Sani RN, 2015, TROP ANIM HEALTH PRO, V47, P1249, DOI 10.1007/s11250-015-0855-y; Schukken YH, 2003, VET RES, V34, P579, DOI 10.1051/vetres:2003028; Sharma A, 2007, ITAL J ANIM SCI, V6, P965; Sharma N, 2011, ASIAN AUSTRAL J ANIM, V24, P429, DOI 10.5713/ajas.2011.10233; Sheet O. H., 2010, Iraqi Journal of Veterinary Sciences, V24; Singh M., 2014, Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, V35, P67, DOI 10.5958/0974-0147.2014.00007.5; Singh M, 2001, ASIAN AUSTRAL J ANIM, V14, P189, DOI 10.5713/ajas.2001.189; SMITH KL, 1993, VET CLIN N AM-FOOD A, V9, P489, DOI 10.1016/S0749-0720(15)30616-2; Sudhan N. A., 2005, Indian Journal of Animal Research, V39, P127; Sumathi BR, 2008, VET WORLD, V1, P37; Sundareshan S, 2012, FRONT J ANIM SCI, V1, P34; Sundareshan S, 2012, CHARACTERIZATION COA; Suriyasathaporn W, 2012, ASIAN AUSTRAL J ANIM, V25, P1322, DOI 10.5713/ajas.2012.12023; Swenson JM, 2007, DIAGN MICR INFEC DIS, V58, P33, DOI 10.1016/j.diagmicrobio.2006.10.022; Taponen S, 2009, VET MICROBIOL, V134, P29, DOI 10.1016/j.vetmic.2008.09.011; Thorberg BM, 2009, J DAIRY SCI, V92, P4962, DOI 10.3168/jds.2009-2184; Tiwari J. G., 2013, Journal of Vaccines and Vaccination, V4, P1000176; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Vanderhaeghen W, 2014, J DAIRY SCI, V97, P5275, DOI 10.3168/jds.2013-7775; Vanderhaeghen W, 2015, VET J, V203, P44, DOI 10.1016/j.tvjl.2014.11.001; Velasco D, 2005, J ANTIMICROB CHEMOTH, V55, P379, DOI 10.1093/jac/dki017; Viguier C, 2009, TRENDS BIOTECHNOL, V27, P486, DOI 10.1016/j.tibtech.2009.05.004; Witte W, 2007, CLIN MICROBIOL INFEC, V13, P408, DOI 10.1111/j.1469-0691.2006.01671.x; Yokoigawa K, 2003, FEMS MICROBIOL LETT, V221, P263, DOI 10.1016/S0378-1097(03)00216-7; Zhao YQ, 2015, TROP ANIM HEALTH PRO, V47, P429, DOI 10.1007/s11250-014-0742-y	85	30	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142717	10.1371/journal.pone.0142717	http://dx.doi.org/10.1371/journal.pone.0142717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588070	Green Published, gold, Green Submitted			2022-12-27	WOS:000365251500014
J	Rameneni, JJ; Lee, Y; Dhandapani, V; Yu, X; Choi, SR; Oh, MH; Lim, YP				Rameneni, Jana Jeevan; Lee, Yeon; Dhandapani, Vignesh; Yu, Xiaona; Choi, Su Ryun; Oh, Man-Ho; Lim, Yong Pyo			Genomic and Post-Translational Modification Analysis of Leucine-Rich-Repeat Receptor-Like Kinases in Brassica rapa	PLOS ONE			English	Article							PROTEIN-KINASES; TYROSINE PHOSPHORYLATION; ARABIDOPSIS; GENES; FAMILY; GROWTH; BAK1; TRANSCRIPTOME; PEPTIDE; RNA	Among several receptor-like kinases (RLKs), leucine-rich-repeat receptor-like kinases (LRR-RLKs) are a major group of genes that play crucial roles in growth, development and stress responses in plant systems. Given that they have several functional roles, it is important to investigate their roles in Brassica rapa. In the present study, 303 LRR-RLKs were identified in the genome of B. rapa and comparative phylogenetic analysis of 1213 combined LRR-RLKs of B. rapa, Arabidopsis thaliana, Oryza sativa and Populus trichocarpa helped us to categorize the gene family into 15 subfamilies based on their sequence and structural similarities. The chromosome localizations of 293 genes allowed the prediction of duplicates, and motif conservation and intron/exon patterns showed differences among the B. rapa LRR-RLK (BrLRR-RLK) genes. Additionally, computational function annotation and expression analysis was used to predict their possible functional roles in the plant system. Biochemical results for 11 selected genes showed variations in phosphorylation activity. Interestingly, BrBAK1 showed strong auto-phosphorylation and trans-phosphorylation on its tyrosine and threonine residues compared with AtBAK1 in previous studies. The AtBAK1 receptor kinase is involved in plant growth and development, plant innate immunity, and programmed cell death, and our results suggest that BrBAK1 might also be involved in the same functions. Another interesting result was that BrBAK1, BrBRI1, BrPEPR1 and BrPEPR2 showed activity with both anti-phosphotyrosine and anti-phosphothreonine antibodies, indicating that they might have dual-specificity kinase activity. This study provides comprehensive results for the BrLRR-RLKs, revealing expansion of the gene family through gene duplications, structural similarities and variations among the genes, and potential functional roles according to gene ontology, transcriptome profiling and biochemical analysis.	[Rameneni, Jana Jeevan; Dhandapani, Vignesh; Yu, Xiaona; Choi, Su Ryun; Lim, Yong Pyo] Chungnam Natl Univ, Coll Agr & Life Sci, Dept Hort, Mol Genet & Genom Lab, Taejon 305764, South Korea; [Lee, Yeon; Oh, Man-Ho] Chungnam Natl Univ, Dept Biol Sci, Coll Biol Sci & Biotechnol, Taejon 305764, South Korea	Chungnam National University; Chungnam National University	Oh, MH (corresponding author), Chungnam Natl Univ, Dept Biol Sci, Coll Biol Sci & Biotechnol, Taejon 305764, South Korea.	manhooh@cnu.ac.kr; yplim@cnu.ac.kr	Dhandapani, Vignesh/X-6677-2019; 최, 수련/AHE-1934-2022	Dhandapani, Vignesh/0000-0002-5745-2409; Oh, Man-Ho/0000-0002-6524-3252	Ministry of Agriculture, Food and Rural Affairs (MAFRA) [213002-04-3-SB110]; Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA); Korea Forest Service (KFS); Chungnam National University; National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A401006751]	Ministry of Agriculture, Food and Rural Affairs (MAFRA)(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of Korea); Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA)(Ministry of Oceans & Fisheries (MOF), Republic of Korea); Korea Forest Service (KFS)(Korea Forest Service); Chungnam National University; National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea)	1. JJR, VD, XY, and YPL received funds to conduct this research, from Golden Seed Project (No. 213002-04-3-SB110), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS). 2. YL and MHO received funds from Chungnam National University and Basic Science Research Program (No. 2014R1A1A401006751) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2014R1A1A401006751).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; Bleecker AB, 2001, P NATL ACAD SCI USA, V107, P63; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Colcombet J, 2005, PLANT CELL, V17, P3350, DOI 10.1105/tpc.105.036731; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Dievart A, 2003, CURR OPIN PLANT BIOL, V6, P507, DOI 10.1016/S1369-5266(03)00089-X; Eyuboglu B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-16; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Godiard L, 2003, PLANT J, V36, P353, DOI 10.1046/j.1365-313X.2003.01877.x; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gou XP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-19; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hwang SG, 2011, GENETICA, V139, P1023, DOI 10.1007/s10709-011-9604-y; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Karve R, 2011, RNA, V17, P1907, DOI 10.1261/rna.2825811; Kim J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-606; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Krupa A, 2004, J MOL BIOL, V339, P1025, DOI 10.1016/j.jmb.2004.04.043; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; Mosher S, 2013, PLANT J, V73, P469, DOI 10.1111/tpj.12050; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nodine MD, 2007, DEV CELL, V12, P943, DOI 10.1016/j.devcel.2007.04.003; Oh MH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00016; Oh MH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00175; Oh MH, 2011, PLANT SIGNAL BEHAV, V6, P400, DOI 10.4161/psb.6.3.14337; Oh MH, 2010, P NATL ACAD SCI USA, V107, P17827, DOI 10.1073/pnas.0915064107; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Schwessinger B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004809; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2004, MOL BIOL EVOL, V21, P828, DOI 10.1093/molbev/msh077; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Stenvik GE, 2008, PLANT CELL, V20, P1805, DOI 10.1105/tpc.108.059139; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; ten Hove CA, 2011, PLANT MOL BIOL, V76, P69, DOI 10.1007/s11103-011-9769-x; Tong CB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-689; Tsuwamoto R, 2008, PLANT J, V54, P30, DOI 10.1111/j.1365-313X.2007.03395.x; VALON C, 1993, PLANT MOL BIOL, V23, P415, DOI 10.1007/BF00029017; WALKER JC, 1990, NATURE, V345, P743, DOI 10.1038/345743a0; Wang J, 2011, J MOL EVOL, V72, P498, DOI 10.1007/s00239-011-9448-1; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2011, PLANT J, V67, P1081, DOI 10.1111/j.1365-313X.2011.04659.x; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Won SK, 2009, PLANT PHYSIOL, V150, P1459, DOI 10.1104/pp.109.140905; Wu X, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00262; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354; Yamaguchi Y, 2010, PLANT CELL, V22, P508, DOI 10.1105/tpc.109.068874; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]; Zan YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-318; Zhao XY, 2013, J EXP BOT, V64, P5599, DOI 10.1093/jxb/ert323	72	29	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142255	10.1371/journal.pone.0142255	http://dx.doi.org/10.1371/journal.pone.0142255			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588465	Green Published, gold, Green Submitted			2022-12-27	WOS:000365251500008
J	Rothuizen, TC; Ocak, G; Verschuren, JJW; Dekker, FW; Rabelink, TJ; Jukema, JW; Rotmans, JI				Rothuizen, Tonia C.; Ocak, Gurbey; Verschuren, Jeffrey J. W.; Dekker, Friedo W.; Rabelink, Ton J.; Jukema, J. Wouter; Rotmans, Joris I.			Candidate Gene Analysis of Mortality in Dialysis Patients	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STAGE RENAL-DISEASE; CORONARY-ARTERY-DISEASE; CHRONIC KIDNEY-DISEASE; RECEPTOR 1 SVEGFR-1; FUNCTIONAL POLYMORPHISMS; HEMODIALYSIS-PATIENTS; CLINICAL RESTENOSIS; RISK MARKER; ASSOCIATION	Background Dialysis patients have high cardiovascular mortality risk. This study aimed to investigate the association between SNPs of genes involved in vascular processes and mortality in dialysis patients. Methods Forty two SNPs in 25 genes involved in endothelial function, vascular remodeling, cell proliferation, inflammation, coagulation and calcium/phosphate metabolism were genotyped in 1330 incident dialysis patients. The effect of SNPs on 5-years cardiovascular and non-cardiovascular mortality was investigated. Results The mortality rate was 114/1000 person-years and 49.4% of total mortality was cardiovascular. After correction for multiple testing, VEGF rs699947 was associated with all-cause mortality (HR1.48, 95% CI 1.14-1.92). The other SNPs were not associated with mortality. Conclusions This study provides further evidence that a SNP in the VEGF gene may contribute to the comorbid conditions of dialysis patients. Future studies should unravel the underlying mechanisms responsible for the increase in mortality in these patients.	[Rothuizen, Tonia C.; Rabelink, Ton J.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Rothuizen, Tonia C.; Rabelink, Ton J.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Ocak, Gurbey; Dekker, Friedo W.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Verschuren, Jeffrey J. W.; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst ICIN, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rotmans, JI (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	j.i.rotmans@lumc.nl	Jukema, J. Wouter/ABD-6503-2021; Rotmans, Joris I./G-8866-2014; Rabelink, Ton J./A-5316-2008; Dekker, Friedo W/B-6452-2011	Jukema, J. Wouter/0000-0002-3246-8359; Rotmans, Joris I./0000-0001-9682-6234; Rabelink, Ton J./0000-0001-6780-5186; Dekker, Friedo W/0000-0002-2433-2494	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community Framework KP7 Programme [HEALTH-F2-2009-223004]; Center for Medical Systems Biology (CMSB), a center of excellence; Netherlands Consortium for Healthy Ageing (NCHA); BioMedical Materials institute [P3.03 DialysisXS]; Dutch Ministry of Economic Affairs, Agriculture and Innovation	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community Framework KP7 Programme; Center for Medical Systems Biology (CMSB), a center of excellence; Netherlands Consortium for Healthy Ageing (NCHA); BioMedical Materials institute; Dutch Ministry of Economic Affairs, Agriculture and Innovation	Funding: JWJ was funded by grants from the Interuniversity Cardiology Institute of the Netherlands (ICIN), the European Community Framework KP7 Programme under grant agreement [no HEALTH-F2-2009-223004], the Center for Medical Systems Biology (CMSB), a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO) and the Netherlands Consortium for Healthy Ageing (NCHA). The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript. TCR and JR were supported by the research program of the BioMedical Materials institute (P3.03 DialysisXS), co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation.	Agema WRP, 2004, EUR HEART J, V25, P1163, DOI 10.1016/j.ehj.2004.05.006; Allon M, 2012, AM J KIDNEY DIS, V59, P682, DOI 10.1053/j.ajkd.2011.11.036; Aucella F, 2009, ATHEROSCLEROSIS, V207, P541, DOI 10.1016/j.atherosclerosis.2009.05.011; Baas AF, 2010, EUR J HUM GENET, V18, P240, DOI 10.1038/ejhg.2009.141; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Balakrishnan VS, 2004, KIDNEY INT, V65, P1449, DOI 10.1111/j.1523-1755.2004.00531.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biselli PM, 2008, HEART VESSELS, V23, P371, DOI 10.1007/s00380-008-1057-6; Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002; Brunet P, 2011, KIDNEY BLOOD PRESS R, V34, P284, DOI 10.1159/000327131; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Casserly LF, 2003, SEMIN DIALYSIS, V16, P245, DOI 10.1046/j.1525-139X.2003.16048.x; Chen Y, 2011, J RHEUMATOL, V38, P802, DOI 10.3899/jrheum.101095; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; COHEN M, 1986, CIRCULATION, V74, P469, DOI 10.1161/01.CIR.74.3.469; Cozzolino M, 2010, BLOOD PURIFICAT, V30, P272, DOI 10.1159/000320706; de Jager DJ, 2014, NAT REV NEPHROL, V10, P208, DOI 10.1038/nrneph.2014.8; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; den Hoedt CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061155; Doi K, 2006, J AM SOC NEPHROL, V17, P823, DOI 10.1681/ASN.2005010094; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Ewing MM, 2012, ATHEROSCLEROSIS, V221, P333, DOI 10.1016/j.atherosclerosis.2012.01.037; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Friedman DJ, 2009, J BONE MINER RES, V24, P1847, DOI [10.1359/JBMR.090516, 10.1359/jbmr.090516]; Girndt M, 2002, KIDNEY INT, V62, P949, DOI 10.1046/j.1523-1755.2002.00504.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gungor Y, 2011, RENAL FAILURE, V33, P169, DOI 10.3109/0886022X.2011.552151; He D, 2010, CAN CARD C 2010; Hernesniemi JA, 2008, ATHEROSCLEROSIS, V198, P152, DOI 10.1016/j.atherosclerosis.2007.09.024; Howell WM, 2005, J MED GENET, V42, P485, DOI 10.1136/jmg.2004.025734; Hsiao PJ, 2007, J ENDOCRINOL, V195, P265, DOI 10.1677/JOE-07-0395; Ianni M, 2013, PROSTATE CANCER P D, V16, P56, DOI 10.1038/pcan.2012.30; Jaber BL, 2004, CYTOKINE, V25, P212, DOI 10.1016/j.cyto.2003.11.004; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kim Youngsu, 2008, Korean Journal of Internal Medicine, V23, P201, DOI 10.3904/kjim.2008.23.4.201; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Lin CC, 2010, CLIN J AM SOC NEPHRO, V5, P1805, DOI 10.2215/CJN.01500210; Ma L, 2012, DNA CELL BIOL, V31, P1064, DOI 10.1089/dna.2011.1552; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Marks A, 2013, FAM PRACT, V30, P282, DOI 10.1093/fampra/cms079; Masago K, 2009, CANCER SCI, V100, P1917, DOI 10.1111/j.1349-7006.2009.01253.x; MATAS AJ, 1975, LANCET, V1, P883; Melder RJ, 1996, NAT MED, V2, P992, DOI 10.1038/nm0996-992; Monraats PS, 2007, GENES IMMUN, V8, P44, DOI 10.1038/sj.gene.6364343; Monraats PS, 2010, EXPERT OPIN THER TAR, V14, P243, DOI 10.1517/14728220903520929; Monraats PS, 2005, FASEB J, V19, P1998, DOI 10.1096/fj.05-4634com; Monraats PS, 2005, THROMB HAEMOSTASIS, V93, P564, DOI 10.1160/TH04-11-0708; Oguri M, 2007, INT J MOL MED, V20, P533; Oishi Y, 2010, FASEB J, V24, P1780, DOI 10.1096/fj.09-146589; Pastinen T, 1998, HUM MOL GENET, V7, P1453, DOI 10.1093/hmg/7.9.1453; Pastuszczak M, 2009, POL ARCH MED WEWN, V119, P719, DOI 10.20452/pamw.821; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pons D, 2009, DIS MARKERS, V26, P75, DOI [10.1155/2009/520653, 10.3233/DMA-2009-0609]; Ram S, 2003, J INVEST MED, V51, P19, DOI 10.2310/6650.2003.33522; Regieli JJ, 2009, INT J CARDIOL, V132, P257, DOI 10.1016/j.ijcard.2007.11.100; Sampietro ML, 2011, HUM MOL GENET, V20, P4748, DOI 10.1093/hmg/ddr389; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Shimoyama Y, 2009, AM J NEPHROL, V30, P383, DOI 10.1159/000235686; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Stenvinkel P, 2005, KIDNEY INT, V67, P2383, DOI 10.1111/j.1523-1755.2005.00345.x; Szeto CC, 2004, KIDNEY INT, V65, P1947, DOI 10.1111/j.1523-1755.2004.00605.x; Thethi I, 2012, CLIN APPL THROMB-HEM, V18, P534, DOI 10.1177/1076029611435837; van Dijk PCW, 2001, NEPHROL DIAL TRANSPL, V16, P1120, DOI 10.1093/ndt/16.6.1120; van Tiel CM, 2009, CIRCULATION, V120, P669, DOI 10.1161/CIRCULATIONAHA.108.842179; Verschuren JJW, 2013, CLIN J AM SOC NEPHRO, V8, P1358, DOI 10.2215/CJN.11091012; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; Walker SR, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-228; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; Yuan JZ, 2013, NEPHROL DIAL TRANSPL, V28, P2356, DOI 10.1093/ndt/gft256; Zhou JQ, 2012, THROMB RES, V130, P602, DOI 10.1016/j.thromres.2012.05.023	74	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143079	10.1371/journal.pone.0143079	http://dx.doi.org/10.1371/journal.pone.0143079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587841	gold, Green Published, Green Submitted			2022-12-27	WOS:000365251500028
J	Zhang, JJ; Chen, G; Li, WR; Xu, TM; Gao, XM				Zhang, Jingjing; Chen, Gui; Li, Weiran; Xu, Tianmin; Gao, Xuemei			Upper Airway Changes after Orthodontic Extraction Treatment in Adults: A Preliminary Study using Cone Beam Computed Tomography	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; BIMAXILLARY PROTRUSION; CHINESE PATIENTS; MORPHOLOGY; OUTCOMES; CBCT; ADVANCEMENT; CAMOUFLAGE; POSITION; OBESITY	Objective Whether the orthodontic treatment with premolar extraction and maximum anchorage in adults will lead to a narrowed upper airway remains under debated. The study aims to investigate the airway changes after orthodontic extraction treatment in adult patients with Class II and hyperdivergent skeletal malocclusion. Materials and Methods This retrospective study enrolled 18 adults with Class II and hyperdivergent skeletal malocclusion (5 males and 13 females, 24.1 +/- 3.8 years of age, BMI 20.33 +/- 1.77 kg/m(2)). And 18 untreated controls were matched 1: 1 with the treated patients for age, sex, BMI, and skeletal pattern. CBCT images before and after treatment were obtained. DOLPHIN 11.7 software was used to reconstruct and measure the airway size, hyoid position, and craniofacial structures. Changes in the airway and craniofacial parameters from pre to post treatment were assessed by Wilcoxon signed rank test. Mann-Whitney U test was used in comparisons of the airway parameters between the treated patients and the untreated controls. Significant level was set at 0.05. Results The upper and lower incisors retracted 7.87 mm and 6.10 mm based on the measurement of U1-VRL and L1-VRL (P < 0.01), while the positions of the upper and lower molars (U6-VRL, and L6-VRL) remained stable. Volume, height, and cross-sectional area of the airway were not significantly changed after treatment, while the sagittal dimensions of SPP-SPPW, U-MPW, PAS, and V-LPW were significantly decreased (P < 0.05), and the morphology of the cross sections passing through SPP-SPPW, U-MPW, PAS, and V-LPW became anteroposteriorly compressed (P < 0.001). No significant differences in the airway volume, height, and cross-sectional area were found between the treated patients and untreated controls. Conclusions The airway changes after orthodontic treatment with premolar extraction and maximum anchorage in adults are mainly morphological changes with anteroposterior dimension compressed in airway cross sections, rather than a decrease in size.	[Zhang, Jingjing; Chen, Gui; Li, Weiran; Xu, Tianmin; Gao, Xuemei] Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University	Gao, XM (corresponding author), Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	xmgao@263.net	Li, weiran/R-6769-2019; Zhang, Jing/HII-4294-2022		National Natural Science Foundation of China [81470272]; Seeding Grant for Medicine and Engineering Sciences of Peking University [BMU20140397]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Seeding Grant for Medicine and Engineering Sciences of Peking University	The study was partly supported by National Natural Science Foundation of China (81470272, recipient XG) and the Seeding Grant for Medicine and Engineering Sciences of Peking University (BMU20140397, recipient XG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al ME, 2012, ANGLE ORTHOD, V82, P853, DOI [10.2319/10711-646.1, DOI 10.2319/101711-646.1]; Alsufyani NA, 2013, SLEEP BREATH, V17, P911, DOI 10.1007/s11325-012-0799-7; [Anonymous], 1940, STAT METHODS MED BIO; [Anonymous], 1907, TREATMENT MALOCCLUSI; Chen X, 2015, PLOS ONE, V10; Chen Y, 2012, ANGLE ORTHOD, V82, P964, DOI 10.2319/110211-675.1; Cordasco G, 2012, INT J PEDIATR OTORHI, V76, P1547, DOI 10.1016/j.ijporl.2012.07.008; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; Demir A, 2005, EUR J ORTHODONT, V27, P524, DOI 10.1093/ejo/cji046; Deng JR, 2012, SLEEP BREATH, V16, P1219, DOI 10.1007/s11325-011-0636-4; Fastuca R, 2014, PROG ORTHOD, V15, DOI 10.1186/s40510-014-0040-2; Germec-Cakan D, 2011, EUR J ORTHODONT, V33, P515, DOI 10.1093/ejo/cjq109; Guven O, 2005, J CRANIOFAC SURG, V16, P23; Hiyama S, 2001, AM J ORTHOD DENTOFAC, V120, P160, DOI 10.1067/mod.2001.113788; Katyal V, 2013, AM J ORTHOD DENTOFAC, V143, P20, DOI 10.1016/j.ajodo.2012.08.021; Kikuchi Makoto, 2005, Sleep Breath, V9, P146, DOI 10.1007/s11325-005-0028-8; Kim JS, 2013, J ORAL MAXILLOFAC SU, V71, P1601; Lee RWW, 2010, SLEEP, V33, P1075, DOI 10.1093/sleep/33.8.1075; Lenza MG, 2010, ORTHOD CRANIOFAC RES, V13, P96, DOI 10.1111/j.1601-6343.2010.01482.x; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094378; Liu SR, 2012, INT J ORAL MAX SURG, V41, P1112, DOI 10.1016/j.ijom.2012.03.011; Mihalik CA, 2003, AM J ORTHOD DENTOFAC, V123, P266, DOI 10.1067/mod.2003.43; PROFFIT WR, 1992, AM J ORTHOD DENTOFAC, V101, P556, DOI 10.1016/0889-5406(92)70131-S; Raffaini M, 2013, J CRANIO MAXILL SURG, V41, P552, DOI 10.1016/j.jcms.2012.11.022; Roedig JJ, 2014, J CLIN SLEEP MED, V10, P397, DOI 10.5664/jcsm.3614; Schendel SA, 2012, J ORAL MAXIL SURG, V70, P2174, DOI 10.1016/j.joms.2011.10.013; Sharma Krishna, 2014, Contemp Clin Dent, V5, P190, DOI 10.4103/0976-237X.132314; Stefanovic N, 2013, ORTHOD CRANIOFAC RES, V16, P87, DOI 10.1111/ocr.12009; Sutherland K, 2012, RESPIROLOGY, V17, P213, DOI 10.1111/j.1440-1843.2011.02082.x; Wang QZ, 2012, ANGLE ORTHOD, V82, P115, DOI 10.2319/011011-13.1; Zicari AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111675	31	15	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143233	10.1371/journal.pone.0143233	http://dx.doi.org/10.1371/journal.pone.0143233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588714	Green Published, gold, Green Submitted			2022-12-27	WOS:000365251500041
J	di Sciara, GN; Lauriano, G; Pierantonio, N; Canadas, A; Donovan, G; Panigada, S				di Sciara, Giuseppe Notarbartolo; Lauriano, Giancarlo; Pierantonio, Nino; Canadas, Ana; Donovan, Greg; Panigada, Simone			The Devil We Don't Know: Investigating Habitat and Abundance of Endangered Giant Devil Rays in the North-Western Mediterranean Sea	PLOS ONE			English	Article							DIVING BEHAVIOR; BASKING SHARKS; AERIAL SURVEY; GULF; CONSERVATION; WHALES; TOOL	The giant devil ray Mobula mobular, the only Mediterranean mobulid, is subject to mortality caused by directed and accidental captures in fisheries throughout the region. Whilst the combination of human impacts, limited range and a low reproductive potential is not inconsistent with its endangered listing, there are insufficient data to enable a quantitative assessment of trends. Without this, it is difficult to assess and prioritise threats and develop effective conservation actions. Using results from aerial surveys conducted between 2009 and 2014 over the Ligurian, Corsican, Sardinian, northern and central Tyrrhenian seas (626,228 km(2)), this study provides the first quantitative information on giant devil ray abundance and habitat choice in the western Mediterranean. Devil rays were observed in all seasons except winter, with their estimated abundance in the study area peaking in summer. The overall uncorrected mean density in the study area during summer was estimated at 0.0257 individuals km(-2) (range: 0.017-0.044), resulting in a total abundance estimate of 6,092 (12.7%CV) individuals at the surface; once corrected for availability bias, this estimate indicates a summer presence of >12,700 devil rays in the study area. Rays were mostly observed alone even if occasionally, larger aggregations up to a maximum of 18 individuals were observed. Although observed throughout the study area, spatial modelling identified their preferred habitat to be over a broad strip connecting the Tuscan Archipelago to Eastern Sardinia, over a wide range of water depths ranging from 10 to 2000m. The observed seasonal changes in giant devil ray distribution in this study, combined with similar evidence from other areas in the Mediterranean, support the hypothesis that the species undertakes latitudinal migrations across the region, taking advantage of highly productive waters in the north during summer, and warmer southern waters during winter.	[di Sciara, Giuseppe Notarbartolo; Pierantonio, Nino; Panigada, Simone] Tethys Res Inst, I-20121 Milan, Italy; [Lauriano, Giancarlo] Ist Super Protez & Ric Ambientale, I-00144 Rome, Italy; [Canadas, Ana] ALNILAM Res & Conservat Ltd, Madrid 28240, Spain; [Donovan, Greg] Int Whaling Commiss, Cambridge CB24 9NP, England	Italian Institute for Environmental Protection & Research (ISPRA)	di Sciara, GN (corresponding author), Tethys Res Inst, Viale GB Gadio 2, I-20121 Milan, Italy.	disciara@tethys.org	di Sciara, Giuseppe Notarbartolo/P-8906-2019; Canadas, Ana/AAA-5761-2019; Lauriano, Giancarlo/ABG-8461-2021; Pierantonio, Nino/AAO-7663-2020	Pierantonio, Nino/0000-0002-1210-8831; Notarbartolo di Sciara, Giuseppe/0000-0003-0353-617X	Italian Ministry of the Environment ("Ministero dell'ambiente e della tutela del territorio e del mare")	Italian Ministry of the Environment ("Ministero dell'ambiente e della tutela del territorio e del mare")	Aerial surveys for the monitoring of cetacean populations in the study area, which provided the opportunity for giant devil ray observations described in this paper, were funded by the Italian Ministry of the Environment ("Ministero dell'ambiente e della tutela del territorio e del mare"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudaya M, 2014, ASSESSMENT GAZA FISH; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akyol O, 2005, TURK J VET ANIM SCI, V29, P1225; Alexander RL, 1996, ZOOL J LINN SOC-LOND, V118, P151, DOI 10.1111/j.1096-3642.1996.tb00224.x; [Anonymous], THESIS; Banaru D, 2010, J OCEAN RES DATA, V3, P33; Bello Giambattista, 1999, Acta Adriatica, V40, P65; Bigelow HB, 1953, MEMOIR SEARS FDN M 2, VI; BINI G, 1967, ATLANTE PESCI COSTE, V1; Boero F., 1979, Bollettino dei Musei e degli Istituti Biologici dell'Universita di Genova, V47, P27; Bradai MN, 2001, CYBIUM, V25, P389; Braun CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088170; Buckland S.T., 2001, pi; Burks CM, 2006, FISH B-NOAA, V104, P579; Canadas A., 2008, Endangered Species Research, V4, P309, DOI 10.3354/esr00073; Canadas A., 2006, Journal of Cetacean Research and Management, V8, P13; Canese Simonepietro, 2011, Endangered Species Research, V14, P171, DOI 10.3354/esr00349; CASANOVA B, 1970, Revue des Travaux de l'Institut des Peches Maritimes, V34, P205; Cavanagh R.D., 2007, OVERVIEW CONSERVATIO; Celona Antonio, 2004, Annales Series Historia Naturalis, V14, P11; Cornax MJ, 2007, THONAILLE USE DRIFTN; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Croll DA, 2012, MAR ECOL PROG SER, V465, P193, DOI 10.3354/meps09900; Dicken ML, 2013, MAR FRESHWATER RES, V64, P530, DOI 10.1071/MF12336; Druon JN, 2012, MAR ECOL PROG SER, V464, P289, DOI 10.3354/meps09810; Dulvy NK, 2014, PEERJ, V2, DOI 10.7717/peerj.400; Ebert D.A., 2013, FAO SPECIES CAT FISH, V7, P1; Fortuna CM, 2014, SCI MAR, V78, P227, DOI 10.3989/scimar.03920.30D; Hedley Sharon L., 1999, Journal of Cetacean Research and Management, V1, P255; Heide-Jorgensen M. P., 2012, Journal of Cetacean Research and Management, V12, P1; Hemida Farid, 2002, Acta Adriatica, V43, P69; Hillyer E.V., 1989, COPEIA, V1989, P607; Holcer D, 2013, J APPL ICHTHYOL, V29, P139, DOI 10.1111/jai.12034; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; JACQUES G, 1989, B SOC ZOOL FR, V114, P17; Kessel ST, 2013, J MAR BIOL, V2013, P1, DOI DOI 10.1155/2013/597383; Lauriano G, 2014, MAR ENVIRON RES, V100, P86, DOI 10.1016/j.marenvres.2014.04.001; Marano G., 1983, THALASSIA SALENTINA, V13, P50; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques FFC, 2004, ADV DISTANCE SAMPLIN; Mauchline J., 1980, ADV MAR BIOL, P3; Munoz-Chapuli R, 1994, P 2 EUR SHARK RAY WO; Northridge S.P., 1991, 320 FAO; Notarbartolo di Sciara G, 1988, ATTI SOC ITAL SCI NA, V129, P396; Notarbartolo di Sciara G, 2006, IUCN RED LIST THREAT; Notarbartolo-Di-Sciara G, 2008, AQUAT CONSERV, V18, P367, DOI 10.1002/aqc.855; NOTARBARTOLODISCIARA G, 1987, ZOOL J LINN SOC-LOND, V91, P1, DOI 10.1111/j.1096-3642.1987.tb01723.x; Orsi Relini L., 1992, RAPP COMM INT MER ME, V33, P263; Orsi Relini L, 1999, BIOL MAR MEDIT, V6, P100; Panigada S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022878; RAMSEY FL, 1987, BIOMETRICS, V43, P1, DOI 10.2307/2531943; Rowat D, 2009, J EXP MAR BIOL ECOL, V368, P1, DOI 10.1016/j.jembe.2008.09.001; Scacco U., 2009, Marine Biodiversity Records, V2, pe93, DOI 10.1017/S1755267209001110; Silvi S, 1981, MONDO SOMMERSO, V251, P56; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Storai T, 2011, FISH RES, V109, P74, DOI 10.1016/j.fishres.2011.01.018; Thomas L., 2009, DISTANCE 6 0 RELEASE; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thorrold SR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5274; Walker Paddy, 2005, P71; Wilson SG, 2004, FISH OCEANOGR, V13, P283, DOI 10.1111/j.1365-2419.2004.00292.x; Wilson SK, 2005, MAR BIOL, V147, P179, DOI 10.1007/s00227-005-1556-2; Wood S., 2006, TECHNICAL REPORT; Wood S.N., 2001, R R NEWS, V1, P20; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240	65	15	16	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141189	10.1371/journal.pone.0141189	http://dx.doi.org/10.1371/journal.pone.0141189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580814	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600012
J	IJsseldijk, LL; Leopold, MF; Rebolledo, ELB; Deaville, R; Haelters, J; Ijzer, J; Jepson, PD; Grone, A				IJsseldijk, Lonneke L.; Leopold, Mardik F.; Rebolledo, Elisa L. Bravo; Deaville, Rob; Haelters, Jan; Ijzer, Jooske; Jepson, Paul D.; Grone, Andrea			Fatal Asphyxiation in Two Long-Finned Pilot Whales (Globicephala melas) Caused by Common Soles (Solea solea)	PLOS ONE			English	Article							PORPOISES PHOCOENA-PHOCOENA; STOMACH CONTENTS; ATLANTIC; NORTH	Long-finned pilot whales (Globicephala melas) are rare visitors to the southern North Sea, but recently two individual strandings occurred on the Dutch coast. Both animals shared the same, unusual cause of death: asphyxiation from a common sole (Solea solea) stuck in their nasal cavity. This is a rare cause of death in cetaceans. Whilst asphyxiation has been reported in smaller odontocetes, there are no recent records of this occurring in Globicephala species. Here we report the stranding, necropsy and diet study results as well as discuss the unusual nature of this phenomenon. Flatfish are not a primary prey species for pilot whales and are rarely eaten by other cetaceans, such as harbour porpoises (Phocoena phocoena), in which there are several reports of asphyxiation due to airway obstruction by soles. This risk may be due to the fish's flexible bodies which can enter small cavities either actively in an attempt to escape or passively due to the whale 'coughing' or 'sneezing' to rid itself of the blockage of the trachea. It is also possible that the fish enter the airways whilst the whale is re-articulating the larynx after trying to ingest large, oddly shaped prey. It is unlikely that the soles entered the airways after the death of the whales and we believe therefore that they are responsible for the death of these animals.	[IJsseldijk, Lonneke L.; Ijzer, Jooske; Grone, Andrea] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Leopold, Mardik F.; Rebolledo, Elisa L. Bravo] Wageningen IMARES, Dept Ecosyst, Den Burg, Texel, Netherlands; [Deaville, Rob; Jepson, Paul D.] Zool Soc London, Inst Zool, UK Cetacean Strandings Invest Programme, London NW1 4RY, England; [Haelters, Jan] RBINS, Operat Directorate Nat Environm, Oostende, Belgium	Utrecht University; Wageningen University & Research; Zoological Society of London	IJsseldijk, LL (corresponding author), Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands.	L.L.IJsseldijk@uu.nl	Leopold, Mardik/AAE-4679-2020					[Anonymous], VISBOECK; Benke H, 1998, ARCH FISH MAR RES, V46, P97; Bloch Dorete, 1993, Reports of the International Whaling Commission Special Issue, V14, P163; Bolin V, 2014, IRISH NAT J, V33, P155; BRABER L, 1973, Netherlands Journal of Sea Research, V6, P163, DOI 10.1016/0077-7579(73)90011-2; Buckland S.T., 1993, Reports of the International Whaling Commission Special Issue, V14, P33; Byard Roger W, 2003, J Clin Forensic Med, V10, P85, DOI 10.1016/S1353-1131(03)00009-9; Byard RW, 2010, FORENSIC SCI MED PAT, V6, P207, DOI 10.1007/s12024-010-9143-3; Camphuysen C. J., 2006, WHALES DOLPHINS N SE; De Heij A., 2005, Basteria, V69, P91; De Pierrepont JF, 2005, J MAR BIOL ASSOC UK, V85, P1539, DOI 10.1017/S0025315405012762; Desportes Genevieve, 1993, Reports of the International Whaling Commission Special Issue, V14, P305; Fullard KJ, 2000, MOL ECOL, V9, P949, DOI 10.1046/j.1365-294x.2000.00957.x; Gannon DP, 1997, MAR ECOL PROG SER, V148, P1, DOI 10.3354/meps148001; Gannon DP, 1997, MAR MAMMAL SCI, V13, P405, DOI 10.1111/j.1748-7692.1997.tb00648.x; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; HULT R W, 1980, Cetology, P1; Jansen O. E, 2013, THESIS; KRUUK H, 1963, NETH J SEA RES, V2, P1; Kuiken T, 1991, P ESC WORKSH LEID; Leopold M.F., 2001, OTOLITHS N SEA FISH; Leopold MF, 2015, J SEA RES, V97, P14, DOI 10.1016/j.seares.2014.12.005; Mignucci-Giannoni Antonio A., 2009, Aquatic Mammals, V35, P48, DOI 10.1578/AM.35.1.2009.48; Monteiro S, 2015, 29 ECS C 23 25 MARCH; OIE, 2012, MAN DIAGN TESTS VACC, V1; Olson PA, 2008, ENCY MARINE MAMMALS; OVERHOLTZ WJ, 1991, FISH B-NOAA, V89, P723; Perkins M, 2015, 29 ECS C 23 25 MARCH; Reid J.B., 2003, ATLAS CETACEAN DISTR; REIDENBERG JS, 1987, ANAT RECORD, V218, P98, DOI 10.1002/ar.1092180115; Sergeant DE, 1962, B FISH RES BD CANADA, V132, P1; Shirihai H, 2006, WHALES DOLPHINS SEAL; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Siebert U, 1993, UNTERSUCHUNGEN UNPUB; Sigurjonsson Johann, 1993, Reports of the International Whaling Commission Special Issue, V14, P407; Simon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115815; Spitz J., 2010, THESIS; Stolen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066828; Taylor B. L., 2008, IUCN RED LIST THREAT; van Egmond F, 2008, VISBOEK WERELD VOLGE; Watson Alastair, 2005, Aquatic Mammals, V31, P447, DOI 10.1578/AM.31.4.2005.447	41	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141951	10.1371/journal.pone.0141951	http://dx.doi.org/10.1371/journal.pone.0141951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580786	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600030
J	Jia, WJ; Wu, JN; Jia, HX; Yang, YP; Zhang, XL; Chen, K; Su, FX				Jia, Weijuan; Wu, Jiannan; Jia, Haixia; Yang, Yaping; Zhang, Xiaolan; Chen, Kai; Su, Fengxi			The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PROGNOSTIC VALUE; GENE-EXPRESSION; IMMUNE CELLS; CHEMOTHERAPY; RECURRENCE; MARKERS	Purpose The peripheral hematologic parameters of patients can be prognostic for many malignant tumors, including breast cancer, although their value has not been investigated among the different molecular subtypes of breast cancer. The purpose of this study was to examine the prognostic significance of the neutrophil-to-lymphocyte ratio (NLR) and the lymphocyte-to-monocyte ratio (LMR) in different molecular subtypes of breast cancer. Methods A retrospective cohort of 1570 operable breast cancer patients was recruited between January 2000 and December 2010. The counts of peripheral neutrophils, lymphocytes, monocytes and platelets were collected and applied to calculate the NLR and the LMR. Univariate and multivariate Cox proportional hazard analyses were used to assess the relationship of the NLR and the LMR with disease-free survival (DFS) and overall survival (OS) in all patients and triple negative breast cancer (TNBC) patients. Results Univariate analysis revealed that lower NLR (<= 2.0) and higher LMR (>4.8) were significantly associated with superior DFS in all patients (NLR, P = 0.005; LMR, P = 0.041) and in TNBC patients (NLR, p = 0.007; LMR, P = 0.011). However, multivariate analysis revealed that only lower NLR was a significant independent predictor of superior DFS and OS in all breast cancer patients (DFS, HR = 1.50 95% CI: 1.14-1.97, P = 0.004; OS, HR = 1.63, 95% CI: 1.07-2.49, P = 0.022) and in TNBC patients (DFS, HR = 2.58, 95% CI: 1.23-5.42, P = 0.012; OS, HR = 3.05, 95% CI: 1.08-8.61, P = 0.035). Both univariate and multivariate analysis revealed that neither the NLR nor the LMR significantly predicted DFS and OS among the patients with other molecular subtypes of breast cancer. Conclusions A higher pretreatment peripheral NLR significantly and independently indicated a poor prognosis for breast cancer and TNBC, and this measurement exhibited greater prognostic value than a lower LMR. The NLR was not a prognostic factor for other breast cancer subtypes.	[Jia, Weijuan; Su, Fengxi] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weijuan; Wu, Jiannan; Yang, Yaping; Zhang, Xiaolan; Chen, Kai; Su, Fengxi] Sun Yat Sen Univ, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Haixia] Guangzhou Med Univ, Dept Breast Surg, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Su, FX (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	fengxisu@vip.163.com	Wu, Jiannan/AAD-9358-2019		National Natural Science Foundation of China [81372817]; key laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013] 163]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes [KLB09001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes	This work was supported by National Natural Science Foundation of China (Grant number: 81372817; http://www.nsfc.gov.cn/) to FS; Grant [2013] 163 from key laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grant [2013] 163 from key laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes.	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Azab B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0432-4; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Buyukkaya E, 2014, CLIN APPL THROMB-HEM, V20, P159, DOI 10.1177/1076029612459675; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Deyarmin B, 2013, ANN SURG ONCOL, V20, P87, DOI 10.1245/s10434-012-2588-8; Donskov F, 2013, SEMIN CANCER BIOL, V23, P200, DOI 10.1016/j.semcancer.2013.02.001; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Engel JB, 2014, ARCH GYNECOL OBSTET, V289, P141, DOI 10.1007/s00404-013-2922-9; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Forget P, 2014, BRIT J ANAESTH, V113, P82, DOI 10.1093/bja/aet464; Forget P, 2013, ANN SURG ONCOL, V20, pS650, DOI 10.1245/s10434-013-3136-x; Forget P, 2010, ANESTH ANALG, V110, P1630, DOI 10.1213/ANE.0b013e3181d2ad07; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Guiu S, 2013, BREAST, V22, P301, DOI 10.1016/j.breast.2012.07.012; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hiller JG, 2015, CURRENT ANESTHESIOLO, V5, P291; Huang SH, 2014, CANCER; Iwamoto T, 2012, J CLIN ONCOL, V30, P729, DOI 10.1200/JCO.2011.36.2574; Khoshnoud MR, 2011, BREAST CANCER RES TR, V126, P421, DOI 10.1007/s10549-010-1202-7; Kilincalp S, 2014, EUR J CANC PREV; LI J, 2013, PLOS ONE, V8, P83069, DOI DOI 10.1371/JOURNAL.PONE.0054839; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Lorente D, 2015, ANN ONCOL, V26, P750, DOI 10.1093/annonc/mdu587; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Malyguine AM, 2012, CANCER IMMUNOL IMMUN, V61, P239, DOI 10.1007/s00262-011-1148-6; Masood S, 2005, CLIN LAB MED, V25, P809, DOI 10.1016/j.cll.2005.08.012; Matsumoto H, 2015, J CLIN PATHOL; Melichar B, 2013, CLIN CHEM LAB MED, V51, P99, DOI 10.1515/cclm-2012-0496; Molina R, 2005, TUMOR BIOL, V26, P281, DOI 10.1159/000089260; Ni XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111886; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Porrata LF, 2013, BONE MARROW RES, DOI 10.1155/2013/658371; Prabhu JS, 2014, J CANCER, V5, P156, DOI 10.7150/jca.7668; Retsky M, 2012, BREAST CANCER RES TR, V134, P881, DOI 10.1007/s10549-012-2094-5; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Yao MY, 2014, ONCOTARGETS THER, V7, P1743, DOI 10.2147/OTT.S69657; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	40	68	69	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143061	10.1371/journal.pone.0143061	http://dx.doi.org/10.1371/journal.pone.0143061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580962	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600074
J	Perez-Barberia, FJ; Small, M; Hooper, RJ; Aldezabal, A; Soriguer-Escofet, R; Bakken, GS; Gordon, IJ				Perez-Barberia, F. J.; Small, M.; Hooper, R. J.; Aldezabal, A.; Soriguer-Escofet, R.; Bakken, G. S.; Gordon, I. J.			State-Space Modelling of the Drivers of Movement Behaviour in Sympatric Species	PLOS ONE			English	Article							STANDARD OPERATIVE TEMPERATURE; RED DEER; SEXUAL SEGREGATION; LARGE HERBIVORES; GRAZING IMPACTS; SOCIAL RANK; MULE DEER; SHEEP; DENSITY; CATTLE	Understanding animal movement behaviour is key to furthering our knowledge on intra- and inter-specific competition, group cohesion, energy expenditure, habitat use, the spread of zoonotic diseases or species management. We used a radial basis function surface approximation subject to minimum description length constraint to uncover the state-space dynamical systems from time series data. This approximation allowed us to infer structure from a mathematical model of the movement behaviour of sheep and red deer, and the effect of density, thermal stress and vegetation type. Animal movement was recorded using GPS collars deployed in sheep and deer grazing a large experimental plot in winter and summer. Information on the thermal stress to which animals were exposed was estimated using the power consumption of mechanical heated models and meteorological records of a network of stations in the plot. Thermal stress was higher in deer than in sheep, with less differences between species in summer. Deer travelled more distance than sheep, and both species travelled more in summer than in winter; deer travel distance showed less seasonal differences than sheep. Animal movement was better predicted in deer than in sheep and in winter than in summer; both species showed a swarming behaviour in group cohesion, stronger in deer. At shorter separation distances swarming repulsion was stronger between species than within species. At longer separation distances inter-specific attraction was weaker than intra-specific; there was a positive density-dependent effect on swarming, and stronger in deer than in sheep. There was not clear evidence which species attracted or repelled the other; attraction between deer at long separation distances was stronger when the model accounted for thermal stress, but in general the dynamic movement behaviour was hardly affected by the thermal stress. Vegetation type affected intra-species interactions but had little effect on inter-species interactions. Our modelling approach is useful in interpreting animal interactions, in order to unravel complex cooperative or competitive behaviours, and to the best of our knowledge is the first modelling attempt to make predictions of multi-species animal movement under different habitat mosaics and abiotic environmental conditions.	[Perez-Barberia, F. J.] Univ Cordoba, Ungulate Res Unit, CRCP, Cordoba, Spain; [Perez-Barberia, F. J.] CSIC, Grp PAIDI RNM118, Estn Biol Donana, Seville 41092, Spain; [Perez-Barberia, F. J.; Hooper, R. J.] James Hutton Inst, Aberdeen AB15 8QH, Scotland; [Small, M.] Univ Western Australia, Sch Math & Stat, Crawley, WA 6009, Australia; [Aldezabal, A.] Euskal Herriko Unibertsitatea UPV EHU, Zientzia & Teknol Fak, Landare Biol & Ekol Saila, Euskal Herria 48080, Bizkaia, Spain; [Soriguer-Escofet, R.] CSIC, Estn Biol Donana, Seville 41013, Spain; [Bakken, G. S.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA; [Gordon, I. J.] James Cook Univ, Trop Environm & Soc, Townsville, Qld 4811, Australia	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); James Hutton Institute; University of Western Australia; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Indiana State University; James Cook University	Perez-Barberia, FJ (corresponding author), Univ Cordoba, Ungulate Res Unit, CRCP, Cordoba, Spain.	j.perezbarberia@gmail.com	Aldezabal, Arantza/V-7930-2017; Perez-Barberia, Javier/M-9847-2017; Gordon, Iain/S-8076-2019; Gordon, Iain J/K-8636-2012; Small, Michael/C-9807-2010; Casimiro-Soriguer, Ramon/J-1494-2014	Aldezabal, Arantza/0000-0001-7917-7690; Perez-Barberia, Javier/0000-0001-7513-5418; Gordon, Iain/0000-0001-9704-0946; Gordon, Iain J/0000-0001-9704-0946; Small, Michael/0000-0001-5378-1582; Casimiro-Soriguer, Ramon/0000-0002-9165-7766	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); 434 Leonardo da Vinci programme (European Commission); Australian Research Council [FT110100896, DP140100203]; University of Granada (Andalucia, Spain); Leonardo da Vinci programme (European Commission); NERC [BIGF010001] Funding Source: UKRI; Natural Environment Research Council [BIGF010001] Funding Source: researchfish	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); 434 Leonardo da Vinci programme (European Commission)(European Commission); Australian Research Council(Australian Research Council); University of Granada (Andalucia, Spain); Leonardo da Vinci programme (European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD), and the 434 Leonardo da Vinci programme (European Commission) provided grant-holders that assisted this study. MS is supported by an Australian Research Council Future Fellowship (FT110100896) and Discovery Project (DP140100203). FJP-B was granted a visiting researcher fellowship by University of Granada (Andalucia, Spain) when writing this paper.; This study is dedicated to the memory of our colleague Dr. Simon Thirgood, who died in his beloved Africa when working on conservation projects. We thank Glensaugh Experimental Field Station's staff for looking after the animals and providing logistic support. Alessandro Gimona who provided us with the kriging function and advice on the analysis, and Adrian Baddeley who helped us with the use of Spatstat software. The services of the Natural Environment Research Council (NERC) British Isles continuous GNSS Facility (BIGF), www.bigf.ac.uk, in providing archived GNSS data to this project, are gratefully acknowledged. The work was funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD), and the Leonardo da Vinci programme (European Commission) provided grant-holders that assisted this study. MS is supported by an Australian Research Council Future Fellowship (FT110100896) and Discovery Project (DP140100203).	AFRC, 1993, ENERGY PROTEIN REQUI; ALADOS CL, 1987, BIOL BEHAV, V12, P245; Albon SD, 2007, J APPL ECOL, V44, P1176, DOI 10.1111/j.1365-2664.2007.01318.x; [Anonymous], 1962, ENERGY METABOLISM RU; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BAKKEN GS, 1981, J THERM BIOL, V6, P23, DOI 10.1016/0306-4565(81)90038-3; BAKKEN GS, 1992, AM ZOOL, V32, P194; BAKKEN GS, 1985, AM ZOOL, V25, P933; Beaver JM, 1996, J THERM BIOL, V21, P345, DOI 10.1016/S0306-4565(96)00020-4; Bon R, 1996, BEHAV PROCESS, V38, P131, DOI 10.1016/S0376-6357(96)00029-0; Bonenfant C, 2007, ECOLOGY, V88, P3202, DOI 10.1890/07-0129.1; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Cain JW, 2008, J ARID ENVIRON, V72, P1518, DOI 10.1016/j.jaridenv.2008.02.010; Chan KS, 2005, OECOLOGIA, V145, P556, DOI 10.1007/s00442-005-0157-6; Clutton-Brock T. H., 1989, RED DEER HIGHLANDS; Clutton-Brock TH, 2004, NATURE, V429, P261, DOI 10.1038/429261a; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Conradt L, 1999, OECOLOGIA, V119, P367, DOI 10.1007/s004420050797; Conradt L, 2004, HABITAT SEGREGATION; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; CRAWFORD KM, 1983, ECOLOGY, V64, P989, DOI 10.2307/1937806; Debeffe L, 2013, ANIM BEHAV, V86, P143, DOI 10.1016/j.anbehav.2013.05.005; Deer Commission for Scotland, 2002, DEER COMM SCOTL ANN; Dennis P, 2008, J APPL ECOL, V45, P279, DOI 10.1111/j.1365-2664.2007.01378.x; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; Duncan AJ, 2001, ANIM SCI, V73, P563, DOI 10.1017/S1357729800058537; Dussault C, 2004, ECOSCIENCE, V11, P321, DOI 10.1080/11956860.2004.11682839; Dzialowski EM, 2005, J THERM BIOL, V30, P317, DOI 10.1016/j.jtherbio.2005.01.005; ESRI (Environmental Systems Resource Institute), 2009, ARCMAP 9 3; Evans DM, 2006, BIOL LETTERS, V2, P636, DOI 10.1098/rsbl.2006.0543; Farnsworth KD, 2002, AM NAT, V159, P24, DOI 10.1086/324114; Fernandez-Moran J, 1997, VET PARASITOL, V73, P163, DOI 10.1016/S0304-4017(97)00061-7; Ferretti F, 2011, EUR J WILDLIFE RES, V57, P775, DOI 10.1007/s10344-010-0487-5; Focardi S, 2006, ECOGRAPHY, V29, P407, DOI 10.1111/j.2006.0906-7590.04442.x; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; GRANT SA, 1976, J APPL ECOL, V13, P857, DOI 10.2307/2402261; Hester AJ, 1999, J APPL ECOL, V36, P133, DOI 10.1046/j.1365-2664.1999.00387.x; Holdo RM, 2007, J ECOL, V95, P115, DOI 10.1111/j.1365-2745.2006.01192.x; Houseal GA, 1995, CAN J ANIM SCI, V75, P501, DOI 10.4141/cjas95-076; Jennings DJ, 2004, ANIM BEHAV, V68, P213, DOI 10.1016/j.anbehav.2003.11.005; JUDD K, 1995, PHYSICA D, V82, P426, DOI 10.1016/0167-2789(95)00050-E; Kattas GD, 2013, ACTA ETHOL, V16, P21, DOI 10.1007/s10211-012-0134-0; Kattas GD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002449; Keating KA, 2007, J WILDLIFE MANAGE, V71, P1344, DOI 10.2193/2006-359; Keren EN, 2006, J THERM BIOL, V31, P371, DOI 10.1016/j.jtherbio.2005.11.029; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; KLEIN DR, 1994, OECOLOGIA, V97, P439, DOI 10.1007/BF00325880; Knoche S, 2012, J WILDLIFE MANAGE, V76, P462, DOI 10.1002/jwmg.302; Komer C, 2004, AMBIO, V13, P11; Kuznetsova A., 2013, LMERTEST TESTS RANDO; Latham J, 1999, FOREST ECOL MANAG, V120, P13, DOI 10.1016/S0378-1127(98)00539-8; MacMillan D, 2004, J ENVIRON MANAGE, V71, P261, DOI 10.1016/j.jenvman.2004.03.005; MASTELLER MA, 1988, CAN J ZOOL, V66, P2585, DOI 10.1139/z88-381; McLeod D, 2002, F99AC402A SCOTT NAT; MERRILL EH, 1991, APPL ANIM BEHAV SCI, V29, P251, DOI 10.1016/0168-1591(91)90252-S; MILNE JA, 1978, BRIT J NUTR, V40, P347, DOI 10.1079/BJN19780131; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Morris DW, 2003, EVOL ECOL, V17, P393, DOI 10.1023/A:1027304601301; Mysterud A, 2007, APPL ANIM BEHAV SCI, V108, P104, DOI 10.1016/j.applanim.2006.10.017; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nores C, 2009, CANTABRIAN CHAMOIS R, P338; Palmer SCF, 2003, ECOLOGY, V84, P2877, DOI 10.1890/02-0245; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Perez-Barberia FJ, 2007, ECOL MONOGR, V77, P631, DOI 10.1890/06-2088.1; Perez-Barberia FJ, 2013, OECOLOGIA, V173, P837, DOI 10.1007/s00442-013-2686-8; Perez-Barberia F.J., 2009, CONSERVACI N GESTI N, V1st, P106; Perez-Barberia FJ, 2002, EVOLUTION, V56, P1276; Pollock ML, 2013, RANGELAND ECOL MANAG, V66, P387, DOI 10.2111/REM-D-11-00123.1; Poudyal Neelam C., 2012, Human Dimensions of Wildlife, V17, P141, DOI 10.1080/10871209.2011.604666; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Richard E, 2010, OECOLOGIA, V163, P91, DOI 10.1007/s00442-009-1538-z; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rodriguez O, 2009, CANTABRIAN CHAMOIS R, P270; SCHAEFER JA, 1995, OECOLOGIA, V104, P39, DOI 10.1007/BF00365560; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Skarpe Christina, 2008, V195, P217, DOI 10.1007/978-3-540-72422-3_9; Small M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066701; Sokal RR, 1995, BIOMETRY; Stenseth NC, 2004, P ROY SOC B-BIOL SCI, V271, P1985, DOI 10.1098/rspb.2004.2794; Stewart KM, 2009, OECOLOGIA, V161, P303, DOI 10.1007/s00442-009-1376-z; Stewart KM, 2002, J MAMMAL, V83, P229, DOI 10.1644/1545-1542(2002)083&lt;0229:TDOEMD&gt;2.0.CO;2; Taillon J, 2007, ANIM BEHAV, V74, P265, DOI 10.1016/j.anbehav.2006.11.018; van Beest FM, 2013, J MAMMAL, V94, P691, DOI 10.1644/12-MAMM-A-080.1; van Wieren Spike E., 2008, V195, P263; Veiberg V, 2004, OECOLOGIA, V138, P135, DOI 10.1007/s00442-003-1399-9; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Yockney IJ, 2013, EPIDEMIOL INFECT, V141, P1407, DOI 10.1017/S0950268813000289; [No title captured]	93	10	10	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142707	10.1371/journal.pone.0142707	http://dx.doi.org/10.1371/journal.pone.0142707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580801	Green Published, gold, Green Accepted			2022-12-27	WOS:000365154600057
J	Ricarte, A; Marcos-Garcia, MA; Hancock, EG; Rotheray, GE				Ricarte, Antonio; Marcos-Garcia, M. Angeles; Hancock, E. Geoffrey; Rotheray, Graham E.			Neotropical Copestylum Macquart (Diptera: Syrphidae) Breeding in Fruits and Flowers, Including 7 New Species	PLOS ONE			English	Article								Ten species of Copestylum (Diptera: Syrphidae) were reared from fruits and flowers in Costa Rica, Ecuador and Trinidad. Seven were new and in this paper, we describe them, their development sites and the third stage larva and/or the puparium of all ten species. One new synonym is proposed, Copestylum pinkusi (Curran) [=Copestylum cinctiventre (Curran)]. Similarities and differences between these new and other Copestylum species, suggest they separate into two groups, referred to as the Vagum and Cinctiventre species groups. Features characterising these groups for both adult and early stages are assessed. Each species was also distinguished using adult and early stage characters. Within the Vagum group, adults were more disparate morphologically than the larval stage; this was reversed in the Cinctiventre group. Adult colour patterns are probably cryptic in function and for disguise. Vagum species have disruptive marks, while the Cinctiventre species have reflective colours. Biologically, the groups are almost distinguished by larval development sites. Vagum species use predominantly fruits and have a larval stage that is relatively generalised in form and habit. Cinctiventre species are confined to developing in flowers and the larva is more specialised. A key to both adult and early stages of all ten species is provided.	[Ricarte, Antonio; Rotheray, Graham E.] Natl Museums Collect Ctr, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Ricarte, Antonio; Marcos-Garcia, M. Angeles] Univ Alicante, Ctr Iberoamer Biodiversidad CIBIO, E-03080 Alicante, Spain; [Hancock, E. Geoffrey] Univ Glasgow, Hunterian Zool Museum, Glasgow, Lanark, Scotland	Universitat d'Alacant; University of Glasgow	Ricarte, A (corresponding author), Univ Alicante, Ctr Iberoamer Biodiversidad CIBIO, E-03080 Alicante, Spain.	ricarte24@gmail.com	Marcos García, Maria Angeles/H-7925-2015; Ricarte, Antonio/S-4483-2016	Marcos García, Maria Angeles/0000-0002-2439-2630; Ricarte, Antonio/0000-0003-2298-981X; Hancock, E Geoffrey/0000-0002-3600-4199	AECID, Agencia Espanola de Cooperacion Internacional para el Desarrollo, Ministerio de Asuntos Exteriores y de Cooperacion [A/4426/05, A/6788/06, A/3415/05, A/020305/08, A/019887/08]; S.W. Williston Diptera Research Fund of the Smithsonian Institution; Pelham-Clinton Fellowship Fund of the National Museums Scotland (E.C. Pelham-Clinton Fellowship) [NMS10/73]	AECID, Agencia Espanola de Cooperacion Internacional para el Desarrollo, Ministerio de Asuntos Exteriores y de Cooperacion; S.W. Williston Diptera Research Fund of the Smithsonian Institution; Pelham-Clinton Fellowship Fund of the National Museums Scotland (E.C. Pelham-Clinton Fellowship)	Fieldwork was funded by the AECID, Agencia Espanola de Cooperacion Internacional para el Desarrollo, Ministerio de Asuntos Exteriores y de Cooperacion (A/4426/05, A/6788/06, A/3415/05, A/020305/08 and A/019887/08; www.aecid.es). The taxonomic study was funded by the S.W. Williston Diptera Research Fund of the Smithsonian Institution (http://entomology.si.edu/) and the Pelham-Clinton Fellowship Fund of the National Museums Scotland (E.C. Pelham-Clinton Fellowship, reference NMS10/73; www.nms.ac.uk).	Curran C. H., 1926, Annals of the Entomological Society of America, V19, P50; CURRAN C. H., 1930, AMER MUS NOVITATES, V413, P1; Curran C.H., 1938, AM MUS NOVIT, V975, P1; Dusek Laska P, 1974, FOLIA FS NAT U PURKY, V15, P77; Edmunds J., 1974, DEFENCE ANIMALS SURV; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Marcos-Garcia MA, 2012, ENVIRON ENTOMOL, V41, P1544, DOI 10.1603/EN12215; Marinoni Luciane, 2004, Studia Dipterologica, V10, P565; Martinez-Falcon AP, 2012, J ARID ENVIRON, V78, P41, DOI 10.1016/j.jaridenv.2011.10.010; Rotheray EL, 2009, J INSECT CONSERV, V13, P569, DOI 10.1007/s10841-008-9204-z; Rotheray G, 1999, ZOOL J LINN SOC-LOND, V127, P1, DOI 10.1111/j.1096-3642.1999.tb01305.x; Rotheray GE, 2007, ZOOL J LINN SOC-LOND, V150, P267, DOI 10.1111/j.1096-3642.2007.00288.x; Rotheray GE, 2009, ZOOL J LINN SOC-LOND, V156, P697, DOI 10.1111/j.1096-3642.2008.00503.x; SEIFERT RP, 1979, ECOLOGY, V60, P462, DOI 10.2307/1936064; THOMPSON F C, 1972, Arquivos de Zoologia (Sao Paulo), V23, P73; Thompson F. C., 1999, Contributions on Entomology, International, V3, P321; Thompson F.C., 1981, Memoirs of the Entomological Society of Washington, P1; Wiedemann C.R.W., 1830, AUSSEREUROPAISCHE ZW	18	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142441	10.1371/journal.pone.0142441	http://dx.doi.org/10.1371/journal.pone.0142441			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580811	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000365154600048
J	Sciacca, V; Caruso, F; Beranzoli, L; Chierici, F; De Domenico, E; Embriaco, D; Favali, P; Giovanetti, G; Larosa, G; Marinaro, G; Papale, E; Pavan, G; Pellegrino, C; Pulvirenti, S; Simeone, F; Viola, S; Riccobene, G				Sciacca, Virginia; Caruso, Francesco; Beranzoli, Laura; Chierici, Francesco; De Domenico, Emilio; Embriaco, Davide; Favali, Paolo; Giovanetti, Gabriele; Larosa, Giuseppina; Marinaro, Giuditta; Papale, Elena; Pavan, Gianni; Pellegrino, Carmelo; Pulvirenti, Sara; Simeone, Francesco; Viola, Salvatore; Riccobene, Giorgio			Annual Acoustic Presence of Fin Whale (Balaenoptera physalus) Offshore Eastern Sicily, Central Mediterranean Sea	PLOS ONE			English	Article							NORTH-ATLANTIC; BLUE; CETACEANS; NOISE; CALLS; VOCALIZATIONS; BIOACOUSTICS; NEUTRINO; RANGE; ARRAY	In recent years, an increasing number of surveys have definitively confirmed the seasonal presence of fin whales (Balaenoptera physalus) in highly productive regions of the Mediterranean Sea. Despite this, very little is yet known about the routes that the species seasonally follows within the Mediterranean basin and, particularly, in the Ionian area. The present study assesses for the first time fin whale acoustic presence offshore Eastern Sicily (Ionian Sea), throughout the processing of about 10 months of continuous acoustic monitoring. The recording of fin whale vocalizations was made possible by the cabled deep-sea multidisciplinary observatory, "NEMO-SN1", deployed 25 km off the Catania harbor at a depth of about 2,100 meters. NEMO-SN1 is an operational node of the European Multidisciplinary Seafloor and water-column Observatory (EMSO) Research Infrastructure. The observatory was equipped with a low-frequency hydrophone (bandwidth: 0.05 Hz-1 kHz, sampling rate: 2 kHz) which continuously acquired data from July 2012 to May 2013. About 7,200 hours of acoustic data were analyzed by means of spectrogram display. Calls with the typical structure and patterns associated to the Mediterranean fin whale population were identified and monitored in the area for the first time. Furthermore, a background noise analysis within the fin whale communication frequency band (17.9-22.5 Hz) was conducted to investigate possible detection-masking effects. The study confirms the hypothesis that fin whales are present in the Ionian Sea throughout all seasons, with peaks in call detection rate during spring and summer months. The analysis also demonstrates that calls were more frequently detected in low background noise conditions. Further analysis will be performed to understand whether observed levels of noise limit the acoustic detection of the fin whales vocalizations, or whether the animals vocalize less in the presence of high background noise.	[Sciacca, Virginia; Caruso, Francesco; De Domenico, Emilio] Univ Messina, Dipartimento Sci Biol & Ambientali, Messina, Italy; [Sciacca, Virginia; Caruso, Francesco; Larosa, Giuseppina; Pulvirenti, Sara; Viola, Salvatore; Riccobene, Giorgio] Ist Nazl Fis Nucl, Lab Nazl Sud, I-95129 Catania, Italy; [Beranzoli, Laura; Embriaco, Davide; Favali, Paolo; Giovanetti, Gabriele; Marinaro, Giuditta] INGV, Rome, Italy; [Beranzoli, Laura; Favali, Paolo] Ist Nazl Geofis & Vulcanol, EMSO Interim Off, Rome, Italy; [Chierici, Francesco] Ist Radioastron INAF IRA, Ist Nazl Astrofis, Bologna, Italy; [Papale, Elena] CNR, IAMC Capo Granitola, Bioacoust Lab, Torretta Granitola, TP, Italy; [Pavan, Gianni] Univ Pavia, CIBRA, Dipartimento Sci Terra & Ambiente, I-27100 Pavia, Italy; [Pellegrino, Carmelo] Ist Nazl Fis Nucl, I-40126 Bologna, Italy; [Pellegrino, Carmelo] Univ Bologna, Dipartimento Fis & Astron, Bologna, Italy; [Simeone, Francesco] Ist Nazl Fis Nucl INFN Roma1, Rome, Italy	University of Messina; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale Geofisica e Vulcanologia (INGV); Istituto Nazionale Geofisica e Vulcanologia (INGV); Istituto Nazionale Astrofisica (INAF); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Pavia; Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN)	Sciacca, V (corresponding author), Univ Messina, Dipartimento Sci Biol & Ambientali, Messina, Italy.	vsciacca@unime.it	Pavan, Gianni/M-4619-2015; Pulvirenti, Sara Rita/AAE-1289-2019; Sciacca, Virginia/AAD-1528-2022; viola, Salvatore/C-1002-2014; Caruso, Francesco/AAB-4845-2019; Sciacca, Virginia/N-7205-2015; Riccobene, Giorgio/A-4502-2010; Embriaco, Davide/B-5827-2016; Favali, Paolo/AAR-5166-2021; Simeone, Francesco/L-1057-2016	Pavan, Gianni/0000-0002-4599-9028; Pulvirenti, Sara Rita/0000-0003-3017-512X; Sciacca, Virginia/0000-0002-7711-1249; viola, Salvatore/0000-0001-9511-8279; Caruso, Francesco/0000-0001-6881-3786; Sciacca, Virginia/0000-0002-7711-1249; Riccobene, Giorgio/0000-0002-0600-2774; Embriaco, Davide/0000-0001-7943-7341; Chierici, Francesco/0000-0003-1199-9705; marinaro, giuditta/0000-0002-6779-279X; Pellegrino, Carmelo/0000-0003-1530-4595; papale, elena/0000-0002-5150-9240; Giovanetti, Gabriele/0000-0002-4804-7006; BERANZOLI, LAURA/0000-0002-2273-3593	Italian Ministry of Education, Universities and Research [RBFR08NRZE]; Italian Ministry of the Environment [DPN/2008/28401]	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of the Environment	This work was conducted under the SMO (Submarine Multidisciplinary Observatory) FIRB 2008 activities, funded by the Italian Ministry of Education, Universities and Research n. RBFR08NRZE (GR FS) (https://web2.infn.it/smo/). GP has been funded by the Italian Ministry of the Environment within the project "Monitoraggio e conservazione dei cetacei in Italia" for the study and protection of marine mammals, contract n. DPN/2008/28401 (http://www.unipv.it/cibra/progettocetacei.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aissi M, 2008, J MAR BIOL ASSOC UK, V88, P1253, DOI 10.1017/S0025315408000891; Berube M, 1998, MOL ECOL, V7, P585, DOI 10.1046/j.1365-294x.1998.00359.x; Best M, 2014, OCEANOGRAPHY, V27, P167, DOI 10.5670/oceanog.2014.52; Boisseau O., 2008, Journal of Cetacean Research and Management, V10, P23; Brancato G, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P131; Canese S, 2006, J MAR BIOL ASSOC UK, V86, P903, DOI 10.1017/S0025315406013853; Caruso F., 2014, Biologia Marina Mediterranea, V21, P393; Castellote M., 2010, POPULATION IDENTITY; Castellote M, 2012, MAR MAMMAL SCI, V28, P325, DOI 10.1111/j.1748-7692.2011.00491.x; Castellote M, 2012, BIOL CONSERV, V147, P115, DOI 10.1016/j.biocon.2011.12.021; Catalano D, 2001, P 15 INT C ECS EUR C, V9, P56; Charif RA, 2002, MAR MAMMAL SCI, V18, P81, DOI 10.1111/j.1748-7692.2002.tb01020.x; Clark CW, 2009, MAR ECOL PROG SER, V395, P201, DOI 10.3354/meps08402; Clark CW, 2002, MAR MAMMAL SCI, V18, P286, DOI 10.1111/j.1748-7692.2002.tb01035.x; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Croll DA, 2001, ANIM CONSERV, V4, P13, DOI 10.1017/S1367943001001020; De Domenico E., 1987, DOCUMENTS TRAVAUX I, V11, P225; Defant A, 1961, PHYS OCEANOGRAPHY, V2, P395; DiSciara GN, 1997, MAR FRESHW BEHAV PHY, V30, P125; Druon JN, 2012, MAR ECOL PROG SER, V464, P289, DOI 10.3354/meps09810; Edds-Walton Peggy L., 1997, Bioacoustics, V8, P47; Embriaco D, 2010, ORION, V2010, P12; Favali P, 2013, IEEE J OCEANIC ENG, V38, P358, DOI 10.1109/JOE.2012.2224536; Favali P, 2011, NUCL INSTRUM METH A, V626, pS53, DOI 10.1016/j.nima.2010.04.139; FORCADA J, 1995, MAMMALIA, V59, P127, DOI 10.1515/mamm.1995.59.1.127; Gannier A., 1997, ESTIMATION ABONDANCE; Gannier Alexandre, 1998, Mesogee, V56, P3; Gimenez J, 2013, RAPID COMMUN MASS SP, V27, P1801, DOI 10.1002/rcm.6633; Guglielmo L, 1969, B PESCA PISC IDROBIO, V24, P71; IBM Corp, 2011, IBM SPSS STAT WIND V; KAWAMURA A, 1980, Scientific Reports of the Whales Research Institute Tokyo, P155; Klinck H, 2012, J ACOUST SOC AM, V132, pEL176, DOI 10.1121/1.4740226; KM3NeT Consortium, 2008, CONC DES DEEP SEA RE; Kusel ET, 2011, J ACOUST SOC AM, V129, P3610, DOI 10.1121/1.3583504; Marini L, 1996, EUROPEAN RES CETACEA, V9, P126; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; McDonald MA, 1999, J ACOUST SOC AM, V105, P2643, DOI 10.1121/1.426880; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Merchant ND, 2015, METHODS ECOL EVOL, V6, P257, DOI 10.1111/2041-210X.12330; Moore SE, 1998, MAR MAMMAL SCI, V14, P617, DOI 10.1111/j.1748-7692.1998.tb00749.x; Nosengo N, 2009, NATURE, V462, P560, DOI 10.1038/462560a; Notarbartolo-di-Sciara G, 2003, MAMMAL REV, V33, P105, DOI 10.1046/j.1365-2907.2003.00005.x; Panigada, 2012, BALAENOPTERA PHYSALU; Panigada S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022878; Pavan G, 1997, MAR FRESHW BEHAV PHY, V30, P99, DOI 10.1080/10236249709379019; Pavan G., 2006, SC58E IWC, V19, P1; Pavan G, 2008, P INT EXP M IT BAS D, P7; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; PORTER MB, 1987, J ACOUST SOC AM, V82, P1349, DOI 10.1121/1.395269; Rebull OG, 2006, J ACOUST SOC AM, V120, P2077, DOI 10.1121/1.2336751; RELINI LO, 1992, B MUS I BIOL U GEN, V56, P247; Riccobene G, 2007, ASTROPART PHYS, V27, P1, DOI 10.1016/j.astropartphys.2006.08.006; Riccobene G, 2009, NUCL INSTRUM METH A, V604, pS149, DOI 10.1016/j.nima.2009.03.195; Sacca A, 2008, HYDROBIOLOGIA, V600, P89, DOI 10.1007/s10750-007-9179-x; Schlitzer R., 2012, OCEAN DATA VIEW; Simeone F., 2011, 2011 IEEE 8th International Conference on Mobile Ad-Hoc and Sensor Systems, P898, DOI 10.1109/MASS.2011.107; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; Stafford KM, 2005, ANIM BEHAV, V69, P951, DOI 10.1016/j.anbehav.2004.06.025; Tringali L.M., 1999, Biologia Marina Mediterranea, V6, P619; van Opzeeland Ilse, 2013, Polarforschung, V83, P47; Vella A, 2010, RAPP COMM INT MER ME, V39, P693; Viola S, 2013, NUCL INSTRUM METH A, V725, P207, DOI 10.1016/j.nima.2012.11.150; Viola S, 2015, GEOPHYS RES ABSTRACT, V17; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685; Weirathmueller MJ, 2013, J ACOUST SOC AM, V133, P741, DOI 10.1121/1.4773277; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161	69	30	31	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141838	10.1371/journal.pone.0141838	http://dx.doi.org/10.1371/journal.pone.0141838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581104	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600024
J	Seronde, MF; Vausort, M; Gayat, E; Goretti, E; Ng, LL; Squire, IB; Vodovar, N; Sadoune, M; Samuel, JL; Thum, T; Solal, AC; Laribi, S; Plaisance, P; Wagner, DR; Mebazaa, A; Devaux, Y				Seronde, Marie-France; Vausort, Melanie; Gayat, Etienne; Goretti, Emeline; Ng, Leong L.; Squire, Iain B.; Vodovar, Nicolas; Sadoune, Malha; Samuel, Jane-Lise; Thum, Thomas; Solal, Alain Cohen; Laribi, Said; Plaisance, Patrick; Wagner, Daniel R.; Mebazaa, Alexandre; Devaux, Yvan		GREAT Network	Circulating microRNAs and Outcome in Patients with Acute Heart Failure	PLOS ONE			English	Article							BIOMARKERS; READMISSION; ASSOCIATION; MARKERS	Background The biomarker value of circulating microRNAs (miRNAs) has been extensively addressed in patients with acute coronary syndrome. However, prognostic performances of miRNAs in patients with acute heart failure (AHF) has received less attention. Methods A test cohort of 294 patients with acute dyspnea (236 AHF and 58 non-AHF) and 44 patients with stable chronic heart failure (CHF), and an independent validation cohort of 711 AHF patients, were used. Admission levels of miR-1/-21/-23/-126/-423-5p were assessed in plasma samples. Results In the test cohort, admission levels of miR-1 were lower in AHF and stable CHF patients compared to non-AHF patients (p = 0.0016). Levels of miR-126 and miR-423-5p were lower in AHF and in non-AHF patients compared to stable CHF patients (both p<0.001). Interestingly, admission levels of miR-423-5p were lower in patients who were re-admitted to the hospital in the year following the index hospitalization compared to patients who were not (p = 0.0001). Adjusted odds ratio [95% confidence interval] for one-year readmission was 0.70 [0.53-0.93] for miR-423-5p (p = 0.01). In the validation cohort, admission levels of miR-423-5p predicted 1-year mortality with an adjusted odds ratio [95% confidence interval] of 0.54 [0.36-0.82], p = 0.004. Patients within the lowest quartile of miR-423-5p were at high risk of long-term mortality (p = 0.02). Conclusions In AHF patients, low circulating levels of miR-423-5p at presentation are associated with a poor long-term outcome. This study supports the value of miR-423-5p as a prognostic biomarker of AHF.	[Seronde, Marie-France] Univ Hosp, Dept Cardiol, EA3920, Besancon, France; [Seronde, Marie-France; Gayat, Etienne; Vodovar, Nicolas; Sadoune, Malha; Samuel, Jane-Lise; Solal, Alain Cohen; Laribi, Said; Plaisance, Patrick; Mebazaa, Alexandre] Univ Paris Diderot, INSERM, UMRS 942, Paris, France; [Vausort, Melanie; Goretti, Emeline; Wagner, Daniel R.; Devaux, Yvan] Ctr Rech Publ Sante, Lab Cardiovasc Res, Luxembourg, Luxembourg; [Gayat, Etienne] St Louis Lariboisiere Hosp, Dept Anesthesiol & Crit Care, Paris, France; [Ng, Leong L.; Squire, Iain B.] Univ Leicester, Leicester, Leics, England; [Ng, Leong L.; Squire, Iain B.] Glenfield Gen Hosp, Natl Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Thum, Thomas] IMTTS, Hannover, Germany; [Solal, Alain Cohen] Lariboisiere Hosp, Dept Cardiol, Paris, France; [Laribi, Said; Plaisance, Patrick] Lariboisiere Hosp, Dept Emergency Med, Paris, France	Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Luxembourg Institute of Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Devaux, Y (corresponding author), Ctr Rech Publ Sante, Lab Cardiovasc Res, Luxembourg, Luxembourg.	yvan.devaux@crp-sante.lu	Laribi, Said/S-3693-2016; Gayat, Etienne/ABG-5308-2021; DEVAUX, Yvan/AAK-3463-2020; Vodovar, Nicolas/S-2947-2019	Laribi, Said/0000-0003-4648-4672; Mebazaa, Alexandre/0000-0001-8715-7753; GAYAT, Etienne/0000-0002-3334-3849; Devaux, Yvan/0000-0002-5321-8543; Ng, Leong/0000-0002-6553-5749; Vodovar, Nicolas/0000-0001-8087-387X; Samuel, Jane-Lise/0000-0002-7346-2404	National Fund for Research of Luxembourg [785036]; European Commission [305507]	National Fund for Research of Luxembourg; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the National Fund for Research of Luxembourg (#785036). NV is supported by a post-doctoral fellowship from the European Commission's Seventh Framework programme under grant agreement No 305507 (HOMAGE).	Ali S, 2012, BRIT J CANCER, V107, P1354, DOI 10.1038/bjc.2012.383; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Devaux Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070644; Devaux Y, 2013, CIRC RES, V113, pe46, DOI 10.1161/CIRCRESAHA.113.302030; Devaux Y, 2013, CIRC-CARDIOVASC GENE, V6, P290, DOI 10.1161/CIRCGENETICS.113.000077; Devaux Y, 2012, CLIN CHEM, V58, P559, DOI 10.1373/clinchem.2011.173823; Dimmeler S, 2010, EUR HEART J, V31, P2705, DOI 10.1093/eurheartj/ehq221; Ellis KL, 2013, EUR J HEART FAIL, V15, P1138, DOI 10.1093/eurjhf/hft078; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goretti E, 2014, TRENDS MOL MED; Goretti E, 2013, INT J CARDIOL, V168, P4548, DOI 10.1016/j.ijcard.2013.06.092; HOLM S, 1979, SCAND J STAT, V6, P65; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; Lassus J, 2013, INT J CARDIOL, V168, P2186, DOI 10.1016/j.ijcard.2013.01.228; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Matsumoto S, 2012, BIOCHEM BIOPH RES CO, V427, P280, DOI 10.1016/j.bbrc.2012.09.039; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ouwerkerk W, 2014, JACC-HEART FAIL, V2, P429, DOI 10.1016/j.jchf.2014.04.006; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pratt AK, 2014, CRIT CARE MED, V42, P158, DOI 10.1097/01.ccm.0000435675.91305.76; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Vogel B, 2013, EUR HEART J, V34, P2812, DOI 10.1093/eurheartj/eht256; Widera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291	31	62	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142237	10.1371/journal.pone.0142237	http://dx.doi.org/10.1371/journal.pone.0142237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580972	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600040
J	Fried, P; Iber, D				Fried, Patrick; Iber, Dagmar			Read-Out of Dynamic Morphogen Gradients on Growing Domains	PLOS ONE			English	Article							DPP MORPHOGEN; DROSOPHILA; PATTERN; CELL; MECHANISMS	Quantitative data from the Drosophila wing imaginal disc reveals that the amplitude of the Decapentaplegic (Dpp) morphogen gradient increases continuously. It is an open question how cells can determine their relative position within a domain based on a continuously increasing gradient. Here we show that pre-steady state diffusion-based dispersal of morphogens results in a zone within the growing domain where the concentration remains constant over the patterning period. The position of the zone that is predicted based on quantitative data for the Dpp morphogen corresponds to where the Dpp-dependent gene expression boundaries of spalt (sal) and daughters against dpp (dad) emerge. The model also suggests that genes that are scaling and are expressed at lateral positions are either under the control of a different read-out mechanism or under the control of a different morphogen. The patterning mechanism explains the extraordinary robustness that is observed for variations in Dpp production, and offers an explanation for the dual role of Dpp in controlling patterning and growth. Pre-steady-state dynamics are pervasive in morphogen-controlled systems, thus making this a probable general mechanism for the scaled read-out of morphogen gradients in growing developmental systems.	[Fried, Patrick; Iber, Dagmar] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Fried, Patrick; Iber, Dagmar] SIB Swiss Inst Bioinformat, Basel, Switzerland	ETH Zurich; Swiss Institute of Bioinformatics	Iber, D (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	dagmar.iber@bsse.ethz.ch	Iber, Dagmar/V-2846-2019	Iber, Dagmar/0000-0001-8051-1035				Aegerter-Wilmsen T, 2012, DEVELOPMENT, V139, P3221, DOI 10.1242/dev.082800; Averbukh I, 2014, DEVELOPMENT, V141, P2150, DOI 10.1242/dev.107011; Bai LG, 2013, PROC SPIE, V8654, DOI 10.1117/12.2008497; Bangi E, 2006, DEV BIOL, V295, P178, DOI 10.1016/j.ydbio.2006.03.021; Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Cook O, 2004, DEVELOPMENT, V131, P2113, DOI 10.1242/dev.01100; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Fried P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6077; Funakoshi Y, 2001, DEVELOPMENT, V128, P67; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; He F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7679; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Kuntz SG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004293; Lander AD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002022; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Schwank G, 2012, SCIENCE, V335, DOI 10.1126/science.1210997; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143226	10.1371/journal.pone.0143226	http://dx.doi.org/10.1371/journal.pone.0143226			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599604	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600040
J	Paletta, D; Fichtner, AS; Starick, L; Porcelli, SA; Savage, PB; Herrmann, T				Paletta, Daniel; Fichtner, Alina Suzann; Starick, Lisa; Porcelli, Steven A.; Savage, Paul B.; Herrmann, Thomas			Species Specific Differences of CD1d Oligomer Loading In Vitro	PLOS ONE			English	Article							T-CELL-RECEPTOR; COMPLEMENTARITY-DETERMINING REGION-2; TRIGLYCERIDE TRANSFER PROTEIN; ANTIGEN PRESENTATION; ALPHA-CHAIN; RECOGNITION; NKT; TETRAMERS; TCR; BINDING	CD1d molecules are MHC class I-like molecules that present glycolipids to iNKT cells. The highly conserved interaction between CD1d:alpha-Galactosylceramide (alpha GC) complexes and the iNKT TCR not only defines this population of alpha beta T cells but can also be used for its direct identification. Therefore, CD1d oligomers are a widely used tool for iNKT cell related investigations. To this end, the lipid chains of the antigen have to be inserted into the hydrophobic pockets of the CD1d binding cleft, often with help of surfactants. In this study, we investigated the influence of different surfactants (Triton X-100, Tween 20, Tyloxapol) on in vitro loading of CD1d molecules derived from four different species (human, mouse, rat and cotton rat) with aGC and derivatives carrying modifications of the acyl-chain (DB01-1, PBS44) and a 6-acetamido-6-deoxy-addition at the galactosyl head group (PBS57). We also compared rat CD1d dimers with tetramers and staining of an iNKT TCR transductant was used as readout for loading efficacy. The results underlined the importance of CD1d loading efficacy for proper analysis of iNKT TCR binding and demonstrated the necessity to adjust loading conditions for each oligomer/glycolipid combination. The efficient usage of surfactants as a tool for CD1d loading was revealed to be species-specific and depending on the origin of the CD1d producing cells. Additional variation of surfactant-dependent loading efficacy between tested glycolipids was influenced by the acyl-chain length and the modification of the galactosyl head group with PBS57 showing the least dependence on surfactants and the lowest degree of species-dependent differences.	[Paletta, Daniel; Fichtner, Alina Suzann; Starick, Lisa; Herrmann, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Savage, Paul B.] Brigham Young Univ, Dept Chem, Provo, UT 84602 USA	University of Wurzburg; Yeshiva University; Albert Einstein College of Medicine; Brigham Young University	Herrmann, T (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany.	herrmann-t@vim.uni-wuerzburg.de	Savage, Paul B/E-1448-2011; Savage, Paul B/HGB-3414-2022; Herrmann, Thomas/J-4943-2012	Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109; Herrmann, Thomas/0000-0002-1093-0194; Fichtner, Alina Suzann/0000-0003-4772-9352	Deutsche Forschungsgemeinschaft DFG [HE 2346/6-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft DFG HE 2346/6-1 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Facciotti F, 2011, P NATL ACAD SCI USA, V108, P14228, DOI 10.1073/pnas.1108809108; Fichtner AS, 2015, IMMUNOLOGY, V146, P618, DOI 10.1111/imm.12532; Freigang S, 2012, J CLIN INVEST, V122, P3943, DOI 10.1172/JCI62267; Gadola SD, 2003, PHILOS T ROY SOC B, V358, P875, DOI 10.1098/rstb.2003.1267; Greenaway HY, 2013, IMMUNOBIOLOGY, V218, P213, DOI 10.1016/j.imbio.2012.04.003; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kasmar A, 2009, CURR OPIN IMMUNOL, V21, P397, DOI 10.1016/j.coi.2009.05.022; KOSEKI H, 1990, P NATL ACAD SCI USA, V87, P5248, DOI 10.1073/pnas.87.14.5248; Kreiss M, 2004, INT IMMUNOL, V16, P655, DOI 10.1093/intimm/dxh068; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Ly D, 2014, CELL MOL LIFE SCI, V71, P3069, DOI 10.1007/s00018-014-1603-6; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; MCMICHAEL AJ, 1979, EUR J IMMUNOL, V9, P205, DOI 10.1002/eji.1830090307; Monzon-Casanova E, 2010, RAT INKT CELLS PHENO, pp51; Monzon-Casanova E, 2013, EUR J IMMUNOL, V43, P404, DOI 10.1002/eji.201242565; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; Paletta D, 2015, EUR J IMMUNOL, V45, P2122, DOI 10.1002/eji.201545534; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Pyz E, 2006, J IMMUNOL, V176, P7447, DOI 10.4049/jimmunol.176.12.7447; Schneck Jonathan P., 2000, Immunological Investigations, V29, P163, DOI 10.3109/08820130009062300; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Van Rhijn I, 2006, J IMMUNOL, V176, P4888, DOI 10.4049/jimmunol.176.8.4888; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	42	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143449	10.1371/journal.pone.0143449	http://dx.doi.org/10.1371/journal.pone.0143449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599805	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600067
J	Sanjuan-Jimenez, R; Toro-Peinado, I; Bermudez, P; Colmenero, JD; Morata, P				Sanjuan-Jimenez, Rocio; Toro-Peinado, Inmaculada; Bermudez, Pilar; Colmenero, Juan D.; Morata, Pilar			Comparative Study of a Real-Time PCR Assay Targeting senX3-regX3 versus Other Molecular Strategies Commonly Used in the Diagnosis of Tuberculosis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; IS6110; DNA; EXTRAPULMONARY; METAANALYSIS; AMPLIFICATION; ACCURACY; COMPLEX	Background Nucleic acid amplification tests are increasingly used for the rapid diagnosis of tuberculosis. We undertook a comparative study of the efficiency and diagnostic yield of a real-time PCR senX3-regX3 based assay versus the classical IS6110 target and the new commercial methods. Methods This single-blind prospective comparative study included 145 consecutive samples: 76 from patients with culture-confirmed tuberculosis (86.8% pulmonary and 13.2% extrapulmonary tuberculosis: 48.7% smear-positive and 51.3% smear-negative) and 69 control samples (24 from patients diagnosed with non-tuberculous mycobacteria infections and 45 from patients with suspected tuberculosis which was eventually ruled out). All samples were tested by two CE-marked assays (Xpert1MTB/RIF and AnyplexTM plus MTB/NTM) and two in-house assays targeting senX3-regX3 and the IS6110 gene. Results The detection limit ranged from 1.00E+01 fg for Anyplex, senX3-regX3 and IS6110 to 1.00E+04 fg for Xpert. All three Xpert, senX3-regX3 and IS6110 assays detected all 37 smear-positive cases. Conversely, Anyplex was positive in 34 (91.9%) smear-positive cases. In patients with smear-negative tuberculosis, differences were observed between the assays; Xpert detected 22 (56.41%) of the 39 smear-negative samples, Anyplex 24 (61.53%), senX3-regX3 28 (71.79%) and IS6110 35 (89.74%). Xpert and senX3-regX3 were negative in all control samples; however, the false positive rate was 8.7% and 13% for Anyplex and IS6110, respectively. The overall sensitivity was 77.6%, 85.7%, 77.3% and 94.7% and the specificity was 100%, 100%, 90.8% and 87.0% for the Xpert, senX3-regX3, Anyplex and IS6110 assays, respectively. Conclusion Real-time PCR assays targeting IS6110 lack the desired specificity. The Xpert MTB/RIF and in-house senX3-regX3 assays are both sensitive and specific for the detection of MTBC in both pulmonary and extrapulmonary samples. Therefore, the real time PCR senX3-regX3 based assay could be a useful and complementary tool in the diagnosis of tuberculosis.	[Sanjuan-Jimenez, Rocio; Morata, Pilar] Univ Malaga, Fac Med, Biochem Mol Biol & Immunol Dept, E-29071 Malaga, Spain; [Toro-Peinado, Inmaculada; Bermudez, Pilar] Reg Univ Hosp, Microbiol Serv, Malaga, Spain; [Colmenero, Juan D.] Reg Univ Hosp, Infect Dis Serv, Malaga, Spain	Universidad de Malaga	Sanjuan-Jimenez, R (corresponding author), Univ Malaga, Fac Med, Biochem Mol Biol & Immunol Dept, E-29071 Malaga, Spain.	rsanjuan@uma.es		Sanjuan-Jimenez, Rocio/0000-0002-6591-0289	Consejeria de Innovacion Ciencia y Empresa of the Junta de Andalucia (Spain) [CTS-276, P-08-CTS-3969]	Consejeria de Innovacion Ciencia y Empresa of the Junta de Andalucia (Spain)(Junta de Andalucia)	This work received financial support from the Consejeria de Innovacion Ciencia y Empresa (grant CTS-276 and P-08-CTS-3969) both of the Junta de Andalucia (Spain). Rocio Sanjuan-Jimenez is a postdoctoral fellow attached to the project P-08-CTS-3969.	Aldous WK, 2005, J CLIN MICROBIOL, V43, P2471, DOI 10.1128/JCM.43.5.2471-2473.2005; Antonenka U, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-280; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Broccolo F, 2003, J CLIN MICROBIOL, V41, P4565, DOI 10.1128/JCM.41.10.4565-4572.2003; Center for Disease Control, 2012, REP EXP CONS US NUCL; Chawla K, 2009, J INFECT DEV COUNTR, V3, P83; Dharan NJ, 2015, J CLIN MICROBIOL; Flores LL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-55; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Greco S, 2009, J CLIN MICROBIOL, V47, P569, DOI 10.1128/JCM.02051-08; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; Queipo-Ortuno MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004526; Lee HS, 2011, J MOL DIAGN, V13, P390, DOI 10.1016/j.jmoldx.2011.02.004; Lim J, 2014, J MICROBIOL BIOTECHN, V24, P1004, DOI 10.4014/jmb.1403.03071; Lok KH, 2002, EMERG INFECT DIS, V8, P1310, DOI 10.3201/eid0811.020291; Maynard-Smith L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0709-7; McHugh TD, 1998, J CLIN MICROBIOL, V36, P1410, DOI 10.1128/JCM.36.5.1410-1413.1998; Miller MB, 2011, J CLIN MICROBIOL, V49, P3458, DOI 10.1128/JCM.05212-11; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Moure R, 2012, J CLIN MICROBIOL, V50, P513, DOI 10.1128/JCM.06467-11; Nghiem MN, 2014, J MICROBIOL BIOTECHN; Organization WHO, 2014, TUB DIAGN XPERT MTB; Perry MD, 2014, J CLIN MICROBIOL, V52, P1708, DOI 10.1128/JCM.03585-13; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Sanjuan-Jimenez R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002593; Sanjuan-Jimenez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058353; Sankar S, 2011, BIOINFORMATION, V6, P283, DOI 10.6026/97320630006283; Santos A, 2010, APMIS, V118, P60, DOI 10.1111/j.1600-0463.2009.02558.x; Sarmiento OL, 2003, J CLIN MICROBIOL, V41, P3233, DOI 10.1128/JCM.41.7.3233-3240.2003; Sharma K, 2015, INDIAN J PATHOL MICR, V58, P27, DOI 10.4103/0377-4929.151164; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Valdes Luis, 2003, Eur J Intern Med, V14, P77, DOI 10.1016/S0953-6205(03)00018-9; World Health Organization, 2014, GLOB TUB REP	35	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143025	10.1371/journal.pone.0143025	http://dx.doi.org/10.1371/journal.pone.0143025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600434	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600026
J	Wang, J; Kato, F; Oyama-Manabe, N; Li, RJ; Cui, Y; Tha, KK; Yamashita, H; Kudo, K; Shirato, H				Wang, Jeff; Kato, Fumi; Oyama-Manabe, Noriko; Li, Ruijiang; Cui, Yi; Tha, Khin Khin; Yamashita, Hiroko; Kudo, Kohsuke; Shirato, Hiroki			Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study	PLOS ONE			English	Article							COMPUTER-AIDED-DIAGNOSIS; MAMMOGRAPHIC DENSITY; SIGNAL ENHANCEMENT; MENSTRUAL-CYCLE; IMAGE-ANALYSIS; RISK; ASSOCIATION; FEATURES; LESIONS; TUMORS	Objectives To determine the added discriminative value of detailed quantitative characterization of background parenchymal enhancement in addition to the tumor itself on dynamic contrast-enhanced (DCE) MRI at 3.0 Tesla in identifying "triple-negative" breast cancers. Materials and Methods In this Institutional Review Board-approved retrospective study, DCE-MRI of 84 women presenting 88 invasive carcinomas were evaluated by a radiologist and analyzed using quantitative computer-aided techniques. Each tumor and its surrounding parenchyma were segmented semi-automatically in 3-D. A total of 85 imaging features were extracted from the two regions, including morphologic, densitometric, and statistical texture measures of enhancement. A small subset of optimal features was selected using an efficient sequential forward floating search algorithm. To distinguish triple-negative cancers from other sub-types, we built predictive models based on support vector machines. Their classification performance was assessed with the area under receiver operating characteristic curve (AUC) using cross-validation. Results Imaging features based on the tumor region achieved an AUC of 0.782 in differentiating triple-negative cancers from others, in line with the current state of the art. When background parenchymal enhancement features were included, the AUC increased significantly to 0.878 (p<0.01). Similar improvements were seen in nearly all subtype classification tasks undertaken. Notably, amongst the most discriminating features for predicting triple-negative cancers were textures of background parenchymal enhancement. Conclusions Considering the tumor as well as its surrounding parenchyma on DCE-MRI for radiomic image phenotyping provides useful information for identifying triple-negative breast cancers. Heterogeneity of background parenchymal enhancement, characterized by quantitative texture features on DCE-MRI, adds value to such differentiation models as they are strongly associated with the triple-negative subtype. Prospective validation studies are warranted to confirm these findings and determine potential implications.	[Wang, Jeff; Tha, Khin Khin; Shirato, Hiroki] Hokkaido Univ, Dept Radiat Med, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kato, Fumi; Oyama-Manabe, Noriko; Kudo, Kohsuke] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Li, Ruijiang] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Wang, Jeff; Oyama-Manabe, Noriko; Li, Ruijiang; Cui, Yi; Tha, Khin Khin; Kudo, Kohsuke; Shirato, Hiroki] Hokkaido Univ, Proton Beam Therapy Ctr, Global Stn Quantum Med Sci & Engn, Global Inst Collaborat Res & Educ GI CoRE,Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Yamashita, Hiroko] Hokkaido Univ Hosp, Dept Breast Surg, Kita Ku, Sapporo, Hokkaido 0608648, Japan	Hokkaido University; Hokkaido University; Stanford University; Hokkaido University; Hokkaido University	Kato, F (corresponding author), Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Kita Ku, North 14 West 5, Sapporo, Hokkaido 0608648, Japan.	fumikato@med.hokudai.ac.jp	Tha, Khin/AAN-7345-2020; Yamashita, Hiroko/D-5102-2012; Kudo, Kohsuke/AAK-9938-2021; Tha, Khin Khin/A-4762-2012; Cui, Yi/L-5804-2013	Yamashita, Hiroko/0000-0003-4281-8727; Kudo, Kohsuke/0000-0001-5351-9242; Tha, Khin Khin/0000-0002-9072-4509; Cui, Yi/0000-0002-6103-6352; Li, Ruijiang/0000-0002-0232-5998	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Agliozzo S, 2012, MED PHYS, V39, P1704, DOI 10.1118/1.3691178; Agner SC, 2014, RADIOLOGY, V272, P91, DOI 10.1148/radiol.14121031; Ahn HS, 2013, QUANTITATIVE ANAL BR; Alic L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110300; American College of Radiology, 2013, ACR BREAST IM REP DA; American Concrete Institute, 2010, ACI522R, P1; Arasu VA, 2011, ACAD RADIOL, V18, P716, DOI 10.1016/j.acra.2011.02.008; Meinel LA, 2007, J MAGN RESON IMAGING, V25, P89, DOI 10.1002/jmri.20794; Bertrand KA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3570; Bhatelia K, 2014, CELL SIGNAL, V26, P2350, DOI 10.1016/j.cellsig.2014.07.035; Bhooshan N, 2010, RADIOLOGY, V254, P680, DOI 10.1148/radiol.09090838; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Chaudhuri O, 2014, NAT MAT; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Delille JP, 2005, BREAST J, V11, P236, DOI 10.1111/j.1075-122X.2005.21499.x; DeMartini WB, 2012, AM J ROENTGENOL, V198, pW373, DOI 10.2214/AJR.10.6272; Deurloo EE, 2005, RADIOLOGY, V234, P693, DOI 10.1148/radiol.2343031580; Dontchos BN, 2015, RADIOLOGY, V276, P371, DOI 10.1148/radiol.2015142304; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eng A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0439-1; Ercan G, 2007, DIGITAL IMAGE PROCES; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Giger Maryellen L., 2014, Breast Imaging. 12th International Workshop, IWDM 2014. Proceedings: LNCS 8539, P195, DOI 10.1007/978-3-319-07887-8_28; Giger ML, 2013, ANNU REV BIOMED ENG, V15, P327, DOI 10.1146/annurev-bioeng-071812-152416; Gillies RJ, 2010, CLIN RADIOL, V65, P517, DOI 10.1016/j.crad.2010.04.005; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goto M, 2007, J MAGN RESON IMAGING, V25, P104, DOI 10.1002/jmri.20812; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hambly NM, 2011, AM J ROENTGENOL, V196, P218, DOI 10.2214/AJR.10.4550; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harris JR, 2014, DISEASES OF THE BREA; Hylton NM, 2012, RADIOLOGY, V263, P663, DOI 10.1148/radiol.12110748; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jones EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061969; King V, 2011, RADIOLOGY, V260, P50, DOI 10.1148/radiol.11102156; Klifa C, 2004, C P IEEE ENG MED BIO; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohavi R., 1995, IJCAI; Kuhl CK, 1997, RADIOLOGY, V203, P137, DOI 10.1148/radiology.203.1.9122382; Lambin P, 2012, EUR J; Lee SH, 2010, MED PHYS, V37, P3940, DOI 10.1118/1.3446799; Lee SH, 2008, KOREAN J RADIOL, V9, P10, DOI 10.3348/kjr.2008.9.1.10; Liu H, 1995, PROC INT C TOOLS ART, P388, DOI 10.1109/TAI.1995.479783; Mandelson MT, 2000, J NATL CANC I; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Mazurowski MA, 2014, RADIOLOGY, V273, P365, DOI 10.1148/radiol.14132641; Meeuwis C, 2010, EUR RADIOL, V20, P522, DOI 10.1007/s00330-009-1573-5; MullerSchimpfle M, 1997, RADIOLOGY, V203, P145; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Pathak AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063146; Pearl J, 1985, HEURISTICS INTELLIGE; Pediconi F, 2009, INVEST RADIOL, V44, P412, DOI 10.1097/RLI.0b013e3181a53654; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Platt J., 1999, ADV KERNEL METHODS S, P41; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schmitz AMT, 2014, BREAST CANCER RES TR, V148, P541, DOI 10.1007/s10549-014-3170-9; Shepherd JA, 2011, CANCER EPIDEM BIOMAR, V20, P1473, DOI 10.1158/1055-9965.EPI-10-1150; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081653; Williams TC, 2007, RADIOLOGY, V244, P94, DOI 10.1148/radiol.2441060634; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yoshioka T, 2013, BREAST CANC; Youk JH, 2012, EUR RADIOL, V22, P1724, DOI 10.1007/s00330-012-2425-2	72	95	108	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143308	10.1371/journal.pone.0143308	http://dx.doi.org/10.1371/journal.pone.0143308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600392	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600048
J	Wen, SW; Everitt, SJ; Bedo, J; Chabrot, M; Ball, DL; Solomon, B; MacManus, M; Hicks, RJ; Moller, A; Leimgruber, A				Wen, Shu Wen; Everitt, Sarah J.; Bedo, Justin; Chabrot, Marine; Ball, David L.; Solomon, Benjamin; MacManus, Michael; Hicks, Rodney J.; Moeller, Andreas; Leimgruber, Antoine			Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy	PLOS ONE			English	Article							SPLENIC VOLUME; CONCURRENT CHEMOTHERAPY; CT; TRIAL; INDUCTION; RADIATION; SIZE	There is renewed interest in the immune regulatory role of the spleen in oncology. To date, very few studies have examined macroscopic variations of splenic volume in the setting of cancer, prior to or during therapy, especially in humans. Changes in splenic volume may be associated with changes in splenic function. The purpose of this study was to investigate variations in spleen volume in NSCLC patients during chemo-radiotherapy. Sixty patients with stage I-IIIB NSCLC underwent radiotherapy (60Gy/30 fractions) for six weeks with concomitant carboplatin/paclitaxel (Ca/P; n = 32) or cisplatin/etoposide (Ci/E; n = 28). A baseline PET/CT scan was performed within 2 weeks prior to treatment and during Weeks 2 and 4 of chemo-radiotherapy. Spleen volume was measured by contouring all CT slices. Significant macroscopic changes in splenic volume occurred early after the commencement of treatment. A significant decrease in spleen volume was observed for 66% of Ca/P and 79% of Ci/E patients between baseline and Week 2. Spleen volume was decreased by 14.2% for Ca/P (p<0.001) and 19.3% for Ci/E (p<0.001) patients. By Week 4, spleen volume was still significantly decreased for Ca/P patients compared to baseline, while for Ci/E patients, spleen volume returned to above baseline levels. This is the first report demonstrating macroscopic changes in the spleen in NSCLC patients undergoing radical chemo-radiotherapy that can be visualized by non-invasive imaging.	[Wen, Shu Wen; Moeller, Andreas] QIMR Berghofer Med Res Inst, Tumour Microenvironm Lab, Herston, Qld, Australia; [Everitt, Sarah J.; Ball, David L.; MacManus, Michael] Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, Dept Radiat Oncol, East Melbourne, Vic, Australia; [Everitt, Sarah J.; Ball, David L.; Solomon, Benjamin; MacManus, Michael; Hicks, Rodney J.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Everitt, Sarah J.] Monash Univ, Dept Med Imaging & Radiat Sci, Clayton, Vic, Australia; [Bedo, Justin] IBM Res Australia, Carlton, Vic, Australia; [Bedo, Justin] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia; [Chabrot, Marine; Hicks, Rodney J.; Leimgruber, Antoine] Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, Ctr Mol Imaging, East Melbourne, Vic, Australia; [Solomon, Benjamin] Peter MacCallum Canc Ctr, Med Oncol, East Melbourne, Vic, Australia; [Moeller, Andreas] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Leimgruber, Antoine] CHU Vaudois, Dept Med Imaging, CH-1011 Lausanne, Switzerland; [Leimgruber, Antoine] Univ Lausanne, Lausanne, Switzerland	QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Monash University; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Queensland; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Moller, A (corresponding author), QIMR Berghofer Med Res Inst, Tumour Microenvironm Lab, Herston, Qld, Australia.	andreas.moller@qimrberghofer.edu.au; antoine.leimgruber@chuv.ch	Möller, Andreas/O-1063-2015	Möller, Andreas/0000-0002-8618-6998; MacManus, Michael/0000-0002-0900-5815; Hicks, Rodney/0000-0002-0758-0824; Solomon, Benjamin/0000-0003-3059-5730; Bedo, Justin/0000-0001-5704-0212	CASS Foundation [SM/12/4249/RMR]; National Health and Medical Research Council [APP106851]; Cancer Council Queensland [APP1045260]; National Breast Cancer Foundation Australia [NC-13-26, ECF-11-09]; NHMRC [APP1003895]; IBM Australia; National Breast Cancer Foundation [NC-13-26] Funding Source: researchfish	CASS Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); National Breast Cancer Foundation Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); IBM Australia(International Business Machines (IBM)); National Breast Cancer Foundation	AL, AM and SE are supported by The CASS Foundation (SM/12/4249/RMR: DR; www.cassfoundation.org). AM and AL are supported by the National Health and Medical Research Council (www.nhmrc.gov.au) project grant APP106851, Cancer Council Queensland grant (APP1045260; www.cancerqld.org.au), and a National Breast Cancer Foundation Australia grant (NC-13-26; www.nbcf.org.au/) and fellowship to AM (ECF-11-09). SE is supported by NHMRC (www.nhmrc.gov.au) grant APP1003895. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder IBM Australia provided support in the form of salaries for Dr Justin Bedo, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr Bedo also holds an adjunct position at The University of Melbourne, Australia, as indicated in the manuscript.	Bezerra AS, 2005, AM J ROENTGENOL, V184, P1510, DOI 10.2214/ajr.184.5.01841510; BREIMAN RS, 1982, AM J ROENTGENOL, V138, P329, DOI 10.2214/ajr.138.2.329; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; COOLS L, 1983, J COMPUT ASSIST TOMO, V7, P426, DOI 10.1097/00004728-198306000-00007; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Galecki A, 2013, SPRINGER TEXTS STAT, P69, DOI 10.1007/978-1-4614-3900-4_4; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Griffith R, 1990, HEMATOPOIETIC SYSTEM; Higashijima J, 2009, ANTICANCER RES, V29, P385; HOLM S, 1979, SCAND J STAT, V6, P65; Imai K, 2014, EJSO-EUR J SURG ONC, V40, P559, DOI 10.1016/j.ejso.2013.12.009; KOGA T, 1975, RADIOLOGY, V115, P157, DOI 10.1148/115.1.157; Lamb PM, 2002, BRIT J RADIOL, V75, P573, DOI 10.1259/bjr.75.895.750573; Leimgruber A, 2014, J NUCL MED, V55, P1075, DOI 10.2967/jnumed.113.136127; Pozo AL, 2009, BLOOD REV, V23, P105, DOI 10.1016/j.blre.2008.10.001; Price A, 2012, NAT REV CLIN ONCOL, V9, P591, DOI 10.1038/nrclinonc.2012.135; Saboo SS, 2012, BRIT J RADIOL, V85, P81, DOI 10.1259/bjr/31542964; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schild SE, 2006, INT J RADIAT ONCOL, V65, P1106, DOI 10.1016/j.ijrobp.2006.02.046; SCHLESINGER AE, 1994, RADIOLOGY, V193, P578, DOI 10.1148/radiology.193.2.7972783; Socinski MA, 2008, J CLIN ONCOL, V26, P2457, DOI 10.1200/JCO.2007.14.7371; Stinchcombe TE, 2008, J THORAC ONCOL, V3, P1279, DOI 10.1097/JTO.0b013e31818b1971; Ugel S, 2012, CELL REP, V2, P628, DOI 10.1016/j.celrep.2012.08.006; Yetter EM, 2003, AM J ROENTGENOL, V181, P1615, DOI 10.2214/ajr.181.6.1811615	24	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142608	10.1371/journal.pone.0142608	http://dx.doi.org/10.1371/journal.pone.0142608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599227	Green Published, gold			2022-12-27	WOS:000365862600014
J	Karweina, D; Kreuzer-Redmer, S; Muller, U; Franken, T; Pieper, R; Baron, U; Olek, S; Zentek, J; Brockmann, GA				Karweina, Diana; Kreuzer-Redmer, Susanne; Mueller, Uwe; Franken, Tobias; Pieper, Robert; Baron, Udo; Olek, Sven; Zentek, Juergen; Brockmann, Gudrun A.			The Zinc Concentration in the Diet and the Length of the Feeding Period Affect the Methylation Status of the ZIP4 Zinc Transporter Gene in Piglets	PLOS ONE			English	Article							ANTIBIOTIC GROWTH PROMOTERS; MESSENGER-RNA; WEANLING PIGS; REDUCED USE; EXPRESSION; TRANSCRIPTION; PROTEIN; OXIDE; WEB; METALLOTHIONEIN	High doses of zinc oxide are commonly used in weaned pig diets to improve performance and health. Recent reports show that this may also lead to an imbalanced zinc homeostasis in the animal. For a better understanding of the regulatory mechanisms of different zinc intakes, we performed a feeding experiment to assess potential epigenetic regulation of the ZIP4 gene expression via DNA methylation in the small intestine of piglets. Fifty-four piglets were fed diets with 57 (LZn), 164 (NZn) or 2,425 (HZn) mg Zn/kg feed for one or four weeks. The ZIP4 expression data provided significant evidence for counter-regulation of zinc absorption with higher dietary zinc concentrations. The CpG + 735 in the second exon had a 56% higher methylation in the HZn group compared to the others after one week of feeding (8.0.10(-4) < p < 0.035); the methylation of this CpG was strongly negatively associated with the expression of the long ZIP4 transcripts (p < 0.007). In the LZn and NZn diets, the expression of the long ZIP4 transcripts were lower after four vs. one week of feeding (2.9.10(-4) < p < 0.017). The strongest switch leading to high DNA methylation in nearly all analysed regions was dependent on feeding duration or age in all diet groups (3.7.10(-10) < p < 0.099). The data suggest that DNA methylation serves as a fine-tuning mechanism of ZIP4 gene regulation to maintain zinc homeostasis. Methylation of the ZIP4 gene may play a minor role in the response to very high dietary zinc concentration, but may affect binding of alternate zinc-responsive transcription factors.	[Karweina, Diana; Kreuzer-Redmer, Susanne; Mueller, Uwe; Franken, Tobias; Brockmann, Gudrun A.] Humboldt Univ, Fac Life Sci, Albrecht Daniel Thaer Inst Agri & Hort, Breeding Biol & Mol Genet, D-10099 Berlin, Germany; [Pieper, Robert; Zentek, Juergen] Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany; [Baron, Udo; Olek, Sven] Epiontis GmbH, Berlin, Germany	Humboldt University of Berlin; Free University of Berlin; Epiontis GmbH	Brockmann, GA (corresponding author), Humboldt Univ, Fac Life Sci, Albrecht Daniel Thaer Inst Agri & Hort, Breeding Biol & Mol Genet, D-10099 Berlin, Germany.	gudrun.brockmann@hu-berlin.de	Kreuzer-Redmer, Susanne/AAV-4840-2020	Kreuzer-Redmer, Susanne/0000-0001-9425-3356; Baron, Udo/0000-0001-7432-3601; Pieper, Robert/0000-0002-0292-1482; Zentek, Jurgen/0000-0003-2864-9250	Deutsche Forschungsgemeinschaft (DFG) [SFB 852]; Epiontis GmbH	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Epiontis GmbH	The study was funded by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/en/) through grant SFB 852 (http://www.sfb852.de/en/) with JZ as the Speaker of the SFB 852. The DFG had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Epiontis GmbH provided support in the form of salaries for authors [UB, SO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Andrews GK, 2001, BIOMETALS, V14, P223, DOI 10.1023/A:1012932712483; Andrews GK, 2008, BIOCHEM SOC T, V36, P1242, DOI 10.1042/BST0361242; Antala S, 2012, BIOCHEMISTRY-US, V51, P963, DOI 10.1021/bi201553p; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bondzio Angelika, 2013, PLoS One, V8, pe81202, DOI 10.1371/journal.pone.0081202; Brugger D, 2014, ARCH ANIM NUTR, V68, P73, DOI 10.1080/1745039X.2014.898392; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Coneyworth LJ, 2009, P NUTR SOC, V68, P142, DOI 10.1017/S0029665109001104; Dasgupta C, 2012, HYPERTENSION, V60, P697, DOI 10.1161/HYPERTENSIONAHA.112.198242; Davin R, 2013, J ANIM PHYSIOL AN N, V97, P6, DOI 10.1111/jpn.12046; DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747; Dong G, 2015, MOL MED REP, V11, P1582, DOI 10.3892/mmr.2014.2969; Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Penny ME, 2013, ANN NUTR METAB, V62, P31, DOI 10.1159/000348263; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Esteller M, 2008, LANCET, pS90; Fairweather-Tait SJ, 2008, EXP GERONTOL, V43, P382, DOI 10.1016/j.exger.2007.10.015; Feng L, 2007, BIOCHEM GENET, V45, P131, DOI 10.1007/s10528-006-9059-5; Fujimura T, 2012, BRIT J NUTR, V107, P1655, DOI 10.1017/S0007114511004867; Fujishiro H, 2009, TOXICOL APPL PHARM, V241, P195, DOI 10.1016/j.taap.2009.08.015; GfE, 2006, EMPF EN NAHRST BEI S; GOODING JM, 1995, BIOCHEM SOC T, V23, pS332, DOI 10.1042/bst023332s; Han YK, 2011, J SWINE HEALTH PROD, V19, P34; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Jackson KA, 2008, BIOCHEM SOC T, V36, P1262, DOI 10.1042/BST0361262; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Krebs NF, 2000, J NUTR, V130, p1374S, DOI 10.1093/jn/130.5.1374S; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu J, 2008, NUTR NEUROSCI, V11, P96, DOI 10.1179/147683008X301432; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Liuzzi JP, 2009, AM J PHYSIOL-GASTR L, V296, pG517, DOI 10.1152/ajpgi.90568.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maret W, 2008, EXP GERONTOL, V43, P378, DOI 10.1016/j.exger.2007.10.005; Martin L, 2013, J NUTR, V143, P1205, DOI 10.3945/jn.113.177881; Martin L, 2013, ARCH ANIM NUTR, V67, P248, DOI 10.1080/1745039X.2013.801138; Meurens F, 2009, MOL IMMUNOL, V46, P927, DOI 10.1016/j.molimm.2008.09.036; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Nielsen FH, 2012, ADV NUTR, V3, P783, DOI 10.3945/an.112.002881; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Owusu-Asiedu A, 2003, J ANIM SCI, V81, P1790; Pettigrew JE, 2006, ANIM BIOTECHNOL, V17, P207, DOI 10.1080/10495390600956946; Pieper R, 2015, J TRACE ELEM MED BIO, V30, P30, DOI 10.1016/j.jtemb.2015.01.008; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qiao H, 2011, BIOCHEM J, V440, P73, DOI 10.1042/BJ20110392; Romero-Tlalolini MA, 2013, BIOCHEM BIOPH RES CO, V438, P54, DOI 10.1016/j.bbrc.2013.07.023; Sales J, 2013, BIOL TRACE ELEM RES, V152, P343, DOI 10.1007/s12011-013-9638-3; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Seal BS, 2013, ANIM HEALTH RES REV, V14, P78, DOI 10.1017/S1466252313000030; Sharif R, 2012, MUTAT RES-FUND MOL M, V733, P111, DOI 10.1016/j.mrfmmm.2011.08.009; Sharma A, 2013, PHYSIOL MOL BIOL PLA, V19, P11, DOI 10.1007/s12298-012-0139-1; Smit AFA, 2015, REPEATMASKER WEB SER; Solomons NW, 2013, ANN NUTR METAB, V62, P8, DOI 10.1159/000348547; Starke Ingo C, 2014, Mol Biol Int, V2014, P548683, DOI 10.1155/2014/548683; Stein HH, 2006, ANIM BIOTECHNOL, V17, P217, DOI 10.1080/10495390600957191; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P426, DOI 10.1079/9781845934729.0426; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VANBEERSSCHREURS HMG, 1992, VET QUART, V14, P29, DOI 10.1080/01652176.1992.9694322; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Weaver BP, 2007, BIOL CHEM, V388, P1301, DOI 10.1515/BC.2007.149; Wong CP, 2013, J NUTR BIOCHEM, V24, P353, DOI 10.1016/j.jnutbio.2012.07.005; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang YQ, 2013, EMBO MOL MED, V5, P1322, DOI 10.1002/emmm.201302507; Zhang YQ, 2010, CLIN CANCER RES, V16, P1423, DOI 10.1158/1078-0432.CCR-09-2405	68	11	12	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143098	10.1371/journal.pone.0143098	http://dx.doi.org/10.1371/journal.pone.0143098			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599865	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900064
J	Luk, KC; Berg, MG; Naccache, SN; Kabre, B; Federman, S; Mbanya, D; Kaptue, L; Chiu, CY; Brennan, CA; Hackett, J				Luk, Ka-Cheung; Berg, Michael G.; Naccache, Samia N.; Kabre, Beniwende; Federman, Scot; Mbanya, Dora; Kaptue, Lazare; Chiu, Charles Y.; Brennan, Catherine A.; Hackett, John, Jr.			Utility of Metagenomic Next-Generation Sequencing for Characterization of HIV and Human Pegivirus Diversity	PLOS ONE			English	Article							CIRCULATING RECOMBINANT FORM; GB-VIRUS-C; VIRAL GENETIC DIVERSITY; SUBTYPE-A; GENOME CHARACTERIZATION; PATHOGEN DISCOVERY; CLINICAL-SAMPLES; TYPE-1; IDENTIFICATION; CAMEROON	Given the dynamic changes in HIV-1 complexity and diversity, next-generation sequencing (NGS) has the potential to revolutionize strategies for effective HIV global surveillance. In this study, we explore the utility of metagenomic NGS to characterize divergent strains of HIV-1 and to simultaneously screen for other co-infecting viruses. Thirty-five HIV-1-infected Cameroonian blood donor specimens with viral loads of >4.4 log(10) copies/ml were selected to include a diverse representation of group M strains. Random-primed NGS libraries, prepared from plasma specimens, resulted in greater than 90% genome coverage for 88% of specimens. Correct subtype designations based on NGS were concordant with sub-region PCR data in 31 of 35 (89%) cases. Complete genomes were assembled for 25 strains, including circulating recombinant forms with relatively limited data available (7 CRF11_cpx, 2 CRF13_cpx, 1 CRF18_cpx, and 1 CRF37_cpx), as well as 9 unique recombinant forms. HPgV (formerly designated GBV-C) co-infection was detected in 9 of 35 (25%) specimens, of which eight specimens yielded complete genomes. The recovered HPgV genomes formed a diverse cluster with genotype 1 sequences previously reported from Ghana, Uganda, and Japan. The extensive genome coverage obtained by NGS improved accuracy and confidence in phylogenetic classification of the HIV-1 strains present in the study population relative to conventional sub-region PCR. In addition, these data demonstrate the potential for metagenomic analysis to be used for routine characterization of HIV-1 and identification of other viral co-infections.	[Luk, Ka-Cheung; Berg, Michael G.; Brennan, Catherine A.; Hackett, John, Jr.] Abbott Diagnost, Infect Dis Res, Abbott Pk, IL 60064 USA; [Naccache, Samia N.; Kabre, Beniwende; Federman, Scot; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Naccache, Samia N.; Kabre, Beniwende; Federman, Scot; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA; [Mbanya, Dora] Univ Yaounde I, Yaounde, Cameroon; [Kaptue, Lazare] Univ Montagnes, Bangangte, Cameroon; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA	University of California System; University of California San Francisco; University of Yaounde I; University of California System; University of California San Francisco	Hackett, J (corresponding author), Abbott Diagnost, Infect Dis Res, Abbott Pk, IL 60064 USA.	john.hackett@abbott.com			National Institutes of Health [R01-HL105704]; UCSF-Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF-Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by the National Institutes of Health, R01-HL105704 (to CYC) and UCSF-Abbott Viral Discovery Award (to CYC). The funder provided support in the form of salaries for authors KCL, MGB, CAB, JH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Archer J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000178; Barin F, 1996, AIDS RES HUM RETROV, V12, P1279, DOI 10.1089/aid.1996.12.1279; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bobkov AF, 2004, J MED VIROL, V74, P191, DOI 10.1002/jmv.20177; Brennan CA, 2008, JAIDS-J ACQ IMM DEF, V49, P432, DOI 10.1097/QAI.0b013e31818a6561; Brennan CA, 2006, J MED VIROL, V78, pS24, DOI 10.1002/jmv.20603; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001; de Oliveira CF, 2000, TRANSFUSION, V40, P1399, DOI 10.1046/j.1537-2995.2000.40111399.x; Delaugerre C, 2011, LANCET, V378, P1894, DOI 10.1016/S0140-6736(11)61457-8; Delwart E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003146; Firth C, 2013, ANNU REV GENOM HUM G, V14, P281, DOI 10.1146/annurev-genom-091212-153446; Ghai RR, 2013, J GEN VIROL, V94, P2670, DOI 10.1099/vir.0.055509-0; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hemelaar J, 2013, J INFECTION, V66, P391, DOI 10.1016/j.jinf.2012.10.026; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Konings FAJ, 2006, JAIDS-J ACQ IMM DEF, V42, P331, DOI 10.1097/01.qai.0000219784.81163.2e; Law J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060595; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Lihana RW, 2012, AIDS REV, V14, P83; Liitsola K, 1998, AIDS, V12, P1907, DOI 10.1097/00002030-199814000-00023; Luk KC, 2007, AIDS RES HUM RETROV, V23, P297, DOI 10.1089/aid.2006.0177; Magiorkinis G, 2003, J GEN VIROL, V84, P2715, DOI 10.1099/vir.0.19180-0; Giret MTM, 2012, CURR HIV-AIDS REP, V9, P26, DOI 10.1007/s11904-011-0109-1; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Montavon C, 2002, AIDS RES HUM RETROV, V18, P231, DOI 10.1089/08892220252781301; Mourez T, 2013, CLIN MICROBIOL REV, V26, P448, DOI 10.1128/CMR.00012-13; Muerhoff AS, 2006, J MED VIROL, V78, P105, DOI 10.1002/jmv.20510; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Peeters M, 2014, AIDS REV, V16, P23; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Powell RLR, 2008, AIDS RES HUM RETROV, V24, P100, DOI 10.1089/aid.2007.0162; Powell RLR, 2007, AIDS RES HUM RETROV, V23, P923, DOI 10.1089/aid.2007.0040; Pyne MT, 2013, J CLIN MICROBIOL, V51, P2662, DOI 10.1128/JCM.00880-13; Redd AD, 2011, J CLIN MICROBIOL, V49, P2859, DOI 10.1128/JCM.00804-11; Sahni H, 2014, J MED VIROL, V86, P426, DOI 10.1002/jmv.23845; Schwarze-Zander C, 2012, EXPERT REV ANTI-INFE, V10, P563, DOI [10.1586/eri.12.37, 10.1586/ERI.12.37]; Semaille C, 2007, J INFECT DIS, V196, P377, DOI 10.1086/519387; Simen BB, 2014, J VIROL METHODS, V204, P31, DOI 10.1016/j.jviromet.2014.04.007; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; Swei A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062083; Thomson MA, 2005, AIDS, V19, P1155, DOI 10.1097/01.aids.0000176215.95119.1d; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Van Heuverswyn F, 2007, VIROLOGY, V368, P155, DOI 10.1016/j.virol.2007.06.018; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Wilbe K, 2002, AIDS RES HUM RETROV, V18, P849, DOI 10.1089/08892220260190326; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; World Health Organization, 2010, CAM HLTH STAT PROF; Yang J, 2011, J CLIN MICROBIOL, V49, P3463, DOI 10.1128/JCM.00273-11; Yin L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-108	60	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141723	10.1371/journal.pone.0141723	http://dx.doi.org/10.1371/journal.pone.0141723			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599538	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900014
J	Stach, CS; Vu, BG; Schlievert, PM				Stach, Christopher S.; Vu, Bao G.; Schlievert, Patrick M.			Determining the Presence of Superantigens in Coagulase Negative Staphylococci from Humans	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; BLOOD-STREAM INFECTIONS; ENTEROTOXIN-F; AUREUS; HOSPITALS; EXOTOXINS	Superantigens (SAgs) are important virulence factors in S. aureus. Recent studies identified their presence in animal coagulase-negative staphylococci (CNS). The emergence of human-associated SAg+ CNS would mark a prodigious shift in virulence capabilities. We examined CNS isolates from healthy human nares and diseased individuals, and determined that no known SAgs were present.	[Stach, Christopher S.; Vu, Bao G.; Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Schlievert, PM (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	patrick-schlievert@uiowa.edu		Schlievert, Patrick/0000-0001-8314-9369	University of Iowa Start-up funds	University of Iowa Start-up funds	This research was supported by the University of Iowa Start-up funds for PMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, J DERMATOL SCI, V24, P142, DOI 10.1016/S0923-1811(00)00122-5; BERGDOLL MS, 1981, LANCET, V1, P1017; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; BONVENTRE PF, 1983, INFECT IMMUN, V40, P1023, DOI 10.1128/IAI.40.3.1023-1029.1983; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; CRASS BA, 1986, J CLIN MICROBIOL, V23, P43, DOI 10.1128/JCM.23.1.43-45.1986; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; KREISWIRTH BN, 1987, J CLIN MICROBIOL, V25, P2028, DOI 10.1128/JCM.25.10.2028-2029.1987; Madhusoodanan J, 2011, J BACTERIOL, V193, P1854, DOI 10.1128/JB.00162-10; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Park JY, 2011, VET MICROBIOL, V147, P142, DOI 10.1016/j.vetmic.2010.06.020; Park JY, 2011, VET MICROBIOL, V147, P149, DOI 10.1016/j.vetmic.2010.06.021; Salgado-Pabon W, 2013, METHODS MOL BIOL, V185, P169, DOI 10.1007/978-1-62703-664-1_10; Schlievert PA, 2007, J CLIN MICROBIOL, V45, P2704, DOI 10.1128/JCM.02295-06; SCHLIEVERT PM, 1988, METHOD ENZYMOL, V165, P339; SCHLIEVERT PM, 1991, J INFECT DIS, V164, P1245, DOI 10.1093/infdis/164.6.1245; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/infdis/143.4.509; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Vu BG, 2014, J INFECT DIS, V210, P1920, DOI 10.1093/infdis/jiu350; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zell C, 2008, INT J FOOD MICROBIOL, V127, P246, DOI 10.1016/j.ijfoodmicro.2008.07.016	22	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143341	10.1371/journal.pone.0143341	http://dx.doi.org/10.1371/journal.pone.0143341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599862	Green Published, gold			2022-12-27	WOS:000365853900096
J	Dong, YB; Wang, QL; Zhang, L; Du, CG; Xiong, WW; Chen, XJ; Deng, F; Ma, ZY; Qiao, DH; Hu, CH; Ren, YL; Li, YL				Dong, Yongbin; Wang, Qilei; Zhang, Long; Du, Chunguang; Xiong, Wenwei; Chen, Xinjian; Deng, Fei; Ma, Zhiyan; Qiao, Dahe; Hu, Chunhui; Ren, Yangliu; Li, Yuling			Dynamic Proteomic Characteristics and Network Integration Revealing Key Proteins for Two Kernel Tissue Developments in Popcorn	PLOS ONE			English	Article							MAIZE ENDOSPERM DEVELOPMENT; QUALITY-RELATED TRAITS; QUANTITATIVE EXPRESSION; MASS-SPECTROMETRY; GENE-EXPRESSION; MESSENGER-RNA; DRYING RATE; PERICARP; ABUNDANCE; HEAT	The formation and development of maize kernel is a complex dynamic physiological and biochemical process that involves the temporal and spatial expression of many proteins and the regulation of metabolic pathways. In this study, the protein profiles of the endosperm and pericarp at three important developmental stages were analyzed by isobaric tags for relative and absolute quantification (iTRAQ) labeling coupled with LC-MS/MS in popcorn inbred N04. Comparative quantitative proteomic analyses among developmental stages and between tissues were performed, and the protein networks were integrated. A total of 6,876 proteins were identified, of which 1,396 were nonredundant. Specific proteins and different expression patterns were observed across developmental stages and tissues. The functional annotation of the identified proteins revealed the importance of metabolic and cellular processes, and binding and catalytic activities for the development of the tissues. The whole, endosperm-specific and pericarp-specific protein networks integrated 125, 9 and 77 proteins, respectively, which were involved in 54 KEGG pathways and reflected their complex metabolic interactions. Confirmation for the iTRAQ endosperm proteins by two-dimensional gel electrophoresis showed that 44.44% proteins were commonly found. However, the concordance between mRNA level and the protein abundance varied across different proteins, stages, tissues and inbred lines, according to the gene cloning and expression analyses of four relevant proteins with important functions and different expression levels. But the result by western blot showed their same expression tendency for the four proteins as by iTRAQ. These results could provide new insights into the developmental mechanisms of endosperm and pericarp, and grain formation in maize.	[Dong, Yongbin; Wang, Qilei; Zhang, Long; Deng, Fei; Ma, Zhiyan; Qiao, Dahe; Hu, Chunhui; Ren, Yangliu; Li, Yuling] Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crop Sci, Coll Agron, Zhengzhou, Peoples R China; [Du, Chunguang; Xiong, Wenwei] Montclair State Univ, Deptment Biol & Mol Biol, Montclair, NJ 07043 USA; [Chen, Xinjian] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	Henan Agricultural University; Montclair State University; Henan Agricultural University	Li, YL (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crop Sci, Coll Agron, 63 Nongye Rd, Zhengzhou, Peoples R China.	yuling_li@126.com	Xiong, Wenwei/G-5010-2015; Ma, Shisong/E-7225-2012	Xiong, Wenwei/0000-0002-1790-7384; Ma, Shisong/0000-0001-5563-448X; Zhang, Long/0000-0002-3856-726X	Plan for Fundamental and Forward Technology Research in Henan Province [121100910400]; Plan for Scientific Innovation Talent of Henan Province [124200510003]; Agricultural Science Creation in Henan Province; Modern Agricultural System in Industry and Technology of Henan Province [S2010-02-G01]	Plan for Fundamental and Forward Technology Research in Henan Province; Plan for Scientific Innovation Talent of Henan Province; Agricultural Science Creation in Henan Province; Modern Agricultural System in Industry and Technology of Henan Province	Funding: This work was funded by the Plan for Fundamental and Forward Technology Research in Henan Province (121100910400), the Plan for Scientific Innovation Talent of Henan Province (124200510003), the Agricultural Science Creation in Henan Province, and the Modern Agricultural System in Industry and Technology of Henan Province (S2010-02-G01).	Al-Whaibi Mohamed H., 2011, Journal of King Saud University Science, V23, P139, DOI 10.1016/j.jksus.2010.06.022; Aprile A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-821; Ayliffe MA, 2002, PLANT PHYSIOL, V129, P169, DOI 10.1104/pp.010940; Balconi C, 2007, MAYDICA, V52, P357; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Berger F, 1999, CURR OPIN PLANT BIOL, V2, P28, DOI 10.1016/S1369-5266(99)80006-5; Bondarenko PV, 2002, ANAL CHEM, V74, P4741, DOI 10.1021/ac0256991; Braun DP, 2007, FERTIL STERIL, V87, P263, DOI 10.1016/j.fertnstert.2006.06.026; Chatelain E, 2012, PLANT CELL ENVIRON, V35, P1440, DOI 10.1111/j.1365-3040.2012.02501.x; Dewitte W, 2007, P NATL ACAD SCI USA, V104, P14537, DOI 10.1073/pnas.0704166104; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Fukao Y, 2011, PLANT PHYSIOL, V155, P1893, DOI 10.1104/pp.110.169730; Gambin BL, 2007, MAYDICA, V52, P431; Ganeshan S, 2008, J EXP BOT, V59, P2393, DOI 10.1093/jxb/ern112; GROTEWOLD E, 1994, MOL GEN GENET, V242, P1; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HOOD EE, 1991, PLANT SCI, V79, P13, DOI 10.1016/0168-9452(91)90063-E; Monteoliva MI, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-21; ITO GM, 1991, J AM SOC HORTIC SCI, V116, P1072, DOI 10.21273/JASHS.116.6.1072; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KENNEDY EP, 1961, FED PROC, V20, P934; Kiesselbach T, 1949, NEBRASKA AGR EXP STA, V161, P3; KIESSELBACH TA, 1998, STRUCTURE REPROD COR; KINIRY JR, 1990, AGRON J, V82, P98, DOI 10.2134/agronj1990.00021962008200010023x; Lai JS, 2004, GENOME RES, V14, P1932, DOI 10.1101/gr.2780504; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; LENDING CR, 1992, PROTOPLASMA, V171, P123, DOI 10.1007/BF01403727; Li JZ, 2011, THEOR APPL GENET, V122, P771, DOI 10.1007/s00122-010-1485-4; Li L, 2007, CARBOHYD POLYM, V67, P630, DOI 10.1016/j.carbpol.2006.08.013; Liu YY, 2010, THEOR APPL GENET, V121, P433, DOI 10.1007/s00122-010-1321-x; Mechin V, 2004, PHYTOCHEMISTRY, V65, P1609, DOI 10.1016/j.phytochem.2004.04.035; Mechin V, 2007, PLANT PHYSIOL, V143, P1203, DOI 10.1104/pp.106.092148; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Motto M, 2011, MAYDICA, V56, P291; Motto M, 2010, GENETIKA-BELGRADE, V42, P23, DOI 10.2298/GENSR1001023M; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Olsen OA, 1999, TRENDS PLANT SCI, V4, P253, DOI 10.1016/S1360-1385(99)01431-4; Owiti J, 2011, PLANT J, V67, P145, DOI 10.1111/j.1365-313X.2011.04582.x; Pechanova O, 2013, PROTEOMICS, V13, P637, DOI 10.1002/pmic.201200275; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Prioul JL, 2008, PLANT BIOTECHNOL J, V6, P855, DOI 10.1111/j.1467-7652.2008.00368.x; PURDY JL, 1967, CROP SCI, V7, P379, DOI 10.2135/cropsci1967.0011183X000700040031x; PURDY JL, 1967, CROP SCI, V7, P294, DOI 10.2135/cropsci1967.0011183X000700040003x; Rasband W., 2009, IMAGE J; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Roy A, 2011, P S DAK ACAD SCI, V90, P186; Sabelli PA, 2005, MAYDICA, V50, P485; Sabelli PA, 2009, PLANT PHYSIOL, V149, P14, DOI 10.1104/pp.108.129437; Scanlon Michael J., 2009, P121, DOI 10.1007/978-0-387-79418-1_7; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; SCHWEIZER L, 1995, P NATL ACAD SCI USA, V92, P7070, DOI 10.1073/pnas.92.15.7070; Silva-Sanchez C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00211; Stymne S., 1987, Biochemistry of Plants, V9, P175; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Szymanski J, 2014, PLANT CELL, V26, P915, DOI 10.1105/tpc.113.118919; Takac T, 2011, J PROTEOMICS, V74, P577, DOI 10.1016/j.jprot.2011.02.002; Takacs EM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00115; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Verza NC, 2005, PLANT MOL BIOL, V59, P363, DOI 10.1007/s11103-005-8924-7; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walley JW, 2013, P NATL ACAD SCI USA, V110, pE4808, DOI 10.1073/pnas.1319113110; Wang XC, 2007, ELECTROPHORESIS, V28, P3976, DOI 10.1002/elps.200600805; Waters AJ, 2011, PLANT CELL, V23, P4221, DOI 10.1105/tpc.111.092668; Watson S. A., 1987, Corn: chemistry and technology., P53; [韦靖鸾 Wei Jingluan], 2011, [分子植物育种, Molecular Plant Breeding], V9, P9; Wienkoop S, 2006, J SEP SCI, V29, P2793, DOI 10.1002/jssc.200600290; WOLF MJ, 1969, AGRON J, V61, P777, DOI 10.2134/agronj1969.00021962006100050037x; Woo YM, 2001, PLANT CELL, V13, P2297, DOI 10.1105/tpc.13.10.2297; Yao RQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087142; Zhang M, 2011, P NATL ACAD SCI USA, V108, P20042, DOI 10.1073/pnas.1112186108	74	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143181	10.1371/journal.pone.0143181	http://dx.doi.org/10.1371/journal.pone.0143181			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587848	gold, Green Published, Green Submitted			2022-12-27	WOS:000365251500036
J	Li, YC; Yang, Y; Zhang, R; Yao, K; Liu, ZG				Li, Yingchun; Yang, Ying; Zhang, Rong; Yao, Kun; Liu, Zhuogang			The Mediating Role of Mental Adjustment in the Relationship between Perceived Stress and Depressive Symptoms in Hematological Cancer Patients: A Cross-Sectional Study	PLOS ONE			English	Article							PSYCHOLOGICAL ADJUSTMENT; BREAST-CANCER; PSYCHOSOMATIC SYMPTOMS; SLEEP QUALITY; COPING STYLE; MINI-MAC; ASSOCIATION; DISTRESS; ANXIETY; WOMEN	Background Depression is a particularly common psychological disorder that affects cancer patients. Diagnosed with hematological malignancies constitute a serious unpredictable and uncontrollable medical stress situation and patients are susceptible to suffer from depressive symptoms. The aims of the study were to explore the correlation between perceived stress and depressive symptoms in patients with hematological malignancies, and assess the mediating role of mental adjustment between these variables. Methods A single center, cross-sectional study was performed by convenience sampling between July 2013 and April 2014 in a hospital of China. The Center for Epidemiologic Studies Depression Scale, Perceived Stress Scale, and Mini-Mental Adjustment Scale, as well as questions about demographic and clinical factors was distributed to 300 hematological cancer patients. Completed questionnaires were received from 227 inpatients. Results The results showed that perceived stress was positively correlated with depressive symptoms. The mental adjustment significantly mediated the relationship between perceived stress and depressive symptoms. Conclusions Among hematological cancer patients perceived stress may be a risk factor for depressive symptoms, whereas positive coping style might be protective against depressive symptoms. Results showed that medical managers could support the development of mental adjustment in the patients to alleviate psychological disorders.	[Li, Yingchun; Yang, Ying; Zhang, Rong; Yao, Kun; Liu, Zhuogang] China Med Univ, Shengjing Hosp, Dept Hematol, Shenyang 110021, Peoples R China	China Medical University	Liu, ZG (corresponding author), China Med Univ, Shengjing Hosp, Dept Hematol, 39 Huaxiang Rd, Shenyang 110021, Peoples R China.	liuzhuogang432@163.com						Albrecht TA, 2012, J HOSP PALLIAT NURS, V14, P462, DOI 10.1097/NJH.0b013e318268d04e; Alcalar N, 2012, JPN J CLIN ONCOL, V42, P940, DOI 10.1093/jjco/hys119; [Anonymous], 2003, GUID CANC SERV IMPR; Batenburg A, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3517; Bergerot CD, 2015, PALLIAT SUPPORT CARE, V13, P115, DOI 10.1017/S1478951513000849; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cohen L, 2004, CANCER-AM CANCER SOC, V100, P2253, DOI 10.1002/cncr.20236; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1995, MEASURING STRESS GUI, P3; Cohen S., 1988, SOCIAL PSYCHOL HLTH; Costa R, 2015, PSYCHO-ONCOLOGY, DOI [10.1002/pon.3765, DOI 10.1002/P0N.3765]; D'Angelo B, 2003, PSYCHOL REP, V92, P416, DOI 10.2466/PR0.92.2.416-418; Daniel L, 2016, SUPPORT CARE CANCER, V24, P539, DOI 10.1007/s00520-015-2798-2; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; Emanuel PD, 2007, HEMATOLOGY CLIN PRIN, P389; Ferlay J, 2008, CANC INCIDENCE MORTA; Fujisawa D, 2015, PSYCHO-ONCOLOGY, DOI [10.1002/pon.3840, DOI 10.1002/P0N.3840]; Golden WL, 1992, DEPRESSION PSYCHOL T, P10; GREER S, 1987, CANCER SURV, V6, P439; Hange D, 2013, INT J GEN MED, V6, P307, DOI 10.2147/IJGM.S42201; Hann D, 1999, J PSYCHOSOM RES, V46, P437, DOI 10.1016/S0022-3999(99)00004-5; He Fei, 2013, PLoS One, V8, pe82939, DOI 10.1371/journal.pone.0082939; Ho SMY, 2003, PSYCHO-ONCOLOGY, V12, P547, DOI 10.1002/pon.672; Hoffbrand AV., 2006, ESSENTIAL HAEMATOLOG, V5th ed; Hong JS, 2014, SUPPORT CARE CANCER, V22, P453, DOI 10.1007/s00520-013-1997-y; Korszun A, 2014, BRIT J HAEMATOL, V164, P790, DOI 10.1111/bjh.12698; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lazarus R.S., 1984, EMOTION ADAPTATION; Lemma S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-237; Losiak W, PROCESS COPYING STRE; Manitta V, 2011, J PAIN SYMPTOM MANAG, V42, P432, DOI 10.1016/j.jpainsymman.2010.12.008; Mashhadi MA, 2013, IRAN J CANCER PREV, V6, P12; Mehnert A, 2013, ACTA ONCOL, V52, P1102, DOI 10.3109/0284186X.2013.765063; Montgomery C, 2003, J PSYCHOSOM RES, V54, P289, DOI 10.1016/S0022-3999(02)00396-3; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pulgar A, 2015, BEHAV MED, V41, P1, DOI 10.1080/08964289.2013.833083; Pulte D, 2010, ANN ONCOL, V21, P335, DOI 10.1093/annonc/mdp309; Que JC, 2013, J PALLIAT MED, V16, P1280, DOI 10.1089/jpm.2013.0022; RANA M, 2015, J ORAL MAXILLOFAC SU, V53, P364, DOI DOI 10.1016/J.BJ0MS.2015.01.019; Rottmann N, 2010, QUAL LIFE RES, V19, P827, DOI 10.1007/s11136-010-9653-1; Sampogna F, 2009, BRIT J DERMATOL, V160, P815, DOI 10.1111/j.1365-2133.2008.08992.x; Schnoll RA, 1998, PSYCHO-ONCOLOGY, V7, P69, DOI 10.1002/(SICI)1099-1611(199803/04)7:2<69::AID-PON286>3.0.CO;2-8; Schou I, 2004, PSYCHO-ONCOLOGY, V13, P309, DOI 10.1002/pon.747; Shiloh S, 2008, PSYCHO-ONCOLOGY, V17, P746, DOI 10.1002/pon.1338; Silva SM, 2012, PSYCHOL HEALTH, V27, P1323, DOI 10.1080/08870446.2012.676644; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028610; WATSON M, 1994, J PSYCHOSOC ONCOL, V12, P33, DOI 10.1300/J077V12N03_03; Wong JYH, 2015, PSYCHOL HEALTH MED, V20, P457, DOI 10.1080/13548506.2014.951372; Wu SM, 2014, PSYCHOSOM MED, V76, P252, DOI 10.1097/PSY.0000000000000060; Yilmaz SD, 2015, CANCER NURS, V38, pE57, DOI 10.1097/NCC.0000000000000186	50	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142913	10.1371/journal.pone.0142913	http://dx.doi.org/10.1371/journal.pone.0142913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW8LQ	26587991	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500021
J	Simonov, AN; Holien, JK; Yeung, JCI; Nguyen, AD; Corbin, CJ; Zheng, J; Kuznetsov, VL; Auchus, RJ; Conley, AJ; Bond, AM; Parker, MW; Rodgers, RJ; Martin, LL				Simonov, Alexandr N.; Holien, Jessica K.; Yeung, Joyee Chun In; Nguyen, Ann D.; Corbin, C. Jo; Zheng, Jie; Kuznetsov, Vladimir L.; Auchus, Richard J.; Conley, Alan J.; Bond, Alan M.; Parker, Michael W.; Rodgers, Raymond J.; Martin, Lisandra L.			Mechanistic Scrutiny Identifies a Kinetic Role for Cytochrome b5 Regulation of Human Cytochrome P450c17 (CYP17A1, P450 17A1)	PLOS ONE			English	Article							MOLECULAR-INTERACTIONS; ZONA-RETICULARIS; ELECTRODE; B(5); STEROIDOGENESIS; EXPRESSION; REDUCTASE; SERVER; LEVEL; 2E1	Cytochrome P450c17 (P450 17A1, CYP17A1) is a critical enzyme in the synthesis of androgens and is now a target enzyme for the treatment of prostate cancer. Cytochrome P450c17 can exhibit either one or two physiological enzymatic activities differentially regulated by cytochrome b5. How this is achieved remains unknown. Here, comprehensive in silico, in vivo and in vitro analyses were undertaken. Fluorescence Resonance Energy Transfer analysis showed close interactions within living cells between cytochrome P450c17 and cytochrome b5. In silico modeling identified the sites of interaction and confirmed that E48 and E49 residues in cytochrome b5 are essential for activity. Quartz crystal microbalance studies identified specific protein-protein interactions in a lipid membrane. Voltammetric analysis revealed that the wild type cytochrome b5, but not a mutated, E48G/E49G cyt b5, altered the kinetics of electron transfer between the electrode and the P450c17. We conclude that cytochrome b5 can influence the electronic conductivity of cytochrome P450c17 via allosteric, protein-protein interactions.	[Simonov, Alexandr N.; Yeung, Joyee Chun In; Bond, Alan M.; Martin, Lisandra L.] Monash Univ, Sch Chem, Clayton, Vic, Australia; [Holien, Jessica K.; Parker, Michael W.] St Vincents Inst Med Res, ACRF Rat Drug Discovery Ctr, Fitzroy, Vic 3065, Australia; [Nguyen, Ann D.; Corbin, C. Jo; Conley, Alan J.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Zheng, Jie] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Kuznetsov, Vladimir L.] Boreskov Inst Catalysis, Prospekt Lavrentieva 5, Novosibirsk, Russia; [Auchus, Richard J.] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Rodgers, Raymond J.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Discipline Obstet & Gynaecol, Adelaide, SA, Australia	Monash University; St. Vincent's Institute of Medical Research; University of California System; University of California Davis; University of California System; University of California Davis; Boreskov Institute of Catalysis, Siberian Branch, Russian Academy of Sciences; University of Michigan System; University of Michigan; University of Melbourne; Robinson Research Institute; University of Adelaide	Martin, LL (corresponding author), Monash Univ, Sch Chem, Clayton, Vic, Australia.	Lisa.Martin@monash.edu	Parker, Michael W/F-9069-2013; Martin, Lisandra L/E-4482-2010; Simonov, Alexandr N/K-1118-2013; Kuznetsov, Vladimir L/C-9648-2012; Simonov, Alexandr/B-6236-2015; Rodgers, Raymond J/C-3476-2009; Holien, Jess/V-7005-2019; Bond, Alan M/Y-7128-2018	Parker, Michael W/0000-0002-3101-1138; Martin, Lisandra L/0000-0003-0486-5813; Simonov, Alexandr N/0000-0003-3063-6539; Kuznetsov, Vladimir L/0000-0002-9087-5630; Simonov, Alexandr/0000-0003-3063-6539; Holien, Jess/0000-0002-8735-2871; Bond, Alan M/0000-0002-1113-5205; Conley, Alan/0000-0003-3798-7390	Australian Research Council; National Health and Medical Research Council; National Institutes of Health [R01GM086596]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: LLM and AMB thank the Australian Research Council, RJR the National Health and Medical Research Council and RJA the National Institutes of Health (R01GM086596) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; [Anonymous], SOLUTION STRUCTURE H, DOI DOI 10.2210/PDB2I96/PDB; Bard A. J., 2001, ELECTROCHEMICAL METH; Bond AM, 2015, ELECTROCHEM COMMUN, V57, P78, DOI 10.1016/j.elecom.2015.04.017; Bond AM, 2014, DEVELOPMENTS IN ELECTROCHEMISTRY: SCIENCE INSPIRED BY MARTIN FLEISCHMANN, P21; Bond AM, 2005, ANAL CHEM, V77, p186A, DOI 10.1021/ac053370k; Bowden JA, 2009, J CHROMATOGR B, V877, P3237, DOI 10.1016/j.jchromb.2009.08.005; Cherstiouk OV, 2010, PHYS STATUS SOLIDI B, V247, P2738, DOI 10.1002/pssb.201000352; Corbin CJ, 2003, BIOL REPROD, V69, P390, DOI 10.1095/biolreprod.103.015578; De Montellano P, 2005, CYTOCHROME P 450 STR; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Dharia S, 2004, BIOL REPROD, V71, P83, DOI 10.1095/biolreprod.103.026732; Elumeeva KV, 2013, AIP ADV, V3, DOI 10.1063/1.4829272; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Fleming BD, 2007, UBIQUITOUS ROLES CYT, V3; HOLMANS PL, 1994, ARCH BIOCHEM BIOPHYS, V312, P554, DOI 10.1006/abbi.1994.1345; Johnson DL, 2006, J MOL ENDOCRINOL, V36, P349, DOI 10.1677/jme.1.01971; Kennedy GF., MONASH ELECTROCHEMIS; Knappe D, 2010, J MED CHEM, V53, P5240, DOI 10.1021/jm100378b; Kuznetsov VL, 2010, PHYS STATUS SOLIDI B, V247, P2695, DOI 10.1002/pssb.201000211; Lee-Robichaud P, 2004, J STEROID BIOCHEM, V92, P119, DOI 10.1016/j.jsbmb.2004.07.005; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Mapes S, 1999, J CLIN ENDOCR METAB, V84, P3382, DOI 10.1210/jc.84.9.3382; Mechler A, 2009, BIOMATERIALS, V30, P682, DOI 10.1016/j.biomaterials.2008.10.016; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Moran FM, 2002, ENDOCRINOLOGY, V143, P3361, DOI 10.1210/en.2002-220329; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; Nguyen AD, 2009, ENDOCRINOLOGY, V150, P1748, DOI 10.1210/en.2008-1303; Nguyen AD, 2008, J ENDOCRINOL, V199, P367, DOI 10.1677/JOE-08-0337; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; Peng HM, 2014, J BIOL CHEM, V289, P33838, DOI 10.1074/jbc.M114.608919; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Praporski S, 2009, J BIOL CHEM, V284, P33224, DOI 10.1074/jbc.M109.006064; Rusling JF, 2003, J COLLOID INTERF SCI, V262, P1, DOI 10.1016/S0021-9797(03)00148-6; Sagara T, 1998, J PHYS CHEM B, V102, P521, DOI 10.1021/jp9713928; Simonov AN, 2014, LANGMUIR, V30, P3264, DOI 10.1021/la404872p; Storbeck KH, 2013, MOL CELL ENDOCRINOL, V371, P87, DOI 10.1016/j.mce.2012.11.020; Szczesna-Skorupa E, 2003, J BIOL CHEM, V278, P31269, DOI 10.1074/jbc.M301489200; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Yoshimoto FK, 2015, J STEROID BIOCHEM, V151, P52, DOI 10.1016/j.jsbmb.2014.11.026	42	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0141252	10.1371/journal.pone.0141252	http://dx.doi.org/10.1371/journal.pone.0141252			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587646	Green Published, gold, Green Submitted			2022-12-27	WOS:000365251500003
J	Tagg, KA; Ginn, AN; Partridge, SR; Iredell, JR				Tagg, Kaitlin A.; Ginn, Andrew N.; Partridge, Sally R.; Iredell, Jonathan R.			MALDI-TOF Mass Spectrometry for Multilocus Sequence Typing of Escherichia coli Reveals Diversity among Isolates Carrying bla(CMY-2)-Like Genes	PLOS ONE			English	Article							BETA-LACTAMASE GENES; RESISTANCE; PLASMIDS; EMERGENCE; VIRULENCE; TYPE-2	Effective surveillance and management of pathogenic Escherichia coli relies on robust and reproducible typing methods such as multilocus sequence typing (MLST). Typing of E. coli by MLST enables tracking of pathogenic clones that are known to carry virulence factors or spread resistance, such as the globally-prevalent ST131 lineage. Standard MLST for E. coli requires sequencing of seven alleles, or a whole genome, and can take several days. Here, we have developed and validated a nucleic-acid-based MALDI-TOF mass spectrometry (MS) method for MLST as a rapid alternative to sequencing that requires minimal operator expertise. Identification of alleles was 99.6% concordant with sequencing. We employed MLST by MALDI-TOF MS to investigate diversity among 62 E. coli isolates from Sydney, Australia, carrying a bla(CMY-2)-like gene on an IncI1 plasmid to determine whether any dominant clonal lineages are associated with the spread of this globally-disseminated resistance gene. Thirty-four known sequence types were identified, including lineages associated with human disease, animal and environmental sources. This suggests that the dissemination of bla(CMY-2)-like-genes is more complex than the simple spread of successful pathogenic clones. E. coli MLST by MALDI-TOF MS, employed here for the first time, can be utilised as an automated tool for large-scale population analyses or for targeted screening for known high-risk clones in a diagnostic setting.	[Iredell, Jonathan R.] Univ Sydney, Ctr Infect Dis & Microbiol, Westmead Inst Med Res, Westmead, NSW 2145, Australia; Westmead Hosp, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Iredell, JR (corresponding author), Univ Sydney, Ctr Infect Dis & Microbiol, Westmead Inst Med Res, Westmead, NSW 2145, Australia.	jonathan.iredell@sydney.edu.au	Partridge, Sally R/Q-9374-2019		Australian Postgraduate Award from the University of Sydney; Westmead Millennium Institute Top-Up Scholarship; National Health and Medical Research Council of Australia [G1046886, PF1002076, G1001021, G512396]; Australian Society for Antimicrobials	Australian Postgraduate Award from the University of Sydney; Westmead Millennium Institute Top-Up Scholarship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Society for Antimicrobials	KAT was supported by an Australian Postgraduate Award from the University of Sydney and a Westmead Millennium Institute Top-Up Scholarship. ANG was supported by G1046886, JRI was supported by PF1002076 and this work was supported by G1001021 and G512396, all from the National Health and Medical Research Council of Australia. Illumina sequencing was funded by a grant from the Australian Society for Antimicrobials.	Borjesson S, 2013, CLIN MICROBIOL INFEC, V19, pE309, DOI 10.1111/1469-0691.12192; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Dunne EM, 2011, J CLIN MICROBIOL, V49, P3756, DOI 10.1128/JCM.05113-11; Ginn AN, 2013, INT J ANTIMICROB AG, V42, P19, DOI 10.1016/j.ijantimicag.2013.03.003; Goering RV, 2010, INFECT GENET EVOL, V10, P866, DOI 10.1016/j.meegid.2010.07.023; Groves MD, 2015, VET MICROBIOL, V177, P394, DOI 10.1016/j.vetmic.2015.03.006; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Honisch C, 2007, P NATL ACAD SCI USA, V104, P10649, DOI 10.1073/pnas.0704152104; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kamruzzaman M, 2013, DIAGN MICR INFEC DIS, V76, P222, DOI 10.1016/j.diagmicrobio.2013.02.016; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Manges AR, 2015, FOODBORNE PATHOG DIS, V12, P302, DOI 10.1089/fpd.2014.1860; Mataseje LF, 2010, DIAGN MICR INFEC DIS, V67, P387, DOI 10.1016/j.diagmicrobio.2010.02.027; Matsumura Y, 2013, CLIN MICROBIOL INFEC, V19, P161, DOI 10.1111/j.1469-0691.2012.03762.x; Naseer U, 2010, CLIN MICROBIOL INFEC, V16, P171, DOI 10.1111/j.1469-0691.2009.02861.x; Naseer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041232; Oteo J, 2010, DIAGN MICR INFEC DIS, V67, P270, DOI 10.1016/j.diagmicrobio.2010.02.008; Partridge SR, 2015, INT J ANTIMICROB AG, V45, P130, DOI 10.1016/j.ijantimicag.2014.10.006; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Riley LW, 2014, CLIN MICROBIOL INFEC, V20, P380, DOI 10.1111/1469-0691.12646; Rybicka M, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.10.004; Sidjabat HE, 2014, INT J ANTIMICROB AG, V44, P203, DOI 10.1016/j.ijantimicag.2014.04.016; Soderlund-Strand A, 2008, CLIN CHEM, V54, P86, DOI 10.1373/clinchem.2007.092627; Stanssens P, 2004, GENOME RES, V14, P126; Syrmis MW, 2011, CLIN MICROBIOL INFEC, V17, P1804, DOI 10.1111/j.1469-0691.2011.03521.x; Tagg KA, 2015, DIAGN MICR INFEC DIS, V83, P56, DOI 10.1016/j.diagmicrobio.2015.06.001; Tagg KA, 2014, ANTIMICROB AGENTS CH, V58, P4949, DOI 10.1128/AAC.02773-14; Voets GM, 2013, INT J FOOD MICROBIOL, V167, P359, DOI 10.1016/j.ijfoodmicro.2013.10.001; Weissman SJ, 2013, INT J ANTIMICROB AG, V41, P414, DOI 10.1016/j.ijantimicag.2013.01.006; Weissman SJ, 2012, APPL ENVIRON MICROB, V78, P1353, DOI 10.1128/AEM.06663-11; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	35	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143446	10.1371/journal.pone.0143446	http://dx.doi.org/10.1371/journal.pone.0143446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588228	Green Published, gold			2022-12-27	WOS:000365251500063
J	Kumar, V; Jha, P				Kumar, Vipan; Jha, Prashant			Growth and Reproduction of Glyphosate-Resistant and Susceptible Populations of Kochia scoparia	PLOS ONE			English	Article							HORSEWEED CONYZA-CANADENSIS; EPSPS GENE AMPLIFICATION; SULFONYLUREA-RESISTANT; MANAGEMENT-PRACTICES; AMARANTHUS-PALMERI; LOLIUM-RIGIDUM; FITNESS COST; GERMINATION; SEED; HERBICIDES	Evolution of glyphosate-resistant kochia is a threat to no-till wheat-fallow and glyphosate-resistant (GR) cropping systems of the US Great Plains. The EPSPS (5-enol-pyruvylshikimate- 3-phosphate synthase) gene amplification confers glyphosate resistance in the tested Kochia scoparia (L.) Schrad populations from Montana. Experiments were conducted in spring to fall 2014 (run 1) and summer 2014 to spring 2015 (run 2) to investigate the growth and reproductive traits of the GR vs. glyphosate-susceptible (SUS) populations of K. scoparia and to determine the relationship of EPSPS gene amplification with the level of glyphosate resistance. GR K. scoparia inbred lines (CHES01 and JOP01) exhibited 2 to 14 relative copies of the EPSPS gene compared with the SUS inbred line with only one copy. In the absence of glyphosate, no differences in growth and reproductive parameters were evident between the tested GR and SUS inbred lines, across an intraspecific competition gradient (1 to 170 plants m(-2)). GR K. scoparia plants with 2 to 4 copies of the EPSPS gene survived the field-use rate (870 g ha(-1)) of glyphosate, but failed to survive the 4,350 g ha(-1) rate of glyphosate (five-times the field-use rate). In contrast, GR plants with 5 to 14 EPSPS gene copies survived the 4,350 g ha(-1) of glyphosate. The results from this research indicate that GR K. scoparia with 5 or more EPSPS gene copies will most likely persist in field populations, irrespective of glyphosate selection pressure.	[Kumar, Vipan; Jha, Prashant] Montana State Univ Bozeman, Southern Agr Res Ctr, Huntley, MT 59037 USA	Montana State University System; Montana State University Bozeman	Jha, P (corresponding author), Montana State Univ Bozeman, Southern Agr Res Ctr, Huntley, MT 59037 USA.	pjha@montana.edu	Kumar, Vipan/N-1879-2019	Kumar, Vipan/0000-0002-8301-5878	Montana Wheat and Barley Committee [4W5159]	Montana Wheat and Barley Committee	The authors acknowledge Montana Wheat and Barley Committee for funding this research, grant# 4W5159. The grant was obtained by PJ.	Al-Ahmadi MJ, 2007, J ARID ENVIRON, V68, P308, DOI 10.1016/j.jaridenv.2006.05.006; Alcorta M, 2011, WEED SCI, V59, P489, DOI 10.1614/WS-D-10-00186.1; Baker DV, 2010, INVAS PLANT SCI MANA, V3, P301, DOI 10.1614/IPSM-D-09-00016.1; Brabham CB, 2011, WEED SCI, V59, P506, DOI 10.1614/WS-D-11-00050.1; Christoffoleti PJ, 1997, WEED SCI, V45, P691; Cranston HJ, 2001, WEED SCI, V49, P164, DOI 10.1614/0043-1745(2001)049[0164:DRIK]2.0.CO;2; Davis VM, 2009, WEED SCI, V57, P417, DOI 10.1614/WS-09-006.1; Eberlein C. V., 1984, Weeds Today, V15, P5; EVERITT JH, 1983, J RANGE MANAGE, V36, P646, DOI 10.2307/3898360; Forcella F., 1985, Weeds Today, V16, P4; Friesen LF, 2009, CAN J PLANT SCI, V89, P141, DOI 10.4141/CJPS08057; Gaines TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065819; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Giacomini D, 2014, WEED SCI, V62, P29, DOI 10.1614/WS-D-13-00066.1; Glettner CE, 2015, WEED SCI, V63, P273, DOI 10.1614/WS-D-14-00040.1; Godar AS, 2015, WEED SCI, V63, P587, DOI 10.1614/WS-D-14-00145.1; Heap I, INT SURVEY HERBICIDE; Jugulam M, 2014, PLANT PHYSIOL, V166, P1200, DOI 10.1104/pp.114.242826; Kumar V, 2015, WEED TECHNOL, V29, P24, DOI 10.1614/WT-D-14-00026.1; Kumar V, 2015, WEED SCI, V63, P758, DOI 10.1614/WS-D-15-00021.1; Kumar V, 2015, CROP PROT, V71, P144, DOI 10.1016/j.cropro.2015.02.016; Kumar V, 2014, WEED TECHNOL, V28, P122, DOI 10.1614/WT-D-13-00115.1; Legere A, 2013, WEED SCI, V61, P267, DOI 10.1614/WS-D-12-00116.1; Lehnhoff EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064478; Lorentz L, 2014, J AGR FOOD CHEM, V62, P8134, DOI 10.1021/jf501040x; Menalled FD, 2007, WEED BIOL MANAG, V7, P115, DOI 10.1111/j.1445-6664.2007.00244.x; Mengistu LW, 2002, WEED SCI, V50, P498, DOI 10.1614/0043-1745(2002)050[0498:GDOK]2.0.CO;2; Nandula VK, 2014, PEST MANAG SCI, V70, P1902, DOI 10.1002/ps.3754; Pan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076872; Preston C, 2008, PEST MANAG SCI, V64, P372, DOI 10.1002/ps.1489; Preston C, 2009, WEED SCI, V57, P435, DOI 10.1614/WS-08-181.1; Salas RA, 2012, PEST MANAG SCI, V68, P1223, DOI 10.1002/ps.3342; Sbatella GM, 2010, WEED TECHNOL, V24, P392, DOI 10.1614/WT-D-09-00023.1; Schwinghamer TD, 2008, WEED SCI, V56, P37, DOI 10.1614/WS-07-098.1; STALLINGS GP, 1995, WEED SCI, V43, P95, DOI 10.1017/S0043174500080887; Steadman KJ, 2006, AUST J AGR RES, V57, P133, DOI 10.1071/AR05122; Vila-Aiub MM, 2015, WEED SCI, V63, P203, DOI 10.1614/WS-D-14-00062.1; Vila-Aiub MM, 2014, PLANTA, V239, P793, DOI 10.1007/s00425-013-2022-x; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Vila-Aiub MM, 2009, J ECOL, V97, P772, DOI 10.1111/j.1365-2745.2009.01511.x; Wiersma AT, 2015, PLANTA, V241, P463, DOI 10.1007/s00425-014-2197-9; YOUNG JA, 1981, AGRON J, V73, P957, DOI 10.2134/agronj1981.00021962007300060012x	42	16	16	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142675	10.1371/journal.pone.0142675	http://dx.doi.org/10.1371/journal.pone.0142675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580558	Green Published, Green Submitted, gold			2022-12-27	WOS:000365154600056
J	Lee, HB; Kim, J; Kim, SH; Kim, S; Kim, OJ; Oh, SH				Lee, Han-Bin; Kim, Jinkwon; Kim, Sang-Heum; Kim, Soonhag; Kim, Ok-Joon; Oh, Seung-Hun			Association between Serum Alkaline Phosphatase Level and Cerebral Small Vessel Disease	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; SILENT BRAIN INFARCTS; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; RISK; MORTALITY; ATHEROSCLEROSIS; PREDICTOR; DEMENTIA	Background Serum alkaline phosphatase (ALP) is a marker of vascular calcification. A high serum ALP level is associated with an increase in cardiovascular events, and predicts poor functional outcome in patients with stroke. We investigated whether serum ALP was associated with cerebral small vessel disease (cSVD) and large cerebral artery stenosis (LCAS). Methods We evaluated vascular risk factors, brain magnetic resonance images (MRIs), and MR angiograms from 1,011 neurologically healthy participants. The presence of silent lacunar infarction (SLI) and moderate-to-severe cerebral white matter hyperintensities (MS-cWMH) were evaluated as indices of cSVD on brain MRIs. Findings of extracranial arterial stenosis (ECAS) or intracranial arterial stenosis (ICAS) were considered to be indices of LCAS on MR angiograms. Results Subjects with SLI (odds ratio [OR]: 2.09; 95% confidence interval [CI]: 1.27-3.42; p = 0.004) and MS-cWMH (OR: 1.48; 95% CI; 1.03-2.13, p = 0.036) were significantly more likely to have ALP levels in the third tertile (ALP >= 195 IU/L) than the first tertile (ALP <= 155 IU/L), after adjusting for cardiovascular risk factors. The mean serum ALP level was significantly higher in patients with SLI or MS-cWMH compared to patients without those findings. After adjustment for confounding factors, the multivariate model found that the statistical significance of serum ALP remained when the presence of SLI (OR: 1.05 per 10 IU/L increase in ALP; 95% CI: 1.02-1.08; p = 0.003) or MS-cWMH (OR: 1.03 per 10 IU/L increase in ALP; 95% CI: 1.00-1.06; p = 0.025) were added to the model. There were no differences in the proportions of patients with LCAS, ICAS, and ECAS across the serum ALP tertiles. Conclusions Our study of neurologically healthy participants found a positive association between serum ALP level and indicators of cSVD, but no association between serum ALP level and the indicators of LCAS.	[Lee, Han-Bin; Kim, Jinkwon; Kim, Ok-Joon; Oh, Seung-Hun] CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea; [Kim, Sang-Heum] CHA Univ, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea; [Kim, Soonhag] Catholic Kwandong Univ, Coll Med, Inst Biomed Convergence, Gangneung Si, South Korea; [Kim, Soonhag] Catholic Kwandong Univ, Int St Marys Hosp, Inchon, South Korea	Pochon Cha University; Pochon Cha University; Catholic Kwandong University; Catholic Kwandong University	Oh, SH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea.	ohsh72@chamc.co.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and Technology [2011-0021344]; Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HC14C3297]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and Technology; Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science and Technology (2011-0021344), and a grant from the Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (HC14C3297).	Alagiakrishnan Kannayiram, 2015, J Clin Med Res, V7, P297, DOI 10.14740/jocmr2119w; Bos D, 2011, ARTERIOSCL THROM VAS, V31, P2331, DOI 10.1161/ATVBAHA.111.232728; Brown WR, 2002, J NEUROL SCI, V203, P159, DOI 10.1016/S0022-510X(02)00283-6; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Chung PW, 2010, CEREBROVASC DIS, V30, P65, DOI 10.1159/000314622; Davaine JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107642; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Drueke TB, 2008, CLIN J AM SOC NEPHRO, V3, P1583, DOI 10.2215/CJN.03250708; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; Hamedani AG, 2013, NEUROLOGY, V81, P1308, DOI 10.1212/WNL.0b013e3182a8235b; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Kim J, 2013, STROKE, V44, P3547, DOI 10.1161/STROKEAHA.113.002959; Kunutsor SK, 2014, ATHEROSCLEROSIS, V236, P7, DOI 10.1016/j.atherosclerosis.2014.06.006; Leonards CO, 2012, STROKE, V43, P3046, DOI 10.1161/STROKEAHA.111.646554; Minn YK, 2014, OSTEOPOROSIS INT, V25, P2465, DOI 10.1007/s00198-014-2785-3; Monteith T, 2014, STROKE, V45, P1830, DOI 10.1161/STROKEAHA.114.005447; Park JB, 2013, EUR HEART J, V34, P920, DOI 10.1093/eurheartj/ehs419; Park SY, 2013, THROMB RES, V131, pE12, DOI 10.1016/j.thromres.2012.11.011; Ryu WS, 2010, NEUROLOGY, V75, P1995, DOI 10.1212/WNL.0b013e3181ff966a; Ryu WS, 2014, ATHEROSCLEROSIS, V232, P313, DOI 10.1016/j.atherosclerosis.2013.11.047; Sigrist MK, 2008, NEPHRON CLIN PRACT, V108, pC121, DOI 10.1159/000114202; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Vidal JS, 2010, STROKE, V41, P891, DOI 10.1161/STROKEAHA.110.579581; Wannamethee SG, 2013, ARTERIOSCL THROM VAS, V33, P1070, DOI 10.1161/ATVBAHA.112.300826; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7	31	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143355	10.1371/journal.pone.0143355	http://dx.doi.org/10.1371/journal.pone.0143355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580067	Green Submitted, gold, Green Published			2022-12-27	WOS:000365154600114
J	Yang, ZY; Dong, LM; Zhang, YS; Yang, C; Gou, SM; Li, YF; Xiong, JX; Wu, HS; Wang, CY				Yang, Zhiyong; Dong, Liming; Zhang, Yushun; Yang, Chong; Gou, Shanmiao; Li, Yongfeng; Xiong, Jiongxin; Wu, Heshui; Wang, Chunyou			Prediction of Severe Acute Pancreatitis Using a Decision Tree Model Based on the Revised Atlanta Classification of Acute Pancreatitis	PLOS ONE			English	Article							DETERMINANT-BASED CLASSIFICATION; EPIDEMIOLOGY; MANAGEMENT; SYSTEM	Objective To develop a model for the early prediction of severe acute pancreatitis based on the revised Atlanta classification of acute pancreatitis. Methods Clinical data of 1308 patients with acute pancreatitis (AP) were included in the retrospective study. A total of 603 patients who were admitted to the hospital within 36 hours of the onset of the disease were included at last according to the inclusion criteria. The clinical data were collected within 12 hours after admission. All the patients were classified as having mild acute pancreatitis (MAP), moderately severe acute pancreatitis (MSAP) and severe acute pancreatitis (SAP) based on the revised Atlanta classification of acute pancreatitis. All the 603 patients were randomly divided into training group (402 cases) and test group (201 cases). Univariate and multiple regression analyses were used to identify the independent risk factors for the development of SAP in the training group. Then the prediction model was constructed using the decision tree method, and this model was applied to the test group to evaluate its validity. Results The decision tree model was developed using creatinine, lactate dehydrogenase, and oxygenation index to predict SAP. The diagnostic sensitivity and specificity of SAP in the training group were 80.9% and 90.0%, respectively, and the sensitivity and specificity in the test group were 88.6% and 90.4%, respectively. Conclusions The decision tree model based on creatinine, lactate dehydrogenase, and oxygenation index is more likely to predict the occurrence of SAP.	[Yang, Zhiyong; Dong, Liming; Zhang, Yushun; Gou, Shanmiao; Li, Yongfeng; Xiong, Jiongxin; Wu, Heshui; Wang, Chunyou] Huazhong Univ Sci & Technol, Pancreat Dis Inst, Dept Gen Surg, Union Hosp,Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Yang, Chong] Hosp Univ Elect Sci & Technol China, Organ Transplantat Ctr, Chengdu, Sichuan, Peoples R China; [Yang, Chong] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China	Huazhong University of Science & Technology; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital	Wang, CY (corresponding author), Huazhong Univ Sci & Technol, Pancreat Dis Inst, Dept Gen Surg, Union Hosp,Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.	chunyouwang52@126.com						Acevedo-Piedra NG, 2014, CLIN GASTROENTEROL H, V12, P311, DOI 10.1016/j.cgh.2013.07.042; Augustin S, 2009, CLIN GASTROENTEROL H, V7, P1347, DOI 10.1016/j.cgh.2009.08.011; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Gao W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130412; Harrison DA, 2007, CRIT CARE MED, V35, P1703, DOI 10.1097/01.CCM.0000269031.13283.C8; Heller SJ, 1997, PANCREAS, V15, P222, DOI 10.1097/00006676-199710000-00002; Hong WD, 2011, DIGEST DIS SCI, V56, P3664, DOI 10.1007/s10620-011-1849-x; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Nawaz H, 2013, AM J GASTROENTEROL, V108, P1911, DOI 10.1038/ajg.2013.348; Rajaratnam SG, 2006, PANCREAS, V33, P27, DOI 10.1097/01.mpa.0000222315.36490.9b; Satoh K, 2011, PANCREAS, V40, P503, DOI 10.1097/MPA.0b013e318214812b; Shen HN, 2012, PANCREAS, V41, P696, DOI 10.1097/MPA.0b013e31823db941; Shen HN, 2011, PANCREAS, V40, P10, DOI 10.1097/MPA.0b013e3181f7e750; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Ueda T, 2007, SURGERY, V141, P51, DOI 10.1016/j.surg.2006.05.008; Uhl W, 2003, PANCREATOLOGY, V3, DOI 10.1159/000067684; Wu BU, 2008, GUT, V57, P1698, DOI 10.1136/gut.2008.152702; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; Zrnic Irena Krznaric, 2007, Lijec Vjesn, V129, P1	21	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143486	10.1371/journal.pone.0143486	http://dx.doi.org/10.1371/journal.pone.0143486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580397	gold, Green Published			2022-12-27	WOS:000365154600125
J	Chiba, K; Tsuchiya, M; Koide, M; Hagiwara, Y; Sasaki, K; Hattori, Y; Watanabe, M; Sugawara, S; Kanzaki, M; Endo, Y				Chiba, Ko; Tsuchiya, Masahiro; Koide, Masashi; Hagiwara, Yoshihiro; Sasaki, Keiichi; Hattori, Yoshinori; Watanabe, Makoto; Sugawara, Shunji; Kanzaki, Makoto; Endo, Yasuo			Involvement of IL-1 in the Maintenance of Masseter Muscle Activity and Glucose Homeostasis	PLOS ONE			English	Article							SKELETAL-MUSCLE; TEMPOROMANDIBULAR DISORDERS; HISTIDINE-DECARBOXYLASE; OLDER-ADULTS; EXERCISE; MICE; INTERLEUKIN-1; FATIGUE; FATIGABILITY; CELLS	Physical exercise reportedly stimulates IL-1 production within working skeletal muscles, but its physiological significance remains unknown due to the existence of two distinct IL-1 isoforms, IL-1 alpha and IL-1 beta. The regulatory complexities of these two isoforms, in terms of which cells in muscles produce them and their distinct/redundant biological actions, have yet to be elucidated. Taking advantage of our masticatory behavior (Restrained/Gnawing) model, we herein show that IL-1 alpha/1 beta-double-knockout (IL-1-KO) mice exhibit compromised masseter muscle (MM) activity which is at least partially attributable to abnormalities of glucose handling (rapid glycogen depletion along with impaired glucose uptake) and dysfunction of IL-6 upregulation in working MMs. In wild-type mice, masticatory behavior clearly increased IL-1 beta mRNA expression but no incremental protein abundance was detectable in whole MM homogenates, whereas immunohistochemical staining analysis revealed that both IL-1 alpha- and IL-1 beta-immunopositive cells were recruited around blood vessels in the perimysium of MMs after masticatory behavior. In addition to the aforementioned phenotype of IL-1-KO mice, we found the IL-6 mRNA and protein levels in MMs after masticatory behavior to be significantly lower in IL-1-KO than in WT. Thus, our findings confirm that the locally-increased IL-1 elicited by masticatory behavior, although present small in amounts, contributes to supporting MM activity by maintaining normal glucose homeostasis in these muscles. Our data also underscore the importance of IL-1-mediated local interplay between autocrine myokines including IL-6 and paracrine cytokines in active skeletal muscles. This interplay is directly involved in MM performance and fatigability, perhaps mediated through maintaining muscular glucose homeostasis.	[Chiba, Ko; Hattori, Yoshinori; Watanabe, Makoto] Tohoku Univ, Grad Sch Dent, Div Aging & Geriatr Dent, Sendai, Miyagi 980, Japan; [Chiba, Ko; Sugawara, Shunji; Endo, Yasuo] Tohoku Univ, Grad Sch Dent, Div Oral Mol Regulat, Sendai, Miyagi 980, Japan; [Tsuchiya, Masahiro; Watanabe, Makoto] Tohoku Fukushi Univ, Kansei Fukushi Res Inst, Sendai, Miyagi, Japan; [Tsuchiya, Masahiro] Tohoku Univ, Grad Sch Dent, Div Oral Diag, Sendai, Miyagi 980, Japan; [Koide, Masashi; Hagiwara, Yoshihiro] Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 980, Japan; [Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 980, Japan; [Kanzaki, Makoto] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Tsuchiya, M (corresponding author), Tohoku Fukushi Univ, Kansei Fukushi Res Inst, Sendai, Miyagi, Japan.	mtsuchiya@tfu-mail.tfu.ac.jp	Tsuchiya, Masahiro/C-5553-2018; Hattori, Yoshinori/AAE-1393-2019; Kanzaki, Makoto/H-6680-2017	Tsuchiya, Masahiro/0000-0002-7000-4547; Hattori, Yoshinori/0000-0002-9076-4359; Kanzaki, Makoto/0000-0002-6884-2955	Japan Society for the Promotion of Science [23390439, 24390429, 25670813]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the following grants from the Japan Society for the Promotion of Science: 23390439 (to M. Watanabe), and 24390429 and 25670813 (both to M. Tsuchiya). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NB, 2010, J AM GERIATR SOC, V58, P967, DOI 10.1111/j.1532-5415.2010.02811.x; Angelini Corrado, 2014, Acta Myol, V33, P119; Armijo-Olivo S, 2012, CLIN J PAIN, V28, P55, DOI 10.1097/AJP.0b013e31822019f2; Ayada K, 2002, PHYSIOL BEHAV, V77, P161, DOI 10.1016/S0031-9384(02)00844-2; Ayada K, 2000, AM J PHYSIOL-REG I, V279, pR2042, DOI 10.1152/ajpregu.2000.279.6.R2042; Bender SD, 2012, HEADACHE, V52, P22, DOI 10.1111/j.1526-4610.2012.02134.x; CANNON JG, 1986, J APPL PHYSIOL, V61, P1869, DOI 10.1152/jappl.1986.61.5.1869; CANNON JG, 1983, SCIENCE, V220, P617, DOI 10.1126/science.6836306; DELREY A, 1987, AM J PHYSIOL, V253, pR794, DOI 10.1152/ajpregu.1987.253.5.R794; Deng X, 2006, TOXICOL APPL PHARM, V213, P64, DOI 10.1016/j.taap.2005.09.005; Deng X, 2012, INT IMMUNOPHARMACOL, V14, P658, DOI 10.1016/j.intimp.2012.10.001; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1991, BLOOD, V77, P1627; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Eldadah BA, 2010, PM&R, V2, P406, DOI 10.1016/j.pmrj.2010.03.022; ENDO Y, 1985, BIOCHIM BIOPHYS ACTA, V840, P37, DOI 10.1016/0304-4165(85)90159-X; ENDO Y, 1991, IMMUNOL LETT, V27, P75, DOI 10.1016/0165-2478(91)90248-9; EVANS WJ, 1986, J APPL PHYSIOL, V61, P1864, DOI 10.1152/jappl.1986.61.5.1864; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; FERRE P, 1985, BIOCHEM J, V228, P103, DOI 10.1042/bj2280103; Fricton James, 2007, Dent Clin North Am, V51, P61, DOI 10.1016/j.cden.2006.10.002; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Glund S, 2008, ACTA PHYSIOL, V192, P37, DOI 10.1111/j.1748-1716.2007.01779.x; Gore AC, 2013, ENDOCRINOLOGY, V154, P579, DOI 10.1210/en.2012-2222; Gorselink M, 2002, AM J PHYSIOL-ENDOC M, V282, pE348, DOI 10.1152/ajpendo.00085.2001; Grzelkowska-Kowalczyk K, 2006, POL J VET SCI, V9, P1; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Isanejad A, 2015, CYTOKINE, V73, P302, DOI 10.1016/j.cyto.2015.03.013; Jemima EA, 2014, MOL IMMUNOL, V62, P19, DOI 10.1016/j.molimm.2014.05.007; Justice JN, 2014, EXP GERONTOL, V55, P92, DOI 10.1016/j.exger.2014.03.018; Kadotani A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1291, DOI 10.1152/ajpendo.00293.2009; Kitaoka Yu, 2014, Biology (Basel), V3, P157, DOI 10.3390/biology3010157; Kubo K, 2006, ARCH ORAL BIOL, V51, P146, DOI 10.1016/j.archoralbio.2005.06.009; LEE MD, 1987, P NATL ACAD SCI USA, V84, P2590, DOI 10.1073/pnas.84.9.2590; Moreh E, 2010, J GERONTOL A-BIOL, V65, P884, DOI 10.1093/gerona/glq064; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Neu D, 2014, EUR J APPL PHYSIOL, V114, P1841, DOI 10.1007/s00421-014-2910-1; Oguri S, 2002, CLIN DIAGN LAB IMMUN, V9, P1307, DOI 10.1128/CDLI.9.6.1307-1312.2002; Peake JM, 2015, EXERC IMMUNOL REV, V21, P8; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Pedersen BK, 2000, IMMUNOL CELL BIOL, V78, P532, DOI 10.1046/j.1440-1711.2000.00962.x; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reddy K, 2008, MOL CANCER RES, V6, P929, DOI 10.1158/1541-7786.MCR-07-2189; Ruano-Rodriguez C, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00101; Rudroff T, 2014, NEUROREHABILITATION, V35, P813, DOI 10.3233/NRE-141179; Sato S, 2009, HISTOCHEM CELL BIOL, V131, P583, DOI 10.1007/s00418-009-0556-6; Tanaka Y, 2012, J LEUKOCYTE BIOL, V91, P485, DOI 10.1189/jlb.1210697; Tsuchiya M, 2012, TOHOKU J EXP MED, V227, P109, DOI 10.1620/tjem.227.109; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P256, DOI 10.1016/0003-2697(65)90013-8; Vedsted P, 2003, ACTA PHYSIOL SCAND, V178, P175, DOI 10.1046/j.1365-201X.2003.01123.x	53	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143635	10.1371/journal.pone.0143635	http://dx.doi.org/10.1371/journal.pone.0143635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599867	Green Published, gold			2022-12-27	WOS:000365862600097
J	Frindte, K; Allgaier, M; Grossart, HP; Eckert, W				Frindte, Katharina; Allgaier, Martin; Grossart, Hans-Peter; Eckert, Werner			Microbial Response to Experimentally Controlled Redox Transitions at the Sediment Water Interface	PLOS ONE			English	Article							ANAEROBIC METHANE OXIDATION; RIBOSOMAL-RNA; COASTAL SEDIMENTS; LAKE STECHLIN; CARBON; BACTERIA; MARINE; OXYGEN; BIOGEOCHEMISTRY; METHANOGENESIS	The sediment-water interface of freshwater lakes is characterized by sharp chemical gradients, shaped by the interplay between physical, chemical and microbial processes. As dissolved oxygen is depleted in the uppermost sediment, the availability of alternative electron acceptors, e.g. nitrate and sulfate, becomes the limiting factor. We performed a time series experiment in a mesocosm to simulate the transition from aerobic to anaerobic conditions at the sediment-water interface. Our goal was to identify changes in the microbial activity due to redox transitions induced by successive depletion of available electron acceptors. Monitoring critical hydrochemical parameters in the overlying water in conjunction with a new sampling strategy for sediment bacteria enabled us to correlate redox changes in the water to shifts in the active microbial community and the expression of functional genes representing specific redox-dependent microbial processes. Our results show that during several transitions from oxic-heterotrophic condition to sulfate-reducing condition, nitrate-availability and the on-set of sulfate reduction strongly affected the corresponding functional gene expression. There was evidence of anaerobic methane oxidation with NOx. DGGE analysis revealed redox-related changes in microbial activity and expression of functional genes involved in sulfate and nitrite reduction, whereas methanogenesis and methanotrophy showed only minor changes during redox transitions. The combination of high-frequency chemical measurements and molecular methods provide new insights into the temporal dynamics of the interplay between microbial activity and specific redox transitions at the sediment-water interface.	[Frindte, Katharina] Univ Bonn, Dept Soil Sci, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany; [Allgaier, Martin] Berlin Ctr Genom Biodivers Res BeGenDiv, Berlin, Germany; [Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Eckert, Werner] Israel Oceanog & Limnol Res, Yigal Allon Kinneret Limnol Lab, Migdal, Israel	University of Bonn; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam; Israel Oceanographic & Limnological Research Institute	Eckert, W (corresponding author), Israel Oceanog & Limnol Res, Yigal Allon Kinneret Limnol Lab, Migdal, Israel.	werner@ocean.org.il	Eckert, Werner/AAP-9335-2021	Eckert, Werner/0000-0002-2361-6911; Frindte, Katharina/0000-0002-6801-5853	German Research Foundation [GR1540/15-1]	German Research Foundation(German Research Foundation (DFG))	This study was funded by the the German Research Foundation (http://www.dfg.de/en/) (grant #: GR1540/15-1).	Adler M, 2011, LIMNOL OCEANOGR, V56, P1525, DOI 10.4319/lo.2011.56.4.1525; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Auman AJ, 2000, APPL ENVIRON MICROB, V66, P5259, DOI 10.1128/AEM.66.12.5259-5266.2000; Braker G, 2001, APPL ENVIRON MICROB, V67, P1893, DOI 10.1128/AEM.67.4.1893-1901.2001; BRANDES JA, 1995, J MAR RES, V53, P771, DOI 10.1357/0022240953213034; Bryant LD, 2010, LIMNOL OCEANOGR, V55, P950, DOI 10.4319/lo.2009.55.2.0950; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; CAPONE DG, 1988, LIMNOL OCEANOGR, V33, P725, DOI 10.4319/lo.1988.33.4_part_2.0725; Casper P, 2003, ADV LIMNOL, V58, P53; CHRISTENSEN PB, 1994, PLANT PHYSIOL, V105, P847, DOI 10.1104/pp.105.3.847; Conrad R, 2007, LIMNOL OCEANOGR, V52, P1393, DOI 10.4319/lo.2007.52.4.1393; Crosby LD, 2003, BIOTECHNIQUES, V34, P790, DOI 10.2144/03344rr01; Crump BC, 2007, APPL ENVIRON MICROB, V73, P6802, DOI 10.1128/AEM.00648-07; Deutzmann JS, 2011, APPL ENVIRON MICROB, V77, P4429, DOI 10.1128/AEM.00340-11; Dumont MG, 2011, ENVIRON MICROBIOL, V13, P1153, DOI 10.1111/j.1462-2920.2010.02415.x; Eckert W, 1997, WATER AIR SOIL POLL, V99, P401, DOI 10.1007/BF02406880; Eckert W, 2002, BIOGEOCHEMISTRY, V61, P291, DOI 10.1023/A:1020206511720; Ercolini D, 2004, J MICROBIOL METH, V56, P297, DOI 10.1016/j.mimet.2003.11.006; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; FRENZEL P, 1990, FEMS MICROBIOL ECOL, V73, P149, DOI 10.1016/0378-1097(90)90661-9; Frindte K, 2013, BIOGEOCHEMISTRY, V113, P423, DOI 10.1007/s10533-012-9769-1; Hakanson L, 1983, PRINCIPLES LAKE SEDI, P1983; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Hunter EM, 2006, APPL ENVIRON MICROB, V72, P5689, DOI 10.1128/AEM.03007-05; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Koschorreck M, 2007, HYDROBIOLOGIA, V592, P387, DOI 10.1007/s10750-007-0776-5; Lewandowski J, 2007, FRESHWATER BIOL, V52, P331, DOI 10.1111/j.1365-2427.2006.01702.x; Lorke A, 2003, LIMNOL OCEANOGR, V48, P2077, DOI 10.4319/lo.2003.48.6.2077; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nercessian O, 2005, APPL ENVIRON MICROB, V71, P6885, DOI 10.1128/AEM.71.11.6885-6899.2005; Ostrovsky I, 1996, LIMNOL OCEANOGR, V41, P323, DOI 10.4319/lo.1996.41.2.0323; Pett-Ridge J, 2005, APPL ENVIRON MICROB, V71, P6998, DOI 10.1128/AEM.71.11.6998-7007.2005; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Rahalkar M, 2009, APPL ENVIRON MICROB, V75, P119, DOI 10.1128/AEM.01350-08; Rosel S, 2012, AQUAT SCI, V74, P87, DOI 10.1007/s00027-011-0198-3; Roper HR, 2003, ADV LIMNOL, V58, P247; SANTSCHI P, 1990, MAR CHEM, V30, P269, DOI 10.1016/0304-4203(90)90076-O; Sass H, 1997, FEMS MICROBIOL ECOL, V22, P245, DOI 10.1016/S0168-6496(96)00096-7; SCHMIDT U, 1993, LIMNOL OCEANOGR, V38, P1214, DOI 10.4319/lo.1993.38.6.1214; Sivan O, 2007, GEOBIOLOGY, V5, P141, DOI 10.1111/j.1472-4669.2007.00098.x; Tsertova N, 2013, AQUAT MICROB ECOL, V70, P77, DOI 10.3354/ame01647; Tsertova N, 2011, ENV MICROBIOL REP, V3, P270, DOI 10.1111/j.1758-2229.2010.00221.x; Urakawa H, 2000, ENVIRON MICROBIOL, V2, P542, DOI 10.1046/j.1462-2920.2000.00137.x; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Ye WJ, 2009, FEMS MICROBIOL ECOL, V70, P263, DOI 10.1111/j.1574-6941.2009.00761.x	48	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143428	10.1371/journal.pone.0143428	http://dx.doi.org/10.1371/journal.pone.0143428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599000	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600065
J	Leiser, OP; Merkley, ED; Clowers, BH; Kaiser, BLD; Lin, A; Hutchison, JR; Melville, AM; Wagner, DM; Keim, PS; Foster, JT; Kreuzer, HW				Leiser, Owen P.; Merkley, Eric D.; Clowers, Brian H.; Kaiser, Brooke L. Deatherage; Lin, Andy; Hutchison, Janine R.; Melville, Angela M.; Wagner, David M.; Keim, Paul S.; Foster, Jeffrey T.; Kreuzer, Helen W.			Investigation of Yersinia pestis Laboratory Adaptation through a Combined Genomics and Proteomics Approach	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; NITROGEN ASSIMILATION; MUTATIONAL ANALYSIS; PROLYL ISOMERASE; PLAGUE; PEPA; METABOLISM; EXPRESSION; SEQUENCE	The bacterial pathogen Yersinia pestis, the cause of plague in humans and animals, normally has a sylvatic lifestyle, cycling between fleas and mammals. In contrast, laboratory-grown Y. pestis experiences a more constant environment and conditions that it would not normally encounter. The transition from the natural environment to the laboratory results in a vastly different set of selective pressures, and represents what could be considered domestication. Understanding the kinds of adaptations Y. pestis undergoes as it becomes domesticated will contribute to understanding the basic biology of this important pathogen. In this study, we performed a parallel serial passage experiment (PSPE) to explore the mechanisms by which Y. pestis adapts to laboratory conditions, hypothesizing that cells would undergo significant changes in virulence and nutrient acquisition systems. Two wild strains were serially passaged in 12 independent populations each for similar to 750 generations, after which each population was analyzed using whole-genome sequencing, LC-MS/MS proteomic analysis, and GC/MS metabolomics. We observed considerable parallel evolution in the endpoint populations, detecting multiple independent mutations in ail, pepA, and zwf, suggesting that specific selective pressures are shaping evolutionary responses. Complementary LC-MS/MS proteomic data provide physiological context to the observed mutations, and reveal regulatory changes not necessarily associated with specific mutations, including changes in amino acid metabolism and cell envelope biogenesis. Proteomic data support hypotheses generated by genomic data in addition to suggesting future mechanistic studies, indicating that future whole-genome sequencing studies be designed to leverage proteomics as a critical complement.	[Leiser, Owen P.; Wagner, David M.; Keim, Paul S.; Foster, Jeffrey T.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86001 USA; [Merkley, Eric D.; Kaiser, Brooke L. Deatherage; Lin, Andy; Hutchison, Janine R.; Melville, Angela M.; Foster, Jeffrey T.; Kreuzer, Helen W.] Pacific NW Natl Lab, Chem & Biol Signature Sci, Richland, WA 99352 USA; [Clowers, Brian H.] Washington State Univ, Dept Chem, Pullman, WA 99354 USA	Northern Arizona University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington State University	Kreuzer, HW (corresponding author), Pacific NW Natl Lab, Chem & Biol Signature Sci, Richland, WA 99352 USA.	helen.kreuzer@pnnl.gov	Clowers, Brian/GLQ-6772-2022; Leiser, Owen/ABA-8089-2021	Clowers, Brian/0000-0002-5809-9379; Foster, Jeffrey/0000-0001-8235-8564; Lin, Andy/0000-0003-0072-612X; Wagner, David/0000-0003-2684-6007; Leiser, Owen/0000-0003-1190-5596; Merkley, Eric/0000-0002-5486-4723	Defense Threat Reduction Agency Basic Research Award [DTRA10027IA-2129]; Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory; U.S. DOE [DE-AC06-76RLO]	Defense Threat Reduction Agency Basic Research Award(United States Department of DefenseDefense Threat Reduction Agency); Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory; U.S. DOE(United States Department of Energy (DOE))	This work was supported by Defense Threat Reduction Agency Basic Research Award DTRA10027IA-2129 and by the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory, a multiprogram national laboratory operated by Battelle for the U.S. Department of Energy. Battelle Memorial Institute operates Pacific Northwest National Laboratory for the U.S. DOE under Contract DE-AC06-76RLO. The funders authorized publication, but had no role in study design, data collection and analysis, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansong C, 2013, MOL BIOSYST, V9, P44, DOI 10.1039/c2mb25287b; Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Bender RA, 2010, J BACTERIOL, V192, P4801, DOI 10.1128/JB.00266-10; Brookes P., 2001, MICROBES ENVIRON, V16, P131, DOI [10.1264/jsme2.2001.131, DOI 10.1264/JSME2.2001.131]; Buetow L, 2007, P NATL ACAD SCI USA, V104, P4321, DOI 10.1073/pnas.0606356104; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; CHARLIER D, 1995, J MOL BIOL, V250, P392, DOI 10.1006/jmbi.1995.0385; Charlier D, 2000, J MOL BIOL, V302, P411, DOI 10.1006/jmbi.2000.4067; Charusanti P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-163; Chauvaux S, 2007, MICROBIOL-SGM, V153, P3112, DOI 10.1099/mic.0.2007/006213-0; Chauvaux S, 2011, INT J MED MICROBIOL, V301, P105, DOI 10.1016/j.ijmm.2010.08.013; Cox Jr, 2014, MOL CELLULLAR PROTEO; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Devroede N, 2006, J BACTERIOL, V188, P3236, DOI 10.1128/JB.188.9.3236-3245.2006; Eisen RJ, 2007, J MED ENTOMOL, V44, P530, DOI 10.1603/0022-2585(2007)44[530:HPITSU]2.0.CO;2; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Eydallin G, 2014, ENVIRON MICROBIOL, V16, P813, DOI 10.1111/1462-2920.12208; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Flores S, 2004, BIOTECHNOL BIOENG, V87, P485, DOI 10.1002/bit.20137; Fox A, 1988, ANAL CARBOHYDRATES G, P87; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Gourlay SC, 2004, MOL MICROBIOL, V52, P53, DOI 10.1111/j.1365-2958.2003.03962.x; Harley WM, 2002, J MICROBIOL METH, V51, P95, DOI 10.1016/S0167-7012(02)00064-7; HINNEBUSCH J, 1993, J CLIN MICROBIOL, V31, P1511, DOI 10.1128/JCM.31.6.1511-1514.1993; Hixson KK, 2006, J PROTEOME RES, V5, P3008, DOI 10.1021/pr060179y; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; Jabbour RE, 2010, J PROTEOME RES, V9, P3647, DOI 10.1021/pr100402y; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kolodkin-Gal A, 2008, J BACTERIOL, V190, P3169, DOI 10.1128/JB.01918-07; Kolodziejek AM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00103; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Leal-Balbino TC, 2004, MEM I OSWALDO CRUZ, V99, P727, DOI 10.1590/S0074-02762004000700011; Lin A, 2015, J MICROBIOL METH, V112, P3, DOI 10.1016/j.mimet.2015.01.015; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Maddamsetti R, 2015, GENETICS, V200, P619, DOI 10.1534/genetics.115.176677; MAKOFF AJ, 1978, MICROBIOL REV, V42, P307, DOI 10.1128/MMBR.42.2.307-328.1978; McGovern TW, 1997, MED ASPECTS CHEM BIO, P479; MIKKOLA R, 1992, MOL BIOL EVOL, V9, P394; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Nicolas C, 2007, FEBS LETT, V581, P3771, DOI 10.1016/j.febslet.2007.06.066; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Paul S, 2004, PLASMID, V52, P63, DOI 10.1016/j.plasmid.2004.04.003; Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pieper R, 2009, MICROBIOL-SGM, V155, P498, DOI 10.1099/mic.0.022160-0; Pieper R, 2008, PROTEOMICS, V8, P1442, DOI 10.1002/pmic.200700923; Pieper R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-30; Pieper R, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-5; Plesniak LA, 2011, BBA-BIOMEMBRANES, V1808, P482, DOI 10.1016/j.bbamem.2010.09.017; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Ponnusamy D, 2011, VET MICROBIOL, V150, P146, DOI 10.1016/j.vetmic.2010.12.025; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Reijns M, 2005, MOL MICROBIOL, V57, P927, DOI 10.1111/j.1365-2958.2005.04716.x; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Sarovich DS, 2010, J MICROBIOL METH, V82, P95, DOI 10.1016/j.mimet.2010.03.019; Sawa J, 2010, CURR OPIN STRUC BIOL, V20, P253, DOI 10.1016/j.sbi.2010.01.014; Saxer G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004872; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Sebbane F, 2001, INFECT IMMUN, V69, P170, DOI 10.1128/IAI.69.1.170-176.2001; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sjodin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011556; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Stevenson HL, 2003, J MED ENTOMOL, V40, P329, DOI 10.1603/0022-2585-40.3.329; STRALEY SC, 1988, REV INFECT DIS, V10, pS323; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Strater N, 1999, EMBO J, V18, P4513, DOI 10.1093/emboj/18.16.4513; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Tanaka K, 2001, J BACTERIOL, V183, P6538, DOI 10.1128/JB.183.22.6538-6542.2001; Tolker-Nielsen T, 2000, MICROB ECOL, V40, P75; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vogler AJ, 2007, MUTAT RES-FUND MOL M, V616, P145, DOI 10.1016/j.mrfmmm.2006.11.007; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2; Wang YP, 2010, BIOGEOSCIENCES, V7, P2261, DOI 10.5194/bg-7-2261-2010; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; WUNSCHEL D, 1995, SYST APPL MICROBIOL, V17, P625, DOI 10.1016/S0723-2020(11)80085-8; Zhao J, 2004, METAB ENG, V6, P164, DOI 10.1016/j.ymben.2004.02.004	92	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142997	10.1371/journal.pone.0142997	http://dx.doi.org/10.1371/journal.pone.0142997			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599979	Green Submitted, gold, Green Published			2022-12-27	WOS:000365862600025
J	Li, MY; Huang, R; Jiang, X; Chen, YX; Zhang, Z; Zhang, XY; Liang, PP; Zhan, SQ; Cao, SB; Zhou, SY; Huang, JJ				Li, Minyan; Huang, Rui; Jiang, Xue; Chen, Yuxi; Zhang, Zhen; Zhang, Xiya; Liang, Puping; Zhan, Shaoquan; Cao, Shanbo; Zhou Songyang; Huang, Junjiu			CRISPR/Cas9 Promotes Functional Study of Testis Specific X-Linked Gene In Vivo	PLOS ONE			English	Article								Mammalian spermatogenesis is a highly regulated multistage process of sperm generation. It is hard to uncover the real function of a testis specific gene in vitro since the in vitro model is not yet mature. With the development of the CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated 9) system, we can now rapidly generate knockout mouse models of testis specific genes to study the process of spermatogenesis in vivo. SYCP3-like X-linked 2 (SLX2) is a germ cell specific component, which contains a Cor1 domain and belongs to the XLR (X-linked, lymphocyte regulated) family. Previous studies suggested that SLX2 might play an important role in mouse spermatogenesis based on its subcellular localization and interacting proteins. However, the function of SLX2 in vivo is still elusive. Here, to investigate the functions of SLX2 in spermatogenesis, we disrupted the Slx2 gene by using the CRISPR/Cas9 system. Since Slx2 is a testis specific X-linked gene, we obtained knockout male mice in the first generation and accelerated the study process. Compared with wild-type mice, Slx2 knockout mice have normal testis and epididymis. Histological observation of testes sections showed that Slx2 knockout affected none of the three main stages of spermatogenesis: mitosis, meiosis and spermiogenesis. In addition, we further confirmed that disruption of Slx2 did not affect the number of spermatogonial stem cells, meiosis progression or XY body formation by immunofluorescence analysis. As spermatogenesis was normal in Slx2 knockout mice, these mice were fertile. Taken together, we showed that Slx2 itself is not an essential gene for mouse spermatogenesis and CRISPR/Cas9 technique could speed up the functional study of testis specific X-linked gene in vivo.	[Li, Minyan; Huang, Rui; Jiang, Xue; Chen, Yuxi; Zhang, Zhen; Zhang, Xiya; Liang, Puping; Zhan, Shaoquan; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Reprod Med, Guangzhou 510275, Guangdong, Peoples R China; [Li, Minyan; Huang, Rui; Jiang, Xue; Chen, Yuxi; Zhang, Zhen; Zhang, Xiya; Liang, Puping; Zhan, Shaoquan; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Li, Minyan; Huang, Rui; Jiang, Xue; Chen, Yuxi; Zhang, Zhen; Zhang, Xiya; Liang, Puping; Zhan, Shaoquan; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, Inst Hlth Aging Res, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Minyan; Huang, Rui; Jiang, Xue; Chen, Yuxi; Zhang, Zhen; Zhang, Xiya; Liang, Puping; Zhan, Shaoquan; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, SYSU BCM Joint Res Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhan, Shaoquan; Cao, Shanbo] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Reprod Med Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Zhou, SY (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Reprod Med, Guangzhou 510275, Guangdong, Peoples R China.	songyanz@mail.sysu.edu.cn; hjunjiu@mail.sysu.edu.cn		Liang, Puping/0000-0003-3593-2599; Li, Minyan/0000-0002-1944-5881	Natural Science Foundation of Guangdong Province [2014A030312011]; National Natural Science Foundation [81330055, 31371508, 31301178, 31401223, J131002]; Science and Technology Planning Project of Guangdong Province [2015B020228002]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province	This study was supported by the Natural Science Foundation of Guangdong Province (2014A030312011), the National Natural Science Foundation (81330055, 31371508, 31301178, 31401223 and J131002) and the Science and Technology Planning Project of Guangdong Province (2015B020228002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank Dr. Yuwen Qiu and Zhini Zhang for their helpful suggestions in animal experimental design; Professor Jian Ren for providing GPS CNN1.0 software for cell counting.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cloutier JM, 2010, CURR BIOL, V20, pR962, DOI 10.1016/j.cub.2010.09.041; Cocquet J, 2010, MOL BIOL CELL, V21, P3497, DOI 10.1091/mbc.E10-07-0601; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; Cohen DI, 1985, NATURE, V314; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Escalier D, 1999, J IMMUNOL, V162, P292; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; Fernandez- Capetillo O, 2003, DEV CELL, V4; Fietz D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062638; Garchon HJ, 1989, NUCL ACIDS RES, V17; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kolas NK, 2004, CYTOGENET GENOME RES, V105, P182, DOI 10.1159/000078188; Kotaja N, 2014, FERTIL STERIL, V101, P1552, DOI 10.1016/j.fertnstert.2014.04.025; Kouznetsova A, 2005, J CELL SCI 10, V118; Kubota H, 2008, METHOD CELL BIOL, V86, P00016, DOI [10.1016/S0091-679X, DOI 10.1016/S0091-679X(08)00016-2]; Lu LY, 2013, NAT COMMUN, P4; Maeda Y, 2002, CELL DEATH DIFFERENT, V9; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meikar O, 2011, REPRODUCTION, V142, P195, DOI 10.1530/REP-11-0057; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pearson H, 2002, NATURE, V415, P8, DOI 10.1038/415008a; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Reynard LN, 2009, BIOL REPROD, V81, DOI [10.1095/biolreprod.109.076117, DOI 10.1095/BIOLREPROD.109.076117]; Sander JD, 2014, NAT BIOTECHNOL, V32; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Shi YQ, 2013, GENE, V527, P352, DOI 10.1016/j.gene.2013.06.033; Shukla KK, 2012, FRONT BIOSCI, P4; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Tsutsumi M, 2011, BIOL REPROD, V85; Turner JM, 2007, DEVELOPMENT, V134; Turner JM, 2005, NAT GENET, V37; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhuang XJ, 2014, CELL CYCLE, V13, P2230, DOI 10.4161/cc.29265; Zhuang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020866	49	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143148	10.1371/journal.pone.0143148	http://dx.doi.org/10.1371/journal.pone.0143148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599493	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600033
J	Lisein, J; Michez, A; Claessens, H; Lejeune, P				Lisein, Jonathan; Michez, Adrien; Claessens, Hugues; Lejeune, Philippe			Discrimination of Deciduous Tree Species from Time Series of Unmanned Aerial System Imagery	PLOS ONE			English	Article							CLASSIFICATION; FOREST	Technology advances can revolutionize Precision Forestry by providing accurate and fine forest information at tree level. This paper addresses the question of how and particularly when Unmanned Aerial System (UAS) should be used in order to efficiently discriminate deciduous tree species. The goal of this research is to determine when is the best time window to achieve an optimal species discrimination. A time series of high resolution UAS imagery was collected to cover the growing season from leaf flush to leaf fall. Full benefit was taken of the temporal resolution of UAS acquisition, one of the most promising features of small drones. The disparity in forest tree phenology is at the maximum during early spring and late autumn. But the phenology state that optimized the classification result is the one that minimizes the spectral variation within tree species groups and, at the same time, maximizes the phenologic differences between species. Sunlit tree crowns (5 deciduous species groups) were classified using a Random Forest approach for monotemporal, two-date and three-date combinations. The end of leaf flushing was the most efficient single-date time window. Multitemporal datasets definitely improve the overall classification accuracy. But single-date high resolution orthophotomosaics, acquired on optimal time-windows, result in a very good classification accuracy (overall out of bag error of 16%).	[Lisein, Jonathan; Michez, Adrien; Claessens, Hugues; Lejeune, Philippe] Univ Liege, Gembloux Agrobio Tech 2, Dept Biosyt Engn, Lab Forest Resources Management, B-5030 Gembloux, Belgium; [Lisein, Jonathan] Ecole Natl Sci Geog, F-77455 Marne La Vallee, France	University of Liege; Universite Gustave-Eiffel	Lisein, J (corresponding author), Univ Liege, Gembloux Agrobio Tech 2, Dept Biosyt Engn, Lab Forest Resources Management, B-5030 Gembloux, Belgium.	jo.lisein@ulg.ac.be	Michez, Adrien/AAB-3241-2019	Michez, Adrien/0000-0003-4329-6422				Aber JS, 2010, SMALL-FORMAT AERIAL PHOTOGRAPHY: PRINCIPLES, TECHNIQUES AND GEOSCIENCE APPLICATIONS, P1; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Baltsavias E, 2008, INT J REMOTE SENS, V29, P1243, DOI 10.1080/01431160701736513; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burkholder A, 2011, PHOTOGRAMM ENG REM S, V77, P793, DOI 10.14358/PERS.77.8.793; Cole B, 2014, ISPRS J PHOTOGRAMM, V90, P49, DOI 10.1016/j.isprsjprs.2014.01.010; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Drauschke M, 2014, P WORKSH UAV BAS REM, P21; Etten RJHJv, 2014, RASTER GEOGRAPHIC AN; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gini R, 2014, EUR J REMOTE SENS, V47, P251, DOI 10.5721/EuJRS20144716; Heinzel JN, 2008, P SILVILASER 2008; Hill RA, 2010, APPL VEG SCI, V13, P86, DOI 10.1111/j.1654-109X.2009.01053.x; Honkavaara E, 2009, REMOTE SENS-BASEL, V1, P577, DOI 10.3390/rs1030577; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; Husson C, 2011, EUR J PLANT PATHOL, V130, P311, DOI 10.1007/s10658-011-9755-9; Immitzer M, 2012, REMOTE SENS-BASEL, V4, P2661, DOI 10.3390/rs4092661; Kempeneers P, 2013, IEEE GEOSCI REMOTE S, V10, P1459, DOI 10.1109/LGRS.2013.2260129; Kempeneers P, 2011, IEEE T GEOSCI REMOTE, V49, P4977, DOI 10.1109/TGRS.2011.2158548; Key T, 2001, REMOTE SENS ENVIRON, V75, P100, DOI 10.1016/S0034-4257(00)00159-0; Lisein J, 2013, FORESTS, V4, P922, DOI 10.3390/f4040922; Masaitis G, 2013, RES RURAL DEV, P20; Motohka T, 2010, REMOTE SENS-BASEL, V2, P2369, DOI 10.3390/rs2102369; Pierrot-Deseilligny M, 2006, INT ARCHIVES OF PHOT, V36; Somers B, 2013, REMOTE SENS ENVIRON, V136, P14, DOI 10.1016/j.rse.2013.04.006; Sripada RP, 2006, AGRON J, V98, P968, DOI 10.2134/agronj2005.0200; Stumpf A, 2011, REMOTE SENS ENVIRON, V115, P2564, DOI 10.1016/j.rse.2011.05.013; Triggs B., 2000, Vision Algorithms: Theory and Practice. International Workshop on Vision Algorithms. Proceedings (Lecture Notes in Computer Science Vol. 1883), P298; Waser LT, 2011, REMOTE SENS ENVIRON, V115, P76, DOI 10.1016/j.rse.2010.08.006; Wu C.-H., 2014, P IEEE PES INN SMART, P1; Zhu XL, 2014, ISPRS J PHOTOGRAMM, V96, P1, DOI 10.1016/j.isprsjprs.2014.06.012; Zhu Z, 2014, REMOTE SENS ENVIRON, V144, P152, DOI 10.1016/j.rse.2014.01.011	33	64	65	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0141006	10.1371/journal.pone.0141006	http://dx.doi.org/10.1371/journal.pone.0141006			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600422	Green Published, gold			2022-12-27	WOS:000365862600003
J	Sugawara, N; Ishioka, M; Tsuchimine, S; Tsuruga, K; Sato, Y; Furukori, H; Kudo, S; Tomita, T; Nakagami, T; Yasui-Furukori, N				Sugawara, Norio; Ishioka, Masamichi; Tsuchimine, Shoko; Tsuruga, Koji; Sato, Yasushi; Furukori, Hanako; Kudo, Shuhei; Tomita, Tetsu; Nakagami, Taku; Yasui-Furukori, Norio			Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan	PLOS ONE			English	Article							RELAPSE-PREVENTION	Background Although the use of placebo in clinical trials of schizophrenia patients is controversial because of medical and ethical concerns, placebo-controlled clinical trials are commonly used in the licensing of new drugs. Aims The objective of this study was to assess the attitudes toward placebo-controlled clinical trials among patients with schizophrenia in Japan. Method Using a cross-sectional design, we recruited patients (n = 251) aged 47.7 +/- 13.2 (mean +/- SD) with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder who were admitted to six psychiatric hospitals from December 2013 to March 2014. We employed a 14-item questionnaire specifically developed to survey patients' attitudes toward placebo-controlled clinical trials. Results The results indicated that 33% of the patients would be willing to participate in a placebocontrolled clinical trial. Expectations for improvement of disease, a guarantee of hospital treatment continuation, and encouragement by family or friends were associated with the willingness to participate in such trials, whereas a belief of additional time required for medical examinations was associated with non-participation. Conclusions Fewer than half of the respondents stated that they would be willing to participate in placebo-controlled clinical trials. Therefore, interpreting the results from placebo-controlled clinical trials could be negatively affected by selection bias.	[Sugawara, Norio] Aomori Prefectural Ctr Mental Hlth & Welf, Aomori, Japan; [Sugawara, Norio; Tsuchimine, Shoko; Tsuruga, Koji; Yasui-Furukori, Norio] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan; [Ishioka, Masamichi; Kudo, Shuhei] Hirosaki Aiseikai Hosp, Dept Psychiat, Hirosaki, Aomori, Japan; [Sato, Yasushi] Seihoku Chuoh Hosp, Dept Psychiat, Goshogawara, Japan; [Furukori, Hanako] Kuroishi Akebono Hosp, Dept Psychiat, Kuroishi, Aomori, Japan; [Tomita, Tetsu; Nakagami, Taku] Odate Municipal Gen Hosp, Dept Neuropsychiat, Odate, Japan	Hirosaki University	Sugawara, N (corresponding author), Aomori Prefectural Ctr Mental Hlth & Welf, Aomori, Japan.	nsuga3@yahoo.co.jp	Tomita, Tetsu/G-4806-2014		Hirosaki Research Institute for the neurosciences; Ministry of Education, Culture, Sports, Science and Technology, Japan; Karoji Memorial Fund for Medical Research; SENSHIN Medical Research Foundation; Astellas Pharma; Dainippon Sumitomo Pharma; Eli Lilly and Company; GlaxoSmithKline; Janssen Pharmaceutical; Meiji Seika Pharma	Hirosaki Research Institute for the neurosciences(Hirosaki Research Institute for Neurosciences); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Karoji Memorial Fund for Medical Research; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Astellas Pharma(Astellas Pharmaceuticals); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Eli Lilly and Company(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen Pharmaceutical; Meiji Seika Pharma	Funding for this study was provided by the Hirosaki Research Institute for the neurosciences; the Hirosaki Research Institute for the neurosciences had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. Norio Sugawara has received funding from a Grant-in-Aid for Young Scientists (B); The Ministry of Education, Culture, Sports, Science and Technology, Japan; the Karoji Memorial Fund for Medical Research (Grant B); and SENSHIN Medical Research Foundation. Norio Yasui-Furukori has received grant/research support or honoraria from, and been on the speakers of Astellas Pharma, Dainippon Sumitomo Pharma, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutical, Meiji Seika Pharma. Mochida Pharmaceutical Company, MSD K.K., Otsuka Pharmaceutical, Pfizer, TAKATA Pharmaceutical and Yoshitomiyakuhin Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas IHM, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-2; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Carpenter WT, 2003, AM J PSYCHIAT, V160, P356, DOI 10.1176/appi.ajp.160.2.356; Chue P, 2014, NEUROPSYCH DIS TREAT, V10, P777, DOI 10.2147/NDT.S43404; CURSON DA, 1986, BRIT MED J, V293, P726, DOI 10.1136/bmj.293.6549.726; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Emsley R, 2013, SCHIZOPHR RES, V150, P427, DOI 10.1016/j.schres.2013.09.008; Emsley R, 2012, SCHIZOPHR RES, V138, P29, DOI 10.1016/j.schres.2012.02.030; Fleischhacker WW, 2003, ARCH GEN PSYCHIAT, V60, P458, DOI 10.1001/archpsyc.60.5.458; Fleischhacker WW, 2002, PSYCHOPHARMACOLOGY, V162, P82, DOI 10.1007/s00213-002-1060-z; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Hummer M, 2003, J CLIN PSYCHIAT, V64, P277, DOI 10.4088/JCP.v64n0308; Kemmler G, 2005, ARCH GEN PSYCHIAT, V62, P1305, DOI 10.1001/archpsyc.62.12.1305; Melamed Yuval, 2009, J Clin Med Res, V1, P132, DOI 10.4021/jocmr2009.07.1247; Mohr P, 2000, J CLIN PSYCHOPHARM, V20, P240, DOI 10.1097/00004714-200004000-00018; Roberts LW, 2002, AM J PSYCHIAT, V159, P573, DOI 10.1176/appi.ajp.159.4.573; Rui Q, 2014, PROG NEURO-PSYCHOPH, V53, P45, DOI 10.1016/j.pnpbp.2014.02.007; Schafer I, 2011, SOC PSYCH PSYCH EPID, V46, P159, DOI 10.1007/s00127-010-0181-7; Sugawara N, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-108; Sugawara N, 2010, SCHIZOPHR RES, V123, P244, DOI 10.1016/j.schres.2010.08.030; Tashiro S, 2012, J NERV MENT DIS, V200, P255, DOI 10.1097/NMD.0b013e318247d24f; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; World Medical Association, 2013, DECL HELS ETH PRINC; Yasui-Furukori N, 2002, PROG NEURO-PSYCHOPH, V26, P53, DOI 10.1016/S0278-5846(01)00218-4; Yasui-Furukori N, 2012, J PSYCHOPHARMACOL, V26, P806, DOI 10.1177/0269881111405555; Zipursky RB, 2014, SCHIZOPHR RES, V152, P408, DOI 10.1016/j.schres.2013.08.001	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143356	10.1371/journal.pone.0143356	http://dx.doi.org/10.1371/journal.pone.0143356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7DU	26600382	gold, Green Submitted, Green Published			2022-12-27	WOS:000365862600055
J	Zhan, WH; Han, TY; Zhang, CF; Xie, CF; Gan, MX; Deng, KY; Fu, MG; Wang, JB				Zhan, Weihua; Han, Tianyu; Zhang, Chenfu; Xie, Caifeng; Gan, Mingxi; Deng, Keyu; Fu, Mingui; Wang, Jian-Bin			TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins	PLOS ONE			English	Article							TRIPARTITE MOTIF; TUMOR-SUPPRESSOR; UBIQUITINATION; DEGRADATION; ASSAY; GENE; P53	TRIM protein family is an evolutionarily conserved gene family implicated in a number of critical processes including inflammation, immunity, antiviral and cancer. In an effort to profile the expression patterns of TRIM superfamily in several non-small cell lung cancer (NSCLC) cell lines, we found that the expression of 10 TRIM genes including TRIM3, TRIM7, TRIM14, TRIM16, TRIM21, TRIM22, TRIM29, TRIM59, TRIM66 and TRIM70 was significantly upregulated in NSCLC cell lines compared with the normal human bronchial epithelial (HBE) cell line, whereas the expression of 7 other TRIM genes including TRIM4, TRIM9, TRIM36, TRIM46, TRIM54, TRIM67 and TRIM76 was significantly down-regulated in NSCLC cell lines compared with that in HBE cells. As TRIM59 has been reported to act as a proto-oncogene that affects both Ras and RB signal pathways in prostate cancer models, we here focused on the role of TRIM59 in the regulation of NSCLC cell proliferation and migration. We reported that TRIM59 protein was significantly increased in various NSCLC cell lines. SiRNA-induced knocking down of TRIM59 significantly inhibited the proliferation and migration of NSCLC cell lines by arresting cell cycle in G2 phase. Moreover, TRIM59 knocking down affected the expression of a number of cell cycle proteins including CDC25C and CDK1. Finally, we knocked down TRIM59 and found that p53 protein expression levels did not upregulate, so we proposed that TRIM59 may promote NSCLC cell growth through other pathways but not the p53 signaling pathway.	[Zhan, Weihua; Han, Tianyu; Zhang, Chenfu; Xie, Caifeng; Gan, Mingxi; Deng, Keyu; Wang, Jian-Bin] Nanchang Univ, Inst Translat Med, Nanchang City 330031, Jiangxi, Peoples R China; [Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA	Nanchang University; University of Missouri System; University of Missouri Kansas City	Wang, JB (corresponding author), Nanchang Univ, Inst Translat Med, Nanchang City 330031, Jiangxi, Peoples R China.	jianbinwang1@gmail.com		Zhan, Weihua/0000-0001-7937-3384	National Natural Science Foundation of China [81372823, 31360282]; Department of Education of Jiangxi Province; National Institutes of Health [AI103618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103618] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education of Jiangxi Province; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially supported by grants to J-B Wang from the National Natural Science Foundation of China (81372823, 31360282), the Department of Education of Jiangxi Province (Science and Technology Luo Di program), and a grant to M-G Fu from the National Institutes of Health (AI103618).	Balint I, 2004, GENE, V332, P45, DOI 10.1016/j.gene.2004.02.045; Bell JL, 2013, CELL CYCLE, V12, P889, DOI 10.4161/cc.23825; Chen L, 2012, J BIOL CHEM, V287, P40106, DOI 10.1074/jbc.M112.380865; Eames HL, 2012, IMMUNOBIOLOGY, V217, P1315, DOI 10.1016/j.imbio.2012.07.026; Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; Johnson DH, 2014, J CLIN ONCOL, V32, P973, DOI 10.1200/JCO.2013.53.1228; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu J, 2012, AM J PATHOL, V180, P839, DOI 10.1016/j.ajpath.2011.10.020; Manocha GD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-24; Marshall GM, 2010, ONCOGENE, V29, P6172, DOI 10.1038/onc.2010.340; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Raheja R, 2014, BIOCHEM J, V458, P537, DOI 10.1042/BJ20131288; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sato T, 2012, J CELL SCI, V125, P1544, DOI 10.1242/jcs.095273; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Tocchini C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004533; Valiyeva F, 2011, MOL CANCER THER, V10, P1229, DOI 10.1158/1535-7163.MCT-11-0077; Versteeg GA, 2014, CYTOKINE GROWTH F R, V25, P563, DOI 10.1016/j.cytogfr.2014.08.001; Yaguchi H, 2012, J BIOL CHEM, V287, P12050, DOI 10.1074/jbc.M111.307678; Zaman MMU, 2013, MOL CELL BIOL, V33, P4971, DOI 10.1128/MCB.00465-13; Zhou ZC, 2014, GASTROENTEROLOGY, V147, P1043, DOI 10.1053/j.gastro.2014.07.021	22	87	95	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142596	10.1371/journal.pone.0142596	http://dx.doi.org/10.1371/journal.pone.0142596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599082	gold, Green Published, Green Submitted			2022-12-27	WOS:000365862600013
J	Infusini, G; Smith, JM; Yuan, H; Pizzolla, A; Ng, WC; Londrigan, SL; Haque, A; Reading, PC; Villadangos, JA; Wakim, LM				Infusini, Giuseppe; Smith, Jeffrey M.; Yuan, He; Pizzolla, Angela; Ng, Wy Ching; Londrigan, Sarah L.; Haque, Ashraful; Reading, Patrick C.; Villadangos, Jose A.; Wakim, Linda M.			Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8(+) T Cell Priming	PLOS ONE			English	Article							DENDRITIC CELLS; INFLUENZA-VIRUS; CUTTING EDGE; INFLAMMATION; RESPONSES; PROTEINS; EXPRESSION; SUBSETS; ANTIGEN	Respiratory dendritic cells (DC) play a pivotal role in the initiation of adaptive immune responses to influenza virus. To do this, respiratory DCs must ferry viral antigen from the lung to the draining lymph node without becoming infected and perishing en route. We show that respiratory DCs up-regulate the expression of the antiviral molecule, interferon-induced transmembrane protein 3 (IFITM3) in response to influenza virus infection, in a manner dependent on type I interferon signaling and the transcription factors IRF7 and IRF3. Failure of respiratory DCs to up-regulate IFITM3 following influenza virus infection resulted in impaired trafficking to the draining LN and consequently in impaired priming of an influenza-specific CD8+ T cell response. The impaired trafficking of IFITM3-deficient DC correlated with an increased susceptibility of these DC to influenza virus infection. This work shows that the expression of IFITM3 protects respiratory DCs from influenza virus infection, permitting migration from lung to LN and optimal priming of a virus specific T-cell response.	[Infusini, Giuseppe] Walter & Eliza Hall Inst Med Res, Div Syst Biol & Personalised Med, Parkville, Vic 3052, Australia; [Smith, Jeffrey M.; Yuan, He; Pizzolla, Angela; Ng, Wy Ching; Londrigan, Sarah L.; Reading, Patrick C.; Villadangos, Jose A.; Wakim, Linda M.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Haque, Ashraful] QIMR Berghofer Med Res Inst, Malaria Immunol Lab, Brisbane, Qld, Australia; [Reading, Patrick C.] Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, Victorian Infect Dis Reference Lab, Melbourne, Vic 3000, Australia; [Villadangos, Jose A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; QIMR Berghofer Medical Research Institute; Victorian Infectious Diseases Reference Laboratory; World Health Organization; University of Melbourne	Villadangos, JA (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.	j.villadangos@unimelb.edu.au; wakiml@unimelb.edu.au	Villadangos, Jose A/AAU-1404-2020; Ng, Wy Ching/GQT-0056-2022; Pizzolla, Angela/AAN-1566-2021; Haque, Ashraful/H-8697-2014	Villadangos, Jose A/0000-0001-6771-8891; Pizzolla, Angela/0000-0003-2024-4144; Smith, Jeffrey/0000-0003-3630-4068; Londrigan, Sarah/0000-0003-0989-4971; Reading, Patrick/0000-0002-8860-5308; Wakim, Linda/0000-0003-1752-9579; Haque, Ashraful/0000-0003-2260-0026	National Health and Medical Research Council (NHMRC) of Australia; University of Melbourne (Early Career Establishment Grant); Bio21 Institute/CSL Ltd.; Australian Government Department of Health	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne (Early Career Establishment Grant); Bio21 Institute/CSL Ltd.; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This work was funded by the National Health and Medical Research Council (NHMRC) of Australia, with additional support from the University of Melbourne (Early Career Establishment Grant) and Bio21 Institute/CSL Ltd. J. A. Villadangos is a NHMRC Principal Research Fellow and L. Wakim is a NHMRC Career Development Fellow. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ingulli E, 2009, J IMMUNOL, V182, P29, DOI 10.4049/jimmunol.182.1.29; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Short KR, 2013, INFECT IMMUN, V81, P645, DOI 10.1128/IAI.01278-12; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Topham DJ, 1997, J IMMUNOL, V159, P5197; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	21	25	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143539	10.1371/journal.pone.0143539	http://dx.doi.org/10.1371/journal.pone.0143539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600246	gold, Green Published			2022-12-27	WOS:000365853900141
J	Kramer, J; Bijnens, B; Stork, S; Ritter, CO; Liu, D; Ertl, G; Wanner, C; Weidemann, F				Kraemer, Johannes; Bijnens, Bart; Stoerk, Stefan; Ritter, Christian O.; Liu, Dan; Ertl, Georg; Wanner, Christoph; Weidemann, Frank			Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; 2-DIMENSIONAL SPECKLE TRACKING; CLINICAL MANIFESTATIONS; MYOCARDIAL-INFARCTION; DISEASE; THERAPY; IDENTIFICATION; DIAGNOSIS; FIBROSIS; IMPACT	Background In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyopathy is not entirely understood. In addition, the impact of blood pressure and alterations in geometry have not been systematically evaluated. Methods In 74 FD patients (mean age 36 +/- 12 years; 45 females) the extent of myocardial fibrosis and its progression were quantified using cardiac magnetic-resonance-imaging with late enhancement technique (LE). Results were compared to standard echocardiography complemented by 2D-speckle-tracking, 3D-sphericity-index (SI) and standardized blood pressure measurement. At baseline, no patient received enzyme replacement therapy (ERT). After 51 +/- 24 months, a follow-up examination was performed. Results Systolic blood pressure (SBP) was higher in patients with vs. without LE: 123 +/- 17 mmHg vs. 115 +/- 13 mmHg; P = 0.04. A positive correlation was found between SI and the amount of LE-positive myocardium (r = 0.51; P< 0.001) indicating an association of higher SI in more advanced stages of the cardiomyopathy. SI at baseline was positively associated with the increase of LE-positive myocardium during follow-up. The highest SBP (125 +/- 19 mmHg) and also the highest SI (0.32 +/- 0.05) was found in the subgroup with a rapidly increasing LE (ie, >= 0.2% per year; n = 16; P = 0.04). Multivariate logistic regression analysis including SI, SBP, EF, left ventricular volumes, wall thickness and NT-proBNP adjusted for age and sex showed SI as the most powerful parameter to detect rapid progression of LE (AUC = 0.785; P<0.05). Conclusions LV geometry as assessed by the sphericity index is altered in relation to the stage of the Fabry cardiomyopathy. Although patients with FD are not hypertensive, the SBP has a clear impact on the progression of the cardiomyopathy.	[Kraemer, Johannes; Stoerk, Stefan; Liu, Dan; Ertl, Georg] Univ Wurzburg, Dept Med 1, Cardiol Unit, D-97070 Wurzburg, Germany; [Kraemer, Johannes] Univ Ulm, Dept Pediat & Adolescent Med, D-89069 Ulm, Germany; [Wanner, Christoph] Univ Wurzburg, Nephrol Unit, Dept Med 1, D-97070 Wurzburg, Germany; [Bijnens, Bart] Univ Pompeu Fabra, ICREA, Barcelona, Spain; [Bijnens, Bart] Katholieke Univ Leuven, Leuven, Belgium; [Kraemer, Johannes; Stoerk, Stefan; Ritter, Christian O.; Liu, Dan; Ertl, Georg; Wanner, Christoph; Weidemann, Frank] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Ritter, Christian O.] Univ Wurzburg, Dept Radiol, D-97070 Wurzburg, Germany; [Weidemann, Frank] Katharinen Hosp Unna, Dept Internal Med 2, D-59423 Unna, Germany	University of Wurzburg; Ulm University; University of Wurzburg; ICREA; Pompeu Fabra University; KU Leuven; University of Wurzburg; University of Wurzburg	Weidemann, F (corresponding author), Katharinen Hosp Unna, Innere Klin 2, Obere Husemannstr 2, D-59423 Unna, Germany.	f.weidemann@katharinen-hospital.de	Stork, Stefan/AAR-4182-2020; Bijnens, Bart/AAE-7186-2021; Bijnens, Bart H/C-2955-2008	Stork, Stefan/0000-0002-1771-7249; Bijnens, Bart/0000-0003-3130-6937; Bijnens, Bart H/0000-0003-3130-6937	Bundesministerium fur Bildung und Forschung [BMFBF01 EO1004]; Genzyme Corporation (Cambridge, MA, USA); Genzyme; Shire Corporation; ICREA Funding Source: Custom	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Genzyme Corporation (Cambridge, MA, USA)(Sanofi-AventisGenzyme Corporation); Genzyme(Sanofi-AventisGenzyme Corporation); Shire Corporation; ICREA(ICREA)	This study was supported by Bundesministerium fur Bildung und Forschung (BMFBF01 EO1004).; This work was supported by grants from the Bundesministerium fur Bildung und Forschung (BMFBF01 EO1004). CW and FW are members of the Fabry Registry European Board of Advisors which is sponsored by Genzyme Corporation (Cambridge, MA, USA). JK, MN, FW and CW have received speakers honoraria and FW and CW has received research support (grant to the institution) from Genzyme and Shire Corporation.	Boyd AC, 2013, J AM SOC ECHOCARDIOG, V26, P1415, DOI 10.1016/j.echo.2013.08.024; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; Coats CJ, 2013, AM J CARDIOL, V111, P111, DOI 10.1016/j.amjcard.2012.08.055; Desnick RJ., 1995, METABOLIC MOL BASES, P2741; Duann JR, 1999, COMPUT MED IMAG GRAP, V23, P89, DOI 10.1016/S0895-6111(98)00065-2; FARAGGIANA T, 1981, AM J PATHOL, V103, P247; Goodfriend TL, 1996, NEW ENGL J MED, V334, P1649, DOI 10.1056/NEJM199606203342507; Jain G, 2011, NEPHRON CLIN PRACT, V118, pC43, DOI 10.1159/000320903; Kleinert J, 2006, AM J HYPERTENS, V19, P782, DOI 10.1016/j.amjhyper.2006.01.011; Kosmala W, 2008, J AM SOC ECHOCARDIOG, V21, P1309, DOI 10.1016/j.echo.2008.10.006; Kramer J, 2014, AM J CARDIOL, V114, P895, DOI 10.1016/j.amjcard.2014.06.019; Kramer J, 2013, EUR HEART J, V34, P1587, DOI 10.1093/eurheartj/eht098; LAMAS GA, 1989, AM J CARDIOL, V63, P1167, DOI 10.1016/0002-9149(89)90173-2; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Mannaerts HFJ, 2004, EUR HEART J, V25, P680, DOI 10.1016/j.ehj.2004.02.030; Marchal P, 2013, EUR HEART J-CARD IMG, V14, P914, DOI 10.1093/ehjci/jet064; Moon JC, 2006, J CARDIOVASC MAGN R, V8, P479, DOI 10.1080/10976640600605002; Moon JCC, 2003, EUR HEART J, V24, P2151, DOI 10.1016/j.ehj.2003.09.017; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Niemann M, 2011, JACC-CARDIOVASC IMAG, V4, P592, DOI 10.1016/j.jcmg.2011.01.020; Nouri M, 2013, J CARDIAC SURG, V28, P359, DOI 10.1111/jocs.12145; Rombach SM, 2010, MOL GENET METAB, V99, P99, DOI 10.1016/j.ymgme.2009.10.004; Shanks M, 2013, J AM SOC ECHOCARDIOG, V26, P1407, DOI 10.1016/j.echo.2013.09.005; Tahir H, 2007, J AM SOC NEPHROL, V18, P2609, DOI 10.1681/ASN.2006121400; Takenaka T, 2008, J CARDIOL, V51, P50, DOI 10.1016/j.jjcc.2007.12.001; Teraguchi Hiroyuki, 2004, J Cardiol, V43, P98; Torralba-Cabeza MA, 2011, MOL GENET METAB, V104, P301, DOI 10.1016/j.ymgme.2011.06.021; Weidemann F, 2005, EUR HEART J, V26, P1221, DOI 10.1093/eurheartj/ehi143; Weidemann F, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-116; Yoon Jae Yong, 2013, J Cardiovasc Ultrasound, V21, P26, DOI 10.4250/jcu.2013.21.1.26; Yousef Z, 2013, EUR HEART J, V34, P802, DOI 10.1093/eurheartj/ehs166	32	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0140627	10.1371/journal.pone.0140627	http://dx.doi.org/10.1371/journal.pone.0140627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600044	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900008
J	Mendez-Lorenzo, L; Porras-Dominguez, JR; Raga-Carbajal, E; Olvera, C; Rodriguez-Alegria, ME; Carrillo-Nava, E; Costas, M; Munguia, AL				Mendez-Lorenzo, Luz; Porras-Dominguez, Jaime R.; Raga-Carbajal, Enrique; Olvera, Clarita; Elena Rodriguez-Alegria, Maria; Carrillo-Nava, Ernesto; Costas, Miguel; Lopez Munguia, Agustin			Intrinsic Levanase Activity of Bacillus subtilis 168 Levansucrase (SacB)	PLOS ONE			English	Article							LACTOBACILLUS-REUTERI; MOLECULAR-WEIGHT	Levansucrase catalyzes the synthesis of fructose polymers through the transfer of fructosyl units from sucrose to a growing fructan chain. Levanase activity of Bacillus subtilis levansucrase has been described since the very first publications dealing with the mechanism of levan synthesis. However, there is a lack of qualitative and quantitative evidence regarding the importance of the intrinsic levan hydrolysis of B. subtilis levansucrase and its role in the levan synthesis process. Particularly, little attention has been paid to the long-term hydrolysis products, including its participation in the final levan molecules distribution. Here, we explored the hydrolytic and transferase activity of the B. subtilis levansucrase (SacB) when levans produced by the same enzyme are used as substrate. We found that levan is hydrolyzed through a first order exo-type mechanism, which is limited to a conversion extent of around 30% when all polymer molecules reach a structure no longer suitable to SacB hydrolysis. To characterize the reaction, Isothermal Titration Calorimetry (ITC) was employed and the evolution of the hydrolysis products profile followed by HPLC, GPC and HPAEC-PAD. The ITC measurements revealed a second step, taking place at the end of the reaction, most probably resulting from disproportionation of accumulated fructo-oligosaccharides. As levanase, levansucrase may use levan as substrate and, through a fructosyl-enzyme complex, behave as a hydrolytic enzyme or as a transferase, as demonstrated when glucose and fructose are added as acceptors. These reactions result in a wide variety of oligosaccharides that are also suitable acceptors for fructo-oligosaccharide synthesis. Moreover, we demonstrate that SacB in the presence of levan and glucose, through blastose and sucrose synthesis, results in the same fructooligosaccharides profile as that observed in sucrose reactions. We conclude that SacB has an intrinsic levanase activity that contributes to the final levan profile in reactions with sucrose as substrate.	[Mendez-Lorenzo, Luz; Porras-Dominguez, Jaime R.; Raga-Carbajal, Enrique; Olvera, Clarita; Elena Rodriguez-Alegria, Maria; Lopez Munguia, Agustin] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico; [Carrillo-Nava, Ernesto; Costas, Miguel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Quim Fis, Lab Biofis Quim, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Munguia, AL (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico.	agustin@ibt.unam.mx		Raga-Carbajal, Enrique/0000-0002-7598-0520; Costas, Miguel/0000-0001-8604-6381; Rodriguez Alegria, Maria Elena/0000-0001-6789-705X; Olvera-Carranza, Clarita/0000-0002-8364-5845; Lopez Munguia, Agustin/0000-0003-4204-4936	MC Direccion General de Asuntos del Personal Academico-Universidad Navidad Autonoma de Mexico (PAPIIT grant) [IN112813]; Consejo Nacional de Ciencia y Tecnologia (CB-SEP-CONACyT) [219728]; DGAPA-UNAM (PAPIIT grant) [IN112813]	MC Direccion General de Asuntos del Personal Academico-Universidad Navidad Autonoma de Mexico (PAPIIT grant); Consejo Nacional de Ciencia y Tecnologia (CB-SEP-CONACyT); DGAPA-UNAM (PAPIIT grant)	This work is supported by MC Direccion General de Asuntos del Personal Academico-Universidad Navidad Autonoma de Mexico (PAPIIT grant number IN112813 to M.C.) and by Consejo Nacional de Ciencia y Tecnologia (CB-SEP-CONACyT No. 219728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Alma Jessica Diaz Salazar and Fernando Gonzalez for their competent technical assistance, as well as Mario Trejo and Martin Patino for administrative support. This work was supported by DGAPA-UNAM (PAPIIT grant number IN112813 to M.C.) and by Consejo Nacional de Ciencia y Tecnologia (CB-SEP-CONACyT) No. 219728.	Albenne C, 2002, FEBS LETT, V527, P67, DOI 10.1016/S0014-5793(02)03168-X; CHAMBERT R, 1974, EUR J BIOCHEM, V41, P285, DOI 10.1111/j.1432-1033.1974.tb03269.x; Dedonder R., 1966, COMPLEX CARBOHYDRATE, P500; HESTRIN S, 1958, BIOCHEM J, V69, P388, DOI 10.1042/bj0690388; Jang KH, 2007, FOOD SCI BIOTECHNOL, V16, P482; Martinez C, 2015, ANAL BIOCH IN PRESS; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Ortiz-Soto ME, 2008, PROTEIN ENG DES SEL, V21, P589, DOI 10.1093/protein/gzn036; Ozimek LK, 2006, MICROBIOL-SGM, V152, P1187, DOI 10.1099/mic.0.28484-0; Porras-Dominguez JR, 2015, CARBOHYD POLYM, V132, P338, DOI 10.1016/j.carbpol.2015.06.056; Porras-Dominguez JR, 2014, PROCESS BIOCHEM, V49, P783, DOI 10.1016/j.procbio.2014.02.005; RAPOPORT G, 1963, B SOC CHIM BIOL, V45, P493; Santos-Moriano P, 2015, J MOL CATAL B-ENZYM, V119, P18, DOI 10.1016/j.molcatb.2015.05.011; SIMMS PJ, 1990, CARBOHYD RES, V208, P193, DOI 10.1016/0008-6215(90)80099-O; TANAKA T, 1981, J BIOCHEM-TOKYO, V90, P521, DOI 10.1093/oxfordjournals.jbchem.a133500; TANAKA T, 1980, J BIOCHEM, V87, P297, DOI 10.1093/oxfordjournals.jbchem.a132737; TANAKA T, 1979, J BIOCHEM-TOKYO, V85, P287, DOI 10.1093/oxfordjournals.jbchem.a132322; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; van Hijum SAFT, 2004, MICROBIOL-SGM, V150, P621, DOI 10.1099/mic.0.26671-0; YAMAMOTO S, 1985, AGR BIOL CHEM TOKYO, V49, P343, DOI 10.1080/00021369.1985.10866727; Yoon EJ, 2004, INT J BIOL MACROMOL, V34, P191, DOI 10.1016/j.ijbiomac.2004.04.001	21	27	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143394	10.1371/journal.pone.0143394	http://dx.doi.org/10.1371/journal.pone.0143394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600431	Green Published, gold			2022-12-27	WOS:000365853900106
J	Mrozek-Wilczkiewicz, A; Spaczynska, E; Malarz, K; Cieslik, W; Rams-Baron, M; Krystof, V; Musiol, R				Mrozek-Wilczkiewicz, Anna; Spaczynska, Ewelina; Malarz, Katarzyna; Cieslik, Wioleta; Rams-Baron, Marzena; Krystof, Vladimir; Musiol, Robert			Design, Synthesis and In Vitro Activity of Anticancer Styrylquinolines. The p53 Independent Mechanism of Action	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITY SPECTRUM; INTEGRASE INHIBITORS; MITOCHONDRIAL-DNA; CP-31398; ANALOGS; APOPTOSIS; REACTIVATION; DERIVATIVES; SERIES; AGENTS	A group of styrylquinolines were synthesized and tested for their anti-proliferative activity. Anti-proliferative activity was evaluated against the human colon carcinoma cell lines that had a normal expression of the p53 protein (HCT116 p53(+/+)) and mutants with a disabled TP53 gene (HCT116 p53(-/-)) and against the GM 07492 normal human fibroblast cell line. A SAR study revealed the importance of Cl and OH as substituents in the styryl moiety. Several of the compounds that were tested were found to have a marked anti-proliferative activity that was similar to or better than doxorubicin and were more active against the p53 null than the wild type cells. The cellular localization tests and caspase activity assays suggest a mechanism of action through the mitochondrial pathway of apoptosis in a p53-independent manner. The activity of the styrylquinoline compounds may be associated with their DNA intercalating ability.	[Mrozek-Wilczkiewicz, Anna; Rams-Baron, Marzena] Univ Silesia, A Chelkowski Inst Phys, Katowice, Poland; [Mrozek-Wilczkiewicz, Anna; Rams-Baron, Marzena] Univ Silesia, Silesian Ctr Educ & Interdisciplinary Res, Chorzow, Poland; [Spaczynska, Ewelina; Malarz, Katarzyna; Cieslik, Wioleta; Musiol, Robert] Univ Silesia, Inst Chem, Katowice, Poland; [Krystof, Vladimir] Palacky Univ, Lab Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Krystof, Vladimir] Inst Expt Bot AS CR, Olomouc, Czech Republic	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Musiol, R (corresponding author), Univ Silesia, Inst Chem, Katowice, Poland.	robert.musiol@us.edu.pl	Malarz, Katarzyna/AAA-2689-2020; Krystof, Vladimir/B-9499-2009; Musioł, Robert/J-4790-2019; Cieślik, Wioleta/AAH-6820-2021	Malarz, Katarzyna/0000-0003-4283-3126; Krystof, Vladimir/0000-0001-5838-2118; Cieślik, Wioleta/0000-0001-6371-9061; Musiol, Robert/0000-0002-6219-7369; Mrozek-Wilczkiewicz, Anna/0000-0003-2228-1475	NCN grant from RM [2013/09/B/NZ7/00423, 2014/13/D/NZ7/00322, 2012/07/N/NZ7/02110]; DoktoRIS; CITTRFUS; National Program for Sustainability I [LO1204]; Polish National Center for Science NCN grants from the R.M. [2013/09/B/NZ7/00423, 2014/13/D/NZ7/00322, WC 2012/07/N/NZ7/02110]	NCN grant from RM; DoktoRIS; CITTRFUS; National Program for Sustainability I; Polish National Center for Science NCN grants from the R.M.	This study is supported by an NCN grant from RM (2013/09/B/NZ7/00423); AM-W (2014/13/D/NZ7/00322); and WC (2012/07/N/NZ7/02110). The authors also appreciate the financial support of the DoktoRIS and CITTRFUS PhD scholarships and the National Program for Sustainability I (grant no. LO1204).; This study is supported by Polish National Center for Science NCN grants from the R.M. (2013/09/B/NZ7/00423) AM-W. (2014/13/D/NZ7/00322) and WC 2012/07/N/NZ7/02110. We also appreciate the financial support of the DoktoRIS and CITTRFUS PhD scholarships and the National Program for Sustainability I (grant no. LO1204).	Ashley N, 2009, ONCOGENE, V28, P3880, DOI 10.1038/onc.2009.242; Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059; Behforouz M, 2007, BIOORGAN MED CHEM, V15, P495, DOI 10.1016/j.bmc.2006.09.039; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bonnenfant S, 2004, J VIROL, V78, P5728, DOI 10.1128/JVI.78.11.5728-5736.2004; Brown CJ, 2011, TRENDS PHARMACOL SCI, V32, P53, DOI 10.1016/j.tips.2010.11.004; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; Chan SH, 2013, ACS MED CHEM LETT, V4, P170, DOI 10.1021/ml300238z; CIESLIK W, 2012, INT B PHARM SCI, V1, P3; Cieslik W, 2012, BIOORGAN MED CHEM, V20, P6960, DOI 10.1016/j.bmc.2012.10.027; Demma MJ, 2004, J BIOL CHEM, V279, P45887, DOI 10.1074/jbc.M401854200; Fang YA, 2003, MOL CANCER THER, V2, P517; Hassani M, 2005, J MED CHEM, V48, P7733, DOI 10.1021/jm050758z; Jampilek J, 2009, MOLECULES, V14, P4246, DOI 10.3390/molecules14104246; JIANG JB, 1990, J MED CHEM, V33, P1721, DOI 10.1021/jm00168a029; Lain S, 2010, SEMIN CANCER BIOL, V20, P1, DOI 10.1016/j.semcancer.2010.03.003; Lukin DJ, 2015, MOL CANCER RES, V13, P16, DOI 10.1158/1541-7786.MCR-14-0177; Luu Y, 2002, EXP CELL RES, V276, P214, DOI 10.1006/excr.2002.5526; Mekouar K, 1998, J MED CHEM, V41, P2846, DOI 10.1021/jm980043e; Mrozek-Wilczkiewicz A, 2010, BIOORGAN MED CHEM, V18, P2664, DOI 10.1016/j.bmc.2010.02.025; Mukhopadhyay A, 2007, ADV DRUG DELIVER REV, V59, P729, DOI 10.1016/j.addr.2007.06.004; Musiol R, 2006, BIOORGAN MED CHEM, V14, P3592, DOI 10.1016/j.bmc.2006.01.016; Musiol R, 2010, CURR MED CHEM, V17, P1960, DOI 10.2174/092986710791163966; Musiol R., 2011, SCI MICROBIAL PATHOG, P72; Musiol R, 2008, BIOORGAN MED CHEM, V16, P4490, DOI 10.1016/j.bmc.2008.02.065; Musiol R, 2007, BIOORGAN MED CHEM, V15, P1280, DOI 10.1016/j.bmc.2006.11.020; Musiol R, 2010, MOLECULES, V15, P288, DOI 10.3390/molecules15010288; Musiol R, 2009, CENT EUR J CHEM, V7, P586, DOI 10.2478/s11532-009-0059-2; Nycz JE, 2011, J MOL STRUCT, V986, P39, DOI 10.1016/j.molstruc.2010.11.032; Podeszwa B, 2007, BIOORG MED CHEM LETT, V17, P6138, DOI 10.1016/j.bmcl.2007.09.040; Polanski J, 2004, Acta Pol Pharm, V61 Suppl, P3; Polanski J, 2012, CURR MED CHEM, V19, P1921, DOI 10.2174/092986712800167356; Rams-Baron M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131210; Roh JL, 2011, ORAL ONCOL, V47, P8, DOI 10.1016/j.oraloncology.2010.10.011; Sahu U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066430; Selivanova G, 2010, SEMIN CANCER BIOL, V20, P46, DOI 10.1016/j.semcancer.2010.02.006; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Solomon VR, 2011, CURR MED CHEM, V18, P1488; Staples OD, 2008, SURG-J R COLL SURG E, V6, P240, DOI 10.1016/S1479-666X(08)80034-0; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Sutherland HS, 2012, INVEST NEW DRUG, V30, P2035, DOI 10.1007/s10637-011-9744-z; Takimoto R, 2002, CANCER BIOL THER, V1, P47, DOI 10.4161/cbt.1.1.41; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198	44	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142678	10.1371/journal.pone.0142678	http://dx.doi.org/10.1371/journal.pone.0142678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599982	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900037
J	Philippe, J; Derhourhi, M; Durand, E; Vaillant, E; Dechaume, A; Rabearivelo, I; Dhennin, V; Vaxillaire, M; De Graeve, F; Sand, O; Froguel, P; Bonnefond, A				Philippe, Julien; Derhourhi, Mehdi; Durand, Emmanuelle; Vaillant, Emmanuel; Dechaume, Aurelie; Rabearivelo, Iandry; Dhennin, Veronique; Vaxillaire, Martine; De Graeve, Franck; Sand, Olivier; Froguel, Philippe; Bonnefond, Amelie			What Is the Best NGS Enrichment Method for the Molecular Diagnosis of Monogenic Diabetes and Obesity?	PLOS ONE			English	Article							EXOME; MUTATIONS; LEPTIN; GENOME; PANEL	Molecular diagnosis of monogenic diabetes and obesity is of paramount importance for both the patient and society, as it can result in personalized medicine associated with a better life and it eventually saves health care spending. Genetic clinical laboratories are currently switching from Sanger sequencing to next-generation sequencing (NGS) approaches but choosing the optimal protocols is not easy. Here, we compared the sequencing coverage of 43 genes involved in monogenic forms of diabetes and obesity, and variant detection rates, resulting from four enrichment methods based on the sonication of DNA (Agilent Sure-Select, RainDance technologies), or using enzymes for DNA fragmentation (Illumina Nextera, Agilent HaloPlex). We analyzed coding exons and untranslated regions of the 43 genes involved in monogenic diabetes and obesity. We found that none of the methods achieves yet full sequencing of the gene targets. Nonetheless, the RainDance, SureSelect and HaloPlex enrichment methods led to the best sequencing coverage of the targets; while the Nextera method resulted in the poorest sequencing coverage. Although the sequencing coverage was high, we unexpectedly found that the HaloPlex method missed 20% of variants detected by the three other methods and Nextera missed 10%. The question of which NGS technique for genetic diagnosis yields the highest diagnosis rate is frequently discussed in the literature and the response is still unclear. Here, we showed that the RainDance enrichment method as well as SureSelect, which are both based on the sonication of DNA, resulted in a good sequencing quality and variant detection, while the use of enzymes to fragment DNA (HaloPlex or Nextera) might not be the best strategy to get an accurate sequencing.	[Philippe, Julien; Derhourhi, Mehdi; Durand, Emmanuelle; Vaillant, Emmanuel; Dechaume, Aurelie; Rabearivelo, Iandry; Dhennin, Veronique; Vaxillaire, Martine; De Graeve, Franck; Sand, Olivier; Froguel, Philippe; Bonnefond, Amelie] Lille Pasteur Inst, CNRS, UMR8199, Lille, France; [Philippe, Julien; Derhourhi, Mehdi; Durand, Emmanuelle; Vaillant, Emmanuel; Dechaume, Aurelie; Rabearivelo, Iandry; Dhennin, Veronique; Vaxillaire, Martine; De Graeve, Franck; Sand, Olivier; Froguel, Philippe; Bonnefond, Amelie] Univ Lille, Lille, France; [Philippe, Julien; Derhourhi, Mehdi; Durand, Emmanuelle; Vaillant, Emmanuel; Dechaume, Aurelie; Rabearivelo, Iandry; Dhennin, Veronique; Vaxillaire, Martine; De Graeve, Franck; Sand, Olivier; Froguel, Philippe; Bonnefond, Amelie] EGID, FR 3508, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Imperial College London	Froguel, P (corresponding author), Lille Pasteur Inst, CNRS, UMR8199, Lille, France.	froguel@good.ibl.fr; amelie.bonnefond@inserm.fr	Bonnefond, Amélie/O-2784-2017; FROGUEL, Philippe/O-6799-2017; Philippe, Julien/R-5183-2019	Bonnefond, Amélie/0000-0001-9976-3005; FROGUEL, Philippe/0000-0003-2972-0784; Philippe, Julien/0000-0003-1906-7259; Sand, Olivier/0000-0003-1465-1640	French National Research Agency [European Genomics Institute for Diabetes] [ANR-10-LABX-46]; French National Research Agency [LIGAN-PM] [ANR-10-EQPX-07-01]; European Research Council (ERC GEPIDIAB) [294785]; FEDER; Region Nord Pas-de-Calais; Inserm	French National Research Agency [European Genomics Institute for Diabetes](French National Research Agency (ANR)); French National Research Agency [LIGAN-PM](French National Research Agency (ANR)); European Research Council (ERC GEPIDIAB)(European Research Council (ERC)); FEDER(European Commission); Region Nord Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from the French National Research Agency	Bonnefond A, 2014, DIABETES CARE, V37, P460, DOI 10.2337/dc13-0698; Bonnefond A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037423; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; Coonrod EM, 2014, BIOTECHNIQUES, V57, P204, DOI 10.2144/000114217; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Greeley SAW, 2011, DIABETES CARE, V34, P622, DOI 10.2337/dc10-1616; Miya F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09331; Naylor RN, 2014, DIABETES CARE, V37, P202, DOI 10.2337/dc13-0410; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Saeed S, 2012, MOL GENET METAB, V106, P121, DOI 10.1016/j.ymgme.2012.03.001; Sun Y, 2015, HUM MUTAT, V36, P648, DOI 10.1002/humu.22783; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	15	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143373	10.1371/journal.pone.0143373	http://dx.doi.org/10.1371/journal.pone.0143373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599467	Green Published, gold, Green Submitted			2022-12-27	WOS:000365853900102
J	Sambri, I; Crespo, J; Aguilo, S; Ingrosso, D; Rodriguez, C; Gonzalez, JM				Sambri, Irene; Crespo, Javier; Aguilo, Silvia; Ingrosso, Diego; Rodriguez, Cristina; Gonzalez, Jose Martinez			miR-17 and-20a Target the Neuron-Derived Orphan Receptor-1 (NOR-1) in Vascular Endothelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KAPPA-B ACTIVATION; NUCLEAR RECEPTORS; GENE-EXPRESSION; GROWTH-FACTOR; TRANSCRIPTIONAL REGULATORS; MICRORNA-17-92 CLUSTER; MESSENGER-RNA; BREAST-CANCER; PROLIFERATION	Neuron-derived orphan receptor-1 (NOR-1) plays a major role in vascular biology by controlling fibroproliferative and inflammatory responses. Because microRNAs (miRNAs) have recently emerged as key players in the regulation of gene expression in the vasculature, here we have investigated the regulation of NOR-1 by miRNAs in endothelial cells. Computational algorithms suggest that NOR-1 could be targeted by members of the miR-17 family. Accordingly, ectopic over-expression of miR-17 or miR-20a in endothelial cells using synthetic premiRNAs attenuated the up-regulation of NOR-1 expression induced by VEGF (as evidenced by real time PCR, Western blot and immunocitochemistry). Conversely, the antagonism of these miRNAs by specific antagomirs prevented the down-regulation of NOR-1 promoted by miR-17 or miR-20a in VEGF-stimulated cells. Disruption of the miRNA-NOR- 1 mRNA interaction using a custom designed target protector evidenced the selectivity of these responses. Further, luciferase reporter assays and seed-sequence mutagenesis confirmed that miR-17 and -20a bind to NOR-1 3'-UTR. Finally, miR-17 and -20a ameliorated the up-regulation of VCAM-1 mediated by NOR-1 in VEGF-stimulated cells. Therefore, miR-17 and -20a target NOR-1 thereby regulating NOR-1-dependent gene expression.	[Sambri, Irene; Crespo, Javier; Aguilo, Silvia; Rodriguez, Cristina; Gonzalez, Jose Martinez] Ctr Invest Cardiovasc CSIC ICCC, IIB St Pau, Barcelona, Spain; [Sambri, Irene; Ingrosso, Diego] Univ Naples 2, Sch Med & Surg, Dept Biochem Biophys & Gen Pathol, Naples, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Universita della Campania Vanvitelli	Gonzalez, JM (corresponding author), Ctr Invest Cardiovasc CSIC ICCC, IIB St Pau, Barcelona, Spain.	jmartinez@csic-iccc.org	Ingrosso, Diego/AHE-4980-2022; Rodriguez, Cristina/D-3099-2011	Rodriguez, Cristina/0000-0002-6472-5647; Crespo, Javier/0000-0001-8248-0172; Martinez-Gonzalez, Jose/0000-0002-3894-7166; Sambri, Irene/0000-0003-3500-6958	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [SAF2012-40127, RD12/0042/0053, PI12/01952]; EMBO fellowship (ASTF) [211-2010]; Fondo Europeo de Desarrollo Regional (FEDER)	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII); EMBO fellowship (ASTF); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [SAF2012-40127 (JMG), RD12/0042/0053 (JMG) and PI12/01952 (CR]. IS was a recipient of an EMBO fellowship (ASTF number: 211- 2010). The study was co-funded by Fondo Europeo de Desarrollo Regional (FEDER)-The way to build Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [SAF2012-40127, RD12/0042/0053 and PI12/01952]. I Sambri was a recipient of an EMBO fellowship (ASTF number: 211-2010). The study was co-funded by Fondo Europeo de Desarrollo Regional (FEDER)-The way to build Europe. We are grateful to Dr. Giulio Piluso, Dept. of General Pathology and Oncology, S.U.N.) for kindly providing us with the construct of TK promoter in pGL3.	Aitken S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004217; Arkenbout EK, 2003, ARTERIOSCL THROM VAS, V23, P1535, DOI 10.1161/01.ATV.0000084639.16462.7A; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Boon RA, 2015, NAT REV CARDIOL, V12, P135, DOI 10.1038/nrcardio.2014.207; Calvayrac O, 2015, J MOL CELL CARDIOL, V80, P34, DOI 10.1016/j.yjmcc.2014.12.015; Crespo J, 2005, CARDIOVASC RES, V67, P333, DOI 10.1016/j.cardiores.2005.03.016; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Duan XD, 2015, CELL SIGNAL, V27, P61, DOI 10.1016/j.cellsig.2014.10.006; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Kaluza D, 2013, ARTERIOSCL THROM VAS, V33, P533, DOI 10.1161/ATVBAHA.112.300415; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kumar S, 2014, ARTERIOSCL THROM VAS, V34, P2206, DOI 10.1161/ATVBAHA.114.303425; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Luo T, 2014, MOL CELL BIOCHEM, V389, P169, DOI 10.1007/s11010-013-1938-6; Marques FZ, 2011, HYPERTENSION, V58, P1093, DOI 10.1161/HYPERTENSIONAHA.111.180729; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; Martorell L, 2007, J THROMB HAEMOST, V5, P1766, DOI 10.1111/j.1538-7836.2007.02627.x; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; Medunjanin S, 2015, CARDIOVASC RES, V106, P488, DOI 10.1093/cvr/cvv126; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pin AL, 2012, ANGIOGENESIS, V15, P593, DOI 10.1007/s10456-012-9283-z; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Rius J, 2006, ATHEROSCLEROSIS, V184, P276, DOI 10.1016/j.atherosclerosis.2005.04.008; Rius J, 2004, ARTERIOSCL THROM VAS, V24, P697, DOI 10.1161/01.ATV.0000121570.00515.dc; Rodriguez-Calvo R, 2015, THROMB HAEMOSTASIS, V113, P1323, DOI 10.1160/TH14-07-0645; Rodriguez-Calvo R, 2013, HUM MOL GENET, V22, P1949, DOI 10.1093/hmg/ddt042; Sambri I, 2011, J BIOL CHEM, V286, P43690, DOI 10.1074/jbc.M111.290437; Schroen B, 2012, CARDIOVASC RES, V93, P605, DOI 10.1093/cvr/cvr268; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Witkos TM, 2011, CURR MOL MED, V11, P93; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhao Y, 2010, CIRC RES, V107, P501, DOI 10.1161/CIRCRESAHA.110.222083; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141932	10.1371/journal.pone.0141932	http://dx.doi.org/10.1371/journal.pone.0141932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600038	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900018
J	Stenfeldt, C; Eschbaumer, M; Pacheco, JM; Rekant, SI; Rodriguez, LL; Arzt, J				Stenfeldt, Carolina; Eschbaumer, Michael; Pacheco, Juan M.; Rekant, Steven I.; Rodriguez, Luis L.; Arzt, Jonathan			Pathogenesis of Primary Foot-and-Mouth Disease Virus Infection in the Nasopharynx of Vaccinated and Non-Vaccinated Cattle	PLOS ONE			English	Article							DIRECT-CONTACT CHALLENGE; KIDNEY-CELL LINE; CARRIER STATE; SECRETORY IGA; SEROTYPE O; IN-VITRO; REPLICATION; INOCULATION; PERSISTENCE; INTERFERON	A time-course pathogenesis study was performed to compare and contrast primary foot-and-mouth disease virus (FMDV) infection following simulated-natural (intra-nasopharyngeal) virus exposure of cattle that were non-vaccinated or vaccinated using a recombinant adenovirus-vectored FMDV vaccine. FMDV genome and infectious virus were detected during the initial phase of infection in both categories of animals with consistent predilection for the nasopharyngeal mucosa. A rapid progression of infection with viremia and widespread dissemination of virus occurred in non-vaccinated animals whilst vaccinated cattle were protected from viremia and clinical FMD. Analysis of micro-anatomic distribution of virus during early infection by lasercapture microdissection localized FMDV RNA to follicle-associated epithelium of the nasopharyngeal mucosa in both groups of animals, with concurrent detection of viral genome in nasopharyngeal MALT follicles in vaccinated cattle only. FMDV structural and non-structural proteins were detected in epithelial cells of the nasopharyngeal mucosa by immunomicroscopy 24 hours after inoculation in both non-vaccinated and vaccinated steers. Co-localization of CD11c(+)/MHC II+ cells with viral protein occurred early at primary infection sites in vaccinated steers while similar host-virus interactions were observed at later time points in non-vaccinated steers. Additionally, numerous CD8(+)/CD3(-) host cells, representing presumptive natural killer cells, were observed in association with foci of primary FMDV infection in the nasopharyngeal mucosa of vaccinated steers but were absent in non-vaccinated steers. Immunomicroscopic evidence of an activated antiviral response at primary infection sites of vaccinated cattle was corroborated by a relative induction of interferon -alpha, -beta, -gamma and -lambda mRNA in micro-dissected samples of nasopharyngeal mucosa. Although vaccination protected cattle from viremia and clinical FMD, there was subclinical infection of epithelial cells of the nasopharyngeal mucosa that could enable shedding and long-term persistence of infectious virus. Additionally, these data indicate different mechanisms within the immediate host response to infection between non-vaccinated and vaccinated cattle.	[Stenfeldt, Carolina; Eschbaumer, Michael; Pacheco, Juan M.; Rekant, Steven I.; Rodriguez, Luis L.; Arzt, Jonathan] ARS, Plum Isl Anim Dis Ctr, Foreign Anim Dis Res Unit, USDA, Greenport, NY 11944 USA; [Stenfeldt, Carolina; Eschbaumer, Michael; Rekant, Steven I.] PIADC Res Participat Program, Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Arzt, J (corresponding author), ARS, Plum Isl Anim Dis Ctr, Foreign Anim Dis Res Unit, USDA, Greenport, NY 11944 USA.	Jonathan.Arzt@ars.usda.gov	Stenfeldt, Carolina/AAG-7940-2021; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Arzt, Jonathan/0000-0002-7517-7893; Stenfeldt, Carolina/0000-0002-2074-3886; Pacheco, Juan/0000-0001-5477-0201	Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQPM-13-X-00131]; US Department of Agriculture - Agricultural Research Service, Current Research Information System Project [1940-32000-057-00D]; Plum Island Animal Disease Center Research Participation Program fellowship	Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); US Department of Agriculture - Agricultural Research Service, Current Research Information System Project; Plum Island Animal Disease Center Research Participation Program fellowship	This research was funded by an interagency agreement with the Science and Technology Directorate of the U.S. Department of Homeland Security (award number HSHQPM-13-X-00131). Additional funding came from US Department of Agriculture - Agricultural Research Service, Current Research Information System Project 1940-32000-057-00D. CS, ME and SIR are recipients of a Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE, www.orau.org) through an interagency agreement with the US Department of Energy. None of the funding sources had influence upon design or performance of experimental studies, interpretation of results or writing of the manuscript.	Aggarwal N, 2002, VACCINE, V20, P2508, DOI 10.1016/S0264-410X(02)00178-0; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Arzt J, 2014, VIROLOGY, V452, P12, DOI 10.1016/j.virol.2014.01.001; Arzt J, 2009, J VET DIAGN INVEST, V21, P779, DOI 10.1177/104063870902100604; BAXT B, 1989, J VIROL, V63, P2143, DOI 10.1128/JVI.63.5.2143-2151.1989; Boysen P, 2009, VET IMMUNOL IMMUNOP, V130, P163, DOI 10.1016/j.vetimm.2009.02.017; Brake DA, 2012, DEV BIOLOGICALS, V134, P123; Brito BP, 2011, TRANSBOUND EMERG DIS, V58, P387, DOI 10.1111/j.1865-1682.2011.01217.x; BROWN CC, 1992, CAN J VET RES, V56, P189; BURROWS R, 1981, J COMP PATHOL, V91, P599, DOI 10.1016/0021-9975(81)90089-X; BURROWS R, 1966, J HYG-CAMB, V64, P81, DOI 10.1017/S0022172400040365; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Cox SJ, 2006, VACCINE, V24, P3184, DOI 10.1016/j.vaccine.2006.01.037; Cox SJ, 2005, VACCINE, V23, P1106, DOI 10.1016/j.vaccine.2004.08.034; DOEL TR, 1994, VACCINE, V12, P592, DOI 10.1016/0264-410X(94)90262-3; Fray MD, 2001, J IMMUNOL METHODS, V249, P235, DOI 10.1016/S0022-1759(00)00359-8; Grubman MJ, 2010, FUTURE VIROL, V5, P51, DOI 10.2217/FVL.09.68; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Guzylack-Piriou L, 2006, EUR J IMMUNOL, V36, P1674, DOI 10.1002/eji.200635866; HEDGER RS, 1970, J HYG-CAMB, V68, P53, DOI 10.1017/S0022172400028497; Ilott MC, 1997, EPIDEMIOL INFECT, V118, P181, DOI 10.1017/S0950268896007376; Juleff N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003434; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; Liebler-Tenorio EM, 2006, VET RES, V37, P257, DOI 10.1051/vetres:2006001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCULLOUGH KC, 1988, IMMUNOLOGY, V65, P187; MCVICAR JW, 1976, J HYG-CAMBRIDGE, V76, P467, DOI 10.1017/S0022172400055406; Moonen P, 2004, VET MICROBIOL, V103, P151, DOI 10.1016/j.vetmic.2004.07.005; Pacheco JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125698; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; Parida S, 2006, VACCINE, V24, P1107, DOI 10.1016/j.vaccine.2005.09.006; Parthiban ABR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128815; Patch JR, 2014, COMP IMMUNOL MICROB, V37, P249, DOI 10.1016/j.cimid.2014.07.004; Perez-Martin E, 2012, J VIROL, V86, P4477, DOI 10.1128/JVI.06683-11; Rasmussen TB, 2003, ARCH VIROL, V148, P2005, DOI 10.1007/s00705-003-0145-2; Reimer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041451; Rieder E, 2005, J VIROL, V79, P12989, DOI 10.1128/JVI.79.20.12989-12998.2005; Sei JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109273; Stenfeldt C, 2012, J COMP PATHOL, V146, P243, DOI 10.1016/j.jcpa.2011.06.005; Stenfeldt C, 2014, TRANSBOUND IN PRESS; Stenfeldt C, 2015, VET MICROBIOL, V178, P50, DOI 10.1016/j.vetmic.2015.04.004; Stenfeldt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106859; Stenfeldt C, 2012, VET MICROBIOL, V154, P230, DOI 10.1016/j.vetmic.2011.07.007; Stenfeldt C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-66; Summerfield A, 2009, VET IMMUNOL IMMUNOP, V128, P205, DOI 10.1016/j.vetimm.2008.10.296; SWANEY LM, 1988, VET MICROBIOL, V18, P1, DOI 10.1016/0378-1135(88)90111-3; Yang M, 2007, J IMMUNOL METHODS, V321, P174, DOI 10.1016/j.jim.2007.01.016; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431	51	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143666	10.1371/journal.pone.0143666	http://dx.doi.org/10.1371/journal.pone.0143666			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599543	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900155
J	Torres, LM; Rivera-Espinosa, L; Chavez-Pacheco, JL; Navas, CF; Demetrio, JA; Alemon-Medina, R; Trujillo, F; Perez, M; Zapata, MM; Cardenas, R; Salinas, C; Aquino, A; Velazquez-Cruz, R; Castillejos, MD				Torres, Luz-Maria; Rivera-Espinosa, Liliana; Chavez-Pacheco, Juan L.; Navas, Carlos F.; Demetrio, Joel A.; Alemon-Medina, Radames; Trujillo, Francisca; Perez, Martin; Zapata, Martha M.; Cardenas, Rocio; Salinas, Citlaltepetl; Aquino, Arnoldo; Velazquez-Cruz, Rafael; Castillejos, Manuel-de-Jesus			A New Method to Quantify Ifosfamide Blood Levels Using Dried Blood Spots and UPLC-MS/MS in Paediatric Patients with Embryonic Solid Tumours	PLOS ONE			English	Article							MASS-SPECTROMETRY; PHARMACOKINETICS; METABOLISM; OXAZAPHOSPHORINES; CHROMATOGRAPHY; CHILDREN; PLASMA; CYCLOPHOSPHAMIDE; INFUSION; DRUGS	Ifosfamide blood concentrations are necessary to monitor its therapeutic response, avoiding any adverse effect. We developed and validated an analytical method by UPLC-MS/MS to quantify ifosfamide in dried blood spots (DBS). Blood samples were collected on Whatman 9031 (R) filter paper cards. Five 3 mm disks were punched out from each dried blood spot. Acetonitrile and ethyl acetate were used for drug extraction. Chromatographic separation was carried out in an Acquity UPLC equipment with a BEH-C18 column, 2.1 x 100 mm, 1.7 mu m (Waters (R)). The mobile phase consisted in 5 mM ammonium formate and methanol: acetonitrile (40:48:12 v/v/v) at 0.2 mL/min. LC-MS/MS detection was done by ESI+ and multiple reaction mode monitoring, ionic transitions were m/z(1+) 260.99 > 91.63 for ifosfamide and 261.00 > 139.90 for cyclophosphamide (internal standard). This method was linear within a 100-10000 ng/mL range and it was accurate, precise and selective. Ifosfamide samples in DBS were stable for up to 52 days at -80 degrees C. The procedure was tested in 14 patients, ages 1 month to 17 years (9 males and 5 females), with embryonic tumours treated with ifosfamide, alone or combined, at a public tertiary referral hospital. Ifosfamide blood levels ranged from 11.1 to 39.7 mu mol/L at 12 hours after the last infusion, while 24-hour levels ranged from 0.7-19.7 mu mol/L. The median at 12 hours was 19.5 mu mol/L (Q(25) 14.4-Q(75) 29.0) and 3.8 mu mol/L (Q(25) 1.5-Q(75) 9.9) at 24 hours, p<0.001. This method is feasible to determine ifosfamide plasma levels in paediatric patients.	[Torres, Luz-Maria; Rivera-Espinosa, Liliana; Chavez-Pacheco, Juan L.; Navas, Carlos F.; Demetrio, Joel A.; Alemon-Medina, Radames; Trujillo, Francisca] Inst Nacl Pediat, Lab Farmacol, Mexico City, DF, Mexico; [Navas, Carlos F.] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Mexico City 04510, DF, Mexico; [Salinas, Citlaltepetl] Inst Nacl Neurol & Neurocirug, Lab Neuropatol, Mexico City, DF, Mexico; [Aquino, Arnoldo] Inst Nacl Enfermedades Resp, Lab Genom Canc, Mexico City, DF, Mexico; [Velazquez-Cruz, Rafael] Inst Nacl Med Genom, Lab Genom Metab Oseo, Mexico City, DF, Mexico; [Castillejos, Manuel-de-Jesus] Inst Nacl Enfermedades Resp, Unidad Vigilancia Epidemiol, Mexico City, DF, Mexico; [Perez, Martin; Zapata, Martha M.; Cardenas, Rocio] Inst Nacl Pediat, Serv Oncol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica	Chavez-Pacheco, JL (corresponding author), Natl Inst Paediat, Pharmacol Lab, Mexico City, DF, Mexico.	jchavez_pacheco@hotmail.com; mcastillejos@gmail.com	SALINAS, CITLALTEPETL/AAG-4810-2020; Velazquez-Cruz, Rafael/AAC-3710-2021	Velazquez-Cruz, Rafael/0000-0003-4515-0777; RIVERA ESPINOSA, LILIANA/0000-0002-1334-0026; Castillejos-Lopez, Manuel de Jesus/0000-0001-8689-9755; Torres-Espindola, Luz-Maria/0000-0001-9929-9361	Fondo Sectorial Salud [SSA-2012-179406]; Fondo Federal, Instituto Nacional de Pediatria [068-2013]; Consejo Nacional de Ciencia y Tecnologia	Fondo Sectorial Salud; Fondo Federal, Instituto Nacional de Pediatria; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank Consejo Nacional de Ciencia y Tecnologia, Fondo Sectorial Salud SSA-2012-179406 (JLCP), and Fondo Federal, Instituto Nacional de Pediatria 068-2013 (LMT). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aleksa K, 2009, CHIRALITY, V21, P674, DOI 10.1002/chir.20662; [Anonymous], 2015, GUID BIOAN METH VAL; [Anonymous], NOM177SSA12013 MEX H; Boddy AV, 1996, CANCER CHEMOTH PHARM, V38, P147, DOI 10.1007/s002800050463; BODDY AV, 1993, CANCER RES, V53, P3758; Boddy AV, 2000, CLIN PHARMACOKINET, V38, P291, DOI 10.2165/00003088-200038040-00001; Code EL, 1997, DRUG METAB DISPOS, V25, P985; Deroussent A, 2011, J CHROMATOGR B, V879, P743, DOI 10.1016/j.jchromb.2011.02.012; Giraud B, 2010, EXPERT OPIN DRUG MET, V6, P919, DOI 10.1517/17425255.2010.487861; Guidance for Industry, 2015, BIOAN METH VAL DRAFT; Kerbusch T, 1998, J CHROMATOGR B, V716, P275, DOI 10.1016/S0378-4347(98)00298-9; Kerbusch T, 2001, DRUG METAB DISPOS, V29, P967; Kerbusch T, 2000, THER DRUG MONIT, V22, P613, DOI 10.1097/00007691-200010000-00018; Klastersky J, 2003, ONCOLOGY-BASEL, V65, P7, DOI 10.1159/000073351; Larson Rodney R, 2003, Appl Occup Environ Hyg, V18, P109; Li F, 2010, BIOCHEM PHARMACOL, V80, P1063, DOI 10.1016/j.bcp.2010.06.002; Martins I, 2009, LAT AM J PHARM, V28, P41; Rivera R, 2010, PROTOCOLOS TECNICOS; Rivera-Luna R, 2013, INT J CANCER, V132, P1646, DOI 10.1002/ijc.27771; Sanson AL, 2011, BRAZ J PHARM SCI, V47, P363, DOI 10.1590/S1984-82502011000200017; Storme T, 2005, J CHROMATOGR B, V820, P251, DOI 10.1016/j.jchromb.2005.03.023; WAGNER T, 1994, CLIN PHARMACOKINET, V26, P439, DOI 10.2165/00003088-199426060-00003; Yin JE, 2010, J CHROMATOGR SCI, V48, P781, DOI 10.1093/chromsci/48.10.781; Zhang J, 2005, DRUG METAB REV, V37, P611, DOI 10.1080/03602530500364023; Zolezzi C, 1999, J CHEMOTHERAPY, V11, P69, DOI 10.1179/joc.1999.11.1.69	25	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143421	10.1371/journal.pone.0143421	http://dx.doi.org/10.1371/journal.pone.0143421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600181	Green Published, gold			2022-12-27	WOS:000365853900115
J	Willsey, GG; Wargo, MJ				Willsey, Graham G.; Wargo, Matthew J.			Extracellular Lipase and Protease Production from a Model Drinking Water Bacterial Community Is Functionally Robust to Absence of Individual Members	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PHOSPHOLIPASE-C; BURKHOLDERIA-CEPACIA; ENZYME-ACTIVITIES; INTERSPECIES COMMUNICATION; MICROBIAL COMMUNITIES; WASTE-WATER; BIOFILMS; BIODIVERSITY; SEA	Bacteria secrete enzymes into the extracellular space to hydrolyze macromolecules into constituents that can be imported for microbial nutrition. In bacterial communities, these enzymes and their resultant products can be modeled as community property. Our goal was to investigate the impact of individual community member absence on the resulting community production of exoenzymes (extracellular enzymes) involved in lipid and protein hydrolysis. Our model community contained nine bacteria isolated from the potable water system of the International Space Station. Bacteria were grown in static conditions individually, all together, or in all combinations of eight species and exoproduct production was measured by colorimetric or fluorometric reagents to assess short chain and long chain lipases, choline-specific phospholipases C, and proteases. The exoenzyme production of each species grown alone varied widely, however, the enzyme activity levels of the mixed communities were functionally robust to absence of any single species, with the exception of phospholipase C production in one community. For phospholipase C, absence of Chryseobacterium gleum led to increased choline-specific phospholipase C production, correlated with increased growth of Burkholderia cepacia and Sphingomonas sanguinis. Because each individual species produced different enzyme activity levels in isolation, we calculated an expected activity value for each bacterial mixture using input levels or known final composition. This analysis suggested that robustness of each exoenzyme activity is not solely mediated by community composition, but possibly influenced by bacterial communication, which is known to regulate such pathways in many bacteria. We conclude that in this simplified model of a drinking water bacterial community, community structure imposes constraints on production and/or secretion of exoenzymes to generate a level appropriate to exploit a given nutrient environment.	[Willsey, Graham G.; Wargo, Matthew J.] Univ Vermont, Dept Microbiol & Mol Genet, Coll Med, Burlington, VT 05405 USA	University of Vermont	Wargo, MJ (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Coll Med, Burlington, VT 05405 USA.	mwargo@uvm.edu		Wargo, Matthew/0000-0001-5659-749X; Willsey, Graham/0000-0001-7595-5854	National Aeronautics and Space Administration [EPSCoR NNX13AD40A]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This project was supported by a grant from the National Aeronautics and Space Administration EPSCoR NNX13AD40A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begon M, 1990, ECOLOGY INDIVIDUALS, Vxii; Bramucci M, 2003, APPL MICROBIOL BIOT, V62, P594, DOI 10.1007/s00253-003-1372-x; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Busse HJ, 1999, J IND MICROBIOL BIOT, V23, P242, DOI 10.1038/sj.jim.2900745; Castro VA, 2004, MICROB ECOL, V47, P119, DOI 10.1007/s00248-003-1030-y; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Dong YH, 2005, MOL MICROBIOL, V56, P1287, DOI 10.1111/j.1365-2958.2005.04612.x; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Fitzsimmons LF, 2012, J BACTERIOL, V194, P4718, DOI 10.1128/JB.00596-12; Flagan S, 2003, APPL ENVIRON MICROB, V69, P909, DOI 10.1128/AEM.69.2.909-916.2003; Flieger A, 2000, ENZYME MICROB TECH, V26, P451, DOI 10.1016/S0141-0229(99)00190-8; FRANKENBERGER WT, 1983, SOIL SCI SOC AM J, V47, P945, DOI 10.2136/sssaj1983.03615995004700050021x; FRIEDMAN BE, 1977, J MOL BIOL, V111, P27; Harrington Kyle I, 2014, Commun Integr Biol, V7, pe28230, DOI 10.4161/cib.28230; Hobley L, 2006, APPL ENVIRON MICROB, V72, P6757, DOI 10.1128/AEM.00844-06; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HOPPE HG, 1988, APPL ENVIRON MICROB, V54, P784, DOI 10.1128/AEM.54.3.784-790.1988; Huang KL, 2014, ECOTOX ENVIRON SAFE, V109, P15, DOI 10.1016/j.ecoenv.2014.07.029; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hutchison ML, 1998, INFECT IMMUN, V66, P2033, DOI 10.1128/IAI.66.5.2033-2039.1998; Korbsrisate S, 2007, MICROBIOL-SGM, V153, P1907, DOI 10.1099/mic.0.2006/003004-0; Lee KWK, 2014, ISME J, V8, P894, DOI 10.1038/ismej.2013.194; Lehman RM, 2002, APPL ENVIRON MICROB, V68, P1569, DOI 10.1128/AEM.68.4.1569-1575.2002; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; Martinez J, 1996, AQUAT MICROB ECOL, V10, P223, DOI 10.3354/ame010223; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; McCoy ST, 2012, J ENVIRON ENG, V138, P786, DOI 10.1061/(ASCE)EE.1943-7870.0000539; MCKENNEY D, 1995, J BACTERIOL, V177, P6989, DOI 10.1128/jb.177.23.6989-6992.1995; MEISS HK, 1969, J BIOL CHEM, V244, P5382; Misic C, 2008, J MARINE SYST, V73, P123, DOI 10.1016/j.jmarsys.2007.10.003; Mongkolthanaruk W, 2002, INT BIODETER BIODEGR, V50, P101, DOI 10.1016/S0964-8305(02)00057-4; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Raghavan V, 2014, MOL MICROBIOL, V93, P1010, DOI 10.1111/mmi.12714; Rao D, 2005, APPL ENVIRON MICROB, V71, P1729, DOI 10.1128/AEM.71.4.1729-1736.2005; RATH J, 1993, MAR ECOL PROG SER, V102, P89, DOI 10.3354/meps102089; Reed DP, 2001, HARVARD BUS REV, V79, P23; Reed DP, 2001, HARVARD BUS REV, V79, P154; Riedel K, 2001, MICROBIOL-SGM, V147, P3249, DOI 10.1099/00221287-147-12-3249; Simoes LC, 2007, APPL ENVIRON MICROB, V73, P6192, DOI 10.1128/AEM.00837-07; SINSABAUGH RL, 1988, FRESHWATER BIOL, V20, P249, DOI 10.1111/j.1365-2427.1988.tb00449.x; STEAD D, 1987, J DAIRY RES, V54, P535, DOI 10.1017/S0022029900025735; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; Sutherland IW, 2004, FEMS MICROBIOL LETT, V232, P1, DOI 10.1016/S0378-1097(04)00041-2; Teh KH, 2013, INT J FOOD MICROBIOL, V163, P129, DOI 10.1016/j.ijfoodmicro.2013.02.009; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Wargo MJ, 2011, AM J RESP CRIT CARE, V184, P345, DOI 10.1164/rccm.201103-0374OC; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Williams CJ, 2006, HYDROBIOLOGIA, V569, P113, DOI 10.1007/s10750-006-0126-z; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Woodcock S, 2007, FEMS MICROBIOL ECOL, V62, P171, DOI 10.1111/j.1574-6941.2007.00379.x; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zhang LF, 2006, NANO LETT, V6, P694, DOI 10.1021/nl052455y	59	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143617	10.1371/journal.pone.0143617	http://dx.doi.org/10.1371/journal.pone.0143617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599415	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900149
J	Yang, MY; Du, LM; Li, WJ; Shen, FJ; Fan, ZX; Jian, ZY; Hou, R; Shen, YM; Yue, BS; Zhang, XY				Yang, Mingyu; Du, Lianming; Li, Wujiao; Shen, Fujun; Fan, Zhenxin; Jian, Zuoyi; Hou, Rong; Shen, Yongmei; Yue, Bisong; Zhang, Xiuyue			Profile of microRNA in Giant Panda Blood: A Resource for Immune-Related and Novel microRNAs	PLOS ONE			English	Article							CANCER; PATHWAY; PROTEIN; GENOME; RECONSTRUCTION; ACTIVATION; APOPTOSIS; SURVIVAL; SYSTEM; MAPK	The giant panda (Ailuropoda melanoleuca) is one of the world's most beloved endangered mammals. Although the draft genome of this species had been assembled, little was known about the composition of its microRNAs (miRNAs) or their functional profiles. Recent studies demonstrated that changes in the expression of miRNAs are associated with immunity. In this study, miRNAs were extracted from the blood of four healthy giant pandas and sequenced by Illumina next generation sequencing technology. As determined by miRNA screening, a total of 276 conserved miRNAs and 51 novel putative miRNAs candidates were detected. After differential expression analysis, we noticed that the expressions of 7 miRNAs were significantly up-regulated in young giant pandas compared with that of adults. Moreover, 2 miRNAs were up-regulated in female giant pandas and 1 in the male individuals. Target gene prediction suggested that the miRNAs of giant panda might be relevant to the expressions of 4,602 downstream genes. Subseuqently, the predicted target genes were conducted to KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis and we found that these genes were mainly involved in host immunity, including the Ras signaling pathway, the PI3K-Akt signaling pathway, and the MAPK signaling pathway. In conclusion, our results provide the first miRNA profiles of giant panda blood, and the predicted functional analyses may open an avenue for further study of giant panda immunity.	[Yang, Mingyu; Du, Lianming; Li, Wujiao; Fan, Zhenxin; Jian, Zuoyi; Yue, Bisong; Zhang, Xiuyue] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China; [Shen, Fujun; Hou, Rong] Chengdu Res Base Giant Panda Breeding, Key Lab Conservat Biol Endangered Wildlife, Chengdu 610081, Sichuan, Peoples R China; [Shen, Yongmei] Gooddoctor Pharmaceut Grp, Chengdu 610000, Sichuan, Peoples R China	Sichuan University	Zhang, XY (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China.	zhangxy317@126.com		Yue, Bisong/0000-0001-6731-538X	Chengdu Panda Breeding Research Foundation [CPF-2012-14]; National Basic Research Program of China (973 Project) [2012CB722207]	Chengdu Panda Breeding Research Foundation; National Basic Research Program of China (973 Project)(National Basic Research Program of China)	The authors thank the Chengdu Research Base of Giant Panda Breeding for their help in collecting the samples for this study. This work was supported by the Chengdu Panda Breeding Research Foundation (CPF-2012-14) and the National Basic Research Program of China (973 Project: 2012CB722207). Gooddoctor pharmaceutical group employee YMS provided data analysis, but the company did not have any additional role in the study design, data collection and decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bates DJ, 2009, BBA-GEN SUBJECTS, V1790, P970, DOI 10.1016/j.bbagen.2009.03.028; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; CLARK GJ, 1995, BREAST CANCER RES TR, V35, P133, DOI 10.1007/BF00694753; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Du LM, 2015, MOL ECOL RESOUR, V15, P1001, DOI 10.1111/1755-0998.12367; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; Gunda V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.78; He WY, 2012, AUTOPHAGY, V8, P1811, DOI 10.4161/auto.22145; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kozomara A., 2013, NUCLEIC ACIDS RES; Kozomara A., 2010, NUCLEIC ACIDS RES; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li CJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-16; Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044906; Morais ATS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-205; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; NARANDA T, 1994, J BIOL CHEM, V269, P32286; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; WATSON MA, 1979, LANCET, V2, P1323; Wei FW, 2000, J MAMMAL, V81, P448, DOI 10.1644/1545-1542(2000)081<0448:HUASBT>2.0.CO;2; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Wynendaele E, 2015, PEPTIDES, V64, P40, DOI 10.1016/j.peptides.2014.12.009; Xie Y, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0629-9; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhang X.-D., 2013, NUCLEIC ACIDS RES, V14, P157	45	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143242	10.1371/journal.pone.0143242	http://dx.doi.org/10.1371/journal.pone.0143242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599861	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900080
J	Bac-Molenaar, JA; Fradin, EF; Rienstra, JA; Vreugdenhil, D; Keurentjes, JJB				Bac-Molenaar, Johanna A.; Fradin, Emilie F.; Rienstra, Juriaan A.; Vreugdenhil, Dick; Keurentjes, Joost J. B.			GWA Mapping of Anthocyanin Accumulation Reveals Balancing Selection of MYB90 in Arabidopsis thaliana	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FLAVONOID BIOSYNTHETIC-PATHWAY; SUCROSE-SPECIFIC INDUCTION; HIGH-LIGHT; NATURAL VARIATION; DNA POLYMORPHISM; LEAF SENESCENCE; REFERENCE GENES; TRAIT ANALYSIS; IDENTIFICATION	Induction of anthocyanin accumulation by osmotic stress was assessed in 360 accessions of Arabidopsis thaliana. A wide range of natural variation, with phenotypes ranging from green to completely red/purple rosettes, was observed. A genome wide association (GWA) mapping approach revealed that sequence diversity in a small 15 kb region on chromosome 1 explained 40% of the variation observed. Sequence and expression analyses of alleles of the candidate gene MYB90 identified a causal polymorphism at amino acid (AA) position 210 of this transcription factor of the anthocyanin biosynthesis pathway. This amino acid discriminates the two most frequent alleles of MYB90. Both alleles are present in a substantial part of the population, suggesting balancing selection between these two alleles. Analysis of the geographical origin of the studied accessions suggests that the macro climate is not the driving force behind positive or negative selection for anthocyanin accumulation. An important role for local climatic conditions is, therefore, suggested. This study emphasizes that GWA mapping is a powerful approach to identify alleles that are under balancing selection pressure in nature.	[Bac-Molenaar, Johanna A.; Fradin, Emilie F.; Rienstra, Juriaan A.; Vreugdenhil, Dick] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands; [Bac-Molenaar, Johanna A.; Fradin, Emilie F.; Keurentjes, Joost J. B.] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Keurentjes, JJB (corresponding author), Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands.	Joost.Keurentjes@wur.nl	Bac-Molenaar, Johanna/R-2265-2016	van Dijk-Fradin, Emilie/0000-0002-5186-4920; Keurentjes, Joost/0000-0001-8918-0711	Dutch Technology Foundation part of the Netherlands Organisation for Scientific Research (NWO) [10996]	Dutch Technology Foundation part of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Funding: This research is part of the 'Learning from Nature' program, supported by the Dutch Technology Foundation (http://www.stw.nl/en/, STW grant number 10996), which is part of the Netherlands Organisation for Scientific Research (NWO).	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chalker-Scott L, 2002, ADV BOT RES, V37, P103, DOI 10.1016/S0065-2296(02)37046-0; Corp IBM, 2010, IBM SPSS STAT WIND V; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Diaz C, 2008, PLANT PHYSIOL, V147, P1437, DOI 10.1104/pp.108.119040; Diaz U, 2006, PLANT CELL PHYSIOL, V47, P74, DOI 10.1093/pcp/pci225; FU YX, 1993, GENETICS, V133, P693; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gutha LR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-187; Hale KL, 2001, PLANT PHYSIOL, V126, P1391, DOI 10.1104/pp.126.4.1391; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Hasdai M, 2006, ANN APPL BIOL, V148, P113, DOI 10.1111/j.1744-7348.2006.00044.x; Hoch WA, 2001, TREE PHYSIOL, V21, P1; Ilk N, 2015, NEW PHYTOL, V206, P422, DOI 10.1111/nph.13177; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Kruijer W, 2015, GENETICS, V199, P379, DOI 10.1534/genetics.114.167916; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mitchell-Olds T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-113; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Park W, 2012, SOIL SCI PLANT NUTR, V58, P334, DOI 10.1080/00380768.2012.684643; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schulz E, 2015, PLANT CELL ENVIRON, V38, P1658, DOI 10.1111/pce.12518; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Seren U, 2012, PLANT CELL, V24, P4793, DOI 10.1105/tpc.112.108068; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sperdouli I, 2012, J PLANT PHYSIOL, V169, P577, DOI 10.1016/j.jplph.2011.12.015; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; TAJIMA F, 1989, GENETICS, V123, P585; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Winefield C, 2009, PREVALENCE FUNCTIONS, P86; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Zeng XQ, 2010, PHYSIOL PLANTARUM, V138, P215, DOI 10.1111/j.1399-3054.2009.01316.x; Zhang KM, 2010, PLANT SCI, V179, P202, DOI 10.1016/j.plantsci.2010.05.006; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	49	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143212	10.1371/journal.pone.0143212	http://dx.doi.org/10.1371/journal.pone.0143212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588092	Green Submitted, Green Published, gold			2022-12-27	WOS:000365251500038
J	Meunchan, M; Michely, S; Devillers, H; Nicaud, JM; Marty, A; Neuveglise, C				Meunchan, Muchalin; Michely, Stephanie; Devillers, Hugo; Nicaud, Jean-Marc; Marty, Alain; Neuveglise, Cecile			Comprehensive Analysis of a Yeast Lipase Family in the Yarrowia Clade	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DIFFERENTIAL EXPRESSION ANALYSIS; SP-NOV.; LIPOLYTICA LIPASE; CANDIDA-DEFORMANS; MOLECULAR-BIOLOGY; GENE-EXPRESSION; OPEN SOFTWARE; LIP2; ENANTIOSELECTIVITY	Lipases are currently the subject of intensive studies due to their large range of industrial applications. The Lip2p lipase from the yeast Yarrowia lipolytica (YlLIP2) was recently shown to be a good candidate for different biotechnological applications. Using a combination of comparative genomics approaches based on sequence similarity, synteny conservation, and phylogeny, we constructed the evolutionary scenario of the lipase family for six species of the Yarrowia clade. RNA-seq based transcriptome analysis revealed the primary role of LIP2 homologues in the assimilation of different substrates. Once identified, these YlLIP2 homologues were expressed in Y. lipolytica. The lipase Lip2a from Candida phangngensis was shown to naturally present better activity and enantioselectivity than YlLip2. Enantioselectivity was further improved by site-directed mutagenesis targeted to the substrate binding site. The mono-substituted variant V232S displayed enantioselectivity greater than 200 and a 2.5 fold increase in velocity. A double-substituted variant 97A-V232F presented reversed enantioselectivity, with a total preference for the R-enantiomer.	[Meunchan, Muchalin; Marty, Alain] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Meunchan, Muchalin; Marty, Alain] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Meunchan, Muchalin; Marty, Alain] CNRS, UMR5504, F-31400 Toulouse, France; [Meunchan, Muchalin] Khon Kaen Univ, Fac Sci, Dept Biochem, Khon Kaen 40002, Thailand; [Michely, Stephanie; Devillers, Hugo; Nicaud, Jean-Marc; Neuveglise, Cecile] INRA, UMR Micalis 1319, F-78352 Jouy En Josas, France; [Michely, Stephanie; Devillers, Hugo; Nicaud, Jean-Marc; Neuveglise, Cecile] AgroParisTech, UMR Micalis, F-78352 Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Khon Kaen University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Marty, A (corresponding author), Univ Toulouse, INSA, UPS, INP,LISBP, 135 Ave Rangueil, F-31077 Toulouse, France.	alain.marty@insa-toulouse.fr; ncecile@grignon.inra.fr	NICAUD, Jean-marc/ABA-9076-2021	Neuveglise, Cecile/0000-0001-5017-7830	French Government [ANR-001-01]; INRA through the AIP-Bioressources YALIP project; Thailand Research Fund (TRF); Khon Kaen University through Royal Golden Jubilee PhD program [PHD/0282/2549]; French Minister of Research via the ABIES doctoral school	French Government; INRA through the AIP-Bioressources YALIP project; Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Khon Kaen University through Royal Golden Jubilee PhD program; French Minister of Research via the ABIES doctoral school	This work was performed, in partnership with the SAS PIVERT, within the frame of the French Institute for the Energy Transition (Institut pour la Transition Energetique - ITE) P.I.V.E.R.T. (www.institutpivert.com) selected as an Investment for the Future ("Investissements d'Avenir"). This work was supported as part of the Investments for the Future, by the French Government under the reference ANR-001-01 and by INRA through the AIP-Bioressources YALIP project. Muchalin Meunchan acknowledges the Thailand Research Fund (TRF) together with Khon Kaen University for financial support through Royal Golden Jubilee PhD program (grant number PHD/0282/2549) and French Embassy. Stephanie Michely has a PhD fellowship funded by the French Minister of Research via the ABIES doctoral school. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	AGGELIS G, 1993, GRASAS ACEITES, V44, P331, DOI 10.3989/gya.1993.v44.i6.1058; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barth G, 1996, NONCONVENTIONAL YEAS, P313, DOI [DOI 10.1007/978-3-642-79856-6_10, 10.1007/978-3-642-79856-6_10]; Benjamin S, 1998, YEAST, V14, P1069, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1069::AID-YEA303>3.3.CO;2-B; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigey F, 2003, YEAST, V20, P233, DOI 10.1002/yea.958; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; Bordes F, 2009, CHEMBIOCHEM, V10, P1705, DOI 10.1002/cbic.200900215; Bordes F, 2007, J MICROBIOL METH, V70, P493, DOI 10.1016/j.mimet.2007.06.008; Bordes F, 2011, J BIOTECHNOL, V156, P117, DOI 10.1016/j.jbiotec.2011.06.035; Bordes F, 2010, BIOPHYS J, V99, P2225, DOI 10.1016/j.bpj.2010.07.040; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cambon E, 2010, BIOTECHNOL BIOENG, V106, P852, DOI 10.1002/bit.22770; Cardenas F, 2001, ENZYME MICROB TECH, V28, P145, DOI 10.1016/S0141-0229(00)00278-7; Casas-Godoy L, 2014, J BIOTECHNOL, V180, P30, DOI 10.1016/j.jbiotec.2014.03.018; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chang CF, 2013, ANTON LEEUW INT J G, V104, P1117, DOI 10.1007/s10482-013-0033-z; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Almeida AF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/435818; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fickers P, 2005, FUNGAL GENET BIOL, V42, P264, DOI 10.1016/j.fgb.2004.12.003; Fickers P, 2011, BIOTECHNOL ADV, V29, P632, DOI 10.1016/j.biotechadv.2011.04.005; Goncalves FAG, 2014, SCI WORLD J, DOI 10.1155/2014/476207; Gopinath SCB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/154549; Groenewald M, 2013, ANTON LEEUW INT J G, V103, P1023, DOI 10.1007/s10482-013-9882-8; Guieysse D, 2004, TETRAHEDRON-ASYMMETR, V15, P3539, DOI 10.1016/j.tetasy.2004.09.008; Guieysse D, 2003, TETRAHEDRON-ASYMMETR, V14, P317, DOI 10.1016/S0957-4166(02)00784-X; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hube B, 2000, ARCH MICROBIOL, V174, P362, DOI 10.1007/s002030000218; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knutsen AK, 2007, INT J SYST EVOL MICR, V57, P2426, DOI 10.1099/ijs.0.65200-0; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtzman CP, 2005, ANTON LEEUW INT J G, V88, P121, DOI 10.1007/s10482-005-2495-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Limtong S, 2008, INT J SYST EVOL MICR, V58, P515, DOI 10.1099/ijs.0.65506-0; Madzak C, 1999, MICROBIOL-UK, V145, P75, DOI 10.1099/13500872-145-1-75; Madzak C, 2000, J MOL MICROB BIOTECH, V2, P207; Masse L, 2001, BIORESOURCE TECHNOL, V77, P145, DOI 10.1016/S0960-8524(00)00146-2; Nagy E, 2014, ANTON LEEUW INT J G, V105, P697, DOI 10.1007/s10482-014-0125-4; Nagy E, 2013, INT J SYST EVOL MICR, V63, P4818, DOI 10.1099/ijs.0.057208-0; OGRYDZIAK DM, 1977, BIOCHIM BIOPHYS ACTA, V497, P525, DOI 10.1016/0304-4165(77)90209-4; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Peter G, 2004, ANTON LEEUW INT J G, V86, P105, DOI 10.1023/B:ANTO.0000036117.03847.bd; Piamtongkam R, 2011, BIOTECHNOL BIOENG, V108, P1749, DOI 10.1002/bit.23124; Pignede G, 2000, J BACTERIOL, V182, P2802, DOI 10.1128/JB.182.10.2802-2810.2000; Pleiss J, 2000, J MOL CATAL B-ENZYM, V10, P491, DOI 10.1016/S1381-1177(00)00092-8; QUINN DM, 1982, BIOCHEMISTRY-US, V21, P6872, DOI 10.1021/bi00269a038; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Tan TW, 2010, BIOTECHNOL ADV, V28, P628, DOI 10.1016/j.biotechadv.2010.05.012; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu Q, 2015, CURR OPIN BIOTECH, V36, P65, DOI 10.1016/j.copbio.2015.08.010	57	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143096	10.1371/journal.pone.0143096	http://dx.doi.org/10.1371/journal.pone.0143096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580812	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600082
J	Lin, YC; Huang, CY; Lin, IL; Shieh, JY; Chung, YT; Chen, KL				Lin, Yu-Ching; Huang, Chien-Yu; Lin, I-Ling; Shieh, Jeng-Yi; Chung, Yu-Ting; Chen, Kuan-Lin			Evaluating Functional Outcomes of Botulinum Toxin Type A Injection Combined with Occupational Therapy in the Upper Limbs of Children with Cerebral Palsy: A 9-Month Follow-Up from the Perspectives of Both Child and Caregiver	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS STATEMENT; RELIABILITY; SPASTICITY; CLASSIFICATION; INTERVENTION; PREVALENCE; VALIDITY; VERSION; MUSCLE	Objective To assess the effectiveness of combining botulinum toxin type A (BoNT-A) with functional occupational therapy (OT) at 9-month follow-up in children with cerebral palsy (CP) with bilateral upper limb impairments from the perspectives of both child and caregiver. Methods Twelve children with CP and their caregivers were assessed across 5 time points over 9 months based on the ICF after BoNT-A injection and functional OT in this open-label study. Results Significant differences were found across the 5 time points (p<.05) for both grasp and visual-motor integration with small effects (effect sizes = 0.12-0.24) and the self-care capability and performance of social function (p<.05). However, based on the effect sizes (0.02-0.14), no significant effects were found at the 4 post-test time points. Small effects were found on the psychological domain (effect sizes = 0.25-0.37) and environmental domains (effect size = 0.27) at follow-ups. Conclusion Combining a BoNT-A injection with OT not only reduced the muscle tone and increased ROM but also improved the upper limb function and self-care capability in children with CP. More importantly, these effects persisted for up to 9 months. Functional OT extends the effectiveness of a BoNT-A injection.	[Lin, Yu-Ching; Chung, Yu-Ting; Chen, Kuan-Lin] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Phys Med & Rehabil, Tainan 70101, Taiwan; [Lin, Yu-Ching] Natl Cheng Kung Univ, Coll Med, Dept Phys Med & Rehabil, Tainan 70101, Taiwan; [Lin, Yu-Ching] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan; [Huang, Chien-Yu] Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei 10764, Taiwan; [Lin, I-Ling] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Shieh, Jeng-Yi] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei 10764, Taiwan; [Chen, Kuan-Lin] Natl Cheng Kung Univ, Coll Med, Sch Occupat Therapy, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Taiwan University; Kaohsiung Medical University; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University	Chen, KL (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Phys Med & Rehabil, Tainan 70101, Taiwan.	klchen@mail.ncku.edu.tw	Chen, Kuan-Lin/AAC-5430-2021; Chen, Kuan-Lin/AAD-4537-2022	Chen, Kuan-Lin/0000-0001-9996-814X; SHIEH, JENG-YI/0000-0002-3906-4269	National Science Council, Taiwan [NSC 101-2314-B-006-003]; National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan [NCKUH-10407018]; Ministry of Education, Taiwan, R.O.C.; Headquarters of University Advancement at the National Cheng Kung University by the Ministry of Education, Taiwan, ROC	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan); Headquarters of University Advancement at the National Cheng Kung University by the Ministry of Education, Taiwan, ROC	This research was supported by the funding from the National Science Council, Taiwan. [NSC 101-2314-B-006-003] and the National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan [NCKUH-10407018]. This research was, in part, supported by the Ministry of Education, Taiwan, R.O.C. The Aim for the Top University Project to the National Cheng Kung University (NCKU). This research received funding from the Headquarters of University Advancement at the National Cheng Kung University, which is sponsored by the Ministry of Education, Taiwan, ROC.	Baird MW, 2010, J CHILD NEUROL, V25, P721, DOI 10.1177/0883073809346846; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brin MF, 2014, BIOL-TARGETS THER, V8, P227, DOI 10.2147/BTT.S65603; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Chen KL, 2009, J REHABIL MED, V41, P273, DOI 10.2340/16501977-0319; Fattal-Valevski A, 2010, J CHILD NEUROL; Fehlings D, 2010, EUR J NEUROL, V17, P38, DOI 10.1111/j.1468-1331.2010.03127.x; Graham HK, 2003, J BONE JOINT SURG BR, V85B, P157, DOI 10.1302/0301620X.85B2.14066; Hoare BJ, 2010, BOTULINUM TOXIN A AD; Hoare B, 2014, J CHILD NEUROL, V29, P1066, DOI 10.1177/0883073814533196; Koman LA, 2013, J HAND SURG-AM, V38A, P435, DOI 10.1016/j.jhsa.2012.12.019; Lannin N, 2004, AUSTR OCCUPATIONAL T, V51, P208; Lin YC, 2015, ARCH PHYS MED REHAB, V96, P760, DOI 10.1016/j.apmr.2014.11.011; Love SC, 2010, EUR J NEUROL, V17, P9, DOI 10.1111/j.1468-1331.2010.03126.x; Ma J, 2004, AM J PHYS MED REHAB, V83, P774, DOI 10.1097/01.PHM.0000137315.17214.93; Molenaers G, 2010, J CHILD ORTHOP, V4, P183, DOI 10.1007/s11832-010-0246-x; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/09638280500158422; Reid SM, 2011, RES DEV DISABIL, V32, P2909, DOI 10.1016/j.ridd.2011.05.012; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Strobl W, 2015, TOXINS, V7, P1629, DOI 10.3390/toxins7051629; Wallen M, 2007, ARCH PHYS MED REHAB, V88, P1, DOI 10.1016/j.apmr.2006.10.017; Wang HH, 2006, PHYS THER, V86, P1351, DOI 10.2522/ptj.20050259; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; World Health Organization (WHO), 2001, INTERNATIONAL CLASSI; Yao G, 2002, J FORMOS MED ASSOC, V101, P342	26	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142769	10.1371/journal.pone.0142769	http://dx.doi.org/10.1371/journal.pone.0142769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599003	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600017
J	Matsubayashi, Y; Takeshita, K; Sumitani, M; Oshima, Y; Tonosu, J; Kato, S; Ohya, J; Oichi, T; Okamoto, N; Tanaka, S				Matsubayashi, Yoshitaka; Takeshita, Katsushi; Sumitani, Masahiko; Oshima, Yasushi; Tonosu, Juichi; Kato, So; Ohya, Junichi; Oichi, Takeshi; Okamoto, Naoki; Tanaka, Sakae			Psychometric Validation of the Japanese Version of the Neuropathic Pain Symptom Inventory	PLOS ONE			English	Article							CLINICAL-TESTS; IDENTIFY; VALIDITY; SYSTEM; SF-36	Objective This study aimed to evaluate the validity and reliability of the Japanese version of the Neuropathic Pain Symptom Inventory (NPSI-J). Design Cross-sectional study design. Subjects and Methods The original Neuropathic Pain Symptom Inventory (NPSI) was translated into Japanese according to published guidelines. Subsequently, an observational study of 60 Japanese patients suffering from neuropathic pain was performed to evaluate the validity and reliability of the NPSI-J. Results The NPSI-J exhibited a statistically significant correlation with pain intensity (Numerical Rating Scale). The Cronbach alpha value for Likert items was 0.86. Using the test-retest analysis method, the intraclass correlation coefficient between the two scores was 0.81. Factor analysis revealed that the main component of NPSI-J comprised three determinative factors. Conclusions The NPSI-J is a reliable and valid pain assessment tool.	[Matsubayashi, Yoshitaka; Oshima, Yasushi; Tonosu, Juichi; Kato, So; Ohya, Junichi; Oichi, Takeshi; Okamoto, Naoki; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Takeshita, Katsushi] Jichi Med Univ, Dept Orthopaed Surg, Shimotsuke, Tochigi, Japan; [Sumitani, Masahiko] Univ Tokyo, Dept Pain & Palliat Med, Tokyo, Japan	University of Tokyo; Jichi Medical University; University of Tokyo	Matsubayashi, Y (corresponding author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan.	ymatsubayashi-tky@umin.ac.jp	Ohya, Junichi/L-5987-2019; Tanaka, Sakae/Y-3061-2019; Ohya, Junichi/AAV-8524-2020	Tanaka, Sakae/0000-0001-9210-9414; Ohya, Junichi/0000-0002-1299-2508; Matsubayashi, Yoshitaka/0000-0002-2087-5774	Japan Agency for Medical Research and Development [H27-itami-shitei-001]; Ministry of Health, Labor, and Welfare [H23-itami-ippan-002]; Grants-in-Aid for Scientific Research [25293316] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by Japan Agency for Medical Research and Development Grant (H27-itami-shitei-001) to MS (URL: http://www.amed.go.jp) and Ministry of Health, Labor, and Welfare Science Research Grant (H23-itami-ippan-002) to KT and MS (URL: http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre-Obadia N, 2008, NEUROLOGY, V71, P833, DOI 10.1212/01.wnl.0000325481.61471.f0; Attal N, 2008, PAIN, V138, P343, DOI 10.1016/j.pain.2008.01.006; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Bouhassira D, 2014, PAIN, V155, P2171, DOI 10.1016/j.pain.2014.08.020; BOUREAU F, 1990, PAIN, V42, P145, DOI 10.1016/0304-3959(90)91158-F; de Andrade DC, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-107; DUBUISSON D, 1976, EXP NEUROL, V51, P480, DOI 10.1016/0014-4886(76)90271-5; Feise RJ, 2001, SPINE, V26, P78, DOI 10.1097/00007632-200101010-00015; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Matsubayashi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068013; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Connor AB, 2009, PHARMACOECONOMICS, V27, P95, DOI 10.2165/00019053-200927020-00002; Padua L, 2009, NEUROL SCI, V30, P99, DOI 10.1007/s10072-009-0025-y; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sommer C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-104; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170; Sumitani M, 2015, J PAIN PALLIAT CARE; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Villoria J, 2011, J PAIN SYMPTOM MANAG, V42, P134, DOI 10.1016/j.jpainsymman.2010.09.018	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143350	10.1371/journal.pone.0143350	http://dx.doi.org/10.1371/journal.pone.0143350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600240	Green Submitted, Green Published, gold			2022-12-27	WOS:000365862600054
J	Bao, FJ; Wang, JJ; Huang, JH; Yu, Y; Deng, ML; Li, LN; Yu, AY; Wang, QM; Davey, PG; Elsheikh, A				Bao, FangJun; Wang, JunJie; Huang, JinHai; Yu, Ye; Deng, ManLi; Li, LinNa; Yu, AYong; Wang, QinMei; Davey, Pinakin Gunvant; Elsheikh, Ahmed			Effect of Misalignment between Successive Corneal Videokeratography Maps on the Repeatability of Topography Data	PLOS ONE			English	Article							SCANNING-SLIT; REPRODUCIBILITY; THICKNESS; CURVATURE; PENTACAM; SYSTEM; POWER	Purpose To improve the reliability of corneal topographic data through the development of a method to estimate the magnitude of misalignment between successive corneal videokeratography (VK) maps and eliminate the effect of misalignment on the repeatability of topography data. Methods Anterior and posterior topography maps were recorded twice for 124 healthy eyes of 124 participants using a Pentacam, and the repeatability of measurements was assessed by calculating the differences in elevation between each two sets of data. The repeatability of measurements was re-assessed following the determination of the magnitude of misalignment components (translational displacements: x(0), y(0) and z(0), and rotational displacements: alpha, beta and gamma) between each two data sets and using them to modify the second data set within each pair based on an Iterative Closest Point (ICP) algorithm. The method simultaneously considered the anterior and posterior maps taken for the same eye since they were assumed to have the same set of misalignment components. A new parameter, named Combined Misalignment parameter (CM), has been developed to combine the effect of all six misalignment components on topography data and so enable study of the association between misalignment and the data repeatability test results. Results The repeatability tests resulted in average root mean square (RMS) differences in elevation data of 8.46 +/- 2.75 mu m before ICP map matching when simultaneously considering anterior and posterior surfaces. With map matching and misalignment correction, the differences decreased to 7.28 +/- 2.58 mu m (P = 0.00). When applied to only the anterior maps, misalignment correction led to a more pronounced reduction in elevation data differences from 4.58 +/- 1.84 mu m to 2.97 +/- 1.29 mu m (P = 0.00). CM was found to be associated with the repeatability error (P = 0.00), with posterior maps being responsible for most of the error due to their relatively lower accuracy compared to anterior maps. Conclusions The ICP algorithm can be used to estimate, and effectively correct for, the potential misalignment between successive corneal videokeratography maps.	[Bao, FangJun; Huang, JinHai; Yu, Ye; Deng, ManLi; Li, LinNa; Yu, AYong; Wang, QinMei] WenZhou Med Univ, Affiliated Eye Hosp, Wenzhou 325027, Peoples R China; [Bao, FangJun; Huang, JinHai; Yu, Ye; Deng, ManLi; Li, LinNa; Yu, AYong; Wang, QinMei] Wenzhou Med Univ, Inst Ocular Biomech, Wenzhou 325027, Zhejiang, Peoples R China; [Wang, JunJie; Elsheikh, Ahmed] Univ Liverpool, Sch Engn, Liverpool L69 3GH, Merseyside, England; [Davey, Pinakin Gunvant] Western Univ Hlth Sci, Coll Optometry, Pomona, CA 91766 USA; [Elsheikh, Ahmed] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England; [Elsheikh, Ahmed] UCL Inst Ophthalmol, London, England	Wenzhou Medical University; Wenzhou Medical University; University of Liverpool; Western University of Health Sciences; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Wang, QM (corresponding author), WenZhou Med Univ, Affiliated Eye Hosp, Wenzhou 325027, Peoples R China.	wanqm55@126.com	Davey, Pinakin/AAI-9869-2021; li, li/HII-4157-2022; Davey, Pinakin/AAK-9804-2021; Huang, Jinhai/ABH-4519-2020	Davey, Pinakin/0000-0002-6683-7052; Elsheikh, Ahmed/0000-0001-7456-1749	Science and Technology Plan Project of Wenzhou Science and Technology Bureau [C20120009-04]; science foundation of the affiliated eye hospital of wenzhou medical university [YNCX201312, YNCX201405]; National Natural Science Foundation of China [81300807]	Science and Technology Plan Project of Wenzhou Science and Technology Bureau; science foundation of the affiliated eye hospital of wenzhou medical university; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Science and Technology Plan Project of Wenzhou Science and Technology Bureau (C20120009-04), science foundation of the affiliated eye hospital of wenzhou medical university (YNCX201312, YNCX201405) and the National Natural Science Foundation of China (81300807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio G, 2001, OPHTHALMOLOGY, V108, P1695, DOI 10.1016/S0161-6420(01)00706-0; Alkhaldi W, 2010, IEEE T BIO-MED ENG, V57, P2429, DOI 10.1109/TBME.2010.2050770; Bao FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073412; Barsky BA, 1997, OPTOMETRY VISION SCI, V74, P917, DOI 10.1097/00006324-199711000-00025; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bhatoa NS, 2010, CONTACT LENS ANTERIO, V33, P128, DOI 10.1016/j.clae.2009.11.004; Buehl W, 2006, AM J OPHTHALMOL, V141, P7, DOI 10.1016/j.ajo.2005.08.048; Chen D, 2007, J CATARACT REFR SURG, V33, P448, DOI 10.1016/j.jcrs.2006.11.008; CHEN Y, 1992, IMAGE VISION COMPUT, V10, P145, DOI 10.1016/0262-8856(92)90066-C; Franklin Ross J, 2006, Eye Contact Lens, V32, P27, DOI 10.1097/01.icl.0000172118.24284.f6; Guilbert E, 2012, J CATARACT REFR SURG, V38, P1198, DOI 10.1016/j.jcrs.2012.01.033; Guler E, 2014, CONTACT LENS ANTERIO, V37, P331, DOI 10.1016/j.clae.2014.04.004; Huang JH, 2013, OPHTHALMOLOGY, V120, P1951, DOI 10.1016/j.ophtha.2013.02.022; Karabatsas CH, 1998, OPHTHALMOLOGY, V105, P1999, DOI 10.1016/S0161-6420(98)91115-0; Kawamorita T, 2009, J CATARACT REFR SURG, V35, P127, DOI 10.1016/j.jcrs.2008.10.019; Lackner B, 2005, OPTOMETRY VISION SCI, V82, P858, DOI 10.1097/01.opx.0000177804.53192.15; Levy D, 2004, OPHTHALMOLOGY, V111, P867, DOI 10.1016/j.ophtha.2003.12.024; MAEDA N, 1995, ARCH OPHTHALMOL-CHIC, V113, P870, DOI 10.1001/archopht.1995.01100070044023; Maldonado MJ, 2006, OPHTHALMOLOGY, V113, P1918, DOI 10.1016/j.ophtha.2006.05.053; Miranda MA, 2009, OPTOMETRY VISION SCI, V86, P266, DOI 10.1097/OPX.0b013e318196a737; Read SA, 2006, INVEST OPHTH VIS SCI, V47, P1404, DOI 10.1167/iovs.05-1181; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Schwiegerling J, 2005, J REFRACT SURG, V21, pS552; Szczotka LB, 1997, OPTOMETRY VISION SCI, V74, P14, DOI 10.1097/00006324-199701000-00015; Wang J, 2014, P I MECH ENG H, V228, P1154, DOI 10.1177/0954411914559080; [No title captured]	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0139541	10.1371/journal.pone.0139541	http://dx.doi.org/10.1371/journal.pone.0139541			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599442	gold, Green Submitted, Green Published			2022-12-27	WOS:000365853900004
J	Dmochowski, JP; Norcia, AM				Dmochowski, Jacek P.; Norcia, Anthony M.			Cortical Components of Reaction-Time during Perceptual Decisions in Humans	PLOS ONE			English	Article							EVIDENCE ACCUMULATION; RESPONSE ACTIVATION; COGNITIVE CONTROL; PREMOTOR CORTEX; FRONTAL-CORTEX; HUMAN BRAIN; SELECTION; MOTOR; MODELS; TASKS	The mechanisms of perceptual decision-making are frequently studied through measurements of reaction time (RT). Classical sequential-sampling models (SSMs) of decision-making posit RT as the sum of non-overlapping sensory, evidence accumulation, and motor delays. In contrast, recent empirical evidence hints at a continuous-flow paradigm in which multiple motor plans evolve concurrently with the accumulation of sensory evidence. Here we employ a trial-to-trial reliability-based component analysis of encephalographic data acquired during a random-dot motion task to directly image continuous flow in the human brain. We identify three topographically distinct neural sources whose dynamics exhibit contemporaneous ramping to time-of-response, with the rate and duration of ramping discriminating fast and slow responses. Only one of these sources, a parietal component, exhibits dependence on strength-of-evidence. The remaining two components possess topographies consistent with origins in the motor system, and their covariation with RT overlaps in time with the evidence accumulation process. After fitting the behavioral data to a popular SSM, we find that the model decision variable is more closely matched to the combined activity of the three components than to their individual activity. Our results emphasize the role of motor variability in shaping RT distributions on perceptual decision tasks, suggesting that physiologically plausible computational accounts of perceptual decision-making must model the concurrent nature of evidence accumulation and motor planning.	[Dmochowski, Jacek P.; Norcia, Anthony M.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Dmochowski, JP (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	jdmochowski@ccny.cuny.edu			National Institutes of Health (NIH) [RO1-EY018875, RO1-EY015790]; NIH [RO1-EY018875, RO1-EY015790]; NATIONAL EYE INSTITUTE [R01EY018875, R01EY015790] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) Grants RO1-EY018875 and RO1-EY015790 to AMN (https://nei.nih.gov/).; This work was supported by NIH Grants RO1-EY018875 and RO1-EY015790. The authors thank Justin Gardner, William Newsome, Diogo Peixoto, Krishna Shenoy, and Chandramouli Chandrasekaran, as well as an anonymous reviewer, for helpful discussions.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bichot NP, 2001, NEUROPSYCHOLOGIA, V39, P972, DOI 10.1016/S0028-3932(01)00022-7; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; de Lange FP, 2013, J NEUROSCI, V33, P1400, DOI 10.1523/JNEUROSCI.1094-12.2013; DEJONG R, 1988, J EXP PSYCHOL HUMAN, V14, P682, DOI 10.1037/0096-1523.14.4.682; Dmochowski JP, 2015, NEUROIMAGE, V109, P63, DOI 10.1016/j.neuroimage.2014.12.078; Dmochowski JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5567; Dmochowski JP, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00112; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Eimer M, 1998, BEHAV RES METH INS C, V30, P146, DOI 10.3758/BF03209424; Fetsch CR, 2014, NEURON, V83, P797, DOI 10.1016/j.neuron.2014.07.011; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Kelly SP, 2013, J NEUROSCI, V33, P19434, DOI 10.1523/JNEUROSCI.3355-13.2013; Kiani R, 2014, NEURON, V84, P1329, DOI 10.1016/j.neuron.2014.12.015; Kubanek J, 2013, NEUROIMAGE, V83, P795, DOI 10.1016/j.neuroimage.2013.06.085; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Perrin F., 1989, ELECTROENCEPHALOGRAP, V72, P184; Philiastides MG, 2014, J NEUROSCI, V34, P16877, DOI 10.1523/JNEUROSCI.3012-14.2014; Polania R, 2014, NEURON, V82, P709, DOI 10.1016/j.neuron.2014.03.014; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Selen LPJ, 2012, J NEUROSCI, V32, P2276, DOI 10.1523/JNEUROSCI.5273-11.2012; Servant M, 2015, J NEUROSCI, V35, P10371, DOI 10.1523/JNEUROSCI.0078-15.2015; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Simen P, 2009, J EXP PSYCHOL HUMAN, V35, P1865, DOI 10.1037/a0016926; Simen P, 2009, BRAIN RES, V1299, P95, DOI 10.1016/j.brainres.2009.07.017; Theil H., 1961, CONTRIBUTIONS EC ANA, V15; van Vugt MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090943	48	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143339	10.1371/journal.pone.0143339	http://dx.doi.org/10.1371/journal.pone.0143339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599741	Green Published, gold			2022-12-27	WOS:000365853900095
J	Doddala, PRC; Minor, MA; Rogers, DJ; Trewick, SA				Doddala, Prasad R. C.; Minor, Maria A.; Rogers, David J.; Trewick, Steven A.			Fifteen into Three Does Go: Morphology, Genetics and Genitalia Confirm Taxonomic Inflation of New Zealand Beetles (Chrysomelidae: Eucolaspis)	PLOS ONE			English	Article							BRONZE BEETLE; COLEOPTERA-CHRYSOMELIDAE; DNA; SEQUENCES; GRASSHOPPERS; ORTHOPTERA; EVOLUTION; INFERENCE; MRBAYES	Eucolaspis Sharp 1886 is a New Zealand native leaf beetle genus (Coleoptera: Chrysomelidae: Eumolpinae) with poorly described species and a complex taxonomy. Many economically important fruit crops are severely damaged by these beetles. Uncertain species taxonomy of Eucolaspis is leaving any biological research, as well as pest management, tenuous. We used morphometrics, mitochondrial DNA and male genitalia to study phylogenetic and geographic diversity of Eucolaspis in New Zealand. Freshly collected beetles from several locations across their distribution range, as well as identified voucher specimens from major museum collections were examined to test the current classification. We also considered phylogenetic relationships among New Zealand and global Eumolpinae (Coleoptera: Chyrosomelidae). We demonstrate that most of the morphological information used previously to define New Zealand Eucolaspis species is insufficient. At the same time, we show that a combination of morphological and genetic evidence supports the existence of just 3 mainland Eucolaspis lineages (putative species), and not 5 or 15, as previously reported. In addition, there may be another closely related lineage (putative species) on an offshore location (Three Kings Islands, NZ). The cladistic structure among the lineages, conferred through mitochondrial DNA data, was well supported by differences in male genitalia. We found that only a single species (lineage) infests fruit orchards in Hawke's Bay region of New Zealand. Species-host plant associations vary among different regions.	[Doddala, Prasad R. C.; Minor, Maria A.; Trewick, Steven A.] Massey Univ, Inst Agr & Environm, Ecol Grp, Palmerston North, New Zealand; [Rogers, David J.] Plant & Food Res Ltd, Havelock North, New Zealand	Massey University; New Zealand Institute for Plant & Food Research Ltd	Doddala, PRC (corresponding author), Swedish Univ Agr Sci, Dept Plant Protect Biol, Div Chem Ecol, Alnarp, Sweden.	prasad.doddala@slu.se	Rogers, Dave/J-4235-2018	Rogers, Dave/0000-0003-1976-6930; Trewick, Steven/0000-0002-4680-8457	Plant and Food Research Ltd.	Plant and Food Research Ltd.	The funder (Plant and Food Research Ltd.) provided support in the form of salaries for authors (DJR), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber HS, 1937, P ENTOMOLOGICAL SOC, V38; Broun T, 1893, J NATURAL HIST 6, V6, P374; Broun T, 1880, MANUAL NZ COLEOPTERA; Broun T, 1909, J NATURAL HIST 8, V8, P275; Broun T, 1893, MANUAL NZ COLEOPTERA; Bryant GE, 1957, PAC SCI, V11, P2; Crosby TK, 1998, NEW ZEAL J ZOOL, V25, P175, DOI 10.1080/03014223.1998.9518148; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Doddala P. R. C., 2010, New Zealand Plant Protection, V63, P195; Doddala PRC, 2015, J APPL ENTOMOLOGY; Doddala PRC, 2012, THESIS; Drummond A. J., 2011, GENEIOUS V5 4; Fabricius J.C., 1781, SPECIES INSECTORUM, V1; Ferro D. N, 1977, Bulletin ent Soc NZ, VNo. 4, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gomez-Zurita J, 2010, J NAT HIST, V44, P2557, DOI 10.1080/00222933.2010.499575; GURNEY ASHLEY B., 1964, ANN ENTOMOL SOC AMER, V57, P240; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kawakami Y, 2010, ANN ENTOMOL SOC AM, V103, P327, DOI 10.1603/AN09074; Kubisz D, 2012, CENT EUR J BIOL, V7, P69, DOI 10.2478/s11535-011-0099-4; Kuschel G., 1990, 3 DSIR; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lysaght AM, 1930, NZ DEP SCI IND RES W, V25; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; McGlone M, 2011, ECOREGIONS TE ARA EN; Montagna M, 2013, PACHYBRACHIS HOLEROR, V3741, P11; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Peterson MA, 2007, CHEMOECOLOGY, V17, P87, DOI 10.1007/s00049-007-0366-z; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rogers D. J., 2007, New Zealand Plant Protection, V60, P1; Rogers D. J., 2006, New Zealand Plant Protection, V59, P57; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Sharp D, 1886, NZ COLEOPTERA DESCRI, P445; Shaw S., 1957, ANN MAGAZINE NATURAL, V12, P641, DOI DOI 10.1080/00222935708656008; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tosevski I, 2011, SYST ENTOMOL, V36, P741, DOI 10.1111/j.1365-3113.2011.00593.x; Trewick SA, 2000, MOL ECOL, V9, P269, DOI 10.1046/j.1365-294x.2000.00873.x; Trewick SA, 2008, CLADISTICS, V24, P240, DOI 10.1111/j.1096-0031.2007.00174.x; Trewick Steven A., 2011, Insects, V2, P297, DOI 10.3390/insects2030297; Vaux F, 2015, BIOL J LINNEAN SOC; Vawter L, 1991, EVOLUTION BLATTOID I; White A, 1846, ZOOLOGY VOYAGE HMS E, P23; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	50	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143258	10.1371/journal.pone.0143258	http://dx.doi.org/10.1371/journal.pone.0143258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600380	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900083
J	Fang, F; Luo, ZC; Dejemli, A; Delvin, E; Zhang, J				Fang, Fang; Luo, Zhong-Cheng; Dejemli, Anissa; Delvin, Edgard; Zhang, Jun			Maternal Smoking and Metabolic Health Biomarkers in Newborns	PLOS ONE			English	Article							GROWTH-FACTOR-I; NICOTINE EXPOSURE; BIRTH-WEIGHT; CIGARETTE-SMOKING; PREGNANT-WOMEN; FETAL-GROWTH; LEPTIN; RISK; CESSATION; PROTEINS	Background Maternal smoking has been associated with elevated risk of type 2 diabetes among the offspring in adulthood. The mechanisms underlying this fetal "programming" effect remain unclear. The present study sought to explore whether maternal smoking affects metabolic health biomarkers in fetuses/newborns. Methods In a prospective singleton pregnancy cohort (n = 248), we compared metabolic health biomarkers in the newborns of smoking and non-smoking mothers. Outcomes included cord plasma insulin, proinsulin, insulin-like growth factor I (IGF-I), IGF-II, leptin and adiponectin concentrations, glucose-to-insulin ratio (an indicator of insulin sensitivity) and proinsulin-to-insulin ratio (an indicator of beta-cell function). Results Independent of maternal (glucose tolerance, age, ethnicity, parity, education, body mass index, alcohol use) and infant (sex, gestational age, birth weight z score, mode of delivery, cord blood glucose concentration) characteristics, the newborns of smoking mothers had lower IGF-I concentrations (mean: 6.7 vs. 8.4 nmol/L, adjusted p = 0.006), and marginally higher proinsulin-to-insulin ratios (0.94 vs. 0.72, adjusted p = 0.06) than the newborns of non-smoking mothers. Cord plasma insulin, proinsulin, IGF-II, leptin and adiponectin concentrations and glucose-to-insulin ratios were similar in the newborns of smoking and nonsmoking mothers. Conclusions Maternal smoking was associated with decreased fetal IGF-I levels, and borderline lower fetal beta-cell function. Larger cohort studies are required to confirm the latter finding. The preliminary findings prompt the hypothesis that these early life metabolic changes may be involved in the impact of maternal smoking on future risk of metabolic syndrome related disorders in the offspring.	[Fang, Fang; Luo, Zhong-Cheng; Zhang, Jun] Shanghai Jiao Tong Univ, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp, Minist Educ,Sch Med, Shanghai 200092, Peoples R China; [Luo, Zhong-Cheng] Univ Montreal, Res Ctr, Dept Obstet & Gynecol, St Justine Hosp, Montreal, PQ H3T 1C5, Canada; [Dejemli, Anissa; Delvin, Edgard] Univ Montreal, Res Ctr, Dept Clin Biochem, St Justine Hosp, Montreal, PQ H3T 1C5, Canada	Shanghai Jiao Tong University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Luo, ZC (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp, Minist Educ,Sch Med, Shanghai 200092, Peoples R China.	zhongcheng_luo3@163.com	Luo, Zhong-Cheng/T-3882-2017	Luo, Zhong-Cheng/0000-0002-1794-1312	Canadian Institutes of Health Research (CIHR grant) [79896]; National Natural Science Foundation of China [81370742]	Canadian Institutes of Health Research (CIHR grant)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Canadian Institutes of Health Research (CIHR grant # 79896) and National Natural Science Foundation of China (grant # 81370742). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 1997, BRIT MED BULL, V53, P96; Bruin JE, 2007, J ENDOCRINOL, V194, P171, DOI 10.1677/JOE-07-0050; Burks DJ, 2001, DIABETES, V50, pS140, DOI 10.2337/diabetes.50.2007.S140; Chelchowska Magdalena, 2014, Przegl Lek, V71, P567; Chelchowska Magdalena, 2013, Przegl Lek, V70, P800; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027260; Dempsey D, 2002, J PHARMACOL EXP THER, V301, P594, DOI 10.1124/jpet.301.2.594; Dukic VM, 2009, INT J ENV RES PUB HE, V6, P1744, DOI 10.3390/ijerph6061744; Elghazi L, 2009, TRENDS ENDOCRIN MET, V20, P243, DOI 10.1016/j.tem.2009.03.002; Ermis B, 2004, HORM RES, V62, P288, DOI 10.1159/000081974; Gluckman PD, 2003, J NUTR, V133, p1741S, DOI 10.1093/jn/133.5.1741S; Helland IB, 2001, ACTA PAEDIATR, V90, P282, DOI 10.1080/080352501300067578; Ingvarsson RF, 2007, ACTA PAEDIATR, V96, P383, DOI 10.1111/j.1651-2227.2007.00103.x; Jaddoe VWV, 2014, DIABETES CARE, V37, P2966, DOI 10.2337/dc13-1679; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; La Merrill MA, 2015, J DEV ORIG HLTH DIS, V6, P242, DOI 10.1017/S2040174415000045; Luo ZC, 2013, OBESITY, V21, P210, DOI 10.1002/oby.20250; Luo ZC, 2012, J CLIN ENDOCR METAB, V97, P1720, DOI 10.1210/jc.2011-3296; Luo ZC, 2010, DIABETES CARE, V33, P2055, DOI 10.2337/dc10-0819; Mantzoros CS, 1997, J CLIN ENDOCR METAB, V82, P2856, DOI 10.1210/jc.82.9.2856; Mathews T J, 2001, Natl Vital Stat Rep, V49, P1; Ozkan B, 2005, ENDOCR RES, V31, P177, DOI 10.1080/07435800500371748; Pickett KE, 2009, NICOTINE TOB RES, V11, P1166, DOI 10.1093/ntr/ntp117; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Pringle PJ, 2005, J CLIN ENDOCR METAB, V90, P2556, DOI 10.1210/jc.2004-1674; REECE EA, 1994, OBSTET GYNECOL, V84, P88; Rogers John M., 2008, Birth Defects Research, V84, P1, DOI 10.1002/bdrc.20119; Russell TV, 2004, NICOTINE TOB RES, V6, pS141, DOI 10.1080/14622200410001669141; Sargeant LA, 2001, INT J EPIDEMIOL, V30, P547, DOI 10.1093/ije/30.3.547; Somm E, 2008, ENDOCRINOLOGY, V149, P6289, DOI 10.1210/en.2008-0361; Vardavas CI, 2010, EUR J PEDIATR, V169, P741, DOI 10.1007/s00431-009-1107-9; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826; Xu D, 2013, ACTA PHARMACOL SIN, V34, P1526, DOI 10.1038/aps.2013.171; Zhang HR, 2010, OBESITY, V18, P2071, DOI 10.1038/oby.2010.91; Zhao JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085054, 10.1371/journal.pone.0108005]	36	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143660	10.1371/journal.pone.0143660	http://dx.doi.org/10.1371/journal.pone.0143660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599278	Green Submitted, Green Published, gold			2022-12-27	WOS:000365853900153
J	van Hulst, BM; de Zeeuw, P; Lupas, K; Bos, DJ; Neggers, SFW; Durston, S				van Hulst, Branko M.; de Zeeuw, Patrick; Lupas, Kellina; Bos, Dienke J.; Neggers, Sebastiaan F. W.; Durston, Sarah			Reward Anticipation in Ventral Striatum and Individual Sensitivity to Reward: A Pilot Study of a Child-Friendly fMRI Task	PLOS ONE			English	Article							DISORDER; ADHD; ADOLESCENCE; RELIABILITY; IMPULSIVITY	Reward processing has been implicated in developmental disorders. However, the classic task to probe reward anticipation, the monetary incentive delay task, has an abstract coding of reward and no storyline and may therefore be less appropriate for use with developmental populations. We modified the task to create a version appropriate for use with children. We investigated whether this child-friendly version could elicit ventral striatal activation during reward anticipation in typically developing children and young adolescents (aged 9.5-14.5). In addition, we tested whether our performance-based measure of reward sensitivity was associated with anticipatory activity in ventral striatum. Reward anticipation was related to activity in bilateral ventral striatum. Moreover, we found an association between individual reward sensitivity and activity in ventral striatum. We conclude that this task assesses ventral striatal activity in a child-friendly paradigm. The combination with a performance-based measure of reward sensitivity potentially makes the task a powerful tool for developmental imaging studies of reward processing.	[van Hulst, Branko M.; de Zeeuw, Patrick; Lupas, Kellina; Bos, Dienke J.; Neggers, Sebastiaan F. W.; Durston, Sarah] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, NICHE Lab, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van Hulst, BM (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, NICHE Lab, Utrecht, Netherlands.	b.vanhulst@umcutrecht.nl	Lupas, Kellina/ABG-3448-2020	Lupas, Kellina/0000-0003-4293-5923	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) [Vici-453-10-005]	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) (S.D., grant number Vici-453-10-005). The funding source had no influence on study design, data analysis or the written report.	de Zeeuw P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051416; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Helfinstein SM, 2013, SOC COGN AFFECT NEUR, V8, P720, DOI 10.1093/scan/nss057; Hoogman M, 2011, AM J PSYCHIAT, V168, P1099, DOI 10.1176/appi.ajp.2011.10101446; Kappel V, 2013, J NEURAL TRANSM, V120, P1259, DOI 10.1007/s00702-012-0962-0; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Lamm C, 2014, BRAIN COGNITION, V89, P51, DOI 10.1016/j.bandc.2013.12.003; Lorenz RC, 2015, NEUROIMAGE, V117, P250, DOI 10.1016/j.neuroimage.2015.05.024; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Matthys W, 2013, DEV PSYCHOPATHOL, V25, P193, DOI 10.1017/S0954579412000272; Mazaika P., 2009, NEUROIMAGE, V47, pS58, DOI DOI 10.1016/S1053-8119(09)70238-1; Mir P, 2011, EXP BRAIN RES, V209, P551, DOI 10.1007/s00221-011-2583-5; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Plichta MM, 2012, NEUROIMAGE, V60, P1746, DOI 10.1016/j.neuroimage.2012.01.129; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Stoppel CM, 2011, BRAIN RES, V1383, P218, DOI 10.1016/j.brainres.2011.01.095; Stringaris A, 2015, AM J PSYCHIAT, V172, P1215, DOI 10.1176/appi.ajp.2015.14101298; Vaidya JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058708; van Hulst BM, 2015, PSYCHOL MED, V45, P735, DOI 10.1017/S0033291714001792	22	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142413	10.1371/journal.pone.0142413	http://dx.doi.org/10.1371/journal.pone.0142413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599542	Green Published, Green Submitted, gold			2022-12-27	WOS:000365853900023
J	Mao, JQ; Zhang, HQ; Dai, HC; Yuan, BH; Hu, TF				Mao, J. Q.; Zhang, H. Q.; Dai, H. C.; Yuan, B. H.; Hu, T. F.			Hydrodynamic and Sediment Responses of Open Channels to Exposed Pipe Encasements	PLOS ONE			English	Article							LOCAL SCOUR; DOWNSTREAM	The effects of exposed pipe encasements on the local variation of hydrodynamic and sediment conditions in a river channel are examined. Laboratory experiments are performed to assess the response of water level, flow regime and bed deformation to several representative types of concrete encasements. The experimental conditions considered are: three types of exposed pipe encasements exposed on the bed, including trapezoidal shape, circular-arc shape and polygonal shape, and three sets of discharges, including annual discharge, once-in-3-year flood, and once-in-50-year flood. Our experiments show that: (1) the amount of backwater definitely depends on the encasement geometric shape and the background discharge; (2) smaller discharges generally tend to induce local scour of river bed downstream of the encasement, and the order of sensitivity of bed deformation to the encasement geometric shape is trapezoidal > circular-arc > polygonal; (3) comparatively speaking, the polygonal encasement may be considered as a suitable protective structure for pipelines across alluvial rivers, with relatively modest effects on the local hydrodynamic conditions and bed stabilization.	[Mao, J. Q.; Zhang, H. Q.; Dai, H. C.; Hu, T. F.] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, H. Q.] Zhejiang Inst Hydraul & Estuary, Hangzhou, Zhejiang, Peoples R China; [Yuan, B. H.] Hohai Univ, Sch Earth Sci & Engn, Nanjing, Jiangsu, Peoples R China	Hohai University; Hohai University	Mao, JQ (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China.	maojq@hhu.edu.cn			National Natural Science Foundation of China [51379059, 51279047]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1233]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The study is supported by the National Natural Science Foundation of China (grant No. 51379059, 51279047), and Program for Changjiang Scholars and Innovative Research Team in University (IRT1233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZC, 2005, J HYDRAUL RES, V43, P703, DOI 10.1080/00221680509500390; Cheng L, 2003, COAST ENG J, V45, P189, DOI 10.1142/S0578563403000737; FARHOUDI J, 1985, J HYDRAUL RES, V23, P343, DOI 10.1080/00221688509499344; Kim MK, 2013, STRUCT INFRASTRUCT E, V9, P860, DOI 10.1080/15732479.2011.627349; Lan HT, 2015, J PIPELINE SYST ENG, V6, DOI 10.1061/(ASCE)PS.1949-1204.0000128; Liang DF, 2005, OCEAN ENG, V32, P1590, DOI 10.1016/j.oceaneng.2004.10.025; Moncada-M AT, 1999, J HYDRAUL ENG-ASCE, V125, P953, DOI 10.1061/(ASCE)0733-9429(1999)125:9(953); Oliveto G, 2009, J HYDRAUL ENG, V135, P846, DOI 10.1061/(ASCE)HY.1943-7900.0000078; Radice A, 2012, J HYDRAUL RES, V50, P44, DOI 10.1080/00221686.2011.641764; SEPA, 2010, ENG WAT ENV GOOD PRA; USACE, 1987, HYDR DES CRIT; USDOI, 2005, DES CRIT RED RIV VAL; Wang ZY, 1999, J HYDRAUL RES, V37, P17, DOI 10.1080/00221689909498530; Wildman LAS, 2005, GEOMORPHOLOGY, V71, P245, DOI 10.1016/j.geomorph.2004.08.018; Yen BC, 2002, J HYDRAUL ENG-ASCE, V128, P20, DOI 10.1061/(ASCE)0733-9429(2002)128:1(20); Zhang RJ, 2007, RIVER DYNAMICS, P4660; [No title captured]	18	0	0	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143300	10.1371/journal.pone.0143300	http://dx.doi.org/10.1371/journal.pone.0143300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588840	Green Published, Green Submitted, gold			2022-12-27	WOS:000365251500050
J	Irikura, D; Monma, C; Suzuki, Y; Nakama, A; Kai, A; Fukui-Miyazaki, A; Horiguchi, Y; Yoshinari, T; Sugita-Konishi, Y; Kamata, Y				Irikura, Daisuke; Monma, Chie; Suzuki, Yasunori; Nakama, Akiko; Kai, Akemi; Fukui-Miyazaki, Aya; Horiguchi, Yasuhiko; Yoshinari, Tomoya; Sugita-Konishi, Yoshiko; Kamata, Yoichi			Identification and Characterization of a New Enterotoxin Produced by Clostridium perfringens Isolated from Food Poisoning Outbreaks	PLOS ONE			English	Article							ARGININE ADP-RIBOSYLATION; IOTA-TOXIN; ENZYMATIC COMPONENTS; C2 TOXIN; SPIROFORME; EXPRESSION; RECEPTOR; CLONING	There is a strain of Clostridium perfringens, W5052, which does not produce a known enterotoxin. We herein report that the strain W5052 expressed a homologue of the iota-like toxin components sa and sb of C. spiroforme, named Clostridium perfringens iota-like enterotoxin, CPILE-a and CPILE-b, respectively, based on the results of a genome sequencing analysis and a systematic protein screening. In the nicotinamide glyco-hydrolase (NADase) assay the hydrolysis activity was dose-dependently increased by the concentration of rCPILE-a, as judged by the mass spectrometry analysis. In addition, the actin monomer of the lysates of Vero and L929 cells were radiolabeled in the presence of ([32P])NAD and rCPILE-a. These findings indicated that CPILE-a possesses ADP-ribosylation activity. The culture supernatant of W5052 facilitated the rounding and killing of Vero and L929 cells, but the rCPILE-a or a non-proteolyzed rCPILE-b did not. However, a trypsintreated rCPILE-b did. Moreover, a mixture of rCPILE-a and the trypsin-treated rCPILE-b enhanced the cell rounding and killing activities, compared with that induced by the trypsintreated rCPILE-b alone. The injection of the mixture of rCPILE-a and the trypsin-treated rCPILE-b into an ileum loop of rabbits evoked the swelling of the loop and accumulation of the fluid dose-dependently, suggesting that CPILE possesses enterotoxic activity. The evidence presented in this communication will facilitate the epidemiological, etiological, and toxicological studies of C. perfringens food poisoning, and also stimulate studies on the transfer of the toxins' gene(s) among the Genus Clostridium.	[Irikura, Daisuke; Yoshinari, Tomoya; Sugita-Konishi, Yoshiko; Kamata, Yoichi] Natl Inst Hlth Sci, Div Microbiol, Tokyo, Japan; [Monma, Chie; Suzuki, Yasunori; Nakama, Akiko] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Tokyo 1690073, Japan; [Kai, Akemi; Fukui-Miyazaki, Aya; Horiguchi, Yasuhiko] Osaka Univ, Microbial Dis Res Inst, Dept Mol Biol, Osaka, Japan; [Sugita-Konishi, Yoshiko] Azabu Univ, Grad Sch Life & Environm Sci, Dept Food & Life Sci, Kanagawa, Japan; [Kamata, Yoichi] Iwate Univ, Dept Vet Med, Morioka, Iwate 020, Japan	National Institute of Health Sciences - Japan; Tokyo Metropolitan Institute of Public Health; Osaka University; Azabu University; Iwate University	Kamata, Y (corresponding author), Natl Inst Hlth Sci, Div Microbiol, Tokyo, Japan.	ykamata@iwate-u.ac.jp		Suzuki, Yasunori/0000-0001-9278-0232	Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant from the Ministry of Health, Labour and Welfare of Japan.	AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bain MS, 1998, VET REC, V142, P47; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Carmen R, 2010, OPEN TOXIN J, V3, P43; Carver T, 2003, BIOINFORMATICS, V19, P1837, DOI 10.1093/bioinformatics/btg251; CZECZULIN JR, 1993, INFECT IMMUN, V61, P3429, DOI 10.1128/IAI.61.8.3429-3439.1993; Gibert M, 2000, INFECT IMMUN, V68, P3848, DOI 10.1128/IAI.68.7.3848-3853.2000; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; Kobayashi K, 2008, MICROB PATHOGENESIS, V44, P265, DOI 10.1016/j.micpath.2007.10.010; McClane BA, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P423; MELVILLE SB, 1994, INFECT IMMUN, V62, P5550, DOI 10.1128/IAI.62.12.5550-5558.1994; Miyamoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020376; Monma C, 2015, J CLIN MICROBIOL, V53, P859, DOI 10.1128/JCM.02859-14; Nagahama M, 2012, INFECT IMMUN, V80, P3410, DOI 10.1128/IAI.00483-12; Nagahama M, 2011, INFECT IMMUN, V79, P4353, DOI 10.1128/IAI.05677-11; NAKAMURA S, 1978, MICROBIOL IMMUNOL, V22, P591, DOI 10.1111/j.1348-0421.1978.tb00409.x; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Perelle S, 1997, FEMS MICROBIOL LETT, V146, P117, DOI [10.1016/S0378-1097(96)00463-6, 10.1111/j.1574-6968.1997.tb10180.x]; PERELLE S, 1993, INFECT IMMUN, V61, P5147, DOI 10.1128/IAI.61.12.5147-5156.1993; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; Popoff MR, 1998, BIOCHEM BIOPH RES CO, V152, P1361; Sakurai J, 1997, J TOXICOL-TOXIN REV, V16, P195, DOI 10.3109/15569549709016456; Sakurai J., 1995, Reviews in Medical Microbiology, V6, P175; Sakurai J, 2009, TOXINS, V1, P208, DOI 10.3390/toxins1020208; SIMPSON LL, 1989, INFECT IMMUN, V57, P255, DOI 10.1128/IAI.57.1.255-261.1989; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; STRONG DH, 1970, APPL MICROBIOL, V19, P980, DOI 10.1128/AEM.19.6.980-987.1970; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Uzal FA, 2008, J VET DIAGN INVEST, V20, P253, DOI 10.1177/104063870802000301; Yonogi S, 2014, INFECT IMMUN, V82, P2390, DOI 10.1128/IAI.01759-14	33	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2015	10	11							e0138183	10.1371/journal.pone.0138183	http://dx.doi.org/10.1371/journal.pone.0138183			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LG	26584048	Green Published, gold, Green Submitted			2022-12-27	WOS:000365250500001
J	Guillot, A; Di Rienzo, F; Pialoux, V; Simon, G; Skinner, S; Rogowski, I				Guillot, Aymeric; Di Rienzo, Franck; Pialoux, Vincent; Simon, Germain; Skinner, Sarah; Rogowski, Isabelle			Implementation of Motor Imagery during Specific Aerobic Training Session in Young Tennis Players	PLOS ONE			English	Article							MENTAL PRACTICE; PERFORMANCE; INTENSITY; EXERCISE	The aim of this study was to investigate the effects of implementing motor imagery (MI) during specific tennis high intensity intermittent training (HIIT) sessions on groundstroke performance in young elite tennis players. Stroke accuracy and ball velocity of forehand and backhand drives were evaluated in ten young tennis players, immediately before and after having randomly performed two HIIT sessions. One session included MI exercises during the recovery phases, while the other included verbal encouragements for physical efforts and served as control condition. Results revealed that similar cardiac demand was observed during both sessions, while implementing MI maintained groundstroke accuracy. Embedding MI during HIIT enabled the development of physical fitness and the preservation of stroke performance. These findings bring new insight to tennis and conditioning coaches in order to fulfil the benefits of specific playing HIIT sessions, and therefore to optimise the training time.	[Guillot, Aymeric; Pialoux, Vincent] Inst Univ France, F-75000 Paris, France; [Guillot, Aymeric; Di Rienzo, Franck; Pialoux, Vincent; Simon, Germain; Skinner, Sarah; Rogowski, Isabelle] Univ Lyon 1, Ctr Rech & Innovat Sport, EA 647, UFRSTAPS, F-69622 Villeurbanne, France; [Simon, Germain] Ligue Lyonnais Tennis, Bron, France	Institut Universitaire de France; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rogowski, I (corresponding author), Univ Lyon 1, Ctr Rech & Innovat Sport, EA 647, UFRSTAPS, F-69622 Villeurbanne, France.	isabelle.rogowski@univ-lyon1.fr						Atienza FL, 1998, PERCEPT MOTOR SKILL, V87, P519, DOI 10.2466/pms.1998.87.2.519; Bisio A, 2004, NEUROSC, V265, P196; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Coelho RW, 2007, PERCEPT MOTOR SKILL, V105, P458, DOI 10.2466/PMS.105.2.458-468; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crespo M, 1998, ITF MANUAL ADV COACH; Cumming J., 2013, MOVEMENT SPORT SCI, V82, P69, DOI [10.1051/sm/2013098, DOI 10.1051/SM/2013098, 10.3917/sm.082.0069, DOI 10.3917/SM.082.0069]; Debarnot U, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00280; Dellal A, 2010, J STRENGTH COND RES, V24, P3219, DOI 10.1519/JSC.0b013e3181b94a63; Di Rienzo F, 2014, NEUROPSYCHOL REV, V24, P116, DOI 10.1007/s11065-014-9257-6; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Fernandez J, 2006, BRIT J SPORT MED, V40, P387, DOI 10.1136/bjsm.2005.023168; Fernandez-Fernandez J, 2012, J STRENGTH COND RES, V26, P53, DOI 10.1519/JSC.0b013e318220b4ff; Fernandez-Fernandez J, 2011, J SPORT SCI MED, V10, P540; Fernandez-Fernandez J, 2010, J STRENGTH COND RES, V24, P3255, DOI 10.1519/JSC.0b013e3181e8745f; Gaggioli A., 2013, PSYCHOLOGY, V4, P1, DOI [DOI 10.4236/PSYCH.2013.49A2001, 10.4236/psych.2013.49A2001]; Genevois C, 2013, J STRENGTH COND RES, V27, P677, DOI 10.1519/JSC.0b013e31825c3290; Girard O, 2006, BRIT J SPORT MED, V40, P791, DOI 10.1136/bjsm.2006.027680; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2005, BIOL SPORT, V22, P215; Guillot A., 2008, INT REV SPORT EXER P, V1, P31, DOI [10.1080/17509840701823139, DOI 10.1080/17509840701823139]; Guillot A, 2013, J SPORT SCI MED, V12, P332; Guillot A, 2012, PSYCHOL SPORT EXERC, V13, P533, DOI 10.1016/j.psychsport.2012.03.002; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Jackson PL, 2003, NEUROIMAGE, V20, P1171, DOI 10.1016/S1053-8119(03)00369-0; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kovacs MS, 2006, BRIT J SPORT MED, V40, P381, DOI 10.1136/bjsm.2005.023309; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Lorant J., 2004, MOVEMENT SPORT SCI, V3, P57, DOI [10.1037/h0087213, DOI 10.1037/H0087213]; Louis M, 2011, J COGN PSYCHOL, V23, P374, DOI 10.1080/20445911.2011.521739; MacIntyre T., 2007, Journal of Imagery Research in Sport and Physical Activity, V2, P4; Mamassis G., 2005, ITF COACHING SPORT S, V35, P3; Mizuguchi N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00104; Moran A, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00023; Olsson CJ, 2008, SCAND J PSYCHOL, V49, P133, DOI 10.1111/j.1467-9450.2008.00625.x; Pialoux V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122718; Ramsey R, 2010, BRAIN COGNITION, V74, P249, DOI 10.1016/j.bandc.2010.08.005; Robin N, 2007, INT J SPORT EXERC PS, V5, P175, DOI 10.1080/1612197X.2007.9671818; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Taube W, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00972; TOMPOROWSKI PD, 1986, PSYCHOL BULL, V99, P338, DOI 10.1037/0033-2909.99.3.338; Wakefield C, 2013, INT REV SPORT EXER P, V6, P105, DOI 10.1080/1750984X.2012.724437; Wang Z, 2014, NEUROSCIENCE, V275, P102, DOI 10.1016/j.neuroscience.2014.06.004; Williams SE, 2012, J SPORT EXERCISE PSY, V34, P621, DOI 10.1123/jsep.34.5.621	46	28	30	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143331	10.1371/journal.pone.0143331	http://dx.doi.org/10.1371/journal.pone.0143331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26580804	Green Submitted, Green Published, gold			2022-12-27	WOS:000365154600109
J	Poyet, M; Le Roux, V; Gibert, P; Meirland, A; Prevost, G; Eslin, P; Chabrerie, O				Poyet, Mathilde; Le Roux, Vincent; Gibert, Patricia; Meirland, Antoine; Prevost, Genevieve; Eslin, Patrice; Chabrerie, Olivier			The Wide Potential Trophic Niche of the Asiatic Fruit Fly Drosophila suzukii: The Key of Its Invasion Success in Temperate Europe?	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; DIPTERA DROSOPHILIDAE; SEED DISPERSAL; FLIES DIPTERA; PARASITOIDS HYMENOPTERA; ECOSYSTEM SERVICES; OVIPOSITION; PEST; TEPHRITIDAE; ALKALOIDS	The Asiatic fruit fly Drosophila suzukii has recently invaded Europe and North and South America, causing severe damage to fruit production systems. Although agronomic host plants of that fly are now well documented, little is known about the suitability of wild and ornamental hosts in its exotic area. In order to study the potential trophic niche of D. suzukii with relation to fruit characteristics, fleshy fruits from 67 plant species were sampled in natural and anthropic ecosystems (forests, hedgerows, grasslands, coastal areas, gardens and urban areas) of the north of France and submitted to experimental infestations. A set of fruit traits (structure, colour, shape, skin texture, diameter and weight, phenology) potentially interacting with oviposition choices and development success of D. suzukii was measured. Almost half of the tested plant species belonging to 17 plant families allowed the full development of D. suzukii. This suggests that the extreme polyphagy of the fly and the very large reservoir of hosts producing fruits all year round ensure temporal continuity in resource availability and contribute to the persistence and the exceptional invasion success of D. suzukii in natural habitats and neighbouring cultivated systems. Nevertheless, this very plastic trophic niche is not systematically beneficial to the fly. Some of the tested plants attractive to D. suzukii gravid females stimulate oviposition but do not allow full larval development. Planted near sensitive crops, these "trap plants" may attract and lure D. suzukii, therefore contributing to the control of the invasive fly.	[Poyet, Mathilde; Le Roux, Vincent; Meirland, Antoine; Prevost, Genevieve; Eslin, Patrice; Chabrerie, Olivier] Univ Picardie Jules Verne, Unite Ecol & Dynam Syst Anthropises FRE CNRS 3498, Amiens, France; [Poyet, Mathilde; Gibert, Patricia] Univ Lyon 1, Lab Biometrie & Biol Evolut UMR CNRS 55, F-69622 Villeurbanne, France; [Meirland, Antoine] Maison Univ Picardie Jules Verne, Grp Etud Milieux Estuariens & Littoraux GEMEL, St Valery Sur Somme, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Chabrerie, O (corresponding author), Univ Picardie Jules Verne, Unite Ecol & Dynam Syst Anthropises FRE CNRS 3498, Amiens, France.	olivier.chabrerie@u-picardie.fr		Chabrerie, Olivier/0000-0002-8949-1859; Gibert, Patricia/0000-0002-9461-6820				ANDERSEN AN, 1988, OIKOS, V52, P337, DOI 10.2307/3565207; Aniszewski T, 2007, ALKALOIDS SECRETS LI; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Atallah J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2840; AVERILL AL, 1987, ECOLOGY, V68, P878, DOI 10.2307/1938359; Balagawi S, 2005, AUST J ENTOMOL, V44, P97, DOI 10.1111/j.1440-6055.2005.00459.x; Bargel H, 2006, FUNCT PLANT BIOL, V33, P893, DOI 10.1071/FP06139; Barthlott W., 1990, SCANNING ELECT MICRO, P69; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bellamy DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061227; BENTLEY MD, 1984, ANN ENTOMOL SOC AM, V77, P401, DOI 10.1093/aesa/77.4.401; Berg MP, 2010, EVOL ECOL, V24, P617, DOI 10.1007/s10682-009-9347-8; Berlocher S. H., 2009, Biorational tree-fruit pest management, P32, DOI 10.1079/9781845934842.0032; Bernays EA, 1999, ECOL ENTOMOL, V24, P260, DOI 10.1046/j.1365-2311.1999.00193.x; Bird TL, 2006, B ENTOMOL RES, V96, P15, DOI 10.1079/BER2005398; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bolda M.P., 2010, AGR RESOUR EC UPDATE, V13, P5, DOI DOI 10.1016/J.JFF.2015.04.027; BROWER LP, 1975, SCIENCE, V188, P19, DOI 10.1126/science.188.4183.19; Brunneton J, 2005, PLANTES TOXIQUES VEG; Burrack HJ, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM12012; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Cha DH, 2015, ENTOMOL EXP APPL, V154, P251, DOI 10.1111/eea.12276; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Chabrerie O, 2010, BIOL INVASIONS, V12, P1891, DOI 10.1007/s10530-009-9599-9; Charles H, 2007, IMPACTS INVASIVE SPE, P217; CHEW FS, 1991, AM NAT, V138, P729, DOI 10.1086/285246; Cini A, 2014, J PEST SCI, V87, P559, DOI 10.1007/s10340-014-0617-z; Cini A, 2012, B INSECTOL, V65, P149; Clark NE, 2014, TRENDS ECOL EVOL, V29, P198, DOI 10.1016/j.tree.2014.01.009; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Daniel M., 2006, MED PLANTS CHEM PROP; Danielson PB, 1996, PESTIC BIOCHEM PHYS, V55, P172, DOI 10.1006/pest.1996.0046; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Dewick PM., 2009, MED NATURAL PRODUCTS, V3rd ed., DOI 10.1002/9780470742761.ch3; Diaz-Fleischer F, 2003, J INSECT BEHAV, V16, P537, DOI 10.1023/A:1027307424150; Dimitrov K, 2005, SEP PURIF TECHNOL, V46, P41, DOI 10.1016/j.seppur.2005.04.008; Dixon MD, 1997, OECOLOGIA, V111, P201, DOI 10.1007/s004420050226; Dreves AJ., 2009, NEW PEST ATTACKING H; DREW RAI, 1987, ANN ENTOMOL SOC AM, V80, P629, DOI 10.1093/aesa/80.5.629; Drew RAI, 2003, ENTOMOL EXP APPL, V107, P39, DOI 10.1046/j.1570-7458.2003.00039.x; DREW RAI, 1987, AUST J ZOOL, V35, P283, DOI 10.1071/ZO9870283; Dukas R, 2001, ECOL ENTOMOL, V26, P587, DOI 10.1046/j.1365-2311.2001.00359.x; Fogleman JC, 2000, CHEM-BIOL INTERACT, V125, P93, DOI 10.1016/S0009-2797(99)00161-1; Garcia D, 1999, OIKOS, V85, P536, DOI 10.2307/3546703; Garcia D, 2012, P ROY SOC B-BIOL SCI, V279, P3106, DOI 10.1098/rspb.2012.0175; Garcia D, 2010, CONSERV BIOL, V24, P1070, DOI 10.1111/j.1523-1739.2009.01440.x; Gariepy TD, 2014, J PEST SCI, V87, P17, DOI 10.1007/s10340-013-0529-3; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Gorb E, 2008, ARTHROPOD-PLANT INTE, V2, P247, DOI 10.1007/s11829-008-9049-0; Guglielmo CG, 1996, ECOLOGY, V77, P1103, DOI 10.2307/2265579; Hamby KA, 2014, ENVIRON ENTOMOL, V43, P1008, DOI 10.1603/EN13245; Harris DW, 2014, J ASIA-PAC ENTOMOL, V17, P857, DOI 10.1016/j.aspen.2014.08.006; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Held DW, 2004, OECOLOGIA, V140, P312, DOI 10.1007/s00442-004-1582-7; Heldt H.-W., 2005, PLANT BIOCH; Henneman ML, 1999, ENTOMOL EXP APPL, V93, P249, DOI 10.1023/A:1003892401712; Henry T. A, 1949, THE PLANT ALKALOIDS, V4th, P43; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; HOFFMANN AA, 1984, HEREDITY, V53, P139, DOI 10.1038/hdy.1984.69; HOFFMANN AA, 1985, AM NAT, V126, P41, DOI 10.1086/284394; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; Hortical, 2015, HORT CAL JARD; Imai K, 2004, ECOL ENTOMOL, V29, P420, DOI 10.1111/j.0307-6946.2004.00627.x; Imai K, 2006, GALLING ARTHROPODS AND THEIR ASSOCIATES: ECOLOGY AND EVOLUTION, P169, DOI 10.1007/4-431-32185-3_14; JANZEN DH, 1977, PHYTOCHEMISTRY, V16, P223, DOI 10.1016/S0031-9422(00)86790-4; Jerde CL, 2007, AM NAT, V170, P1, DOI 10.1086/518179; JOHNSON ND, 1988, J CHEM ECOL, V14, P1391, DOI 10.1007/BF01020143; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Kanzawa T., 1939, STUDIES DROSOPHILA S; Kanzawa T., 1935, RES FRUIT FLY DROSOP; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Keesey IW, 2015, J CHEM ECOL, V41, P121, DOI 10.1007/s10886-015-0544-3; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; KING PD, 1982, NEW ZEAL J EXP AGR, V10, P337, DOI 10.1080/03015521.1982.10427894; Koch K, 2008, MICRON, V39, P759, DOI 10.1016/j.micron.2007.11.010; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lambinon J., 2004, NOUVELLE FLORE BELGI, V5e; LAMPREY H F, 1974, East African Wildlife Journal, V12, P81; Lavorel S, 1998, ACTA OECOL, V19, P227, DOI 10.1016/S1146-609X(98)80027-1; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lee JC, 2015, ANN ENTOMOL SOC AM, V108, P117, DOI 10.1093/aesa/sau014; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; LEVINE E, 1977, J ECON ENTOMOL, V70, P603, DOI 10.1093/jee/70.5.603; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Liu ZL, 2012, PARASITOL RES, V111, P991, DOI 10.1007/s00436-012-2923-9; Louapre P, 2014, ECOL ENTOMOL, V39, P343, DOI 10.1111/een.12105; MA WW, 1990, J NAT PROD, V53, P1009, DOI 10.1021/np50070a041; MALCOLM SB, 1989, EXPERIENTIA, V45, P284, DOI 10.1007/BF01951814; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; MANZUR MI, 1984, OIKOS, V43, P265, DOI 10.2307/3544142; Matsuki M, 2011, AGR FOREST ENTOMOL, V13, P1, DOI 10.1111/j.1461-9563.2010.00492.x; Matsumura S, 1931, 6000 ILLUSTRATED INS; Mazzetto F, 2015, J ASIA-PAC ENTOMOL, V18, P321, DOI 10.1016/j.aspen.2015.04.001; MCDONALD PT, 1985, ENTOMOL EXP APPL, V37, P207, DOI 10.1007/BF00191650; MCINNIS DO, 1989, J ECON ENTOMOL, V82, P1382, DOI 10.1093/jee/82.5.1382; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Mioulane P, 2002, ENCY UNIVERSELLE 150; Mitsui H, 2006, POPUL ECOL, V48, P233, DOI 10.1007/s10144-006-0260-5; Mitsui H, 2010, ENTOMOL SCI, V13, P60, DOI 10.1111/j.1479-8298.2010.00372.x; Mortelmans J, 2012, BELG J ZOOL, V142, P143; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nelson L.S., 2007, HDB POISONOUS INJURI, V2nd ed.; OAKESHOTT JG, 1989, OECOLOGIA, V78, P533, DOI 10.1007/BF00378745; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Pairon M, 2006, ACTA OECOL, V30, P238, DOI 10.1016/j.actao.2006.05.002; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Pengelly A., 2004, CONSTITUENTS MED PLA; PHILOGENE BJR, 1984, J CHEM ECOL, V10, P115, DOI 10.1007/BF00987648; Picot S, 2008, HEREDITY, V101, P53, DOI 10.1038/hdy.2008.27; Powell K.S., 2012, ARTHROPOD MANAGEMENT, P219, DOI DOI 10.1007/978-94-007-4032-7_10; Poyet M, 2014, AGR FOREST ENTOMOL, V16, P251, DOI 10.1111/afe.12052; Poyet M, 2013, PHYSIOL ENTOMOL, V38, P45, DOI 10.1111/phen.12002; PROKOPY RJ, 1968, ENTOMOL EXP APPL, V11, P403, DOI 10.1007/BF00364572; PROKOPY RJ, 1971, ENTOMOL EXP APPL, V14, P1, DOI 10.1007/BF00341121; PROKOPY RJ, 1993, J INSECT BEHAV, V6, P167, DOI 10.1007/BF01051502; Provost M, 1998, FLORE VASCULAIRE BAS; PUECH A, 1972, J CHROMATOGR, V68, P161, DOI 10.1016/S0021-9673(00)88773-7; Rameau J.-C., 1989, FLORE FORESTIERE FRA; Rey PJ, 2014, PERSPECT PLANT ECOL, V16, P21, DOI 10.1016/j.ppees.2013.11.001; RONSCH H, 1966, PHYTOCHEMISTRY, V5, P1227, DOI 10.1016/S0031-9422(00)86118-X; Roques Alain, 2010, BioRisk, V4, P11; Rota-Stabelli O, 2013, CURR BIOL, V23, pR8, DOI 10.1016/j.cub.2012.11.021; Rothe G, 2002, PLANT SCI, V163, P979, DOI 10.1016/S0168-9452(02)00247-9; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schreiber K., 1968, ALKALOIDS CHEM CHEMI, V10, P1, DOI 10.1016/S1876-0813(08)60253-5; Schwarz S, 2014, NATURWISSENSCHAFTEN, V101, P61, DOI 10.1007/s00114-013-1129-z; Senat, 2012, COMPT REND AN OFF 17; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Skuhrava M., 2010, BIORISK - Biodiversity and Ecosystem Risk Assessment, P553; Stachowicz JJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P41; Steck GJ, 2009, DROSOPHILA SUZUKII; Tela Botanica, 2015, E FLOR; VALBURG LK, 1992, OIKOS, V65, P25, DOI 10.2307/3544883; VANHAGA PR, 1954, NATURE, V174, P833, DOI 10.1038/174833b0; VARGAS RI, 1991, J ECON ENTOMOL, V84, P1503, DOI 10.1093/jee/84.5.1503; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; WEBER DC, 1994, ADVANCES IN POTATO PEST, P54; Wermelinger Beat, 2008, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V81, P1; Wilson AJ, 2012, ARTHROPOD-PLANT INTE, V6, P635, DOI 10.1007/s11829-012-9205-4; WINK M, 1990, J COMP PHYSIOL B, V160, P389, DOI 10.1007/BF01075670; Zhang K, 2014, ENTOMOL EXP APPL, V152, P148, DOI 10.1111/eea.12210	151	139	143	5	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142785	10.1371/journal.pone.0142785	http://dx.doi.org/10.1371/journal.pone.0142785			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581101	Green Published, gold, Green Submitted			2022-12-27	WOS:000365154600060
J	Wang, ZT; Nachtigall, PE; Akamatsu, T; Wang, KX; Wu, YP; Liu, JC; Duan, GQ; Cao, HJ; Wang, D				Wang, Zhi-Tao; Nachtigall, Paul E.; Akamatsu, Tomonari; Wang, Ke-Xiong; Wu, Yu-Ping; Liu, Jian-Chang; Duan, Guo-Qin; Cao, Han-Jiang; Wang, Ding			Passive Acoustic Monitoring the Diel, Lunar, Seasonal and Tidal Patterns in the Biosonar Activity of the Indo-Pacific Humpback Dolphins (Sousa chinensis) in the Pearl River Estuary, China	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PORPOISES PHOCOENA-PHOCOENA; TRANSMISSION BEAM PATTERN; HARBOR PORPOISES; TURSIOPS-TRUNCATUS; ECHOLOCATION BEHAVIOR; SOTALIA-GUIANENSIS; HONG-KONG; ABUNDANCE; SOUTHERN	A growing demand for sustainable energy has led to an increase in construction of offshore windfarms. Guishan windmill farm will be constructed in the Pearl River Estuary, China, which sustains the world's largest known population of Indo-Pacific humpback dolphins (Sousa chinensis). Dolphin conservation is an urgent issue in this region. By using passive acoustic monitoring, a baseline distribution of data on this species in the Pearl River Estuary during pre-construction period had been collected. Dolphin biosonar detection and its diel, lunar, seasonal and tidal patterns were examined using a Generalized Linear Model. Significant higher echolocation detections at night than during the day, in winter-spring than in summer-autumn, at high tide than at flood tide were recognized. Significant higher echolocation detections during the new moon were recognized at night time. The diel, lunar and seasonal patterns for the echolocation encounter duration also significantly varied. These patterns could be due to the spatial-temporal variability of dolphin prey and illumination conditions. The baseline information will be useful for driving further effective action on the conservation of this species and in facilitating later assessments of the effects of the offshore windfarm on the dolphins by comparing the baseline to post construction and post mitigation efforts.	[Wang, Zhi-Tao; Wang, Ke-Xiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhi-Tao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Zhi-Tao; Nachtigall, Paul E.] Univ Hawaii, Hawaii Inst Marine Biol, Marine Mammal Res Program, Honolulu, HI 96822 USA; [Akamatsu, Tomonari] Fisheries Res Agcy, Natl Res Inst Fisheries Engn, Ibaraki, Japan; [Wu, Yu-Ping] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Jian-Chang] Minist Transport, Transport Planning & Res Inst, Beijing, Peoples R China; [Duan, Guo-Qin; Cao, Han-Jiang] Hongkong Zhuhai Macao Bridge Author, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Hawaii System; Japan Fisheries Research & Education Agency (FRA); Sun Yat Sen University; Ministry of Transport of the People's Republic of China	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; Zhao, chang-lin/AAE-9022-2019	Wang, Zhi-Tao/0000-0002-5734-7385; 	National Natural Science Foundation (NNSF) of China [31070347]; Ministry of Science and Technology of China [2011BAG07B05-3]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; State Oceanic Administration of China [201105011-3]; NNSF of China [31170501]; China Scholarship Council [[2014]3026]	National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; State Oceanic Administration of China; NNSF of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	Grants for this study were provided by the National Natural Science Foundation (NNSF) of China (Grant No. 31070347), the Ministry of Science and Technology of China (Grant No. 2011BAG07B05-3), the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX2-EW-Z-4) and the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (Grant No. 201203086) to DW, the State Oceanic Administration of China (Grant No. 201105011-3) and NNSF of China (Grant No. 31170501) to KXW and the China Scholarship Council (Grant No. [2014]3026) to ZTW. The funders had no roles in designing the study, collecting data, analyzing data, preparing the manuscript or deciding where to publish the manuscript.	Akamatsu T, 1998, J ACOUST SOC AM, V104, P2511, DOI 10.1121/1.423757; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, P ROY SOC B-BIOL SCI, V272, P797, DOI 10.1098/rspb.2004.3024; AKAMATSU T, 1992, MARINE MAMMAL SENSORY SYSTEMS, P299; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W. W., 1993, SONAR DOLPHINS; Au W.W.L., 2008, PRINCIPLES MARINE BI; Au WWL, 1999, J ACOUST SOC AM, V106, P3699, DOI 10.1121/1.428221; Azevedo AF, 2007, J MAR BIOL ASSOC UK, V87, P201, DOI 10.1017/S0025315407054422; Barros Nelio B., 2004, Aquatic Mammals, V30, P179, DOI 10.1578/AM.30.1.2004.179; Baumann-Pickering S, 2015, BEHAV ECOL SOCIOBIOL, V69, P1553, DOI 10.1007/s00265-015-1967-0; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Berrow SD, 1996, BIOL ENVIRON, V96B, P1; Brandt MJ, 2014, MAR MAMMAL SCI, V30, P1109, DOI 10.1111/mms.12112; Brandt MJ, 2011, MAR ECOL PROG SER, V421, P205, DOI 10.3354/meps08888; Bushnell ME, 2010, J FISH BIOL, V76, P1343, DOI 10.1111/j.1095-8649.2010.02569.x; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Chen BY, 2008, MAMM BIOL, V73, P156, DOI 10.1016/j.mambio.2006.12.002; Chen T, 2011, MAMM BIOL, V76, P93, DOI 10.1016/j.mambio.2010.01.001; Chen T, 2010, MAMMALIA, V74, P117, DOI 10.1515/MAMM.2010.024; David JA, 2006, WATER ENVIRON J, V20, P48, DOI 10.1111/j.1747-6593.2005.00023.x; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; de Freitas M, 2015, J ACOUST SOC AM, V137, P3033, DOI 10.1121/1.4921277; deBruyn AMH, 2001, MAR ECOL PROG SER, V214, P307, DOI 10.3354/meps214307; Desjardins JK, 2011, J ZOOL, V285, P66, DOI 10.1111/j.1469-7998.2011.00814.x; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FISHER FH, 1977, J ACOUST SOC AM, V62, P558, DOI 10.1121/1.381574; Fury CA, 2011, ESTUAR COAST SHELF S, V93, P389, DOI 10.1016/j.ecss.2011.05.003; Goold JC, 2000, MAR MAMMAL SCI, V16, P240, DOI 10.1111/j.1748-7692.2000.tb00915.x; Gregory Paul R., 2001, Aquatic Mammals, V27, P105; Guilherme-Silveira F. R., 2009, Marine Biodiversity Records, V2, pe122, DOI 10.1017/S1755267209000906; He Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep05995; Hodge LEW, 2013, MAR MAMMAL SCI, V29, pE411, DOI 10.1111/mms.12006; Hung Samuel K., 2004, Aquatic Mammals, V30, P159, DOI 10.1578/AM.30.1.2004.159; Jefferson TA, 2000, WILDLIFE MONOGR, P1; Jefferson TA, 2002, RAFFLES B ZOOL, P43; Jefferson TA, 2014, MAR MAMMAL SCI, V30, P1494, DOI 10.1111/mms.12152; Jefferson Thomas A., 2001, Mammalian Species, V655, P1, DOI 10.1644/1545-1410(2001)655<0001:SC>2.0.CO;2; Jensen FH, 2015, J EXP BIOL, V218, P1314, DOI 10.1242/jeb.116285; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Keenan SE, 2003, AM FISH S S, V36, P167; Kerckhof F, 2010, UNDERWATER TECHNOL, V29, P137, DOI 10.3723/ut.29.137; Kimura S, 2016, J MAR BIOL ASSOC UK, V96, P845, DOI 10.1017/S0025315414000071; Langhamer O, 2012, SCI WORLD J, DOI 10.1100/2012/386713; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li Yong-zhen, 2000, Journal of Fisheries of China, V24, P312; Lin T-H, 2013, MAR BIOL, V160, P1; Lin TH, 2015, ESTUAR COAST, V38, P1376, DOI 10.1007/s12237-014-9886-2; Lin TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123943; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; Madsen PT, 2006, MAR ECOL PROG SER, V309, P279, DOI 10.3354/meps309279; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Mellink Eric, 2006, Aquatic Mammals, V32, P133, DOI 10.1578/AM.32.2.2006.133; Mendes S, 2002, MAR ECOL PROG SER, V239, P221, DOI 10.3354/meps239221; Mikkelsen L, 2013, MAR ECOL PROG SER, V481, P239, DOI 10.3354/meps10260; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Norris K.S., 1994, HAWAIIAN SPINNER DOL; Parra GJ, 2014, MAR MAMMAL SCI, V30, P1184, DOI 10.1111/mms.12088; Parsons E. C. M., 1998, Aquatic Mammals, V24, P91; Philpott E, 2007, J MAR BIOL ASSOC UK, V87, P11, DOI 10.1017/S002531540705494X; Preen A, 2004, BIOL CONSERV, V118, P205, DOI 10.1016/j.biocon.2003.08.014; Rasmussen MH, 2004, J ACOUST SOC AM, V116, P1826, DOI 10.1121/1.1775274; Reeves RR, 2008, SOUSA CHINENSIS; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Rivamonte Lorenzo A., 2009, Aquatic Mammals, V35, P269, DOI 10.1578/AM.35.2.2009.269; Scheidat M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/025102; SHANE SH, 1980, FISH B-NOAA, V78, P593; Shen PP, 2011, CONT SHELF RES, V31, P1672, DOI 10.1016/j.csr.2011.07.002; Soldevilla MS, 2010, AQUAT BIOL, V9, P49, DOI 10.3354/ab00224; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Surlykke A, 2014, SPRINGER HANDB AUDIT, V51, P1, DOI 10.1007/978-1-4614-9146-0; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Wang D., 2006, S CHIN FISH SCI, V2, P37, DOI DOI 10.3969/J.ISSN.2095-0780.2006.04.007; Wang ZT, 2015, INTEGR ZOOL, V10, P122, DOI 10.1111/1749-4877.12102; Wang ZT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110590; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Wang ZT, 2013, J ACOUST SOC AM, V133, P2479, DOI 10.1121/1.4794390; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Yamamoto Y, 2015, MARINE MAMMAL SCI; Yeung YM, 2008, PANPEARL RIVER DELTA; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhang X, 2013, CONT SHELF RES, V56, P1, DOI 10.1016/j.csr.2013.01.015; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	86	38	41	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141807	10.1371/journal.pone.0141807	http://dx.doi.org/10.1371/journal.pone.0141807			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580966	Green Published, gold			2022-12-27	WOS:000365154600022
J	Wang, ZH; Liang, XW; Wu, ZQ; Lin, JL; Huang, JJ				Wang, Zhonghao; Liang, Xuanwei; Wu, Ziqiang; Lin, Jialiu; Huang, Jingjing			A Novel Method for Measuring Anterior Segment Area of the Eye on Ultrasound Biomicroscopic Images Using Photoshop	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CHAMBER ANGLE MEASUREMENT; CLOSURE GLAUCOMA; INTRAOBSERVER; THICKNESS	Purpose To describe a novel method for quantitative measurement of area parameters in ocular anterior segment ultrasound biomicroscopy (UBM) images using Photoshop software and to assess its intraobserver and interobserver reproducibility. Methods Twenty healthy volunteers with wide angles and twenty patients with narrow or closed angles were consecutively recruited. UBM images were obtained and analyzed using Photoshop software by two physicians with different-level training on two occasions. Borders of anterior segment structures including cornea, iris, lens, and zonules in the UBM image were semi-automatically defined by the Magnetic Lasso Tool in the Photoshop software according to the pixel contrast and modified by the observers. Anterior chamber area (ACA), posterior chamber area (PCA), iris cross-section area (ICA) and angle recess area (ARA) were drawn and measured. The intraobserver and interobserver reproducibilities of the anterior segment area parameters and scleral spur location were assessed by limits of agreement, coefficient of variation (CV), and intraclass correlation coefficient (ICC). Results All of the parameters were successfully measured by Photoshop. The intraobserver and interobserver reproducibilities of ACA, PCA, and ICA were good, with no more than 5% CV and more than 0.95 ICC, while the CVs of ARA were within 20%. The intraobserver and interobserver reproducibilities for defining the spur location were more than 0.97 ICCs. Although the operating times for both observers were less than 3 minutes per image, there was significant difference in the measuring time between two observers with different levels of training (p<0.001). Conclusion Measurements of ocular anterior segment areas on UBM images by Photoshop showed good intraobserver and interobserver reproducibilties. The methodology was easy to adopt and effective in measuring.	[Wang, Zhonghao; Liang, Xuanwei; Lin, Jialiu; Huang, Jingjing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Ziqiang] Ctr Adv Eye Care, Carson City, NV USA	Sun Yat Sen University	Huang, JJ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	hjjing@mail.sysu.edu.cn	Wang, Zhi-Tao/F-1176-2015; Zhao, chang-lin/AAE-9022-2019	Wang, Zhi-Tao/0000-0002-5734-7385; 	Fundamental Research Funds of State Key Laboratory of Ophthalmology (China) [2011Q02]; Guangdong Medical Research Foundation (China) [A2014240]	Fundamental Research Funds of State Key Laboratory of Ophthalmology (China); Guangdong Medical Research Foundation (China)	This study was supported by Grant 2011Q02 from the Fundamental Research Funds of State Key Laboratory of Ophthalmology (China) (URLs: http://mso.sysu.edu.cn/Item/5664.aspx), Grant A2014240 from the Guangdong Medical Research Foundation (China) (URLs: http://www.gdwst.gov.cn/lixiang/cj.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Center for Advanced Eye Care, a private medical practice, provided support in the form of salaries for author	Bolz M, 2009, OPHTHALMOLOGY, V116, P66, DOI 10.1016/j.ophtha.2008.09.042; Console JW, 2008, BRIT J OPHTHALMOL, V92, P1612, DOI 10.1136/bjo.2007.129932; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gupta P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096661; Ishikawa H, 1999, JPN J OPHTHALMOL, V43, P526, DOI 10.1016/S0021-5155(99)00139-2; Jiang YZ, 2010, INVEST OPHTH VIS SCI, V51, P2035, DOI 10.1167/iovs.09-4145; Jung JW, 2014, BRIT J OPHTHALMOL, V98, P207, DOI 10.1136/bjophthalmol-2013-303645; Leung CKS, 2006, ARCH OPHTHALMOL-CHIC, V124, P1395, DOI 10.1001/archopht.124.10.1395; Lin Z, 2014, J GLAUCOMA, V23, P61, DOI 10.1097/IJG.0b013e3182698094; Muller M, 2006, J CATARACT REFR SURG, V32, P1803, DOI 10.1016/j.jcrs.2006.07.014; PAVLIN CJ, 1992, AM J OPHTHALMOL, V113, P381, DOI 10.1016/S0002-9394(14)76159-8; Quigley HA, 2009, AM J OPHTHALMOL, V148, P657, DOI 10.1016/j.ajo.2009.08.009; Radhakrishnan S, 2005, ARCH OPHTHALMOL-CHIC, V123, P1053, DOI 10.1001/archopht.123.8.1053; Spaeth GL, 1997, J GLAUCOMA, V6, P13; TELLO C, 1994, INVEST OPHTH VIS SCI, V35, P3549; Wang BS, 2011, BRIT J OPHTHALMOL, V95, P46, DOI 10.1136/bjo.2009.178129; Wang BS, 2010, OPHTHALMOLOGY, V117, P11, DOI 10.1016/j.ophtha.2009.06.017	17	38	41	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120843	10.1371/journal.pone.0120843	http://dx.doi.org/10.1371/journal.pone.0120843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	26580966	gold, Green Published, Green Submitted			2022-12-27	WOS:000353889600103
